PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sakala, C; Newburn, M				Sakala, Carol; Newburn, Mary			Meeting needs of childbearing women and newborn infants through strengthened midwifery	LANCET			English	Editorial Material							HEALTH		[Sakala, Carol] Natl Partnership Women & Families, Childbirth Connect Programs, Washington, DC 20009 USA; [Newburn, Mary] NCT, London W3 6NH, England		Sakala, C (corresponding author), Natl Partnership Women & Families, Childbirth Connect Programs, Washington, DC 20009 USA.	csakala@nationalpartnership.org						Bell AF, 2014, J MIDWIFERY WOM HEAL, V59, P35, DOI 10.1111/jmwh.12101; Buckley S., 2014, HORMONAL PHYSL CHILD; Care Quality Commission, NAT FIND 2013 SURV W; Collado MC, 2012, GUT MICROBES, V3, P352, DOI 10.4161/gmic.21215; Csaba G, 2011, CLIN EPIGENETICS, V2, P187, DOI 10.1007/s13148-011-0024-8; Dahlen HG, 2013, MED HYPOTHESES, V80, P656, DOI 10.1016/j.mehy.2013.01.017; Declercq ER, 2013, LISTENING MOTHERS IL; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Halfon N, 2014, MATERN CHILD HLTH J, V18, P344, DOI 10.1007/s10995-013-1346-2; International Confederation of Midwives, 2010, ESS COMP BAS MIDW PR; Kriebel D, 2001, AM J PUBLIC HEALTH, V91, P1351, DOI 10.2105/AJPH.91.9.1351; Olza-Fernandez I, 2014, FRONT NEUROENDOCRIN, V35, P459, DOI 10.1016/j.yfrne.2014.03.007; Renfrew MJ, 2014, LANCET; UNFPA, 2014, STAT WORLDS MIDW 201	14	26	26	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					E39	E40		10.1016/S0140-6736(14)60856-4	http://dx.doi.org/10.1016/S0140-6736(14)60856-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	24965817				2022-12-24	WOS:000342630600001
J	Azzolin, L; Panciera, T; Soligo, S; Enzo, E; Bicciato, S; Dupont, S; Bresolin, S; Frasson, C; Basso, G; Guzzardo, V; Fassina, A; Cordenonsi, M; Piccolo, S				Azzolin, Luca; Panciera, Tito; Soligo, Sandra; Enzo, Elena; Bicciato, Silvio; Dupont, Sirio; Bresolin, Silvia; Frasson, Chiara; Basso, Giuseppe; Guzzardo, Vincenza; Fassina, Ambrogio; Cordenonsi, Michelangelo; Piccolo, Stefano			YAP/TAZ Incorporation in the beta-Catenin Destruction Complex Orchestrates the Wnt Response	CELL			English	Article							CELL SELF-RENEWAL; HIPPO SIGNALING PATHWAY; INTESTINAL REGENERATION; DIFFERENTIATION; INHIBITION; TAZ; TUMORIGENESIS; DISEASE; KINASE; GROWTH	The Hippo transducers YAP/TAZ have been shown to play positive, as well as negative, roles in Wnt signaling, but the underlying mechanisms remain unclear. Here, we provide biochemical, functional, and genetic evidence that YAP and TAZ are integral components of the beta-catenin destruction complex that serves as cytoplasmic sink for YAP/TAZ. In Wnt-ON cells, YAP/TAZ are physically dislodged from the destruction complex, allowing their nuclear accumulation and activation of Wnt/YAP/TAZ-dependent biological effects. YAP/TAZ are required for intestinal crypt overgrowth induced by APC deficiency and for crypt regeneration ex vivo. In Wnt-OFF cells, YAP/TAZ are essential for beta-TrCP recruitment to the complex and b-catenin inactivation. In Wnt-ON cells, release of YAP/TAZ from the complex is instrumental for Wnt/beta-catenin signaling. In line, the beta-catenin-dependent maintenance of ES cells in an undifferentiated state is sustained by loss of YAP/TAZ. This work reveals an unprecedented signaling framework relevant for organ size control, regeneration, and tumor suppression.	[Azzolin, Luca; Panciera, Tito; Soligo, Sandra; Enzo, Elena; Dupont, Sirio; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Sch Med, Dept Mol Med, I-35126 Padua, Italy; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Ctr Genome Res, Dept Biomed Sci, I-41100 Modena, Italy; [Bresolin, Silvia; Frasson, Chiara; Basso, Giuseppe] Univ Padua, Dept Paediat, I-35128 Padua, Italy; [Guzzardo, Vincenza; Fassina, Ambrogio] Univ Padua, Sch Med, Dept Med, I-35126 Padua, Italy	University of Padua; Universita di Modena e Reggio Emilia; University of Padua; University of Padua	Cordenonsi, M (corresponding author), Univ Padua, Sch Med, Dept Mol Med, Viale Colombo 3, I-35126 Padua, Italy.	michelangelo.cordenonsi@unipd.it; piccolo@bio.unipd.it	Bresolin, Silvia/K-6576-2016; BICCIATO, Silvio/J-4466-2019; Dupont, Sirio/AAP-8133-2021; Bicciato, Silvio/C-9825-2009; Azzolin, Luca/K-8012-2016; Cordenonsi, Michelangelo/K-7692-2016	Bresolin, Silvia/0000-0001-7677-7084; BICCIATO, Silvio/0000-0002-1944-7078; Bicciato, Silvio/0000-0002-1944-7078; Azzolin, Luca/0000-0002-2425-6153; Cordenonsi, Michelangelo/0000-0002-8253-5724; PICCOLO, STEFANO/0000-0002-2037-0004; Enzo, Elena/0000-0001-9768-6368; BASSO, GIUSEPPE/0000-0002-2634-9302; Panciera, Tito/0000-0002-9272-5716; Dupont, Sirio/0000-0002-6869-1966	"Young Italian Researchers'' grant from the Italian Welfare Ministry; AIRC-MFAG; Fondazione Citta della Speranza Grant; AIRC Special Program Molecular Clinical Oncology "5 per mille''; Epigenetics Flagship project CNR-Miur; HSFP; Excellence-IIT	"Young Italian Researchers'' grant from the Italian Welfare Ministry; AIRC-MFAG(Fondazione AIRC per la ricerca sul cancro); Fondazione Citta della Speranza Grant; AIRC Special Program Molecular Clinical Oncology "5 per mille''(Fondazione AIRC per la ricerca sul cancro); Epigenetics Flagship project CNR-Miur; HSFP; Excellence-IIT	We thank O. Wessely and Francesca Zanconato for comments; E. Batlle for training with crypt cultures; G. Martello and A. Smith for reagents and suggestions with ES experiments. We are indebted to the following colleagues for generously sharing transgenic mice: A. Clarke (APC fl/fl), D. J. Pan (YAP fl/fl), J. Miyazaki (CAG-Cre), and Sylvie Robine (Villin-CreERT2). We thank Lorenza Ronzani and the transgenic core facility (CFCM-San Raffaele) for TAZ conditional knockout. Axin plasmid was deposited by F. Costantini in Addgene. This work is supported by a "Young Italian Researchers'' grant from the Italian Welfare Ministry and AIRC-MFAG to M. C.; from Fondazione Citta della Speranza Grant to G. B.; from AIRC Special Program Molecular Clinical Oncology "5 per mille'' to S. P. and S. B.; from a donation in memoriam of Liana Simonutti; and from HSFP, Excellence-IIT, and Epigenetics Flagship project CNR-Miur grants to S. P.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Buske P, 2012, FEBS J, V279, P3475, DOI 10.1111/j.1742-4658.2012.08646.x; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Cordero JB, 2012, ACTA PHYSIOL, V204, P137, DOI 10.1111/j.1748-1716.2011.02288.x; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Roman AKS, 2014, STEM CELL REP, V2, P127, DOI 10.1016/j.stemcr.2013.12.012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	686	709	5	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					157	170		10.1016/j.cell.2014.06.013	http://dx.doi.org/10.1016/j.cell.2014.06.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24976009	Bronze			2022-12-24	WOS:000340943100015
J	Ben-Johny, M; Yang, PS; Niu, J; Yang, WJ; Joshi-Mukherjee, R; Yue, DT				Ben-Johny, Manu; Yang, Philemon S.; Niu, Jacqueline; Yang, Wanjun; Joshi-Mukherjee, Rosy; Yue, David T.			Conservation of Ca2+/Calmodulin Regulation across Na and Ca2+ Channels	CELL			English	Article							CA2+-DEPENDENT INACTIVATION; CA2+-SENSITIVE INACTIVATION; EF-HAND; CALMODULIN-BINDING; CALCIUM REGULATION; CA(V)1.3 CHANNELS; SKELETAL-MUSCLE; C-TERMINUS; MOTIF; DETERMINANTS	Voltage-gated Na and Ca2+ channels comprise distinct ion channel superfamilies, yet the carboxy tails of these channels exhibit high homology, hinting at a long-shared and purposeful module. For different Ca2+ channels, carboxyl-tail interactions with calmodulin do elaborate robust and similar forms of Ca2+ regulation. However, Na channels have only shown subtler Ca2+ modulation that differs among reports, challenging attempts at unified understanding. Here, by rapid Ca2+ photorelease onto Na channels, we reset this view of Na channel regulation. For cardiac-muscle channels (Na(V)1.5), reported effects from which most mechanistic proposals derive, we observe no Ca2+ modulation. Conversely, for skeletal-muscle channels (Na(V)1.4), we uncover fast Ca2+ regulation eerily similar to that of Ca2+ channels. Channelopathic myotonia mutations halve Na(V)1.4 Ca2+ regulation, and transplanting the Na(V)1.4 carboxy tail onto Ca2+ channels recapitulates Ca2+ regulation. Thus, we argue for the persistence and physiological relevance of an ancient Ca2+ regulatory module across Na and Ca2+ channels.	[Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Calcium Signals Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Ross Bldg,Room 713,720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@jhmi.edu		Ben-Johny, Manu/0000-0002-5645-0815; Joshi-Mukherjee, Rosy/0000-0003-0162-1004	NINDS; NIMH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073874] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Gordon Tomaselli, King-Wai Yau, Paul Adams, and members of the Ca<SUP>2+</SUP> signals lab for comments. Michael Tadross helped construct and advised on the use of the flash photolysis setup. We thank Dr. Yi Chen-Izu for the generous loan of a flash photolysis system and Drs. Manfred Grabner and Bernhard Flucher for GLT cells. This work was supported by grants from the NINDS (to D.T.Y.) and NIMH (M.B.J.).	Adams P. J., 2007, V45, P215; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; Bazzazi H, 2013, CELL REP, V5, P367, DOI 10.1016/j.celrep.2013.09.006; BENJOHNY M, 2012, BIOPHYS J, V102, pA125; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Biswas S, 2008, J GEN PHYSIOL, V131, P197, DOI 10.1085/jgp.200709863; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081063; Biswas S, 2009, CIRC RES, V104, P870, DOI 10.1161/CIRCRESAHA.108.193565; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Cannon SC, 1997, NEUROMUSCULAR DISORD, V7, P241, DOI 10.1016/S0960-8966(97)00430-6; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Clausen T, 2011, EXP PHYSIOL, V96, P356, DOI 10.1113/expphysiol.2010.054999; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Dunlap K, 2007, J GEN PHYSIOL, V129, P379, DOI 10.1085/jgp.200709786; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Herzog RI, 2003, J NEUROSCI, V23, P8261; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Huang H, 2012, NEURON, V73, P304, DOI 10.1016/j.neuron.2011.11.022; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Kubota T, 2009, MUSCLE NERVE, V39, P666, DOI 10.1002/mus.21155; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; Miloushev VZ, 2009, J BIOL CHEM, V284, P6446, DOI 10.1074/jbc.M807401200; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; PRESTON RR, 1991, ANNU REV PHYSIOL, V53, P309, DOI 10.1146/annurev.ph.53.030191.001521; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tadross MR, 2013, P NATL ACAD SCI USA, V110, P15794, DOI 10.1073/pnas.1313898110; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; Van Petegem F, 2012, BIOPHYS J, V103, P2243, DOI 10.1016/j.bpj.2012.10.020; Wagner Stefan, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS26, DOI 10.1111/j.1540-8167.2006.00382.x; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Wu FF, 2005, J PHYSIOL-LONDON, V565, P371, DOI 10.1113/jphysiol.2005.082909; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	64	71	73	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1657	1670		10.1016/j.cell.2014.04.035	http://dx.doi.org/10.1016/j.cell.2014.04.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949975	Bronze, Green Accepted			2022-12-24	WOS:000340941900019
J	Andersen, NN; Pasternak, B; Basit, S; Andersson, M; Svanstrom, H; Caspersen, S; Munkholm, P; Hviid, A; Jess, T				Andersen, Nynne Nyboe; Pasternak, Bjorn; Basit, Saima; Andersson, Mikael; Svanstrom, Henrik; Caspersen, Sarah; Munkholm, Pia; Hviid, Anders; Jess, Tine			Association Between Tumor Necrosis Factor-alpha Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONMELANOMA SKIN CANCERS; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; INFLIXIMAB; THERAPY; MALIGNANCIES; METAANALYSIS; MAINTENANCE; COHORT	IMPORTANCE A Cochrane review and network meta-analysis concluded that there is need for more research on adverse effects, including cancer, after treatment with tumor necrosis factor a (TNF-alpha) antagonists and that national registries and large databases would provide relevant sources of data to evaluate these effects. OBJECTIVE To investigate whether patients with inflammatory bowel disease (IBD) exposed to TNF-alpha antagonists were at increased risk of developing cancer. DESIGN, SETTING, AND PARTICIPANTS Nationwide register-based cohort study in Denmark, 1999-2012. Participants were 56 146 patients 15 years or older with IBD identified in the National Patient Registry, of whom 4553 (8.1%) were exposed to TNF-alpha antagonists. Cancer cases were identified in the Danish Cancer Registry. MAIN OUTCOMES AND MEASURES Rate ratios (RRs) for incident cancer (overall and site-specific) comparing TNF-alpha antagonist users and nonusers, estimated using Poisson regression adjusted for age, calendar year, disease duration, propensity scores, and use of other IBD medications. RESULTS During 489 433 person-years of follow-up (median, 9.3 years [interquartile range, 4.2-14.0]), 81 of 4553 patients exposed to TNF-alpha antagonists (1.8%) (median follow-up, 3.7 years [interquartile range, 1.8-6.0]) and 3465 of 51 593 unexposed patients (6.7%) developed cancer, yielding a fully adjusted RR of 1.07 (95% CI, 0.85-1.36). There was no significantly increased risk of cancer by TNF-alpha antagonist exposure. No site-specific cancers were in significant excess in fully adjusted models. [GRAPHICS] CONCLUSIONS AND RELEVANCE In this Danish nationwide study, exposure to TNF-alpha antagonists among patients with IBD was not associated with an increased risk of cancer over a median follow-up of 3.7 years among those exposed. An increased risk associated with longer-term accumulated doses and follow-up cannot be excluded.	[Andersen, Nynne Nyboe; Pasternak, Bjorn; Basit, Saima; Andersson, Mikael; Svanstrom, Henrik; Hviid, Anders; Jess, Tine] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; [Caspersen, Sarah; Munkholm, Pia] Herlev Univ Hosp, Gastroenterol Unit, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen; Herlev & Gentofte Hospital	Andersen, NN (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	nyna@ssi.dk	Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012; Munkholm, Pia/ABD-2432-2021; Andersen, Nynne Nyboe/I-1043-2019	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466; Andersen, Nynne Nyboe/0000-0003-0874-0356	Lundbeck Foundation [R83-A7812]; Danish Cancer Society [R40-A1737-11-S2]; Crohn's & Colitis Association of Denmark; Danish Council of Independent Research [09-066323]	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Crohn's & Colitis Association of Denmark; Danish Council of Independent Research(Det Frie Forskningsrad (DFF))	This study was supported by grants from the Lundbeck Foundation (R83-A7812), the Danish Cancer Society (R40-A1737-11-S2), and the Crohn's & Colitis Association of Denmark. Dr Jess holds a Female Research Leader grant (09-066323) from the Danish Council of Independent Research.	Andersen TF, 1999, DAN MED BULL, V46, P263; Askling J, 2009, ARTHRITIS RHEUM-US, V60, P3180, DOI 10.1002/art.24941; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Caspersen S, 2008, CLIN GASTROENTEROL H, V6, P1212, DOI 10.1016/j.cgh.2008.05.010; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Fidder H, 2009, GUT, V58, P501, DOI 10.1136/gut.2008.163642; Fonager K, 1996, SCAND J GASTROENTERO, V31, P154, DOI 10.3109/00365529609031980; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Haynes K, 2013, ARTHRITIS RHEUM-US, V65, P48, DOI 10.1002/art.37740; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lichtenstein GR, 2012, AM J GASTROENTEROL, V107, P1051, DOI 10.1038/ajg.2012.89; Long MD, 2012, GASTROENTEROLOGY, V143, P390, DOI 10.1053/j.gastro.2012.05.004; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Moulis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048991; Osterman MT, 2014, GASTROENTEROLOGY, V146, P941, DOI 10.1053/j.gastro.2013.12.025; Pasternak B, 2013, AM J EPIDEMIOL, V177, P1296, DOI 10.1093/aje/kws375; Pedersen CB, 2006, DAN MED BULL, V53, P441; Peyrin-Biroulet L, 2011, GASTROENTEROLOGY, V141, P1621, DOI 10.1053/j.gastro.2011.06.050; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Setshedi M, 2012, J GASTROEN HEPATOL, V27, P385, DOI 10.1111/j.1440-1746.2011.06865.x; Singh H, 2011, GASTROENTEROLOGY, V141, P1612, DOI 10.1053/j.gastro.2011.07.039; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Storm HH, 1997, DAN MED BULL, V44, P535; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; van Schaik FDM, 2011, CLIN GASTROENTEROL H, V9, P449, DOI 10.1016/j.cgh.2011.01.021; Williams CJM, 2014, ALIMENT PHARM THER, V39, P447, DOI 10.1111/apt.12624	31	160	162	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2406	2413		10.1001/jama.2014.5613	http://dx.doi.org/10.1001/jama.2014.5613			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938563	Bronze			2022-12-24	WOS:000337301500021
J	Mazur, PK; Reynoird, N; Khatri, P; Jansen, PWTC; Wilkinson, AW; Liu, SC; Barbash, O; Van Aller, GS; Huddleston, M; Dhanak, D; Tummino, PJ; Kruger, RG; Garcia, BA; Butte, AJ; Vermeulen, M; Sage, J; Gozani, O				Mazur, Pawel K.; Reynoird, Nicolas; Khatri, Purvesh; Jansen, Pascal W. T. C.; Wilkinson, Alex W.; Liu, Shichong; Barbash, Olena; Van Aller, Glenn S.; Huddleston, Michael; Dhanak, Dashyant; Tummino, Peter J.; Kruger, Ryan G.; Garcia, Benjamin A.; Butte, Atul J.; Vermeulen, Michiel; Sage, Julien; Gozani, Or			SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer	NATURE			English	Article							HISTONE METHYLTRANSFERASE; LUNG-CANCER; GROWTH-FACTOR; MOUSE MODEL; ACTIVATION; PROTEIN; PROGRESSION; KINASE; IDENTIFICATION; CHROMATIN	Deregulation of lysine methylation signalling has emerged as a common aetiological factor in cancer pathogenesis, with inhibitors of several histone lysine methyltransferases (KMTs) being developed as chemotherapeutics(1). The largely cytoplasmic KMT SMYD3 (SET and MYND domain containing protein 3) is overexpressed in numerous human tumours(2-4). However, the molecular mechanism by which SMYD3 regulates cancer pathways and its relationship to tumor-igenesisin vivo are largely unknown. Here we show that methylation of MAP3K2 by SMYD3 increases MAP kinase signalling and promotes the formation of Ras-driven carcinomas. Using mouse models for pancreatic ductal adenocarcinoma and lung adenocarcinoma, we found that abrogating SMYD3 catalytic activity inhibits tumour development in response to oncogenic Ras. We used protein array technology to identify the MAP3K2 kinase as a target of SMYD3. In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis. Finally, the PP2A phosphatase complex, a key negative regulator of the MAP kinase pathway, binds to MAP3K2 and this interaction is blocked by methylation. Together, our results elucidate a new role for lysine methylation in integrating cytoplasmic kinase-signalling cascades and establish a pivotal role for SMYD3 in the regulation of oncogenic Ras signalling.	[Mazur, Pawel K.; Butte, Atul J.; Sage, Julien] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Mazur, Pawel K.; Butte, Atul J.; Sage, Julien] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Reynoird, Nicolas; Wilkinson, Alex W.; Gozani, Or] Stanford Univ, Dept Biol, Sch Med, Stanford, CA 94305 USA; [Khatri, Purvesh] Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA; [Khatri, Purvesh] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Jansen, Pascal W. T. C.; Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Mol Canc Res, NL-3508 AB Utrecht, Netherlands; [Jansen, Pascal W. T. C.; Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3508 AB Utrecht, Netherlands; [Liu, Shichong; Garcia, Benjamin A.] Univ Penn, Epigenet Program, Philadelphia, PA 19104 USA; [Liu, Shichong; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barbash, Olena; Van Aller, Glenn S.; Huddleston, Michael; Dhanak, Dashyant; Tummino, Peter J.; Kruger, Ryan G.] GlaxoSmithKline, Oncol R&D, Canc Epigenet DPU, Collegeville, PA 19426 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; GlaxoSmithKline	Sage, J (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	julsage@stanford.edu; ogozani@stanford.edu	reynoird, nicolas/M-7568-2017; Vermeulen, Michiel/C-8883-2013; Reynoird, Nicolas/AAX-4043-2020; Mazur, Pawel K./AAU-6343-2021	reynoird, nicolas/0000-0003-1578-2781; Vermeulen, Michiel/0000-0003-0836-6894; Reynoird, Nicolas/0000-0003-1578-2781; Mazur, Pawel K./0000-0002-5820-8344; Gozani, Or/0000-0002-1365-4463; Khatri, Purvesh/0000-0002-4143-4708	NIH [RO1 CA172560]; NIH from the Office of the Director for B.A.G. [DP2 OD007447]; NWO-VIDI; Tobacco-Related Disease Research Program; Stanford University; Child Health Research Institute; Lucile Packard Foundation for Children's Health at Stanford; Fondation pour la Recherche Medicale; NATIONAL CANCER INSTITUTE [R01CA172560, P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the Office of the Director for B.A.G.; NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); Tobacco-Related Disease Research Program(University of California System); Stanford University(Stanford University); Child Health Research Institute; Lucile Packard Foundation for Children's Health at Stanford; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Gozani and Sage laboratories for critical reading of the manuscript, A. Smits for help with mass spectrometry data visualization and P.J. Utz and the Floren Family Trust for providing ProtoArrays. This work was supported in part by grants from the NIH to O.G. and J.S. (RO1 CA172560) and an NIH Innovator grant (DP2 OD007447) from the Office of the Director for B.A.G.; M. V. was supported by a grant from NWO-VIDI, P. K. M. was supported by the Tobacco-Related Disease Research Program, a Dean's Fellowship from Stanford University, and the Child Health Research Institute and Lucile Packard Foundation for Children's Health at Stanford. N.R. was supported by a grant from the Fondation pour la Recherche Medicale. J.S. is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases.	Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; BRUNET A, 1994, ONCOGENE, V9, P3379; Choi MC, 2012, MOL CELL, V47, P122, DOI 10.1016/j.molcel.2012.04.025; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Enomoto A, 2008, ONCOGENE, V27, P1930, DOI 10.1038/sj.onc.1210828; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Gaedcke J, 2010, GENE CHROMOSOME CANC, V49, P1024, DOI 10.1002/gcc.20811; Green EM, 2012, NAT STRUCT MOL BIOL, V19, P361, DOI 10.1038/nsmb.2252; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Heid I, 2011, GASTROENTEROLOGY, V141, P719, DOI 10.1053/j.gastro.2011.04.043; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Levy D, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-19; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Maruyama T, 2010, EMBO J, V29, P2501, DOI 10.1038/emboj.2010.141; Matitau AE, 2013, J BIOL CHEM, V288, P28293, DOI 10.1074/jbc.M113.511352; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Van Aller GS, 2012, EPIGENETICS-US, V7, P340, DOI 10.4161/epi.19506; Watanabe T, 2011, EUR J CANCER, V47, P1946, DOI 10.1016/j.ejca.2011.03.029; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	48	255	266	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					283	+		10.1038/nature13320	http://dx.doi.org/10.1038/nature13320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24847881	Green Accepted, Green Submitted			2022-12-24	WOS:000337032400053
J	Ludwig, DS; Friedman, MI				Ludwig, David S.; Friedman, Mark I.			Increasing Adiposity Consequence or Cause of Overeating?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WEIGHT-LOSS MAINTENANCE; ENERGY-EXPENDITURE; GLYCEMIC INDEX; OBESITY; FAT		[Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Friedman, Mark I.] Nutr Sci Initiat, San Diego, CA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ludwig, DS (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730, P30DK040561] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24 DK082730, P30 DK040561] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1924, JAMA, V83, P1003; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; FRIEDMAN MI, 1976, PSYCHOL REV, V83, P409, DOI 10.1037/0033-295X.83.6.409; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Taubes G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1050; Walsh CO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058172	10	92	94	2	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2167	2168		10.1001/jama.2014.4133	http://dx.doi.org/10.1001/jama.2014.4133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24839118				2022-12-24	WOS:000336668400012
J	Friend, SH; Schadt, EE				Friend, Stephen H.; Schadt, Eric E.			Clues from the resilient	SCIENCE			English	Editorial Material							GENETIC-VARIATION; CYSTIC-FIBROSIS; DISEASE		[Friend, Stephen H.] Sage Bionetworks, Seattle, WA 98109 USA; [Friend, Stephen H.; Schadt, Eric E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Friend, Stephen H.; Schadt, Eric E.] Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Friend, SH (corresponding author), Sage Bionetworks, Seattle, WA 98109 USA.	friend@sagebase.org; eric.schadt@exchange.mssm.edu						Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Gorry PR, 2002, LANCET, V359, P1832, DOI 10.1016/S0140-6736(02)08681-6; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartman JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r49; Hartman JL, 2007, P NATL ACAD SCI USA, V104, P11700, DOI 10.1073/pnas.0705212104; Hood L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008665; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kaiser J, 2014, SCIENCE, V344, P687, DOI 10.1126/science.344.6185.687; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Stenson Peter D, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s39; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	16	32	32	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					970	972		10.1126/science.1255648	http://dx.doi.org/10.1126/science.1255648			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876479				2022-12-24	WOS:000336495800020
J	Luquero, FJ; Grout, L; Ciglenecki, I; Sakoba, K; Traore, B; Heile, M; Diallo, AA; Itama, C; Page, AL; Quilici, ML; Mengel, MA; Eiros, JM; Serafini, M; Legros, D; Grais, RF				Luquero, Francisco J.; Grout, Lise; Ciglenecki, Iza; Sakoba, Keita; Traore, Bala; Heile, Melat; Diallo, Alpha Amadou; Itama, Christian; Page, Anne-Laure; Quilici, Marie-Laure; Mengel, Martin A.; Maria Eiros, Jose; Serafini, Micaela; Legros, Dominique; Grais, Rebecca F.			Use of Vibrio cholerae Vaccine in an Outbreak in Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MASS VACCINATION; CONTROLLED-TRIAL; BANGLADESH; CAMPAIGN; EPIDEMIC; EFFICACY; KOLKATA; BURDEN; INDIA	BACKGROUND The use of vaccines to prevent and control cholera is currently under debate. Shanchol is one of the two oral cholera vaccines prequalified by the World Health Organization; however, its effectiveness under field conditions and the protection it confers in the first months after administration remain unknown. The main objective of this study was to estimate the short-term effectiveness of two doses of Shanchol used as a part of the integrated response to a cholera outbreak in Africa. METHODS We conducted a matched case-control study in Guinea between May 20 and October 19, 2012. Suspected cholera cases were confirmed by means of a rapid test, and controls were selected among neighbors of the same age and sex as the case patients. The odds of vaccination were compared between case patients and controls in bivariate and adjusted conditional logistic-regression models. Vaccine effectiveness was calculated as (1-odds ratio) x 100. RESULTS Between June 8 and October 19, 2012, we enrolled 40 case patients and 160 controls in the study for the primary analysis. After adjustment for potentially confounding variables, vaccination with two complete doses was associated with significant protection against cholera (effectiveness, 86.6%; 95% confidence interval, 56.7 to 95.8; P=0.001). CONCLUSIONS In this study, Shanchol was effective when used in response to a cholera outbreak in Guinea. This study provides evidence supporting the addition of vaccination as part of the response to an outbreak. It also supports the ongoing efforts to establish a cholera vaccine stockpile for emergency use, which would enhance outbreak prevention and control strategies. (Funded by Medecins sans Frontieres.)	[Luquero, Francisco J.; Grout, Lise; Page, Anne-Laure; Grais, Rebecca F.] Epictr, F-75011 Paris, France; [Sakoba, Keita; Mengel, Martin A.] Agence Med Prevent, African Cholera Surveillance Network, Paris, France; [Quilici, Marie-Laure] Inst Pasteur, Natl Reference Ctr Vibrios & Cholera, Enter Bacterial Pathogens Res & Expertise Unit, Paris, France; [Grout, Lise; Ciglenecki, Iza; Serafini, Micaela; Legros, Dominique] Med Sans Frontieres, Geneva, Switzerland; [Sakoba, Keita] Minist Hlth, Conakry, Guinea; [Traore, Bala] Minist Hlth, Direct Prefectorale Sante, Conakry, Guinea; [Diallo, Alpha Amadou] Minist Hlth, Res & Documentat Serv, Conakry, Guinea; [Heile, Melat] Med Sans Frontieres, Conakry, Guinea; [Itama, Christian] WHO, Conakry, Guinea; [Maria Eiros, Jose] Univ Valladolid, Dept Microbiol, Valladolid, Spain	Agence de Medecine Preventive; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Doctors Without Borders; World Health Organization; Universidad de Valladolid	Luquero, FJ (corresponding author), Epictr, 8 Rue St Sabin, F-75011 Paris, France.	francisco.luquero@epicentre.msf.org		Eiros, Jose M/0000-0002-5357-6340; Freeman Grais, Rebecca/0000-0002-5037-8218	Medecins sans Frontieres; Division of Disease Prevention and Control of the Ministry of Health of Guinea, Africhol; Institut Pasteur; French Institute for Public Health Surveillance	Medecins sans Frontieres; Division of Disease Prevention and Control of the Ministry of Health of Guinea, Africhol; Institut Pasteur(European Commission); French Institute for Public Health Surveillance	Supported by Medecins sans Frontieres.; We thank the people of Guinea for their support and participation in the conduct of this survey; the Division of Disease Prevention and Control of the Ministry of Health of Guinea, Africhol, and all the district health and medical officers involved in the study for their support; Jean Rauzier for the work performed at the French National Reference Center for Vibrios and Cholera, which is funded by the Institut Pasteur and the French Institute for Public Health Surveillance; Charles Gaudry, head of mission for Medecins sans Frontieres in Guinea, and the emergency coordinators, logisticians, and administrative staff of the Medecins sans Frontieres Geneva operational center for their patience and enthusiastic support; the study teams and the Medecins sans Frontieres teams in Boffa and Forecariah, especially the research assistants Drs. Soumah Abubacar and Oumar Toure; and Dr. Pedro Pablo Palma, medical director of the Medecins sans Frontieres Barcelona-Athens operational center, for his comments and insight into this project and his continuing support.	AHMED ZU, 1994, MICROBIOL IMMUNOL, V38, P837, DOI 10.1111/j.1348-0421.1994.tb02135.x; Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Ali M, 2013, CLIN INFECT DIS, V56, P1123, DOI 10.1093/cid/cit009; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bhattacharya SK, 2013, LANCET INFECT DIS, V13, P1011, DOI 10.1016/S1473-3099(13)70347-5; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512; CLEMENS JD, 1986, LANCET, V2, P124; Dorlencourt F, 1999, B WORLD HEALTH ORGAN, V77, P949; Fournier J. M., 1992, LAB METHODS DIAGNOSI, P59; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Hoshino K, 1998, FEMS IMMUNOL MED MIC, V20, P201, DOI 10.1111/j.1574-695X.1998.tb01128.x; Khatib AM, 2012, LANCET INFECT DIS, V12, P837, DOI 10.1016/S1473-3099(12)70196-2; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Luquero FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002465; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Martin S, 2012, B WORLD HEALTH ORGAN, V90, P714, DOI 10.2471/BLT.12.112433; Martinez-Pino I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002366; Medecins Sans Frontieres, 2004, CHOL GUID, V2nd; Page AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037360; Pastor M, 2013, VACCINE, V31, P4069, DOI 10.1016/j.vaccine.2013.06.096; Shin S, 2011, CLIN INFECT DIS, V52, P1343, DOI 10.1093/cid/cir141; Sur D, 2010, LANCET, V376, P1392; Sur D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001289; World Health Organisation, 2010, CHOL OUTBR ASS OUTBR, pWorld health organisation; World Health Organization, 2010, 1 STEPS MAN OUTBR AC; Zuckerman JN, 2007, LANCET INFECT DIS, V7, P521, DOI 10.1016/S1473-3099(07)70138-X	30	105	106	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2111	2120		10.1056/NEJMoa1312680	http://dx.doi.org/10.1056/NEJMoa1312680			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9BM	24869721	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000336434000009
J	Hakim, AM				Hakim, Antoine M.			PERSPECTIVE Silent, but preventable, perils	NATURE			English	Editorial Material							VASCULAR DEMENTIA; STROKE		[Hakim, Antoine M.] Ottawa Hosp, Res Inst, Canadian Stroke Network, Ottawa, ON, Canada; [Hakim, Antoine M.] Ottawa Hosp, Res Inst, Neurosci Res Program, Ottawa, ON, Canada; [Hakim, Antoine M.] Univ Ottawa Canada, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Hakim, AM (corresponding author), Ottawa Hosp, Res Inst, Canadian Stroke Network, Ottawa, ON, Canada.	ahakim@ohri.ca						Aguero-Torres H, 2006, DEMENT GERIATR COGN, V22, P244, DOI 10.1159/000094973; [Anonymous], 2010, POP PROJ CAN PROV TE; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Leary MC, 2003, CEREBROVASC DIS, V16, P280, DOI 10.1159/000071128; Neltner JH, 2014, BRAIN, V137, P255, DOI 10.1093/brain/awt318; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pergola P. E., 2014, AM J HYPERTENS; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278	9	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S12	S12		10.1038/510S12a	http://dx.doi.org/10.1038/510S12a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964022	Bronze			2022-12-24	WOS:000337806300008
J	Wang, T; Sha, HY; Ji, DM; Zhang, HL; Chen, DW; Cao, YX; Zhu, JH				Wang, Tian; Sha, Hongying; Ji, Dongmei; Zhang, Helen L.; Chen, Dawei; Cao, Yunxia; Zhu, Jianhong			Polar Body Genome Transfer for Preventing the Transmission of Inherited Mitochondrial Diseases	CELL			English	Article							MOUSE EMBRYOS; PREIMPLANTATION EMBRYOS; POINT MUTATIONS; MTDNA MUTATIONS; HUMAN OOCYTES; DIGITAL PCR; DNA; METHYLATION; SEGREGATION; BODIES	Inherited mtDNA diseases transmit maternally and cause severe phenotypes. Currently, there is no effective therapy or genetic screens for these diseases; however, nuclear genome transfer between patients' and healthy eggs to replace mutant mtDNAs holds promises. Considering that a polar body contains few mitochondria and shares the same genomic material as an oocyte, we perform polar body transfer to prevent the transmission of mtDNA variants. We compare the effects of different types of germline genome transfer, including spindle-chromosome transfer, pronuclear transfer, and first and second polar body transfer, in mice. Reconstructed embryos support normal fertilization and produce live offspring. Importantly, genetic analysis confirms that the F1 generation from polar body transfer possesses minimal donor mtDNA carryover compared to the F1 generation from other procedures. Moreover, the mtDNA genotype remains stable in F2 progeny after polar body transfer. Our preclinical model demonstrates polar body transfer has great potential to prevent inherited mtDNA diseases.	[Wang, Tian; Sha, Hongying; Zhu, Jianhong] Fudan Univ, Inst Brain Sci, Sch Basic Med Sci, Dept Neurobiol, Shanghai 200032, Peoples R China; [Wang, Tian; Sha, Hongying; Zhu, Jianhong] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, Shanghai 200032, Peoples R China; [Ji, Dongmei; Chen, Dawei; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Ctr Reprod Med, Dept Obstet & Gynecol, Hefei 230022, Peoples R China; [Zhang, Helen L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Fudan University; Fudan University; Anhui Medical University; Harvard University; Harvard Medical School	Sha, HY (corresponding author), Fudan Univ, Inst Brain Sci, Sch Basic Med Sci, Dept Neurobiol, Shanghai 200032, Peoples R China.	shahongying@fudan.edu.cn; jzhu@fudan.edu.cn	Wang, Tian/AAX-8754-2021; Chen, Dawei/V-4296-2019	Chen, Dawei/0000-0002-8201-0549	National Basic Research Program of China [2010CB945500, 2012CB966304, 2012CB944704]; Shanghai Municipality Project [11JC1401000]; National NSF [81271003]; Shanghai Medical College Accelerated Eight-Year Program (Zhengyi Scholarship) [2011S06]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipality Project; National NSF(National Natural Science Foundation of China (NSFC)); Shanghai Medical College Accelerated Eight-Year Program (Zhengyi Scholarship)	We are grateful to Dr. Bin Lai (Fudan) for assisting confocal analysis, Yimin Tian (Shanghai Geneland Biotech) for help with pyrosequencing, and Drs. Hongkui Deng (Peking University), Dangsheng Li (SIBCB), and Alastair Murchie (Fudan) for critical reading of the manuscript. This study was supported by grants from National Basic Research Program of China (2010CB945500 to J.Z., 2012CB966304 to H.S., 2012CB944704 to Y.C.), Shanghai Municipality Project (11JC1401000 to H.S.), National NSF grant (81271003 to J.Z.) and Shanghai Medical College Accelerated Eight-Year Program (Zhengyi Scholarship 2011S06 to T.W.).	Ballana E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/humu.20639; BIEBER FR, 1981, SCIENCE, V213, P775, DOI 10.1126/science.7196086; Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358; Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232; Christopikou D, 2013, HUM REPROD, V28, P1426, DOI 10.1093/humrep/det053; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; FDA: Cellular Tissue and Gene Therapies Advisory Committee, 2014, BRIEF DOC OOC MOD AS; Geraedts J, 2011, HUM REPROD, V26, P3173, DOI 10.1093/humrep/der294; Gigarel N, 2011, AM J HUM GENET, V88, P494, DOI 10.1016/j.ajhg.2011.03.010; Gu L, 2010, CELL CYCLE, V9, P1942, DOI 10.4161/cc.9.10.11599; HFEA, 2012, MIT PUBL CONS 2012 M; Hino T, 2013, J ASSIST REPROD GEN, V30, P91, DOI 10.1007/s10815-012-9899-3; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; HOULISTON E, 1988, DEVELOPMENT, V102, P271; HUTCHISO.CA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Link J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003261; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Lorthongpanich C, 2013, SCIENCE, V341, P1110, DOI 10.1126/science.1240617; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; Meirelles FV, 1997, GENETICS, V145, P445; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wakayama S, 2007, STEM CELLS, V25, P986, DOI 10.1634/stemcells.2006-0615; Wakayama T, 1997, J REPROD FERTIL, V110, P263, DOI 10.1530/jrf.0.1100263; Wakayama T, 1998, BIOL REPROD, V59, P100, DOI 10.1095/biolreprod59.1.100; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190	48	105	120	8	101	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1591	1604		10.1016/j.cell.2014.04.042	http://dx.doi.org/10.1016/j.cell.2014.04.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949971	Bronze			2022-12-24	WOS:000340941900014
J	Cunningham, JT; Moreno, MV; Lodi, A; Ronen, SM; Ruggero, D				Cunningham, John T.; Moreno, Melissa V.; Lodi, Alessia; Ronen, Sabrina M.; Ruggero, Davide			Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer	CELL			English	Article							INITIATION-FACTOR 4E; C-MYC; METABOLISM; MTOR; TRANSLATION; ACTIVATION; MOUSE; SUPPRESSION; INHIBITION; EXPRESSION	Cancer cells must integrate multiple biosynthetic demands to drive indefinite proliferation. How these key cellular processes, such as metabolism and protein synthesis, crosstalk to fuel cancer cell growth is unknown. Here, we uncover the mechanism by which the Myc oncogene coordinates the production of the two most abundant classes of cellular macromolecules, proteins, and nucleic acids in cancer cells. We find that a single rate-limiting enzyme, phosphoribosyl- pyrophosphate synthetase 2 (PRPS2), promotes increased nucleotide biosynthesis in Myc-transformed cells. Remarkably, Prps2 couples protein and nucleotide biosynthesis through a specialized cis-regulatory element within the Prps2 50 UTR, which is controlled by the oncogene and translation initiation factor eIF4E downstream Myc activation. We demonstrate with a Prps2 knockout mouse that the nexus between protein and nucleotide biosynthesis controlled by PRPS2 is crucial for Myc-driven tumorigenesis. Together, these studies identify a translationally anchored anabolic circuit critical for cancer cell survival and an unexpected vulnerability for ``undruggable'' oncogenes, such as Myc.	[Cunningham, John T.; Moreno, Melissa V.; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA; [Cunningham, John T.; Moreno, Melissa V.; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Lodi, Alessia; Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Ruggero, D (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA.	davide.ruggero@ucsf.edu	Cunningham, John T./AAS-5008-2021	Cunningham, John T./0000-0001-6490-4533	NIH [R01 CA130812, R01 CA154915, R01CA140456, R01CA154916, U01HG004085]; American Cancer Society [121364-PF-11-184-01-TBG]; Children's Hospital Oakland Research Institute (CHORI)/Sanger/UC Davis Consortium [U01HG004080]; KOMP Repository at UC Davis and CHORI [U42RR024244]; NATIONAL CANCER INSTITUTE [R01CA154916, R01CA154915, R01CA140456] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004085, U01HG004080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Children's Hospital Oakland Research Institute (CHORI)/Sanger/UC Davis Consortium; KOMP Repository at UC Davis and CHORI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Maria Barna and Kevan Shokat for helpful discussions and their critical reading of the manuscript. D. R. is a Leukemia and Lymphoma Society Scholar. This work was supported by NIH (R01 CA130812 and R01 CA154915 to S. M. R. and R01CA140456 and R01CA154916 to D. R.) and the American Cancer Society (121364-PF-11-184-01-TBG to J.T.C.). NIH grants to Velocigene at Regeneron (U01HG004085) and the Children's Hospital Oakland Research Institute (CHORI)/Sanger/UC Davis Consortium (U01HG004080) funded the generation of gene-targeted ES cells for 8,500 genes in the KOMP Program and archived and distributed by the KOMP Repository at UC Davis and CHORI (U42RR024244). J.T.C. and D.R. are joint inventors on a UC Regents-owned patent application covering these molecules that has been licensed to eFFECTOR Therapeutics. D.R. is a shareholder of eFFECTOR Therapeutics and a member of its scientific advisory board.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; BECKER MA, 1990, GENOMICS, V8, P555, DOI 10.1016/0888-7543(90)90043-T; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; BOSS GR, 1982, J BIOL CHEM, V257, P4242; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Dang Chi V, 2010, Genes Cancer, V1, P526; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GEYER PK, 1982, MOL CELL BIOL, V2, P685, DOI 10.1128/MCB.2.6.685; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Graves JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013717; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh AC, 2010, CLIN CANCER RES, V16, P4914, DOI 10.1158/1078-0432.CCR-10-0433; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pourdehnada M, 2013, P NATL ACAD SCI USA, V110, P11988, DOI 10.1073/pnas.1310230110; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Ronen SM, 2001, BRIT J CANCER, V84, P691, DOI 10.1054/bjoc.2000.1663; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8	47	147	156	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1088	1103		10.1016/j.cell.2014.03.052	http://dx.doi.org/10.1016/j.cell.2014.03.052			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855946	Bronze, Green Accepted			2022-12-24	WOS:000336437200012
J	Humphrey, JD; Milewicz, DM; Tellides, G; Schwartz, MA				Humphrey, Jay D.; Milewicz, Dianna M.; Tellides, George; Schwartz, Martin A.			Dysfunctional Mechanosensing in Aneurysms	SCIENCE			English	Editorial Material							SMOOTH-MUSCLE-CELLS; HOMEOSTASIS; COLLAGEN; FOCUS		[Humphrey, Jay D.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Tellides, George] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Schwartz, Martin A.] Yale Univ, Sch Med, Cardiovasc Res Ctr, New Haven, CT USA	Yale University; University of Texas System; University of Texas Health Science Center Houston; Yale University; Yale University	Humphrey, JD (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	martin.schwartz@yale.edu		schwartz, martin/0000-0002-2071-1243	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109942, R01HL075092, P01HL110869] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075092, P01 HL110869, R01 HL109942] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dajnowiec D, 2007, CLIN SCI, V113, P15, DOI 10.1042/CS20060337; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Forte A, 2010, CARDIOVASC RES, V88, P395, DOI 10.1093/cvr/cvq224; Humphrey JD, 2008, CELL BIOCHEM BIOPHYS, V50, P53, DOI 10.1007/s12013-007-9002-3; Kuang SQ, 2013, ARTERIOSCL THROM VAS, V33, P2172, DOI 10.1161/ATVBAHA.113.301624; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Li Q, 1998, J VASC RES, V35, P93, DOI 10.1159/000025570; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066	12	99	100	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					476	478		10.1126/science.1253026	http://dx.doi.org/10.1126/science.1253026			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786066	Green Accepted			2022-12-24	WOS:000335157700027
J	Morris, SC; Caron, JB				Morris, Simon Conway; Caron, Jean-Bernard			A primitive fish from the Cambrian of North America	NATURE			English	Article							PIKAIA-GRACILENS WALCOTT; BURGESS SHALE; VERTEBRATE JAW; EVOLUTION; CHORDATE; LAMPREY; ANATOMY	Knowledge of the early evolution of fish largely depends on soft-bodied material from the Lower (Series 2) Cambrian period of South China(1,2). Owing to the rarity of some of these forms and a general lack of comparative material from other deposits, interpretations of various features remain controversial(3,4), as do their wider relationships amongst post-Cambrian early un-skeletonized jawless vertebrates. Here we redescribe Metaspriggina(5) on the basis of new material from the Burgess Shale and exceptionally preserved material collected near Marble Canyon, British Columbia(6), and three other Cambrian Burgess Shale-type deposits from Laurentia. This primitive fish displays unambiguous vertebrate features: a notochord, a pair of prominent camera-type eyes, paired nasal sacs, possible cranium and arcualia, W-shaped myomeres, and a post-anal tail. A striking feature is the branchial area with an array of bipartite bars. Apart from the anterior most bar, which appears to be slightly thicker, each is associated with externally located gills, possibly housed in pouches. Phylogenetic analysis places Metaspriggina as a basal vertebrate, apparently close to the Chengjiang taxa Haikouichthys(1-4) and Myllokunmingia(1), demonstrating also that this primitive group of fish was cosmopolitan during Lower-Middle Cambrian times (Series 2-3). However, the arrangement of the branchial region in Metaspriggina has wider implications for reconstructing the morphology of the primitive vertebrate. Each bipartite bar is identified as being respectively equivalent to an epibranchial and ceratobranchial. This configuration suggests that a bipartite arrangement is primitive and reinforces the view that the branchial basket of lampreys(7) is probably derived. Other features of Metaspriggina, including the external position of the gills and possible absence of a gill opposite the more robust anterior-most bar, are characteristic of gnathostomes(8) and so may be primitive within vertebrates.	[Morris, Simon Conway] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada; [Caron, Jean-Bernard] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada	University of Cambridge; Royal Ontario Museum; University of Toronto	Morris, SC (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	sc113@cam.ac.uk; jcaron@rom.on.ca		Caron, Jean-Bernard/0000-0002-1670-5502	Department of Earth Sciences and St John's College, Cambridge; Natural Sciences and Engineering Research Council [341944]; Royal Ontario Museum [53]	Department of Earth Sciences and St John's College, Cambridge; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Ontario Museum	We thank T. Lacalli for comments on an earlier draft of the manuscript,J. Mallatt for an extensive series of critiques, and J. Hoyal-Cuthill and C. Aria for assistance with phylogenetic analyses. We also thank M. Collins for technical drawings and reconstructions, and R. Thomas and M. Webster for information on the Kinzers and Parker formations, respectively. S.C.M. thanks V. Brown for manuscript preparation, and the Department of Earth Sciences and St John's College, Cambridge for support. We thank Parks Canada for granting a collection and research permit to J.-B.C. (YNP-2012-12054). Fieldwork support for the 2012 expedition comes from the Royal Ontario Museum (DMV Research and Acquisition Fund and DNH Fieldwork Fund), M. Streng (Uppsala University and the Swedish Research Council), R. Gaines (Pomona College), G. Mangano (University of Saskatchewan) and a Natural Sciences and Engineering Research Council Discovery Grant (to J.-B.C., #341944). This is Royal Ontario Museum Burgess Shale project number 53.	Caron JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4210; Depew MJ, 2008, J EXP ZOOL PART B, V310B, P315, DOI 10.1002/jez.b.21205; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; Gillis JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2429; Hou XG, 2002, P ROY SOC B-BIOL SCI, V269, P1865, DOI 10.1098/rspb.2002.2104; Janvier P, 2006, NATURE, V440, P1183, DOI 10.1038/nature04471; Janvier P, 1996, OXFORD MONOGRAPHS GE, V33; Janvier P, 2007, GEODIVERSITAS, V29, P143; Johnston KJ, 2009, PALAEOGEOGR PALAEOCL, V277, P106, DOI 10.1016/j.palaeo.2009.02.015; Kuratani S, 2005, J ANAT, V207, P489, DOI 10.1111/j.1469-7580.2005.00483.x; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Lacalli T, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-12; MALLATT J, 1984, J ZOOL, V204, P169; Mallatt J, 2013, J EXP ZOOL PART B, V320B, P247, DOI 10.1002/jez.b.22500; Martin WM, 2009, DEV DYNAM, V238, P3126, DOI 10.1002/dvdy.22164; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; MORRIS SC, 1993, PALAEONTOLOGY, V36, P593; Morris SC, 2008, J PALEONTOL, V82, P424, DOI 10.1666/06-130.1; Morris SC, 2012, BIOL REV, V87, P480, DOI 10.1111/j.1469-185X.2012.00220.x; Nichols JT, 2013, DEVELOPMENT, V140, P2765, DOI 10.1242/dev.090639; Sansom RS, 2013, PALAEONTOLOGY, V56, P457, DOI 10.1111/pala.12037; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Van Leeuwen JL, 1999, J EXP BIOL, V202, P3405; Webster M, 2009, MEM ASSOC AUSTRALAS, V37, P369; Zhang XG, 2004, J EVOLUTION BIOL, V17, P1162, DOI 10.1111/j.1420-9101.2004.00741.x	27	94	94	2	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					419	U413		10.1038/nature13414	http://dx.doi.org/10.1038/nature13414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	24919146				2022-12-24	WOS:000340840600031
J	New, K; Konstantopoulos, A; Arulkumaran, S; Day-Stirk, F				New, Karen; Konstantopoulos, Andreas; Arulkumaran, Sabaratnam; Day-Stirk, Frances			Every Newborn: the professional organisations' perspective	LANCET			English	Editorial Material									[New, Karen] Council Int Neonatal Nurses, Boston, MA 02131 USA; [Konstantopoulos, Andreas] Int Pediat Assoc, Elk Grove Village, IL USA; [Arulkumaran, Sabaratnam] Int Federat Gynecol & Obstet, London, England; [Day-Stirk, Frances] Int Confederat Midw, The Hague, Netherlands		New, K (corresponding author), Council Int Neonatal Nurses, Boston, MA 02131 USA.	karennew@coinnurses.org	New, Karen/E-7548-2011	New, Karen/0000-0002-6196-2452				Bhutta ZA, 2014, LANCET; Darmstadt GL, 2014, LANCET; Dickson KE, 2014, LANCET; Lawn JE, 2014, LANCET; Mason E, 2014, LANCET; Save the Children, 2013, SURV 1 DAY STAT WORL; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; World Health Organization, 2014, EV NEWB ACT PLAN END; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	9	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					E25	E26		10.1016/S0140-6736(14)60692-9	http://dx.doi.org/10.1016/S0140-6736(14)60692-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24853602				2022-12-24	WOS:000338921500003
J	Wang, LH; Yamaguchi, S; Burstein, MD; Terashima, K; Chang, K; Ng, HK; Nakamura, H; He, ZX; Doddapaneni, H; Lewis, L; Wang, M; Suzuki, T; Nishikawa, R; Natsume, A; Terasaka, S; Dauser, R; Whitehead, W; Adekunle, A; Sun, JY; Qiao, Y; Marth, G; Muzny, DM; Gibbs, RA; Leal, SM; Wheeler, DA; Lau, CC				Wang, Linghua; Yamaguchi, Shigeru; Burstein, Matthew D.; Terashima, Keita; Chang, Kyle; Ng, Ho-Keung; Nakamura, Hideo; He, Zongxiao; Doddapaneni, Harshavardhan; Lewis, Lora; Wang, Mark; Suzuki, Tomonari; Nishikawa, Ryo; Natsume, Atsushi; Terasaka, Shunsuke; Dauser, Robert; Whitehead, William; Adekunle, Adesina; Sun, Jiayi; Qiao, Yi; Marth, Gabor; Muzny, Donna M.; Gibbs, Richard A.; Leal, Suzanne M.; Wheeler, David A.; Lau, Ching C.			Novel somatic and germline mutations in intracranial germ cell tumours	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SEQUENCING DATA; CANCER-CELLS; LUNG-CANCER; SNP ARRAYS; GENE; RESISTANCE; VARIANTS; COMMON; JMJD1C	Intracranial germ cell tumours (IGCTs) are a group of rare heterogeneous brain tumours that are clinically and histologically similar to the more common gonadal GCTs. IGCTs show great variation in their geographical and gender distribution, histological composition and treatment outcomes. The incidence of IGCTs is historically five- to eightfold greater in Japan and other East Asian countries than in Western countries(1), with peak incidence near the time of puberty(2). About half of the tumours are located in the pineal region. The male to-female incidence ratio is approximately 3-4:1 overall, but is even higher for tumours located in the pineal region(3). Owing to the scarcity of tumour specimens available for research, little is currently known about this rare disease. Here we report the analysis of 62 cases by next-generation sequencing, single nucleotide polymorphism array and expression array. We find the KIT/RAS signalling pathway frequently mutated in more than 50% of IGCTs, including novel recurrent somatic mutations in KIT, its downstream mediators KRAS and NRAS, and its negative regulator CBL. Novel somatic alterations in the AKT/mTOR pathway included copy number gains of the AKT1 locus at 14q32.33 in 19% of patients, with corresponding upregulation of AKT1 expression. We identified loss-of-function mutations in BCORL1, a transcriptional co-repressor and tumour suppressor. We report significant enrichment of novel and rare germline variants in JMJD1C, which codes for a histone demethylase and is a coactivator of the androgen receptor, among Japanese IGCT patients. This study establishes a molecular foundation for understanding the biology of IGCTs and suggests potentially promising therapeutic strategies focusing on the inhibition of KIT/RAS activation and the AKT1/mTOR pathway.	[Wang, Linghua; Chang, Kyle; Doddapaneni, Harshavardhan; Lewis, Lora; Wang, Mark; Muzny, Donna M.; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Yamaguchi, Shigeru; Terashima, Keita; Lau, Ching C.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Yamaguchi, Shigeru; Terashima, Keita; Lau, Ching C.] Baylor Coll Med, Texas Childrens Hematol Ctr, Houston, TX 77030 USA; [Burstein, Matthew D.] Baylor Coll Med, Struct & Computat Biol & Mol Biophys Program, Houston, TX 77030 USA; [Burstein, Matthew D.; Sun, Jiayi; Lau, Ching C.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Terashima, Keita] Natl Ctr Child Hlth & Dev, Tokyo 1578535, Japan; [Ng, Ho-Keung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Nakamura, Hideo] Kumamoto Univ, Dept Neurosurg, Kumamoto 8600862, Japan; [He, Zongxiao; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Suzuki, Tomonari; Nishikawa, Ryo] Saitama Med Univ, Dept Neurosurg, Saitama 3500495, Japan; [Natsume, Atsushi] Nagoya Univ, Dept Neurosurg, Nagoya, Aichi 4668550, Japan; [Terasaka, Shunsuke] Hokkaido Univ, Dept Neurosurg, Sapporo, Hokkaido 0600808, Japan; [Dauser, Robert; Whitehead, William] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Adekunle, Adesina] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Qiao, Yi; Marth, Gabor] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Lau, Ching C.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Center for Child Health & Development - Japan; Chinese University of Hong Kong; Prince of Wales Hospital; Kumamoto University; Baylor College of Medicine; Saitama Medical University; Nagoya University; Hokkaido University; Baylor College of Medicine; Baylor College of Medicine; Boston College; Baylor College of Medicine	Wheeler, DA (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	wheeler@bcm.edu; cclau@txch.org	Burstein, Matthew/GWZ-8436-2022; Yamaguchi, Shigeru/G-5419-2012; Ng, Ho Keung/I-3952-2015; Wheeler, David A/M-9740-2018; Dauser, Thomas/AAU-1209-2020; Natsume, Atsushi/I-7364-2014	Yamaguchi, Shigeru/0000-0003-3710-5888; Wheeler, David A/0000-0002-9056-6299; Dauser, Thomas/0000-0003-4583-9048; Natsume, Atsushi/0000-0002-9113-0470; doddapaneni, harshavardhan/0000-0002-2433-633X; Wang, Linghua/0000-0001-9380-0266; Chang, Kyle/0000-0001-5295-9676	National Human Genome Research Institute (NHGRI) [5U54HG003273]; Children Brain Tumor Foundation; Gillson Longenbaugh Foundation; Anderson Charitable Foundation; CCBTP Fellowship from the Cancer Prevention & Research Institute of Texas (CPRIT) [RP101489]; St Baldrick's Foundation; NLM predoctoral fellowships [5T15 LM07093-18, 5T15 LM07093-19]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Children Brain Tumor Foundation; Gillson Longenbaugh Foundation; Anderson Charitable Foundation; CCBTP Fellowship from the Cancer Prevention & Research Institute of Texas (CPRIT); St Baldrick's Foundation; NLM predoctoral fellowships; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by research funding from the National Human Genome Research Institute (NHGRI, grant number 5U54HG003273) to D. A. W., the Children Brain Tumor Foundation, the Gillson Longenbaugh Foundation and Anderson Charitable Foundation to C. C. L., the CCBTP Fellowship from the Cancer Prevention & Research Institute of Texas (CPRIT grant RP101489) to S.Y., the St Baldrick's Foundation to K. T. and the NLM predoctoral fellowships to M. D. B. (5T15 LM07093-18) and J.S. (5T15 LM07093-19). We thank H. H. Dinh and Y. Han for their technical support, J. G. Reid for Illumina sequence mapping.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; Hatzivassiliou G, 2012, MOL CANCER THER, V11, P1143, DOI 10.1158/1535-7163.MCT-11-1010; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; Jin GF, 2012, HUM MOL GENET, V21, P5222, DOI 10.1093/hmg/dds361; Kamakura Y, 2006, J NEUROSURG, V104, P173, DOI 10.3171/ped.2006.104.3.173; Katoh M, 2003, INT J MOL MED, V12, P817; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuroki S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108597; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, BLOOD, V118, P5914, DOI 10.1182/blood-2011-05-356204; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Makishima H, 2012, LEUKEMIA, V26, P1547, DOI 10.1038/leu.2012.7; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; Matsutani M, 1997, J NEUROSURG, V86, P446, DOI 10.3171/jns.1997.86.3.0446; McCarthy BJ, 2012, NEURO-ONCOLOGY, V14, P1194, DOI 10.1093/neuonc/nos155; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Okada Y, 2002, J NEUROPATH EXP NEUR, V61, P531, DOI 10.1093/jnen/61.6.531; Packer R J, 2000, Oncologist, V5, P312; Pagan JK, 2007, J BIOL CHEM, V282, P15248, DOI 10.1074/jbc.M700246200; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rickert CH, 2000, J NEUROPATH EXP NEUR, V59, P815, DOI 10.1093/jnen/59.9.815; Sakuma Y, 2004, CANCER SCI, V95, P716, DOI 10.1111/j.1349-7006.2004.tb03251.x; Schneider DT, 2006, MODERN PATHOL, V19, P864, DOI 10.1038/modpathol.3800607; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; Terashima K, 2014, PEDIATR BLOOD CANCER, V61, P593, DOI 10.1002/pbc.24833; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wolf SS, 2007, ARCH BIOCHEM BIOPHYS, V460, P56, DOI 10.1016/j.abb.2007.01.017; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	41	116	121	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					241	+		10.1038/nature13296	http://dx.doi.org/10.1038/nature13296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24896186	Green Accepted			2022-12-24	WOS:000338649800048
J	Monk, J; Palsson, BO				Monk, Jonathan; Palsson, Bernhard O.			Predicting microbial growth	SCIENCE			English	Editorial Material									[Monk, Jonathan; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92093 USA	University of California System; University of California San Diego	Monk, J (corresponding author), Univ Calif San Diego, Dept Bioengn, San Diego, CA 92093 USA.	palsson@ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785; Monk, Jonathan M./0000-0002-3895-8949				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barua D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000970; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Deutschbauer A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002385; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; Orth JD, 2010, BIOTECHNOL BIOENG, V107, P403, DOI 10.1002/bit.22844; Rolfsson O, 2013, BIOCHEM J, V449, P427, DOI 10.1042/BJ20120980; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846	12	31	31	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1448	1449		10.1126/science.1253388	http://dx.doi.org/10.1126/science.1253388			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970063				2022-12-24	WOS:000337889900019
J	Shi, YK; Hu, FB				Shi, Yuankai; Hu, Frank B.			The global implications of diabetes and cancer	LANCET			English	Editorial Material							PROSTATE-CANCER; MELLITUS; RISK; MORTALITY; ADULTS; TYPE-2; WOMEN		[Shi, Yuankai] Chinese Acad Med Sci, Canc Inst Hosp, Peking Union Med Coll, Dept Med Oncol, Beijing 100730, Peoples R China; [Shi, Yuankai] Natl Ctr Anticanc Drugs Clin Study, Beijing, Peoples R China; [Shi, Yuankai] Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shi, YK (corresponding author), Chinese Acad Med Sci, Canc Inst Hosp, Peking Union Med Coll, Dept Med Oncol, Beijing 100730, Peoples R China.	syuankai@cicams.ac.cn						Bensimon L, 2014, CANCER CAUSE CONTROL, V25, P329, DOI 10.1007/s10552-013-0334-6; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Gallagher EJ, 2013, DIABETES CARE, V36, pS233, DOI 10.2337/dcS13-2001; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Goodwin PJ, 2008, CLIN BREAST CANCER, V8, P501, DOI 10.3816/CBC.2008.n.060; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Home P, 2013, DIABETES CARE, V36, pS240, DOI 10.2337/dcS13-2002; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Le TN, 2012, TRENDS ENDOCRIN MET, V23, P32, DOI 10.1016/j.tem.2011.09.005; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Vangoitsenhoven R, 2012, ENDOCR-RELAT CANCER, V19, pF77, DOI 10.1530/ERC-12-0111; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118	13	271	292	2	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1947	1948		10.1016/S0140-6736(14)60886-2	http://dx.doi.org/10.1016/S0140-6736(14)60886-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PV	24910221				2022-12-24	WOS:000336848200004
J	Tallis, R				Tallis, Ray			Assisted dying is not the same as euthanasia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												raymond@rtallis.wanadoo.co.uk						Hartropp P., 2014, BMJ; YouGov, 2013, YOU GOV DIGN DYING S	2	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2014	348								g3532	10.1136/bmj.g3532	http://dx.doi.org/10.1136/bmj.g3532			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EH	24871316				2022-12-24	WOS:000336742000009
J	Kossin, JP; Emanuel, KA; Vecchi, GA				Kossin, James P.; Emanuel, Kerry A.; Vecchi, Gabriel A.			The poleward migration of the location of tropical cyclone maximum intensity	NATURE			English	Article							VERTICAL WIND SHEAR; CLUSTER-ANALYSIS; REANALYSIS; TRACKS; TRENDS	Temporally inconsistent and potentially unreliable global historical data hinder the detection of trends in tropical cyclone activity(1-3). This limits our confidence in evaluating proposed linkages between observed trends in tropical cyclones and in the environment(4,5). Here we mitigate this difficulty by focusing on a metric that is comparatively insensitive to past data uncertainty, and identify a pronounced poleward migration in the average latitude at which tropical cyclones have achieved their lifetime-maximum intensity over the past 30 years. The poleward trends are evident in the global historical data in both the Northern and the Southern hemispheres, with rates of 53 and 62 kilometres per decade, respectively, and are statistically significant. When considered together, the trends in each hemisphere depict a global-average migration of tropical cyclone activity away from the tropics at a rate of about one degree of latitude per decade, which lies within the range of estimates of the observed expansion of the tropics over the same period(6). The global migration remains evident and statistically significant under a formal data homogenization procedure(3), and is unlikely to be a data artefact. The migration away from the tropics is apparently linked to marked changes in the mean meridional structure of environmental vertical wind shear and potential intensity, and can plausibly be linked to tropical expansion, which is thought to have anthropogenic contributions(6).	[Kossin, James P.] Univ Wisconsin, NOAA Natl Climat Data Ctr, CIMSS, Madison, WI 53706 USA; [Emanuel, Kerry A.] MIT, Program Atmospheres Oceans & Climate, Cambridge, MA 02139 USA; [Vecchi, Gabriel A.] NOAA Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Wisconsin System; University of Wisconsin Madison; Massachusetts Institute of Technology (MIT); National Oceanic Atmospheric Admin (NOAA) - USA	Kossin, JP (corresponding author), Univ Wisconsin, NOAA Natl Climat Data Ctr, CIMSS, 1225 W Dayton St, Madison, WI 53706 USA.	james.kossin@.noaa.gov	Kossin, James/C-2022-2016; Vecchi, Gabriel/A-2413-2008	Kossin, James/0000-0003-0461-9794; Vecchi, Gabriel/0000-0002-5085-224X				Barnston AG, 1997, ATMOS OCEAN, V35, P367; Bell GD, 2000, B AM METEOROL SOC, V81, pS1, DOI 10.1175/1520-0477(2000)81[s1:CAF]2.0.CO;2; Bindoff NL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P867; Bister M, 1998, METEOROL ATMOS PHYS, V65, P233, DOI 10.1007/BF01030791; Camargo SJ, 2007, J CLIMATE, V20, P3654, DOI 10.1175/JCLI4203.1; Camargo SJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001861; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel KA, 1999, NATURE, V401, P665, DOI 10.1038/44326; Emanuel K, 2013, J CLIMATE, V26, P2288, DOI 10.1175/JCLI-D-12-00242.1; Emanuel K, 2010, J ADV MODEL EARTH SY, V2, DOI 10.3894/JAMES.2010.2.1; Frank WM, 2007, MON WEATHER REV, V135, P3587, DOI 10.1175/MWR3435.1; Holland G, 2014, CLIM DYNAM, V42, P617, DOI 10.1007/s00382-013-1713-0; Jiang HY, 2010, J CLIMATE, V23, P1526, DOI 10.1175/2009JCLI3303.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Knaff JA, 2004, MON WEATHER REV, V132, P2503, DOI 10.1175/1520-0493(2004)132<2503:OTIOVW>2.0.CO;2; Knapp KR, 2010, MON WEATHER REV, V138, P1459, DOI 10.1175/2009MWR3123.1; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kossin JP, 2013, J CLIMATE, V26, P9960, DOI 10.1175/JCLI-D-13-00262.1; Kossin JP, 2010, J CLIMATE, V23, P3057, DOI 10.1175/2010JCLI3497.1; Lam H, 2012, WEATHER, V67, P16, DOI 10.1002/wea.836; Landsea CW, 2010, J CLIMATE, V23, P2508, DOI 10.1175/2009JCLI3034.1; Lucas C, 2014, WIRES CLIM CHANGE, V5, P89, DOI 10.1002/wcc.251; Peduzzi P, 2012, NAT CLIM CHANGE, V2, P289, DOI 10.1038/NCLIMATE1410; Ramsay HA, 2012, CLIM DYNAM, V39, P897, DOI 10.1007/s00382-011-1225-8; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Ross GJ, 2013, CPM SEQUENTIAL PARAM; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Vecchi GA, 2013, J CLIMATE, V26, P3877, DOI 10.1175/JCLI-D-12-00503.1; Vecchi GA, 2011, J CLIMATE, V24, P1736, DOI 10.1175/2010JCLI3810.1; Zhang FQ, 2013, J ATMOS SCI, V70, P975, DOI 10.1175/JAS-D-12-0133.1	32	347	354	7	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					349	+		10.1038/nature13278	http://dx.doi.org/10.1038/nature13278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828193	Green Submitted			2022-12-24	WOS:000336121200036
J	Matter, K; Balda, MS				Matter, Karl; Balda, Maria S.			SnapShot: Epithelial Tight Junctions	CELL			English	Editorial Material									[Matter, Karl; Balda, Maria S.] UCL, Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England	University of London; University College London	Matter, K (corresponding author), UCL, Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England.		Matter, Karl/C-4880-2008	Matter, Karl/0000-0001-8026-7220; /0000-0002-8427-6746	Biotechnology and Biological Sciences Research Council [BB/L007584/1, BB/H002294/1, BB/C514458/1] Funding Source: Medline; Medical Research Council [G0100200, G0400678, G0700743, G0900098] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/J015032/1] Funding Source: researchfish; Fight for Sight [1393/94] Funding Source: researchfish; BBSRC [BB/J015032/1, BB/H002294/1, BB/L007584/1] Funding Source: UKRI; MRC [G0100200, G0700743, G0400678, G0900098] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fight for Sight; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Gonzalez-Mariscal L, 2012, ANN NY ACAD SCI, V1257, P133, DOI 10.1111/j.1749-6632.2012.06537.x; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Steed E, 2014, J CELL BIOL, V204, P821, DOI 10.1083/jcb.201304115; Yano T, 2013, J CELL BIOL, V203, P605, DOI 10.1083/jcb.201304194; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zihni C, 2014, J CELL BIOL, V204, P111, DOI 10.1083/jcb.201304064	9	28	33	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4								10.1016/j.cell.2014.04.027	http://dx.doi.org/10.1016/j.cell.2014.04.027			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813618	Bronze			2022-12-24	WOS:000335765500024
J	Feldmann, H				Feldmann, Heinz			Ebola - A Growing Threat?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIAID, Rocky Mt Labs, Virol Lab, Div Intramural Res, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Feldmann, H (corresponding author), NIAID, Rocky Mt Labs, Virol Lab, Div Intramural Res, Hamilton, MT 59840 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089, ZIAAI001188, ZIAAI001163] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Falzarano D, 2014, CELL RES; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Friedrich BM, 2012, VIRUSES-BASEL, V4, P1619, DOI 10.3390/v4091619; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536	5	61	70	0	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1375	1378		10.1056/NEJMp1405314	http://dx.doi.org/10.1056/NEJMp1405314			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ3FJ	24805988				2022-12-24	WOS:000342674800005
J	Macaraig, M; Burzynski, J; Varma, JK				Macaraig, Michelle; Burzynski, Joseph; Varma, Jay K.			Tuberculosis Control in New York City - A Changing Landscape	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Macaraig, Michelle; Burzynski, Joseph; Varma, Jay K.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA	New York City Department of Health & Mental Hygiene	Macaraig, M (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.							[Anonymous], 2013, CONTR ANN TUB SUMM; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Krueger K, 2010, INT J TUBERC LUNG D, V14, P779; REICHMAN LB, 1991, AM REV RESPIR DIS, V144, P741, DOI 10.1164/ajrccm/144.4.741; Warkentin J, 2013, MMWR-MORBID MORTAL W, V62, P398	5	11	11	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2362	2365		10.1056/NEJMp1402147	http://dx.doi.org/10.1056/NEJMp1402147			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0OA	24941176				2022-12-24	WOS:000337353000004
J	Khan, SS; Butler, J; Gheorghiade, M				Khan, Sadiya S.; Butler, Javed; Gheorghiade, Mihai			Management of Comorbid Diabetes Mellitus and Worsening Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTDISCHARGE OUTCOMES; ASSOCIATION		[Khan, Sadiya S.; Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Butler, Javed] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA	Northwestern University; Feinberg School of Medicine; Emory University	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 201 E Huron St,Galter 3-150, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu		Khan, Sadiya/0000-0003-0643-1859				Bertoni AG, 2004, DIABETES CARE, V27, P699, DOI 10.2337/diacare.27.3.699; Das SR, 2004, AM HEART J, V148, P883, DOI 10.1016/j.ahj.2004.04.019; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Greenberg BH, 2007, AM HEART J, V154, P646, DOI 10.1016/j.ahj.2007.05.001; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Maggioni AP, 2013, EUR HEART J, V34, P3117, DOI 10.1093/eurheartj/eht342; Sarma S, 2013, EUR J HEART FAIL, V15, P194, DOI 10.1093/eurjhf/hfs153; Shah SJ, 2013, CIRC-HEART FAIL, V6, P184, DOI 10.1161/CIRCHEARTFAILURE.112.972794; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049	10	39	41	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2379	2380		10.1001/jama.2014.4115	http://dx.doi.org/10.1001/jama.2014.4115			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24938559				2022-12-24	WOS:000337301500015
J	Hwang, TJ; Carpenter, D; Kesselheim, AS				Hwang, Thomas J.; Carpenter, Daniel; Kesselheim, Aaron S.			Target small firms for antibiotic innovation	SCIENCE			English	Editorial Material							DRUGS		[Hwang, Thomas J.; Carpenter, Daniel] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Carpenter, Daniel] Harvard Univ, Radclif Inst Adv Study, Cambridge, MA 02138 USA; [Hwang, Thomas J.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02115 USA; [Hwang, Thomas J.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hwang, TJ (corresponding author), Blackstone Grp, London W1J5AL, England.	tjhwang@post.harvard.edu; akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Hwang, Thomas/0000-0003-0717-1497				Blume-Kohout ME, 2012, J POLICY ANAL MANAG, V31, P641, DOI 10.1002/pam.21640; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Holmes D, 2014, NAT MED, V20, P320, DOI 10.1038/nm0414-320; Hwang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071966; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Rex JH, 2013, LANCET INFECT DIS, V13, P269, DOI 10.1016/S1473-3099(12)70293-1	9	11	11	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					967	969		10.1126/science.1251419	http://dx.doi.org/10.1126/science.1251419			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876477				2022-12-24	WOS:000336495800018
J	Keramati, AR; Fathzadeh, M; Go, GW; Singh, R; Choi, M; Faramarzi, S; Mane, S; Kasaei, M; Sarajzadeh-Fard, K; Hwa, J; Kidd, KK; Bigi, MAB; Malekzadeh, R; Hosseinian, A; Babaei, M; Lifton, RP; Mani, A				Keramati, Ali R.; Fathzadeh, Mohsen; Go, Gwang-Woong; Singh, Rajvir; Choi, Murim; Faramarzi, Saeed; Mane, Shrikant; Kasaei, Mohammad; Sarajzadeh-Fard, Kazem; Hwa, John; Kidd, Kenneth K.; Bigi, Mohammad A. Babaee; Malekzadeh, Reza; Hosseinian, Adallat; Babaei, Masoud; Lifton, Richard P.; Mani, Arya			A Form of the Metabolic Syndrome Associated with Mutations in DYRK1B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITOTIC CLONAL EXPANSION; PROTEIN-KINASE; FAMILIAL HYPERCHOLESTEROLEMIA; BINDING PROTEIN; RISK-FACTORS; GENE; PREVALENCE; EXPRESSION; OBESITY; INHIBITION	BACKGROUND Genetic analysis has been successful in identifying causative mutations for individual cardiovascular risk factors. Success has been more limited in mapping susceptibility genes for clusters of cardiovascular risk traits, such as those in the metabolic syndrome. METHODS We identified three large families with coinheritance of early-onset coronary artery disease, central obesity, hypertension, and diabetes. We used linkage analysis and whole-exome sequencing to identify the disease-causing gene. RESULTS A founder mutation was identified in DYRK1B, substituting cysteine for arginine at position 102 in the highly conserved kinase-like domain. The mutation precisely cosegregated with the clinical syndrome in all the affected family members and was absent in unaffected family members and unrelated controls. Functional characterization of the disease gene revealed that nonmutant protein encoded by DYRK1B inhibits the SHH (sonic hedgehog) and Wnt signaling pathways and consequently enhances adipogenesis. Furthermore, DYRK1B promoted the expression of the key gluconeogenic enzyme glucose-6-phosphatase. The R102C allele showed gain-of-function activities by potentiating these effects. A second mutation, substituting proline for histidine 90, was found to cosegregate with a similar clinical syndrome in an ethnically distinct family. CONCLUSIONS These findings indicate a role for DYRK1B in adipogenesis and glucose homeostasis and associate its altered function with an inherited form of the metabolic syndrome.	[Keramati, Ali R.; Fathzadeh, Mohsen; Go, Gwang-Woong; Singh, Rajvir; Faramarzi, Saeed; Hwa, John; Mani, Arya] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Choi, Murim; Mane, Shrikant; Lifton, Richard P.; Mani, Arya] Yale Univ, Sch Med, Yale Ctr Mendelian Genom, New Haven, CT USA; [Kidd, Kenneth K.; Lifton, Richard P.; Mani, Arya] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Fathzadeh, Mohsen; Sarajzadeh-Fard, Kazem; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Tehran, Iran; [Fathzadeh, Mohsen] Univ Tehran Med Sci, Dept Med Genet, Tehran, Iran; [Kasaei, Mohammad; Sarajzadeh-Fard, Kazem; Bigi, Mohammad A. Babaee] Shiraz Univ Med Sci, Cardiovasc Res Ctr, Shiraz, Iran; [Hosseinian, Adallat; Babaei, Masoud] Ardabil Univ Med Sci, Ardebil, Iran	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Shiraz University of Medical Science; Ardabil University of Medical Sciences	Mani, A (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA.	arya.mani@yale.edu	Choi, Murim/AAP-9120-2021; kasaei, mohammad/ABB-5658-2020; Kasaei, Mohammad/AAN-2386-2020; Hosseinian, Adalat/V-6083-2017; Wang, Guilin/G-8794-2018; SINGH, RAJVIR/C-8191-2012; Malekzadeh, Reza/U-1382-2017; Kasaei, Mohammad Mehdi/AAR-3903-2021; Fathzadeh, Mohsen/AAJ-5249-2020	Kasaei, Mohammad/0000-0001-6574-7568; Hosseinian, Adalat/0000-0003-1328-8413; Malekzadeh, Reza/0000-0002-9820-6335; Kasaei, Mohammad Mehdi/0000-0001-9478-9783; Fathzadeh, Mohsen/0000-0002-7962-9148; Malekzadeh, Reza/0000-0003-1043-3814; Keramati, Ali/0000-0002-8728-1508	National Institutes of Health (NIH) [R01HL094784-01, R01HL094574-03]; NIH Centers for Mendelian Genomics [5U54HG006504]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094784, R01HL122830, R01HL115247, R01HL094574] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Centers for Mendelian Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (NIH) (R01HL094784-01 and R01HL094574-03, to Dr. Mani) and by a grant from the NIH Centers for Mendelian Genomics (5U54HG006504).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ahlqvist E, 2011, CLIN CHEM, V57, P241, DOI 10.1373/clinchem.2010.157016; Akyurek LM, 2010, BIOCHEM BIOPH RES CO, V396, P359, DOI 10.1016/j.bbrc.2010.04.097; Alexander CM, 2008, DIABETES OBES METAB, V10, P246, DOI 10.1111/j.1463-1326.2006.00695.x; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Argaud D, 1996, DIABETES, V45, P1563, DOI 10.2337/diabetes.45.11.1563; Barak T, 2011, NAT GENET, V43, P590, DOI 10.1038/ng.836; BEAGLEHOLE R, 1990, EPIDEMIOL REV, V12, P1; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; Borycki AG, 2000, DEVELOPMENT, V127, P2075; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diez-Juan A, 2001, FASEB J, V15, P1989, DOI 10.1096/fj.01-0130com; Ewton DZ, 2003, INT J CANCER, V103, P21, DOI 10.1002/ijc.10743; Friedman E, 2013, INT J MOL SCI, V14, P5560, DOI 10.3390/ijms14035560; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Katakura M, 2003, DIABETES CARE, V26, P638, DOI 10.2337/diacare.26.3.638; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Leder S, 2003, BIOCHEM J, V372, P881, DOI 10.1042/BJ20030182; Lee K, 2000, CANCER RES, V60, P3631; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LIU ZQ, 1994, BIOCHEM BIOPH RES CO, V205, P680, DOI 10.1006/bbrc.1994.2719; Mani A, 2013, SCIENCE, V341, P959; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Naaz A, 2004, FASEB J, V18, P1925; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; Pishdad GR, 1996, INT J OBESITY, V20, P963; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; SEGAL HL, 1959, J BIOL CHEM, V234, P1937; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; von Groote-Bidlingmaier F, 2003, BIOCHEM BIOPH RES CO, V300, P764, DOI 10.1016/S0006-291X(02)02914-5; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	52	82	86	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1909	1919		10.1056/NEJMoa1301824	http://dx.doi.org/10.1056/NEJMoa1301824			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24827035	Green Accepted			2022-12-24	WOS:000336123600007
J	Gornall, J				Gornall, Jonathan			Is the billion unit pledge just window dressing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jonathangornall@mac.com						[Anonymous], 2008, JUST DRINKS     0626; [Anonymous], 2009, DRUM            0419; Cave A, 2012, SUNDAY TELEGRAP 1216; Department of Health, PUBL HLTH RESP DEAL; Department of Health, 2014, LIV WELL LONG NAT SU; Department of Health, 2012, ALC NETW GROUP M 19; Dinkovski N, 2012, MORNING ADVERTI 0408; Gornall J., 2014, BMJ-BRIT MED J, V348, pf7646; Jones L., 2012, CAN PROMOTION LOWER; Joseph S., 2012, MARKETING WEEK; Public Health Responsibility Deal Alcohol Network, PLEDG A8 ALC UN RED; Responsibility Deal Alcohol Network, 2014, PLEDG REM 1 BILL UN; Wilson S, 2013, 12 PLEN M EUR ALCH H	13	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2014	348								g3190	10.1136/bmj.g3190	http://dx.doi.org/10.1136/bmj.g3190			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5BW	24821683				2022-12-24	WOS:000336144400006
J	Wright, G				Wright, Gerard			PERSPECTIVE Synthetic biology revives antibiotics	NATURE			English	Editorial Material									McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University	Wright, G (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.		Wright, G/ABB-7666-2021	Wright, Gerard/0000-0002-9129-7131				Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Thaker MN, 2013, NAT BIOTECHNOL, V31, P922, DOI 10.1038/nbt.2685	2	20	20	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S13	S13		10.1038/509S13a	http://dx.doi.org/10.1038/509S13a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784423	Bronze			2022-12-24	WOS:000335199100007
J	Valdiserri, RO; Koh, HK				Valdiserri, Ronald O.; Koh, Howard K.			Breaking the Silence on Viral Hepatitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES		[Valdiserri, Ronald O.; Koh, Howard K.] US Dept HHS, Washington, DC 20201 USA		Valdiserri, RO (corresponding author), US Dept HHS, 200 Independence Ave SW,HHH Bldg,Room 443-H, Washington, DC 20201 USA.	ron.valdiserri@hhs.gov						Berg CL, 2009, AM J TRANSPLANT, V9, P907, DOI 10.1111/j.1600-6143.2009.02567.x; Centers for Disease Control and Prevention, 2011, VIR HEP STAT SURV SU; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Ngo-Metzger Q, 2013, ANN INTERN MED, V159, P364, DOI 10.7326/0003-4819-159-5-201309030-00675; U.S. Department of Health and Human Services, ACT PLAN PREV CAR TR; US Department of Health Human Services, 2011, COMB SIL EP VIR HEP; Valdiserri RO, 2014, AM J PUBLIC HEALTH, pe1	10	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					147	+		10.7326/M14-0404	http://dx.doi.org/10.7326/M14-0404			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	24781348				2022-12-24	WOS:000339764600025
J	Ali, M				Ali, Mohsin			Treating tuberculosis as a social disease	LANCET			English	Editorial Material									Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England	University of Cambridge	Ali, M (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England.	ma611@cam.ac.uk						Barnes DS, 2000, MICROBES INFECT, V2, P431, DOI 10.1016/S1286-4579(00)00323-3; Craig GM, 2007, J ADV NURS, V58, P418, DOI 10.1111/j.1365-2648.2007.04257.x; Craig GA, 2008, J ADV NURS, V61, P413, DOI 10.1111/j.1365-2648.2007.04498.x; De Vries G, 2014, EURO SURVEILL, V19; Dubos R, 1952, WHITE PLAGUE TUBERCU; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, TUB SURV MON EUR 201; Public Health England, 2014, TB STRAT CONS; van Hest NA, 2014, EURO SURVEILL, V19	8	14	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2195	2195		10.1016/S0140-6736(14)61063-1	http://dx.doi.org/10.1016/S0140-6736(14)61063-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24976317				2022-12-24	WOS:000338657600008
J	Riffell, JA; Shlizerman, E; Sanders, E; Abrell, L; Medina, B; Hinterwirth, AJ; Kutz, JN				Riffell, Jeffrey A.; Shlizerman, Eli; Sanders, Elischa; Abrell, Leif; Medina, Billie; Hinterwirth, Armin J.; Kutz, J. Nathan			Flower discrimination by pollinators in a dynamic chemical environment	SCIENCE			English	Article							PROJECTION NEURONS; MANDUCA-SEXTA; ODOR; RESPONSES; INSECTS	Pollinators use their sense of smell to locate flowers from long distances, but little is known about how they are able to discriminate their target odor from a m lange of other natural and anthropogenic odors. Here, we measured the plume from Datura wrightii flowers, a nectar resource for Manduca sexta moths, and show that the scent was dynamic and rapidly embedded among background odors. The moth's ability to track the odor was dependent on the background and odor frequency. By influencing the balance of excitation and inhibition in the antennal lobe, background odors altered the neuronal representation of the target odor and the ability of the moth to track the plume. These results show that the mix of odors present in the environment influences the pollinator's olfactory ability.	[Riffell, Jeffrey A.; Sanders, Elischa; Medina, Billie; Hinterwirth, Armin J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Shlizerman, Eli; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Abrell, Leif] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Abrell, Leif] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Arizona; University of Arizona	Riffell, JA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jriffell@u.washington.edu	Lei, Hong/ABH-1356-2020	Shlizerman, Eli/0000-0002-3136-4531; Abrell, Leif/0000-0003-2490-1180	University of Washington	University of Washington(University of Washington)	The authors thank B. Nguyen, W. Chan, K. Jardine, and J. Thornton for their assistance. This work was supported by funds from the University of Washington (J. A. R.). The electrophysiology data reported in this paper are tabulated in the supplementary materials (database S1).	Christensen TA, 1998, J NEUROSCI, V18, P5999; Dorsey Alfred, 2000, TOXICOLOGICAL PROFIL; FIELD RA, 1992, ATMOS ENVIRON A-GEN, V26, P2983, DOI 10.1016/0960-1686(92)90290-2; Girling RD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02779; Heinbockel T, 1999, J COMP NEUROL, V409, P1; HELMIG D, 1992, SCI TOTAL ENVIRON, V112, P233, DOI 10.1016/0048-9697(92)90190-4; Herrmann A., 2010, CHEM BIOL VOLATILES, DOI 10.1002/9780470669532; Jardine K, 2010, ATMOS CHEM PHYS, V10, P12191, DOI 10.5194/acp-10-12191-2010; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Raguso RA, 2003, INT J PLANT SCI, V164, P877, DOI 10.1086/378539; Riffell JA, 2008, J CHEM ECOL, V34, P837, DOI 10.1007/s10886-008-9490-7; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Shlizerman E., FRONT COMPU IN PRESS; STOCKHOUSE RE, 1976, AM MIDL NAT, V96, P241; THIERY D, 1986, ENTOMOL EXP APPL, V41, P165, DOI 10.1007/BF00195573; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Zimmer RK, 2008, J CHEM ECOL, V34, P822, DOI 10.1007/s10886-008-9486-3	22	129	135	6	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1515	1518		10.1126/science.1251041	http://dx.doi.org/10.1126/science.1251041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970087				2022-12-24	WOS:000337889900050
J	Hoag, H				Hoag, Hannah			DRUG DELIVERY Brain food	NATURE			English	Editorial Material							NEUROGENESIS; GENERATION											Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Caicco MJ, 2013, J CONTROL RELEASE, V166, P197, DOI 10.1016/j.jconrel.2013.01.002; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Nakaguchi K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/915160; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Wang Y, 2013, CURR TOP NUTRACEUT R, V11, P1	8	3	3	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S6	S7		10.1038/510S6a	http://dx.doi.org/10.1038/510S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24964026	Bronze			2022-12-24	WOS:000337806300005
J	Shah, M				Shah, Maitri			Elephantiasis Nostras Verrucosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Conemaugh Hlth Syst, Johnstown, PA 15905 USA		Shah, M (corresponding author), Conemaugh Hlth Syst, Johnstown, PA 15905 USA.	maitri86@gmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2520	2520		10.1056/NEJMicm1310890	http://dx.doi.org/10.1056/NEJMicm1310890			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963571				2022-12-24	WOS:000337804400010
J	Rees, J; Bultitude, M; Challacombe, B				Rees, Jonathan; Bultitude, Matthew; Challacombe, Ben			The management of lower urinary tract symptoms in men	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BENIGN PROSTATIC HYPERPLASIA; SEXUAL DYSFUNCTION; METAANALYSIS; COMBINATION; FINASTERIDE; NOCTURIA; DISEASE; PATHOPHYSIOLOGY; EPIDEMIOLOGY; MONOTHERAPY		[Rees, Jonathan] Backwell & Nailsea Med Grp, North Somerset BS48 1BZ, England; [Bultitude, Matthew; Challacombe, Ben] Guys & St Thomas NHS Fdn Trust, Urol Ctr, London, England	Guy's & St Thomas' NHS Foundation Trust	Rees, J (corresponding author), Backwell & Nailsea Med Grp, North Somerset BS48 1BZ, England.	drjonrees@gmail.com	Challacombe, Ben/AAM-9505-2020	Challacombe, Ben/0000-0001-8631-0314	GSK; Lilly; Pfizer; Astellas	GSK(GlaxoSmithKline); Lilly(Eli Lilly); Pfizer(Pfizer); Astellas(Astellas Pharmaceuticals)	We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: JR has received fees for advisory boards and speaker fees from GSK, Lilly, Pfizer, and Astellas. MB has no interests to declare. BC has received speaker fees from GSK and Astellas.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Ahyai SA, 2010, EUR UROL, V58, P384, DOI 10.1016/j.eururo.2010.06.005; [Anonymous], 2013, NICE TECHN APPR 290; Athanasopoulos A, 2011, EUR UROL, V60, P94, DOI 10.1016/j.eururo.2011.03.054; Blake-James BT, 2007, BJU INT, V99, P85, DOI 10.1111/j.1464-410X.2006.06574.x; Bosch JLHR, 2010, J UROLOGY, V184, P440, DOI 10.1016/j.juro.2010.04.011; Boyle P, 1996, UROLOGY, V48, P398, DOI 10.1016/S0090-4295(96)00353-6; Cornu JN, 2012, EUR UROL, V62, P877, DOI 10.1016/j.eururo.2012.07.004; Emberton M, 2003, UROLOGY, V61, P267, DOI 10.1016/S0090-4295(02)02371-3; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; Gacci M, 2012, EUR UROL, V61, P994, DOI 10.1016/j.eururo.2012.02.033; Gulur DM, 2011, BJU INT, V107, P702, DOI 10.1111/j.1464-410X.2010.09763.x; Hall SA, 2012, BJU INT, V109, P1676, DOI 10.1111/j.1464-410X.2011.10593.x; Hammarsten J, 2011, NAT REV UROL, V8, P483, DOI 10.1038/nrurol.2011.112; Hutchison A, 2006, EUR UROL, V50, P555, DOI 10.1016/j.eururo.2006.05.001; Irwin DE, 2009, EUR UROL, V56, P14, DOI 10.1016/j.eururo.2009.02.026; Kaplan SA, 2011, INT J CLIN PRACT, V65, P487, DOI 10.1111/j.1742-1241.2010.02611.x; Kashyap M, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-57; Lourenco Tania, 2008, BMJ, V337, pa449, DOI 10.1136/bmj.39575.517674.BE; MacDonald R, 2012, BJU INT, V109, P1756, DOI 10.1111/j.1464-410X.2012.11172.x; Matsumoto S, 2013, BJU INT, V111, P647, DOI 10.1111/j.1464-410X.2012.11591.x; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; McVary K, 2006, BJU INT, V97, P23, DOI 10.1111/j.1464-410X.2006.06102.x; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; National Institute for Health and Clinical Excellence, MAN LOW UR TRACT SYM; Nickel JC, 2011, BJU INT, V108, P388, DOI 10.1111/j.1464-410X.2011.10195.x; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Oelke M, 2012, EUR UROL, V61, P917, DOI 10.1016/j.eururo.2012.01.013; Omar MI, 2014, BJU INT, V113, P24, DOI 10.1111/bju.12281; Parsons JK, 2009, BJU INT, V104, P63, DOI 10.1111/j.1464-410X.2008.08317.x; Paterson J, 1997, BRIT J UROL, V79, P892, DOI 10.1046/j.1464-410X.1997.00180.x; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Speakman MJ, 2004, BJU INT, V93, P985, DOI 10.1111/j.1464-410X.2004.04765.x; T Brown C, 2007, BRIT MED J, V334, P25, DOI 10.1136/bmj.39010.551319.AE; Tacklind J, 2010, COCHRANE DB SYST REV, V10; Treagust J, 2001, J PUBLIC HEALTH MED, V23, P141, DOI 10.1093/pubmed/23.2.141; Weiss JP, 2011, BJU INT, V108, P6, DOI 10.1111/j.1464-410X.2011.10175.x; Wilt TJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f325	39	11	11	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2014	348								g3861	10.1136/bmj.g3861	http://dx.doi.org/10.1136/bmj.g3861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UG	24963071				2022-12-24	WOS:000338201800004
J	Wolfe, SM				Wolfe, Sidney M.			A morphine-oxycodone combo pill: toward the "holy grail" for opioids or a justifiably rejected drug?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA		Wolfe, SM (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA.	Swolfe@citizen.org						Corbett AD, 2006, BRIT J PHARMACOL, V147, pS153, DOI 10.1038/sj.bjp.0706435; FDA, 4 22 14 ADV COMM M, P122; FDA, 4 22 14 ADV COMM M, P5; Food and Drug Administration, 2014, AN AN DRUG PROD ADV; QRx Pharma, 2012, NONC OV DUAL OP TECH	5	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2014	348								g3620	10.1136/bmj.g3620	http://dx.doi.org/10.1136/bmj.g3620			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1DS	24912942	Bronze, Green Published			2022-12-24	WOS:000337396600005
J	Falaschetti, E; Mindell, J; Knott, C; Poulter, N				Falaschetti, Emanuela; Mindell, Jennifer; Knott, Craig; Poulter, Neil			Hypertension management in England: a serial cross-sectional study from 1994 to 2011	LANCET			English	Article							HEALTH SURVEY; BLOOD-PRESSURE; UNITED-KINGDOM; GLOBAL BURDEN; CANADA; IMPROVEMENT; GUIDELINES; OUTCOMES; SOCIETY; DISEASE	Background Hypertension is the leading risk factor contributing to the global burden of disease. We aimed to assess the change in blood pressure management between 1994 and 2011 in England with a series of annual surveys. Methods We did a serial cross-sectional study of five Health Survey for England surveys based on nationally representative samples of non-institutionalised adults (aged >= 16 years). Mean blood pressure levels and rates of awareness, treatment, and control of hypertension were assessed. Hypertension was defined as systolic blood pressure 140 mm Hg or higher, diastolic blood pressure 90 mm Hg or higher, or receiving treatment for high blood pressure. Findings The mean blood pressure levels of men and women in the general population and among patients with treated hypertension progressively improved between 1994 and 2011. In patients with treated hypertension, blood pressure improved from 150.0 (SE 0.59)/80.2 (0.27) mm Hg to 135.4 (0.58)/73.5 (0.41) mm Hg. Awareness, treatment, and control rates among men and women combined also improved significantly across each stage of this 17-year period, with the prevalence of control among treated patients almost doubling from 33% (SE 1.4) in 1994 to 63% (1.7) in 2011. Nevertheless, of all adults with survey-defined hypertension in 2011, hypertension was controlled in only 37%. Interpretation If the same systematic improvement in all aspects of hypertension management continues until 2022, 80% of patients with treated hypertension will have controlled blood pressure levels with a potential annual saving of about 50 000 major cardiovascular events.	[Falaschetti, Emanuela] Univ London Imperial Coll Sci Technol & Med, Imperial Clin Trials Unit, Sch Publ Hlth, London W2 1PG, England; [Poulter, Neil] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, Natl Heart & Lung Inst, London W2 1PG, England; [Mindell, Jennifer; Knott, Craig] UCL, Dept Epidemiol & Publ Hlth, London, England	Imperial College London; Imperial College London; University of London; University College London	Falaschetti, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Clin Trials Unit, Sch Publ Hlth, London W2 1PG, England.	e.falaschetti@imperial.ac.uk	Mindell, Jennifer S/G-2241-2011	Mindell, Jennifer S/0000-0002-7604-6131; Falaschetti, Emanuela/0000-0001-6964-2042	HSCIC; National Institute for Health Research [NF-SI-0510-10055] Funding Source: researchfish	HSCIC; National Institute for Health Research(National Institute for Health Research (NIHR))	JM is and EF and CK were funded by the HSCIC to work on the HSE, but the study reported in this paper was not funded.	Campbell NRC, 2013, CAN J CARDIOL, V29, P564, DOI 10.1016/j.cjca.2012.05.006; Colhoun HM, 1998, J HYPERTENS, V16, P747, DOI 10.1097/00004872-199816060-00005; Craig R, 2012, HLTH SURVY ENGLAND 2, V2; Department of Health, 2003, DEL INV GEN PRACT IM; Elliott William J, 2003, J Clin Hypertens (Greenwich), V5, P3, DOI 10.1111/j.1524-6175.2003.02463.x; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; National Collaborating Centre for Chronic Conditions, 2006, HYP MAN HYP AD PRIM; ONS, 20 CENT MORT FIL 199; Primatesta P, 2001, HYPERTENSION, V38, P827, DOI 10.1161/hyp.38.4.827; Primatesta P, 2006, J HYPERTENS, V24, P1187, DOI 10.1097/01.hjh.0000226210.95936.bc; Ryan AM, 2012, MED CARE, V50, P191, DOI 10.1097/MLR.0b013e318244e6b5; Sadler K, 2013, NAT DIET NUTR SURV A; Serumaga Brian, 2011, BMJ, V342, pd108, DOI 10.1136/bmj.d108; SMITH WCS, 1990, BRIT MED J, V300, P981, DOI 10.1136/bmj.300.6730.981; Turnbull F, 2003, LANCET, V362, P1527; Volpe M, 2007, J HYPERTENS, V25, P1491, DOI 10.1097/HJH.0b013e3280fa83a6; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10	28	170	176	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1912	1919		10.1016/S0140-6736(14)60688-7	http://dx.doi.org/10.1016/S0140-6736(14)60688-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24881995				2022-12-24	WOS:000336847800031
J	van Roosmalen, J; Meguid, T				van Roosmalen, Jos; Meguid, Tarek			The dilemma of vaginal breech delivery worldwide	LANCET			English	Editorial Material							CESAREAN-SECTION; TERM; DISAGREEMENT; TRIAL; ROOM		[van Roosmalen, Jos] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [van Roosmalen, Jos] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Meguid, Tarek] Mnazi Mmoja Hosp, Zanzibar, Tanzania; [Meguid, Tarek] State Univ Zanzibar, Sch Hlth & Med Sci, Zanzibar, Tanzania; [Meguid, Tarek] Haukeland Hosp, Helse Bergen, N-5021 Bergen, Norway	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bergen; Haukeland University Hospital	van Roosmalen, J (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.	j.j.m.van_roosmalen@lumc.nl						Grivell RM., 2011, EXPERT REV OBSTET GY, V6, P205, DOI [10.1586/eog.11.5, DOI 10.1586/eog.11.5]; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Hendriks J, 2013, VOX SANG, V104, P234, DOI 10.1111/j.1423-0410.2012.01654.x; Kotaska AR, 2004, BRIT MED J, V329, P1039, DOI 10.1136/bmj.329.7473.1039; Lawson GW, 2012, BIRTH-ISS PERINAT C, V39, P3, DOI 10.1111/j.1523-536X.2011.00507.x; Lumley J, 2000, LANCET, V356, P1368, DOI 10.1016/S0140-6736(00)02833-6; Maaloe N, 2012, BJOG-INT J OBSTET GY, V119, P605, DOI 10.1111/j.1471-0528.2012.03284.x; Naicker Saraladevi, 2009, Ethn Dis, V19, pS1; Onah HE, 2002, INT J GYNECOL OBSTET, V76, P321, DOI 10.1016/S0020-7292(01)00578-1; Rietberg CCT, 2005, BJOG-INT J OBSTET GY, V112, P205, DOI 10.1111/j.1471-0528.2004.00317.x; Schutte JM, 2007, ACTA OBSTET GYN SCAN, V86, P240, DOI 10.1080/00016340601104054; van Roosmalen J, 2002, BJOG-INT J OBSTET GY, V109, P967, DOI 10.1016/S1470-0328(02)01705-6; Vlemmix F, 2013, AM J OBSTET GYNECOL, V208, pS321, DOI 10.1016/j.ajog.2012.10.102	13	33	33	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1863	1864		10.1016/S0140-6736(14)60618-8	http://dx.doi.org/10.1016/S0140-6736(14)60618-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24881976				2022-12-24	WOS:000336847800007
J	Lampert, A; Hastings, A; Grosholz, ED; Jardine, SL; Sanchirico, JN				Lampert, Adam; Hastings, Alan; Grosholz, Edwin D.; Jardine, Sunny L.; Sanchirico, James N.			Optimal approaches for balancing invasive species eradication and endangered species management	SCIENCE			English	Article							BIRDS; CONSERVATION; FISHERIES; IMPACTS	Resolving conflicting ecosystem management goals-such as maintaining fisheries while conserving marine species or harvesting timber while preserving habitat-is a widely recognized challenge. Even more challenging may be conflicts between two conservation goals that are typically considered complementary. Here, we model a case where eradication of an invasive plant, hybrid Spartina, threatens the recovery of an endangered bird that uses Spartina for nesting. Achieving both goals requires restoration of native Spartina. We show that the optimal management entails less intensive treatment over longer time scales to fit with the time scale of natural processes. In contrast, both eradication and restoration, when considered separately, would optimally proceed as fast as possible. Thus, managers should simultaneously consider multiple, potentially conflicting goals, which may require flexibility in the timing of expenditures.	[Lampert, Adam; Hastings, Alan; Grosholz, Edwin D.; Sanchirico, James N.] Univ Calif Davis, Davis, CA 95616 USA; [Jardine, Sunny L.] Univ Delaware, Newark, DE 19716 USA; [Sanchirico, James N.] Resources Future Inc, Washington, DC 20036 USA	University of California System; University of California Davis; University of Delaware; Resources for the Future	Lampert, A (corresponding author), Univ Calif Davis, One Shield Ave, Davis, CA 95616 USA.	alampert@ucdavis.edu	Hastings, Alan/O-6864-2019	Hastings, Alan/0000-0002-0717-8026	NSF [DEB 1009957]; Division Of Environmental Biology [1009957] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the personnel of the Invasive Spartina Project, including P. Olofson, E. Grijalva, D. Kerr, I. Hogle, W. Thornton, M. Latta, and others, who provided data on Spartina distributions, clapper rail populations, and costs of eradication and restoration efforts. We thank D. Kling for research assistance and P. Reynolds for comments on the manuscript. We thank the California State Coastal Conservancy and the California State Wildlife Conservation Board for use of their data. The data used for this paper are summarized in table S1 (24) and are given in more detail in (24). This research was supported by NSF grant no. DEB 1009957 to A. H., E. D. G., J.N.S., A. L., and S.L.J.	Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Ayres DR, 2004, BIOL INVASIONS, V6, P221, DOI 10.1023/B:BINV.0000022140.07404.b7; Buckley YM, 2008, J APPL ECOL, V45, P397, DOI 10.1111/j.1365-2664.2008.01471.x; Clark C.W., 1990, MATH BIOECONOMICS OP; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Faber P, 2000, COAST OCEAN, V16, P14; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Groom M.J., 2006, PRINCIPLES CONSERVAT; Grosholz E.D., 2009, HUMAN IMPACTS SALT M, P23; Hambright KD, 2000, AQUAT CONSERV, V10, P393, DOI 10.1002/1099-0755(200011/12)10:6<393::AID-AQC419>3.0.CO;2-O; Hastings A, 2003, ECOL APPL, V13, pS65; Hastings A, 2006, THEOR POPUL BIOL, V70, P431, DOI 10.1016/j.tpb.2006.05.003; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Holge I., 2012, SAN FRANCISCO ESTUAR; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Levin LA, 2006, ECOLOGY, V87, P419, DOI 10.1890/04-1752; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mark Freeberg J.G.Pope, 1994, GLOBAL ASSESSMENT FI; Martin TG, 2006, BIOL CONSERV, V127, P201, DOI 10.1016/j.biocon.2005.08.014; McBroom J., 2011, 2010 CALIFORNIA CLAP; Nalle D. J., 2004, Journal of Environmental Economics and Management, V48, P997, DOI 10.1016/j.jeem.2004.01.001; Neilan W, 2006, BIOL CONSERV, V129, P393, DOI 10.1016/j.biocon.2005.11.007; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sogge MK, 2008, RESTOR ECOL, V16, P146, DOI 10.1111/j.1526-100X.2008.00357.x; Soule M. E., 1980, CONSERVATION BIOL EV; Strong DR, 2013, ANNU REV ECOL EVOL S, V44, P389, DOI 10.1146/annurev-ecolsys-110512-135803; SWANSON FJ, 1992, ECOL APPL, V2, P262, DOI 10.2307/1941860; Taylor CM, 2004, J APPL ECOL, V41, P1049, DOI 10.1111/j.0021-8901.2004.00979.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yokomizo H, 2012, BIOL INVASIONS, V14, P839, DOI 10.1007/s10530-011-0120-x	31	80	83	6	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1028	1031		10.1126/science.1250763	http://dx.doi.org/10.1126/science.1250763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876497				2022-12-24	WOS:000336495800045
J	Ravi, B; Jenkinson, R; Austin, PC; Croxford, R; Wasserstein, D; Escott, B; Paterson, JM; Kreder, H; Hawker, GA				Ravi, Bheeshma; Jenkinson, Richard; Austin, Peter C.; Croxford, Ruth; Wasserstein, David; Escott, Benjamin; Paterson, J. Michael; Kreder, Hans; Hawker, Gillian A.			Relation between surgeon volume and risk of complications after total hip arthroplasty: propensity score matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TOTAL KNEE REPLACEMENT; BODY-MASS INDEX; UNITED-STATES; PANCREATIC RESECTION; JOINT ARTHROPLASTY; SMOKING-CESSATION; DIABETES-MELLITUS; HOSPITAL VOLUME; SURGICAL VOLUME; OUTCOMES	Objectives To identify a cut point in annual surgeon volume associated with increased risk of complications after primary elective total hip arthroplasty and to quantify any risk identified. Design Propensity score matched cohort study. Setting Ontario, Canada Participants 37 881 people who received their first primary total hip arthroplasty during 2002-09 and were followed for at least two years after their surgery. Main outcome measure The rates of various surgical complications within 90 days (venous thromboembolism, death) and within two years (infection, dislocation, periprosthetic fracture, revision) of surgery. Results Multivariate splines were developed to visualize the relation between surgeon volume and the risk for various complications. A threshold of 35 cases a year was identified, under which there was an increased risk of dislocation and revision. 6716 patients whose total hip arthroplasty was carried out by surgeons who had done <= 35 such procedure in the previous year were successfully matched to patients whose surgeon had carried out more than 35 procedures. Patients in the former group had higher rates of dislocation (1.9% v 1.3%, P=0.006; NNH 172) and revision (1.5% v 1.0%, P=0.03; NNH 204). Conclusions In a cohort of first time recipients of total hip arthroplasty, patients whose operation was carried by surgeons who had performed 35 or fewer such procedures in the year before the index procedure were at increased risk for dislocation and early revision. Surgeons should consider performing 35 cases or more a year to minimize the risk for complications. Furthermore, the methods used to visualize the relationship between surgeon volume and the occurrence of complications can be easily applied in any jurisdiction, to help inform and optimize local healthcare delivery.	[Ravi, Bheeshma; Jenkinson, Richard; Wasserstein, David; Escott, Benjamin; Kreder, Hans] Univ Toronto, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada; [Austin, Peter C.; Croxford, Ruth; Paterson, J. Michael; Kreder, Hans; Hawker, Gillian A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Austin, Peter C.; Paterson, J. Michael; Kreder, Hans; Hawker, Gillian A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hawker, Gillian A.] Womens Coll Hosp, Dept Med, Div Rheumatol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Ravi, B (corresponding author), Univ Toronto, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada.	bheeshma.ravi@mail.utoronto.ca		Austin, Peter/0000-0003-3337-233X	Canadian Institutes of Health Research; Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care; FM Hill Chair in Academic Women's Medicine; Ministry of Health and Long-Term Care; CIHR [MOP-15468]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); FM Hill Chair in Academic Women's Medicine; Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research and by the Institute for Clinical Evaluative Sciences, a non-profit research institute funded by the Ontario Ministry of Health and Long-Term Care. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by the Institute for Clinical Evaluative Sciences or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. GAH is supported in part by the FM Hill Chair in Academic Women's Medicine. ICES received support from the Ministry of Health and Long-Term Care. CIHR Grant number: MOP-15468.	Agabiti N, 2007, INT J QUAL HEALTH C, V19, P37, DOI 10.1093/intqhc/mzl065; Alberton GM, 2002, J BONE JOINT SURG AM, V84A, P1788, DOI 10.2106/00004623-200210000-00008; Austin PC, 2011, STAT MED, V30, P1292, DOI 10.1002/sim.4200; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Baker P, 2011, SURG-J R COLL SURG E, V9, P13, DOI 10.1016/j.surge.2010.08.011; Bakhshi E, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/639124; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Bini S, 2013, J BONE JOINT SURG AM, V95A, P2195, DOI 10.2106/JBJS.L.01006; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Block EFJ, 2010, J TRAUMA, V69, P640, DOI 10.1097/TA.0b013e3181efbed9; Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9; Burns AWR, 2006, CLIN ORTHOP RELAT R, P29, DOI 10.1097/01.blo.0000214420.14088.76; Clyburn TA, 2013, J AM ACAD ORTHOP SUR; Collier R, 2010, CAN MED ASSOC J, V182, P331, DOI 10.1503/cmaj.109-3167; Colosia AD, 2013, DIABETES METAB SYNDR, V6, P327, DOI 10.2147/DMSO.S51325; Cook RE, 2008, CLIN ORTHOP RELAT R, V466, P1652, DOI 10.1007/s11999-008-0289-1; Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4; Cowan JA, 2003, J VASC SURG, V37, P1169, DOI 10.1016/S0741-5214(03)00085-5; Dawson NV, 2012, MED DECIS MAKING, V32, P225, DOI 10.1177/0272989X12437605; de Palma L, 2012, HIP INT, V22, P62, DOI 10.5301/HIP.2012.9059; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dobzyniak M, 2006, CLIN ORTHOP RELAT R, P76, DOI 10.1097/01.blo.0000203484.90711.52; FitzGerald JD, 2012, ARTHRIT CARE RES, V64, P890, DOI 10.1002/acr.21611; Franklin J, 2007, INJURY, V38, P655, DOI 10.1016/j.injury.2007.02.049; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Glazier RH, 2000, CAN J PUBLIC HEALTH, V91, P268, DOI 10.1007/BF03404286; Grossman E, 2008, ADV CARDIOL, V45, P82, DOI 10.1159/000115189; Gustafson P, 2002, BIOMETRICS, V58, P878, DOI 10.1111/j.0006-341X.2002.00878.x; Halimi JM, 2000, KIDNEY INT, V58, P1285, DOI 10.1046/j.1523-1755.2000.00284.x; HASTINGS DE, 1975, CLIN ORTHOP RELAT R, P76; Haverkamp D, 2011, ACTA ORTHOP, V82, P417, DOI 10.3109/17453674.2011.588859; Hu FB, 2003, LIPIDS, V38, P103, DOI 10.1007/s11745-003-1038-4; Hu JC, 2003, J CLIN ONCOL, V21, P401, DOI 10.1200/JCO.2003.05.169; Hubbard RE, 2009, J NUTR HEALTH AGING, V13, P468, DOI 10.1007/s12603-009-0085-y; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Information CIfH, 2008, RED GAPS HLTH FOC SO; Information CIfH, 2006, ASS THEIR HLTH STAT; Kapadia BH, 2014, J ARTHROPLASTY, V29, P777, DOI 10.1016/j.arth.2013.08.023; Katz JN, 2007, ARTHRITIS RHEUM, V56, P568, DOI 10.1002/art.22333; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; Katz JN, 2003, ARTHRITIS RHEUM, V48, P560, DOI 10.1002/art.10754; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; KIRK PG, 1993, CAN J SURG, V36, P229; Kluess D, 2007, MED ENG PHYS, V29, P465, DOI 10.1016/j.medengphy.2006.07.001; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kralj B, 2000, ONTARIO MED REV, P37; Kralj B., 2005, MEASURING RURALITY P; Lau RL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-250; LAVERNIA CJ, 1995, J ARTHROPLASTY, V10, P133, DOI 10.1016/S0883-5403(05)80119-6; Lewis Steven, 2004, Healthc Pap, V5, P12; LIEBERMAN MD, 1995, ANN SURG, V222, P638, DOI 10.1097/00000658-199511000-00006; Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008; Losina E, 2004, ARTHRITIS RHEUM-US, V50, P1338, DOI 10.1002/art.20148; Losina E, 2007, ARCH INTERN MED, V167, P182, DOI 10.1001/archinte.167.2.182; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; Masonis JL, 2002, CLIN ORTHOP RELAT R, P46, DOI 10.1097/01.blo.0000038476.05771.6c; Matheson F., 2011, ONTARIO MARGINALIZAT; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; Matheson FI, 2006, SOC SCI MED, V63, P2604, DOI 10.1016/j.socscimed.2006.07.001; Matheson FI, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112441; McMinn D, 2006, P I MECH ENG H, V220, P239, DOI 10.1243/095441105X68944; Morrey B F, 1992, J Arthroplasty, V7, P71, DOI 10.1016/0883-5403(92)90035-O; Morris AH, 2001, J BONE JOINT SURG AM, V83A, P1754, DOI 10.2106/00004623-200111000-00022; Moser BK, 2004, STAT MED, V23, P1843, DOI 10.1002/sim.1776; Nilsdotter AK, 2003, ANN RHEUM DIS, V62, P923, DOI 10.1136/ard.62.10.923; O'Donnell DE, 2012, PULM MED, V2012, DOI 10.1155/2012/818925; Papakostidou I, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-116; Paterson JM, 2010, CAN J SURG, V53, P175; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; RAGLAND DR, 1992, EPIDEMIOLOGY, V3, P434, DOI 10.1097/00001648-199209000-00009; Ravi B, 2014, ARTHRITIS RHEUMATOL, V66, P254, DOI 10.1002/art.38231; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Rutkowski P, 2006, J RENAL NUTR, V16, P216, DOI 10.1053/j.jrn.2006.04.017; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Santaguida PL, 2008, CAN J SURG, V51, P428; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; SHAH PK, 1988, CHEST, V94, P449, DOI 10.1378/chest.94.3.449; Simunovic M, 1999, CAN MED ASSOC J, V160, P643; Stavrakis AI, 2007, SURGERY, V142, P887, DOI 10.1016/j.surg.2007.09.003; Tashkin DP, 2009, RESP MED, V103, P963, DOI 10.1016/j.rmed.2009.02.013; Tu Karen, 2007, Open Med, V1, pe18; Urquhart DM, 2010, J ARTHROPLASTY, V25, P1216, DOI 10.1016/j.arth.2009.08.011; Weiner J., 2011, J HOPKINS ACG SYSTEM; White HL, 2011, HEALTH PLACE, V17, P361, DOI 10.1016/j.healthplace.2010.11.016; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540	88	150	151	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2014	348								g3284	10.1136/bmj.g3284	http://dx.doi.org/10.1136/bmj.g3284			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9AC	24859902	Green Published, hybrid			2022-12-24	WOS:000336429700004
J	Kirby, T				Kirby, Tony			Profile: Australia's Baker IDI Heart and Diabetes Institute	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1452	1452		10.1016/S0140-6736(14)60704-2	http://dx.doi.org/10.1016/S0140-6736(14)60704-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24779053				2022-12-24	WOS:000335325800012
J	Yamada, M; Johannesson, B; Sagi, I; Burnett, LC; Kort, DH; Prosser, RW; Paull, D; Nestor, MW; Freeby, M; Greenberg, E; Goland, RS; Leibel, RL; Solomon, SL; Benvenisty, N; Sauer, MV; Egli, D				Yamada, Mitsutoshi; Johannesson, Bjarki; Sagi, Ido; Burnett, Lisa Cole; Kort, Daniel H.; Prosser, Robert W.; Paull, Daniel; Nestor, Michael W.; Freeby, Matthew; Greenberg, Ellen; Goland, Robin S.; Leibel, Rudolph L.; Solomon, Susan L.; Benvenisty, Nissim; Sauer, Mark V.; Egli, Dieter			Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells	NATURE			English	Article							IN-VITRO; MOUSE; MATURATION; STABILITY; HOTSPOTS; PROTEIN; MEMORY; MODEL; ES	The transfer of somatic cell nuclei into oocytes can give rise to pluripotent stem cells that are consistently equivalent to embryonic stem cells(1-3), holding promise for autologous cell replacement therapy(4,5). Although methods to induce pluripotent stem cells from somatic cells by transcription factors(6) are widely used in basic research, numerous differences between induced pluripotent stem cells and embryonic stem cells have been reported(7-11), potentially affecting their clinical use. Because of the therapeutic potential of diploid embryonic stem-cell lines derived from adult cells of diseased human subjects, we have systematically investigated the parameters affecting efficiency of blastocyst development and stem-cell derivation. Here we show that improvements to the oocyte activation protocol, including the use of both kinase and translation inhibitors, and cell culture in the presence of histone deacetylase inhibitors, promote development to the blastocyst stage. Developmental efficiency varied between oocyte donors, and was inversely related to the number of days of hormonal stimulation required for oocyte maturation, whereas the daily dose of gonadotropin or the total number of metaphase II oocytes retrieved did not affect developmental outcome. Because the use of concentrated Sendai virus for cell fusion induced an increase in intracellular calcium concentration, causing premature oocyte activation, we used diluted Sendai virus in calcium-free medium. Using this modified nuclear transfer protocol, we derived diploid pluripotent stem-cell lines from somatic cells of a newborn and, for the first time, an adult, a female with type 1 diabetes.	[Yamada, Mitsutoshi; Johannesson, Bjarki; Paull, Daniel; Nestor, Michael W.; Solomon, Susan L.; Egli, Dieter] New York Stem Cell Fdn Res Inst, New York, NY 10032 USA; [Sagi, Ido; Benvenisty, Nissim] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Burnett, Lisa Cole; Freeby, Matthew; Greenberg, Ellen; Goland, Robin S.; Leibel, Rudolph L.] Columbia Univ, Coll Phys & Surg, Dept Pediat, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Kort, Daniel H.; Prosser, Robert W.; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Ctr Womens Reprod Care, New York, NY 10019 USA; [Kort, Daniel H.; Prosser, Robert W.; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10019 USA	Hebrew University of Jerusalem; Columbia University; Columbia University; Columbia University	Egli, D (corresponding author), New York Stem Cell Fdn Res Inst, New York, NY 10032 USA.	d.egli@nyscf.org			New York Stem Cell Foundation (NYSCF); New York State Stem Cell Science (NYSTEM) IIRP [C026184]; Russell Berrie Foundation Program in Cellular Therapies of Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007647] Funding Source: NIH RePORTER	New York Stem Cell Foundation (NYSCF); New York State Stem Cell Science (NYSTEM) IIRP; Russell Berrie Foundation Program in Cellular Therapies of Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported the New York Stem Cell Foundation (NYSCF) and a New York State Stem Cell Science (NYSTEM) IIRP Award no. C026184, and the Russell Berrie Foundation Program in Cellular Therapies of Diabetes. We thank S. Mitalipov for helpful discussions and providing reagents, S. Micucci for counting cells in S-phase, and Z. Hall for critical reading of the manuscript. D.E. is a NYSCF-Robertson Investigator.	Bar-Hava I, 2005, GYNECOL ENDOCRINOL, V21, P232, DOI 10.1080/09513590500282331; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Choudhary M, 2012, CELL STEM CELL, V10, P239, DOI 10.1016/j.stem.2012.02.001; Cohen MA, 1999, HUM REPROD, V14, P2755, DOI 10.1093/humrep/14.11.2755; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Egli D., 2014, PROTOCOL EXCH; Egli D, 2011, CELL STEM CELL, V9, P293, DOI 10.1016/j.stem.2011.08.002; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Egli Dieter, 2006, J Vis Exp, P116, DOI 10.3791/116; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Fan Y, 2011, STEM CELLS DEV, V20, P1951, DOI 10.1089/scd.2010.0451; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hua H, 2013, J CLIN INVEST, V123, P3146, DOI 10.1172/JCI67638; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Klitzman R, 2009, REPROD BIOMED ONLINE, V18, P603, DOI 10.1016/S1472-6483(10)60002-8; Koyanagi-Aoi M, 2013, P NATL ACAD SCI USA, V110, P20569, DOI 10.1073/pnas.1319061110; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu L, 2000, NAT BIOTECHNOL, V18, P223, DOI 10.1038/72692; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Shang LS, 2014, DIABETES, V63, P923, DOI 10.2337/db13-0717; STERN S, 1972, BIOL REPROD, V7, P341, DOI 10.1093/biolreprod/7.3.341; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tachibana M, 2010, NAT PROTOC, V5, P1138, DOI 10.1038/nprot.2010.75; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wang T, 2013, NAT CELL BIOL, V15, P700, DOI 10.1038/ncb2748; Winston NJ, 1997, BIOL CELL, V89, P211, DOI 10.1016/S0248-4900(97)80037-8	38	123	131	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					533	+		10.1038/nature13287	http://dx.doi.org/10.1038/nature13287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24776804				2022-12-24	WOS:000337806300046
J	Crombie, AT; Murrell, JC				Crombie, Andrew T.; Murrell, J. Colin			Trace-gas metabolic versatility of the facultative methanotroph Methylocella silvestris	NATURE			English	Article							METHANE MONOOXYGENASE; PROPANE; OXIDATION; ETHANE; SYSTEM	The climate-active gas methane is generated both by biological processes and by thermogenic decomposition of fossil organic material, which forms methane and short-chain alkanes, principally ethane, propane and butane(1,2). In addition to natural sources, environments are exposed to anthropogenic inputs of all these gases from oil and gas extraction and distribution. The gases provide carbon and/or energy for a diverse range of microorganisms that can metabolize them in both anoxic(3) and oxic zones. Aerobic methanotrophs, which can assimilate methane, have been considered to be entirely distinct from utilizers of short-chain alkanes, and studies of environments exposed to mixtures of methane and multi-carbon alkanes have assumed that disparate groups of microorganisms are responsible for the metabolism of these gases. Here we describe the mechanism by which a single bacterial strain, Methylocella silvestris, can use methane or propane as a carbon and energy source, documenting a methanotroph that can utilize a short-chain alkane as an alternative to methane. Furthermore, during growth on a mixture of these gases, efficient consumption of both gases occurred at the same time. Two soluble di-iron centre monooxygenase (SDIMO) gene clusters were identified and were found to be differentially expressed during bacterial growth on these gases, although both were required for efficient propane utilization. This report of a methanotroph expressing an additional SDIMO that seems to be uniquely involved in short-chain alkane metabolism suggests that such metabolic flexibility may be important in many environments where methane and short-chain alkanes co-occur.	[Crombie, Andrew T.; Murrell, J. Colin] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Murrell, JC (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	j.c.murrell@uea.ac.uk	Crombie, Andrew/C-9167-2012; Murrell, John C/B-1443-2012	Crombie, Andrew/0000-0002-8577-2602	Natural Environmental Research Council (NERC) [NE/E016855/1]; University of East Anglia; Earth and Life Systems Alliance of the Norwich Research Park; Natural Environment Research Council [NE/E016855/1, NER/A/S/2002/00876] Funding Source: researchfish; NERC [NE/E016855/1] Funding Source: UKRI	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of East Anglia; Earth and Life Systems Alliance of the Norwich Research Park; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environmental Research Council (NERC) grant (NE/E016855/1) and a NERC studentship to A.T.C. Additional funding was provided by the University of East Anglia and the Earth and Life Systems Alliance of the Norwich Research Park. We thank A. Johnston for critical reading of the manuscript.	ANTHONY C, 1964, BIOCHEM J, V92, P614, DOI 10.1042/bj0920614; ASHRAF W, 1994, FEMS MICROBIOL LETT, V122, P1, DOI 10.1111/j.1574-6968.1994.tb07134.x; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Chen Y, 2010, J BACTERIOL, V192, P3840, DOI 10.1128/JB.00506-10; COLBY J, 1977, BIOCHEM J, V165, P395, DOI 10.1042/bj1650395; Coleman NV, 2006, ENVIRON MICROBIOL, V8, P1228, DOI 10.1111/j.1462-2920.2006.01015.x; Cooley RB, 2009, MICROBIOL-SGM, V155, P2086, DOI 10.1099/mic.0.028175-0; Crombie A, 2011, METHOD ENZYMOL, P119, DOI 10.1016/B978-0-12-386905-0.00008-5; Dedysh SN, 2005, J BACTERIOL, V187, P4665, DOI 10.1128/JB.187.13.4665-4670.2005; Etiope G, 2013, MAR PETROL GEOL, V43, P178, DOI 10.1016/j.marpetgeo.2013.02.009; Etiope G, 2010, GLOBAL PLANET CHANGE, V72, P265, DOI 10.1016/j.gloplacha.2010.01.002; Etiope G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033623; Etiope G, 2009, SCIENCE, V323, P478, DOI 10.1126/science.1165904; Furuya T, 2011, APPL ENVIRON MICROB, V77, P1214, DOI 10.1128/AEM.02316-10; Gilbert B, 2000, APPL ENVIRON MICROB, V66, P966, DOI 10.1128/AEM.66.3.966-975.2000; GREEN MJ, 1984, METHOD ENZYMOL, V105, P3; Guerlava P, 1998, CURR MICROBIOL, V36, P131, DOI 10.1007/PL00006756; Hamamura N, 2000, FEMS MICROBIOL LETT, V186, P21, DOI 10.1111/j.1574-6968.2000.tb09076.x; Heider J, 1998, FEMS MICROBIOL REV, V22, P459, DOI 10.1111/j.1574-6976.1998.tb00381.x; Hinrichs KU, 2006, P NATL ACAD SCI USA, V103, P14684, DOI 10.1073/pnas.0606535103; Johnson EL, 2006, APPL ENVIRON MICROB, V72, P950, DOI 10.1128/AEM.72.1.950-952.2006; Kotani T, 2003, J BACTERIOL, V185, P7120, DOI 10.1128/JB.185.24.7120-7128.2003; Kotani T, 2006, J BIOSCI BIOENG, V102, P184, DOI 10.1263/jbb.102.184; Leahy JG, 2003, FEMS MICROBIOL REV, V27, P449, DOI 10.1016/S0168-6445(03)00023-8; MACKAY D, 1981, J PHYS CHEM REF DATA, V10, P1175, DOI 10.1063/1.555654; MANGO FD, 1994, NATURE, V368, P536, DOI 10.1038/368536a0; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; McDonald IR, 2008, APPL ENVIRON MICROB, V74, P1305, DOI 10.1128/AEM.02233-07; Osborn SG, 2011, P NATL ACAD SCI USA, V108, P8172, DOI 10.1073/pnas.1100682108; Patel NA, 2012, J PROTEOME RES, V11, P4755, DOI 10.1021/pr300253s; Patel VJ, 2009, J PROTEOME RES, V8, P3752, DOI 10.1021/pr900080y; PRIOR SD, 1985, FEMS MICROBIOL LETT, V29, P105; Rahman MT, 2011, ISME J, V5, P1061, DOI 10.1038/ismej.2010.190; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Reeburgh W.S., 2003, TREATISE GEOCHEM, V4, P347; Sambrook J., 2001, MOL CLONING LAB MANU; Semrau JD, 2011, FEMS MICROBIOL LETT, V323, P1, DOI 10.1111/j.1574-6968.2011.02315.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theisen AR, 2005, MOL MICROBIOL, V58, P682, DOI 10.1111/j.1365-2958.2005.04861.x	40	57	60	3	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					148	+		10.1038/nature13192	http://dx.doi.org/10.1038/nature13192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24776799	Green Accepted			2022-12-24	WOS:000336768900046
J	Liberali, P; Snijder, B; Pelkmans, L				Liberali, Prisca; Snijder, Berend; Pelkmans, Lucas			A Hierarchical Map of Regulatory Genetic Interactions in Membrane Trafficking	CELL			English	Article							ORGANIZATION; ENDOCYTOSIS; RNAI; ENDOSOME; KINASES; PATHWAY; SCREEN; YEAST	Endocytosis is critical for cellular physiology and thus is highly regulated. To identify regulatory interactions controlling the endocytic membrane system, we conducted 13 RNAi screens on multiple endocytic activities and their downstream organelles. Combined with image analysis of thousands of single cells per perturbation and their cell-to-cell variability, this created a high-quality and cross-comparable quantitative data set. Unbiased analysis revealed emergent properties of the endocytic membrane system and how its complexity evolved and distinct programs of regulatory control that coregulate specific subsets of endocytic uptake routes and organelle abundances. We show that these subset effects allow the mapping of functional regulatory interactions and their interaction motifs between kinases, membrane-trafficking machinery, and the cytoskeleton at a large scale, some of which we further characterize. Our work presents a powerful approach to identify regulatory interactions in complex cellular systems from parallel single-gene or double-gene perturbation screens in human cells and yeast.	[Liberali, Prisca; Snijder, Berend; Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Liberali, P (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	prisca.liberali@uzh.ch; lucas.pelkmans@imls.uzh.ch	Snijder, Berend/O-9206-2019; Snijder, Berend/M-2998-2017	Snijder, Berend/0000-0003-3386-6583; Liberali, Prisca/0000-0003-0695-6081; Pelkmans, Lucas/0000-0002-6754-9730	FEBS; SystemsX.ch Research, Technology, and Development project PhosphoNetX; SystemsX.ch Research, Technology, and Development project LipidX; University of Zurich	FEBS; SystemsX.ch Research, Technology, and Development project PhosphoNetX; SystemsX.ch Research, Technology, and Development project LipidX; University of Zurich	We thank Y. Heer, N. Battich, B. Thijssen, M. Stark, C. von Meering, and K. Mench for help with experiments and computation, Y. Yakimovich for IT support, and lab members for comments on the manuscript. P. L. is supported by a FEBS. L. P. acknowledges financial support from the SystemsX.ch Research, Technology, and Development projects PhosphoNetX and LipidX and the University of Zurich.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Liberali P, 2008, ANNU REV CELL DEV BI, V24, P501, DOI 10.1146/annurev.cellbio.041008.145637; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Moustakas A, 1999, J CELL SCI, V112, P1169; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/nmeth.2398, 10.1038/NMETH.2398]; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Walz HA, 2010, J BIOL CHEM, V285, P14101, DOI 10.1074/jbc.M110.110536	38	66	66	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1473	1487		10.1016/j.cell.2014.04.029	http://dx.doi.org/10.1016/j.cell.2014.04.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906158	Bronze			2022-12-24	WOS:000340881400021
J	McCall, AS; Cummings, CF; Bhave, G; Vanacore, R; Page-McCaw, A; Hudson, BG				McCall, A. Scott; Cummings, Christopher F.; Bhave, Gautam; Vanacore, Roberto; Page-McCaw, Andrea; Hudson, Billy G.			Bromine Is an Essential Trace Element for Assembly of Collagen IV Scaffolds in Tissue Development and Architecture	CELL			English	Article							BASEMENT-MEMBRANE; EXTRACELLULAR-MATRIX; DROSOPHILA; THIOCYANATE; MUTATIONS; ACIDS; INTERMEDIATE; REACTIVITY; OXIDATION; ELEGANS	Bromine is ubiquitously present in animals as ionic bromide (Br-) yet has no known essential function. Herein, we demonstrate that Br- is a required cofactor for peroxidasin-catalyzed formation of sulfilimine crosslinks, a posttranslational modification essential for tissue development and architecture found within the collagen IV scaffold of basement membranes (BMs). Bromide, converted to hypobromous acid, forms a bromosulfonium-ion intermediate that energetically selects for sulfilimine formation. Dietary Br deficiency is lethal in Drosophila, whereas Br replenishment restores viability, demonstrating its physiologic requirement. Importantly, Br-deficient flies phenocopy the developmental and BM defects observed in peroxidasin mutants and indicate a functional connection between Br-, collagen IV, and peroxidasin. We establish that Br- is required for sulfilimine formation within collagen IV, an event critical for BM assembly and tissue development. Thus, bromine is an essential trace element for all animals, and its deficiency may be relevant to BM alterations observed in nutritional and smoking-related disease.	[McCall, A. Scott] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Cummings, Christopher F.; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Cummings, Christopher F.; Bhave, Gautam; Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Ctr Matrix Biol, Nashville, TN 37232 USA; [Page-McCaw, Andrea] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Page-McCaw, Andrea] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Page-McCaw, Andrea; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc3, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hudson, BG (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 607 Light Hall, Nashville, TN 37232 USA.	billy.hudson@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020	Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100	NIH [R01 DK18381, F30 DK100094-01, KO8 DK097306, R01 GM073883]; NIGMS [T32 GM07347]; Canby Robinson Society; Vanderbilt Physician Scientist Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381, F30DK100094, K08DK097306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R01GM073883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canby Robinson Society; Vanderbilt Physician Scientist Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following: NIH R01 DK18381 to B. G. H.; NIH F30 DK100094-01 to A. S. M.; NIGMS T32 GM07347 to the Vanderbilt Medical-Scientist Training Program and the Canby Robinson Society in support of A. S. M.; NIH KO8 DK097306 and the Vanderbilt Physician Scientist Development Award to G. B.; and NIH R01 GM073883 to A.P.-M. We are grateful to K. L. Rose at Vanderbilt Mass Spectrometry Resource Center; J. Clanton, X. Wang, and E. Shannon for assistance with Drosophila; J. Williams and W. G. Jerome for assistance with Electron Microscopy and sample preparation, performed with use of the VUMC Cell Imaging Shared Resource; and the Bloomington Drosophila Stock Center, Yale FlyTrap, and the VDRC for fly stocks. The technical assistance of P. Todd and M. Rafi is appreciated. We acknowledge S. Kraft for helpful chemistry discussions. C. F. C. and B. G. H. are cofounders of SULFILATEC, INC. C. F. C. is a director and officer without salary of SULFILATEC, INC.	ANKE M, 1990, Acta Agronomica Hungarica, V39, P297; Armesto XL, 2000, TETRAHEDRON, V56, P1103, DOI 10.1016/S0040-4020(99)01066-2; ASMUSSEN I, 1979, Clinical Cardiology, V2, P246; BARRATT TM, 1969, J CLIN INVEST, V48, P56, DOI 10.1172/JCI105974; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Borchiellini C, 1996, MECH DEVELOP, V58, P179, DOI 10.1016/S0925-4773(96)00574-6; BOZEMAN PM, 1990, J IMMUNOL METHODS, V126, P125, DOI 10.1016/0022-1759(90)90020-V; Brodie BB, 1939, J BIOL CHEM, V130, P555; Chmutova G., 1999, RUSS J ORG CHEM+, V35, P56; DAHLSTROM KA, 1986, J PEDIATR-US, V109, P625, DOI 10.1016/S0022-3476(86)80225-6; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Groos S, 2003, J SURG RES, V109, P74, DOI 10.1016/S0022-4804(02)00094-X; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; Haigo SL, 2011, SCIENCE, V331, P1071, DOI 10.1126/science.1199424; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; KLOPMAN G, 1968, J AM CHEM SOC, V90, P223, DOI 10.1021/ja01004a002; LANGEVELD JPM, 1988, J BIOL CHEM, V263, P10481; LIN CQ, 1993, FASEB J, V7, P737, DOI 10.1096/fasebj.7.9.8330681; MAYENO AN, 1989, J BIOL CHEM, V264, P5660; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Miura Y, 2002, NUCL INSTRUM METH B, V189, P443, DOI 10.1016/S0168-583X(01)01122-3; Nagy P, 2006, CHEM RES TOXICOL, V19, P587, DOI 10.1021/tx050338c; Nielsen FH, 1998, J TRACE ELEM EXP MED, V11, P251, DOI 10.1002/(SICI)1520-670X(1998)11:2/3&lt;251::AID-JTRA15&gt;3.0.CO;2-Q; Oe P., 1981, TRACE ELEMENT METABO, P526; Olszowy HA, 1998, J ANAL TOXICOL, V22, P225, DOI 10.1093/jat/22.3.225; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Pavelka S, 2005, PHYSIOL RES, V54, P639, DOI 10.33549/physiolres.930691; PEARSON RG, 1968, J CHEM EDUC, V45, P581, DOI 10.1021/ed045p581; Peskin AV, 2009, BIOCHEMISTRY-US, V48, P10175, DOI 10.1021/bi901266w; PIEDADEGUERREIRO J, 1987, J RADIOAN NUCL CH AR, V110, P531, DOI 10.1007/BF02035542; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rodriguez A, 1996, GENETICS, V143, P929; SEEMAN JI, 1983, CHEM REV, V83, P83, DOI 10.1021/cr00054a001; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; Soltani A, 2012, HISTOPATHOLOGY, V60, P964, DOI 10.1111/j.1365-2559.2011.04147.x; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; TRAUTNER M, 1968, ACTA PHYSIOL SCAND, V74, P606, DOI 10.1111/j.1748-1716.1968.tb04271.x; Tsuge K, 2000, J HEALTH SCI, V46, P343; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; VANLEEUWEN FXR, 1987, CRIT REV TOXICOL, V18, P189, DOI 10.3109/10408448709089861; VANLOGTEN MJ, 1974, TOXICOLOGY, V2, P257, DOI 10.1016/0300-483X(74)90017-1; VRACKO R, 1974, AM J PATHOL, V77, P314; WALLAEYS B, 1986, KIDNEY INT, V30, P599, DOI 10.1038/ki.1986.227; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WOLF RL, 1950, AM J PHYSIOL, V163, P436, DOI 10.1152/ajplegacy.1950.163.2.436; WOODS AE, 1979, B ENVIRON CONTAM TOX, V23, P179, DOI 10.1007/BF01769938; YOUNG PR, 1978, J AM CHEM SOC, V100, P7121, DOI 10.1021/ja00490a082; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	53	224	226	6	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1380	1392		10.1016/j.cell.2014.05.009	http://dx.doi.org/10.1016/j.cell.2014.05.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906154	Green Accepted, Bronze			2022-12-24	WOS:000340881400014
J	Zumla, A; Hui, DS				Zumla, Alimuddin; Hui, David S.			Infection control and MERS-CoV in health-care workers	LANCET			English	Editorial Material							ACUTE RESPIRATORY SYNDROME; HONG-KONG; CORONAVIRUS; SARS; OUTBREAK		[Zumla, Alimuddin] UCL, Dept Infect, Div Infect & Immun, Ctr Clin Microbiol, London, England; [Zumla, Alimuddin] Univ Coll London Hosp, NIHR Biomed Res Ctr, London, England; [Hui, David S.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Hui, David S.] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Chinese University of Hong Kong; Chinese University of Hong Kong	Hui, DS (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	dschui@cuhk.edu.hk	Hui, David Shu-Cheong/O-2754-2015; ZUMLA, Alimuddin/ABA-8208-2020	Hui, David Shu-Cheong/0000-0003-4382-2445; ZUMLA, Alimuddin/0000-0002-5111-5735				Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; CDC, 2014, INT INF PREV CONTR R; Hijawi B, 2013, E MEDITERR HEALTH J, V19, pS12; Hui DS, 2014, CURR OPIN PULM MED, V20, P233, DOI 10.1097/MCP.0000000000000046; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Seto WH, 2013, E MEDITERR HEALTH J, V19, pS39; SIEGEL JD, 2007, 2007 GUID IS PREC PR; Tomlinson B, 2003, LANCET, V361, P1486, DOI 10.1016/S0140-6736(03)13218-7; WHO, 2014, GLOB AL RESP MIDD E; WHO (World Health Organization), 2016, ASS RISK ASS INFL A; World Health Organization, 2014, WHO STAT 5 M IHR EM; Yu IT, 2007, CLIN INFECT DIS, V44, P1017, DOI 10.1086/512819; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	17	58	59	2	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1869	1871		10.1016/S0140-6736(14)60852-7	http://dx.doi.org/10.1016/S0140-6736(14)60852-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24857701	Bronze, Green Published			2022-12-24	WOS:000336847800011
J	Lu, M; Zak, J; Chen, SO; Sanchez-Pulido, L; Severson, DT; Endicott, J; Ponting, CP; Schofield, CJ; Lu, X				Lu, Min; Zak, Jaroslav; Chen, Shuo; Sanchez-Pulido, Luis; Severson, David T.; Endicott, Jane; Ponting, Chris P.; Schofield, Christopher J.; Lu, Xin			A Code for RanGDP Binding in Ankyrin Repeats Defines a Nuclear Import Pathway	CELL			English	Article							CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; TRANSPORT FACTOR; PROTEIN IMPORT; LOCALIZATION; P53; CELLS; ASPP1; INHIBITOR; APOPTOSIS	Regulation of nuclear import is fundamental to eukaryotic biology. The majority of nuclear import pathways are mediated by importin-cargo interactions. Yet not all nuclear proteins interact with importins, necessitating the identification of a general importin-independent nuclear import pathway. Here, we identify a code that determines importin-independent nuclear import of ankyrin repeats (ARs), a structural motif found in over 250 human proteins with diverse functions. AR-containing proteins (ARPs) with a hydrophobic residue at the 13th position of two consecutive ARs bind RanGDP efficiently, and consequently enter the nucleus. This code, experimentally tested in 17 ARPs, predicts the nuclear-cytoplasmic localization of over 150 annotated human ARPs with high accuracy and is acquired by the most common familial melanoma-associated CDKN2A mutation, leading to nuclear accumulation of mutant p16ink4a. The RaDAR (RanGDP/AR) pathway represents a general importin-independent nuclear import pathway and is frequently used by AR-containing transcriptional regulators, especially those regulating NF-kappa B/p53.	[Lu, Min; Zak, Jaroslav; Chen, Shuo; Severson, David T.; Lu, Xin] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford OX3 7DQ, England; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3PT, England; [Endicott, Jane] Univ Newcastle, Northern Inst Canc Res, Newcastle NE2 4HH, Tyne & Wear, England; [Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England	Ludwig Institute for Cancer Research; University of Oxford; University of Oxford; Newcastle University - UK; University of Oxford	Lu, X (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford OX3 7DQ, England.	xin.lu@ludwig.ox.ac.uk	lu, min/E-5407-2014; Ponting, Chris/AAV-2621-2021	Ponting, Chris/0000-0003-0202-7816; Zak, Jaroslav/0000-0002-8135-856X; Schofield, Christopher/0000-0002-0290-6565; lu, min/0000-0001-6902-3751; Sanchez Pulido, Luis/0000-0002-2300-8502; Endicott, Jane/0000-0003-4868-0116; Severson, David T/0000-0002-1750-8332; Lu, Xin/0000-0002-6587-1152	Ludwig Institute for Cancer Research Ltd.; Biotechnology and Biological Sciences Research Council [BB/L009846/1] Funding Source: researchfish; Medical Research Council [G0901526, MC_UU_12021/1, MC_U137761446] Funding Source: researchfish; BBSRC [BB/L009846/1] Funding Source: UKRI; MRC [MC_UU_12021/1, G0901526, MC_U137761446] Funding Source: UKRI	Ludwig Institute for Cancer Research Ltd.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Ludwig Institute for Cancer Research Ltd. We thank Andrew Wilde, Katrien Van Impe, Paul Clarke, Svitlana Korolchuk, Ming Yang, Vann Bennett, Matthew Cockman, and Mark Hannink for the generous gift of plasmids or proteins. We thank Yvonne Jones for generous access to facilities for protein production. We thank Claire Beveridge and Kimberley Bryon-Dodd for critical reading of the manuscript.	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aylon Y, 2010, GENE DEV, V24, P2420, DOI 10.1101/gad.1954410; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chaillan-Huntington C, 2000, J BIOL CHEM, V275, P5874, DOI 10.1074/jbc.275.8.5874; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dreier B, 2013, P NATL ACAD SCI USA, V110, pE869, DOI 10.1073/pnas.1213653110; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Ghiorzo P, 2004, HUM PATHOL, V35, P25, DOI 10.1016/j.humpath.2003.08.017; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Kim S, 2013, BIOPHYS J, V105, P565, DOI 10.1016/j.bpj.2013.04.025; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Notari M, 2011, P NATL ACAD SCI USA, V108, P16645, DOI 10.1073/pnas.1102292108; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Slee EA, 2004, ONCOGENE, V23, P9007, DOI 10.1038/sj.onc.1208088; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Wang Y, 2013, CELL DEATH DIFFER, V20, P525, DOI 10.1038/cdd.2013.3; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662	46	50	51	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1130	1145		10.1016/j.cell.2014.05.006	http://dx.doi.org/10.1016/j.cell.2014.05.006			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855949	Bronze			2022-12-24	WOS:000336437200015
J	Shimizu, H; Woodcock, SA; Wilkin, MB; Trubenova, B; Monk, NAM; Baron, M				Shimizu, Hideyuki; Woodcock, Simon A.; Wilkin, Marian B.; Trubenova, Barbora; Monk, Nicholas A. M.; Baron, Martin			Compensatory Flux Changes within an Endocytic Trafficking Network Maintain Thermal Robustness of Notch Signaling	CELL			English	Article							OF-DELTEX GENE; DROSOPHILA-MELANOGASTER; ACTIVATION; RECEPTOR; PATHWAY; SUPPRESSOR; REGULATOR; REQUIRES; COMPLEX	Developmental signaling is remarkably robust to environmental variation, including temperature. For example, in ectothermic animals such as Drosophila, Notch signaling is maintained within functional limits across a wide temperature range. We combine experimental and computational approaches to show that temperature compensation of Notch signaling is achieved by an unexpected variety of endocytic-dependent routes to Notch activation which, when superimposed on ligand-induced activation, act as a robustness module. Thermal compensation arises through an altered balance of fluxes within competing trafficking routes, coupled with temperature-dependent ubiquitination of Notch. This flexible ensemble of trafficking routes supports Notch signaling at low temperature but can be switched to restrain Notch signaling at high temperature and thus compensates for the inherent temperature sensitivity of ligand-induced activation. The outcome is to extend the physiological range over which normal development can occur. Similar mechanisms may provide thermal robustness for other developmental signals.	[Shimizu, Hideyuki; Woodcock, Simon A.; Wilkin, Marian B.; Trubenova, Barbora; Baron, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Monk, Nicholas A. M.] Univ Sheffield, Sch Math & Stat, Sheffield S3 7RH, S Yorkshire, England	University of Manchester; University of Sheffield	Baron, M (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	mbaron@manchester.ac.uk	Trubenova, Barbora/GQB-4224-2022	Trubenova, Barbora/0000-0002-6873-2967; Love, Marian/0000-0003-2203-3551; Monk, Nick/0000-0002-5465-4857	Manchester Fly Facility; Biotechnology and Biological Sciences Research Council [H000976]; Wellcome Trust [087928]; BBSRC [BB/H000976/1, BB/E002285/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H000976/1, BB/C503162/1, BB/E002285/1] Funding Source: researchfish	Manchester Fly Facility; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Sarah Bray, Gunter Merdes, Spyros Artavanis-Tsakonas, Matthew Scott, Helmut Kramer, Suzanne Eaton, Stephen Brown, Michael Cornell, Bezhad Rowshanravan, David Hughes, the Bloomington Drosophila Stock Center (University of Indiana), and the Developmental Studies Hybridoma Bank (University of Iowa) for reagents, constructs, and fly lines, and the University of Sheffield RNAi Screening Facility, (Wellcome Trust-084757) for RNAi. We also acknowledge technical support from Deborah Ashworth, Sanjai Patel and the Manchester Fly Facility, and the Biotechnology and Biological Sciences Research Council (H000976) and Wellcome Trust (087928) for funding. We thank Shane Herbert for critical discussion. Research materials generated in this work are available on request.	Allgood AG, 2011, J MOL BIOL, V414, P243, DOI 10.1016/j.jmb.2011.09.050; Baron M, 2012, SEMIN CELL DEV BIOL, V23, P437, DOI 10.1016/j.semcdb.2012.01.008; Bishop SA, 1999, DEVELOPMENT, V126, P2993; Christian AE, 1997, J LIPID RES, V38, P2264; Cornell M, 1999, GENETICS, V152, P567; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Fostier M, 1998, GENETICS, V150, P1477; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Hori K, 2011, J CELL BIOL, V195, P1005, DOI 10.1083/jcb.201104146; Hortsch R, 2010, MOL BIOL CELL, V21, P778, DOI 10.1091/mbc.E09-01-0005; Katkere B, 2010, J IMMUNOL, V185, P5032, DOI 10.4049/jimmunol.1001653; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Mazaleyrat SL, 2003, DEV BIOL, V255, P363, DOI 10.1016/S0012-1606(02)00086-6; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Schmid SL, 2013, NATURE, V499, P161, DOI 10.1038/nature12408; Schneider M, 2013, J CELL SCI, V126, P645, DOI 10.1242/jcs.116590; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Venkatachalam K, 2013, AUTOPHAGY, V9, P98, DOI 10.4161/auto.22260; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Whiteman P, 2013, J BIOL CHEM, V288, P7305, DOI 10.1074/jbc.M112.428854; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; XU T, 1990, GENETICS, V126, P665; Zheng L, 2013, MOL BIOL CELL, V24, P297, DOI 10.1091/mbc.E12-02-0081	30	44	46	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1160	1174		10.1016/j.cell.2014.03.050	http://dx.doi.org/10.1016/j.cell.2014.03.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855951	hybrid, Green Published			2022-12-24	WOS:000336437200017
J	Steinhoff, MC; MacDonald, N; Pfeifer, D; Muglia, LJ				Steinhoff, Mark C.; MacDonald, Noni; Pfeifer, Dina; Muglia, Louis J.			Influenza vaccine in pregnancy: policy and research strategies	LANCET			English	Editorial Material							NEONATAL OUTCOMES; PRETERM BIRTH; H1N1 INFLUENZA; IMMUNIZATION		[Steinhoff, Mark C.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Global Child Hlth Ctr, Cincinnati, OH 45229 USA; [MacDonald, Noni] Dalhousie Univ, IWK Hlth Ctr, Halifax, NS, Canada; [Pfeifer, Dina] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; [Muglia, Louis J.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Ctr Prevent Preterm Birth, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Dalhousie University; World Health Organization; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Steinhoff, MC (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Global Child Hlth Ctr, Cincinnati, OH 45229 USA.	mark.steinhoff@cchmc.org			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Dodds L, 2012, J OBSTET GYNAECOL CA, V34, P714, DOI 10.1016/S1701-2163(16)35336-1; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Kallen B, 2012, BJOG-INT J OBSTET GY, V119, P1583, DOI 10.1111/j.1471-0528.2012.03470.x; Legge A, 2014, CAN MED ASSOC J, V186, pE157, DOI 10.1503/cmaj.130499; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Poehling KA, 2013, PEDIATRICS, V131, P207, DOI 10.1542/peds.2012-1255; Rasmussen SA, 2012, AM J OBSTET GYNECO S, V207, P3; Richards JL, 2013, CLIN INFECT DIS, V56, P1216, DOI 10.1093/cid/cit045; Rubinstein F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f393; Steinhoff MC, 2012, CAN MED ASSOC J, V184, P645, DOI 10.1503/cmaj.110754; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	14	27	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1611	1613		10.1016/S0140-6736(14)60583-3	http://dx.doi.org/10.1016/S0140-6736(14)60583-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG8LV	24814446				2022-12-24	WOS:000335670800004
J	Agarwal, G; Stevenson, IH; Berenyi, A; Mizuseki, K; Buzsaki, G; Sommer, FT				Agarwal, Gautam; Stevenson, Ian H.; Berenyi, Antal; Mizuseki, Kenji; Buzsaki, Gyoergy; Sommer, Friedrich T.			Spatially Distributed Local Fields in the Hippocampus Encode Rat Position	SCIENCE			English	Article							PLACE CELLS; COMPONENT ANALYSIS; THETA-RHYTHM; EEG; RECONSTRUCTION; ENSEMBLE; ORIGIN; CORTEX; MEMORY	Although neuronal spikes can be readily detected from extracellular recordings, synaptic and subthreshold activity remains undifferentiated within the local field potential (LFP). In the hippocampus, neurons discharge selectively when the rat is at certain locations, while LFPs at single anatomical sites exhibit no such place-tuning. Nonetheless, because the representation of position is sparse and distributed, we hypothesized that spatial information can be recovered from multiple-site LFP recordings. Using high-density sampling of LFP and computational methods, we show that the spatiotemporal structure of the theta rhythm can encode position as robustly as neuronal spiking populations. Because our approach exploits the rhythmicity and sparse structure of neural activity, features found in many brain regions, it is useful as a general tool for discovering distributed LFP codes.	[Agarwal, Gautam; Stevenson, Ian H.; Sommer, Friedrich T.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA; [Berenyi, Antal; Mizuseki, Kenji; Buzsaki, Gyoergy] NYU, Sch Med, Ctr Neural Sci, Inst Neurosci, New York, NY 10016 USA; [Berenyi, Antal; Mizuseki, Kenji; Buzsaki, Gyoergy] Univ Szeged, Magyar Tudomanyos Akad Szegedi Tudomanyegyetem MT, Momentum Oscillatory Neuronal Networks Res Grp, Dept Physiol, H-6720 Szeged, Hungary	University of California System; University of California Berkeley; New York University; Szeged University	Buzsaki, G (corresponding author), NYU, Sch Med, Ctr Neural Sci, Inst Neurosci, New York, NY 10016 USA.	gyorgy.buzsaki@nyumc.org; fsommer@berkeley.edu	Mizuseki, Kenji/A-9214-2011; Berényi, Antal/A-9174-2013	Mizuseki, Kenji/0000-0002-1456-2149; Berényi, Antal/0000-0003-0084-8530; Buzsaki, Gyorgy/0000-0002-3100-4800; Stevenson, Ian/0000-0002-1428-5946; Agarwal, Gautam/0000-0001-7300-7586	NIH National Research Service Award [1F32MH093048]; NSF CIF-D-018 [0937060, 0855272, 1219212]; Marie Curie FP7-PEOPLE-2009-IOF grant [254780]; EU-FP7-ERC-2013-Starting grant [337075]; Lendulet program of the Hungarian Academy of Sciences; Japan Society for the Promotion of Science's Research Fellowship for Research Abroad; NIH [NS-034994, MH-54671, NS074015]; NSF SBE [0542013]; J. D. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH093048, R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS074015] Funding Source: NIH RePORTER; Division Of Computer and Network Systems [0855272] Funding Source: National Science Foundation	NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CIF-D-018; Marie Curie FP7-PEOPLE-2009-IOF grant; EU-FP7-ERC-2013-Starting grant; Lendulet program of the Hungarian Academy of Sciences; Japan Society for the Promotion of Science's Research Fellowship for Research Abroad; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF SBE; J. D. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by NIH National Research Service Award fellowship no. 1F32MH093048 (G.A.); NSF CIF-D-018 no. 0937060 (I. H. S.); Marie Curie FP7-PEOPLE-2009-IOF grant no. 254780, EU-FP7-ERC-2013-Starting grant no. 337075, and the Lendulet program of the Hungarian Academy of Sciences (A. B.); Japan Society for the Promotion of Science's Research Fellowship for Research Abroad (K. M.); NIH nos. NS-034994, MH-54671, and NS074015, NSF SBE no. 0542013, and the J. D. McDonnell Foundation (G. B.); NSF nos. 0855272 and 1219212 (F. S.). We thank D. Kaufman and J. Wolfe for advice on movies; C. Thanapirom for suggesting the Kuramoto model for rendering; K. D. Harris for suggestions about modeling; A. Khosrowshahi, J. Culpepper, C. Cadieu, and B. Olshausen for convolutional sparse coding; Walter Freeman for feedback; and members of the Buzsaki laboratory and the Redwood Center for discussions. All data collected from 32- to 64-electrode arrays is available in the hc-3 data set at crcns. org (26).	Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; de Cheveigne A, 2013, J NEUROPHYSIOL, V109, P261, DOI 10.1152/jn.00040.2012; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; FREEMAN WJ, 1987, BEHAV NEUROSCI, V101, P393, DOI 10.1037/0735-7044.101.3.393; Freeman WJ, 2004, CLIN NEUROPHYSIOL, V115, P2077, DOI 10.1016/j.clinph.2004.02.029; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Hillar C., 2011, CAN DICT LEARNING UN; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; JOHN ER, 1972, SCIENCE, V177, P850, DOI 10.1126/science.177.4052.850; Khosrowshahi A., 2010, EXPLORING STAT STRUC; Leski S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003137; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Mizuseki K., 2013, Multiple single unit recordings from different rat hippocampal and entorhinal regions while the animals were performing multiple behavioral tasks; Novey Mike, 2006, Proceedings of the 2006 IEEE Signal Processing Society Workshop, P79, DOI 10.1109/MLSP.2006.275526; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Schmidt R, 2009, J NEUROSCI, V29, P13232, DOI 10.1523/JNEUROSCI.2270-09.2009; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	26	89	89	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					626	630		10.1126/science.1250444	http://dx.doi.org/10.1126/science.1250444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812401	Green Accepted			2022-12-24	WOS:000335537400042
J	Ding, QH; Wallace, JM; Battisti, DS; Steig, EJ; Gallant, AJE; Kim, HJ; Geng, L				Ding, Qinghua; Wallace, John M.; Battisti, David S.; Steig, Eric J.; Gallant, Ailie J. E.; Kim, Hyung-Jin; Geng, Lei			Tropical forcing of the recent rapid Arctic warming in northeastern Canada and Greenland	NATURE			English	Article							SEA-ICE; SURFACE-TEMPERATURE	Rapid Arctic warming and sea-ice reduction in the Arctic Ocean are widely attributed to anthropogenic climate change(1-3). The Arctic warming exceeds the global average warming because of feedbacks that include sea-ice reduction(4,5) and other dynamical and radiative feedbacks(6-13). We find that the most prominent annual mean surface and tropospheric warming in the Arctic since 1979 has occurred in northeastern Canada and Greenland. In this region, much of the year-to-year temperature variability is associated with the leading mode of large-scale circulation variability in the North Atlantic, namely, the North Atlantic Oscillation(14,15). Here we show that the recent warming in this region is strongly associated with a negative trend in the North Atlantic Oscillation, which is a response to anomalous Rossby wave-train activity originating in the tropical Pacific. Atmospheric model experiments forced by prescribed tropical sea surface temperatures simulate the observed circulation changes and associated tropospheric and surface warming over northeastern Canada and Greenland. Experiments from the Coupled Model Intercomparison Project Phase 5 (ref. 16) models with prescribed anthropogenic forcing show no similar circulation changes related to the North Atlantic Oscillation or associated tropospheric warming. This suggests that a substantial portion of recent warming in the northeastern Canada and Greenland sector of the Arctic arises from unforced natural variability.	[Ding, Qinghua; Steig, Eric J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Ding, Qinghua; Steig, Eric J.] Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; [Wallace, John M.; Battisti, David S.; Geng, Lei] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Gallant, Ailie J. E.] Monash Univ, Sch Geog & Environm Sci, Clayton, Vic 3800, Australia; [Kim, Hyung-Jin] APEC Climate Ctr, Climate Res Dept, Pusan 612020, South Korea	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Monash University	Ding, QH (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	qinghua@uw.edu	Steig, Eric J/G-9088-2015; Battisti, David S/A-3340-2013; geng, lei/O-6804-2014; ding, qinghua/G-1186-2011; Geng, Lei/M-3418-2018	Steig, Eric J/0000-0002-8191-5549; Battisti, David S/0000-0003-4871-1293; Geng, Lei/0000-0003-2175-2538; Gallant, Ailie/0000-0002-7917-1069	US National Science Foundation [OPP 1043092, ATM 1122989]; University of Washington's Quaternary Research Center; National Basic Research Program of China (973 Program) [2013CB430203]; APEC Climate Center	US National Science Foundation(National Science Foundation (NSF)); University of Washington's Quaternary Research Center; National Basic Research Program of China (973 Program)(National Basic Research Program of China); APEC Climate Center	We thank the Max Planck Institute for Meteorology model developer for making ECHAM4.6 available and C. Bitz, Q. Fu, D. L. Hartmann, D. Frierson and W.-J. Li for discussion. This work was supported by the US National Science Foundation (OPP 1043092 and ATM 1122989). Q. D. acknowledges support from the University of Washington's Quaternary Research Center and the National Basic Research Program of China (973 Program-2013CB430203). H.-J.K. acknowledges support from the APEC Climate Center.	Abbot DS, 2009, J CLIMATE, V22, P5719, DOI 10.1175/2009JCLI2854.1; [Anonymous], 2006, EOS T AM GEOPHYS UN, DOI DOI 10.1029/2006EO460001; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Bromwich DH, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007859; Chylek P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038777; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Graf HF, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016493; Graversen RG, 2008, NATURE, V451, P53, DOI 10.1038/nature06502; Guilyardi E, 2012, B AM METEOROL SOC, V93, P235, DOI 10.1175/BAMS-D-11-00106.1; Hansen J, 2004, P NATL ACAD SCI USA, V101, P423, DOI 10.1073/pnas.2237157100; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Huffman GJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040000; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Lee S, 2012, J CLIMATE, V25, P4015, DOI 10.1175/JCLI-D-12-00055.1; PLUMB RA, 1985, J ATMOS SCI, V42, P217, DOI 10.1175/1520-0469(1985)042<0217:OTTDPO>2.0.CO;2; Polyakov IV, 2012, B AM METEOROL SOC, V93, P145, DOI 10.1175/BAMS-D-11-00070.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Roeckner E., 1996, ATMOSPHERIC GEN CIRC; Screen JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051598; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Serreze MC, 2009, CRYOSPHERE, V3, P11, DOI 10.5194/tc-3-11-2009; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Shindell D, 2009, NAT GEOSCI, V2, P294, DOI 10.1038/NGEO473; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; WALLACE JM, 1992, J CLIMATE, V5, P561, DOI 10.1175/1520-0442(1992)005<0561:SVDOWS>2.0.CO;2; WILLMOTT CJ, 1995, J APPL METEOROL, V34, P2577, DOI 10.1175/1520-0450(1995)034<2577:SIOAAA>2.0.CO;2; Yoo C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049881	32	241	252	8	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					209	+		10.1038/nature13260	http://dx.doi.org/10.1038/nature13260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805345				2022-12-24	WOS:000335454300035
J	Chokshi, DA				Chokshi, Dave A.			Improving Health Care for Veterans - A Watershed Moment for the VA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSFORMATION; SYSTEM		[Chokshi, Dave A.] NYU, Dept Populat Hlth, Langone Med Ctr, New York, NY 10012 USA; [Chokshi, Dave A.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Chokshi, DA (corresponding author), NYU, Dept Populat Hlth, Langone Med Ctr, New York, NY 10012 USA.			Chokshi, Dave/0000-0001-7467-4591				Department of Veterans Affairs Office of Public and Intergovernmental Affairs, 2014, IND 2013 SURV SHOWS; Government Accountability Office, 2012, GAO13130; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kizer KW, 2012, J GEN INTERN MED, V27, P395, DOI 10.1007/s11606-011-1981-5; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575	6	28	28	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					297	299		10.1056/NEJMp1406868	http://dx.doi.org/10.1056/NEJMp1406868			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7TY	24896820	Bronze			2022-12-24	WOS:000339339800005
J	Pouchelon, G; Gambino, F; Bellone, C; Telley, L; Vitali, I; Luscher, C; Holtmaat, A; Jabaudon, D				Pouchelon, Gabrielle; Gambino, Frederic; Bellone, Camilla; Telley, Ludovic; Vitali, Ilaria; Luescher, Christian; Holtmaat, Anthony; Jabaudon, Denis			Modality-specific thalamocortical inputs instruct the identity of postsynaptic L4 neurons	NATURE			English	Article							NEURITE GROWTH-INHIBITORS; SOMATOSENSORY CORTEX; FUNCTIONAL RECOVERY; BARREL CORTEX; CONNECTIVITY; EXPRESSION; PLASTICITY; PROJECTION; CORTICES; PATHWAYS	During development, thalamocortical (TC) input has a critical role in the spatial delineation and patterning of cortical areas(1-6), yet the underlying cellular and molecular mechanisms that drive cortical neuron differentiation are poorly understood. In the primary (S1) and secondary (S2) somatosensory cortex, layer 4 (L4) neurons receive mutually exclusive input originating from two thalamic nuclei(7,8): the ventrobasalis (VB), which conveys tactile input(9,10), and the posterior nucleus (Po), which conveys modulatory and nociceptive input(11-14). Recently, we have shown that L4 neuron identity is not fully committed postnatally(15), implying a capacity for TC input to influence differentiation during cortical circuit assembly. Here we investigate whether the cell-type-specific molecular and functional identity of L4 neurons is instructed by the origin of their TC input. Genetic ablation of the VB at birth resulted in an anatomical and functional rewiring of Po projections onto L4 neurons in S1. This induced acquisition of Po input led to a respecification of postsynaptic L4 neurons, which developed functional molecular features of Po-target neurons while repressing VB-target traits. Respecified L4 neurons were able to respond both to touch and to noxious stimuli, in sharp contrast to the normal segregation of these sensory modalities in distinct cortical circuits. These findings reveal a behaviourally relevant TC-input-type-specific control over the molecular and functional differentiation of postsynaptic L4 neurons and cognate intracortical circuits, which instructs the development of modality-specific neuronal and circuit properties during corticogenesis.	[Pouchelon, Gabrielle; Gambino, Frederic; Bellone, Camilla; Telley, Ludovic; Vitali, Ilaria; Luescher, Christian; Holtmaat, Anthony; Jabaudon, Denis] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian; Jabaudon, Denis] Univ Hosp Geneva, Clin Neurol, Dept Clin Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian; Jabaudon, Denis] Univ Geneva, Inst Genet & Genom Geneva IGE3, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Jabaudon, D (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	denis.jabaudon@unige.ch	Lüscher, Christian/A-2496-2011; Jabaudon, Denis/B-8802-2014	Lüscher, Christian/0000-0001-7917-4596; Jabaudon, Denis/0000-0003-2438-4769; Holtmaat, Anthony/0000-0002-7577-0769; Vitali, Ilaria/0000-0001-9536-0292; bellone, camilla/0000-0002-6774-6275; Telley, Ludovic/0000-0002-5041-1997; gambino, frederic/0000-0002-2981-5030	Swiss National Science Foundation (SNF) [PP00P3_123447]; Leenaards Foundation; Synapsis Foundation; NARSAD Foundation; Ambizione grant from the SNF; Gertrude von Meissner Foundation; SNF; Simons Foundation Autism Research Initiative (SFARI); SNF [31003A-135631]; EMBO; International Foundation for Research in Paraplegia; Hans Wilsdorf Foundation	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Leenaards Foundation; Synapsis Foundation; NARSAD Foundation(NARSAD); Ambizione grant from the SNF; Gertrude von Meissner Foundation; SNF; Simons Foundation Autism Research Initiative (SFARI); SNF; EMBO(European Molecular Biology Organization (EMBO)); International Foundation for Research in Paraplegia; Hans Wilsdorf Foundation	We thank S. Endo for the gift of the G-substrate antibody, N. Aagaard Jensen for the gift of the miR-Zbtb20 construct, F. Ango for the gift of the Sema3a-Tomato construct, and A. Goffinet for the gift of Dlx5/6::Cre/Celsr3<SUP>flox</SUP> tissue. We are thankful to A. Benoit and F. Smets for technical assistance, to B. Golding for help with the in situ hybridizations, to O. Schaad, C. Barraclough and M. Docquier of the Genomics Platform of the University of Geneva for help with the microarray experiments. We thank E. Azim and F. Rijli for their comments on the manuscript. Work in the Jabaudon laboratory is supported by the Swiss National Science Foundation (SNF) (PP00P3_123447), the Leenaards Foundation, the Synapsis Foundation and the NARSAD Foundation. C.B. was supported by an Ambizione grant from the SNF and by the Gertrude von Meissner Foundation, C.L. by the SNF and the Simons Foundation Autism Research Initiative (SFARI), and F.C. and A.H. by the SNF (grant 31003A-135631), EMBO, the International Foundation for Research in Paraplegia, and the Hans Wilsdorf Foundation.	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bisler S, 2002, J CHEM NEUROANAT, V23, P187, DOI 10.1016/S0891-0618(01)00155-7; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Cioni JM, 2013, CURR BIOL, V23, P850, DOI 10.1016/j.cub.2013.04.007; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; DEHAY C, 1989, NATURE, V337, P265, DOI 10.1038/337265a0; Endo S, 2012, PROG MOL BIOL TRANSL, V106, P381, DOI 10.1016/B978-0-12-396456-4.00004-3; Frangeul L., 2014, EUR J NEUROSCI; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gambino F, 2012, NEURON, V75, P490, DOI 10.1016/j.neuron.2012.05.020; Gauriau C, 2004, J NEUROSCI, V24, P752, DOI 10.1523/JNEUROSCI.3272-03.2004; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jabaudon D, 2012, CEREB CORTEX, V22, P996, DOI 10.1093/cercor/bhr182; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kichula EA, 2008, J COMP NEUROL, V509, P239, DOI 10.1002/cne.21690; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Le Bars D, 2001, PHARMACOL REV, V53, P597; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; Li H, 2013, NEURON, V79, P970, DOI 10.1016/j.neuron.2013.06.043; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masri R, 2009, J NEUROPHYSIOL, V102, P181, DOI 10.1152/jn.00152.2009; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Narboux-Neme N, 2008, NEUROPHARMACOLOGY, V55, P994, DOI 10.1016/j.neuropharm.2008.08.020; Nicolelis MAL, 2005, J PHYSIOL-LONDON, V566, P37, DOI 10.1113/jphysiol.2005.083709; Nielsen JV, 2010, CEREB CORTEX, V20, P1904, DOI 10.1093/cercor/bhp261; Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Tomassy GS, 2010, P NATL ACAD SCI USA, V107, P3576, DOI 10.1073/pnas.0911792107; Viaene AN, 2011, P NATL ACAD SCI USA, V108, P18156, DOI 10.1073/pnas.1114828108; Wagener RJ, 2010, J NEUROSCI, V30, P15700, DOI 10.1523/JNEUROSCI.3707-10.2010; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Yun J, 2013, J BIOL CHEM, V288, P2655, DOI 10.1074/jbc.M112.413310; Z'Graggen WJ, 1998, J NEUROSCI, V18, P4744; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	46	82	83	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					471	+		10.1038/nature13390	http://dx.doi.org/10.1038/nature13390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24828045				2022-12-24	WOS:000339335700047
J	Liu, E; Lee, HS; Aronsson, CA; Hagopian, WA; Koletzko, S; Rewers, MJ; Eisenbarth, GS; Bingley, PJ; Bonifacio, E; Simell, V; Agardh, D				Liu, Edwin; Lee, Hye-Seung; Aronsson, Carin A.; Hagopian, William A.; Koletzko, Sibylle; Rewers, Marian J.; Eisenbarth, George S.; Bingley, Polly J.; Bonifacio, Ezio; Simell, Ville; Agardh, Daniel		TEDDY Study Grp	Risk of Pediatric Celiac Disease According to HLA Haplotype and Country	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE DOSAGE; AUTOIMMUNITY; ANTIBODIES; CHILDHOOD; CHILDREN; GLUTEN	Background The presence of HLA haplotype DR3-DQ2 or DR4-DQ8 is associated with an increased risk of celiac disease. In addition, nearly all children with celiac disease have serum antibodies against tissue transglutaminase (tTG). Methods We studied 6403 children with HLA haplotype DR3-DQ2 or DR4-DQ8 prospectively from birth in the United States, Finland, Germany, and Sweden. The primary end point was the development of celiac disease autoimmunity, which was defined as the presence of tTG antibodies on two consecutive tests at least 3 months apart. The secondary end point was the development of celiac disease, which was defined for the purpose of this study as either a diagnosis on biopsy or persistently high levels of tTG antibodies. Results The median follow-up was 60 months (interquartile range, 46 to 77). Celiac disease autoimmunity developed in 786 children (12%). Of the 350 children who underwent biopsy, 291 had confirmed celiac disease; an additional 21 children who did not undergo biopsy had persistently high levels of tTG antibodies. The risks of celiac disease autoimmunity and celiac disease by the age of 5 years were 11% and 3%, respectively, among children with a single DR3-DQ2 haplotype, and 26% and 11%, respectively, among those with two copies (DR3-DQ2 homozygosity). In the adjusted model, the hazard ratios for celiac disease autoimmunity were 2.09 (95% confidence interval [CI], 1.70 to 2.56) among heterozygotes and 5.70 (95% CI, 4.66 to 6.97) among homozygotes, as compared with children who had the lowest-risk genotypes (DR4-DQ8 heterozygotes or homozygotes). Residence in Sweden was also independently associated with an increased risk of celiac disease autoimmunity (hazard ratio, 1.90; 95% CI, 1.61 to 2.25). Conclusions Children with the HLA haplotype DR3-DQ2, especially homozygotes, were found to be at high risk for celiac disease autoimmunity and celiac disease early in childhood. The higher risk in Sweden than in other countries highlights the importance of studying environmental factors associated with celiac disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.)	[Liu, Edwin] Univ Colorado Denver, Digest Hlth Inst, Childrens Hosp Colorado, Aurora, CO USA; [Liu, Edwin; Rewers, Marian J.; Eisenbarth, George S.] Univ Colorado Denver, Barbara Davis Ctr, Aurora, CO USA; [Lee, Hye-Seung] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL USA; [Aronsson, Carin A.; Agardh, Daniel] Lund Univ, Diabet & Celiac Dis Unit, Dept Clin Sci, Malmo, Sweden; [Hagopian, William A.] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Koletzko, Sibylle] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; [Bonifacio, Ezio] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany; [Bonifacio, Ezio] Helmholz Zentrum Munchen, Forschergrp Diabet, Neuherberg, Germany; [Bingley, Polly J.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Simell, Ville] Univ Turku, Dept Pediat, Turku Univ Hosp, Turku, Finland	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of South Florida; Lund University; Pacific Northwest Diabetes Research Institute (PNDRI); University of Munich; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bristol; University of Turku	Agardh, D (corresponding author), Skane Univ Hosp SUS, Dept Pediat, Diabet & Celiac Dis Unit, Entrance 72 60 10, SE-20502 Malmo, Sweden.	daniel.agardh@med.lu.se	Bonifacio, Ezio/E-7700-2010; Ziegler, Anette-Gabriele/M-4614-2014	Bonifacio, Ezio/0000-0002-8704-4713; Ziegler, Anette-Gabriele/0000-0002-6290-5548; Carreno, Gabriela/0000-0003-4725-6225; Kurppa, Kalle/0000-0003-4757-2164; Knip, Mikael/0000-0003-0474-0033; Hyoty, Heikki/0000-0003-0370-4145; Ridewood, Sophie/0000-0002-1845-361X; Ilonen, Jorma/0000-0002-9973-2062; Elding Larsson, Helena/0000-0003-3306-1742; Virtanen, Suvi/0000-0001-8928-0878	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK063861, U01DK063861, U01DK063829, UC4DK095300, U01DK063790, UC4DK063836, UC4DK063829, UC4DK063821, U01DK063863, U01DK063865, U01DK063821, UC4DK063863, UC4DK063865, U01DK063836] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.	Andren Aronsson C, 2013, MATERN CHILD NUTR; Bazzigaluppi E, 1999, J AUTOIMMUN, V12, P51, DOI 10.1006/jaut.1998.0253; Hagopian WA, 2011, PEDIATR DIABETES, V12, P733, DOI 10.1111/j.1399-5448.2011.00774.x; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P356, DOI 10.1067/mpd.2000.107582; Hoffenberg EJ, 2003, J PEDIATR-US, V143, P308, DOI 10.1067/S0022-3476(03)00282-8; Hummel M, 2000, DIABETOLOGIA, V43, P1005, DOI 10.1007/s001250051483; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Krischer J, 2007, PEDIATR DIABETES, V8, P286; Lernmark B, 2011, CONTEMP CLIN TRIALS, V32, P517, DOI 10.1016/j.cct.2011.03.009; Li M, 2009, AM J GASTROENTEROL, V104, P154, DOI 10.1038/ajg.2008.8; Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Murray JA, 2007, CLIN GASTROENTEROL H, V5, P1406, DOI 10.1016/j.cgh.2007.08.013; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; PLOSKI R, 1993, TISSUE ANTIGENS, V41, P173, DOI 10.1111/j.1399-0039.1993.tb01998.x; Simell S, 2005, SCAND J GASTROENTERO, V40, P1182, DOI 10.1080/00365520510024034; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Vehik K, 2013, DIABETES-METAB RES, V29, P557, DOI 10.1002/dmrr.2427; Zubillaga P, 2002, J PEDIATR GASTR NUTR, V34, P548, DOI 10.1097/00005176-200205000-00014	21	197	203	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					42	49		10.1056/NEJMoa1313977	http://dx.doi.org/10.1056/NEJMoa1313977			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24988556	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000338265700008
J	Penny, AM; Wood, R; Curtis, A; Bowyer, F; Tostevin, R; Hoffman, KH				Penny, A. M.; Wood, R.; Curtis, A.; Bowyer, F.; Tostevin, R.; Hoffman, K-H			Ediacaran metazoan reefs from the Nama Group, Namibia	SCIENCE			English	Article							LIFE-STYLES; CLOUDINA; SECTION; BORINGS; FOSSILS; GROWTH	Reef-building in metazoans represents an important ecological innovation whereby individuals collectively enhance feeding efficiency and gain protection from competitors and predation. The appearance of metazoan reefs in the fossil record therefore indicates an adaptive response to complex ecological pressures. In the Nama Group, Namibia, we found evidence of reef-building by the earliest known skeletal metazoan, the globally distributed Cloudina, similar to 548 million years ago. These Cloudina reefs formed open frameworks without a microbial component but with mutual attachment and cementation between individuals. Orientated growth implies a passive suspension-feeding habit into nutrient-rich currents. The characteristics of Cloudina support the view that metazoan reef-building was promoted by the rise of substrate competitors and predators.	[Penny, A. M.; Wood, R.; Curtis, A.; Bowyer, F.] Univ Edinburgh, Sch GeoSci, Edinburgh EH9 3JW, Midlothian, Scotland; [Tostevin, R.] UCL, Dept Earth Sci, London WC1E 6BT, England; [Hoffman, K-H] Geol Survey Namibia, Windhoek, Namibia	University of Edinburgh; University of London; University College London	Penny, AM (corresponding author), Univ Edinburgh, Sch GeoSci, W Mains Rd, Edinburgh EH9 3JW, Midlothian, Scotland.	a.m.penny@ed.ac.uk		Tostevin, Rosalie/0000-0003-2843-7741	University of Edinburgh, School of Geosciences Scholarship; International Centre for Carbonate Reservoirs; Natural Environment Research Council (NERC) project "Re-inventing the planet: the Neoproterozoic revolution in oxygenation, biogeochemistry and biological complexity" [NE/I005978/1]; NERC [NE/I005978/1, NE/I005935/1] Funding Source: UKRI; Natural Environment Research Council [1511982, 1220713, NE/I005978/1, NE/I005935/1] Funding Source: researchfish	University of Edinburgh, School of Geosciences Scholarship; International Centre for Carbonate Reservoirs; Natural Environment Research Council (NERC) project "Re-inventing the planet: the Neoproterozoic revolution in oxygenation, biogeochemistry and biological complexity"(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	A.M.P. acknowledges funding from a University of Edinburgh, School of Geosciences Scholarship and the International Centre for Carbonate Reservoirs. R. W., R. T., and A. M. P. acknowledge support from Natural Environment Research Council (NERC) project "Re-inventing the planet: the Neoproterozoic revolution in oxygenation, biogeochemistry and biological complexity" (NE/I005978/1). F. B. thanks the Laidlaw Trust for fieldwork support. We thank the Geological Survey of Namibia; C. Husselmann for access to Driedoornvlagte; M. Hall for technical support; and A. Yu. Zhuravlev, B. MacGabhann, and S. Brusatte for comments and discussion. All data are available online in the supplementary materials on Science Online.	BENGTSON S, 1992, SCIENCE, V257, P367, DOI 10.1126/science.257.5068.367; Bengtson S., 2004, PALEONTOLOGICAL SOC, V10, P67, DOI DOI 10.1017/S1089332600002345; Bengtson S., 1992, TOP GEOBIOL, V20, P447; Brasier M.D., 1989, Oxford Monographs on Geology and Geophysics, V12, P117; Cai YP, 2014, GONDWANA RES, V25, P1008, DOI 10.1016/j.gr.2012.12.027; Cortijo I, 2010, PRECAMBRIAN RES, V176, P1, DOI 10.1016/j.precamres.2009.10.010; Droser ML, 2008, SCIENCE, V319, P1660, DOI 10.1126/science.1152595; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; GERMS GJB, 1972, AM J SCI, V272, P752, DOI 10.2475/ajs.272.8.752; GRANT SWF, 1990, AM J SCI, V290A, P261; Grotzinger J. P., 2002, COMMUN GEOL SURV NAM, V11, P77; Grotzinger JP, 2000, PALEOBIOLOGY, V26, P334, DOI 10.1666/0094-8373(2000)026<0334:CMITSR>2.0.CO;2; Hua H, 2005, GEOLOGY, V33, P277, DOI 10.1130/G21198.1; Hua H, 2003, PALAIOS, V18, P454, DOI 10.1669/0883-1351(2003)018<0454:BICSCP>2.0.CO;2; Jackson J. B. C., 1983, BIOTIC INTERACTIONS, V39; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Kontorovich AE, 2008, RUSS GEOL GEOPHYS+, V49, P932, DOI 10.1016/j.rgg.2008.06.012; KRUSE PD, 1995, PALAIOS, V10, P291, DOI 10.2307/3515157; Narbonne GM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P413, DOI 10.1016/B978-0-444-59425-9.00018-4; Narbonne GM, 1997, J PALEONTOL, V71, P953, DOI 10.1017/S0022336000035940; Saylor BZ, 1998, J SEDIMENT RES, V68, P1223, DOI 10.2110/jsr.68.1223; Seilacher A, 1999, PALAIOS, V14, P86, DOI 10.2307/3515363; Vermeij G.J., 1993, NATURAL HIST SHELLS; Warren LV, 2011, TERRA NOVA, V23, P382, DOI 10.1111/j.1365-3121.2011.01023.x; Wood R., 1999, REEF EVOLUTION; Wood RA, 2002, SCIENCE, V296, P2383, DOI 10.1126/science.1071599; Wood RA, 2011, EARTH-SCI REV, V106, P184, DOI 10.1016/j.earscirev.2011.01.011	27	97	99	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1504	1506		10.1126/science.1253393	http://dx.doi.org/10.1126/science.1253393			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970084	Green Accepted			2022-12-24	WOS:000337889900047
J	Dutta, S; Whicher, JR; Hansen, DA; Hale, WA; Chemler, JA; Congdon, GR; Narayan, ARH; Hakansson, K; Sherman, DH; Smith, JL; Skiniotis, G				Dutta, Somnath; Whicher, Jonathan R.; Hansen, Douglas A.; Hale, Wendi A.; Chemler, Joseph A.; Congdon, Grady R.; Narayan, Alison R. H.; Hakansson, Kristina; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios			Structure of a modular polyketide synthase	NATURE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; ACYL CARRIER PROTEIN; 6-DEOXYERYTHRONOLIDE B SYNTHASE; ITERATIVE CHAIN ELONGATION; NEAR-ATOMIC-RESOLUTION; FATTY-ACID SYNTHASE; CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; DOCKING DOMAINS; SUBSTRATE-SPECIFICITY	Polyketide natural products constitute a broad class of compounds with diverse structural features and biological activities. Their biosynthetic machinery, represented by type I polyketide synthases (PKSs), has an architecture in which successive modules catalyse two-carbon linear extensions and keto-group processing reactions on intermediates covalently tethered to carrier domains. Here we used electron cryo-microscopy to determine sub-nanometre-resolution three-dimensional reconstructions of a full-length PKS module from the bacterium Streptomyces venezuelae that revealed an unexpectedly different architecture compared to the homologous dimeric mammalian fatty acid synthase. A single reaction chamber provides access to all catalytic sites for the intramodule carrier domain. In contrast, the carrier from the preceding module uses a separate entrance outside the reaction chamber to deliver the upstream polyketide intermediate for subsequent extension and modification. This study reveals for the first time, to our knowledge, the structural basis for both intramodule and intermodule substrate transfer in polyketide synthases, and establishes a new model for molecular dissection of these multifunctional enzyme systems.	[Dutta, Somnath; Whicher, Jonathan R.; Hansen, Douglas A.; Chemler, Joseph A.; Congdon, Grady R.; Narayan, Alison R. H.; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Whicher, Jonathan R.] Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Hansen, Douglas A.; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Hale, Wendi A.; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Skiniotis, G (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.	skinioti@umich.edu	Hakansson, Kristina/G-9428-2016; Dutta, Somnath/AAI-2977-2020	Hakansson, Kristina/0000-0003-1926-0542; Hansen, Douglas/0000-0003-4681-650X; Skiniotis, Georgios/0000-0003-0238-7846	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program; Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship; Life Sciences Research Foundation; National Institutes of Health [1R21CA138331-01A1, GM076477, DK042303, DK090165]; Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE [R21CA138331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090165, R37DK042303, R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076477, T32GM008597] Funding Source: NIH RePORTER	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program(University of Michigan System); Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Henderson for sharing the phase-randomization program and for valuable advice on the implementation of the tilt-pair validation, and Y. Cheng and X. Li for sharing the image sub-frame alignment program. This work was supported by the Pew Scholar Program in Biomedical Sciences (G.S.), the University of Michigan Biological Sciences Scholars Program (G.S.), Rackham Merit and American Foundation for Pharmaceutical Education predoctoral fellowships (D.A.H.), a National Research Service Award postdoctoral fellowship (J.A.C.), the Life Sciences Research Foundation (A.R.H.N.), National Institutes of Health grants 1R21CA138331-01A1 (K.H.),GM076477 (D.H.S. and J.L.S.), DK042303 (J.L.S.) and DK090165 (G.S.), and the Hans W. Vahlteich Professorship (to D.H.S.).	Akey DL, 2010, STRUCTURE, V18, P94, DOI 10.1016/j.str.2009.10.018; Aldrich CC, 2005, J AM CHEM SOC, V127, P8910, DOI 10.1021/ja0504340; Aldrich CC, 2005, J AM CHEM SOC, V127, P8441, DOI 10.1021/ja042592h; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126; Beck BJ, 2003, J AM CHEM SOC, V125, P4682, DOI 10.1021/ja029974c; Beck BJ, 2002, CHEM BIOL, V9, P575, DOI 10.1016/S1074-5521(02)00146-1; Bonnett SA, 2013, CHEM BIOL, V20, P772, DOI 10.1016/j.chembiol.2013.04.014; Bonnett SA, 2011, CHEM BIOL, V18, P1075, DOI 10.1016/j.chembiol.2011.07.016; Broadhurst RW, 2003, CHEM BIOL, V10, P723, DOI 10.1016/S1074-5521(03)00156-X; Buchholz TJ, 2009, ACS CHEM BIOL, V4, P41, DOI 10.1021/cb8002607; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Chemler JA, 2012, J AM CHEM SOC, V134, P7359, DOI 10.1021/ja2112228; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gehret JJ, 2011, J BIOL CHEM, V286, P14445, DOI 10.1074/jbc.M110.214635; Gokhale RS, 1998, BIOCHEMISTRY-US, V37, P2524, DOI 10.1021/bi971887n; Hansen DA, 2013, J AM CHEM SOC, V135, P11232, DOI 10.1021/ja404134f; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Kao CM, 1996, BIOCHEMISTRY-US, V35, P12363, DOI 10.1021/bi9616312; Kapur S, 2012, P NATL ACAD SCI USA, V109, P4110, DOI 10.1073/pnas.1118734109; Kapur S, 2010, P NATL ACAD SCI USA, V107, P22066, DOI 10.1073/pnas.1014081107; Keatinge-Clay A, 2004, NAT STRUCT MOL BIOL, V11, P888, DOI 10.1038/nsmb808; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Kittendorf JD, 2007, CHEM BIOL, V14, P944, DOI 10.1016/j.chembiol.2007.07.013; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Murray SC, 2013, STRUCTURE, V21, P900, DOI 10.1016/j.str.2013.04.016; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rowe CJ, 2001, CHEM BIOL, V8, P475, DOI 10.1016/S1074-5521(01)00024-2; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Scaglione JB, 2010, ANGEW CHEM INT EDIT, V49, P5726, DOI 10.1002/anie.201000032; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Staunton J, 1996, NAT STRUCT BIOL, V3, P188, DOI 10.1038/nsb0296-188; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Tsai SC, 2002, BIOCHEMISTRY-US, V41, P12598, DOI 10.1021/bi0260177; Whicher JR, 2013, CHEM BIOL, V20, P1340, DOI 10.1016/j.chembiol.2013.09.015; Wu N, 2001, J AM CHEM SOC, V123, P6465, DOI 10.1021/ja010219t; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Yin YF, 2003, J AM CHEM SOC, V125, P5671, DOI 10.1021/ja034574q; Yuzawa S, 2012, BIOCHEMISTRY-US, V51, P3708, DOI 10.1021/bi300399u; Zheng JT, 2013, ACS CHEM BIOL, V8, P1263, DOI 10.1021/cb400047s; Zheng JT, 2012, NAT CHEM BIOL, V8, P615, DOI [10.1038/nchembio.964, 10.1038/NCHEMBIO.964]; Zheng JT, 2011, J MOL BIOL, V410, P105, DOI 10.1016/j.jmb.2011.04.065; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015	64	185	191	3	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					512	+		10.1038/nature13423	http://dx.doi.org/10.1038/nature13423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965652	Green Accepted			2022-12-24	WOS:000337806300041
J	Whicher, JR; Dutta, S; Hansen, DA; Hale, WA; Chemler, JA; Dosey, AM; Narayan, ARH; Hakansson, K; Sherman, DH; Smith, JL; Skiniotis, G				Whicher, Jonathan R.; Dutta, Somnath; Hansen, Douglas A.; Hale, Wendi A.; Chemler, Joseph A.; Dosey, Annie M.; Narayan, Alison R. H.; Hakansson, Kristina; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios			Structural rearrangements of a polyketide synthase module during its catalytic cycle	NATURE			English	Article							CHAIN ELONGATION; BIOSYNTHESIS; PIKROMYCIN; RESOLUTION; RECOGNITION; REVEALS; DESIGN; DOMAIN	The polyketide synthase (PKS) mega-enzyme assembly line uses a modular architecture to synthesize diverse and bioactive natural products that often constitute the core structures or complete chemical entities for many clinically approved therapeutic agents(1). The architecture of a full-length PKS module from the pikromycin pathway of Streptomyces venezuelae creates a reaction chamber for the intra-module acyl carrier protein (ACP) domain that carries building blocks and intermediates between acyltransferase, ketosynthase and ketoreductase active sites (see accompanying paper(2)). Here we determine electron cryo-microscopy structures of a full-length pikromycin PKS module in three key biochemical states of its catalytic cycle. Each biochemical state was confirmed by bottom-up liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry. The ACP domain is differentially and precisely positioned after polyketide chain substrate loading on the active site of the ketosynthase, after extension to the beta-keto intermediate, and after beta-hydroxy product generation. The structures reveal the ACP dynamics for sequential interactions with catalytic domains within the reaction chamber, and for transferring the elongated and processed polyketide substrate to the next module in the PKS pathway. During the enzymatic cycle the ketoreductase domain undergoes dramatic conformational rearrangements that enable optimal positioning for reductive processing of the ACP-bound polyketide chain elongation intermediate. These findings have crucial implications for the design of functional PKS modules, and for the engineering of pathways to generate pharmacologically relevant molecules.	[Whicher, Jonathan R.; Dutta, Somnath; Hansen, Douglas A.; Chemler, Joseph A.; Dosey, Annie M.; Narayan, Alison R. H.; Sherman, David H.; Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Whicher, Jonathan R.] Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Hansen, Douglas A.; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Hale, Wendi A.; Hakansson, Kristina; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Smith, Janet L.; Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Skiniotis, G (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kicki@umich.edu; davidhs@umich.edu; JanetSmith@umich.edu; skinioti@umich.edu	Hakansson, Kristina/G-9428-2016; Dutta, Somnath/AAI-2977-2020	Hakansson, Kristina/0000-0003-1926-0542; Hansen, Douglas/0000-0003-4681-650X; Skiniotis, Georgios/0000-0003-0238-7846	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program; Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship; Life Sciences Research Foundation; National Institutes of Health [1 R21CA138331-01A1, GM076477, DK042303, DK090165]; Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE [R21CA138331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042303, R37DK042303, R01DK090165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008597, R01GM076477] Funding Source: NIH RePORTER	Pew Scholar Program in Biomedical Sciences; University of Michigan Biological Sciences Scholars Program(University of Michigan System); Rackham Merit fellowship; American Foundation for Pharmaceutical Education predoctoral fellowship; National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans W. Vahlteich Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Pew Scholar Program in Biomedical Sciences (G.S.), the University of Michigan Biological Sciences Scholars Program (G.S.), Rackham Merit and American Foundation for Pharmaceutical Education predoctoral fellowships (D.A.H.), a National Research Service Award postdoctoral fellowship (J.A.C.), the Life Sciences Research Foundation (A.R.H.N.), National Institutes of Health grant 1 R21CA138331-01A1 (K.H.), GM076477 (D.H.S. and J.L.S.), DK042303 (J.L.S.), and DK090165 (G.S.), and the Hans W. Vahlteich Professorship (to D.H.S.).	Aldrich CC, 2005, J AM CHEM SOC, V127, P8910, DOI 10.1021/ja0504340; Aldrich CC, 2005, J AM CHEM SOC, V127, P8441, DOI 10.1021/ja042592h; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Beck BJ, 2003, J AM CHEM SOC, V125, P4682, DOI 10.1021/ja029974c; Bonnett SA, 2013, CHEM BIOL, V20, P772, DOI 10.1016/j.chembiol.2013.04.014; Bonnett SA, 2011, CHEM BIOL, V18, P1075, DOI 10.1016/j.chembiol.2011.07.016; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Hansen DA, 2013, J AM CHEM SOC, V135, P11232, DOI 10.1021/ja404134f; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Kittendorf JD, 2006, CURR OPIN BIOTECH, V17, P597, DOI 10.1016/j.copbio.2006.09.005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Menzella HG, 2007, CURR OPIN MICROBIOL, V10, P238, DOI 10.1016/j.mib.2007.05.005; Menzella HG, 2007, CHEM BIOL, V14, P143, DOI 10.1016/j.chembiol.2006.12.002; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sherman DH, 2005, NAT BIOTECHNOL, V23, P1083, DOI 10.1038/nbt0905-1083; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Walsh CT, 2002, CHEMBIOCHEM, V3, P125; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Yin YF, 2003, J AM CHEM SOC, V125, P5671, DOI 10.1021/ja034574q; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015	37	125	127	0	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					560	+		10.1038/nature13409	http://dx.doi.org/10.1038/nature13409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965656	Green Accepted			2022-12-24	WOS:000337806300052
J	Harris, MF; Knechtli, C				Harris, Michael Frank; Knechtli, Christopher			A PATIENT'S JOURNEY Lymphoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harris, Michael Frank] Gore Cottage, Old Gore Lane, Emborough BA3 4SJ, Radstock, England; [Knechtli, Christopher] Royal United Hosp Bath NHS Trust, Bath BA1 3NG, Avon, England		Harris, MF (corresponding author), Gore Cottage, Old Gore Lane, Emborough BA3 4SJ, Radstock, England.	michaelharris681@btinternet.com						Ardeshna KM, 2014, LANCET ONCOL, V15, P424, DOI 10.1016/S1470-2045(14)70027-0	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2014	348								g3736	10.1136/bmj.g3736	http://dx.doi.org/10.1136/bmj.g3736			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KX	24934281	Green Published, Bronze			2022-12-24	WOS:000337804300010
J	Walch, M; Dotiwala, F; Mulik, S; Thiery, J; Kirchhausen, T; Clayberger, C; Krensky, AM; Martinvalet, D; Lieberman, J				Walch, Michael; Dotiwala, Farokh; Mulik, Sachin; Thiery, Jerome; Kirchhausen, Tomas; Clayberger, Carol; Krensky, Alan M.; Martinvalet, Denis; Lieberman, Judy			Cytotoxic Cells Kill Intracellular Bacteria through Granulysin-Mediated Delivery of Granzymes	CELL			English	Article							ESCHERICHIA-COLI; COMPLEX-I; HYDROGEN-PEROXIDE; T-CELLS; SUPEROXIDE; DEATH; ANTIBIOTICS; SCAVENGER; APOPTOSIS; OXIDOREDUCTASE	When killer lymphocytes recognize infected cells, perforin delivers cytotoxic proteases (granzymes) into the target cell to trigger apoptosis. What happens to intracellular bacteria during this process is unclear. Human, but not rodent, cytotoxic granules also contain granulysin, an antimicrobial peptide. Here, we show that granulysin delivers granzymes into bacteria to kill diverse bacterial strains. In Escherichia coli, granzymes cleave electron transport chain complex I and oxidative stress defense proteins, generating reactive oxygen species (ROS) that rapidly kill bacteria. ROS scavengers and bacterial antioxidant protein overexpression inhibit bacterial death. Bacteria overexpressing a GzmB-uncleavable mutant of the complex I subunit nuoF or strains that lack complex I still die, but more slowly, suggesting that granzymes disrupt multiple vital bacterial pathways. Mice expressing transgenic granulysin are better able to clear Listeria monocytogenes. Thus killer cells play an unexpected role in bacterial defense.	[Walch, Michael; Dotiwala, Farokh; Mulik, Sachin; Thiery, Jerome; Kirchhausen, Tomas; Martinvalet, Denis; Lieberman, Judy] Harvard Univ, Sch Med, Boston Childrens Hosp, Cellular & Mol Med Program, Boston, MA 02115 USA; [Clayberger, Carol; Krensky, Alan M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Northwestern University; Feinberg School of Medicine	Walch, M (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Cellular & Mol Med Program, 200 Longwood Ave, Boston, MA 02115 USA.	michael.walch@unifr.ch; judy.lieberman@childrens.harvard.edu	Dotiwala, Farokh/S-5367-2019; Lieberman, Judy/A-2717-2015; THIERY, Jerome/N-2469-2018	Dotiwala, Farokh/0000-0002-7387-2219; THIERY, Jerome/0000-0002-0998-3627; Walch, Michael/0000-0001-7284-3291; MULIK, SACHIN/0000-0003-2568-3402	NIH [AI-045587, GM-075252]; Stiefel-Zangger Foundation; Kurt and Senta Herrmann Foundation; PCMM-Glaxo Smith Kline Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045587, R01AI045587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stiefel-Zangger Foundation; Kurt and Senta Herrmann Foundation; PCMM-Glaxo Smith Kline Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH AI-045587 (to J.L.), the Stiefel-Zangger and the Kurt and Senta Herrmann Foundations (to M. W.), and PCMM-Glaxo Smith Kline Alliance (to F. D.), and by NIH grant GM-075252 (to T. K.). We thank Zhan Xu and Solange Kharoubi Hess for technical support, Luis Filgueira for helpful discussions, Marshall Thomas for HeLa-BCL2 cells, James Imlay (University of Illinois) for valuable suggestions and for the L106 E. coli strain, Susan Lovett (Brandeis) for the recA strain, Thorsten Friedrich (Albert-Ludwigs-University, Freiburg, Germany) for E. coli strain ANN0221/pBADnuo/His-nuoF, and Darren Higgins (Harvard Medical School) for the Lm expression plasmid pLIV1 and Eric Marino for maintaining the Imaging Resource used in this study.	Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; Gallo RL, 2003, CURR ALLERGY ASTHM R, V3, P402, DOI 10.1007/s11882-003-0074-x; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hirche TO, 2008, J IMMUNOL, V181, P4945, DOI 10.4049/jimmunol.181.7.4945; Huang LP, 2007, J IMMUNOL, V178, P77, DOI 10.4049/jimmunol.178.1.77; KAGI D, 1994, EUR J IMMUNOL, V24, P3068, DOI 10.1002/eji.1830241223; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Konola JT, 2000, MUTAT RES-DNA REPAIR, V459, P187, DOI 10.1016/S0921-8777(99)00073-7; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; LEDENEV AN, 1986, BIOCHEM INT, V13, P391; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Pitabut N, 2011, MICROBIOL IMMUNOL, V55, P565, DOI 10.1111/j.1348-0421.2011.00348.x; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; Spehr V, 1999, BIOCHEMISTRY-US, V38, P16261, DOI 10.1021/bi9919605; Steinwede K, 2012, J IMMUNOL, V188, P4476, DOI 10.4049/jimmunol.1103346; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Taiwo FA, 2008, SPECTROSC-INT J, V22, P491, DOI 10.1155/2008/953692; Thiery J., 2010, CURR PROTOC CELL BIO; Thoma-Uszynski S, 2000, J IMMUNOL, V165, P5773, DOI 10.4049/jimmunol.165.10.5773; Walch M, 2009, J IMMUNOL, V182, P7569, DOI 10.4049/jimmunol.0800296; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	32	115	119	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1309	1323		10.1016/j.cell.2014.03.062	http://dx.doi.org/10.1016/j.cell.2014.03.062			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906149	Green Accepted, Bronze			2022-12-24	WOS:000340881400009
J	Peacock, S				Peacock, Sharon			Bring microbial sequencing to hospitals	NATURE			English	Editorial Material									[Peacock, Sharon] Univ Cambridge, Cambridge CB2 1TN, England; [Peacock, Sharon] Publ Hlth England, London, England; [Peacock, Sharon] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England	University of Cambridge; Public Health England; University of Cambridge	Peacock, S (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	sjp97@medschl.cam.ac.uk	Peacock, Sharon J/ABE-6331-2020					Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Reuter S, 2013, JAMA INTERN MED, V173, P1397, DOI 10.1001/jamainternmed.2013.7734; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	5	13	13	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					557	559		10.1038/509557a	http://dx.doi.org/10.1038/509557a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24877182	Bronze			2022-12-24	WOS:000336457100024
J	Wright, J				Wright, Jessica			NANOTECHNOLOGY Deliver on a promise	NATURE			English	Editorial Material																		Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124	3	27	27	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S58	S59		10.1038/509S58a	http://dx.doi.org/10.1038/509S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870822				2022-12-24	WOS:000336457100005
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION What is an open label trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALLOCATION		Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Bawaskar HS, 2010, BMJ-BRIT MED J, V341, pc7136; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5518; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2409; Sedgwick P, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3345; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6068	5	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2014	348								g3434	10.1136/bmj.g3434	http://dx.doi.org/10.1136/bmj.g3434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9AC	24859904				2022-12-24	WOS:000336429700012
J	Larrieu, D; Britton, S; Demir, M; Rodriguez, R; Jackson, SP				Larrieu, Delphine; Britton, Sebastien; Demir, Mukerrem; Rodriguez, Raphael; Jackson, Stephen P.			Chemical Inhibition of NAT10 Corrects Defects of Laminopathic Cells	SCIENCE			English	Article							HUTCHINSON-GILFORD PROGERIA; A-TYPE LAMINS; NUCLEAR MORPHOLOGY; NUCLEOLAR PROTEIN; HELA-CELLS; ACETYLTRANSFERASE; FARNESYLATION; FIBROBLASTS; EXPRESSION; MUTATIONS	Down-regulation and mutations of the nuclear-architecture proteins lamin A and C cause misshapen nuclei and altered chromatin organization associated with cancer and laminopathies, including the premature-aging disease Hutchinson-Gilford progeria syndrome (HGPS). Here, we identified the small molecule "Remodelin" that improved nuclear architecture, chromatin organization, and fitness of both human lamin A/C-depleted cells and HGPS-derived patient cells and decreased markers of DNA damage in these cells. Using a combination of chemical, cellular, and genetic approaches, we identified the acetyl-transferase protein NAT10 as the target of Remodelin that mediated nuclear shape rescue in laminopathic cells via microtubule reorganization. These findings provide insights into how NAT10 affects nuclear architecture and suggest alternative strategies for treating laminopathies and aging.	[Larrieu, Delphine; Britton, Sebastien; Demir, Mukerrem; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust Canc Res UK CRUK Gurdon Inst, Cambridge CB2 1QN, England; [Larrieu, Delphine; Britton, Sebastien; Demir, Mukerrem; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Rodriguez, Raphael] CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France; [Jackson, Stephen P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Wellcome Trust Sanger Institute	Rodriguez, R (corresponding author), CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France.	raphael.rodriguez@cnrs.fr; s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014; Britton, Sébastien/AAL-1862-2020	Jackson, Stephen Philip/0000-0001-9317-7937; Britton, Sébastien/0000-0002-7008-5316; Rodriguez, Raphael/0000-0001-7668-446X; Larrieu, Delphine/0000-0002-2335-9361	Cancer Research UK [C6/A11224]; European Research Council; European Community [HEALTH-F2-2010-259893]; CRUK [C6946/A14492]; Wellcome Trust [WT092096]; University of Cambridge, UK; European Molecular Biology Organization (EMBO) long-term fellowship [ALTF 834-2011]; Medical Research Council, UK [MR/L019116/1]; EMBO [ALTF 93-2010]; CRUK; CNRS; European Research Council grant DDREAM; MRC [MR/L019116/1] Funding Source: UKRI; Cancer Research UK [11224] Funding Source: researchfish; Medical Research Council [MR/L019116/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); CRUK(Cancer Research UK); Wellcome Trust(Wellcome Trust); University of Cambridge, UK(University of Cambridge); European Molecular Biology Organization (EMBO) long-term fellowship(European Molecular Biology Organization (EMBO)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO(European Molecular Biology Organization (EMBO)); CRUK(Cancer Research UK); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council grant DDREAM; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all members of the Jackson laboratory for help and support, J. Forment for discussions, and K. Dry and J. Travers for discussions and critical reading of the manuscript. We thank R. Belotserkovskaya for the GFP-H2B U2OS cell line and S. Heidorn and M. Garnett (Wellcome Trust Sanger Institute) for providing us with the cancer cells used in the lamin A/C expression screen. We thank Imagif and Institut de Chimie des Substances Naturelles, Centre National de la Recherche Scientifique (CNRS) de Gif-sur-Yvette, France, for proteomic analysis. Research in the Jackson laboratory is funded by Cancer Research UK program grant C6/A11224, the European Research Council, and the European Community Seventh Framework Programme grant agreement HEALTH-F2-2010-259893 (DDR). Core funding is provided by CRUK (C6946/A14492) and the Wellcome Trust (WT092096). S. P. J. receives his salary from the University of Cambridge, UK, supplemented by CRUK. D. L is funded by a European Molecular Biology Organization (EMBO) long-term fellowship ALTF 834-2011 and by a Project Grant from the Medical Research Council, UK MR/L019116/1. S. B. was funded by a EMBO long-term fellowship ALTF 93-2010 and CRUK. R. R. is supported by CNRS. M. D. is supported by the European Research Council grant DDREAM. A patent (application number 1405991.9) on the small molecule Remodelin and structural analogs for the treatment of disease has been filed by the University of Cambridge and CNRS. The data presented in this paper are included in the main paper and the supplementary materials. D. L. conceptualized the study and carried out all the experiments unless stated otherwise. S. B. cloned NAT10 expression constructs, performed the NAT10 structure analysis, produced high-resolution microscopy images, and contributed to live-cell imaging. R. R. designed and synthesized the small molecules and performed circular dichroism spectroscopy experiment. M. D. provided assistance with IF, fluorescence-activated cell sorting, and western blotting experiments. D. L. designed the experiments and analyzed the data. D. L. and S. P. J wrote the paper, with contributions from R. R., and S.B.	Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Amin MA, 2007, BIOCHEM BIOPH RES CO, V360, P320, DOI 10.1016/j.bbrc.2007.06.092; BROERS JLV, 1993, AM J PATHOL, V143, P211; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Chen CY, 2012, CELL, V149, P565, DOI 10.1016/j.cell.2012.01.059; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Chimenti F, 2009, J MED CHEM, V52, P530, DOI 10.1021/jm800885d; Chimnaronk S, 2009, EMBO J, V28, P1362, DOI 10.1038/emboj.2009.69; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Galiova G, 2008, EUR J CELL BIOL, V87, P291, DOI 10.1016/j.ejcb.2008.01.013; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Ibrahim MX, 2013, SCIENCE, V340, P1330, DOI 10.1126/science.1238880; Li X, 2012, J AM CHEM SOC, V134, P1982, DOI 10.1021/ja210528v; Moss SF, 1999, GUT, V45, P723, DOI 10.1136/gut.45.5.723; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Suzuki N, 1998, P NATL ACAD SCI USA, V95, P10499, DOI 10.1073/pnas.95.18.10499; Tamiello C, 2013, NUCLEUS-AUSTIN, V4, P61, DOI 10.4161/nucl.23388; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Venables RS, 2001, BRIT J CANCER, V84, P512, DOI 10.1054/bjoc.2000.1632; Verstraeten VLRM, 2011, P NATL ACAD SCI USA, V108, P4997, DOI 10.1073/pnas.1019532108; Wang GX, 2010, J BIOL CHEM, V285, P19060, DOI 10.1074/jbc.M110.100396; Wang YX, 2012, NUCLEUS-AUSTIN, V3, P452, DOI 10.4161/nucl.21675; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028	26	183	186	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					527	532		10.1126/science.1252651	http://dx.doi.org/10.1126/science.1252651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786082	Green Accepted, Green Submitted			2022-12-24	WOS:000335157700046
J	Cully, M				Cully, Megan			PUBLIC HEALTH The politics of antibiotics	NATURE			English	Editorial Material														Cully, Megan/0000-0003-4726-134X				Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; European Medicines Agency, 2013, SAL VET ANT AG 25 EU; Hollis A, 2013, NEW ENGL J MED, V369, P2474, DOI 10.1056/NEJMp1311479; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	4	75	77	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S16	S17		10.1038/509S16a	http://dx.doi.org/10.1038/509S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784425	Bronze			2022-12-24	WOS:000335199100009
J	Sklansky, M; Nadkarni, N; Ramirez-Avila, L				Sklansky, Mark; Nadkarni, Nikhil; Ramirez-Avila, Lynn			Banning the Handshake From the Health Care Setting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRANSMISSION		[Sklansky, Mark] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Cardiol,Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Nadkarni, Nikhil] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ramirez-Avila, Lynn] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Infect Dis,Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Ramirez-Avila, Lynn] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Sklansky, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, 200 Med Plaza,Ste 330, Los Angeles, CA 90095 USA.	msklansky@mednet.ucla.edu						Boyce JM, 2002, INFECT CONT HOSP EP, V23, pS3, DOI 10.1086/503164; Doring G, 1996, PEDIATR PULM, V21, P90, DOI 10.1002/(SICI)1099-0496(199602)21:2<90::AID-PPUL5>3.0.CO;2-T; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Ghareeb PA, 2013, J HOSP INFECT, V85, P321, DOI 10.1016/j.jhin.2013.08.010; HAMBURGER M, 1947, AM J MED, V2, P23, DOI 10.1016/0002-9343(47)90003-X; Jabbar U, 2010, INFECT CONT HOSP EP, V31, P565, DOI 10.1086/652772; KINGERY F A, 1964, JAMA, V189, P850	7	18	18	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2477	2478		10.1001/jama.2014.4675	http://dx.doi.org/10.1001/jama.2014.4675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	24833502				2022-12-24	WOS:000337757000016
J	Jones, C; Pollit, V; Fitzmaurice, D; Cowan, C				Jones, Clare; Pollit, Vicki; Fitzmaurice, David; Cowan, Campbell		Guideline Dev Grp	The management of atrial fibrillation: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTICOAGULANTS; STROKE; RISK		[Jones, Clare; Pollit, Vicki] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Fitzmaurice, David] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Cowan, Campbell] Leeds Gen Infirm, Dept Cardiol, Leeds, W Yorkshire, England	Royal College of Physicians; University of Birmingham; Leeds General Infirmary; University of Leeds	Jones, C (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	clare.jones@rcplondon.ac.uk						Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cowan C, 2013, HEART, V99, P1166, DOI 10.1136/heartjnl-2012-303472; GRADE Working Group, GRAD REC ASS DEV EV; Holt TA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656856; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lord J, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17580; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; National Institute for Health and Care Excellence, 2012, RIV PREV STROK SYST, V256; National Institute for Health and Care Excellence, 2012, DAB ET PREV STROK SY; National Institute for Health and Care Excellence, 2013, DEV NICE CLIN GUID; National Institute for Health and Care Excellence, 2013, SUPP COMM ANT THER; National Institute for Health and Care Excellence, 2012, VEN THROMB DIS MAN V, VCG144; National Institute for Health and Care Excellence, 2014, NICE CLIN GUID; National Institute for Health and Care Excellence, 2013, AP PREV STROK SYST E; National Institute for Health and Care Excellence, 2012, PAT EXP AD NHS SERV; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236	18	56	62	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2014	348								g3655	10.1136/bmj.g3655	http://dx.doi.org/10.1136/bmj.g3655			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LH	24948694	Green Published			2022-12-24	WOS:000337805800007
J	Woyach, JA; Furman, RR; Liu, TM; Ozer, HG; Zapatka, M; Ruppert, AS; Xue, L; Li, DHH; Steggerda, SM; Versele, M; Dave, SS; Zhang, J; Yilmaz, AS; Jaglowski, SM; Blum, KA; Lozanski, A; Lozanski, G; James, DF; Barrientos, JC; Lichter, P; Stilgenbauer, S; Buggy, JJ; Chang, BY; Johnson, AJ; Byrd, JC				Woyach, Jennifer A.; Furman, Richard R.; Liu, Ta-Ming; Ozer, Hatice Gulcin; Zapatka, Marc; Ruppert, Amy S.; Xue, Ling; Li, Daniel Hsieh-Hsin; Steggerda, Susanne M.; Versele, Matthias; Dave, Sandeep S.; Zhang, Jenny; Yilmaz, Ayse Selen; Jaglowski, Samantha M.; Blum, Kristie A.; Lozanski, Arletta; Lozanski, Gerard; James, Danelle F.; Barrientos, Jacqueline C.; Lichter, Peter; Stilgenbauer, Stephan; Buggy, Joseph J.; Chang, Betty Y.; Johnson, Amy J.; Byrd, John C.			Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACQUIRED-RESISTANCE; CLINICAL RESISTANCE; THERAPEUTIC TARGET; MYELOID-LEUKEMIA; MUTATION; CANCER; SURVIVAL; IMATINIB; GENOME	BACKGROUND Ibrutinib is an irreversible inhibitor of Bruton's tyrosine kinase (BTK) and is effective in chronic lymphocytic leukemia (CLL). Resistance to irreversible kinase inhibitors and resistance associated with BTK inhibition have not been characterized. Although only a small proportion of patients have had a relapse during ibrutinib therapy, an understanding of resistance mechanisms is important. We evaluated patients with relapsed disease to identify mutations that may mediate ibrutinib resistance. METHODS We performed whole-exome sequencing at baseline and the time of relapse on samples from six patients with acquired resistance to ibrutinib therapy. We then performed functional analysis of identified mutations. In addition, we performed Ion Torrent sequencing for identified resistance mutations on samples from nine patients with prolonged lymphocytosis. RESULTS We identified a cysteine-to-serine mutation in BTK at the binding site of ibrutinib in five patients and identified three distinct mutations in PLC gamma 2 in two patients. Functional analysis showed that the C481S mutation of BTK results in a protein that is only reversibly inhibited by ibrutinib. The R665W and L845F mutations in PLC gamma 2 are both potentially gain-of-function mutations that lead to autonomous B-cell-receptor activity. These mutations were not found in any of the patients with prolonged lymphocytosis who were taking ibrutinib. CONCLUSIONS Resistance to the irreversible BTK inhibitor ibrutinib often involves mutation of a cysteine residue where ibrutinib binding occurs. This finding, combined with two additional mutations in PLC gamma 2 that are immediately downstream of BTK, underscores the importance of the B-cell-receptor pathway in the mechanism of action of ibrutinib in CLL.	[Woyach, Jennifer A.; Liu, Ta-Ming; Ruppert, Amy S.; Jaglowski, Samantha M.; Blum, Kristie A.; Lozanski, Arletta; Johnson, Amy J.; Byrd, John C.] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA; [Ozer, Hatice Gulcin; Yilmaz, Ayse Selen] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Lozanski, Gerard] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Furman, Richard R.] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY USA; [Zapatka, Marc; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Stilgenbauer, Stephan] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Xue, Ling; Li, Daniel Hsieh-Hsin; Steggerda, Susanne M.; James, Danelle F.; Buggy, Joseph J.; Chang, Betty Y.] Pharmacycl Sunnyvale, Sunnyvale, CA USA; [Dave, Sandeep S.; Zhang, Jenny] Duke Univ, Duke Canc Inst, Durham, NC USA; [Barrientos, Jacqueline C.] Hofstra North Shore LIJ Sch Med, Div Hematol Oncol, Dept Med, New Hyde Pk, NY USA; [Versele, Matthias] Janssen Res & Dev, Beerse, Belgium	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cornell University; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Duke University; Hofstra University; Northwell Health; Johnson & Johnson; Janssen Pharmaceuticals	Byrd, JC (corresponding author), Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA.	john.byrd@osumc.edu	Barrientos, Jacqueline/AAE-6683-2022; Zapatka, Marc/G-9896-2013; Stilgenbauer, Stephan/ABE-6609-2020; Woyach, Jennifer Ann/F-1087-2015; Zhang, Jenny/GXV-4980-2022	Zapatka, Marc/0000-0001-8287-5967; Barrientos, Jacqueline Claudia/0000-0001-6018-5535	National Cancer Institute [P50 CA140158, R01 CA177292, K23 CA178183]; Four Winds Foundation; D. Warren Brown Foundation; Harry T. Mangurian Jr. Foundation; Leukemia and Lymphoma Society; Pharmacyclics; Conquer Cancer Foundation; American Society of Hematology Scholar Award; Else Kroner-Fresenius-Stiftung [2010_Kolleg24, 2012_A146]; Helmholtz Virtual Institute [VH-VI-404, TP2]; German Research Foundation (SFB) [1074, B2]; NATIONAL CANCER INSTITUTE [P30CA016058, P50CA140158, K12CA133250, P01CA095426, R01CA183444, P30CA014236, P01CA081534, K23CA178183, R01CA177292] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Four Winds Foundation; D. Warren Brown Foundation; Harry T. Mangurian Jr. Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Pharmacyclics; Conquer Cancer Foundation; American Society of Hematology Scholar Award; Else Kroner-Fresenius-Stiftung; Helmholtz Virtual Institute; German Research Foundation (SFB)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the National Cancer Institute (P50 CA140158, R01 CA177292, and K23 CA178183), the Four Winds Foundation, the D. Warren Brown Foundation, Mr. and Mrs. Michael Thomas, Mr. and Mrs. Al Lipkin, the Harry T. Mangurian Jr. Foundation, the Leukemia and Lymphoma Society, Pharmacyclics, the Conquer Cancer Foundation, an American Society of Hematology Scholar Award, Else Kroner-Fresenius-Stiftung (2010_Kolleg24, Project 2012_A146), Helmholtz Virtual Institute (VH-VI-404, TP2), and the German Research Foundation (SFB 1074 Project B2).	Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Awad MM, 2013, NEW ENGL J MED, V368, P2395, DOI 10.1056/NEJMoa1215530; Bernal A, 2001, BLOOD, V98, P3050, DOI 10.1182/blood.V98.10.3050; Burger JA, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.866.866; Byrd JC, 2014, NEW ENGL J MED, V370, P786, DOI 10.1056/NEJMx130049; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Deglesne PA, 2006, CANCER RES, V66, P7158, DOI 10.1158/0008-5472.CAN-06-0085; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Furman RR, 2014, NEW ENGL J MED, V370, P2352, DOI 10.1056/NEJMc1402716; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Stoklosa T, 2008, CANCER RES, V68, P2576, DOI 10.1158/0008-5472.CAN-07-6858; Valiaho J, 2006, HUM MUTAT, V27, P1209, DOI 10.1002/humu.20410; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Woyach JA, 2014, BLOOD, V123, P1810, DOI 10.1182/blood-2013-09-527853; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	33	831	901	11	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2286	2294		10.1056/NEJMoa1400029	http://dx.doi.org/10.1056/NEJMoa1400029			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24869598	Green Accepted, Bronze			2022-12-24	WOS:000337033700008
J	Ni, WM; Xu, SL; Tepperman, JM; Stanley, DJ; Maltby, DA; Gross, JD; Burlingame, AL; Wang, ZY; Quail, PH				Ni, Weimin; Xu, Shou-Ling; Tepperman, James M.; Stanley, David J.; Maltby, Dave A.; Gross, John D.; Burlingame, Alma L.; Wang, Zhi-Yong; Quail, Peter H.			A mutually assured destruction mechanism attenuates light signaling in Arabidopsis	SCIENCE			English	Article							BHLH TRANSCRIPTION FACTORS; PHYTOCHROME B; INDUCED PHOSPHORYLATION; UBIQUITIN LIGASES; DEGRADATION; PIF3; PROTEINS; ACTS; LOOP	After light-induced nuclear translocation, phytochrome photoreceptors interact with and induce rapid phosphorylation and degradation of basic helix-loop-helix transcription factors, such as PHYTOCHROME-INTERACTING FACTOR 3 (PIF3), to regulate gene expression. Concomitantly, this interaction triggers feedback reduction of phytochrome B (phyB) levels. Light-induced phosphorylation of PIF3 is necessary for the degradation of both proteins. We report that this PIF3 phosphorylation induces, and is necessary for, recruitment of LRB [Light-Response Bric-a-Brack/Tramtrack/Broad (BTB)] E3 ubiquitin ligases to the PIF3-phyB complex. The recruited LRBs promote concurrent polyubiqutination and degradation of both PIF3 and phyB in vivo. These data reveal a linked signal-transmission and attenuation mechanism involving mutually assured destruction of the receptor and its immediate signaling partner.	[Ni, Weimin; Tepperman, James M.; Quail, Peter H.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ni, Weimin; Tepperman, James M.; Quail, Peter H.] ARS, Plant Gene Express Ctr, USDA, Albany, CA 94710 USA; [Xu, Shou-Ling; Stanley, David J.; Maltby, Dave A.; Gross, John D.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Xu, Shou-Ling; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA); University of California System; University of California San Francisco; Carnegie Institution for Science	Quail, PH (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	quail@berkeley.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; xu, shouling/0000-0002-6741-9506	National Institutes of Health (NIH) [2R01 GM-047475]; U.S. Department of Energy (DOE) [DEFG03-87ER13742]; USDA ARS Current Research Information System [5335-21000-032-00D]; NIH [5R01GM066258, 8P41GM103481, P50 GM082250]; DOE [DEFG02-08ER15973]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, P50GM082250, R01GM047475, R01GM066258, T32GM008284] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); USDA ARS Current Research Information System(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. J. Chalkley, A. Pfeiffer, M. Zhuang, and B. A. Schulman for materials and technical assistance and S. McCormick for comments on the manuscript. We also thank the Salk Institute and Arabidopsis Biological Resource Center for the Arabidopsis T-DNA insertion lines. The plasmid pGEX-CUL3 (split 'n' coexpress)-Rbx1 used in the in vitro ubiquitination assays was provided by B. A. Schulman under a materials transfer agreement with St. Jude Children's Research Hospital. For access to this reagent, contact B. A. Schulman. The supplementary materials contain additional data. This work was supported by the National Institutes of Health (NIH) (2R01 GM-047475), the U.S. Department of Energy (DOE) (DEFG03-87ER13742), and USDA ARS Current Research Information System (5335-21000-032-00D) to P. H. Q; by NIH (5R01GM066258) and DOE (DEFG02-08ER15973) to Z.Y.W.; by NIH (8P41GM103481) to A. L. B; and by NIH (P50 GM082250) to J.D.G.	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Al-Sady B, 2008, P NATL ACAD SCI USA, V105, P2232, DOI 10.1073/pnas.0711675105; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Christians MJ, 2012, PLANT PHYSIOL, V160, P118, DOI 10.1104/pp.112.199109; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Jang IC, 2010, PLANT CELL, V22, P2370, DOI 10.1105/tpc.109.072520; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Khanna R, 2007, PLANT CELL, V19, P3915, DOI 10.1105/tpc.107.051508; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2012, MOL PLANT, V5, P734, DOI 10.1093/mp/sss031; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Ni WM, 2013, PLANT CELL, V25, P2679, DOI 10.1105/tpc.113.112342; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Shen H, 2008, PLANT CELL, V20, P1586, DOI 10.1105/tpc.108.060020; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Tang XJ, 2012, P NATL ACAD SCI USA, V109, P3287, DOI 10.1073/pnas.1116455109; Yarden Y, 2010, ONCOLOGIST, V15, P1, DOI 10.1634/theoncologist.2010-S5-01; Zhang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003244	25	182	192	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1160	1164		10.1126/science.1250778	http://dx.doi.org/10.1126/science.1250778			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904166	Green Accepted			2022-12-24	WOS:000336791200048
J	Eisenstein, M				Eisenstein, Michael			CLINICAL TRIALS More trials, fewer tribulations	NATURE			English	Editorial Material							CELL LUNG-CANCER; GEFITINIB											Hoos WA, 2013, J CLIN ONCOL, V31, P3432, DOI 10.1200/JCO.2013.49.4823; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Prowell TM, 2012, NEW ENGL J MED, V366, P2438, DOI 10.1056/NEJMp1205737; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8	6	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S55	S57		10.1038/509S55a	http://dx.doi.org/10.1038/509S55a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870821	Bronze			2022-12-24	WOS:000336457100004
J	Trotta, F; Da Cas, R; Alegiani, SS; Gramegna, M; Venegoni, M; Zocchetti, C; Traversa, G				Trotta, Francesco; Da Cas, Roberto; Alegiani, Stefania Spila; Gramegna, Maria; Venegoni, Mauro; Zocchetti, Carlo; Traversa, Giuseppe			Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							H1N1 INFLUENZA; CONGENITAL-ABNORMALITIES; FETAL-DEATH; RISK; OUTCOMES; WOMEN	Objective To assess the risk of maternal, fetal, and neonatal outcomes associated with the administration of an MF59 adjuvanted A/H1N1 vaccine during pregnancy. Design Historical cohort study. Setting Singleton pregnancies of the resident population of the Lombardy region of Italy. Participants All deliveries between 1 October 2009 and 30 September 2010. Data on exposure to A/H1N1 pandemic vaccine, pregnancy, and birth outcomes were retrieved from regional databases. Vaccinated and non-vaccinated women were compared in a propensity score matched analysis to estimate risks of adverse outcomes. Main outcome measures Main maternal outcomes included type of delivery, admission to intensive care unit, eclampsia, and gestational diabetes; fetal and neonatal outcomes included perinatal deaths, small for gestational age births, and congenital malformations. Results Among the 86 171 eligible pregnancies, 6246 women were vaccinated (3615 (57.9%) in the third trimester and 2557 (40.9%) in the second trimester). No difference was observed in terms of spontaneous deliveries (adjusted odds ratio 1.02, 95% confidence interval 0.96 to 1.08) or admissions to intensive care units (0.95, 0.47 to 1.88), whereas a limited increase in the prevalence of gestational diabetes (1.26, 1.04 to 1.53) and eclampsia (1.19, 1.04 to 1.39) was seen in vaccinated women. Rates of fetal and neonatal outcomes were similar in vaccinated and non-vaccinated women. A slight increase in congenital malformations, although not statistically significant, was present in the exposed cohort (1.14, 0.99 to 1.31). Conclusions Our findings add relevant information about the safety of the MF59 adjuvanted A/H1N1 vaccine in pregnancy. Residual confounding may partly explain the increased risk of some maternal outcomes. Meta-analysis of published studies should be conducted to further clarify the risk of infrequent outcomes, such as specific congenital malformations.	[Trotta, Francesco; Da Cas, Roberto; Alegiani, Stefania Spila; Traversa, Giuseppe] Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, I-00161 Rome, Italy; [Trotta, Francesco] Italian Med Agcy AIFA, Pharmacovigilance Unit, I-00187 Rome, Italy; [Gramegna, Maria] Gen Directorate Hlth, Unit Prevent Med, I-20124 Milan, Italy; [Venegoni, Mauro] Gen Directorate Hlth, Reg Ctr Pharmacovigilance, I-20124 Milan, Italy; [Zocchetti, Carlo] Gen Directorate Hlth, Unit Local Hlth Serv Governance, I-20124 Milan, Italy	Istituto Superiore di Sanita (ISS)	Traversa, G (corresponding author), Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, Viale Regina Elena 299, I-00161 Rome, Italy.	giuseppe.traversa@iss.it	Venegoni, Mauro/H-3416-2019; Trotta, Francesco/G-8702-2013	Trotta, Francesco/0000-0001-6889-8484; Venegoni, Mauro/0000-0002-5462-5327				Acs N, 2005, BIRTH DEFECTS RES A, V73, P989, DOI 10.1002/bdra.20195; [Anonymous], MALF COD GUID; Chan M., 2009, WORLD NOW START 2009; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Conlin AMS, 2013, OBSTET GYNECOL, V121, P511, DOI 10.1097/AOG.0b013e318280d64e; Czeizel AE, 2008, BIRTH DEFECTS RES A, V82, P139, DOI 10.1002/bdra.20431; European Medicines Agency European Centre for Disease Prevention and Control, 2009, EUR STRAT INFL A H1N; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; GRIFFITH GW, 1972, BMJ-BRIT MED J, V3, P553, DOI 10.1136/bmj.3.5826.553; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Heikkinen T, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.007; Jamieson DJ, 2012, AM J OBSTET GYNECOL, V207, P145, DOI 10.1016/j.ajog.2012.07.011; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kallen B, 2012, BJOG-INT J OBSTET GY, V119, P1583, DOI 10.1111/j.1471-0528.2012.03470.x; Laibl VR, 2005, CLIN PERINATOL, V32, P727, DOI 10.1016/j.clp.2005.04.009; Ludvigsson JF, 2013, EUR J EPIDEMIOL, V28, P579, DOI 10.1007/s10654-013-9813-z; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Mereckiene J, 2012, EURO SURVEILL, V17; Ministero del Lavoro della Salute e delle Politiche Sociali, 2009, MIS URG MAT PROT VIR; Nishiura H, 2009, EUR J OBSTET GYN R B, V147, P115, DOI 10.1016/j.ejogrb.2009.07.009; Oppermann M, 2012, VACCINE, V30, P4445, DOI 10.1016/j.vaccine.2012.04.081; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Pasternak B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2794; Richards JL, 2013, CLIN INFECT DIS, V56, P1216, DOI 10.1093/cid/cit045; Rubinstein F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f393; Sammon CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051734; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Steinhoff MC, 2012, JAMA-J AM MED ASSOC, V308, P184, DOI 10.1001/jama.2012.7911; VAILLANT L, 2009, EURO SURVEILL, V14	29	31	31	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2014	348								g3361	10.1136/bmj.g3361	http://dx.doi.org/10.1136/bmj.g3361			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EK	24874845	hybrid, Green Published			2022-12-24	WOS:000336742400003
J	Browne, KM; Murphy, O; Clover, AJP				Browne, Katherine M.; Murphy, Olive; Clover, A. James P.			UNCERTAINTIES PAGE Should we advise patients with sutures not to swim?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RECREATIONAL WATER; UNITED-STATES; HEALTH EVENTS; SURVEILLANCE; OUTBREAKS; DISEASE		[Browne, Katherine M.; Clover, A. James P.] Cork Univ Hosp, Dept Plast Surg, Cork, Ireland; [Murphy, Olive] Bon Secour Hosp, Dept Pathol, Cork, Ireland	University College Cork	Browne, KM (corresponding author), Cork Univ Hosp, Dept Plast Surg, Cork, Ireland.	katheribrowne@rcsi.ie						AUERBACH PS, 1987, ANN EMERG MED, V16, P643, DOI 10.1016/S0196-0644(87)80061-6; Barna Z, 2012, ANN I SUPER SANITA, V48, P374, DOI 10.4415/ANN_12_04_05; Bross MH, 2007, AM FAM PHYSICIAN, V76, P539; Cappello MA, 2011, J ENVIRON HEALTH, V73, P19; Fernandez R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003861.pub3; Finkelstein Renato, 2011, Curr Infect Dis Rep, V13, P470, DOI 10.1007/s11908-011-0199-3; GOLD WL, 1993, CLIN INFECT DIS, V16, P69, DOI 10.1093/clinids/16.1.69; Hlavsa Michele C., 2011, Morbidity and Mortality Weekly Report, V60, P1; National Collaborating Centre for Women's and Children's Health, 2008, SURG SIT INF PREV TR; NHS, 2012, SOON CAN I GO SWIMM; NHS, 2013, ADV PAT UND FRAM SUR; Rich L, 2012, WIDE LOCAL EXCISION; SCHLECH WF, 1986, CAN MED ASSOC J, V134, P909; Toon CD, 2013, COCHRANE DB SYST REV, V10; WHO, 2003, GUID SAF RECR WAT EN; Yoder Jonathan S, 2008, MMWR Surveill Summ, V57, P1	16	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2014	348								g3171	10.1136/bmj.g3171	http://dx.doi.org/10.1136/bmj.g3171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9AC	24859900				2022-12-24	WOS:000336429700001
J	Brodsky, EE; Lay, T				Brodsky, Emily E.; Lay, Thorne			Recognizing Foreshocks from the 1 April 2014 Chile Earthquake	SCIENCE			English	Editorial Material							TOHOKU-OKI EARTHQUAKE		[Brodsky, Emily E.; Lay, Thorne] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Brodsky, EE (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	brodsky@pmc.ucsc.edu; tlay@ucsc.edu	Lay, Thorne/ABE-6272-2021	Brodsky, Emily/0000-0002-6855-6860	Directorate For Geosciences [1245717] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Abercrombie RE, 1996, NATURE, V381, P303, DOI 10.1038/381303a0; Barnes CR, 2013, IEEE J OCEANIC ENG, V38, P144, DOI 10.1109/JOE.2012.2212751; Bouchon M, 2013, NAT GEOSCI, V6, P299, DOI [10.1038/ngeo1770, 10.1038/NGEO1770]; Burgmann R., 2014, ANN REV EARTH PLANET, V42; Felzer KR, 2004, B SEISMOL SOC AM, V94, P88, DOI 10.1785/0120030069; Helmstetter A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002409; Hino R, 2014, MAR GEOPHYS RES, V35, P181, DOI 10.1007/s11001-013-9208-2; Holtkamp SG, 2011, GEOPHYS J INT, V187, P128, DOI 10.1111/j.1365-246X.2011.05137.x; Ito Y, 2013, TECTONOPHYSICS, V600, P14, DOI 10.1016/j.tecto.2012.08.022; JONES L, 1976, NATURE, V262, P677, DOI 10.1038/262677a0; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Marsan D, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009039; Monastersky R, 2012, NATURE, V483, P144, DOI 10.1038/483144a; Smith A., 2014, NBC NEWS        0325; Vigny C, 2009, PHYS EARTH PLANET IN, V175, P86, DOI 10.1016/j.pepi.2008.02.013	15	73	78	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					700	702		10.1126/science.1255202	http://dx.doi.org/10.1126/science.1255202			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833379	Green Published			2022-12-24	WOS:000335912900024
J	Vinci, SR; Rifas-Shiman, SL; Cheng, JK; Mannix, RC; Gillman, MW; de Ferranti, SD				Vinci, Samuel R.; Rifas-Shiman, Sheryl L.; Cheng, Jennifer K.; Mannix, Rebekah C.; Gillman, Matthew W.; de Ferranti, Sarah D.			Cholesterol Testing Among Children and Adolescents During Health Visits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Vinci, Samuel R.; Cheng, Jennifer K.] Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Rifas-Shiman, Sheryl L.; Gillman, Matthew W.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Mannix, Rebekah C.] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [de Ferranti, Sarah D.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	de Ferranti, SD (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	sarah.deferranti@cardio.chboston.org	Mannix, Rebekah/AAD-8702-2020	Mannix, Rebekah/0000-0003-3608-2792				Centers for Disease Control and Prevention, ABOUT THE AMBULATORY; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Gillman MW, 2012, JAMA-J AM MED ASSOC, V307, P259, DOI 10.1001/jama.2011.2012; Haney EM, 2007, PEDIATRICS, V120, pE189, DOI 10.1542/peds.2006-1801; Kimm SYS, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.5.e50; Kit BK, 2012, JAMA-J AM MED ASSOC, V308, P591, DOI 10.1001/jama.2012.9136	6	38	38	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1804	1807		10.1001/jama.2014.2410	http://dx.doi.org/10.1001/jama.2014.2410			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794376	Bronze			2022-12-24	WOS:000335382300028
J	Butterworth, A				Butterworth, Andy			The moral problem with commercial seal hunting	NATURE			English	Editorial Material									Univ Bristol, Bristol BS8 1TH, Avon, England	University of Bristol	Butterworth, A (corresponding author), Univ Bristol, Bristol BS8 1TH, Avon, England.	andy.butterworth@bristol.ac.uk		Butterworth, Andrew/0000-0002-5904-8397				Butterworth A, 2013, MAR POLICY, V38, P457, DOI 10.1016/j.marpol.2012.07.006	1	4	4	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					9	9		10.1038/509009a	http://dx.doi.org/10.1038/509009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784181	Bronze			2022-12-24	WOS:000335199100013
J	Matsuzaki, S; Uchiyama, J; Takemura-Uchiyama, I; Daibata, M				Matsuzaki, Shigenobu; Uchiyama, Jumpei; Takemura-Uchiyama, Iyo; Daibata, Masanori			PERSPECTIVE The age of the phage	NATURE			English	Editorial Material							INFECTION MODEL		[Matsuzaki, Shigenobu; Uchiyama, Jumpei; Takemura-Uchiyama, Iyo; Daibata, Masanori] Kochi Univ, Sch Med, Kochi, Japan	Kochi University	Matsuzaki, S (corresponding author), Kochi Univ, Sch Med, Kochi, Japan.		Uchiyama, Jumpei/GWC-4189-2022; Uchiyama, Jumpei/GNP-6661-2022	Uchiyama, Jumpei/0000-0003-0846-0100	Grants-in-Aid for Scientific Research [26461504, 24791025] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2012, YAKUGAKU ZASSHI, V132, P79, DOI 10.1248/yakushi.132.79; Takemura-Uchiyama I, 2013, FEMS MICROBIOL LETT, V347, P52, DOI 10.1111/1574-6968.12220	3	38	40	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S9	S9		10.1038/509S9a	http://dx.doi.org/10.1038/509S9a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784429				2022-12-24	WOS:000335199100005
J	Dunlop, DD; Song, J; Semanik, PA; Sharma, L; Bathon, JM; Eaton, CB; Hochberg, MC; Jackson, RD; Kwoh, CK; Mysiw, WJ; Nevitt, MC; Chang, RW				Dunlop, Dorothy D.; Song, Jing; Semanik, Pamela A.; Sharma, Leena; Bathon, Joan M.; Eaton, Charles B.; Hochberg, Marc C.; Jackson, Rebecca D.; Kwoh, C. Kent; Mysiw, W. Jerry; Nevitt, Michael C.; Chang, Rowland W.			Relation of physical activity time to incident disability in community dwelling adults with or at risk of knee arthritis: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; OBESE ADULTS; OSTEOARTHRITIS; EXERCISE; HEALTH; FITNESS; LIFE; OUTCOMES; DISEASE; ARTHROPLASTY	Objective To investigate whether objectively measured time spent in light intensity physical activity is related to incident disability and to disability progression. Design Prospective multisite cohort study from September 2008 to December 2012. Setting Baltimore, Maryland; Columbus, Ohio; Pittsburgh, Pennsylvania; and Pawtucket, Rhode Island, USA. Participants Disability onset cohort of 1680 community dwelling adults aged 49 years or older with knee osteoarthritis or risk factors for knee osteoarthritis; the disability progression cohort included 1814 adults. Main outcome measures Physical activity was measured by accelerometer monitoring. Disability was ascertained from limitations in instrumental and basic activities of daily living at baseline and two years. The primary outcome was incident disability. The secondary outcome was progression of disability defined by a more severe level (no limitations, limitations to instrumental activities only, 1-2 basic activities, or >= 3 basic activities) at two years compared with baseline. Results Greater time spent in light intensity activities had a significant inverse association with incident disability. Less incident disability and less disability progression were each significantly related to increasing quartile categories of daily time spent in light intensity physical activities (hazard ratios for disability onset 1.00, 0.62, 0.47, and 0.58, P for trend=0.007; hazard ratios for progression 1.00, 0.59, 0.50, and 0.53, P for trend=0.003) with control for socioeconomic factors (age, sex, race/ethnicity, education, income) and health factors (comorbidities, depressive symptoms, obesity, smoking, lower extremity pain and function, and knee assessments: osteoarthritis severity, pain, symptoms, prior injury). This finding was independent of time spent in moderate-vigorous activities. Conclusion These prospective data showed an association between greater daily time spent in light intensity physical activities and reduced risk of onset and progression of disability in adults with osteoarthritis of the knee or risk factors for knee osteoarthritis. An increase in daily physical activity time may reduce the risk of disability, even if the intensity of that additional activity is not increased.	[Dunlop, Dorothy D.; Song, Jing; Sharma, Leena; Chang, Rowland W.] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth, Chicago, IL 60611 USA; [Dunlop, Dorothy D.; Song, Jing; Sharma, Leena; Chang, Rowland W.] Northwestern Univ, Feinberg Sch Med, Med Ctr Healthcare Studies, Chicago, IL 60611 USA; [Semanik, Pamela A.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Bathon, Joan M.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Eaton, Charles B.] Brown Univ, Pawtucket, RI USA; [Hochberg, Marc C.] Univ Maryland, Baltimore, MD 21201 USA; [Jackson, Rebecca D.; Mysiw, W. Jerry] Ohio State Univ, Columbus, OH 43210 USA; [Kwoh, C. Kent; Nevitt, Michael C.] Univ Arizona, Coll Med, Tucson, AZ USA; [Nevitt, Michael C.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Rush University; Columbia University; Brown University; University System of Maryland; University of Maryland Baltimore; University System of Ohio; Ohio State University; University of Arizona; University of California System; University of California San Francisco	Dunlop, DD (corresponding author), Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth, 750 Lakeshore Dr, Chicago, IL 60611 USA.	ddunlop@northwestern.edu	Mysiw, Walter/E-3724-2011	Eaton, Charles/0000-0002-7723-9461	National Institute for Arthritis and Musculoskeletal Diseases [R01-AR054155, R21-AR059412, P60-AR064464]; Falk Medical Trust; National Institutes of Health, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]; Merck Research Laboratories; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Pfizer; Foundation for the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022258, P60AR064464, N01AR022262, R01AR054155, R21AR059412, N01AR022261, N01AR022260, N01AR022259] Funding Source: NIH RePORTER	National Institute for Arthritis and Musculoskeletal Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Falk Medical Trust; National Institutes of Health, a branch of the Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); Novartis Pharmaceuticals Corporation(Novartis); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study is funded in part by National Institute for Arthritis and Musculoskeletal Diseases (grant No R01-AR054155, R21-AR059412, and P60-AR064464) and by the Falk Medical Trust. The publicly released Osteoarthritis Initiative (OAI) data were funded through a public-private partnership comprising five contracts (N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262) awarded by the National Institutes of Health, a branch of the Department of Health and Human Services. Private funding partners include Merck Research Laboratories, Novartis Pharmaceuticals Corporation, GlaxoSmithKline, and Pfizer. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. The funders had no role in the collection, management, analysis, and interpretation of the data; the writing of the manuscript; or the decision to submit the manuscript for publication. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the private funding partners, or the Osteoarthritis Initiative.	ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; Anderson WL, 2010, PUBLIC HEALTH REP, V125, P44, DOI 10.1177/003335491012500107; [Anonymous], 2013, DATA NEWS; Bates JH, 2001, JAMA-J AM MED ASSOC, V285, P2973, DOI 10.1001/jama.285.23.2973; Blair SN, 2004, JAMA-J AM MED ASSOC, V292, P1232, DOI 10.1001/jama.292.10.1232; Brault M.W., 2012, AM DISABILITIES 2010, P1; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Eckstein F, 2012, NAT REV RHEUMATOL, V8, P622, DOI 10.1038/nrrheum.2012.113; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Fong DYT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e70; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gill TM, 2012, ANN INTERN MED, V156, P131, DOI 10.7326/0003-4819-156-2-201201170-00009; Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728; Jette AM, 2002, J GERONTOL A-BIOL, V57, pM209, DOI 10.1093/gerona/57.4.M209; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lane NE, 2007, NEW ENGL J MED, V357, P1413, DOI 10.1056/NEJMcp071112; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; Lin JS, 2010, ANN INTERN MED, V153, P736, DOI 10.7326/0003-4819-153-11-201012070-00007; Loprinzi PD, 2012, RES Q EXERCISE SPORT, V83, P422; Lubitz J, 2003, NEW ENGL J MED, V349, P1048, DOI 10.1056/NEJMsa020614; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Martin CK, 2009, ARCH INTERN MED, V169, P269, DOI 10.1001/archinternmed.2008.545; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Miller ME, 2000, J AM GERIATR SOC, V48, P1264, DOI 10.1111/j.1532-5415.2000.tb02600.x; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Pandya R, 2005, PSYCHOSOMATICS, V46, P131, DOI 10.1176/appi.psy.46.2.131; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Penninx BWJH, 2001, ARCH INTERN MED, V161, P2309, DOI 10.1001/archinte.161.19.2309; Peterfy C, 2003, SKELETAL RADIOL, V32, P128, DOI 10.1007/s00256-002-0603-z; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Rodgers W, 1997, J GERONTOL B-PSYCHOL, V52, P21, DOI 10.1093/geronb/52B.Special_Issue.21; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Voelker R, 2011, JAMA-J AM MED ASSOC, V306, P1428, DOI 10.1001/jama.2011.1388; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Willis BL, 2012, ARCH INTERN MED, V172, P1333, DOI 10.1001/archinternmed.2012.3400; Yang Y, 2005, J AGING HEALTH, V17, P263, DOI 10.1177/0898264305276295	46	73	74	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2014	348								g2472	10.1136/bmj.g2472	http://dx.doi.org/10.1136/bmj.g2472			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RF	24782514	Green Published, hybrid			2022-12-24	WOS:000335475500003
J	King, AM; Reid-Yu, SA; Wang, WL; King, DT; De Pascale, G; Strynadka, NC; Walsh, TR; Coombes, BK; Wright, GD				King, Andrew M.; Reid-Yu, Sarah A.; Wang, Wenliang; King, Dustin T.; De Pascale, Gianfranco; Strynadka, Natalie C.; Walsh, Timothy R.; Coombes, Brian K.; Wright, Gerard D.			Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance	NATURE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; KLEBSIELLA-PNEUMONIAE; MICROBIAL INHIBITORS	The emergence and spread of carbapenem-resistant Gram-negative pathogens is a global public health problem. The acquisition of metallo-beta-lactamases (MBLs) such as NDM-1 is a principle contributor to the emergence of carbapenem-resistant Gram-negative pathogens that threatens the use of penicillin, cephalosporin and carbapenem antibiotics to treat infections. To date, a clinical inhibitor of MBLs that could reverse resistance and re-sensitize resistant Gram-negative pathogens to carbapenems has not been found. Here we have identified a fungal natural product, aspergillomarasmine A (AMA), that is a rapid and potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2. AMA also fully restored the activity of meropenem against Enterobacteriaceae, Acinetobacter spp. and Pseudomonas spp. possessing either VIM or NDM-type alleles. In mice infected with NDM-1-expressing Klebsiella pneumoniae, AMA efficiently restored meropenem activity, demonstrating that a combination of AMA and a carbapenem antibiotic has therapeutic potential to address the clinical challenge of MBL-positive carbapenem-resistant Gram-negative pathogens.	[King, Andrew M.; Wang, Wenliang; De Pascale, Gianfranco; Wright, Gerard D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [King, Andrew M.; Wright, Gerard D.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4K1, Canada; [Reid-Yu, Sarah A.; Coombes, Brian K.; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [King, Dustin T.; Strynadka, Natalie C.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Walsh, Timothy R.] Cardiff Univ, Cardiff Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	McMaster University; McMaster University; McMaster University; University of British Columbia; Cardiff University	Wright, GD (corresponding author), McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Wright, Gerard/0000-0002-9129-7131; King, Dustin/0000-0003-1775-2885; Coombes, Brian/0000-0001-9883-1010; Walsh, Timothy/0000-0003-4315-4096	UK Medical Research Council [G1100135]; Canadian Institutes of Health Research [MT-13536]; Natural Sciences and Engineering Research Council [237480]; Canada Research Chair in Infectious Disease Pathogenesis; Antibiotic Biochemistry; Medical Research Council [G1100135] Funding Source: researchfish; MRC [G1100135] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Infectious Disease Pathogenesis; Antibiotic Biochemistry; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Mulvey (Public Health Agency of Canada) and R. Melano (Public Health Ontario) for clinical strains. We thank L. Rossi for her work in constructing the screening strain. AMA inhibition activity on clinical strains by T.R.W. was funded by the UK Medical Research Council (G1100135). This research was funded by a Canadian Institutes of Health Research Grant (MT-13536), Natural Sciences and Engineering Research Council Grant (237480), and by a Canada Research Chair in Infectious Disease Pathogenesis (to B.K.C.) and Antibiotic Biochemistry (to G.D.W.).	ARAI K, 1993, BIOSCI BIOTECH BIOCH, V57, P1944, DOI 10.1271/bbb.57.1944; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Buynak JD, 2013, EXPERT OPIN THER PAT, V23, P1469, DOI 10.1517/13543776.2013.831071; CDC, 2013, ANTIBIOTIC RESISTANC; Chang Y, 2013, LAB TRENDS DECEMBER; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Edelstein MV, 2013, LANCET INFECT DIS, V13, P867, DOI 10.1016/S1473-3099(13)70168-3; Endimiani A, 2011, ANTIMICROB AGENTS CH, V55, P82, DOI 10.1128/AAC.01198-10; EUCAST, 2014, BREAKP TABL INT MICS; Fast W, 2013, BBA-PROTEINS PROTEOM, V1834, P1648, DOI 10.1016/j.bbapap.2013.04.024; Frere J. M., 2011, BETA LACTAMASES; Frias M, 2014, MMWR-MORBID MORTAL W, V62, P1051; HAENNI AL, 1965, HELV CHIM ACTA, V48, P729, DOI 10.1002/hlca.19650480409; HOLMQUIST B, 1979, ANAL BIOCHEM, V95, P540, DOI 10.1016/0003-2697(79)90769-3; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Lee M, 2005, J ORG CHEM, V70, P367, DOI 10.1021/jo0487395; Marra A, 2012, ANTIMICROB AGENTS CH, V56, P4671, DOI 10.1128/AAC.00276-12; MATSUURA A, 1993, JPN J PHARMACOL, V63, P187, DOI 10.1254/jjp.63.187; MIKAMI Y, 1983, AGR BIOL CHEM TOKYO, V47, P2693, DOI 10.1080/00021369.1983.10866020; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pillai SK, 2005, ANTIBIOTICS LAB MED, P365; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Shlaes DM, 2013, ANN NY ACAD SCI, V1277, P105, DOI 10.1111/nyas.12010; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	358	376	4	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					503	+		10.1038/nature13445	http://dx.doi.org/10.1038/nature13445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24965651	Green Accepted			2022-12-24	WOS:000337806300039
J	Lee, YJ; Dominy, JE; Choi, YJ; Jurczak, M; Tolliday, N; Camporez, JP; Chim, H; Lim, JH; Ruan, HB; Yang, XY; Vazquez, F; Sicinski, P; Shulman, GI; Puigserver, P				Lee, Yoonjin; Dominy, John E.; Choi, Yoon Jong; Jurczak, Michael; Tolliday, Nicola; Camporez, Joao Paulo; Chim, Helen; Lim, Ji-Hong; Ruan, Hai-Bin; Yang, Xiaoyong; Vazquez, Francisca; Sicinski, Piotr; Shulman, Gerald I.; Puigserver, Pere			Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression	NATURE			English	Article							HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE; MICE LACKING; PHOSPHORYLATION; INHIBITION; EXPRESSION; CDK4; PGC-1-ALPHA; ACTIVATION; RECEPTOR	Insulin constitutes a principal evolutionarily conserved hormonal axis for maintaining glucose homeostasis(1-3); dysregulation of this axis causes diabetes(2,4). PGC-1 alpha(peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha) links insulin signalling to the expression of glucose and lipid metabolic genes(5-7). The histone acetyltransferase GCN5 (general control non-repressed protein 5) acetylates PGC-1 alpha and suppresses its transcriptional activity, whereas sirtuin 1 deacetylates and activates PGC-1 alpha(8,9). Although insulin is a mitogenic signal in proliferative cells(10,11), whether components of the cell cycle machinery contribute to its metabolic action is poorly understood. Here we report that in mice insulin activates cyclin D1-cyclin-dependent kinase 4 (Cdk4), which, in turn, increases GCN5 acetyltransferase activity and suppresses hepatic glucose production independently of cell cycle progression. Through a cell-based high-throughput chemical screen, we identify a Cdk4 inhibitor that potently decreases PGC-1 alpha acetylation. Insulin/GSK-3 beta (glycogen synthase kinase 3-beta) signalling induces cyclin D1 protein stability by sequestering cyclin D1 in the nucleus. In parallel, dietary amino acids increase hepatic cyclin D1 messenger RNA transcripts. Activated cyclin D1-Cdk4 kinase phosphorylates and activates GCN5, which then acetylates and inhibits PGC-1 alpha activity on gluconeogenic genes. Loss of hepatic cyclin D1 results in increased gluconeogenesis and hyperglycaemia. In diabetic models, cyclin D1-Cdk4 is chronically elevated and refractory to fasting/feeding transitions; nevertheless further activation of this kinase normalizes glycaemia. Our findings show that insulin uses components of the cell cycle machinery in post-mitotic cells to control glucose homeostasis independently of cell division.	[Lee, Yoonjin; Dominy, John E.; Choi, Yoon Jong; Chim, Helen; Lim, Ji-Hong; Vazquez, Francisca; Sicinski, Piotr; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Lee, Yoonjin; Dominy, John E.; Chim, Helen; Lim, Ji-Hong; Vazquez, Francisca; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lee, Yoonjin] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Choi, Yoon Jong; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Jurczak, Michael; Camporez, Joao Paulo; Ruan, Hai-Bin; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Sch Med, Yales Mouse Metab Phenotyping Ctr, New Haven, CT 06510 USA; [Jurczak, Michael; Camporez, Joao Paulo; Ruan, Hai-Bin; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Jurczak, Michael; Camporez, Joao Paulo; Ruan, Hai-Bin; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Tolliday, Nicola] Broad Inst Harvard & MIT, Chem Biol Platform, Cambridge Ctr 7, Cambridge, MA 02141 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Yale University; Yale University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Puigserver, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	pere_puigserver@dfci.harvard.edu	Camporez, Joao Paulo G/B-9122-2015; Ruan, Hai-Bin/G-9907-2012; Vazquez, Francisca/AAA-3751-2020; Ruan, Hai-Bin/AAN-7777-2021; Vazquez, Francisca/ABC-4620-2020; Shulman, Gerald I./P-7176-2019	Ruan, Hai-Bin/0000-0002-3858-1272; Vazquez, Francisca/0000-0002-2857-4685; Ruan, Hai-Bin/0000-0002-3858-1272; Shulman, Gerald I./0000-0003-1529-5668; Jurczak, Michael/0000-0002-6335-6915; Camporez, Joao Paulo/0000-0003-3486-4301	Ewha Womans University; National Research Service Award Kirschstein Fellowship from the National Institutes of Health (NIH); Dana-Farber Cancer Institute; American Diabetes Association; Department of Defense; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [R01069966, R24DK080261-06]; NIH [R03 MH092174, R01 CA108420, DK059635]; NATIONAL CANCER INSTITUTE [R01CA083688, R01CA108420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069966, R01DK089098, U2CDK059635, F32DK083871, U24DK059635, R24DK080261, P30DK034989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032468] Funding Source: NIH RePORTER	Ewha Womans University; National Research Service Award Kirschstein Fellowship from the National Institutes of Health (NIH); Dana-Farber Cancer Institute; American Diabetes Association(American Diabetes Association); Department of Defense(United States Department of Defense); NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all the members of the Puigserver laboratory for discussions and suggestions about this project. We also appreciate the consultations with and efforts by M. Jedrychowski and S. Gygi for proteomic analysis. Y.L. was supported in part by a 21st Century Leaders scholarship from Ewha Womans University. J.E.D. was supported in part by a National Research Service Award Kirschstein Fellowship from the National Institutes of Health (NIH). The participating researchers were supported with funds from the Dana-Farber Cancer Institute and with grants from the American Diabetes Association, Department of Defense, NIH/National Institute of Diabetes and Digestive and Kidney Diseases (R01069966 and R24DK080261-06), NIH (R03 MH092174) awarded to P.P., NIH (R01 CA108420) awarded to P.S. and NIH (DK059635) awarded to Yale's Mouse Metabolic Phenotyping Center/G.I.S.	Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571; Fry DW, 2004, MOL CANCER THER, V3, P1427; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; KATO J, 1993, GENE DEV, V7, P331; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li DM, 2009, APPL BIOCHEM BIOTECH, V158, P253, DOI 10.1007/s12010-008-8391-0; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MCKEEHAN WL, 1984, CANCER RES, V44, P1998; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Soni R, 2000, BIOCHEM BIOPH RES CO, V275, P877, DOI 10.1006/bbrc.2000.3349; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	35	167	174	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					547	+		10.1038/nature13267	http://dx.doi.org/10.1038/nature13267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24870244	Green Accepted, Green Submitted			2022-12-24	WOS:000337806300049
J	Gierisch, JM; Myers, ER; Schmit, KM; McCrory, DC; Coeytaux, RR; Crowley, MJ; Chatterjee, R; Kendrick, AS; Sanders, GD				Gierisch, Jennifer M.; Myers, Evan R.; Schmit, Kristine M.; McCrory, Douglas C.; Coeytaux, Remy R.; Crowley, Matthew J.; Chatterjee, Ranee; Kendrick, Amy S.; Sanders, Gillian D.			Prioritization of Patient-Centered Comparative Effectiveness Research for Osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; RHEUMATIC CONDITIONS; KNEE OSTEOARTHRITIS; ARTHRITIS; PREVALENCE; HEALTH; CARE; PAIN	Osteoarthritis is a leading cause of disability in the United States. This article describes a prioritized research agenda about osteoarthritis management developed for the Patient-Centered Outcomes Research Institute. Evidence gaps were identified by reviewing existing literature and engaging diverse stakeholders to expand and refine gaps. Stakeholders ranked evidence gaps by importance from their perspectives. Prioritized evidence gaps included the need to determine or evaluate key patient-centered outcomes; optimal duration, intensity, and frequency of nonsurgical interventions; whether the comparative effectiveness of nonsurgical interventions varies by socioeconomic factors; when and how to transition from nonsurgical to surgical interventions; effective ways to engage patients in self-management and promote long-term behavior change; standardized screening tools that improve early diagnosis; biomechanical strategies that improve symptoms; mechanisms for promoting and delivering coordinated, longitudinal care; and comparative effectiveness of nonsurgical therapies. Searches of PubMed and ClinicalTrials.gov showed many recent and ongoing studies addressing comparative effectiveness of nonsurgical interventions; relatively few of these evaluated treatments across categories (for example, drug therapy vs. weight management) or combined categories of treatment. Few studies addressed other high-priority evidence gaps.	Duke Clin Res Inst, Duke Evidence Synth Grp, Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; Duke Univ, Sch Med, Durham, NC 27701 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Gierisch, JM (corresponding author), Duke Univ, Med Ctr, Dept Med, Campus Box 104427 DUMC, Durham, NC 27701 USA.	j.gierisch@dm.duke.edu	Gierisch, Jennifer/GLU-1269-2022	Kendrick, Amy/0000-0001-8769-1702; Gierisch, Jennifer/0000-0002-5057-4964	PCORI	PCORI(Patient-Centered Outcomes Research Institute - PCORI)	By PCORI.	Brasure M, 2013, 13EHC048EF AG HEALTH; Centers for Disease Control and Prevention, NHIS ARTHR SURV SPEC; Chang SM, 2012, ANN INTERN MED, V157, P439, DOI 10.7326/0003-4819-157-6-201209180-00515; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Gabriel SE, 1999, J RHEUMATOL, V26, P2475; Gierisch JM, 2014, ANN INTERN MED, V160, P484, DOI 10.7326/M13-2548; Ip S, 2013, AHRQ PUBLICATION, V13-EHC016-EF; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee D W, 2001, Value Health, V4, P329, DOI 10.1046/j.1524-4733.2001.44012.x; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Murphy L, 2012, AM J NURS, V112, pS13, DOI 10.1097/01.NAJ.0000412646.80054.21; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Nuki G, 1999, Z RHEUMATOL, V58, P142, DOI 10.1007/s003930050164; Patient-Centered Outcomes Research Institute, 2014, PRAGM CLIN STUD LARG; Patsopoulos Nikolaos A, 2011, Dialogues Clin Neurosci, V13, P217; Rosemann T, 2008, PAIN MED, V9, P903, DOI 10.1111/j.1526-4637.2008.00498.x; Thorpe KE, 2009, CAN MED ASSOC J, V180, pE47, DOI 10.1503/cmaj.090523; Yelin E, 2007, ARTHRITIS RHEUM-US, V56, P1397, DOI 10.1002/art.22565	19	25	25	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					836	U52		10.7326/M14-0318	http://dx.doi.org/10.7326/M14-0318			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24821227				2022-12-24	WOS:000337374900017
J	Hernandez-Molina, FJ; Stow, DAV; Alvarez-Zarikian, CA; Acton, G; Bahr, A; Balestra, B; Ducassou, E; Flood, R; Flores, JA; Furota, S; Grunert, P; Hodell, D; Jimenez-Espejo, FJ; Kim, JK; Krissek, L; Kuroda, J; Li, BH; Llave, E; Lofi, J; Lourens, L; Miller, M; Nanayama, F; Nishida, N; Richter, C; Roque, C; Pereira, H; Goni, MFS; Sierro, FJ; Singh, AD; Sloss, C; Takashimizu, Y; Tzanova, A; Voelker, A; Williams, T; Xuan, C				Hernandez-Molina, F. Javier; Stow, Dorrik A. V.; Alvarez-Zarikian, Carlos A.; Acton, Gary; Bahr, Andre; Balestra, Barbara; Ducassou, Emmanuelle; Flood, Roger; Flores, Jose-Abel; Furota, Satoshi; Grunert, Patrick; Hodell, David; Jimenez-Espejo, Francisco J.; Kim, Jin Kyoung; Krissek, Lawrence; Kuroda, Junichiro; Li, Baohua; Llave, Estefania; Lofi, Johanna; Lourens, Lucas; Miller, Madeline; Nanayama, Futoshi; Nishida, Naohisa; Richter, Carl; Roque, Cristina; Pereira, Helder; Goni, Maria Fernanda Sanchez; Sierro, Francisco J.; Singh, Arun Deo; Sloss, Craig; Takashimizu, Yasuhiro; Tzanova, Alexandrina; Voelker, Antje; Williams, Trevor; Xuan, Chuang			Onset of Mediterranean outflow into the North Atlantic	SCIENCE			English	Article							DEEP-WATER CIRCULATION; HEMISPHERE GLACIATION; CONTOURITE DRIFTS; ALGARVE MARGIN; LATE PLIOCENE; ICE VOLUME; SEA-LEVEL; EVOLUTION; CLIMATE; CADIZ	Sediments cored along the southwestern Iberian margin during Integrated Ocean Drilling Program Expedition 339 provide constraints on Mediterranean Outflow Water (MOW) circulation patterns from the Pliocene epoch to the present day. After the Strait of Gibraltar opened (5.33 million years ago), a limited volume of MOW entered the Atlantic. Depositional hiatuses indicate erosion by bottom currents related to higher volumes of MOW circulating into the North Atlantic, beginning in the late Pliocene. The hiatuses coincide with regional tectonic events and changes in global thermohaline circulation (THC). This suggests that MOW influenced Atlantic Meridional Overturning Circulation (AMOC), THC, and climatic shifts by contributing a component of warm, saline water to northern latitudes while in turn being influenced by plate tectonics.	[Hernandez-Molina, F. Javier] Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Stow, Dorrik A. V.] Heriot Watt Univ, Inst Petr Engn, Edinburgh EH14 4AS, Midlothian, Scotland; [Alvarez-Zarikian, Carlos A.] Texas A&M Univ, Dept Oceanog, Int Ocean Discovery Program, College Stn, TX 77845 USA; [Acton, Gary] Sam Houston State Univ, Dept Geog & Geol, Huntsville, TX 77341 USA; [Bahr, Andre] Goethe Univ Frankfurt, Inst Geosci, D-60438 Frankfurt, Germany; [Balestra, Barbara] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Ducassou, Emmanuelle] Univ Bordeaux, EPOC, F-33615 Pessac, France; [Flood, Roger] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Flores, Jose-Abel; Sierro, Francisco J.] Univ Salamanca, Dept Geol, Salamanca 3008, Spain; [Furota, Satoshi] Hokkaido Univ, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Grunert, Patrick] Graz Univ, Inst Earth Sci, A-8010 Graz, Austria; [Hodell, David] Univ Cambridge, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England; [Jimenez-Espejo, Francisco J.] JAMSTEC, Dept Biogeochem, Yokosuka, Kanagawa 2370061, Japan; [Kim, Jin Kyoung] Korea Inst Ocean Sci & Technol, Ansan 426744, South Korea; [Krissek, Lawrence] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Kuroda, Junichiro] JAMSTEC, IFREE, Yokosuka, Kanagawa 2370061, Japan; [Li, Baohua] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Dept Micropalaeontol, Nanjing 210008, Jiangsu, Peoples R China; [Llave, Estefania] Inst Geol & Minero Espana, Madrid 28003, Spain; [Lofi, Johanna] Univ Montpellier 2, Geosci Montpellier, F-34090 Montpellier, France; [Lofi, Johanna] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Lourens, Lucas] Univ Utrecht, Inst Earth Sci, NL-3584 CD Utrecht, Netherlands; [Miller, Madeline] CALTECH, Dept Mech Engn, Pasadena, CA 91125 USA; [Nanayama, Futoshi; Nishida, Naohisa] Geol Survey Japan AIST, Inst Geol & Geoinformat, Ibaraki 3058567, Japan; [Richter, Carl] Univ Louisiana, Sch Geosci, Lafayette, LA 70504 USA; [Roque, Cristina; Voelker, Antje] IPMA, Div Geol & Georecursos Marinhos, P-1749077 Lisbon, Portugal; [Pereira, Helder] Escola Secundaria Loule, Grp Biol & Geol, P-8100740 Loule, Portugal; [Goni, Maria Fernanda Sanchez] Univ Bordeaux, EPOC, Ecole Prat Hautes Etud, F-33615 Pessac, France; [Singh, Arun Deo] Banaras Hindu Univ, Dept Geol, Varanasi 221005, Uttar Pradesh, India; [Sloss, Craig] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Takashimizu, Yasuhiro] Niigata Univ, Dept Geol, Fac Educ, Niigata 9502181, Japan; [Tzanova, Alexandrina] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Williams, Trevor] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Xuan, Chuang] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England	University of London; Royal Holloway University London; Heriot Watt University; Texas A&M University System; Texas A&M University College Station; Texas State University System; Sam Houston State University; Goethe University Frankfurt; University of California System; University of California Santa Cruz; UDICE-French Research Universities; Universite de Bordeaux; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Salamanca; Hokkaido University; University of Graz; University of Cambridge; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Korea Institute of Ocean Science & Technology (KIOST); University System of Ohio; Ohio State University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Chinese Academy of Sciences; Universite de Montpellier; University of Leicester; Utrecht University; California Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); University of Louisiana Lafayette; Instituto Portugues do Mar e da Atmosfera; UDICE-French Research Universities; Universite de Bordeaux; Banaras Hindu University (BHU); Queensland University of Technology (QUT); Niigata University; Brown University; Columbia University; NERC National Oceanography Centre; University of Southampton	Hernandez-Molina, FJ (corresponding author), Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England.	javier.hernandez-molina@rhul.ac.uk	Voelker, Antje H L/C-5427-2012; Acton, Gary/B-6108-2016; Nanayama, Futoshi/L-4453-2018; Jimenez-Espejo, Francisco J./AAR-2318-2020; Llave, Estefania/H-2232-2015; Roque, Cristina/A-8146-2013; Nanayama, Futoshi/K-2190-2019; Nishida, Naohisa/I-7483-2016; Kuroda, Junichiro/A-3007-2016; Xuan, Chuang/E-2039-2011; Jimenez-Espejo, Francisco J/F-4486-2016; Lofi, Johanna/I-5159-2018; Sierro, Francisco/A-4714-2008; Goñi, Maria Fernanda Sanchez/R-3699-2019; Flores, José-Abel/D-4218-2009	Voelker, Antje H L/0000-0001-6465-6023; Nanayama, Futoshi/0000-0001-8693-4784; Llave, Estefania/0000-0001-7873-7211; Roque, Cristina/0000-0002-2583-594X; Nanayama, Futoshi/0000-0001-8693-4784; Kuroda, Junichiro/0000-0002-2218-4854; Xuan, Chuang/0000-0003-4043-3073; Jimenez-Espejo, Francisco J/0000-0002-0335-8580; Lofi, Johanna/0000-0002-0602-595X; Sierro, Francisco/0000-0002-8647-456X; Goñi, Maria Fernanda Sanchez/0000-0001-8238-7488; Flores, José-Abel/0000-0003-1909-293X; Takashimizu, Yasuhiro/0000-0002-3840-9325; Alvarez Zarikian, Carlos/0000-0002-3785-3336; Pereira, Helder/0000-0001-7664-7650; Hodell, David/0000-0001-8537-1588; Acton, Gary/0000-0002-3285-4022; Sloss, Craig/0000-0001-8694-6822; Miller, Madeline/0000-0003-2598-6518; , barbara/0000-0001-7064-3173; Bahr, Andre/0000-0001-5890-8773	 [CTM 2008-06399-C04/MAR];  [CTM 2012-39599-C03];  [CGL2011-26493];  [CTM2012-38248];  [IGCP-619];  [INQUA 1204];  [FWF P25831-N29]; NERC [NE/J017922/1] Funding Source: UKRI; Austrian Science Fund (FWF) [P 25831] Funding Source: researchfish; Natural Environment Research Council [NE/J017922/1] Funding Source: researchfish	; ; ; ; ; ; ; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research used samples and data collected through the Integrated Ocean Drilling Program (IODP). The research was partially supported through the CTM 2008-06399-C04/MAR, CTM 2012-39599-C03, CGL2011-26493, CTM2012-38248, IGCP-619, INQUA 1204, and FWF P25831-N29 Projects. The Continental Margins Research Group at Royal Holloway, University of London, also contributed to the research. We thank REPSOL and TGS-NOPEC (Tomlinson Geophysical Services Inc. and Norwegian Petroleum Exploration Consultants) Geophysical Company ASA for use of an unpublished seismic record. We thank N. Khelifi (Springer, Germany) and M. Rogerson (University of Hull, UK) for discussing the changes in MOW density during the Pliocene and Quaternary, as well as the anonymous reviewers whose suggestions improved the final version of our manuscript. Data available at http://doi.pangaea.de/10.1594/PANGAEA.832885?format=html and at the IODP web page, http://iodp.tamu.edu/scienceops/expeditions/mediterranean_outflow.html.	Bailey I, 2013, QUATERNARY SCI REV, V75, P181, DOI 10.1016/j.quascirev.2013.06.004; Bartoli G, 2005, EARTH PLANET SC LETT, V237, P33, DOI 10.1016/j.epsl.2005.06.020; Billups K, 1998, PALEOCEANOGRAPHY, V13, P84, DOI 10.1029/97PA02995; Brackenridge RE, 2013, MAR PETROL GEOL, V46, P36, DOI 10.1016/j.marpetgeo.2013.05.015; CLOETINGH S, 1990, J GEOL SOC LONDON, V147, P495, DOI 10.1144/gsjgs.147.3.0495; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; Duarte JC, 2011, MAR GEOL, V289, P135, DOI 10.1016/j.margeo.2011.09.014; DWYER GS, 1995, SCIENCE, V270, P1347, DOI 10.1126/science.270.5240.1347; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Esteras M., 2000, REV SOC GEOL ESPAN, V13, P539; Flinch JF, 1998, SEPM SPECIAL PUBLICA, V60, P199; Gutscher MA, 2002, GEOLOGY, V30, P1071, DOI 10.1130/0091-7613(2002)030<1071:EFASBG>2.0.CO;2; Hay WW, 1996, GEOL RUNDSCH, V85, P409, DOI 10.1007/BF02369000; Hernandez-Molina FJ, 2014, GEOLOGY, V42, P227, DOI 10.1130/G35083.1; Khelifi N, 2009, GEOLOGY, V37, P811, DOI 10.1130/G30058A.1; Knutz PC, 2008, DEVEL SEDIM, V60, P511, DOI 10.1016/S0070-4571(08)00224-0; LEDBETTER MT, 1978, NATURE, V272, P237, DOI 10.1038/272237a0; Llave E, 2007, GEOL SOC SPEC PUBL, V276, P49, DOI 10.1144/GSL.SP.2007.276.01.03; Martinez-Garcia P, 2013, BASIN RES, V25, P361, DOI 10.1111/bre.12005; Maslin MA, 1998, QUATERNARY SCI REV, V17, P411, DOI 10.1016/S0277-3791(97)00047-4; Medialdea T, 2004, MAR GEOL, V209, P173, DOI 10.1016/j.margeo.2004.05.029; Miller KG, 2011, OCEANOGRAPHY, V24, P40, DOI 10.5670/oceanog.2011.26; Nisancioglu KH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000767; Potter PE, 2009, EARTH-SCI REV, V96, P279, DOI 10.1016/j.earscirev.2009.07.003; Rogerson M, 2012, CLIM DYNAM, V39, P589, DOI 10.1007/s00382-011-1148-4; Rogerson M, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000376; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Roque C, 2012, MAR GEOL, V303, P42, DOI 10.1016/j.margeo.2011.11.001; Roveri M, 2014, MAR GEOL, V352, P25, DOI 10.1016/j.margeo.2014.02.002; Serra N, 2010, OCEAN SCI, V6, P191, DOI 10.5194/os-6-191-2010; Summerhayes C. P., 1986, N ATLANTIC PALEOCEAN, P103; White N, 1997, NATURE, V387, P888, DOI 10.1038/43151; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zitellini N, 2009, EARTH PLANET SC LETT, V280, P13, DOI 10.1016/j.epsl.2008.12.005	34	120	123	0	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1244	1250		10.1126/science.1251306	http://dx.doi.org/10.1126/science.1251306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926012	Green Published, Green Submitted			2022-12-24	WOS:000337077500031
J	Youngs, H; Somerville, C				Youngs, Heather; Somerville, Chris			PLANT SCIENCE Best practices for biofuels	SCIENCE			English	Editorial Material							CROP RESIDUE; IMPACTS		[Youngs, Heather; Somerville, Chris] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Somerville, Chris] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Arid Land Agr, Jeddah 21413, Saudi Arabia	University of California System; University of California Berkeley; King Abdulaziz University	Youngs, H (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	crs@berkeley.edu						Anderson-Teixeira K. J., 2013, Ecosystems, V16, P508, DOI 10.1007/s10021-012-9628-x; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bonner IJ, 2014, BIOENERG RES, V7, P576, DOI 10.1007/s12155-014-9423-y; Edenhofer O., 2011, IPCC SPECIAL REPORT; Hertel TW, 2013, GLOB FOOD SECUR-AGR, V2, P131, DOI 10.1016/j.gfs.2013.05.003; Karlen DL, 2014, BIOENERG RES, V7, P528, DOI [10.1007/s12155-014-9419-7, 10.1007/s12155-014-9407-y]; Liska AJ, 2014, NAT CLIM CHANGE, V4, P398, DOI [10.1038/NCLIMATE2187, 10.1038/nclimate2187]; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Scarlat N, 2011, ENERG POLICY, V39, P1630, DOI 10.1016/j.enpol.2010.12.039; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970	11	29	30	0	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1095	1096		10.1126/science.1255812	http://dx.doi.org/10.1126/science.1255812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904145				2022-12-24	WOS:000336791200026
J	White, SR; Moore, JS; Sottos, NR; Krull, BP; Cruz, WAS; Gergely, RCR				White, S. R.; Moore, J. S.; Sottos, N. R.; Krull, B. P.; Cruz, W. A. Santa; Gergely, R. C. R.			Restoration of Large Damage Volumes in Polymers	SCIENCE			English	Article							LIMB REGENERATION; DEDIFFERENTIATION; COMPOSITES; CHEMISTRY; SURFACE; WEIGHT; CELLS	The regenerative power of tissues and organs in biology has no analog in synthetic materials. Although self-healing of microscopic defects has been demonstrated, the regrowth of material lost through catastrophic damage requires a regenerative-like approach. We demonstrate a vascular synthetic system that restores mechanical performance in response to large-scale damage. Gap-filling scaffolds are created through a two-stage polymer chemistry that initially forms a shape-conforming dynamic gel but later polymerizes to a solid structural polymer with robust mechanical properties. Through the control of reaction kinetics and vascular delivery rate, we filled impacted regions that exceed 35 mm in diameter within 20 min and restored mechanical function within 3 hours. After restoration of impact damage, 62% of the total absorbed energy was recovered in comparison with that in initial impact tests.	[White, S. R.] Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA; [White, S. R.; Moore, J. S.; Sottos, N. R.; Krull, B. P.; Cruz, W. A. Santa; Gergely, R. C. R.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Moore, J. S.; Cruz, W. A. Santa] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Sottos, N. R.; Krull, B. P.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Gergely, R. C. R.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	White, SR (corresponding author), Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA.	swhite@illinois.edu	White, Scott/G-9667-2013	White, Scott/0000-0002-0831-9097; Moore, Jeffrey/0000-0001-5841-6269	Air Force Office of Scientific Research [FA9550-10-1-0255]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research has been financially supported by the Air Force Office of Scientific Research (grant FA9550-10-1-0255). We extend our gratitude to the Mechanical Testing Instructional Laboratory (MTIL) and the Beckman Institute for facilities; Y. Fedonina, J. Carlson, A. Komnick, and C. Kirk for assistance with sample fabrication and material synthesis; and G. Milner for test fixture construction.	Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Beiermann BA, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/8/085001; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; CARNEVALI MDC, 1995, J EXP ZOOL, V272, P464, DOI 10.1002/jez.1402720608; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Deng GH, 2010, MACROMOLECULES, V43, P1191, DOI 10.1021/ma9022197; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Esfandiari P, 2013, J POLYM SCI POL CHEM, V51, P4261, DOI 10.1002/pola.26848; Harkins WD, 1919, J AM CHEM SOC, V41, P499, DOI 10.1021/ja01461a003; Hoyle CE, 2004, J POLYM SCI POL CHEM, V42, P5301, DOI 10.1002/pola.20366; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kim YB, 2005, J APPL POLYM SCI, V95, P342, DOI 10.1002/app.21248; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; LANDO JL, 1967, J COLLOID INTERF SCI, V25, P526, DOI 10.1016/0021-9797(67)90064-1; Lauzon RJ, 2002, DEV BIOL, V249, P333, DOI 10.1006/dbio.2002.0772; Mark JE, 1999, POLYM DATA HDB, P656; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Murphy EB, 2010, PROG POLYM SCI, V35, P223, DOI 10.1016/j.progpolymsci.2009.10.006; Nacu E, 2011, ANNU REV CELL DEV BI, V27, P409, DOI 10.1146/annurev-cellbio-092910-154115; Odelberg Shannon J., 2005, Anatomical Record Part B:The New Anatomist, V287, P25, DOI 10.1002/ar.b.20080; Patrick JF, 2014, ADV MATER, V26, P4302, DOI 10.1002/adma.201400248; SHEPPARD CS, 1979, POLYM ENG SCI, V19, P597, DOI 10.1002/pen.760190902; Slack JMW, 2006, TRENDS CELL BIOL, V16, P273, DOI 10.1016/j.tcb.2006.04.007; TATE T., 1864, PHILOS MAG, V27, P176; Toohey KS, 2009, ADV FUNCT MATER, V19, P1399, DOI 10.1002/adfm.200801824; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; Wojtecki RJ, 2011, NAT MATER, V10, P14, DOI [10.1038/nmat2891, 10.1038/NMAT2891]; Wool RP, 2008, SOFT MATTER, V4, P400, DOI 10.1039/b711716g	31	179	188	6	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					620	623		10.1126/science.1251135	http://dx.doi.org/10.1126/science.1251135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812399				2022-12-24	WOS:000335537400040
J	Hovenden, MJ; Newton, PCD; Wills, KE				Hovenden, Mark J.; Newton, Paul C. D.; Wills, Karen E.			Seasonal not annual rainfall determines grassland biomass response to carbon dioxide	NATURE			English	Article							ELEVATED CO2; CLIMATE-CHANGE; NITROGEN INTERACTIONS; WATER RELATIONS; ECOSYSTEMS; PRODUCTIVITY; LIMITATION; RANGELANDS; LESSONS; TRENDS	The rising atmospheric concentration of carbon dioxide (CO2) should stimulate ecosystem productivity, but to what extent is highly uncertain, particularly when combined with changing temperature and precipitation(1). Ecosystem response to CO2 is complicated by biogeochemical feedbacks(2) but must be understood if carbon storage and associated dampening of climate warming are to be predicted(3). Feedbacks through the hydrological cycle are particularly important(4) and the physiology is well known; elevated CO2 reduces stomatal conductance and increases plant water use efficiency (the amount of water required to produce a unit of plant dry matter)(5). The CO2 response should consequently be strongest when water is limiting(6); although this has been shown in some experiments(7), it is absent frommany(8-11). Here we show that large annual variation in the stimulation of above-ground biomass by elevated CO2 in a mixed C-3/C-4 temperate grassland can be predicted accurately using seasonal rainfall totals; summer rainfall had a positive effect but autumn and spring rainfall had negative effects on the CO2 response. Thus, the elevated CO2 effect mainly depended upon the balance between summer and autumn/spring rainfall. This is partly because high rainfall during cool, moist seasons leads to nitrogen limitation, reducing or even preventing biomass stimulation by elevated CO2. Importantly, the prediction held whether plots were warmed by 2 degrees C or left unwarmed, and was similar for C-3 plants and total biomass, allowing us to make a powerful generalization about ecosystem responses to elevated CO2. This new insight is particularly valuable because climate projections predict large changes in the timing of rainfall, even where annual totals remain static(12). Our findings will help resolve apparent differences in the outcomes of CO2 experiments and improve the formulation and interpretation of models that are insensitive to differences in the seasonal effects of rainfall on the CO2 response(7,13,14).	[Hovenden, Mark J.; Wills, Karen E.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Newton, Paul C. D.] AgResearch, Land & Environm Management, Palmerston North 4474, New Zealand	University of Tasmania; AgResearch - New Zealand	Hovenden, MJ (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia.	Mark.Hovenden@utas.edu.au	Wills, Karen/M-2652-2019; Wills, Karen E/H-4390-2012; Hovenden, Mark/A-1323-2008	Wills, Karen/0000-0003-3897-2908; Wills, Karen E/0000-0003-3897-2908; Hovenden, Mark/0000-0001-7208-9700	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by grants from the Australian Research Council Discovery Projects scheme. We thank the Australian Department of Defence for access to the Pontville Small Arms Range Complex. J. Vander Schoor, A. Williams, J. Janes, J. Buettel and M. Porter provided technical assistance. R. Mallett assisted with statistical analyses and L. Barmuta provided advice on multimodel inference.	Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; De Kauwe MG, 2013, GLOBAL CHANGE BIOL, V19, P1759, DOI 10.1111/gcb.12164; Derner JD, 2003, GLOBAL CHANGE BIOL, V9, P452, DOI 10.1046/j.1365-2486.2003.00579.x; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Grunzweig JM, 2001, OECOLOGIA, V128, P251, DOI 10.1007/s004420100657; Hovenden MJ, 2006, AUST J BOT, V54, P1, DOI 10.1071/BT04194; K/rner C., 2007, TERRESTRIAL ECOSYSTE, P9, DOI [10.1007/978-3-540-32730-1_2, DOI 10.1007/978-3-540-32730-1_2]; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leuzinger S, 2010, GLOBAL CHANGE BIOL, V16, P246, DOI 10.1111/j.1365-2486.2009.01937.x; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Marissink M, 2002, AGR ECOSYST ENVIRON, V93, P107, DOI 10.1016/S0167-8809(01)00356-5; Matthews HD, 2007, GLOBAL CHANGE BIOL, V13, P1068, DOI 10.1111/j.1365-2486.2007.01343.x; McMurtrie RE, 2008, FUNCT PLANT BIOL, V35, P521, DOI 10.1071/FP08128; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Morgan JA, 2004, ECOL APPL, V14, P208, DOI 10.1890/02-5213; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Osanai Y, 2012, PLANT SOIL, V350, P365, DOI 10.1007/s11104-011-0920-x; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Polley HW, 2013, RANGELAND ECOL MANAG, V66, P493, DOI 10.2111/REM-D-12-00068.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reich PB, 2013, NAT CLIM CHANGE, V3, P278, DOI [10.1038/nclimate1694, 10.1038/NCLIMATE1694]; Singh D, 2013, J GEOPHYS RES-ATMOS, V118, P7063, DOI 10.1002/jgrd.50543; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Soussana JF, 2007, GRASS FORAGE SCI, V62, P127, DOI 10.1111/j.1365-2494.2007.00577.x; Webb NP, 2012, CLIMATIC CHANGE, V112, P925, DOI 10.1007/s10584-011-0236-0	34	107	115	8	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					583	+		10.1038/nature13281	http://dx.doi.org/10.1038/nature13281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	24870242				2022-12-24	WOS:000339566300033
J	Phillippe, M				Phillippe, Mark			Cell-free Fetal DNA - A Trigger for Parturition	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MATERNAL PLASMA; PRENATAL-DIAGNOSIS		Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Phillippe, M (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA.							[Anonymous], 1998, AM J HUM GENET, V62, P768; Birch L, 2005, CLIN CHEM, V51, P312, DOI 10.1373/clinchem.2004.042713; Khosrotehrani K, 2004, HUM REPROD, V19, P2460, DOI 10.1093/humrep/deh445; Leung TN, 1999, LANCET, V354, P780; Majer S, 2007, PRENATAL DIAG, V27, P1219, DOI 10.1002/pd.1875; Mitsunaga F, 2010, EXP ANIM TOKYO, V59, P255, DOI 10.1538/expanim.59.255; Scharfe-Nugent A, 2012, J IMMUNOL, V188, P5706, DOI 10.4049/jimmunol.1103454	7	50	54	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2534	2536		10.1056/NEJMcibr1404324	http://dx.doi.org/10.1056/NEJMcibr1404324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963574				2022-12-24	WOS:000337804400014
J	Yong, E				Yong, Ed			FIRST RESPONSE Race against time	NATURE			English	Editorial Material																		Fassbender K, 2003, STROKE, V34, pE44, DOI 10.1161/01.STR.0000075573.22885.3B; Fassbender K, 2013, LANCET NEUROL, V12, P585, DOI 10.1016/S1474-4422(13)70100-5; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Silke W., 2012, LANCET NEUROL, V11, P397	4	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S5	S5		10.1038/510S5a	http://dx.doi.org/10.1038/510S5a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964025				2022-12-24	WOS:000337806300004
J	Ahrends, R; Ota, A; Kovary, KM; Kudo, T; Park, BO; Teruel, MN				Ahrends, Robert; Ota, Asuka; Kovary, Kyle M.; Kudo, Takamasa; Park, Byung Ouk; Teruel, Mary N.			Controlling low rates of cell differentiation through noise and ultrahigh feedback	SCIENCE			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; STEM-CELLS; DEDIFFERENTIATION; ADIPOGENESIS; EXPRESSION; DYNAMICS; BIOLOGY; BINDING	Mammalian tissue size is maintained by slow replacement of de-differentiating and dying cells. For adipocytes, key regulators of glucose and lipid metabolism, the renewal rate is only 10% per year. We used computational modeling, quantitative mass spectrometry, and single-cell microscopy to show that cell-to-cell variability, or noise, in protein abundance acts within a network of more than six positive feedbacks to permit pre-adipocytes to differentiate at very low rates. This reconciles two fundamental opposing requirements: High cell-to-cell signal variability is needed to generate very low differentiation rates, whereas low signal variability is needed to prevent differentiated cells from de-differentiating. Higher eukaryotes can thus control low rates of near irreversible cell fate decisions through a balancing act between noise and ultrahigh feedback connectivity.	[Ahrends, Robert; Ota, Asuka; Kovary, Kyle M.; Kudo, Takamasa; Park, Byung Ouk; Teruel, Mary N.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Teruel, MN (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mteruel@stanford.edu		Teruel, Mary/0000-0002-2854-3598; Ahrends, Robert/0000-0003-0232-3375; Kovary, Kyle/0000-0002-7616-2968	Stanford University New Faculty Startup Funds; NIH [P50GM107615]; Deutsche Forschungsgemeinschaft Fellowship [AH 220/1-1]; American Heart Association Fellowship [13POST17090092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	Stanford University New Faculty Startup Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Fellowship(German Research Foundation (DFG)); American Heart Association Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Meyer, S. Collins, G. Anderson, S. Spencer, together with members of the Teruel lab, for thoughtful comments and discussions. This work is supported by Stanford University New Faculty Startup Funds and NIH P50GM107615 (M.N.T.), Deutsche Forschungsgemeinschaft Fellowship AH 220/1-1 (R. A.), and American Heart Association Fellowship 13POST17090092 (A.O.).	Abell E, 2011, P NATL ACAD SCI USA, V108, P14485, DOI 10.1073/pnas.1018266108; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Berry DC, 2013, DEVELOPMENT, V140, P3939, DOI 10.1242/dev.080549; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Kim HE, 2013, BIOCHEM J, V453, P49, DOI 10.1042/BJ20121598; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Palani S, 2012, CELL REP, V1, P215, DOI 10.1016/j.celrep.2012.01.007; Park BO, 2012, CELL REP, V2, P976, DOI 10.1016/j.celrep.2012.08.038; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Poloni A, 2012, STEM CELLS, V30, P965, DOI 10.1002/stem.1067; Reiff T, 2010, J NEUROSCI, V30, P905, DOI 10.1523/JNEUROSCI.5368-09.2010; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tchoukalova YD, 2004, AM J PHYSIOL-REG I, V287, pR1132, DOI 10.1152/ajpregu.00337.2004; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	29	57	57	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1384	1389		10.1126/science.1252079	http://dx.doi.org/10.1126/science.1252079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948735	Green Accepted			2022-12-24	WOS:000337531700037
J	Weedon-Fekjaer, H; Romundstad, PR; Vatten, LJ				Weedon-Fekjaer, Harald; Romundstad, Pal R.; Vatten, Lars J.			Modern mammography screening and breast cancer mortality: population study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NORWAY; REGISTRY; QUALITY; TRENDS; IMPACT	Objective To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. Design Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 years. Participants All Norwegian women aged 50-79 between 1986 and 2009. Main outcome measures Multiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime. Results During 15 193 034 person years of observation (1986-2009), deaths from breast cancer occurred in 1175 women with a diagnosis after being invited to screening and 8996 women who had not been invited before diagnosis. After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95% confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95% confidence interval 266 to 508) women would need to be invited to screening. Conclusion Invitation to modern mammography screening may reduce deaths from breast cancer by about 28%.	[Weedon-Fekjaer, Harald; Romundstad, Pal R.; Vatten, Lars J.] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7491 Trondheim, Norway; [Weedon-Fekjaer, Harald] Univ Oslo, Oslo Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway; [Weedon-Fekjaer, Harald] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Vatten, Lars J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Weedon-Fekjaer, H (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7491 Trondheim, Norway.	harald.weedon-fekjar@medisin.uio.no	Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022; Weedon-Fekjær, Harald/B-6900-2008	Weedon-Fekjær, Harald/0000-0002-9109-0034; Romundstad, Pal Richard/0000-0003-2061-4336	Norwegian Research Council [189503]; NATIONAL CANCER INSTITUTE [U01CA152958] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Norwegian Research Council (reference No 189503).	Ancelle-Park R, 2012, J MED SCREEN, V19, P5, DOI 10.1258/jms.2012.012077; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], IARC HDB CANC PREV H; Ascunce EN, 2007, J MED SCREEN, V14, P14, DOI 10.1258/096914107780154558; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; CISNET. Cancer Intervention and Surveillance Modeling Network, 2012, CANC INT SURV MOD NE; Clarke M, 1998, LANCET, V351, P1451; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Falk RS, 2013, INT J CANCER, V133, P705, DOI 10.1002/ijc.28052; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Hakama M, 1997, BRIT MED J, V314, P864; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Hofvind S, 2013, CANCER-AM CANCER SOC, V119, P3106, DOI 10.1002/cncr.28174; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lynge E, 2011, ACTA ONCOL, V50, P1062, DOI 10.3109/0284186X.2011.599339; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Moss SM, 2012, J MED SCREEN, V19, P26, DOI 10.1258/jms.2012.012079; Njor S, 2012, J MED SCREEN, V19, P33, DOI 10.1258/jms.2012.012080; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Olsen AH, 2005, BMJ-BRIT MED J, V330, P220, DOI 10.1136/bmj.38313.639236.82; Olsen AH, 2007, EPIDEMIOLOGY, V18, P487, DOI 10.1097/EDE.0b013e318060cbbd; Olsen AH, 2013, INT J CANCER, V132, P208, DOI 10.1002/ijc.27609; Paci E, 2002, EUR J CANCER, V38, P568, DOI 10.1016/S0959-8049(01)00382-3; Plevritis Sylvia K, 2006, J Natl Cancer Inst Monogr, P86, DOI 10.1093/jncimonographs/lgj012; Sorum R, 2010, BREAST, V19, P499, DOI 10.1016/j.breast.2010.05.014; Weedon-Fekjaer H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e299; Welch HG, 2010, NEW ENGL J MED, V363, P1276, DOI 10.1056/NEJMe1008369	31	92	99	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2014	348								g3701	10.1136/bmj.g3701	http://dx.doi.org/10.1136/bmj.g3701			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LA	24951459	Green Published, hybrid			2022-12-24	WOS:000337804900001
J	Goldacre, B; Godlee, F; Heneghan, C; Tovey, D; Lehman, R; Chalmers, I; Barbour, V; Brown, T				Goldacre, Ben; Godlee, Fiona; Heneghan, Carl; Tovey, David; Lehman, Richard; Chalmers, Iain; Barbour, Virginia; Brown, Tracey			OPEN DATA CAMPAIGN Open letter: European Medicines Agency should remove barriers to access clinical trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Goldacre, Ben] London Sch Hyg & Trop Med, London, England; [Heneghan, Carl] Ctr Evidence based Med, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Goldacre, B (corresponding author), London Sch Hyg & Trop Med, London, England.			Goldacre, Ben/0000-0002-5127-4728; Barbour, Virginia/0000-0002-2358-2440; Brown, Tracey/0000-0002-8112-6873					0	7	7	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2014	348								g3768	10.1136/bmj.g3768	http://dx.doi.org/10.1136/bmj.g3768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CE	24906718	Green Published, Bronze			2022-12-24	WOS:000337038000010
J	Kohout, AL; Williams, MJM; Dean, SM; Meylan, MH				Kohout, A. L.; Williams, M. J. M.; Dean, S. M.; Meylan, M. H.			Storm-induced sea-ice breakup and the implications for ice extent	NATURE			English	Article							OCEAN WAVES; ATTENUATION; TRENDS; ZONE; CLIMATE	The propagation of large, storm-generated waves through sea ice has so far not been measured, limiting our understanding of how ocean waves break sea ice. Without improved knowledge of ice breakup, we are unable to understand recent changes, or predict future changes, in Arctic and Antarctic sea ice. Here we show that storm-generated ocean waves propagating through Antarctic sea ice are able to transport enough energy to break sea ice hundreds of kilometres from the ice edge. Our results, which are based on concurrent observations at multiple locations, establish that large waves break sea ice much farther from the ice edge than would be predicted by the commonly assumed exponential decay(1-3). We observed the wave height decay to be almost linear for large waves-those with a significant wave height greater than three metres-and to be exponential only for small waves. This implies a more prominent role for large ocean waves in sea-ice breakup and retreat than previously thought. We examine the wider relevance of this by comparing observed Antarctic sea-ice edge positions with changes in modelled significant wave heights for the Southern Ocean between 1997 and 2009, and find that the retreat and expansion of the sea-ice edge correlate with mean significant wave height increases and decreases, respectively. This includes capturing the spatial variability in sea-ice trends found in the Ross and Amundsen-Bellingshausen seas. Climate models fail to capture recent changes in sea ice in both polar regions(4,5). Our results suggest that the incorporation of explicit or parameterized interactions between ocean waves and sea ice may resolve this problem.	[Kohout, A. L.] Natl Inst Water & Atmospher Res, Christchurch 8011, New Zealand; [Williams, M. J. M.; Dean, S. M.] Natl Inst Water & Atmospher Res, Wellington 6021, New Zealand; [Meylan, M. H.] Univ Newcastle, Newcastle, NSW 2308, Australia	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Newcastle	Kohout, AL (corresponding author), Natl Inst Water & Atmospher Res, Christchurch 8011, New Zealand.	alison.kohout@niwa.co.nz	Williams, Michael/H-9674-2014; Meylan, Michael/A-7341-2010; Dean, Sam/F-7711-2011	Meylan, Michael/0000-0002-3164-1367; Dean, Sam/0000-0001-6338-4601	New Zealand Foundation of Research Science and Technology; Marsden Fund Council; NIWA, under National Climate Centre Climate Systems programme; Antarctic Climate and Ecosystems Cooperative Research Centre; Australian Antarctic Science project [4073]	New Zealand Foundation of Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); NIWA, under National Climate Centre Climate Systems programme; Antarctic Climate and Ecosystems Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Antarctic Science project	We thank Inprod Pty Ltd for instrument design and construction; M. Doble, V. Squire and T. Haskell for contributions toward instrument design; T. Toyota for the provision of ice floe size and ice thickness data; the captain and crew of RSV Aurora Australis and the second Sea Ice Physics and Ecosystem Experiment (SIPEX II) for their assistance in deploying the waves-in-ice instruments; and V. Squire, T. Toyota, L. Bennetts and T. Williams for contributions toward interpretation and editing. The work was funded by a New Zealand Foundation of Research Science and Technology Postdoctoral award to A. L. K.; the Marsden Fund Council, administered by the Royal Society of New Zealand; NIWA, through core funding under the National Climate Centre Climate Systems programme; the Antarctic Climate and Ecosystems Cooperative Research Centre; and Australian Antarctic Science project 4073.	[Anonymous], GEOPHYS RES LETT, DOI [10.1029/2007/GL029703, DOI 10.1029/2007GL029703]; Chawla A, 2013, OCEAN MODEL, V70, P189, DOI 10.1016/j.ocemod.2012.07.005; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dobrynin M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052843; Downer J, 2001, ANN GLACIOL, V33, P345, DOI 10.3189/172756401781818923; Dumont D, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006682; Earle M. D., 1996, 9601 NDBC US DEP COM; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Kaleschke L, 2001, CAN J REMOTE SENS, V27, P526, DOI 10.1080/07038992.2001.10854892; Kaleschke L., 2006, SEA ICE CONCENTRATIO; Kohout AL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004434; Kohout A. L., 2013, WAVES IN ICE OBSERVA; Komen G. J., 1994, DYNAMICS MODELLING O, P232; LIU AK, 1992, ATMOS OCEAN, V30, P192, DOI 10.1080/07055900.1992.9649437; LONGUETHIGGINS MS, 1952, J MAR RES, V11, P245; Marko J. R., 2003, J GEOPHYS RES, V108, pC9; Meier W., 2013, NOAANSIDC CLIMATE DA; Parkinson CL, 2012, CRYOSPHERE, V6, P871, DOI 10.5194/tc-6-871-2012; Peng G, 2013, EARTH SYST SCI DATA, V5, P311, DOI 10.5194/essd-5-311-2013; Prinsenberg SJ, 2011, ANN GLACIOL, V52, P35, DOI 10.3189/172756411795931688; Shackleton E. H., 1982, S STORY SHACKLETONS, V103; Spreen G, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2005JC003384; Squire VA, 2007, COLD REG SCI TECHNOL, V49, P110, DOI 10.1016/j.coldregions.2007.04.007; SQUIRE VA, 1980, NATURE, V283, P365, DOI 10.1038/283365a0; SQUIRE VA, 1995, ANNU REV FLUID MECH, V27, P115, DOI 10.1146/annurev.fl.27.010195.000555; Toyota T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024556; Tucker M.J., 2001, WAVES OCEAN ENG; Turner J, 2013, J CLIMATE, V26, P1473, DOI 10.1175/JCLI-D-12-00068.1; WADHAMS P, 1988, J GEOPHYS RES-OCEANS, V93, P6799, DOI 10.1029/JC093iC06p06799; Wadhams P., 2002, ICE OCEAN, P202; Williams TD, 2013, OCEAN MODEL, V71, P92, DOI 10.1016/j.ocemod.2013.05.011; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	34	191	197	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					604	+		10.1038/nature13262	http://dx.doi.org/10.1038/nature13262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870546				2022-12-24	WOS:000336457100046
J	Capewell, S				Capewell, Simon			PERSONAL VIEW Sugar sweetened drinks should carry obesity warnings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION; TOBACCO; ADULTS; FOOD		Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Capewell, S (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	Capewell@liverpool.ac.uk						Academy of Medical Royal Colleges, 2013, MEAS MED PROF PRESCR; [Anonymous], BBC NEWS; Capewell S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d287; Chantler C, 2014, INDEPENDENT REV STAN; Cochrane Library, 2011, TREATM OB; Credit Suisse Research Institute, 2013, SUG CONS CROSSR; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Editorial, 2011, LANCET, V378, P741; Finlex, RAD IND MIN REG LAB; Hennessy M., 2014, FOOD NAVIGATOR  0424; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; National Institute for Health and Care Excellence, 2010, PREV CARD DIS; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Quinn I, 2014, GROCER          0510; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563	17	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3428	10.1136/bmj.g3428	http://dx.doi.org/10.1136/bmj.g3428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24870354				2022-12-24	WOS:000336741400010
J	Amos, CB; Audet, P; Hammond, WC; Burgmann, R; Johanson, IA; Blewitt, G				Amos, Colin B.; Audet, Pascal; Hammond, William C.; Buergmann, Roland; Johanson, Ingrid A.; Blewitt, Geoffrey			Uplift and seismicity driven by groundwater depletion in central California	NATURE			English	Article							SIERRA-NEVADA; SEASONAL-VARIATION; ROCK UPLIFT; GPS; SUBSIDENCE; PARKFIELD; STRAIN; REGION; MODEL; FAULT	Groundwater use in California's San Joaquin Valley exceeds replenishment of the aquifer, leading to substantial diminution of this resource(1-4) and rapid subsidence of the valley floor(5). The volume of groundwater lost over the past century and a half also represents a substantial reduction in mass and a large-scale unburdening of the lithosphere, with significant but unexplored potential impacts on crustal deformation and seismicity. Here we use vertical global positioning system measurements to show that a broad zone of rock uplift of up to 1-3 mm per year surrounds the southern San Joaquin Valley. The observed uplift matches well with predicted flexure from a simple elastic model of current rates of water-storage loss, most of which is caused by groundwater depletion(3). The height of the adjacent central Coast Ranges and the Sierra Nevada is strongly seasonal and peaks during the dry late summer and autumn, out of phase with uplift of the valley floor during wetter months. Our results suggest that long-term and late-summer flexural uplift of the Coast Ranges reduce the effective normal stress resolved on the San Andreas Fault. This process brings the fault closer to failure, thereby providing a viable mechanism for observed seasonality in microseismicity at Parkfield(6) and potentially affecting long-term seismicity rates for fault systems adjacent to the valley. We also infer that the observed contemporary uplift of the southern Sierra Nevada previously attributed to tectonic or mantle-derived forces(7-10) is partly a consequence of human-caused groundwater depletion.	[Amos, Colin B.] Western Washington Univ, Dept Geol, Bellingham, WA 98225 USA; [Audet, Pascal] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Hammond, William C.; Blewitt, Geoffrey] Univ Nevada, Nevada Geodet Lab, Nevada Bur Mines & Geol, Reno, NV 89557 USA; [Hammond, William C.; Blewitt, Geoffrey] Univ Nevada, Nevada Seismol Lab, Reno, NV 89557 USA; [Buergmann, Roland; Johanson, Ingrid A.] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Buergmann, Roland] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	Western Washington University; University of Ottawa; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Amos, CB (corresponding author), Western Washington Univ, Dept Geol, Bellingham, WA 98225 USA.	colin.amos@wwu.edu	Amos, Colin/B-2397-2008; Burgmann, Roland/AAE-5138-2022	Amos, Colin/0000-0002-3862-9344; Audet, Pascal/0000-0003-2364-9454; Burgmann, Roland/0000-0002-3560-044X; Johanson, Ingrid/0000-0002-6049-2225	NSF Earth Scope award [EAR-1252210]; Directorate For Geosciences [1252210] Funding Source: National Science Foundation; Division Of Earth Sciences [0951430] Funding Source: National Science Foundation	NSF Earth Scope award(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this work comes from NSF Earth Scope award number EAR-1252210 to G. B. and W. C. H. GPS data were collected using the EarthScope Plate Boundary Observatory, SCIGN, BARGEN, BARD, CORS and IGS networks. We are particularly grateful to UNAVCO for operating the vast majority of GPS stations used in this project. GPS data were processed using the GIPSY OASIS II software and data products from the Jet Propulsion Laboratory.	Altamimi Z, 2011, J GEODESY, V85, P457, DOI 10.1007/s00190-011-0444-4; Argus DF, 2014, GEOPHYS RES LETT, V41, P1971, DOI 10.1002/2014GL059570; Bar-Sever YE, 1998, J GEOPHYS RES-SOL EA, V103, P5019, DOI 10.1029/97JB03534; Ben-Zion Y, 2013, EARTH PLANET SC LETT, V379, P120, DOI 10.1016/j.epsl.2013.08.024; Bennett RA, 2009, EARTH PLANET SC LETT, V287, P255, DOI 10.1016/j.epsl.2009.08.011; Bertiger W, 2010, J GEODESY, V84, P327, DOI 10.1007/s00190-010-0371-9; Bettinelli P, 2008, EARTH PLANET SC LETT, V266, P332, DOI 10.1016/j.epsl.2007.11.021; BLEWITT G, 1989, J GEOPHYS RES-SOLID, V94, P10187, DOI 10.1029/JB094iB08p10187; Blewitt G, 2013, J GEODYN, V72, P11, DOI 10.1016/j.jog.2013.08.004; Boehm J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025546; California Department of Water Resources, 2005, DEP WAT RES B, V1, P160; CHRISTENSEN MN, 1966, GEOL SOC AM BULL, V77, P163, DOI 10.1130/0016-7606(1966)77[163:LCCMIT]2.0.CO;2; Christiansen LB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028634; DETTINGER MD, 1995, J CLIMATE, V8, P606, DOI 10.1175/1520-0442(1995)008<0606:LSAFOR>2.0.CO;2; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Faunt C.C., 2009, GROUNDWATER AVAILABI, P225; Fay NP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034949; Fu YN, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008925; Gonzalez PJ, 2012, NAT GEOSCI, V5, P821, DOI [10.1038/ngeo1610, 10.1038/NGEO1610]; Hammond WC, 2012, GEOLOGY, V40, P667, DOI 10.1130/G32968.1; Harris RA, 1998, J GEOPHYS RES-SOL EA, V103, P24347, DOI 10.1029/98JB01576; Heki K, 2003, EARTH PLANET SC LETT, V207, P159, DOI 10.1016/S0012-821X(02)01148-2; HOLZER TL, 1979, J GEOPHYS RES, V84, P4689, DOI 10.1029/JB084iB09p04689; Jeager J.C., 2007, FUNDAMENTALS ROCK ME; Jiang Y, 2010, NAT GEOSCI, V3, P404, DOI 10.1038/NGEO845; Le Pourhiet L, 2013, GEOLOGY, V41, P999, DOI 10.1130/G34244.1; Luttrell K, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004752; Nof RN, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008961; Poland JF, 1975, 437H US GEOL SURV, P78; Rebischung P, 2012, GPS SOLUT, V16, P483, DOI 10.1007/s10291-011-0248-2; Saleeby J, 2013, GEOSPHERE, V9, P394, DOI 10.1130/GES00816.1; Scanlon BR, 2012, P NATL ACAD SCI USA, V109, P9320, DOI 10.1073/pnas.1200311109; SCHERNECK HG, 1991, GEOPHYS J INT, V106, P677, DOI 10.1111/j.1365-246X.1991.tb06339.x; Schmidt DA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002267; SMALL EE, 1995, SCIENCE, V270, P277, DOI 10.1126/science.270.5234.277; STEIN RS, 1992, J GEOPHYS RES-SOL EA, V97, P4865, DOI 10.1029/91JB02847; Toda S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000172; van Dam T, 2001, GEOPHYS RES LETT, V28, P651, DOI 10.1029/2000GL012120; Williamson A, 1989, 1401D US GEOL SURV, DOI 10.3133/pp1401D; Zumberge JF, 1997, J GEOPHYS RES-SOL EA, V102, P5005, DOI 10.1029/96JB03860	40	155	156	10	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					483	+		10.1038/nature13275	http://dx.doi.org/10.1038/nature13275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828048				2022-12-24	WOS:000336126000037
J	Brownell, KD; Pomeranz, JL				Brownell, Kelly D.; Pomeranz, Jennifer L.			The Trans-Fat Ban-Food Regulation and Long-Term Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The FDA proposes to declare partially hydrogenated oils unsafe and to allow only a small amount of artificial trans fats in foods. The move portends future government actions regarding the food supply that will affect human health much more broadly. Trans fats naturally exist in small amounts in the fat in meat and milk, but most trans fats in the food supply have been added by food manufacturers. Since 1911, when Procter and Gamble introduced Crisco, companies have used artificial trans fats because of their commercially favorable properties, such as long shelf life, stability during deep frying, and palatability. These fats have therefore been incorporated into a great many foods, including snack and deep-fried foods, baked goods, margarines, and crackers (see graph). The primary dietary source of artificial trans fat is partially hydrogenated oils, created by adding hydrogen to vegetable ...	[Brownell, Kelly D.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Pomeranz, Jennifer L.] Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA; [Pomeranz, Jennifer L.] Temple Univ, Ctr Obes Res & Educ, Philadelphia, PA 19122 USA	Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Brownell, KD (corresponding author), Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA.							Dietz WH, 2012, JAMA-J AM MED ASSOC, V308, P143, DOI 10.1001/jama.2012.7379; Food and Drug Administration (FDA), 2013, FED REGISTER, V78, P67169; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035	3	43	44	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1773	1775		10.1056/NEJMp1314072	http://dx.doi.org/10.1056/NEJMp1314072			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH3CD	24806156				2022-12-24	WOS:000335997900002
J	Naganuma, M; Sekine, S; Chong, YE; Guo, M; Yang, XL; Gamper, H; Hou, YM; Schimmel, P; Yokoyama, S				Naganuma, Masahiro; Sekine, Shun-ichi; Chong, Yeeting Esther; Guo, Min; Yang, Xiang-Lei; Gamper, Howard; Hou, Ya-Ming; Schimmel, Paul; Yokoyama, Shigeyuki			The selective tRNA aminoacylation mechanism based on a single G center dot U pair	NATURE			English	Article							CRYSTAL-STRUCTURE; ACCEPTOR-STEM; MAJOR DETERMINANT; SYNTHETASE; RECOGNITION; IDENTITY; TRNA(ALA); SEQUENCE; CRYSTALLOGRAPHY; SPECIFICITY	Ligation of tRNAs with their cognate amino acids, by aminoacyl-tRNA synthetases, establishes the genetic code. Throughout evolution, tRNA(Ala) selection by alanyl-tRNAsynthetase (AlaRS) has depended predominantly on a single wobble base pair in the acceptor stem, G3 center dot U70, mainly on the k(cat) level. Here we report the crystal structures of an archaeal AlaRS in complex with tRNAAla with G3 center dot U70 and its A3 center dot U70 variant. AlaRS interacts with both the minor-and the major-groove sides of G3 center dot U70, widening the major groove. The geometry difference between G3 center dot U70 and A3 center dot U70 is transmitted along the acceptor stemto the 3'-CCA region. Thus, the 3'-CCA region of tRNA(Ala) with G3 center dot U70 is oriented to the reactive route that reaches the active site, whereas that of the A3 center dot U70 variant is folded back into the non-reactive route. This novel mechanism enables the single wobble pair to dominantly determine the specificity of tRNA selection, by an approximate 100-fold difference in k(cat) .	[Naganuma, Masahiro; Sekine, Shun-ichi; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Naganuma, Masahiro; Sekine, Shun-ichi; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem & Lab Struct Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Naganuma, Masahiro; Yokoyama, Shigeyuki] RIKEN Struct Biol Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Sekine, Shun-ichi] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Chong, Yeeting Esther; Guo, Min; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Chong, Yeeting Esther; Guo, Min; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Gamper, Howard; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Schimmel, Paul] Scripps Florida Res Inst, Jupiter, FL 33458 USA	RIKEN; University of Tokyo; RIKEN; RIKEN; Scripps Research Institute; Scripps Research Institute; Jefferson University; State University System of Florida; University of Florida	Yokoyama, S (corresponding author), RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@riken.jp	Sekine, Shun-ichi/N-5450-2015; Chong, Yeeting/AAE-3792-2020; Yang, Xiang-Lei/AAR-7107-2020; Yokoyama, Shigeyuki/N-6911-2015	Sekine, Shun-ichi/0000-0001-8174-8704; Yokoyama, Shigeyuki/0000-0003-3133-7338; Yang, Xiang-Lei/0000-0003-2554-084X; Hou, Ya-Ming/0000-0001-6546-2597	Targeted Proteins Research Program; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science [20247008]; MEXT; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT; National Institutes of Health [GM015539, GM023562, NS085092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100136, R01GM023562, R01GM108972, R37GM015539, R01GM015539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085092] Funding Source: NIH RePORTER	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the staff of the beam line AR-NW12A at the Photon Factory and the beam lines BL32XU and BL41XU at SPring-8 for their assistance during data collection. This work was supported by the Targeted Proteins Research Program, and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work was also supported by a Grant-in-Aid for Scientific Research (No. 20247008) from the Japan Society for the Promotion of Science and MEXT, and the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT. Research support was also provided by National Institutes of Health grants GM015539 and GM023562 to P.S. and NS085092 to X.-L.Y.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beuning PJ, 1999, BIOPOLYMERS, V52, P1; Beuning PJ, 2002, RNA, V8, P659, DOI 10.1017/S1355838202020277; Beuning PJ, 1997, J AM CHEM SOC, V119, P8397, DOI 10.1021/ja971020c; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chang KY, 1999, P NATL ACAD SCI USA, V96, P11764, DOI 10.1073/pnas.96.21.11764; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; DEDUVE C, 1988, NATURE, V333, P117, DOI 10.1038/333117a0; Dignam JD, 2011, BIOCHEMISTRY-US, V50, P9886, DOI 10.1021/bi2012004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; FRANCKLYN C, 1992, SCIENCE, V255, P1121, DOI 10.1126/science.1546312; Fukunaga R, 2007, NAT STRUCT MOL BIOL, V14, P272, DOI 10.1038/nsmb1219; Fukunaga R, 2007, ACTA CRYSTALLOGR F, V63, P224, DOI 10.1107/S1744309107006264; Gabriel K, 1996, SCIENCE, V271, P195, DOI 10.1126/science.271.5246.195; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; HOU YM, 1989, BIOCHEMISTRY-US, V28, P6800, DOI 10.1021/bi00443a003; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; MCCLAIN WH, 1988, SCIENCE, V242, P1681, DOI 10.1126/science.2462282; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; McClain WH, 1999, J MOL BIOL, V290, P391, DOI 10.1006/jmbi.1999.2884; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER WT, 1991, BIOCHEMISTRY-US, V30, P2635, DOI 10.1021/bi00224a011; Mueller U, 1999, RNA, V5, P670, DOI 10.1017/S1355838299982304; MUSIERFORSYTH K, 1992, NATURE, V357, P513, DOI 10.1038/357513a0; MUSIERFORSYTH K, 1991, SCIENCE, V253, P784, DOI 10.1126/science.1876835; Naganuma M, 2009, P NATL ACAD SCI USA, V106, P8489, DOI 10.1073/pnas.0901572106; Nakagawa H, 2013, PROTEINS, V81, P1232, DOI 10.1002/prot.24273; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARK SJ, 1989, BIOCHEMISTRY-US, V28, P2740, DOI 10.1021/bi00432a056; PUTZ J, 1993, EMBO J, V12, P2949, DOI 10.1002/j.1460-2075.1993.tb05957.x; Ramos A, 1997, NUCLEIC ACIDS RES, V25, P2083, DOI 10.1093/nar/25.11.2083; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; ROGERS MJ, 1994, P NATL ACAD SCI USA, V91, P291, DOI 10.1073/pnas.91.1.291; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; SHI JP, 1990, BIOCHEMISTRY-US, V29, P3621, DOI 10.1021/bi00467a005; Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1080, P126, DOI 10.1016/0167-4838(91)90138-P; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; WEYGANDDURASEVIC I, 1994, J MOL BIOL, V240, P111, DOI 10.1006/jmbi.1994.1425; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015	61	55	60	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					507	511		10.1038/nature13440	http://dx.doi.org/10.1038/nature13440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24919148	Green Accepted			2022-12-24	WOS:000337806300040
J	Arie, S				Arie, Sophie			Would today's international agreements prevent another outbreak like SARS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						[Anonymous], 2014, LANCET RESP MED, V2, P436; [Anonymous], 2014, NEWSWEEK; Heymann DL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1499; MacKenzie D., 2014, NEW SCI; McCarthy M, 2014, BMJ-BRIT MED J, V348, pg1589; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; Sridhar D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3841; World Bank, PEOPL PATH OUR PLAN, V2; World Health Organization, MIDDL E RESP SYNDR C; World Health Organization (WHO), AL RESP CAP BUILD IN	10	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2014	348								g4123	10.1136/bmj.g4123	http://dx.doi.org/10.1136/bmj.g4123			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UE	24957245				2022-12-24	WOS:000338201400010
J	Beura, LK; Masopust, D				Beura, Lalit K.; Masopust, David			SnapShot: Resident Memory T Cells	CELL			English	Editorial Material							CUTTING EDGE; TISSUE; INFECTION; DIFFERENTIATION; PROTECTION; IMMUNITY; VIRUS; SKIN		[Beura, Lalit K.; Masopust, David] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Beura, Lalit K.; Masopust, David] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Beura, LK (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.		masopust, david/B-5027-2008; Beura, Lalit/W-6281-2019					Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243	10	24	25	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1488	+	1488.e1	10.1016/j.cell.2014.05.026	http://dx.doi.org/10.1016/j.cell.2014.05.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906159	Bronze			2022-12-24	WOS:000340881400022
J	Pezzella, F; Harris, AL				Pezzella, Francesco; Harris, Adrian L.			When Cancer Co-opts the Vasculature	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METASTASIS		[Pezzella, Francesco] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 9DU, England; [Harris, Adrian L.] Univ Oxford, Mol Oncol Labs, Dept Med Oncol, Weatherall Inst Mol Med, Oxford, England	University of Oxford; University of Oxford	Pezzella, F (corresponding author), Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 9DU, England.		Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409	National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; Cancer Research UK [11359] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)		Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Hu JT, 2005, ONCOGENE, V24, P1212, DOI 10.1038/sj.onc.1208242; Pezzella F, 1997, AM J PATHOL, V151, P1417; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Van den Eynden GG, 2013, CANCER RES, V73, P2031, DOI 10.1158/0008-5472.CAN-12-3931	5	5	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2146	2147		10.1056/NEJMcibr1402407	http://dx.doi.org/10.1056/NEJMcibr1402407			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24869725				2022-12-24	WOS:000336434000015
J	Riera, CE; Huising, MO; Follett, P; Leblanc, M; Halloran, J; Van Andel, R; de Magalhaes, CD; Merkwirth, C; Dillin, A				Riera, Celine E.; Huising, Mark O.; Follett, Patricia; Leblanc, Mathias; Halloran, Jonathan; Van Andel, Roger; de Magalhaes Filho, Carlos Daniel; Merkwirth, Carsten; Dillin, Andrew			TRPV1 Pain Receptors Regulate Longevity and Metabolism by Neuropeptide Signaling	CELL			English	Article							GENE-RELATED PEPTIDE; LIFE-SPAN EXTENSION; INSULIN-SECRETION; CAPSAICIN RECEPTOR; MESSENGER-RNA; MICE LACKING; SUBSTANCE-P; ION-CHANNEL; BETA-CELLS; CALCITONIN	The sensation of pain is associated with increased mortality, but it is unknown whether pain perception can directly affect aging. We find that mice lacking TRPV1 pain receptors are long- lived, displaying a youthful metabolic profile at old age. Loss of TRPV1 inactivates a calcium- signaling cascade that ends in the nuclear exclusion of the CREB- regulated transcriptional coactivator CRTC1 within pain sensory neurons originating from the spinal cord. In long- lived TRPV1 knockout mice, CRTC1 nuclear exclusion decreases production of the neuropeptide CGRP from sensory endings innervating the pancreatic islets, subsequently promoting insulin secretion and metabolic health. In contrast, CGRP homeostasis is disrupted with age in wild- type mice, resulting in metabolic decline. We show that pharmacologic inactivation of CGRP receptors in old wildtype animals can restore metabolic health. These data suggest that ablation of select pain sensory receptors or the inhibition of CGRP are associated with increased metabolic health and control longevity.	[Riera, Celine E.; Halloran, Jonathan; Van Andel, Roger; Dillin, Andrew] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Riera, Celine E.; Follett, Patricia; Dillin, Andrew] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Riera, Celine E.; Follett, Patricia; Leblanc, Mathias; de Magalhaes Filho, Carlos Daniel; Merkwirth, Carsten; Dillin, Andrew] Glenn Ctr Aging Res, La Jolla, CA 92037 USA; [Huising, Mark O.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; Salk Institute	Dillin, A (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	dillin@berkeley.edu	Merkwirth, Carsten/H-5992-2012; Huising, Mark O./H-3885-2019	Merkwirth, Carsten/0000-0001-8895-3495; Huising, Mark O./0000-0002-6594-2205	Glenn Foundation for Medical Research; Howard Hughes Medical Institute; Swiss National Foundation (SNF/FNS)	Glenn Foundation for Medical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swiss National Foundation (SNF/FNS)	We thank M. Allen, T. van der Meulen, L. Pei, S. Jordan, J. Mathur, A. Patapoutian, A. Friedman, and W. Mair for technical assistance and advice. We thank S. C. Wolff and D. Hockemeyer for valuable suggestions on the manuscript. C. E. R. is a recipient of the Swiss National Foundation (SNF/FNS). A. D. is cofounder of Proteostasis Therapeutics and Mitokyne and declares no financial interest related to this work. This work was supported by the Glenn Foundation for Medical Research and the Howard Hughes Medical Institute (C. E. R. and A. D.). We dedicate this work to Dr. W. Vale (Salk Institute).	AHREN B, 1987, DIABETOLOGIA, V30, P354, DOI 10.1007/BF00299030; Akiba Y, 2004, BIOCHEM BIOPH RES CO, V321, P219, DOI 10.1016/j.bbrc.2004.06.149; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Bernardini N, 2004, NEUROSCIENCE, V126, P585, DOI 10.1016/j.neuroscience.2004.03.017; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Colbert HA, 1997, J NEUROSCI, V17, P8259; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; EMESON RB, 1989, NATURE, V341, P76, DOI 10.1038/341076a0; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Gram DX, 2007, EUR J NEUROSCI, V25, P213, DOI 10.1111/j.1460-9568.2006.05261.x; Gram DX, 2005, EUR J ENDOCRINOL, V153, P963, DOI 10.1530/eje.1.02046; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Huising MO, 2010, P NATL ACAD SCI USA, V107, P912, DOI 10.1073/pnas.0913610107; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; KOGIRE M, 1991, PANCREAS, V6, P459, DOI 10.1097/00006676-199107000-00013; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; McBeth J, 2003, ARTHRITIS RHEUM, V48, P1686, DOI 10.1002/art.10973; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; MELNYK A, 1995, OBES RES, V3, P337, DOI 10.1002/j.1550-8528.1995.tb00159.x; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Moreno H, 2012, HIPPOCAMPUS, V22, P1107, DOI 10.1002/hipo.20957; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Nakanishi M, 2010, MOL BIOL CELL, V21, P2568, DOI 10.1091/mbc.E10-01-0049; Nitter AK, 2013, SCAND J PAIN, V4, P86, DOI 10.1016/j.sjpain.2012.12.002; Noble MD, 2006, AM J PHYSIOL-GASTR L, V291, pG128, DOI 10.1152/ajpgi.00442.2005; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Park TJ, 2003, J COMP NEUROL, V465, P104, DOI 10.1002/cne.10824; PETTERSSON M, 1986, ENDOCRINOLOGY, V119, P865, DOI 10.1210/endo-119-2-865; Poyner DR, 1998, BRIT J PHARMACOL, V124, P1659, DOI 10.1038/sj.bjp.0702032; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Speakman JR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P900, DOI 10.1086/427059; Suri A, 2008, TRENDS PHARMACOL SCI, V29, P29, DOI 10.1016/j.tips.2007.10.016; Szallasi A, 1995, BRAIN RES, V703, P175, DOI 10.1016/0006-8993(95)01094-7; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tanaka H, 2011, LIFE SCI, V88, P559, DOI 10.1016/j.lfs.2011.01.016; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; WEST MJ, 1993, NEUROBIOL AGING, V14, P287, DOI 10.1016/0197-4580(93)90113-P; Westerterp-Plantenga MS, 2005, INT J OBESITY, V29, P682, DOI 10.1038/sj.ijo.0802862; Woods JA, 2012, AGING DIS, V3, P130; Zhang SY, 2004, DEVELOPMENT, V131, P1629, DOI 10.1242/dev.01047; Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065	62	133	138	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1023	1036		10.1016/j.cell.2014.03.051	http://dx.doi.org/10.1016/j.cell.2014.03.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855942	Bronze			2022-12-24	WOS:000336437200007
J	Attaran, A				Attaran, Amir			A modest but meaningful decision for Indian drug patents	LANCET			English	Editorial Material									Univ Ottawa, Fac Law & Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Fac Law & Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca						[Anonymous], 2013, HINDU BUSINESS  0605; Eban K, LATEST CLAIM FRAUD G; Eban K, 2013, DIRTY MED; Hitchings AW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7941; India-Parliamentary Standing Committee on Health and Family Welfare, 59 IND PARL STAND CO; Laxminarayan P, 2013, India Patent, Patent No. 255388; United States Department of Justice, GEN DRUG MAN RANB PL	7	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					477	479		10.1016/S0140-6736(13)60845-4	http://dx.doi.org/10.1016/S0140-6736(13)60845-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9JR	24976117				2022-12-24	WOS:000340198300008
J	Seaquist, ER				Seaquist, Elizabeth R.			Addressing the Burden of Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYPOGLYCEMIA; MORTALITY		Univ Minnesota, Div Endocrinol & Diabet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Seaquist, ER (corresponding author), Univ Minnesota, Div Endocrinol & Diabet, MMC101,420 Delaware St SE, Minneapolis, MN 55455 USA.	seaqu001@umn.edu						Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Centers for Disease Control and Prevention, DIABETES IN THE UNIT; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Geller AI, 2014, JAMA INTERN MED, V174, P678, DOI 10.1001/jamainternmed.2014.136; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278	10	24	24	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2267	2268		10.1001/jama.2014.6451	http://dx.doi.org/10.1001/jama.2014.6451			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915253				2022-12-24	WOS:000336972600013
J	Burke, JE; Inglis, AJ; Perisic, O; Masson, GR; McLaughlin, SH; Rutaganira, F; Shokat, KM; Williams, RL				Burke, John E.; Inglis, Alison J.; Perisic, Olga; Masson, Glenn R.; McLaughlin, Stephen H.; Rutaganira, Florentine; Shokat, Kevan M.; Williams, Roger L.			Structures of PI4KIII beta complexes show simultaneous recruitment of Rab11 and its effectors	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 4-KINASES; MEMBRANE RECRUITMENT; RECYCLING ENDOSOME; GOLGI-COMPLEX; REPLICATION; FAMILY; P110-ALPHA; COMPONENTS; PROTEINS; PATHWAY	Phosphatidylinositol 4-kinases (PI4Ks) and small guanosine triphosphatases (GTPases) are essential for processes that require expansion and remodeling of phosphatidylinositol 4-phosphate (PI4P)-containing membranes, including cytokinesis, intracellular development of malarial pathogens, and replication of a wide range of RNA viruses. However, the structural basis for coordination of PI4K, GTPases, and their effectors is unknown. Here, we describe structures of PI4K beta (PI4KIII beta) bound to the small GTPase Rab11a without and with the Rab11 effector protein FIP3. The Rab11-PI4KIII beta interface is distinct compared with known structures of Rab complexes and does not involve switch regions used by GTPase effectors. Our data provide a mechanism for how PI4KIII beta coordinates Rab11 and its effectors on PI4P-enrichedmembranes and also provide strategies for the design of specific inhibitors that could potentially target plasmodial PI4KIII beta to combat malaria.	[Burke, John E.; Inglis, Alison J.; Perisic, Olga; Masson, Glenn R.; McLaughlin, Stephen H.; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Rutaganira, Florentine; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Rutaganira, Florentine; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	MRC Laboratory Molecular Biology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Burke, JE (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	jeburke@uvic.ca; rlw@mrc-lmb.cam.ac.uk	Masson, Glenn/AAD-6546-2022; Burke, John/H-3922-2019	Burke, John/0000-0001-7904-9859; Williams, Roger/0000-0001-7754-4207; McLaughlin, Stephen/0000-0001-9135-6253; Masson, Glenn/0000-0002-1386-4719; Perisic, Olga/0000-0002-3842-2896; Inglis, Alison/0000-0002-9008-8565	British Heart Foundation [PG11/109/29247]; NSF; NIH [RO1AI099245]; UK MRC [MC_U105184308]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER; British Heart Foundation [PG/11/109/29247] Funding Source: researchfish; Medical Research Council [1358691, MC_U105184308] Funding Source: researchfish; MRC [MC_U105184308] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Mueller-Dieckmann and D. De Sanctis at the European Synchrotron Radiation Facility and C. Lobley at Diamond Light Source for assistance with beamlines ID23-EH2, ID29, and I04-1; S. Maslen, M. Skehel, and S. Y. Peak-Chew for help with HDX-MS setup; and M. Yu for help with x-ray data collection. J.E.B. was supported by a grant from the British Heart Foundation (PG11/109/29247) and F. Rutaganira by an NSF predoctoral fellowship. This work was funded by the NIH (RO1AI099245 to K. M. S.) and the UK MRC (MC_U105184308 to R. L. W). K. M. S. has filed for patent protection on PIK93 analogs in the following application between UCSF and Stanford University: PCT/US2012/059023. Coordinates and structure factors have been deposited in the Protein Data Bank with accession numbers 4D0L and 4D0M, for PI4KIII beta/Rab11a and PI4KIII beta/Rab11a/FIP3 complexes, respectively. Author contributions: J.E.B., O.P., and R. L. W. initiated the project and designed the experiments; J.E.B., A.J.I., G. R. M., and O.P. performed the experiments; J.E.B. and R. L. W. carried out the structure determination and analysis; S. H. M. performed SPR analysis; F. R. and K. M. S. synthesized PI4K inhibitors; and J.E.B., O.P., and R. L. W. wrote the manuscript.	Altan-Bonnet N, 2012, TRENDS BIOCHEM SCI, V37, P293, DOI 10.1016/j.tibs.2012.03.004; Arita M, 2011, J VIROL, V85, P2364, DOI 10.1128/JVI.02249-10; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Balla A, 2008, BIOCHEMISTRY-US, V47, P1599, DOI 10.1021/bi7017927; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Khan AR, 2013, STRUCTURE, V21, P1284, DOI 10.1016/j.str.2013.06.016; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Polevoy G, 2009, J CELL BIOL, V187, P847, DOI 10.1083/jcb.200908107; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van der Schaar HM, 2013, ANTIMICROB AGENTS CH, V57, P4971, DOI 10.1128/AAC.01175-13; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927	30	96	99	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1035	1038		10.1126/science.1253397	http://dx.doi.org/10.1126/science.1253397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876499	Green Accepted			2022-12-24	WOS:000336495800047
J	Singh, R; Meier, TB; Kuplicki, R; Savitz, J; Mukai, I; Cavanagh, L; Allen, T; Teague, TK; Nerio, C; Polanski, D; Bellgowan, PSF				Singh, Rashmi; Meier, Timothy B.; Kuplicki, Rayus; Savitz, Jonathan; Mukai, Ikuko; Cavanagh, LaMont; Allen, Thomas; Teague, T. Kent; Nerio, Christopher; Polanski, David; Bellgowan, Patrick S. F.			Relationship of Collegiate Football Experience and Concussion With Hippocampal Volume and Cognitive Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; DEFICITS; PLAYERS; STRESS; IDENTIFICATION; PERFORMANCE; RECOVERY; IMPACT; MODEL	IMPORTANCE Concussion and subconcussive impacts have been associated with short-term disrupted cognitive performance in collegiate athletes, but there are limited data on their long-term neuroanatomic and cognitive consequences. OBJECTIVE To assess the relationships of concussion history and years of football experience with hippocampal volume and cognitive performance in collegiate football athletes. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional study conducted between June 2011 and August 2013 at a US psychiatric research institute specializing in neuroimaging among collegiate football players with a history of clinician-diagnosed concussion (n = 25), collegiate football players without a history of concussion (n = 25), and non-football-playing, age-, sex-, and education-matched healthy controls (n = 25). EXPOSURES History of clinician-diagnosed concussion and years of football experience. MAIN OUTCOMES AND MEASURES High-resolution anatomical magnetic resonance imaging was used to quantify brain volumes. Baseline scores on a computerized concussion-related cognitive battery were used for cognitive assessment in athletes. RESULTS Players with and without a history of concussion had smaller hippocampal volumes relative to healthy control participants (with concussion: t(48) = 7.58; P < .001; mean difference, 1788 mu L; 95% CI, 1317-2258 mu L; without concussion: t(48) = 4.35; P < .001, mean difference, 1027 mu L; 95% CI, 556-1498 mu L). Players with a history of concussion had smaller hippocampal volumes than players without concussion (t(48) = 3.15; P < .001; mean difference, 761 mu L; 95% CI, 280-1242 mu L). In both athlete groups, there was a statistically significant inverse relationship between left hippocampal volume and number of years of football played (t(46) = -3.62; P < .001; coefficient = -43.54; 95% CI, -67.66 to -19.41). Behavioral testing demonstrated no differences between athletes with and without a concussion history on 5 cognitive measures but did show an inverse correlation between years of playing football and reaction time (rho(42) = -0.43; 95% CI, -0.46 to -0.40; P = .005). CONCLUSIONS AND RELEVANCE Among a group of collegiate football athletes, there was a significant inverse relationship of concussion and years of football played with hippocampal volume. Years of football experience also correlated with slower reaction time. Further research is needed to determine the temporal relationships of these findings.	[Singh, Rashmi; Meier, Timothy B.; Kuplicki, Rayus; Savitz, Jonathan; Mukai, Ikuko; Bellgowan, Patrick S. F.] Laureate Inst Brain Res, Tulsa, OK 74136 USA; [Kuplicki, Rayus] Univ Tulsa, Tandy Sch Comp Sci, Tulsa, OK 74104 USA; [Savitz, Jonathan; Bellgowan, Patrick S. F.] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA; [Cavanagh, LaMont; Allen, Thomas] Univ Oklahoma, Dept Family Med, Oklahoma Sch Community Med, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Dept Surg, Oklahoma Sch Community Med, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Dept Psychiat, Oklahoma Sch Community Med, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Dept Pharmaceut Sci, Oklahoma Coll Pharm, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Nerio, Christopher; Polanski, David] Univ Tulsa, Dept Athlet, Tulsa, OK 74104 USA	Laureate Institute for Brain Research, Inc.; University of Tulsa; University of Tulsa; University of Oklahoma System; University of Oklahoma - Tulsa; University of Oklahoma System; University of Oklahoma - Tulsa; University of Oklahoma System; University of Oklahoma - Tulsa; University of Oklahoma System; University of Oklahoma - Tulsa; Oklahoma State University System; Oklahoma State University Center for Health Sciences; University of Tulsa	Bellgowan, PSF (corresponding author), Laureate Inst Brain Res, 6655 S Yale Ave, Tulsa, OK 74136 USA.	pbellgowan@laureateinstitute.org	Savitz, Jonathan/C-3088-2009; Teague, T. Kent/A-2527-2008	Savitz, Jonathan/0000-0001-8143-182X; Teague, T. Kent/0000-0002-4680-5440; Bellgowan, Patrick/0000-0002-6753-8302	Laureate Institute for Brain Research; William K. Warren Foundation	Laureate Institute for Brain Research; William K. Warren Foundation	This research was conducted using internal funds from the Laureate Institute for Brain Research, which is supported by the William K. Warren Foundation.	Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Erk S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.57; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Franko E, 2014, HUM BRAIN MAPP, V35, P248, DOI 10.1002/hbm.22170; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mastorakos G, 2005, HORM METAB RES, V37, P577, DOI 10.1055/s-2005-870426; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nakajima Y, 2010, TOHOKU J EXP MED, V221, P229, DOI 10.1620/tjem.221.229; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x	30	90	91	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1883	1888		10.1001/jama.2014.3313	http://dx.doi.org/10.1001/jama.2014.3313			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825643	Bronze			2022-12-24	WOS:000335798100020
J	Jahrling, PB; Tomori, O				Jahrling, Peter B.; Tomori, Owale			Variola virus archives: a new century, a new approach	LANCET			English	Editorial Material									[Jahrling, Peter B.] NIAID, NIH, Ft Detrick, MD 21702 USA; [Tomori, Owale] Redeemers Univ, Redemption City, Ogin State, Nigeria	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Redeemers University	Jahrling, PB (corresponding author), NIAID, NIH, Ft Detrick, MD 21702 USA.	jahrlingp@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIDAI009006] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Farlow J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-110; Henderson DA, 2014, BIOSECUR BIOTERROR, V12, P117, DOI 10.1089/bsp.2014.1509.comm; Kindrachuk J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015701; Kugelman JR, 2014, EMERG INFECT DIS, V20, P232, DOI 10.3201/eid2002.130118; Law GL, 2013, CURR OPIN IMMUNOL, V25, P588, DOI 10.1016/j.coi.2013.08.004; McFadden G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000727; Mucker EM, 2013, ANTIMICROB AGENTS CH, V57, P6246, DOI 10.1128/AAC.00977-13; Reynolds MG, 2013, AM J TROP MED HYG, V88, P982, DOI 10.4269/ajtmh.12-0758	9	2	2	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1525	1526		10.1016/S0140-6736(14)60693-0	http://dx.doi.org/10.1016/S0140-6736(14)60693-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24792843				2022-12-24	WOS:000335495400005
J	ten Hoope-Bender, P; de Bernis, L; Campbell, J; Downe, S; Fauveau, V; Fogstad, H; Homer, CSE; Kennedy, HP; Matthews, Z; McFadden, A; Renfrew, MJ; Van Lerberghe, W				ten Hoope-Bender, Petra; de Bernis, Luc; Campbell, James; Downe, Soo; Fauveau, Vincent; Fogstad, Helga; Homer, Caroline S. E.; Kennedy, Holly Powell; Matthews, Zoe; McFadden, Alison; Renfrew, Mary J.; Van Lerberghe, Wim			Improvement of maternal and newborn health through midwifery	LANCET			English	Article							EFFECTIVE COVERAGE; GLOBAL HEALTH; CARE; INTERVENTIONS; AFGHANISTAN; STRENGTHEN; RETENTION; FRAMEWORK; POST-2015; MORTALITY	In the concluding paper of this Series about midwifery, we look at the policy implications from the framework for quality maternal and newborn care, the potential effect of life-saving interventions that fall within the scope of practice of midwives, and the historic sequence of health system changes that made a reduction in maternal mortality possible in countries that have expanded their midwifery workforce. Achievement of better health outcomes for women and newborn infants is possible, but needs improvements in the quality of reproductive, maternal, and newborn care, alongside necessary increases in universal coverage. In this report, we propose three priority research areas and outline how national investment in midwives and in their work environment, education, regulation, and management can improve quality of care. Midwifery and midwives are crucial to the achievement of national and international goals and targets in reproductive, maternal, newborn, and child health; now and beyond 2015.	[ten Hoope-Bender, Petra; Campbell, James] Inst Cooperac Social Integrare, Barcelona 08007, Spain; [de Bernis, Luc] UN Populat Fund, Geneva, Switzerland; [Downe, Soo] Univ Cent Lancashire, Sch Hlth, Preston PR1 2HE, Lancs, England; [Fauveau, Vincent] Holist Sante, Montpellier, France; [Fogstad, Helga] Norwegian Agcy Dev Cooperat, Oslo, Norway; [Homer, Caroline S. E.] Univ Technol, Fac Hlth, Sydney, NSW, Australia; [Kennedy, Holly Powell] Yale Univ, Sch Nursing, New Haven, CT 06536 USA; [Matthews, Zoe] Univ Southampton, Southampton, Hants, England; [McFadden, Alison; Renfrew, Mary J.] Univ Dundee, Coll Med Dent & Nursing, Sch Nursing & Midwifery, Mother & Infant Res Unit, Dundee, Scotland; [Van Lerberghe, Wim] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark	United Nations Population Fund; University of Central Lancashire; University of Technology Sydney; Yale University; University of Southampton; University of Dundee; World Health Organization	ten Hoope-Bender, P (corresponding author), Inst Cooperac Social Integrare, Barcelona 08007, Spain.	petra.tenhoope@integrare.es	Matthews, Zoe/HGD-0506-2022; Homer, Caroline/J-2101-2014	Renfrew, Mary/0000-0003-2905-403X; Matthews, Zoe/0000-0003-1533-6618; Homer, Caroline/0000-0002-7454-3011; McFadden, Alison/0000-0002-5164-2025	Bill & Melinda Gates Foundation [OPP1042500]; University of Dundee; Instituto de Cooperacion Social Integrare	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of Dundee; Instituto de Cooperacion Social Integrare	The work on this paper was supported partly through a grant from the Bill & Melinda Gates Foundation (grant number OPP1042500). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers or the Bill & Melinda Gates Foundation. MJR's work was supported by the University of Dundee. PtH-B's work was supported by the Instituto de Cooperacion Social Integrare. Maria Guerra Arias managed and checked all the references. Thomson Prentice edited sections of the first draft. Joanne McManus edited the second draft. Administrative support was provided by Jenny Brown and Tracy Sparey, and Natalie Muir provided project support. We thank all series co-authors, dose readers, and the reviewers from ICM, FIGO, WHO, and the Bill & Melinda Gates Foundation for their contributions and support.	Abe Eghe, 2008, Afr J Reprod Health, V12, P17; [Anonymous], 1986, WHO CHRON, V40, P175; [Anonymous], 2012, UNICEF PROGR REPORT; [Anonymous], 2011, GLOB REV KEY INT REL; [Anonymous], 2008, PRIM HLTH CAR NOW MO; Bailey PE, 2011, INT J GYNECOL OBSTET, V115, P300, DOI 10.1016/j.ijgo.2011.09.004; Bhutta Z, 2010, LANCET, V376, P1375; Bowser D, 2010, EXPLORING EVIDENCE D; Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7; Campbell, 2013, UNIVERSAL TRUTH NO H; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Campbell J, 2013, LANCET, V381, P725, DOI 10.1016/S0140-6736(13)60579-6; Colston J., 2011, USE EFFECTIVE COVERA; Ebener S, 2013, 5 INT C HLTH BANGK T; Evans T., 2013, VAL MON ASS COMM BAS; Family Planning 2020, 2012, LOND SUMM FAM PLANN; Gibbons L, 2010, GLOBAL NUMBERS COSTS; Global Alliance for Vaccine and Immunization (GAVI), IMM IS ON MOST COST; Hassan-Bitar S, 2011, MIDWIFERY, V27, P154, DOI 10.1016/j.midw.2009.05.007; High-Level Panel of Eminent Persons on the Post-2015 Development Agenda, 2013, NEW GLOB PARTN ER PO; Homer CSE, 2014, LANCET; Horton R, 2013, LANCET, V382, P382, DOI 10.1016/S0140-6736(13)61641-4; ICM, 2011, ICM INT DEF MIDW; ILO, 2012, INT STAND CLASS OCC, V1; Independent Expert Review Group (iERG), 2013, EV WOM EV CHILD STRE; Info MME, 2013, MAL MAT MORT EST 201; International Confederation of midwives (ICM), 2013, ESS COMP BAS MIDW PR; Jaffre Y, 2003, B AMADES, V56, P639; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Kruk ME, 2014, BUSTING MYTHS DO HLT; Kyei NNA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046475; Langer A, 2013, LANCET, V381, P601, DOI 10.1016/S0140-6736(13)60259-7; Lawn JE, 2011, LANCET; Leap N., 2009, BRIT J MIDWIFERY, V17, P12, DOI [10.12968/bjom.2009.17.1.37646, DOI 10.12968/BJOM.2009.17.1.37646]; Lemiere C, 2011, WOR BANK WORK PAPER, P1, DOI 10.1596/978-0-8213-8599-9; Lemiere C, 2014, PRINC MAH AW C 2014; Mansoor GF, 2013, MIDWIFERY, V29, P1088, DOI 10.1016/j.midw.2013.07.021; Montenegro H, 2012, INT J PERS CENT MED, V2, P93; Ngwenya BN, 2011, HEALTH CARE WOMEN IN, V32, P917, DOI 10.1080/07399332.2011.603860; Rath AD, 2007, REPROD HEALTH MATTER, V15, P72, DOI 10.1016/S0968-8080(07)30329-7; Renfrew MJ, 2014, LANCET; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Schaaf M, 2013, HLTH POLICY PLAN, DOI [10.1093/heapol/czt09, DOI 10.1093/HEAPOL/CZT09]; Scheffler R., 2012, LABOUR MARKET HUMAN; Shaban I, 2012, MIDWIFERY, V28, P106, DOI 10.1016/j.midw.2010.11.012; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Soucat A, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9555-4; Sousa A, 2013, B WORLD HEALTH ORGAN, V91, P892, DOI 10.2471/BLT.13.118927; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2; ten Hoope-Bender P, 2011, INT J GYNECOL OBSTET, V114, P211, DOI 10.1016/j.ijgo.2011.06.002; UNAIDS, 2011, COUNTD ZER GLOB PLAN; UNFPA, 2011, STAT WORLDS MIDW 201; UNFPA, 2014, STAT WORLDS MIDW 201; United Nations Fund for Population Activities (UNFPA), 2014, FRAM ACT FOLL UP PRO; United Nations Human Rights Council, 2011, PRACT AD HUM RIGHTS; United Nations - Department of Economic and Social Affairs - Population Division, 2012, WORLD POP PROSP 2012; Van Lerberghe W, 2014, LANCET; van Teijlingen E, 2014, MIDWIFERY, V30, P1, DOI 10.1016/j.midw.2013.10.022; Vega J, 2013, LANCET, V381, P179, DOI 10.1016/S0140-6736(13)60062-8; Vujicic M, 2009, MEASURING HLTH WORKF; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO, 2014, EV NEWB DRAFT ACT PL; WHO, 2010, TRENDS MAT MORT 1990; WHO, 2007, EV BUS STRENGTH HLTH; WHO, 2005, MAK EV MOTH CHILD CO; Wood ME, 2013, MIDWIFERY, V29, P1137, DOI 10.1016/j.midw.2013.07.004; World Health Organization, 2011, WHO GUID PREV EARL P; World Health Organization, 2000, HLTH SYST IMPR PERF; World Health Organization, 2010, FRAM ACT INT ED COLL; World Health Organization, 2001, BACKGR PAP TECHN CON; World Health Organization, 2010, WORKL IND STAFF NEED; World Health Organization, 2013, TRANSFORMING SCALING; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH; World Health Organization & World Bank, 2013, MON PROGR UN HLTH CO	78	250	251	5	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1226	1235		10.1016/S0140-6736(14)60930-2	http://dx.doi.org/10.1016/S0140-6736(14)60930-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7MT	24965818				2022-12-24	WOS:000343002600029
J	Miething, C; Scuoppo, C; Bosbach, B; Appelmann, I; Nakitandwe, J; Ma, J; Wu, G; Lintault, L; Auer, M; Premsrirut, PK; Teruya-Feldstein, J; Hicks, J; Benveniste, H; Speicher, MR; Downing, JR; Lowe, SW				Miething, Cornelius; Scuoppo, Claudio; Bosbach, Benedikt; Appelmann, Iris; Nakitandwe, Joy; Ma, Jing; Wu, Gang; Lintault, Laura; Auer, Martina; Premsrirut, Prem K.; Teruya-Feldstein, Julie; Hicks, James; Benveniste, Helene; Speicher, Michael R.; Downing, James R.; Lowe, Scott W.			PTEN action in leukaemia dictated by the tissue microenvironment	NATURE			English	Article							CCR9 CHEMOKINE RECEPTOR; CELL; GENE; THYMOCYTES; EXPRESSION; PI3K; SET; DIFFERENTIATION; ANTAGONIST; INHIBITORS	PTEN encodes a lipid phosphatase that is underexpressed in many cancers owing to deletions, mutations or gene silencing(1-3). PTEN dephosphorylates phosphatidylinositol (3,4,5)-triphosphate, thereby opposing the activity of class I phosphatidylinositol 3-kinases that mediate growth-and survival-factor signalling through phosphatidylinositol 3-kinase effectors such as AKT and mTOR(2). To determine whether continued PTEN inactivation is required to maintain malignancy, here we generate anRNA interference-based transgenic mouse model that allows tetracycline-dependent regulation of PTEN in a time-and tissue-specific manner. Postnatal Pten knockdown in the haematopoietic compartment produced highly disseminated T-cell acute lymphoblastic leukaemia. Notably, reactivation of PTEN mainly reduced T-cell leukaemia dissemination but had little effect on tumour load in haematopoietic organs. Leukaemia infiltration into the intestine was dependent on CCR9G-protein-coupled receptor signalling, which was amplified by PTEN loss. Our results suggest that in the absence of PTEN, G-protein-coupled receptors may have an unanticipated role in driving tumour growth and invasion in an unsupportive environment. They further reveal that the role of PTEN loss in tumour maintenance is not invariant and can be influenced by the tissue microenvironment, thereby producing a form of intratumoral heterogeneity that is independent of cancer genotype.	[Miething, Cornelius; Bosbach, Benedikt; Appelmann, Iris; Teruya-Feldstein, Julie; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Miething, Cornelius; Scuoppo, Claudio; Appelmann, Iris; Lintault, Laura; Premsrirut, Prem K.; Hicks, James; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Nakitandwe, Joy; Ma, Jing; Wu, Gang; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Lintault, Laura; Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA; [Auer, Martina; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Benveniste, Helene] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Benveniste, Helene] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; St Jude Children's Research Hospital; Howard Hughes Medical Institute; Medical University of Graz; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	lowes@mskcc.org	Miething, Cornelius/F-9498-2014; Speicher, Michael R/B-5362-2013; Wu, Gang/M-8012-2014; Downing, James R./N-8102-2018	Miething, Cornelius/0000-0003-4699-3805; Speicher, Michael R/0000-0003-0105-955X; Wu, Gang/0000-0002-1678-5864; 	DFG [Mi1210/1-1]; Deutsche Krebshilfe (DKH) [109902]; Angel Foundation; National Cancer Institute, a Leukemia and Lymphoma Society Specialized Center of Research; Don Monti Foundation; Geoffrey Beene Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA045508, U01CA105388, P01CA013106, P01CA087497, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016282] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe (DKH)(Deutsche Krebshilfe); Angel Foundation; National Cancer Institute, a Leukemia and Lymphoma Society Specialized Center of Research; Don Monti Foundation; Geoffrey Beene Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to J. Cappellani, D. Grace, J. Simon and M. Taylor for technical assistance, S.-Y. Kim for performing tetraploid embryo complementation, J. Cheng for RNA-seq analysis, M. Riggs for CGH array analysis, M. Lupu and C. Le for MRI imaging, V. Longo and P. Zanzonico for PET analysis, J. Pichardo for data management, L. Lopez and A. Giri for tissue microarray construction, M. Saborowski for help with IHC staining, A. Rosello-Diez and M. Asher for expertise in antibody staining characterization and C. Sherr for constructive comments and editorial advice. We thank J. Jaen, M. Penfold and M. Walters from ChemoCentryx for providing the CCR9 small molecule inhibitor. C. M. was supported by a fellowship from the DFG (Mi1210/1-1). I.A. received support by a fellowship from the Deutsche Krebshilfe (DKH no. 109902). C. S. was supported by the Angel Foundation with a Curt Engelhorn fellowship. This work was also supported by a program project grant from the National Cancer Institute, a Leukemia and Lymphoma Society Specialized Center of Research, and philanthropic funds from the Don Monti Foundation. S. W. L. is supported by the Geoffrey Beene Foundation and is an investigator at the Howard Hughes Medical Institute.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; BERGER RL, 1994, J AM STAT ASSOC, V89, P1012, DOI 10.2307/2290928; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Campbell DJ, 2002, J CLIN INVEST, V110, P1079, DOI 10.1172/JCI200216946; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Eksteen B, 2010, IDRUGS, V13, P472; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; ERIKSON J, 1986, SCIENCE, V232, P884, DOI 10.1126/science.3486470; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Jotta PY, 2010, LEUKEMIA, V24, P239, DOI 10.1038/leu.2009.209; Kim WI, 2007, EXP HEMATOL, V35, P1231, DOI 10.1016/j.exphem.2007.04.012; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Lakshmi B, 2006, P NATL ACAD SCI USA, V103, P11234, DOI 10.1073/pnas.0602984103; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stambolic V, 2000, CANCER RES, V60, P3605; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tubo NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050498; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Youn BS, 1999, BLOOD, V94, P2533, DOI 10.1182/blood.V94.7.2533.419k37_2533_2536; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	49	39	39	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					402	+		10.1038/nature13239	http://dx.doi.org/10.1038/nature13239			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24805236	Green Accepted			2022-12-24	WOS:000337350200036
J	Cathomen, T; Ehl, S				Cathomen, Toni; Ehl, Stephan			Translating the Genomic Revolution - Targeted Genome Editing in Primates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENE; CELLS		[Cathomen, Toni; Ehl, Stephan] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Cathomen, Toni] Univ Med Ctr Freiburg, Inst Cell & Gene Therapy, Freiburg, Germany; [Ehl, Stephan] Univ Med Ctr Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Cathomen, T (corresponding author), Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany.		Ehl, Stephan/AAM-6006-2020; Cathomen, Toni/ABG-8410-2021; Cathomen, Toni/GZL-2702-2022	Cathomen, Toni/0000-0002-7757-4630; Cathomen, Toni/0000-0002-7757-4630; Ehl, Stephan/0000-0002-9265-2721				[Anonymous], 2013, SCIENCE, V342, P1434; de Souza N, 2012, NAT METHODS, V9, P27, DOI 10.1038/nmeth.1848; Garate Z, 2013, HUM GENE THER, V24, P571, DOI 10.1089/hum.2012.251; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662	6	15	15	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2342	2345		10.1056/NEJMcibr1403629	http://dx.doi.org/10.1056/NEJMcibr1403629			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918378				2022-12-24	WOS:000337033700015
J	Woolhouse, M; Farrar, J				Woolhouse, Mark; Farrar, Jeremy			An intergovernmental panel on antimicrobial resistance	NATURE			English	Editorial Material							ANTIBIOTIC-RESISTANCE		[Woolhouse, Mark] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH8 9YL, Midlothian, Scotland; [Farrar, Jeremy] Wellcome Trust Res Labs, London, England	University of Edinburgh	Woolhouse, M (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH8 9YL, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk; j.farrar@wellcome.ac.uk	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X				Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Vernet G, 2014, EMERG INFECT DIS, V20, P434, DOI [10.3201/eid2003.121157, 10.3201/EID2003.121157]; Wertheim HFL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001429; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; World Health Organization, 2014, ANT RES GLOB REP SUR	8	106	110	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					555	557		10.1038/509555a	http://dx.doi.org/10.1038/509555a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24877180	Bronze			2022-12-24	WOS:000336457100023
J	Sato, Y; Maekawa, S; Ishii, R; Sanada, M; Morikawa, T; Shiraishi, Y; Yoshida, K; Nagata, Y; Sato-Otsubo, A; Yoshizato, T; Suzuki, H; Shiozawa, Y; Kataoka, K; Kon, A; Aoki, K; Chiba, K; Tanaka, H; Kume, H; Miyano, S; Fukayama, M; Nureki, O; Homma, Y; Ogawa, S				Sato, Yusuke; Maekawa, Shigekatsu; Ishii, Ryohei; Sanada, Masashi; Morikawa, Teppei; Shiraishi, Yuichi; Yoshida, Kenichi; Nagata, Yasunobu; Sato-Otsubo, Aiko; Yoshizato, Tetsuichi; Suzuki, Hiromichi; Shiozawa, Yusuke; Kataoka, Keisuke; Kon, Ayana; Aoki, Kosuke; Chiba, Kenichi; Tanaka, Hiroko; Kume, Haruki; Miyano, Satoru; Fukayama, Masashi; Nureki, Osamu; Homma, Yukio; Ogawa, Seishi			Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome	SCIENCE			English	Article							PROTEIN-KINASE; ADRENAL-HYPERPLASIA; CATALYTIC SUBUNIT; RESPONSE-ELEMENT; PHOSPHODIESTERASE; BINDING; GENE; PDE11A	Cushing's syndrome is caused by excess cortisol production from the adrenocortical gland. In corticotropin-independent Cushing's syndrome, the excess cortisol production is primarily attributed to an adrenocortical adenoma, in which the underlying molecular pathogenesis has been poorly understood. We report a hotspot mutation (L206R) in PRKACA, which encodes the catalytic subunit of cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA), in more than 50% of cases with adrenocortical adenomas associated with corticotropin-independent Cushing's syndrome. The L206R PRKACA mutant abolished its binding to the regulatory subunit of PKA (PRKAR1A) that inhibits catalytic activity of PRKACA, leading to constitutive, cAMP-independent PKA activation. These results highlight the major role of cAMP-independent activation of cAMP/PKA signaling by somatic mutations in corticotropin-independent Cushing's syndrome, providing insights into the diagnosis and therapeutics of this syndrome.	[Sato, Yusuke; Sanada, Masashi; Yoshida, Kenichi; Nagata, Yasunobu; Sato-Otsubo, Aiko; Yoshizato, Tetsuichi; Suzuki, Hiromichi; Shiozawa, Yusuke; Kataoka, Keisuke; Kon, Ayana; Aoki, Kosuke; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Sato, Yusuke; Maekawa, Shigekatsu; Kume, Haruki; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Ishii, Ryohei; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Morikawa, Teppei; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan	Kyoto University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Homma, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan.	homma-uro@umin.ac.jp; sogawa-tky@umin.ac.jp	Ogawa, Seishi/AAE-7088-2019; NUREKI, OSAMU/G-4960-2014; Suzuki, Hiromichi/AAO-4664-2021; Yoshizato, Tetsuichi/AAD-7308-2019; Kataoka, Keisuke/AAS-2546-2020	Suzuki, Hiromichi/0000-0002-8858-0294; Yoshizato, Tetsuichi/0000-0003-4283-2983; Kataoka, Keisuke/0000-0002-8263-9902; Ishii, Ryohei/0000-0003-2486-1393; Yoshida, Kenichi/0000-0003-4612-2778; Miyano, Satoru/0000-0002-1753-6616	Japan Society for the Promotion of Science (JSPS) [22134006]; Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program)	We thank Y. Mori, M. Nakamura, N. Mizota, S. Ichimura, and M. Yamakawa for their technical assistance. The retroviral vector, pGCDNsamIRES-EGFP, was kindly provided by M. Onodera (National Research Institute for Child Health and Development). This work was supported by the Japan Society for the Promotion of Science (JSPS) through Grants-in-Aid for Scientific Research (KAKENHI) grant number 22134006 and the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program). Data for exome sequencing, as well as SNP array analysis, are found in the European Genome-phenome Archive (EGA) under accession EGAS00001000661. Author contributions: Y.Sa., S.Ma., K.Y., Y.N., T.Y., H.S., and A.K. performed library preparation and DNA sequencing. Y.Shira., Y.Shio., K.C., H.T., and S.Mi. were committed to bioinformatics analyses of resequencing data. Y.Sa. and A.S.-O. performed SNP array analysis. Y.Sa., S.Ma., M.S., RI., K.K., and O.N. performed the functional analyses of PRKACA mutant. T. M., H. K., M. F., and Y.H. provided specimens and were also involved in planning the project. Y.Sa., S.Ma., M. S., R. I., and S.O. generated figures and tables and wrote the manuscript. S.O. led the entire project. All authors participated in the discussion and interpretation of data and results. Y.Sa., S.Ma., M.S., Y.H., and S.O. are inventors on a patent applied for by Kyoto University that covers the inspection method for Cushing's syndrome and biomarker and theraputic agent thereof (2014-37189).	Assie G, 2013, NEW ENGL J MED, V369, P2105, DOI 10.1056/NEJMoa1304603; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; Hatipoglu BA, 2012, J SURG ONCOL, V106, P565, DOI 10.1002/jso.23197; Horvath A, 2008, NEW ENGL J MED, V358, P750, DOI 10.1056/NEJMc0706182; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Horvath A, 2006, CANCER RES, V66, P11571, DOI 10.1158/0008-5472.CAN-06-2914; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Lefrancois-Martinez AM, 2011, J BIOL CHEM, V286, P32976, DOI 10.1074/jbc.M111.218016; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Moore MJ, 2003, J BIOL CHEM, V278, P10613, DOI 10.1074/jbc.M210807200; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; Stratakis Constantine A., 2008, V13, P117, DOI 10.1159/000134829; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	20	136	138	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					917	920		10.1126/science.1252328	http://dx.doi.org/10.1126/science.1252328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855271				2022-12-24	WOS:000336233800052
J	Rutter, PD; Donaldson, LJ				Rutter, Paul D.; Donaldson, Liam J.			Mandatory polio vaccination for travellers: protecting global public health	LANCET			English	Editorial Material									[Rutter, Paul D.; Donaldson, Liam J.] St Marys Hosp, Independent Monitoring Board, Global Polio Eradicat Initiat, London W2 1NY, England	Imperial College London	Rutter, PD (corresponding author), St Marys Hosp, Independent Monitoring Board, Global Polio Eradicat Initiat, QEQM Bldg, London W2 1NY, England.	imb-prutter@polioeradication.org						[Anonymous], 2013, Wkly Epidemiol Rec, V88, P153; Aylward RB, 2014, LANCET, V383, P489, DOI 10.1016/S0140-6736(14)60132-X; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P366; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P253; Global Polio Eradication Initiative, 2013, STAT REP SEPT 2013; Global Polio Eradication Initiative, 2014, DAT MON POL CAS COUN; Independent Monitoring Board of the Global Polio Eradication Initiative, 2012, 6 IND MON BOARD GLOB; Independent Monitoring Board of the Global Polio Eradication Initiative, 2011, 1 IND MON BOARD GLOB; Independent Monitoring Board of the Global Polio Eradication Initiative, 2013, 8 IND MON BOARD GLOB; WHO, 2013, IHR EM COMM MIDDL E; *WHO, 1988, WHA4128 WHO; WHO, 2014, INT TRAV HLTH POL; World Health Organization, 2014, WHO STAT M INT HLTH; World Health Organization (WHO), 2011, STAND TERM PAND A H1; World Health Orhanisation, 2009, IHR EM COMM INFL PAN	15	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1695	1697		10.1016/S0140-6736(14)60756-X	http://dx.doi.org/10.1016/S0140-6736(14)60756-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6UO	24814089	Green Published, Bronze			2022-12-24	WOS:000336267300004
J	Minteer, B				Minteer, Ben			Is it right to reverse extinction?	NATURE			English	Editorial Material									Arizona State Univ, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Minteer, B (corresponding author), Arizona State Univ, Tempe, AZ 85287 USA.	ben.minteer@asu.edu							0	15	16	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					261	261		10.1038/509261a	http://dx.doi.org/10.1038/509261a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH4TM	24828156	Bronze			2022-12-24	WOS:000336121200004
J	Lee, T; Cai, LX; Lelyveld, VS; Hai, A; Jasanoff, A				Lee, Taekwan; Cai, Lili X.; Lelyveld, Victor S.; Hai, Aviad; Jasanoff, Alan			Molecular-Level Functional Magnetic Resonance Imaging of Dopaminergic Signaling	SCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; RAT-BRAIN; DIRECTED EVOLUTION; SHELL; SUBTERRITORIES; TRANSPORTER	We demonstrate a technique for mapping brain activity that combines molecular specificity and spatial coverage using a neurotransmitter sensor detectable by magnetic resonance imaging (MRI). This molecular functional MRI (fMRI) method yielded time-resolved volumetric measurements of dopamine release evoked by reward-related lateral hypothalamic brain stimulation of rats injected with the neurotransmitter sensor. Peak dopamine concentrations and release rates were observed in the anterior nucleus accumbens core. Substantial dopamine transients were also present in more caudal areas. Dopamine-release amplitudes correlated with the rostrocaudal stimulation coordinate, suggesting participation of hypothalamic circuitry in modulating dopamine responses. This work provides a foundation for development and application of quantitative molecular fMRI techniques targeted toward numerous components of neural physiology.	[Lee, Taekwan; Cai, Lili X.; Lelyveld, Victor S.; Hai, Aviad; Jasanoff, Alan] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Jasanoff, Alan] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Jasanoff, Alan] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jasanoff, A (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jasanoff@mit.edu		Cai, Lili/0000-0003-3260-2367; /0000-0002-3890-0288	NIH [R01-DA02899, R01-NS076462, DP2-OD002114]; Defense Advanced Research Projects Agency [W911NF-10-0059]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076462] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002114] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R01-DA02899, R01-NS076462 and DP2-OD002114, and Defense Advanced Research Projects Agency grant W911NF-10-0059 to A.J. We thank G. Westmeyer for technical guidance and A. Graybiel for comments on the manuscript. We also thank C. Blaha, A. Graybiel, M. Howe, T. Rogers, and T. Schneider for assistance with electrochemistry; E. Brustad and F. Arnold for collaboration on sensor development; and A. Liang and S. Lippard for help with stopped-flow measurements. U.S. patent application 12/675,256 pertains to BM3h-9D7.	Addy NA, 2010, J NEUROPHYSIOL, V104, P922, DOI 10.1152/jn.00413.2010; Brustad EM, 2012, J MOL BIOL, V422, P245, DOI 10.1016/j.jmb.2012.05.029; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; EWING AG, 1983, SCIENCE, V221, P169, DOI 10.1126/science.6857277; FREED C, 1995, J COMP NEUROL, V359, P340, DOI 10.1002/cne.903590211; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jasanoff A, 2007, CURR OPIN NEUROBIOL, V17, P593, DOI 10.1016/j.conb.2007.11.002; Jones SR, 1996, SYNAPSE, V23, P224, DOI 10.1002/(SICI)1098-2396(199607)23:3<224::AID-SYN12>3.3.CO;2-6; MAY LJ, 1988, J NEUROCHEM, V51, P1060, DOI 10.1111/j.1471-4159.1988.tb03069.x; NIEUWENHUYS R, 1982, J COMP NEUROL, V206, P49, DOI 10.1002/cne.902060106; Park J, 2010, NEUROSCIENCE, V169, P132, DOI 10.1016/j.neuroscience.2010.04.076; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Saddoris Michael P, 2013, Front Biosci (Elite Ed), V5, P273; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shapiro MG, 2010, NAT BIOTECHNOL, V28, P264, DOI 10.1038/nbt.1609; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Zahm DS, 1999, ANN NY ACAD SCI, V877, P113, DOI 10.1111/j.1749-6632.1999.tb09264.x	20	91	93	8	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					533	535		10.1126/science.1249380	http://dx.doi.org/10.1126/science.1249380			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786083				2022-12-24	WOS:000335157700047
J	Samarasekera, U; Horton, R				Samarasekera, Udani; Horton, Richard			The world we want for every newborn child	LANCET			English	Editorial Material									[Samarasekera, Udani; Horton, Richard] The Lancet, London NW1 7BY, England		Samarasekera, U (corresponding author), The Lancet, London NW1 7BY, England.							Bhutta ZA, 2014, LANCET; Darmstadt GL, 2014, LANCET; Dickson KE, 2014, LANCET; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Lawn JE, 2014, LANCET; Mason E, 2014, LANCET; World Health Organization, 2014, EV NEWB ACT PLAN END; You D, 2013, LEVELS TRENDS CHILD	8	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					107	109		10.1016/S0140-6736(14)60837-0	http://dx.doi.org/10.1016/S0140-6736(14)60837-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24853598				2022-12-24	WOS:000338921500009
J	Dar, RD; Hosmane, NN; Arkin, MR; Siliciano, RF; Weinberger, LS				Dar, Roy D.; Hosmane, Nina N.; Arkin, Michelle R.; Siliciano, Robert F.; Weinberger, Leor S.			Screening for noise in gene expression identifies drug synergies	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; LATENT INFECTION; HIV-1 LATENCY; STOCHASTICITY; CONSEQUENCES; FREQUENCY; PROMOTER; CELLS; CURE	Stochastic fluctuations are inherent to gene expression and can drive cell-fate specification. We used such fluctuations to modulate reactivation of HIV from latency-a quiescent state that is a major barrier to an HIV cure. By screening a diverse library of bioactive small molecules, we identified more than 80 compounds that modulated HIV gene-expression fluctuations (i.e., "noise"), without changing mean expression. These noise-modulating compounds would be neglected in conventional screens, and yet, they synergized with conventional transcriptional activators. Noise enhancers reactivated latent cells significantly better than existing best-in-class reactivation drug combinations (and with reduced off-target cytotoxicity), whereas noise suppressors stabilized latency. Noise-modulating chemicals may provide novel probes for the physiological consequences of noise and an unexplored axis for drug discovery, allowing enhanced control over diverse cell-fate decisions.	[Dar, Roy D.; Weinberger, Leor S.] Gladstone Inst, San Francisco, CA 94158 USA; [Hosmane, Nina N.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94158 USA; [Arkin, Michelle R.] Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94143 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weinberger, LS (corresponding author), Gladstone Inst, 1650 Owens St, San Francisco, CA 94158 USA.	leor.weinberger@gladstone.ucsf.edu	Arkin, Michelle/AAO-2009-2021; arkin, michelle/AAN-4298-2021	arkin, michelle/0000-0002-9366-6770; Dar, Roy/0000-0002-6006-4888	NIH National Research Service Award fellowship [AI104380]; NIH Director's New Innovator Award [DP2-OD006677]; NIH Delaney Collaboratory of AIDS Researchers for a Cure [U19AI096113]; UCSF CTSI-SOS Award; UCSF-GIVI CFAR [P30AI027763]; UCSF-CSSB [P50GM081879]; Pew Scholars in the Biomedical Sciences; Alfred P. Sloan Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113, F32AI104380, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, T32GM008752] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006677] Funding Source: NIH RePORTER	NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Delaney Collaboratory of AIDS Researchers for a Cure; UCSF CTSI-SOS Award; UCSF-GIVI CFAR; UCSF-CSSB; Pew Scholars in the Biomedical Sciences; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank I. Golding, J. Weissman, O. Weiner, E. Verdin, M. Simpson, C. Lee, A. Pai and the Weinberger lab for thoughtful discussions. We thank C. Wilson, M. Cavrois, M. Gesner, and M. Titus for technical expertise and assistance. R. D. D. was supported by an NIH National Research Service Award fellowship (AI104380). This work was supported by the NIH Director's New Innovator Award DP2-OD006677 (L. S. W.), the NIH Delaney Collaboratory of AIDS Researchers for a Cure (U19AI096113), a UCSF CTSI-SOS Award, UCSF-GIVI CFAR (P30AI027763), UCSF-CSSB (P50GM081879), the Pew Scholars in the Biomedical Sciences, and the Alfred P. Sloan Foundation.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Simpson ML, 2004, J THEOR BIOL, V229, P383, DOI 10.1016/j.jtbi.2004.04.017; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Vardi N, 2013, CURR BIOL, V23, P2051, DOI 10.1016/j.cub.2013.08.043; Weinberger AD, 2013, CELL, V155, P497, DOI 10.1016/j.cell.2013.09.039; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199	27	137	140	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1392	1396		10.1126/science.1250220	http://dx.doi.org/10.1126/science.1250220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24903562	Green Accepted			2022-12-24	WOS:000337531700039
J	Vater, LB; Donohue, JM; Arnold, R; White, DB; Chu, E; Schenker, Y				Vater, Laura B.; Donohue, Julie M.; Arnold, Robert; White, Douglas B.; Chu, Edward; Schenker, Yael			What Are Cancer Centers Advertising to the Public? A Content Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							PALLIATIVE RADIOTHERAPY; PRESCRIPTION DRUGS; LUNG-CANCER; EXPECTATIONS; PATIENT; CARE; PERCEPTIONS; PROGNOSIS; THERAPY; COST	Background: Although critics have expressed concerns about cancer center advertising, analyses of the content of these advertisements are lacking. Objective: To characterize the information and emotional content of direct-to-consumer cancer center advertisements. Design: Content analysis. Setting: Top U. S. consumer magazines (n = 269) and television networks (n = 44) in 2012. Measurements: Types of clinical services promoted; information provided about clinical services, including risks, benefits, costs, and insurance availability; use of emotional advertising appeals; and use of patient testimonials were assessed. Two investigators independently coded advertisements using ATLAS.ti, and kappa values ranged from 0.77 to 1.00. Results: A total of 102 cancer centers placed 409 unique clinical advertisements in top media markets in 2012. Advertisements promoted treatments (88%) more often than screening (18%) or supportive services (13%). Benefits of advertised therapies were described more often than risks (27% vs. 2%) but were rarely quantified (2%). Few advertisements mentioned coverage or costs (5%), and none mentioned specific insurance plans. Emotional appeals were frequent (85%), evoking hope for survival (61%), describing cancer treatment as a fight or battle (41%), and inducing fear (30%). Nearly one half of advertisements included patient testimonials, which were usually focused on survival, rarely included disclaimers (15%), and never described the results that a typical patient may expect. Limitation: Internet advertisements were not included. Conclusion: Clinical advertisements by cancer centers frequently promote cancer therapy with emotional appeals that evoke hope and fear while rarely providing information about risks, benefits, costs, or insurance availability. Further work is needed to understand how these advertisements influence patient understanding and expectations of benefit from cancer treatments.	Univ Pittsburgh, Grad Sch Publ Hlth, Biobehav Oncol Program, Canc Inst,Palliat & Support Inst,Med Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Ctr, Pittsburgh, PA 15213 USA; Indiana Univ, Sch Med, South Bend, IN 46615 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University South Bend	Schenker, Y (corresponding author), Univ Pittsburgh, Sect Palliat Care & Med Eth, Div Gen Med, 230 McKee Pl,Suite 600, Pittsburgh, PA 15213 USA.	schenkery@upmc.edu		Vater, Laura/0000-0002-5920-9576; Donohue, Julie/0000-0003-2418-6017	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Primary Funding Source: National Institutes of Health.	Abel GA, 2007, J CLIN ONCOL, V25, P1267, DOI 10.1200/JCO.2006.09.5968; Abel GA, 2009, J CLIN ONCOL, V27, P4182, DOI 10.1200/JCO.2008.20.6599; Algie J, 2010, J PREV INTERV COMMUN, V38, P264, DOI 10.1080/10852352.2010.509019; Ambler T, 1999, J ADVERTISING RES, V39, P25; American College of Surgeons, SEARCH COC HOSP LOC; American College of Surgeons, ACCR; Armstrong J.Scott., 2010, PERSUASIVE ADVERTISI, DOI 10.1057/9780230285804; Bell RA, 2000, J FAM PRACTICE, V49, P329; Burns CM, 2007, SUPPORT CARE CANCER, V15, P187, DOI 10.1007/s00520-006-0116-8; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Chen AB, 2013, J CLIN ONCOL, V31, P2730, DOI 10.1200/JCO.2012.48.5748; Chow E, 2001, CLIN ONCOL-UK, V13, P204, DOI 10.1053/clon.2001.9255; Dillard JP, 2006, J COMMUN, V56, pS123, DOI 10.1111/j.1460-2466.2006.00286.x; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Dunlop SM, 2014, J HEALTH COMMUN, V19, P41, DOI 10.1080/10810730.2013.798375; Dunlop SM, 2012, TOB CONTROL; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503; Gray SW, 2012, J ONCOL PRACT, V8, P124, DOI 10.1200/JOP.2011.000513; Illes J, 2004, ARCH INTERN MED, V164, P2415, DOI 10.1001/archinte.164.22.2415; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Larson RJ, 2005, ARCH INTERN MED, V165, P645, DOI 10.1001/archinte.165.6.645; Lee SJ, 2001, JAMA-J AM MED ASSOC, V285, P1034, DOI 10.1001/jama.285.8.1034; Lovett KM, 2012, J CLIN ONCOL, V30, P1411, DOI 10.1200/JCO.2011.37.8984; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Mehrotra A, 2006, HEALTH AFFAIR, V25, P759, DOI 10.1377/hlthaff.25.3.759; Mitera G, 2012, CLIN ONCOL-UK, V24, P134, DOI 10.1016/j.clon.2011.09.001; National Cancer Institute, NCI DES CANC CTR; National Research Council, 2013, DEL HIGH QUAL CANC C; Newman A. A., 2011, NY TIMES; Parrott Roxanne, 2008, Health Mark Q, V25, P8, DOI 10.1080/07359680802126061; PRONZATO P, 1994, SUPPORT CARE CANCER, V2, P242, DOI 10.1007/BF00365729; Ravdin PM, 1998, J CLIN ONCOL, V16, P515, DOI 10.1200/JCO.1998.16.2.515; Sapir R, 2000, SUPPORT CARE CANCER, V8, P458, DOI 10.1007/s005200000163; Schenker Y, 2014, AM J BIOETHICS, V14, P34, DOI 10.1080/15265161.2013.879943; SCHWARTZ IM, 1989, J ADOLESCENT HEALTH, V10, P473, DOI 10.1016/0197-0070(89)90009-0; Singer Natasha, 2009, NY TIMES        0805, pA1; STERN BB, 1994, J CONSUM RES, V20, P601, DOI 10.1086/209373; Tellis GJ, 2004, EFFECTIVE ADVERTISIN; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Volpp KG, 2012, JAMA-J AM MED ASSOC, V308, P1635, DOI 10.1001/jama.2012.13616; Warren JL, 2008, J NATL CANCER I, V100, P888, DOI 10.1093/jnci/djn175; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Weissman J. S., 2004, HLTH AFF MILLWOOD S	47	39	39	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					813	U24		10.7326/M14-0500	http://dx.doi.org/10.7326/M14-0500			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0VR	24863081	Green Accepted			2022-12-24	WOS:000337374900014
J	Kessler, R				Kessler, Rebecca			PREVENTION Air of danger	NATURE			English	Editorial Material							BREAST-CANCER; EXPOSURE; DDT; AGE											Cohn BA, 2007, ENVIRON HEALTH PERSP, V115, P1406, DOI 10.1289/ehp.10260; Cohn BA, 2012, BREAST CANCER RES TR, V136, P267, DOI 10.1007/s10549-012-2257-4; Cohn BA, 2010, ARCH ENVIRON OCCUP H, V65, P127, DOI 10.1080/19338241003730887; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; National Toxicology Program, 2011, REP CARC; Prins GS, 2014, ENDOCRINOLOGY, V155, P805, DOI 10.1210/en.2013-1955; Straif K., 2013, AIR POLLUTION CANC; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; [No title captured]	10	15	16	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S62	S63		10.1038/509S62a	http://dx.doi.org/10.1038/509S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870824	Bronze			2022-12-24	WOS:000336457100007
J	Palmer, T				Palmer, Tim			Record-breaking winters and global climate change	SCIENCE			English	Editorial Material							WEST-PACIFIC		Univ Oxford, Oxford Martin Programme Modelling & Predicting Cl, Oxford OX1 3BD, England	University of Oxford	Palmer, T (corresponding author), Univ Oxford, Oxford Martin Programme Modelling & Predicting Cl, Oxford OX1 3BD, England.	t.n.palmer@atm.ox.ac.uk		Palmer, Tim/0000-0002-7121-2196				Balmaseda MA, 2013, GEOPHYS RES LETT, V40, P1754, DOI 10.1002/grl.50382; Clement A, 2014, SCIENCE, V343, P976, DOI 10.1126/science.1248115; Hartmann D. L., 2013, CLIM CHANG 2013 PHYS; Hume T., 2014, CNN             0122; Kintisch E, 2014, SCIENCE, V344, P250, DOI 10.1126/science.344.6181.250; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Met Office, 2014, REC STORMS FLOODS UK; PALMER TN, 1984, NATURE, V310, P483, DOI 10.1038/310483a0; PALMER TN, 1986, MON WEATHER REV, V114, P648, DOI 10.1175/1520-0493(1986)114<0648:APRBSW>2.0.CO;2; SIMMONS AJ, 1983, J ATMOS SCI, V40, P1363, DOI 10.1175/1520-0469(1983)040<1363:BWPAIA>2.0.CO;2; Tang QH, 2014, NAT CLIM CHANGE, V4, P45, DOI [10.1038/nclimate2065, 10.1038/NCLIMATE2065]	11	84	85	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					803	804		10.1126/science.1255147	http://dx.doi.org/10.1126/science.1255147			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855240				2022-12-24	WOS:000336233800012
J	Rich, JD; Allen, SA; Williams, BA				Rich, Josiah D.; Allen, Scott A.; Williams, Brie A.			Responding to Hepatitis C through the Criminal Justice System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Rich, Josiah D.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Rich, Josiah D.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Rich, Josiah D.; Allen, Scott A.] Miriam Hosp, Ctr Prisoner Hlth & Human Rights, Providence, RI 02906 USA; [Allen, Scott A.] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA; [Williams, Brie A.] Univ Calif San Francisco, Dept Med, Dept Geriatr, San Francisco, CA USA	Brown University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; University of California System; University of California Riverside; University of California System; University of California San Francisco	Rich, JD (corresponding author), Brown Univ, Dept Med, Providence, RI 02912 USA.		Allen, Scott/D-2403-2015	Allen, Scott/0000-0001-8815-4714	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030778, K24DA022112] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA030778, K24 DA022112] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Institute of Medicine, 2010, HEP LIV CANC NAT STR; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; Rich JD, 2014, HEALTH AFFAIR, V33, P462, DOI 10.1377/hlthaff.2013.1133; Rich JD, 2011, NEW ENGL J MED, V364, P2081, DOI 10.1056/NEJMp1102385; Varan AK, 2014, PUBLIC HEALTH REP, V129, P187, DOI 10.1177/003335491412900213	5	35	35	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1871	1874		10.1056/NEJMp1311941	http://dx.doi.org/10.1056/NEJMp1311941			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UH	24827032	Green Published			2022-12-24	WOS:000336123600002
J	Orleans, RJ; Li, L; Kim, MJ; Guo, J; Sobhan, M; Soule, L; Joffe, HV				Orleans, Ronald J.; Li, Li; Kim, Myong-Jin; Guo, Jia; Sobhan, Mahboob; Soule, Lisa; Joffe, Hylton V.			FDA Approval of Paroxetine for Menopausal Hot Flushes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							POSTMENOPAUSAL WOMEN; TAMOXIFEN; ESTROGEN; CYP2D6	An FDA advisory committee recommended against approving paroxetine for menopausal vasomotor symptoms. But recognizing the lack of hormone-free products for this indication, and after reviewing the drug's efficacy and safety, the FDA decided it can benefit some women. The recent approval by the Food and Drug Administration (FDA) of paroxetine (Brisdelle, Noven) for the treatment of moderate-to-severe vasomotor symptoms associated with menopause was distinctive for at least two reasons. First, it offered the first nonhormonal option to women who cannot or do not want to use hormonal medications to treat their menopausal vasomotor symptoms. Second, the approval ran counter to the recommendation of the FDA Reproductive Health Drugs Advisory Committee, which had concluded, by a vote of 10 to 4, that the overall benefit-risk profile of Brisdelle did not support approval. The FDA always carefully considers the advice ...	[Orleans, Ronald J.; Li, Li; Kim, Myong-Jin; Guo, Jia; Sobhan, Mahboob; Soule, Lisa; Joffe, Hylton V.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Orleans, RJ (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Hertz DL, 2012, ONCOLOGIST, V17, P620, DOI 10.1634/theoncologist.2011-0418; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Zembutsu H, 2011, EXPERT REV ANTICANC, V11, P185, DOI [10.1586/era.10.228, 10.1586/ERA.10.228]	5	34	40	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1777	1779		10.1056/NEJMp1402080	http://dx.doi.org/10.1056/NEJMp1402080			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH3CD	24806158				2022-12-24	WOS:000335997900004
J	Dyer, O				Dyer, Owen			The slow death of lethal injection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												owen_dyer@hotmail.com						Colburn D., 2005, SEATTLE TIMES; Hasselle D., 2013, LENS            1021; Moore P, 2014, YOUGOV          0121; Shaughnessy AF, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7432; State of Florida Florida Department of Corrections, 2013, EX LETH INJ PROC; Ward M, 2013, AUSTIN AM STATE 1007	6	4	4	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2014	348								g2670	10.1136/bmj.g2670	http://dx.doi.org/10.1136/bmj.g2670			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RF	24781110				2022-12-24	WOS:000335475500005
J	Fazel, S; Zetterqvist, J; Larsson, H; Langstrom, N; Lichtenstein, P				Fazel, Seena; Zetterqvist, Johan; Larsson, Henrik; Langstroem, Nikfas; Lichtenstein, Paul			Antipsychotics, mood stabilisers, and risk of violent crime	LANCET			English	Article							BIPOLAR DISORDER; SCHIZOPHRENIA; MEDICATIONS; TRENDS; INTERVENTIONS; METAANALYSIS; AGGRESSION; PREVENTION; MORTALITY; REGISTER	Background Antipsychotics and mood stabilisers are prescribed widely to patients with psychiatric disorders worldwide. Despite clear evidence for their efficacy in relapse prevention and symptom relief, their effect on some adverse outcomes, including the perpetration of violent crime, is unclear. We aimed to establish the effect of antipsychotics and mood stabilisers on the rate of violent crime committed by patients with psychiatric disorders in Sweden. Methods We used linked Swedish national registers to study 82 647 patients who were prescribed antipsychotics or mood stabilisers, their psychiatric diagnoses, and subsequent criminal convictions in 2006-09. We did withinindividual analyses to compare the rate of violent criminality during the time that patients were prescribed these medications versus the rate for the same patients while they were not receiving the drugs to adjust for all confounders that remained constant within each participant during follow-up. The primary outcome was the occurrence of violent crime, according to Sweden's national crime register. Findings In 2006-09, 40 937 men in Sweden were prescribed antipsychotics or mood stabilisers, of whom 2657 (6.5%) were convicted of a violent crime during the study period. In the same period, 41 710 women were prescribed these drugs, of whom 604 (1.4 %) had convictions for violent crime. Compared with periods when participants were not on medication, violent crime fell by 45% in patients receiving antipsychotics (hazard ratio [HR] 0.55, 95% CI 0.47-0.64) and by 24% in patients prescribed mood stabilisers (0. 76, 0.62-0.93). However, we identified potentially important differences by diagnosis mood stabilisers were associated with a reduced rate of violent crime only in patients with bipolar disorder. The rate of violence reduction for antipsychotics remained between 22% and 29% in sensitivity analyses that used different outcomes (any crime, drug-related crime, less severe crime, and violent arrest), and was stronger in patients who were prescribed higher drug doses than in those prescribed low doses. Notable reductions in violent crime were also recorded for depot medication (HR adjusted for concomitant oral medications 0. 60, 95% CI 0.39-0.92). Interpretation In addition to relapse prevention and psychiatric symptom relief, the benefits of antipsychotics and mood stabilisers might also include reductions in the rates of violent crime. The potential effects of these drugs on violence and crime should be taken into account when treatment options for patients with psychiatric disorders are being considered.	[Fazel, Seena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Zetterqvist, Johan; Larsson, Henrik; Langstroem, Nikfas; Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Oxford; Karolinska Institutet	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Langstrom, Niklas/C-5615-2009; Fazel, Seena/B-5307-2008; Larsson, Henrik/GYD-5161-2022	Langstrom, Niklas/0000-0002-2686-6799; Fazel, Seena/0000-0002-5383-5365; Larsson, Henrik/0000-0002-6851-3297; lichtenstein, paul/0000-0003-3037-5287	Welcome Trust [095806]; Swedish Prison and Probation Service; Swedish Research Council; Swedish Research Council for Health, Working Life and Welfare	Welcome Trust(Wellcome Trust); Swedish Prison and Probation Service; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by grants from the Welcome Trust (095806), the Swedish Prison and Probation Service, the Swedish Research Council, and the Swedish Research Council for Health, Working Life and Welfare.	Allison PD, 1996, SOCIOL METHOD RES, V25, P207, DOI 10.1177/0049124196025002003; American Psychiatric Association, 2004, PRACT GUID TREATM PA; [Anonymous], 2010, INT STAT CRIME JUSTI; Arango C, 2006, EUR PSYCHIAT, V21, P34, DOI 10.1016/j.eurpsy.2005.07.006; Baldwin DS, 2007, ADV PSYCHIAT TREAT, V13, P414, DOI DOI 10.1192/APT.BP.107.004184; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Beynon S, 2009, J PSYCHOPHARMACOL, V23, P574, DOI 10.1177/0269881108093885; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Citrome L, 2002, PSYCHIATR SERV, V53, P1212, DOI 10.1176/appi.ps.53.10.1212; Citrome L, 2007, J CLIN PSYCHIAT, V68, P331, DOI 10.4088/JCP.v68n0220; Citrome L, 2010, PSYCHIAT SERV, V61, P9, DOI 10.1176/appi.ps.61.1.9; Coid JW, 2013, JAMA PSYCHIAT, V70, P465, DOI 10.1001/jamapsychiatry.2013.12; De Hert M, 2010, SCHIZOPHR RES, V117, P68, DOI 10.1016/j.schres.2009.12.029; Dove D, 2012, PEDIATRICS, V130, P717, DOI 10.1542/peds.2012-0683; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Fazel S, 2010, ARCH GEN PSYCHIAT, V67, P931, DOI 10.1001/archgenpsychiatry.2010.97; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Frogley C, 2012, INT J NEUROPSYCHOPH, V15, P1351, DOI 10.1017/S146114571100201X; Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217; Haw C, 2005, J PSYCHOPHARMACOL, V19, P402, DOI 10.1177/0269881105053307; Hockenhull J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16120; Huband N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003499.pub3; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; Jones RM, 2011, BRIT J PSYCHIAT, V198, P93, DOI 10.1192/bjp.bp.110.083030; Kishimoto T, 2014, SCHIZOPHRENIA BULL, V40, P192, DOI 10.1093/schbul/sbs150; Kooyman I, 2007, BRIT J PSYCHIAT, V191, pS29, DOI 10.1192/bjp.191.50.s29; Kyaga S, 2013, J PSYCHIATR RES, V47, P83, DOI 10.1016/j.jpsychires.2012.09.010; Leucht C, 2011, SCHIZOPHR RES, V127, P83, DOI 10.1016/j.schres.2010.11.020; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Leucht S, 2007, PHYSICAL ILLNESS AND SCHIZOPHRENIA: A REVIEW OF THE EVIDENCE, P3, DOI 10.1017/CBO9780511543951.003; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Loy JH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008559.pub2; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; McGuire J, 2008, PHILOS T R SOC B, V363, P2577, DOI 10.1098/rstb.2008.0035; Mercer D, 2009, J PERS DISORD, V23, P156, DOI 10.1521/pedi.2009.23.2.156; *NAT I CLIN EXC, 2003, SCHIZ FULL NAT CLIN; National Council for Crime Prevention, 2011, KRIM 2010; Nelson JC, 2009, AM J PSYCHIAT, V166, P980, DOI 10.1176/appi.ajp.2009.09030312; Pamer CA, 2010, PHARMACOEPIDEM DR S, V19, P158, DOI 10.1002/pds.1886; Paulose-Ram R, 2007, PHARMACOEPIDEM DR S, V16, P560, DOI 10.1002/pds.1367; Pringsheim T, 2012, CAN J PSYCHIAT, V57, P722, DOI 10.1177/070674371205701203; Raschi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081208; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Schwarz C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004028.pub3; Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x; Stagnitti M, 2010, TRENDS ANTIPSYCHOTIC; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Stephenson CP, 2013, AUST NZ J PSYCHIAT, V47, P74, DOI 10.1177/0004867412466595; Swanson JW, 2008, BRIT J PSYCHIAT, V193, P37, DOI 10.1192/bjp.bp.107.042630; Topiwala A, 2011, EXPERT REV NEUROTHER, V11, P53, DOI [10.1586/ern.10.180, 10.1586/ERN.10.180]; Verdoux H, 2010, ACTA PSYCHIAT SCAND, V121, P4, DOI 10.1111/j.1600-0447.2009.01425.x; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	57	122	124	1	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1206	1214		10.1016/S0140-6736(14)60379-2	http://dx.doi.org/10.1016/S0140-6736(14)60379-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7MT	24816046	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000343002600027
J	Hwang, TJ; Bourgeois, FT; Seeger, JD				Hwang, Thomas J.; Bourgeois, Florence T.; Seeger, John D.			Drug Safety in the Digital Age	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WIKIPEDIA; INFORMATION		[Hwang, Thomas J.] Blackstone Grp, London, England; [Bourgeois, Florence T.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Bourgeois, Florence T.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Bourgeois, Florence T.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Seeger, John D.] Harvard Univ, Sch Med, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA; [Seeger, John D.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Hwang, TJ (corresponding author), Blackstone Grp, London, England.		Bourgeois, Florence/H-6710-2016	Bourgeois, Florence/0000-0001-7798-4560; Hwang, Thomas/0000-0003-0717-1497				Bould MD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1585; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Heilman JM, 2011, J MED INTERNET RES, V13, P153, DOI 10.2196/jmir.1589; Hwang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071966; Kupferberg N, 2011, J MED LIBR ASSOC, V99, P310, DOI 10.3163/1536-5050.99.4.010	5	16	17	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2460	2462		10.1056/NEJMp1401767	http://dx.doi.org/10.1056/NEJMp1401767			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24963564				2022-12-24	WOS:000337804400002
J	Greenwood, B				Greenwood, Brian			The use of a placebo in vaccine trials	LANCET			English	Editorial Material							CONJUGATE VACCINE; MENINGITIS; PNEUMONIA; DISEASE		London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Greenwood, B (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England.	brian.greenwood@lshtm.ac.uk						Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Rid A, 2014, VACCINE, V32, P4708, DOI 10.1016/j.vaccine.2014.04.022; WHO, 2013, EXP CONS USE PLAC VA	10	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2101	2102		10.1016/S0140-6736(14)60926-0	http://dx.doi.org/10.1016/S0140-6736(14)60926-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ7VG	24953464				2022-12-24	WOS:000337906600004
J	Dajani, R				Dajani, Rana			Jordan's stem-cell law can guide the Middle East	NATURE			English	Editorial Material									Hashemite Univ, Zarqa, Jordan	Hashemite University	Dajani, R (corresponding author), Hashemite Univ, Zarqa, Jordan.	rdajani@hu.edu.jo	Dajani, Rana/C-3466-2014	Dajani, Rana/0000-0002-4355-9977					0	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					189	189		10.1038/510189a	http://dx.doi.org/10.1038/510189a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24919888	Bronze			2022-12-24	WOS:000337032400004
J	van Hees, F; Habbema, JDF; Meester, RG; Lansdorp-Vogelaar, I; van Ballegooijen, M; Zauber, AG				van Hees, Frank; Habbema, J. Dik F.; Meester, Reinier G.; Lansdorp-Vogelaar, Iris; van Ballegooijen, Marjolein; Zauber, Ann G.			Should Colorectal Cancer Screening Be Considered in Elderly Persons Without Previous Screening? A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							LARGE-INTESTINE; LARGE-BOWEL; TASK-FORCE; COLONOSCOPY; POLYPS; PREVALENCE; GUIDELINES; SIGMOIDOSCOPY; NECROPSY; STATES	Background: The U.S. Preventive Services Task Force recommends against routine screening for colorectal cancer (CRC) in adequately screened persons older than 75 years but does not address the appropriateness of screening in elderly persons without previous screening. Objective: To determine at what ages CRC screening should be considered in unscreened elderly persons and to determine which test is indicated at each age. Design: Microsimulation modeling study. Data Sources: Observational and experimental studies. Target Population: Unscreened persons aged 76 to 90 years with no, moderate, and severe comorbid conditions. Time Horizon: Lifetime. Perspective: Societal. Intervention: One-time colonoscopy, sigmoidoscopy, or fecal immunochemical test (FIT) screening. Outcome Measures: Quality-adjusted life-years gained, costs, and costs per quality-adjusted life-year gained. Results of Base-Case Analysis: In unscreened elderly persons with no comorbid conditions, CRC screening was cost-effective up to age 86 years. Screening with colonoscopy was indicated up to age 83 years, sigmoidoscopy was indicated at age 84 years, and FIT was indicated at ages 85 and 86 years. In unscreened persons with moderate comorbid conditions, screening was cost-effective up to age 83 years (colonoscopy indicated up to age 80 years, sigmoidoscopy at age 81 years, and FIT at ages 82 and 83 years). In unscreened persons with severe comorbid conditions, screening was cost-effective up to age 80 years (colonoscopy indicated up to age 77 years, sigmoidoscopy at age 78 years, and FIT at ages 79 and 80 years). Results of Sensitivity Analyses: Results were most sensitive to assuming a lower willingness to pay per quality-adjusted life-year gained. Limitation: Only persons at average risk for CRC were considered. Conclusion: In unscreened elderly persons CRC screening should be considered well beyond age 75 years. A colonoscopy is indicated at most ages.	Erasmus Univ, Med Ctr, NL-3000 CA Rotterdam, Netherlands; Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	Erasmus University Rotterdam; Erasmus MC; Memorial Sloan Kettering Cancer Center	van Hees, F (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	f.vanhees@erasmusmc.nl			National Cancer Institute as part of the Cancer Intervention and Surveillance Modeling Network [U01-CA152959]; NATIONAL CANCER INSTITUTE [U01CA152959, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute as part of the Cancer Intervention and Surveillance Modeling Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (grant U01-CA152959) as part of the Cancer Intervention and Surveillance Modeling Network.	ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Bureau of Labor Statistics, 2013, CONS PRIC IND; Bureau of Labor Statistics, 2013, CURR EMPL STAT NAT; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; Freedman AN, 2009, J CLIN ONCOL, V27, P686, DOI 10.1200/JCO.2008.17.4797; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Goodwin JS, 2011, ARCH INTERN MED, V171, P1335, DOI 10.1001/archinternmed.2011.212; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; Lansdorp-Vogelaar I, 2009, CANCER-AM CANCER SOC, V115, P2410, DOI 10.1002/cncr.24256; Lansdorp-Vogelaar I, 2009, GASTROINTEST ENDOSC, V70, P96, DOI 10.1016/j.gie.2008.08.040; Leffler DA, 2010, ARCH INTERN MED, V170, P1752, DOI 10.1001/archinternmed.2010.373; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Lin OS, 2006, JAMA-J AM MED ASSOC, V295, P2357, DOI 10.1001/jama.295.20.2357; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Ness RM, 1999, AM J GASTROENTEROL, V94, P1650; Painter J, 1999, ENDOSCOPY, V31, P227, DOI 10.1055/s-1999-13673; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Rozen P, 2011, EUR J CANCER PREV, V20, P46, DOI 10.1097/CEJ.0b013e328341e309; Rutter CM, 2013, JNCI-J NATL CANCER I, V105, P1806, DOI 10.1093/jnci/djt299; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192; Shellnut JK, 2010, DIS COLON RECTUM, V53, P5, DOI 10.1007/DCR.0b013e3181bc01d1; Surveillance Epidemiology and End Results (SEER) Program, 2002, SEER STAT DAT INC SE; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Zauber AG, 2007, COST EFFECTIVENESS D; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	39	77	77	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11					750	+		10.7326/M13-2263	http://dx.doi.org/10.7326/M13-2263			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MT	24887616	Green Accepted			2022-12-24	WOS:000337348700002
J	Coombes, R				Coombes, Rebecca			Cannabis regulation: high time for change?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Coombes, R (corresponding author), BMJ, London, England.	rcoombes@bmj.com						ALICE RAP, 2014, 5 ALICE RAP; [Anonymous], TREATM EP DAT SETS T; [Anonymous], 2014, AMSTERDAM HERAL 0127; David Remnick, 2014, NEW YORKER; Drugscope, CANN LAWS; Transform, REG CANN PRACT GUID; Transform, 2013, UK SUPP CANN LAW REF; United Nations Office on Drugs and Crime, WORLD DRUG REP 2012; Vindenes V, 2013, FORENSIC SCI INT, V226, P197, DOI 10.1016/j.forsciint.2013.01.017	9	6	7	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2014	348								g3382	10.1136/bmj.g3382	http://dx.doi.org/10.1136/bmj.g3382			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZX	24850823				2022-12-24	WOS:000336429200004
J	Yeh, JM; Nohria, A; Diller, L				Yeh, Jennifer M.; Nohria, Anju; Diller, Lisa			Routine Echocardiography Screening for Asymptomatic Left Ventricular Dysfunction in Childhood Cancer Survivors: A Model-Based Estimation of the Clinical and Economic Effects	ANNALS OF INTERNAL MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; MEDICAL DECISION-MAKING; LONG-TERM SURVIVORS; 5-YEAR SURVIVORS; LATE MORTALITY; SYSTOLIC DYSFUNCTION; ADOLESCENT CANCER; ADULT SURVIVORS; UNITED-STATES; TASK-FORCE	Background: Childhood cancer survivors treated with cardiotoxic therapies are recommended to have routine cardiac assessment every 1 to 5 years, but the long-term benefits are uncertain. Objective: To estimate the cost-effectiveness of routine cardiac assessment to detect asymptomatic left ventricular dysfunction and of angiotensin-converting enzyme inhibitor and beta-blocker treatment to reduce congestive heart failure (CHF) incidence in childhood cancer survivors. Design: Simulation model. Data Sources: Literature, including data from the Childhood Cancer Survivor Study. Target Population: Childhood cancer survivors. Time Horizon: Lifetime. Perspective: Societal. Intervention: Interval-based echocardiography assessment every 1, 2, 5, or 10 years, with subsequent angiotensin-converting enzyme inhibitor or beta-blocker treatment for patients with positive test results. Outcome Measures: Lifetime risk for systolic CHF, lifetime costs, quality-adjusted life expectancy, and incremental cost-effectiveness ratios (ICERs). Results of Base-Case Analysis: The lifetime risk for systolic CHF among 5-year childhood cancer survivors aged 15 years was 18.8% without routine cardiac assessment (average age at onset, 58.8 years). Routine echocardiography reduced lifetime risk for CHF by 2.3% (with assessment every 10 years) to 8.7% (annual assessment). The ICER for assessment every 10 years was $111600 per quality-adjusted life-year (QALY) compared with no assessment. Assessment every 5 years had an ICER of $117900 per QALY, and ICERs for more frequent assessment exceeded $165000 per QALY. Results of Sensitivity Analysis: Results were sensitive to treatment effectiveness, absolute excess risk for CHF, and asymptomatic left ventricular dysfunction asymptomatic period. The probability that assessment every 10 or 5 years was preferred at a $100000-per-QALY threshold was 0.33 for the overall cohort. Limitation: Treatment effectiveness was based on adult data. Conclusion: Current recommendations for cardiac assessment may reduce CHF incidence, but less frequent assessment may be preferable.	Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard T.H. Chan School of Public Health	Yeh, JM (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA.	jyeh@hsph.harvard.edu	Nohria, Anju/AAD-4925-2022		National Cancer Institute [K07-CA143044]; NATIONAL CANCER INSTITUTE [K07CA143044] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Yeh was supported by the National Cancer Institute (grant K07-CA143044).	[Anonymous], 2013, TRUV HLTH AN; Armstrong GT, 2012, J CLIN ONCOL, V30, P2876, DOI 10.1200/JCO.2011.40.3584; BECK JR, 1983, MED DECIS MAKING, V3, P3, DOI 10.1177/0272989X8300300102; Bureau of Labor Statistics, 2012, OCC EMPL WAG; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; Centers for Disease Control and Prevention, 2009, CDCP SERIES, V20; Centers for Medicare and Medicaid Services, 2012, RES STAT DAT SYST; Children's Oncology Group, 2008, LONG TERM FOLL UP GU; de Moor JS, 2013, CANCER EPIDEM BIOMAR, V22, P561, DOI 10.1158/1055-9965.EPI-12-1356; Exner DV, 1999, J AM COLL CARDIOL, V33, P916, DOI 10.1016/S0735-1097(98)00675-5; Foerster Susan R, 2008, Paediatr Drugs, V10, P125, DOI 10.2165/00148581-200810020-00007; Gohler A, 2009, VALUE HEALTH, V12, P185, DOI 10.1111/j.1524-4733.2008.00425.x; Gold MR, 1996, COST EFFECTIVENESS H; Green DM, 1999, J CLIN ONCOL, V17, P3207, DOI 10.1200/JCO.1999.17.10.3207; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Heidenreich PA, 2004, J AM COLL CARDIOL, V43, P1019, DOI 10.1016/j.jacc.2003.10.043; Inskip PD, 2007, INT J CANCER, V121, P2233, DOI 10.1002/ijc.22827; Lawless SCW, 2007, PEDIATR BLOOD CANCER, V48, P333, DOI 10.1002/pbc.20723; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; Lipshultz SE, 2004, J CLIN ONCOL, V22, P769, DOI 10.1200/JCO.2004.12.937; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Lipshultz SE, 2013, CIRCULATION, V128, P1927, DOI 10.1161/CIR.0b013e3182a88099; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; MacArthur AC, 2007, PEDIATR BLOOD CANCER, V48, P460, DOI 10.1002/pbc.20922; Mant J, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13320; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Moller TR, 2001, J CLIN ONCOL, V19, P3173; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; National Heart Lung and Blood Institute, 2006, BLOOD; Neumann PJ, 2000, HEALTH AFFAIR, V19, P92, DOI 10.1377/hlthaff.19.2.92; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Shaddy RE, 2007, JAMA-J AM MED ASSOC, V298, P1171, DOI 10.1001/jama.298.10.1171; Shankar SM, 2008, PEDIATRICS, V121, pE387, DOI 10.1542/peds.2007-0575; Sieswerda E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008011.pub2; Silber JH, 2004, J CLIN ONCOL, V22, P820, DOI 10.1200/JCO.2004.06.022; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yeh JM, 2010, ANN INTERN MED, V152, P409, DOI 10.7326/0003-4819-152-7-201004060-00005; Yusuf S, 2000, NEW ENGL J MED, V342, P145	45	67	67	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					661	+		10.7326/M13-2266	http://dx.doi.org/10.7326/M13-2266			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842413	Green Accepted			2022-12-24	WOS:000337347100013
J	Treves, A; Bruskotter, J				Treves, Adrian; Bruskotter, Jeremy			Tolerance for Predatory Wildlife	SCIENCE			English	Editorial Material							CARNIVORE CONSERVATION; WOLVES		[Treves, Adrian] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Bruskotter, Jeremy] Ohio State Univ, Sch Environment & Nat Resources, Columbus, OH 43210 USA	University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; Ohio State University	Treves, A (corresponding author), Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA.	atreves@wisc.edu	Treves, Adrian/P-3707-2018; Bruskotter, Jeremy T/B-3240-2012	Treves, Adrian/0000-0002-3052-4708; Bruskotter, Jeremy T/0000-0002-1782-7835				[Anonymous], 2013, FED REG, V78, P35664; Bruskotter JT, 2014, CONSERV LETT, V7, P401, DOI 10.1111/conl.12081; Carter NH, 2012, ORYX, V46, P525, DOI 10.1017/S0030605312000245; Hazzah L, 2014, CONSERV BIOL, V28, P851, DOI 10.1111/cobi.12244; Hogberg J., 2014, THESIS U WISCONSIN; Karlsson J, 2011, ECOL SOC, V16; Liberg O., 2011, P ROY SOC LOND B BIO, V270, P91; Marchini S, 2012, BIOL CONSERV, V147, P213, DOI 10.1016/j.biocon.2012.01.002; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Slagle K, 2013, J WILDLIFE MANAGE, V77, P863, DOI 10.1002/jwmg.515; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; Zabel A, 2008, CONSERV BIOL, V22, P247, DOI 10.1111/j.1523-1739.2008.00898.x	14	169	179	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					475	476		10.1126/science.1252690	http://dx.doi.org/10.1126/science.1252690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786065				2022-12-24	WOS:000335157700026
J	Kanthor, R				Kanthor, Rebecca			DIAGNOSTICS Detection drives defence	NATURE			English	Editorial Material																		Collins DA, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-21; Li ZL, 2013, INT J CLIN EXP MED, V6, P693; Lin CY, 2013, J AM SOC NEPHROL, V24, P2002, DOI 10.1681/ASN.2013040332; Liong M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2745; Luo Y, 2014, ENVIRON SCI TECH LET, V1, P26, DOI 10.1021/ez400152e	5	8	9	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S14	S15		10.1038/509S14a	http://dx.doi.org/10.1038/509S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784424	Bronze			2022-12-24	WOS:000335199100008
J	Dyachuk, V; Furlan, A; Shahidi, MK; Giovenco, M; Kaukua, N; Konstantinidou, C; Pachnis, V; Memic, F; Marklund, U; Muller, T; Birchmeier, C; Fried, K; Ernfors, P; Adameyko, I				Dyachuk, Vyacheslav; Furlan, Alessandro; Shahidi, Maryam Khatibi; Giovenco, Marcela; Kaukua, Nina; Konstantinidou, Chrysoula; Pachnis, Vassilis; Memic, Fatima; Marklund, Ulrika; Mueller, Thomas; Birchmeier, Carmen; Fried, Kaj; Ernfors, Patrik; Adameyko, Igor			Parasympathetic neurons originate from nerve-associated peripheral glial progenitors	SCIENCE			English	Article							NEURAL CREST; DIFFERENTIATION; SPECIFICATION; MELANOCYTES; CELLS; ERBB2	The peripheral autonomic nervous system reaches far throughout the body and includes neurons of diverse functions, such as sympathetic and parasympathetic. We show that the parasympathetic system in mice-including trunk ganglia and the cranial ciliary, pterygopalatine, lingual, submandibular, and otic ganglia-arise from glial cells in nerves, not neural crest cells. The parasympathetic fate is induced in nerve-associated Schwann cell precursors at distal peripheral sites. We used multicolor Cre-reporter lineage tracing to show that most of these neurons arise from bi-potent progenitors that generate both glia and neurons. This nerve origin places cellular elements for generating parasympathetic neurons in diverse tissues and organs, which may enable wiring of the developing parasympathetic nervous system.	[Dyachuk, Vyacheslav; Furlan, Alessandro; Giovenco, Marcela; Memic, Fatima; Marklund, Ulrika; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, Stockholm, Sweden; [Dyachuk, Vyacheslav] Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Vladivostok 690022, Russia; [Shahidi, Maryam Khatibi] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Kaukua, Nina; Fried, Kaj] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Konstantinidou, Chrysoula; Pachnis, Vassilis] Med Res Council MRC Natl Inst Med Res, Div Mol Neurobiol, London, England; [Mueller, Thomas; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany; [Adameyko, Igor] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Karolinska Institutet; Karolinska Institutet; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Karolinska Institutet	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, Stockholm, Sweden.	patrik.ernfors@ki.se; igor.adameyko@ki.se	Dyachuk, Vyacheslav/U-9115-2019; Marklund, Ulrika/I-8814-2012; Furlan, Alessandro/AAM-4680-2021	Dyachuk, Vyacheslav/0000-0001-8100-7367; Marklund, Ulrika/0000-0003-1426-1271; Furlan, Alessandro/0000-0001-5149-6331; Adameyko, Igor/0000-0001-5471-0356; Pachnis, Vassilis/0000-0001-9733-7686; Muller, Thomas/0000-0001-8096-1853	Swedish Research Council for Medicine and Health; Swedish Cancer Society; Strategiska Forskningsomradena (SFO); Swedish Brain Foundation; Wallenberg Scholar; Soderberg Foundation; European Research Council (ERC) [232675]; Swedish Research Council; Bertil Hallsten Research Foundation; SFO on Stem Cells and Regenerative Medicine (StratRegen); Knut and Alice Wallenberg Foundation (CLICK); Swedish Dental Association; Stockholm County Council; Swedish National Graduate School in Odontological Science; German Science Foundation [SFB 665]; MRC [A2525RF00]; MRC National Institute of Medical Research; Knut and Alice Wallenberg Foundation [KAW2008.0123]; Swedish Research Council [521-2012-1676]; Swedish Doctoral Society [SLS330921, SLS331191]; Ruth and Richard Julin Foundation [36938]; Ake Wiberg Foundation [613512953]; Eva and Oscar Ahren Foundation; Medical Research Council [MC_U117537087] Funding Source: researchfish; MRC [MC_U117537087] Funding Source: UKRI	Swedish Research Council for Medicine and Health; Swedish Cancer Society(Swedish Cancer Society); Strategiska Forskningsomradena (SFO); Swedish Brain Foundation; Wallenberg Scholar; Soderberg Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Bertil Hallsten Research Foundation; SFO on Stem Cells and Regenerative Medicine (StratRegen); Knut and Alice Wallenberg Foundation (CLICK)(Knut & Alice Wallenberg Foundation); Swedish Dental Association; Stockholm County Council(Stockholm County Council); Swedish National Graduate School in Odontological Science; German Science Foundation(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC National Institute of Medical Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Doctoral Society; Ruth and Richard Julin Foundation; Ake Wiberg Foundation; Eva and Oscar Ahren Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Lubke for breeding Ret mice; J.-F. Brunet, M. Wegner, and F. Lallemend for generously providing Phox2b, Sox10, and 2H3 antibodies; H. Clevers for Confetti; H. Enomoto (RIKEN) for Ret <SUP>CFP</SUP> mice; and the CLICK Imaging Facility supported by the Wallenberg Foundation. This work was supported by the Swedish Research Council for Medicine and Health, the Swedish Cancer Society and Strategiska Forskningsomradena (SFO) grants, the Swedish Brain Foundation, Wallenberg Scholar, Soderberg Foundation, and European Research Council (ERC) advanced grant (232675) to P. E. I. A. and K. F. were supported by grants from Swedish Research Council, The Bertil Hallsten Research Foundation, SFO on Stem Cells and Regenerative Medicine (StratRegen), and the Knut and Alice Wallenberg Foundation (CLICK). N.K. and M. K. S. received support from the Swedish Dental Association and Stockholm County Council. M. K. S. also received support from Swedish National Graduate School in Odontological Science. C. B. was supported by a grant from German Science Foundation (SFB 665). V. P. was supported by MRC (grant-in-aid A2525RF00). C. K. is a recipient of a Ph.D. studentship from the MRC National Institute of Medical Research. U. M. was supported by the Knut and Alice Wallenberg Foundation (KAW2008.0123), Swedish Research Council (521-2012-1676), Swedish Doctoral Society (SLS330921 and SLS331191), Ruth and Richard Julin Foundation (36938), Ake Wiberg Foundation (613512953), and Eva and Oscar Ahren Foundation. In-house-generated plasmids and antibodies are freely available from the authors. Mouse strains Plp<SUP>CreERT2</SUP>, Ascl1<SUP>CreERT2</SUP>, R26R<SUP>YFP</SUP>, R26R<SUP>TOMATO</SUP>, and R26R<SUP>Confetti</SUP> are freely available from The Jacksons Laboratory (United States). Other strains will require materials transfer agreements (MTAs) of future users: Sox10<SUP>CreERT2</SUP> and Ascl1<SUP>NGN2</SUP>(MTA from MRC), ErbB3 KO (MTA from the Max Delbruck Center for Molecular Medicine), and Ret <SUP>CFP</SUP> (MTA from RIKEN). MTA for Ret <SUP>CFP</SUP> mice is attached with submission. The supplementary materials contain additional data.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; Enomoto H, 2000, DEVELOPMENT, V127, P4877; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Honore SM, 2003, DEV BIOL, V259, P502; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Le Douarin N, 1999, NEURAL CREST, Vxxiii; Lee VM, 2003, DEV BIOL, V263, P176, DOI 10.1016/j.ydbio.2003.07.004; Muller F, 2002, DEVELOPMENT, V129, P5707, DOI 10.1242/dev.00165; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Young HM, 2011, AUTON NEUROSCI-BASIC, V165, P10, DOI 10.1016/j.autneu.2010.03.002	20	134	134	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					82	87		10.1126/science.1253281	http://dx.doi.org/10.1126/science.1253281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24925909				2022-12-24	WOS:000338284400055
J	Espinosa-Medina, I; Outin, E; Picard, CA; Chettouh, Z; Dymecki, S; Consalez, GG; Coppola, E; Brunet, JF				Espinosa-Medina, I.; Outin, E.; Picard, C. A.; Chettouh, Z.; Dymecki, S.; Consalez, G. G.; Coppola, E.; Brunet, J. -F.			Parasympathetic ganglia derive from Schwann cell precursors	SCIENCE			English	Article							STEM-CELLS; NEUROGENIN 2; MOUSE LINE; EXPRESSION; DIFFERENTIATION; PHOX2B; ORIGIN	Neural crest cells migrate extensively and give rise to most of the peripheral nervous system, including sympathetic, parasympathetic, enteric, and dorsal root ganglia. We studied how parasympathetic ganglia form close to visceral organs and what their precursors are. We find that many cranial nerve-associated crest cells coexpress the pan-autonomic determinant Paired-like homeodomain 2b (Phox2b) together with markers of Schwann cell precursors. Some give rise to Schwann cells after down-regulation of PHOX2b. Others form parasympathetic ganglia after being guided to the site of ganglion formation by the nerves that carry preganglionic fibers, a parsimonious way of wiring the pathway. Thus, cranial Schwann cell precursors are the source of parasympathetic neurons during normal development.	[Espinosa-Medina, I.; Outin, E.; Picard, C. A.; Chettouh, Z.; Coppola, E.; Brunet, J. -F.] Inserm U1024, Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Espinosa-Medina, I.; Outin, E.; Picard, C. A.; Chettouh, Z.; Coppola, E.; Brunet, J. -F.] CNRS UMR 8197, F-75005 Paris, France; [Dymecki, S.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Consalez, G. G.] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Harvard University; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Brunet, JF (corresponding author), Inserm U1024, Ecole Normale Super, Inst Biol, F-75005 Paris, France.	jfbrunet@biologie.ens.fr	Consalez, Giacomo/AAA-2146-2019	Consalez, Giacomo/0000-0003-4594-6273; Brunet, Jean-Francois/0000-0002-1985-6103	Agence Nationale de la Recherche [ANR-12-BSV4-0007-01]; Investissements d'Avenir [ANR-10-LABX-54 MEMO LIFE, ANR-11-IDEX-0001-02]; Federation pour la Recherche sur le Cerveau; NIH [R01 DK067826, R21 DA023643, P01 HD036379]; Fondazione CARIPLO, Milan, Italy; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023643] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Investissements d'Avenir(French National Research Agency (ANR)); Federation pour la Recherche sur le Cerveau; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione CARIPLO, Milan, Italy(Fondazione Cariplo); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Lazdunski for the ASIC2a<SUP>G430F</SUP> clone; C. Birchmeier, T. Muller, and M. Wegner for antibodies; M.-C. Tiveron for the original discovery of the limb ganglion; V. Michel for preliminary experiments; the imaging facilities of IBENS and Institut de la Vision, B. Mathieu, and D. Godefroy for technical assistance; and C. Goridis for helpful discussions. This work was supported by the Agence Nationale de la Recherche (ANR-12-BSV4-0007-01) and Investissements d'Avenir (ANR-10-LABX-54 MEMO LIFE and ANR-11-IDEX-0001-02 PSL* Research University) (to J.-F.B.); Federation pour la Recherche sur le Cerveau (to Institut de la Vision); and NIH grants R01 DK067826, R21 DA023643, and P01 HD036379 (to S.D.). G.G.C. was funded by the Fondazione CARIPLO, Milan, Italy, and I.-E.M. received a Ph.D. studentship.	Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Al J, 2007, NEUROSCIENCE, V149, P845, DOI 10.1016/j.neuroscience.2007.07.062; Blessing W, 1997, LOWER BRAINSTEM BODI; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Coppola E, 2010, P NATL ACAD SCI USA, V107, P2066, DOI 10.1073/pnas.0910213107; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Florio M, 2012, DEVELOPMENT, V139, P2308, DOI 10.1242/dev.075861; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; FURBER S, 1987, J NEUROSCI, V7, P1816; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hirsch MR, 2013, GENESIS, V51, P506, DOI 10.1002/dvg.22393; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Le Douarin NM, 1999, NEURAL CREST, V2; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Takahashi Y, 2013, SCIENCE, V341, P860, DOI 10.1126/science.1230717; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5	26	127	128	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					87	90		10.1126/science.1253286	http://dx.doi.org/10.1126/science.1253286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24925912				2022-12-24	WOS:000338284400056
J	Willis, NA; Chandramouly, G; Huang, B; Kwok, A; Follonier, C; Deng, CX; Scully, R				Willis, Nicholas A.; Chandramouly, Gurushankar; Huang, Bin; Kwok, Amy; Follonier, Cindy; Deng, Chuxia; Scully, Ralph			BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks	NATURE			English	Article							STRAND BREAK REPAIR; EPSTEIN-BARR-VIRUS; SISTER-CHROMATID RECOMBINATION; TRACT GENE CONVERSION; DNA-DAMAGE RESPONSE; ESCHERICHIA-COLI; IN-VITRO; CELLS; PROTEIN; ORIP	Replication fork stalling can promote genomic instability, predisposing to cancer and other diseases(1-3). Stalled replication forks may be processed by sister chromatid recombination (SCR), generating error-free or error-prone homologous recombination (HR) outcomes(4-8). In mammalian cells, a long-standing hypothesis proposes that the major hereditary breast/ovarian cancer predisposition gene products, BRCA1 and BRCA2, control HR/SCR at stalled replication forks(9). Although BRCA1 and BRCA2 affect replication fork processing(10-12), direct evidence that BRCA gene products regulate homologous recombination at stalled chromosomal replication forks is lacking, due to a dearth of tools for studying this process. Here we report that the Escherichia coli Tus/Ter complex(13-16) can be engineered to induce site-specific replication fork stalling and chromosomal HR/SCR in mouse cells. Tus/Ter-induced homologous recombination entails processing of bidirectionally arrested forks. We find that the Brca1 carboxy (C)-terminal tandem BRCT repeat and regions of Brca1 encoded by exon 11-two Brca1 elements implicated in tumour suppression-control Tus/Ter-induced homologous recombination. Inactivation of either Brca1 or Brca2 increases the absolute frequency of 'long-tract' gene conversions at Tus/Ter-stalled forks, an outcome not observed in response to a site-specific endonuclease-mediated chromosomal double-strand break. Therefore, homologous recombination at stalled forks is regulated differently from homologous recombination at double-strand breaks arising independently of a replication fork. We propose that aberrant long-tract homologous recombination at stalled replication forks contributes to genomic instability and breast/ovarian cancer predisposition in BRCA mutant cells.	[Willis, Nicholas A.; Chandramouly, Gurushankar; Huang, Bin; Kwok, Amy; Scully, Ralph] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Willis, Nicholas A.; Chandramouly, Gurushankar; Huang, Bin; Kwok, Amy; Scully, Ralph] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Follonier, Cindy] Princeton Univ, Lewis Thomas Lab 101, Princeton, NJ 08544 USA; [Deng, Chuxia] NIDDK, NIH, Bethesda, MD 20814 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Princeton University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Scully, R (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	rscully@bidmc.harvard.edu	Scully, Ralph/F-5008-2013; deng, chuxia/N-6713-2016		NIH [R01CA095175, R01GM073894, R21CA144017, R37GM26938]; NIH/NCI [5T32CA081156]; ACS [PF-12-248-01-DMC]; NATIONAL CANCER INSTITUTE [R01CA095175, R21CA144017, T32CA081156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056011, ZIADK056009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026938, R01GM073894, R37GM026938, R01GM043265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Michel for reagents and advice; D. Livingston, K. Marians, J. Walter, I. Hickson, S. Powell, V. Zakian and members of the Scully laboratory for helpful discussions; I. Hickson and S. Powell for sharing their unpublished data on Tus/Ter replication blocks in eukaryotes; R. Baer for antibodies and A. Ashworth for Brca1 conditional ES cell line 11C0/47T. This work was supported by NIH grants R01CA095175, R01GM073894 and R21CA144017 (to R.S.). N.A.W. was supported by an NIH/NCI postdoctoral fellowship (5T32CA081156) and an ACS postdoctoral research fellowship (PF-12-248-01-DMC). C.F. was supported by NIH grant R37GM26938 (to V.A.Z.).	AMIN AA, 1992, J BIOL CHEM, V267, P18612; Bidnenko V, 2002, EMBO J, V21, P3898, DOI 10.1093/emboj/cdf369; Carr AM, 2013, J MOL BIOL, V425, P4733, DOI 10.1016/j.jmb.2013.04.023; Castor D, 2013, MOL CELL, V52, P221, DOI 10.1016/j.molcel.2013.08.036; Chandramouly G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3404; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Follonier C, 2014, METHODS MOL BIOL, V1094, P209, DOI 10.1007/978-1-62703-706-8_16; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; Garner E, 2013, CELL REP, V5, P207, DOI 10.1016/j.celrep.2013.08.041; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Huber LJ, 2001, MOL CELL BIOL, V21, P4005, DOI 10.1128/MCB.21.12.4005-4015.2001; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KIRCHMAIER AL, 1995, J VIROL, V69, P1280, DOI 10.1128/JVI.69.2.1280-1283.1995; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nagaraju G, 2006, MOL CELL BIOL, V26, P8075, DOI 10.1128/MCB.01235-06; Pathania S, 2011, MOL CELL, V44, P235, DOI 10.1016/j.molcel.2011.09.002; Puget N, 2005, DNA REPAIR, V4, P149, DOI 10.1016/j.dnarep.2004.08.010; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Saini N, 2013, NATURE, V502, P389, DOI 10.1038/nature12584; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	33	100	102	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					556	+		10.1038/nature13295	http://dx.doi.org/10.1038/nature13295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24776801	Green Accepted, Green Submitted			2022-12-24	WOS:000337806300051
J	Fell, GL; Robinson, KC; Mao, J; Woolf, CJ; Fisher, DE				Fell, Gillian L.; Robinson, Kathleen C.; Mao, Jianren; Woolf, Clifford J.; Fisher, David E.			Skin beta-Endorphin Mediates Addiction to UV Light	CELL			English	Article							FREQUENT INDOOR TANNERS; ULTRAVIOLET-RADIATION; ENDOGENOUS OPIOIDS; NUCLEUS-ACCUMBENS; PLASMA-LEVELS; SUN EXPOSURE; MICE; WITHDRAWAL; INDUCTION; EXERCISE	UV light is an established carcinogen, yet evidence suggests that UV-seeking behavior has addictive features. Following UV exposure, epidermal keratinocytes synthesize proopiomelanocortin (POMC) that is processed to melanocyte-stimulating hormone, inducing tanning. We show that, in rodents, another POMC-derived peptide, beta-endorphin, is coordinately synthesized in skin, elevating plasma levels after low-dose UV. Increases in pain-related thresholds are observed and reversed by pharmacologic opioid antagonism. Opioid blockade also elicits withdrawal signs after chronic UV exposure. This effect was sufficient to guide operant behavioral choices to avoidance of opioid withdrawal (conditioned place aversion). These UV-induced nociceptive and behavioral effects were absent in beta-endorphin knockout mice and in mice lacking p53-mediated POMC induction in epidermal keratinocytes. Although primordial UV addiction, mediated by the hedonic action of beta-endorphin and anhedonic effects of withdrawal, may theoretically have enhanced evolutionary vitamin D biosynthesis, it now may contribute to the relentless rise in skin cancer incidence in humans.	[Fell, Gillian L.; Robinson, Kathleen C.; Fisher, David E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr,Dept Dermatol, Boston, MA 02114 USA; [Fell, Gillian L.; Robinson, Kathleen C.; Fisher, David E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MGH Canc Ctr, Boston, MA 02114 USA; [Mao, Jianren] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MGH Ctr Translat Pain Res,Dept Anesthesia Critica, Boston, MA 02114 USA; [Woolf, Clifford J.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02114 USA; [Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Fisher, DE (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr,Dept Dermatol, Boston, MA 02114 USA.	dfisher3@partners.org	Woolf, Clifford/A-9784-2010; Fisher, David/AAH-2878-2019		NIH [R01 AR043369-16, P01CA163222, R01 CA150226-03]; Melanoma Research Alliance; US-Israel Binational Science Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE [P01CA163222, R01CA150226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS039518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge Dr. Charles Berde, Dr. Jeff Mogil, Ms. Vivien Igras, Mr. John Dellorusso, Ms. Teri Herbert, Ms. Leeza Hargreaves, Dr. Roydon Price, and Dr. Grewo Lim for productive discussions during the early phases of this project and for technical assistance with the experiments and manuscript. The authors thank Dr. Mary Jeanne Kreek for useful discussions. The authors also acknowledge Douglas Hayden from the MGH Biostatistics Center for consultation regarding the statistical analysis. This work was supported by NIH under award numbers R01 AR043369-16, P01CA163222, and R01 CA150226-03 and by grants from the Melanoma Research Alliance, the US-Israel Binational Science Foundation, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (D.E.F.).	ARAVICH PF, 1993, BRAIN RES, V622, P1, DOI 10.1016/0006-8993(93)90794-N; Bender T, 2007, EUR J APPL PHYSIOL, V100, P371, DOI 10.1007/s00421-007-0469-9; BILBEY DLJ, 1960, BRIT J PHARM CHEMOTH, V15, P540, DOI 10.1111/j.1476-5381.1960.tb00277.x; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Dassule HR, 2000, DEVELOPMENT, V127, P4775; de Gruijl FR, 1999, EUR J CANCER, V35, P2003, DOI 10.1016/S0959-8049(99)00283-X; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Fassoulaki A, 2007, ANESTH ANALG, V104, P312, DOI 10.1213/01.ane.0000250911.43942.4e; Feldman SR, 2004, J AM ACAD DERMATOL, V51, P45, DOI 10.1016/j.jaad.2004.01.053; Gambichler T, 2002, BRIT J DERMATOL, V147, P1207, DOI 10.1046/j.1365-2133.2002.04859.x; Gandini S, 2011, PROG BIOPHYS MOL BIO, V107, P362, DOI 10.1016/j.pbiomolbio.2011.09.011; Gianoulakis C, 1996, ALCOHOL, V13, P19, DOI 10.1016/0741-8329(95)02035-7; Gianoulakis C, 2009, CURR TOP MED CHEM, V9, P999, DOI 10.2174/156802609789630956; Glass MJ, 2008, EXP NEUROL, V213, P57, DOI 10.1016/j.expneurol.2008.04.045; Harrington CR, 2011, CLIN EXP DERMATOL, V36, P33, DOI 10.1111/j.1365-2230.2010.03882.x; Harrington CR, 2012, ADDICT BIOL, V17, P680, DOI 10.1111/j.1369-1600.2010.00312.x; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; KASTIN AJ, 1979, PHARMACOL BIOCHEM BE, V11, P713, DOI 10.1016/0091-3057(79)90268-5; Kaur M, 2006, J AM ACAD DERMATOL, V54, P919, DOI 10.1016/j.jaad.2006.01.062; Kaur M, 2006, J AM ACAD DERMATOL, V54, P709, DOI 10.1016/j.jaad.2005.11.1059; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Kourosh AS, 2010, AM J DRUG ALCOHOL AB, V36, P284, DOI 10.3109/00952990.2010.491883; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Leppaluoto J, 2008, SCAND J CLIN LAB INV, V68, P145, DOI 10.1080/00365510701516350; LEVINS PC, 1983, LANCET, V2, P166; Mao J, 2000, NEUROSCI LETT, V280, P13, DOI 10.1016/S0304-3940(99)00998-2; Marino S, 2000, GENE DEV, V14, P994; MCMURRAY RG, 1990, CHRONOBIOL INT, V7, P135, DOI 10.3109/07420529009056965; Mogil JS, 1999, PAIN, V80, P83, DOI 10.1016/S0304-3959(98)00196-1; Mosher CE, 2010, ARCH DERMATOL, V146, P412, DOI 10.1001/archdermatol.2009.385; Nguyen AT, 2012, EUR J PHARMACOL, V686, P50, DOI 10.1016/j.ejphar.2012.04.040; Olive MF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0002.2001; Olson VG, 2006, SYNAPSE, V60, P553, DOI 10.1002/syn.20328; PETRAGLIA F, 1990, J ENDOCRINOL INVEST, V13, P19, DOI 10.1007/BF03348571; Racz I, 2008, BIOL PSYCHIAT, V64, P989, DOI 10.1016/j.biopsych.2008.05.008; Robinson JK, 1997, J AM ACAD DERMATOL, V37, P179, DOI 10.1016/S0190-9622(97)80122-3; Roma PG, 2005, PHARMACOL BIOCHEM BE, V82, P163, DOI 10.1016/j.pbb.2005.08.004; Roth-Deri I, 2003, J NEUROCHEM, V84, P930, DOI 10.1046/j.1471-4159.2003.01584.x; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; SCHOFFELMEER ANM, 1991, J PHARMACOL EXP THER, V258, P237; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Technology Planning and Management Corporation, 2000, REP CARC BACKGR DOC; Trigo JM, 2009, NEUROPHARMACOLOGY, V56, P1147, DOI 10.1016/j.neuropharm.2009.03.013; TSENG LF, 1976, NATURE, V263, P239, DOI 10.1038/263239a0; US-EPA, 1994, FED EXP ULTR IND WHA; Warthan MM, 2005, ARCH DERMATOL, V141, P963, DOI 10.1001/archderm.141.8.963; Weitemier AZ, 2009, EUR J NEUROSCI, V29, P1015, DOI 10.1111/j.1460-9568.2009.06652.x; Welch CC, 1996, BRAIN RES, V721, P126, DOI 10.1016/0006-8993(96)00151-5; Wintzen M, 2001, PHOTODERMATOL PHOTO, V17, P256, DOI 10.1034/j.1600-0781.2001.170602.x; Zeller S, 2006, J AM ACAD DERMATOL, V54, P589, DOI 10.1016/j.jaad.2005.12.038	54	152	156	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1527	1534		10.1016/j.cell.2014.04.032	http://dx.doi.org/10.1016/j.cell.2014.04.032			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949966	Green Accepted, Bronze			2022-12-24	WOS:000340941900009
J	Jousimo, J; Tack, AJM; Ovaskainen, O; Mononen, T; Susi, H; Tollenaere, C; Laine, AL				Jousimo, Jussi; Tack, Ayco J. M.; Ovaskainen, Otso; Mononen, Tommi; Susi, Hanna; Tollenaere, Charlotte; Laine, Anna-Liisa			DISEASE ECOLOGY Ecological and evolutionary effects of fragmentation on infectious disease dynamics	SCIENCE			English	Article							PLANT-PATHOGEN METAPOPULATION; LOCAL ADAPTATION; HOST; POPULATION; COEVOLUTION; RESISTANCE; DISPERSAL; SCALE; SIZE	Ecological theory predicts that disease incidence increases with increasing density of host networks, yet evolutionary theory suggests that host resistance increases accordingly. To test the combined effects of ecological and evolutionary forces on host-pathogen systems, we analyzed the spatiotemporal dynamics of a plant (Plantago lanceolata)-fungal pathogen (Podosphaera plantaginis) relationship for 12 years in over 4000 host populations. Disease prevalence at the metapopulation level was low, with high annual pathogen extinction rates balanced by frequent (re-) colonizations. Highly connected host populations experienced less pathogen colonization and higher pathogen extinction rates than expected; a laboratory assay confirmed that this phenomenon was caused by higher levels of disease resistance in highly connected host populations.	[Jousimo, Jussi; Tack, Ayco J. M.; Ovaskainen, Otso; Mononen, Tommi; Susi, Hanna; Tollenaere, Charlotte; Laine, Anna-Liisa] Univ Helsinki, Metapopulat Res Grp, Dept Biosci, FI-00014 Helsinki, Finland; [Mononen, Tommi] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, FI-00076 Aalto, Finland	University of Helsinki; Aalto University	Laine, AL (corresponding author), Univ Helsinki, Metapopulat Res Grp, Dept Biosci, Post Off Box 65,Viikinkaari 1, FI-00014 Helsinki, Finland.	anna-liisa.laine@helsinki.fi	Tack, Ayco/B-7120-2017; Ovaskainen, Otso/AGN-4838-2022; Tollenaere, Charlotte/ABB-6175-2020; Ovaskainen, Otso/D-9119-2012; Laine, Anna-Liisa/B-1398-2016	Tack, Ayco/0000-0002-3550-1070; Ovaskainen, Otso/0000-0001-9750-4421; Tollenaere, Charlotte/0000-0003-2045-2824; Ovaskainen, Otso/0000-0001-9750-4421; Laine, Anna-Liisa/0000-0002-0703-5850; Mononen, Tommi/0000-0002-3603-0813	Academy of Finland [250444, 136393, 133499]; European Research Council (Independent Starting grant PATHEVOL) [281517]	Academy of Finland(Academy of Finland); European Research Council (Independent Starting grant PATHEVOL)	We acknowledge I. Hanski, S. Ojanen, and M. Nieminen for organizing the large-scale field surveys in land and E. Meyke for managing the database. The numerous biology students who have participated in years 2001 and 2012 are gratefully acknowledged for their hard work in the field. H. Hohti and the Finnish Meteorological Institute kindly provided the rainfall radar images. I. Hanski, J.Antonovics, and R. Penczykowski provided valuable comments on the manuscript. This work was supported by funding from the Academy of Finland (grant nos. 250444, 136393, and 133499) and the European Research Council (Independent Starting grant PATHEVOL; 281517) to A.L.L. The data presented in this paper are deposited in Dryad (10.5061/dryad.vf210).	Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Antonovics J., 2004, ECOLOGY GENETICS EVO, P471, DOI DOI 10.1016/B978-012323448-3/50021-0; AYLOR DE, 1990, ANNU REV PHYTOPATHOL, V28, P73, DOI 10.1146/annurev.py.28.090190.000445; Borer ET, 2010, ECOL LETT, V13, P810, DOI 10.1111/j.1461-0248.2010.01475.x; Bradley DJ, 2008, ECOL LETT, V11, P461, DOI 10.1111/j.1461-0248.2008.01162.x; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Carlsson-Graner U, 2002, OIKOS, V97, P97, DOI 10.1034/j.1600-0706.2002.970110.x; Cressey D, 2013, NATURE, V493, P587, DOI 10.1038/493587a; Decaestecker E, 2013, ECOL LETT, V16, P1455, DOI 10.1111/ele.12186; Duffy MA, 2012, SCIENCE, V335, P1636, DOI 10.1126/science.1215429; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gandon S, 2009, AM NAT, V173, P212, DOI 10.1086/593706; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; Hanski I., 1999, METAPOPULATION ECOLO; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Laine AL, 2006, P ROY SOC B-BIOL SCI, V273, P267, DOI 10.1098/rspb.2005.3303; Laine AL, 2006, J ECOL, V94, P217, DOI 10.1111/j.1365-2745.2005.01075.x; Laine AL, 2004, J ECOL, V92, P990, DOI 10.1111/j.0022-0477.2004.00925.x; Laine AL, 2007, J EVOLUTION BIOL, V20, P1665, DOI 10.1111/j.1420-9101.2007.01359.x; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Ovaskainen O, 2006, ECOLOGY, V87, P880, DOI 10.1890/0012-9658(2006)87[880:IESFED]2.0.CO;2; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Smith DL, 2011, J ECOL, V99, P634, DOI 10.1111/j.1365-2745.2010.01788.x; Tack AJM, 2014, NEW PHYTOL, V202, P297, DOI 10.1111/nph.12646; Thompson J. N., 2005, INTERSPEC INTERACT; Thrall PH, 2012, ECOL LETT, V15, P425, DOI 10.1111/j.1461-0248.2012.01749.x; Thrall PH, 2002, PLANT PATHOL, V51, P169, DOI 10.1046/j.1365-3059.2002.00683.x; THRALL PH, 1995, CAN J BOT, V73, pS1249, DOI 10.1139/b95-385; Tollenaere C, 2013, J EVOLUTION BIOL, V26, P1716, DOI 10.1111/jeb.12169; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237	31	123	124	1	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1289	1293		10.1126/science.1253621	http://dx.doi.org/10.1126/science.1253621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926021				2022-12-24	WOS:000337077500042
J	Martin, WF; Sousa, FL; Lane, N				Martin, William F.; Sousa, Filipa L.; Lane, Nick			EVOLUTION Energy at life's origin	SCIENCE			English	Editorial Material							CARBON; FIXATION; DEEP; ACID		[Martin, William F.; Sousa, Filipa L.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany; [Lane, Nick] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England	Heinrich Heine University Dusseldorf; University of London; University College London	Martin, WF (corresponding author), Univ Dusseldorf, Inst Mol Evolut, Univ Str 1, D-40225 Dusseldorf, Germany.	bill@hhu.de	Sousa, Filipa L./H-6192-2012; Martin, William F./O-5446-2015; Sousa, Filipa/ACC-2848-2022	Sousa, Filipa L./0000-0002-4075-1701; Martin, William F./0000-0003-1478-6449; Sousa, Filipa/0000-0002-4084-1942; Lane, Nick/0000-0002-5433-3973				Arndt NT, 2012, ANNU REV EARTH PL SC, V40, P521, DOI 10.1146/annurev-earth-042711-105316; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; DECKER K, 1970, ANGEW CHEM INT EDIT, V9, P138, DOI 10.1002/anie.197001381; ECK RV, 1966, SCIENCE, V152, P363, DOI 10.1126/science.152.3720.363; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; Lane N, 2012, CELL, V151, P1406, DOI 10.1016/j.cell.2012.11.050; Mayer F, 2014, FEMS MICROBIOL REV, V38, P449, DOI 10.1111/1574-6976.12043; McCollom TM, 2013, ELEMENTS, V9, P129, DOI 10.2113/gselements.9.2.129; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Schrenk MO, 2013, REV MINERAL GEOCHEM, V75, P575, DOI 10.2138/rmg.2013.75.18	15	81	84	2	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1092	1093		10.1126/science.1251653	http://dx.doi.org/10.1126/science.1251653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904143				2022-12-24	WOS:000336791200024
J	Finkelstein, Y; Macdonald, EM; Li, P; Hutson, JR; Juurlink, DN				Finkelstein, Yaron; Macdonald, Erin M.; Li, Ping; Hutson, Janine R.; Juurlink, David N.			Recurrence and Mortality Following Severe Cutaneous Adverse Reactions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS		[Finkelstein, Yaron; Hutson, Janine R.] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Macdonald, Erin M.; Li, Ping] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Finkelstein, Y (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	yaron.finkelstein@sickkids.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Finkelstein Y, 2011, PEDIATRICS, V128, P723, DOI 10.1542/peds.2010-3322; Mockenhaupt M, 2011, EXPERT REV CLIN IMMU, V7, P803, DOI [10.1586/eci.11.66, 10.1586/ECI.11.66]; Papay J, 2012, PHARMACOEPIDEM DR S, V21, P289, DOI 10.1002/pds.2276; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Phillips EJ, 2011, J ALLERGY CLIN IMMUN, V127, pS60, DOI 10.1016/j.jaci.2010.11.046	6	36	36	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2231	2232		10.1001/jama.2014.839	http://dx.doi.org/10.1001/jama.2014.839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893093				2022-12-24	WOS:000336668400027
J	Frisch, S				Frisch, Suzy			Going hungry in America	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												suzyfrisch@yahoo.com						Bartlett S, 2013, HEALTHY INCENTIVES P; Beatty T, 2013, SUPPLEMENTAL NUTRITI; Gregory C, 2013, ECONOMIC RESEARCH RE; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; US Department of Agriculture Food and Nutrition Service Office of Research and Analysis, 2012, BUILDING A HEALTHY A; USDA, 2013, SUPPLEMENTAL NUTRITI	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2014	348								g3548	10.1136/bmj.g3548	http://dx.doi.org/10.1136/bmj.g3548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EO	24879820				2022-12-24	WOS:000336742800003
J	Flower, TP; Gribble, M; Ridley, AR				Flower, Tom P.; Gribble, Matthew; Ridley, Amanda R.			Deception by Flexible Alarm Mimicry in an African Bird	SCIENCE			English	Article							SIGNALS; SONGBIRDS; EVOLUTION; HANDICAP	Deception is common in nature, but victims of deception discriminate against and ultimately ignore deceptive signals when they are produced too frequently. Flexible variation of signals could allow evasion of such constraints. Fork-tailed drongos (Dicrurus adsimilis) use false alarm calls to scare other species away from food that they then steal. We show that drongos mimic the alarms of targeted species. Further, target species reduce their response to false alarm calls when they are repeated. However, the fear response is maintained when the call is varied. Drongos exploit this propensity by changing their alarm-call type when making repeated theft attempts on a particular species. Our results show that drongos can evade the frequency-dependent constraints that typically limit deception payoffs through flexible variation of their alarm calls.	[Flower, Tom P.; Ridley, Amanda R.] Univ Cape Town, Percy FitzPatrick Inst, Dept Sci & Technol, Natl Res Fdn Ctr Excellence, ZA-7701 Rondebosch, South Africa; [Flower, Tom P.; Gribble, Matthew] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Ridley, Amanda R.] Univ Western Australia, Sch Anim Biol M092, Ctr Evolutionary Biol, Crawley, WA 6009, Australia	National Research Foundation - South Africa; University of Cape Town; University of Cambridge; University of Western Australia	Flower, TP (corresponding author), Univ Cape Town, Percy FitzPatrick Inst, Dept Sci & Technol, Natl Res Fdn Ctr Excellence, ZA-7701 Rondebosch, South Africa.	thomas.flower@uct.ac.za	Ridley, Amanda/D-2636-2011	Ridley, Amanda/0000-0001-5886-0992; Flower, Thomas/0000-0003-0531-8010	Natural Environment Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Kalahari Research Trust, T. H. Clutton-Brock, and M. Manser kindly provided study site access. Northern Cape Conservation provided research permission (FAUNA 270/2008), and the University of Cape Town provided ethical permission (2010/V20/TF). We thank N. Davies for supervision and M. Nelson-Flower, A. Thornton, R. Sutcliffe, J. Samson, and three anonymous reviewers for their help and comments. Work was funded by a Natural Environment Research Council grant awarded to T. P. F. Data available from the Dryad Digital Repository (10.5061/dryad.f60j5).	Broom M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1560; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Cheney D., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; CHENEY DL, 1988, ANIM BEHAV, V36, P477, DOI 10.1016/S0003-3472(88)80018-6; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Dong S, 2009, NEUROBIOL LEARN MEM, V92, P183, DOI 10.1016/j.nlm.2008.09.009; Fisher R.A., 1930, GENETICAL THEORY NAT; Flower T, 2011, P ROY SOC B-BIOL SCI, V278, P1548, DOI 10.1098/rspb.2010.1932; Flower TP, 2013, J ANIM ECOL, V82, P245, DOI 10.1111/j.1365-2656.2012.02026.x; Fortune ES, 2011, SCIENCE, V334, P666, DOI 10.1126/science.1209867; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; JACKSON RR, 1993, BEHAVIOUR, V127, P21, DOI 10.1163/156853993X00407; JOHNSTONE RA, 1993, ANIM BEHAV, V46, P759, DOI 10.1006/anbe.1993.1253; Kelley LA, 2008, ANIM BEHAV, V76, P521, DOI 10.1016/j.anbehav.2008.04.012; Langmore NE, 2008, EVOLUTION, V62, P1689, DOI 10.1111/j.1558-5646.2008.00405.x; Magrath RD, 2009, BEHAV ECOL, V20, P745, DOI 10.1093/beheco/arp055; Mitchell RW, 1986, DECEPTION PERSPECTIV; MUNN CA, 1986, NATURE, V319, P143, DOI 10.1038/319143a0; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Radford AN, 2011, EVOLUTION, V65, P900, DOI 10.1111/j.1558-5646.2010.01180.x; Ridley AR, 2007, BEHAV ECOL, V18, P324, DOI 10.1093/beheco/arl092; SHEPPARD PM, 1959, COLD SPRING HARB SYM, V24, P131, DOI 10.1101/SQB.1959.024.01.013; Thorogood R, 2012, SCIENCE, V337, P578, DOI 10.1126/science.1220759; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	27	67	68	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					513	516		10.1126/science.1249723	http://dx.doi.org/10.1126/science.1249723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786078				2022-12-24	WOS:000335157700042
J	Morell, V				Morell, Virginia			When the bat sings	SCIENCE			English	Editorial Material																			0	6	6	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1334	1337		10.1126/science.344.6190.1334	http://dx.doi.org/10.1126/science.344.6190.1334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948718				2022-12-24	WOS:000337531700015
J	Gornall, J				Gornall, Jonathan			ALCOHOL World Cup 2014: festival of football or alcohol?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						All Party Parliamentary Beer Group, REG ALL PART GROUPS; [Anonymous], 2010, DUTCH NEWS      0717; [Anonymous], 2009, REUTERS; Brown L, 2013, MORNING ADVERTI 1220; Charles G., 2011, MARKETING; Clarke Miles, 2010, COMMUNICATION; Conn D., 2013, GUARDIAN; Costa B., 2014, WALL STREET J; Crumley B., 1997, ADVERTISING AGE; Fifa, 2004, SAF GUID; Foottit L., 2009, MORNING ADVERTI 1208; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7646; Hogan T., 2013, IRISH INDEPENDE 0327; Home Office, 2014, WORLD CUP LIC HOURS; Joint Committee on Transport and Communications, 2013, REP SPONS SPORTS ALC; Joseph S., 2014, MARKETING WEEK; Kelso Paul, 2009, TELEGRAPH; Quigg Z, 2012, EUR J PUBLIC HLTH; Rigaud A, 2004, GLOBE, V1, P1; Simoes C, 2014, BLOOMBERG; South African Sport and Recreation Department, 2013, 2010 FIF WORLD CUP C	21	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2014	348								g3772	10.1136/bmj.g3772	http://dx.doi.org/10.1136/bmj.g3772			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1GY	24916959				2022-12-24	WOS:000337405200009
J	May, M				May, Mike			ATTACKING AN EPIDEMIC	NATURE			English	Editorial Material																			0	26	28	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S50	S51		10.1038/509S50a	http://dx.doi.org/10.1038/509S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870819	Bronze			2022-12-24	WOS:000336457100002
J	Aveyard, P; Lindson-Hawley, N; Hastings, G; de Andrade, M				Aveyard, Paul; Lindson-Hawley, Nicola; Hastings, Gerard; de Andrade, Marisa			Should smokers be advised to cut down as well as quit?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NICOTINE REPLACEMENT; SMOKING REDUCTION; CESSATION; CIGARETTES		[Aveyard, Paul; Lindson-Hawley, Nicola] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Hastings, Gerard; de Andrade, Marisa] Univ Stirling, Stirling FK9 4LA, Scotland; [Hastings, Gerard] Ecole Hautes Etud Sante Publ, Rennes, France	University of Oxford; University of Stirling	Aveyard, P (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	paul.aveyard@phc.ox.ac.uk; gerard.hastings@stir.ac.uk		Lindson, Nicola/0000-0003-2539-9268; Aveyard, Paul/0000-0002-1802-4217	MRC [G0802135] Funding Source: UKRI; British Heart Foundation [PG/08/047/25082] Funding Source: researchfish; Cancer Research UK [15192] Funding Source: researchfish; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, G0802135, MR/K023195/1B] Funding Source: researchfish; National Institute for Health Research [CSA/02/06/001] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Balfour DJK, 2004, NICOTINE TOB RES, V6, P899, DOI 10.1080/14622200412331324965; Beard E, 2011, ADDICTION, V106, P197, DOI 10.1111/j.1360-0443.2010.03215.x; Beard E, 2012, DRUG ALCOHOL DEPEN, V126, P354, DOI 10.1016/j.drugalcdep.2012.05.039; British American Tobacco, 2013, FOC HARM RED WHY IT; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Chapman S., 2014, WHY IS BIG TOBACCO I; CINCIRIPINI PM, 1995, J CONSULT CLIN PSYCH, V63, P388, DOI 10.1037/0022-006X.63.3.388; Connock M, 2009, BMJ-BRIT MED J, V338, pb102; de Andrade M., 2013, MARKETING ELECT CIGA; De Andrade M, 2013, TOBACCO HARM REDUCTI; de Andrade Marisa, 2013, BMJ, V347, pf7473, DOI 10.1136/bmj.f7473; Hastings G, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8412; Hughes JR, 2006, NICOTINE TOB RES, V8, P739, DOI 10.1080/14622200600789726; Hughes JR, 2013, DRUG ALCOHOL DEPEN, V128, P171, DOI 10.1016/j.drugalcdep.2012.08.010; Lindson N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008033.pub2; National Institute for Health and Clinical Excellence, 2013, TOB HARM RED APPR SM; O'Reilly D, 2009, TOBACCO HARM REDUCTI; Office for National Statistics, 2013, GEN LIF SURV OV A RE; Pisinger C, 2007, NICOTINE TOB RES, V9, P631, DOI 10.1080/14622200701365327; Royal College of Physicians, 2007, HARM RED NIC ADD HEL; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; Shiffman S, 2007, NICOTINE TOB RES, V9, P1177, DOI 10.1080/14622200701648441; Wang D, 2008, HEALTH TECHNOL ASSES, V12, P1; West R, 2014, LATEST TRENDS SMOKIN	24	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2014	348								g2787	10.1136/bmj.g2787	http://dx.doi.org/10.1136/bmj.g2787			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZV	24840739	Green Published			2022-12-24	WOS:000336428800001
J	Sedgwick, P				Sedgwick, Philip			Clinical trials: units of randomisation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CROSSOVER TRIAL		Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3191; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2820; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2573; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5420; Vuillermin PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c843	5	4	4	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2014	348								g3297	10.1136/bmj.g3297	http://dx.doi.org/10.1136/bmj.g3297			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5HF	24838104				2022-12-24	WOS:000336158400003
J	Garraway, LA				Garraway, Levi A.			A Notch for Noncoding RNA in Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Garraway, Levi A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Garraway, LA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.							Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Forloni M, 2014, ELIFE, V3, DOI 10.7554/eLife.01460; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690	5	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1950	1951		10.1056/NEJMcibr1402173	http://dx.doi.org/10.1056/NEJMcibr1402173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24827041				2022-12-24	WOS:000336123600013
J	Dabelea, D; Mayer-Davis, EJ; Saydah, S; Imperatore, G; Linder, B; Divers, J; Bell, R; Badaru, A; Talton, JW; Crume, T; Liese, AD; Merchant, AT; Lawrence, JM; Reynolds, K; Dolan, L; Liu, LL; Hamman, RF				Dabelea, Dana; Mayer-Davis, Elizabeth J.; Saydah, Sharon; Imperatore, Giuseppina; Linder, Barbara; Divers, Jasmin; Bell, Ronny; Badaru, Angela; Talton, Jennifer W.; Crume, Tessa; Liese, Angela D.; Merchant, Anwar T.; Lawrence, Jean M.; Reynolds, Kristi; Dolan, Lawrence; Liu, Lenna L.; Hamman, Richard F.		SEARCH Diabet Youth Study	Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDHOOD TYPE-1; UNITED-STATES; INCREASING INCIDENCE; RISK-FACTORS; US YOUTH; MELLITUS; POPULATION; OBESITY; SEARCH; COHORT	IMPORTANCE Despite concern about an "epidemic," there are limited data on trends in prevalence of either type 1 or type 2 diabetes across US race and ethnic groups. OBJECTIVE To estimate changes in the prevalence of type 1 and type 2 diabetes in US youth, by sex, age, and race/ethnicity between 2001 and 2009. DESIGN, SETTING, AND PARTICIPANTS Case patients were ascertained in 4 geographic areas and 1 managed health care plan. The study population was determined by the 2001 and 2009 bridged-race intercensal population estimates for geographic sites and membership counts for the health plan. MAIN OUTCOMES AND MEASURES Prevalence (per 1000) of physician-diagnosed type 1 diabetes in youth aged 0 through 19 years and type 2 diabetes in youth aged 10 through 19 years. RESULTS In 2001, 4958 of 3.3 million youth were diagnosed with type 1 diabetes for a prevalence of 1.48 per 1000 (95% CI, 1.44-1.52). In 2009, 6666 of 3.4 million youth were diagnosed with type 1 diabetes for a prevalence of 1.93 per 1000 (95% CI, 1.88-1.97). In 2009, the highest prevalence of type 1 diabetes was 2.55 per 1000 among white youth (95% CI, 2.48-2.62) and the lowest was 0.35 per 1000 in American Indian youth (95% CI, 0.26-0.47) and type 1 diabetes increased between 2001 and 2009 in all sex, age, and race/ethnic subgroups except for those with the lowest prevalence (age 0-4 years and American Indians). Adjusted for completeness of ascertainment, there was a 21.1% (95% CI, 15.6%-27.0%) increase in type 1 diabetes over 8 years. In 2001, 588 of 1.7 million youth were diagnosed with type 2 diabetes for a prevalence of 0.34 per 1000 (95% CI, 0.31-0.37). In 2009, 819 of 1.8 million were diagnosed with type 2 diabetes for a prevalence of 0.46 per 1000 (95% CI, 0.43-0.49). In 2009, the prevalence of type 2 diabetes was 1.20 per 1000 among American Indian youth (95% CI, 0.96-1.51); 1.06 per 1000 among black youth (95% CI, 0.93-1.22); 0.79 per 1000 among Hispanic youth (95% CI, 0.70-0.88); and 0.17 per 1000 among white youth (95% CI, 0.15-0.20). Significant increases occurred between 2001 and 2009 in both sexes, all age-groups, and in white, Hispanic, and black youth, with no significant changes for Asian Pacific Islanders and American Indians. Adjusted for completeness of ascertainment, there was a 30.5%(95% CI, 17.3%-45.1%) overall increase in type 2 diabetes. CONCLUSIONS AND RELEVANCE Between 2001 and 2009 in 5 areas of the United States, the prevalence of both type 1 and type 2 diabetes among children and adolescents increased. Further studies are required to determine the causes of these increases.	[Dabelea, Dana; Crume, Tessa; Hamman, Richard F.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO 80045 USA; [Mayer-Davis, Elizabeth J.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Saydah, Sharon; Imperatore, Giuseppina] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA; [Linder, Barbara] NIDDK, Childhood Diabet Res Div Diabet Endocrinol & Meta, Bethesda, MD 20892 USA; [Divers, Jasmin; Talton, Jennifer W.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Bell, Ronny] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Badaru, Angela] Childrens Hosp & Reg Med Ctr, Dept Pediat Endocrinol & Diabet, Seattle, WA USA; [Liese, Angela D.; Merchant, Anwar T.] Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC USA; [Lawrence, Jean M.; Reynolds, Kristi] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Dolan, Lawrence] Childrens Hosp Med Ctr, Dept Endocrinol, Cincinnati, OH USA; [Liu, Lenna L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Liu, Lenna L.] Seattle Childrens Hosp, Seattle, WA USA	Colorado School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wake Forest University; Wake Forest University; Seattle Children's Hospital; Kaiser Permanente; Cincinnati Children's Hospital Medical Center; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Dabelea, D (corresponding author), Colorado Sch Publ Hlth, Dept Epidemiol, 13001 East 17th Pl,Campus Box B-119, Aurora, CO 80045 USA.	dana.dabelea@ucdenver.edu	Crume, Tessa/T-9554-2019; Reynolds, Kristi/AAN-1434-2021	Crume, Tessa/0000-0002-5397-4154; Reynolds, Kristi/0000-0001-7619-1649; Lawrence, Jean/0000-0002-2480-8480; Maahs, David/0000-0002-4602-7909	CDC [PA00097, DP-05-069, DP-10-001]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIDDK; National Institutes of Health (NIH) National Center for Research Resources [UL1RR029882]; NIH [UL1 TR00423]; Clinical and Translational Research Center [UL1 TR000154]; Diabetes and Endocrinology Research Center, NIH [P30 DK57516]; National Center for Research Resources [8 UL1 TR000077]; National Center for Advancing Translational Sciences, NIH; Children with Medical Handicaps program;  [U48/CCU919219];  [U01 DP000246];  [U18DP002714];  [U48/CCU819241-3];  [U01 DP000247];  [U18DP000247-06A1];  [U48/CCU519239];  [U01 DP000248];  [1U18DP002709];  [U48/CCU419249];  [U01 DP000254];  [U18DP002708-01];  [U58/CCU019235-4];  [U01 DP000244];  [U18DP002710-01];  [U01 DP000250];  [200-2010-35171]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, UL1TR001082, UL1TR000154, UL1TR000423] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U01DP000247, U01DP000248, U18DP003256, U01DP000254, U18DP002708, U18DP002710, U18DP002709, U01DP000250, U18DP002714, U01DP000246, U01DP000244] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104706, P30DK057516, K23DK089017] Funding Source: NIH RePORTER	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Research Center; Diabetes and Endocrinology Research Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, NIH; Children with Medical Handicaps program; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SEARCH for Diabetes in Youth is funded by grants PA00097, DP-05-069, and DP-10-001 from the CDC and by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Additional funding was provided to the CDC for these cooperative agreements by the NIDDK. The site contracts grants are U48/CCU919219, U01 DP000246, and U18DP002714 to Kaiser Permanente Southern California; U48/CCU819241-3, U01 DP000247, and U18DP000247-06A1 to the University of Colorado Denver; U48/CCU519239, U01 DP000248, and 1U18DP002709 to the Children's Hospital Medical Center, Cincinnati, Ohio; U48/CCU419249, U01 DP000254, and U18DP002708-01 to the University of North Carolina at Chapel Hill; U58/CCU019235-4, U01 DP000244, and U18DP002710-01 to the University of Washington School of Medicine; U48/CCU919219, U01 DP000250, and 200-2010-35171 to the Wake Forest University School of Medicine. This project was also support by grants UL1RR029882 from the National Institutes of Health (NIH) National Center for Research Resources to the South Carolina Clinical & Translational Research [SCTR] Institute, at the Medical University of South Carolina; UL1 TR00423 from the NIH Clinical and Translational Science Award to the Seattle Children's Hospital of the University of Washington; UL1 TR000154 from the Clinical and Translational Research Center to the University of Colorado Pediatric Clinical; P30 DK57516 from the Diabetes and Endocrinology Research Center, NIH, to the Barbara Davis Center at the University of Colorado at Denver; 8 UL1 TR000077 from the National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH; and the Children with Medical Handicaps program managed by the Ohio Department of Health.	Baranowski T, 2006, DIABETES CARE, V29, P212; Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bishop YM., 2007, DISCRETE MULTIVARIAT; Bonifacio E, 2010, J CLIN ENDOCR METAB, V95, P3360, DOI 10.1210/jc.2010-0293; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Dabelea D, 2011, DIABETES CARE, V34, P1628, DOI 10.2337/dc10-2324; Dean H, 1998, CLIN PEDIATR, V37, P89, DOI 10.1177/000992289803700205; Demmer RT, 2013, AM J EPIDEMIOL, V178, P1106, DOI 10.1093/aje/kwt088; Diabet Children Adolescents Work G, 2004, PEDIATRICS, V114, P259; Dolan LM, 2005, J PEDIATR-US, V146, P751, DOI 10.1016/j.jpeds.2005.01.045; Feltbower RG, 2003, ARCH DIS CHILD, V88, P676, DOI 10.1136/adc.88.8.676; GART JJ, 1990, BIOMETRICS, V46, P637, DOI 10.2307/2532084; Harjutsalo V, 2013, JAMA-J AM MED ASSOC, V310, P427, DOI 10.1001/jama.2013.8399; HELGASON T, 1992, DIABETOLOGIA, V35, P880, DOI 10.1007/BF00399936; Imperatore G, 2012, DIABETES CARE, V35, P2515, DOI 10.2337/dc12-0669; Ingram Deborah D, 2003, Vital Health Stat 2, P1; Kaufman FR, 2009, DIABETES CARE, V32, P953, DOI 10.2337/dc08-1774; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; Lipman TH, 2013, J DIABETES, V5, P456, DOI 10.1111/1753-0407.12039; Lipman TH, 2013, DIABETES CARE, V36, P1597, DOI 10.2337/dc12-0767; Neufeld ND, 1998, DIABETES CARE, V21, P80, DOI 10.2337/diacare.21.1.80; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ortega-Rodriguez E, 2001, DIABETES METAB, V27, P574; Oster RT, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18501; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Petitti DB, 2009, J PEDIAT, V155, pe1; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Pettitt DJ, 2014, DIABETES CARE, V37, P402, DOI 10.2337/dc13-1838; Pettitt DJ, 2004, CONTROL CLIN TRIALS, V25, P458, DOI 10.1016/j.cct.2004.08.002; Pinhas-Hamiel O, 2000, PREV MED, V31, P702, DOI 10.1006/pmed.2000.0752; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; REUNANEN A, 1982, ACTA PAEDIATR SCAND, V71, P893, DOI 10.1111/j.1651-2227.1982.tb09545.x; Saydah Sharon, 2012, Morbidity and Mortality Weekly Report, V61, P869; SCHOBER E, 2009, J PEDIAT, V155, pE1; Schober E, 2009, J PEDIATR-US, V155, P190, DOI 10.1016/j.jpeds.2009.03.010; Smith TLS, 2007, J PEDIATR ENDOCR MET, V20, P1093; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Vehik K, 2007, DIABETES CARE, V30, P503, DOI 10.2337/dc06-1837; Verlato G, 2000, DIABETES CARE, V23, P759, DOI 10.2337/diacare.23.6.759; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	43	869	885	6	110	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1778	1786		10.1001/jama.2014.3201	http://dx.doi.org/10.1001/jama.2014.3201			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794371	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000335382300023
J	Rosman, Y; Eisenkraft, A; Milk, N; Shiyovich, A; Ophir, N; Shrot, S; Kreiss, Y; Kassirer, M				Rosman, Yossi; Eisenkraft, Arik; Milk, Nadav; Shiyovich, Arthur; Ophir, Nimrod; Shrot, Shai; Kreiss, Yitshak; Kassirer, Michael			Lessons Learned From the Syrian Sarin Attack: Evaluation of a Clinical Syndrome Through Social Media	ANNALS OF INTERNAL MEDICINE			English	Article							TOKYO SUBWAY; MANAGEMENT; PROGRESS	On the night of 21 August 2013, sarin was dispersed in the eastern outskirts of Damascus, killing 1400 civilians and severely affecting thousands more. This article aims to delineate the clinical presentation and management of a mass casualty event caused by a nerve agent as shown in the social media. Authors searched YouTube for videos uploaded of this attack and identified 210 videos. Of these, 67 met inclusion criteria and were evaluated in the final analysis. These videos displayed 130 casualties; 119 (91.5%) of which were defined as moderately injured or worse. The most common clinical signs were dyspnea (53.0%), diaphoresis (48.5%), and loss of consciousness (40.7%). Important findings included a severe shortage of supporting measures and lack of antidotal autoinjectors. Decontamination, documented in 25% of the videos, was done in an inefficient manner. Protective gear was not noticed, except for sporadic use of latex gloves and surgical masks. This is believed to be the first time that social media was used to evaluate clinical data and management protocols to better prepare against future possible events.	Israel Def Forces, Med Corps, IL-52621 Tel Hashomer, Israel; Hebrew Univ Jerusalem, Jerusalem, Israel	Hebrew University of Jerusalem	Rosman, Y (corresponding author), Hashaked 4-19, IL-54044 Givat Shemuel, Israel.	rosmanyossi@gmail.com	shrot, shai/ABF-7714-2021	shrot, shai/0000-0001-8954-3244				Alasaad S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-94; Alexander J, 2013, J CANCER EDUC, V28, P744, DOI 10.1007/s13187-013-0534-5; Baker MD, 2007, CURR OPIN PEDIATR, V19, P211, DOI 10.1097/MOP.0b013e328012cba2; Collier Nigel, 2011, J Biomed Semantics, V2 Suppl 5, pS9, DOI 10.1186/2041-1480-2-S5-S9; Dizon DS, 2012, J ONCOL PRACT, V8, pE114, DOI 10.1200/JOP.2012.000610; DUNN MA, 1989, JAMA-J AM MED ASSOC, V262, P649, DOI 10.1001/jama.262.5.649; Fischer J, 2013, JCR-J CLIN RHEUMATOL, V19, P373, DOI 10.1097/RHU.0b013e3182a69fb2; Foltin G, 2006, PEDIATR EMERG CARE, V22, P239, DOI 10.1097/01.pec.0000214594.78261.65; Greene J., 2013, B ATOM SCI; Krivoy A, 2005, PREHOSPITAL DISASTER, V20, P155, DOI 10.1017/S1049023X00002375; Markel G, 2008, ISR MED ASSOC J, V10, P761; McDonough JH, 2000, EPILEPSY RES, V38, P1; Nozaki H, 1995, INTENS CARE MED, V21, P1032, DOI 10.1007/BF01700667; Ohbu S, 1997, SOUTHERN MED J, V90, P587, DOI 10.1097/00007611-199706000-00002; Okumura T, 1998, ACAD EMERG MED, V5, P618, DOI 10.1111/j.1553-2712.1998.tb02471.x; Okumura T, 1996, ANN EMERG MED, V28, P129, DOI 10.1016/S0196-0644(96)70052-5; Plakht Y, 2011, ISR MED ASSOC J, V13, P69; Rebmann T, 2009, J EMERG MED, V37, P139, DOI 10.1016/j.jemermed.2007.09.043; Rosman Y, 2012, J APPL TOXICOL, V32, P409, DOI 10.1002/jat.1715; Shrot S, 2009, NEUROTOXICOLOGY, V30, P167, DOI 10.1016/j.neuro.2008.12.006; Tokuda Y, 2006, RESUSCITATION, V68, P193, DOI 10.1016/j.resuscitation.2005.05.023	21	108	110	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					644	U218		10.7326/M13-2799	http://dx.doi.org/10.7326/M13-2799			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI0GO	24798526				2022-12-24	WOS:000336524400008
J	Roth, JA; Etzioni, R; Waters, TM; Pettinger, M; Rossouw, JE; Anderson, GL; Chlebowski, RT; Manson, JE; Hlatky, M; Johnson, KC; Ramsey, SD				Roth, Joshua A.; Etzioni, Ruth; Waters, Teresa M.; Pettinger, Mary; Rossouw, Jacques E.; Anderson, Garnet L.; Chlebowski, Rowan T.; Manson, JoAnn E.; Hlatky, Mark; Johnson, Karen C.; Ramsey, Scott D.			Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial	ANNALS OF INTERNAL MEDICINE			English	Article							POSTMENOPAUSAL HORMONE-THERAPY; REPLACEMENT THERAPY; SAMPLE INFORMATION; COST-EFFECTIVENESS; FOLLOW-UP; BENEFITS; RISKS; DISEASE; PREVENTION; BURDEN	Background: The findings of the Women's Health Initiative (WHI) estrogen plus progestin (E+P) trial led to a substantial reduction in use of combined hormone therapy (cHT) among postmenopausal women in the United States. The economic effect of this shift has not been evaluated relative to the trial's $260 million cost (2012 U. S. dollars). Objective: To estimate the economic return from the WHI E+P trial. Design: Decision model to simulate health outcomes for a "WHI scenario" with observed cHT use and a "no-WHI scenario" with cHT use extrapolated from the pretrial period. Data Sources: Primary analyses of WHI outcomes, peer-reviewed literature, and government sources. Target Population: Postmenopausal women in the United States, aged 50 to 79 years, who did not have a hysterectomy. Time Horizon: 2003 to 2012. Perspective: Payer. Intervention: Combined hormone therapy. Outcome Measures: Disease incidence, expenditure, quality-adjusted life-years, and net economic return. Results of Base-Case Analysis: The WHI scenario resulted in 4.3 million fewer cHT users, 126 000 fewer breast cancer cases, 76 000 fewer cardiovascular disease cases, 263 000 more fractures, 145 000 more quality-adjusted life-years, and expenditure savings of $35.2 billion. The corresponding net economic return of the trial was $37.1 billion ($140 per dollar invested in the trial) at a willingness-to-pay level of $100 000 per quality-adjusted life-year. Results of Sensitivity Analysis: The 95% CI for the net economic return of the trial was $23.1 to $51.2 billion. Limitation: No evaluation of indirect costs or outcomes beyond 2012. Conclusion: The WHI E+P trial made high-value use of public funds with a substantial return on investment. These results can contribute to discussions about the role of public funding for large, prospective trials with high potential for public health effects.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98121 USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; NHLBI, NIH, Bethesda, MD 20824 USA; Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Stanford Univ, Stanford Med Sch, Stanford, CA 94305 USA	Fred Hutchinson Cancer Center; Group Health Cooperative; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University	Ramsey, SD (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M3-B-232, Seattle, WA 98109 USA.	sramsey@fhcrc.org		Roth, Joshua/0000-0001-6621-8342; Anderson, Garnet/0000-0001-5087-7837; Waters, Teresa/0000-0002-3823-5177; Hlatky, Mark/0000-0003-4686-9441	National Heart, Lung, and Blood Institute; NATIONAL INSTITUTE ON AGING [T32AG027677] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Heart, Lung, and Blood Institute.	Ades AE, 2006, HEALTH ECON, V15, P373, DOI 10.1002/hec.1068; Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; [Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; [Anonymous], 1993, ASS NIH WOM HLTH IN; Bisias D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034569; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Burkman RT, 2001, AM J OBSTET GYNECOL, V185, pS13, DOI 10.1067/mob.2001.117414; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Donaldson C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-8; Garber AF, 2003, BROOKINGS REV, V21, P44; Garrison LP, 2009, VALUE HEALTH, V12, pS36, DOI 10.1111/j.1524-4733.2009.00520.x; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Gyrd-Hansen D, 2003, HEALTH ECON, V12, P1049, DOI 10.1002/hec.799; Hall PS, 2012, MED DECIS MAKING, V32, pE11, DOI 10.1177/0272989X12443010; HARLAP S, 1992, AM J OBSTET GYNECOL, V166, P1986, DOI 10.1016/0002-9378(92)91399-U; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Johnson FR, 2009, VALUE HEALTH, V12, pS38, DOI 10.1111/j.1524-4733.2009.00521.x; Kim N, 2005, J GEN INTERN MED, V20, P1026, DOI 10.1111/j.1525-1497.2005.0221.x; Kind P, 2009, VALUE HEALTH, V12, pS27, DOI 10.1111/j.1524-4733.2009.00519.x; Leary WE, NY TIMES; Lekander I, 2009, J WOMENS HEALTH, V18, P1669, DOI 10.1089/jwh.2008.1246; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Moyer VA, 2013, ANN INTERN MED, V158, P47, DOI 10.7326/0003-4819-158-1-201301010-00553; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; Richardson G, 2004, HEALTH ECON, V13, P1203, DOI 10.1002/hec.901; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roth J, 2013, VALUE HEALTH, V16, pA75, DOI 10.1016/j.jval.2013.03.341; Sasser AC, 2005, EXPERT OPIN PHARMACO, V6, P1803, DOI 10.1517/14656566.6.11.1803; Siebert U, 2012, VALUE HEALTH, V15, P812, DOI 10.1016/j.jval.2012.06.014; Smith MD, 2009, VALUE HEALTH, V12, pS1, DOI 10.1111/j.1524-4733.2009.00514.x; Sprague BL, 2012, OBSTET GYNECOL, V120, P595, DOI 10.1097/AOG.0b013e318265df42; Stagnitti MN., 2011, TRENDS HORMONE REPLA; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Steinkellner AR, 2012, MENOPAUSE, V19, P616, DOI 10.1097/gme.0b013e31824bb039; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Willan AR, 2005, STAT MED, V24, P1791, DOI 10.1002/sim.2069	42	36	37	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					594	U128		10.7326/M13-2348	http://dx.doi.org/10.7326/M13-2348			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI0GO	24798522	Green Accepted			2022-12-24	WOS:000336524400002
J	Rivera, LB; Bergers, G				Rivera, Lee B.; Bergers, Gabriele			Targeting vascular sprouts	SCIENCE			English	Editorial Material							ENDOTHELIAL-CELLS; GLYCOLYSIS; ANGIOGENESIS; PGC-1-ALPHA; CANCER		[Rivera, Lee B.; Bergers, Gabriele] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Brain Tumor Res Ctr, Dept Neurol Surg, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Rivera, LB (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Brain Tumor Res Ctr, Dept Neurol Surg, San Francisco, CA 94158 USA.	gabriele.bergers@ucsf.edu	Bergers, Gabriele/AAJ-5535-2020	Bergers, Gabriele/0000-0003-3545-5171				Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; DOBRINA A, 1983, BIOCHIM BIOPHYS ACTA, V762, P295, DOI 10.1016/0167-4889(83)90084-8; Granchi C, 2012, CHEMMEDCHEM, V7, P1318, DOI 10.1002/cmdc.201200176; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; KRUTZFELDT A, 1990, J MOL CELL CARDIOL, V22, P1393, DOI 10.1016/0022-2828(90)90984-A; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008	12	21	22	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1449	1450		10.1126/science.1257071	http://dx.doi.org/10.1126/science.1257071			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970064				2022-12-24	WOS:000337889900020
J	Hatziioannou, T; Del Prete, GQ; Keele, BF; Estes, JD; McNatt, MW; Bitzegeio, J; Raymond, A; Rodriguez, A; Schmidt, F; Mac Trubey, C; Smedley, J; Piatak, M; KewalRamani, VN; Lifson, JD; Bieniasz, PD				Hatziioannou, Theodora; Del Prete, Gregory Q.; Keele, Brandon F.; Estes, Jacob D.; McNatt, Matthew W.; Bitzegeio, Julia; Raymond, Alice; Rodriguez, Anthony; Schmidt, Fabian; Mac Trubey, C.; Smedley, Jeremy; Piatak, Michael, Jr.; KewalRamani, Vineet N.; Lifson, Jeffrey D.; Bieniasz, Paul D.			HIV-1-induced AIDS in monkeys	SCIENCE			English	Article							IMMUNODEFICIENCY; INFECTION; HIV/AIDS; MODELS	Primate lentiviruses exhibit narrow host tropism, reducing the occurrence of zoonoses but also impairing the development of optimal animal models of AIDS. To delineate the factors limiting cross-species HIV-1 transmission, we passaged a modified HIV-1 in pigtailed macaques that were transiently depleted of CD8(+) cells during acute infection. During adaptation over four passages in macaques, HIV-1 acquired the ability to antagonize the macaque restriction factor tetherin, replicated at progressively higher levels, and ultimately caused marked CD4(+) T cell depletion and AIDS-defining conditions. Transient treatment with an antibody to CD8 during acute HIV-1 infection caused rapid progression to AIDS, whereas untreated animals exhibited an elite controller phenotype. Thus, an adapted HIV-1 can cause AIDS in macaques, and stark differences in outcome can be determined by immunological perturbations during early infection.	[Hatziioannou, Theodora; McNatt, Matthew W.; Bitzegeio, Julia; Raymond, Alice; Rodriguez, Anthony; Schmidt, Fabian; Bieniasz, Paul D.] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Del Prete, Gregory Q.; Keele, Brandon F.; Estes, Jacob D.; Mac Trubey, C.; Piatak, Michael, Jr.; Lifson, Jeffrey D.] Frederick Natl Lab, AIDS & Canc Virus Program, Leidos Biomed Res, Frederick, MD 21702 USA; [McNatt, Matthew W.; Bitzegeio, Julia; Schmidt, Fabian; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10016 USA; [Smedley, Jeremy] Frederick Natl Lab, Lab Anim Sci Program, Leidos Biomed Res, Frederick, MD 21702 USA; [KewalRamani, Vineet N.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Bieniasz, Paul D.] Howard Hughes Med Inst, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute	Hatziioannou, T (corresponding author), Aaron Diamond AIDS Res Ctr, 455 First Ave, New York, NY 10016 USA.	thatziio@adarc.org; vineet.kewalramani@nih.gov; lifsonj@mail.nih.gov; pbienias@adarc.org	KewalRamani, Vineet/V-5084-2019	Smedley, Jeremy/0000-0003-3369-4662	NIH [R37AI64003, R01AI50111, R01AI078788]; Deutsche Forschungsgemeinschaft [BI1540/1-1]; Howard Hughes Medical Institute; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050111, R37AI064003, R01AI078788] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data presented in this paper are tabulated in the main paper and in the supplementary materials. HIV-1 Env sequences used in Fig. 3 have been deposited in GenBank (accession numbers KJ201545 through KJ201764). Sequences encompassing the full-length viral genome for P5 and P6 have also been deposited in GenBank (accession numbers KJ767573 through KJ767592). This work was supported by NIH grants R37AI64003 and R01AI50111 (to P. D. B.) and R01AI078788 (to T. H.); Deutsche Forschungsgemeinschaft fellowship BI1540/1-1 (to J.B.); the Howard Hughes Medical Institute; and in part with federal funds from the National Cancer Institute, NIH, under contract no. HHSN261200800001E. We thank V. Coalter, A. Wiles, R. Wiles, and D. Johnson for assistance with study coordination and sample processing. Histology support was provided by the Pathology/Histotechnology Laboratory core service located at the Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	Ambrose Z, 2007, TRENDS BIOTECHNOL, V25, P333, DOI 10.1016/j.tibtech.2007.05.004; Blanco-Melo D, 2012, IMMUNITY, V37, P399, DOI 10.1016/j.immuni.2012.08.013; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Hirsch VM, 2004, J VIROL, V78, P275, DOI 10.1128/JVI.78.1.275-284.2004; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Liao CH, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000304692.09143.1b; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Orzechowska BU, 2008, BLOOD, V112, P4227, DOI 10.1182/blood-2008-04-151498; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; RAO TKS, 1991, ANNU REV MED, V42, P391, DOI 10.1146/annurev.med.42.1.391; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; Sina ST, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S7; Stephens EB, 1998, J VIROL, V72, P8820, DOI 10.1128/JVI.72.11.8820-8832.1998; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Veazey RS, 2008, J VIROL, V82, P5618, DOI 10.1128/JVI.02748-07; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; Virgen CA, 2007, J VIROL, V81, P13932, DOI 10.1128/JVI.01760-07	24	66	66	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1401	1405		10.1126/science.1250761	http://dx.doi.org/10.1126/science.1250761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948736	Green Accepted			2022-12-24	WOS:000337531700041
J	Sasaki, E; Zhang, X; Sun, HG; Lu, MYJ; Liu, TL; Ou, A; Li, JY; Chen, YH; Ealick, SE; Liu, HW				Sasaki, Eita; Zhang, Xuan; Sun, He G.; Lu, Mei-Yeh Jade; Liu, Tsung-lin; Ou, Albert; Li, Jeng-yi; Chen, Yu-hsiang; Ealick, Steven E.; Liu, Hung-wen			Co-opting sulphur-carrier proteins from primary metabolic pathways for 2-thiosugar biosynthesis	NATURE			English	Article							MOLYBDENUM COFACTOR; SUGAR BIOSYNTHESIS; CRYSTAL-STRUCTURE; THIOLATION; MECHANISM; SEQUENCE; GENES; MOCS3	Sulphur is an essential element for life and is ubiquitous in living systems(1,2). Yet how the sulphur atom is incorporated into many sulphur-containing secondary metabolites is poorly understood. For bond formation between carbon and sulphur in primary metabolites, the major ionic sulphur sources are the persulphide and thiocarboxylate groups on sulphur-carrier (donor) proteins(3,4). Each group is post-translationally generated through the action of a specific activating enzyme. In all reported bacterial cases, the gene encoding the enzyme that catalyses the carbon-sulphur bond formation reaction and that encoding the cognate sulphur-carrier protein exist in the same gene cluster(5). To study the production of the 2-thiosugar moiety in BE-7585A, an antibiotic from Amycolatopsis orientalis, we identified a putative 2-thioglucose synthase, BexX, whose protein sequence and mode of action seem similar to those of ThiG, the enzyme that catalyses thiazole formation in thiamine biosynthesis(6,7). However, no gene encoding a sulphur-carrier protein could be located in the BE-7585A cluster. Subsequent genome sequencing uncovered a few genes encoding sulphur-carrier proteins that are probably involved in the biosynthesis of primary metabolites but only one activating enzyme gene in the A. orientalis genome. Further experiments showed that this activating enzyme can adenylate each of these sulphur carrier proteins and probably also catalyses the subsequent thiolation, through its rhodanese domain. A proper combination of these sulphur-delivery systems is effective for BexX-catalysed2-thioglucose production. The ability of BexX to selectively distinguish sulphur-carrier proteins is given a structural basis using X-ray crystallography. This study is, to our knowledge, the first complete characterization of thiosugar formation in nature and also demonstrates the receptor promiscuity of the A. orientalis sulphur-delivery system. Our results also show that co-opting the sulphur-delivery machinery of primary metabolism for the biosynthesis of sulphur-containing natural products is probably a general strategy found in nature.	[Sasaki, Eita; Liu, Hung-wen] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Zhang, Xuan; Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Sun, He G.; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Lu, Mei-Yeh Jade; Li, Jeng-yi; Chen, Yu-hsiang] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Lu, Mei-Yeh Jade; Liu, Tsung-lin; Ou, Albert] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Liu, Tsung-lin] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan	University of Texas System; University of Texas Austin; Cornell University; University of Texas System; University of Texas Austin; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Cheng Kung University	Liu, HW (corresponding author), Univ Texas Austin, Dept Chem, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu	Sasaki, Eita/T-7408-2019	Lu, Mei-Yeh Jade/0000-0002-4053-4889	Academia Sinica; National Institutes of Health (NIH) [GM035906, DK67081]; Welch Foundation [F-1511]; National Institute of General Medical Sciences, NIH [GM103403]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R37GM035906, R01GM035906, P41GM103485] Funding Source: NIH RePORTER	Academia Sinica(Academia Sinica - Taiwan); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C.-H. Wong and R. Chen, as well as Academia Sinica for funding, for the whole-genome draft sequencing; and the staff at the Analytical Instrumentation Facility of the College of Pharmacy (University of Texas), the Advanced Photon Source (APS) Northeastern Collaborative Access Team (NE-CAT) beamlines and the Cornell High Energy Synchrotron Source (CHESS) beamlines (Cornell University) for their assistance in data collection. We also thank D. Kim for assistance with the early biochemical experiments, C. Kinsland for providing the cysO/pTYB1 clone, Y. Zhang for help with the structure determination of BexX-CysO and L. Kinsland for help in preparing the manuscript. This work was supported in part by grants from the National Institutes of Health (NIH) (GM035906 to H.-W.L. and DK67081 to S. E. E.) and the Welch Foundation (F-1511 to H.-W.L.). The X-ray crystallography work was conducted at the APS NE-CAT beamlines, which are supported by award GM103403 from the National Institute of General Medical Sciences, NIH. Use of the APS is	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Begley TP, 2006, NAT PROD REP, V23, P15, DOI 10.1039/b207131m; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braunshausen A, 2011, J AM CHEM SOC, V133, P1757, DOI 10.1021/ja109378e; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Chowdhury MM, 2012, J BIOL CHEM, V287, P17297, DOI 10.1074/jbc.M112.351429; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fontecave M, 2003, CHEM REV, V103, P2149, DOI 10.1021/cr020427j; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kinsland C, 1998, PROTEIN SCI, V7, P1839, DOI 10.1002/pro.5560070821; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lin CI, 2013, CHEM SOC REV, V42, P4377, DOI 10.1039/c2cs35438a; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2003, BIOCHEMISTRY-US, V42, P12430, DOI 10.1021/bi034902z; Parry R. J., 1999, COMPREHENSIVE NATURA, V1, P825; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Sasaki E, 2010, J AM CHEM SOC, V132, P15544, DOI 10.1021/ja108061c; Sasaki E, 2010, J AM CHEM SOC, V132, P7405, DOI 10.1021/ja1014037; SCHLESINGER P, 1974, J BIOL CHEM, V249, P780; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Settembre EC, 2004, BIOCHEMISTRY-US, V43, P11647, DOI 10.1021/bi0488911; Shigi N, 2008, EMBO J, V27, P3267, DOI 10.1038/emboj.2008.246; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V24, P324, DOI 10.1016/0006-3002(57)90201-9; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Voss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028170	45	41	42	4	84	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					427	+		10.1038/nature13256	http://dx.doi.org/10.1038/nature13256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24814342	Green Accepted			2022-12-24	WOS:000337350200041
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Unit of observation versus unit of analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS; RANDOMIZATION		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; Pickett KE, 2007, BMJ-BRIT MED J, V335, P1080, DOI 10.1136/bmj.39377.580162.55; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3297; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2979; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2820; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1215; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1816; Sedgwick P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4654; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4670	9	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2014	348								g3840	10.1136/bmj.g3840	http://dx.doi.org/10.1136/bmj.g3840			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1IW	24927764				2022-12-24	WOS:000337410400002
J	Lipska, KJ; Ross, JS; Van Houten, HK; Beran, D; Yudkin, JS; Shah, ND				Lipska, Kasia J.; Ross, Joseph S.; Van Houten, Holly K.; Beran, David; Yudkin, John S.; Shah, Nilay D.			Use and Out-of-Pocket Costs of Insulin for Type 2 Diabetes Mellitus From 2000 Through 2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Lipska, Kasia J.; Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Beran, David] Univ Geneva, Fac Med, Geneva, Switzerland; [Yudkin, John S.] UCL, London, England; [Van Houten, Holly K.; Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA	Yale University; University of Geneva; University of London; University College London; Mayo Clinic	Lipska, KJ (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	kasia.lipska@yale.edu	Beran, David/E-4422-2013; Yudkin, John S/C-1988-2008	Beran, David/0000-0001-7229-3920; Ross, Joseph/0000-0002-9218-3320	AHRQ HHS [R21HS17628] Funding Source: Medline; NCATS NIH HHS [UL1 TR000142] Funding Source: Medline; NIA NIH HHS [K08 AG032886, P30 AG021342, R03 AG045086, K23 AG048359, R03AG045086, P30 AG21342] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R21HS017628] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342, R03AG045086, K23AG048359, K08AG032886] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gale EAM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4611; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; Ginde Adit A, 2008, BMC Endocr Disord, V8, P4, DOI 10.1186/1472-6823-8-4; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3	5	62	63	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2331	2333		10.1001/jama.2014.6316	http://dx.doi.org/10.1001/jama.2014.6316			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915266	Bronze, Green Accepted			2022-12-24	WOS:000336972600026
J	Shinohara, H; Behar, M; Inoue, K; Hiroshima, M; Yasuda, T; Nagashima, T; Kimura, S; Sanjo, H; Maeda, S; Yumoto, N; Ki, S; Akira, S; Sako, Y; Hoffmann, A; Kurosaki, T; Okada-Hatakeyama, M				Shinohara, Hisaaki; Behar, Marcelo; Inoue, Kentaro; Hiroshima, Michio; Yasuda, Tomoharu; Nagashima, Takeshi; Kimura, Shuhei; Sanjo, Hideki; Maeda, Shiori; Yumoto, Noriko; Ki, Sewon; Akira, Shizuo; Sako, Yasushi; Hoffmann, Alexander; Kurosaki, Tomohiro; Okada-Hatakeyama, Mariko			Positive Feedback Within a Kinase Signaling Complex Functions as a Switch Mechanism for NF-kappa B Activation	SCIENCE			English	Article							T-CELL-ACTIVATION; INDUCED PHOSPHORYLATION; BCL10; BETA; FATE	A switchlike response in nuclear factor-kappa B (NF-kappa B) activity implies the existence of a threshold in the NF-kappa B signaling module. We show that the CARD-containing MAGUK protein 1 (CARMA1, also called CARD11)-TAK1 (MAP3K7)-inhibitor of NF-kappa B (I kappa B) kinase-beta (IKK beta) module is a switch mechanism for NF-kappa B activation in B cell receptor (BCR) signaling. Experimental and mathematical modeling analyses showed that IKK activity is regulated by positive feedback from IKK beta to TAK1, generating a steep dose response to BCR stimulation. Mutation of the scaffolding protein CARMA1 at serine-578, an IKK beta target, abrogated not only late TAK1 activity, but also the switchlike activation of NF-kappa B in single cells, suggesting that phosphorylation of this residue accounts for the feedback.	[Shinohara, Hisaaki; Inoue, Kentaro; Nagashima, Takeshi; Yumoto, Noriko; Ki, Sewon; Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci IMS RCAI, Lab Integrated Cellular Syst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif Los Angeles, Inst Quantitat & Computat Biosci QC Bio, Los Angeles, CA 90025 USA; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90025 USA; [Hiroshima, Michio] RIKEN Quantitat Biol Ctr QBiC, Lab Cell Signaling Dynam, Suita, Osaka 5650874, Japan; [Hiroshima, Michio; Sako, Yasushi] RIKEN, Cellular Informat Lab, Wako, Saitama 3510198, Japan; [Yasuda, Tomoharu; Sanjo, Hideki; Maeda, Shiori; Kurosaki, Tomohiro] RIKEN Ctr Integrat Med Sci IMS RCAI, Lab Lymphocyte Differentiat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kimura, Shuhei] Tottori Univ, Grad Sch Engn, Tottori 6808552, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan; [Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka 5650871, Japan	RIKEN; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RIKEN; RIKEN; RIKEN; Tottori University; Osaka University; Osaka University	Hoffmann, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA.	ahoffmann@ucla.edu; kurosaki@rcai.riken.jp; marikoh@rcai.riken.jp	Akira, Shizuo/C-3134-2009; Yasuda, Tomoharu/J-5102-2019; Kurosaki, Tomohiro/D-1306-2009; Shinohara, Hisaaki/E-3969-2010; Inoue, Kentaro/P-4920-2016; Sako, Yasushi/B-3253-2015	Kurosaki, Tomohiro/0000-0002-6352-304X; Shinohara, Hisaaki/0000-0002-6331-2138; Inoue, Kentaro/0000-0002-7447-5856; Sako, Yasushi/0000-0002-5707-5455; Yasuda, Tomoharu/0000-0001-9997-6852	RIKEN RCAI project for Interdisciplinary Research; Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology, Japan; Aihara Innovative Mathematical Modelling Project, FIRST program, Japan Society for the Promotion of Science; Cancer Research Institute; NIH [5R01CA141722]; NATIONAL CANCER INSTITUTE [R01CA141722] Funding Source: NIH RePORTER	RIKEN RCAI project for Interdisciplinary Research; Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Aihara Innovative Mathematical Modelling Project, FIRST program, Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Takemori, M. Nomura, S. Magi, A. Imamoto, and P.D. Burrows for advice and review of the manuscript and M. Reth for providing mb1-Cre mice. The study is supported by a RIKEN RCAI project for Interdisciplinary Research to H. S., and in part by Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology, Japan and the Aihara Innovative Mathematical Modelling Project, FIRST program, Japan Society for the Promotion of Science, to M.O.-H. M. B. was funded by a Postdoctoral Research Fellowship from the Cancer Research Institute and NIH grant 5R01CA141722 to A. H. The microarray data are deposited at Gene Expression Omnibus under accession number GSE41176. The authors declare no competing financial interests. H. S. designed the research; H. S., T.Y., S. M., N.Y., and S. K. performed the experiments; M. B., K. I., and S. K. performed computational analysis; H. S., M. H, and Y.S. performed single-cell imaging analysis; T.N. analyzed the microarray data; H. S. and S. A. provided essential reagents; H. S., M. B., K. I., and M.O.-H. analyzed the data; H. S., M. B., K. I., A. H., and M.O.-H. wrote the paper; and A. H., T. K., and M.O-H. conceived the study and provided overall direction.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Basak S, 2012, IMMUNOL REV, V246, P221, DOI 10.1111/j.1600-065X.2011.01092.x; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lobry C, 2007, P NATL ACAD SCI USA, V104, P908, DOI 10.1073/pnas.0606982104; Ninfa Alexander J, 2004, Sci STKE, V2004, ppe20, DOI 10.1126/stke.2322004pe20; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Zeng H, 2007, MOL CELL BIOL, V27, P5235, DOI 10.1128/MCB.01645-06	21	63	64	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					760	764		10.1126/science.1250020	http://dx.doi.org/10.1126/science.1250020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833394				2022-12-24	WOS:000335912900045
J	Li, SS; Flint, A; Pai, JK; Forman, JP; Hu, FB; Willett, WC; Rexrode, KM; Mukamal, KJ; Rimm, EB				Li, Shanshan; Flint, Alan; Pai, Jennifer K.; Forman, John P.; Hu, Frank B.; Willett, Walter C.; Rexrode, Kathryn M.; Mukamal, Kenneth J.; Rimm, Eric B.			Dietary fiber intake and mortality among survivors of myocardial infarction: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; TOTAL-ENERGY-INTAKE; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; REINFARCTION TRIAL; EUROPEAN-SOCIETY; FOOD; REPRODUCIBILITY; VALIDITY; RISK	Objective To evaluate the associations of dietary fiber after myocardial infarction (MI) and changes in dietary fiber intake from before to after MI with all cause and cardiovascular mortality. Design Prospective cohort study. Setting Two large prospective cohort studies of US women and men with repeated dietary measurements: the Nurses' Health Study and the Health Professionals Follow-Up Study. Participants 2258 women and 1840 men who were free of cardiovascular disease, stroke, or cancer at enrollment, survived a first MI during follow-up, were free of stroke at the time of initial onset of MI, and provided food frequency questionnaires pre-MI and at least one post-MI. Main outcome measures Associations of dietary fiber post-MI and changes from before to after MI with all cause and cardiovascular mortality using Cox proportional hazards models, adjusting for drug use, medical history, and lifestyle factors. Results Higher post-MI fiber intake was significantly associated with lower all cause mortality (comparing extreme fifths, pooled hazard ratio 0.75, 95% confidence interval 0.58 to 0.97). Greater intake of cereal fiber was more strongly associated with all cause mortality (pooled hazard ratio 0.73, 0.58 to 0.91) than were other sources of dietary fiber. Increased fiber intake from before to after MI was significantly associated with lower all cause mortality (pooled hazard ratio 0.69, 0.55 to 0.87). Conclusions In this prospective study of patients who survived MI, a greater intake of dietary fiber after MI, especially cereal fiber, was inversely associated with all cause mortality. In addition, increasing consumption of fiber from before to after MI was significantly associated with lower all cause and cardiovascular mortality.	[Li, Shanshan; Hu, Frank B.; Willett, Walter C.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Flint, Alan; Hu, Frank B.; Willett, Walter C.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Dept Nutr, Boston, MA 02115 USA; [Pai, Jennifer K.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Forman, John P.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Rexrode, Kathryn M.] Brigham & Womens Hosp, Dept Prevent Med, Boston, MA 02115 USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Brookline, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Li, SS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	shl607@mail.harvard.edu	Rexrode, Kathryn M/I-1177-2018; Mukamal, Kenneth/GVR-7978-2022; Li, Shanshan/N-2593-2019	Li, Shanshan/0000-0001-6268-125X	National Institute of Health [AA11181, HL35464, HL34594, HL60712, CA55075, CA87969, CA055075]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712, R01HL034594, R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institute of Health grants AA11181, HL35464, HL34594, HL60712, CA55075, CA87969, and CA055075. The funders play no role in the study design, data collection, analysis and interpretation, the writing of the manuscript, and the decision to submit the article for publication.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; Bonnet J, 2008, CLIN THER, V30, P2298, DOI 10.1016/j.clinthera.2008.12.023; Burr ML, 2007, P NUTR SOC, V66, P9, DOI 10.1017/S0029665107005241; BURR ML, 1989, LANCET, V2, P757; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Dandona P, 2010, EXP MOL MED, V42, P245, DOI 10.3858/emm.2010.42.4.033; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Estruch R, 2009, J EPIDEMIOL COMMUN H, V63, P582, DOI 10.1136/jech.2008.082214; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Flight I, 2006, EUR J CLIN NUTR, V60, P1145, DOI 10.1038/sj.ejcn.1602435; Ha MA, 2000, EUR J CLIN NUTR, V54, P861, DOI 10.1038/sj.ejcn.1601109; Hall AS, 2009, EUR J CARDIOV PREV R, V16, P712, DOI 10.1097/HJR.0b013e3283316ce8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Ioannidis JP, 2014, BMJ-BRIT MED J, V348, pg2659; Johnson C, 2008, AM J CARDIOL, V102, P1312, DOI 10.1016/j.amjcard.2008.07.023; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Liu SM, 2002, J AM COLL CARDIOL, V39, P49, DOI 10.1016/S0735-1097(01)01695-3; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Mead A, 2006, J HUM NUTR DIET, V19, P401, DOI 10.1111/j.1365-277X.2006.00726.x; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Ness AR, 2002, EUR J CLIN NUTR, V56, P512, DOI 10.1038/sj.ejcn.1601342; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447; Satija A, 2012, CURR ATHEROSCLER REP, V14, P505, DOI 10.1007/s11883-012-0275-7; Schmidt LE, 2002, DRUGS, V62, P1481, DOI 10.2165/00003495-200262100-00005; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; Skinner JS, 2007, BRIT MED J, V334, P1112, DOI 10.1136/bmj.39204.531586.AD; United States Department of Agriculture, 2014, DIET GUID AM 2010; Wellenius GA, 2008, AM HEART J, V156, P483, DOI 10.1016/j.ahj.2008.04.009; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wolk A, 1999, JAMA-J AM MED ASSOC, V281, P1998, DOI 10.1001/jama.281.21.1998; Wong JMW, 2012, J AOAC INT, V95, P24, DOI 10.5740/jaoacint.SGE_Wong	47	22	24	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2014	348								g2659	10.1136/bmj.g2659	http://dx.doi.org/10.1136/bmj.g2659			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RF	24782515	Green Published, hybrid			2022-12-24	WOS:000335475500004
J	Stolper, DA; Lawson, M; Davis, CL; Ferreira, AA; Neto, EVS; Ellis, GS; Lewan, MD; Martini, AM; Tang, Y; Schoell, M; Sessions, AL; Eiler, JM				Stolper, D. A.; Lawson, M.; Davis, C. L.; Ferreira, A. A.; Santos Neto, E. V.; Ellis, G. S.; Lewan, M. D.; Martini, A. M.; Tang, Y.; Schoell, M.; Sessions, A. L.; Eiler, J. M.			Formation temperatures of thermogenic and biogenic methane	SCIENCE			English	Article							NATURAL-GAS GENERATION; ISOTOPE FRACTIONATION; PETROLEUM; CARBON; CONSTRAINTS; SHALE; OIL; OXIDATION; EXPULSION; KINETICS	Methane is an important greenhouse gas and energy resource generated dominantly by methanogens at low temperatures and through the breakdown of organic molecules at high temperatures. However, methane-formation temperatures in nature are often poorly constrained. We measured formation temperatures of thermogenic and biogenic methane using a "clumped isotope" technique. Thermogenic gases yield formation temperatures between 157 degrees and 221 degrees C, within the nominal gas window, and biogenic gases yield formation temperatures consistent with their comparatively lower-temperature formational environments (<50 degrees C). In systems where gases have migrated and other proxies for gas-generation temperature yield ambiguous results, methane clumped-isotope temperatures distinguish among and allow for independent tests of possible gas-formation models.	[Stolper, D. A.; Sessions, A. L.; Eiler, J. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lawson, M.; Davis, C. L.] ExxonMobil Upstream Res Co, Houston, TX USA; [Ferreira, A. A.; Santos Neto, E. V.] Petrobras Res & Dev Ctr CENPES, Div Geochem, Rio De Janeiro, RJ, Brazil; [Ellis, G. S.; Lewan, M. D.] US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA; [Martini, A. M.] Amherst Coll, Dept Geol, Amherst, MA 01002 USA; [Tang, Y.] Power Environm & Energy Res Inst, Covina, CA USA; [Schoell, M.] GasConsult Int Inc, Berkeley, CA USA	California Institute of Technology; Exxon Mobil Corporation; Petrobras; United States Department of the Interior; United States Geological Survey; Amherst College	Stolper, DA (corresponding author), CALTECH, Div Geol & Planetary Sci, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	dstolper@caltech.edu	Sessions, Alex/ABC-9207-2020; Ellis, Geoffrey S/G-8970-2011	Sessions, Alex/0000-0001-6120-2763; Lawson, Michael/0000-0003-2743-3773; Ellis, Geoffrey/0000-0003-4519-3320	NSF; Petrobras; ExxonMobil; Caltech	NSF(National Science Foundation (NSF)); Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); ExxonMobil(Exxon Mobil Corporation); Caltech	This work was supported by the NSF, Petrobras, ExxonMobil, and Caltech. We thank Petrobras and ExxonMobil for providing samples and permission to publish, C. Araujo and B. Peterson for helpful discussions, and R. Burruss and three anonymous reviewers for helpful comments on the manuscript. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. All data used to support the conclusions in this manuscript are provided in the supplementary materials.	[Anonymous], 21665 UCID LAWR LIV; CLAYTON C, 1991, MAR PETROL GEOL, V8, P232, DOI 10.1016/0264-8172(91)90010-X; Curtis JB, 2002, AAPG BULL, V86, P1921, DOI 10.1306/61eeddbe-173e-11d7-8645000102c1865d; Eiler JM, 2007, EARTH PLANET SC LETT, V262, P309, DOI 10.1016/j.epsl.2007.08.020; ENGLAND WA, 1987, J GEOL SOC LONDON, V144, P327, DOI 10.1144/gsjgs.144.2.0327; ESPITALIE J, 1988, ORG GEOCHEM, V13, P893, DOI 10.1016/0146-6380(88)90243-4; Hammes U, 2011, AAPG BULL, V95, P1643, DOI 10.1306/02141110128; Hoering T., 1984, ORG GEOCHEM, V5, P267, DOI DOI 10.1016/0146-6380(84)90014-7; Hunt J.M., 1996, PETROLEUM GEOLOGY GE; Lash GG, 2011, AAPG BULL, V95, P61, DOI 10.1306/06301009150; Lewan MD, 2002, ORG GEOCHEM, V33, P1457, DOI 10.1016/S0146-6380(02)00182-1; Lewan MD, 1997, GEOCHIM COSMOCHIM AC, V61, P3691, DOI 10.1016/S0016-7037(97)00176-2; Lorant F, 1998, CHEM GEOL, V147, P249, DOI 10.1016/S0009-2541(98)00017-5; Mahlstedt N, 2012, MAR PETROL GEOL, V31, P27, DOI 10.1016/j.marpetgeo.2011.06.011; Mango FD, 1997, GEOCHIM COSMOCHIM AC, V61, P5347, DOI 10.1016/S0016-7037(97)00310-4; MANGO FD, 1994, NATURE, V368, P536, DOI 10.1038/368536a0; Martini AM, 1996, NATURE, V383, P155, DOI 10.1038/383155a0; Ni YY, 2011, GEOCHIM COSMOCHIM AC, V75, P2696, DOI 10.1016/j.gca.2011.02.016; PRICE LC, 1995, NATURE, V378, P368, DOI 10.1038/378368a0; Prinzhofer AA, 1995, CHEM GEOL, V126, P281, DOI 10.1016/0009-2541(95)00123-9; Prinzhofer A, 2010, MAR PETROL GEOL, V27, P1273, DOI 10.1016/j.marpetgeo.2010.03.004; QUIGLEY TM, 1988, NATURE, V333, P549, DOI 10.1038/333549a0; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; SCHOELL M, 1983, AAPG BULL, V67, P2225; Seewald JS, 2003, NATURE, V426, P327, DOI 10.1038/nature02132; Seewald JS, 1998, GEOCHIM COSMOCHIM AC, V62, P1599, DOI 10.1016/S0016-7037(98)00000-3; Stolper DA, 2014, GEOCHIM COSMOCHIM AC, V126, P169, DOI 10.1016/j.gca.2013.10.045; Stolper D. A., 2014, MINERAL MAG, V78, P2393; Tang Y, 2000, GEOCHIM COSMOCHIM AC, V64, P2673, DOI 10.1016/S0016-7037(00)00377-X; Tissot B.P., 1984, PETROLEUM FORMATION, Vsecond, DOI [10.1007/978-3-642-87813-8, DOI 10.1007/978-3-642-87813-8]; TRINDADE LAF, 1992, AAPG BULL, V76, P1903; UNGERER P, 1990, ORG GEOCHEM, V16, P1, DOI 10.1016/0146-6380(90)90022-R; Valentine DL, 2011, ANNU REV MAR SCI, V3, P147, DOI 10.1146/annurev-marine-120709-142734; Valentine DL, 2004, GEOCHIM COSMOCHIM AC, V68, P1571, DOI 10.1016/j.gca.2003.10.012; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Wilhelms A, 2001, NATURE, V411, P1034, DOI 10.1038/35082535; Xiao Y, 2001, REV MINERAL GEOCHEM, V42, P383, DOI 10.2138/rmg.2001.42.11	38	171	187	7	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1500	1503		10.1126/science.1254509	http://dx.doi.org/10.1126/science.1254509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970083	Green Accepted			2022-12-24	WOS:000337889900046
J	Scott, DC; Sviderskiy, VO; Monda, JK; Lydeard, JR; Cho, SE; Harper, JW; Schulman, BA				Scott, Daniel C.; Sviderskiy, Vladislav O.; Monda, Julie K.; Lydeard, John R.; Cho, Shein Ei; Harper, J. Wade; Schulman, Brenda A.			Structure of a RING E3 Trapped in Action Reveals Ligation Mechanism for the Ubiquitin-like Protein NEDD8	CELL			English	Article							COMPLEX REVEALS; LIGASE COMPLEX; ACTIVATION; SCF; CONJUGATION; SUBSTRATE; ENZYME; INSIGHTS; BINDING; E2	Most E3 ligases use a RING domain to activate a thioester-linked E2 similar to ubiquitin-like protein (UBL) intermediate and promote UBL transfer to a remotely bound target protein. Nonetheless, RING E3 mechanisms matching a specific UBL and acceptor lysine remain elusive, including for RBX1, which mediates NEDD8 ligation to cullins and >10% of all ubiquitination. We report the structure of a trapped RING E3-E2 similar to UBL-target intermediate representing RBX1-UBC12 similar to NEDD8-CUL1-DCN1, which reveals the mechanism of NEDD8 ligation and how a particular UBL and acceptor lysine are matched by a multifunctional RING E3. Numerous mechanisms specify cullin neddylation while preventing noncognate ubiquitin ligation. Notably, E2-E3-target and RING-E2 similar to UBL modules are not optimized to function independently, but instead require integration by the UBL and target for maximal reactivity. The UBL and target regulate the catalytic machinery by positioning the RING-E2 similar to UBL catalytic center, licensing the acceptor lysine, and influencing E2 reactivity, thereby driving their specific coupling by a multifunctional RING E3.	[Scott, Daniel C.; Sviderskiy, Vladislav O.; Monda, Julie K.; Cho, Shein Ei; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Scott, Daniel C.; Sviderskiy, Vladislav O.; Monda, Julie K.; Cho, Shein Ei; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Scott, Daniel C.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Lydeard, John R.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Harvard University; Harvard Medical School	Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale, Memphis, TN 38105 USA.	brenda.schulman@stjude.org		Harper, Jeffrey/0000-0002-6944-7236; Sviderskiy, Vladislav/0000-0002-9692-5328; Schulman, Brenda/0000-0002-3083-1126	Howard Hughes Medical Institute (HHMI); American Lebanese Syrian Associated Charities (ALSAC); NIH [5P30CA021765, R01GM069530, R01AG011085]; Damon Runyon [DRG 2061-10]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Bozeman, D. W. Miller, J. Bollinger, D. J. Miller, and I. Kurinov for support. Funding was provided by the Howard Hughes Medical Institute (HHMI), the American Lebanese Syrian Associated Charities (ALSAC), NIH (5P30CA021765, R01GM069530 to B.A.S. and R01AG011085 to J.W.H.), and Damon Runyon (DRG 2061-10 to J.R.L.). B.A.S. is an Investigator of Howard Hughes Medical Institute.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Berndsen CE, 2013, NAT CHEM BIOL, V9, P154, DOI [10.1038/NCHEMBIO.1159, 10.1038/nchembio.1159]; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang H, 2014, NAT CHEM BIOL, V10, P156, DOI [10.1038/NCHEMBIO.1412, 10.1038/nchembio.1412]; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Kobashigawa Y, 2011, P NATL ACAD SCI USA, V108, P20579, DOI 10.1073/pnas.1110712108; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; Stanley DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003085; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	52	128	133	2	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1671	1684		10.1016/j.cell.2014.04.037	http://dx.doi.org/10.1016/j.cell.2014.04.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949976	Green Accepted, Bronze			2022-12-24	WOS:000340941900020
J	[Anonymous]				[Anonymous]			Screening an Asymptomatic Person for Genetic Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Dimmock, David/I-7913-2015	Dimmock, David/0000-0001-6690-2523					0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2442	2443						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0OA	24941182				2022-12-24	WOS:000337353000014
J	Roumie, CL; Greevy, RA; Grijalva, CG; Hung, AM; Liu, XL; Murff, HJ; Elasy, TA; Griffin, MR				Roumie, Christianne L.; Greevy, Robert A.; Grijalva, Carlos G.; Hung, Adriana M.; Liu, Xulei; Murff, Harvey J.; Elasy, Tom A.; Griffin, Marie R.			Association Between Intensification of Metformin Treatment With Insulin vs Sulfonylureas and Cardiovascular Events and All-Cause Mortality Among Patients With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MARGINAL STRUCTURAL MODELS; AFFAIRS HEALTH-CARE; BETA-CELL FUNCTION; SEVERE HYPOGLYCEMIA; GLUCOSE CONTROL; FOLLOW-UP; TYPE-2; RISK; THERAPIES; OUTCOMES	IMPORTANCE Preferred second-line medication for diabetes treatment after metformin failure remains uncertain. OBJECTIVE To compare time to acute myocardial infarction (AMI), stroke, or death in a cohort of metformin initiators who added insulin or a sulfonylurea. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort constructed with national Veterans Health Administration, Medicare, and National Death Index databases. The study population comprised veterans initially treated with metformin from 2001 through 2008 who subsequently added either insulin or sulfonylurea. Propensity score matching on characteristics was performed, matching each participant who added insulin to 5 who added a sulfonylurea. Patients were followed through September 2011 for primary analyses or September 2009 for cause-of-death analyses. MAIN OUTCOMES AND MEASURES Risk of a composite outcome of AMI, stroke hospitalization, or all-cause death was compared between therapies with marginal structural Cox proportional hazard models adjusting for baseline and time-varying demographics, medications, cholesterol level, hemoglobin A(1c) level, creatinine level, blood pressure, body mass index, and comorbidities. RESULTS Among 178 341 metformin monotherapy patients, 2948 added insulin and 39 990 added a sulfonylurea. Propensity score matching yielded 2436 metformin + insulin and 12 180 metformin + sulfonylurea patients. At intensification, patients had received metformin for a median of 14 months (IQR, 5-30), and hemoglobin A(1c) level was 8.1% (IQR, 7.2%-9.9%). Median follow-up after intensification was 14 months (IQR, 6-29 months). There were 172 vs 634 events for the primary outcome among patients who added insulin vs sulfonylureas, respectively (42.7 vs 32.8 events per 1000 person-years; adjusted hazard ratio [aHR],1.30; 95% Cl, 1.07-1.58; P = .009). Acute myocardial infarction and stroke rates were statistically similar, 41 vs 229 events (10.2 and 11.9 events per 1000 person-years; aHR, 0.88; 95% Cl, 0.59-1.30; P =.52), whereas all-cause death rates were 137 vs 444 events, respectively (33.7 and 22.7 events per 1000 person-years; aHR, 1.44; 95% Cl, 1.15-1.79; P = .001). There were 54 vs 258 secondary outcomes: AMI, stroke hospitalizations, or cardiovascular deaths (22.8 vs 22.5 events per 1000 person-years; aHR, 0.98; 95% Cl, 0.71-1.34; P = .87). CONCLUSIONS AND RELEVANCE Among patients with diabetes who were receiving metformin, the addition of insulin vs a sulfonylurea was associated with an increased risk of a composite of nonfatal cardiovascular outcomes and all-cause mortality. These findings require further investigation to understand risks associated with insulin use in these patients.	[Roumie, Christianne L.; Greevy, Robert A.; Grijalva, Carlos G.; Hung, Adriana M.; Liu, Xulei; Murff, Harvey J.; Elasy, Tom A.; Griffin, Marie R.] Geriatr Res Educ Clin Ctr, Vet Hlth Adm Valley Healthcare Syst, HSR&D Ctr, Nashville, TN USA; [Roumie, Christianne L.; Hung, Adriana M.; Murff, Harvey J.; Elasy, Tom A.; Griffin, Marie R.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Greevy, Robert A.; Liu, Xulei] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Grijalva, Carlos G.; Griffin, Marie R.] Vanderbilt Univ, Dept Hlth Policy, Nashville, TN 37235 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vanderbilt University; Vanderbilt University; Vanderbilt University	Roumie, CL (corresponding author), Geriatr Res Educ Clin Ctr, Nashville VA Med Ctr, 1310 24th Ave S, Nashville, TN 37212 USA.	christianne.roumie@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	Agency for Healthcare Research and Quality, US Department of Health and Human Services [HHSA2902010000161]; VA Clinical Science Research and Development investigator-initiated grant [I01CX000570-01]; Center for Diabetes Translation Research [P30DK092986]; VA Career Development Award [2-031-09S]; Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, Veterans Affairs Information Resource Center [SDR 02-237, 98-004]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092986] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000570] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, US Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); VA Clinical Science Research and Development investigator-initiated grant; Center for Diabetes Translation Research; VA Career Development Award; Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, Veterans Affairs Information Resource Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This project was funded by the Agency for Healthcare Research and Quality, US Department of Health and Human Services, contract HHSA2902010000161, as part of the Developing Evidence to Inform Decisions About Effectiveness (DEcIDE 2) program. This work was supported in part by VA Clinical Science Research and Development investigator-initiated grant I01CX000570-01 (Dr Roumie) and the Center for Diabetes Translation Research P30DK092986 (Drs Roumie and Elasy). Dr Hung (2-031-09S) was supported by a VA Career Development Award. Support for Veterans Affairs/Centers for Medicare & Medicaid Services data was provided by the Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, Veterans Affairs Information Resource Center (project numbers SDR 02-237 and 98-004).	Alvarsson M, 2008, DIABETES OBES METAB, V10, P421, DOI 10.1111/j.1463-1326.2007.00719.x; [Anonymous], 2010, OPTMACH FUNCTIONS FO; [Anonymous], 2010, RITOOLS RANDOMIZATIO; Arnold N, 2006, COMPARISON OF VA OUT; Bonds DE, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-5; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Centers for Disease Control and Prevention, ADULTS WITH DIABETES; Cohen FJ, 2003, DIABETES CARE, V26, P1847, DOI 10.2337/diacare.26.6.1847; Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042; D'Agostino RB, 2000, J AM STAT ASSOC, V95, P749, DOI 10.2307/2669455; Gamble JM, 2010, DIABETES OBES METAB, V12, P47, DOI 10.1111/j.1463-1326.2009.01125.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Greevy RA, 2011, CLIN PHARMACOL THER, V90, P813, DOI 10.1038/clpt.2011.228; Harrison LB, 2012, DIABETES CARE, V35, P1406, DOI 10.2337/dc11-2170; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Humensky J, 2012, MEDICARE MEDICAID RE, V2; Hung AM, 2012, KIDNEY INT, V81, P698, DOI 10.1038/ki.2011.444; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; National Center for Health Statistics, 1988, INTERNATIONAL CLASSI; Niesner K, 2013, EPIDEMIOLOGY, V24, P334, DOI 10.1097/EDE.0b013e3182821e75; Office of Minority Health Department of Health and Human Services, HEART DISEASE AND AF; Parsons L., REDUCING BIAS IN A P; Peyrot Mark, 2010, Prim Care Diabetes, V4 Suppl 1, pS11, DOI 10.1016/S1751-9918(10)60004-6; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Roumie CL, 2012, PHARMACOEPIDEM DR S, V21, P515, DOI 10.1002/pds.3249; Roumie CL, 2011, PHARMACOEPIDEM DR S, V20, P36, DOI 10.1002/pds.2029; Schneeweiss S, 2005, EPIDEMIOLOGY, V16, P17, DOI 10.1097/01.ede.0000147164.11879.b5; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Yuan Y. C., 2011, MULTIPLE IMPUTATION	40	134	138	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2288	2296		10.1001/jama.2014.4312	http://dx.doi.org/10.1001/jama.2014.4312			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915260	Bronze, Green Accepted			2022-12-24	WOS:000336972600020
J	William, L				William, Leeroy			PERSONAL VIEW Non-palliative care staff need to deliver generalist end of life care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PATHWAYS		[William, Leeroy] Monash Hlth, Monash Med Ctr, Melbourne, Vic, Australia; [William, Leeroy] Eastern Hlth, Box Hill Hosp, Melbourne, Vic, Australia; [William, Leeroy] Monash Univ, Melbourne, Vic 3004, Australia	Monash University; Box Hill Hospital; Monash University	William, L (corresponding author), Monash Hlth, Monash Med Ctr, Melbourne, Vic, Australia.	leeroy.william@monashhealth.org.au	Ram, Prem/K-4511-2012; William, Leeroy/D-7029-2017; William, Leeroy/AAY-4041-2021; William, Leeroy/Q-4186-2019	William, Leeroy/0000-0002-8661-2221; 				Boyd K, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7718; Campbell H, 1998, BMJ-BRIT MED J, V316, P133; Chinthapalli K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4669; Department of Health, 2013, MOR CAS LESS PATHW R; Egan T, 2009, HEALTH, V13, P107, DOI 10.1177/1363459308097363; Heyland DK, 2006, CAN MED ASSOC J, V174, P627, DOI 10.1503/cmaj.050626; Janssen AL, 2010, PATIENT EDUC COUNS, V81, P251, DOI 10.1016/j.pec.2010.02.009; MacLeod RD, 2001, SOC SCI MED, V52, P1719, DOI 10.1016/S0277-9536(00)00289-6; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Roach MS, 1984, PERSPECTIVES CARING, V1; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; Sleeman KE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4779	12	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2014	348								g3426	10.1136/bmj.g3426	http://dx.doi.org/10.1136/bmj.g3426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZW	24846881				2022-12-24	WOS:000336429100011
J	McClung, CR				McClung, C. Robertson			Making Hunger Yield	SCIENCE			English	Editorial Material							FOOD SECURITY; AGRICULTURE; PROGRESS		Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	McClung, CR (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	c.robertson.mcclung@dartmouth.edu		McClung, C. Robertson/0000-0002-7875-3614				Alberts B, 2013, SCIENCE, V341, P1320, DOI 10.1126/science.1245017; Bailey-Serres J, 2010, RICE, V3, P138, DOI 10.1007/s12284-010-9048-5; Cabrera-Bosquet L, 2012, J INTEGR PLANT BIOL, V54, P312, DOI 10.1111/j.1744-7909.2012.01116.x; Duvick DN, 2005, MAYDICA, V50, P193; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Godfray HCJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0273; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Johns T, 2007, FOOD POLICY, V32, P1, DOI 10.1016/j.foodpol.2006.03.014; Jones JDG, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2013.0087, 10.1098/rstb.2013.008]; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Lutz W, 2010, PHILOS T R SOC B, V365, P2779, DOI 10.1098/rstb.2010.0133; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177	15	27	27	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					699	700		10.1126/science.1254135	http://dx.doi.org/10.1126/science.1254135			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH1WQ	24833378				2022-12-24	WOS:000335912900023
J	Albertazzi, L; van der Zwaag, D; Leenders, CMA; Fitzner, R; van der Hofstad, RW; Meijer, EW				Albertazzi, Lorenzo; van der Zwaag, Daan; Leenders, Christianus M. A.; Fitzner, Robert; van der Hofstad, Remco W.; Meijer, E. W.			Probing Exchange Pathways in One-Dimensional Aggregates with Super-Resolution Microscopy	SCIENCE			English	Article							SUPRAMOLECULAR POLYMERIZATION; POLYMERS; KINETICS; IMAGES	Supramolecular fibers are prominent structures in biology and chemistry. A quantitative understanding of molecular exchange pathways in these one-dimensional aggregates was obtained by a combination of super-resolution stochastic optical reconstruction microscopy and stochastic simulation. The potential of this methodology is demonstrated with a set of well-defined synthetic building blocks that self-assemble into supramolecular fibrils. Previous ensemble measurements hid all molecular phenomena underpinning monomer exchange, but the molecular pathway determined from single-aggregate studies revealed unexpected homogeneous exchange along the polymer backbone. These results pave the way for experimental investigation of the structure and exchange pathways of synthetic and natural supramolecular fibers.	[Albertazzi, Lorenzo; van der Zwaag, Daan; Leenders, Christianus M. A.; van der Hofstad, Remco W.; Meijer, E. W.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MD Eindhoven, Netherlands; [Albertazzi, Lorenzo; Meijer, E. W.] Eindhoven Univ Technol, Lab Chem Biol, NL-5600 MD Eindhoven, Netherlands; [van der Zwaag, Daan; Leenders, Christianus M. A.; Meijer, E. W.] Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MD Eindhoven, Netherlands; [Fitzner, Robert; van der Hofstad, Remco W.] Eindhoven Univ Technol, Dept Math & Comp Sci, NL-5600 MD Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Eindhoven University of Technology; Eindhoven University of Technology	Albertazzi, L (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MD Eindhoven, Netherlands.	l.albertazzi@tue.nl; e.w.meijer@tue.nl	Albertazzi, Lorenzo/E-8323-2013; Meijer, E.W./K-7632-2013	Albertazzi, Lorenzo/0000-0002-6837-0812; Meijer, E.W./0000-0003-4126-7492; van der Zwaag, Daan/0000-0003-0320-8715; van der Hofstad, Remco/0000-0003-1331-9697	European Research Council; Dutch Science Foundation (NWO); Netherlands Initiative for Regenerative Medicine; Dutch Ministry of Education, Culture and Science [024.001.035]	European Research Council(European Research Council (ERC)European Commission); Dutch Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Initiative for Regenerative Medicine; Dutch Ministry of Education, Culture and Science	We thank X. Zhuang and Nikon Europe for sharing data sets. Data sets for in vitro microtubules (18) were provided by X. Zhuang; data sets for microtubules in BSC-1 cells were provided by Nikon Europe. We thank T. de Greef and A. Palmans for useful discussions and the Institute for Complex Molecular Systems animation studio for the artwork. This work was supported by the European Research Council; the Dutch Science Foundation (NWO); the Netherlands Initiative for Regenerative Medicine; and the Dutch Ministry of Education, Culture and Science (Gravity program 024.001.035).	Adamcik J, 2010, NAT NANOTECHNOL, V5, P423, DOI [10.1038/nnano.2010.59, 10.1038/NNANO.2010.59]; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Albertazzi L, 2013, P NATL ACAD SCI USA, V110, P12203, DOI 10.1073/pnas.1303109110; Cantekin S, 2012, CHEM SOC REV, V41, P6125, DOI 10.1039/c2cs35156k; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Leenders CMA, 2013, CHEM COMMUN, V49, P1963, DOI 10.1039/c3cc38949a; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Pinotsi D, 2014, NANO LETT, V14, P339, DOI 10.1021/nl4041093; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P, 2013, NAT PROTOC, V8, P345, DOI 10.1038/nprot.2013.005; Shikata T, 2004, J PHYS CHEM B, V108, P508, DOI 10.1021/jp030510q; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Valle F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.158105; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c	21	184	185	5	233	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					491	495		10.1126/science.1250945	http://dx.doi.org/10.1126/science.1250945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786073				2022-12-24	WOS:000335157700036
J	Loscalzo, J				Loscalzo, Joseph			Keshan Disease, Selenium Deficiency, and the Selenoproteome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CLOSTRIDIAL GLYCINE REDUCTASE; GLUTATHIONE-PEROXIDASE; MUSCLE DISEASE; SELENOCYSTEINE; IDENTIFICATION; MOUSE; HEART; APOPTOSIS; COMPONENT; CODON		[Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Loscalzo, Joseph] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Loscalzo, J (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Loscalzo, Joseph/ABD-8980-2021					[Anonymous], 1979, CHINESE MED J-PEKING, V92, P471; Beck MA, 2003, J NUTR, V133, p1463S, DOI 10.1093/jn/133.5.1463S; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHEN CS, 1980, P NATL ACAD SCI-BIOL, V77, P1403, DOI 10.1073/pnas.77.3.1403; Chen JS, 2012, ASIA PAC J CLIN NUTR, V21, P320; CONE JE, 1976, P NATL ACAD SCI USA, V73, P2659, DOI 10.1073/pnas.73.8.2659; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; FORSTROM JW, 1978, BIOCHEMISTRY-US, V17, P2639, DOI 10.1021/bi00606a028; Horn MJ, 1941, J BIOL CHEM, V139, P649; Ishihara H, 1999, J NEUROL NEUROSUR PS, V67, P829, DOI 10.1136/jnnp.67.6.829; Jin RC, 2011, CIRCULATION, V123, P1963, DOI 10.1161/CIRCULATIONAHA.110.000034; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Li Y, 1995, Zhonghua Yi Xue Za Zhi, V75, P344; LI Y, 1995, ZHONGHUA YIXUE ZAZHI, V75, P382; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; Longtin R, 2004, J NATL CANCER I, V96, P504, DOI 10.1093/jnci/96.7.504; Loscalzo J, 2008, CELL METAB, V8, P182, DOI 10.1016/j.cmet.2008.08.004; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Maulik N, 1999, MOL CELL BIOCHEM, V196, P13, DOI 10.1023/A:1006905910140; MUTH OH, 1958, SCIENCE, V128, P1090, DOI 10.1126/science.128.3331.1090; Ottaviano FG, 2008, CIRC J, V72, P1, DOI 10.1253/circj.72.1; Ottaviano FG, 2009, MOL CELL BIOCHEM, V327, P111, DOI 10.1007/s11010-009-0049-x; Peng TQ, 2000, J CLIN MICROBIOL, V38, P3538, DOI 10.1128/JCM.38.10.3538-3543.2000; PINSENT J, 1954, BIOCHEM J, V57, P10, DOI 10.1042/bj0570010; Rivera MT, 2002, AM J TROP MED HYG, V66, P706, DOI 10.4269/ajtmh.2002.66.706; ROTRUCK JT, 1971, NATURE-NEW BIOL, V231, P223, DOI 10.1038/newbio231223a0; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; SHRIFT A, 1963, BIOCHIM BIOPHYS ACTA, V71, P483, DOI 10.1016/0006-3002(63)91113-2; TRELEASE SF, 1960, SCIENCE, V132, P618, DOI 10.1126/science.132.3427.618; TURNER DC, 1973, ARCH BIOCHEM BIOPHYS, V154, P366, DOI 10.1016/0003-9861(73)90069-6; Voetsch B, 2007, STROKE, V38, P41, DOI 10.1161/01.STR.0000252027.53766.2b; Wang G Y, 1979, Zhonghua Yu Fang Yi Xue Za Zhi, V13, P204; WELZ B, 1987, PURE APPL CHEM, V59, P927, DOI 10.1351/pac198759070927; Yang G Q, 1984, Adv Nutr Res, V6, P203; Yang G Q, 1988, World Rev Nutr Diet, V55, P98; Zhang Y, 2011, J BIOL CHEM, V286, P23623, DOI 10.1074/jbc.R110.172833; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	44	141	152	5	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1756	1760		10.1056/NEJMcibr1402199	http://dx.doi.org/10.1056/NEJMcibr1402199			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24785212				2022-12-24	WOS:000335405200017
J	Libri, V; Yandim, C; Athanasopoulos, S; Loyse, N; Natisvili, T; Law, PP; Chan, PK; Mohammad, T; Mauri, M; Tam, KT; Leiper, J; Piper, S; Ramesh, A; Parkinson, MH; Huson, L; Giunti, P; Festenstein, R				Libri, Vincenzo; Yandim, Cihangir; Athanasopoulos, Stavros; Loyse, Naomi; Natisvili, Theona; Law, Pui Pik; Chan, Ping Kei; Mohammad, Tariq; Mauri, Marta; Tam, Kin Tung; Leiper, James; Piper, Sophie; Ramesh, Aravind; Parkinson, Michael H.; Huson, Les; Giunti, Paola; Festenstein, Richard			Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; CLINICAL-TRIAL; MOUSE MODEL; HISTONE H3; INHIBITION; FRATAXIN; PHARMACOKINETICS; PROTEIN; METHYLTRANSFERASE; HETEROCHROMATIN	Background Friedreich's ataxia is a progressive degenerative disorder caused by deficiency of the frataxin protein. Expanded GAA repeats within intron 1 of the frataxin (FXN) gene lead to its heterochromatinisation and transcriptional silencing. Preclinical studies have shown that the histone deacetylase inhibitor nicotinamide (vitamin B3) can remodel the pathological heterochromatin and upregulate expression of FXN. We aimed to assess the epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia. Methods In this exploratory, open-label, dose-escalation study in the UK, male and female patients (aged 18 years or older) with Friedreich's ataxia were given single doses (phase 1) and repeated daily doses of 2-8 g oral nicotinamide for 5 days (phase 2) and 8 weeks (phase 3). Doses were gradually escalated during phases 1 and 2, with individual maximum tolerated doses used in phase 3. The primary outcome was the upregulation of frataxin expression. We also assessed the safety and tolerability of nicotinamide, used chromatin immunoprecipitation to investigate changes in chromatin structure at the FXN gene locus, and assessed the effect of nicotinamide treatment on clinical scales for ataxia. This study is registered with ClinicalTrials.gov, number NCT01589809. Findings Nicotinamide was generally well tolerated; the main adverse event was nausea, which in most cases was mild, dose-related, and resolved spontaneously or after dose reduction, use of antinausea drugs, or both. Phase 1 showed a dose-response relation for proportional change in frataxin protein concentration from baseline to 8 h post-dose, which increased with increasing dose (p = 0.0004). Bayesian analysis predicted that 3.8 g would result in a 1 5-times increase and 7.5 g in a doubling of frataxin protein concentration. Phases 2 and 3 showed that daily dosing at 3 5-6 g resulted in a sustained and significant (p < 0.0001) upregulation of frataxin expression, which was accompanied by a reduction in heterochromatin modifications at the FXN locus. Clinical measures showed no significant changes. Interpretation Nicotinamide was associated with a sustained improvement in frataxin concentrations towards those seen in asymptomatic carriers during 8 weeks of daily dosing. Further investigation of the long-term clinical benefits of nicotinamide and its ability to ameliorate frataxin deficiency in Friedreich's ataxia is warranted.	[Libri, Vincenzo] UCL, Leonard Wolfson Expt Neurol Ctr, London, England; [Parkinson, Michael H.; Giunti, Paola] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Athanasopoulos, Stavros; Loyse, Naomi; Mohammad, Tariq; Huson, Les] Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, Natl Inst Hlth Res Wellcome Trust, Imperial Clin Res Facil, London W12 0NN, England; [Yandim, Cihangir; Natisvili, Theona; Law, Pui Pik; Chan, Ping Kei; Festenstein, Richard] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, Gene Control Mech & Dis Grp, London W12 0NN, England; [Yandim, Cihangir; Natisvili, Theona; Law, Pui Pik; Chan, Ping Kei; Festenstein, Richard] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci, London W12 0NN, England; [Leiper, James; Piper, Sophie] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci,Nitr Oxide Signalling Grp, London W12 0NN, England; [Mauri, Marta] Max Delbruck Ctr Mol Med, Berlin, Germany; [Tam, Kin Tung] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Ramesh, Aravind] Christchurch Hosp, Dept Intens Care, Christchurch, New Zealand	University of London; University College London; University of London; University College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hong Kong; Christchurch Hospital New Zealand	Festenstein, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, Gene Control Mech & Dis Grp, London W12 0NN, England.	r.festenstein@imperial.ac.uk	YANDIM, Cihangir/AAA-2250-2021; Giunti, Paola/E-5526-2012	YANDIM, Cihangir/0000-0002-2050-6186; Giunti, Paola/0000-0003-3508-4788; Mauri, Marta/0000-0003-0098-3900; Leiper, James/0000-0003-4656-519X; Ramesh, Aravind/0000-0001-8302-7097; Law, Pui Pik/0000-0001-8924-0462	Ataxia UK; Ataxia Ireland; Association Suisse de l'Ataxie de Friedreich; Associazione Italiana per le Sindromi Atassiche; UK National Institute for Health Research; European Friedreich's Ataxia Consortium for Translational Studies; Imperial Biomedical Research Centre; MRC [MC_U120081321, MC_U120097118, MC_EX_G0801765, G116/182] Funding Source: UKRI; Medical Research Council [MC_U120097118, G116/182, MC_EX_G0801765, MC_U120081321] Funding Source: researchfish; Ataxia UK [7003] Funding Source: researchfish	Ataxia UK; Ataxia Ireland; Association Suisse de l'Ataxie de Friedreich; Associazione Italiana per le Sindromi Atassiche(Fondazione AIRC per la ricerca sul cancro); UK National Institute for Health Research(National Institute for Health Research (NIHR)); European Friedreich's Ataxia Consortium for Translational Studies; Imperial Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Ataxia UK	Ataxia UK, Ataxia Ireland, Association Suisse de l'Ataxie de Friedreich, Associazione Italiana per le Sindromi Atassiche, UK National Institute for Health Research, European Friedreich's Ataxia Consortium for Translational Studies, and Imperial Biomedical Research Centre.	Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BEAL MF, 1994, ANN NEUROL, V36, P882, DOI 10.1002/ana.410360613; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chan PK, 2013, HUM MOL GENET, V22, P2662, DOI 10.1093/hmg/ddt115; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Festenstein R, 2006, NAT CHEM BIOL, V2, P512, DOI 10.1038/nchembio1006-512; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; HORSMAN MR, 1993, RADIOTHER ONCOL, V27, P131, DOI 10.1016/0167-8140(93)90133-S; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; Koeppen AH, 2013, J NEUROCHEM, V126, P4, DOI 10.1111/jnc.12218; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lynch DR, 2012, MOVEMENT DISORD, V27, P1026, DOI 10.1002/mds.25058; Lynch DR, 2005, MOVEMENT DISORD, V20, P777, DOI 10.1002/mds.20449; Marcotte PA, 2004, ANAL BIOCHEM, V332, P90, DOI 10.1016/j.ab.2004.05.039; Mariotti C, 2012, MOVEMENT DISORD, V27, P446, DOI 10.1002/mds.24066; Meier T, 2012, J NEUROL, V259, P284, DOI 10.1007/s00415-011-6174-y; Ntzoufras I., 2009, BAYESIAN MODELING US; Oja H, 2010, MULTIVARIATE NONPARA; Perlman SL, 2012, J CHILD NEUROL, V27, P1217, DOI 10.1177/0883073812453872; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rufini A, 2011, HUM MOL GENET, V20, P1253, DOI 10.1093/hmg/ddq566; Sacca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017627; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schmitz-Hubsch T, 2008, NEUROLOGY, V71, P486, DOI 10.1212/01.wnl.0000324863.76290.19; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; SPECTOR R, 1979, J NEUROCHEM, V33, P291, DOI 10.1111/j.1471-4159.1979.tb11731.x; STRATFORD MRL, 1994, CANCER CHEMOTH PHARM, V34, P399, DOI 10.1007/s002800050161; Stratford MRL, 1996, BRIT J CANCER, V74, P16, DOI 10.1038/bjc.1996.309; Subramony SH, 2005, NEUROLOGY, V64, P1261, DOI 10.1212/01.WNL.0000156802.15466.79; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Willis JH, 2008, MOL GENET METAB, V94, P491, DOI 10.1016/j.ymgme.2008.03.019; Yandim C, 2013, J NEUROCHEM, V126, P21, DOI 10.1111/jnc.12254; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998	45	91	94	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					504	513		10.1016/S0140-6736(14)60382-2	http://dx.doi.org/10.1016/S0140-6736(14)60382-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9JR	24794816	Green Accepted, hybrid			2022-12-24	WOS:000340198300029
J	Maianti, JP; McFedries, A; Foda, ZH; Kleiner, RE; Du, XQ; Leissring, MA; Tang, WJ; Charron, MJ; Seeliger, MA; Saghatelian, A; Liu, DR				Maianti, Juan Pablo; McFedries, Amanda; Foda, Zachariah H.; Kleiner, Ralph E.; Du, Xiu Quan; Leissring, Malcolm A.; Tang, Wei-Jen; Charron, Maureen J.; Seeliger, Markus A.; Saghatelian, Alan; Liu, David R.			Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones	NATURE			English	Article							GENOME-WIDE ASSOCIATION; HIGH-FAT DIET; GLUCOSE-TOLERANCE; RISK LOCI; DEGRADATION; AMYLIN; MICE; MACROCYCLES; RECOGNITION; THERAPIES	Despite decades of speculation that inhibiting endogenous insulin degradation might treat type-2 diabetes(1,2), and the identification of IDE (insulin-degrading enzyme) as a diabetes susceptibility gene(3,4), the relationship between the activity of the zinc metalloprotein IDE and glucose homeostasis remains unclear. Although Ide(-/-) mice have elevated insulin levels, they exhibit impaired, rather than improved, glucose tolerance that may arise from compensatory insulin signalling dysfunction(5,6). IDE inhibitors that are active in vivo are therefore needed to elucidate IDE's physiological roles and to determine its potential to serve as a target for the treatment of diabetes. Here we report the discovery of a physiologically active IDE inhibitor identified from a DNA-templated macrocycle library. An X-ray structure of the macrocycle bound to IDE reveals that it engages a binding pocket away from the catalytic site, which explains its remarkable selectivity. Treatment of lean and obese mice with this inhibitor shows that IDE regulates the abundance and signalling of glucagon and amylin, in addition to that of insulin. Under physiological conditions that augment insulin and amylin levels, such as oral glucose administration, acute IDE inhibition leads to substantially improved glucose tolerance and slower gastric emptying. These findings demonstrate the feasibility of modulating IDE activity as a new therapeutic strategy to treat type-2 diabetes and expand our understanding of the roles of IDE in glucose and hormone regulation.	[Maianti, Juan Pablo; McFedries, Amanda; Kleiner, Ralph E.; Saghatelian, Alan; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Foda, Zachariah H.; Seeliger, Markus A.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Du, Xiu Quan; Charron, Maureen J.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Leissring, Malcolm A.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Irvine; University of Chicago; Harvard University; Howard Hughes Medical Institute	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	saghatelian@chemistry.harvard.edu; drliu@fas.harvard.edu	LEISSRING, MALCOLM/AAW-5361-2021; Seeliger, Markus A/D-6409-2013; Liu, David R./HCH-3132-2022	LEISSRING, MALCOLM/0000-0001-7185-4255; Tang, Wei-Jen/0000-0002-8267-8995; Seeliger, Markus/0000-0003-0990-1756	NIH/NIGMS [R01 GM065865, R00 GM080097, R01 GM81539, T32 GM008444, F30 CA174152, DP2 OD002374]; Howard Hughes Medical Institute; Diabetes and Cancer Centers of Albert Einstein College of Medicine; American Diabetes Association [7-11-CD-06]; Burroughs Wellcome Fund CABS; Searle Scholars Program; Fonds de Recherche en Sante du Quebec (FRSQ); Alfred Bader Fund; NATIONAL CANCER INSTITUTE [F30CA174152] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598, R01GM065865, P41GM111244, R01GM081539, R00GM080097, T32GM008444] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002374] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Diabetes and Cancer Centers of Albert Einstein College of Medicine; American Diabetes Association(American Diabetes Association); Burroughs Wellcome Fund CABS; Searle Scholars Program; Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Alfred Bader Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH/NIGMS (R01 GM065865 (D.R.L.), R00 GM080097 (M.A.S.), R01 GM81539 (W.-J.T.), T32 GM008444 (Z.H.F.), F30 CA174152 (Z.H.F.), DP2 OD002374 (A.S.)), Howard Hughes Medical Institute (D.R.L.), Diabetes and Cancer Centers of Albert Einstein College of Medicine (M.J.C.), American Diabetes Association no. 7-11-CD-06 (M.A.L.), Burroughs Wellcome Fund CABS (A.S.), and the Searle Scholars Program (A.S.). The Fonds de Recherche en Sante du Quebec (FRSQ) and the Alfred Bader Fund supported J.P.M. We thank C. Russ and H. Spurling (Broad Institute) and C. Daly (FAS Center for Systems Biology) for DNA sequencing assistance. We are grateful to S. Johnston and C. Mosher (Broad Institute) for 6bK stability measurements. W. Nolte provided mouse IDE, L. McCord purified CF-IDE and Y.-G. Kim performed CGRP cleavage assays. We are grateful to A. Badran, E. Homan, A.M. Lone and M. Leidl (Harvard University) for experimental assistance. We thank B. Kahn and N. Gray for discussions.	Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Ahren B, 2008, J ENDOCRINOL, V197, P181, DOI 10.1677/JOE-07-0460; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1974, DIABETES, V23, P536, DOI 10.2337/diab.23.6.536; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Gartner ZJ, 2004, SCIENCE, V305, P1601, DOI 10.1126/science.1102629; Gedulin BR, 2006, REGUL PEPTIDES, V137, P121, DOI 10.1016/j.regpep.2006.06.004; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Kim YG, 2012, P NATL ACAD SCI USA, V109, P8523, DOI 10.1073/pnas.1203195109; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; Mooradian AD, 1999, DRUGS, V57, P19, DOI 10.2165/00003495-199957010-00003; Riddle MC, 2006, DIABETES CARE, V29, P435, DOI 10.2337/diacare.29.02.06.dc05-1267; Sadry SA, 2013, NAT REV ENDOCRINOL, V9, P425, DOI 10.1038/nrendo.2013.47; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Tse BN, 2008, J AM CHEM SOC, V130, P15611, DOI 10.1021/ja805649f; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Young Andrew, 2005, Adv Pharmacol, V52, P193, DOI 10.1016/S1054-3589(05)52010-6; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	28	165	177	2	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					94	U474		10.1038/nature13297	http://dx.doi.org/10.1038/nature13297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24847884	Green Accepted, Green Published			2022-12-24	WOS:000338199400043
J	Hollowed, AB; Sundby, S				Hollowed, Anne B.; Sundby, Svein			ECOLOGY Change is coming to the northern oceans	SCIENCE			English	Editorial Material							POLLOCK THERAGRA-CHALCOGRAMMA; EASTERN BERING-SEA; CLIMATE-CHANGE; RECRUITMENT; ATLANTIC		[Hollowed, Anne B.] NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Sundby, Svein] Inst Marine Res, N-5005 Bergen, Norway; [Sundby, Svein] Hjort Ctr Marine Ecosyst Dynam, N-5005 Bergen, Norway	National Oceanic Atmospheric Admin (NOAA) - USA; Institute of Marine Research - Norway	Hollowed, AB (corresponding author), NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	anne.hollowed@noaa.gov; svein.sundby@imr.no		Sundby, Svein/0000-0002-0815-9740				Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; ELLERTSEN B, 1989, RAP PROCES, V191, P209; Gaichas S, 2009, PROG OCEANOGR, V81, P47, DOI 10.1016/j.pocean.2009.04.005; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; International Council for the Exploration of the Sea, 2013, 2013ACOM05 ICES CM, P05; Kjesbu OS, 2014, P NATL ACAD SCI USA, V111, P3478, DOI 10.1073/pnas.1316342111; Kotwicki S, 2013, DEEP-SEA RES PT II, V94, P231, DOI 10.1016/j.dsr2.2013.03.017; Mueter FJ, 2011, ICES J MAR SCI, V68, P1284, DOI 10.1093/icesjms/fsr022; NAKKEN O, 1994, ICES MAR SC, V198, P212; North Pacific Fishery Management Council (NPFMC), 2013, BER SEA AL ISL GROUN; Overland JE, 2012, DEEP-SEA RES PT II, V65-70, P6, DOI 10.1016/j.dsr2.2012.02.013; Saetersdal B., 1987, FISH RES, V5, P253; Sigler MF, 2011, OCEANOGRAPHY, V24, P250, DOI 10.5670/oceanog.2011.77; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085	14	33	35	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1084	1085		10.1126/science.1251166	http://dx.doi.org/10.1126/science.1251166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904138				2022-12-24	WOS:000336791200019
J	Zhang, Z; Wang, J; Schultz, N; Zhang, F; Parhad, SS; Tu, S; Vreven, T; Zamore, PD; Weng, ZP; Theurkauf, WE				Zhang, Zhao; Wang, Jie; Schultz, Nadine; Zhang, Fan; Parhad, Swapnil S.; Tu, Shikui; Vreven, Thom; Zamore, Phillip D.; Weng, Zhiping; Theurkauf, William E.			The HP1 Homolog Rhino Anchors a Nuclear Complex that Suppresses piRNA Precursor Splicing	CELL			English	Article							WIDE RNAI SCREEN; I-TASSER; PROTEIN; HETEROCHROMATIN; REQUIRES; PATHWAY; GENE; CAP; MECHANISM; CUTOFF	piRNAs guide an adaptive genome defense system that silences transposons during germline development. The Drosophila HP1 homolog Rhino is required for germline piRNA production. We show that Rhino binds specifically to the heterochromatic clusters that produce piRNA precursors, and that binding directly correlates with piRNA production. Rhino colocalizes to germline nuclear foci with Rai1/DXO-related protein Cuff and the DEAD box protein UAP56, which are also required for germline piRNA production. RNA sequencing indicates that most cluster transcripts are not spliced and that rhino, cuff, and uap56 mutations increase expression of spliced cluster transcripts over 100-fold. LacI::Rhino fusion protein binding suppresses splicing of a reporter transgene and is sufficient to trigger piRNA production from a trans combination of sense and antisense reporters. We therefore propose that Rhino anchors a nuclear complex that suppresses cluster transcript splicing and speculate that stalled splicing differentiates piRNA precursors from mRNAs.	[Zhang, Zhao; Schultz, Nadine; Zhang, Fan; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Wang, Jie; Tu, Shikui; Vreven, Thom; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Zhang, Zhao; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Zhang, Zhao; Zamore, Phillip D.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Zamore, Phillip D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, 368 Plantation St, Worcester, MA 01605 USA.	zhiping.weng@umassmed.edu; william.theurkauf@umassmed.edu	Parhad, Swapnil S./J-7174-2019	Parhad, Swapnil S./0000-0002-5723-9384; Zamore, Phillip/0000-0002-4505-9618; Theurkauf, William/0000-0001-7342-1912	National Institute of Child Health and Human Development, NIH [R01HD049116]; National Institutes of Health [GM62862]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Theurkauf and Weng labs and the UMass RNA biology community for critical feedback and encouragement. This work was supported by a grant R01HD049116 from the National Institute of Child Health and Human Development, NIH, to W. E. T., Z.W. and P.D.Z., and in part by National Institutes of Health grant GM62862 to P.D.Z.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Guzzardo PM, 2013, CURR OPIN GENET DEV, V23, P44, DOI 10.1016/j.gde.2012.12.003; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Keller C, 2012, MOL CELL, V47, P215, DOI 10.1016/j.molcel.2012.05.009; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Muerdter F, 2012, RNA, V18, P42, DOI 10.1261/rna.029769.111; Pane A, 2011, EMBO J, V30, P4601, DOI 10.1038/emboj.2011.334; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Zhao, 2012, Silence, V3, P9, DOI 10.1186/1758-907X-3-9; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	46	133	139	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1353	1363		10.1016/j.cell.2014.04.030	http://dx.doi.org/10.1016/j.cell.2014.04.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906152	Green Accepted, Bronze			2022-12-24	WOS:000340881400012
J	Reed, C				Reed, Christina			Winter is coming	SCIENCE			English	Editorial Material													Abreu, Carlos A F de/AGB-1792-2022	Abreu, Carlos A F de/0000-0001-5440-9563					0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1054	1054		10.1126/science.344.6187.1054	http://dx.doi.org/10.1126/science.344.6187.1054			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876500				2022-12-24	WOS:000336495800050
J	Joughin, I; Smith, BE; Medley, B				Joughin, Ian; Smith, Benjamin E.; Medley, Brooke			Marine Ice Sheet Collapse Potentially Under Way for the Thwaites Glacier Basin, West Antarctica	SCIENCE			English	Article							PINE ISLAND; SHELF; SATELLITE	Resting atop a deep marine basin, the West Antarctic Ice Sheet has long been considered prone to instability. Using a numerical model, we investigated the sensitivity of Thwaites Glacier to ocean melt and whether its unstable retreat is already under way. Our model reproduces observed losses when forced with ocean melt comparable to estimates. Simulated losses are moderate (<0.25 mm per year at sea level) over the 21st century but generally increase thereafter. Except possibly for the lowest-melt scenario, the simulations indicate that early-stage collapse has begun. Less certain is the time scale, with the onset of rapid (>1 mm per year of sea-level rise) collapse in the different simulations within the range of 200 to 900 years.	[Joughin, Ian; Smith, Benjamin E.; Medley, Brooke] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Joughin, I (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, 1013 NE 40th St, Seattle, WA 98105 USA.		Joughin, Ian R/A-2998-2008; Joughin, Ian/AAR-7778-2021	Joughin, Ian R/0000-0001-6229-679X; Joughin, Ian/0000-0001-6229-679X	NSF [ANT-0424589, ANT-0631973]; NASA [NNX09AE47G]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	Comments by M. Maki, D. Shapero, and four anonymous reviewers improved the manuscript. NSF supported I.J. and B.M.'s contribution (grants ANT-0424589 and ANT-0631973), and B.E.S. was supported by NASA (grant NNX09AE47G). We acknowledge NASA's Operation IceBridge, which provided much of the data used to constrain the model. The data used to constrain the model are archived at the University of Washington Library (http://dx.doi.org/10.6069/H5CC0XMK).	Borstad C. P., 2013, CRYOSPHERE DISCUSS, V7, P3567; Depoorter MA, 2013, NATURE, V502, P89, DOI 10.1038/nature12567; Favier L, 2014, NAT CLIM CHANGE, V4, P117, DOI [10.1038/nclimate2094, 10.1038/NCLIMATE2094]; Gagliardini O, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043334; Genthon C, 2009, ANN GLACIOL, V50, P55, DOI 10.3189/172756409787769681; Holt JW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025561; HUGHES TJ, 1981, J GLACIOL, V27, P518, DOI 10.3189/S002214300001159X; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jamieson SSR, 2012, NAT GEOSCI, V5, P799, DOI [10.1038/ngeo1600, 10.1038/NGEO1600]; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Joughin I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044819; Joughin I, 2009, J GLACIOL, V55, P245, DOI 10.3189/002214309788608705; Larour E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021693; MACAYEAL DR, 1989, J GEOPHYS RES-SOLID, V94, P4071, DOI 10.1029/JB094iB04p04071; Medley B., 2014, CRYOSPHERE DISCUSS, V8, P953, DOI DOI 10.5194/TCD-8-953-2014; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Mouginot J, 2014, GEOPHYS RES LETT, V41, P1576, DOI 10.1002/2013GL059069; Parizek BR, 2013, J GEOPHYS RES-EARTH, V118, P638, DOI 10.1002/jgrf.20044; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033365; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Shepherd A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014183; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; Tinto KJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049026; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]	32	519	530	5	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					735	738		10.1126/science.1249055	http://dx.doi.org/10.1126/science.1249055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24821948				2022-12-24	WOS:000335912900038
J	Potenski, CJ; Niu, HY; Sung, P; Klein, HL				Potenski, Catherine J.; Niu, Hengyao; Sung, Patrick; Klein, Hannah L.			Avoidance of ribonucleotide-induced mutations by RNase H2 and Srs2-Exo1 mechanisms	NATURE			English	Article							RAD51 PRESYNAPTIC FILAMENT; SACCHAROMYCES-CEREVISIAE; MISMATCH REPAIR; SRS2 HELICASE; ANTI-RECOMBINASE; TOPOISOMERASE-I; DNA; YEAST; PROTEIN; SIGNALS	Srs2 helicase is known to dismantle nucleofilaments of Rad51 recombinase to prevent spurious recombination events(1-6) and unwind trinucleotide sequences that are prone to hairpin formation(7). Here we document a new, unexpected genome maintenance role of Srs2 in the suppression of mutations arising from mis-insertion of ribonucleoside monophosphates during DNA replication. In cells lacking RNase H2, Srs2 unwinds DNA from the 5' side of a nick generated by DNA topoisomerase I-8 at a ribonucleoside monophosphate residue. In addition, Srs2 interacts with and enhances the activity of the nuclease Exo1, to generate a DNA gap in preparation for repair. Srs2-Exo1 thus functions in a new pathway of nick processing-gap filling that mediates tolerance of ribonucleoside monophosphates in the genome. Our results have implications for understanding the basis of Aicardi-Goutieres syndrome, which stems from inactivation of the human RNase H2 complex(9).	[Potenski, Catherine J.; Klein, Hannah L.] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA; [Niu, Hengyao; Sung, Patrick] Yale Univ, Sch Med, New Haven, CT 06520 USA	New York University; Yale University	Sung, P (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	patrick.sung@yale.edu; Hannah.Klein@nyumc.org	Niu, Hengyao/AAE-9269-2020	Klein, Hannah/0000-0003-4228-8535; Potenski, Catherine/0000-0002-4843-7071	National Institutes of Health [RO1GM053738, RO1ES007061, K99ES021441]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061, K99ES021441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Jinks-Robertson and T. Kunkel for plasmids used in strain construction, R. Bermejo and M. Foiani for the genome sequencing of the original hpr4 strain, and G.-M. Li and S. Lee for providing hEXO1. This work was supported by National Institutes of Health grants RO1GM053738 (to H. L. K.), RO1ES007061 (to P. S.) and K99ES021441 (to H.N.).	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; AGUILERA A, 1988, GENETICS, V119, P779; Bhattacharyya S, 2004, MOL CELL BIOL, V24, P7324, DOI 10.1128/MCB.24.17.7324-7330.2004; Chanet R, 1996, MOL CELL BIOL, V16, P4782; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Cho JE, 2013, DNA REPAIR, V12, P205, DOI 10.1016/j.dnarep.2012.12.004; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Scheller J, 2000, GENETICS, V155, P1069; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Seong C, 2009, J BIOL CHEM, V284, P24363, DOI 10.1074/jbc.M109.032953; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Spell Rachelle Miller, 2004, Methods Mol Biol, V262, P3; Van Komen S, 2003, J BIOL CHEM, V278, P44331, DOI 10.1074/jbc.M307256200; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585	26	69	69	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					251	+		10.1038/nature13292	http://dx.doi.org/10.1038/nature13292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24896181	Green Accepted			2022-12-24	WOS:000338649800050
J	McCartney, M				McCartney, Margaret			Jeremy Hunt's bizarre ideas show that he doesn't understand general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Adams Stephen, 2014, DAILY MAIL; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; NHS Choices, GUID NHS WAIT TIM	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2014	349								g4368	10.1136/bmj.g4368	http://dx.doi.org/10.1136/bmj.g4368			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YY	24986834	Green Published, hybrid			2022-12-24	WOS:000338645400021
J	Frank, M; Knechtli, C				Frank, Michael; Knechtli, Christopher			Lymphoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												michaelharris681@btinternet.com						Ardeshna KM, 2014, LANCET ONCOL, V15, P424, DOI 10.1016/S1470-2045(14)70027-0	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2014	348								g3736	10.1136/bmj.g3736	http://dx.doi.org/10.1136/bmj.g3736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LH	24934281	Bronze, Green Published			2022-12-24	WOS:000337805800010
J	Handel, MA; Eppig, JJ; Schimenti, JC				Handel, Mary Ann; Eppig, John J.; Schimenti, John C.			Applying "Gold Standards" to In-Vitro-Derived Germ Cells	CELL			English	Article							EMBRYONIC STEM-CELLS; METABOLIC COOPERATIVITY; MOUSE; MEIOSIS; OOCYTES; FATE; OOGENESIS; GENETICS; OVARIES; MICE	Germ cells are the ultimate stem cells, and reports of their in vitro derivation generate excitement due to potential applications in reproductive medicine. To date, there is no firm evidence that meiosis, the hallmark of gametogenesis, can be faithfully replicated outside of the gonad. We propose benchmarks for evaluating in vitro derivation of germ cells, facilitating realization of their potential.	[Handel, Mary Ann; Eppig, John J.] Jackson Lab, Bar Harbor, ME 04609 USA; [Schimenti, John C.] Cornell Univ, Ithaca, NY 14853 USA	Jackson Laboratory; Cornell University	Handel, MA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	maryann.handel@jax.org; jcs92@cornell.edu			NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045415] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA034196] Funding Source: Medline; NIGMS NIH HHS [R01 GM045415] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bolcun-Filas E, 2012, INT REV CEL MOL BIO, V298, P179, DOI 10.1016/B978-0-12-394309-5.00005-5; Dokshin GA, 2013, NAT GENET, V45, P877, DOI 10.1038/ng.2672; Duncan FE, 2009, BIOL REPROD, V81, P768, DOI 10.1095/biolreprod.109.077909; Eguizabal C, 2011, STEM CELLS, V29, P1186, DOI 10.1002/stem.672; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Lei L, 2013, P NATL ACAD SCI USA, V110, P8585, DOI 10.1073/pnas.1306189110; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Morgan CT, 2013, P NATL ACAD SCI USA, V110, P3411, DOI 10.1073/pnas.1300928110; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Oatley J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.100297; Okae H, 2014, HUM MOL GENET, V23, P992, DOI 10.1093/hmg/ddt495; Ramathal C, 2014, CELL REP, V7, P1284, DOI 10.1016/j.celrep.2014.03.067; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Woods DC, 2013, REPROD SCI, V20, P7, DOI 10.1177/1933719112462632; Wu GM, 2005, GENETICS, V170, P327, DOI 10.1534/genetics.104.039479; Yuan JH, 2013, STEM CELLS, V31, P2538, DOI 10.1002/stem.1480; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109	22	60	63	3	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1257	1261		10.1016/j.cell.2014.05.019	http://dx.doi.org/10.1016/j.cell.2014.05.019			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906145	Green Accepted, Bronze			2022-12-24	WOS:000340881400005
J	Majeed, A				Majeed, Azeem			PRIMARY CARE Statins for primary prevention of cardiovascular disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, London, England; [Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	Imperial College London; Imperial College London	Majeed, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	a.majeed@imperial.ac.uk		Majeed, Azeem/0000-0002-2357-9858	Department of Health Funding Source: Medline	Department of Health		Artac M, 2013, FAM PRACT, V30, P426, DOI 10.1093/fampra/cmt002; Artac M, 2013, PREV MED, V57, P129, DOI 10.1016/j.ypmed.2013.05.002; Iacobucci G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1748; Majeed A, 2014, BMJ; NICE, LIP MOD UPD GUID CON; OECD, 2013, HLTH GLANC 2013 OECD	6	6	6	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3491	10.1136/bmj.g3491	http://dx.doi.org/10.1136/bmj.g3491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24868092				2022-12-24	WOS:000336741400013
J	Dillon, CP; Weinlich, R; Rodriguez, DA; Cripps, JG; Quarato, G; Gurung, P; Verbist, KC; Brewer, TL; Llambi, F; Gong, YN; Janke, LJ; Kelliher, MA; Kanneganti, TD; Green, DR				Dillon, Christopher P.; Weinlich, Ricardo; Rodriguez, Diego A.; Cripps, James G.; Quarato, Giovanni; Gurung, Prajwal; Verbist, Katherine C.; Brewer, Taylor L.; Llambi, Fabien; Gong, Yi-Nan; Janke, Laura J.; Kelliher, Michelle A.; Kanneganti, Thirumala-Devi; Green, Douglas R.			RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3	CELL			English	Article							DEATH DOMAIN KINASE; NECROSIS-FACTOR RECEPTOR; KAPPA-B ACTIVATION; PROGRAMMED NECROSIS; CELL-DEATH; TNF; UBIQUITINATION; SURVIVAL; INDUCE; FADD	Receptor-interacting protein kinase (RIPK)-1 is involved in RIPK3-dependent and -independent signaling pathways leading to cell death and/or inflammation. Genetic ablation of ripk1 causes postnatal lethality, which was not prevented by deletion of ripk3, caspase-8, or fadd. However, animals that lack RIPK1, RIPK3, and either caspase-8 or FADD survived weaning and matured normally. RIPK1 functions in vitro to limit caspase-8-dependent, TNFR-induced apoptosis, and animals lacking RIPK1, RIPK3, and TNFR1 survive to adulthood. The role of RIPK3 in promoting lethality in ripk1(-/-) mice suggests that RIPK3 activation is inhibited by RIPK1 postbirth. Whereas TNFR-induced RIPK3-dependent necroptosis requires RIPK1, cells lacking RIPK1 were sensitized to necroptosis triggered by poly I: C or interferons. Disruption of TLR (TRIF) or type I interferon (IFNAR) signaling delayed lethality in ripk1(-/-)tnfr1(-/-) mice. These results clarify the complex roles for RIPK1 in postnatal life and provide insights into the regulation of FADD-caspase-8 and RIPK3-MLKL signaling by RIPK1.	[Dillon, Christopher P.; Weinlich, Ricardo; Rodriguez, Diego A.; Cripps, James G.; Quarato, Giovanni; Gurung, Prajwal; Verbist, Katherine C.; Brewer, Taylor L.; Llambi, Fabien; Gong, Yi-Nan; Kanneganti, Thirumala-Devi; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Janke, Laura J.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Kelliher, Michelle A.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Massachusetts System; University of Massachusetts Worcester	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale, Memphis, TN 38105 USA.	douglas.green@stjude.org	Green, Douglas R/N-8083-2018; Weinlich, Ricardo/S-7495-2016; Kanneganti, Thirumala-Devi/Y-2503-2019; Weinlich, Ricardo/AAW-3154-2020; Dillon, Christopher/P-4457-2014; Quarato, Giovanni/F-8272-2016; Kanneganti, Thirumala-Devi/M-9435-2018; Janke, Laura/N-8121-2018	Green, Douglas R/0000-0002-7332-1417; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Weinlich, Ricardo/0000-0001-6822-7330; Dillon, Christopher/0000-0002-9458-0266; Quarato, Giovanni/0000-0003-1167-3422; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Janke, Laura/0000-0002-9871-6239; Rodriguez, Diego/0000-0003-4771-0221; Gurung, Prajwal/0000-0002-7451-9433; Verbist, Katherine/0000-0002-3511-5639	U.S. National Institutes of Health [AI44828, CA169291]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA169291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075118, R01AI044828, R37AI044828] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Mao Yang, Patrick Fitzgerald, and Maggie Barr for extensive technical assistance. The work was supported by grants from the U.S. National Institutes of Health (AI44828 and CA169291 to D.R.G.) and the American Lebanese Syrian Associated Charities.	Amara JF, 1997, P NATL ACAD SCI USA, V94, P10618, DOI 10.1073/pnas.94.20.10618; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Khan N, 2014, CURR OPIN IMMUNOL, V26, P76, DOI 10.1016/j.coi.2013.10.017; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Tait SWG, 2013, CELL REP, V5, P878, DOI 10.1016/j.celrep.2013.10.034; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wittkopf N, 2013, GASTROENTEROLOGY, V145, P1369, DOI 10.1053/j.gastro.2013.08.059; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	55	375	381	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1189	1202		10.1016/j.cell.2014.04.018	http://dx.doi.org/10.1016/j.cell.2014.04.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24813850	Green Accepted, Bronze			2022-12-24	WOS:000336437200019
J	Setoguchi, S; Stevenson, LW; Stewart, GC; Bhatt, DL; Epstein, AE; Desai, M; Williams, LA; Chen, CY				Setoguchi, Soko; Stevenson, Lynne Warner; Stewart, Garrick C.; Bhatt, Deepak L.; Epstein, Andrew E.; Desai, Manisha; Williams, Lauren A.; Chen, Chih-Ying			Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOMERULAR-FILTRATION-RATE; OCCUPATIONAL EPIDEMIOLOGY; MYOCARDIAL-INFARCTION; MORTALITY; THERAPY; DISEASE; DEATH; HOSPITALIZATION; COLLABORATION; POPULATION	Objective To assess the potential contribution of unmeasured general health status to patient selection in assessments of the clinical effectiveness of implantable cardioverter-defibrillator (ICD) therapy. Design Retrospective cohort study. Setting Linked data from an ICD registry, heart failure registry, and Medicare claims data for ICDs implanted in 2005 through 2009. Participants 29 426 patients admitted to hospital with heart failure aged 66 years or older and eligible for ICD therapy for primary prevention. Main outcome measures Non-traumatic hip fracture, admission to a skilled nursing facility, and 30 day mortality-outcomes unlikely to be improved by ICD therapy. Results Compared with 17 853 patients without ICD therapy, 11 573 patients with ICD therapy were younger and had lower ejection fraction and more cardiac admissions to hospital but fewer non-cardiac admissions to hospital and comorbid conditions. Patients with ICD therapy had greater freedom from unrelated events after adjusting for age and sex: hip fracture (hazard ratio 0.77, 95% confidence interval 0.64 to 0.92), skilled nursing facility admission (0.53, 0.50 to 0.55), and 30 day mortality (0.12, 0.10 to 0.15). Conclusions Lower risks of measured outcomes likely reflect unmeasured differences in comorbidity and frailty. The findings highlight potential pitfalls of observational comparative effectiveness research and support physician consideration of general health status in selecting patients for ICD therapy.	[Setoguchi, Soko; Williams, Lauren A.; Chen, Chih-Ying] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Setoguchi, Soko; Stevenson, Lynne Warner; Stewart, Garrick C.; Bhatt, Deepak L.; Williams, Lauren A.; Chen, Chih-Ying] Harvard Univ, Sch Med, Boston, MA USA; [Setoguchi, Soko] Duke Univ, Duke Clin Res Inst, Sch Med, Durham, NC 27715 USA; [Stevenson, Lynne Warner; Stewart, Garrick C.; Bhatt, Deepak L.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Epstein, Andrew E.] Univ Penn, Cardiovasc Div, Electrophysiol Sect, Philadelphia, PA 19104 USA; [Desai, Manisha] Stanford Univ, Sch Med, Quantitat Sci Unit, Palo Alto, CA 94304 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Duke University; Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Stanford University	Setoguchi, S (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	soko@post.harvard.edu			Agency for Healthcare Research and Quality, US Department of Health and Human Services as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program [HHSA29020050016I]; Centers for Medicare & Medicaid Services, US Department of Health and Human Services [HHSM500201000001I]; Agency for Healthcare Research and Quality [K02HS017731]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017731] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, US Department of Health and Human Services as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Centers for Medicare & Medicaid Services, US Department of Health and Human Services; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded under contract No HHSA29020050016I, task order 3, from the Agency for Healthcare Research and Quality, US Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program; and contract No HHSM500201000001I, task orders 2 and 6, from the Centers for Medicare & Medicaid Services, US Department of Health and Human Services. SS was supported by midcareer development award K02HS017731 from the Agency for Healthcare Research and Quality.	Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bavry AA, 2006, J CLIN EPIDEMIOL, V59, P763, DOI 10.1016/j.jclinepi.2005.12.015; Cacciatore F, 2005, EUR J CLIN INVEST, V35, P723, DOI 10.1111/j.1365-2362.2005.01572.x; Centers for Medicare & Medicaid Services, 2013, NAT COV DET NCD IMPL; Chan PS, 2006, ARCH INTERN MED, V166, P2228, DOI 10.1001/archinte.166.20.2228; CHECKOWAY H, 1990, ARCH ENVIRON HEALTH, V45, P95, DOI 10.1080/00039896.1990.9935932; Fonarow GC, 2011, AM HEART J, V161, P1024, DOI 10.1016/j.ahj.2011.01.027; FOX AJ, 1976, BRIT J PREV SOC MED, V30, P225; Frasure-Smith N, 2009, CIRCULATION, V120, P134, DOI 10.1161/CIRCULATIONAHA.109.851675; Friedmann E, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.009; Glynn RJ, 2006, J CLIN EPIDEMIOL, V59, P819, DOI 10.1016/j.jclinepi.2005.12.012; HALLSTROM AP, 1991, STAT MED, V10, P1621, DOI 10.1002/sim.4780101013; HEMMINKI E, 1993, J CLIN EPIDEMIOL, V46, P211, DOI 10.1016/0895-4356(93)90068-C; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Hernandez AF, 2010, CIRC-HEART FAIL, V3, P7, DOI 10.1161/CIRCHEARTFAILURE.109.884395; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Knol MJ, 2010, J CLIN EPIDEMIOL, V63, P728, DOI 10.1016/j.jclinepi.2009.08.028; Konstam V, 1996, AM J CARDIOL, V78, P890, DOI 10.1016/S0002-9149(96)00463-8; Lee DS, 2007, J AM COLL CARDIOL, V49, P2408, DOI 10.1016/j.jacc.2007.02.058; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Little R.J.A., 2002, STAT ANAL MISSING DA; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mehta PA, 2008, EUR J HEART FAIL, V10, P1108, DOI 10.1016/j.ejheart.2008.09.004; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Murberg TA, 2004, INT J PSYCHIAT MED, V34, P207, DOI 10.2190/GKJ2-P8BD-V59X-MJNQ; Piccini JP, 2008, CIRCULATION, V118, P926, DOI 10.1161/CIRCULATIONAHA.108.773838; RAY WA, 1992, J CLIN EPIDEMIOL, V45, P703, DOI 10.1016/0895-4356(92)90047-Q; Ray WA, 2002, INJ PREV, V8, P276, DOI 10.1136/ip.8.4.276; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; ROBINS J, 1989, STAT MED, V8, P679, DOI 10.1002/sim.4780080608; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; Setoguchi S, 2014, CIRC CARDIOVASC QUAL; Setoguchi S, 2007, CIRCULATION, V115, P27, DOI 10.1161/CIRCULATIONAHA.106.650176; Setoguchi S, 2009, CAN MED ASSOC J, V180, P611, DOI 10.1503/cmaj.080769; Skali H, 2011, AM HEART J, V162, P548, DOI 10.1016/j.ahj.2011.06.006; Smith SC, 2008, HEART RHYTHM, V5, P934, DOI 10.1016/j.hrthm.2008.04.015; Stevenson LW, 2008, J AM COLL CARDIOL, V52, P1702, DOI 10.1016/j.jacc.2008.08.028; Stewart GC, 2010, J CARD FAIL, V16, P106, DOI 10.1016/j.cardfail.2009.09.003; Tung P, 2013, NAT REV CARDIOL, V10, P135, DOI 10.1038/nrcardio.2012.201	44	27	27	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2014	348								g2866	10.1136/bmj.g2866	http://dx.doi.org/10.1136/bmj.g2866			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OM	24812112	Green Published, hybrid			2022-12-24	WOS:000335819700002
J	Costandi, M				Costandi, Moheb			REHABILITATION Machine recovery	NATURE			English	Editorial Material							ROBOT-ASSISTED THERAPY; UPPER-LIMB IMPAIRMENT; STROKE											Burgar CG, 2011, J REHABIL RES DEV, V48, P445, DOI 10.1682/JRRD.2010.04.0062; Jarrasse N., 2013, IEEE INT C REH ROB; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Lambercy O, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-63; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Maciejasz P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-3; Taheri H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-10; Volpe BT, 2000, NEUROLOGY, V54, P1938, DOI 10.1212/WNL.54.10.1938; Wagner TH, 2011, STROKE, V42, P2630, DOI 10.1161/STROKEAHA.110.606442	9	8	8	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S8	S9		10.1038/510S8a	http://dx.doi.org/10.1038/510S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964027				2022-12-24	WOS:000337806300006
J	Fukushima, FB; Bezerra, DM; Boas, PJFV; Valle, AP; Vidal, EIO				Fukushima, Fernanda B.; Bezerra, Dailson M.; Villas Boas, Paulo J. F.; Valle, Adriana P.; Vidal, Edison I. O.			Complex regional pain syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fukushima, Fernanda B.; Bezerra, Dailson M.] Univ Estadual Paulista UNESP, Dept Anesthesiol, BR-18618970 Botucatu, SP, Brazil; [Villas Boas, Paulo J. F.; Valle, Adriana P.; Vidal, Edison I. O.] Univ Estadual Paulista UNESP, Dept Internal Med, BR-18618970 Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Fukushima, FB (corresponding author), Univ Estadual Paulista UNESP, Dept Anesthesiol, BR-18618970 Botucatu, SP, Brazil.	ffukushima@fmb.unesp.br	Fukushima, Fernanda Bono/AAR-2740-2021; Valle, Adriana/ABI-5894-2020; Vidal, Edison Iglesias de Oliveira/G-1882-2012; Fukushima, Fernanda Bono/E-3196-2012; Boas, Paulo J F Villas/I-4656-2014; Valle, Adriana P/F-9897-2014	Vidal, Edison Iglesias de Oliveira/0000-0002-1573-4678; Fukushima, Fernanda Bono/0000-0001-8055-5425; Boas, Paulo J F Villas/0000-0001-9876-3222; Valle, Adriana P/0000-0002-0090-8524				Albazaz R, 2008, ANN VASC SURG, V22, P297, DOI 10.1016/j.avsg.2007.10.006; Allen G, 1999, PAIN, V80, P539, DOI 10.1016/S0304-3959(98)00246-2; Beerthuizen A, 2012, PAIN, V153, P1187, DOI 10.1016/j.pain.2012.01.026; Centre for Clinical Practice at NICE (UK)-National Institute for Health and Care Excellence: Clinical Guidelines, 2010, NEUR PAIN PHARM MAN; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; de Mos M, 2009, CLIN J PAIN, V25, P590, DOI 10.1097/AJP.0b013e3181a11623; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Goebel A, 2012, COMPLEX REGIONAL PAI; Harden RN, 2013, PAIN MED, V14, P180, DOI 10.1111/pme.12033; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; International Association for the Study of Pain, CLASSIFICATION CHRON; Marinus Johan, 2011, Lancet Neurol, V10, P637, DOI 10.1016/S1474-4422(11)70106-5; Moseley GL, 2014, J PAIN, V15, P16, DOI 10.1016/j.jpain.2013.08.009; O'Connell NE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009416.pub2; Sandroni P, 2003, PAIN, V103, P199, DOI 10.1016/S0304-3959(03)00065-4	15	8	9	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2014	348								g3683	10.1136/bmj.g3683	http://dx.doi.org/10.1136/bmj.g3683			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UK	24965221	Green Published			2022-12-24	WOS:000338202200001
J	Wilkinson, ST; D'Souza, DC				Wilkinson, Samuel T.; D'Souza, Deepak Cyril			Problems With the Medicalization of Marijuana	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		[Wilkinson, Samuel T.; D'Souza, Deepak Cyril] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA; [D'Souza, Deepak Cyril] Connecticut Mental Hlth Ctr, Abraham Ribicoff Res Facil, New Haven, CT 06519 USA; [D'Souza, Deepak Cyril] VA Connecticut Healthcare Syst, Schizophrenia & Neuropharmacol Res Grp, West Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	D'Souza, DC (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Psychiat Serv 116A,VA Connecticut Healthcare Syst, 950 Campbell Ave, West Haven, CT 06516 USA.	deepak.dsouza@yale.edu	Wilkinson, Samuel/GQP-1952-2022		NIMH NIH HHS [R25 MH071584, L30 MH111000] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH071584] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bhattacharyya S, 2010, NEUROPSYCHOPHARMACOL, V35, P764, DOI 10.1038/npp.2009.184; Budney AJ, 2006, CURR OPIN PSYCHIATR, V19, P233, DOI 10.1097/01.yco.0000218592.00689.e5; Callaghan RC, 2013, CANCER CAUSE CONTROL, V24, P1811, DOI 10.1007/s10552-013-0259-0; Castle D, 2012, MARIJUANA MADNESS; Cooper ZD, 2013, NEUROPSYCHOPHARMACOL, V38, P1984, DOI 10.1038/npp.2013.97; Kleber HD, 2012, AM J PSYCHIAT, V169, P564, DOI 10.1176/appi.ajp.2012.12030373; Leweke FM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.15; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Verweij PE, 2000, JAMA-J AM MED ASSOC, V284, P2875, DOI 10.1001/jama.284.22.2875	10	33	36	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2377	2378		10.1001/jama.2014.6175	http://dx.doi.org/10.1001/jama.2014.6175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24845238	Green Accepted			2022-12-24	WOS:000337301500014
J	Farvid, MS; Cho, E; Chen, WY; Eliassen, AH; Willett, WC				Farvid, Maryam S.; Cho, Eunyoung; Chen, Wendy Y.; Eliassen, A. Heather; Willett, Walter C.			Dietary protein sources in early adulthood and breast cancer incidence: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHASEOLUS-VULGARIS L.; TOTAL-ENERGY-INTAKE; FOOD-CONSUMPTION; FATTY-ACIDS; MEAT INTAKE; RISK; WOMEN; METAANALYSIS; NUTRITION; HEALTH	Objective To investigate the association between dietary protein sources in early adulthood and risk of breast cancer. Design Prospective cohort study. Setting Health professionals in the United States. Participants 88 803 premenopausal women from the Nurses' Health Study II who completed a questionnaire on diet in 1991. Main outcome measure Incident cases of invasive breast carcinoma, identified through self report and confirmed by pathology report. Results We documented 2830 cases of breast cancer during 20 years of follow-up. Higher intake of total red meat was associated with an increased risk of breast cancer overall (relative risk 1.22, 95% confidence interval 1.06 to 1.40; P-trend=0.01, for highest fifth v lowest fifth of intake). However, higher intakes of poultry, fish, eggs, legumes, and nuts were not related to breast cancer overall. When the association was evaluated by menopausal status, higher intake of poultry was associated with a lower risk of breast cancer in postmenopausal women (0.73, 0.58 to 0.91; P-trend=0.02, for highest fifth v lowest fifth of intake) but not in premenopausal women (0.93, 0.78 to 1.11; P-trend=0.60, for highest fifth v lowest fifth of intake). In estimating the effects of exchanging different protein sources, substituting one serving/day of legumes for one serving/day of red meat was associated with a 15% lower risk of breast cancer among all women (0.85, 0.73 to 0.98) and a 19% lower risk among premenopausal women (0.81, 0.66 to 0.99). Also, substituting one serving/day of poultry for one serving/day of red meat was associated with a 17% lower risk of breast cancer overall (0.83, 0.72 to 0.96) and a 24% lower risk of postmenopausal breast cancer (0.76, 0.59 to 0.99). Furthermore, substituting one serving/day of combined legumes, nuts, poultry, and fish for one serving/day of red meat was associated with a 14% lower risk of breast cancer overall (0.86, 0.78 to 0.94) and premenopausal breast cancer (0.86, 0.76 to 0.98). Conclusion Higher red meat intake in early adulthood may be a risk factor for breast cancer, and replacing red meat with a combination of legumes, poultry, nuts and fish may reduce the risk of breast cancer.	[Farvid, Maryam S.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Farvid, Maryam S.] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Dept Community Nutr, Tehran, Iran; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA; [Cho, Eunyoung; Chen, Wendy Y.; Eliassen, A. Heather; Willett, Walter C.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Cho, Eunyoung; Chen, Wendy Y.; Eliassen, A. Heather; Willett, Walter C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chen, Wendy Y.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Eliassen, A. Heather; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Shahid Beheshti University Medical Sciences; Brown University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Farvid, MS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	mfarvid@hsph.harvard.edu	Cho, Eunyoung/AAV-4469-2020; f, m/AAM-2063-2021	Cho, Eunyoung/0000-0001-6594-2582; Eliassen, A Heather/0000-0002-3961-6609; Farvid, Maryam/0000-0003-1783-4186	National Institutes of Health [R01CA050385]; NATIONAL CANCER INSTITUTE [UM1CA176726, R01CA050385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health grant (R01CA050385). The study sponsors were not involved in the study design and collection, analysis, and interpretation of data, or the writing of the article or the decision to submit it for publication. The authors were independent from study sponsors.	Alexander DD, 2010, NUTR RES REV, V23, P349, DOI 10.1017/S0954422410000235; Andersson AM, 1999, EUR J ENDOCRINOL, V140, P477, DOI 10.1530/eje.0.1400477; Aune D, 2012, ANN ONCOL, V23, P1394, DOI 10.1093/annonc/mdr589; Buck K, 2010, AM J CLIN NUTR, V92, P141, DOI 10.3945/ajcn.2009.28573; Carruba G, 2006, NUTR CANCER, V56, P253, DOI 10.1207/s15327914nc5602_18; Cho EY, 2006, ARCH INTERN MED, V166, P2253, DOI 10.1001/archinte.166.20.2253; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; DeStefani E, 1997, CANCER EPIDEM BIOMAR, V6, P573; Dial S, 1995, TOCOPHEROLS TOCOTRIE, P327; Engeset D, 2006, INT J CANCER, V119, P175, DOI 10.1002/ijc.21819; Farvid MS, 2014, BREAST CANCER RES TR, V145, P255, DOI 10.1007/s10549-014-2895-9; Ferrucci LM, 2009, BRIT J CANCER, V101, P178, DOI 10.1038/sj.bjc.6605118; Gago-Dominguez M, 2003, BRIT J CANCER, V89, P1686, DOI 10.1038/sj.bjc.6601340; Genkinger JM, 2013, CANCER CAUSE CONTROL, V24, P675, DOI 10.1007/s10552-013-0146-8; Halton TL, 2006, AM J CLIN NUTR, V83, P284; Holland GWA, 1991, COMPOSITION FOODS; Holmes MD, 2003, INT J CANCER, V104, P221, DOI 10.1002/ijc.10910; Kallianpur AR, 2008, BREAST CANCER RES TR, V107, P123, DOI 10.1007/s10549-007-9538-3; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Lauber SN, 2004, CARCINOGENESIS, V25, P2509, DOI 10.1093/carcin/bgh268; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Missmer SA, 2002, INT J EPIDEMIOL, V31, P78, DOI 10.1093/ije/31.1.78; Nutrient Database for Standard Reference Release 14, 2001, NUTR DAT STAND REF R; Pala V, 2009, AM J CLIN NUTR, V90, P602, DOI 10.3945/ajcn.2008.27173; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Steck SE, 2007, EPIDEMIOLOGY, V18, P373, DOI 10.1097/01.ede.0000259968.11151.06; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; Thompson MD, 2012, CELL CYCLE, V11, P835, DOI 10.4161/cc.11.5.19676; Thompson MD, 2012, CARCINOGENESIS, V33, P226, DOI 10.1093/carcin/bgr247; Wahner-Roedler DL, 2003, MAYO CLIN PROC, V78, P708, DOI 10.4065/78.6.708; Weroha SJ, 2012, ENDOCRIN METAB CLIN, V41, P335, DOI 10.1016/j.ecl.2012.04.014; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Willett WC, 1997, AM J CLIN NUTR, P1229; Zheng JS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3706	36	71	72	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2014	348								g3437	10.1136/bmj.g3437	http://dx.doi.org/10.1136/bmj.g3437			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1FH	24916719	hybrid, Green Published			2022-12-24	WOS:000337400800001
J	Rickard, JA; O'Donnell, JA; Evans, JM; Lalaoui, N; Poh, AR; Rogers, T; Vince, JE; Lawlor, KE; Ninnis, RL; Anderton, H; Hall, C; Spall, SK; Phesse, TJ; Abud, HE; Cengia, LH; Corbin, J; Mifsud, S; Di Rago, L; Metcalf, D; Ernst, M; Dewson, G; Roberts, AW; Alexander, WS; Murphy, JM; Ekert, PG; Masters, SL; Vaux, DL; Croker, BA; Gerlic, M; Silke, J				Rickard, James A.; O'Donnell, Joanne A.; Evans, Joseph M.; Lalaoui, Najoua; Poh, Ashleigh R.; Rogers, TeWhiti; Vince, James E.; Lawlor, Kate E.; Ninnis, Robert L.; Anderton, Holly; Hall, Cathrine; Spall, Sukhdeep K.; Phesse, Toby J.; Abud, Helen E.; Cengia, Louise H.; Corbin, Jason; Mifsud, Sandra; Di Rago, Ladina; Metcalf, Donald; Ernst, Matthias; Dewson, Grant; Roberts, Andrew W.; Alexander, Warren S.; Murphy, James M.; Ekert, Paul G.; Masters, Seth L.; Vaux, David L.; Croker, Ben A.; Gerlic, Motti; Silke, John			RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis	CELL			English	Article							TUMOR-NECROSIS-FACTOR; MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; CELL-DEATH; TNF; NECROPTOSIS; CASPASE-8; ACTIVATION; INDUCTION; APOPTOSIS	Upon ligand binding, RIPK1 is recruited to tumor necrosis factor receptor superfamily (TNFRSF) and Toll-like receptor (TLR) complexes promoting prosurvival and inflammatory signaling. RIPK1 also directly regulates caspase-8-mediated apoptosis or, if caspase-8 activity is blocked, RIPK3-MLKL-dependent necroptosis. We show that C57BL/6 Ripk1(-/-) mice die at birth of systemic inflammation that was not transferable by the hematopoietic compartment. However, Ripk1(-/-) progenitors failed to engraft lethally irradiated hosts properly. Blocking TNF reversed this defect in emergency hematopoiesis but, surprisingly, Tnfr1 deficiency did not prevent inflammation in Ripk1(-/-) neonates. Deletion of Ripk3 or Mlkl, but not Casp8, prevented extracellular release of the necroptotic DAMP, IL-33, and reduced Myd88-dependent inflammation. Reduced inflammation in the Ripk1(-/-) Ripk3(-/-), Ripk1(-/-)Mlkl(-/-), and Ripk1(-/-)Myd88(-/-) mice prevented neonatal lethality, but only Ripk1(-/-)Ripk3(-/-)Casp8(-/-) mice survived past weaning. These results reveal a key function for RIPK1 in inhibiting necroptosis and, thereby, a role in limiting, not only promoting, inflammation.	[Rickard, James A.; O'Donnell, Joanne A.; Evans, Joseph M.; Lalaoui, Najoua; Poh, Ashleigh R.; Vince, James E.; Lawlor, Kate E.; Ninnis, Robert L.; Anderton, Holly; Hall, Cathrine; Spall, Sukhdeep K.; Phesse, Toby J.; Cengia, Louise H.; Corbin, Jason; Mifsud, Sandra; Di Rago, Ladina; Metcalf, Donald; Ernst, Matthias; Dewson, Grant; Roberts, Andrew W.; Alexander, Warren S.; Murphy, James M.; Ekert, Paul G.; Masters, Seth L.; Vaux, David L.; Croker, Ben A.; Gerlic, Motti; Silke, John] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Rickard, James A.; O'Donnell, Joanne A.; Lalaoui, Najoua; Poh, Ashleigh R.; Vince, James E.; Lawlor, Kate E.; Ninnis, Robert L.; Anderton, Holly; Hall, Cathrine; Spall, Sukhdeep K.; Phesse, Toby J.; Cengia, Louise H.; Corbin, Jason; Mifsud, Sandra; Di Rago, Ladina; Metcalf, Donald; Ernst, Matthias; Dewson, Grant; Roberts, Andrew W.; Alexander, Warren S.; Murphy, James M.; Ekert, Paul G.; Masters, Seth L.; Vaux, David L.; Croker, Ben A.; Gerlic, Motti; Silke, John] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Evans, Joseph M.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Rogers, TeWhiti] Univ Melbourne, Dept Pathol, Parkville, Vic 3050, Australia; [Abud, Helen E.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Roberts, Andrew W.] Univ Melbourne, Fac Med, Parkville, Vic 3050, Australia; [Croker, Ben A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol & Oncol, Boston, MA 02115 USA; [Gerlic, Motti] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel	Walter & Eliza Hall Institute; University of Melbourne; La Trobe University; University of Melbourne; Monash University; University of Melbourne; Harvard University; Boston Children's Hospital; Harvard Medical School; Tel Aviv University; Sackler Faculty of Medicine	Gerlic, M (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	mgerlic@post.tau.ac.il; j.silke@latrobe.edu.au	Mifsud, Sandra/AAM-6041-2021; Gerlic, Motti/U-3484-2017; Masters, Seth L/N-2886-2013; Roberts, Andrew W./C-6736-2012; O'Donnell, Joanne/HHZ-2106-2022; dewson, grant/C-7646-2013; Murphy, James/B-4863-2017; Vaux, David L/C-7249-2013; Ernst, Matthias/D-5111-2012; Ekert, Paul/Q-1842-2015; gerlic, Motti/I-5492-2019; Lalaoui, Najoua/C-1410-2014; Silke, John/B-7622-2008	Gerlic, Motti/0000-0001-9518-1833; Masters, Seth L/0000-0003-4763-576X; Roberts, Andrew W./0000-0002-7341-5720; dewson, grant/0000-0003-4251-8898; Murphy, James/0000-0003-0195-3949; Vaux, David L/0000-0003-2703-1651; Ernst, Matthias/0000-0002-6399-1177; Ekert, Paul/0000-0002-2976-8617; gerlic, Motti/0000-0001-9518-1833; Lalaoui, Najoua/0000-0002-0165-3324; Silke, John/0000-0002-7611-5774; Lawlor, Kate/0000-0003-0471-6842; O'Donnell, Joanne/0000-0002-8434-1050; Anderton, Holly/0000-0003-3913-9686; Poh, Ashleigh/0000-0001-8375-4753; Abud, Helen/0000-0003-3792-4023; Mifsud, Sandra/0000-0002-1010-292X; Croker, Ben/0000-0002-0885-3599; Phesse, Toby/0000-0001-9568-4916	NHMRC [1016647, 461221, 1016701, 1025594, 1046984, 1046010, 1025239, 637367, 1008131, 1057905]; Australian Research Council Fellowship; APA scholarship; Dora Lush Scholarship; La Trobe University Postgraduate Research Scholarship; VESKI innovation fellowship; ARC Fellowship; Cancer Council Victoria Carden Fellowship; NHMRC fellowships [541901, 1058344, 637309]; Australian Cancer Research Fund, Victorian State Government Operational Infrastructure Support; NHMRC IRIISS grant [361646]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Fellowship(Australian Research Council); APA scholarship; Dora Lush Scholarship; La Trobe University Postgraduate Research Scholarship; VESKI innovation fellowship; ARC Fellowship(Australian Research Council); Cancer Council Victoria Carden Fellowship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC fellowships(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Fund, Victorian State Government Operational Infrastructure Support; NHMRC IRIISS grant(National Health and Medical Research Council (NHMRC) of Australia)	We thank staff in the WEHI Bioservices facility, Vishva Dixit for Ripk3<SUP>-/-</SUP> mice, Michelle Kelliher for Ripk1<SUP>-/-</SUP> mice, Heinrich Korner for Tnf<SUP>-/-</SUP> and Tnfr1<SUP>-/-</SUP> mice, Stephen Hedrick for Casp8<SUP>fl/fl</SUP> mice, and Anne Voss for helpful discussions. This work was supported by NHMRC grants (1016647, 461221, 1016701, 1025594, 1046984, 1046010, 1025239, 637367, 1008131, and 1057905), an Australian Research Council Fellowship (B.A.C.), an APA scholarship (J.A.R.), a Dora Lush Scholarship (J.A.O.), a La Trobe University Postgraduate Research Scholarship (J.M. E.), a VESKI innovation fellowship (S.L.M.), ARC Fellowship (J.M. M.), Cancer Council Victoria Carden Fellowship (D.M.), and NHMRC fellowships to J.S., W.S.A., and A.W.R. (541901, 1058344, and 637309) with additional support from the Australian Cancer Research Fund, Victorian State Government Operational Infrastructure Support, and an NHMRC IRIISS grant (361646).	Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Panayotova-Dimitrova D, 2013, CELL REP, V5, P397, DOI 10.1016/j.celrep.2013.09.035; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pearl-Yafe M, 2010, STEM CELLS, V28, P1270, DOI 10.1002/stem.448; Piao XH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003558; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmukle AC, 2012, J CELL SCI, V125, P549, DOI 10.1242/jcs.091793; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Weill D, 1996, J INTERF CYTOK RES, V16, P395, DOI 10.1089/jir.1996.16.395; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wong WWL, 2014, BLOOD, V123, P2562, DOI 10.1182/blood-2013-06-510743; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	46	407	416	9	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1175	1188		10.1016/j.cell.2014.04.019	http://dx.doi.org/10.1016/j.cell.2014.04.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24813849	Bronze			2022-12-24	WOS:000336437200018
J	Naqvi, N; Li, M; Calvert, JW; Tejada, T; Lambert, JP; Wu, JX; Kesteven, SH; Holman, SR; Matsuda, T; Lovelock, JD; Howard, WW; Iismaa, SE; Chan, AY; Crawford, BH; Wagner, MB; Martin, DIK; Lefer, DJ; Graham, RM; Husain, A				Naqvi, Nawazish; Li, Ming; Calvert, John W.; Tejada, Thor; Lambert, Jonathan P.; Wu, Jianxin; Kesteven, Scott H.; Holman, Sara R.; Matsuda, Torahiro; Lovelock, Joshua D.; Howard, Wesley W.; Iismaa, Siiri E.; Chan, Andrea Y.; Crawford, Brian H.; Wagner, Mary B.; Martin, David I. K.; Lefer, David J.; Graham, Robert M.; Husain, Ahsan			A Proliferative Burst during Preadolescence Establishes the Final Cardiomyocyte Number	CELL			English	Article							GROWTH-FACTOR-I; THYROID-HORMONE; TRANSGENIC MICE; MYOCYTE PROLIFERATION; HEART REGENERATION; CARDIAC-FUNCTION; DNA-SYNTHESIS; HYPERTROPHY; OVEREXPRESSION; CONTRACTILITY	It is widely believed that perinatal cardiomyocyte terminal differentiation blocks cytokinesis, thereby causing binucleation and limiting regenerative repair after injury. This suggests that heart growth should occur entirely by cardiomyocyte hypertrophy during preadolescence when, in mice, cardiac mass increases many-fold over a few weeks. Here, we show that a thyroid hormone surge activates the IGF-1/IGF-1-R/Akt pathway on postnatal day 15 and initiates a brief but intense proliferative burst of predominantly binuclear cardiomyocytes. This proliferation increases cardiomyocyte numbers by similar to 40%, causing a major disparity between heart and cardiomyocyte growth. Also, the response to cardiac injury at postnatal day 15 is intermediate between that observed at postnatal days 2 and 21, further suggesting persistence of cardiomyocyte proliferative capacity beyond the perinatal period. If replicated in humans, this may allow novel regenerative therapies for heart diseases.	[Naqvi, Nawazish; Tejada, Thor; Matsuda, Torahiro; Lovelock, Joshua D.; Howard, Wesley W.; Husain, Ahsan] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; [Li, Ming; Wu, Jianxin; Kesteven, Scott H.; Holman, Sara R.; Iismaa, Siiri E.; Chan, Andrea Y.; Graham, Robert M.] Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; [Calvert, John W.; Lambert, Jonathan P.; Lefer, David J.] Emory Univ, Sch Med, Carlyle Fraser Heart Ctr, Div Cardiothorac Surg,Dept Surg, Atlanta, GA 30308 USA; [Crawford, Brian H.; Wagner, Mary B.] Childrens Healthcare Atlanta, Ctr Cardiovasc Biol, Atlanta, GA 30322 USA; [Martin, David I. K.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Iismaa, Siiri E.; Graham, Robert M.] Univ New S Wales, Kensington, NSW 2033, Australia	Emory University; Victor Chang Cardiac Research Institute; Emory University; Children's Healthcare of Atlanta (CHOA); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of New South Wales Sydney	Graham, RM (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia.	b.graham@victorchang.edu.au; ahusai2@emory.edu	Lambert, Jonathan P/P-1766-2018; Iismaa, Siiri/C-9300-2013; Calvert, John W/F-4497-2014; Husain, Ahsan/J-6861-2012; Kesteven, Scott/I-8008-2015	Lambert, Jonathan P/0000-0001-7048-6841; Iismaa, Siiri/0000-0003-2409-7356; Calvert, John W/0000-0001-6858-6042; Husain, Ahsan/0000-0003-3426-3469; Lefer, David/0000-0003-2293-7278; Li, Ming/0000-0002-7699-4502	Division of Cardiology, Department of Medicine, Emory University; Carlyle Fraser Heart Center, Emory University Hospital Midtown; NIH [HL079040]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079040, T32HL007745, P20HL113452, R01HL098481, R01HL088488] Funding Source: NIH RePORTER	Division of Cardiology, Department of Medicine, Emory University; Carlyle Fraser Heart Center, Emory University Hospital Midtown; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Cardiology, Department of Medicine, Emory University; the Carlyle Fraser Heart Center, Emory University Hospital Midtown; NIH grants to A.H. (HL079040), J.W.C. (HL098481), M.B.W. (HL088488), and T.T. (T32HL007745); a John and Mary Brock Translational Research Fund grant (to A. H.); a Regenerative Engineering and Medicine (REM) center at Emory and Georgia Tech grant (to A.H. and N.N.); an Emory and Children's Center for Cardiovascular Biology pilot grant (to A. H., N.N., and M.B.W.); an American Heart Association Scientist Development grant (to N.N.); National Health and Medical Research Council of Australia grants (to R.M. G, S.E.I., and M.L.); a Heart Foundation of Australia grant (to R.M. G., M.L., and S.E.I.); an R.T. Hall Estate grant (to R.M.G., M.L., and S.E.I.); and an Australian Research Council Stem Cells Australia, Special Initiative in Stem Cell Science grant (to R.M.G.). We thank Michael P. Feneley for help with interpretation of the cardiac hemodynamic data, and Alexa Mattheyses at the Integrated Cellular Imaging Core, Emory University, for advice and training in 3D-SIM microscopy.	Bizzozero G, 1894, BMJ, Vi, P728; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chowdhury D, 2001, J THORAC CARDIOV SUR, V122, P1023, DOI 10.1067/mtc.2001.116192; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Dai WD, 2011, CIRC-CARDIOVASC INTE, V4, P311, DOI 10.1161/CIRCINTERVENTIONS.111.964049; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Haddad F, 2008, AM J PHYSIOL-HEART C, V294, pH29, DOI 10.1152/ajpheart.01125.2007; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; KRISS JP, 1962, CANCER RES, V22, P254; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li M, 2008, CIRC RES, V102, P677, DOI 10.1161/CIRCRESAHA.107.161737; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; MIRSKY I, 1973, BIOPHYS J, V13, P1141, DOI 10.1016/S0006-3495(73)86051-5; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Pantos C, 2007, MOL CELL BIOCHEM, V297, P65, DOI 10.1007/s11010-006-9323-3; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Poolman RA, 1998, J MOL CELL CARDIOL, V30, P2121, DOI 10.1006/jmcc.1998.0808; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Saiki Y, 1997, SURGERY, V122, P412, DOI 10.1016/S0039-6060(97)90034-9; Schiros CG, 2013, AM J CARDIOL, V111, P1067, DOI 10.1016/j.amjcard.2012.12.027; Sedmera D, 2003, J MOL CELL CARDIOL, V35, P301, DOI 10.1016/S0022-2828(03)00011-7; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Sundgren NC, 2003, AM J PHYSIOL-REG I, V285, pR1481, DOI 10.1152/ajpregu.00232.2003; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Xing WR, 2012, J BONE MINER RES, V27, P1067, DOI 10.1002/jbmr.1551; Zhu CJ, 2005, BIOCHEM J, V389, P373, DOI 10.1042/BJ20050097	36	184	190	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					795	807		10.1016/j.cell.2014.03.035	http://dx.doi.org/10.1016/j.cell.2014.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813607	Green Accepted, Bronze			2022-12-24	WOS:000335765500009
J	Viros, A; Sanchez-Laorden, B; Pedersen, M; Furney, SJ; Rae, J; Hogan, K; Ejiama, S; Girotti, MR; Cook, M; Dhomen, N; Marais, R				Viros, Amaya; Sanchez-Laorden, Berta; Pedersen, Malin; Furney, Simon J.; Rae, Joel; Hogan, Kate; Ejiama, Sarah; Girotti, Maria Romina; Cook, Martin; Dhomen, Nathalie; Marais, Richard			Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53	NATURE			English	Article							MELANOCYTIC NEVI; SEQUENCING DATA; P53 GAIN; MUTATIONS; MICE; SUNSCREEN; CANCER; EXPRESSION; PREVENTION; EXPOSURE	Cutaneous melanoma is epidemiologically linked to ultraviolet radiation (UVR), but the molecular mechanisms by which UVR drives melanomagenesis remain unclear(1,2). The most common somatic mutation in melanoma is a V600E substitution in BRAF, which is an early event(3). To investigate how UVR accelerates oncogenic BRAF-driven melanomagenesis, we used a BRAF(V600E) mouse model. In mice expressing BRAF(V600E) in their melanocytes, a single dose of UVR that mimicked mild sunburn in humans induced clonal expansion of the melanocytes, and repeated doses of UVR increased melanoma burden. Here we show that sunscreen (UVA superior, UVB sun protection factor (SPF) 50) delayed the onset of UVR-driven melanoma, but only provided partial protection. The UVR-exposed tumours showed increased numbers of single nucleotide variants and we observed mutations (H39Y, S124F, R245C, R270C, C272G) in the Trp53 tumour suppressor in approximately 40% of cases. TP53 is an accepted UVR target in human non-melanoma skin cancer, but is not thought to have a major role in melanoma(4). However, we show that, in mice, mutant Trp53 accelerated BRAF(V600E)-driven melanomagenesis, and that TP53 mutations are linked to evidence of UVR-induced DNA damage inhuman melanoma. Thus, we provide mechanistic insight into epidemiological data linking UVR to acquired naevi in humans(5). Furthermore, we identify TP53/Trp53 as a UVR-target gene that cooperates with BRAF(V600E) to induce melanoma, providing molecular insight into how UVR accelerates melanomagenesis. Our study validates public health campaigns that promote sunscreen protection for individuals at risk of melanoma.	[Viros, Amaya; Sanchez-Laorden, Berta; Furney, Simon J.; Hogan, Kate; Ejiama, Sarah; Girotti, Maria Romina; Cook, Martin; Marais, Richard] Univ Manchester, Canc Res UK Manchester Inst, Mol Oncol Grp, Manchester M20 4BX, Lancs, England; [Pedersen, Malin; Rae, Joel; Dhomen, Nathalie; Marais, Richard] Inst Canc Res, Signal Transduct Team, London SW3 6JB, England; [Cook, Martin] Royal Surrey Cty Hosp, Guildford GU2 7XX, Surrey, England	Cancer Research UK; University of Manchester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Surrey County Hospital	Marais, R (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Mol Oncol Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	richard.marais@cruk.manchester.ac.uk	Sanchez-Laorden, Berta/T-2177-2017	Sanchez-Laorden, Berta/0000-0002-6499-6332; Viros, Amaya/0000-0001-5177-5015; Furney, Simon/0000-0002-8920-6800; Marais, Richard/0000-0001-7484-4183; Dhomen, Nathalie/0000-0003-1961-2173	Cancer Research UK [C107/A10433, C5759/A12328, A13540, A17240]; Wenner-Gren Foundations; Stockholm; Teggerstiftelsen; FEBS Long-Term Fellowship; Cancer Research UK [17240, 19279] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wenner-Gren Foundations; Stockholm; Teggerstiftelsen; FEBS Long-Term Fellowship; Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (C107/A10433; C5759/A12328; A13540; A17240), the Wenner-Gren Foundations, Stockholm, Teggerstiftelsen (M.P.) and a FEBS Long-Term Fellowship (B.S.-L.). We thank G. Ashton for technical assistance and A. Young for helpful discussions. We would like to acknowledge the contribution of the melanoma specimen donors and research groups to The Cancer Genome Atlas.	Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Goldenhersh MA, 2011, J CLIN ONCOL, V29, pE557, DOI 10.1200/JCO.2011.35.5727; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; HARRISON SL, 1994, LANCET, V344, P1529, DOI 10.1016/S0140-6736(94)90348-4; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo C, 2013, CANCER RES, V73, P4337, DOI 10.1158/0008-5472.CAN-12-4454; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Patton EE, 2005, ZEBRAFISH, V1, P363, DOI 10.1089/zeb.2005.1.363; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Planta MB, 2011, J AM BOARD FAM MED, V24, P735, DOI 10.3122/jabfm.2011.06.100178; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; PONTEN F, 1995, J INVEST DERMATOL, V105, P402, DOI 10.1111/1523-1747.ep12321071; Rudolph P, 1998, HUM PATHOL, V29, P1480, DOI 10.1016/S0046-8177(98)90019-3; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Thomas NE, 2007, CANCER EPIDEM BIOMAR, V16, P991, DOI 10.1158/1055-9965.EPI-06-1038; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Turajlic S, 2012, GENOME RES, V22, P196, DOI 10.1101/gr.125591.111; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Vultur Adina, 2013, Cancer Cell, V23, P706, DOI 10.1016/j.ccr.2013.05.001; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yeh I, 2013, JNCI-J NATL CANCER I, V105, P917, DOI 10.1093/jnci/djt119; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	38	147	150	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					478	+		10.1038/nature13298	http://dx.doi.org/10.1038/nature13298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24919155	Green Accepted			2022-12-24	WOS:000339335700049
J	Berkley, S; Dybul, M; Godal, T; Lake, A				Berkley, Seth; Dybul, Mark; Godal, Tore; Lake, Anthony			Integration and innovation to advance newborn survival	LANCET			English	Editorial Material									[Berkley, Seth] GAVI Alliance, CH-1202 Geneva, Switzerland; [Dybul, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Godal, Tore] Norwegian Minist Foreign Affairs, Oslo, Norway; [Lake, Anthony] UNICEF, New York, NY USA	UNICEF	Berkley, S (corresponding author), GAVI Alliance, CH-1202 Geneva, Switzerland.	sberkley@gavialliance.org						Bhutta ZA, 2014, LANCET; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Darmstadt GL, 2014, LANCET; Dickson KE, 2014, LANCET; Gertler P, REWARDING P IN PRESS; Lawn JE, 2014, LANCET; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Mason E, 2014, LANCET; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Nair H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S30; Save the Children, 2014, END NEWB DEATHS ENS; WHO, 2014, MAT NEON TET MNT EL; You D, 2013, LEVELS TRENDS CHILD	13	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					E22	E23		10.1016/S0140-6736(14)60691-7	http://dx.doi.org/10.1016/S0140-6736(14)60691-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24853595				2022-12-24	WOS:000338921500001
J	Alcaide, M; Scordato, ESC; Price, TD; Irwin, DE				Alcaide, Miguel; Scordato, Elizabeth S. C.; Price, Trevor D.; Irwin, Darren E.			Genomic divergence in a ring species complex	NATURE			English	Article							PHYLLOSCOPUS-TROCHILOIDES; SPECIATION; EVOLUTION; ADAPTATION; COMPONENT; SYMPATRY; SOFTWARE; DISTANCE	Ring species provide particularly clear demonstrations of how one species can gradually evolve into two, but are rare in nature(1-3). In the greenish warbler (Phylloscopus trochiloides) species complex, a ring of populations wraps around Tibet. Two reproductively isolated forms co-exist in central Siberia, with a gradient of genetic and phenotypic characteristics through the southern chain of populations connecting them(4-6). Previous genetic evidence has proven inconclusive, however, regarding whether species divergence took place in the face of continuous gene flow and whether hybridization between the terminal forms of the ring ever occurred(7-9). Here we use genome-wide analyses to show that, although spatial patterns of genetic variation are currently mostly as expected of a ring species, historical breaks in gene flow have existed at more than one location around the ring, and the two Siberian forms have occasionally interbred. Substantial periods of geographical isolation occurred not only in the north but also in the western Himalayas, where there is now an extensive hybrid zone between genetically divergent forms. Limited asymmetric introgression has occurred directly between the Siberian forms, although it has not caused a blending of those forms, suggesting selection against introgressed genes in the novel genetic background. Levels of reproductive isolation and genetic introgression are consistent with levels of phenotypic divergence around the ring, with phenotypic similarity and extensive interbreeding across the southwestern contact zone and strong phenotypic divergence and nearly complete reproductive isolation across the northern contact zone. These results cast doubt on the hypothesis that the greenish warbler should be viewed as a rare example of speciation by distance(6), but demonstrate that the greenish warbler displays a continuum from slightly divergent neighbouring populations to almost fully reproductively isolated species.	[Alcaide, Miguel; Irwin, Darren E.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Alcaide, Miguel; Irwin, Darren E.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Alcaide, Miguel] CSIC, Dept Evolutionary Ecol, Estn Biol Donana, Seville 41092, Spain; [Scordato, Elizabeth S. C.; Price, Trevor D.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Scordato, Elizabeth S. C.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of British Columbia; University of British Columbia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Chicago; University of Colorado System; University of Colorado Boulder	Irwin, DE (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	irwin@zoology.ubc.ca	Irwin, Darren E./G-6183-2012	Irwin, Darren E./0000-0002-1050-5841; Alcaide, Miguel/0000-0001-6945-0972	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [273773]; NSERC discovery grant [311931]; US NSF	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); US NSF(National Science Foundation (NSF))	This research was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (project no. 273773) and an NSERC discovery grant (no. 311931). Original collections were made with a grant from the US NSF. We thank Z. Benowitz-Fredericks, J. Gibson, S. Gross, J. Irwin, G. Kelberg, A. Knorre, K. Marchetti and B. Sheldon for assistance in the field. For additional samples we thank P. Alstrom, K. Marchetti, U. Olsson, A. Richman and J. Tiainen. We thank J. Irwin and L. Rieseberg for comments and discussion and A. Kuzmin for assistance during library preparation.	BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Cacho NI, 2012, P ROY SOC B-BIOL SCI, V279, P3377, DOI 10.1098/rspb.2012.0498; Coyne JA, 2004, SPECIATION, V37; Dobzhansky T., 1958, CENTURY DARWIN, P19; Drummond A., 2011, GENEIOUS V5 5; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endler J.A., 1977, Monographs in Population Biology, pi; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; Irwin D.E., 2012, CREATING CONSILIENCE, P163; Irwin Darren E., 2005, P27; Irwin DE, 2012, AM NAT, V180, P35, DOI 10.1086/666002; Irwin DE, 2005, SCIENCE, V307, P414, DOI 10.1126/science.1105201; Irwin DE, 2001, GENETICA, V112, P223, DOI 10.1023/A:1013319217703; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kovylov NS, 2012, BIOL BULL+, V39, P729, DOI 10.1134/S1062359012090038; Martins AB, 2013, P NATL ACAD SCI USA, V110, P5080, DOI 10.1073/pnas.1217034110; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Price T, 2008, SPECIATION BIRDS; Price TD, 2002, EVOLUTION, V56, P2083; Pritchard JK, 2000, GENETICS, V155, P945; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Ticehurst CB., 1938, SYSTEMATIC REV GENUS; Wake DB, 2001, NATURE, V409, P299, DOI 10.1038/35053264; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Weir JT, 2011, AM NAT, V177, P462, DOI 10.1086/658910	34	93	99	1	202	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					83	U433		10.1038/nature13285	http://dx.doi.org/10.1038/nature13285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870239				2022-12-24	WOS:000338199400040
J	Silver, J				Silver, Jonathan			Drugs for Macular Degeneration, Price Discrimination, and Medicare's Responsibility Not to Overpay	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									George Washington Univ, Washington, DC 20052 USA	George Washington University	Silver, J (corresponding author), George Washington Univ, 801 22nd St NW,Ste 739, Washington, DC 20052 USA.	jesilver@gwu.edu		Silver, Jonathan/0000-0001-9231-6368				[Anonymous], 2012, MED PAYM DRUGS US TE; [Anonymous], REV MED PART B AV LU; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Rodwin Marc, 2013, MANAGING OFF LABEL D	4	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					23	24		10.1001/jama.2014.6672	http://dx.doi.org/10.1001/jama.2014.6672			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	24860863				2022-12-24	WOS:000338131100012
J	Corbyn, Z				Corbyn, Zoe			A GROWING GLOBAL BURDEN	NATURE			English	Editorial Material																			0	40	48	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S2	S3		10.1038/510S2a	http://dx.doi.org/10.1038/510S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ6LK	24964023	Bronze			2022-12-24	WOS:000337806300002
J	Li, PY; Qian, H; Wu, JH				Li, Peiyue; Qian, Hui; Wu, Jianhua			Accelerate research on land creation	NATURE			English	Editorial Material									[Li, Peiyue; Qian, Hui; Wu, Jianhua] Changan Univ, Sch Environm Sci & Engn, Xian, Peoples R China	Chang'an University	Li, PY (corresponding author), Changan Univ, Sch Environm Sci & Engn, Xian, Peoples R China.	lipy2@163.com	Wu, Jianhua/G-4389-2017; Qian, Hui/B-9558-2019; Li, Peiyue/F-3831-2011	Wu, Jianhua/0000-0001-6423-1762; Qian, Hui/0000-0002-9354-4060; Li, Peiyue/0000-0001-8771-3369				Allen F, 2005, J FINANC ECON, V77, P57, DOI 10.1016/j.jfineco.2004.06.010; Burns Shirley Stewart, 2007, BRINGING MOUNTAINS I; Crotty M.G., 2002, VILLANOVA ENV LAW J, V13, P287; Li M., 1992, POPULATION MODERN CH, P83; Qian W., 2013, NEWSWEEK, V2, P26; Song Q., 2013, CHINA CONSTRUCTION, V20, P21; Sun JZ, 2005, LOESSOLOGY, V1; [张明泉 ZHANG Ming-quan], 2009, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V23, P77; Zhao F., 2013, CHINA BUS J A, VA13, P1	9	175	202	20	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					29	31		10.1038/510029a	http://dx.doi.org/10.1038/510029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24910868	Bronze			2022-12-24	WOS:000336768900015
J	Bourzac, K				Bourzac, Katherine			BIOLOGY Three known unknowns	NATURE			English	Editorial Material																		Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543	1	32	34	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S69	S71		10.1038/509S69a	http://dx.doi.org/10.1038/509S69a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870828	Bronze			2022-12-24	WOS:000336457100011
J	El-Sadr, WM; Philip, NM; Justman, J				El-Sadr, Wafaa M.; Philip, Neena M.; Justman, Jessica			Letting HIV Transform Academia - Embracing Implementation Science	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[El-Sadr, Wafaa M.; Philip, Neena M.; Justman, Jessica] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY 10027 USA	Columbia University	El-Sadr, WM (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY 10027 USA.		Justman, Jessica/AAA-3572-2020					[Anonymous], 1890, P INST SETH LOW LL D; Hirokazu Yoshikawa, 2013, INVESTING OUR FUTURE; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V56, P199, DOI 10.1097/QAI.0b013e31820bb448; Wildavsky B., 2010, GREAT BRAIN RACE GLO	5	17	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1679	1681		10.1056/NEJMp1314777	http://dx.doi.org/10.1056/NEJMp1314777			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG4QM	24785205	Green Published			2022-12-24	WOS:000335405200005
J	Fuentes, I; Stegemann, S; Golczyk, H; Karcher, D; Bock, R				Fuentes, Ignacia; Stegemann, Sandra; Golczyk, Hieronim; Karcher, Daniel; Bock, Ralph			Horizontal genome transfer as an asexual path to the formation of new species	NATURE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; INTERCELLULAR MOVEMENT; TISSUE; PLANTS; ORGANIZATION; POLYPLOIDY; PROTOPLASM; DIVERSITY; NUCLEAR; GLAUCA	Allopolyploidization, the combination of the genomes from two different species, has been a major source of evolutionary innovation and a driver of speciation and environmental adaptation(1-4). Inplants, it has also contributed greatly to crop domestication, as the superior properties of many modern crop plants were conferred by ancient allopolyploidization events(5,6). It is generally thought that allopolyploidization occurred through hybridization events between species, accompanied or followed by genome duplication(6,7). Although many allopolyploids arose from closely related species (congeners), there are also allopolyploid species that were formed from more distantly related progenitor species belonging to different genera or even different tribes(8). Here we have examined the possibility that allopolyploidization can also occur by asexual mechanisms. We show that upon grafting-a mechanism of plant-plant interaction that is widespread in nature-entire nuclear genomes can be transferred between plant cells. We provide direct evidence for this process resulting in speciation by creating a new allopolyploid plant species from a herbaceous species and a woody species in the nightshade family. The new species is fertile and produces fertile progeny. Our data highlight natural grafting as a potential asexual mechanism of speciation and also provide a method for the generation of novel allopolyploid crop species.	[Fuentes, Ignacia; Stegemann, Sandra; Karcher, Daniel; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany; [Golczyk, Hieronim] John Paul II Catholic Univ Lublin, Inst Biotechnol, Dept Mol Biol, PL-20708 Lublin, Poland	Max Planck Society; Catholic University of Lublin	Bock, R (corresponding author), Max Planck Inst Mol Pflanzenphysiol, Muhlenberg 1, D-14476 Potsdam, Germany.	rbock@mpimp-golm.mpg.de	Fuentes, Ignacia/G-4785-2016; Bock, Ralph/B-4352-2009	Bock, Ralph/0000-0001-7502-6940; Karcher, Daniel/0000-0001-6393-7376	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank the MPI-MP Green Team for help with plant transformation, K. Kohl for providing the hpt vector and S. Ruf (MPI-MP) for discussions. We are grateful to J. Fuchs (IPK Gatersleben) for advice on flow cytometry measurements. This research was financed by the Max Planck Society.	Beddie A. D., 1942, T P R SOC NZ, V71, P199; Chester M, 2012, P NATL ACAD SCI USA, V109, P1176, DOI 10.1073/pnas.1112041109; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; EVANS DA, 1980, PHYSIOL PLANTARUM, V48, P225, DOI 10.1111/j.1399-3054.1980.tb03246.x; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Joly S, 2009, MOL PHYLOGENET EVOL, V51, P365, DOI 10.1016/j.ympev.2009.02.015; KUSTER E, 1899, JB WISS BOT, V0033, P00487; Larson P.R., 1994, SPRINGER SERIES, P1; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Moon HS, 2008, GENOME, V51, P547, DOI 10.1139/G08-039; Mudge K., 2009, Horticultural Reviews, V35, P437; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mursalimov SR, 2013, PLANTA, V238, P415, DOI 10.1007/s00425-013-1914-0; Paterson AH, 2005, GENETICA, V123, P191, DOI 10.1007/s10709-003-2742-0; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Seidel C. F., 1879, NATURWISS GES ISIS D, P161; SHEPARD JF, 1983, SCIENCE, V219, P683, DOI 10.1126/science.219.4585.683; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Thyssen G, 2012, P NATL ACAD SCI USA, V109, P2439, DOI 10.1073/pnas.1114297109; Trojak-Goluch A, 2003, J APPL GENET, V44, P45; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; YU HS, 1994, PLANT CELL, V6, P1477, DOI 10.1105/tpc.6.10.1477; ZHANG WC, 1990, PROTOPLASMA, V153, P193, DOI 10.1007/BF01354004; Zhang WC, 2002, ACTA BOT SIN, V44, P1068	37	123	140	7	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					232	+		10.1038/nature13291	http://dx.doi.org/10.1038/nature13291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24909992				2022-12-24	WOS:000338649800046
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Overprescribing antidepressants: where's the evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Gotzsche P., 2014, GUARDIAN; Health and Social Care Information Centre, 2012, PRESCR DISP COMM STA; Health Foundation Nuffield Trust; QualityWatch, 2014, FOC ANT PRESCR; Moberly T., 2011, GP              0705; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Siddique H., 2014, GUARDIAN; Thompson S., 2014, DAILY TELEGRAPH	8	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2014	348								g4218	10.1136/bmj.g4218	http://dx.doi.org/10.1136/bmj.g4218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YU	24982509	Bronze, Green Published			2022-12-24	WOS:000338644600002
J	Gupta, S				Gupta, Sujata			MENTAL HEALTH Ups and downs	NATURE			English	Editorial Material							POSTSTROKE DEPRESSION; CONTROLLED-TRIAL; MOOD DISORDER; COMPLICATION; MORTALITY; STROKE											Carson AJ, 2012, J NEUROL NEUROSUR PS, V83, P859, DOI 10.1136/jnnp-2011-301854; Casal S. L., 2014, STROKE, V45, pANS3; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; El Husseini N, 2012, STROKE, V43, P1609, DOI 10.1161/STROKEAHA.111.643130; FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018; Jorge RE, 2003, AM J PSYCHIAT, V160, P1823, DOI 10.1176/appi.ajp.160.10.1823; MORRIS PLP, 1993, AM J PSYCHIAT, V150, P124; ROBINSON RG, 1975, NATURE, V255, P332, DOI 10.1038/255332a0; Robinson RG, 2008, JAMA-J AM MED ASSOC, V299, P2391, DOI 10.1001/jama.299.20.2391	9	0	0	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S10	S11		10.1038/510S10a	http://dx.doi.org/10.1038/510S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24964021	Bronze			2022-12-24	WOS:000337806300007
J	Belluz, J				Belluz, Julia			FEATURE The Truvada wars	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIRETROVIRAL PROPHYLAXIS		MIT, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT)	Belluz, J (corresponding author), MIT, Cambridge, MA 02142 USA.	jbelluz@gmail.com						Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Centers for Disease Control and Prevention, PREEXP PROPH PREP; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Crary DT, 2014, HUFFINGTON POST; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Mascolini M., 2013, 53 ICAAC INT C ANT A; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Public Health England, PROUD STUD EX IMP GA	8	12	12	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2014	348								g3811	10.1136/bmj.g3811	http://dx.doi.org/10.1136/bmj.g3811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK1UG	24961949				2022-12-24	WOS:000338201800003
J	Kneussel, M; Triller, A; Choquet, D				Kneussel, Matthias; Triller, Antoine; Choquet, Daniel			SnapShot: Receptor Dynamics at Plastic Synapses	CELL			English	Article									[Kneussel, Matthias] Univ Med Ctr Hamburg Eppendorf, D-20251 Hamburg, Germany; [Triller, Antoine] Ecole Normale Super, Inst Biol IBENS, CNRS UMR 8197, Inserm 1024, F-75005 Paris, France; [Choquet, Daniel] Bordeaux Univ, CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33077 Bordeaux, France	University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Kneussel, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Falkenried 94, D-20251 Hamburg, Germany.		Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/K-7893-2018	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Kneussel, Matthias/0000-0003-4900-366X; TRILLER, Antoine/0000-0002-7530-1233				Choquet D, 2013, NEURON, V80, P691, DOI 10.1016/j.neuron.2013.10.013; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022	6	18	18	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7							1738.e1	10.1016/j.cell.2014.06.002	http://dx.doi.org/10.1016/j.cell.2014.06.002			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CB3RL	24949980	Bronze			2022-12-24	WOS:000349545900001
J	Prasad, V				Prasad, Vinay			Statins, Primary Prevention, and Overall Mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LOW-RISK; MEN; DISEASE; PEOPLE		NCI, NIH, 10 Ctr Dr,Bldg 10,Room 12N226, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Prasad, V (corresponding author), NCI, NIH, 10 Ctr Dr,Bldg 10,Room 12N226, Bethesda, MD 20892 USA.	vinayak.prasad@nih.gov		Prasad, Vinayak/0000-0002-6110-8221				Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Conference of State Legislatures, 2010, AUT REC; Newman DH, 2012, LANCET, V380, P1814, DOI 10.1016/S0140-6736(12)62020-0; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Redberg RF, 2012, JAMA-J AM MED ASSOC, V307, P1491, DOI 10.1001/jama.2012.423; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Robinson JG, 2013, JAMA-J AM MED ASSOC, V310, P2405, DOI 10.1001/jama.2013.281355; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Zomer E, 2012, LANCET, V380, P1817, DOI 10.1016/S0140-6736(12)62026-1	11	4	4	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					867	+		10.7326/M13-2974	http://dx.doi.org/10.7326/M13-2974			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935491				2022-12-24	WOS:000337374900025
J	Mortensen, EM; Halm, EA; Pugh, MJ; Copeland, LA; Metersky, M; Fine, MJ; Johnson, CS; Alvarez, CA; Frei, CR; Good, C; Restrepo, MI; Downs, JR; Anzueto, A				Mortensen, Eric M.; Halm, Ethan A.; Pugh, Mary Jo; Copeland, Laurel A.; Metersky, Mark; Fine, Michael J.; Johnson, Christopher S.; Alvarez, Carlos A.; Frei, Christopher R.; Good, Chester; Restrepo, Marcos I.; Downs, John R.; Anzueto, Antonio			Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; EMPIRIC ANTIBIOTIC-THERAPY; ELDERLY-PATIENTS; ANTIMICROBIAL THERAPY; SECONDARY PREVENTION; VETERANS-AFFAIRS; BETA-LACTAM; MACROLIDE; OUTCOMES; QUALITY	IMPORTANCE Although clinical practice guidelines recommend combination therapy with macrolides, including azithromycin, as first-line therapy for patients hospitalized with pneumonia, recent research suggests that azithromycin may be associated with increased cardiovascular events. OBJECTIVE To examine the association of azithromycin use with all-cause mortality and cardiovascular events for patients hospitalized with pneumonia. DESIGN Retrospective cohort study comparing older patients hospitalized with pneumonia from fiscal years 2002 through 2012 prescribed azithromycin therapy and patients receiving other guideline-concordant antibiotic therapy. SETTING This study was conducted using national Department of Veterans Affairs administrative data of patients hospitalized at any Veterans Administration acute care hospital. PARTICIPANTS Patients were included if they were aged 65 years or older, were hospitalized with pneumonia, and received antibiotic therapy concordant with national clinical practice guidelines. MAIN OUTCOMES AND MEASURES Outcomes included 30- and 90-day all-cause mortality and 90-day cardiac arrhythmias, heart failure, myocardial infarction, and any cardiac event. Propensity score matching was used to control for the possible effects of known confounders with conditional logistic regression. RESULTS Of 73 690 patients from 118 hospitals identified, propensity-matched groups were composed of 31 863 patients exposed to azithromycin and 31 863 matched patients who were not exposed. There were no significant differences in potential confounders between groups after matching. Ninety-day mortality was significantly lower in those who received azithromycin (exposed, 17.4%, vs unexposed, 22.3%; odds ratio [On 0.73; 95% CI, 0.70-0.76). However, we found significantly increased odds of myocardial infarction (5.1% vs 4.4%; OR, 1.17; 95% CI,1.08-1.25) but not any cardiac event (43.0% vs 42.7%; OR, 1.01; 95% CI, 0.98-1.05), cardiac arrhythmias (25.8% vs 26.0%; OR, 0.99; 95% CI, 0.95-1.02), or heart failure (26.3% vs 26.2%; OR, 1.01; 95% CI, 0.97-1.04). CONCLUSIONS AND RELEVANCE Among older patients hospitalized with pneumonia, treatment that included azithromycin compared with other antibiotics was associated with a lower risk of 90-day mortality and a smaller increased risk of myocardial infarction. These findings are consistent with a net benefit associated with azithromycin use. Copyright 2014 American Medical Association. All rights reserved.	[Mortensen, Eric M.; Johnson, Christopher S.; Alvarez, Carlos A.] VA North Texas Hlth Care Syst, Dallas, TX USA; [Mortensen, Eric M.; Halm, Ethan A.; Johnson, Christopher S.; Alvarez, Carlos A.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Alvarez, Carlos A.] Texas Tech Univ, Hlth Sci Ctr, Dallas, TX USA; [Pugh, Mary Jo; Restrepo, Marcos I.; Downs, John R.; Anzueto, Antonio] South Texas Vet Hlth Care Syst, VERDICT Res Program, San Antonio, TX USA; [Pugh, Mary Jo; Frei, Christopher R.; Restrepo, Marcos I.; Downs, John R.; Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Fine, Michael J.; Good, Chester] Univ Pittsburgh, VA Ctr Hlth Equ Res & Promot, VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Copeland, Laurel A.] Cent Texas Vet Hlth Care Syst Jointly Scott & Whi, Ctr Appl Hlth Res, Temple, TX USA; [Metersky, Mark] Univ Connecticut, Med Ctr, Farmington, CT USA; [Frei, Christopher R.] Univ Texas Austin, Austin, TX 78712 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Tech University System; Texas Tech University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; University of Connecticut; University of Texas System; University of Texas Austin	Mortensen, EM (corresponding author), Dallas VA Med Ctr, Gen Internal Med Sect, 4500 S Lancaster,Ste 111E, Dallas, TX 75216 USA.	eric.mortensen@utsouthwestern.edu	Pugh, Mary Jo/K-5336-2019; Restrepo, Marcos I/H-4442-2014; Frei, Christopher/AAI-1421-2020; Copeland, Laurel A/C-3763-2017; Mortensen, Eric/AAF-2713-2020; Good, Chester B/K-2818-2019	Pugh, Mary Jo/0000-0003-4196-7763; Frei, Christopher/0000-0002-0692-4787; Copeland, Laurel A/0000-0002-9478-0209; Good, Chester B/0000-0003-4388-4558; Mortensen, Eric/0000-0002-3880-5563	National Institute of Nursing Research [R01NR010828]; National Heart, Lung, and Blood Institute [K23HL096054]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, KL2TR001118, KL2TR001103, UL1TR001105] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024983] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL096054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010828] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by a grant from the National Institute of Nursing Research (R01NR010828), and Dr Restrepo was supported by the National Heart, Lung, and Blood Institute (K23HL096054). This material is the result of work supported with resources and the use of facilities at the VA North Texas Health Care System.	Anderson JL, 1999, CIRCULATION, V99, P1540, DOI 10.1161/01.CIR.99.12.1540; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Asadi L, 2012, CLIN INFECT DIS, V55, P371, DOI 10.1093/cid/cis414; Ashitani J, 1998, EUR RESPIR J, V11, P104, DOI 10.1183/09031936.98.11010104; Battleman DS, 2002, ARCH INTERN MED, V162, P682, DOI 10.1001/archinte.162.6.682; Culic O, 2002, EUR J PHARMACOL, V450, P277, DOI 10.1016/S0014-2999(02)02042-3; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Frei CR, 2006, AM J MED, V119, P865, DOI 10.1016/j.amjmed.2006.02.014; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Heron Melonie, 2012, Natl Vital Stat Rep, V60, P1; Houck PM, 2001, CHEST, V119, P1420, DOI 10.1378/chest.119.5.1420; Huang BH, 2007, PACE, V30, P1579, DOI 10.1111/j.1540-8159.2007.00912.x; Ianaro A, 2000, J PHARMACOL EXP THER, V292, P156; Kadota J, 2003, RESP MED, V97, P844, DOI 10.1016/S0954-6111(03)00042-8; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829, DOI 10.1164/ajrccm.157.6.9710075; Labro M. T., 1998, Journal of Antimicrobial Chemotherapy, V41, P37, DOI 10.1093/jac/41.suppl_2.37; Leuven E, PSMATCH2 STATA MODUL; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3977, DOI 10.1128/AAC.00006-07; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martinez JA, 2003, CLIN INFECT DIS, V36, P389, DOI 10.1086/367541; Matsunaga Naohisa, 2003, N Z Med J, V116, pU666; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Meterky ML, 2007, CHEST, V131, P466, DOI 10.1378/chest.06-1426; Mortensen EM, 2004, AM J MED, V117, P726, DOI 10.1016/j.amjmed.2004.06.028; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Mortensen EM, 2006, CRIT CARE, V10, DOI 10.1186/cc3934; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; Perry TW, 2011, AM J MED, V124, P244, DOI 10.1016/j.amjmed.2010.11.014; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Restrepo MI, 2009, EUR RESPIR J, V33, P153, DOI 10.1183/09031936.00054108; Rodriguez A, 2007, CRIT CARE MED, V35, P1493, DOI 10.1097/01.CCM.0000266755.75844.05; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Stahl JE, 1999, ARCH INTERN MED, V159, P2576, DOI 10.1001/archinte.159.21.2576; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Tamaoki J, 2004, AM J MED, V117, P5, DOI 10.1016/j.amjmed.2004.07.023; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Waterer GW, 2001, ARCH INTERN MED, V161, P1837, DOI 10.1001/archinte.161.15.1837; Wilson BZ, 2012, CRIT CARE MED, V40, P2310, DOI 10.1097/CCM.0b013e31825151a8; Yamamoto M, 1990, Nihon Kyobu Shikkan Gakkai Zasshi, V28, P1305	45	110	116	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2199	2208		10.1001/jama.2014.4304	http://dx.doi.org/10.1001/jama.2014.4304			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893087	Green Accepted, Bronze			2022-12-24	WOS:000336668400021
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Was the flu drug zanamivir a breakthrough or money for old rope?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					[Anonymous], 2003, FRONTLINE; [Anonymous], 2002, BMJ; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Loder E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2630; Moynihan R., 1999, BULLETIN	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2014	348								g3611	10.1136/bmj.g3611	http://dx.doi.org/10.1136/bmj.g3611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CA	24891329				2022-12-24	WOS:000337037500006
J	Marx, V				Marx, Vivien			TECHNOLOGY FEATURE AN ATLAS OF EXPRESSION	NATURE			English	Editorial Material																		Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319	4	12	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					645	649		10.1038/509645a	http://dx.doi.org/10.1038/509645a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870547	Bronze			2022-12-24	WOS:000336457100054
J	Ekstrand, MI; Nectow, AR; Knight, ZA; Latcha, KN; Pomeranz, LE; Friedman, JM				Ekstrand, Mats I.; Nectow, Alexander R.; Knight, Zachary A.; Latcha, Kaamashri N.; Pomeranz, Lisa E.; Friedman, Jeffrey M.			Molecular Profiling of Neurons Based on Connectivity	CELL			English	Article							CNS CELL-TYPES; NUCLEUS-ACCUMBENS; RABIES VIRUS; CRE RECOMBINASE; DOPAMINE; NANOBODIES; SYSTEM; REWARD; CONNECTOMICS; CIRCUITS	The complexity and cellular heterogeneity of neural circuitry presents a major challenge to understanding the role of discrete neural populations in controlling behavior. While neuroanatomical methods enable high- resolution mapping of neural circuitry, these approaches do not allow systematic molecular profiling of neurons based on their connectivity. Here, we report the development of an approach for molecularly profiling projective neurons. We show that ribosomes can be tagged with a camelid nanobody raised against GFP and that this system can be engineered to selectively capture translating mRNAs from neurons retrogradely labeled with GFP. Using this system, we profiled neurons projecting to the nucleus accumbens. We then used an AAV to selectively profile midbrain dopamine neurons projecting to the nucleus accumbens. By comparing the captured mRNAs from each experiment, we identified a number of markers specific to VTA dopaminergic projection neurons. The current method provides a means for profiling neurons based on their projections.	[Ekstrand, Mats I.; Nectow, Alexander R.; Knight, Zachary A.; Latcha, Kaamashri N.; Pomeranz, Lisa E.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, 1230 York Ave, New York, NY 10065 USA.	friedj@rockefeller.edu	Core, Vector/CAF-4832-2022	Pomeranz, Lisa/0000-0002-8117-7355; Knight, Zachary/0000-0001-7621-1478	Howard Hughes Medical Institute; JPB Foundation; NIDA [1RO1DA018799-01]; New York Stem Cell Foundation; Klingenstein Fund; Sloan Foundation; McKnight Foundation; Brain and Behavior Research Foundations; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK083531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018799] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); New York Stem Cell Foundation; Klingenstein Fund(Klingenstein Philanthropies); Sloan Foundation(Alfred P. Sloan Foundation); McKnight Foundation; Brain and Behavior Research Foundations; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Howard Hughes Medical Institute, the JPB Foundation, and NIDA grant 1RO1DA018799-01 (J.M.F.). Z.A.K. acknowledges support from the New York Stem Cell Foundation, the Klingenstein Fund, Sloan Foundation, the McKnight Foundation, and the Brain and Behavior Research Foundations. We thank Scott Dewell and the Rockefeller University Genomics Core for help with RNA-seq and bioinformatics, and Ana Milosevic, Yong Kim, and Paul Greengard for contributing p11-EGFP mice. We thank Karl Deisseroth for contributing the plasmid pAAV-EF1a-DIO-hChR2(H134R)-mCherry (Addgene 20297), which was used in the creation of AAV-FLEX-NBL10. We also thank Eric F. Schmidt for helpful discussions. Imaging was performed at the Rockefeller University Bio-Imaging Resource Center. CAV-GFP was obtained from the Montpellier vector platform.	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bru T, 2010, VIRUSES-BASEL, V2, P2134, DOI 10.3390/v2092134; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Croizier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015471; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li XP, 2013, BRAIN STRUCT FUNCT, V218, P1159, DOI 10.1007/s00429-012-0452-z; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Morgan JL, 2013, NAT METHODS, V10, P494, DOI 10.1038/nmeth.2480; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Oh YS, 2013, CELL, V152, P831, DOI 10.1016/j.cell.2013.01.014; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tang JCY, 2013, CELL, V154, P928, DOI 10.1016/j.cell.2013.07.021; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999	52	95	96	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1230	1242		10.1016/j.cell.2014.03.059	http://dx.doi.org/10.1016/j.cell.2014.03.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855954	Green Accepted, Bronze			2022-12-24	WOS:000336437200022
J	Krapivinsky, G; Krapivinsky, L; Manasian, Y; Clapham, DE				Krapivinsky, Grigory; Krapivinsky, Luba; Manasian, Yunona; Clapham, David E.			The TRPM7 Chanzyme Is Cleaved to Release a Chromatin-Modifying Kinase	CELL			English	Article							HISTONE H3 PHOSPHORYLATION; MG2+ HOMEOSTASIS; PROTEIN; CHANNEL; TRANSCRIPTION; CELL; ACETYLATION; INTERACTS; COMPLEX; GENE	TRPM7 is a ubiquitous ion channel and kinase, a unique "chanzyme," required for proper early embryonic development. It conducts Zn2+, Mg2+, and Ca2+ as well as monovalent cations and contains a functional serine/threonine kinase at its carboxyl terminus. Here, we show that in normal tissues and cell lines, the kinase is proteolytically cleaved from the channel domain in a cell-type-specific manner. These TRPM7 cleaved kinase fragments (M7CKs) translocate to the nucleus and bind multiple components of chromatin-remodeling complexes, including Polycomb group proteins. In the nucleus, the kinase phosphorylates specific serines/threonines of histones. M7CK-dependent phosphorylation of H3Ser10 at promoters of TRPM7-dependent genes correlates with their activity. We also demonstrate that cytosolic free [Zn2+] is TRPM7 dependent and regulates M7CK binding to transcription factors containing zinc-finger domains. These findings suggest that TRPM7-mediated modulation of intracellular Zn2+ concentration couples ion-channel signaling to epigenetic chromatin covalent modifications that affect gene expression patterns.	[Krapivinsky, Grigory; Krapivinsky, Luba; Manasian, Yunona; Clapham, David E.] Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Enders Bldg 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD018655] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Banerjee T, 2011, MOL CELL BIOL, V31, P4858, DOI 10.1128/MCB.05631-11; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Berger SL, 2010, COLD SH Q B, V75, P23, DOI 10.1101/sqb.2010.75.044; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chini CCS, 2010, J BIOL CHEM, V285, P40830, DOI 10.1074/jbc.M110.153270; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001876; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Dorovkov MV, 2004, J BIOL CHEM, V279, P50643, DOI 10.1074/jbc.C400441200; Du JY, 2010, CIRC RES, V106, P992, DOI 10.1161/CIRCRESAHA.109.206771; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hanano T, 2004, J PHARMACOL SCI, V95, P403, DOI 10.1254/jphs.FP0040273; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Iovine B, 2011, INT J BIOCHEM CELL B, V43, P1664, DOI 10.1016/j.biocel.2011.09.001; Jacob Eyal, 2011, J Mol Signal, V6, P5, DOI 10.1186/1750-2187-6-5; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Jin J, 2012, P NATL ACAD SCI USA, V109, pE225, DOI 10.1073/pnas.1120033109; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Krapivinsky G, 2011, P NATL ACAD SCI USA, V108, P19234, DOI 10.1073/pnas.1117231108; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Lau PNI, 2011, P NATL ACAD SCI USA, V108, P2801, DOI 10.1073/pnas.1012798108; Lee BC, 2011, CELL PHYSIOL BIOCHEM, V27, P313, DOI 10.1159/000327958; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; Middelbeek J, 2012, CANCER RES, V72, P4250, DOI 10.1158/0008-5472.CAN-11-3863; Miranda JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049371; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Perraud AL, 2011, CELL SIGNAL, V23, P586, DOI 10.1016/j.cellsig.2010.11.011; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Taki M, 2004, J AM CHEM SOC, V126, P712, DOI 10.1021/ja039073j; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Vella P, 2012, NUCLEIC ACIDS RES, V40, P3403, DOI 10.1093/nar/gkr1290; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	71	102	104	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1061	1072		10.1016/j.cell.2014.03.046	http://dx.doi.org/10.1016/j.cell.2014.03.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855944	Green Accepted, Bronze			2022-12-24	WOS:000336437200010
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Doctors and patients confuse cervical screening with diagnostic tests	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2014, DORSET ECHO     0409; [Anonymous], NHS CERV SCREEN PROG; [Anonymous], 2013, MIRROR          0307; NHS, 2010, CLIN PRACT GUID ASS; *NICE, 2005, REF GUID SUSP CANC; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Scottish Executive, 2007, SCOTT REF GUID SUSP; Stoppard M., 2013, MIRROR          0527; Templeton SK, 2014, SUNDAY TIMES	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2014	348								g3334	10.1136/bmj.g3334	http://dx.doi.org/10.1136/bmj.g3334			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZW	24846386				2022-12-24	WOS:000336429100004
J	Wong, FL; Bhatia, S; Landier, W; Francisco, L; Leisenring, W; Hudson, MM; Armstrong, GT; Mertens, A; Stovall, M; Robison, LL; Lyman, GH; Lipshultz, SE; Armenian, SH				Wong, F. Lennie; Bhatia, Smita; Landier, Wendy; Francisco, Liton; Leisenring, Wendy; Hudson, Melissa M.; Armstrong, Gregory T.; Mertens, Ann; Stovall, Marilyn; Robison, Leslie L.; Lyman, Gary H.; Lipshultz, Steven E.; Armenian, Saro H.			Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Article							VENTRICULAR EJECTION FRACTION; ACUTE LYMPHOBLASTIC-LEUKEMIA; DOXORUBICIN THERAPY; ADULT SURVIVORS; 5-YEAR SURVIVORS; CARDIAC EVENTS; LATE MORTALITY; ENALAPRIL; ECHOCARDIOGRAPHY; CARDIOMYOPATHY	Background: Childhood cancer survivors treated with anthracyclines are at high risk for asymptomatic left ventricular dysfunction (ALVD), subsequent heart failure, and death. The consensus-based Children's Oncology Group (COG) Long-Term Follow-up Guidelines recommend lifetime echocardiographic screening for ALVD. Objective: To evaluate the efficacy and cost-effectiveness of the COG guidelines and to identify more cost-effective screening strategies. Design: Simulation of life histories using Markov health states. Data Sources: Childhood Cancer Survivor Study; published literature. Target Population: Childhood cancer survivors. Time Horizon: Lifetime. Perspective: Societal. Intervention: Echocardiographic screening followed by angiotensin-converting enzyme (ACE) inhibitor and beta-blocker therapies after ALVD diagnosis. Outcome Measures: Quality-adjusted life-years (QALYs), costs, incremental cost-effectiveness ratios (ICERs) in dollars per QALY, and cumulative incidence of heart failure. Results of Base-Case Analysis: The COG guidelines versus no screening have an ICER of $61 500, extend life expectancy by 6 months and QALYs by 1.6 months, and reduce the cumulative incidence of heart failure by 18% at 30 years after cancer diagnosis. However, less frequent screenings are more cost-effective than the guidelines and maintain 80% of the health benefits. Results of Sensitivity Analysis: The ICER was most sensitive to the magnitude of ALVD treatment efficacy; higher treatment efficacy resulted in lower ICER. Limitation: Lifetime non-heart failure mortality and the cumulative incidence of heart failure more than 20 years after diagnosis were extrapolated; the efficacy of ACE inhibitor and beta-blocker therapy in childhood cancer survivors with ALVD is undetermined (or unknown). Conclusion: The COG guidelines could reduce the risk for heart failure in survivors at less than $100 000/QALY. Less frequent screening achieves most of the benefits and would be more cost-effective than the COG guidelines.	[Wong, F. Lennie] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Leisenring, Wendy] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Emory Univ, Sch Med, Atlanta, GA USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Wayne State Univ, Sch Med, Detroit, MI 48201 USA; Childrens Hosp Michigan, Detroit, MI 48201 USA	City of Hope; Fred Hutchinson Cancer Center; St Jude Children's Research Hospital; Emory University; University of Texas System; UTMD Anderson Cancer Center; Wayne State University; Children's Hospital of Michigan	Wong, FL (corresponding author), City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA.	lwong@coh.org	Hudson, Melissa M/N-4441-2018; Robison, Leslie/N-8122-2018; Lyman, Gary H/K-5227-2019; Armstrong, Gregory/N-8096-2018	Hudson, Melissa M/0000-0001-6984-2407; Lyman, Gary H/0000-0002-0823-8086; Leisenring, Wendy/0000-0001-7405-0906	Lance Armstrong Foundation; National Cancer Institute [U24-CA55727, U10-CA098543, 2 K12-CA001727-14]; NATIONAL CANCER INSTITUTE [P30CA033572, U10CA098543, U10CA180886, P30CA016672, K12CA001727, U24CA055727] Funding Source: NIH RePORTER	Lance Armstrong Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	In part by the Lance Armstrong Foundation (Drs. Wong and Armenian) and grants U24-CA55727 (Dr. Robison), U10-CA098543 (primary investigator Dr. Adamson), and 2 K12-CA001727-14 (primary investigator Dr. Mortimer) from the National Cancer Institute.	Armenian SH, 2011, BLOOD, V118, P6023, DOI 10.1182/blood-2011-06-358226; Armstrong GT, 2013, J CLIN ONCOL, V31, P3673, DOI 10.1200/JCO.2013.49.3205; Armstrong GT, 2010, J CLIN ONCOL, V28, P1224, DOI 10.1200/JCO.2009.24.4608; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Armstrong GT, 2009, JNCI-J NATL CANCER I, V101, P946, DOI 10.1093/jnci/djp148; Blanco E, 2012, LEUKEMIA LYMPHOMA, V53, P878, DOI 10.3109/10428194.2011.639018; CANTOR SB, 1994, MED DECIS MAKING, V14, P259, DOI 10.1177/0272989X9401400308; Cardinale D, 2010, J AM COLL CARDIOL, V55, P213, DOI 10.1016/j.jacc.2009.03.095; Centers for Disease Control and Prevention, 2001, NAT HOSP DISCH SURV; ERBEL R, 1984, EUR HEART J, V5, P477, DOI 10.1093/oxfordjournals.eurheartj.a061694; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; First DataBank, 2010, DRUG PRIC POL; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; Gimelli A, 2008, INT J CARDIOVAS IMAG, V24, P793, DOI 10.1007/s10554-008-9317-1; Gold MR, 1996, COST EFFECTIVENESS H; Guldner L, 2006, RADIOTHER ONCOL, V81, P47, DOI 10.1016/j.radonc.2006.08.020; Habash-Bseiso DE, 2005, CLIN MED RES, V3, P75, DOI 10.3121/cmr.3.2.75; Healthcare Cost and Utilization Project (HCUP), 2008, OV NAT INP SAMPL; Heidenreich PA, 2004, J AM COLL CARDIOL, V43, P1019, DOI 10.1016/j.jacc.2003.10.043; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kirsch J, 2000, HEALTH ECON, V9, P149, DOI 10.1002/(SICI)1099-1050(200003)9:2<149::AID-HEC501>3.0.CO;2-N; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; Lipshultz SE, 2002, J CLIN ONCOL, V20, P4517, DOI 10.1200/JCO.2002.12.102; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Lipshultz SE, 2008, HEART, V94, P525, DOI 10.1136/hrt.2007.136093; Lipshultz SE, 2013, CIRCULATION, V128, P1927, DOI 10.1161/CIR.0b013e3182a88099; Lucariello RJ, 1997, CLIN CARDIOL, V20, P943, DOI 10.1002/clc.4960201108; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; NAIK MM, 1995, J AM COLL CARDIOL, V25, P937, DOI 10.1016/0735-1097(94)00506-L; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Pein F, 2004, BRIT J CANCER, V91, P37, DOI 10.1038/sj.bjc.6601904; Roberts RA, 2009, EAR HEARING, V30, P369, DOI 10.1097/AUD.0b013e31819f316a; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Rovai D, 2008, ACTA CARDIOL, V63, P507, DOI 10.2143/AC.63.4.2033051; Shankar SM, 2008, PEDIATRICS, V121, pE387, DOI 10.1542/peds.2007-0575; Silber JH, 2004, J CLIN ONCOL, V22, P820, DOI 10.1200/JCO.2004.06.022; Stinett AA, 1996, COST EFFECTIVENESS H, P349; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; U.S. Census Bureau, 2011, STAT ABSTR US; U.S. Department of Labor, 2010, NAT COMP SURV; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	47	72	74	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					672	+		10.7326/M13-2498	http://dx.doi.org/10.7326/M13-2498			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842414	Green Accepted			2022-12-24	WOS:000337347100014
J	Lupulescu, AI; Rimer, JD				Lupulescu, Alexandra I.; Rimer, Jeffrey D.			In Situ Imaging of Silicalite-1 Surface Growth Reveals the Mechanism of Crystallization	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; ANGLE X-RAY; CRYSTAL-GROWTH; ELEVATED-TEMPERATURES; CRYO-TEM; NUCLEATION; NANOPARTICLES; SCATTERING; EVOLUTION; DIRECTION	The growth mechanism of silicalite-1 (MFI zeolite) is juxtaposed between classical models that postulate silica molecules as primary growth units and nonclassical pathways based on the aggregation of metastable silica nanoparticle precursors. Although experimental evidence gathered over the past two decades suggests that precursor attachment is the dominant pathway, direct validation of this hypothesis and the relative roles of molecular and precursor species has remained elusive. We present an in situ study of silicalite-1 crystallization at characteristic synthesis conditions. Using time-resolved atomic force microscopy images, we observed silica precursor attachment to crystal surfaces, followed by concomitant structural rearrangement and three-dimensional growth by accretion of silica molecules. We confirm that silicalite-1 growth occurs via the addition of both silica molecules and precursors, bridging classical and nonclassical mechanisms.	[Lupulescu, Alexandra I.; Rimer, Jeffrey D.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA	University of Houston System; University of Houston	Rimer, JD (corresponding author), Univ Houston, Dept Chem & Biomol Engn, 4800 Calhoun Rd, Houston, TX 77204 USA.	jrimer@central.uh.edu			NSF [CAREER-1151098, BRIGE-1032621, MRI-1040446]; American Chemical Society [PRF 52422-DNI5]; Welch Foundation [E-1794]	NSF(National Science Foundation (NSF)); American Chemical Society(American Chemical Society); Welch Foundation(The Welch Foundation)	We acknowledge support from NSF (grants CAREER-1151098 and BRIGE-1032621), the American Chemical Society (grant PRF 52422-DNI5), and the Welch Foundation (grant E-1794). SAXS measurements were performed on an instrument that was purchased with support from NSF (grant MRI-1040446). We are grateful to J. Li and M. Rutgers at Asylum Research for technical assistance.	Aerts A, 2011, PHYS CHEM CHEM PHYS, V13, P4318, DOI 10.1039/c0cp01592j; Anderson MW, 2007, FARADAY DISCUSS, V136, P143, DOI 10.1039/b617782b; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Baumgartner J, 2013, NAT MATER, V12, P310, DOI [10.1038/NMAT3558, 10.1038/nmat3558]; BURKETT SL, 1995, CHEM MATER, V7, P920, DOI 10.1021/cm00053a017; Cubillas P, 2013, CHEM-EUR J, V19, P8236, DOI 10.1002/chem.201300778; Davis TM, 2006, NAT MATER, V5, P400, DOI 10.1038/nmat1636; de Moor PPEA, 1997, J PHYS CHEM B, V101, P11077, DOI 10.1021/jp9724784; Fedeyko JM, 2004, J PHYS CHEM B, V108, P12271, DOI 10.1021/jp047623+; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Habraken WJEM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2490; Holden MA, 2012, J AM CHEM SOC, V134, P13066, DOI 10.1021/ja303814p; Kirschhock CEA, 1999, J PHYS CHEM B, V103, P11021, DOI 10.1021/jp992272y; Knight CTG, 2006, PHYS CHEM CHEM PHYS, V8, P3099, DOI 10.1039/b606419a; Kumar S, 2007, J PHYS CHEM B, V111, P3398, DOI 10.1021/jp0677445; Kumar S, 2011, MICROPOR MESOPOR MAT, V144, P74, DOI 10.1016/j.micromeso.2011.02.029; Kumar S, 2008, J AM CHEM SOC, V130, P17284, DOI 10.1021/ja8063167; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Liao HG, 2012, SCIENCE, V336, P1011, DOI 10.1126/science.1219185; Lupulescu AI, 2012, ANGEW CHEM INT EDIT, V51, P3345, DOI 10.1002/anie.201107725; Meza LI, 2007, J AM CHEM SOC, V129, P15192, DOI 10.1021/ja0739887; Nikolakis V, 2000, CHEM MATER, V12, P845, DOI 10.1021/cm990653i; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Rimer JD, 2005, J PHYS CHEM B, V109, P12762, DOI 10.1021/jp052045y; Rimer JD, 2007, CHEM MATER, V19, P4189, DOI 10.1021/cm070708d; Rimer JD, 2010, SCIENCE, V330, P337, DOI 10.1126/science.1191968; Schoeman BJ, 1998, MICROPOR MESOPOR MAT, V22, P9, DOI 10.1016/S1387-1811(98)00080-8; Van Driessche AES, 2012, SCIENCE, V336, P69, DOI 10.1126/science.1215648; Wallace AF, 2013, SCIENCE, V341, P885, DOI 10.1126/science.1230915; Watson JN, 1996, CHEM COMMUN, P2767, DOI 10.1039/cc9960002767; Yau ST, 2001, J AM CHEM SOC, V123, P1080, DOI 10.1021/ja003039c; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	33	246	253	57	647	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					729	732		10.1126/science.1250984	http://dx.doi.org/10.1126/science.1250984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833388				2022-12-24	WOS:000335912900036
J	Marin, JR; Weaver, MD; Yealy, DM; Mannix, RC				Marin, Jennifer R.; Weaver, Matthew D.; Yealy, Donald M.; Mannix, Rebekah C.			Trends in Visits for Traumatic Brain Injury to Emergency Departments in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Marin, Jennifer R.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Weaver, Matthew D.; Yealy, Donald M.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15224 USA; [Mannix, Rebekah C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School	Marin, JR (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, 4401 Penn Ave,AOB Ste 2400, Pittsburgh, PA 15224 USA.	jennifer.marin@chp.edu	Mannix, Rebekah/AAD-8702-2020	Marin, Jennifer/0000-0003-3090-664X; Mannix, Rebekah/0000-0003-3608-2792	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL109068] Funding Source: NIH RePORTER; NHLBI NIH HHS [K12HL109068] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], INJURY PREVENTION AN; [Anonymous], NATIONWIDE EMERGENCY; Faul M., TRAUMATIC BRAIN INJU; Langlois JA, 2004, TRAUMATIC BRAIN INJU; National Conference of State Legislatures, TRAUMATIC BRAIN INJU; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954	6	153	155	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1917	1919		10.1001/jama.2014.3979	http://dx.doi.org/10.1001/jama.2014.3979			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825648	Bronze			2022-12-24	WOS:000335798100025
J	Jack, A				Jack, Andrew			Tamiflu: "a nice little earner"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				Biocryst Pharmaceuticals, 2013, ANN REPORT; Freemantle N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2371; Jack A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3811; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Love J., 2005, FINANCIAL TIMES; Murthuri SG, 2014, LANCET; United States Government Accountability Office, 2011, INFL PAND LESS H1N1	7	6	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2014	348								g2524	10.1136/bmj.g2524	http://dx.doi.org/10.1136/bmj.g2524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SE	24811410				2022-12-24	WOS:000334348700016
J	Chowdhury, R; Sekirnik, R; Brissett, NC; Krojer, T; Ho, CH; Ng, SS; Clifton, IJ; Ge, W; Kershaw, NJ; Fox, GC; Muniz, JRC; Vollmar, M; Phillips, C; Pilka, ES; Kavanagh, KL; von Delft, F; Oppermann, U; McDonough, MA; Doherty, AJ; Schofield, CJ				Chowdhury, Rasheduzzaman; Sekirnik, Rok; Brissett, Nigel C.; Krojer, Tobias; Ho, Chia-hua; Ng, Stanley S.; Clifton, Ian J.; Ge, Wei; Kershaw, Nadia J.; Fox, Gavin C.; Muniz, Joao R. C.; Vollmar, Melanie; Phillips, Claire; Pilka, Ewa S.; Kavanagh, Kathryn L.; von Delft, Frank; Oppermann, Udo; McDonough, Michael A.; Doherty, Aidan J.; Schofield, Christopher J.			Ribosomal oxygenases are structurally conserved from prokaryotes to humans	NATURE			English	Article							TRANSCRIPTION FACTOR OSTERIX; CRYSTAL-STRUCTURE; LYSYL-HYDROXYLATION; SUBSTRATE-BINDING; HISTONE; PROTEIN; 2-OXOGLUTARATE; INSIGHTS; SYSTEM; DOMAIN	2-Oxoglutarate (2OG)-dependent oxygenases have important roles in the regulation of gene expression via demethylation of N-methylated chromatin components(1,2) and in the hydroxylation of transcription factors(3) and splicing factor proteins(4). Recently, 2OG-dependent oxygenases that catalyse hydroxylation of transferRNA(5-7) and ribosomal proteins(8) have been shown to be important in translation relating to cellular growth, T(H)17-cell differentiation and translational accuracy(9-12). The finding that ribosomal oxygenases (ROXs) occur in organisms ranging from prokaryotes to humans(8) raises questions as to their structural and evolutionary relationships. In Escherichia coli, YcfD catalyses arginine hydroxylation in the ribosomal protein L16; in humans, MYC-induced nuclear antigen (MINA53; also known as MINA) and nucleolar protein 66 (NO66) catalyse histidine hydroxylation in the ribosomal proteins RPL27A and RPL8, respectively. The functional assignments of ROXs open therapeutic possibilities via either ROX inhibition or targeting of differentially modified ribosomes. Despite differences in the residue and protein selectivities of prokaryotic and eukaryotic ROXs, comparison of the crystal structures of E. coli YcfD and Rhodothermus marinus YcfD with those of human MINA53 and NO66 reveals highly conserved folds and novel dimerization modes defining a new structural subfamily of 2OG-dependent oxygenases. ROX structures with and without their substrates support their functional assignments as hydroxylases but not demethylases, and reveal how the subfamily has evolved to catalyse the hydroxylation of different residue side chains of ribosomal proteins. Comparison of ROX crystal structures with those of other JmjC-domain-containing hydroxylases, including the hypoxia-inducible factor asparaginyl hydroxylase FIH and histone N-epsilon -methyl lysine demethylases, identifies branch points in 2OG-dependent oxygenase evolution and distinguishes between JmjC-containing hydroxylases and demethylases catalysing modifications of translational and transcriptional machinery. The structures reveal that new protein hydroxylation activities can evolve by changing the coordination position from which the iron-bound substrate-oxidizing species reacts. This coordination flexibility has probably contributed to the evolution of the wide range of reactions catalysed by oxygenases.	[Chowdhury, Rasheduzzaman; Sekirnik, Rok; Ho, Chia-hua; Clifton, Ian J.; Ge, Wei; Kershaw, Nadia J.; McDonough, Michael A.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England; [Chowdhury, Rasheduzzaman; Sekirnik, Rok; Ho, Chia-hua; Clifton, Ian J.; Ge, Wei; Kershaw, Nadia J.; McDonough, Michael A.; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England; [Brissett, Nigel C.; Doherty, Aidan J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Krojer, Tobias; Ng, Stanley S.; Muniz, Joao R. C.; Vollmar, Melanie; Phillips, Claire; Pilka, Ewa S.; Kavanagh, Kathryn L.; von Delft, Frank; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Fox, Gavin C.] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France; [Oppermann, Udo] Botnar Res Ctr, NIHR Oxford Biomed Res Unit, Oxford OX3 7LD, England	University of Oxford; University of Oxford; University of Sussex; University of Oxford; SOLEIL Synchrotron; University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Mansfield Rd, Oxford OX1 3TA, England.	rasheduzzaman.chowdhury@chem.ox.ac.uk; christopher.schofield@chem.ox.ac.uk	Chowdhury, Rashed/I-7697-2014; Krojer, Tobias/ABE-3829-2021; McDonough, Michael A/G-2744-2013; McDonough, Michael/N-8913-2019; Muniz, Joao R/B-7782-2016	Chowdhury, Rashed/0000-0002-8058-6149; McDonough, Michael A/0000-0003-4664-6942; McDonough, Michael/0000-0003-4664-6942; Muniz, Joao R/0000-0003-2731-3966; Krojer, Tobias/0000-0003-0661-0814; Vollmar, Melanie/0000-0002-9162-9159; von Delft, Frank/0000-0003-0378-0017; Doherty, Aidan/0000-0002-6370-1109; Kershaw, Nadia/0000-0002-3554-2622; Schofield, Christopher/0000-0002-0290-6565; Brissett, Nigel/0000-0003-3645-6408; Sekirnik, Rok/0000-0001-6008-9500	Biotechnology and Biological Sciences Research Council; Wellcome Trust; European Research Council; Medical Research Council; Oxford NIHR Biomedical Research Unit; Cancer Research UK; Arthritis Research UK; Bayer Healthcare; Rosetree Foundation; Slovenian Academy of Sciences and Arts; Abbvie; Boehringer Ingelheim; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Eli Lilly; Genome Canada; GlaxoSmithKline; Ontario Ministry of Economic Development and Innovation; Janssen; Novartis Research Foundation; Pfizer; Takeda; BBSRC [BB/L004275/1, BB/J003018/1, BB/L009846/1, BB/J018643/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J018643/1, BB/J003018/1, BB/L004275/1, BB/L009846/1, BB/C518230/1] Funding Source: researchfish; Cancer Research UK [6947] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford NIHR Biomedical Research Unit; Cancer Research UK(Cancer Research UK); Arthritis Research UK(Versus Arthritis); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Rosetree Foundation(Rosetrees Trust); Slovenian Academy of Sciences and Arts; Abbvie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Eli Lilly(Eli Lilly); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Ontario Ministry of Economic Development and Innovation; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, European Research Council, Medical Research Council, Oxford NIHR Biomedical Research Unit, Cancer Research UK, Arthritis Research UK, Bayer Healthcare, the Rosetree Foundation and the Slovenian Academy of Sciences and Arts (R. S.) for funding. We thank the scientists of beamlines X10SA (Swiss Light Source) and I02, I03, I04, I04-1 (Diamond Light Source) for assistance. The Structural Genomics Consortium is a registered charity (number 1097737) funded by Abbvie, Boehringer Ingelheim, the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Eli Lilly, Genome Canada, GlaxoSmithKline, the Ontario Ministry of Economic Development and Innovation, Janssen, Novartis Research Foundation, Pfizer, Takeda and the Wellcome Trust.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Del Rizzo PA, 2012, MOL CELL BIOL, V32, P4044, DOI 10.1128/MCB.00513-12; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng T, 2014, MOL CELL, V53, P645, DOI 10.1016/j.molcel.2013.12.028; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Henri J, 2010, J BIOL CHEM, V285, P30767, DOI 10.1074/jbc.M110.106864; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Iyer LM, 2010, NUCLEIC ACIDS RES, V38, P5261, DOI 10.1093/nar/gkq265; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kato M, 2011, NUCLEIC ACIDS RES, V39, P1576, DOI 10.1093/nar/gkq919; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; MILLER R, 1993, SCIENCE, V259, P1430, DOI 10.1126/science.8451639; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tao Y, 2013, J BIOL CHEM, V288, P16430, DOI 10.1074/jbc.M112.446849; Teichmann M, 2012, TRANSCR-AUSTIN, V3, P2, DOI 10.4161/trns.3.1.18917; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; Walport LJ, 2012, CURR OPIN CHEM BIOL, V16, P525, DOI 10.1016/j.cbpa.2012.09.015; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong SD, 2013, NATURE, V499, P320, DOI 10.1038/nature12304; Woon ECY, 2012, ANGEW CHEM INT EDIT, V51, P1631, DOI 10.1002/anie.201107833; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang M, 2013, ANGEW CHEM INT EDIT, V52, P1700, DOI 10.1002/anie.201208046; Yang M, 2011, FEBS J, V278, P1086, DOI 10.1111/j.1742-4658.2011.08022.x; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	59	75	78	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					422	+		10.1038/nature13263	http://dx.doi.org/10.1038/nature13263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24814345	Green Accepted, Green Submitted			2022-12-24	WOS:000337350200040
J	Cohen, RL; Settleman, J				Cohen, Robert L.; Settleman, Jeff			From Cancer Genomics to Precision Oncology-Tissue's Still an Issue	CELL			English	Article							ABL TYROSINE KINASE; CELL LUNG-CANCER; TARGETED THERAPY; INHIBITION; MULTICENTER; SORAFENIB; MELANOMA; SURVIVAL; LABEL	Rapidly evolving genome technology has enabled extensive molecular analysis of limited tumor biopsy material, thereby facilitating the broader implementation of personalized cancer medicine. However, genomics-based patient stratification across diverse tumor types is unlikely to supplant tissue-of-origin considerations in addressing clinical needs, including the development and application of novel "rationally targeted" cancer therapies.	[Cohen, Robert L.] Calico Life Sci, San Francisco, CA 94080 USA; [Settleman, Jeff] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Settleman, J (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	settleman.jeffrey@gene.com						AACR Cancer Progress Report Writing Committee, 2013, Clin Cancer Res, V19, pS4, DOI 10.1158/1078-0432.CCR-13-2107; Bauml J, 2013, CLIN LUNG CANCER, V14, P581, DOI 10.1016/j.cllc.2013.05.002; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Crowther M, 2013, HEMATOL-AM SOC HEMAT, P15, DOI 10.1182/asheducation-2013.1.15; Custodio A, 2013, CRIT REV ONCOL HEMAT, V85, P45, DOI 10.1016/j.critrevonc.2012.05.001; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eifert C, 2012, NAT REV CANCER, V12, P572, DOI 10.1038/nrc3299; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Figueroa-Magalhaes MC, 2014, BREAST, V23, P128, DOI 10.1016/j.breast.2013.11.011; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Heng DYC, 2008, CURR CANCER DRUG TAR, V8, P676, DOI 10.2174/156800908786733450; Horning SJ, 2013, CLIN CANCER RES, V19, P4297, DOI 10.1158/1078-0432.CCR-13-0523; Iyer R, 2010, EXPERT OPIN PHARMACO, V11, P1943, DOI 10.1517/14656566.2010.496453; Minuti G, 2013, EXPERT OPIN BIOL TH, V13, P1401, DOI 10.1517/14712598.2013.827657; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Mullighan CG, 2012, J CLIN INVEST, V122, P3407, DOI 10.1172/JCI61203; Mullins CD, 2012, J CLIN ONCOL, V30, P661, DOI 10.1200/JCO.2011.35.5198; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Willyard C, 2013, NAT MED, V19, P655, DOI 10.1038/nm0613-655	28	21	26	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1509	1514		10.1016/j.cell.2014.05.027	http://dx.doi.org/10.1016/j.cell.2014.05.027			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949964	Bronze			2022-12-24	WOS:000340941900007
J	Ball, P				Ball, Philip			The art of medicine Unnatural reactions	LANCET			English	Editorial Material																			0	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1964	1965		10.1016/S0140-6736(14)60945-4	http://dx.doi.org/10.1016/S0140-6736(14)60945-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PV	24936628				2022-12-24	WOS:000336848200014
J	Al-Khatib, SM; Hellkamp, AS; Fonarow, GC; Mark, DB; Curtis, LH; Hernandez, AF; Anstrom, KJ; Peterson, ED; Sanders, GD; Al-Khalidi, HR; Hammill, BG; Heidenreich, PA; Hammill, SC				Al-Khatib, Sana M.; Hellkamp, Anne S.; Fonarow, Gregg C.; Mark, Daniel B.; Curtis, Lesley H.; Hernandez, Adrian F.; Anstrom, Kevin J.; Peterson, Eric D.; Sanders, Gillian D.; Al-Khalidi, Hussein R.; Hammill, Bradley G.; Heidenreich, Paul A.; Hammill, Stephen C.			Association Between Prophylactic Implantable Cardioverter-Defibrillators and Survival in Patients With Left Ventricular Ejection Fraction Between 30% and 35%	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGESTIVE-HEART-FAILURE; MYOCARDIAL-INFARCTION; PREVENTION; PROGRAM; DISEASE; HF	IMPORTANCE Clinical trials of prophylactic implantable cardioverter-defibrillators (ICDs) have included a minority of patients with a left ventricular ejection fraction (LVEF) between 30% and 35%. Because a large number of ICDs in the United States are implanted in such patients, it is important to study survival associated with this therapy. OBJECTIVE To characterize patients with LVEF between 30% and 35% and compare the survival of those with and without ICDs. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of Medicare beneficiaries in the National Cardiovascular Data Registry ICD registry (January 1, 2006, through December 31, 2007) with an LVEF between 30% and 35% who received an ICD during a heart failure hospitalization and similar patients in the Get With The Guidelines-Heart Failure (GWTG-HF) database (January 1, 2005, through December 31, 2009) with no ICD. The analysis was repeated in patients with an LVEF less than 30%. There were 3120 patients with an LVEF between 30% and 35% (816 in matched cohorts) and 4578 with an LVEF less than 30% (2176 in matched cohorts). Propensity score matching and Cox models were applied. MAIN OUTCOMES AND MEASURES The primary outcome was all-cause mortality; data were obtained from Medicare claims through December 31, 2011. RESULTS There were no significant differences in the baseline characteristics of the matched groups (n = 408 for both groups). Among patients with an LVEF between 30% and 35%, there were 248 deaths in the ICD Registry group, within a median follow-up of 4.4 years (interquartile range, 2.7-4.9) and 249 deaths in the GWTG HF group, within a median follow-up of 2.9 years (interquartile range, 2.1-4.4). The risk of all-cause mortality in patients with an LVEF between 30% and 35% and an ICD was significantly lower than that in matched patients without an ICD (3-year mortality rates: 51.4% vs 55.0%; hazard ratio, 0.83 [95% CI, 0.69-0.991; P = .04). Presence of an ICD also was associated with better survival in patients with an LVEF less than 30% (3-year mortality rates: 45.0% vs 57.6%; 634 and 660 total deaths; hazard ratio, 0.72 [95% CI, 0.65-0.811; P < .001) (P = .20 for interaction). CONCLUSIONS AND RELEVANCE Among Medicare beneficiaries hospitalized for heart failure and with an LVEF between 30% and 35% and less than 30%, survival at 3 years was better in patients who received a prophylactic ICD than in comparable patients with no ICD. These findings support guideline recommendations to implant prophylactic ICDs in eligible patients with an LVEF of 35% or less. Copyright 2014 American Medical Association. All rights reserved.	[Al-Khatib, Sana M.; Hellkamp, Anne S.; Mark, Daniel B.; Curtis, Lesley H.; Hernandez, Adrian F.; Anstrom, Kevin J.; Peterson, Eric D.; Sanders, Gillian D.; Al-Khalidi, Hussein R.; Hammill, Bradley G.; Hammill, Stephen C.] Duke Univ, Med Ctr, Dept Med, Duke Clin Res Inst, Durham, NC 27710 USA; [Curtis, Lesley H.; Hammill, Stephen C.] Duke Univ, Med Ctr, Dept Med, Ctr Clin & Genet Econ, Durham, NC 27710 USA; [Al-Khatib, Sana M.; Mark, Daniel B.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Curtis, Lesley H.] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27710 USA; [Fonarow, Gregg C.] Ronald Reagan UCLA Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA; [Heidenreich, Paul A.] Stanford Univ, Palo Alto Vet Hlth Care Syst, Palo Alto, CA 94304 USA; [Hammill, Stephen C.] Mayo Clin, Rochester, MN USA	Duke University; Duke University; Duke University; Duke University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Mayo Clinic	Al-Khatib, SM (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	alkha001@mc.duke.edu	Fonarow, Gregg C/D-5988-2014; Hernandez, Adrian F/A-7818-2016; Heidenreich, Paul/AAU-6864-2021; Peterson, Eric David/ABF-5033-2021	Fonarow, Gregg C/0000-0002-3192-8093; Hernandez, Adrian F/0000-0003-3387-9616; Heidenreich, Paul/0000-0001-7730-8490; Mark, Daniel/0000-0001-6340-8087	National Heart, Lung, and Blood Institute [1R01-HL093071-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093071] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This analysis was funded by grant 1R01-HL093071-01A1 from the National Heart, Lung, and Blood Institute.	Al-Khatib SM, 2014, INT J CARDIOL, V172, P253, DOI 10.1016/j.ijcard.2013.12.278; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Curtis LH, 2008, ARCH INTERN MED, V168, P2481, DOI 10.1001/archinte.168.22.2481; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Hammill SC, 2007, HEART RHYTHM, V4, P1260, DOI 10.1016/j.hrthm.2007.07.021; Hammill SC, 2009, HEART RHYTHM, V6, P1397, DOI 10.1016/j.hrthm.2009.07.015; Hellermann JP, 2005, EUR J HEART FAIL, V7, P119, DOI 10.1016/j.ejheart.2004.04.011; Hjalmarson A, 1999, LANCET, V353, P2001; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kremers MS, 2013, HEART RHYTHM, V10, pE59, DOI 10.1016/j.hrthm.2013.01.035; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Weir Robin A P, 2006, Curr Heart Fail Rep, V3, P175, DOI 10.1007/s11897-006-0019-5	20	22	22	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2209	2215		10.1001/jama.2014.5310	http://dx.doi.org/10.1001/jama.2014.5310			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893088	Green Accepted, Bronze			2022-12-24	WOS:000336668400022
J	Gravitz, L				Gravitz, Lauren			THERAPY This time it's personal	NATURE			English	Editorial Material							CANCER; IMMUNOTHERAPY											Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497	6	8	9	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S52	S54		10.1038/509S52a	http://dx.doi.org/10.1038/509S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870820	Bronze			2022-12-24	WOS:000336457100003
J	Pape, JW; Rouzier, V				Pape, Jean William; Rouzier, Vanessa			Embracing Oral Cholera Vaccine - The Shifting Response to Cholera	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pape, Jean William; Rouzier, Vanessa] Ctr GHESKIO, Port Au Prince, Haiti; [Pape, Jean William] Weill Cornell Med Coll, Ctr Global Hlth, Div Infect Dis, New York, NY USA	Cornell University	Pape, JW (corresponding author), Ctr GHESKIO, Port Au Prince, Haiti.							Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Date KA, 2011, EMERG INFECT DIS, V17, P2105, DOI 10.3201/eid1711.110822; Ivers LC, 2013, AM J TROP MED HYG, V89, P617, DOI 10.4269/ajtmh.13-0183; Rouzier V, 2013, AM J TROP MED HYG, V89, P671, DOI 10.4269/ajtmh.13-0171; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P289	5	10	11	2	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2067	2069		10.1056/NEJMp1402837	http://dx.doi.org/10.1056/NEJMp1402837			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24869720	Bronze			2022-12-24	WOS:000336434000004
J	Bintanja, R; Selten, FM				Bintanja, R.; Selten, F. M.			Future increases in Arctic precipitation linked to local evaporation and sea-ice retreat	NATURE			English	Article							CLIMATE; AMPLIFICATION; CYCLE	Precipitation changes projected for the end of the twenty-first century show an increase of more than 50 per cent in the Arctic regions(1,2). This marked increase, which is among the highest globally, has previously been attributed primarily to enhanced poleward moisture transport from lower latitudes(3,4). Here we use state-of-the-art global climate models(5) to show that the projected increases in Arctic precipitation over the twenty-first century, which peak in late autumn and winter, are instead due mainly to strongly intensified local surface evaporation (maximum in winter), and only to a lesser degree due to enhanced moisture inflow from lower latitudes(maximum in late summer and autumn). Moreover, we show that the enhanced surface evaporation results mainly from retreating winter sea ice, signalling an amplified Arctic hydrological cycle. This demonstrates that increases in Arctic precipitation are firmly linked to Arctic warming and sea-ice decline. As a result, the Arctic mean precipitation sensitivity (4.5 per cent increase per degree of temperature warming) is much larger than the global value (1.6 to 1.9 per cent per kelvin). The associated seasonally varying increase in Arctic precipitation is likely to increase river discharge(6-8) and snowfall over ice sheets(9) (thereby affecting global sea level), and could even affect global climate through freshening of the Arctic Ocean and subsequent modulations of the Atlantic meridional overturning circulation(10,11).	[Bintanja, R.; Selten, F. M.] Royal Netherlands Meteorol Inst KNMI, NL-3731 GA De Bilt, Netherlands	Royal Netherlands Meteorological Institute	Bintanja, R (corresponding author), Royal Netherlands Meteorol Inst KNMI, Utrechtseweg 297, NL-3731 GA De Bilt, Netherlands.	bintanja@knmi.nl		Swanton, Charles/0000-0002-4299-3018				Alexeev VA, 2005, CLIM DYNAM, V24, P655, DOI 10.1007/s00382-005-0018-3; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; Barry RG, 2000, NATO SCI S PRT 2 ENV, V70, P45; Bengtsson L, 2011, TELLUS A, V63, P907, DOI 10.1111/j.1600-0870.2011.00534.x; Bintanja R, 2013, NAT GEOSCI, V6, P376, DOI [10.1038/NGEO1767, 10.1038/ngeo1767]; Bintanja R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01556; Bintanja R, 2012, CLIM DYNAM, V39, P2659, DOI 10.1007/s00382-011-1272-1; Bintanja R, 2011, NAT GEOSCI, V4, P758, DOI [10.1038/ngeo1285, 10.1038/NGEO1285]; Cai M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024481; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Davies FJ, 2014, CLIM DYNAM, V42, P2099, DOI 10.1007/s00382-013-1849-y; Francis JA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000902; Hazeleger W, 2010, B AM METEOROL SOC, V91, P1357, DOI 10.1175/2010BAMS2877.1; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Holland MM, 2006, J CLIMATE, V19, P6221, DOI 10.1175/JCLI3967.1; Holland MM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI [10.1029/2006JG000354, 10.1029/2006JG000286]; Kattsov VM, 2007, J HYDROMETEOROL, V8, P571, DOI 10.1175/JHM575.1; Kattsov VM, 2000, J CLIMATE, V13, P1362, DOI 10.1175/1520-0442(2000)013<1362:TCTOAP>2.0.CO;2; Kug JS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043673; Kurita N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046064; Liu JP, 2012, P NATL ACAD SCI USA, V109, P4074, DOI 10.1073/pnas.1114910109; Min SK, 2008, SCIENCE, V320, P518, DOI 10.1126/science.1153468; Peterson BJ, 2002, SCIENCE, V298, P2171, DOI 10.1126/science.1077445; Screen JA, 2012, CLIM DYNAM, V38, P2243, DOI 10.1007/s00382-011-1105-2; Singarayer JS, 2006, J CLIMATE, V19, P1109, DOI 10.1175/JCLI3649.1; Stephens GL, 2008, J CLIMATE, V21, P6141, DOI 10.1175/2008JCLI2144.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Walsh JE, 1998, J CLIMATE, V11, P72, DOI 10.1175/1520-0442(1998)011<0072:APAEMR>2.0.CO;2; Walsh JE, 2000, NATO SCI S PRT 2 ENV, V70, P21; Zhang XD, 2013, NAT CLIM CHANGE, V3, P47, DOI [10.1038/nclimate1631, 10.1038/NCLIMATE1631]	30	368	372	12	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					479	+		10.1038/nature13259	http://dx.doi.org/10.1038/nature13259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24805239				2022-12-24	WOS:000336126000036
J	Sniderman, AD; Toth, PP; Thanassoulis, G; Pencina, MJ; Furberg, CD				Sniderman, Allan D.; Toth, Peter P.; Thanassoulis, George; Pencina, Michael J.; Furberg, Curt D.			Taking a longer term view of cardiovascular risk: the causal exposure paradigm	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; AGE; METAANALYSIS; PREVENTION; GUIDELINES; STATINS; CALCIUM; BURDEN		[Sniderman, Allan D.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Mike Rosenbloom Lab Cardiovasc Res, Montreal, PQ H3A 1A1, Canada; [Toth, Peter P.] Univ Illinois, Sch Med, Dept Family & Community Med, Peoria, IL USA; [Thanassoulis, George] CGH Med Ctr, Sterling, IL USA; [Thanassoulis, George] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Cardiol Div,Dept Med, Montreal, PQ H3A 1A1, Canada; [Pencina, Michael J.] Duke Clin Res Inst, Durham, NC USA; [Furberg, Curt D.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA	McGill University; Royal Victoria Hospital; University of Illinois System; University of Illinois Peoria; McGill University; Royal Victoria Hospital; Duke University; Wake Forest University	Sniderman, AD (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Mike Rosenbloom Lab Cardiovasc Res, Room H7-22,687 Pine Ave West, Montreal, PQ H3A 1A1, Canada.	allansniderman@hotmail.com	Toth, Peter/GMW-6552-2022					Anderson TJ, 2013, CAN J CARDIOL, V29, P151, DOI 10.1016/j.cjca.2012.11.032; Arad Y, 2005, J AM COLL CARDIOL, V46, P166, DOI 10.1016/j.jacc.2005.02.089; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lemstra M, 2012, CAN J CARDIOL, V28, P574, DOI 10.1016/j.cjca.2012.05.007; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Pencina MJ, 2014, N ENGL J MED; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Sattar N, 2012, ATHEROSCLEROSIS SUPP, V13, P1, DOI 10.1016/j.atherosclerosissup.2012.06.001; Sniderman AD, 2008, LANCET, V371, P1547, DOI [10.1016/S0140-6736(08)60313-X, 10.1016/s0140-6736(08)60313-x]; Sniderman AD, 2013, MAYO CLIN PROC, V88, P1108, DOI 10.1016/j.mayocp.2013.07.012; Stone NJ, 2013, CIRCULATION	18	19	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2014	348								g3047	10.1136/bmj.g3047	http://dx.doi.org/10.1136/bmj.g3047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZX	24850828				2022-12-24	WOS:000336429200001
J	Shamian, J				Shamian, Judith			Interprofessional collaboration, the only way to Save Every Woman and Every Child	LANCET			English	Editorial Material									Int Council Nurses, CH-1201 Geneva, Switzerland		Shamian, J (corresponding author), Int Council Nurses, Pl Jean Marteau, CH-1201 Geneva, Switzerland.	shamianjudith@gmail.com							0	14	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					E41	E42		10.1016/S0140-6736(14)60858-8	http://dx.doi.org/10.1016/S0140-6736(14)60858-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ2PU	24965821				2022-12-24	WOS:000342630600002
J	Ghany, MG; Gara, N				Ghany, Marc G.; Gara, Naveen			QUEST for a cure for hepatitis C virus: the end is in sight	LANCET			English	Editorial Material							HCV GENOTYPE 1; PLUS SOFOSBUVIR; ABT-450/R-OMBITASVIR; TELAPREVIR; LEDIPASVIR; RIBAVIRIN; DASABUVIR; SIMEPREVIR; BOCEPREVIR; VARIANTS		[Ghany, Marc G.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Gara, Naveen] Washington Hosp Ctr, Dept Gastroenterol, Washington, DC 20010 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); MedStar Washington Hospital Center	Ghany, MG (corresponding author), NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA.	marcg@intra.niddk.nih.gov	Ghany, Marc/AAU-4238-2021	Ghany, Marc/0000-0003-2837-0188	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075009] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK075009] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P18; Barnard RJO, 2013, VIROLOGY, V444, P329, DOI 10.1016/j.virol.2013.06.029; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Jacobson IM, 2014, LANCET; Jacobson IM, 2013, HEPATOLOGY, V58, p1379A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Janssen Therapeutics, 2013, OL SIM CAPS OR US FU; Kieffer TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034372; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, J HEPATOL, V60, pS524, DOI 10.1016/S0168-8278(14)61460-4; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manns M, 2014, LANCET; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; WHO, 2014, GUID SCREEN CAR TREA; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	28	6	6	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					381	383		10.1016/S0140-6736(14)60807-2	http://dx.doi.org/10.1016/S0140-6736(14)60807-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	24907223	Green Accepted			2022-12-24	WOS:000340195800006
J	Pena, LD; Goldstein, SL				Pena, Leopoldo D.; Goldstein, Steven L.			Thermohaline circulation crisis and impacts during the mid-Pleistocene transition	SCIENCE			English	Article							MIDDLE PLEISTOCENE TRANSITION; CARBON-DIOXIDE CONCENTRATION; OCEAN CIRCULATION; DEEP-WATER; ICE; EVOLUTION; CLIMATE; TEMPERATURE; NEODYMIUM; SEA	The mid-Pleistocene transition (MPT) marked a fundamental change in glacial-interglacial periodicity, when it increased from similar to 41-thousand-year to 100-thousand-year cycles and developed higher-amplitude climate variability without substantial changes in the Milankovitch forcing. Here, we document, by using Nd isotopes, a major disruption of the ocean thermohaline circulation (THC) system during the MPT between marine isotope stages (MISs) 25 and 21 at similar to 950 to 860 thousand years ago, which effectively marks the first 100-thousand-year cycle, including an exceptional weakening through a critical interglacial (MIS 23) at similar to 900 thousand years ago. Its recovery into the post-MPT 100-thousand-year world is characterized by continued weak glacial THC. The MPT ocean circulation crisis facilitated the coeval drawdown of atmospheric CO2 and high-latitude ice sheet growth, generating the conditions that stabilized 100-thousand-year cycles.	[Pena, Leopoldo D.; Goldstein, Steven L.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Goldstein, Steven L.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA	Columbia University; Columbia University	Pena, LD (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, 61 Route 9W, Palisades, NY 10964 USA.	leopoldo@ldeo.columbia.edu	Pena, Leopoldo/A-7085-2015; Pena, Leopoldo/B-8140-2013	Pena, Leopoldo/0000-0001-6414-6293; Pena, Leopoldo/0000-0001-6414-6293	NSF [OCE-10-31198]; Storke Endowment of the Department of Earth and Environmental Sciences, Columbia University; Directorate For Geosciences [1031198] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Storke Endowment of the Department of Earth and Environmental Sciences, Columbia University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We acknowledge support from NSF grant OCE-10-31198. We also thank two anonymous reviewers for valuable comments. This study was partly supported by the Storke Endowment of the Department of Earth and Environmental Sciences, Columbia University. Samples were provided by the ODP, which is sponsored by the NSF and participating countries under management of Joint Oceanographic Institutions. R. Lupien helped with sample processing. The data in this paper will be available in the supplementary materials and deposited with National Oceanic and Atmospheric Administration-National Climate Data Center at www.ncdc.noaa.gov. This is LDEO contribution number 7809.	Abouchami W, 1997, GEOCHIM COSMOCHIM AC, V61, P3957, DOI 10.1016/S0016-7037(97)00218-4; Berger W.H., 1994, GEOPHYS MONOGR SER, P295, DOI DOI 10.1029/GM085P0295; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Broecker W. S., 1991, OCEANOGRAPHY, V4, P79, DOI [10.5670/oceanog.1991.07, DOI 10.5670/0CEAN0G.1991.07, DOI 10.5670/OCEANOG.1991.07]; Broecker WS, 1992, GLOBAL BIOGEOCHEM CY, V6, P315, DOI 10.1029/92GB01672; Burton KW, 1999, EARTH PLANET SC LETT, V171, P149, DOI 10.1016/S0012-821X(99)00138-7; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; Gildor H, 2000, PALEOCEANOGRAPHY, V15, P605, DOI 10.1029/1999PA000461; Goldstein S.L., 2003, TREATISE GEOCHEMISTR, P453, DOI [10.1016/B0-08-043751-6/06179-X, DOI 10.1016/B0-08-043751-6/06179-X]; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Huybers P, 2007, QUATERNARY SCI REV, V26, P37, DOI 10.1016/j.quascirev.2006.07.013; Kohler P, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001703; Kohler P, 2008, CLIM PAST, V4, P311, DOI 10.5194/cp-4-311-2008; Ling HF, 2005, EARTH PLANET SC LETT, V232, P345, DOI 10.1016/j.epsl.2004.12.009; Lisiecki LE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045109; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; MACKENSEN A, 1993, PALEOCEANOGRAPHY, V8, P587, DOI 10.1029/93PA01291; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; McClymont EL, 2013, EARTH-SCI REV, V123, P173, DOI 10.1016/j.earscirev.2013.04.006; Piotrowski AM, 2005, SCIENCE, V307, P1933, DOI 10.1126/science.1104883; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; RAYMO ME, 1990, EARTH PLANET SC LETT, V97, P353, DOI 10.1016/0012-821X(90)90051-X; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Stichel T, 2012, EARTH PLANET SC LETT, V317, P282, DOI 10.1016/j.epsl.2011.11.025; Tachikawa K, 1999, EARTH PLANET SC LETT, V170, P433, DOI 10.1016/S0012-821X(99)00127-2; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Venz KA, 2002, PALAEOGEOGR PALAEOCL, V182, P197, DOI 10.1016/S0031-0182(01)00496-5	36	93	96	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					318	322		10.1126/science.1249770	http://dx.doi.org/10.1126/science.1249770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	24968939				2022-12-24	WOS:000339400700049
J	Palen, WJ; Sisk, TD; Ryan, ME; Arvai, JL; Jaccard, M; Salomon, AK; Homer-Dixon, T; Lertzman, KP				Palen, Wendy J.; Sisk, Thomas D.; Ryan, Maureen E.; Arvai, Joseph L.; Jaccard, Mark; Salomon, Anne K.; Homer-Dixon, Thomas; Lertzman, Ken P.			Consider the global impacts of oil pipelines	NATURE			English	Editorial Material									[Palen, Wendy J.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Sisk, Thomas D.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Ryan, Maureen E.; Jaccard, Mark; Salomon, Anne K.; Lertzman, Ken P.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; [Arvai, Joseph L.] Univ Calgary, Dept Geog, Calgary, AB T2N 1N4, Canada; [Homer-Dixon, Thomas] Univ Waterloo, Balsillie Sch Int Affairs, Waterloo, ON N2L 3G1, Canada	Simon Fraser University; Northern Arizona University; Simon Fraser University; University of Calgary; University of Waterloo	Palen, WJ (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	wpalen@sfu.ca						[Anonymous], 2013, CAN EM TRENDS; Arvai J., 2014, J ENV PLAN MAGMT; Arvai J, 2012, ISSUES SCI TECHNOL, V28, P43; Canadian Association of Petroleum Producers, 2014, 2014 CAPP CRUD OIL F; Chen, 2009, CANC INCIDENCE FORT; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Kurek J, 2013, P NATL ACAD SCI USA, V110, P1761, DOI 10.1073/pnas.1217675110; Office of the Auditor General of Canada, 2012, 2012 SPRING REP COMM; Rooney RC, 2012, P NATL ACAD SCI USA, V109, P4933, DOI 10.1073/pnas.1117693108	9	19	19	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					465	467		10.1038/510465a	http://dx.doi.org/10.1038/510465a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24971438	Bronze			2022-12-24	WOS:000337806300021
J	Chang, YQ; Bruni, R; Kloss, B; Assur, Z; Kloppmann, E; Rost, B; Hendrickson, WA; Liu, Q				Chang, Yanqi; Bruni, Renato; Kloss, Brian; Assur, Zahra; Kloppmann, Edda; Rost, Burkhard; Hendrickson, Wayne A.; Liu, Qun			Structural basis for a pH-sensitive calcium leak across membranes	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM CA2+; BAX INHIBITOR-1; CELL-DEATH; CRYSTAL-STRUCTURE; APOPTOSIS; TOPOLOGY; HOMEOSTASIS; EXPRESSION; PREDICTION; MECHANISM	Calcium homeostasis balances passive calcium leak and active calcium uptake. Human Bax inhibitor-1 (hBI-1) is an antiapoptotic protein that mediates a calcium leak and is representative of a highly conserved and widely distributed family, the transmembrane Bax inhibitor motif (TMBIM) proteins. Here, we present crystal structures of a bacterial homolog and characterize its calcium leak activity. The structure has a seven-transmembrane-helix fold that features two triple-helix sandwiches wrapped around a central C-terminal helix. Structures obtained in closed and open conformations are reversibly interconvertible by change of pH. A hydrogen-bonded, pK(a) (where K-a is the acid dissociation constant)-perturbed pair of conserved aspartate residues explains the pH dependence of this transition, and biochemical studies show that pH regulates calcium influx in proteoliposomes. Homology models for hBI-1 provide insights into TMBIM-mediated calcium leak and cytoprotective activity.	[Chang, Yanqi; Bruni, Renato; Kloss, Brian; Kloppmann, Edda; Rost, Burkhard; Hendrickson, Wayne A.; Liu, Qun] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA; [Assur, Zahra; Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Kloppmann, Edda; Rost, Burkhard] Tech Univ Munich, Fak Informat, Dept Bioinformat & Computat Biol, Garching, Germany; [Hendrickson, Wayne A.; Liu, Qun] Brookhaven Natl Lab, Natl Synchrotron Light Source NSLS X4, New York Struct Biol Ctr, Upton, NY 11973 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Technical University of Munich; United States Department of Energy (DOE); Brookhaven National Laboratory; Columbia University	Liu, Q (corresponding author), New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA.	qunliu@bnl.gov	Rost, Burkhard/A-1908-2016; Liu, Qun/A-8757-2011	Rost, Burkhard/0000-0003-0179-8424; Liu, Qun/0000-0002-1179-290X; Kloss, Brian/0000-0003-0130-8739; Bruni, Renato/0000-0002-2312-0254	NIH [GM095315, GM107462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107462, U54GM095315] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Schwanof and R. Abramowitz at NSLS beamlines X4A and X4C for their assistance in data collection, J. Love for help in initial high-throughput screening, M. Punta for help in initial target selection, M. Su for help with the phylogenetic presentation, and F. Mancia and L. Shapiro for discussions. This work was supported in part by NIH grants GM095315 and GM107462. Beamlines X4A and X4C of the NSLS at Brookhaven National Laboratory, a U. S. Department of Energy facility, is supported by the New York Structural Biology Center. Atomic coordinates and structure factor files have been deposited in the Protein Data Bank (PDB) under the accession codes 4PGR for closed-form at pH 8, 4PGS for open-form at pH 6 by soaking, 4PGU for closed/open-form at pH 7 by back-soaking, 4PGV for closed-form at pH 8 by back-soaking, and 4PGW for open-form in C222<INF>1</INF> lattice. Q. L., Y.C., and W. A. H. are inventors on a patent application filed by the New York Structural Biology Center on uses of the three-dimensional structures of BsYetJ and homology models of hBI-1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bultynck G, 2012, J BIOL CHEM, V287, P2544, DOI 10.1074/jbc.M111.275354; Carrara G, 2012, J BIOL CHEM, V287, P15896, DOI 10.1074/jbc.M111.336149; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; Henke N, 2011, CELL CALCIUM, V50, P251, DOI 10.1016/j.ceca.2011.05.005; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kiviluoto S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.103; Kiviluoto S, 2013, CELL CALCIUM, V54, P186, DOI 10.1016/j.ceca.2013.06.002; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Nishizawa T, 2013, SCIENCE, V341, P168, DOI 10.1126/science.1239002; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Sano R, 2012, GENE DEV, V26, P1041, DOI 10.1101/gad.184325.111; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Smaili SS, 2013, CURR MOL MED, V13, P252; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Tanaka R, 2006, CANCER-AM CANCER SOC, V106, P648, DOI 10.1002/cncr.21639; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Waight AB, 2013, NATURE, V499, P107, DOI 10.1038/nature12233; Westphalen BC, 2005, CELL DEATH DIFFER, V12, P304, DOI 10.1038/sj.cdd.4401547; Wu MS, 2013, P NATL ACAD SCI USA, V110, P11367, DOI 10.1073/pnas.1302515110; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9	40	69	71	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1131	1135		10.1126/science.1252043	http://dx.doi.org/10.1126/science.1252043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904158	Green Accepted			2022-12-24	WOS:000336791200040
J	Flynn, TM; O'Loughlin, EJ; Mishra, B; DiChristina, TJ; Kemner, KM				Flynn, Theodore M.; O'Loughlin, Edward J.; Mishra, Bhoopesh; DiChristina, Thomas J.; Kemner, Kenneth M.			Sulfur-mediated electron shuttling during bacterial iron reduction	SCIENCE			English	Article							MICROBIAL REDUCTION; SULFATE REDUCTION; AQUIFER; FE(III); LIFE; KINETICS; SULFIDE; GROWTH; REDOX; GENE	Microbial reduction of ferric iron [Fe(III)] is an important biogeochemical process in anoxic aquifers. Depending on groundwater pH, dissimilatory metal-reducing bacteria can also respire alternative electron acceptors to survive, including elemental sulfur (S degrees). To understand the interplay of Fe/S cycling under alkaline conditions, we combined thermodynamic geochemical modeling with bioreactor experiments using Shewanella oneidensis MR-1. Under these conditions, S. oneidensis can enzymatically reduce S degrees but not goethite (alpha-FeOOH). The HS- produced subsequently reduces goethite abiotically. Because of the prevalence of alkaline conditions in many aquifers, Fe(III) reduction may thus proceed via S degrees-mediated electron-shuttling pathways.	[Flynn, Theodore M.; O'Loughlin, Edward J.; Mishra, Bhoopesh; Kemner, Kenneth M.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Flynn, Theodore M.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Mishra, Bhoopesh] IIT, Dept Phys, Chicago, IL 60616 USA; [DiChristina, Thomas J.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Illinois Institute of Technology; University System of Georgia; Georgia Institute of Technology	Kemner, KM (corresponding author), Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	kemner@anl.gov	Flynn, Theodore/C-1221-2008; O'Loughlin, Edward/C-9565-2013	Flynn, Theodore/0000-0002-1838-8942; O'Loughlin, Edward/0000-0003-1607-9529	Subsurface Biogeochemical Research Program, U.S. Department of Energy (DOE) Office of Science, Office of Biological and Environmental Research, under DOE [DE-AC02-06CH11357]; NSF-Earth Sciences [EAR-1128799]; DOE-GeoSciences [DE-FG02-94ER14466]; DOE Office of Science, Office of Basic Energy Sciences; Argonne Director's Fellowship; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Service [HHSN272200900040C]; NSF (Molecular and Cellular Biosciences) [1021735]; Div Of Molecular and Cellular Bioscience [1021735] Funding Source: National Science Foundation	Subsurface Biogeochemical Research Program, U.S. Department of Energy (DOE) Office of Science, Office of Biological and Environmental Research, under DOE; NSF-Earth Sciences(National Science Foundation (NSF)); DOE-GeoSciences(United States Department of Energy (DOE)); DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Argonne Director's Fellowship; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Service; NSF (Molecular and Cellular Biosciences); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research is part of the Subsurface Science Scientific Focus Area at Argonne National Laboratory supported by the Subsurface Biogeochemical Research Program, U.S. Department of Energy (DOE) Office of Science, Office of Biological and Environmental Research, under DOE contract DE-AC02-06CH11357. We appreciate the technical assistance of M. Newville, and A. Lanzirotti. K. Nealson, J. Fredrickson, and K. Haugen provided helpful comments that improved the manuscript. X-ray analyses were conducted at Argonne National Laboratory's Advanced Photon Source (APS), GeoSoilEnviroCARS (Sector 13), supported by NSF-Earth Sciences (EAR-1128799) and DOE-GeoSciences (DE-FG02-94ER14466). Use of the APS was supported by the DOE Office of Science, Office of Basic Energy Sciences. T. F. was supported in part by an Argonne Director's Fellowship and the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Service (contract no. HHSN272200900040C). T. D. was supported by NSF (Molecular and Cellular Biosciences grant no. 1021735). All additional data have been archived in the supplementary materials.	ANDREWS JN, 1994, WATER RESOUR RES, V30, P45, DOI 10.1029/93WR02226; Bethke CM, 2011, AM J SCI, V311, P183, DOI 10.2475/03.2011.01; Bickle MJ, 2009, NAT GEOSCI, V2, P815, DOI 10.1038/ngeo687; Borch T, 2010, ENVIRON SCI TECHNOL, V44, P15, DOI 10.1021/es9026248; Burns JL, 2009, APPL ENVIRON MICROB, V75, P5209, DOI 10.1128/AEM.00888-09; Edwards KJ, 2012, ANNU REV EARTH PL SC, V40, P551, DOI 10.1146/annurev-earth-042711-105500; Flynn TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-146; Fuller SJ, 2014, APPL ENVIRON MICROB, V80, P128, DOI 10.1128/AEM.02282-13; Haveman SA, 2008, APPL ENVIRON MICROB, V74, P4277, DOI 10.1128/AEM.02901-07; Heimann A, 2010, EARTH PLANET SC LETT, V294, P8, DOI 10.1016/j.epsl.2010.02.015; Hellige K, 2012, GEOCHIM COSMOCHIM AC, V81, P69, DOI 10.1016/j.gca.2011.12.014; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Jakobsen R, 1999, GEOCHIM COSMOCHIM AC, V63, P137, DOI 10.1016/S0016-7037(98)00272-5; Jin Q, 2007, AM J SCI, V307, P643, DOI 10.2475/04.2007.01; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; KEMPE S, 1985, CHEM GEOL, V53, P95, DOI 10.1016/0009-2541(85)90023-3; Kirk MF, 2009, APPL GEOCHEM, V24, P426, DOI 10.1016/j.apgeochem.2008.12.022; Kirk MF, 2004, GEOLOGY, V32, P953, DOI 10.1130/G20842.1; Ledin M, 1996, EARTH-SCI REV, V41, P67, DOI 10.1016/0012-8252(96)00016-5; Lovley D, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P635, DOI 10.1007/0-387-30742-7_21; McGrail BP, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004169; MCMAHON PB, 1991, NATURE, V349, P233, DOI 10.1038/349233a0; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; Nealson KH, 1997, ANNU REV EARTH PL SC, V25, P403, DOI 10.1146/annurev.earth.25.1.403; Poulton SW, 2003, CHEM GEOL, V202, P79, DOI 10.1016/S0009-2541(03)00237-7; Poulton SW, 2004, GEOCHIM COSMOCHIM AC, V68, P3703, DOI 10.1016/j.gca.2004.03.012; Straub KL, 2004, APPL ENVIRON MICROB, V70, P5744, DOI 10.1128/AEM.70.10.5744-5749.2004; Welch AH, 2000, GROUND WATER, V38, P589, DOI 10.1111/j.1745-6584.2000.tb00251.x; Williamson AJ, 2013, APPL ENVIRON MICROB, V79, P3320, DOI 10.1128/AEM.03063-12; Wu LL, 2009, GEOCHIM COSMOCHIM AC, V73, P5584, DOI 10.1016/j.gca.2009.06.026	30	130	143	23	396	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1039	1042		10.1126/science.1252066	http://dx.doi.org/10.1126/science.1252066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24789972	Green Submitted, Green Accepted			2022-12-24	WOS:000336495800048
J	Chow, WY; Rajan, R; Muller, KH; Reid, DG; Skepper, JN; Wong, WC; Brooks, RA; Green, M; Bihan, D; Farndale, RW; Slatter, DA; Shanahan, CM; Duer, MJ				Chow, W. Ying; Rajan, Rakesh; Muller, Karin H.; Reid, David G.; Skepper, Jeremy N.; Wong, Wai Ching; Brooks, Roger A.; Green, Maggie; Bihan, Dominique; Farndale, Richard W.; Slatter, David A.; Shanahan, Catherine M.; Duer, Melinda J.			NMR Spectroscopy of Native and in Vitro Tissues Implicates PolyADP Ribose in Biomineralization	SCIENCE			English	Article							SOLID-STATE NMR; ORGANIC-MINERAL INTERFACE; POLY(ADP-RIBOSE) POLYMERASE; MAGNETIC-RESONANCE; CHEMICAL-SHIFTS; BONE; C-13; DYNAMICS; SURFACE; DEATH	Nuclear magnetic resonance (NMR) spectroscopy is useful to determine molecular structure in tissues grown in vitro only if their fidelity, relative to native tissue, can be established. Here, we use multidimensional NMR spectra of animal and in vitro model tissues as fingerprints of their respective molecular structures, allowing us to compare the intact tissues at atomic length scales. To obtain spectra from animal tissues, we developed a heavy mouse enriched by about 20% in the NMR-active isotopes carbon-13 and nitrogen-15. The resulting spectra allowed us to refine an in vitro model of developing bone and to probe its detailed structure. The identification of an unexpected molecule, poly(adenosine diphosphate ribose), that may be implicated in calcification of the bone matrix, illustrates the analytical power of this approach.	[Chow, W. Ying; Reid, David G.; Wong, Wai Ching; Duer, Melinda J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Rajan, Rakesh; Brooks, Roger A.] Univ Cambridge, Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 0QQ, England; [Muller, Karin H.; Skepper, Jeremy N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Green, Maggie] Univ Cambridge, Sch Clin Med, Cambridge CB2 0SZ, England; [Bihan, Dominique; Farndale, Richard W.; Slatter, David A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Shanahan, Catherine M.] Kings Coll London, British Heart Fdn Ctr Res Excellence, James Black Ctr, Div Cardiovasc, London SE5 9NU, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of London; King's College London	Duer, MJ (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	mjd13@cam.ac.uk	Muller, Karin/W-2453-2019; , Roger/N-7021-2019; Slatter, David/AAV-5771-2020; Chow, Ying/G-9297-2011; Slatter, David/AAW-6938-2021	Chow, Ying/0000-0003-0719-5958; Muller, Karin Helga/0000-0003-4693-8558; Duer, Melinda/0000-0002-9196-5072; Shanahan, Catherine/0000-0002-8352-8171	BBSRC [BB/G021392/1]; BHF [PG/08/011/24416, PG/10/43/28390]; EPSRC; MRC [G0500707]; National Institute of Health Research; Biotechnology and Biological Sciences Research Council [BB/G021392/1] Funding Source: researchfish; British Heart Foundation [RG/09/003/27122, PG/10/43/28390, RG/11/14/29056] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1235152] Funding Source: researchfish; Medical Research Council [G0500707] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF(British Heart Foundation); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors appreciate advice from M. Norman and J. Keeley; technical support from S. Thomas and R. Westwood (Central Biological Services, University of Cambridge); helpful interactions with D. Martel (SAFE, Augy, France); and advice and assistance with AFM from R. Oliver and C. Grover (University of Cambridge). The authors acknowledge funding from BBSRC for D.A.S., D.G.R. (BB/G021392/1), M.J.D., R.R., and R.W.F.; from BHF for D.A.S. and R.W.F. (PG/08/011/24416), K.H.M. (PG/10/43/28390), M.J.D., J.N.S., and C.M.S.; from EPSRC for W.Y.C. and W.C.W.; from MRC for D.B. and R.W.F. (G0500707); and from the National Institute of Health Research for R.A.B.	Aliev AE, 2005, BIOPOLYMERS, V77, P230, DOI 10.1002/bip.20217; Bertazzo S, 2012, NANOSCALE, V4, P2851, DOI 10.1039/c2nr30431g; Bockmann A, 2006, CR CHIM, V9, P381, DOI 10.1016/j.crci.2005.06.008; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dey A, 2010, NAT MATER, V9, P1010, DOI [10.1038/nmat2900, 10.1038/NMAT2900]; Duer MJ, 2008, ARTERIOSCL THROM VAS, V28, P2030, DOI 10.1161/ATVBAHA.108.172387; Gagne JP, 2012, NUCLEIC ACIDS RES, V40, P7788, DOI 10.1093/nar/gks486; GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Hohwy M, 1998, J CHEM PHYS, V108, P2686, DOI 10.1063/1.475661; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; McNally EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029258; Nikel O, 2012, J PHYS CHEM C, V116, P6320, DOI 10.1021/jp2125312; Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642; SARKAR SK, 1983, J BIOL CHEM, V258, P9762; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; SPIRO RG, 1969, J BIOL CHEM, V244, P602; TORCHIA DA, 1985, BIOPOLYMERS, V24, P65, DOI 10.1002/bip.360240107; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wise ER, 2007, CHEM MATER, V19, P5055, DOI 10.1021/cm702054c; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; ZIMMERMANN B, 1994, CELL TISSUE RES, V275, P345, DOI 10.1007/BF00319433	26	64	64	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					742	746		10.1126/science.1248167	http://dx.doi.org/10.1126/science.1248167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833391	Green Submitted			2022-12-24	WOS:000335912900040
J	Mercado-Marin, EV; Garcia-Reynaga, P; Romminger, S; Pimenta, EF; Romney, DK; Lodewyk, MW; Williams, DE; Andersen, RJ; Miller, SJ; Tantillo, DJ; Berlinck, RGS; Sarpong, R				Mercado-Marin, Eduardo V.; Garcia-Reynaga, Pablo; Romminger, Stelamar; Pimenta, Eli F.; Romney, David K.; Lodewyk, Michael W.; Williams, David E.; Andersen, Raymond J.; Miller, Scott J.; Tantillo, Dean J.; Berlinck, Roberto G. S.; Sarpong, Richmond			Total synthesis and isolation of citrinalin and cyclopiamine congeners	NATURE			English	Article							ENANTIOSELECTIVE TOTAL-SYNTHESIS; MARINE-DERIVED FUNGUS; OXIDATION; STEPHACIDIN; METABOLITES; DERIVATIVES; ALKALOIDS; CHEMISTRY; SECONDARY; REVISION	Many natural products that contain basic nitrogen atoms-for example alkaloids like morphine and quinine-have the potential to treat a broad range of human diseases. However, the presence of a nitrogen atom in a target molecule can complicate its chemical synthesis because of the basicity of nitrogen atoms and their susceptibility to oxidation. Obtaining such compounds by chemical synthesis can be further complicated by the presence of multiple nitrogen atoms, but it can be done by the selective introduction and removal of functional groups that mitigate basicity. Here we use such a strategy to complete the chemical syntheses of citrinalin B and cyclopiamine B. The chemical connections that have been realized as a result of these syntheses, in addition to the isolation of both 17-hydroxycitrinalin B and citrinalin C (which contains a bicyclo[2.2.2]diazaoctane structural unit) through carbon-13 feeding studies, support the existence of a common bicyclo[2.2.2]diazaoctane-containing biogenetic precursor to these compounds, as has been proposed previously.	[Mercado-Marin, Eduardo V.; Garcia-Reynaga, Pablo; Sarpong, Richmond] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Romminger, Stelamar; Pimenta, Eli F.; Berlinck, Roberto G. S.] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil; [Romney, David K.; Miller, Scott J.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Lodewyk, Michael W.; Tantillo, Dean J.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Williams, David E.; Andersen, Raymond J.] Univ British Columbia, Dept Chem & Earth & Ocean Sci, Vancouver, BC V6T 1Z1, Canada	University of California System; University of California Berkeley; Universidade de Sao Paulo; Yale University; University of California System; University of California Davis; University of British Columbia	Berlinck, RGS (corresponding author), Univ Sao Paulo, Inst Quim Sao Carlos, CP 780, BR-13560970 Sao Carlos, SP, Brazil.	rgsberlinck@iqsc.usp.br; rsarpong@berkeley.edu	Miller, Scott/N-7761-2017; Berlinck, Roberto G. S./G-4756-2010	Miller, Scott/0000-0001-7817-1318; Berlinck, Roberto G. S./0000-0003-0118-2523; Romney, David/0000-0003-0498-7597; Sarpong, Richmond/0000-0002-0028-6323	US National Institutes of Health (NIH) [NIGMS RO1 086374]; US National Science Foundation (NSF); Brazilian National Council of Technological and Scientific Development (CNPq) [470643/2010-2]; Sao Paulo Research Foundation (FAPESP) [2012/50026-3]; NSEPC; NSF [CHE-0957416, CHE-030089]; NIH [GM096403, S10-RR027172]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096403] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF)(National Science Foundation (NSF)); Brazilian National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NSEPC; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.S. and P.G.-R. thank the US National Institutes of Health (NIH; NIGMS RO1 086374) for financial support. R. S. is a Camille Dreyfus Teacher Scholar. E. V. M.-M. acknowledges the US National Science Foundation (NSF) for a graduate fellowship (GRFP). S. R., E. F. P. and R. G. S. B. are grateful to the Brazilian National Council of Technological and Scientific Development (CNPq; grant 470643/2010-2) and the Sao Paulo Research Foundation (FAPESP; grant 2012/50026-3) for funding. D. E. W. and R.J.A. thank NSEPC for funding. M. W. L. and D.J.T. acknowledge support from the NSF (CHE-0957416 and supercomputing resources through a grant from the XSEDE programme: CHE-030089). S.J.M. is grateful to the NIH for support (GM096403). We thank A. DiPasquale for solving the crystal structures of ent-2 center dot HCl, 6, 27 and 36 (supported by NIH Shared Instrumentation Grant S10-RR027172). We would like to thank T. Lebold, R. M. Williams and D. Sherman for discussions.	Bian ZG, 2013, J AM CHEM SOC, V135, P10886, DOI 10.1021/ja405547f; BOND RF, 1979, J CHEM SOC PERK T 1, P1751, DOI 10.1039/p19790001751; BORCH RF, 1968, TETRAHEDRON LETT, P61; DAVIS FA, 1982, J ORG CHEM, V47, P1774, DOI 10.1021/jo00348a039; Ding YS, 2010, J AM CHEM SOC, V132, P12733, DOI 10.1021/ja1049302; Finefield JM, 2012, J NAT PROD, V75, P812, DOI 10.1021/np200954v; GHAFFAR T, 1995, TETRAHEDRON LETT, V36, P8657, DOI 10.1016/0040-4039(95)01785-G; Grotjahn DB, 2004, J AM CHEM SOC, V126, P12232, DOI 10.1021/ja046360u; Grubbs AW, 2007, ANGEW CHEM INT EDIT, V46, P2257, DOI 10.1002/anie.200604377; Guerrero CA, 2011, ORG LETT, V13, P5164, DOI 10.1021/ol2020362; GULLER R, 1994, TETRAHEDRON LETT, V35, P865, DOI 10.1016/S0040-4039(00)75984-3; Herzon SB, 2005, J AM CHEM SOC, V127, P5342, DOI 10.1021/ja0510616; Jewett JC, 2007, ANGEW CHEM INT EDIT, V46, P6502, DOI 10.1002/anie.200701677; JOHNSON CR, 1992, TETRAHEDRON LETT, V33, P917, DOI 10.1016/S0040-4039(00)91575-2; Kishi Y., 1970, TETRAHEDRON LETT, V11, P5127; Kolundzic F, 2011, J AM CHEM SOC, V133, P9104, DOI 10.1021/ja202706g; Kong K, 2013, J AM CHEM SOC, V135, P10890, DOI 10.1021/ja405548b; Kushida N, 2007, J ANTIBIOT, V60, P667, DOI 10.1038/ja.2007.85; Lodewyk MW, 2012, CHEM REV, V112, P1839, DOI 10.1021/cr200106v; Marti C, 2003, EUR J ORG CHEM, V2003, P2209, DOI 10.1002/ejoc.200300050; MILLER DG, 1990, J ORG CHEM, V55, P2924, DOI 10.1021/jo00296a067; Miller KA, 2009, CHEM SOC REV, V38, P3160, DOI 10.1039/b816705m; MORIARTY RM, 1993, J ORG CHEM, V58, P2478, DOI 10.1021/jo00061a022; Movassaghi M, 2008, ORG LETT, V10, P4009, DOI 10.1021/ol8015176; Mugishima T, 2005, J ORG CHEM, V70, P9430, DOI 10.1021/jo051499o; Myers AG, 2003, J AM CHEM SOC, V125, P12080, DOI 10.1021/ja0372006; OHIRA S, 1989, SYNTHETIC COMMUN, V19, P561, DOI 10.1080/00397918908050700; OMURA K, 1978, TETRAHEDRON, V34, P1651, DOI 10.1016/0040-4020(78)80197-5; Parry R, 2011, NAT PROD REP, V28, P152, DOI 10.1039/c0np00024h; Pimenta EF, 2010, J NAT PROD, V73, P1821, DOI 10.1021/np100470h; Stocking EM, 1999, ANGEW CHEM INT EDIT, V38, P786, DOI 10.1002/(SICI)1521-3773(19990315)38:6<786::AID-ANIE786>3.0.CO;2-7; Tsuda M, 2004, ORG LETT, V6, P3087, DOI 10.1021/ol048900y; ZHANG XJ, 1993, J AM CHEM SOC, V115, P8867, DOI 10.1021/ja00072a061	33	111	111	6	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					318	324		10.1038/nature13273	http://dx.doi.org/10.1038/nature13273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828190	Green Accepted, Green Submitted			2022-12-24	WOS:000336121200030
J	Batshaw, ML; Groft, SC; Krischer, JP				Batshaw, Mark L.; Groft, Stephen C.; Krischer, Jeffrey P.			Research Into Rare Diseases of Childhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILDREN		[Batshaw, Mark L.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Groft, Stephen C.] NIH, Off Rare Dis Res, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Krischer, Jeffrey P.] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL USA	Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); State University System of Florida; University of South Florida	Batshaw, ML (corresponding author), Childrens Natl Med Ctr, 111 Michigan Ave NW, Washington, DC 20010 USA.	mbatshaw@childrensnational.org			NCRR NIH HHS [U54 RR019453] Funding Source: Medline; NICHD NIH HHS [U54 HD061221] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019453] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], ORPHAN PRODUCT DESIG; [Anonymous], RESEARCH CONDITION A; HANLEY WB, 1971, CAN MED ASSOC J, V104, P1089; LeMons C, DRUGS FOR RARE DISEA; MSALL M, 1984, NEW ENGL J MED, V310, P1500, DOI 10.1056/NEJM198406073102304; Sun Angela, 2012, Adv Pediatr, V59, P209, DOI 10.1016/j.yapd.2012.04.013; Thorat C, 2012, PEDIATRICS, V129, P516, DOI 10.1542/peds.2011-1798	7	16	17	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1729	1730		10.1001/jama.2013.285873	http://dx.doi.org/10.1001/jama.2013.285873			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794360	Green Accepted			2022-12-24	WOS:000335382300012
J	Wiener, RS				Wiener, Renda Soylemez			Balancing the Benefits and Harms of Low-Dose Computed Tomography Screening for Lung Cancer: Medicare's Options for Coverage	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MORTALITY; NODULE; RISK		Boston Univ, Sch Med, Boston, MA 02118 USA; Edith Nourse Rogers Mem Vet Hosp, Bedford, MA USA	Boston University	Wiener, RS (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 72 East Concord St,R-304, Boston, MA 02118 USA.	rwiener@bu.edu	Wiener, Renda/AAO-1557-2020	Wiener, Renda/0000-0001-7712-2135	NATIONAL CANCER INSTITUTE [K07CA138772] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA138772] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Arenberg D, 2012, J NATL COMPR CANC NE, V10, P277, DOI 10.6004/jnccn.2012.0024; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Kozower BD, 2010, ANN THORAC SURG, V90, P875, DOI 10.1016/j.athoracsur.2010.03.115; Mazzone P, 2012, CLEV CLIN J MED, V79, P337, DOI 10.3949/ccjm.79a.12018; Mckee BJ, 2013, J AM COLL RADIOL, V10, P586, DOI 10.1016/j.jacr.2013.02.015; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Pinsky PF, 2013, RADIOLOGY, V268, P865, DOI 10.1148/radiol.13121530; Roth JA, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.7_suppl.77; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003	10	13	13	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					445	U107		10.7326/M14-1352	http://dx.doi.org/10.7326/M14-1352			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	24957566				2022-12-24	WOS:000343894400021
J	Ali, K; Soond, DR; Pineiro, R; Hagemann, T; Pearce, W; Lim, EL; Bouabe, H; Scudamore, CL; Hancox, T; Maecker, H; Friedman, L; Turner, M; Okkenhaug, K; Vanhaesebroeck, B				Ali, Khaled; Soond, Dalya R.; Pineiro, Roberto; Hagemann, Thorsten; Pearce, Wayne; Lim, Ee Lyn; Bouabe, Hicham; Scudamore, Cheryl L.; Hancox, Timothy; Maecker, Heather; Friedman, Lori; Turner, Martin; Okkenhaug, Klaus; Vanhaesebroeck, Bart			Inactivation of PI(3)K p110 delta breaks regulatory T-cell-mediated immune tolerance to cancer	NATURE			English	Article							PHOSPHOINOSITIDE 3-KINASE; SUPPRESSOR-CELLS; INFLAMMATION; IDELALISIB; INHIBITION; ISOFORM; DELTA; PI3K	Inhibitors against thep110 delta isoform of phosphoinositide-3-OH kinase (PI(3) K) have shown remarkable therapeutic efficacy in some human leukaemias(1,2). As p110 delta is primarily expressed in leukocytes(3), drugs against p110 delta have not been considered for the treatment of solid tumours(4). Here we report that p110 delta inactivation in mice protects against a broad range of cancers, including non-haematological solid tumours. We demonstrate that p110 delta inactivation in regulatory T cells unleashes CD8(+) cytotoxic T cells and induces tumour regression. Thus, p110 delta inhibitors can break tumour-induced immune tolerance and should be considered for wider use in oncology.	[Ali, Khaled; Pineiro, Roberto; Pearce, Wayne; Vanhaesebroeck, Bart] UCL, UCL Canc Inst, London WC1E 6DD, England; [Soond, Dalya R.; Lim, Ee Lyn; Bouabe, Hicham; Turner, Martin; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Hagemann, Thorsten] Queen Mary Univ London, Barts Canc Inst, Ctr Canc & Inflammat, London EC1M 6BQ, England; [Scudamore, Cheryl L.] MRC Harwell, Mary Lyon Ctr, Harwell OX11 0RD, Berks, England; [Hancox, Timothy] Piramed Pharma, Slough SL1 4NL, Berks, England; [Maecker, Heather; Friedman, Lori] Genentech Inc, Canc Signaling & Translat Oncol, San Francisco, CA 94080 USA	University of London; University College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of London; Queen Mary University London; MRC Harwell; Roche Holding; Genentech	Ali, K (corresponding author), Amgen Inc, Oncol Res, 1120 Vet Blvd, San Francisco, CA 94080 USA.	khaleda@amgen.com; klaus.okkenhaug@babraham.ac.uk; bart.vanh@ucl.ac.uk	Piñeiro, Roberto/AAN-5561-2020; Okkenhaug, Klaus/H-3154-2019; Turner, Martin/N-9976-2014	Piñeiro, Roberto/0000-0001-9479-139X; Okkenhaug, Klaus/0000-0002-9432-4051; Pearce, Wayne/0000-0001-5407-4767; Turner, Martin/0000-0002-3801-9896; Scudamore, Cheryl/0000-0002-7101-1714; Lim, Ee Lyn/0000-0002-5173-2979; Maecker, Heather/0000-0002-5378-1141; , Dalya/0000-0001-9326-0896	Cancer Research UK [C23338/A10200, C23338/A15965, C18270/A12888]; Biotechnology and Biological Sciences Research Council [BB/E009867/1]; Wellcome Trust [095691/Z/11/Z]; BBSRC [BB/E009867/1, BBS/E/B/000C0407, BB/I007806/2] Funding Source: UKRI; MRC [G0901338, MC_UP_1502/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BB/I007806/2, BBS/B/02010] Funding Source: researchfish; Cancer Research UK [12888, 15965, 14355] Funding Source: researchfish; Medical Research Council [G0901338, MC_UP_1502/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by Cancer Research UK (C23338/A10200; C23338/A15965 to B. V. and C18270/A12888 to T. Hagemann), Biotechnology and Biological Sciences Research Council (BB/E009867/1 to K.O.) and Wellcome Trust (095691/Z/11/Z) (to K.O.). We thank D. Sutherlin, J. Nonomiya, J. Lesnick and K. Reif (Genentech) for technical assistance, M. Whitehead, D. Dubuisson, D. Patton, E. Slack, N. Harrington, G. Rosignoli, W. P. Day, A. Brown, P. Depledge, F. Leenders, J. Pang, L. Salphati and X. Zhang for experimental help, D. Fearon and J. Arnold for LLC-OVA cells, and A. Rudensky for FoxP3<SUP>YFP-Cre</SUP> mice.	Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Murray JM, 2012, J MED CHEM, V55, P7686, DOI 10.1021/jm300717c; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Patton DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017359; Pulaski BA, 2002, CANCER RES, V62, P4406; Putz EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040852; Safina BS, 2012, J MED CHEM, V55, P5887, DOI 10.1021/jm3003747; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Soler A, 2013, J EXP MED, V210, P1937, DOI 10.1084/jem.20121571; Soond DR, 2012, J IMMUNOL, V188, P5935, DOI 10.4049/jimmunol.1102116; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	23	360	376	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					407	+		10.1038/nature13444	http://dx.doi.org/10.1038/nature13444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24919154	Green Accepted			2022-12-24	WOS:000337350200037
J	Lu, CY; Zhang, F; Lakoma, MD; Madden, JM; Rusinak, D; Penfold, RB; Simon, G; Ahmedani, BK; Clarke, G; Hunkeler, EM; Waitzfelder, B; Owen-Smith, A; Raebel, MA; Rossom, R; Coleman, KJ; Copeland, LA; Soumerai, SB				Lu, Christine Y.; Zhang, Fang; Lakoma, Matthew D.; Madden, Jeanne M.; Rusinak, Donna; Penfold, Robert B.; Simon, Gregory; Ahmedani, Brian K.; Clarke, Gregory; Hunkeler, Enid M.; Waitzfelder, Beth; Owen-Smith, Ashli; Raebel, Marsha A.; Rossom, Rebecca; Coleman, Karen J.; Copeland, Laurel A.; Soumerai, Stephen B.			Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERRUPTED TIME-SERIES; PEDIATRIC SUICIDALITY; E-CODES; RISK; DEPRESSION; ADOLESCENTS; FLUOXETINE; CHILDREN; DECLINE; TRENDS	Objective To investigate if the widely publicized warnings in 2003 from the US Food and Drug Administration about a possible increased risk of suicidality with antidepressant use in young people were associated with changes in antidepressant use, suicide attempts, and completed suicides among young people. Design Quasi-experimental study assessing changes in outcomes after the warnings, controlling for pre-existing trends. Setting Automated healthcare claims data (2000-10) derived from the virtual data warehouse of 11 health plans in the US Mental Health Research Network. Participants Study cohorts included adolescents (around 1.1 million), young adults (around 1.4 million), and adults (around 5 million). Main outcome measures Rates of antidepressant dispensings, psychotropic drug poisonings (a validated proxy for suicide attempts), and completed suicides. Results Trends in antidepressant use and poisonings changed abruptly after the warnings. In the second year after the warnings, relative changes in antidepressant use were -31.0% (95% confidence interval -33.0% to -29.0%) among adolescents, -24.3% (-25.4% to -23.2%) among young adults, and -14.5% (-16.0% to -12.9%) among adults. These reflected absolute reductions of 696, 1216, and 1621 dispensings per 100 000 people among adolescents, young adults, and adults, respectively. Simultaneously, there were significant, relative increases in psychotropic drug poisonings in adolescents (21.7%, 95% confidence interval 4.9% to 38.5%) and young adults (33.7%, 26.9% to 40.4%) but not among adults (5.2%, -6.5% to 16.9%). These reflected absolute increases of 2 and 4 poisonings per 100 000 people among adolescents and young adults, respectively (approximately 77 additional poisonings in our cohort of 2.5 million young people). Completed suicides did not change for any age group. Conclusions Safety warnings about antidepressants and widespread media coverage decreased antidepressant use, and there were simultaneous increases in suicide attempts among young people. It is essential to monitor and reduce possible unintended consequences of FDA warnings and media reporting.	[Lu, Christine Y.; Zhang, Fang; Lakoma, Matthew D.; Madden, Jeanne M.; Soumerai, Stephen B.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Lu, Christine Y.; Zhang, Fang; Lakoma, Matthew D.; Madden, Jeanne M.; Soumerai, Stephen B.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Penfold, Robert B.; Simon, Gregory] Grp Hlth Res Inst, Seattle, WA USA; [Penfold, Robert B.] Univ Washington, Dept Hlth Serv Res, Seattle, WA 98195 USA; [Simon, Gregory] Mental Hlth Res Network, Detroit, MI USA; [Ahmedani, Brian K.] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Clarke, Gregory] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Hunkeler, Enid M.] Kaiser Permanente Med Care Program Northern Calif, Div Res, Oakland, CA USA; [Waitzfelder, Beth] Kaiser Permanente Ctr Hlth Res Hawaii, Honolulu, HI USA; [Owen-Smith, Ashli] Kaiser Permanente Georgia, Ctr Hlth Res Southeast, Atlanta, GA USA; [Raebel, Marsha A.] Kaiser Permanente Colorado Inst Hlth Res, Denver, CO USA; [Rossom, Rebecca] HealthPartners Inst Educ & Res, Bloomington, MN USA; [Coleman, Karen J.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Copeland, Laurel A.] Cent Texas Vet Hlth Care Syst Jointly Scott & Whi, Ctr Appl Hlth Res, Temple, TX USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Washington; University of Washington Seattle; Henry Ford Health System; Henry Ford Hospital; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; HealthPartners Institute for Education & Research; Kaiser Permanente	Lu, CY (corresponding author), 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	christine_lu@harvardpilgrim.org	Rossom, Rebecca/R-7103-2019; Copeland, Laurel A/C-3763-2017; Zhang, Fang/HHN-2153-2022	Copeland, Laurel A/0000-0002-9478-0209; Rossom, Rebecca/0000-0002-9531-914X	US National Institute of Mental Health [U19MH092201]; Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) (NIDDK) [1P30-DK092924]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH092201] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This research was supported by a cooperative agreement (U19MH092201; principal investigator, GS) with the US National Institute of Mental Health; SBS was the study principal investigator. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. The sponsor had no role in the design and conduct of the study; analysis, and interpretation of the data; the preparation of the manuscript; and the decision to submit the manuscript for publication. SBS was supported in part by the Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) (NIDDK grant 1P30-DK092924).	Baldessarini RJ, 2006, ARCH GEN PSYCHIAT, V63, P246, DOI 10.1001/archpsyc.63.3.246; Barry CL, 2010, PEDIATRICS, V125, P88, DOI 10.1542/peds.2009-0792; Busch SH, 2010, PSYCHIAT SERV, V61, P11, DOI 10.1176/appi.ps.61.1.11; Centers for Disease Control and Prevention, 2011, STRATEGIES PREVENT O, P60; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P321; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; FDA, 2007, QUEST ANSW ANT US CH; FDA, 2004, JOINT M PSYCH DRUGS; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P580, DOI 10.1001/archgenpsychiatry.2011.2048; Gibbons RD, 2011, DRUG SAFETY, V34, P375, DOI 10.2165/11589350-000000000-00000; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Harris G, 2004, NY TIMES; Hornbrook Mark C, 2005, J Natl Cancer Inst Monogr, P12; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kaizar EE, 2006, CLIN TRIALS, V3, P96; Kaizar EE, 2006, CLIN TRIALS, V3, P73, DOI 10.1191/1740774506cn139oa; Klein DF, 2006, NEUROPSYCHOPHARMACOL, V31, P689, DOI 10.1038/sj.npp.1300996; Leckman JF, 2007, AM J PSYCHIAT, V164, P1304, DOI 10.1176/appi.ajp.2007.07050880; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Libby AM, 2009, ARCH GEN PSYCHIAT, V66, P633, DOI 10.1001/archgenpsychiatry.2009.46; Lu CY, 2014, PHARMACOEPIDEM DR S, V23, P218, DOI 10.1002/pds.3551; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; March JS, 2007, ARCH GEN PSYCHIAT, V64, P1132; Morrato EH, 2008, AM J PSYCHIAT, V165, P42, DOI 10.1176/appi.ajp.2007.07010205; National Institute of Mental Health, 2013, SUIC US STAT PREV; Olfson M, 2008, J CLIN PSYCHIAT, V69, P425, DOI 10.4088/JCP.v69n0313; Pamer CA, 2010, PHARMACOEPIDEM DR S, V19, P158, DOI 10.1002/pds.1886; Patrick AR, 2010, PHARMACOEPIDEM DR S, V19, P1263, DOI 10.1002/pds.2037; Schneeweiss S, 2010, ARCH GEN PSYCHIAT, V67, P497, DOI 10.1001/archgenpsychiatry.2010.39; Simon GE, 2006, AM J PSYCHIAT, V163, P41, DOI 10.1176/appi.ajp.163.1.41; Simon GE, 2006, NEW ENGL J MED, V355, P2722, DOI 10.1056/NEJMp068270; SOUMERAI SB, 1992, MILBANK Q, V70, P155, DOI 10.2307/3350088; Spettell CM, 2003, HEALTH SERV RES, V38, P1081, DOI 10.1111/1475-6773.00164; Spiller HA, 2010, LEGAL MED, V12, P177, DOI 10.1016/j.legalmed.2010.04.005; Strom BL, 2012, PHARMACOEPIDEMIOLOGY, V5th, P163; Ting SA, 2012, GEN HOSP PSYCHIAT, V34, P557, DOI 10.1016/j.genhosppsych.2012.03.020; Townsend L, 2012, PHARMACOEPIDEM DR S, V21, P163, DOI 10.1002/pds.2310; Valuck RJ, 2007, AM J PSYCHIAT, V164, P1198, DOI 10.1176/appi.ajp.2007.07010007; Vedantam S, 2004, WASHINGTON POST; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wagner Edward H, 2005, J Natl Cancer Inst Monogr, P3, DOI 10.1093/jncimonographs/lgi032; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	43	119	120	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2014	348								g3596	10.1136/bmj.g3596	http://dx.doi.org/10.1136/bmj.g3596			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6LF	24942789	Green Published, hybrid			2022-12-24	WOS:000337805600001
J	Bushnell, C; McCullough, L				Bushnell, Cheryl; McCullough, Louise			Stroke Prevention in Women: Synopsis of the 2014 American Heart Association/American Stroke Association Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; HEALTH-CARE PROFESSIONALS; SEX-DIFFERENCES; ISCHEMIC-STROKE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; GENDER-DIFFERENCES; OUTCOMES	Description: In February 2014, the American Heart Association/American Stroke Association released their first guideline focused on stroke prevention in women. This new guideline highlights unique risk factors for stroke in women, including oral contraception and hormone therapy, and pregnancy-associated disorders, such as preeclampsia, that may have long-lasting consequences on a woman's health. It also addresses hypertension; atrial fibrillation; migraine headache with aura; and the epidemiology of types of stroke, such as aneurysmal subarachnoid hemorrhage and cerebral vein thrombosis, that are predominant in women. Methods: Members of a multidisciplinary expert panel searched, reviewed, and critiqued relevant English-language literature published between 1990 and May 2013. The panel devised evidence tables and developed recommendations using American Heart Association guideline procedures and levels of evidence. Recommendations: This synopsis of the guideline summarizes the evidence about risk factors for stroke in women and suggests prevention strategies. It also describes the new recommendations relevant to identifying and treating hypertensive disorders in pregnancy that increase risk for stroke.	[Bushnell, Cheryl] Wake Forest Baptist Med Ctr, Winston Salem, NC 27157 USA; Univ Connecticut, Ctr Hlth, Farmington, CT USA; Hartford Hosp, Stroke Ctr, Hartford, CT 06115 USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Connecticut; Hartford Hospital	Bushnell, C (corresponding author), Wake Forest Baptist Med Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA.	cbushnel@wakehealth.edu	McCullough, Louise/R-2824-2019		Hazel K. Goddess Fund for Stroke Research in Women; World Federation of Neurology; National Institutes of Health [RO1 NS055215, RO1 NS077769, R21 NS082906]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077769, R21NS082906, R01NS055215] Funding Source: NIH RePORTER	Hazel K. Goddess Fund for Stroke Research in Women; World Federation of Neurology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Bushnell is supported the Hazel K. Goddess Fund for Stroke Research in Women and the World Federation of Neurology. Dr. McCullough is supported by grants RO1 NS055215, RO1 NS077769, and R21 NS082906 from the National Institutes of Health.	Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; Andersson HM, 2012, BLOOD, V119, P1555, DOI 10.1182/blood-2011-09-380618; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Berry JD, 2014, CIRCULATION, V129, P399, DOI DOI 10.1161/01.CIR.0000442015.53336.12; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; Bushnell CD, 2014, NEUROLOGY, V82, P922, DOI 10.1212/WNL.0000000000000208; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gall SL, 2012, STROKE, V43, P1982, DOI 10.1161/STROKEAHA.111.632547; Gargano JW, 2007, STROKE, V38, P2541, DOI 10.1161/STROKEAHA.107.485482; Giralt D, 2012, ACTA NEUROL SCAND, V125, P83, DOI 10.1111/j.1600-0404.2011.01514.x; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Gray LJ, 2007, STROKE, V38, P2960, DOI 10.1161/STROKEAHA.107.488304; Howard VJ, 2011, LANCET NEUROL, V10, P530, DOI 10.1016/S1474-4422(11)70080-1; Jacobs AK, 2013, CIRCULATION, V127, P268, DOI 10.1161/CIR.0b013e31827e8e5f; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Kurth T, 2009, NEUROLOGY, V73, P581, DOI 10.1212/WNL.0b013e3181ab2c20; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; Merikangas KR, 2013, HEADACHE, V53, P230, DOI 10.1111/head.12038; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pan A, 2011, STROKE, V42, P2770, DOI 10.1161/STROKEAHA.111.617043; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Peters SA, 2014, LANCET; Poisson SN, 2010, STROKE, V41, P1891, DOI 10.1161/STROKEAHA.110.580977; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Sturm JW, 2004, STROKE, V35, P2340, DOI 10.1161/01.STR.0000141977.18520.3b; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	35	35	37	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					853	U71		10.7326/M14-0762	http://dx.doi.org/10.7326/M14-0762			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24935489	Green Accepted			2022-12-24	WOS:000337374900020
J	Jampol, LM; Bressler, NM; Glassman, AR				Jampol, Lee M.; Bressler, Neil M.; Glassman, Adam R.			Revolution to a New Standard Treatment of Diabetic Macular Edema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEFERRED LASER; RANIBIZUMAB; PROMPT		[Jampol, Lee M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bressler, Neil M.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Glassman, Adam R.] Jaeb Ctr Hlth Res, Tampa, FL 33647 USA	Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Medicine; JAEB Center For Health Research	Glassman, AR (corresponding author), Jaeb Ctr Hlth Res, 15310 Amberly Dr,Ste 350, Tampa, FL 33647 USA.	drcrstat2@jaeb.org		Glassman, Adam/0000-0003-0173-1684	NATIONAL EYE INSTITUTE [U10EY023207, U10EY014231, U10EY018817, U10EY014229] Funding Source: NIH RePORTER; NEI NIH HHS [U10 EY014231, U10 EY023207, U10 EY014229, EY14231, EY023207, U10 EY018817, EY18817] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aiello LP, 2011, OPHTHALMOLOGY, V118, pE5, DOI 10.1016/j.ophtha.2011.09.058; Bressler NM, 2014, JAMA OPHTHALMOL, V132, P168, DOI 10.1001/jamaophthalmol.2013.6426; Centers for Disease Control and Prevention, 2011 NAT DIAB FACT S; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Varma R, 2012, AM AC OPHTH 2012 ANN	8	32	33	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2269	2270		10.1001/jama.2014.2536	http://dx.doi.org/10.1001/jama.2014.2536			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915254	Green Accepted			2022-12-24	WOS:000336972600014
J	Chun, S; Westmoreland, JJ; Bayazitov, IT; Eddins, D; Pani, AK; Smeyne, RJ; Yu, J; Blundon, JA; Zakharenko, SS				Chun, Sungkun; Westmoreland, Joby J.; Bayazitov, Ildar T.; Eddins, Donnie; Pani, Amar K.; Smeyne, Richard J.; Yu, Jing; Blundon, Jay A.; Zakharenko, Stanislav S.			Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models	SCIENCE			English	Article							DIGEORGE-SYNDROME REGION; HALLUCINATIONS; HYPOTHESIS; MICE	Auditory hallucinations in schizophrenia are alleviated by antipsychotic agents that inhibit D2 dopamine receptors (Drd2s). The defective neural circuits and mechanisms of their sensitivity to antipsychotics are unknown. We identified a specific disruption of synaptic transmission at thalamocortical glutamatergic projections in the auditory cortex in murine models of schizophrenia-associated 22q11 deletion syndrome (22q11DS). This deficit is caused by an aberrant elevation of Drd2 in the thalamus, which renders 22q11DS thalamocortical projections sensitive to antipsychotics and causes a deficient acoustic startle response similar to that observed in schizophrenic patients. Haploinsufficiency of the microRNA-processing gene Dgcr8 is responsible for the Drd2 elevation and hypersensitivity of auditory thalamocortical projections to antipsychotics. This suggests that Dgcr8-microRNA-Drd2-dependent thalamocortical disruption is a pathogenic event underlying schizophrenia-associated psychosis.	[Chun, Sungkun; Westmoreland, Joby J.; Bayazitov, Ildar T.; Eddins, Donnie; Pani, Amar K.; Smeyne, Richard J.; Yu, Jing; Blundon, Jay A.; Zakharenko, Stanislav S.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Zakharenko, SS (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	stanislav.zakharenko@stjude.org	Zakharenko, Stanislav/D-3287-2013; Chun, Sungkun/R-1614-2016	Zakharenko, Stanislav/0000-0001-8115-202X; Chun, Sungkun/0000-0001-9837-2299; Smeyne, Richard/0000-0002-8459-5472	NIH [R01 MH097742, R01 MH095810, R01 DC012833]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097742, R01MH095810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012833] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in part, by NIH grants R01 MH097742, R01 MH095810, and R01 DC012833 and the American Lebanese Syrian Associated Charities. We thank E. Illingworth, P. Scambler, A. Wynshaw-Boris, J. Gogos, S. Strittmatter, B. Morrow, and E. Fuchs for providing mutant mice; A. Lessard and the Maryland Brain Collection for providing postmortem human brain samples; K. J. Sample and P. Devaraju for technical assistance; and St. Jude Children's Research Hospital, University of Tennessee, University of North Carolina, and University of Pennsylvania Vector Cores for producing adeno-associated viruses and lentiviruses.	Behrendt RP, 2003, CONSCIOUS COGN, V12, P413, DOI 10.1016/S1053-8100(03)00017-5; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Hubl D, 2007, BRIT J PSYCHIAT, V190, P57, DOI 10.1192/bjp.bp.106.022954; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; Snyder SH, 1999, PHILOS T ROY SOC B, V354, P1985, DOI 10.1098/rstb.1999.0538; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	13	81	82	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1178	1182		10.1126/science.1253895	http://dx.doi.org/10.1126/science.1253895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904170	Green Accepted			2022-12-24	WOS:000336791200052
J	Collin, J; Johnson, E; Hill, S				Collin, Jeff; Johnson, Emma; Hill, Sarah			Government support for alcohol industry: promoting exports, jeopardising global health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRADE AGREEMENTS		[Collin, Jeff; Hill, Sarah] Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Edinburgh EH8 9LD, Midlothian, Scotland; [Johnson, Emma] NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland	University of Edinburgh	Collin, J (corresponding author), Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Edinburgh EH8 9LD, Midlothian, Scotland.	jeff.collin@ed.ac.uk		Hill, Sarah/0000-0003-3555-433X	Economic and Social Research Council [ES/L001284/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA160695] Funding Source: NIH RePORTER; ESRC [ES/L001284/1] Funding Source: UKRI; NCI NIH HHS [R01 CA160695, R01CA160695] Funding Source: Medline	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2011, HEALTH IS GLOBAL AN; Australian Government, 2011, TRADE POLICY STATEME; Department of Health, 2011, THE PUBLIC HEALTH RE; Department of Health, 2011, HEALTHY LIVES HEALTH; Department of Health, 2007, UK GOVERNMENT SIDE S; Department of Health Foreign and Commonwealth Office, 2013, UNITED KINGDOMS REVI; Diageo, ANNUAL REPORT 2013; Diageo, 2011, GENERATING PROSPERIT; Donaldson L., 2007, HEALTH IS GLOBAL; Euromonitor, 2012, LEGISLATION IN ALCOH; Euromonitor, 2013, ALCOHOLIC DRINKS IN; Euromonitor, 2012, ALCOHOLIC DRINKS FOR; Euromonitor, 2012, ALCOHOLIC DRINKS IN; Euromonitor, 2012, NEW PRODUCT DEVELOPM; Euromonitor, 2012, WHISKIES GROWTH OPPO; European Commission, 2013, FREE TRADE AGREEMENT; Gornall J., 2014, BMJ-BRIT MED J, V348, pf7646, DOI DOI 10.1136/BMJ.F7646; Hague W., 2011, PREFECT POLICE F PEC; HM Government, 2008, HEALTH IS GLOBAL A U; HM Government, 2011, TECHNICAL DOCUMENT D; HM Government, 2012, THE GOVERNMENTS ALCO; Jernigan D., 2008, ADDICTION.S, V104, P6; Kelsey J, 2012, ADDICTION, V107, P1719, DOI 10.1111/j.1360-0443.2012.03874.x; Lawrence F., 2012, GUARDIAN        0913; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McCambridge J, 2014, ADDICTION, V109, P519, DOI 10.1111/add.12356; Nair S, 2014, MONEYCONTROL; O'Brien P, 2013, DRUG ALCOHOL REV, V32, P5, DOI 10.1111/j.1465-3362.2012.00485.x; Pomfret J, 2011, REUTERS         0624; SABMiller, 2013, SABMILLER PLC QUARTE; SABMiller, 2012, INVESTOR RELATIONS Q; SABMiller, 2013, FIRST HALF RESULTS S; SABMiller, 2013, INVESTOR RELATIONS Q; SABMiller. Company snapshot, 2013, COMPANY SNAPSHOT 201; Scotch Whisky Association, 2013, TRADE MATTERS INTERN; The Scottish Government, 2009, CHANGING SCOTLANDS R; UK Trade and Investment, 2012, EXPANDING IN ETHIOPI; UK Trade and Investment Department for Environment and Rural Affairs, 2013, UK FOOD AND DRINK IN; United Nations, 2011, DRAFT POLITICAL DECL; United Nations, 2011, LIST OF CIVIL SOCIET; United Nations, 2013, NEW GLOB PARTN ER PO; WHO, 2011, GLOBAL STATUS REPORT; WHO, 2009, 2008 2013 ACTION PLA; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Trade Organization, 2010, TAXES ON ALCOHOLIC B; World Trade Organization, 2013, PHILIPPINES TAXES ON; World Trade Organization, 2010, INDIA MEASURES AFFEC; Zeigler DW, 2009, ADDICTION, V104, P13, DOI 10.1111/j.1360-0443.2008.02431.x	48	14	14	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2014	348								g3648	10.1136/bmj.g3648	http://dx.doi.org/10.1136/bmj.g3648			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI7CE	24906713	Green Published			2022-12-24	WOS:000337038000011
J	Bender, E				Bender, Eric			DEVELOPING WORLD Global warning	NATURE			English	Editorial Material																		Safaeian M, 2013, CANCER PREV RES, V6, P1242, DOI 10.1158/1940-6207.CAPR-13-0203; Shastri SS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju009; Stewart B, 2014, WORLD CANC REPORT 20	3	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S64	S65		10.1038/509S64a	http://dx.doi.org/10.1038/509S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870825	Bronze			2022-12-24	WOS:000336457100008
J	Schmid, M; Jensen, TH				Schmid, Manfred; Jensen, Torben Heick			SnapShot: Nuclear RNAPII Transcript Modification	CELL			English	Editorial Material									[Schmid, Manfred; Jensen, Torben Heick] Aarhus Univ, Dept Mol Biol & Genet, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus, Denmark	Aarhus University	Schmid, M (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus, Denmark.		Schmid, Manfred/E-6725-2012; Jensen, Torben H/G-2954-2017	Schmid, Manfred/0000-0003-0516-3055; Jensen, Torben Heick/0000-0001-5127-1239	Novo Nordisk Fonden [NNF12OC0001211] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)			0	0	0	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5							1244.e1	10.1016/j.cell.2014.05.003	http://dx.doi.org/10.1016/j.cell.2014.05.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855955	Bronze, Green Accepted			2022-12-24	WOS:000336437200024
J	McKnight, K; Hoang, HD; Prasain, JK; Brown, N; Vibbert, J; Hollister, KA; Moore, R; Ragains, JR; Reese, J; Miller, MA				McKnight, Katherine; Hoang, Hieu D.; Prasain, Jeevan K.; Brown, Naoko; Vibbert, Jack; Hollister, Kyle A.; Moore, Ray; Ragains, Justin R.; Reese, Jeff; Miller, Michael A.			Neurosensory Perception of Environmental Cues Modulates Sperm Motility Critical for Fertilization	SCIENCE			English	Article							PROSTAGLANDINS; CHANNEL	Environmental exposures affect gamete function and fertility, but the mechanisms are poorly understood. Here, we show that pheromones sensed by ciliated neurons in the Caenorhabditis elegans nose alter the lipid microenvironment within the oviduct, thereby affecting sperm motility. In favorable environments, pheromone-responsive sensory neurons secrete a transforming growth factor-beta ligand called DAF-7, which acts as a neuroendocrine factor that stimulates prostaglandin-endoperoxide synthase [cyclooxygenase (Cox)]-independent prostaglandin synthesis in the ovary. Oocytes secrete F-class prostaglandins that guide sperm toward them. These prostaglandins are also synthesized in Cox knockout mice, raising the possibility that similar mechanisms exist in other animals. Our data indicate that environmental cues perceived by the female nervous system affect sperm function.	[McKnight, Katherine] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Birmingham, AL 35294 USA; [Hoang, Hieu D.; Vibbert, Jack; Miller, Michael A.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Prasain, Jeevan K.; Moore, Ray] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Brown, Naoko; Reese, Jeff] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Hollister, Kyle A.; Ragains, Justin R.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Reese, Jeff] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Vanderbilt University; Louisiana State University System; Louisiana State University; Vanderbilt University	Miller, MA (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	mamiller@uab.edu		Reese, Jeff/0000-0001-8751-6146; Hoang, Hieu/0000-0002-5893-7651; Miller, Michael/0000-0003-4872-7121	NIH [GM085105, HL096967, HL109199]; University of Alabama at Birmingham (UAB) Reproductive Endocrinology and Infertility Fellowship Program; UAB Skin Disease Research Center [P30 AR050948]; UAB-University of California San Diego O'Brien Acute Kidney Injury Center [P30 DK079337]; UAB Lung Health Center [HL114439, HL110950]; UAB Center for Free Radical Biology; National Center for Research Resources Shared Instrumentation grant [S10 RR19261]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110950, R01HL109199, R01HL096967, R01HL114439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085105] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham (UAB) Reproductive Endocrinology and Infertility Fellowship Program; UAB Skin Disease Research Center; UAB-University of California San Diego O'Brien Acute Kidney Injury Center; UAB Lung Health Center; UAB Center for Free Radical Biology; National Center for Research Resources Shared Instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Ashrafi, R. Butcher, J. Parant, I. Kadisha, and T. van Groen for reagents or technical assistance and the NIH-supported Caenorhabditis Genetics Center (P40 OD010440) for strains. This work was supported by NIH grants (GM085105 to M. A. M.; HL096967 and HL109199 to J. R.) and the University of Alabama at Birmingham (UAB) Reproductive Endocrinology and Infertility Fellowship Program. The UAB Targeted Metabolomics and Proteomics Laboratory has been supported by the UAB Skin Disease Research Center (P30 AR050948), UAB-University of California San Diego O'Brien Acute Kidney Injury Center (P30 DK079337), UAB Lung Health Center (HL114439 and HL110950), UAB Center for Free Radical Biology, and a National Center for Research Resources Shared Instrumentation grant (S10 RR19261). All data are provided in the main paper and supplementary materials. We declare no conflicts of interest.	Cariboni A, 2007, TRENDS NEUROSCI, V30, P638, DOI 10.1016/j.tins.2007.09.002; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Dalfo D, 2012, CURR BIOL, V22, P712, DOI 10.1016/j.cub.2012.02.064; Edmonds JW, 2011, DEV BIOL, V359, P47, DOI 10.1016/j.ydbio.2011.08.014; Edmonds JW, 2010, DEV CELL, V19, P858, DOI 10.1016/j.devcel.2010.11.005; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Gumienny Tina L, 2013, WormBook, P1, DOI 10.1895/wormbook.1.22.2; Hoang HD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003271; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Kubagawa HM, 2006, NAT CELL BIOL, V8, P1143, DOI 10.1038/ncb1476; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Ludewig A. H., 2013, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.155.1, DOI 10.1895/WORMBOOK.1.155.1]; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Prasain JK, 2013, JOVE-J VIS EXP, DOI 10.3791/50447; Reese J, 2000, P NATL ACAD SCI USA, V97, P9759, DOI 10.1073/pnas.97.17.9759; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005	20	32	33	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					754	757		10.1126/science.1250598	http://dx.doi.org/10.1126/science.1250598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833393	Green Accepted			2022-12-24	WOS:000335912900043
J	Insel, TR				Insel, Thomas R.			Mental Disorders in Childhood Shifting the Focus From Behavioral Symptoms to Neurodevelopmental Trajectories	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PSYCHOSIS		NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Insel, TR (corresponding author), NIMH, NIH, NIMH Room 8129,6001 Execut Blvd, Bethesda, MD 20892 USA.	insel@mail.nih.gov						BrainSpan, BRAINSPAN ATL DEV HU; Brent BK, 2013, CHILD ADOL PSYCH CL, V22, P689, DOI 10.1016/j.chc.2013.06.003; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P768; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Stafford MR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f185; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447	10	61	62	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1727	1728		10.1001/jama.2014.1193	http://dx.doi.org/10.1001/jama.2014.1193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794359				2022-12-24	WOS:000335382300011
J	Cannon, B				Cannon, Bill			MICROBIOLOGY Resistance fighters	NATURE			English	Editorial Material							ANTIBIOTIC-RESISTANCE											Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Carrel M, 2014, INFECT CONT HOSP EP, V35, P190, DOI 10.1086/674860; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chait R, 2012, NAT CHEM BIOL, V8, P2, DOI 10.1038/nchembio.745; Dantas G, 2014, AM SCI, V102, P42, DOI 10.1511/2014.106.42; David MZ, 2012, INFECT CONT HOSP EP, V33, P782, DOI 10.1086/666640; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014	8	10	10	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S6	S8		10.1038/509S6a	http://dx.doi.org/10.1038/509S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784428	Bronze			2022-12-24	WOS:000335199100004
J	Belluz, J				Belluz, Julia			Tug of war for antiviral drugs data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Belluz, J (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jbelluz@gmail.com						Doshi P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1615; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106	4	1	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2014	348								g2227	10.1136/bmj.g2227	http://dx.doi.org/10.1136/bmj.g2227			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SE	24811408				2022-12-24	WOS:000334348700017
J	Perkins, RB; Stier, EA				Perkins, Rebecca B.; Stier, Elizabeth A.			Should U.S. Women Be Screened for Cervical Cancer With Pap Tests, HPV Tests, or Both?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; ABNORMALITIES; CYTOLOGY		[Perkins, Rebecca B.; Stier, Elizabeth A.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Perkins, RB (corresponding author), Boston Univ, Sch Med, 85 East Concord St,6th Floor, Boston, MA 02118 USA.	rbperkin@bu.edu		Stier, Elizabeth/0000-0003-3526-0032; Perkins, Rebecca/0000-0002-7054-3014				Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Gertig DM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-227; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Murphy J, 2012, J OBSTET GYNAECOL CA, V34, P443, DOI 10.1016/S1701-2163(16)35241-0; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P946; U.S. Department of Health and Human Services, 2014, BRIEF SUMM MICR DEV; Zhao C, 2014, ARCH PATHOL LAB MED	11	4	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					295	+		10.7326/M14-1043	http://dx.doi.org/10.7326/M14-1043			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	24912666				2022-12-24	WOS:000342347300021
J	Karayannis, T; Au, E; Patel, JC; Kruglikov, I; Markx, S; Delorme, R; Heron, D; Salomon, D; Glessner, J; Restituito, S; Gordon, A; Rodriguez-Murillo, L; Roy, NC; Gogos, JA; Rudy, B; Rice, ME; Karayiorgou, M; Hakonarson, H; Keren, B; Huguet, G; Bourgeron, T; Hoeffer, C; Tsien, RW; Peles, E; Fishell, G				Karayannis, T.; Au, E.; Patel, J. C.; Kruglikov, I.; Markx, S.; Delorme, R.; Heron, D.; Salomon, D.; Glessner, J.; Restituito, S.; Gordon, A.; Rodriguez-Murillo, L.; Roy, N. C.; Gogos, J. A.; Rudy, B.; Rice, M. E.; Karayiorgou, M.; Hakonarson, H.; Keren, B.; Huguet, G.; Bourgeron, T.; Hoeffer, C.; Tsien, R. W.; Peles, E.; Fishell, G.			Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission	NATURE			English	Article							CORTICAL INTERNEURONS; GABA(A) RECEPTORS; PREPULSE INHIBITION; TOURETTES-SYNDROME; SCHIZOPHRENIA; SYNAPSES; NUMBER; ASSOCIATION; LINKAGE; RELEASE	Although considerable evidence suggests that the chemical synapse is a lynchpin underlying affective disorders, how molecular insults differentially affect specific synaptic connections remains poorly understood. For instance, Neurexin 1a and 2 (NRXN1 and NRXN2) and CNTNAP2 (also known as CASPR2), all members of the neurexin superfamily of transmembrane molecules, have been implicated in neuropsychiatric disorders. However, their loss leads to deficits that have been best characterized with regard to their effect on excitatory cells(1,2). Notably, other disease-associated genes such as BDNF and ERBB4 implicate specific interneuron synapses in psychiatric disorders(3,4). Consistent with this, cortical interneuron dysfunction has been linked to epilepsy, schizophrenia and autism(5,6). Using a microarray screen that focused upon synapse-associated molecules, we identified Cntnap4 (contactin associated protein-like 4, also known as Caspr4) as highly enriched in developing murine interneurons. In this study we show that Cntnap4 is localized presynaptically and its loss leads to a reduction in the output of cortical parvalbumin (PV)-positive GABAergic (gamma-aminobutyric acid producing) basket cells. Paradoxically, the loss of Cntnap4 augments midbrain dopaminergic release in the nucleus accumbens. In Cntnap4 mutant mice, synaptic defects in these disease-relevant neuronal populations are mirrored by sensory-motor gating and grooming endophenotypes; these symptoms could be pharmacologically reversed, providing promise for therapeutic intervention in psychiatric disorders.	[Karayannis, T.; Au, E.; Kruglikov, I.; Restituito, S.; Roy, N. C.; Rudy, B.; Hoeffer, C.; Tsien, R. W.; Fishell, G.] NYU, Dept Neurosci & Physiol, Neurosci Inst, New York, NY 10016 USA; [Patel, J. C.; Rice, M. E.] NYU, Dept Neurosurg Neurosci & Physiol, Langone Med Ctr, New York, NY 10016 USA; [Markx, S.; Rodriguez-Murillo, L.; Karayiorgou, M.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Delorme, R.; Hakonarson, H.; Huguet, G.; Bourgeron, T.] Inst Pasteur, Human Genet & Cognit Funct Unit, F-75724 Paris, France; [Delorme, R.; Huguet, G.; Bourgeron, T.] Inst Pasteur, URA Genes Synapses & Cognit 2182, CNRS, F-75724 Paris, France; [Delorme, R.] Hop Robert Debre, AP HP, Dept Child & Adolescent Psychiat, F-75019 Paris, France; [Heron, D.] Grp Hosp Pitie Salpetriere, AP HP, Unite Fonct Genet Med, Dept Genet & Cytogenet,Ctr Reference,CRicm,UMR S9, F-75013 Paris, France; [Salomon, D.; Gordon, A.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Glessner, J.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Roy, N. C.] Natl Inst Deafness & Other Commun Disorders, Sect Synapt Transmiss, NIH, Bethesda, MD 20892 USA; [Gogos, J. A.] Columbia Univ, Med Ctr, Dept Physiol, New York, NY 10032 USA; [Gogos, J. A.] Columbia Univ, Med Ctr, Dept Cellular Biophys & Neurosci, New York, NY 10032 USA; [Keren, B.] Grp Hosp Pitie Salpetriere, AP HP, Unite Fonct Genet Chromosom, Dept Genet & Cytogenet,CRicm,UMR S975, F-75013 Paris, France; [Huguet, G.; Bourgeron, T.] Univ Paris Diderot, Sorbonne Paris Cite, F-75005 Paris, France; [Bourgeron, T.] FondaMental Fdn, F-94000 Creteil, France	New York University; New York University; NYU Langone Medical Center; Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Weizmann Institute of Science; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Columbia University; Columbia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Fishell, G (corresponding author), NYU, Dept Neurosci & Physiol, Neurosci Inst, New York, NY 10016 USA.	gordon.fishell@med.nyu.edu	Kruglikov, Ilya/AAC-9131-2020; Karayannis, Theofanis/GRR-3982-2022; Huguet, Guillaume/GPX-3656-2022; Karayannis, Theofanis/O-5194-2014	Kruglikov, Ilya/0000-0002-1575-4636; Karayannis, Theofanis/0000-0002-3267-6254; Huguet, Guillaume/0000-0002-4746-6030; Patel, Jyoti/0000-0003-0295-6180; Fishell, Gordon/0000-0002-9640-9278; Rice, Margaret/0000-0003-1793-2798; Bourgeron, Thomas/0000-0001-8164-9220; Glessner, Joseph/0000-0001-5131-2811; Delorme, Richard/0000-0002-5614-3663; Peles, Elior/0000-0002-3325-0597; Au, Edmund/0000-0003-3190-9711; Rudy, Bernardo/0000-0001-5748-6900	NIH [R01 NS081297, R01 MH071679, R01 NS074972, P01 NS074972, R01 NS036362, R01 DA033811, NS30989, NS50220]; Simons Foundation [94534]; Attilio and Olympia Ricciardi Research Fund; Israel Science Foundation; Patterson Trust; Roche; New York State through its NYSTEM initiative [C024326]; Canadian Institutes of Health Research; NYU COE Addiction Seed Grant; Institut Pasteur; INSERM; AP-HP; University Paris Diderot; Bettencourt-Schueller foundation; Orange foundation; FondaMental foundation; Conny-Maeva foundation; Cognacq-Jay foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Attilio and Olympia Ricciardi Research Fund; Israel Science Foundation(Israel Science Foundation); Patterson Trust; Roche(Roche Holding); New York State through its NYSTEM initiative; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NYU COE Addiction Seed Grant; Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AP-HP; University Paris Diderot; Bettencourt-Schueller foundation; Orange foundation; FondaMental foundation; Conny-Maeva foundation; Cognacq-Jay foundation	The authors are grateful to R. Froemke for critically reading the manuscript, to B. Benedetti, M. McKenzie Chang, L. Cobbs, B. A. Heller, T. Petros and N. Yumoto (all NYU) for help with experiments and analysis and to Charles Nicholson (NYU) for providing specialized software to analyse Vmax. Research in the Fishell laboratory is supported by the NIH (grants R01 NS081297, R01 MH071679, R01 NS074972, P01 NS074972 to B. R. and G. F.) and the Simons Foundation (94534). The Rice laboratory is supported by the NIH (grants R01 NS036362 and R01 DA033811) and the Attilio and Olympia Ricciardi Research Fund. The Rudy laboratory is supported by the NIH (NS30989). The Peles laboratory is supported by the NIH (grant NS50220) and the Israel Science Foundation. T. K. support was provided through postdoctoral fellowships from the Patterson Trust and Roche. E. A. support was provided by New York State through its NYSTEM initiative (C024326) and fellowship from Canadian Institutes of Health Research. J.C.P support was provided by NYU COE Addiction Seed Grant. This work was funded by the Institut Pasteur, INSERM, AP-HP, University Paris Diderot and the Bettencourt-Schueller, Orange, FondaMental, Conny-Maeva, Cognacq-Jay foundations.	Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Ashrafi S, 2014, NEURON, V81, P120, DOI 10.1016/j.neuron.2013.10.060; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Belzil C, 2013, J BIOL CHEM, V288, P24452, DOI 10.1074/jbc.M113.483107; Berghuis P, 2004, EUR J NEUROSCI, V20, P1290, DOI 10.1111/j.1460-9568.2004.03561.x; Blatt GJ, 2011, ANAT REC, V294, P1646, DOI 10.1002/ar.21252; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Champagne FA, 2004, J NEUROSCI, V24, P4113, DOI 10.1523/JNEUROSCI.5322-03.2004; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; Crowley JJ, 2012, PHARMACOGENOMICS J, V12, P147, DOI 10.1038/tpj.2010.82; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Foster AC, 2004, J PHARMACOL EXP THER, V311, P547, DOI 10.1124/jpet.103.063487; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez MI, 2013, EPILEPSIA, V54, P616, DOI 10.1111/epi.12063; Grados MA, 2009, CURR PSYCHIAT REP, V11, P162, DOI 10.1007/s11920-009-0025-x; HAYCOCK JW, 1987, BRAIN RES BULL, V19, P619, DOI 10.1016/0361-9230(87)90046-3; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Karayiorgou M, 2004, AM J MED GENET B, V124B, P20, DOI 10.1002/ajmg.b.20090; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Labasque M, 2010, FEBS LETT, V584, P1787, DOI 10.1016/j.febslet.2009.08.025; Lewis DA, 2012, EUR J NEUROSCI, V35, P1871, DOI 10.1111/j.1460-9568.2012.08156.x; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Nicholson C., 2010, P 13 INT C IN VIV ME, P328; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Patel Jyoti C, 2013, Methods Mol Biol, V964, P243, DOI 10.1007/978-1-62703-251-3_15; Patel JC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2144; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Petroski RE, 2006, J PHARMACOL EXP THER, V317, P369, DOI 10.1124/jpet.105.096701; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Stark KL, 2009, INT J NEUROPSYCHOPH, V12, P983, DOI 10.1017/S1461145709000492; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	66	104	111	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					236	+		10.1038/nature13248	http://dx.doi.org/10.1038/nature13248			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24870235	Green Accepted			2022-12-24	WOS:000338649800047
J	Mann, C				Mann, Clifford			World Cup's extended pub opening hours make no sense	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Coll Emergency Med, Taunton, Somerset, England		Mann, C (corresponding author), Coll Emergency Med, Taunton, Somerset, England.	cliff.mann@me.com						Alcohol Concern, 2010, FACTSH GRASP NETTL A; [Anonymous], 2001, J SUBST ABUSE, V6, P235; Galanter M., 1997, RECENT DEV ALCOHOLIS, V13; Home Office, 2014, CONS REL LIC HOURS F; National Treatment Agency for Substance Misuse, 2013, ALC TREATM ENGL 2011; Newton, 2007, EMJ, V24, P532	6	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2014	348								g3805	10.1136/bmj.g3805	http://dx.doi.org/10.1136/bmj.g3805			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1GY	24916687				2022-12-24	WOS:000337405200014
J	Caprio, J; Shimohara, M; Marui, T; Harada, S; Kiyohara, S				Caprio, John; Shimohara, Mami; Marui, Takayuki; Harada, Shuitsu; Kiyohara, Sadao			Marine teleost locates live prey through pH sensing	SCIENCE			English	Article							CHANNEL CATFISH; ION-CHANNEL; TASTE-BUDS; OCEAN; BEHAVIOR; CARBON; FISH; ABILITY; CELLS	We report that the Japanese sea catfish Plotosus japonicus senses local pH-associated increases in H+/CO2 equating to a decrease of <= 0.1 pH unit in ambient seawater. We demonstrated that these sensors, located on the external body of the fish, detect undamaged cryptic respiring prey, such as polychaete worms. Sensitivity is maximal at the natural pH of seawater (pH 8.1 to 8.2) and decreases dramatically in seawater with a pH <8.0.	[Caprio, John] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Shimohara, Mami; Kiyohara, Sadao] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem & BioSci, Kagoshima 8900065, Japan; [Harada, Shuitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Physiol, Kagoshima 8908544, Japan	Louisiana State University System; Louisiana State University; Kagoshima University; Kagoshima University	Caprio, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jcap@lsu.edu			NIH U.S.-Japan Brain Research Cooperative Program [NS-04-014]; Louisiana State University College of Science; Ministry of Education, Science, Sports, and Culture of Japan [22580205]	NIH U.S.-Japan Brain Research Cooperative Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University College of Science; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank A. Nikonov, M. Brown, and J. Belanger for aid in preparation of Fig. 1; A. Kiyohara for Fig. 1A; C. Derby, A. Hansen, W. C. Michel, W. Silver, D. Mulkey, and T. Dietz for their constructive comments on the manuscript; and C. Derby for statistical aid. We also thank M. Kirino, T. Ikenaga, R. Kawabata and K. Kawano for assitance in the laboratory. Supported in part by the NIH U.S.-Japan Brain Research Cooperative Program (grant NS-04-014) and the George C. Kent Professorship (Louisiana State University College of Science) to J. C. and a grant (22580205) to S. K. from the Ministry of Education, Science, Sports, and Culture of Japan. All primary electrophysiological data (VCR tapes) are archived in the Department of Biological Sciences, Louisiana State University. The authors declare no competing financial interests. Readers are welcome to comment on the online version of the paper. Correspondence and requests for materials should be addressed to J. C. (jcap@lsu.edu).	ATEMA J, 1971, BRAIN BEHAV EVOLUT, V4, P273, DOI 10.1159/000125438; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chen XM, 2007, J BIOL CHEM, V282, P30406, DOI 10.1074/jbc.M702229200; Clark Eugenie, 2011, Aqua, V17, P211; DAVENPORT CJ, 1982, J COMP PHYSIOL, V147, P217, DOI 10.1007/BF00609846; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; FINGER TE, 1976, J COMP NEUROL, V165, P513, DOI 10.1002/cne.901650407; Finger TE, 1997, BRAIN BEHAV EVOLUT, V50, P234, DOI 10.1159/000113337; Finger TE, 1996, J COMP NEUROL, V373, P129, DOI 10.1002/(SICI)1096-9861(19960909)373:1<129::AID-CNE11>3.0.CO;2-F; FINGER TE, 1991, J COMP NEUROL, V314, P55, DOI 10.1002/cne.903140106; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Kasai M, 2010, J COMP PHYSIOL A, V196, P901, DOI 10.1007/s00359-010-0572-y; KIYOHARA S, 1986, BRAIN RES, V379, P353, DOI 10.1016/0006-8993(86)90789-4; KOTRSCHAL K, 1992, ENVIRON BIOL FISH, V35, P273, DOI 10.1007/BF00001894; Kristensen E, 2001, Geochem Trans, V2, P92, DOI 10.1186/1467-4866-2-92; Meigh L, 2013, ELIFE, V2, DOI 10.7554/eLife.01213; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Perry SF, 2012, RESP PHYSIOL NEUROBI, V184, P309, DOI 10.1016/j.resp.2012.06.013; REUTTER K, 1974, CELL TISSUE RES, V149, P143; SCHARRER E, 1947, J COMP NEUROL, V86, P183, DOI 10.1002/cne.900860204; Service RF, 2012, SCIENCE, V337, P146, DOI 10.1126/science.337.6091.146; SILVER WL, 1984, J COMP PHYSIOL, V154, P167, DOI 10.1007/BF00604982; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Sorensen P. W., 1997, PHYSL FISHES, P375; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; Wang S, 2013, J NEUROSCI, V33, P16033, DOI 10.1523/JNEUROSCI.2451-13.2013; Yoshino Tetsuo, 2008, Bulletin of the National Museum of Nature and Science Series A-Zoology, P1	31	27	27	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1154	1156		10.1126/science.1252697	http://dx.doi.org/10.1126/science.1252697			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904164				2022-12-24	WOS:000336791200046
J	Rao, RR; Long, JZ; White, JP; Svensson, KJ; Lou, J; Lokurkar, I; Jedrychowski, MP; Ruas, JL; Wrann, CD; Lo, JC; Camera, DM; Lachey, J; Gygi, S; Seehra, J; Hawley, JA; Spiegelman, BM				Rao, Rajesh R.; Long, Jonathan Z.; White, James P.; Svensson, Katrin J.; Lou, Jesse; Lokurkar, Isha; Jedrychowski, Mark P.; Ruas, Jorge L.; Wrann, Christiane D.; Lo, James C.; Camera, Donny M.; Lachey, Jenn; Gygi, Steven; Seehra, Jasbir; Hawley, John A.; Spiegelman, Bruce M.			Meteorin-like Is a Hormone that Regulates Immune-Adipose Interactions to Increase Beige Fat Thermogenesis	CELL			English	Article							SKELETAL-MUSCLE; WHITE FAT; EXERCISE; PGC-1-ALPHA; MACROPHAGES; COACTIVATOR; ACTIVATION; DYSFUNCTION; ADIPOCYTES; PREVENTION	Exercise training benefits many organ systems and offers protection against metabolic disorders such as obesity and diabetes. Using the recently identified isoform of PGC1-alpha (PGC1-alpha 4) as a discovery tool, we report the identification of meteorin-like (Metrnl), a circulating factor that is induced in muscle after exercise and in adipose tissue upon cold exposure. Increasing circulating levels of Metrnl stimulates energy expenditure and improves glucose tolerance and the expression of genes associated with beige fat thermogenesis and anti-inflammatory cytokines. Metrnl stimulates an eosinophil-dependent increase in IL-4 expression and promotes alternative activation of adipose tissue macrophages, which are required for the increased expression of the thermogenic and anti-inflammatory gene programs in fat. Importantly, blocking Metrnl actions in vivo significantly attenuates chronic cold-exposure-induced alternative macrophage activation and thermogenic gene responses. Thus, Metrnl links host-adaptive responses to the regulation of energy homeostasis and tissue inflammation and has therapeutic potential for metabolic and inflammatory diseases.	[Rao, Rajesh R.; Long, Jonathan Z.; White, James P.; Svensson, Katrin J.; Lou, Jesse; Lokurkar, Isha; Wrann, Christiane D.; Lo, James C.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Rao, Rajesh R.; Long, Jonathan Z.; White, James P.; Svensson, Katrin J.; Lou, Jesse; Lokurkar, Isha; Jedrychowski, Mark P.; Wrann, Christiane D.; Lo, James C.; Gygi, Steven; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ruas, Jorge L.] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Camera, Donny M.; Hawley, John A.] Australian Catholic Univ, Dept Exercise Sci, Exercise & Nutr Res Grp, Fitzroy, Vic 3065, Australia; [Hawley, John A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 2AJ, Merseyside, England; [Lachey, Jenn; Seehra, Jasbir] Ember Therapeut Inc, Watertown, MA 02472 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Karolinska Institutet; Australian Catholic University; Liverpool John Moores University	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Ruas, Jorge/AAE-6094-2019; Camera, Donny/J-1571-2018; Hawley, John A/U-3814-2018; Svensson, Katrin J./AAA-4770-2021; Lo, James/GYR-1149-2022	Ruas, Jorge/0000-0002-1110-2606; Camera, Donny/0000-0002-6494-9472; Hawley, John A/0000-0002-0886-9881; Svensson, Katrin J./0000-0001-5376-5128; Lo, James/0000-0003-0244-1670; Long, Jonathan/0000-0003-2631-7463	National Institutes of Health [DK061562]; JPB foundation; Irvington Institute Fellowship Program of the Cancer Research Institute; American Diabetics Association/Canadian Diabetics Association (ADA/CDA) joint postdoctoral fellowship; Swedish Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK097303, R01DK061562, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS087096, K99NS087096] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF12OC1016062] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; Irvington Institute Fellowship Program of the Cancer Research Institute; American Diabetics Association/Canadian Diabetics Association (ADA/CDA) joint postdoctoral fellowship; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank members of the Spiegelman laboratory for useful discussions and suggestions on the manuscript. This work was funded by National Institutes of Health grant (DK061562) to B. M. S. and a grant from the JPB foundation. R. R. R. is supported by Irvington Institute Fellowship Program of the Cancer Research Institute. J.Z.L. is supported by the American Diabetics Association/Canadian Diabetics Association (ADA/CDA) joint postdoctoral fellowship. K.J.S. was supported by a Swedish Research Council postdoctoral fellowship. B. M. S. is a consultant and shareholder in Ember Therapeutics.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baynard T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/767953; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; COUSIN B, 1992, J CELL SCI, V103, P931; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; PACY PJ, 1986, SPORTS MED, V3, P89, DOI 10.2165/00007256-198603020-00002; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	32	549	575	12	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1279	1291		10.1016/j.cell.2014.03.065	http://dx.doi.org/10.1016/j.cell.2014.03.065			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906147	Green Accepted, Bronze			2022-12-24	WOS:000340881400007
J	Rice, CM; Saeed, M				Rice, Charles M.; Saeed, Mohsan			Treatment triumphs	NATURE			English	Editorial Material							GENOTYPE 1 INFECTION; CHRONIC HEPATITIS-C; HCV; SOFOSBUVIR; LEDIPASVIR; ABT-450/R-OMBITASVIR; RIBAVIRIN; DASABUVIR; VIRUS		[Rice, Charles M.; Saeed, Mohsan] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA	Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA.	ricec@rockefeller.edu	Saeed, Mohsan/AAM-8375-2021					Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; ALTER HJ, 1975, LANCET, V2, P838, DOI 10.1016/S0140-6736(75)90234-2; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Dore GJ, 2014, J VIRAL HEPATITIS, V21, P1, DOI 10.1111/jvh.12253; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; PRINCE AM, 1974, LANCET, V2, P241; Sulkowski MS, 2014, NEW ENGL J MED, V370, P1560, DOI 10.1056/NEJMc1401726; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	15	28	30	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					43	44		10.1038/510043a	http://dx.doi.org/10.1038/510043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24899301				2022-12-24	WOS:000336768900028
J	Quackenbush, J				Quackenbush, John			PERSPECTIVE Learning to share	NATURE			English	Editorial Material									Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Quackenbush, J (corresponding author), Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02115 USA.	johnq@jimmy.harvard.edu		Quackenbush, John/0000-0002-2702-5879	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111759] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL111759] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))			0	1	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S68	S68		10.1038/509S68a	http://dx.doi.org/10.1038/509S68a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870827	Green Accepted			2022-12-24	WOS:000336457100010
J	Glendenning, P; Bell, DA; Clifton-Bligh, RJ				Glendenning, Paul; Bell, Damon A.; Clifton-Bligh, Roderick J.			RATIONAL TESTING Investigating hypophosphataemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY HYPERPARATHYROIDISM; 25-HYDROXYVITAMIN D; VITAMIN-D; PHOSPHATE; MANAGEMENT; CALCIUM	This series of occasional articles provides an update on the best use of key diagnostic tests in the initial investigation of common or important clinical presentations. The series advisers are Steve Atkin, professor, head of department of academic endocrinology, diabetes, and metabolism, Hull York Medical School; and Eric Kilpatrick, honorary professor, department of clinical biochemistry, Hull Royal Infirmary, Hull York Medical School. To suggest a topic for this series, please email us at practice@bmj.com.	[Glendenning, Paul; Bell, Damon A.] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Glendenning, Paul; Bell, Damon A.] Royal Perth Hosp, Dept Clin Biochem, PathWest Lab Med, Perth, WA 6000, Australia; [Clifton-Bligh, Roderick J.] Kolling Inst Royal North Shore Hosp, St Leonards, NSW, Australia	Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Glendenning, P (corresponding author), Royal Perth Hosp, Dept Clin Biochem, PathWest Lab Med, Perth, WA 6000, Australia.	Paul.Glendenning@health.wa.gov.au		Clifton-Bligh, Roderick/0000-0002-1545-0368; Bell, Damon/0000-0002-6592-6184				Bhattacharyya N, 2012, TRENDS ENDOCRIN MET, V23, P610, DOI 10.1016/j.tem.2012.07.002; Brunelli SM, 2007, J AM SOC NEPHROL, V18, P1999, DOI 10.1681/ASN.2007020143; Chong WH, 2011, ENDOCR-RELAT CANCER, V18, pR53, DOI 10.1530/ERC-11-0006; Felsenfeld AJ, 2012, AM J KIDNEY DIS, V60, P655, DOI 10.1053/j.ajkd.2012.03.024; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; Glendenning P, 2013, ANN CLIN BIOCHEM, V50, P191, DOI 10.1177/0004563213482892; Gok DE, 2011, J ENDOCRINOL INVEST, V34, P3, DOI [10.1007/BF03346687, 10.3275/6902]; Jayasena CN, 2013, CLIN ENDOCRINOL, V78, P838, DOI 10.1111/cen.12062; Kim YJ, 2012, TRANSPL P, V44, P651, DOI 10.1016/j.transproceed.2011.12.050; Liamis G, 2010, QJM-INT J MED, V103, P449, DOI 10.1093/qjmed/hcq039; Moosgaard B, 2007, CLIN ENDOCRINOL, V66, P35, DOI 10.1111/j.1365-2265.2006.02680.x; Payne RB, 1998, ANN CLIN BIOCHEM, V35, P201, DOI 10.1177/000456329803500203; Priemel M, 2010, J BONE MINER RES, V25, P305, DOI 10.1359/jbmr.090728; RAANANI P, 1992, POSTGRAD MED J, V68, P283, DOI 10.1136/pgmj.68.798.283; Skipper A, 2012, NUTR CLIN PRACT, V27, P34, DOI 10.1177/0884533611427916; Witteveen JE, 2013, EUR J ENDOCRINOL, V168, pR45, DOI 10.1530/EJE-12-0528	16	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2014	348								g3172	10.1136/bmj.g3172	http://dx.doi.org/10.1136/bmj.g3172			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EH	24871308				2022-12-24	WOS:000336742000001
J	Vanholder, R; Van Biesen, W; Lameire, N				Vanholder, Raymond; Van Biesen, Wim; Lameire, Norbert			Renal replacement therapy: how can we contain the costs?	LANCET			English	Editorial Material							DIALYSIS; DISEASE		[Vanholder, Raymond; Van Biesen, Wim] Ghent Univ Hosp, Sect Internal Med, Div Renal, B-9000 Ghent, Belgium; [Lameire, Norbert] Ghent Univ Hosp, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Vanholder, R (corresponding author), Ghent Univ Hosp, Sect Internal Med, Div Renal, B-9000 Ghent, Belgium.	raymond.vanholder@ugent.be						Couchoud C, 2009, NEPHROL DIAL TRANSPL, V24, P1553, DOI 10.1093/ndt/gfn698; Desai AA, 2009, CLIN J AM SOC NEPHRO, V4, P772, DOI 10.2215/CJN.05661108; Icks A, 2010, NEPHROL DIAL TRANSPL, V25, P1647, DOI 10.1093/ndt/gfp672; Jassal SV, 2002, NEPHROL DIAL TRANSPL, V17, P474, DOI 10.1093/ndt/17.3.474; Kleophas Werner, 2007, Int J Health Care Finance Econ, V7, P185, DOI 10.1007/s10754-007-9020-0; Lameire N, 2010, NEW ENGL J MED, V363, P678, DOI 10.1056/NEJMe1006669; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Ponce P, 2012, BLOOD PURIF; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Rubin HR, 2004, JAMA-J AM MED ASSOC, V291, P697, DOI 10.1001/jama.291.6.697; Swanepoel CR, 2013, NAT REV NEPHROL, V9, P610, DOI 10.1038/nrneph.2013.168; Vanholder R, 2012, J AM SOC NEPHROL, V23, P1291, DOI 10.1681/ASN.2011111094	13	14	14	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1783	1785		10.1016/S0140-6736(14)60721-2	http://dx.doi.org/10.1016/S0140-6736(14)60721-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6US	24856012				2022-12-24	WOS:000336267800004
J	DasGupta, S; Ferreira, CH; Miesenbock, G				DasGupta, Shamik; Ferreira, Clara Howcroft; Miesenboeck, Gero			FoxP influences the speed and accuracy of a perceptual decision in Drosophila	SCIENCE			English	Article							NEURAL BASIS; DISCRIMINATION; NEURONS; GENE; PLASTICITY; MODELS; TIME	Decisions take time if information gradually accumulates to a response threshold, but the neural mechanisms of integration and thresholding are unknown. We characterized a decision process in Drosophila that bears the behavioral signature of evidence accumulation. As stimulus contrast in trained odor discriminations decreased, reaction times increased and perceptual accuracy declined, in quantitative agreement with a drift-diffusion model. FoxP mutants took longer than wild-type flies to form decisions of similar or reduced accuracy, especially in difficult, low-contrast tasks. RNA interference with FoxP expression in ab core Kenyon cells, or the overexpression of a potassium conductance in these neurons, recapitulated the FoxP mutant phenotype. A mushroom body subdomain whose development or function require the transcription factor FoxP thus supports the progression of a decision toward commitment.	[DasGupta, Shamik; Ferreira, Clara Howcroft; Miesenboeck, Gero] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3SR, England	University of Oxford	Miesenbock, G (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England.	gero.miesenboeck@cncb.ox.ac.uk		DasGupta, Shamik/0000-0001-5803-8982; Ferreira, Clara/0000-0002-3955-1059; DasGupta, Shamik/0000-0001-5566-7548; Miesenboeck, Gero/0000-0003-2940-3228	Wellcome Trust; Gatsby Charitable Foundation; NIH; Oxford Martin School; Human Frontier Science Program; Fundacao Champalimaud; Fundacao para a Ciencia e Tecnologia; Marie Curie Actions Fellowships; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030601] Funding Source: NIH RePORTER; Medical Research Council [G0701225, G0700888] Funding Source: researchfish; Wellcome Trust [090309/Z/09/Z] Funding Source: researchfish; MRC [G0701225, G0700888] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxford Martin School; Human Frontier Science Program(Human Frontier Science Program); Fundacao Champalimaud; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Actions Fellowships; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Shadlen for discussions and code; J. Flint, A. Lin, and S. Waddell for comments; and M. Ramaswami for flies. This work was supported by the Wellcome Trust, the Gatsby Charitable Foundation, NIH, and the Oxford Martin School (G.M.); Human Frontier Science Program and Marie Curie Actions Fellowships (S.D.G.); and Fundacao Champalimaud and Fundacao para a Ciencia e Tecnologia (C.H.F.).	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Santos ME, 2011, MOL BIOL EVOL, V28, P237, DOI 10.1093/molbev/msq182; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Ito K, 1997, DEVELOPMENT, V124, P761; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Luce R. D., 1986, RESPONSE TIMES; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Perisse E, 2013, NEURON, V79, P945, DOI 10.1016/j.neuron.2013.07.045; Qin HT, 2012, CURR BIOL, V22, P608, DOI 10.1016/j.cub.2012.02.014; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Sia GM, 2013, SCIENCE, V342, P987, DOI 10.1126/science.1245079; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6	30	63	64	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					901	904		10.1126/science.1252114	http://dx.doi.org/10.1126/science.1252114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855268	Green Accepted			2022-12-24	WOS:000336233800048
J	O'Dowd, A				O'Dowd, Adrian			Respiratory Medicine Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2014	348								g2941	10.1136/bmj.g2941	http://dx.doi.org/10.1136/bmj.g2941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5SI	24789473				2022-12-24	WOS:000335478400003
J	Cohen, IG; Lynch, HF; Curfman, GD				Cohen, I. Glenn; Lynch, Holly Fernandez; Curfman, Gregory D.			When Religious Freedom Clashes with Access to Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, I. Glenn; Lynch, Holly Fernandez] Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.								0	14	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					596	599		10.1056/NEJMp1407965	http://dx.doi.org/10.1056/NEJMp1407965			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZL	24988298				2022-12-24	WOS:000340819600005
J	Colussi, TM; Costantino, DA; Hammond, JA; Ruehle, GM; Nix, JC; Kieft, JS				Colussi, Timothy M.; Costantino, David A.; Hammond, John A.; Ruehle, Grant M.; Nix, Jay C.; Kieft, Jeffrey S.			The structural basis of transfer RNA mimicry and conformational plasticity by a viral RNA	NATURE			English	Article							MOSAIC-VIRUS RNA; MINUS-STRAND SYNTHESIS; STRUCTURE VALIDATION; CRYSTAL-STRUCTURE; 3' END; INITIATION; RIBOSOME; BINDING; VALINE; TRANSLATION	RNA is arguably the most functionally diverse biological macromolecule. In some cases a single discrete RNA sequence performs multiple roles, and this can be conferred by a complex three-dimensional structure. Such multifunctionality can also be driven or enhanced by the ability of a given RNA to assume different conformational (and therefore functional) states'. Despite its biological importance, a detailed structural understanding of the paradigm of RNA structure-driven multifunctionality is lacking. To address this gap it is useful to study examples from single-stranded positive-sense RNA viruses, a prototype being the tRNA-like structure (TLS) found at the 3' end of the turnip yellow mosaic virus (TYMV). This TLS not only acts like a tRNA to drive aminoacylation of the viral genomic (g)RNA(2-4), but also interacts with other structures in the 3' untranslated region of the gRNA(5), contains the promoter for negative-strand synthesis, and influences several infection-critical processes'. TLS RNA can provide a glimpse into the structural basis of RNA multifunctionality and plasticity, but for decades its high-resolution structure has remained elusive. Here we present the crystal structure of the complete TYMV TLS to 2.0 angstrom resolution. Globally, the RNA adopts a shape that mimics tRNA, but it uses a very different set of intramolecular interactions to achieve this shape. These interactions also allow the TLS to readily switch conformations. In addition, the TLS structure is 'two faced': one face closely mimics tRNA and drives aminoacylation, the other face diverges from tRNA and enables additional functionality. The TLS is thus structured to perform several functions and interact with diverse binding partners, and we demonstrate its ability to specifically bind to ribosomes.	[Colussi, Timothy M.; Costantino, David A.; Hammond, John A.; Ruehle, Grant M.; Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Colussi, Timothy M.; Costantino, David A.; Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, Howard Hughes Med Inst, Aurora, CO 80045 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biol Consortium, Adv Light Source, Berkeley, CA 94720 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kieft, JS (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jeffrey.kieft@ucdenver.edu		Hammond, John/0000-0002-1170-3532	UC Cancer Center [P30CA046934]; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-ACO2-05CH11231]; National Institutes of Health [GM081346, GM097333]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081346, R01GM097333] Funding Source: NIH RePORTER	UC Cancer Center; Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Noller for the gift of 70S ribosomes. We thank I. Tinoco Jr, C. Musselman and T. Dreher for critical reading of this manuscript. The University of Colorado (UC) Denver X-ray Facility is supported by UC Cancer Center Support Grant P30CA046934. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract #DE-ACO2-05CH11231. J.S.K. is supported by grants GM081346 and GM097333 from the National Institutes of Health and is an Early Career Scientist of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barends S, 2003, CELL, V112, P123, DOI 10.1016/S0092-8674(02)01256-4; BERTHELOT F, 1973, MOL CELL BIOCHEM, V1, P63, DOI 10.1007/BF01659939; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cliffe AR, 2009, J VIROL, V83, P2321, DOI 10.1128/JVI.02303-08; Costantino D, 2005, RNA, V11, P332, DOI 10.1261/rna.7184705; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Dreher TW, 2010, WIRES RNA, V1, P402, DOI 10.1002/wrna.42; Dreher TW, 2009, VIRUS RES, V139, P217, DOI 10.1016/j.virusres.2008.06.010; Dreher TW, 1998, NUCLEIC ACIDS RES, V26, P4356, DOI 10.1093/nar/26.19.4356; DREHER TW, 1992, BIOCHEMISTRY-US, V31, P9183, DOI 10.1021/bi00153a010; DUMAS P, 1987, J BIOMOL STRUCT DYN, V4, P707, DOI 10.1080/07391102.1987.10507674; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLORENTZ C, 1982, EMBO J, V1, P269, DOI 10.1002/j.1460-2075.1982.tb01158.x; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Giege R, 1998, CURR OPIN STRUC BIOL, V8, P286, DOI 10.1016/S0959-440X(98)80060-2; GIEGE R, 1993, BIOCHIMIE, V75, P569, DOI 10.1016/0300-9084(93)90063-X; Hammond JA, 2010, J MOL BIOL, V399, P450, DOI 10.1016/j.jmb.2010.04.016; Hammond JA, 2009, RNA, V15, P294, DOI 10.1261/rna.1360709; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keel AY, 2007, STRUCTURE, V15, P761, DOI 10.1016/j.str.2007.06.003; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kolk MH, 1998, SCIENCE, V280, P434, DOI 10.1126/science.280.5362.434; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Litvak S, 1970, FEBS Lett, V11, P316, DOI 10.1016/0014-5793(70)80557-9; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; PINCK M, 1970, NATURE, V226, P954, DOI 10.1038/226954a0; RIETVELD K, 1983, EMBO J, V2, P1079, DOI 10.1002/j.1460-2075.1983.tb01549.x; RIETVELD K, 1982, NUCLEIC ACIDS RES, V10, P1929, DOI 10.1093/nar/10.6.1929; RIETVELD K, 1984, EMBO J, V3, P2613, DOI 10.1002/j.1460-2075.1984.tb02182.x; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Singh RN, 1997, VIROLOGY, V233, P430, DOI 10.1006/viro.1997.8621; Singh RN, 1998, RNA, V4, P1083, DOI 10.1017/S1355838298980694; Skuzeski JM, 1996, J VIROL, V70, P2107, DOI 10.1128/JVI.70.4.2107-2115.1996; Wientges J, 2000, BIOCHEMISTRY-US, V39, P6207, DOI 10.1021/bi992852l; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; YOT P, 1970, P NATL ACAD SCI USA, V67, P1345, DOI 10.1073/pnas.67.3.1345; Zhu JY, 2011, P NATL ACAD SCI USA, V108, P1839, DOI 10.1073/pnas.1018582108	45	56	58	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					366	+		10.1038/nature13378	http://dx.doi.org/10.1038/nature13378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24909993	Green Accepted			2022-12-24	WOS:000338992200040
J	Fang, Y				Fang, Yu			PERSONAL VIEW China should curb non-prescription use of antibiotics in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ATTITUDES; KNOWLEDGE		Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Fang, Y (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian, Shaanxi, Peoples R China.	yufang@mail.xjtu.edu.cn						China Food and Drug Administration, PROV SUP DRUG DISTR; China Food and Drug Administration, 2013, 2013 ANN REP NAT ADV; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; Jiang MH, 2013, CHINESE J HLTH POLIC, V1, P40; Li YF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-995; Liu ZJ, 2011, EVALUATION ANAL DRUG, V11, P853; Lv B, 2014, TROP MED INT HEALTH, V19, P769, DOI 10.1111/tmi.12322; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; The State Council, 12 5 YEAR PLAN DRUG; Xiao Y., 2010, CHINESE HLTH EC, V29, P94, DOI [10.3969/j.issn.1003-0743.2010.05.034, DOI 10.3969/J.ISSN.1003-0743.2010.05.034]; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001; Xiao YH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001556; Xiao YH, 2013, LANCET INFECT DIS, V13, P189, DOI 10.1016/S1473-3099(13)70011-2; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Yu M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-112; SHANGHAI DAILY	17	30	30	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2014	348								g4233	10.1136/bmj.g4233	http://dx.doi.org/10.1136/bmj.g4233			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YU	24982508				2022-12-24	WOS:000338644600003
J	Albert, JS; Yerges-Armstrong, LM; Horenstein, RB; Pollin, TI; Sreenivasan, UT; Chai, S; Blaner, WS; Snitker, S; O'Connell, JR; Gong, DW; Breyer, RJ; Ryan, AS; McLenithan, JC; Shuldiner, AR; Sztalryd, C; Damcott, CM				Albert, Jessica S.; Yerges-Armstrong, Laura M.; Horenstein, Richard B.; Pollin, Toni I.; Sreenivasan, Urmila T.; Chai, Sumbul; Blaner, William S.; Snitker, Soren; O'Connell, Jeffrey R.; Gong, Da-Wei; Breyer, Richard J., III; Ryan, Alice S.; McLenithan, John C.; Shuldiner, Alan R.; Sztalryd, Carole; Damcott, Coleen M.			Null Mutation in Hormone-Sensitive Lipase Gene and Risk of Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; DIET-INDUCED OBESITY; PPAR-GAMMA; PARTIAL LIPODYSTROPHY; DEFICIENT MICE; TISSUE; DISEASE; EXPRESSION; RESISTANCE; LIPOLYSIS	BACKGROUND Lipolysis regulates energy homeostasis through the hydrolysis of intracellular triglycerides and the release of fatty acids for use as energy substrates or lipid mediators in cellular processes. Genes encoding proteins that regulate energy homeostasis through lipolysis are thus likely to play an important role in determining susceptibility to metabolic disorders. METHODS We sequenced 12 lipolytic-pathway genes in Old Order Amish participants whose fasting serum triglyceride levels were at the extremes of the distribution and identified a novel 19-bp frameshift deletion in exon 9 of LIPE, encoding hormone-sensitive lipase (HSL), a key enzyme for lipolysis. We genotyped the deletion in DNA from 2738 Amish participants and performed association analyses to determine the effects of the deletion on metabolic traits. We also obtained biopsy specimens of abdominal subcutaneous adipose tissue from 2 study participants who were homozygous for the deletion (DD genotype), 10 who were heterozygous (ID genotype), and 7 who were noncarriers (II genotype) for assessment of adipose histologic characteristics, lipolysis, enzyme activity, cytokine release, and messenger RNA (mRNA) and protein levels. RESULTS Carriers of the mutation had dyslipidemia, hepatic steatosis, systemic insulin resistance, and diabetes. In adipose tissue from study participants with the DD genotype, the mutation resulted in the absence of HSL protein, small adipocytes, impaired lipolysis, insulin resistance, and inflammation. Transcription factors responsive to peroxisome-proliferator-activated receptor gamma (PPAR-gamma) and downstream target genes were down-regulated in adipose tissue from participants with the DD genotype, altering the regulation of pathways influencing adipogenesis, insulin sensitivity, and lipid metabolism. CONCLUSIONS These findings indicate the physiological significance of HSL in adipocyte function and the regulation of systemic lipid and glucose homeostasis and underscore the severe metabolic consequences of impaired lipolysis.	[Albert, Jessica S.; Yerges-Armstrong, Laura M.; Horenstein, Richard B.; Pollin, Toni I.; Sreenivasan, Urmila T.; Chai, Sumbul; Snitker, Soren; O'Connell, Jeffrey R.; Gong, Da-Wei; McLenithan, John C.; Shuldiner, Alan R.; Sztalryd, Carole; Damcott, Coleen M.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Albert, Jessica S.; Yerges-Armstrong, Laura M.; Horenstein, Richard B.; Pollin, Toni I.; Sreenivasan, Urmila T.; Chai, Sumbul; Snitker, Soren; O'Connell, Jeffrey R.; Gong, Da-Wei; McLenithan, John C.; Shuldiner, Alan R.; Sztalryd, Carole; Damcott, Coleen M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Gong, Da-Wei; Ryan, Alice S.; Shuldiner, Alan R.; Sztalryd, Carole] Baltimore VA Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD USA; [Breyer, Richard J., III] Baltimore VA Med Ctr, Dept Radiol & Nucl Med, Baltimore, MD USA; [Ryan, Alice S.] Baltimore VA Med Ctr, Vet Affairs VA Res Serv, Dept Med, Div Gerontol & Geriatr Med, Baltimore, MD USA; [Blaner, William S.] Columbia Univ, Dept Med, New York, NY USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Columbia University	Damcott, CM (corresponding author), Univ Maryland, Sch Med, 660 W Redwood St,Rm 592, Baltimore, MD 21201 USA.	cdamcott@medicine.umaryland.edu	Sreenivasan, Urmila/AAV-6154-2020	Shuldiner, Alan/0000-0001-9921-4305	National Institutes of Health [R01DK075017, R01DK74828, U01HL072515, R01DK54261, U01HL84756, U01GM074518, R01HL104193, R01HL088119]; American Heart Association [11PRE7610008]; University of Maryland Multidisciplinary Clinical Research Career Development Program [NIH K12RR023250]; Mid-Atlantic Nutrition and Obesity Research Center [NIH P30DK072488]; Baltimore Diabetes Research Center [NIH P60DK079637]; American Diabetes Association; U.S. Department of Agriculture National Institute of Food and Agriculture (National Research Initiative Competitive) [2007-35205-17883]; Geriatric Research Education and Clinical Center, Baltimore Veterans Affairs (VA) Medical Center; VA Research Career Scientist Award; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084756, R01HL088119, R01HL104193, U01HL072515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK068437, P60DK079637, R01DK074828, R01DK054261, R01DK075017, P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Maryland Multidisciplinary Clinical Research Career Development Program; Mid-Atlantic Nutrition and Obesity Research Center; Baltimore Diabetes Research Center; American Diabetes Association(American Diabetes Association); U.S. Department of Agriculture National Institute of Food and Agriculture (National Research Initiative Competitive); Geriatric Research Education and Clinical Center, Baltimore Veterans Affairs (VA) Medical Center; VA Research Career Scientist Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health (R01DK075017, R01DK74828, U01HL072515, R01DK54261, U01HL84756, U01GM074518, R01HL104193, and R01HL088119), the American Heart Association (11PRE7610008, to Dr. Albert), the University of Maryland Multidisciplinary Clinical Research Career Development Program (NIH K12RR023250, to Dr. Damcott), the Mid-Atlantic Nutrition and Obesity Research Center (NIH P30DK072488), the Baltimore Diabetes Research Center (NIH P60DK079637), the American Diabetes Association, the U.S. Department of Agriculture National Institute of Food and Agriculture (National Research Initiative Competitive Grant 2007-35205-17883), and the Geriatric Research Education and Clinical Center, Baltimore Veterans Affairs (VA) Medical Center, and by a VA Research Career Scientist Award (to Dr. Ryan).	BEILER K, 1988, FISHER FAMILY HIST D; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Gray SL, 2005, BIOCHEM SOC T, V33, P1053, DOI 10.1042/BST0331053; Grober J, 2003, J BIOL CHEM, V278, P6510, DOI 10.1074/jbc.M208513200; Haemmerle G, 2003, CURR OPIN LIPIDOL, V14, P289, DOI 10.1097/00041433-200306000-00009; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Rizos CV, 2009, EXPERT OPIN DRUG SAF, V8, P15, DOI [10.1517/14740330802597821 , 10.1517/14740330802597821]; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shen WJ, 2011, BBA-MOL CELL BIOL L, V1811, P9, DOI 10.1016/j.bbalip.2010.10.001; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	24	120	122	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2307	2315		10.1056/NEJMoa1315496	http://dx.doi.org/10.1056/NEJMoa1315496			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24848981	Green Accepted			2022-12-24	WOS:000337033700010
J	Sacks, DB; John, WG				Sacks, David B.; John, W. Garry			Interpretation of Hemoglobin A(1c) Values	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEM; CHAOS		[Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA; [John, W. Garry] Norfolk & Norwich Univ Hosp, Dept Clin Biochem, Norwich, Norfolk, England; [John, W. Garry] Norwich Med Sch, Norwich, Norfolk, England	National Institutes of Health (NIH) - USA; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of East Anglia	Sacks, DB (corresponding author), NIH, Bldg 10,Room 2C306,10 Ctr Dr, Bethesda, MD 20892 USA.	sacksdb@mail.nih.gov		Sacks, David/0000-0003-3100-0735				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Berg AH, 2008, J CLIN PATHOL, V61, P983, DOI 10.1136/jcp.2007.049205; Bry L, 2001, CLIN CHEM, V47, P153; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Little RR, 2011, CLIN CHEM, V57, P205, DOI 10.1373/clinchem.2010.148841; National Glycohemoglobin Standardization Program, HARMONIZING HEMOGLOB; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Weykamp C, 2008, CLIN CHEM, V54, P240, DOI 10.1373/clinchem.2007.097402	9	35	36	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2271	2272		10.1001/jama.2014.6342	http://dx.doi.org/10.1001/jama.2014.6342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915255				2022-12-24	WOS:000336972600015
J	Maund, E; Tendal, B; Hrobjartsson, A; Lundh, A; Gotzsche, PC				Maund, Emma; Tendal, Britta; Hrobjartsson, Asbjorn; Lundh, Andreas; Gotzsche, Peter C.			Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the effects of coding and coding conventions on summaries and tabulations of adverse events data on suicidality within clinical study reports. Design Systematic electronic search for adverse events of suicidality in tables, narratives, and listings of adverse events in individual patients within clinical study reports. Where possible, for each event we extracted the original term reported by the investigator, the term as coded by the medical coding dictionary, medical coding dictionary used, and the patient's trial identification number. Using the patient's trial identification number, we attempted to reconcile data on the same event between the different formats for presenting data on adverse events within the clinical study report. Setting 9 randomised placebo controlled trials of duloxetine for major depressive disorder submitted to the European Medicines Agency for marketing approval. Data sources Clinical study reports obtained from the EMA in 2011. Results Six trials used the medical coding dictionary COSTART (Coding Symbols for a Thesaurus of Adverse Reaction Terms) and three used MedDRA (Medical Dictionary for Regulatory Activities). Suicides were clearly identifiable in all formats of adverse event data in clinical study reports. Suicide attempts presented in tables included both definitive and provisional diagnoses. Suicidal ideation and preparatory behaviour were obscured in some tables owing to the lack of specificity of the medical coding dictionary, especially COSTART. Furthermore, we found one event of suicidal ideation described in narrative text that was absent from tables and adverse event listings of individual patients. The reason for this is unclear, but may be due to the coding conventions used. Conclusion Data on adverse events in tables in clinical study reports may not accurately represent the underlying patient data because of the medical dictionaries and coding conventions used. In clinical study reports, the listings of adverse events for individual patients and narratives of adverse events can provide additional information, including original investigator reported adverse event terms, which can enable a more accurate estimate of harms.	[Maund, Emma; Tendal, Britta; Hrobjartsson, Asbjorn; Lundh, Andreas; Gotzsche, Peter C.] Rigshosp, Dept 7811, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Lundh, Andreas] Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Maund, E (corresponding author), Rigshosp, Dept 7811, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark.	em@cochrane.dk		Lundh, Andreas/0000-0002-4982-8680	Rigshospitalets Forskningsudvalg	Rigshospitalets Forskningsudvalg	This study is part of a PhD (EM) funded by Rigshospitalets Forskningsudvalg. The funding source had no role in the design and conduct of the study; data collection, management, analysis, and interpretation; preparation, review, and approval of the manuscript; or the decision to submit the paper for publication.	ABBYY, 2013, ABBYY FINEREADER 11; [Anonymous], 2014, SELECTIVE SEROTONIN; [Anonymous], 2013, SCI DISCUSSION EMA 2; [Anonymous], 1995, STRUCT CONT CLIN STU; [Anonymous], 2014, CHALLENGES WRITING 1; [Anonymous], 2013, GUID GOOD CLIN PRACT; [Anonymous], 1998, STAT PRINC CLIN TRIA; Brown DR, 1997, INT J PHARM MED, V11, P85; Brown EG, 2004, STEPHENS DETECTION N, P533; Central authorisation of medicines, 2014, CENTRAL AUTHORISATIO; Chow SC, 2004, DESIGN ANAL CLIN TRI; Committee for medicinal products for human use (CHMP), 2004, CHMPEWP299803; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Fizames C., 1997, THER INNOV REGUL SCI, V31, P85, DOI [10.1177/009286159703100112, DOI 10.1177/009286159703100112]; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Healy David, 2004, LET THEM EAT PROZAC; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; ICH Secretariat, 2014, MEDDRA TERM SEL POIN; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Kornai A, 2004, STUD FUZZ SOFT COMP, V140, P413; Lundh A, 2011, LANCET, V378, P1995, DOI 10.1016/S0140-6736(11)61871-0; Matsumoto C, 1991, DRUG INF J, V25, P201; MedDRA, 2013, HISTORY; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; US FDA, 2010, ADV COMM M NDA 21071; White CA, 1998, DRUG INF J, V32, P347, DOI 10.1177/009286159803200204	27	6	6	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2014	348								g3555	10.1136/bmj.g3555	http://dx.doi.org/10.1136/bmj.g3555			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CC	24899651	Green Published, hybrid			2022-12-24	WOS:000337037700002
J	Ford, AC; Moayyedi, P				Ford, Alexander C.; Moayyedi, Paul			UNCERTAINTIES PAGE Whom should we "test and treat" for Helicobacter pylori?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-LIFE; ERADICATION THERAPY; GASTRIC-CANCER; METAANALYSIS; DYSPEPSIA; RISK; INFECTION; COMMUNITY; DISEASE; GERD		[Ford, Alexander C.] Leeds Gen Infirm, Leeds Gastroenterol Inst, Leeds, W Yorkshire, England; [Ford, Alexander C.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Moayyedi, Paul] McMaster Univ, Med Ctr, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada	Leeds General Infirmary; University of Leeds; University of Leeds; McMaster University	Moayyedi, P (corresponding author), McMaster Univ, Med Ctr, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.	moayyep@mcmaster.ca	Ford, Alexander/K-5491-2012; Moayyedi, Paul/M-6178-2014	Ford, Alexander/0000-0001-6371-4359; Moayyedi, Paul/0000-0002-3616-9292				Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Ford AC, 2005, GASTROENTEROLOGY, V129, P1910, DOI 10.1053/j.gastro.2005.09.016; Ford AC, 2005, AM J EPIDEMIOL, V162, P454, DOI 10.1093/aje/kwi218; Ford AC, 2005, GASTROENTEROLOGY, V128, P1838, DOI 10.1053/j.gastro.2005.03.004; Ford AC, 2004, AM J GASTROENTEROL, V99, P1833, DOI 10.1111/j.1572-0241.2004.40014.x; Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174; Ford AC, 2010, CLIN GASTROENTEROL H, V8, P830, DOI 10.1016/j.cgh.2010.05.031; Graham DY, 2011, HELICOBACTER, V16, P343, DOI 10.1111/j.1523-5378.2011.00891.x; Harvey RF, 2010, ALIMENT PHARM THER, V32, P394, DOI 10.1111/j.1365-2036.2010.04363.x; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; IARC. Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994, INT AGENCY RES CANC, V61, P177; Islami F, 2008, CANCER PREV RES, V1, P329, DOI 10.1158/1940-6207.CAPR-08-0109; Lane JA, 2006, BMJ-BRIT MED J, V332, P199, DOI 10.1136/bmj.38702.662546.55; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Moayyedi P, 2000, LANCET, V355, P1665, DOI 10.1016/S0140-6736(00)02236-4; Moayyedi P, 2000, BRIT MED J, V321, P659, DOI 10.1136/bmj.321.7262.659; Moayyedi P, 2000, AM J GASTROENTEROL, V95, P1448, DOI 10.1111/j.1572-0241.2000.2126_1.x; Moayyedi P, 2011, ARCH INTERN MED, V171, P1936, DOI 10.1001/archinternmed.2011.541; Plummer M, 2013, AM J GASTROENTEROL, V108, P216, DOI 10.1038/ajg.2012.409; Raghunath A, 2003, BMJ-BRIT MED J, V326, P737, DOI 10.1136/bmj.326.7392.737; Saad AM, 2012, SCAND J GASTROENTERO, V47, P129, DOI 10.3109/00365521.2011.648955; Sonnenberg A, 2013, AM J GASTROENTEROL, V108, P208, DOI 10.1038/ajg.2012.407; Videlock EJ, 2012, ALIMENT PHARM THER, V35, P1355, DOI 10.1111/j.1365-2036.2012.05104.x; Wang Q, 2013, HELICOBACTER, V18, P41, DOI 10.1111/hel.12012; Xie TT, 2013, EUR J GASTROEN HEPAT, V25, P1195, DOI 10.1097/MEG.0b013e328363e2c7; Yaghoobi M, 2010, AM J GASTROENTEROL, V105, P1007, DOI 10.1038/ajg.2009.734; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65	28	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2014	348								g3320	10.1136/bmj.g3320	http://dx.doi.org/10.1136/bmj.g3320			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZW	24846521				2022-12-24	WOS:000336429100003
J	Reese, TA; Wakeman, BS; Choi, HS; Hufford, MM; Huang, SC; Zhang, X; Buck, MD; Jezewski, A; Kambal, A; Liu, CY; Goel, G; Murray, PJ; Xavier, RJ; Kaplan, MH; Renne, R; Speck, SH; Artyomov, MN; Pearce, EJ; Virgin, HW				Reese, T. A.; Wakeman, B. S.; Choi, H. S.; Hufford, M. M.; Huang, S. C.; Zhang, X.; Buck, M. D.; Jezewski, A.; Kambal, A.; Liu, C. Y.; Goel, G.; Murray, P. J.; Xavier, R. J.; Kaplan, M. H.; Renne, R.; Speck, S. H.; Artyomov, M. N.; Pearce, E. J.; Virgin, H. W.			Helminth infection reactivates latent gamma-herpesvirus via cytokine competition at a viral promoter	SCIENCE			English	Article							MURINE GAMMAHERPESVIRUS 68; SWITCH GENE 50; B-CELLS; MACROPHAGES; INTERFERON; VIRUS; TRANSACTIVATOR; PROLIFERATION; ESTABLISHMENT; INFLAMMATION	Mammals are coinfected by multiple pathogens that interact through unknown mechanisms. We found that helminth infection, characterized by the induction of the cytokine interleukin-4 (IL-4) and the activation of the transcription factor Stat6, reactivated murine gamma-herpesvirus infection in vivo. IL-4 promoted viral replication and blocked the antiviral effects of interferon-gamma (IFN gamma) by inducing Stat6 binding to the promoter for an important viral transcriptional transactivator. IL-4 also reactivated human Kaposi's sarcoma-associated herpesvirus from latency in cultured cells. Exogenous IL-4 plus blockade of IFN gamma reactivated latent murine gamma-herpesvirus infection in vivo, suggesting a "two-signal" model for viral reactivation. Thus, chronic herpesvirus infection, a component of the mammalian virome, is regulated by the counterpoised actions of multiple cytokines on viral promoters that have evolved to sense host immune status.	[Reese, T. A.; Huang, S. C.; Zhang, X.; Buck, M. D.; Jezewski, A.; Kambal, A.; Liu, C. Y.; Artyomov, M. N.; Pearce, E. J.; Virgin, H. W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Wakeman, B. S.; Speck, S. H.] Emory Univ, Vaccine Ctr, Atlanta, GA 30322 USA; [Choi, H. S.; Renne, R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Hufford, M. M.; Kaplan, M. H.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Hufford, M. M.; Kaplan, M. H.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Goel, G.; Xavier, R. J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Goel, G.; Xavier, R. J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Murray, P. J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Murray, P. J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Washington University (WUSTL); Emory University; State University System of Florida; University of Florida; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Huang, Stanley Ching-Cheng/AAE-7866-2019; Murray, Peter J/K-4725-2018; Speck, Samuel/L-5893-2019	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Murray, Peter J/0000-0001-6329-9802; Virgin, Herbert/0000-0001-8580-7628; Jezewski, Andrew/0000-0002-2004-1278; Reese, Tiffany/0000-0003-2325-6546; Buck, Michael/0000-0002-9611-1199	Damon Runyon Postdoctoral Fellowship; Crohn's and Colitis Foundation [274415, AI032573, CA164062, CA119917, CA52004];  [U54 AI057160];  [AI084887]; NATIONAL CANCER INSTITUTE [R01CA164062, R01CA096511, R01CA052004, R01CA119917, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032573, R01AI084887, U54AI057160, R01AI032573, R01AI095282] Funding Source: NIH RePORTER	Damon Runyon Postdoctoral Fellowship; Crohn's and Colitis Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T. A. R. was supported by a Damon Runyon Postdoctoral Fellowship. This work was supported by grants U54 AI057160 and AI084887 and Crohn's and Colitis Foundation grant 274415 to H. W. V., grants AI032573 and CA164062 to E.J.P., grant CA119917 to R. R., and grant CA52004 to S. H. S. We thank R. Schreiber and K. Sheehan for supplying anti-IFNg and PIP, G. Randolph and E. Gautier for PPAR gamma f/f x LyzMcre mice and helpful discussion, J. Urban for help setting up the H. polygyrus system, D. Kreamalmeyer for animal care and breeding, members of the Virgin lab for manuscript review and discussion, the Genome Technology Access Center at Washington University for sequencing, and the Flow Cytometry Core at Washington University for assistance with sorting. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The GEO accession numbers for RNAseq data on virus-infected cells and for the BMDMs are GSE58116 and GSE21895, respectively. T. A. R. designed the project, performed experiments, and wrote the paper. H. W. V. assisted with project design and paper writing. B. S. W. and S. H. S. defined promoters and performed promoter assays. X.Z. created and characterized MHV68-cre virus and performed limiting dilution PCR and Western blots. H. S. C. and R. R. performed KSHV experiments. M. M. H. and M. H. K. performed ChIP experiments. S. C. H. and E. J. P. helped design helminth experiments and supplied reagents. M. D. B. did RT-PCR for gene 50 and host genes. A. J. did flow cytometry with IL-4 in RAW264.7 cells. A. K. did Western blots. C.Y.L. did plaque assays. G. G. and R. J. X. did initial bioinformatic analysis of gene expression by array, later replaced with RNASeq. P. J. M. provided arginase mice. M.N.A. analyzed sequencing data.	Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Goodwin MM, 2010, J VIROL, V84, P12039, DOI 10.1128/JVI.00396-10; Goodwin MM, 2010, J VIROL, V84, P3711, DOI 10.1128/JVI.02099-09; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gray KS, 2009, J VIROL, V83, P314, DOI 10.1128/JVI.01444-08; HARTY JT, 1992, P NATL ACAD SCI USA, V89, P11612, DOI 10.1073/pnas.89.23.11612; Hwang S, 2008, J VIROL, V82, P12498, DOI 10.1128/JVI.01152-08; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kis LL, 2011, BLOOD, V117, P165, DOI 10.1182/blood-2010-01-265272; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Moser JM, 2005, J VIROL, V79, P9480, DOI 10.1128/JVI.79.15.9480-9491.2005; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nguyen YN, 2008, VIROLOGY, V380, P182, DOI 10.1016/j.virol.2008.07.031; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; Peacock JW, 2003, EUR J IMMUNOL, V33, P1849, DOI 10.1002/eji.200323148; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Saito F, 2013, INFLAMMATION, V36, P1295, DOI 10.1007/s10753-013-9668-1; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Steed A, 2007, J VIROL, V81, P6134, DOI 10.1128/JVI.00108-07; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wakeham K, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-15; Wakeman BS, 2014, J VIROL, V88, P5474, DOI 10.1128/JVI.03110-13; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999	30	140	143	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					573	577		10.1126/science.1254517	http://dx.doi.org/10.1126/science.1254517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	24968940	Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000339651300048
J	Feldman, AM; DiSesa, VJ				Feldman, Arthur M.; DiSesa, Verdi J.			Transcatheter Aortic Valve Replacement Flattening the Cost Curve	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIGH-RISK PATIENTS; STENOSIS		[Feldman, Arthur M.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA; [DiSesa, Verdi J.] Temple Univ, Sch Med, Dept Surg, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Feldman, AM (corresponding author), Temple Univ, Sch Med, Dept Med, 3500 N Broad St,Ste 1150, Philadelphia, PA 19140 USA.	arthur.feldman@tuhs.temple.edu						Abdel-Wahab M, 2011, HEART, V97, P899, DOI 10.1136/hrt.2010.217158; Brennan JM, 2013, CIRCULATION, V127, P1647, DOI 10.1161/CIRCULATIONAHA.113.002003; Doble B, 2013, J THORAC CARDIOVASC, V146, pe3; Doble B, 2013, J THORAC CARDIOV SUR, V146, P52, DOI 10.1016/j.jtcvs.2012.06.018; Gurvitch R, 2011, CATHETER CARDIO INTE, V78, P977, DOI 10.1002/ccd.22961; Holmes DR, 2012, J AM COLL CARDIOL, V59, P1200, DOI 10.1016/j.jacc.2012.01.001; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Simons CT, 2013, CIRC-CARDIOVASC QUAL, V6, P419, DOI 10.1161/CIRCOUTCOMES.113.000280; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510	9	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					25	26		10.1001/jama.2014.4606	http://dx.doi.org/10.1001/jama.2014.4606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	24798052				2022-12-24	WOS:000338131100013
J	Koroshetz, WJ				Koroshetz, Walter J.			PERSPECTIVE Time to tackle blood pressure	NATURE			English	Editorial Material							PREVALENCE; DEMENTIA		US Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Koroshetz, WJ (corresponding author), US Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.	koroshetzw@ninds.nih.gov						Cholerton B, 2013, J ALZHEIMERS DIS, V36, P699, DOI 10.3233/JAD-130281; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Gillespie CD, 2013, MMWR-MORBID MORTAL W, V62, P157; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Lv JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001293; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Wang J, 2014, AM J HYPERTENS	10	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					S4	S4		10.1038/510S4a	http://dx.doi.org/10.1038/510S4a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24964024	Bronze			2022-12-24	WOS:000337806300003
J	Madiraju, AK; Erion, DM; Rahimi, Y; Zhang, XM; Braddock, DT; Albright, RA; Prigaro, BJ; Wood, JL; Bhanot, S; MacDonald, MJ; Jurczak, MJ; Camporez, JP; Lee, HY; Cline, GW; Samuel, VT; Kibbey, RG; Shulman, GI				Madiraju, Anila K.; Erion, Derek M.; Rahimi, Yasmeen; Zhang, Xian-Man; Braddock, Demetrios T.; Albright, Ronald A.; Prigaro, Brett J.; Wood, John L.; Bhanot, Sanjay; MacDonald, Michael J.; Jurczak, Michael J.; Camporez, Joao-Paulo; Lee, Hui-Young; Cline, Gary W.; Samuel, Varman T.; Kibbey, Richard G.; Shulman, Gerald I.			Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase	NATURE			English	Article							GLYCEROL 3-PHOSPHATE DEHYDROGENASE; ACTIVATED PROTEIN-KINASE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; REDOX STATE; HEPATIC GLUCONEOGENESIS; REDUCING EQUIVALENTS; GLUCOSE-HOMEOSTASIS; LIVER; DIET; PHOSPHORYLATION	Metformin is considered to be one of the most effective therapeutics for treating type 2 diabetes because it specifically reduces hepatic gluconeogenesis without increasing insulin secretion, inducing weight gain or posing a risk of hypoglycaemia(1,2). For over half a century, this agent has been prescribed to patients with type 2 diabetes world wide, yet the underlying mechanism by which metformin inhibits hepatic gluconeogenesis remains unknown. Here we show that metformin non-competitively inhibits the redox shuttle enzyme mitochondrial glycerophosphate dehydrogenase, resulting in an altered hepatocellular redox state, reduced conversion of lactate and glycerol to glucose, and decreased hepatic gluconeogenesis. Acute and chronic low-dose metformin treatment effectively reduced endogenous glucose production, while increasing cytosolic redox and decreasing mitochondrial redox states. Antisense oligonucleotide knockdown of hepatic mitochondrial glycerophosphate dehydrogenase in rats resulted in a phenotype akin to chronic metformin treatment, and abrogated metformin-mediated increases in cytosolic redox state, decreases in plasma glucose concentrations, and inhibition of endogenous glucose production. These findings were replicated in whole-body mitochondrial glycerophosphate dehydrogenase knockout mice. These results have significant implications for understanding the mechanism of metformin's blood glucose lowering effects and provide a new therapeutic target for type 2 diabetes.	[Madiraju, Anila K.; Erion, Derek M.; Rahimi, Yasmeen; Zhang, Xian-Man; Jurczak, Michael J.; Camporez, Joao-Paulo; Lee, Hui-Young; Cline, Gary W.; Samuel, Varman T.; Kibbey, Richard G.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Madiraju, Anila K.; Erion, Derek M.; Kibbey, Richard G.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Madiraju, Anila K.; Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Braddock, Demetrios T.; Albright, Ronald A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Prigaro, Brett J.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Wood, John L.] Baylor Univ, Dept Chem & Biochem, Canc Prevent Res Inst Texas Scholar, Waco, TX 76798 USA; [Bhanot, Sanjay] ISIS Pharmaceut, Carlsbad, CA 92010 USA; [MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Shulman, Gerald I.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Colorado State University; Baylor University; Isis Pharmaceuticals Inc; University of Wisconsin System; University of Wisconsin Madison; Novo Nordisk Foundation; University of Copenhagen	Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Camporez, Joao Paulo G/B-9122-2015; Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Jurczak, Michael/0000-0002-6335-6915; MacDonald, Michael/0000-0002-0201-9245; Lee, Hui-Young/0000-0002-3464-6382; Camporez, Joao Paulo/0000-0003-3486-4301	National Institutes of Health [R24 DK-085638, R01 DK-40936, P30 DK-45735, P30 DK-034989, U24 DK-059635, R01 DK-28348, K01 DK-099402, R01 DK-092606]; American Diabetes Association [7-12-BS-092, 1-14-Merck-10]; VA Merit Award [I01-BX000901]; Novo Nordisk Foundation Center for Basic Metabolic Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK085638, R01DK092606, K01DK099402, R01DK040936, P30DK034989, U24DK059635, R01DK028348, P30DK045735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); VA Merit Award(US Department of Veterans Affairs); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Dong, M. Kahn, Y. Kosover and J. J. Hsiao for their technical support, and S. Singh and D. Gregg for discussions. This publication was supported by grants from the National Institutes of Health: R24 DK-085638, R01 DK-40936, P30 DK-45735, P30 DK-034989, U24 DK-059635, R01 DK-28348, K01 DK-099402, R01 DK-092606; grants from the American Diabetes Association: 7-12-BS-092, 1-14-Merck-10; a VA Merit Award (I01-BX000901); and by the Novo Nordisk Foundation Center for Basic Metabolic Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the National Center for Research Resources or National Institutes of Health.	Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barbera A, 2003, DIABETOLOGIA, V46, P1394, DOI 10.1007/s00125-003-1206-5; BREMER J, 1975, BIOCHIM BIOPHYS ACTA, V376, P387, DOI 10.1016/0005-2728(75)90161-9; Brown LJ, 2002, J BIOL CHEM, V277, P32892, DOI 10.1074/jbc.M202408200; Carmignani M, 2001, J MED CHEM, V44, P2950, DOI 10.1021/jm001017v; CEDERBAU.AI, 1973, ARCH BIOCHEM BIOPHYS, V158, P763, DOI 10.1016/0003-9861(73)90571-7; COLE ES, 1978, J BIOL CHEM, V253, P7952; Colussi T, 2008, BIOCHEMISTRY-US, V47, P965, DOI 10.1021/bi701685u; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; FAUPEL RP, 1972, ARCH BIOCHEM BIOPHYS, V148, P509, DOI 10.1016/0003-9861(72)90170-1; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; GARRIB A, 1986, J BIOL CHEM, V261, P8042; HARDING JW, 1975, BIOCHEM J, V146, P223, DOI 10.1042/bj1460223; HARDING JW, 1975, BIOCHEM J, V148, P545, DOI 10.1042/bj1480545; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; KREBS HA, 1968, BIOCHEM J, V108, P513, DOI 10.1042/bj1080513; MacDonald MJ, 2000, ARCH BIOCHEM BIOPHYS, V384, P143, DOI 10.1006/abbi.2000.2107; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PROCHAZKA M, 1989, J BIOL CHEM, V264, P4679; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; SUGANO T, 1980, J BIOCHEM-TOKYO, V87, P153, DOI 10.1093/oxfordjournals.jbchem.a132721; WHITE HB, 1969, J BIOL CHEM, V244, P6031; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yang LL, 2008, J BIOL CHEM, V283, P21978, DOI 10.1074/jbc.M803454200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	33	769	797	9	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					542	+		10.1038/nature13270	http://dx.doi.org/10.1038/nature13270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24847880	Green Accepted			2022-12-24	WOS:000337806300048
J	Lee, K; Zhong, XF; Gu, SY; Kruel, AM; Dorner, MB; Perry, K; Rummel, A; Dong, M; Jin, RS				Lee, Kwangkook; Zhong, Xiaofen; Gu, Shenyan; Kruel, Anna Magdalena; Dorner, Martin B.; Perry, Kay; Rummel, Andreas; Dong, Min; Jin, Rongsheng			Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex	SCIENCE			English	Article							CLOSTRIDIUM-BOTULINUM; ADHERENS JUNCTIONS; CRYSTAL-STRUCTURE; ORAL TOXICITIES; BINDING; CELL; TOXINS; TRANSCYTOSIS; DOMAINS	How botulinum neurotoxins (BoNTs) cross the host intestinal epithelial barrier in foodborne botulism is poorly understood. Here, we present the crystal structure of a clostridial hemagglutinin (HA) complex of serotype BoNT/A bound to the cell adhesion protein E-cadherin at 2.4 angstroms. The HA complex recognizes E-cadherin with high specificity involving extensive intermolecular interactions and also binds to carbohydrates on the cell surface. Binding of the HA complex sequesters E-cadherin in the monomeric state, compromising the E-cadherin-mediated intercellular barrier and facilitating paracellular absorption of BoNT/A. We reconstituted the complete 14-subunit BoNT/A complex using recombinantly produced components and demonstrated that abolishing either E-cadherin- or carbohydrate-binding of the HA complex drastically reduces oral toxicity of BoNT/A complex in vivo. Together, these studies establish the molecular mechanism of how HAs contribute to the oral toxicity of BoNT/A.	[Lee, Kwangkook; Gu, Shenyan; Jin, Rongsheng] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Zhong, Xiaofen; Dong, Min] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Neurosci,New England Primate Res Ctr, Southborough, MA 01772 USA; [Kruel, Anna Magdalena; Rummel, Andreas] Hannover Med Sch, Inst Toxikol, D-30625 Hannover, Germany; [Dorner, Martin B.] Robert Koch Inst, Ctr Biol Threats & Special Pathogens Biol Toxins, D-13353 Berlin, Germany; [Perry, Kay] Cornell Univ, Northeastern Collaborat Access Team NE CAT, Argonne Natl Lab, Argonne, IL 60439 USA; [Perry, Kay] Cornell Univ, Dept Chem & Chem Biol, Argonne Natl Lab, Argonne, IL 60439 USA	University of California System; University of California Irvine; Harvard University; Hannover Medical School; Robert Koch Institute; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Jin, RS (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	r.jin@uci.edu	Dorner, Martin B/C-5703-2013; Jin, Rongsheng/M-7797-2013	Dorner, Martin B/0000-0002-8176-797X; Jin, Rongsheng/0000-0003-0348-7363; Rummel, Andreas/0000-0002-0645-1641; Lipton, Stuart/0000-0002-3490-1259	National Institute of Allergy and Infectious Diseases (NIAID) [R01AI091823]; NIH [8P51OD011103-51, 1R56AI097834-01, 1R01NS080833-01]; Swiss Federal Office for Civil Protection BABS [353003325]; National Institute of General Medical Sciences [P41 GM103403]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097834, R01AI091823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076411, R01NS080833] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Federal Office for Civil Protection BABS; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Bobkov for technical assistance. This work was partly supported by National Institute of Allergy and Infectious Diseases (NIAID) grant R01AI091823 to R.J.; by the NIH grant 8P51OD011103-51 (to the New England Primate Research Center), 1R56AI097834-01, and 1R01NS080833-01 to M. D.; and by the Swiss Federal Office for Civil Protection BABS #353003325 to A. R. NE-CAT at the Advanced Photon Source (APS) is supported by a grant from the National Institute of General Medical Sciences (P41 GM103403). Use of the APS, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract DE-AC02-06CH11357. The atomic coordinates and structure factors of the mini-HA-EC1-EC2 complex have been deposited in the Protein Data Bank under the accession code 4QD2. BoNT availability is subject to the restrictions that apply to Centers for Disease Control and Prevention select agents and NIAID Category A pathogens. R.J. is named as an inventor on a U.S. patent application applied for by University of California, Irvine related to oral drug delivery systems.	Amatsu S, 2013, J BIOL CHEM, V288, P35617, DOI 10.1074/jbc.M113.521179; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Cheng LW, 2008, TOXICOLOGY, V249, P123, DOI 10.1016/j.tox.2008.04.018; Collins MD, 1998, J APPL MICROBIOL, V84, P5, DOI 10.1046/j.1365-2672.1997.00313.x; Couesnon A, 2008, CELL MICROBIOL, V10, P375, DOI 10.1111/j.1462-5822.2007.01051.x; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Gu SY, 2012, SCIENCE, V335, P977, DOI 10.1126/science.1214270; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Ito H, 2011, FEMS IMMUNOL MED MIC, V61, P323, DOI 10.1111/j.1574-695X.2011.00779.x; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Lee K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003690; Lin GY, 2010, APPL ENVIRON MICROB, V76, P40, DOI 10.1128/AEM.01882-09; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Maksymowych AB, 2004, J PHARMACOL EXP THER, V310, P633, DOI 10.1124/jpet.104.066845; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; OHISHI I, 1984, INFECT IMMUN, V43, P487, DOI 10.1128/IAI.43.2.487-490.1984; OHISHI I, 1977, INFECT IMMUN, V16, P107, DOI 10.1128/IAI.16.1.107-109.1977; Parisini E, 2007, J MOL BIOL, V373, P401, DOI 10.1016/j.jmb.2007.08.011; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; Vendome J, 2011, NAT STRUCT MOL BIOL, V18, P693, DOI 10.1038/nsmb.2051	28	79	84	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1405	1410		10.1126/science.1253823	http://dx.doi.org/10.1126/science.1253823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948737	Green Accepted			2022-12-24	WOS:000337531700042
J	Mahroo, OA; Graham, EM				Mahroo, Omar A.; Graham, Elizabeth M.			Roth Spots in Infective Endocarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mahroo, Omar A.; Graham, Elizabeth M.] St Thomas Hosp, London, England	Guy's & St Thomas' NHS Foundation Trust	Mahroo, OA (corresponding author), St Thomas Hosp, London, England.	oarm2@cam.ac.uk		Mahroo, Omar/0000-0003-1254-0832	National Institute for Health Research [CL-2011-17-501] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	5	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					E38	E38		10.1056/NEJMicm1312093	http://dx.doi.org/10.1056/NEJMicm1312093			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0OA	24941198				2022-12-24	WOS:000337353000001
J	Estrada, K; Aukrust, I; Bjorkhaug, L; Burtt, NP; Mercader, JM; Garcia-Ortiz, H; Huerta-Chagoya, A; Moreno-Macias, H; Walford, G; Flannick, J; Williams, AL; Gomez-Vazquez, MJ; Fernandez-Lopez, JC; Martinez-Hernandez, A; Centeno-Cruz, F; Mendoza-Caamal, E; Revilla-Monsalve, C; Islas-Andrade, S; Cordova, EJ; Soberon, X; Gonzalez-Villalpando, ME; Henderson, E; Wilkens, LR; Le Marchand, L; Arellano-Campos, O; Ordonez-Sanchez, ML; Rodriguez-Torres, M; Rodriguez-Guillen, R; Riba, L; Najmi, LA; Jacobs, SBR; Fennell, T; Gabriel, S; Fontanillas, P; Hanis, CL; Lehman, DM; Jenkinson, CP; Abboud, HE; Bell, GI; Cortes, ML; Boehnke, M; Gonzalez-Villalpando, C; Orozco, L; Haiman, CA; Tusie-Luna, T; Aguilar-Salinas, CA; Altshuler, D; Njolstad, PR; Florez, JC; MacArthur, DG				Estrada, Karol; Aukrust, Ingvild; Bjorkhaug, Lise; Burtt, Noel P.; Mercader, Josep M.; Garcia-Ortiz, Humberto; Huerta-Chagoya, Alicia; Moreno-Macias, Hortensia; Walford, Geoffrey; Flannick, Jason; Williams, Amy L.; Gomez-Vazquez, Maria J.; Fernandez-Lopez, Juan C.; Martinez-Hernandez, Angelica; Centeno-Cruz, Federico; Mendoza-Caamal, Elvia; Revilla-Monsalve, Cristina; Islas-Andrade, Sergio; Cordova, Emilio J.; Soberon, Xavier; Gonzalez-Villalpando, Maria E.; Henderson, E.; Wilkens, Lynne R.; Le Marchand, Loic; Arellano-Campos, Olimpia; Ordonez-Sanchez, Maria L.; Rodriguez-Torres, Maribel; Rodriguez-Guillen, Rosario; Riba, Laura; Najmi, Laeya A.; Jacobs, Suzanne B. R.; Fennell, Timothy; Gabriel, Stacey; Fontanillas, Pierre; Hanis, Craig L.; Lehman, Donna M.; Jenkinson, Christopher P.; Abboud, Hanna E.; Bell, Graeme I.; Cortes, Maria L.; Boehnke, Michael; Gonzalez-Villalpando, Clicerio; Orozco, Lorena; Haiman, Christopher A.; Tusie-Luna, Teresa; Aguilar-Salinas, Carlos A.; Altshuler, David; Njolstad, Pal R.; Florez, Jose C.; MacArthur, Daniel G.		SIGMA Type 2 Diabet Consortium	Association of a Low-Frequency Variant in HNF1A With Type 2 Diabetes in a Latino Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; MEXICAN-AMERICANS; YOUNG MODY; RARE VARIANTS; ONSET; MUTATIONS; MELLITUS; PREVALENCE; COMMON; HNF-1-ALPHA	IMPORTANCE Latino populations have one of the highest prevalences of type 2 diabetes worldwide. OBJECTIVES To investigate the association between rare protein-coding genetic variants and prevalence of type 2 diabetes in a large Latino population and to explore potential molecular and physiological mechanisms for the observed relationships. DESIGN, SETTING, AND PARTICIPANTS Whole-exome sequencing was performed on DNA samples from 3756 Mexican and US Latino individuals (1794 with type 2 diabetes and 1962 without diabetes) recruited from 1993 to 2013. One variant was further tested for allele frequency and association with type 2 diabetes in large multiethnic data sets of 14 276 participants and characterized in experimental assays. MAIN OUTCOME AND MEASURES Prevalence of type 2 diabetes. Secondary outcomes included age of onset, body mass index, and effect on protein function. RESULTS A single rare missense variant (c.1522G>A [p.E508K]) was associated with type 2 diabetes prevalence (odds ratio [OR], 5.48; 95% Cl, 2.83-10.61; P = 4.4 x 10(-7)) in hepatocyte nuclear factor 1-a (HNF1A), the gene responsible for maturity onset diabetes of the young type 3 (MODY3). This variant was observed in 0.36% of participants without type 2 diabetes and 2.1% of participants with it. In multiethnic replication data sets, the p.E508K variant was seen only in Latino patients (n = 1443 with type 2 diabetes and 1673 without it) and was associated with type 2 diabetes (OR, 4.16; 95% Cl, 1.75-9.92; P = .0013). In experimental assays, HNF-1A protein encoding the p.E508K mutant demonstrated reduced transactivation activity of its target promoter compared with a wild-type protein. In our data, carriers and noncarriers of the p.E508K mutation with type 2 diabetes had no significant differences in compared clinical characteristics, including age at onset. The mean (SD) age for carriers was 45.3 years (11.2) vs 47.5 years (11.5) for noncarriers (P = .49) and the mean (SD) BMI for carriers was 28.2 (5.5) vs 29.3 (5.3) for noncarriers (P = .19). CONCLUSIONS AND RELEVANCE Using whole-exome sequencing, we identified a single low-frequency variant in the MODY3-causing gene HNF1A that is associated with type 2 diabetes in Latino populations and may affect protein function. This finding may have implications for screening and therapeutic modification in this population, but additional studies are required.	[Estrada, Karol; Burtt, Noel P.; Mercader, Josep M.; Flannick, Jason; Williams, Amy L.; Jacobs, Suzanne B. R.; Fontanillas, Pierre; Altshuler, David; Florez, Jose C.; MacArthur, Daniel G.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Estrada, Karol] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Estrada, Karol; Walford, Geoffrey; Altshuler, David; Florez, Jose C.; MacArthur, Daniel G.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Aukrust, Ingvild; Bjorkhaug, Lise; Najmi, Laeya A.; Njolstad, Pal R.] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, Bergen, Norway; [Bjorkhaug, Lise; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Aukrust, Ingvild] Univ Bergen, Dept Biomed, Bergen, Norway; [Mercader, Josep M.; Walford, Geoffrey; Altshuler, David; Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Mercader, Josep M.; Walford, Geoffrey; Altshuler, David; Florez, Jose C.] Massachusetts Gen Hosp, Diabet Res Ctr, Diabet Unit, Boston, MA 02114 USA; [Mercader, Josep M.] Barcelona Supercomp Ctr, Joint BSC CRG IRB Res Program Computat Biol, Barcelona, Spain; [Garcia-Ortiz, Humberto; Fernandez-Lopez, Juan C.; Martinez-Hernandez, Angelica; Centeno-Cruz, Federico; Mendoza-Caamal, Elvia; Cordova, Emilio J.; Soberon, Xavier; Orozco, Lorena] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Huerta-Chagoya, Alicia; Riba, Laura; Tusie-Luna, Teresa] UNAM INCMNSZ, UNAM Unidad Biol Mol & Med Genom, Inst Invest Biomed, Mexico City, DF, Mexico; [Moreno-Macias, Hortensia] Univ Autonoma Metropolitana, Mexico City, DF, Mexico; [Gonzalez-Villalpando, Maria E.; Gonzalez-Villalpando, Clicerio] Inst Nacl Salud Publ, Ctr Estudios Diabet, Unidad Invest Diabet & Riesgo Cardiovasc, Ctr Invest Salud Poblac, Mexico City, DF, Mexico; [Flannick, Jason; Altshuler, David] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA USA; [Williams, Amy L.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Henderson, E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Gomez-Vazquez, Maria J.; Arellano-Campos, Olimpia; Ordonez-Sanchez, Maria L.; Rodriguez-Torres, Maribel; Rodriguez-Guillen, Rosario; Tusie-Luna, Teresa; Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Secc 16, Mexico City, DF, Mexico; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David] MIT, Dept Biol, Cambridge, MA 02139 USA; [Revilla-Monsalve, Cristina; Islas-Andrade, Sergio] Inst Mexicano Seguro Social, CMN SXXI, Unidad Invest Med Enfermedades Metab, Mexico City, DF, Mexico; [Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Najmi, Laeya A.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Fennell, Timothy; Gabriel, Stacey; Cortes, Maria L.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Hanis, Craig L.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Lehman, Donna M.; Jenkinson, Christopher P.; Abboud, Hanna E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Bell, Graeme I.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Instituto Nacional de Medicina Genomica; Universidad Autonoma Metropolitana - Mexico; Instituto Nacional de Salud Publica; Harvard University; Harvard Medical School; Columbia University; University of Michigan System; University of Michigan; University of Southern California; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Instituto Mexicano del Seguro Social; Cancer Research Center of Hawaii; University of Hawaii System; University of Bergen; Haukeland University Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health San Antonio; University of Chicago; University of Chicago	Florez, JC (corresponding author), Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Diabet Unit, Boston, MA 02114 USA.	jcflorez@partners.org	Aukrust, Ingvild/AAY-9434-2020; Revilla-Monsalve, Cristina/ABG-6663-2021; Aukrust, Ingvild/ABB-4526-2021; Fernandez, Juan Carlos/C-4976-2013; Salinas, Carlos A Aguilar/AAL-4491-2020; Bjørkhaug, Lise/AAA-4356-2021; /ABI-8453-2020; Najmi, Laeya Abdoli/AAC-9091-2019; Altshuler, David M/A-4476-2009; Najmi, Laeya/AAB-5487-2022; del Rosario, Rodriguez-Guillen Maria/ADO-2554-2022; Aukrust, Ingvild/ABG-2219-2021	Fernandez, Juan Carlos/0000-0003-3680-4193; Bjørkhaug, Lise/0000-0002-9695-4559; /0000-0002-9402-4219; Altshuler, David M/0000-0002-7250-4107; del Rosario, Rodriguez-Guillen Maria/0000-0002-6587-5786; Garcia-Ortiz, Humberto/0000-0002-0453-980X; MacArthur, Daniel/0000-0002-5771-2290; Huerta-Chagoya, Alicia/0000-0001-6218-3904; Orozco, Lorena/0000-0002-5801-9180; Mercader, Josep M/0000-0001-8494-3660; Williams, Amy L./0000-0003-0737-0533; Centeno Cruz, Federico/0000-0002-3512-4519; Jacobs, Suzanne/0000-0002-8103-1700; Revilla Monsalve, Maria Cristina/0000-0002-6202-1160	Carlos Slim Health Institute in Mexico; Consejo Nacional de Ciencia y Tecnologia [138826, 128877, CONACT-SALUD 2009-01-115250, 86867]; Direccion General de Asuntos del Personal Academic, UNAM [IT 214711]; Instituto Carlos Slim de la Salud, A.C.; National Institutes of Health (NIH) [R01HL24799]; Consejo Nacional de Ciencia y Tenologia [2092, M9303, F677-M9407, 251M, 2005-C01-14502, SALUD 2010-2-151165]; NIH [CA164973, CA054281, CA063464, R01 CA55069, R35 CA53890, R01 CA80205, R01 CA144034, U01DK085526, U01DK085501]; National Medical Research Council of Singapore; Veterans Administration Epidemiologic grant; University of Bergen; Research Council of Norway; KG Jebsen Foundation; Helse Vest; European Research Council; Instituto Carlos III, Spain; Netherlands Organization for Scientific Research [825.12.023];  [R01 DK042273];  [R01 DK047482];  [R01DK053889];  [R01 DK057295];  [P01 HL045522]	Carlos Slim Health Institute in Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academic, UNAM(Universidad Nacional Autonoma de Mexico); Instituto Carlos Slim de la Salud, A.C.; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tenologia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Veterans Administration Epidemiologic grant; University of Bergen; Research Council of Norway(Research Council of Norway); KG Jebsen Foundation; Helse Vest; European Research Council(European Research Council (ERC)European Commission); Instituto Carlos III, Spain(Instituto de Salud Carlos III); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ; ; ; ; 	The work was conducted as part of the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Health Institute in Mexico. The UNAM/INCMNSZ Diabetes Study was supported by Consejo Nacional de Ciencia y Tecnologia grants 138826, 128877, CONACT-SALUD 2009-01-115250, and a grant from Direccion General de Asuntos del Personal Academic, UNAM, IT 214711. The Diabetes in Mexico Study was supported by Consejo Nacional de Ciencia y Tecnologia grant 86867 and by Instituto Carlos Slim de la Salud, A.C. The Mexico City Diabetes Study was supported by National Institutes of Health (NIH) grant R01HL24799 and by the Consejo Nacional de Ciencia y Tenologia grants 2092, M9303, F677-M9407, 251M, and 2005-C01-14502, SALUD 2010-2-151165. The Multiethnic Cohort was supported by NIH grants CA164973, CA054281, and CA063464. The Singapore Chinese Health Study was funded by the National Medical Research Council of Singapore under its individual research grant scheme and by NIH grants R01 CA55069, R35 CA53890, R01 CA80205, and R01 CA144034. The Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) project was supported by NIH grants U01DK085526 and U01DK085501. The San Antonio Mexican American Family Studies (SAMAFS) were supported by R01 DK042273, R01 DK047482, R01DK053889, R01 DK057295, P01 HL045522, and a Veterans Administration Epidemiologic grant (R.A.D). The University of Bergen, Research Council of Norway, KG Jebsen Foundation, Helse Vest, and European Research Council funded the Norwegian team. Dr Mercader was supported by Sara Borrell Fellowship from the Instituto Carlos III, Spain. Dr Estrada was supported by The Netherlands Organization for Scientific Research under the Rubicon fellowship 825.12.023.	Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aukrust I, 2013, J BIOL CHEM, V288, P5951, DOI 10.1074/jbc.M112.393769; Barquera S, 2003, ARCH MED RES, V34, P407, DOI 10.1016/S0188-4409(03)00075-4; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; Bellanne-Chantelot C, 2008, DIABETES, V57, P503, DOI 10.2337/db07-0859; Bjorkhaug L, 2003, J CLIN ENDOCR METAB, V88, P920, DOI 10.1210/jc.2002-020945; Bjorkhaug L, 2000, BIOCHEM BIOPH RES CO, V279, P792, DOI 10.1006/bbrc.2000.4024; CHOUARD T, 1990, NUCLEIC ACIDS RES, V18, P5853, DOI 10.1093/nar/18.19.5853; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eide SA, 2008, DIABETIC MED, V25, P775, DOI 10.1111/j.1464-5491.2008.02459.x; Ellard S, 2000, HUM MUTAT, V16, P377, DOI 10.1002/1098-1004(200011)16:5<377::AID-HUMU1>3.0.CO;2-2; FALCONER DS, 1967, ANN HUM GENET, V31, P1; Fang Qi-chen, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P329; Flannick J, 2013, NAT GENET, V45, P1380, DOI 10.1038/ng.2794; Forlani G, 2010, DIABETES CARE, V33, P2336, DOI 10.2337/dc10-0561; HANIS CL, 1983, AM J EPIDEMIOL, V118, P659, DOI 10.1093/oxfordjournals.aje.a113677; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Hegele RA, 1999, J CLIN ENDOCR METAB, V84, P1077, DOI 10.1210/jc.84.3.1077; Hunt KJ, 2011, ANN EPIDEMIOL, V21, P899, DOI 10.1016/j.annepidem.2011.07.003; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kristinsson SY, 2001, DIABETOLOGIA, V44, P2098, DOI 10.1007/s001250100016; Kropff J, 2011, DIABETOLOGIA, V54, P1261, DOI 10.1007/s00125-011-2090-z; LEDERMANN HM, 1995, DIABETOLOGIA, V38, P1482, DOI 10.1007/BF00400611; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Lorenzo C, 2005, DIABETES CARE, V28, P2480, DOI 10.2337/diacare.28.10.2480; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Molven A, 2011, EXPERT REV MOL DIAGN, V11, P313, DOI [10.1586/ERM.10.123, 10.1586/erm.10.123]; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nishigori H, 1998, J HUM GENET, V43, P107, DOI 10.1007/s100380050049; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Shepherd M, 2009, DIABETIC MED, V26, P437, DOI 10.1111/j.1464-5491.2009.02690.x; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Sovik O, 1998, DIABETOLOGIA, V41, P607, DOI 10.1007/s001250050956; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tonooka N, 2002, DIABETOLOGIA, V45, P1709, DOI 10.1007/s00125-002-0978-3; TRONCHE F, 1992, BIOESSAYS, V14, P579, DOI 10.1002/bies.950140902; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS19, DOI 10.1590/S0036-36342010000700005; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yorifuji T, 2012, PEDIATR DIABETES, V13, P26, DOI 10.1111/j.1399-5448.2011.00827.x; Zaitlen N, 2012, BIOINFORMATICS, V28, P1729, DOI 10.1093/bioinformatics/bts259; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	51	152	153	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2305	2314		10.1001/jama.2014.6511	http://dx.doi.org/10.1001/jama.2014.6511			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915262	Green Accepted, Bronze			2022-12-24	WOS:000336972600022
J	Mohn, F; Sienski, G; Handler, D; Brennecke, J				Mohn, Fabio; Sienski, Grzegorz; Handler, Dominik; Brennecke, Julius			The Rhino-Deadlock-Cutoff Complex Licenses Noncanonical Transcription of Dual-Strand piRNA Clusters in Drosophila	CELL			English	Article							QUALITY-CONTROL MECHANISM; SMALL RNAS; CHROMATIN STATE; MULTIPLE ROLES; GENOME DEFENSE; PIWI; HETEROCHROMATIN; GERMLINE; PROTEIN; TRANSPOSONS	Argonaute proteins of the PIWI clade are central to transposon silencing in animal gonads. Their target specificity is defined by 23-30 nt PIWI interacting RNAs (piRNAs), which mostly originate from discrete genomic loci termed piRNA clusters. Here, we show that a complex composed of Rhino, Deadlock, and Cutoff (RDC) defines dual-strand piRNA clusters genome-wide in Drosophila ovaries. The RDC is anchored to H3K9me3-marked chromatin in part via Rhino's chromodomain. Depletion of Piwi results in loss of the RDC and small RNAs at a subset of piRNA clusters, demonstrating a feedback loop between Piwi and piRNA source loci. Intriguingly, profiles of RNA polymerase II occupancy, nascent transcription, and steady-state RNA levels reveal that the RDC licenses noncanonical transcription of dual-strand piRNA clusters. Likely, this process involves 50 end protection of nascent RNAs and suppression of transcription termination. Our data provide key insight into the regulation and evolution of piRNA clusters.	[Mohn, Fabio; Sienski, Grzegorz; Handler, Dominik; Brennecke, Julius] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Mohn, F (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	fabio.mohn@imba.oeaw.ac.at; julius.brennecke@imba.oeaw.ac.at	Brennecke, Julius/C-1626-2015; Brennecke, Julius/T-5883-2019	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814; Mohn, Fabio/0000-0001-9889-5225; Handler, Dominik/0000-0002-1059-4960	Austrian Academy of Sciences; European Community (ERC) [260711EU]; Austrian Science Fund (FWF) [510-B12]; SNF; HFSP; Boehringer Ingelheim Fonds; Austrian Science Fund (FWF) [Y 510] Funding Source: researchfish	Austrian Academy of Sciences; European Community (ERC)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); SNF; HFSP(Human Frontier Science Program); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank F. Gruber, K. Meixner, K. Senti, J. Batki, and A. Wenger for experimental support, M. Madalinski for antibody purifications, S. Lopez for fly injections, the VDRC, the TrIP collection, the Bloomington stock center, and B. Theurkauf, T. Schupbach for flies, A. Schleiffer, D. Jurczak, and R. Sachidanandam for bioinformatics support, the CSF NGS unit for deep sequencing and P. Refsing Andersen for comments on the manuscript. This work was supported by the Austrian Academy of Sciences, the European Community's 7th Framework Programme (FP7/2007-2013; ERC grant # 260711EU) and the Austrian Science Fund (FWF; Y 510-B12). F. M. is supported by SNF and HFSP fellowships; G. S. is supported by the Boehringer Ingelheim Fonds.	Andersen PR, 2013, NAT STRUCT MOL BIOL, V20, P1367, DOI 10.1038/nsmb.2703; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; de Vanssay A, 2012, NATURE, V490, P112, DOI 10.1038/nature11416; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Keller C, 2012, MOL CELL, V47, P215, DOI 10.1016/j.molcel.2012.05.009; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Muerdter F, 2012, RNA, V18, P42, DOI 10.1261/rna.029769.111; Pane A, 2011, EMBO J, V30, P4601, DOI 10.1038/emboj.2011.334; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rangan P, 2011, CURR BIOL, V21, P1373, DOI 10.1016/j.cub.2011.06.057; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Shpiz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004138; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Wehr K, 2006, DEV BIOL, V294, P406, DOI 10.1016/j.ydbio.2006.03.002; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040	36	202	213	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1364	1379		10.1016/j.cell.2014.04.031	http://dx.doi.org/10.1016/j.cell.2014.04.031			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906153	Bronze			2022-12-24	WOS:000340881400013
J	Detsky, AS; Krumholz, HM				Detsky, Allan S.; Krumholz, Harlan M.			Reducing the Trauma of Hospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Univ Toronto, Mt Sinai Hosp, Inst Hlth Policy Management & Evaluat, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Krumholz, Harlan M.] Yale Univ, Yale New Haven Hosp, Sect Cardiovasc Med, Sch Med,Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Yale University; Yale University	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 429, Toronto, ON M5N 2N8, Canada.	adetsky@mtsinai.on.ca	, Harlan/AAI-2875-2020					Chen C, 2014, JAMA-J AM MED ASSOC, V311, P673, DOI 10.1001/jama.2014.11; Detsky ME, 2008, JAMA-J AM MED ASSOC, V300, P954, DOI 10.1001/jama.300.8.954; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Sinha SK, 2012, JAMA-J AM MED ASSOC, V308, P2573, DOI 10.1001/jama.2012.68313	5	65	65	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2169	2170		10.1001/jama.2014.3695	http://dx.doi.org/10.1001/jama.2014.3695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24788549				2022-12-24	WOS:000336668400013
J	Sedgwick, P				Sedgwick, Philip			Understanding statistical hypothesis testing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUESTION		Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Fagerstrom K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6549; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2130; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6282	3	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2014	348								g3557	10.1136/bmj.g3557	http://dx.doi.org/10.1136/bmj.g3557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EO	24879817				2022-12-24	WOS:000336742800004
J	Uesaka, N; Uchigashima, M; Mikuni, T; Nakazawa, T; Nakao, H; Hirai, H; Aiba, A; Watanabe, M; Kano, M				Uesaka, Naofumi; Uchigashima, Motokazu; Mikuni, Takayasu; Nakazawa, Takanobu; Nakao, Harumi; Hirai, Hirokazu; Aiba, Atsu; Watanabe, Masahiko; Kano, Masanobu			Retrograde semaphorin signaling regulates synapse elimination in the developing mouse brain	SCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; CLIMBING FIBER; CA2+ CHANNEL; INNERVATION; COMPETITION; RECEPTOR; 7A	Neural circuits are shaped by elimination of early-formed redundant synapses during postnatal development. Retrograde signaling from postsynaptic cells regulates synapse elimination. In this work, we identified semaphorins, a family of versatile cell recognition molecules, as retrograde signals for elimination of redundant climbing fiber to Purkinje cell synapses in developing mouse cerebellum. Knockdown of Sema3A, a secreted semaphorin, in Purkinje cells or its receptor in climbing fibers accelerated synapse elimination during postnatal day 8 (P8) to P18. Conversely, knockdown of Sema7A, a membrane-anchored semaphorin, in Purkinje cells or either of its two receptors in climbing fibers impaired synapse elimination after P15. The effect of Sema7A involves signaling by metabotropic glutamate receptor 1, a canonical pathway for climbing fiber synapse elimination. These findings define how semaphorins retrogradely regulate multiple processes of synapse elimination.	[Uesaka, Naofumi; Mikuni, Takayasu; Nakazawa, Takanobu; Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan; [Uchigashima, Motokazu; Watanabe, Masahiko] Hokkaido Univ, Dept Anat, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Nakao, Harumi; Aiba, Atsu] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrated Med, Lab Anim Resources, Tokyo 1130033, Japan; [Hirai, Hirokazu] Gunma Univ, Grad Sch Med, Dept Neurophysiol, Maebashi, Gunma 3718511, Japan	University of Tokyo; Hokkaido University; University of Tokyo; Gunma University	Kano, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan.	mkano-tky@m.u-tokyo.ac.jp	Watanabe, Masahiko/S-3614-2019; Hirai, Hirokazu/ABP-1143-2022; Uesaka, Naofumi/S-6072-2018; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; Uesaka, Naofumi/0000-0002-9744-944X; WATANABE, Masahiko/0000-0001-5037-7138; NAKAZAWA, Takanobu/0000-0003-4863-1277; Kano, Masanobu/0000-0002-0725-3292; Mikuni, Takayasu/0000-0002-9769-9369; Hirai, Hirokazu/0000-0002-0721-4293; Aiba, Atsu/0000-0002-8192-0778; Nakao, Harumi/0000-0003-1729-7405	Funding Program for Next Generation World-Leading Researchers [LS021]; Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior); Comprehensive Brain Science Network; Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology of Japan;  [21220006];  [25000015];  [19100005];  [24220007];  [23650160]; Grants-in-Aid for Scientific Research [25115010] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior); Comprehensive Brain Science Network; Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Nienhuis for the gifts of the lentiviral backbone vector and the packaging plasmid. A Purkinje cell-tropic viral vector has been patented (19). We also thank K. Kitamura, K. Hashimoto, Y. Sugaya, and M. Mahoney for helpful discussions and K. Matsuyama, M. Sekiguchi, M. Watanabe, S. Tanaka, and A. Koseki for technical assistance. This work was supported by Grants-in-Aid for Scientific Research (21220006 and 25000015 to M. K., 19100005 and 24220007 to M. W., and 23650160 to N.U.), the Funding Program for Next Generation World-Leading Researchers (LS021) to H. H., the Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior), Comprehensive Brain Science Network, and the Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. H. H. and T. Torashima are inventors on a Japanese and a U.S. patent application for a Purkinje cell-tropic viral vector (the modified L7 promoter sequences that enable robust transgene expression specifically in cerebellar Purkinje cells, PCT/JP2007/055017 filed on 7 March 2007 and US20100146649), which is owned by Japan Science and Technology Agency (19). Materials described here are available from H. H. and A. Nienhuis, subject to a material transfer agreement (MTA) with Gunma University for the modified L7 promoter and an MTA with St. Jude Children's Research Hospital and the George Washington University for the pCL20c MSCV-GFP. Additional data can be found in the supplementary materials.	CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; CREPEL F, 1981, DEV BRAIN RES, V1, P59, DOI 10.1016/0165-3806(81)90094-8; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; Hashimoto K, 2011, P NATL ACAD SCI USA, V108, P9987, DOI 10.1073/pnas.1101488108; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Hirai H., 2012, Japanese Patent, Patent No. 4975733; Kakizawa S, 2000, J NEUROSCI, V20, P4954; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kano M, 2009, CURR OPIN NEUROBIOL, V19, P154, DOI 10.1016/j.conb.2009.05.002; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Mikuni T, 2013, NEURON, V78, P1024, DOI 10.1016/j.neuron.2013.04.036; Miyazaki T, 2004, J NEUROSCI, V24, P1734, DOI 10.1523/JNEUROSCI.4208-03.2004; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Scott GA, 2009, J INVEST DERMATOL, V129, P954, DOI 10.1038/jid.2008.329; Uesaka N, 2012, J NEUROSCI, V32, P11657, DOI 10.1523/JNEUROSCI.1097-12.2012; Watanabe M, 2011, EUR J NEUROSCI, V34, P1697, DOI 10.1111/j.1460-9568.2011.07894.x	19	76	77	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1020	1023		10.1126/science.1252514	http://dx.doi.org/10.1126/science.1252514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24831527				2022-12-24	WOS:000336495800043
J	Baillie, JK				Baillie, J. Kenneth			Targeting the host immune response to fight infection	SCIENCE			English	Editorial Material							VIRUS; RESISTANCE; GENOME		[Baillie, J. Kenneth] Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Baillie, J. Kenneth] Royal Infirm Edinburgh NHS Trust, Intens Care Unit, Edinburgh EH16 4SA, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Baillie, JK (corresponding author), Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland.	j.k.baillie@ed.ac.uk	Baillie, Kenneth/AEK-6650-2022; Baillie, John Kenneth/F-3124-2011	Baillie, Kenneth/0000-0001-5258-793X; Baillie, John Kenneth/0000-0001-5258-793X				Alejandria MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001090.pub2; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bousfiha A, 2010, CLIN IMMUNOL, V135, P204, DOI 10.1016/j.clim.2010.02.001; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Busse PJ, 2002, J ALLERGY CLIN IMMUN, V109, P1001, DOI 10.1067/mai.2002.124999; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Chaigne-Delalande B, 2013, SCIENCE, V341, P186, DOI 10.1126/science.1240094; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Renzette N, 2014, J VIROL, V88, P272, DOI 10.1128/JVI.01067-13; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202	15	17	17	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					807	808		10.1126/science.1255074	http://dx.doi.org/10.1126/science.1255074			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855243				2022-12-24	WOS:000336233800015
J	Saio, T; Guan, X; Rossi, P; Economou, A; Kalodimos, CG				Saio, Tomohide; Guan, Xiao; Rossi, Paolo; Economou, Anastassios; Kalodimos, Charalampos G.			Structural Basis for Protein Antiaggregation Activity of the Trigger Factor Chaperone	SCIENCE			English	Article							MALTOSE-BINDING PROTEIN; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; NASCENT CHAIN; ALKALINE-PHOSPHATASE; CHEMICAL-EXCHANGE; MEMBRANE-PROTEIN; EXCITED-STATES; NMR	Molecular chaperones prevent aggregation and misfolding of proteins, but scarcity of structural data has impeded an understanding of the recognition and antiaggregation mechanisms. We report the solution structure, dynamics, and energetics of three trigger factor (TF) chaperone molecules in complex with alkaline phosphatase (PhoA) captured in the unfolded state. Our data show that TF uses multiple sites to bind to several regions of the PhoA substrate protein primarily through hydrophobic contacts. Nuclear magnetic resonance (NMR) relaxation experiments show that TF interacts with PhoA in a highly dynamic fashion, but as the number and length of the PhoA regions engaged by TF increase, a more stable complex gradually emerges. Multivalent binding keeps the substrate protein in an extended, unfolded conformation. The results show how molecular chaperones recognize unfolded polypeptides and, by acting as unfoldases and holdases, prevent the aggregation and premature (mis)folding of unfolded proteins.	[Saio, Tomohide; Guan, Xiao; Rossi, Paolo; Kalodimos, Charalampos G.] Rutgers State Univ, Ctr Integrat Prote Res, Piscataway, NJ 08854 USA; [Saio, Tomohide; Guan, Xiao; Rossi, Paolo; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & chem Biol, Piscataway, NJ 08854 USA; [Economou, Anastassios] Katholieke Univ Leuven, Rega Inst, Lab Mol Bacteriol, Dept Microbiol & Immunol, Minderbroedersstraat 10, B-3000 Leuven, Belgium; [Economou, Anastassios] Univ Crete, Inst Mol Biol & Biotechnol FORTH, POB 1385, GR-71110 Iraklion, NE, Greece; [Economou, Anastassios] Univ Crete, Dept Biol, POB 1385, GR-71110 Iraklion, NE, Greece	Rutgers State University New Brunswick; Rutgers State University New Brunswick; KU Leuven; University of Crete; University of Crete	Kalodimos, CG (corresponding author), Rutgers State Univ, Ctr Integrat Prote Res, Piscataway, NJ 08854 USA.	babis@rutgers.edu	Economou, Anastassios/P-8292-2017; Kalodimos, Charalampos/Q-9846-2018	Economou, Anastassios/0000-0002-1770-507X; Kalodimos, Charalampos/0000-0001-6354-2796; Guan, Xiao/0000-0001-7180-6536; Saio, Tomohide/0000-0003-3639-7399	NIH [GM073854]; Nonaco (Aristeia-Excellence) [1473]; KUL-Spa; RiMembR; StrepSynth; Japanese Society for the Promotion of Science; American Heart Association [14POST18600039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nonaco (Aristeia-Excellence); KUL-Spa; RiMembR; StrepSynth; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C. G. K. thanks L. E. Kay and B. Bukau for fruitful discussions and comments. We thank M. T. Pai and A. Bhattacharya for contributions during the early phase of the project, S. Patel for the use of a spectrofluorometer, and S. Kim and Y. Xia (University of Minnesota) for their help with setting up NMR experiments. This work is supported by NIH grant GM073854 (C. G. K.), Nonaco (Aristeia-Excellence, #1473), KUL-Spa, RiMembR, and StrepSynth (A. E.). T. S. is the recipient of postdoctoral fellowships from the Japanese Society for the Promotion of Science and the American Heart Association (14POST18600039). We thank Bruker Biospin for the use of the 700-MHz instrument. Coordinates and structural restraints have been deposited with the Protein Data Bank under accession codes 2MLY, 2MLX, and 2MLZ, for TF-PhoA<SUP>a-c</SUP>, TF-PhoA<SUP>d-e</SUP>, and TF-PhoA<SUP>f-g</SUP>, respectively.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; AKIYAMA Y, 1989, J BIOL CHEM, V264, P437; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Betton JM, 1996, J BIOL CHEM, V271, P8046, DOI 10.1074/jbc.271.14.8046; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chen L, 2011, MOL CELL, V44, P734, DOI 10.1016/j.molcel.2011.09.022; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Dyson HJ, 2005, METHOD ENZYMOL, V394, P299, DOI 10.1016/S0076-6879(05)94011-1; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Hoffmann A, 2009, NAT STRUCT MOL BIOL, V16, P1006, DOI 10.1038/nsmb1009-1006; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Horwich AL, 2011, NAT MED, V17, P1211, DOI 10.1038/nm.2468; Hsu STD, 2009, BIOMOL NMR ASSIGN, V3, P17, DOI 10.1007/s12104-008-9130-8; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; Lakshmipathy SK, 2010, J BIOL CHEM, V285, P27911, DOI 10.1074/jbc.M110.134163; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Novokhatny V, 1997, PROTEIN SCI, V6, P141; O'Brien EP, 2012, J AM CHEM SOC, V134, P10920, DOI 10.1021/ja302305u; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Raffy S, 1998, PROTEIN SCI, V7, P2136, DOI 10.1002/pro.5560071010; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Saul FA, 2003, PROTEIN SCI, V12, P577, DOI 10.1110/ps.0235103; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Stirling PC, 2006, NAT STRUCT MOL BIOL, V13, P865, DOI 10.1038/nsmb1153; Sugase K, 2007, J AM CHEM SOC, V129, P13406, DOI 10.1021/ja0762238; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Tomikiewicz D, 2008, J MOL BIOL, V377, P83, DOI 10.1016/j.jmb.2008.01.014; Tyagi NK, 2009, P NATL ACAD SCI USA, V106, P20264, DOI 10.1073/pnas.0911556106; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Velyvis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043725; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Yao Y, 2008, J BIOMOL NMR, V40, P23, DOI 10.1007/s10858-007-9207-1; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	93	182	186	4	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					597	+	1250494	10.1126/science.1250494	http://dx.doi.org/10.1126/science.1250494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812405	Green Accepted			2022-12-24	WOS:000335537400034
J	Okabe, Y; Medzhitov, R				Okabe, Yasutaka; Medzhitov, Ruslan			Tissue-Specific Signals Control Reversible Program of Localization and Functional Polarization of Macrophages	CELL			English	Article							RETINOIC-ACID; VITAMIN-A; DENDRITIC CELLS; MILKY SPOTS; T-CELLS; DIFFERENTIATION; BETA; ACTIVATION; GENERATION; EXPRESSION	Tissue-resident macrophages are highly heterogeneous in terms of their functions and phenotypes as a consequence of adaptation to different tissue environments. Local tissue-derived signals are thought to control functional polarization of resident macrophages; however, the identity of these signals remains largely unknown. It is also unknown whether functional heterogeneity is a result of irreversible lineage-specific differentiation or a consequence of continuous but reversible induction of diverse functional programs. Here, we identified retinoic acid as a signal that induces tissue-specific localization and functional polarization of peritoneal macrophages through the reversible induction of transcription factor GATA6. We further found that GATA6 in macrophages regulates gut IgA production through peritoneal B-1 cells. These results provide insight into the regulation of tissue-resident macrophage functional specialization by tissue-derived signals.	[Okabe, Yasutaka; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Okabe, Yasutaka; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu		Okabe, Yasutaka/0000-0002-1913-7280	Japan Society for the Promotion of Science (JSPS); Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; Blavatnik Family Foundation; NIH [AI046688, AI089771, CA157461]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA157461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI046688, R01AI089771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Blavatnik Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Medzhitov laboratory and the W. M. Keck facility for microarray analysis. Y.O. was supported by the Japan Society for the Promotion of Science (JSPS), Uehara Memorial Foundation, and Kanae Foundation for the Promotion of Medical Science. R. M. lab is supported by The Blavatnik Family Foundation, grants from NIH (AI046688, AI089771, CA157461) and the Howard Hughes Medical Institute.	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Capo-chichi CD, 2005, DEV BIOL, V286, P574, DOI 10.1016/j.ydbio.2005.07.037; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Chang J, 2013, EUR J IMMUNOL, V43, P967, DOI 10.1002/eji.201242772; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; DAEMS WT, 1982, IMMUNOBIOLOGY, V161, P204, DOI 10.1016/S0171-2985(82)80075-2; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fortunel NO, 2000, BLOOD, V96, P2022; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraushaar DC, 2013, INT J BIOL SCI, V9, P1134, DOI 10.7150/ijbs.7998; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kutty RK, 2001, J BIOL CHEM, V276, P2831, DOI 10.1074/jbc.M007421200; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Maruya M, 2011, P NATL ACAD SCI USA, V108, P722, DOI 10.1073/pnas.1014697108; Mauney JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011513; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; RATAJCZAK MZ, 1987, CLIN EXP IMMUNOL, V69, P198; Roy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082121; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; SMITH SM, 1987, J NUTR, V117, P857, DOI 10.1093/jn/117.5.857; Sodhi CP, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-19; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; WIJFFELS JFAM, 1992, RES IMMUNOL, V143, P401, DOI 10.1016/S0923-2494(05)80072-0; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	53	564	581	4	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					832	844		10.1016/j.cell.2014.04.016	http://dx.doi.org/10.1016/j.cell.2014.04.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24792964	Green Accepted, Bronze			2022-12-24	WOS:000335765500012
J	Appleby, J				Appleby, John			Health related lifestyles of children: getting better?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						[Anonymous], 2013, BBC NEWS; Buck D., 2012, IMPLICATIONS POLICY; Chief Medical Officer, 2014, ANN REP CHIEF MED OF; Chief Medical Officer, 2013, ANN REP CHIEF MED OF; Hale DR, 2012, J PUBLIC HEALTH-UK, V34, pI11, DOI 10.1093/pubmed/fdr112; Health and Social Care Information Centre, 2013, HLTH SURV ENGL 2012; Mcdermott N, 2013, DAILY MAIL      1013; The Health and Social Care Information Centre, 2013, SMOK DRINK DRUG US Y; The Health and Social Care Information Centre LS, NAT CHILD MEAS PROGR	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2014	348								g3025	10.1136/bmj.g3025	http://dx.doi.org/10.1136/bmj.g3025			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5SN	24792237				2022-12-24	WOS:000335478900002
J	May, M				May, Mike			DRUG DEVELOPMENT Time for teamwork	NATURE			English	Editorial Material																		Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Spellberg B, 2012, APUA CLIN NEWSL, V30, P8; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	3	31	32	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S4	S5		10.1038/509S4a	http://dx.doi.org/10.1038/509S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784427				2022-12-24	WOS:000335199100003
J	Zhang, J; Zhang, KH; Gao, ZG; Paoletta, S; Zhang, DD; Han, GW; Li, TT; Ma, LM; Zhang, WR; Muller, CE; Yang, HY; Jiang, HL; Cherezov, V; Katritch, V; Jacobson, KA; Stevens, RC; Wu, BL; Zhao, Q				Zhang, Jin; Zhang, Kaihua; Gao, Zhan-Guo; Paoletta, Silvia; Zhang, Dandan; Han, Gye Won; Li, Tingting; Ma, Limin; Zhang, Wenru; Mueller, Christa E.; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Katritch, Vsevolod; Jacobson, Kenneth A.; Stevens, Raymond C.; Wu, Beili; Zhao, Qiang			Agonist-bound structure of the human P2Y(12) receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; RESOLUTION CRYSTAL-STRUCTURE; A(2A) ADENOSINE RECEPTOR; MEMBRANE-PROTEINS; IDENTIFICATION; ANTAGONISTS; ACTIVATION; RHODOPSIN; COMPLEX	The P2Y(12) receptor (P2Y(12)R), one of eight members of the P2YR family expressed in humans, is one of the most prominent clinical drug targets for inhibition of platelet aggregation. Although mutagenesis and modelling studies of the P2Y(12)R provided useful insights into ligand binding(1-4), the agonist and antagonist recognition and function at the P2Y(12)R remain poorly understood at the molecular level. Here we report the structures of the human P2Y(12)R in complex with the full agonist 2-methylthio-adenosine-5'-diphosphate (2MeSADP, a close analogue of endogenous agonist ADP) at 2.5 angstrom resolution, and the corresponding ATP derivative 2-methylthio-adenosine-5'-triphosphate (2MeSATP) at 3.1 angstrom resolution. These structures, together with the structure of the P2Y(12)R with antagonist ethyl 6-(4-((benzylsulfonyl) carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283)(5), reveal striking conformational changes between nucleotide and non-nucleotide ligand complexes in the extracellular regions. Further analysis of these changes provides insight into a distinct ligand binding landscape inthed-group of class AG-protein-coupled receptors (GPCRs). Agonist and non-nucleotide antagonist adopt different orientations in the P2Y(12)R, with only partially overlapped binding pockets. The agonist-bound P2Y(12)R structure answers long-standing questions surrounding P2Y(12)R-agonist recognition, and reveals interactions with several residues that had not been reported to be involved in agonist binding. As a first example, to our knowledge, of a GPCR in which agonist access to the binding pocket requires large-scale rearrangements in the highly malleable extracellular region, the structural and docking studies will therefore provide invaluable insight into the pharmacology and mechanisms of action of agonists and different classes of antagonists for the P2Y(12)R and potentially for other closely related P2YRs.	[Zhang, Jin; Zhang, Kaihua; Zhang, Dandan; Li, Tingting; Ma, Limin; Zhang, Wenru; Wu, Beili; Zhao, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Gao, Zhan-Guo; Paoletta, Silvia; Jacobson, Kenneth A.] Natl Inst Diabet & Digest & Kidney Dis, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Han, Gye Won; Cherezov, Vadim; Katritch, Vsevolod; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Mueller, Christa E.] Univ Bonn, PharmaCtr Bonn, D-53121 Bonn, Germany; [Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Stevens, Raymond C.] ShanghaiTech Univ, IHuman Inst, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Scripps Research Institute; University of Bonn; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; ShanghaiTech University	Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	beiliwu@simm.ac.cn; zhaoq@simm.ac.cn	Müller, Christa Elisabeth/C-7748-2014; Jacobson, Kenneth Alan/A-1530-2009; Cherezov, Vadim/L-9812-2013; Katritch, Vsevolod/Q-8357-2016; Zhang, Kaihua/AAD-7882-2022; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLQ-8673-2022; Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022	Müller, Christa Elisabeth/0000-0002-0013-6624; Jacobson, Kenneth Alan/0000-0001-8104-1493; Cherezov, Vadim/0000-0002-5265-3914; Katritch, Vsevolod/0000-0003-3883-4505; Zhang, Kaihua/0000-0003-3734-3624; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; Zhang, Dandan/0000-0002-8863-5806	National Basic Research Program of China [2012CB910400, 2012CB518000, 2014CB910400]; National Institutes of Health [R01AI100604, U54 GM094618]; National Science Foundation of China [31370729]; National Science and Technology Major Project [2013ZX09507001, 2012ZX09301001]; National Institutes of Health NIDDK Intramural Research Program; National Natural Science Foundation of China [91313000]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031116, ZIADK031126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; National Institutes of Health NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Basic Research Program of China grants 2012CB910400, 2012CB518000 and 2014CB910400 (B. W., Q.Z.), the National Institutes of Health grants R01AI100604 (B. W., Q.Z.) and U54 GM094618 (V. C., V. K., R. C. S.; Target GPCR-87), the National Science Foundation of China grants 31370729 and National Science and Technology Major Project 2013ZX09507001 and 2012ZX09301001 (B. W., Q.Z.), National Institutes of Health NIDDK Intramural Research Program (K.A.J.) and the National Natural Science Foundation of China 91313000 (H.J.). The authors thank S. Nylander, E. Kiselev and S. Moss for scientific feedback on the manuscript, A. Walker for assistance with manuscript preparation and K. Kadyshevskaya for help with figure preparation. The synchrotron radiation experiments were performed at the BL41XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal no. 2013B1049). We thank the beamline staff members of the BL41XU for help with X-ray data collection.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cattaneo M, 2011, BLOOD, V117, P2102, DOI 10.1182/blood-2010-08-263111; Chang H, 2012, J THROMB HAEMOST, V10, P2573, DOI 10.1111/jth.12035; Chang H, 2010, THROMB RES, V125, P159, DOI 10.1016/j.thromres.2009.11.006; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Daly ME, 2009, BLOOD, V113, P4110, DOI 10.1182/blood-2008-11-190850; Ding ZG, 2006, MOL PHARMACOL, V69, P338, DOI 10.1124/mol.105.014654; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fujioka M, 2012, DRUG DISCOV TODAY, V17, P1133, DOI 10.1016/j.drudis.2012.06.010; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hoffmann K, 2008, BIOCHEM PHARMACOL, V76, P1201, DOI 10.1016/j.bcp.2008.08.029; Ignatovica V, 2012, FEBS J, V279, P180, DOI 10.1111/j.1742-4658.2011.08410.x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kauffenstein G, 2004, J THROMB HAEMOST, V2, P1980, DOI 10.1111/j.1538-7836.2004.00926.x; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schmidt P, 2013, MOL PHARMACOL, V83, P256, DOI 10.1124/mol.112.082198; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Srinivasan S, 2009, J BIOL CHEM, V284, P16108, DOI 10.1074/jbc.M809780200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhao Q, 2012, ACTA PHARMACOL SIN, V33, P324, DOI 10.1038/aps.2011.187; Zhou XE, 2012, ACTA PHARMACOL SIN, V33, P291, DOI 10.1038/aps.2011.171	34	226	240	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					119	122		10.1038/nature13288	http://dx.doi.org/10.1038/nature13288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784220	Green Accepted			2022-12-24	WOS:000335199100051
J	Miller, PS; Aricescu, AR				Miller, Paul S.; Aricescu, A. Radu			Crystal structure of a human GABA(A) receptor	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SIZE-EXCLUSION CHROMATOGRAPHY; LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; EXTRACELLULAR DOMAIN; ALPHA-BUNGAROTOXIN; ION SELECTIVITY; CHANNEL; MUTATION; EXPRESSION	Type-A gamma-aminobutyric acid receptors (GABA(A)Rs) are the principal mediators of rapid inhibitory synaptic transmission in the human brain. A decline in GABA(A)R signalling triggers hyperactive neurological disorders such as insomnia, anxiety and epilepsy. Here we present the first three-dimensional structure of a GABA(A)R, the human beta 3homopentamer, at 3 angstrom resolution. This structure reveals architectural elements unique to eukaryotic Cys-loop receptors, explains the mechanistic consequences of multiple human disease mutations and shows an unexpected structural role for a conserved N-linked glycan. The receptor was crystallized bound to a previously unknown agonist, benzamidine, opening a new avenue for the rational design of GABA(A)R modulators. The channel region forms a closed gate at the base of the pore, representative of a desensitized state. These results offer new insights into the signalling mechanisms of pentameric ligand-gated ion channels and enhance current understanding of GABAergic neurotransmission.	[Miller, Paul S.; Aricescu, A. Radu] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Aricescu, AR (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	paul@strubi.ox.ac.uk; radu@strubi.ox.ac.uk		Aricescu, Alexandru ARadu/0000-0003-3783-1388; Miller, Paul/0000-0002-6512-9441	Wellcome Trust (OXION: Ion channels and Disease Initiative) [084655]; UK Medical Research Council ((MRC)) [G0700232]; Royal Society [RG090810]; Wellcome Trust [090532/Z/09/Z]; Medical Research Council [G0700232, MR/L009609/1] Funding Source: researchfish; MRC [G0700232, MR/L009609/1] Funding Source: UKRI	Wellcome Trust (OXION: Ion channels and Disease Initiative); UK Medical Research Council ((MRC))(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Malinauskas, Y. Kong and staff at Diamond Light Source beamlines I03 and I24 for synchrotron assistance; K. Harlos and T. Walter for technical support with crystallization; G. Schertler and J. Standfuss for advice concerning the Rho-1D4 affinity purification method; T. Nakagawa for electron microscopy sample examination; F. Ashcroft, S. Tucker, M. Clausen and P. Proks for access to electrophysiology equipment and assistance with electrophysiological recordings; J. McIlhinney, M. Sansom, L. Carpenter, S. Newstead, I. de Moraes and members of the Aricescu laboratory for discussions; E. Y. Jones, D. I. Stuart and C. Siebold for reading the manuscript. This work was supported by grants from the Wellcome Trust (OXION: Ion channels and Disease Initiative, 084655), the UK Medical Research Council ((MRC) G0700232) and the Royal Society (RG090810). Further support from the Wellcome Trust Core Award Grant Number 090532/Z/09/Z is acknowledged. P. S. M. was a Wellcome Trust OXION Training Fellow. A. R. A. is an MRC Senior Research Fellow.	Akabas MH, 2013, P NATL ACAD SCI USA, V110, P16700, DOI 10.1073/pnas.1316157110; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Aricescu AR, 2013, CURR OPIN STRUC BIOL, V23, P345, DOI 10.1016/j.sbi.2013.04.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Blanc E., 2011, BUSTER VERSION 2 11; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 2002, HUM GENET, V111, P154, DOI 10.1007/s00439-002-0766-7; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farre C, 2009, COMB CHEM HIGH T SCR, V12, P24, DOI 10.2174/138620709787047966; GRENNINGLOH G, 1987, NATURE, V330, P25, DOI 10.1038/330025b0; Gurba KN, 2012, J BIOL CHEM, V287, P12083, DOI 10.1074/jbc.M111.332528; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Horenstein J, 1998, MOL PHARMACOL, V53, P870; Huang S, 2013, BIOCHEM J, V454, P303, DOI 10.1042/BJ20130636; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jensen ML, 2002, J BIOL CHEM, V277, P41438, DOI 10.1074/jbc.M205645200; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lo WY, 2010, J BIOL CHEM, V285, P31348, DOI 10.1074/jbc.M110.151449; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Parker JL, 2012, PROTEIN SCI, V21, P1358, DOI 10.1002/pro.2122; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Sancar F, 2004, J BIOL CHEM, V279, P47034, DOI 10.1074/jbc.M403388200; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Tasneem A, 2005, GENOME BIOL, V6; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wagner DA, 2004, J NEUROSCI, V24, P2733, DOI 10.1523/JNEUROSCI.4316-03.2004; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	80	499	513	10	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					270	+		10.1038/nature13293	http://dx.doi.org/10.1038/nature13293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	24909990	Green Accepted			2022-12-24	WOS:000340508200026
J	Gitlin, AD; Shulman, Z; Nussenzweig, MC				Gitlin, Alexander D.; Shulman, Ziv; Nussenzweig, Michel C.			Clonal selection in the germinal centre by regulated proliferation and hypermutation	NATURE			English	Article							DENDRITIC CELLS; AFFINITY MATURATION; IN-VIVO; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; DYNAMICS; RECEPTOR; CENTROBLASTS; ORGANIZATION; GENERATION	During immune responses, B lymphocytes clonally expand and undergo secondary diversification of their immunoglobulin genes in germinal centres (GCs)(1-4). High-affinity B cells are expanded through iterative interzonal cycles of division and hypermutation in the GC dark zone followed by migration to the GC light zone, where they are selected on the basis of affinity to return to the dark zone(5-10). Here we combine a transgenic strategy to measure cell division and a photoactivatable fluorescent reporter to examine whether the extent of clonal expansion and hypermutation are regulated during interzonal GC cycles. We find that both cell division and hypermutation are directly proportional to the amount of antigen captured and presented by GC B cells to follicular helper T cells in the light zone. Our data explain how GC B cells with the highest affinity for antigen are selectively expanded and diversified.	[Gitlin, Alexander D.; Shulman, Ziv; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019	Gitlin, Alexander/0000-0002-9229-0919	Empire State Stem Cell Fund through New York State Department of Health [C023046]; National Institutes of Health (NIH) [T32GM07739]; NIH [AI037526-19, AI072529-06]; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R01AI037526, UM1AI100663, R01AI072529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Empire State Stem Cell Fund through New York State Department of Health; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. W. Lowe and D. R. Fooksman for mice; D. Bosque and T. Eisenreich for help with mouse colony management; A. Abadir for protein production; K. Yao for technical help; K. Velinzon for help with cell sorting; D. Mucida and all members of the Nussenzweig laboratory for discussion. Support for the Rockefeller University multiphoton microscope was granted by the Empire State Stem Cell Fund through New York State Department of Health contract C023046. Supported by National Institutes of Health (NIH) Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program (A.D.G.); NIH grants AI037526-19 and AI072529-06 (M.C.N.); and the NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI100663-01 (M.C.N). Z.S. is a Human Frontiers of Science Fellow. M.C.N. is an HHMI investigator.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Oprea M, 1997, J IMMUNOL, V158, P5155; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wiesner SM, 2005, BLOOD, V106, P1054, DOI 10.1182/blood-2004-08-3306	30	358	361	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					637	+		10.1038/nature13300	http://dx.doi.org/10.1038/nature13300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24805232	Bronze, Green Accepted			2022-12-24	WOS:000336457100052
J	Mitchell, KJ; Llamas, B; Soubrier, J; Rawlence, NJ; Worthy, TH; Wood, J; Lee, MSY; Cooper, A				Mitchell, Kieren J.; Llamas, Bastien; Soubrier, Julien; Rawlence, Nicolas J.; Worthy, Trevor H.; Wood, Jamie; Lee, Michael S. Y.; Cooper, Alan			Ancient DNA reveals elephant birds and kiwi are sister taxa and clarifies ratite bird evolution	SCIENCE			English	Article							MOA; VICARIANCE; LOSSES; FLIGHT	The evolution of the ratite birds has been widely attributed to vicariant speciation, driven by the Cretaceous breakup of the supercontinent Gondwana. The early isolation of Africa and Madagascar implies that the ostrich and extinct Madagascan elephant birds (Aepyornithidae) should be the oldest ratite lineages. We sequenced the mitochondrial genomes of two elephant birds and performed phylogenetic analyses, which revealed that these birds are the closest relatives of the New Zealand kiwi and are distant from the basal ratite lineage of ostriches. This unexpected result strongly contradicts continental vicariance and instead supports flighted dispersal in all major ratite lineages. We suggest that convergence toward gigantism and flightlessness was facilitated by early Tertiary expansion into the diurnal herbivory niche after the extinction of the dinosaurs.	[Mitchell, Kieren J.; Llamas, Bastien; Soubrier, Julien; Rawlence, Nicolas J.; Lee, Michael S. Y.; Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Worthy, Trevor H.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Wood, Jamie] Landcare Res, Lincoln 7640, New Zealand; [Lee, Michael S. Y.] S Australian Museum, Adelaide, SA 5000, Australia	University of Adelaide; Flinders University South Australia; Landcare Research - New Zealand	Cooper, A (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, North Terrace Campus, Adelaide, SA 5005, Australia.	alan.cooper@adelaide.edu.au	Worthy, Trevor/B-3781-2012; Llamas, Bastien/AAK-1693-2021; Llamas, Bastien/Y-2781-2018; Soubrier, Julien/AAX-9560-2021; Wood, Jamie/AAU-5530-2021; Mitchell, Kieren/AAF-5837-2019; Wood, Jamie/A-9393-2008	Worthy, Trevor/0000-0001-7047-4680; Llamas, Bastien/0000-0002-5550-9176; Llamas, Bastien/0000-0002-5550-9176; Soubrier, Julien/0000-0001-9350-7369; Mitchell, Kieren/0000-0002-3921-0262; Wood, Jamie/0000-0001-8008-6083; Cooper, Alan/0000-0002-7738-7851	New Zealand Marsden Fund; Australian Research Council	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Australian Research Council(Australian Research Council)	This study was funded by the New Zealand Marsden Fund and the Australian Research Council. Grid computing facilities were provided by eRSA (e-research South Australia) and CIPRES (Cyberinfrastructure for Phylogenetic Research). We thank the Museum of New Zealand Te Papa Tongarewa (P. Millener, S. Bartle, A. Tennyson), Natural History Museum Oslo (N. Heintz), and National Museum of Natural History Paris (C. Lefevre) for samples. We acknowledge D. Penny, M. Phillips, D. Burney and R. Ward for valuable advice and assistance. All data associated with this study are available on GenBank (accession nos. KJ749824 and KJ749825) and DRYAD (doi:10.5061/dryad.2727k).	Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; Black KH, 2012, EARTH LIFE GLOBAL BI, P983, DOI DOI 10.1007/978-90-481-3428-1_35; BLEDSOE A H, 1988, Annals of Carnegie Museum, V57, P73; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; COOPER A, 1992, P NATL ACAD SCI USA, V89, P8741, DOI 10.1073/pnas.89.18.8741; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CRACRAFT J, 1974, IBIS, V116, P494, DOI 10.1111/j.1474-919X.1974.tb07648.x; CRACRAFT J, 1973, J ZOOL, V169, P455; Haddrath O, 2012, P ROY SOC B-BIOL SCI, V279, P4617, DOI 10.1098/rspb.2012.1630; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Hume J.P., 2012, EXTINCT BIRDS; Johnston P, 2011, ZOOL J LINN SOC-LOND, V163, P959, DOI 10.1111/j.1096-3642.2011.00730.x; Lee Krista, 1997, P173, DOI 10.1016/B978-012498315-1/50011-X; Mayr G., 2009, PALEOGENE FOSSIL BIR, P25; Parker TJ, 1895, T ZOOLOGICAL SOC LON, V13, P373, DOI [10.1111/j.1096-3642.1895.tb00044.x, DOI 10.1111/J.1096-3642.1895.TB00044.X]; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Schellart WP, 2006, EARTH-SCI REV, V76, P191, DOI 10.1016/j.earscirev.2006.01.002; Smith JV, 2013, SYST BIOL, V62, P35, DOI 10.1093/sysbio/sys067; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; WORTHY TH, 2002, LOST WORLD MOA; Worthy Trevor H., 2013, P63	21	177	181	7	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					898	900		10.1126/science.1251981	http://dx.doi.org/10.1126/science.1251981			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855267				2022-12-24	WOS:000336233800047
J	Alushin, GM; Lander, GC; Kellogg, EH; Zhang, R; Baker, D; Nogales, E				Alushin, Gregory M.; Lander, Gabriel C.; Kellogg, Elizabeth H.; Zhang, Rui; Baker, David; Nogales, Eva			High-Resolution Microtubule Structures Reveal the Structural Transitions in alpha beta-Tubulin upon GTP Hydrolysis	CELL			English	Article							SLOWLY HYDROLYZABLE ANALOG; NDC80 KINETOCHORE COMPLEX; STATHMIN-LIKE DOMAIN; ELECTRON CRYSTALLOGRAPHY; CRYOELECTRON MICROSCOPY; DYNAMIC INSTABILITY; GAMMA-TUBULIN; DENSITY MAPS; UCSF CHIMERA; BINDING	Dynamic instability, the stochastic switching between growth and shrinkage, is essential for microtubule function. This behavior is driven by GTP hydrolysis in the microtubule lattice and is inhibited by anticancer agents like Taxol. We provide insight into the mechanism of dynamic instability, based on high-resolution cryo-EM structures (4.7-5.6 angstrom) of dynamic microtubules and microtubules stabilized by GMPCPP or Taxol. We infer that hydrolysis leads to a compaction around the E-site nucleotide at longitudinal interfaces, as well as movement of the alpha-tubulin intermediate domain and H7 helix. Displacement of the C-terminal helices in both alpha- and beta-tubulin subunits suggests an effect on interactions with binding partners that contact this region. Taxol inhibits most of these conformational changes, allosterically inducing a GMPCPP-like state. Lateral interactions are similar in all conditions we examined, suggesting that microtubule lattice stability is primarily modulated at longitudinal interfaces.	[Alushin, Gregory M.] Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA; [Lander, Gabriel C.; Zhang, Rui; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Kellogg, Elizabeth H.; Baker, David] Univ Washington, Dept Biochem, Howard Hughes Med Inst, Seattle, WA 98105 USA; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	enogales@lbl.gov	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Lander, Gabriel C./0000-0003-4921-1135; Alushin, Gregory/0000-0001-7250-4484	National Institute of General Medical Sciences [GM051487]; Damon Runyon Cancer Research Foundation [DRG 2055-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Patricia Grob and Tom Houweling for electron microscopy and computer support, respectively, Tom Goddard for help with UCSF Chimera, Yifan Song and Frank DiMaio for making code available for use prior to publication, and Stuart Howes for assistance with kinesin purification. We are grateful to Robert Glaeser for assistance with data collection and many discussions. The kinesin expression construct was the gift of Erik Jonsson and Ron Vale. This work was funded by the National Institute of General Medical Sciences (GM051487) (to E.N.) and a Damon Runyon Cancer Research Foundation fellowship (DRG 2055-10) (to G. C. L.). E.N. and D. B. are Howard Hughes Medical Institute Investigators.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Alushin GM, 2012, NAT STRUCT MOL BIOL, V19, P1161, DOI 10.1038/nsmb.2411; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; ARNAL I, 1995, CURR BIOL, V5, P900, DOI 10.1016/S0960-9822(95)00180-1; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Aylett CHS, 2011, INT REV CEL MOL BIO, V292, P1, DOI 10.1016/B978-0-12-386033-0.00001-3; Barbier P, 2010, J BIOL CHEM, V285, P31672, DOI 10.1074/jbc.M110.141929; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Grafmuller A, 2013, J MOL BIOL, V425, P2232, DOI 10.1016/j.jmb.2013.03.029; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hyams J. S, 1993, MICROTUBULES; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; McIntosh JR, 2010, J CELL SCI, V123, P3425, DOI 10.1242/jcs.067611; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1993, SCIENCE, V261, P1044, DOI 10.1126/science.8102497; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; NOGALES E, 1995, J STRUCT BIOL, V115, P199, DOI 10.1006/jsbi.1995.1044; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; SIMON JR, 1990, J CELL SCI, V96, P571; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; VALE RD, 1994, J BIOL CHEM, V269, P23769; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Yajima H, 2012, J CELL BIOL, V198, P315, DOI 10.1083/jcb.201201161	56	391	396	2	142	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1117	1129		10.1016/j.cell.2014.03.053	http://dx.doi.org/10.1016/j.cell.2014.03.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855948	Green Accepted, Bronze			2022-12-24	WOS:000336437200014
J	Arnegard, ME; McGee, MD; Matthews, B; Marchinko, KB; Conte, GL; Kabir, S; Bedford, N; Bergek, S; Chan, YF; Jones, FC; Kingsley, DM; Peichel, CL; Schluter, D				Arnegard, Matthew E.; McGee, Matthew D.; Matthews, Blake; Marchinko, Kerry B.; Conte, Gina L.; Kabir, Sahriar; Bedford, Nicole; Bergek, Sara; Chan, Yingguang Frank; Jones, Felicity C.; Kingsley, David M.; Peichel, Catherine L.; Schluter, Dolph			Genetics of ecological divergence during speciation	NATURE			English	Article							DEPENDENT POSTMATING ISOLATION; ADAPTIVE RADIATION; NATURAL-SELECTION; 3-SPINED STICKLEBACKS; TROPHIC POSITION; SPECIES-PAIR; HABITAT USE; EVOLUTION; ADAPTATION; SIZE	Ecological differences often evolve early in speciation as divergent natural selection drives adaptation to distinct ecological niches, leading ultimately to reproductive isolation. Although this process is a major generator of biodiversity, its genetic basis is still poorly understood. Here we investigate the genetic architecture of niche differentiation in a sympatric species pair of threespine stickleback fish by mapping the environment-dependent effects of phenotypic traits on hybrid feeding and performance under semi-natural conditions. We show that multiple, unlinked loci act largely additively to determine position along the major niche axis separating these recently diverged species. We also find that functional mismatch between phenotypic traits reduces the growth of some stickleback hybrids beyond that expected from an intermediate phenotype, suggesting a role for epistasis between the underlying genes. This functional mismatch might lead to hybrid incompatibilities that are analogous to those underlying intrinsic reproductive isolation but depend on the ecological context.	[Arnegard, Matthew E.; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; [Arnegard, Matthew E.; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Arnegard, Matthew E.; Marchinko, Kerry B.; Conte, Gina L.; Kabir, Sahriar; Bedford, Nicole; Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Arnegard, Matthew E.; Marchinko, Kerry B.; Conte, Gina L.; Kabir, Sahriar; Bedford, Nicole; Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [McGee, Matthew D.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Matthews, Blake] EAWAG, Ctr Ecol Evolut & Biogeochem, Dept Aquat Ecol, CH-6047 Kastanienbaum, Switzerland; [Bergek, Sara] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; [Chan, Yingguang Frank; Jones, Felicity C.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Chan, Yingguang Frank; Jones, Felicity C.; Kingsley, David M.] Howard Hughes Med Inst, Stanford, CA 94305 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of British Columbia; University of British Columbia; University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Uppsala University; Stanford University; Howard Hughes Medical Institute	Arnegard, ME (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1100 Fairview Ave North, Seattle, WA 98109 USA.	marnegar@fhcrc.org	Matthews, Blake/B-5608-2009; Jones, Felicity C/AAY-3523-2021; Chan, Yingguang Frank/ABG-9852-2020	Matthews, Blake/0000-0001-9089-704X; Jones, Felicity C/0000-0002-5027-1031; Chan, Yingguang Frank/0000-0001-6292-9681; Peichel, Catherine/0000-0002-7731-8944; Bedford, Nicole/0000-0001-5700-1774; Schluter, Dolph/0000-0003-1683-7836	US National Institutes of Health [F32GM086125, R01 GM089733, P50 HG002568]; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086125, R01GM089733] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Perez for counting gill rakers; C. Sather for performing lab work for SNP genotyping; and K. Broman, G. Coop, I. Goodliffe, A. Greenwood, P. Wainwright, M. White and M. Wund for constructive comments. Stable isotopes were analysed at the University of California, Davis, Stable Isotope Facility. Funding was provided by grants from the US National Institutes of Health (F32GM086125 to M. E. A., R01 GM089733 to C. L. P. and D. S., and P50 HG002568 to C. L. P. and D. M. K.), the Natural Sciences and Engineering Research Council of Canada (to D. S.) and the Canada Foundation for Innovation (to D.S.).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; Arnegard ME, 2010, AM NAT, V176, P335, DOI 10.1086/655221; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Behm JE, 2010, AM NAT, V175, P11, DOI 10.1086/648559; Bolnick D. I., 2011, INT J ECOL, V2011, DOI [10.1155/2011/942847, DOI 10.1155/2011/942847)]; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Candolin U, 2001, OIKOS, V95, P225, DOI 10.1034/j.1600-0706.2001.950204.x; Carlson SM, 2010, ECOLOGY, V91, P1016, DOI 10.1890/09-0252.1; Chase J.M., 2009, ECOLOGICAL NICHES LI; Coyne JA, 2004, SPECIATION, V37; Darwin C., 1859, ORIGIN SPECIES MEANS; Dryden I. L., 2009, PACKAGE SHAPES STAT; Egan SP, 2009, P NATL ACAD SCI USA, V106, P19426, DOI 10.1073/pnas.0909424106; ENGLE RF, 1986, APPL MATH COMPUT, V20, P313, DOI 10.1016/0096-3003(86)90009-3; Erickson DL, 2004, MOL ECOL, V13, P2505, DOI 10.1111/j.1365-294X.2004.02254.x; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Fisher R.A., 1930, GENETICAL THEORY NAT; Fry B., 2006, STABLE ISOTOPE ECOLO; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; Gow JL, 2007, J EVOLUTION BIOL, V20, P2173, DOI 10.1111/j.1420-9101.2007.01427.x; Gow JL, 2006, MOL ECOL, V15, P739, DOI 10.1111/j.1365-294X.2006.02825.x; Hadfield J., 2012, PACKAGE MASTERBAYES; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hothorn T, 2012, PACKAGE IMTEST TESTI; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Jones FC, 2012, CURR BIOL, V22, P83, DOI 10.1016/j.cub.2011.11.045; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lumley T, 2009, PACKAGE LEAPS REGRES; MacColl ADC, 2009, BIOL J LINN SOC, V96, P425, DOI 10.1111/j.1095-8312.2008.01123.x; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maechler M., 2011, PACKAGE DIPTEST HART; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Marchinko KB, 2009, EVOLUTION, V63, P127, DOI 10.1111/j.1558-5646.2008.00529.x; Matthews B, 2010, ECOLOGY, V91, P1025, DOI 10.1890/09-0235.1; McBride CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000529; McGee MD, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-277; McGee MD, 2013, EVOLUTION, V67, P1204, DOI 10.1111/j.1558-5646.2012.01839.x; McIntyre PB, 2006, OECOLOGIA, V148, P12, DOI 10.1007/s00442-005-0354-3; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; Miller A., 2002, MG STAT PRO, V95; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rogers SM, 2012, EVOLUTION, V66, P2439, DOI 10.1111/j.1558-5646.2012.01622.x; Rohlf F.J., 2006, TPSDIG2; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 2002, EVOLUTION, V56, P322, DOI 10.1111/j.0014-3820.2002.tb01342.x; Sambrook J, 2001, MOL CLONING LAB MANU; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Yeaman S, 2011, EVOLUTION, V65, P1897, DOI 10.1111/j.1558-5646.2011.01269.x	82	186	187	14	451	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					307	+		10.1038/nature13301	http://dx.doi.org/10.1038/nature13301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24909991	Green Accepted			2022-12-24	WOS:000338992200027
J	Nabavi, S; Fox, R; Proulx, CD; Lin, JY; Tsien, RY; Malinow, R				Nabavi, Sadegh; Fox, Rocky; Proulx, Christophe D.; Lin, John Y.; Tsien, Roger Y.; Malinow, Roberto			Engineering a memory with LTD and LTP	NATURE			English	Article							LONG-TERM POTENTIATION; FEAR; AMYGDALA; EXPRESSION; NEURONS; ACQUISITION; RECEPTORS; INDUCTION; NETWORKS; CIRCUITS	It has been proposed that memories are encoded by modification of synaptic strengths through cellular mechanisms such as long-term potentiation (LTP) and long-term depression (LTD)(1). However, the causal link between these synaptic processes and memory has been difficult to demonstrate(2). Here we show that fear conditioning(3-8), a type of associative memory, can be inactivated and reactivated by LTD and LTP, respectively. We began by conditioning an animal to associate a foot shock with optogenetic stimulation of auditory inputs targeting the amygdala, a brain region known to be essential for fear conditioning(3-8). Subsequent optogenetic delivery of LTD conditioning to the auditory input inactivates memory of the shock. Then subsequent optogenetic delivery of LTP conditioning to the auditory input reactivates memory of the shock. Thus, we have engineered inactivation and reactivation of a memory using LTD and LTP, supporting a causal link between these synaptic processes and memory.	[Nabavi, Sadegh; Fox, Rocky; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Nabavi, Sadegh; Fox, Rocky; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Lin, John Y.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Malinow, R (corresponding author), Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA.	rmalinow@ucsd.edu		Proulx, Christophe/0000-0001-6484-9677; Nabavi, Sadegh/0000-0002-3940-1210; Lin, John/0000-0002-1723-4597	NIH [MH049159, NS27177]; Cure Alzheimer's Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH049159, R01MH091119, R37MH049159, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, R01NS027177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Isaacson, L. Squire and members of the Malinow laboratory for suggestions. This study was supported by NIH MH049159 and Cure Alzheimer's Foundation grants to R. M. and NIH grant NS27177 to R. T.; R. T. is an Investigator of the HHMI.	Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hoffman DA, 1998, J NEUROSCI, V18, P3521; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kirby ED, 2012, JOVE-J VIS EXP, DOI 10.3791/4079; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Li XF, 1996, LEARN MEMORY, V3, P229, DOI 10.1101/lm.3.2-3.229; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Squire L.R., 2009, MEMORY MIND MOL; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006	36	567	577	7	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					348	+		10.1038/nature13294	http://dx.doi.org/10.1038/nature13294			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24896183	Green Accepted, Green Submitted			2022-12-24	WOS:000338992200036
J	Kryazhimskiy, S; Rice, DP; Jerison, ER; Desai, MM				Kryazhimskiy, Sergey; Rice, Daniel P.; Jerison, Elizabeth R.; Desai, Michael M.			Global epistasis makes adaptation predictable despite sequence-level stochasticity	SCIENCE			English	Article							BENEFICIAL MUTATIONS; ESCHERICHIA-COLI; CLONAL INTERFERENCE; EVOLUTION; POPULATIONS; EVOLVABILITY; RATES	Epistatic interactions between mutations can make evolutionary trajectories contingent on the chance occurrence of initial mutations. We used experimental evolution in Saccharomyces cerevisiae to quantify this contingency, finding differences in adaptability among 64 closely related genotypes. Despite these differences, sequencing of 104 evolved clones showed that initial genotype did not constrain future mutational trajectories. Instead, reconstructed combinations of mutations revealed a pattern of diminishing-returns epistasis: Beneficial mutations have consistently smaller effects in fitter backgrounds. Taken together, these results show that beneficial mutations affecting a variety of biological processes are globally coupled; they interact strongly, but only through their combined effect on fitness. As a consequence, fitness evolution follows a predictable trajectory even though sequence-level adaptation is stochastic.	[Kryazhimskiy, Sergey; Rice, Daniel P.; Desai, Michael M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Jerison, Elizabeth R.; Desai, Michael M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Kryazhimskiy, Sergey; Rice, Daniel P.; Jerison, Elizabeth R.; Desai, Michael M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Kryazhimskiy, S (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	skryazhi@oeb.harvard.edu; mdesai@oeb.harvard.edu	Kryazhimskiy, Sergey/AAV-1258-2020	Kryazhimskiy, Sergey/0000-0001-9128-8705; Jerison, Elizabeth/0000-0003-3793-8839; Desai, Michael/0000-0002-9581-1150	Burroughs Wellcome Foundation; NSF graduate research fellowships; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Harvard Milton Fund; NSF [PHY 1313638]; NIH [GM104239]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104239] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1313638] Funding Source: National Science Foundation	Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NSF graduate research fellowships(National Science Foundation (NSF)); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Harvard Milton Fund; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Murray, Q. Justman, B. Good, D. van Dyken, M. McDonald for useful discussions; A. Subramaniam, G. Lang, M. Muller, and J. Koschwanez for experimental advice and strains; and P. Rogers and C. Daly for technical support. Supported by the Burroughs Wellcome Foundation (S.K.), NSF graduate research fellowships (D.P.R., E.R.J.), and the James S. McDonnell Foundation, the Alfred P. Sloan Foundation, the Harvard Milton Fund, NSF grant PHY 1313638, and NIH grant GM104239 (M.M.D.). Sequence data have been deposited to GenBank under BioProject identifier PRJNA242140.	Barrick JE, 2010, MOL BIOL EVOL, V27, P1338, DOI 10.1093/molbev/msq024; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bollback JP, 2007, MOL BIOL EVOL, V24, P1397, DOI 10.1093/molbev/msm056; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Gould S. J., 1989, WONDERFUL LIFE; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Perfeito L, 2014, EVOLUTION, V68, P150, DOI 10.1111/evo.12234; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	20	222	224	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1519	1522		10.1126/science.1250939	http://dx.doi.org/10.1126/science.1250939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970088	Green Submitted, Green Accepted			2022-12-24	WOS:000337889900051
J	Masamha, CP; Xia, Z; Yang, JX; Albrecht, TR; Li, M; Shyu, AB; Li, W; Wagner, EJ				Masamha, Chioniso P.; Xia, Zheng; Yang, Jingxuan; Albrecht, Todd R.; Li, Min; Shyu, Ann-Bin; Li, Wei; Wagner, Eric J.			CFIm25 links alternative polyadenylation to glioblastoma tumour suppression	NATURE			English	Article							3' UNTRANSLATED REGIONS; MESSENGER-RNAS; GLUTAMINE-METABOLISM; PROSTATE-CANCER; ANTISENSE RNA; C-MYC; GROWTH; WIDESPREAD; EXPRESSION; MICRORNAS	The global shortening of messenger RNAs through alternative polyadenylation (APA) that occurs during enhanced cellular proliferation represents an important, yet poorly understood mechanism of regulated gene expression(1,2). The 3' untranslated region (UTR) truncation of growth-promoting mRNA transcripts that relieves intrinsic microRNA-and AU-rich-element-mediated repression has been observed to correlate with cellular transformation(3); however, the importance to tumorigenicity of RNA 3'-end-processing factors that potentially govern APA is unknown. Here we identify CFIm25 as a broad repressor of proximal poly(A) site usage that, when depleted, increases cell proliferation. Applying a regression model on standard RNA-sequencing data for novel APA events, we identified at least 1,450 genes with shortened 3'UTRs after CFIm25knockdown, representing 11% of significantly expressed mRNAs in human cells. Marked increases in the expression of several known oncogenes, including cyclin D1, are observed as a consequence of CFIm25 depletion. Importantly, we identified a subset of CFIm25-regulated APA genes with shortened 39 UTRs in glioblastoma tumours that have reduced CFIm25 expression. Downregulation of CFIm25 expression in glioblastoma cells enhances their tumorigenic properties and increases tumour size, where as CFIm25 overexpression reduces these properties and inhibits tumour growth. These findings identify a pivotal role of CFIm25 in governing APA and reveal a previously unknown connection between CFIm25 and glioblastoma tumorigenicity.	[Masamha, Chioniso P.; Albrecht, Todd R.; Shyu, Ann-Bin; Wagner, Eric J.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Xia, Zheng; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Xia, Zheng; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yang, Jingxuan; Li, Min] Univ Texas Houston, Sch Med, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Wagner, EJ (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	Ann-Bin.Shyu@uth.tmc.edu; WL1@bcm.edu; Eric.J.Wagner@uth.tmc.edu	Xia, Zheng/AAC-5360-2022; Xia, Zheng/F-6561-2014; Yang, Jingxuan/K-5047-2015	Xia, Zheng/0000-0003-3364-8324; Xia, Zheng/0000-0003-3364-8324; Yang, Jingxuan/0000-0003-3265-161X; Li, Wei/0000-0001-9931-5990	CPRIT [RP100107, RP110471-C3]; Department of Defense [W81XWH-11-1-0304, W81XWH-10-1-0501]; National Institutes of Health (NIH) [GM046454, CA167752, CA166274]; Houston Endowment; NIH [R01HG007538]; Dr Marnie Rose Foundation; William and Ella Owens Medical Research Foundation; Department of Defense Postdoctoral Visionary Award [W81XWH-12-1-0218]; NATIONAL CANCER INSTITUTE [R01CA166274, R03CA167752] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046454] Funding Source: NIH RePORTER	CPRIT; Department of Defense(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Houston Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr Marnie Rose Foundation; William and Ella Owens Medical Research Foundation; Department of Defense Postdoctoral Visionary Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank members of the E.J.W., A.-B.S. and W. L. laboratories for helpful discussions, P. Carpenter for reviewing the manuscript, and Q. Zhu and T. Shan of LC Sciences for their efforts on the RNA-seq. This work was supported by a CPRIT grant to E.J.W. and A.-B.S. (RP100107), and in part by a Department of Defense grant to E.J.W. (W81XWH-11-1-0304), National Institutes of Health (NIH) grants to A.-B.S. (GM046454) and E.J.W. (CA167752 and CA166274), and an endowment from Houston Endowment (to A.-B.S.). Work in the W. L. laboratory is funded by grants from the Department of Defense (W81XWH-10-1-0501), CPRIT (RP110471-C3) and NIH (R01HG007538). Work in the M. L. laboratory is funded by grants from the Dr Marnie Rose Foundation and the William and Ella Owens Medical Research Foundation. C. P. M. acknowledges a Department of Defense Postdoctoral Visionary Award (W81XWH-12-1-0218).	Bernard D, 2006, ONCOGENE, V25, P1358, DOI 10.1038/sj.onc.1209179; Braulke T, 1999, HORM METAB RES, V31, P235, DOI 10.1055/s-2007-978724; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Deshpande A, 2009, CELL CYCLE, V8, P3592, DOI 10.4161/cc.8.21.9993; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Elkon R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r59; Ellis MJ, 1998, BREAST CANCER RES TR, V52, P175, DOI 10.1023/A:1006127621512; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gomez-Angelats M, 1999, MOL CARCINOGEN, V25, P157, DOI 10.1002/(SICI)1098-2744(199907)25:3<157::AID-MC1>3.0.CO;2-8; Hu JF, 1999, BIOCHEM BIOPH RES CO, V257, P604, DOI 10.1006/bbrc.1999.0380; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kaplan PJ, 1999, CANCER RES, V59, P2203; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Kubo T, 2006, NUCLEIC ACIDS RES, V34, P6264, DOI 10.1093/nar/gkl794; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Miura P, 2013, GENOME RES, V23, P812, DOI 10.1101/gr.146886.112; Nakayama T, 2008, ONCOGENE, V27, P3221, DOI 10.1038/sj.onc.1210984; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; Thomas PE, 2012, PLANT CELL, V24, P4376, DOI 10.1105/tpc.112.096107; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Ward A, 1998, J PATHOL, V185, P342, DOI 10.1002/(SICI)1096-9896(199808)185:4<342::AID-PATH136>3.0.CO;2-9; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109	39	244	251	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					412	+		10.1038/nature13261	http://dx.doi.org/10.1038/nature13261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24814343	Green Accepted			2022-12-24	WOS:000337350200038
J	Genovese, P; Schiroli, G; Escobar, G; Di Tomaso, T; Firrito, C; Calabria, A; Moi, D; Mazzieri, R; Bonini, C; Holmes, MC; Gregory, PD; van der Burg, M; Gentner, B; Montini, E; Lombardo, A; Naldini, L				Genovese, Pietro; Schiroli, Giulia; Escobar, Giulia; Di Tomaso, Tiziano; Firrito, Claudia; Calabria, Andrea; Moi, Davide; Mazzieri, Roberta; Bonini, Chiara; Holmes, Michael C.; Gregory, Philip D.; van der Burg, Mirjam; Gentner, Bernhard; Montini, Eugenio; Lombardo, Angelo; Naldini, Luigi			Targeted genome editing in human repopulating haematopoietic stem cells	NATURE			English	Article							ZINC-FINGER NUCLEASES; GENE-THERAPY; LENTIVIRAL VECTOR; T-CELLS; INTEGRATION; SAFE; CCR5	Targeted genome editing by artificial nucleases has brought the goal of site-specific transgene integration and gene correction within the reach of gene therapy. However, its application to long-term repopulating haematopoietic stem cells (HSCs) has remained elusive. Here we show that poor permissiveness to gene transfer and limited proficiency of the homology-directed DNA repair pathway constrain gene targeting in human HSCs. By tailoring delivery platforms and culture conditions we overcame these barriers and provide stringent evidence of targeted integration in human HSCs by long-term multilineage repopulation of transplanted mice. We demonstrate the therapeutic potential of our strategy by targeting a corrective complementary DNA into the IL2RG gene of HSCs from healthy donors and a subject with X-linked severe combined immunodeficiency (SCID-X1). Gene-edited HSCs sustained normal haematopoiesis and gave rise to functional lymphoid cells that possess a selective growth advantage over those carrying disruptive IL2RG mutations. These results open up new avenues for treating SCID-X1 and other diseases.	[Genovese, Pietro; Schiroli, Giulia; Escobar, Giulia; Di Tomaso, Tiziano; Firrito, Claudia; Calabria, Andrea; Moi, Davide; Mazzieri, Roberta; Gentner, Bernhard; Montini, Eugenio; Lombardo, Angelo; Naldini, Luigi] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, TIGET, I-20132 Milan, Italy; [Schiroli, Giulia; Escobar, Giulia; Gentner, Bernhard; Lombardo, Angelo; Naldini, Luigi] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Bonini, Chiara] Ist Sci San Raffaele, Expt Hematol Unit, I-20132 Milan, Italy; [Holmes, Michael C.; Gregory, Philip D.] Sangamo BioSci Inc, Richmond, CA 94804 USA; [van der Burg, Mirjam] Univ Med Ctr, Erasmus MC, Dept Immunol, NL-3015 Rotterdam, Netherlands	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sangamo Therapeutics, Inc.; Erasmus University Rotterdam; Erasmus MC	Naldini, L (corresponding author), Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, TIGET, I-20132 Milan, Italy.	naldini.luigi@hsr.it	Mazzieri, Roberta/C-9773-2015; Genovese, Pietro/H-3710-2018; Escobar, Giulia/AFD-7497-2022; lombardo, angelo/J-6241-2016; Calabria, Andrea/AAA-3349-2019; bonini, chiara/I-9202-2012; Montini, Eugenio/L-1152-2016	Mazzieri, Roberta/0000-0002-5172-0927; Genovese, Pietro/0000-0001-9507-9003; lombardo, angelo/0000-0001-8262-042X; Calabria, Andrea/0000-0003-3515-3384; Montini, Eugenio/0000-0003-1771-6067; NALDINI, Luigi/0000-0002-7835-527X; Escobar, Giulia/0000-0001-9177-0251; BONINI, Maria Chiara/0000-0002-0772-1674; Gregory, Philip/0000-0001-9249-2468; Gentner, Bernhard/0000-0001-6024-4718; Moi, Davide/0000-0002-1198-5146; Schiroli, Giulia/0000-0002-9812-8728	Telethon (TIGET grant) [D2]; EU [249845]; Italian Ministry of Health	Telethon (TIGET grant)(Fondazione Telethon); EU(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	We thank D. Weissman for advice on mRNA production and the whole Naldini laboratory for discussion, F. Benedicenti for help with MiSeq sequencing, L. Sergi Sergi, T. Plati, V. Valtolina, B. Camisa and A. Ranghetti for technical help. SR1 was provided by T. Boitano and M. Cooke under an MTA with the Genomics Institute of the Novartis Research Foundation. This work was supported by grants to L.N. from Telethon (TIGET grant D2) EU (FP7 222878 PERSIST, FP7 601958 SUPERSIST, ERC Advanced Grant 249845 TARGETINGGENETHERAPY) and the Italian Ministry of Health.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Akatsuka Y, 1999, TISSUE ANTIGENS, V53, P122, DOI 10.1034/j.1399-0039.1999.530202.x; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazza A, 2013, HUM GENE THER, V24, P119, DOI 10.1089/hum.2012.203; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Escobar G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006353; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Harris DT, 2013, CLIN EXP IMMUNOL, V174, P402, DOI 10.1111/cei.12192; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Matrai J, 2011, HEPATOLOGY, V53, P1696, DOI 10.1002/hep.24230; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Wu CJ, 2000, BLOOD, V95, P352; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161	42	396	423	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					235	+		10.1038/nature13420	http://dx.doi.org/10.1038/nature13420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24870228	Green Accepted			2022-12-24	WOS:000337032400043
J	Blackledge, NP; Farcas, AM; Kondo, T; King, HW; McGouran, JF; Hanssen, LLP; Ito, S; Cooper, S; Kondo, K; Koseki, Y; Ishikura, T; Long, HK; Sheahan, TW; Brockdorff, N; Kessler, BM; Koseki, H; Klose, RJ				Blackledge, Neil P.; Farcas, Anca M.; Kondo, Takashi; King, Hamish W.; McGouran, Joanna F.; Hanssen, Lars L. P.; Ito, Shinsuke; Cooper, Sarah; Kondo, Kaori; Koseki, Yoko; Ishikura, Tomoyuki; Long, Hannah K.; Sheahan, Thomas W. p; Brockdorff, Neil; Kessler, Benedikt M.; Koseki, Haruhiko; Klose, Robert J.			Variant PRC1 Complex-Dependent H2A Ubiquitylation Drives PRC2 Recruitment and Polycomb Domain Formation	CELL			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; EMBRYONIC STEM-CELLS; UBIQUITIN LIGASE COMPLEX; GROUP PROTEINS RING1A/B; REPRESSIVE COMPLEX; GENOME-WIDE; CPG ISLANDS; DROSOPHILA-MELANOGASTER; X-INACTIVATION; SAM DOMAIN	Chromatin modifying activities inherent to polycomb repressive complexes PRC1 and PRC2 play an essential role in gene regulation, cellular differentiation, and development. However, the mechanisms by which these complexes recognize their target sites and function together to form repressive chromatin domains remain poorly understood. Recruitment of PRC1 to target sites has been proposed to occur through a hierarchical process, dependent on prior nucleation of PRC2 and placement of H3K27me3. Here, using a de novo targeting assay in mouse embryonic stem cells we unexpectedly discover that PRC1-dependent H2AK119ub1 leads to recruitment of PRC2 and H3K27me3 to effectively initiate a polycomb domain. This activity is restricted to variant PRC1 complexes, and genetic ablation experiments reveal that targeting of the variant PCGF1/PRC1 complex by KDM2B to CpG islands is required for normal polycomb domain formation and mouse development. These observations provide a surprising PRC1-dependent logic for PRC2 occupancy at target sites in vivo.	[Blackledge, Neil P.; Farcas, Anca M.; King, Hamish W.; Hanssen, Lars L. P.; Long, Hannah K.; Sheahan, Thomas W. p; Klose, Robert J.] Univ Oxford, Dept Biochem, Lab Chromatin Biol & Transcript, Oxford OX1 3QU, England; [Kondo, Takashi; Ito, Shinsuke; Kondo, Kaori; Koseki, Yoko; Ishikura, Tomoyuki; Koseki, Haruhiko] RIKEN, Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa 2300045, Japan; [McGouran, Joanna F.; Kessler, Benedikt M.] Univ Oxford, Target Discovery Inst, Nuffield Dept Med, Cent Prote Facil,Ubiquitin Proteolysis Grp, Oxford OX3 7BN, England; [Cooper, Sarah; Brockdorff, Neil] Univ Oxford, Dept Biochem, Lab Dev Epigenet, Oxford OX1 3QU, England	University of Oxford; RIKEN; University of Oxford; University of Oxford	Klose, RJ (corresponding author), Univ Oxford, Dept Biochem, Lab Chromatin Biol & Transcript, S Parks Rd, Oxford OX1 3QU, England.	rob.klose@bioch.ox.ac.uk	Koseki, Haruhiko/I-3825-2014; McGouran, Joanna/A-1545-2019; Long, Hannah/X-9731-2019; Kessler, Benedikt/AAY-8614-2021; Long, Hannah/A-6301-2013; King, Hamish/U-9808-2019	Koseki, Haruhiko/0000-0001-8424-5854; McGouran, Joanna/0000-0002-9349-2141; Long, Hannah/0000-0002-5694-0398; Kessler, Benedikt/0000-0002-8160-2446; Long, Hannah/0000-0002-5694-0398; King, Hamish/0000-0001-5972-8926; Brockdorff, Neil/0000-0003-4838-2653; Sheahan, Thomas/0000-0002-9457-4691; Farcas, Anca Madalina/0000-0002-6467-494X; jin teng, long/0000-0002-1948-9331; Hanssen, Lars/0000-0002-2551-2278	Wellcome Trust [WT0834922, WT081385]; CRUK [C28585/A10839]; NIHR; EMBO; Lister Institute of Preventative Medicine; RIKEN; MEXT; JST CREST; MRC [G0501068] Funding Source: UKRI; Medical Research Council [G0501068] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); NIHR(National Institute for Health Research (NIHR)); EMBO(European Molecular Biology Organization (EMBO)); Lister Institute of Preventative Medicine; RIKEN; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Dr. Tom Milne for comments and suggestions, Marie-Laetitia Thezenas and Dr. Rebecca Konietzny for mass spectrometry expertise. This study was funded by the Wellcome Trust (WT0834922 and WT081385), CRUK (C28585/A10839), NIHR, EMBO, Lister Institute of Preventative Medicine, RIKEN, MEXT, and JST CREST. The WTCHG Genomics Facility carried out massively parallel sequencing.	Akasaka T, 1996, DEVELOPMENT, V122, P1513; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dietrich N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002494; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Hosogane M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003698; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Klose RJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003717; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Posfai E, 2012, GENE DEV, V26, P920, DOI 10.1101/gad.188094.112; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Suzuki M, 2002, DEVELOPMENT, V129, P4171; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang RJ, 2010, STRUCTURE, V18, P966, DOI 10.1016/j.str.2010.04.013; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	68	473	485	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1445	1459		10.1016/j.cell.2014.05.004	http://dx.doi.org/10.1016/j.cell.2014.05.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24856970	Green Published, hybrid			2022-12-24	WOS:000340881400019
J	Tsai, KL; Tomomori-Sato, C; Sato, S; Conaway, RC; Conaway, JW; Asturias, FJ				Tsai, Kuang-Lei; Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C.; Conaway, Joan W.; Asturias, Francisco J.			Subunit Architecture and Functional Modular Rearrangements of the Transcriptional Mediator Complex	CELL			English	Article							RNA-POLYMERASE-II; HEAD MODULE; YEAST MEDIATOR; MIDDLE MODULE; TAIL MODULE; IN-VIVO; ACTIVATOR; DOMAIN; BINDING; CRSP	The multisubunit Mediator, comprising similar to 30 distinct proteins, plays an essential role in gene expression regulation by acting as a bridge between DNA-binding transcription factors and the RNA polymerase II (RNAPII) transcription machinery. Efforts to uncover the Mediator mechanism have been hindered by a poor understanding of its structure, subunit organization, and conformational rearrangements. By overcoming biochemical and image analysis hurdles, we obtained accurate EM structures of yeast and human Mediators. Subunit localization experiments, docking of partial X-ray structures, and biochemical analyses resulted in comprehensive mapping of yeast Mediator subunits and a complete reinterpretation of our previous Mediator organization model. Large-scale Mediator rearrangements depend on changes at the interfaces between previously described Mediator modules, which appear to be facilitated by factors conducive to transcription initiation. Conservation across eukaryotes of Mediator structure, subunit organization, and RNA polymerase II interaction suggest conservation of fundamental aspects of the Mediator mechanism.	[Tsai, Kuang-Lei; Asturias, Francisco J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Scripps Research Institute; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Asturias, FJ (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	asturias@scripps.edu		Tomomori-Sato, Chieri/0000-0002-2543-293X; Conaway, Joan/0000-0002-2786-0663	US National Institutes of Health [R01 GM67167, R01 GM41628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067167, R01GM041628] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants R01 GM67167 (F.J.A.) and R01 GM41628 (R. C. C. and J.W.C.) and by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation. We thank Y. Takagi for providing the plasmid for MBP tagging in yeast, G. C. Lander for critical reading of manuscript, and Patrick Cramer for providing a Med19 Delta yeast strain. We thank T. Otomo for providing the plasmid for HA-tagging in yeast. EM data collection was carried out at the National Resource for Automated Macromolecular Microscopy (NRAMM).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Ansari SA, 2012, EMBO J, V31, P44, DOI 10.1038/emboj.2011.362; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Cai G, 2012, STRUCTURE, V20, P899, DOI 10.1016/j.str.2012.02.023; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Hallberg M, 2006, MOL GENET GENOMICS, V276, P197, DOI 10.1007/s00438-006-0135-7; Hoeppner S, 2005, J MOL BIOL, V350, P833, DOI 10.1016/j.jmb.2005.05.041; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Ito M, 2002, EMBO J, V21, P3464, DOI 10.1093/emboj/cdf348; Kim S, 2013, J BIOL CHEM, V288, P12197, DOI 10.1074/jbc.M112.449553; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Koschubs T, 2010, NUCLEIC ACIDS RES, V38, P3186, DOI 10.1093/nar/gkq029; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lariviere L, 2013, NUCLEIC ACIDS RES, V41, P9266, DOI 10.1093/nar/gkt704; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Linder T, 2006, BIOCHEM BIOPH RES CO, V349, P948, DOI 10.1016/j.bbrc.2006.08.099; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sato S, 2003, J BIOL CHEM, V278, P49671, DOI 10.1074/jbc.C300444200; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2004, NAT STRUCT MOL BIOL, V11, P664, DOI 10.1038/nsmb789; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	56	142	146	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1430	1444		10.1016/j.cell.2014.05.015	http://dx.doi.org/10.1016/j.cell.2014.05.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24882805	Green Accepted, Bronze			2022-12-24	WOS:000340881400018
J	Pascoli, V; Terrier, J; Espallergues, J; Valjent, E; O'Connor, EC; Luscher, C				Pascoli, Vincent; Terrier, Jean; Espallergues, Julie; Valjent, Emmanuel; O'Connor, Eoin Cornelius; Luescher, Christian			Contrasting forms of cocaine-evoked plasticity control components of relapse	NATURE			English	Article							ACCUMBENS-PROJECTION NEURONS; LONG-TERM DEPRESSION; NUCLEUS-ACCUMBENS; SYNAPTIC PLASTICITY; AMPA RECEPTORS; ADDICTION; MECHANISMS; DOPAMINE; INCUBATION; REWARD	Nucleus accumbens neurons serve to integrate information from cortical and limbic regions to direct behaviour. Addictive drugs are proposed to hijack this system, enabling drug-associated cues to trigger relapse to drug seeking. However, the connections affected and proof of causality remain to be established. Here we use a mouse model of delayed cue-associated cocaine seeking with ex vivo electrophysiology in optogenetically delineated circuits. We find that seeking correlates with rectifying AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor transmission and a reduced AMPA/NMDA (N-methyl-D-aspartate) ratio at medial prefrontal cortex (mPFC) to nucleus accumbens shell D1-receptor medium-sized spiny neurons (D1R-MSNs). In contrast, the AMPA/NMDA ratio increases at ventral hippocampus to D1R-MSNs. Optogenetic reversal of cocaine-evoked plasticity at both inputs abolishes seeking, whereas selective reversal at mPFC or ventral hippocampus synapses impairs response discrimination or reduces response vigour during seeking, respectively. Taken together, we describe how information integration in the nucleus accumbens is commandeered by cocaine at discrete synapses to allow relapse. Our approach holds promise for identifying synaptic causalities in other behavioural disorders.	[Pascoli, Vincent; Terrier, Jean; O'Connor, Eoin Cornelius; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Espallergues, Julie; Valjent, Emmanuel] CNRS, INSERM, U661, F-34094 Montpellier, France; [Espallergues, Julie; Valjent, Emmanuel] CNRS, Inst Genom Fonct, UMR 5203, F-34094 Montpellier, France; [Espallergues, Julie; Valjent, Emmanuel] Univ Montpellier I, UMR 5203, F-34094 Montpellier, France; [Espallergues, Julie; Valjent, Emmanuel] Univ Montpellier 2, UMR 5203, F-34094 Montpellier, France; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Clin Neurol, CH-1211 Geneva, Switzerland	University of Geneva; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011; Core, Vector/CAF-4832-2022	Lüscher, Christian/0000-0001-7917-4596; O'Connor, Eoin/0000-0002-7810-1915; Valjent, Emmanuel/0000-0002-1034-606X	Swiss National Science Foundation; National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation; European Research Council advanced grant (MeSSI); MD-PhD grant of the Swiss Confederation; Avenir grant (Inserm); Agence Nationale de la Recherche	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation; European Research Council advanced grant (MeSSI); MD-PhD grant of the Swiss Confederation; Avenir grant (Inserm); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank D. Huber and M. Brown as well the members of the Luscher laboratory for discussion and comments on the manuscript, and A. Hiver for assisting in animal surgery. This work was financed by a grant from the Swiss National Science Foundation, the National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation and a European Research Council advanced grant (MeSSI). J.T. is supported by an MD-PhD grant of the Swiss Confederation. The E. V. laboratory was supported by an Avenir grant (Inserm) and by the Agence Nationale de la Recherche.	Ambroggi F, 2009, NAT NEUROSCI, V12, P247, DOI 10.1038/nn.2282; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bock R, 2013, NAT NEUROSCI, V16, P632, DOI 10.1038/nn.3369; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Cerovic M, 2013, NEUROBIOL LEARN MEM, V105, P63, DOI 10.1016/j.nlm.2013.06.013; Chistyakov Vladimir S., 2006, Journal of Pharmacological and Toxicological Methods, V53, P117, DOI 10.1016/j.vascn.2005.03.009; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Counotte DS, 2014, PSYCHOPHARMACOLOGY, V231, P1675, DOI 10.1007/s00213-013-3294-3; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; French SJ, 2003, NEUROSCIENCE, V119, P19, DOI 10.1016/S0306-4522(03)00150-7; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; FREUND TF, 1984, NEUROSCIENCE, V13, P1189, DOI 10.1016/0306-4522(84)90294-X; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00022; Gipson CD, 2013, NEURON, V77, P867, DOI 10.1016/j.neuron.2013.01.005; Goto Y, 2005, NEURON, V47, P255, DOI 10.1016/j.neuron.2005.06.017; Goto Y, 2008, TRENDS NEUROSCI, V31, P552, DOI 10.1016/j.tins.2008.08.002; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Koya E, 2009, NEUROPHARMACOLOGY, V56, P177, DOI 10.1016/j.neuropharm.2008.04.022; Lee BR, 2013, NAT NEUROSCI, V16, P1644, DOI 10.1038/nn.3533; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; MacAskill AF, 2012, NAT NEUROSCI, V15, P1624, DOI 10.1038/nn.3254; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; Ortinski PI, 2012, NEUROPSYCHOPHARMACOL, V37, P1671, DOI 10.1038/npp.2012.12; OUIMET CC, 1984, J NEUROSCI, V4, P111; Papp E, 2012, BRAIN STRUCT FUNCT, V217, P37, DOI 10.1007/s00429-011-0331-z; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Saddoris Michael P, 2013, Front Biosci (Elite Ed), V5, P273; Schultz W, 2011, NEURON, V69, P603, DOI 10.1016/j.neuron.2011.02.014; Smith DG, 2013, BIOL PSYCHIAT, V73, P804, DOI 10.1016/j.biopsych.2012.08.026; Smith RJ, 2013, CURR OPIN NEUROBIOL, V23, P546, DOI 10.1016/j.conb.2013.01.026; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Thomsen M, 2007, BEHAV GENET, V37, P101, DOI 10.1007/s10519-006-9097-0	50	266	267	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					459	+		10.1038/nature13257	http://dx.doi.org/10.1038/nature13257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24848058	Green Accepted			2022-12-24	WOS:000336126000032
J	Brooks, AJ; Dai, W; O'Mara, ML; Abankwa, D; Chhabra, Y; Pelekanos, RA; Gardon, O; Tunny, KA; Blucher, KM; Morton, CJ; Parker, MW; Sierecki, E; Gambin, Y; Gomez, GA; Alexandrov, K; Wilson, IA; Doxastakis, M; Mark, AE; Waters, MJ				Brooks, Andrew J.; Dai, Wei; O'Mara, Megan L.; Abankwa, Daniel; Chhabra, Yash; Pelekanos, Rebecca A.; Gardon, Olivier; Tunny, Kathryn A.; Blucher, Kristopher M.; Morton, Craig J.; Parker, Michael W.; Sierecki, Emma; Gambin, Yann; Gomez, Guillermo A.; Alexandrov, Kirill; Wilson, Ian A.; Doxastakis, Manolis; Mark, Alan E.; Waters, Michael J.			Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor	SCIENCE			English	Article							TYROSINE-PHOSPHATASE-ALPHA; ERYTHROPOIETIN RECEPTOR; THROMBOPOIETIN RECEPTOR; TRANSMEMBRANE DOMAIN; SIGNAL-TRANSDUCTION; CYTOKINE RECEPTOR; GLYCOPHORIN-A; GH RECEPTOR; CONSTITUTIVE ACTIVATION; EXTRACELLULAR DOMAIN	Signaling from JAK (Janus kinase) protein kinases to STAT (signal transducers and activators of transcription) transcription factors is key to many aspects of biology and medicine, yet the mechanism by which cytokine receptors initiate signaling is enigmatic. We present a complete mechanistic model for activation of receptor-bound JAK2, based on an archetypal cytokine receptor, the growth hormone receptor. For this, we used fluorescence resonance energy transfer to monitor positioning of the JAK2 binding motif in the receptor dimer, substitution of the receptor extracellular domains with Jun zippers to control the position of its transmembrane (TM) helices, atomistic modeling of TM helix movements, and docking of the crystal structures of the JAK2 kinase and its inhibitory pseudokinase domain with an opposing kinase-pseudokinase domain pair. Activation of the receptor dimer induced a separation of its JAK2 binding motifs, driven by a ligand-induced transition from a parallel TM helix pair to a left-handed crossover arrangement. This separation leads to removal of the pseudokinase domain from the kinase domain of the partner JAK2 and pairing of the two kinase domains, facilitating trans-activation. This model may well generalize to other class I cytokine receptors.	[Brooks, Andrew J.; Abankwa, Daniel; Chhabra, Yash; Pelekanos, Rebecca A.; Gardon, Olivier; Tunny, Kathryn A.; Blucher, Kristopher M.; Sierecki, Emma; Gambin, Yann; Gomez, Guillermo A.; Alexandrov, Kirill; Mark, Alan E.; Waters, Michael J.] Univ Queensland, IMB, St Lucia, Qld 4072, Australia; [Dai, Wei; Doxastakis, Manolis] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77004 USA; [O'Mara, Megan L.; Mark, Alan E.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Morton, Craig J.; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Morton, Craig J.; Parker, Michael W.] St Vincents Inst Med Res, Australian Canc Res Fdn ACRF Rat Drug Discovery C, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Parker, Michael W.] Univ Melbourne, Inst Bio21, Parkville, Vic 3052, Australia; [Wilson, Ian A.] Scripps Res Inst, La Jolla, CA 92037 USA	University of Queensland; University of Houston System; University of Houston; University of Queensland; St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; Scripps Research Institute	Brooks, AJ (corresponding author), Univ Queensland, IMB, St Lucia, Qld 4072, Australia.	a.brooks@uq.edu.au; m.waters@uq.edu.au	SIERECKI, Emma/L-2556-2019; Morton, Craig/GON-8638-2022; GAMBIN, Yann/AAI-8501-2021; Gomez, Guillermo/J-2993-2014; Mark, Alan E/A-8799-2011; O'Mara, Megan/ABF-8913-2020; Brooks, Andrew/A-9969-2011; O'Mara, Megan L/A-4962-2011; GAMBIN, Yann/M-8799-2014; Alexandrov, Kirill/A-5830-2013; Chhabra, Yash/C-8801-2018; Parker, Michael W/F-9069-2013; Sierecki, Emma/I-2920-2019; Sierecki, Emma/A-4810-2012; waters, michael j/C-9582-2014; O'Mara, Megan/AAY-5934-2021; Pelekanos, Rebecca/C-8546-2011	SIERECKI, Emma/0000-0001-9970-868X; Morton, Craig/0000-0001-5452-5193; Gomez, Guillermo/0000-0002-0494-2404; Mark, Alan E/0000-0001-5880-4798; Brooks, Andrew/0000-0002-2691-1668; O'Mara, Megan L/0000-0002-8764-1585; Alexandrov, Kirill/0000-0002-0957-6511; Chhabra, Yash/0000-0003-2883-4675; Parker, Michael W/0000-0002-3101-1138; O'Mara, Megan/0000-0002-8764-1585; Pelekanos, Rebecca/0000-0002-9463-7381; Doxastakis, Manolis/0000-0002-9175-9906; GAMBIN, Yann/0000-0001-7378-8976; Abankwa, Daniel/0000-0003-2769-0745	National Health and Medical Research Council of Australia [511120, 1002893, 102082]; Australian Research Council; Victorian Government; NSF (USA) Chemical, Bioengineering, Environmental, and Transport Systems Division [1067356]; Kids Cancer Project of the Oncology Research Foundation; Directorate For Engineering [1067356] Funding Source: National Science Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Government; NSF (USA) Chemical, Bioengineering, Environmental, and Transport Systems Division; Kids Cancer Project of the Oncology Research Foundation; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by grants from the National Health and Medical Research Council of Australia (511120, 1002893, and 102082) and the Australian Research Council to M.J.W., A.J.B, A.E.M., and M.W.P. Infrastructure funding from the Victorian Government to St Vincent's Institute is gratefully acknowledged. W.D. and M.D. acknowledge financial support by the NSF (USA) Chemical, Bioengineering, Environmental, and Transport Systems Division (grant number 1067356) and central processing unit time by the University of Houston Research Computing Center. G.A.G. acknowledges financial support by the Kids Cancer Project of the Oncology Research Foundation. We thank W.A. Johnston for optimizing the Leishmania-based cell-free lysate expression system used in the single-molecule and Alpha screen interaction studies. Confocal imaging was performed at the IMB/ACRF Cancer Biology Imaging Facility, established with the support of the Australian Cancer Research Foundation.	Abankwa D, 2007, J CELL SCI, V120, P2953, DOI 10.1242/jcs.001404; Bader AN, 2011, CHEMPHYSCHEM, V12, P475, DOI 10.1002/cphc.201000801; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Behncken SN, 2000, J BIOL CHEM, V275, P17000, DOI 10.1074/jbc.275.22.17000; Bernat B, 2003, P NATL ACAD SCI USA, V100, P952, DOI 10.1073/pnas.0235023100; Biener-Ramanujan E, 2006, GROWTH HORM IGF RES, V16, P247, DOI 10.1016/j.ghir.2006.06.001; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Chen CM, 1997, J BIOL CHEM, V272, P5133, DOI 10.1074/jbc.272.8.5133; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DUQUESNOY P, 1994, EMBO J, V13, P1386, DOI 10.1002/j.1460-2075.1994.tb06392.x; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Ghosh S, 2012, METHOD ENZYMOL, V505, P291, DOI 10.1016/B978-0-12-388448-0.00024-3; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; He K, 2003, MOL ENDOCRINOL, V17, P2211, DOI 10.1210/me.2003-0256; Henin J, 2005, J AM CHEM SOC, V127, P8478, DOI 10.1021/ja050581y; ISHIZAKAIKEDA E, 1993, P NATL ACAD SCI USA, V90, P123, DOI 10.1073/pnas.90.1.123; Janosi L, 2010, BIOPHYS J, V99, P284, DOI 10.1016/j.bpj.2010.04.005; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kubatzky KF, 2005, J BIOL CHEM, V280, P14844, DOI 10.1074/jbc.M411251200; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Lupardus PJ, 2011, STRUCTURE, V19, P45, DOI 10.1016/j.str.2010.10.010; Matthews EE, 2011, FASEB J, V25, P2234, DOI 10.1096/fj.10-178673; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Ozdirekcan S, 2005, BIOCHEMISTRY-US, V44, P1004, DOI 10.1021/bi0481242; Poger D, 2010, PROTEINS, V78, P1163, DOI 10.1002/prot.22636; Prakash A, 2011, BIOPHYS J, V101, P1949, DOI 10.1016/j.bpj.2011.09.017; Ruan WM, 2004, J BIOL CHEM, V279, P3273, DOI 10.1074/jbc.M309311200; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Staerk J, 2006, BLOOD, V107, P1864, DOI 10.1182/blood-2005-06-2600; Staerk J, 2011, EMBO J, V30, P4398, DOI 10.1038/emboj.2011.315; Tertoolen LGJ, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-8; van Kerkhof P, 2002, ENDOCRINOLOGY, V143, P1243, DOI 10.1210/en.143.4.1243; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; Zhang Y, 1999, J BIOL CHEM, V274, P33072, DOI 10.1074/jbc.274.46.33072	54	266	273	5	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					710	+	1249783	10.1126/science.1249783	http://dx.doi.org/10.1126/science.1249783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833397				2022-12-24	WOS:000335912900031
J	Chung, S; Lee, EJ; Yun, S; Choe, HK; Park, SB; Son, HJ; Kim, KS; Dluzen, DE; Lee, I; Hwang, O; Son, GH; Kim, K				Chung, Sooyoung; Lee, Eun Jeong; Yun, Seongsik; Choe, Han Kyoung; Park, Seong-Beom; Son, Hyo Jin; Kim, Kwang-Soo; Dluzen, Dean E.; Lee, Inah; Hwang, Onyou; Son, Gi Hoon; Kim, Kyungjin			Impact of Circadian Nuclear Receptor REV-ERB alpha on Midbrain Dopamine Production and Mood Regulation	CELL			English	Article							TYROSINE-HYDROXYLASE; CLOCK; GENE; TRANSCRIPTION; EXPRESSION; COMPONENT; BEHAVIOR; RHYTHM; IDENTIFICATION; DISRUPTION	The circadian nature of mood and its dysfunction in affective disorders is well recognized, but the underlying molecular mechanisms are still unclear. Here, we show that the circadian nuclear receptor REV-ERB alpha, which is associated with bipolar disorder, impacts midbrain dopamine production and mood-related behavior in mice. Genetic deletion of the Rev-erb alpha gene or pharmacological inhibition of REV-ERB alpha activity in the ventral midbrain induced mania-like behavior in association with a central hyperdopaminergic state. Also, REV-ERB alpha repressed tyrosine hydroxylase (TH) gene transcription via competition with nuclear receptor-related 1 protein (NURR1), another nuclear receptor crucial for dopa-minergic neuronal function, thereby driving circadian TH expression through a target-dependent antagonistic mechanism. In conclusion, we identified a molecular connection between the circadian timing system and mood regulation, suggesting that REVERBa could be targeting in the treatment of circadian rhythm-related affective disorders.	[Chung, Sooyoung; Lee, Eun Jeong; Yun, Seongsik; Choe, Han Kyoung; Kim, Kyungjin] Seoul Natl Univ, Frontier Program Neurosci 21, Dept Biol Sci, Seoul 151742, South Korea; [Chung, Sooyoung; Lee, Eun Jeong; Yun, Seongsik; Choe, Han Kyoung; Kim, Kyungjin] Seoul Natl Univ, Frontier Program Neurosci 21, Brain Res Ctr, Seoul 151742, South Korea; [Park, Seong-Beom; Kim, Kyungjin] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul 151742, South Korea; [Son, Hyo Jin; Hwang, Onyou] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul 138736, South Korea; [Kim, Kwang-Soo] Harvard Univ, Sch Med, Harvard Stem Cell Inst,Mol Neurobiol Lab, McLean Hosp,Dept Psychiat & Program Neurosci, Belmont, MA 02478 USA; [Dluzen, Dean E.] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat & Neurobiol, Rootstown, OH 44272 USA; [Son, Gi Hoon] Korea Univ, Coll Med, Dept Legal Med, Seoul 136705, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Harvard University; McLean Hospital; Northeast Ohio Medical University (NEOMED); Korea University; Korea University Medicine (KU Medicine)	Son, GH (corresponding author), Korea Univ, Coll Med, Dept Legal Med, Seoul 136705, South Korea.	songh@korea.ac.kr; kyungjin@snu.ac.kr	Choe, Han Kyoung/ABD-5083-2020; Core, Vector/CAF-4832-2022	Choe, Han Kyoung/0000-0001-7849-7094; Park, Seong-Beom/0000-0002-1346-4301; Son, Gi Hoon/0000-0001-9758-5903	Brain Research Center of the 21<SUP>st</SUP> Century Frontier Research Program [2009K001287]; Neural Technology Development and Service for Neuroscience Research [2013056731]; National Research Foundation of Korea [2010-0025112, 2011-0019232, 2012M3A9C7050135]	Brain Research Center of the 21<SUP>st</SUP> Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Neural Technology Development and Service for Neuroscience Research; National Research Foundation of Korea(National Research Foundation of Korea)	We thank Dr. U. Schibler (University of Geneva) for providing Rev-erb alpha mutant mice, Dr. T. P. Burris (Scripps Institute) for providing SR8278, Dr. H. Kim (Korea University) for help with microarray experiments, Dr. T. Chun (Korea University) for assistance with FACS experiments, and S. Lee (Seoul National University) for constructing hyperdrives. This work was supported by the Brain Research Center of the 21<SUP>st</SUP> Century Frontier Research Program (2009K001287), the Neural Technology Development and Service for Neuroscience Research (2013056731), and the National Research Foundation of Korea (2010-0025112, 2011-0019232, 2012M3A9C7050135). BioScience Writers edited the manuscript.	Aumann TD, 2011, J NEUROCHEM, V116, P646, DOI 10.1111/j.1471-4159.2010.07151.x; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chopin-Delannoy S, 2003, J MOL ENDOCRINOL, V30, P197, DOI 10.1677/jme.0.0300197; Chung S, 2005, ENDOCRINOLOGY, V146, P3202, DOI 10.1210/en.2004-1458; Cryan JF, 2007, CURR OPIN PSYCHIATR, V20, P1, DOI 10.1097/YCO.0b013e3280117733; De Bundel D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00152; Etain B, 2011, EUR NEUROPSYCHOPHARM, V21, pS676, DOI 10.1016/j.euroneuro.2011.07.007; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Geldenhuys WJ, 2009, EUR J PHARMACOL, V619, P38, DOI 10.1016/j.ejphar.2009.08.012; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Johansson AS, 2011, J BIOL RHYTHM, V26, P541, DOI 10.1177/0748730411419775; Kim KS, 2003, J NEUROCHEM, V85, P622, DOI 10.1046/j.1471-4159.2003.01671.x; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kondratova AA, 2010, AGING-US, V2, P285; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lee EJ, 2011, J NEUROSCI, V31, P7131, DOI 10.1523/JNEUROSCI.4692-10.2011; Lemos DR, 2007, ENDOCRINOLOGY, V148, P5811, DOI 10.1210/en.2007-0610; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033292; McCarthy MJ, 2011, GENES BRAIN BEHAV, V10, P852, DOI 10.1111/j.1601-183X.2011.00725.x; McCarthy MJ, 2012, J BIOL RHYTHM, V27, P339, DOI 10.1177/0748730412456367; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019; Menet JS, 2011, CURR OPIN NEUROBIOL, V21, P849, DOI 10.1016/j.conb.2011.06.008; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Mukherjee S, 2010, BIOL PSYCHIAT, V68, P503, DOI 10.1016/j.biopsych.2010.04.031; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Severino G, 2009, BIPOLAR DISORD, V11, P215, DOI 10.1111/j.1399-5618.2009.00667.x; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Son GH, 2007, BIOCHEM BIOPH RES CO, V352, P823, DOI 10.1016/j.bbrc.2006.11.104; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Spencer S, 2012, J NEUROCHEM, V123, P124, DOI 10.1111/j.1471-4159.2012.07857.x; SURI C, 1993, J NEUROSCI, V13, P1280; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yang S, 2009, MOL PSYCHIATR, V14, P143, DOI 10.1038/mp.2008.10; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	51	185	189	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					858	868		10.1016/j.cell.2014.03.039	http://dx.doi.org/10.1016/j.cell.2014.03.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813609	Bronze			2022-12-24	WOS:000335765500014
J	Harms, MJ; Thornton, JW				Harms, Michael J.; Thornton, Joseph W.			Historical contingency and its biophysical basis in glucocorticoid receptor evolution	NATURE			English	Article							MOLECULAR-DYNAMICS METHOD; LIGAND-BINDING DOMAIN; DIRECTED EVOLUTION; KEY INNOVATION; FORCE-FIELD; PROTEIN; MUTATIONS; SIMULATIONS; RESISTANCE; EPISTASIS	Understanding how chance historical events shape evolutionary processes is a central goal of evolutionary biology(1-7). Direct insights into the extent and causes of evolutionary contingency have been limited to experimental systems(7-9), because it is difficult to know what happened in the deep past and to characterize other paths that evolution could have followed. Here we combine ancestral protein reconstruction, directed evolution and biophysical analysis to explore alternative 'might-have-been' trajectories during the ancient evolution of a novel protein function. We previously found that the evolution of cortisol specificity in the ancestral glucocorticoid receptor (GR) was contingent on permissive substitutions, which had no apparent effect on receptor function but were necessary for GR to tolerate the large-effect mutations that caused the shift in specificity(6). Here we show that alternative mutations that could have permitted the historical function-switching substitutions are extremely rare in the ensemble of genotypes accessible to the ancestral GR. In a library of thousands of variants of the ancestral protein, we recovered historical permissive substitutions but no alternative permissive genotypes. Using biophysical analysis, we found that permissive mutations must satisfy at least three physical requirements-they must stabilize specific local elements of the protein structure, maintain the correct energetic balance between functional conformations, and be compatible with the ancestral and derived structures-thus revealing why permissive mutations are rare. These findings demonstrate that GR evolution depended strongly on improbable, non-deterministic events, and this contingency arose from intrinsic biophysical properties of the protein.	[Harms, Michael J.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Harms, Michael J.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA; [Harms, Michael J.; Thornton, Joseph W.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Harms, Michael J.; Thornton, Joseph W.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Thornton, Joseph W.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Oregon; University of Oregon; University of Chicago; University of Chicago; University of Oregon	Thornton, JW (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	joet1@uchicago.edu	Thornton, Joseph/GSN-4190-2022	Harms, Michael/0000-0002-0241-4122	National Institutes of Health (NIH) [F32-GM090650, NIH R01-GM081592, R01-GM104397]; NSF [IOB-0546906]; Howard Hughes Medical Institute Early Career Scientist award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104397, R01GM081592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute Early Career Scientist award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bridgham, members of the Thornton laboratory, and B. Buckley McAllister for technical assistance and fruitful discussions. We thank M. Stallcup for sharing plasmids and the University of Oregon ACISS cluster for computing resources (National Science Foundation (NSF) OCI-0960354). This work was supported by National Institutes of Health (NIH) F32-GM090650 (M.J.H.), NIH R01-GM081592 (J.W.T.) and R01-GM104397 (J.W.T.), NSF IOB-0546906 (J.W.T.) and a Howard Hughes Medical Institute Early Career Scientist award (J.W.T.).	Beatty J, 2006, J PHILOS, V103, P336, DOI 10.5840/jphil2006103716; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bledsoe RK, 2004, VITAM HORM, V68, P49; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100119; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carroll SM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002117; Chen ZL, 2004, J BIOL CHEM, V279, P33855, DOI 10.1074/jbc.M402118200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Field SF, 2010, MOL BIOL EVOL, V27, P225, DOI 10.1093/molbev/msp230; Fisher R.A., 1958, GENETICAL THEORY NAT; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Gould S. J., 1990, WONDERFUL LIFE BURGE; Granovsky A. A., FIREFLY VERSION 7 1; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Lynch VJ, 2011, NATURE, V480, P383, DOI 10.1038/nature10595; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Monod J., 1972, CHANCE NECESSITY ESS; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Morris S. C., 2000, CRUCIBLE CREATION BU; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	48	101	102	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					203	+		10.1038/nature13410	http://dx.doi.org/10.1038/nature13410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	24930765	Green Accepted			2022-12-24	WOS:000340200700034
J	Voorhees, RM; Fernandez, IS; Scheres, SHW; Hegde, RS				Voorhees, Rebecca M.; Fernandez, Israel S.; Scheres, Sjors H. W.; Hegde, Ramanujan S.			Structure of the Mammalian Ribosome-Sec61 Complex to 3.4 angstrom Resolution	CELL			English	Article							EM STRUCTURE DETERMINATION; ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; PROTEIN-CONDUCTING CHANNEL; NASCENT SECRETORY PROTEINS; TRANSFER-RNA; CRYO-EM; ELECTRON CRYOMICROSCOPY; TRANSLOCATION CHANNEL; ELONGATION CYCLE	Cotranslational protein translocation is a universally conserved process for secretory and membrane protein biosynthesis. Nascent polypeptides emerging from a translating ribosome are either transported across or inserted into the membrane via the ribosome-bound Sec61 channel. Here, we report structures of a mammalian ribosome-Sec61 complex in both idle and translating states, determined to 3.4 and 3.9 angstrom resolution. The data sets permit building of a near-complete atomic model of the mammalian ribosome, visualization of A/P and P/E hybrid-state tRNAs, and analysis of a nascent polypeptide in the exit tunnel. Unprecedented chemical detail is observed for both the ribosome-Sec61 interaction and the conformational state of Sec61 upon ribosome binding. Comparison of the maps from idle and translating complexes suggests how conformational changes to the Sec61 channel could facilitate translocation of a secreted polypeptide. The high-resolution structure of the mammalian ribosome-Sec61 complex provides a valuable reference for future functional and structural studies.	[Voorhees, Rebecca M.; Fernandez, Israel S.; Scheres, Sjors H. W.; Hegde, Ramanujan S.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Voorhees, RM (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	voorhees@mrc-lmb.cam.ac.uk; rhegde@mrc-lmb.cam.ac.uk	Scheres, Sjors H.W./AAY-2265-2021	Scheres, Sjors H.W./0000-0002-0462-6540; VOORHEES, REBECCA/0000-0003-1640-2293; Hegde, Ramanujan/0000-0001-8338-852X; Fernandez, Israel/0000-0001-7218-1603	UK Medical Research Council [MC_UP_A022_1007, MC_UP_A025_1013, MC_U105184332]; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; MRC [MC_UP_A022_1007, MC_U105184332, MC_UP_A025_1013] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1013, MC_UP_A022_1007, MC_U105184332] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Kasim Sader and Vinothkumar Ragunath for help with data collection; Alice Clark for reagents; Tim Stevens for bioinformatic analysis; Christos Savva for help with sample preparation and data collection; Shaoxia Chen, Greg McMullan, Jake Grimmett, and Toby Darling for technical support; and Alan Brown, Garib Murshudov, and Paul Emsley for help with model building and refinement. We are especially grateful to V. Ramakrishnan for advice, support, and critical reading of the manuscript. This work was supported by the UK Medical Research Council (MC_UP_A022_1007 to R.S.H., MC_UP_A025_1013 to S.H.W.S.) and a Wellcome Trust postdoctoral fellowship (R.M.V.). I.S.F. is supported by grants to V. Ramakrishnan including the UK Medical Research Council (MC_U105184332), a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation.	ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Chen E, 2014, MOL CELL, V54, P407, DOI 10.1016/j.molcel.2014.03.023; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; CONNOLLY T, 1989, J CELL BIOL, V108, P299, DOI 10.1083/jcb.108.2.299; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; HIRSH, 1971, J MOL BIOL, V58, P439, DOI 10.1016/0022-2836(71)90362-7; HIRSH D, 1971, J MOL BIOL, V58, P459, DOI 10.1016/0022-2836(71)90363-9; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; PALADE GE, 1955, J BIOPHYS BIOCHEM CY, V1, P59, DOI 10.1083/jcb.1.1.59; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Pool MR, 2009, J CELL BIOL, V185, P889, DOI 10.1083/jcb.200807066; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Scheres SHW, 2010, METHOD ENZYMOL, V482, P295, DOI 10.1016/S0076-6879(10)82012-9; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	65	228	237	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1632	1643		10.1016/j.cell.2014.05.024	http://dx.doi.org/10.1016/j.cell.2014.05.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24930395	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000340941900017
J	Szyk, A; Deaconescu, AM; Spector, J; Goodman, B; Valenstein, ML; Ziolkowska, NE; Kormendi, V; Grigorieff, N; Roll-Mecak, A				Szyk, Agnieszka; Deaconescu, Alexandra M.; Spector, Jeffrey; Goodman, Benjamin; Valenstein, Max L.; Ziolkowska, Natasza E.; Kormendi, Vasilisa; Grigorieff, Nikolaus; Roll-Mecak, Antonina			Molecular Basis for Age-Dependent Microtubule Acetylation by Tubulin Acetyltransferase	CELL			English	Article							CHLAMYDOMONAS ALPHA-TUBULIN; STRUCTURAL BASIS; POSTTRANSLATIONAL MODIFICATION; CRYOELECTRON TOMOGRAPHY; CELLULAR MICROTUBULES; BINDING; MEC-17; RESOLUTION; LATTICE; NEURONS	Acetylation of alpha-tubulin Lys40 by tubulin acetyltransferase (TAT) is the only known posttranslational modification in the microtubule lumen. It marks stable microtubules and is required for polarity establishment and directional migration. Here, we elucidate the mechanistic underpinnings for TAT activity and its preference for microtubules with slow turnover. 1.35 angstrom TAT cocrystal structures with bisubstrate analogs constrain TAT action to the microtubule lumen and reveal Lys40 engaged in a suboptimal active site. Assays with diverse tubulin polymers show that TAT is stimulated by microtubule interprotofilament contacts. Unexpectedly, despite the confined intraluminal location of Lys40, TAT efficiently scans the microtubule bidirectionally and acetylates stochastically without preference for ends. First-principles modeling and single-molecule measurements demonstrate that TAT catalytic activity, not constrained luminal diffusion, is rate limiting for acetylation. Thus, because of its preference for microtubules over free tubulin and its modest catalytic rate, TAT can function as a slow clock for microtubule lifetimes.	[Szyk, Agnieszka; Spector, Jeffrey; Goodman, Benjamin; Valenstein, Max L.; Ziolkowska, Natasza E.; Kormendi, Vasilisa; Roll-Mecak, Antonina] Porter Neurosci Res Ctr, Natl Inst Neurol Disorders & Stroke, Cell Biol & Biophys Unit, Bethesda, MD 20892 USA; [Deaconescu, Alexandra M.; Grigorieff, Nikolaus] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Roll-Mecak, Antonina] NHLBI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roll-Mecak, A (corresponding author), Porter Neurosci Res Ctr, Natl Inst Neurol Disorders & Stroke, Cell Biol & Biophys Unit, Bethesda, MD 20892 USA.	antonina@mail.nih.gov	Deaconescu, Alexandra/AAW-8139-2021	Grigorieff, Nikolaus/0000-0002-1506-909X; Roll-Mecak, Antonina/0000-0003-2621-7307; Valenstein, Max/0000-0001-7616-0148; Deaconescu, Alexandra/0000-0002-2742-5493	NIH [P01 GM62580]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Piszczek (National Heart, Lung and Blood Institute Biophysics core) for AUC help, B. Castle and D. Odde (University of Minnesota) for modifying the TipTracker program, and G. Brouhard (McGill University) for the doublecortin expression plasmid. A.R.-M. thanks A. Szabo for discussions on diffusion and A. Ferre-D'Amare, E. Giniger, S. Gottesman, K. Swartz, and R. Vale for critical reading of the manuscript. We are grateful to Chen Xu for training at the Brandeis University EM facility where the EM data was collected (supported by NIH grant P01 GM62580 awarded to N.G.). A.R.-M. is a Searle Scholar and supported by the intramural program of the NIH.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; BLACK MM, 1989, J NEUROSCI, V9, P358; Bungay P. M., 1973, INT J MULTIPHAS FLOW, V1, P25, DOI DOI 10.1016/0301-9322(73)90003-7; BURTON PR, 1984, J CELL BIOL, V99, P520, DOI 10.1083/jcb.99.2.520; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; CUEVA JG, 2012, CURR BIOL, V22, P1066, DOI [DOI 10.1016/j.cub.2012.05.012, DOI 10.1016/J.CUB.2012.05.012]; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Garvalov BK, 2006, J CELL BIOL, V174, P759, DOI 10.1083/jcb.200606074; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; GREER K, 1985, J CELL BIOL, V101, P2081, DOI 10.1083/jcb.101.6.2081; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; Howes SC, 2014, MOL BIOL CELL, V25, P257, DOI 10.1091/mbc.E13-07-0387; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li L, 2012, J NEUROSCI, V32, P12673, DOI 10.1523/JNEUROSCI.0016-12.2012; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Neumann B, 2014, CELL REP, V6, P93, DOI 10.1016/j.celrep.2013.12.004; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Odde D, 1998, EUR BIOPHYS J BIOPHY, V27, P514, DOI 10.1007/s002490050161; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Subramanian R, 2013, CELL, V154, P377, DOI 10.1016/j.cell.2013.06.021; Sui HX, 2006, NATURE, V442, P475, DOI 10.1038/nature04816; TAKEMURA R, 1992, J CELL SCI, V103, P953; Taschner M, 2012, P NATL ACAD SCI USA, V109, P19649, DOI 10.1073/pnas.1209343109; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yajima H, 2012, J CELL BIOL, V198, P315, DOI 10.1083/jcb.201201161; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891; Ziolkowska NE, 2013, METHODS MOL BIOL, V1046, P323, DOI 10.1007/978-1-62703-538-5_19	59	130	137	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1405	1415		10.1016/j.cell.2014.03.061	http://dx.doi.org/10.1016/j.cell.2014.03.061			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906155	Green Accepted, Bronze			2022-12-24	WOS:000340881400016
J	Crosby, J; Peloso, GM; Auer, PL; Crosslin, DR; Stitziel, NO; Lange, LA; Lu, YC; Tang, ZZ; Zhang, H; Hindy, G; Masca, N; Stirrups, K; Kanoni, S; Do, R; Jun, G; Hu, YN; Kang, HM; Xue, CY; Goel, A; Farrall, M; Duga, S; Merlini, PA; Asselta, R; Girelli, D; Olivieri, O; Martinelli, N; Yin, W; Reilly, D; Speliotes, E; Fox, CS; Hveem, K; Holmen, OL; Nikpay, M; Farlow, DN; Assimes, TL; Franceschini, N; Robinson, J; North, KE; Martin, LW; DePristo, M; Gupta, N; Escher, SA; Jansson, JH; Van Zuydam, N; Palmer, CNA; Wareham, N; Koch, W; Meitinger, T; Peters, A; Lieb, W; Erbel, R; Konig, IR; Kruppa, J; Degenhardt, F; Gottesman, O; Bottinger, EP; O'Donnell, CJ; Psaty, BM; Ballantyne, CM; Abecasis, G; Ordovas, JM; Melander, O; Watkins, H; Orho-Melander, M; Ardissino, D; Loos, RJF; McPherson, R; Willer, CJ; Erdmann, J; Hall, AS; Samani, NJ; Deloukas, P; Schunkert, H; Wilson, JG; Kooperberg, C; Rich, SS; Tracy, RP; Lin, DY; Altshuler, D; Gabriel, S; Nickerson, DA; Jarvik, GP; Cupples, LA; Reiner, AP; Boerwinkle, E; Kathiresan, S				Crosby, Jacy; Peloso, Gina M.; Auer, Paul L.; Crosslin, David R.; Stitziel, Nathan O.; Lange, Leslie A.; Lu, Yingchang; Tang, Zheng-zheng; Zhang, He; Hindy, George; Masca, Nicholas; Stirrups, Kathleen; Kanoni, Stavroula; Do, Ron; Jun, Goo; Hu, Youna; Kang, Hyun Min; Xue, Chenyi; Goel, Anuj; Farrall, Martin; Duga, Stefano; Merlini, Pier Angelica; Asselta, Rosanna; Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola; Yin, Wu; Reilly, Dermot; Speliotes, Elizabeth; Fox, Caroline S.; Hveem, Kristian; Holmen, Oddgeir L.; Nikpay, Majid; Farlow, Deborah N.; Assimes, Themistocles L.; Franceschini, Nora; Robinson, Jennifer; North, Kari E.; Martin, Lisa W.; DePristo, Mark; Gupta, Namrata; Escher, Stefan A.; Jansson, Jan-Hakan; Van Zuydam, Natalie; Palmer, Colin N. A.; Wareham, Nicholas; Koch, Werner; Meitinger, Thomas; Peters, Annette; Lieb, Wolfgang; Erbel, Raimund; Konig, Inke R.; Kruppa, Jochen; Degenhardt, Franziska; Gottesman, Omri; Bottinger, Erwin P.; O'Donnell, Christopher J.; Psaty, Bruce M.; Ballantyne, Christie M.; Abecasis, Goncalo; Ordovas, Jose M.; Melander, Olle; Watkins, Hugh; Orho-Melander, Marju; Ardissino, Diego; Loos, Ruth J. F.; McPherson, Ruth; Willer, Cristen J.; Erdmann, Jeanette; Hall, Alistair S.; Samani, Nilesh J.; Deloukas, Panos; Schunkert, Heribert; Wilson, James G.; Kooperberg, Charles; Rich, Stephen S.; Tracy, Russell P.; Lin, Dan-Yu; Altshuler, David; Gabriel, Stacey; Nickerson, Deborah A.; Jarvik, Gail P.; Cupples, L. Adrienne; Reiner, Alex P.; Boerwinkle, Eric; Kathiresan, Sekar		Exome Sequencing Project; Natl Heart Lung Blood Inst	Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN C-III; CARDIOVASCULAR-DISEASE; PLASMA TRIGLYCERIDES; RICH LIPOPROTEINS; RARE VARIANTS; PCSK9; ASSOCIATIONS; INHIBITION; CAPTURE; DESIGN	Background Plasma triglyceride levels are heritable and are correlated with the risk of coronary heart disease. Sequencing of the protein-coding regions of the human genome (the exome) has the potential to identify rare mutations that have a large effect on phenotype. Methods We sequenced the protein-coding regions of 18,666 genes in each of 3734 participants of European or African ancestry in the Exome Sequencing Project. We conducted tests to determine whether rare mutations in coding sequence, individually or in aggregate within a gene, were associated with plasma triglyceride levels. For mutations associated with triglyceride levels, we subsequently evaluated their association with the risk of coronary heart disease in 110,970 persons. Results An aggregate of rare mutations in the gene encoding apolipoprotein C3 (APOC3) was associated with lower plasma triglyceride levels. Among the four mutations that drove this result, three were loss-of-function mutations: a nonsense mutation (R19X) and two splice-site mutations (IVS2+1G -> A and IVS3+1G -> T). The fourth was a missense mutation (A43T). Approximately 1 in 150 persons in the study was a heterozygous carrier of at least one of these four mutations. Triglyceride levels in the carriers were 39% lower than levels in noncarriers (P<1x10(-20)), and circulating levels of APOC3 in carriers were 46% lower than levels in noncarriers (P = 8x10(-10)). The risk of coronary heart disease among 498 carriers of any rare APOC3 mutation was 40% lower than the risk among 110,472 noncarriers (odds ratio, 0.60; 95% confidence interval, 0.47 to 0.75; P = 4x10(-6)). Conclusions Rare mutations that disrupt APOC3 function were associated with lower levels of plasma triglycerides and APOC3. Carriers of these mutations were found to have a reduced risk of coronary heart disease. (Funded by the National Heart, Lung, and Blood Institute and others.)	[Crosby, Jacy] Univ Texas Houston, Dept Biostat Bioinformat & Syst Biol, Grad Sch Biomed Sci, Houston, TX USA; [Crosby, Jacy; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Ballantyne, Christie M.; Boerwinkle, Eric] Baylor Coll Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA; [Peloso, Gina M.; Do, Ron; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Peloso, Gina M.; Do, Ron; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Peloso, Gina M.; Do, Ron; Altshuler, David; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Yin, Wu; Reilly, Dermot] Merck Sharp & Dohme Ltd, Boston, MA USA; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Peloso, Gina M.; Do, Ron; Farlow, Deborah N.; DePristo, Mark; Gupta, Namrata; Altshuler, David; Gabriel, Stacey; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Auer, Paul L.] Univ Wisconsin, Sch Publ Hlth, Milwaukee, WI 53201 USA; [Crosslin, David R.; Nickerson, Deborah A.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol & Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Kooperberg, Charles; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63130 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO 63130 USA; [Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Tang, Zheng-zheng; Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Lu, Yingchang; Gottesman, Omri; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA; [Zhang, He; Speliotes, Elizabeth; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zhang, He; Xue, Chenyi; Speliotes, Elizabeth; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Zhang, He; Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Jun, Goo; Hu, Youna; Kang, Hyun Min; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Speliotes, Elizabeth] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Abecasis, Goncalo] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Hindy, George; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Clin Res Ctr, Malmo, Sweden; [Escher, Stefan A.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Melander, Olle] Lund Univ, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; Malmo Univ Hosp, Malmo, Sweden; [Jansson, Jan-Hakan] Skelleftea Hosp, Dept Med, Skelleftea, Sweden; [Jansson, Jan-Hakan] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Masca, Nicholas; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Masca, Nicholas; Samani, Nilesh J.] Natl Inst Hlth Res Leicester, Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Stirrups, Kathleen; Kanoni, Stavroula; Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Van Zuydam, Natalie; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Wareham, Nicholas; Cupples, L. Adrienne] Addenbrookes Hosp, Med Res Council Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Hall, Alistair S.] Univ Leeds, Sch Med, Div Epidemiol, Leeds LS2 9JT, W Yorkshire, England; [Duga, Stefano; Asselta, Rosanna] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy; [Merlini, Pier Angelica] Osped Niguarda Ca Granda, Div Cardiol, Milan, Italy; [Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola] Univ Verona, Dept Med, Sch Med, I-37100 Verona, Italy; [Ardissino, Diego] Azienda Osped Univ Parma, Div Cardiol, Parma, Italy; [Fox, Caroline S.; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Fox, Caroline S.] Ctr Populat Studies, Framingham, MA USA; [Hveem, Kristian; Holmen, Oddgeir L.] Norwegian Univ Sci & Technol, Nord Trondelag Hlth Study HUNT Res Ctr, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Hveem, Kristian] Levanger Hosp, Levanger, Norway; [Holmen, Oddgeir L.] Univ Trondheim Hosp, St Olav Hosp, Trondheim, Norway; [Nikpay, Majid; McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Robinson, Jennifer] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Ames, IA USA; [Robinson, Jennifer] Univ Iowa, Dept Med, Coll Publ Hlth, Ames, IA USA; [Martin, Lisa W.] Washington Univ, Sch Med & Hlth Sci, Div Cardiol, Washington, DC USA; [Koch, Werner; Schunkert, Heribert] Deutsch Herzzentrum Munich, Munich, Germany; [Koch, Werner] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, D-80290 Munich, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Koch, Werner; Peters, Annette] German Ctr Cardiovasc Res, Munich, Germany; [Peters, Annette] Helmholtz Zentrum Munchen, Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol & Biobank popgen, Kiel, Germany; [Erbel, Raimund] West German Heart Ctr, Dept Cardiol, Essen, Germany; [Konig, Inke R.; Kruppa, Jochen] Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, Lubeck, Germany; [Erdmann, Jeanette] Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Integrat & Expt Genom, Lubeck, Germany; [Konig, Inke R.; Kruppa, Jochen] Univ Lubeck, Univ Klinikum Schleswig Holstein, Lubeck, Germany; [Erdmann, Jeanette] DZHK German Res Ctr Cardiovasc Res, Lubeck, Germany; [Degenhardt, Franziska] Univ Bonn, Inst Human Genet, Bonn, Germany; [Ordovas, Jose M.] Natl Ctr Cardiovasc Invest, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Ordovas, Jose M.] Inst Madrileno Estudios Avanzados Alimentac, Madrid, Spain; [Deloukas, Panos] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA USA; [Tracy, Russell P.] Univ Vermont, Dept Pathol, Coll Med, Burlington, VT 05405 USA; [Tracy, Russell P.] Univ Vermont, Dept Biochem, Coll Med, Burlington, VT 05405 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Merck & Company; Tufts University; United States Department of Agriculture (USDA); Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Wisconsin System; University of Wisconsin Milwaukee; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Fred Hutchinson Cancer Center; Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lund University; Lund University; Lund University; Lund University; Skane University Hospital; Umea University; University of Leicester; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Dundee; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Wellcome Trust Sanger Institute; University of Leeds; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Verona; University of Parma; University Hospital of Parma; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Ottawa; University of Ottawa Heart Institute; Stanford University; University of Iowa; University of Iowa; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; German Centre for Cardiovascular Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; German Centre for Cardiovascular Research; University of Bonn; Centro Nacional de Investigaciones Cardiovasculares (CNIC); King Abdulaziz University; University of Mississippi; University of Mississippi Medical Center; University of Virginia; University of Vermont; University of Vermont	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA.	skathiresan@partners.org	Meitinger, Thomas/O-1318-2015; Peters, Annette/A-6117-2011; Kanoni, Stavroula/AAN-7161-2021; Olivieri, Oliviero/A-9126-2008; König, Inke R/A-4544-2009; Erdmann, Jeanette/P-7513-2014; Hveem, Kristian/AFV-4683-2022; Girelli, Domenico/B-1183-2008; Loos, Ruth/GON-5877-2022; Jarvik, Gail P/N-6476-2014; Stitziel, Nathan/AAL-8413-2021; Asselta, Rosanna/AAC-2367-2019; Auer, Paul/AAC-5060-2019; Jun, Goo/F-1941-2017; Martinelli, Nicola/J-5622-2016; Degenhardt, Franziska/H-4169-2017; , Jennifer/AAD-8336-2019; Lieb, Wolfgang/AAC-7650-2022; Erdmann, Jeanette/A-4417-2009; Study, GoDARTS/K-9448-2016; Ardissino, Diego/AAC-4041-2022; Ballantyne, Christie/A-6599-2008; Palmer, Colin NA/C-7053-2008; Duga, Stefano/F-8173-2014; Hall, Alistair/K-1953-2019; Altshuler, David M/A-4476-2009; Assimes, Themistocles Leonard/D-9696-2015; Deloukas, Panos/B-2922-2013; Loos, Ruth J F/Q-2862-2016; Ordovas, Jose/B-8727-2013	Peters, Annette/0000-0001-6645-0985; Kanoni, Stavroula/0000-0002-1691-9615; Olivieri, Oliviero/0000-0001-8209-9056; König, Inke R/0000-0003-0504-6465; Erdmann, Jeanette/0000-0002-4486-6231; Girelli, Domenico/0000-0001-9684-1899; Jarvik, Gail P/0000-0002-6710-8708; Stitziel, Nathan/0000-0002-4963-8211; Asselta, Rosanna/0000-0001-5351-0619; Jun, Goo/0000-0003-0891-0204; Martinelli, Nicola/0000-0001-6465-5119; Palmer, Colin NA/0000-0002-6415-6560; Duga, Stefano/0000-0003-3457-1410; Altshuler, David M/0000-0002-7250-4107; Assimes, Themistocles Leonard/0000-0003-2349-0009; Deloukas, Panos/0000-0001-9251-070X; Loos, Ruth J F/0000-0002-8532-5087; Zhang, He/0000-0001-9198-6503; Kruppa, Jochen/0000-0001-8376-8864; Goel, Anuj/0000-0003-2307-4021; Martin, Lisa Warsinger/0000-0003-4352-0914; Ballantyne, Christie/0000-0002-6432-1730; Cupples, L. Adrienne/0000-0003-0273-7965; Hall, Alistair/0000-0003-0306-7887; Hindy, George/0000-0002-7257-9299; solinas, emilia/0000-0003-3532-1317; Watkins, Hugh/0000-0002-5287-9016; Rich, Stephen/0000-0003-3872-7793; Meitinger, Thomas/0000-0002-8838-8403; Ordovas, Jose/0000-0002-7581-5680; Melander, Olle/0000-0002-2581-484X	National Heart, Lung, and Blood Institute; NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102924, R01HL109946, ZIAHL006002, RC2HL103010, ZIAHL006094, RC2HL102925, K08HL114642, R01HL107816, T32HL007208, ZIAHL006173, RC2HL102926, RC2HL102923, ZIAHL006175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG049505] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011049, NNF13OC0005339, NNF14OC0009819] Funding Source: researchfish	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funded by the National Heart, Lung, and Blood Institute and others.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; ACCORD Stud Group, 2010, NEW ENGL J MED, V1362, P1748; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bochem AE, 2014, CLIN GENET, V85, P433, DOI 10.1111/cge.12201; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Huff MW, 2013, CIRC RES, V112, P1405, DOI 10.1161/CIRCRESAHA.113.301464; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Liu HQ, 2000, J LIPID RES, V41, P1760; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WINDLER E, 1985, J LIPID RES, V26, P556; Zheng CY, 2010, CIRCULATION, V121, P1722, DOI 10.1161/CIRCULATIONAHA.109.875807	40	687	729	2	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					22	31		10.1056/NEJMoa1307095	http://dx.doi.org/10.1056/NEJMoa1307095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24941081	Green Accepted, Green Published			2022-12-24	WOS:000338265700006
J	Liu, V; Escobar, GJ; Greene, JD; Soule, J; Whippy, A; Angus, DC; Iwashyna, TJ				Liu, Vincent; Escobar, Gabriel J.; Greene, John D.; Soule, Jay; Whippy, Alan; Angus, Derek C.; Iwashyna, Theodore J.			Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MORTALITY		[Liu, Vincent; Escobar, Gabriel J.; Greene, John D.] Kaiser Permanente, Div Res, Oakland, CA USA; [Soule, Jay; Whippy, Alan] Permanente Med Grp Inc, Oakland, CA USA; [Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Iwashyna, Theodore J.] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	Kaiser Permanente; Permanente Medical Groups; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan	Liu, V (corresponding author), 2000 Broadway, Oakland, CA 94612 USA.	vincent.x.liu@kp.org	Angus, Derek C/E-9671-2012	Iwashyna, Theodore/0000-0002-4226-9310				Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP), INTR HCUP NAT INP SA; Escobar GJ, 2013, MED CARE, V51, P446, DOI 10.1097/MLR.0b013e3182881c8e; Gordon NP, SIMILARITY ADULT KAI; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu Vincent, 2013, Ann Am Thorac Soc, V10, P466, DOI 10.1513/AnnalsATS.201304-099OC	6	506	540	2	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					90	92		10.1001/jama.2014.5804	http://dx.doi.org/10.1001/jama.2014.5804			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	24838355	Bronze			2022-12-24	WOS:000338131100026
J	Yang, Y; Lisberger, SG				Yang, Yan; Lisberger, Stephen G.			Purkinje-cell plasticity and cerebellar motor learning are graded by complex-spike duration	NATURE			English	Article							PARALLEL FIBERS; CLIMBING FIBERS; OSCILLATIONS; DENDRITES; MODEL	Behavioural learning is mediated by cellular plasticity, such as changes in the strength of synapses at specific sites in neural circuits. The theory of cerebellar motor learning(1-3) relies on movement errors signalled by climbing-fibre inputs to cause long-term depression of synapses from parallel fibres to Purkinje cells(4,5). However, a recent review(6) has called into question the widely held view that the climbing-fibre input is an 'all-or-none' event. In anaesthetized animals, there is wide variation in the duration of the complex spike (CS) caused in Purkinje cells by a climbing-fibre input(7). Furthermore, the amount of plasticity in Purkinje cells is graded according to the duration of electrically controlled bursts in climbing fibres(8,9). The duration of bursts depends on the 'state' of the inferior olive and therefore may be correlated across climbing fibres(8,10). Here we provide a potential functional context for these mechanisms during motor learning in behaving monkeys. The magnitudes of both plasticity and motor learning depend on the duration of the CS responses. Furthermore, the duration of CS responses seems to be a meaningful signal that is correlated across the Purkinje-cell population during motor learning. We suggest that during learning, longer bursts in climbing fibres lead to longer-duration CS responses in Purkinje cells, more calcium entry into Purkinje cells, larger synaptic depression, and stronger learning. The same graded impact of instructive signals for plasticity and learning might occur throughout the nervous system.	[Yang, Yan; Lisberger, Stephen G.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Lisberger, Stephen G.] Duke Univ, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Lisberger, SG (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27710 USA.	yanyang@neuro.duke.edu; lisberger@neuro.duke.edu	Yang, Yan/A-8505-2016	Yang, Yan/0000-0002-9139-5532	Howard Hughes Medical Institute; National Eye Institute of the National Institutes of Health [R01-EY003878]; NATIONAL EYE INSTITUTE [R01EY003878] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank C. Hull, L. Glickfeld and R. Mooney for helpful comments, and M. Joshua and J. Lee for 'blind' tests of our measurements of complex-spike duration. Research supported by the Howard Hughes Medical Institute and by the National Eye Institute of the National Institutes of Health under Award Number R01-EY003878. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Bazzigaluppi P, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00091; Bengtsson F, 2006, CEREBELLUM, V5, P7, DOI 10.1080/14734220500462757; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; GILBERT PFC, 1974, BRAIN RES, V70, P1, DOI 10.1016/0006-8993(74)90208-X; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; HIGHSTEIN SM, 1973, EXP BRAIN RES, V17, P301; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Kahlon M, 2000, J NEUROPHYSIOL, V84, P2945, DOI 10.1152/jn.2000.84.6.2945; Kenyon GT, 1998, J COMPUT NEUROSCI, V5, P17, DOI 10.1023/A:1008874209991; Kitamura K, 2011, J NEUROSCI, V31, P10847, DOI 10.1523/JNEUROSCI.2525-10.2011; Lisberger S. G., 2014, J NEUROSCI IN PRESS; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Maruta J, 2007, J NEUROSCI, V27, P11263, DOI 10.1523/JNEUROSCI.2559-07.2007; Mathy A, 2009, NEURON, V62, P388, DOI 10.1016/j.neuron.2009.03.023; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Medina JF, 2007, J NEUROSCI, V27, P6832, DOI 10.1523/JNEUROSCI.1323-07.2007; Miall RC, 1998, NAT NEUROSCI, V1, P13, DOI 10.1038/212; Najafi F, 2014, CELL REP, V6, P792, DOI 10.1016/j.celrep.2014.02.001; Najafi F, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00115; Ohyama T, 2006, J NEUROSCI, V26, P12656, DOI 10.1523/JNEUROSCI.4023-06.2006; Rasmussen A, 2013, J NEUROSCI, V33, P13436, DOI 10.1523/JNEUROSCI.1527-13.2013; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Yang Y, 2013, ELIFE, V2, DOI 10.7554/eLife.01574; Yang Y, 2010, J NEUROPHYSIOL, V104, P2850, DOI 10.1152/jn.00761.2010; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878, DOI 10.1152/jn.1981.46.4.878	29	119	120	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					529	+		10.1038/nature13282	http://dx.doi.org/10.1038/nature13282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24814344	Green Submitted, Green Accepted			2022-12-24	WOS:000337806300045
J	Patel, AP; Tirosh, I; Trombetta, JJ; Shalek, AK; Gillespie, SM; Wakimoto, H; Cahill, DP; Nahed, BV; Curry, WT; Martuza, RL; Louis, DN; Rozenblatt-Rosen, O; Suva, ML; Regev, A; Bernstein, BE				Patel, Anoop P.; Tirosh, Itay; Trombetta, John J.; Shalek, Alex K.; Gillespie, Shawn M.; Wakimoto, Hiroaki; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Louis, David N.; Rozenblatt-Rosen, Orit; Suva, Mario L.; Regev, Aviv; Bernstein, Bradley E.			Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma	SCIENCE			English	Article							STEM-LIKE CELLS; INTEGRATED GENOMIC ANALYSIS; TUMOR HETEROGENEITY; GROWTH; EXPRESSION; EVOLUTION; RECEPTOR; GENOTYPE; REVEALS; CANCER	Human cancers are complex ecosystems composed of cells with distinct phenotypes, genotypes, and epigenetic states, but current models do not adequately reflect tumor composition in patients. We used single-cell RNA sequencing (RNA-seq) to profile 430 cells from five primary glioblastomas, which we found to be inherently variable in their expression of diverse transcriptional programs related to oncogenic signaling, proliferation, complement/immune response, and hypoxia. We also observed a continuum of stemness-related expression states that enabled us to identify putative regulators of stemness in vivo. Finally, we show that established glioblastoma subtype classifiers are variably expressed across individual cells within a tumor and demonstrate the potential prognostic implications of such intratumoral heterogeneity. Thus, we reveal previously unappreciated heterogeneity in diverse regulatory programs central to glioblastoma biology, prognosis, and therapy.	[Patel, Anoop P.; Wakimoto, Hiroaki; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Patel, Anoop P.; Gillespie, Shawn M.; Wakimoto, Hiroaki; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Louis, David N.; Suva, Mario L.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Patel, Anoop P.; Gillespie, Shawn M.; Louis, David N.; Suva, Mario L.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Patel, Anoop P.; Tirosh, Itay; Trombetta, John J.; Shalek, Alex K.; Gillespie, Shawn M.; Rozenblatt-Rosen, Orit; Suva, Mario L.; Regev, Aviv; Bernstein, Bradley E.] Broad Inst Harvard & Massachusetts Inst Techonol, Cambridge, MA 02142 USA; [Patel, Anoop P.; Gillespie, Shawn M.; Regev, Aviv; Bernstein, Bradley E.] Howard Hughes Med Inst Chevy Chase, Chevy Chase, MD 20815 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Suva, ML (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	suva.mario@mgh.harvard.edu; aregev@broadinstitute.org; bernstein.bradley@mgh.harvard.edu	Wakimoto, Hiroaki/H-4533-2019; Rozenblatt-Rosen, Orit/HDN-4182-2022; Suva, Mario/AAY-7798-2020; wang, edwin/G-5372-2010; Shalek, Alex/Y-2434-2019; Nahed, Brian/E-4239-2014	Wakimoto, Hiroaki/0000-0001-8225-241X; Suva, Mario/0000-0001-9898-5351; Shalek, Alex/0000-0001-5670-8778; Cahill, Daniel/0000-0003-2552-6546; Nahed, Brian/0000-0001-8537-106X; Gillespie, Shawn/0000-0003-1913-0860	NIH- National Institute of Neurological Disorders and Stroke [R25NS065743]; Human Frontier Science Program fellowship; Rothschild fellowship; Medic Foundation; Howard Hughes Medical Institute; Burroughs Wellcome Fund; Harvard Stem Cell Institute; NIH [R01 NS032677, U24 CA180922]; National Brain Tumor Society; Klarman Family Foundation; NATIONAL CANCER INSTITUTE [U24CA180922, P50CA165962] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032677, R25NS065743] Funding Source: NIH RePORTER	NIH- National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontier Science Program fellowship(Human Frontier Science Program); Rothschild fellowship; Medic Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Society; Klarman Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Shefler for project management, E. Rheinbay for graphical contributions, J. Kim and P. Santos for histology, and P. Bautista and Y. Yagi for slide scanning. A. P. P was supported by NIH- National Institute of Neurological Disorders and Stroke R25NS065743. I. T. was supported by a Human Frontier Science Program fellowship and a Rothschild fellowship. M. L. S was supported by a grant from Medic Foundation. This research was supported by funds from Howard Hughes Medical Institute, Burroughs Wellcome Fund, Harvard Stem Cell Institute, NIH (R01 NS032677 to R. L. M. and U24 CA180922 to A. R.), National Brain Tumor Society, and Klarman Family Foundation. A. R. is a scientific advisory board member for Syros Pharmaceuticals and a consultant for Cancer Therapeutics Innovation Group. B. E. B. is a scientific advisory board member for Syros Pharmaceuticals and a founder and scientific advisor for HiFiBio SAS. RNA-seq data are deposited in Gene Expression Omnibus with accession no. GSE57872.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cho MS, 2014, CELL REP, V6, P1085, DOI 10.1016/j.celrep.2014.02.014; Choi BD, 2013, P NATL ACAD SCI USA, V110, P270, DOI 10.1073/pnas.1219817110; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martynoga B, 2013, GENE DEV, V27, P1769, DOI 10.1101/gad.216804.113; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shostak KO, 2003, J SURG ONCOL, V82, P57, DOI 10.1002/jso.10180; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wang H, 2011, NEOPLASIA, V13, P461, DOI 10.1593/neo.101744; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Xu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04223; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	42	2342	2426	34	492	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1396	1401		10.1126/science.1254257	http://dx.doi.org/10.1126/science.1254257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24925914	Green Submitted, Green Accepted			2022-12-24	WOS:000337531700040
J	Marion, E; Song, OR; Christophe, T; Babonneau, J; Fenistein, D; Eyer, J; Letournel, F; Henrion, D; Clere, N; Paille, V; Guerineau, NC; Saint Andre, JP; Gersbach, P; Altmann, KH; Stinear, TP; Comoglio, Y; Sandoz, G; Preisser, L; Delneste, Y; Yeramian, E; Marsollier, L; Brodin, P				Marion, Estelle; Song, Ok-Ryul; Christophe, Thierry; Babonneau, Jeremie; Fenistein, Denis; Eyer, Joel; Letournel, Frank; Henrion, Daniel; Clere, Nicolas; Paille, Vincent; Guerineau, Nathalie C.; Saint Andre, Jean-Paul; Gersbach, Philipp; Altmann, Karl-Heinz; Stinear, Timothy Paul; Comoglio, Yannick; Sandoz, Guillaume; Preisser, Laurence; Delneste, Yves; Yeramian, Edouard; Marsollier, Laurent; Brodin, Priscille			Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways	CELL			English	Article							MYCOLACTONE; MODULATION; INFECTION; PAINLESSNESS; INHIBITION; ANTAGONIST; ACTIVATION; DIAGNOSIS; EFFICACY; CANCER	Mycobacterium ulcerans, the etiological agent of Buruli ulcer, causes extensive skin lesions, which despite their severity are not accompanied by pain. It was previously thought that this remarkable analgesia is ensured by direct nerve cell destruction. We demonstrate here that M. ulcerans-induced hypoesthesia is instead achieved through a specific neurological pathway triggered by the secreted mycobacterial polyketide mycolactone. We decipher this pathway at the molecular level, showing that mycolactone elicits signaling through type 2 angiotensin II receptors (AT(2)Rs), leading to potassium-dependent hyperpolarization of neurons. We further validate the physiological relevance of this mechanism with in vivo studies of pain sensitivity in mice infected with M. ulcerans, following the disruption of the identified pathway. Our findings shed new light on molecular mechanisms evolved by natural systems for the induction of very effective analgesia, opening up the prospect of new families of analgesics derived from such systems.	[Marion, Estelle; Song, Ok-Ryul; Marsollier, Laurent] Inserm Avenir, F-49933 Angers, France; [Marion, Estelle; Song, Ok-Ryul; Christophe, Thierry; Babonneau, Jeremie; Fenistein, Denis; Marsollier, Laurent; Brodin, Priscille] Inserm Avenir, Inst Pasteur Korea, Songnam 463400, Gyeonggi Do, South Korea; [Song, Ok-Ryul; Brodin, Priscille] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun, Inserm U1019,CNRS UMR8204, F-59000 Lille, France; [Eyer, Joel; Letournel, Frank] UPRES, EA 3143, Lab Neurobiol & Transgenese, F-49933 Angers, France; [Fenistein, Denis; Paille, Vincent; Guerineau, Nathalie C.] Inserm 1083, CNRS, UMR 6214, Lab Biol Neurovasc & Mitochondriale Integree, F-49933 Angers, France; [Clere, Nicolas] Inserm U1063, F-49933 Angers, France; [Saint Andre, Jean-Paul] Lab Anatomie Pathol, F-49933 Angers, France; [Gersbach, Philipp; Altmann, Karl-Heinz] ETH, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Stinear, Timothy Paul] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Comoglio, Yannick; Sandoz, Guillaume] Univ Nice Sophia Antipolis, Inst Biol Valrose,Inserm Avenir, Labs Excellence Lon Channel Sci & Therapeut Nice, Inserm U1091,CNRS UMR 7277, F-06108 Nice, France; [Preisser, Laurence; Delneste, Yves; Marsollier, Laurent] Univ & CHU, CRCNA, CNRS U6299, Equipe 7,Inserm U892, F-49933 Angers, France; [Yeramian, Edouard] CNRS, Inst Pasteur, UMR 3528, Unite Bioinformat Struct, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Pasteur Korea; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Marsollier, L (corresponding author), Inserm Avenir, 4 Rue Larrey, F-49933 Angers, France.	laurent.marsollier@inserm.fr; priscille.brodin@inserm.fr	Delneste, Yves/O-3956-2016; Letournel, Franck/K-4263-2015; Henrion, Daniel/AAK-1995-2021; DELNESTE, Yves/K-7367-2015; Marsollier, Laurent/P-6178-2015; Henrion, Daniel/J-8141-2015; Brodin, Priscille/N-6979-2019; Eyer, Joel/V-8679-2019; Brodin, Priscille/E-5802-2014; Clere, Nicolas/K-4414-2015; Henrion, Daniel/N-7023-2015; Eyer, Joel/K-4265-2015; sandoz, guillaume/AAI-9236-2020; Marion, Estelle/G-3437-2016; preisser, laurence/K-7583-2015	Henrion, Daniel/0000-0003-1094-0285; DELNESTE, Yves/0000-0002-2142-596X; Henrion, Daniel/0000-0003-1094-0285; Brodin, Priscille/0000-0003-0991-7344; Eyer, Joel/0000-0001-6301-7465; Brodin, Priscille/0000-0003-0991-7344; Henrion, Daniel/0000-0003-1094-0285; Eyer, Joel/0000-0001-6301-7465; sandoz, guillaume/0000-0003-1251-0852; Marion, Estelle/0000-0003-4917-9665; Stinear, Timothy/0000-0003-0150-123X; Clere, Nicolas/0000-0002-6008-597X; Guerineau, Nathalie/0000-0003-2517-4210; Paille, Vincent/0000-0003-0424-0821; letournel, franck/0000-0003-2925-4453; Laurent, Marsollier/0000-0001-5497-5995; deboosere, Nathalie/0000-0002-2873-5485	Korea Research Foundation [K20802001409-09B1300-03700]; INSERM-Avenir; ANRS; Projet Tranversal de Recherche de l'Institut Pasteur [PTR212]; STAR Project; Raoul Follereau Foundation; European Community (ERC-STG) [260901]; European Community (MM4TB) [260872]; Agence Nationale de Recherche; Feder (Equipex Imaginex BioMed) [12001407 (D-AL)]; Region Nord Pas de Calais [1200080]; Region Pays de la Loire (ARMINA project)	Korea Research Foundation(National Research Foundation of Korea); INSERM-Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); ANRS(ANRSFrench National Research Agency (ANR)); Projet Tranversal de Recherche de l'Institut Pasteur; STAR Project; Raoul Follereau Foundation; European Community (ERC-STG); European Community (MM4TB); Agence Nationale de Recherche(French National Research Agency (ANR)); Feder (Equipex Imaginex BioMed); Region Nord Pas de Calais(Region Hauts-de-France); Region Pays de la Loire (ARMINA project)(Region Pays de la Loire)	We gratefully acknowledge Natacha Denisenko, Viviane Cassisa, Camille Dantec, Rimi Oh, Jean-Philippe Carralot, Antoine Caillon, and Pierre Legras for their technical assistance; Gerd Pluschke and Nicole Scherr for generous gift of the synthetic mycolactone; Gaspard Deloison, Elizabeth Werkmeister, Antonino Bongiovanni, and Frank Lafont from the Biolmaging Center of Lille for technical assistance; Guillaume Mabilleau from the SCIAM platform for electron microscopy; Francois Trottein for advices on prostaglandins; and Olivier Neyrolles for his critical reading of the manuscript. Lutz Hein generated and generously offered the AT<INF>2</INF>R KO mice for the experiments. Financial support for this work was provided by the Korea Research Foundation (Grant K20802001409-09B1300-03700), INSERM-Avenir, ANRS, Projet Tranversal de Recherche de l'Institut Pasteur (PTR212), the STAR Project, the Raoul Follereau Foundation, the European Community (ERC-STG Grant n degrees 260901, MM4TB Grant n degrees 260872), the Agence Nationale de Recherche, the Feder (12001407 (D-AL) Equipex Imaginex BioMed), the Region Nord Pas de Calais (1200080), and the Region Pays de la Loire (ARMINA project).	Anand U, 2013, EUR J PAIN, V17, P1012, DOI 10.1002/j.1532-2149.2012.00269.x; Asiedu K, 2000, BURULI ULCER MYCOBAC; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bedecs K, 1997, BIOCHEM J, V325, P449, DOI 10.1042/bj3250449; Besson JM, 1999, LANCET, V353, P1610, DOI 10.1016/S0140-6736(99)01313-6; Carralot JP, 2009, J BIOMOL SCREEN, V14, P151, DOI 10.1177/1087057108328762; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; DallAsta V, 1997, EXP CELL RES, V231, P260, DOI 10.1006/excr.1996.3469; En J, 2008, INFECT IMMUN, V76, P2002, DOI 10.1128/IAI.01588-07; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Gersbach P, 2011, CHEM-EUR J, V17, P13017, DOI 10.1002/chem.201101799; Goto M, 2006, AM J PATHOL, V168, P805, DOI 10.2353/ajpath.2006.050375; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Guenin-Mace L, 2013, J CLIN INVEST, V123, P1501, DOI 10.1172/JCI66576; Guenin-Mace L, 2011, P NATL ACAD SCI USA, V108, P12833, DOI 10.1073/pnas.1016496108; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Hoeijmakers JG, 2012, NAT REV NEUROL, V8, P369, DOI 10.1038/nrneurol.2012.97; Johnson PDR, 2005, PLOS MED, V2, P282, DOI 10.1371/journal.pmed.0020108; KANG J, 1994, AM J PHYSIOL-CELL PH, V267, pC1389, DOI 10.1152/ajpcell.1994.267.5.C1389; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Marsollier L, 2005, CELL MICROBIOL, V7, P935, DOI 10.1111/j.1462-5822.2005.00521.x; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Muralidharan A, 2014, PAIN MED, V15, P93, DOI 10.1111/pme.12258; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Nouet S, 2000, TRENDS ENDOCRIN MET, V11, P1, DOI 10.1016/S1043-2760(99)00205-2; Pelegrini-Da-Silva A, 2005, NEUROSCIENCE, V132, P453, DOI 10.1016/j.neuroscience.2004.12.046; Rice ASC, 2014, LANCET, V383, P1637, DOI 10.1016/S0140-6736(13)62337-5; Sandoz G, 2012, NEURON, V74, P1005, DOI 10.1016/j.neuron.2012.04.026; Sarfo FS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002101; Scherr N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002143; Simmonds RE, 2009, J IMMUNOL, V182, P2194, DOI 10.4049/jimmunol.0802294; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; Smith MT, 2013, PAIN MED, V14, P692, DOI 10.1111/pme.12063; Sumners C, 1998, CELL SIGNAL, V10, P303, DOI 10.1016/S0898-6568(97)00133-2; Szelenyi I, 2013, INFLAMM RES, V62, P251, DOI 10.1007/s00011-013-0592-5; Tobias NJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000553; Torrado E, 2010, J IMMUNOL, V184, P947, DOI 10.4049/jimmunol.0902717; Wansbrough-Jones M, 2006, LANCET, V367, P1849, DOI 10.1016/S0140-6736(06)68807-7; Williams FMK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003095	42	118	121	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1565	1576		10.1016/j.cell.2014.04.040	http://dx.doi.org/10.1016/j.cell.2014.04.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949969	Bronze			2022-12-24	WOS:000340941900012
J	Marquardt, S; Escalante-Chong, R; Pho, N; Wang, J; Churchman, LS; Springer, M; Buratowski, S				Marquardt, Sebastian; Escalante-Chong, Renan; Pho, Nam; Wang, Jue; Churchman, L. Stirling; Springer, Michael; Buratowski, Stephen			A Chromatin-Based Mechanism for Limiting Divergent Noncoding Transcription	CELL			English	Article							HISTONE H3; BIDIRECTIONAL PROMOTERS; SET2 METHYLATION; RNA; ACETYLATION; LYSINE-56; TERMINATION; CHAPERONE; UPSTREAM; EXCHANGE	In addition to their annotated transcript, many eukaryotic mRNA promoters produce divergent noncoding transcripts. To define determinants of divergent promoter directionality, we used genomic replacement experiments. Sequences within noncoding transcripts specified their degradation pathways, and functional protein-coding transcripts could be produced in the divergent direction. To screen for mutants affecting the ratio of transcription in each direction, a bidirectional fluorescent protein reporter construct was introduced into the yeast nonessential gene deletion collection. We identified chromatin assembly as an important regulator of divergent transcription. Mutations in the CAF-I complex caused genome-wide derepression of nascent divergent noncoding transcription. In opposition to the CAF-I chromatin assembly pathway, H3K56 hyperacetylation, together with the nucleosome remodeler SWI/SNF, facilitated divergent transcription by promoting rapid nucleosome turnover. We propose that these chromatin-mediated effects control divergent transcription initiation, complementing downstream pathways linked to early termination and degradation of the noncoding RNAs.	[Marquardt, Sebastian; Buratowski, Stephen] Harvard Med Sch, Dept Biol Chem & Mol Physiol, Boston, MA 02115 USA; [Escalante-Chong, Renan; Wang, Jue; Springer, Michael] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Pho, Nam] Harvard Med Sch, Res Comp Grp, Boston, MA 02115 USA; [Churchman, L. Stirling] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Physiol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu	Marquardt, Sebastian/AAU-8009-2021; Marquardt, Sebastian/C-2902-2015	Marquardt, Sebastian/0000-0003-1709-2717; Marquardt, Sebastian/0000-0003-1709-2717; /0000-0001-6913-4910	Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; NIH [HG007173NIH, GM46498, GM56663]; Harvard Medical School [NCRR 1S10RR028832-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056663, R01GM046498, R29GM046498] Funding Source: NIH RePORTER	Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ollie Rando for strains, Magdelana Murawska for help with NET-seq, Jody Moore for help with flow cytometry, Hannah Mischo for reagents, and members of S.B. and M.S. labs for discussion. This work was supported by a Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation to S.M., grants from the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, and NIH HG007173NIH to S.C., and NIH grants GM46498 and GM56663 to S.B. Support for the high-performance computer cluster at Harvard Medical School provided through grant NCRR 1S10RR028832-01.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Churchman L Stirling, 2012, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0414s98; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Preker P, 2009, CELL CYCLE, V8, P1106; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	48	76	78	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1712	1723		10.1016/j.cell.2014.04.036	http://dx.doi.org/10.1016/j.cell.2014.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949978	Bronze, Green Accepted			2022-12-24	WOS:000340941900023
J	Munz, M; Gobert, D; Schohl, A; Poquerusse, J; Podgorski, K; Spratt, P; Ruthazer, ES				Munz, Martin; Gobert, Delphine; Schohl, Anne; Poquerusse, Jessie; Podgorski, Kaspar; Spratt, Perry; Ruthazer, Edward S.			Rapid Hebbian axonal remodeling mediated by visual stimulation	SCIENCE			English	Article							RECEPTOR ANTAGONISTS DISRUPT; NMDA RECEPTOR; MAP FORMATION; IN-VIVO; RETINOTECTAL SYSTEM; TOPOGRAPHIC MAP; EXPERIENCE; INFUSION; ARBORS; MICE	We examined how correlated firing controls axon remodeling, using in vivo time-lapse imaging and electrophysiological analysis of individual retinal ganglion cell (RGC) axons that were visually stimulated either synchronously or asynchronously relative to neighboring inputs in the Xenopus laevis optic tectum. RGCs stimulated out of synchrony rapidly lost the ability to drive tectal postsynaptic partners while their axons grew and added many new branches. In contrast, synchronously activated RGCs produced fewer new branches, but these were more stable. The effects of synchronous activation were prevented by the inhibition of neurotransmitter release and N-methyl-D-aspartate receptor (NMDAR) blockade, which is consistent with a role for synaptic NMDAR activation in the stabilization of axonal branches and suppression of further exploratory branch addition.	[Munz, Martin; Gobert, Delphine; Schohl, Anne; Poquerusse, Jessie; Spratt, Perry; Ruthazer, Edward S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Poquerusse, Jessie] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Podgorski, Kaspar] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	McGill University; Dartmouth College; University of British Columbia	Ruthazer, ES (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Rue Univ, Montreal, PQ H3A 2B4, Canada.	edward.ruthazer@mcgill.ca	Ruthazer, Edward/H-4782-2019; Ruthazer, Edward S/P-5935-2014	Ruthazer, Edward/0000-0003-0452-3151; Ruthazer, Edward S/0000-0003-0452-3151; Podgorski, Kaspar/0000-0002-0374-2005	Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council (NSERC) of Canada; Deutscher Akademischer Austausch Dienst; NSERC CREATE Neuroengineering Training Program; Fonds de la recherche en sante du Quebec; NSERC	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); NSERC CREATE Neuroengineering Training Program; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank the laboratory of K. Haas (UBC) for assistance with the MATLAB analysis tool Dynamo for dynamic morphometric analysis. We also thank M. Meyer for providing us with the tetanus toxin light chain plasmid (5UAS-TeNT-EGFP) and D. Freiheit for photography of tadpoles. We are grateful to S. Glasgow for advice on statistical analysis and to H. Cline and W. Sossin for useful comments on our manuscript. This work was supported by grants from the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Council (NSERC) of Canada to E. S. R. and by fellowships from the Deutscher Akademischer Austausch Dienst and the NSERC CREATE Neuroengineering Training Program to M.M., the Fonds de la recherche en sante du Quebec to D.G., and NSERC to P.S. The authors declare that they have no conflicts of interest.	BEAR MF, 1990, J NEUROSCI, V10, P909; Benjumeda I, 2013, J NEUROSCI, V33, P18208, DOI 10.1523/JNEUROSCI.1931-13.2013; Cang JH, 2013, ANNU REV NEUROSCI, V36, P51, DOI 10.1146/annurev-neuro-062012-170341; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; DEBSKI EA, 1990, J NEUROBIOL, V21, P18, DOI 10.1002/neu.480210103; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; FREDJ NB, 2010, J NEUROSCI, V30, P10939, DOI DOI 10.1523/JNEUR0SCI.1556-10.2010; Hebb Donald O., 1949, ORG BEHAV; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; LIU H, 1994, P NATL ACAD SCI USA, V91, P8383, DOI 10.1073/pnas.91.18.8383; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062132; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Tremblay M, 2009, J NEUROSCI, V29, P14066, DOI 10.1523/JNEUROSCI.3542-09.2009; UDIN SB, 1983, NATURE, V301, P336, DOI 10.1038/301336a0; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	26	51	51	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					904	909		10.1126/science.1251593	http://dx.doi.org/10.1126/science.1251593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855269				2022-12-24	WOS:000336233800049
J	Engels, S; Schneider, NL; Lefeldt, N; Hein, CM; Zapka, M; Michalik, A; Elbers, D; Kittel, A; Hore, PJ; Mouritsen, H				Engels, Svenja; Schneider, Nils-Lasse; Lefeldt, Nele; Hein, Christine Maira; Zapka, Manuela; Michalik, Andreas; Elbers, Dana; Kittel, Achim; Hore, P. J.; Mouritsen, Henrik			Anthropogenic electromagnetic noise disrupts magnetic compass orientation in a migratory bird	NATURE			English	Article							MAGNETORECEPTION; MECHANISM; MODEL; CUES	Electromagnetic noise is emitted everywhere humans use electronic devices. For decades, it has been hotly debated whether man-made electric and magnetic fields affect biological processes, including human health(1-5). So far, no putative effect of anthropogenic electromagnetic noise at intensities below the guidelines adopted by the World Health Organization(1,2) has withstood the test of independent replication under truly blinded experimental conditions. No effect has therefore been widely accepted as scientifically proven(1-6). Here we show that migratory birds are unable to use their magnetic compass in the presence of urban electromagnetic noise. When European robins, Erithacus rubecula, were exposed to the background electromagnetic noise present in unscreened wooden huts at the University of Oldenburg campus, they could not orient using their magnetic compass. Their magnetic orientation capabilities reappeared inelectrically grounded, aluminium-screened huts, which attenuated electromagnetic noise in the frequency range from 50 kHz to 5 MHz by approximately two orders of magnitude. When the grounding was removed or when broadband electromagnetic noise was deliberately generated inside the screened and grounded huts, the birds again lost their magnetic orientation capabilities. The disruptive effect of radiofrequency electromagnetic fields is not confined to a narrow frequency band and birds tested far from sources of electromagnetic noise required no screening to orient with their magnetic compass. These fully double-blinded tests document a reproducible effect of anthropogenic electromagnetic noise on the behaviour of an intact vertebrate.	[Engels, Svenja; Schneider, Nils-Lasse; Lefeldt, Nele; Hein, Christine Maira; Zapka, Manuela; Michalik, Andreas; Elbers, Dana; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany; [Engels, Svenja; Schneider, Nils-Lasse; Lefeldt, Nele; Hein, Christine Maira; Zapka, Manuela; Michalik, Andreas; Elbers, Dana; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany; [Kittel, Achim] Carl von Ossietzky Univ Oldenburg, Inst Phys, D-26111 Oldenburg, Germany; [Hore, P. J.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; University of Oxford	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de	Hore, Peter/R-1923-2017; Mouritsen, Henrik/A-5401-2010	Hore, Peter/0000-0002-8863-570X; Mouritsen, Henrik/0000-0001-7082-4839	Defense Advanced Research Projects Agency [QuBE: N66001-10-1-4061]; VW-Stiftung; DFG [FOR 701, MO 1408/2-2]; Heinz Neumuller Stiftung; BMBF; European Research Council; EMF Biological Research Trust	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); VW-Stiftung; DFG(German Research Foundation (DFG)); Heinz Neumuller Stiftung; BMBF(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission); EMF Biological Research Trust(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Wuschek, Rohde & Schwarz, Bundesnetzagentur, and ETS Lindgren for help with measuring the electromagnetic fields, the workshops at the University of Oldenburg, especially T. Geiger, for building equipment, etc, and a large number of Bachelors, Masters and PhD students for help in conducting the experiments. We are grateful to the following for financial support: Defense Advanced Research Projects Agency (QuBE: N66001-10-1-4061 to P.J.H. and H. M.), VW-Stiftung (Lichtenberg professorship to H. M.), DFG (FOR 701 and MO 1408/2-2 to H. M.), Heinz Neumuller Stiftung (to C. M. H. and S. E.), BMBF (to H. M.), the European Research Council (to P.J.H.) and the EMF Biological Research Trust (to P.J.H.).	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Batschelet E, 1981, CIRCULAR STAT BIOL; Bruderer B, 1997, NATURWISSENSCHAFTEN, V84, P45, DOI 10.1007/s001140050348; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Chernetsov N, 2011, J EXP BIOL, V214, P2540, DOI 10.1242/jeb.057729; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; EMLEN ST, 1966, AUK, V83, P361, DOI 10.2307/4083048; Engels S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043271; Gauger EM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.040503; Health Protection Agency, 2012, HLTH EFF RAD EL FIEL; Hein CM, 2011, NATURE, V471, pE11, DOI 10.1038/nature09875; Hein CM, 2011, J ORNITHOL, V152, P27, DOI 10.1007/s10336-010-0540-x; Hein CM, 2010, J R SOC INTERFACE, V7, pS227, DOI 10.1098/rsif.2009.0376.focus; Johansen C, 2001, JNCI-J NATL CANCER I, V93, P203, DOI 10.1093/jnci/93.3.203; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Kirschvink JL, 2010, J R SOC INTERFACE, V7, pS179, DOI 10.1098/rsif.2009.0491.focus; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; MERKEL FRIEDRICH WILHELM, 1965, VOGELWARTE, V23, P71; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Mouritsen H, 2009, J ORNITHOL, V150, P713, DOI 10.1007/s10336-009-0421-3; Muheim R, 2006, SCIENCE, V313, P837, DOI 10.1126/science.1129709; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Solov'yov IA, 2014, SCI REP-UK, V4, DOI 10.1038/srep03845; Swanson J, 2006, RADIAT RES, V165, P470, DOI 10.1667/RR3522.1; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R., 1995, TIEROSYCHOL; World Health Organization, 2007, ENV HLTH CRIT MON, V238; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528; Ziegelberger G, 2009, HEALTH PHYS, V97, P257, DOI 10.1097/HP.0b013e3181aff9db	36	220	222	8	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					353	+		10.1038/nature13290	http://dx.doi.org/10.1038/nature13290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805233	Green Submitted			2022-12-24	WOS:000336121200037
J	Molofsky, AV; Kelley, KW; Tsai, HH; Redmond, SA; Chang, SM; Madireddy, L; Chan, JR; Baranzini, SE; Ullian, EM; Rowitch, DH				Molofsky, Anna V.; Kelley, Kevin W.; Tsai, Hui-Hsin; Redmond, Stephanie A.; Chang, Sandra M.; Madireddy, Lohith; Chan, Jonah R.; Baranzini, Sergio E.; Ullian, Erik M.; Rowitch, David H.			Astrocyte-encoded positional cues maintain sensorimotor circuit integrity	NATURE			English	Article							DEVELOPING SPINAL-CORD; MOTOR-NEURONS; SEMAPHORIN-III; BRAIN-DEVELOPMENT; SENSORY AXONS; ADULT-MOUSE; SPECIFICATION; GENERATION; EXPRESSION; IDENTIFICATION	Astrocytes, the most abundant cells in the central nervous system, promote synapse formation and help to refine neural connectivity. Although they are allocated to spatially distinct regional domains during development, it is unknown whether region-restricted astrocytes are functionally heterogeneous. Here we show that postnatal spinal cord astrocytes express several region-specific genes, and that ventral astrocyte-encoded semaphorin 3a (Sema3a) is required for proper motor neuron and sensory neuron circuit organization. Loss of astrocyte-encoded Sema3a leads to dysregulated alpha-motor neuron axon initial segment orientation, markedly abnormal synaptic inputs, and selective death of alpha- but not of adjacent gamma-motor neurons. In addition, a subset of TrkA(+) sensory afferents projects to ectopic ventral positions. These findings demonstrate that stable maintenance of a positional cue by developing astrocytes influences multiple aspects of sensorimotor circuit formation. More generally, they suggest that regional astrocyte heterogeneity may help to coordinate postnatal neural circuit refinement.	[Molofsky, Anna V.; Kelley, Kevin W.; Tsai, Hui-Hsin; Chang, Sandra M.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Molofsky, Anna V.; Kelley, Kevin W.; Tsai, Hui-Hsin; Chang, Sandra M.; Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Molofsky, Anna V.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Kelley, Kevin W.; Tsai, Hui-Hsin; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Kelley, Kevin W.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Kelley, Kevin W.; Redmond, Stephanie A.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Redmond, Stephanie A.; Madireddy, Lohith; Chan, Jonah R.; Baranzini, Sergio E.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ullian, Erik M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Rowitch, David H.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rowitch, DH (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	rowitchd@peds.ucsf.edu	Ritter, Stefanie L/D-9312-2012; Molofsky, Anna Victoria/P-2506-2018	Molofsky, Anna Victoria/0000-0002-4709-2411; Rowitch, David/0000-0002-0079-0060; Baranzini, Sergio/0000-0003-0067-194X; Redmond, Stephanie/0000-0002-5580-6269	NIMH [5T32MH089920-04, R01MH099595-01]; APA/Pfizer MD/PhD Psychiatric Research Fellowship; California Institute for Regenerative Medicine [TG2-01153]; Ruth L. Kirschstein NRSA [FNS081905A]; NINDS [R01 NS059893]; NIH [1DP2OD006507-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099595, T32MH089920, K08MH104417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062796, R01NS059893, F31NS081905] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006507] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); APA/Pfizer MD/PhD Psychiatric Research Fellowship; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Flanagan, T. Jessell, J. de Nooj, N. Balaskas, M. Hancock, S. Ohata and R. Krencik for comments on the manuscript and technical suggestions. We are grateful to K. Sabeur, M. Wong and the UCSF Flow Cytometry and Genomics core facilities for expert technical help, A. Kolodkin for Sema3a probe construct, L. Reichardt for the TrkA antibody, J. Dasen for FoxP1 and Scip antibodies, and N. Heintz and J. Dougherty for Aldh1L1-cre mice. A. V. M. is supported by an NIMH Training Grant (5T32MH089920-04) and an APA/Pfizer MD/PhD Psychiatric Research Fellowship. K. W. K is supported by the California Institute for Regenerative Medicine (TG2-01153). S. A. R. is supported by a Ruth L. Kirschstein NRSA FNS081905A. This work was supported by grants from the NINDS (to D. H. R. (R01 NS059893) and J. R. C.), E. M. U. is supported by NIMH (R01MH099595-01), an NIH New Innovator Award (1DP2OD006507-01) and That Man May See. D. H. R. is a HHMI Investigator.	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Ashrafi S, 2012, J NEUROSCI, V32, P8725, DOI 10.1523/JNEUROSCI.1160-12.2012; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; Brumovsky P. R., 2013, NEUROLOGY, V2013; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAMU W, 1992, J NEUROSCI METH, V44, P59, DOI 10.1016/0165-0270(92)90114-S; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Duflocq A, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-66; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Freeman MR, 2013, NEURON, V80, P613, DOI 10.1016/j.neuron.2013.10.034; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Liu Y, 2011, CURR OPIN NEUROBIOL, V21, P52, DOI 10.1016/j.conb.2010.09.003; Magavi S, 2012, J NEUROSCI, V32, P4762, DOI 10.1523/JNEUROSCI.3560-11.2012; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Mitra P, 2012, J NEUROPHYSIOL, V107, P728, DOI 10.1152/jn.00558.2011; Molofsky AV, 2013, GLIA, V61, P1518, DOI 10.1002/glia.22538; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nishiyama M, 2011, NAT CELL BIOL, V13, P676, DOI 10.1038/ncb2255; Ozaki S, 1997, J COMP NEUROL, V380, P215; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Tien AC, 2012, DEVELOPMENT, V139, P2477, DOI 10.1242/dev.077214; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	44	186	189	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					189	+		10.1038/nature13161	http://dx.doi.org/10.1038/nature13161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24776795	Green Accepted, Green Submitted			2022-12-24	WOS:000335454300031
J	Chae, L; Kim, T; Nilo-Poyanco, R; Rhee, SY				Chae, Lee; Kim, Taehyong; Nilo-Poyanco, Ricardo; Rhee, Seung Y.			Genomic Signatures of Specialized Metabolism in Plants	SCIENCE			English	Article							EVOLUTION; CHEMODIVERSITY; BIOLOGY; VIEW	All plants synthesize basic metabolites needed for survival (primary metabolism), but different taxa produce distinct metabolites that are specialized for specific environmental interactions (specialized metabolism). Because evolutionary pressures on primary and specialized metabolism differ, we investigated differences in the emergence and maintenance of these processes across 16 species encompassing major plant lineages from algae to angiosperms. We found that, relative to their primary metabolic counterparts, genes coding for specialized metabolic functions have proliferated to a much greater degree and by different mechanisms and display lineage-specific patterns of physical clustering within the genome and coexpression. These properties illustrate the differential evolution of specialized metabolism in plants, and collectively they provide unique signatures for the potential discovery of novel specialized metabolic processes.	[Chae, Lee; Kim, Taehyong; Nilo-Poyanco, Ricardo; Rhee, Seung Y.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Rhee, SY (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	srhee@carnegiescience.edu	Poyanco, Ricardo Nilo/AAJ-8006-2021	Poyanco, Ricardo Nilo/0000-0003-3041-7539	Becas Chile-Conicyt; NSF [DBI-0640769, IOS-1026003]; Direct For Biological Sciences [1026003] Funding Source: National Science Foundation	Becas Chile-Conicyt; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Osbourn, E. Sattely, and K. Dreher for comments. Supported by a Becas Chile-Conicyt postdoctoral fellowship (R.N.-P.) and by NSF grants DBI-0640769 and IOS-1026003. Data are available as supplementary data files S1 to S5. The enzyme annotation program is available for download at https://dpb.carnegiescience.edu/labs/rhee-lab/software.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Kliebenstein DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001838; Mishler BD, 2000, TAXON, V49, P661, DOI 10.2307/1223970; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Obayashi T, 2011, PLANT CELL PHYSIOL, V52, P213, DOI 10.1093/pcp/pcq203; Schilmiller AL, 2012, CURR OPIN PLANT BIOL, V15, P338, DOI 10.1016/j.pbi.2011.12.005; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Weng JK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00119; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Wink M., 2010, BIOCH PLANT SECONDAR, V2nd; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Yonekura-Sakakibara K, 2009, NAT PROD REP, V26, P1466, DOI 10.1039/b817077k	16	171	176	7	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					510	513		10.1126/science.1252076	http://dx.doi.org/10.1126/science.1252076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786077				2022-12-24	WOS:000335157700041
J	Xu, H; Yang, JL; Gao, WQ; Li, L; Li, P; Zhang, L; Gong, YN; Peng, XL; Xi, JZJ; Chen, S; Wang, FC; Shao, F				Xu, Hao; Yang, Jieling; Gao, Wenqing; Li, Lin; Li, Peng; Zhang, Li; Gong, Yi-Nan; Peng, Xiaolan; Xi, Jianzhong Jeff; Chen, She; Wang, Fengchao; Shao, Feng			Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome	NATURE			English	Article							FAMILIAL MEDITERRANEAN FEVER; GTP-BINDING PROTEINS; CLOSTRIDIUM-DIFFICILE; BURKHOLDERIA-CENOCEPACIA; TOXIN-B; ACTIN CYTOSKELETON; VIBRIO-CHOLERAE; RTX TOXIN; ACTIVATION; SYSTEM	Cytosolic inflammasome complexes mediated by a pattern recognition receptor (PRR) defend against pathogen infection by activating caspase 1. Pyrin, a candidate PRR, can bind to the inflammasome adaptor ASC to form a caspase 1-activating complex(1,2). Mutations in the Pyrin-encoding gene, MEFV, cause a human autoinflammatory disease known as familial Mediterranean fever(3-5). Despite important roles in immunity and disease, the physiological function of Pyrin remains unknown. Here we show that Pyrin mediates caspase 1 inflammasome activation in response to Rho-glucosylation activity of cytotoxin TcdB(6-8), a major virulence factor of Clostridium difficile, which causes most cases of nosocomial diarrhoea. The glucosyltransferase-inactive TcdB mutant loses the inflammasome-stimulating activity. Other Rho-inactivating toxins, including FIC-domain adenylyltransferases (Vibrioparahaemolyticus VopS and Histophilus somnilbpA) and Clostridium botulinum ADP-ribosylating C3 toxin, can also biochemically activate the Pyrin inflammasome in their enzymatic activitydependent manner. These toxins all target the Rho subfamily and modify a switch-I residue. We further demonstrate that Burkholderia cenocepacia inactivates RHOA by deamidating Asn 41, also in the switch-I region, and thereby triggers Pyrin inflammasome activation, both of which require the bacterial type VI secretion system (T6SS). Loss of the Pyrin inflammasome causes elevated intra-macrophage growth of B. cenocepacia and diminished lung inflammation in mice. Thus, Pyrin functions to sense pathogen modification and inactivation of Rho GTPases, representing a new paradigm in mammalian innate immunity.	[Xu, Hao; Yang, Jieling; Gao, Wenqing; Li, Lin; Li, Peng; Zhang, Li; Gong, Yi-Nan; Peng, Xiaolan; Chen, She; Wang, Fengchao; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yang, Jieling; Shao, Feng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Xi, Jianzhong Jeff] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Shao, Feng] Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Peking University	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Xi, Jianzhong/J-1420-2014	Xu, Hao/0000-0003-3286-0710	International Early Career Scientist grant from the Howard Hughes Medical Institute; National Basic Research Program of China 973 Program [2012CB518700]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020202]; China National Science Foundation Program for Distinguished Young Scholars [31225002]	International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Basic Research Program of China 973 Program(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China National Science Foundation Program for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC))	We thank V. Dixit for providing knockout mice and anti-ASC antibody, D. Lyras for C. sordellii genomic DNA, J. Xiao for IbpA-Fic constructs, T. Iida for V. parahaemolyticus strain, M. Valvano for pDAI-Scel vector and H. Feng for TcdB B. megaterium expression system. We thank members of the Shao laboratory for discussions. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute to F.S. This work was also supported by the National Basic Research Program of China 973 Program (2012CB518700), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08020202) and China National Science Foundation Program for Distinguished Young Scholars (31225002) to F.S.	AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; [Anonymous], 1997, CELL, V90, P797; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Flannagan RS, 2012, CELL MICROBIOL, V14, P239, DOI 10.1111/j.1462-5822.2011.01715.x; French FMF Consortium, 1997, NATURE GENET, V17, P25; Fukazawa A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000228; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Higa N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003142; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Ng J., 2010, GASTROENTEROLOGY, V139; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Rosales-Reyes R, 2012, CELL MICROBIOL, V14, P255, DOI 10.1111/j.1462-5822.2011.01716.x; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Waite AL, 2009, EXP BIOL MED, V234, P40, DOI 10.3181/0806-RM-184; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	39	498	516	8	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					237	+		10.1038/nature13449	http://dx.doi.org/10.1038/nature13449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	24919149	Bronze			2022-12-24	WOS:000341362800051
J	Bingol, B; Tea, JS; Phu, L; Reichelt, M; Bakalarski, CE; Song, QH; Foreman, O; Kirkpatrick, DS; Sheng, MG				Bingol, Baris; Tea, Joy S.; Phu, Lilian; Reichelt, Mike; Bakalarski, Corey E.; Song, Qinghua; Foreman, Oded; Kirkpatrick, Donald S.; Sheng, Morgan			The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy	NATURE			English	Article							DOPAMINERGIC NEURON DEGENERATION; DROSOPHILA MODEL; DISEASE; UBIQUITINATION; MUTATIONS; PINK1; PHOSPHORYLATION; DEPOLARIZATION; DYSFUNCTION; P62/SQSTM1	Cells maintain healthy mitochondria by degrading damaged mitochondria through mitophagy; defective mitophagy is linked to Parkinson's disease. Here we report that USP30, a deubiquitinase localized to mitochondria, antagonizes mitophagy driven by the ubiquitin ligase parkin (also known as PARK2) and protein kinase PINK1, which are encoded by two genes associated with Parkinson's disease. Parkin ubiquitinates and tags damaged mitochondria for clearance. Overexpression of USP 30 removes ubiquitin attached by parkin onto damaged mitochondria and blocks parkin's ability to drive mitophagy, whereas reducing USP30 activity enhances mitochondrial degradation in neurons. Global ubiquitination site profiling identified multiple mitochondrial substrates oppositely regulated by parkin and USP30. Knockdown of USP30 rescues the defective mitophagy caused by pathogenic mutations in parkin and improves mitochondrial integrity in parkin-or PINK1-deficient flies. Knockdown of USP30 in dopaminergic neurons protects flies against paraquat toxicity in vivo, ameliorating defects in dopamine levels, motor function and organismal survival. Thus USP30 inhibition is potentially beneficial for Parkinson's disease by promoting mitochondrial clearance and quality control.	[Bingol, Baris; Tea, Joy S.; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Phu, Lilian; Kirkpatrick, Donald S.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Reichelt, Mike; Foreman, Oded] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Bakalarski, Corey E.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Song, Qinghua] Genentech Inc, Dept Nonclin Biostat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Bingol, B (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	bingol.baris@gene.com	liu, wen/HGE-3071-2022; Liu, Zhanqiang/HGC-0565-2022	Sheng, Morgan/0000-0002-8703-5366; Kirkpatrick, Donald/0000-0003-3091-2804; Tea, Joy/0000-0002-3395-149X; Bakalarski, Corey/0000-0003-1085-7828				Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Bustos D, 2012, MOL CELL PROTEOMICS, V11, P1529, DOI 10.1074/mcp.R112.019117; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Guo M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009944; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Nakamura N, 2008, MOL BIOL CELL, V19, P1903, DOI 10.1091/mbc.E07-11-1103; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pinheiro J., 2011, NLME LINEAR NONLINEA; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sang TK, 2007, J NEUROSCI, V27, P981, DOI 10.1523/JNEUROSCI.4810-06.2007; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang C, 2007, J NEUROSCI, V27, P8563, DOI 10.1523/JNEUROSCI.0218-07.2007; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338	41	515	547	7	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					370	+		10.1038/nature13418	http://dx.doi.org/10.1038/nature13418			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24896179				2022-12-24	WOS:000337350200029
J	Myburg, AA; Grattapaglia, D; Tuskan, GA; Hellsten, U; Hayes, RD; Grimwood, J; Jenkins, J; Lindquist, E; Tice, H; Bauer, D; Goodstein, DM; Dubchak, I; Poliakov, A; Mizrachi, E; Kullan, ARK; Hussey, SG; Pinard, D; Van der Merwe, K; Singh, P; Van Jaarsveld, I; Silva, OB; Togawa, RC; Pappas, MR; Faria, DA; Sansaloni, CP; Petroli, CD; Yang, XH; Ranjan, P; Tschaplinski, TJ; Ye, CY; Li, T; Sterck, L; Vanneste, K; Murat, F; Soler, M; Clemente, HS; Saidi, N; Cassan-Wang, H; Dunand, C; Hefer, CA; Bornberg-Bauer, E; Kersting, AR; Vining, K; Amarasinghe, V; Ranik, M; Naithani, S; Elser, J; Boyd, AE; Liston, A; Spatafora, JW; Dharmwardhana, P; Raja, R; Sullivan, C; Romanel, E; Alves-Ferreira, M; Lheim, CK; Foley, W; Carocha, V; Paiva, J; Kudrna, D; Brommonschenkel, SH; Pasquali, G; Byrne, M; Rigault, P; Tibbits, J; Spokevicius, A; Jones, RC; Steane, DA; Vaillancourt, RE; Potts, BM; Joubert, F; Barry, K; Pappas, GJ; Strauss, SH; Jaiswal, P; Grima-Pettenati, J; Salse, J; Van de Peer, Y; Rokhsar, DS; Schmutz, J				Myburg, Alexander A.; Grattapaglia, Dario; Tuskan, Gerald A.; Hellsten, Uffe; Hayes, Richard D.; Grimwood, Jane; Jenkins, Jerry; Lindquist, Erika; Tice, Hope; Bauer, Diane; Goodstein, David M.; Dubchak, Inna; Poliakov, Alexandre; Mizrachi, Eshchar; Kullan, Anand R. K.; Hussey, Steven G.; Pinard, Desre; Van der Merwe, Karen; Singh, Pooja; Van Jaarsveld, Ida; Silva-Junior, Orzenil B.; Togawa, Roberto C.; Pappas, Marilia R.; Faria, Danielle A.; Sansaloni, Carolina P.; Petroli, Cesar D.; Yang, Xiaohan; Ranjan, Priya; Tschaplinski, Timothy J.; Ye, Chu-Yu; Li, Ting; Sterck, Lieven; Vanneste, Kevin; Murat, Florent; Soler, Maral; Clemente, Helene San; Saidi, Naijib; Cassan-Wang, Hua; Dunand, Christophe; Hefer, Charles A.; Bornberg-Bauer, Erich; Kersting, Anna R.; Vining, Kelly; Amarasinghe, Vindhya; Ranik, Martin; Naithani, Sushma; Elser, Justin; Boyd, Alexander E.; Liston, Aaron; Spatafora, Joseph W.; Dharmwardhana, Palitha; Raja, Rajani; Sullivan, Christopher; Romanel, Elisson; Alves-Ferreira, Marcio; Lheim, Carsten Ku; Foley, William; Carocha, Victor; Paiva, Jorge; Kudrna, David; Brommonschenkel, Sergio H.; Pasquali, Giancarlo; Byrne, Margaret; Rigault, Philippe; Tibbits, Josquin; Spokevicius, Antanas; Jones, Rebecca C.; Steane, Dorothy A.; Vaillancourt, Rene E.; Potts, Brad M.; Joubert, Fourie; Barry, Kerrie; Pappas, Georgios J., Jr.; Strauss, Steven H.; Jaiswal, Pankaj; Grima-Pettenati, Jacqueline; Salse, Jerome; Van de Peer, Yves; Rokhsar, Daniel S.; Schmutz, Jeremy			The genome of Eucalyptus grandis	NATURE			English	Article							WHOLE-GENOME; NUCLEAR-DNA; PLANT; ALIGNMENT; TOOLS; GENE; DIVERSITY; EVOLUTION; DATABASE; TANDEM	Eucalypts are the world's most widely planted hardwood trees. Their outstanding diversity, adaptability and growth have made them a global renewable resource of fibre and energy. We sequenced and assembled >94% of the 640-megabase genome of Eucalyptus grandis. Of 36,376 predicted protein-coding genes, 34% occur in tandem duplications, the largest proportion thus far in plant genomes. Eucalyptus also shows the highest diversity of genes for specialized metabolites such as terpenes that act as chemical defence and provide unique pharmaceutical oils. Genome sequencing of the E. grandis sister species E. globulus and a set of inbred E. grandis tree genomes reveals dynamic genome evolution and hotspots of inbreeding depression. The E. grandis genome is the first reference for the eudicot order Myrtales and is placed here sister to the eurosids. This resource expands our understanding of the unique biology of large woody perennials and provides a powerful tool to accelerate comparative biology, breeding and biotechnology.	[Myburg, Alexander A.; Mizrachi, Eshchar; Kullan, Anand R. K.; Hussey, Steven G.; Pinard, Desre; Van der Merwe, Karen; Singh, Pooja] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst FABI, ZA-0028 Pretoria, South Africa; [Myburg, Alexander A.; Mizrachi, Eshchar; Kullan, Anand R. K.; Hussey, Steven G.; Pinard, Desre; Van der Merwe, Karen; Singh, Pooja; Joubert, Fourie; Van de Peer, Yves] Univ Pretoria, Genom Res Inst GRI, ZA-0028 Pretoria, South Africa; [Grattapaglia, Dario; Pappas, Marilia R.; Faria, Danielle A.; Sansaloni, Carolina P.; Petroli, Cesar D.] EPQB Final W5 Norte, EMBRAPA Recursos Genet & Biotecnol, Lab Genet Vegetal, BR-70770917 Brasilia, DF, Brazil; [Grattapaglia, Dario] Univ Catolica Brasilia SGAN 916, Programa Ciencias Genom & Biotecnol, BR-70790160 Brasilia, DF, Brazil; [Tuskan, Gerald A.; Hellsten, Uffe; Hayes, Richard D.; Lindquist, Erika; Tice, Hope; Bauer, Diane; Goodstein, David M.; Dubchak, Inna; Poliakov, Alexandre; Barry, Kerrie; Rokhsar, Daniel S.; Schmutz, Jeremy] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Tuskan, Gerald A.; Yang, Xiaohan; Ranjan, Priya; Tschaplinski, Timothy J.; Ye, Chu-Yu; Li, Ting] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Grimwood, Jane; Jenkins, Jerry; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35801 USA; [Van Jaarsveld, Ida; Hefer, Charles A.; Joubert, Fourie] Univ Pretoria, Dept Biochem, Bioinformat & Computat Biol Unit, ZA-0028 Pretoria, South Africa; [Silva-Junior, Orzenil B.; Togawa, Roberto C.] EPQB Final W5 Norte, EMBRAPA Recursos Genet & Biotecnol, Lab Bioinformat, BR-70770917 Brasilia, DF, Brazil; [Sterck, Lieven; Vanneste, Kevin; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Murat, Florent; Salse, Jerome] INRA UBP UMR 1095, F-63100 Clermont Ferrand, France; [Soler, Maral; Clemente, Helene San; Saidi, Naijib; Cassan-Wang, Hua; Dunand, Christophe; Carocha, Victor; Grima-Pettenati, Jacqueline] Univ Toulouse 3, Lab Rech Sci Vegetales, UMR 5546, CNRS, F-31326 Castanet Tolosan, France; [Hefer, Charles A.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Bornberg-Bauer, Erich; Kersting, Anna R.] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Kersting, Anna R.] Univ Dusseldorf, Inst Comp Sci, Dept Bioinformat, D-40225 Dusseldorf, Germany; [Vining, Kelly; Amarasinghe, Vindhya; Ranik, Martin; Strauss, Steven H.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Naithani, Sushma; Elser, Justin; Liston, Aaron; Spatafora, Joseph W.; Dharmwardhana, Palitha; Raja, Rajani; Jaiswal, Pankaj] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Naithani, Sushma; Boyd, Alexander E.; Liston, Aaron; Spatafora, Joseph W.; Sullivan, Christopher; Jaiswal, Pankaj] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Romanel, Elisson] Univ Fed Rio de Janeiro, Dept Genet, Lab Biol Evolut Teor & Aplicada, BR-21949900 Rio de Janeiro, Brazil; [Romanel, Elisson] EEL USP, Dept Biotecnol, BR-12602810 Lorena, SP, Brazil; [Romanel, Elisson; Alves-Ferreira, Marcio] Univ Fed Rio de Janeiro, Dept Genet, LGMV, BR-21949900 Rio de Janeiro, Brazil; [Lheim, Carsten Ku; Foley, William] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Carocha, Victor; Paiva, Jorge] IICT MNE, P-1349007 Lisbon, Portugal; [Carocha, Victor; Paiva, Jorge] IBET ITQB, P-2781901 Oeiras, Portugal; [Kudrna, David] Univ Arizona, Arizona Genom Inst, Tucson, AZ 85721 USA; [Brommonschenkel, Sergio H.] Univ Fed Vicosa, Dep Fitopatol, BR-36570000 Vicosa, MG, Brazil; [Pasquali, Giancarlo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil; [Byrne, Margaret] Dept Parks & Wildlife, Sci & Conservat Div, Bentley, WA 6983, Australia; [Rigault, Philippe] GYDLE, Quebec City, PQ G1T 1Z2, Canada; [Tibbits, Josquin] Victorian Govt, Dept Environm & Primary Ind, Yallambie, Vic 3085, Australia; [Spokevicius, Antanas] Univ Melbourne, Melbourne Sch Land & Environm, Melbourne, Vic 3010, Australia; [Jones, Rebecca C.; Steane, Dorothy A.; Vaillancourt, Rene E.; Potts, Brad M.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Jones, Rebecca C.; Steane, Dorothy A.; Vaillancourt, Rene E.; Potts, Brad M.] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas 7001, Australia; [Steane, Dorothy A.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld 4558, Australia; [Pappas, Georgios J., Jr.] Univ Brasilia, Dept Biol Celular, BR-70910900 Brasilia, DF, Brazil	University of Pretoria; University of Pretoria; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Oak Ridge National Laboratory; HudsonAlpha Institute for Biotechnology; University of Pretoria; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Flanders Institute for Biotechnology (VIB); Ghent University; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of British Columbia; University of Munster; Heinrich Heine University Dusseldorf; Oregon State University; Oregon State University; Oregon State University; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Australian National University; University of Arizona; Universidade Federal de Vicosa; Universidade Federal do Rio Grande do Sul; University of Melbourne; University of Tasmania; University of Tasmania; University of the Sunshine Coast; Universidade de Brasilia	Myburg, AA (corresponding author), Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst FABI, Private Bag X20, ZA-0028 Pretoria, South Africa.	zander.myburg@up.ac.za	Steane, Dorothy/N-9940-2013; Myburg, Alexander A/C-5426-2008; Paiva, Jorge A P/C-2858-2008; Dunand, Christophe/I-6424-2012; Vaillancourt, Rene E/J-7456-2014; Jaiswal, Pankaj/H-7599-2016; Soler, Marçal/G-3522-2016; Jones, Rebecca C/J-7901-2014; Jenkins, Jerry/ABE-6479-2020; Van de Peer, Yves/D-4388-2009; Wang, Hua Cassan/AAF-5966-2021; Byrne, Margaret/H-8198-2015; Sterck, Lieven/A-9439-2016; Jaiswal, Pankaj/R-4214-2019; Bornberg-Bauer, Erich/A-1563-2013; Tuskan, Gerald/A-6225-2011; Romanel, Elisson AC/F-1933-2013; Yang, Xiaohan/AAM-2449-2020; Van de Peer, Yves/AAE-7666-2019; Alves-Ferreira, Marcio/C-5849-2009; Vaillancourt, Rene E/C-6123-2013; Potts, Brad M/C-6489-2013; Hussey, Steven/AAM-6245-2021; Grattapaglia, Dario/B-5864-2014; Grattapaglia, Dario/AAB-6805-2020; Yang, Xiaohan/A-6975-2011; Pasquali, Giancarlo/L-6421-2013; Barry, Kerrie Whitelaw/AAA-5500-2020; Kulheim, Carsten/AAR-2734-2021; Hefer, Charles/A-6093-2011; Tschaplinski, Timothy/D-6382-2018; Schmutz, Jeremy/N-3173-2013; Kulheim, Carsten/F-4720-2010; Pappas, Georgios J/D-5933-2016; Pappas, Georgios J./N-8071-2019; Foley, William J/C-8069-2009; Naithani, Sushma/AAU-1450-2021; Grimwood, Jane/ABD-5737-2021; Romanel, Elisson AC/E-5888-2019; Silva-Junior, Orzenil/B-3488-2013; Mizrachi, Eshchar/N-3179-2014	Myburg, Alexander A/0000-0003-0644-5003; Paiva, Jorge A P/0000-0003-3162-4396; Dunand, Christophe/0000-0003-1637-4042; Vaillancourt, Rene E/0000-0002-1159-9149; Jaiswal, Pankaj/0000-0002-1005-8383; Soler, Marçal/0000-0002-9138-9394; Jones, Rebecca C/0000-0002-6491-1423; Jenkins, Jerry/0000-0002-7943-3997; Van de Peer, Yves/0000-0003-4327-3730; Wang, Hua Cassan/0000-0002-7395-9285; Byrne, Margaret/0000-0002-7197-5409; Sterck, Lieven/0000-0001-7116-4000; Jaiswal, Pankaj/0000-0002-1005-8383; Bornberg-Bauer, Erich/0000-0002-1826-3576; Tuskan, Gerald/0000-0003-0106-1289; Romanel, Elisson AC/0000-0002-4794-4215; Yang, Xiaohan/0000-0001-5207-4210; Van de Peer, Yves/0000-0003-4327-3730; Alves-Ferreira, Marcio/0000-0002-6107-3700; Vaillancourt, Rene E/0000-0002-1159-9149; Potts, Brad M/0000-0001-6244-289X; Hussey, Steven/0000-0002-1079-8373; Grattapaglia, Dario/0000-0002-0050-970X; Grattapaglia, Dario/0000-0002-0050-970X; Yang, Xiaohan/0000-0001-5207-4210; Pasquali, Giancarlo/0000-0003-1256-544X; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Hefer, Charles/0000-0001-7527-5461; Tschaplinski, Timothy/0000-0002-9540-6622; Schmutz, Jeremy/0000-0001-8062-9172; Pappas, Georgios J/0000-0002-1100-976X; Pappas, Georgios J./0000-0002-1100-976X; Foley, William J/0000-0001-8587-1814; Naithani, Sushma/0000-0001-7819-4552; Romanel, Elisson AC/0000-0002-4794-4215; Silva-Junior, Orzenil/0000-0002-2104-2010; Steane, Dorothy/0000-0002-8061-8454; Ranjan, Priya/0000-0002-0357-1939; Togawa, Roberto/0000-0001-7179-3210; Rokhsar, Daniel/0000-0002-8704-2224; Mizrachi, Eshchar/0000-0002-3126-9593; Goodstein, David/0000-0001-6287-2697; Spokevicius, Antanas/0000-0003-3507-9583; Singh, Pooja/0000-0001-6576-400X; Pinard, Desre/0000-0001-5600-0139; Kulheim, Carsten/0000-0002-0798-3324; Hayes, Richard/0000-0002-5236-7918; Murat, Florent/0000-0003-2116-2511; Pappas, Marilia/0000-0002-4680-0199; Saidi, Mohamed Najib/0000-0002-7692-4643	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Office of Biological and Environmental Research in the US Department of Energy Office of Science, US DOE Bioenergy Center [DE-AC05-00OR22725]; Brazilian Ministry of Science, Technology and Innovation (MCTI) through (CNPq); Brazilian Ministry of Science, Technology and Innovation (MCTI) through (FINEP); Brazilian Federal District Research Foundation (FAP-DF); Technology and Human Resources for Industry Programme (THRIP) [UID 80118]; South African Department of Science and Technology (DST); National Research Foundation (NRF) [UID 18312, 86936]; Laboratoire d'Excellence [LABEX TULIP ANR-10-LABX-41]; Agence Nationale pour la Recherche (Project Tree For Joules) [ANR-2010-KBBE-007-01]; Fundacao para a Ciencia e Tecnologia (FCT) [P-KBBE/AGR_GPL/0001/2010]; Centre National pour la Recherche Scientifique (CNRS); University Paul Sabatier Toulouse III (UPS); Ghent University; Hercules Foundation; Flemish Government-department EWI; Div Of Industrial Innovation & Partnersh [1238305] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the US Department of Energy Office of Science, US DOE Bioenergy Center(United States Department of Energy (DOE)); Brazilian Ministry of Science, Technology and Innovation (MCTI) through (CNPq); Brazilian Ministry of Science, Technology and Innovation (MCTI) through (FINEP); Brazilian Federal District Research Foundation (FAP-DF); Technology and Human Resources for Industry Programme (THRIP); South African Department of Science and Technology (DST); National Research Foundation (NRF); Laboratoire d'Excellence; Agence Nationale pour la Recherche (Project Tree For Joules)(French National Research Agency (ANR)); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier Toulouse III (UPS); Ghent University(Ghent University); Hercules Foundation; Flemish Government-department EWI; Div Of Industrial Innovation & Partnersh(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. The research and writing of the manuscript was supported, in part, by the Office of Biological and Environmental Research in the US Department of Energy Office of Science under contract DE-AC05-00OR22725 as part of the US DOE Bioenergy Center. Funding for additional components of the study was provided by the Brazilian Ministry of Science, Technology and Innovation (MCTI) through its research funding agencies (CNPq and FINEP), the Brazilian Federal District Research Foundation (FAP-DF), the public-private Genolyptus network of Brazilian forestry companies, the Tree Biosafety and Genomics Research Cooperative (TBGRC, Oregon State University), South African forestry companies Sappi and Mondi, the Technology and Human Resources for Industry Programme (THRIP, UID 80118), the South African Department of Science and Technology (DST) and National Research Foundation (NRF, UID 18312 and 86936), the Laboratoire d'Excellence (LABEX TULIP ANR-10-LABX-41), the Agence Nationale pour la Recherche (Project Tree For Joules ANR-2010-KBBE-007-01; Fundacao para a Ciencia e Tecnologia (FCT, P-KBBE/AGR_GPL/0001/2010), the Centre National pour la Recherche Scientifique (CNRS), the University Paul Sabatier Toulouse III (UPS). Part of this work was carried out using the Stevin Supercomputer Infrastructure at Ghent University, funded by Ghent University, the Hercules Foundation, and the Flemish Government-department EWI. We also acknowledge S. Oda and E. Gonzalez of Suzano Paper and Pulp for providing genetic material of E. grandis genotypes BRASUZ1, G7J1, M35D2 and their progeny used for genome sequencing and resequencing, Forestal Mininco (Chile) for genetic material of X46, the E. globulus genotype used for genome resequencing, M. Hinchee and W. Rottmann of ArborGen for EST sequences used to support gene annotation, Sappi (South Africa) for genetic material of the population used for genetic linkage mapping, and Sappi and Mondi (South Africa) for E. grandis tissues used for RNA sequencing. We acknowledge M. O'Neill of the University of Pretoria for technical assistance with E. grandis RNA sequencing.	Agren JA, 2011, CHROMOSOME RES, V19, P777, DOI 10.1007/s10577-011-9229-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauhus J., 2010, ECOSYSTEM GOODS SERV; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Buljan M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r74; Byrne M., 2008, PLANT GENOME BIODI E, V1, P303; Silva JCE, 2011, HEREDITY, V107, P50, DOI 10.1038/hdy.2010.154; Crisp MD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1191; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dubchak I, 2009, GENOME RES, V19, P682, DOI 10.1101/gr.081778.108; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forslund K, 2008, MOL BIOL EVOL, V25, P254, DOI 10.1093/molbev/msm254; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gardner Paul P, 2011, Nucleic Acids Res, V39, pD141, DOI 10.1093/nar/gkq1129; Goodger JQD, 2011, PHYTOCHEMISTRY, V72, P2259, DOI 10.1016/j.phytochem.2011.08.026; GRATTAPAGLIA D, 1994, CAN J FOREST RES, V24, P1074, DOI 10.1139/x94-142; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; House Susan M., 1997, P30; Hudson CJ, 2012, TREE GENET GENOMES, V8, P339, DOI 10.1007/s11295-011-0444-9; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iglesias I., EUCALYPTOLOGICS INFO; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jaiswal P, 2011, METHODS MOL BIOL, V678, P247, DOI 10.1007/978-1-60761-682-5_18; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Kullan ARK, 2012, TREE GENET GENOMES, V8, P163, DOI 10.1007/s11295-011-0430-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Martin W, 2005, TRENDS PLANT SCI, V10, P203, DOI 10.1016/j.tplants.2005.03.007; Mizrachi E, 2012, NEW PHYTOL, V194, P54, DOI 10.1111/j.1469-8137.2011.03971.x; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Peterson DG, 1997, PLANT MOL BIOL REP, V15, P148, DOI 10.1007/BF02812265; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petroli CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044684; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Robbertse B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1213; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; Salse J, 2009, BRIEF BIOINFORM, V10, P619, DOI 10.1093/bib/bbp037; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tibbits JFG, 2006, PLANT MOL BIOL REP, V24, P81, DOI 10.1007/BF02914048; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148	70	527	561	17	312	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					356	+		10.1038/nature13308	http://dx.doi.org/10.1038/nature13308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24919147	hybrid, Green Published			2022-12-24	WOS:000337350200027
J	Churcher, TS; Cohen, JM; Novotny, J; Ntshalintshali, N; Kunene, S; Cauchemez, S				Churcher, Thomas S.; Cohen, Justin M.; Novotny, Joseph; Ntshalintshali, Nyasatu; Kunene, Simon; Cauchemez, Simon			PUBLIC HEALTH Measuring the path toward malaria elimination	SCIENCE			English	Editorial Material									[Churcher, Thomas S.; Cauchemez, Simon] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Cohen, Justin M.; Novotny, Joseph; Ntshalintshali, Nyasatu] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Novotny, Joseph; Ntshalintshali, Nyasatu] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Kunene, Simon] Natl Malaria Control Program, Manzini, Swaziland; [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France	Imperial College London; University of California System; University of California San Francisco; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cauchemez, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	simon.cauchemez@pasteur.fr		Churcher, Thomas/0000-0002-8442-0525; Cohen, Justin/0000-0003-4481-6784	Medical Research Council [MR/K010174/1B] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER; Medical Research Council [MR/K010174/1] Funding Source: Medline; NIGMS NIH HHS [U54 GM088491] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Dureau J, 2013, BIOSTATISTICS, V14, P541, DOI 10.1093/biostatistics/kxs052; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Kunene S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-313; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, DIS SURV MAL EL OP M	9	53	53	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1230	1232		10.1126/science.1251449	http://dx.doi.org/10.1126/science.1251449			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI7ND	24926005	Green Accepted, Green Submitted			2022-12-24	WOS:000337077500021
J	Venn, O; Turner, I; Mathieson, I; de Groot, N; Bontrop, R; McVean, G				Venn, Oliver; Turner, Isaac; Mathieson, Iain; de Groot, Natasja; Bontrop, Ronald; McVean, Gil			NONHUMAN GENETICS Strong male bias drives germline mutation in chimpanzees	SCIENCE			English	Article							HUMAN-EVOLUTION; GENOME; HUMANS; NUCLEOTIDE; RATES; APES; MAP; DNA	Germline mutation determines rates of molecular evolution, genetic diversity, and fitness load. In humans, the average point mutation rate is 1.2 x 10(-8) per base pair per generation, with every additional year of father's age contributing two mutations across the genome and males contributing three to four times as many mutations as females. To assess whether such patterns are shared with our closest living relatives, we sequenced the genomes of a nine-member pedigree of Western chimpanzees, Pan troglodytes verus. Our results indicate a mutation rate of 1.2 x 10(-8) per base pair per generation, but a male contribution seven to eight times that of females and a paternal age effect of three mutations per year of father's age. Thus, mutation rates and patterns differ between closely related species.	[Venn, Oliver; Turner, Isaac; Mathieson, Iain; McVean, Gil] Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England; [de Groot, Natasja; Bontrop, Ronald] Biomed Primate Res Ctr, NL-2288 GJ Rijswijk, Netherlands	University of Oxford; Wellcome Centre for Human Genetics	McVean, G (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	mcvean@well.ox.ac.uk	Turner, Isaac/T-1092-2019; Bontrop, Ronald E/J-3628-2012	Bontrop, Ronald E/0000-0003-0874-6467; McVean, Gil/0000-0002-5012-4162; Turner, Isaac/0000-0002-2378-4886	Wellcome Trust [086786/Z/08/Z, 090532/Z/09/Z]; MRC hub grant [G0900747 91070]; MRC [G0900747] Funding Source: UKRI; Medical Research Council [G0900747] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by Wellcome Trust grants 086786/Z/08/Z to O.V. and 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics and by MRC hub grant G0900747 91070. We thank M. Przeworski and D. Reich for discussion and comments on the manuscript and A. Kong for providing data on request from reference (6). Samples were provided through the Transnational Access Activity in the European Primate Network (EUPRIM-NET) under the Convention on International Trade of Endangered Species (CITES) authorization and a Material Transfer Agreement between the University of Oxford and the Foundation Biomedical Primate Research Centre. Read-level data are accessible under SRA Study accession no. PRJEB5937 from www.ebi.ac.uk/ena/data/view/PRJEB5937. All other project data are available from ftp://birch.well.ox.ac.uk.	Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Hvilsom C, 2012, P NATL ACAD SCI USA, V109, P2054, DOI 10.1073/pnas.1106877109; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Kondrashov FA, 2010, PHILOS T R SOC B, V365, P1169, DOI 10.1098/rstb.2009.0286; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; MARSON J, 1991, BIOL REPROD, V44, P448, DOI 10.1095/biolreprod44.3.448; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; Nachman MW, 2000, GENETICS, V156, P297; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Perry GH, 2010, MOL ECOL, V19, P5332, DOI 10.1111/j.1365-294X.2010.04888.x; Presgraves DC, 2009, TRENDS ECOL EVOL, V24, P533, DOI 10.1016/j.tree.2009.04.007; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Short R.V., 1979, Advances in the Study of Behavior, V9, P131, DOI 10.1016/S0065-3454(08)60035-2; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060	24	86	86	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1272	1275		10.1126/science.344.6189.1272	http://dx.doi.org/10.1126/science.344.6189.1272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926018	Green Accepted			2022-12-24	WOS:000337077500038
J	Martin, E; Palmic, N; Sanquer, S; Lenoir, C; Hauck, F; Mongellaz, C; Fabrega, S; Nitschke, P; Degli Esposti, M; Schwartzentruber, J; Taylor, N; Majewski, J; Jabado, N; Wynn, RF; Picard, C; Fischer, A; Arkwright, PD; Latour, S				Martin, Emmanuel; Palmic, Noe; Sanquer, Sylvia; Lenoir, Christelle; Hauck, Fabian; Mongellaz, Cedric; Fabrega, Sylvie; Nitschke, Patrick; Degli Esposti, Mauro; Schwartzentruber, Jeremy; Taylor, Naomi; Majewski, Jacek; Jabado, Nada; Wynn, Robert F.; Picard, Capucine; Fischer, Alain; Arkwright, Peter D.; Latour, Sylvain			CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation	NATURE			English	Article							NOVO PYRIMIDINE SYNTHESIS; EPSTEIN-BARR-VIRUS; KILLER T-CELLS; DE-NOVO; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; VIRAL-INFECTION; SYNTHETASE; ACTIVATION; PATHWAY	Lymphocyte functions triggered by antigen recognition and costimulation signals are associated with a rapid and intense cell division, and hence with metabolism adaptation(1). The nucleotide cytidine 5' triphosphate (CTP) is a precursor required for the metabolism of DNA, RNA and phospholipids(2-4). CTP originates from two sources: a salvage pathway and a de novo synthesis pathway that depends on two enzymes, the CTP synthases (or synthetases) 1 and 2 (CTPS1 with CTPS2); the respective roles of these two enzymes are not known(5-7). CTP synthase activity is a potentially important step for DNA synthesis in lymphocytes(8,9). Here we report the identification of a loss-of- function homozygous mutation (rs145092287) in CTPS1 in humans that causes a novel and life-threatening immunodeficiency, characterized by an impaired capacity of activated T and B cells to proliferate in response to antigen receptor-mediated activation. In contrast, proximal and distal T-cell receptor (TCR) signalling events and responses were only weakly affected by the absence of CTPS1. Activated CTPS1-deficient cells had decreased levels of CTP. Normal T-cell proliferation was restored in CTPS1-deficient cells by expressing wild-type CTPS1 or by addition of exogenous CTP or its nucleoside precursor, cytidine. CTPS1 expression was found to be low in resting T cells, but rapidly upregulated following TCR activation. These results highlight a key and specific role of CTPS1 in the immune system by its capacity to sustain the proliferation of activated lymphocytes during the immune response. CTPS1 may therefore represent a therapeutic target of immunosuppressive drugs that could specifically dampen lymphocyte activation.	[Martin, Emmanuel; Palmic, Noe; Lenoir, Christelle; Hauck, Fabian; Fischer, Alain; Latour, Sylvain] Hop Necker Enfants Malad, Lab Activat Lymphocytaire & Susceptibilite EBV, INSERM, UMR 1163, F-75015 Paris, France; [Martin, Emmanuel; Palmic, Noe; Lenoir, Christelle; Hauck, Fabian; Fabrega, Sylvie; Nitschke, Patrick; Picard, Capucine; Fischer, Alain; Latour, Sylvain] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France; [Sanquer, Sylvia; Latour, Sylvain] Hop Necker Enfants Malad, Lab Biochim Metabol & Proteom, F-75015 Paris, France; [Mongellaz, Cedric; Taylor, Naomi] Inst Genet Mol Montpellier, CNRS, UMR 5535, F-34293 Montpellier, France; [Fabrega, Sylvie] Hop Necker Enfants Malad, Plateforme Vecteurs Viraux & Transfert Genes, IFR94, F-75015 Paris, France; [Nitschke, Patrick] Hop Necker Enfants Malad, Serv Bioinformat, F-75015 Paris, France; [Degli Esposti, Mauro; Wynn, Robert F.; Arkwright, Peter D.] Univ Manchester, Royal Manchester Childrens Hosp, Manchester M13 0WL, Lancs, England; [Degli Esposti, Mauro] Italian Inst Technol, I-16163 Genoa, Italy; [Schwartzentruber, Jeremy; Majewski, Jacek; Jabado, Nada] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Schwartzentruber, Jeremy; Majewski, Jacek; Jabado, Nada] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Jabado, Nada] McGill Univ, Hlth Ctr Res Inst, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Ctr Etude Deficits Immunitaires, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, INSERM, Lab Genet Humaine Malad Infect, UMR 1163, F-75015 Paris, France; [Fischer, Alain] Hop Necker Enfants Malad, AP HP, Unite Immunol & Hematol Pediat, F-75015 Paris, France; [Fischer, Alain] Coll France, F-75005 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Royal Manchester Children's Hospital; University of Manchester; Istituto Italiano di Tecnologia - IIT; McGill University; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Latour, S (corresponding author), Hop Necker Enfants Malad, Lab Activat Lymphocytaire & Susceptibilite EBV, INSERM, UMR 1163, F-75015 Paris, France.	sylvain.latour@inserm.fr	Taylor, Naomi/H-4016-2014; Hauck, Fabian/H-5556-2016; Jabado, Nada/AAN-4026-2020; Picard, Capucine/H-3914-2017; Martin, Emmanuel/F-9743-2016; Latour, Sylvain/H-3652-2017	Picard, Capucine/0000-0001-8788-5056; Martin, Emmanuel/0000-0003-4211-7373; Latour, Sylvain/0000-0001-8238-4391; Degli Esposti, Mauro/0000-0002-0977-119X; Schwartzentruber, Jeremy/0000-0002-6183-2092; Wynn, robert/0000-0002-6046-8428; Arkwright, Peter/0000-0002-7411-5375; Hauck, Fabian/0000-0001-9644-2003	INSERM; ANR [ANR-08-MIEN-012-01, ANR-2010-MIDI-005-02, ANR-10-IAHU-01]; Fondation ARC (France); European Research Council [ERC-2009-AdG_20090506, FP7-249816]; Rare Diseases Fondation (France); ANR (France); Ligue contre le cancer (France); Wellcome Trust; Medical Research Council [WT095219MA, G1001799]; MRC [G1001799] Funding Source: UKRI	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Fondation ARC (France); European Research Council(European Research Council (ERC)European Commission); Rare Diseases Fondation (France); ANR (France)(French National Research Agency (ANR)); Ligue contre le cancer (France); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the patients, their families and the healthy donors for cooperation. We thank S. Rigaud, S. Gerart, C. Synaeve and R. Rodriguez for help with experiments and P. Revy for discussion. This work was supported by grants from INSERM, ANR (ANR-08-MIEN-012-01, ANR-2010-MIDI-005-02 and ANR-10-IAHU-01), Fondation ARC (France), the European Research Council (ERC-2009-AdG_20090506 noFP7-249816) and the Rare Diseases Fondation (France). S. L. is a senior scientist of CNRS (France). E. M. is supported by ANR (France) and Ligue contre le cancer (France). We are also grateful to the UK 1958 Birth Cohort (http://www2.le.ac.uk/projects/birthcohort) for providing DNA from 752 individuals born in the northwest of England. Access to these resources was enabled via the 58READIE Project funded by the Wellcome Trust and Medical Research Council (grant numbers WT095219MA and G1001799). A full list of the financial, institutional and personal contributions to the development of the 1958 Birth Cohort Biomedical resource is available at (http://www2.le.ac.uk/projects/birthcohort).	Austin WR, 2012, J EXP MED, V209, P2215, DOI 10.1084/jem.20121061; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Chung BK, 2013, BLOOD, V122, P2600, DOI 10.1182/blood-2013-01-480665; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Gulow K, 2005, J IMMUNOL, V174, P5249, DOI 10.4049/jimmunol.174.9.5249; Higgins MJ, 2007, J BIOL CHEM, V282, P29493, DOI 10.1074/jbc.M703948200; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Huang M, 2003, CELL MOL LIFE SCI, V60, P321, DOI 10.1007/s000180300027; Kassel KM, 2010, J BIOL CHEM, V285, P33727, DOI 10.1074/jbc.M110.178566; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MARIJNEN YMT, 1989, BIOCHIM BIOPHYS ACTA, V1012, P148, DOI 10.1016/0167-4889(89)90088-8; MCPARTLAND RP, 1974, CANCER RES, V34, P3107; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NADKARNI AK, 1995, J BIOL CHEM, V270, P24982, DOI 10.1074/jbc.270.42.24982; Notarangelo LD, 2013, ANNU REV IMMUNOL, V31, P195, DOI 10.1146/annurev-immunol-032712-095927; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Qiu Y, 2000, TRANSPLANTATION, V69, P890; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; SCAVENNEC J, 1982, CANCER RES, V42, P1326; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; van Kuilenburg ABP, 2000, BBA-GENE STRUCT EXPR, V1492, P548, DOI 10.1016/S0167-4781(00)00141-X; VANDENBERG AA, 1994, LEUKEMIA, V8, P1375; VANDENBERG AA, 1995, EUR J CANCER, V31A, P108, DOI 10.1016/0959-8049(94)00442-8; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wynn RF, 2005, LANCET ONCOL, V6, P344, DOI 10.1016/S1470-2045(05)70171-6	33	126	138	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					288	+		10.1038/nature13386	http://dx.doi.org/10.1038/nature13386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24870241	Green Accepted			2022-12-24	WOS:000337032400054
J	Lee, YS; Kim, JW; Osborne, O; Oh, DY; Sasik, R; Schenk, S; Chen, A; Chung, H; Murphy, A; Watkins, SM; Quehenberger, O; Johnson, RS; Olefsky, JM				Lee, Yun Sok; Kim, Jung-whan; Osborne, Olivia; Oh, Da Young; Sasik, Roman; Schenk, Simon; Chen, Ai; Chung, Heekyung; Murphy, Anne; Watkins, Steven M.; Quehenberger, Oswald; Johnson, Randall S.; Olefsky, Jerrold M.			Increased Adipocyte O-2 Consumption Triggers HIF-1 alpha, Causing Inflammation and Insulin Resistance in Obesity	CELL			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; WHITE ADIPOSE-TISSUE; NITRIC-OXIDE; MITOCHONDRIAL RESPIRATION; ENERGY-EXPENDITURE; HYPOXIA; MICE; FAT; MACROPHAGES; INHIBITION	Adipose tissue hypoxia and inflammation have been causally implicated in obesity-induced insulin resistance. Here, we report that, early in the course of high-fat diet (HFD) feeding and obesity, adipocyte respiration becomes uncoupled, leading to increased oxygen consumption and a state of relative adipocyte hypoxia. These events are sufficient to trigger HIF-1 alpha induction, setting off the chronic adipose tissue inflammatory response characteristic of obesity. At the molecular level, these events involve saturated fatty acid stimulation of the adenine nucleotide translocase 2 (ANT2), an inner mitochondrial membrane protein, which leads to the uncoupled respiratory state. Genetic or pharmacologic inhibition of either ANT2 or HIF-1 alpha can prevent or reverse these pathophysiologic events, restoring a state of insulin sensitivity and glucose tolerance. These results reveal the sequential series of events in obesity-induced inflammation and insulin resistance.	[Lee, Yun Sok; Osborne, Olivia; Oh, Da Young; Sasik, Roman; Chen, Ai; Chung, Heekyung; Quehenberger, Oswald; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Kim, Jung-whan; Johnson, Randall S.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Schenk, Simon] Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Murphy, Anne] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Watkins, Steven M.] Lipomics Technol Inc, West Sacramento, CA 95691 USA; [Johnson, Randall S.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Johnson, Randall S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Karolinska Institutet; University of Cambridge	Johnson, RS (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	rsj33@cam.ac.uk; jolefsky@ucsd.edu	Lee, Yun Sok/ABC-9195-2021; Lee, Yun Sok/B-3265-2015; Johnson, Randall/AAM-1189-2021; Murphy, Anne N/H-3217-2016	Lee, Yun Sok/0000-0001-7967-4734; Lee, Yun Sok/0000-0001-7967-4734; Johnson, Randall/0000-0002-4084-6639; Murphy, Anne N/0000-0002-5222-9902; Kim, Jung-whan/0000-0002-7829-1480; Schenk, Simon/0000-0002-8224-3203	National Institutes of Health (NIH) [DK-033651, DK-074868, DK-063491, P01-DK054441]; American Diabetes Association; National Institute of Aging; National Institute of Child Health and Human Development of the NIH [R01AG043120, R24HD050837]; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303, R24HD050837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, P01DK054441, T32DK007494, R37DK033651, P01DK074868, P30DK063491, R01DK101395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043120] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development of the NIH; Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH) grants DK-033651, DK-074868, DK-063491, and P01-DK054441. Y.S.L. was supported by a Mentor-Based Postdoctoral Fellowship Award from the American Diabetes Association. S. S. is supported by the National Institute of Aging and National Institute of Child Health and Human Development of the NIH under award numbers R01AG043120 and R24HD050837. R.S.J. is supported by a Principal Research Fellowship from the Wellcome Trust.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; ANDREYEV AY, 1988, FEBS LETT, V226, P265, DOI 10.1016/0014-5793(88)81436-4; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Garcia-Arcos I, 2013, J BIOL CHEM, V288, P14046, DOI 10.1074/jbc.M113.469270; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Lee KY, 2011, CELL METAB, V14, P491, DOI 10.1016/j.cmet.2011.08.006; Lee YS, 2008, MOL ENDOCRINOL, V22, P2176, DOI 10.1210/me.2008-0023; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; LEIBEL RL, 1985, AM J CLIN NUTR, V42, P198, DOI 10.1093/ajcn/42.2.198; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Melillo G, 1996, J IMMUNOL, V157, P2638; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Qvisth V, 2007, AM J PHYSIOL-ENDOC M, V292, pE709, DOI 10.1152/ajpendo.00104.2006; Rohm M, 2013, CELL METAB, V17, P575, DOI 10.1016/j.cmet.2013.02.010; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Sridharan V, 2008, AM J PHYSIOL-CELL PH, V295, pC29, DOI 10.1152/ajpcell.00466.2007; Sun K, 2013, MOL CELL BIOL, V33, P904, DOI 10.1128/MCB.00951-12; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118	46	314	318	2	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1339	1352		10.1016/j.cell.2014.05.012	http://dx.doi.org/10.1016/j.cell.2014.05.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906151	Green Accepted, Bronze			2022-12-24	WOS:000340881400011
J	Poulter, B; Frank, D; Ciais, P; Myneni, RB; Andela, N; Bi, J; Broquet, G; Canadell, JG; Chevallier, F; Liu, YY; Running, SW; Sitch, S; van der Werf, GR				Poulter, Benjamin; Frank, David; Ciais, Philippe; Myneni, Ranga B.; Andela, Niels; Bi, Jian; Broquet, Gregoire; Canadell, Josep G.; Chevallier, Frederic; Liu, Yi Y.; Running, Steven W.; Sitch, Stephen; van der Werf, Guido R.			Contribution of semi-arid ecosystems to interannual variability of the global carbon cycle	NATURE			English	Article							BIOMASS BURNING EMISSIONS; ATMOSPHERIC CO2 GROWTH; TERRESTRIAL CARBON; VEGETATION INDEX; DYNAMICS; COVER; AUSTRALIA; RESPONSES; LAND	The land and ocean act as a sink for fossil-fuel emissions, thereby slowing the rise of atmospheric carbon dioxide concentrations(1). Although the uptake of carbon by oceanic and terrestrial processes has kept pace with accelerating carbon dioxide emissions until now, atmospheric carbon dioxide concentrations exhibit a large variability on interannual timescales(2), considered to be driven primarily by terrestrial ecosystem processes dominated by tropical rainforests(3). We use a terrestrial biogeochemical model, atmospheric carbon dioxide inversion and global carbon budget accounting methods to investigate the evolution of the terrestrial carbon sink over the past 30 years, with a focus on the underlying mechanisms responsible for the exceptionally large land carbon sink reported in 2011 (ref. 2). Here we show that our three terrestrial carbon sink estimates are in good agreement and support the finding of a 2011 record land carbon sink. Surprisingly, we find that the global carbon sink anomaly was driven by growth of semi-arid vegetation in the Southern Hemisphere, with almost 60 per cent of carbon uptake attributed to Australian ecosystems, where prevalent La Nina conditions caused up to six consecutive seasons of increased precipitation. In addition, since 1981, a six per cent expansion of vegetation cover over Australia was associated with a fourfold increase in the sensitivity of continental net carbon uptake to precipitation. Our findings suggest that the higher turnover rates of carbon pools in semi-arid biomes are an increasingly important driver of global carbon cycle inter-annual variability and that tropical rainforests may become less relevant drivers in the future. More research is needed to identify to what extent the carbon stocks accumulated during wet years are vulnerable to rapid decomposition or loss through fire in subsequent years.	[Poulter, Benjamin] Montana State Univ, Inst Ecosyst, Bozeman, MT 59717 USA; [Poulter, Benjamin] Dept Ecol, Bozeman, MT 59717 USA; [Poulter, Benjamin; Ciais, Philippe; Broquet, Gregoire; Chevallier, Frederic] CEA CNRS UVSQ, LSCE, F-91191 Gif Sur Yvette, France; [Frank, David] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Frank, David] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Myneni, Ranga B.; Bi, Jian] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Andela, Niels; van der Werf, Guido R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [Canadell, Josep G.] CSIRO, Global Carbon Project, Marine & Atmospher Res, Canberra, ACT 2601, Australia; [Liu, Yi Y.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Liu, Yi Y.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Running, Steven W.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Sitch, Stephen] Univ Exeter, Coll Engn Comp & Math, Exeter EX4 4QF, Devon, England	Montana State University System; Montana State University Bozeman; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; Boston University; Vrije Universiteit Amsterdam; Commonwealth Scientific & Industrial Research Organisation (CSIRO); ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of New South Wales Sydney; University of Montana System; University of Montana; University of Exeter	Poulter, B (corresponding author), Montana State Univ, Inst Ecosyst, Bozeman, MT 59717 USA.	benjamin.poulter@montana.edu	Ciais, Philippe/A-6840-2011; van der Werf, Guido/M-8260-2016; Liu, Yi/M-7169-2015; Liu, Yi/H-9226-2013; Myneni, Ranga B./AAU-6088-2021; Chevallier, Frederic JM/E-9608-2016; Frank, David/C-7764-2013; Myneni, Ranga B/F-5129-2012; Canadell, Pep/E-9419-2010; Poulter, Ben/ABB-5886-2021; Sitch, Stephen A/F-8034-2015	Ciais, Philippe/0000-0001-8560-4943; van der Werf, Guido/0000-0001-9042-8630; Liu, Yi/0000-0001-9059-8269; Chevallier, Frederic JM/0000-0002-4327-3813; Myneni, Ranga B/0000-0002-0234-6393; Canadell, Pep/0000-0002-8788-3218; Poulter, Ben/0000-0002-9493-8600; Sitch, Stephen A/0000-0003-1821-8561; Broquet, Gregoire/0000-0001-7447-6907; Bi, Jian/0000-0002-0890-9839; Frank, David/0000-0001-5463-5640	EU FP7 GEOCARBON programme [283080]; Australian Climate Change Science Program; NASA Earth Science Division; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	EU FP7 GEOCARBON programme; Australian Climate Change Science Program; NASA Earth Science Division; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	We acknowledge support from the EU FP7 GEOCARBON programme (283080), and thank the researchers involved with collecting and maintaining the climate data at the Climate Research Unit, University of East Anglia, UK, and the National Center for Atmospheric Research, USA. We also acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP. We thank the climate modelling groups for producing and making available their model output. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We also thank M. Jung for providing the 'upscaled' NEE data used in our analysis. J.G.C. acknowledges the support of the Australian Climate Change Science Program. R. B. M. and S. W. R. were funded by the NASA Earth Science Division. C. Le Quere and L. Cernusak provide dcomments and suggestions that improved the manuscript. This paper is a contribution to the Global Carbon Budget activity of the Global Carbon Project.	Andela N, 2013, BIOGEOSCIENCES, V10, P6657, DOI 10.5194/bg-10-6657-2013; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Bastos A, 2013, J GEOPHYS RES-BIOGEO, V118, P1247, DOI 10.1002/jgrg.20100; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053055; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; Chevallier F, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013887; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; Donohue RJ, 2013, GEOPHYS RES LETT, V40, P3031, DOI 10.1002/grl.50563; Donohue RJ, 2009, GLOBAL CHANGE BIOL, V15, P1025, DOI 10.1111/j.1365-2486.2008.01746.x; Francey RJ, 2013, NAT CLIM CHANGE, V3, P520, DOI [10.1038/nclimate1817, 10.1038/NCLIMATE1817]; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Haverd V, 2013, BIOGEOSCIENCES, V10, P2011, DOI 10.5194/bg-10-2011-2013; Haverd V, 2013, BIOGEOSCIENCES, V10, P851, DOI 10.5194/bg-10-851-2013; Jung M, 2009, BIOGEOSCIENCES, V6, P2001, DOI 10.5194/bg-6-2001-2009; Kaiser JW, 2012, BIOGEOSCIENCES, V9, P527, DOI 10.5194/bg-9-527-2012; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Kang SM, 2013, GEOPHYS RES LETT, V40, P4054, DOI 10.1002/grl.50769; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; Le Quere C., 2013, EARTH SYST SCI DATA, V5, P1107; Liu YY, 2013, GLOBAL ECOL BIOGEOGR, V22, P692, DOI 10.1111/geb.12024; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Myneni RB, 1996, GEOPHYS RES LETT, V23, P729, DOI 10.1029/96GL00266; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Poulter B, 2011, BIOGEOSCIENCES, V8, P2027, DOI 10.5194/bg-8-2027-2011; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Sitch S., 2013, BIOGEOSCI DISCUSS, V10, P20113, DOI [10.5194/bgd-10-20113-2013, DOI 10.5194/BGD-10-20113-2013]; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; Van der Werf G. R., 2010, ATMOS CHEM PHYS DISC, V10, P16153, DOI DOI 10.5194/ACPD-10-16153-2010; Wang WL, 2013, P NATL ACAD SCI USA, V110, P13061, DOI 10.1073/pnas.1219683110; Wolter K, 1993, P 17 CLIM DIAGN WORK, P52; Woodward FI, 2008, PHILOS T R SOC B, V363, P2779, DOI 10.1098/rstb.2008.0017; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]; Zhu ZC, 2013, REMOTE SENS-BASEL, V5, P927, DOI 10.3390/rs5020927	40	817	842	44	696	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					600	+		10.1038/nature13376	http://dx.doi.org/10.1038/nature13376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24847888	Green Accepted			2022-12-24	WOS:000336457100045
J	Birnbaum, ME; Mendoza, JL; Sethi, DK; Dong, S; Glanville, J; Dobbins, J; Ozkan, E; Davis, MM; Wucherpfennig, KW; Garcia, KC				Birnbaum, Michael E.; Mendoza, Juan L.; Sethi, Dhruv K.; Dong, Shen; Glanville, Jacob; Dobbins, Jessica; Oezkan, Engin; Davis, Mark M.; Wucherpfennig, Kai W.; Garcia, K. Christopher			Deconstructing the Peptide-MHC Specificity of T Cell Recognition	CELL			English	Article							CROSS-REACTIVITY; RECEPTOR RECOGNITION; DIRECTED EVOLUTION; SURFACE DISPLAY; ANTIGEN; BINDING; TCR; DEGENERACY; SELF; IDENTIFICATION	In order to survey a universe of major histocompatibility complex (MHC)-presented peptide antigens whose numbers greatly exceed the diversity of the T cell repertoire, T cell receptors (TCRs) are thought to be cross- reactive. However, the nature and extent of TCR cross- reactivity has not been conclusively measured experimentally. We developed a system to identify MHC-presented peptide ligands by combining TCR selection of highly diverse yeast-displayed peptide-MHC libraries with deep sequencing. Although we identified hundreds of peptides reactive with each of five different mouse and human TCRs, the selected peptides possessed TCR recognition motifs that bore a close resemblance to their known antigens. This structural conservation of the TCR interaction surface allowed us to exploit deep-sequencing information to computationally identify activating microbial and self-ligands for human autoimmune TCRs. The mechanistic basis of TCR cross- reactivity described here enables effective surveillance of diverse self and foreign antigens without necessitating degenerate recognition of nonhomologous peptides.	[Birnbaum, Michael E.; Mendoza, Juan L.; Dong, Shen; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Birnbaum, Michael E.; Mendoza, Juan L.; Dong, Shen; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Glanville, Jacob; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Birnbaum, Michael E.; Glanville, Jacob; Davis, Mark M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Oezkan, Engin; Davis, Mark M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Sethi, Dhruv K.; Dobbins, Jessica; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Dobbins, Jessica; Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Dong, Shen/ABC-2875-2020	Kohler, Jessica/0000-0002-6074-5595; Davis, Mark/0000-0001-6868-657X; dong, Shen/0000-0001-8839-7046; Ozkan, Engin/0000-0002-0263-6729; Birnbaum, Michael/0000-0002-2281-3518; Mendoza, Juan/0000-0001-6972-7476	Regina Casper Stanford Graduate Fellowship; Gerald J. Lieberman Fellowship; National Science Foundation; Helen Hay Whitney Foundation; NIH [PO1 AI045757, R01 AI03867, R01 AI022511, U19 4100041120, P41GM103393]; HHMI; U.S. Department of Energy [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NCI-K01CA175127; NATIONAL CANCER INSTITUTE [K01CA175127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, U19AI057229, R01AI103867, R01AI022511, R01AI048540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK097681] Funding Source: NIH RePORTER	Regina Casper Stanford Graduate Fellowship; Gerald J. Lieberman Fellowship; National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NCI-K01CA175127; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Suzanne Fischer, Gary Mantalas, and Nelida Prado for technical assistance and Jarrett Adams, Lauren Ely, and Evan Newell for helpful discussions. M.E.B. was supported by a Regina Casper Stanford Graduate Fellowship, a Gerald J. Lieberman Fellowship, and a National Science Foundation Graduate Fellowship. J.L.M. was supported by NCI-K01CA175127 and a Helen Hay Whitney Foundation postdoctoral fellowship. This work was supported by the NIH (PO1 AI045757 to K.W.W., R01 AI03867 to K. C. G., R01 AI022511 to M. M. D., and U19 4100041120 to M. M. D. and K. C. G.) and HHMI (to M. M. D. and K. C. G.). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health (including P41GM103393).	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Boder ET, 2005, BIOTECHNOL BIOENG, V92, P485, DOI 10.1002/bit.20616; Borbulevych OY, 2011, J IMMUNOL, V186, P2950, DOI 10.4049/jimmunol.1003150; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; COCKCROFT VB, 1991, FEBS LETT, V293, P149, DOI 10.1016/0014-5793(91)81173-6; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; De la Herran-Arita AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007762; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; EHRICH EW, 1993, J EXP MED, V178, P713, DOI 10.1084/jem.178.2.713; Esteban O, 2004, J MOL BIOL, V340, P81, DOI 10.1016/j.jmb.2004.04.054; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hausmann S, 1999, J IMMUNOL, V162, P338; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Hemmer B, 1998, J IMMUNOL, V160, P3631; Hemmer B, 1998, IMMUNOL TODAY, V19, P163, DOI 10.1016/S0167-5699(97)01217-6; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jiang W, 2010, P NATL ACAD SCI USA, V107, P13258, DOI 10.1073/pnas.1006344107; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Morris GP, 2011, P NATL ACAD SCI USA, V108, P3695, DOI 10.1073/pnas.1017015108; Newell EW, 2011, J IMMUNOL, V186, P5823, DOI 10.4049/jimmunol.1100197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; REAY PA, 1994, J IMMUNOL, V152, P3946; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Shann F, 2010, PEDIATR INFECT DIS J, V29, P457, DOI 10.1097/INF.0b013e3181c91361; Shih FF, 2004, MOL IMMUNOL, V40, P1041, DOI 10.1016/j.molimm.2003.11.008; Starwalt SE, 2003, PROTEIN ENG, V16, P147, DOI 10.1093/proeng/gzg018; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Wang YB, 2005, P NATL ACAD SCI USA, V102, P2476, DOI 10.1073/pnas.0409798102; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Wen F, 2008, J IMMUNOL METHODS, V336, P37, DOI 10.1016/j.jim.2008.03.008; Wen F, 2011, PROTEIN ENG DES SEL, V24, P701, DOI 10.1093/protein/gzr035; Wilson DB, 1999, J IMMUNOL, V163, P6424; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Yin YY, 2009, IMMUNITY, V31, P849, DOI 10.1016/j.immuni.2009.12.002; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359; Zhao YD, 2001, J IMMUNOL, V167, P2130, DOI 10.4049/jimmunol.167.4.2130	68	332	342	3	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1073	1087		10.1016/j.cell.2014.03.047	http://dx.doi.org/10.1016/j.cell.2014.03.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855945	Green Accepted, Bronze			2022-12-24	WOS:000336437200011
J	Lobell, DB; Roberts, MJ; Schlenker, W; Braun, N; Little, BB; Rejesus, RM; Hammer, GL				Lobell, David B.; Roberts, Michael J.; Schlenker, Wolfram; Braun, Noah; Little, Bertis B.; Rejesus, Roderick M.; Hammer, Graeme L.			Greater Sensitivity to Drought Accompanies Maize Yield Increase in the US Midwest	SCIENCE			English	Article							STRESS TOLERANCE; ENVIRONMENTS; SIMULATION; TRENDS; TRAIT; BELT; HEAT	A key question for climate change adaptation is whether existing cropping systems can become less sensitive to climate variations. We use a field-level data set on maize and soybean yields in the central United States for 1995 through 2012 to examine changes in drought sensitivity. Although yields have increased in absolute value under all levels of stress for both crops, the sensitivity of maize yields to drought stress associated with high vapor pressure deficits has increased. The greater sensitivity has occurred despite cultivar improvements and increased carbon dioxide and reflects the agronomic trend toward higher sowing densities. The results suggest that agronomic changes tend to translate improved drought tolerance of plants to higher average yields but not to decreasing drought sensitivity of yields at the field scale.	[Lobell, David B.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Lobell, David B.] Stanford Univ, Ctr Food Secur & Environm, Stanford, CA 94305 USA; [Roberts, Michael J.] Univ Hawaii Manoa, Dept Econ, Honolulu, HI 96822 USA; [Schlenker, Wolfram] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Braun, Noah; Rejesus, Roderick M.] N Carolina State Univ, Dept Agr & Resource Econ, Raleigh, NC 27695 USA; [Little, Bertis B.] Tarleton State Univ, Dept Math, Off Provost, Stephenville, TX USA; [Little, Bertis B.] Tarleton State Univ, Div Acad Affairs, Stephenville, TX USA; [Hammer, Graeme L.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia	Stanford University; Stanford University; University of Hawaii System; University of Hawaii Manoa; Columbia University; University of North Carolina; North Carolina State University; Texas A&M University System; Tarleton State University; Texas A&M University System; Tarleton State University; University of Queensland	Lobell, DB (corresponding author), Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA.	dlobell@stanford.edu	Hammer, Graeme L/A-3785-2008	Hammer, Graeme L/0000-0002-1180-7374; Braun, Noah/0000-0002-9710-0686; Lobell, David/0000-0002-5969-3476	NSF [SES-0962625]; National Oceanic and Atmospheric Administration [NA11OAR4310095]; USDA's Risk Management Agency; Australian Research Council [LP100100495]	NSF(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); USDA's Risk Management Agency; Australian Research Council(Australian Research Council)	We thank G. McLean for assistance with APSIM simulations and acknowledge the modeling groups, the Program for Climate Model Diagnosis and Intercomparison, and the Working Group on Coupled Modelling of the World Climate Research Programme (WCRP) for their roles in making available the WCRP CMIP5 multimodel data set. This work was supported by NSF grant SES-0962625 and National Oceanic and Atmospheric Administration grant NA11OAR4310095. B.B.L. was supported by a Research Services Agreement from USDA's Risk Management Agency, and G.L.H. by grant LP100100495 from the Australian Research Council. Data used in this study are available as supplementary materials on Science Online.	Banziger M, 2006, AGR WATER MANAGE, V80, P212, DOI 10.1016/j.agwat.2005.07.014; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; Chenu K, 2013, NEW PHYTOL, V198, P801, DOI 10.1111/nph.12192; Connor D.J., 2011, CROP ECOLOGY PRODUCT; Donohue RJ, 2013, GEOPHYS RES LETT, V40, P3031, DOI 10.1002/grl.50563; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Fonseca AE, 2005, FIELD CROP RES, V94, P114, DOI 10.1016/j.fcr.2004.12.001; Food and Agriculture Organization of the United Nations (FAO), 2013, FAO STATISTICAL DATA; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Lyon DJ, 2003, AGRON J, V95, P884, DOI 10.2134/agronj2003.0884; McGrath JM, 2011, GLOBAL CHANGE BIOL, V17, P2689, DOI 10.1111/j.1365-2486.2011.02406.x; Messina CD, 2011, J EXP BOT, V62, P855, DOI 10.1093/jxb/erq329; National Agriculture Statistics Service, 2007, CORN OBJECTIVE YIELD; National Agriculture Statistics Service, 2013, 2013 ILLINOIS ANNUAL; National Agriculture Statistics Service, 2007, SOYBEAN OBJECTIVE YI; National Research Council (NRC), 2010, THE IMPACT OF GENETI; Ray JD, 2002, PLANT SOIL, V239, P113, DOI 10.1023/A:1014947422468; Roberts M. J., 2011, THE ECONOMICS OF CLI, P225; Tardieu F, 2012, J EXP BOT, V63, P25, DOI 10.1093/jxb/err269; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; Tollenaar M, 1999, CROP SCI, V39, P1597, DOI 10.2135/cropsci1999.3961597x; Woli P, 2012, AGRON J, V104, P287, DOI 10.2134/agronj2011.0286	26	601	629	24	468	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					516	519		10.1126/science.1251423	http://dx.doi.org/10.1126/science.1251423			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786079				2022-12-24	WOS:000335157700043
J	de Iongh, A				de Iongh, Anya			Patients need support to self manage their long term conditions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												anya.deiongh@cantab.net						Health Foundation, 2014, CLOS DOORS; NHS Confederation, 2012, INV EM PSYCH WELLB P; NHS England, DOM 2 ENH QUAL LIF P; The Health Foundation, 2013, SUST SPREAD SELF MAN	4	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2973	10.1136/bmj.g2973	http://dx.doi.org/10.1136/bmj.g2973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24778324	Green Published, Bronze			2022-12-24	WOS:000335471000011
J	Bertazzo, S; Steele, JAM; Chester, AH; Yacoub, MH; Stevens, MM				Bertazzo, Sergio; Steele, Joseph A. M.; Chester, Adrian H.; Yacoub, Magdi H.; Stevens, Molly M.			Cardiovascular calcification violet pearl	LANCET			English	Editorial Material									[Bertazzo, Sergio; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, Dept Bioengn, London SW7 2AZ, England; [Chester, Adrian H.; Yacoub, Magdi H.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, London SW7 2AZ, England; [Steele, Joseph A. M.; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Bertazzo, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.	s.bertazzo@imperial.ac.uk; m.stevens@imperial.ac.uk	Bertazzo, Sergio/J-7357-2016	Bertazzo, Sergio/0000-0003-4889-8190; Steele, Joseph/0000-0002-7913-0531					0	4	4	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1294	1294		10.1016/S0140-6736(13)62369-7	http://dx.doi.org/10.1016/S0140-6736(13)62369-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	24857203				2022-12-24	WOS:000343003400032
J	Gallant, JR; Traeger, LL; Volkening, JD; Moffett, H; Chen, PH; Novina, CD; Phillips, GN; Anand, R; Wells, GB; Pinch, M; Guth, R; Unguez, GA; Albert, JS; Zakon, HH; Samanta, MP; Sussman, MR				Gallant, Jason R.; Traeger, Lindsay L.; Volkening, Jeremy D.; Moffett, Howell; Chen, Po-Hao; Novina, Carl D.; Phillips, George N., Jr.; Anand, Rene; Wells, Gregg B.; Pinch, Matthew; Gueth, Robert; Unguez, Graciela A.; Albert, James S.; Zakon, Harold H.; Samanta, Manoj P.; Sussman, Michael R.			NONHUMAN GENETICS Genomic basis for the convergent evolution of electric organs	SCIENCE			English	Article							GROWTH; PROTEINS; SUBUNIT; MUSCLE; SIZE; EXPRESSION; MEMBRANES; DOGS	Little is known about the genetic basis of convergent traits that originate repeatedly over broad taxonomic scales. The myogenic electric organ has evolved six times in fishes to produce electric fields used in communication, navigation, predation, or defense. We have examined the genomic basis of the convergent anatomical and physiological origins of these organs by assembling the genome of the electric eel (Electrophorus electricus) and sequencing electric organ and skeletal muscle transcriptomes from three lineages that have independently evolved electric organs. Our results indicate that, despite millions of years of evolution and large differences in the morphology of electric organ cells, independent lineages have leveraged similar transcription factors and developmental and cellular pathways in the evolution of electric organs.	[Gallant, Jason R.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Gallant, Jason R.; Zakon, Harold H.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Traeger, Lindsay L.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Traeger, Lindsay L.; Volkening, Jeremy D.; Sussman, Michael R.] Univ Wisconsin, Biotechnol Ctr, Madison, WI 53706 USA; [Volkening, Jeremy D.; Sussman, Michael R.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Moffett, Howell; Chen, Po-Hao; Novina, Carl D.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Moffett, Howell; Chen, Po-Hao; Novina, Carl D.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Chen, Po-Hao; Novina, Carl D.] Broad Inst Harvard & MIT, Cambridge, MA 02141 USA; [Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Phillips, George N., Jr.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Anand, Rene] Ohio State Univ, Coll Med, Dept Pharmacol, Wexner Med Ctr, Columbus, OH 43210 USA; [Anand, Rene] Ohio State Univ, Coll Med, Dept Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA; [Wells, Gregg B.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77483 USA; [Pinch, Matthew; Gueth, Robert; Unguez, Graciela A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Albert, James S.] Univ Louisiana, Dept Biol, Lafayette, LA 70503 USA; [Zakon, Harold H.] Univ Texas Austin, Austin, TX 78712 USA; [Zakon, Harold H.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Samanta, Manoj P.] Systemix Inst, Redmond, WA 98053 USA	Michigan State University; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rice University; Rice University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Texas A&M University System; Texas A&M University College Station; New Mexico State University; University of Louisiana Lafayette; University of Texas System; University of Texas Austin; Marine Biological Laboratory - Woods Hole	Zakon, HH (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.	h.zakon@austin.utexas.edu; manoj.samanta@systemix.org; msussman@wisc.edu	Volkening, Jeremy/AAC-2454-2020; Wells, Gregg/AAU-7798-2021; Gallant, Jason/A-9629-2015	Volkening, Jeremy/0000-0002-8892-7155; Gallant, Jason/0000-0002-6528-090X	NSF grant MCB [1144012]; NSF grant CNS [1248109]; NSF grant DEB [0741450]; W.M. Keck Foundation; NIH [R01 GM084879, R01 GM088670, 1SC1GM092297-01A1]; Texas A&M University Health Science Center College of Medicine; Cornell University Center for Vertebrate Genomics; University of Wisconsin Genetics NIH Graduate Training Grant; Morgridge Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133, SC1GM092297, R01GM088670, R01GM084879] Funding Source: NIH RePORTER	NSF grant MCB; NSF grant CNS; NSF grant DEB; W.M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Health Science Center College of Medicine; Cornell University Center for Vertebrate Genomics; University of Wisconsin Genetics NIH Graduate Training Grant; Morgridge Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded in part by NSF grants MCB no. 1144012 (M.R.S.), CNS no. 1248109 (G.A.U.), and DEB no. 0741450 (J.S.A.); the W.M. Keck Foundation Distinguished Young Scholars in Medical Research (C.D.N.); NIH grants R01 GM084879 (H.H.Z.), R01 GM088670 (R.A.), and 1SC1GM092297-01A1 (G.A.U.); the Texas A&M University Health Science Center College of Medicine (G.B.W.); the Cornell University Center for Vertebrate Genomics (J.R.G.); the University of Wisconsin Genetics NIH Graduate Training Grant (L.L.T.); and the Morgridge Graduate Fellowship (J.D.V.). E. V. Armbrust provided computing assistance, and S. B. McKay assisted with data analysis. M. P. S. acknowledges useful discussions with R. Chikhi, R. Luo, and J. Simpson. We thank J. Bayliss for dissection of E. electricus and R. Amasino for help in preparing this manuscript. M. R. S. and L. L. T. acknowledge the guidance of J. Hyman, M. Adams, and J. Speers from the University of Wisconsin Biotechnology Center for their excellent assistance in E. electricus sequencing. The raw sequencing reads have been deposited in the National Center for Biotechnology Information short-read archive for the E. electricus genome (BioProject ID: PRJNA249073) and transcriptome sequences of E. electricus, S. macrurus, E. virescens, M. electricus, and B. brachyistius (BioProject ID: PRJNA248545). The whole-genome assemblies and annotation, together with the transcriptome assemblies, are available at http://efishgenomics.zoology.msu.edu, along with BLAST and genome-browsing services.	Albert J. S., 2005, PHYSL FISHES, P431; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; BLOCK BA, 1991, AM ZOOL, V31, P726; Buas MF, 2010, J BIOL CHEM, V285, P1249, DOI 10.1074/jbc.M109.046441; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Darwin C., 1859, ORIGIN SPECIES MEANS, V1, pix, DOI [10.5962/bhl.title.82303, DOI 10.5962/BHL.TITLE.82303]; Datta K, 2009, J BIOL CHEM, V284, P29666, DOI 10.1074/jbc.M109.034041; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Ghanbari H, 2001, MECH DEVELOP, V101, P271, DOI 10.1016/S0925-4773(00)00572-4; Hoopes BC, 2012, MAMM GENOME, V23, P780, DOI 10.1007/s00335-012-9417-z; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; Kluver N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029063; Kokubo H, 2007, DEVELOPMENT, V134, P747, DOI 10.1242/dev.02777; Lowe J, 2004, BBA-BIOMEMBRANES, V1661, P40, DOI 10.1016/j.bbamem.2003.11.020; Mate SE, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-20; Mothe I, 1997, MOL ENDOCRINOL, V11, P1911, DOI 10.1210/me.11.13.1911; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Otto A, 2010, EXP CELL RES, V316, P3059, DOI 10.1016/j.yexcr.2010.04.009; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Unguez GA, 1998, J NEUROSCI, V18, P9924; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064	24	126	128	14	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1522	1525		10.1126/science.1254432	http://dx.doi.org/10.1126/science.1254432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970089	Green Accepted			2022-12-24	WOS:000337889900052
J	Eswarappa, SM; Potdar, AA; Koch, WJ; Fan, Y; Vasu, K; Lindner, D; Wiiiard, B; Graham, LM; DiCorieto, PE; Fox, PL				Eswarappa, Sandeepa M.; Potdar, Alka A.; Koch, William J.; Fan, Yi; Vasu, Kommireddy; Lindner, Daniel; Wiiiard, Belinda; Graham, Linda M.; DiCorieto, Paul E.; Fox, Paul L.			Programmed Translational Readthrough Generates Antiangiogenic VEGF-Ax	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; STOP CODON READTHROUGH; INHIBITORY SPLICE VARIANT; SUPPRESSOR TRANSFER-RNAS; MESSENGER-RNA; IN-VIVO; TERMINATION CODONS; ESCHERICHIA-COLI; FACTOR ISOFORM; TUMOR-GROWTH	Translational readthrough, observed primarily in less complex organisms from viruses to Drosophila, expands the proteome by translating select transcripts beyond the canonical stop codon. Here, we show that vascular endothelial growth factor A (VEGFA) mRNA in mammalian endothelial cells undergoes programmed translational readthrough (PTR) generating VEGF-Ax, an isoform containing a unique 22-amino-acid C terminus extension. A cis-acting element in the VEGFA 30 UTR serves a dual function, not only encoding the appended peptide but also directing the PTR by decoding the UGA stop codon as serine. Heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 binds this element and promotes readthrough. Remarkably, VEGF-Ax exhibits antiangiogenic activity in contrast to the proangiogenic activity of VEGF-A. Pathophysiological significance of VEGF-Ax is indicated by robust expression in multiple human tissues but depletion in colon adenocarcinoma. Furthermore, genome-wide analysis revealed AGO1 and MTCH2 as authentic readthrough targets. Overall, our studies reveal a novel protein-regulated PTR event in a vertebrate system.	[Eswarappa, Sandeepa M.; Potdar, Alka A.; Koch, William J.; Fan, Yi; Vasu, Kommireddy; DiCorieto, Paul E.; Fox, Paul L.] Lerner Res Inst, Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Potdar, Alka A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Lindner, Daniel] Taussig Canc Ctr, Cleveland Clin, Cleveland, OH 44195 USA; [Wiiiard, Belinda] Lerner Res Inst, Cleveland Clin, Mass Spectrometry Lab Prot Sequencing, Cleveland, OH 44195 USA; [Graham, Linda M.] Lerner Res Inst, Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Fox, PL (corresponding author), Lerner Res Inst, Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.	foxp@ccf.org	Kommireddy, Vasu/C-3928-2018; Eswarappa, Sandeep/AFG-1997-2022; Lindner, Daniel/ABB-5440-2020	Kommireddy, Vasu/0000-0002-7608-7566; Koch, William/0000-0002-4820-3451	NIH [P01 HL029582, P01 HL076491, R01 GM086430, R01 DK083359, R21 HL094841, S10 RR031537]; American Heart Association, Great Rivers Affiliate; Athymic Animal and Xenograft Core, NCI of the Case Comprehensive Cancer Center [P30 CA043703-23]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094841, P01HL029582, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Great Rivers Affiliate(American Heart Association); Athymic Animal and Xenograft Core, NCI of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants P01 HL029582, P01 HL076491, R01 GM086430, R01 DK083359, and R21 HL094841 (to P.L. F.). S.M.E. was supported by a fellowship from the American Heart Association, Great Rivers Affiliate. A shared instrument grant (S10 RR031537) from the NIH (to B.W.) was used to purchase the Orbitrap mass spectrometer. Mouse studies were supported by the Athymic Animal and Xenograft Core, NCI P30 CA043703-23, of the Case Comprehensive Cancer Center (to D. L.). We are grateful to Donna Driscoll and Jodi Bubenik for helpful discussions. S.M.E. and P.L.F. are inventors on a patent that has been filed related to this work.	AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Bates DO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068399; Bates DO, 2002, CANCER RES, V62, P4123; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Cebe-Suarez S, 2008, FASEB J, V22, P3078, DOI 10.1096/fj.08-107219; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; Cromer W, 2010, MICROCIRCULATION, V17, P536, DOI 10.1111/j.1549-8719.2010.00047.x; DIAMOND A, 1981, CELL, V25, P497, DOI 10.1016/0092-8674(81)90068-4; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; FENG YX, 1990, P NATL ACAD SCI USA, V87, P8860, DOI 10.1073/pnas.87.22.8860; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Harris S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035231; HATFIELD DL, 1990, CRIT REV BIOCHEM MOL, V25, P71, DOI 10.3109/10409239009090606; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Howard MT, 2004, ANN NEUROL, V55, P422, DOI 10.1002/ana.20052; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JALAJAKUMARI MB, 1989, MOL MICROBIOL, V3, P1685, DOI 10.1111/j.1365-2958.1989.tb00154.x; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kondo Jiro, 2005, Nucleic Acids Symp Ser (Oxf), P253; Konopatskaya O, 2006, MOL VIS, V12, P626; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; LI GP, 1989, J VIROL, V63, P1326, DOI 10.1128/JVI.63.3.1326-1337.1989; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Manetti M, 2011, CIRC RES, V109, pE14, DOI 10.1161/CIRCRESAHA.111.242057; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; PELHAM HRB, 1978, NATURE, V272, P469, DOI 10.1038/272469a0; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Qiu Y, 2008, FASEB J, V22, P1104, DOI 10.1096/fj.07-9718com; Rajon E, 2011, P NATL ACAD SCI USA, V108, P1082, DOI 10.1073/pnas.1012918108; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Rennel ES, 2009, BRIT J CANCER, V101, P1183, DOI 10.1038/sj.bjc.6605249; Rennel ES, 2008, EUR J CANCER, V44, P1883, DOI 10.1016/j.ejca.2008.05.027; Robinson DN, 1997, DEVELOPMENT, V124, P1405; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; SCHWARTZ SM, 1978, LAB INVEST, V38, P568; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shan JG, 2003, J NEUROSCI, V23, P8859; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; Suarez SC, 2006, CELL MOL LIFE SCI, V63, P2067, DOI 10.1007/s00018-006-6254-9; Tate WP, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1342; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Yamaguchi Y, 2012, J BIOL CHEM, V287, P17765, DOI 10.1074/jbc.M111.314468; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057	66	128	129	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1605	1618		10.1016/j.cell.2014.04.033	http://dx.doi.org/10.1016/j.cell.2014.04.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949972	Green Accepted, Bronze			2022-12-24	WOS:000340941900015
J	Procko, E; Berguig, GY; Shen, BW; Song, YF; Frayo, S; Convertine, AJ; Margineantu, D; Booth, G; Correia, BE; Cheng, YH; Schief, WR; Hockenbery, DM; Press, OW; Stoddard, BL; Stayton, PS; Baker, D				Procko, Erik; Berguig, Geoffrey Y.; Shen, Betty W.; Song, Yifan; Frayo, Shani; Convertine, Anthony J.; Margineantu, Daciana; Booth, Garrett; Correia, Bruno E.; Cheng, Yuanhua; Schief, William R.; Hockenbery, David M.; Press, Oliver W.; Stoddard, Barry L.; Stayton, Patrick S.; Baker, David			A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells	CELL			English	Article							INTRACELLULAR DELIVERY; EPITOPE-SCAFFOLDS; B-CELLS; VIRUS; HOMOLOG; BHRF1; ANTIBODIES; DYNAMICS; LIGANDS; PEPTIDE	Because apoptosis of infected cells can limit virus production and spread, some viruses have co-opted prosurvival genes from the host. This includes the Epstein-Barr virus (EBV) gene BHRF1, a homolog of human Bcl-2 proteins that block apoptosis and are associated with cancer. Computational design and experimental optimization were used to generate a novel protein called BINDI that binds BHRF1 with picomolar affinity. BINDI recognizes the hydrophobic cleft of BHRF1 in a manner similar to other Bcl-2 protein interactions but makes many additional contacts to achieve exceptional affinity and specificity. BINDI induces apoptosis in EBV-infected cancer lines, and when delivered with an antibody-targeted intracellular delivery carrier, BINDI suppressed tumor growth and extended survival in a xenograft disease model of EBV-positive human lymphoma. High-specificity-designed proteins that selectively kill target cells may provide an advantage over the toxic compounds used in current generation antibody-drug conjugates.	[Procko, Erik; Song, Yifan; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Berguig, Geoffrey Y.; Convertine, Anthony J.; Cheng, Yuanhua; Stayton, Patrick S.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Shen, Betty W.; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Frayo, Shani; Margineantu, Daciana; Booth, Garrett; Hockenbery, David M.; Press, Oliver W.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Correia, Bruno E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Schief, William/ABF-3645-2020; Stayton, Patrick/C-1975-2018; Baker, David/K-8941-2012	Schief, William/0000-0002-1120-0150; Stayton, Patrick/0000-0001-6939-6371; Baker, David/0000-0001-7896-6217; Press, Oliver/0000-0002-3147-8037; Procko, Erik/0000-0002-0028-490X	National Institute of General Medical Studies of the National Institutes of Health (NIH) [P41GM103533, R01GM49857]; NIH [R21EB014572, R01CA076287, R01CA154897]; Washington State Life Sciences Discovery Fund [2496490]; Defence Threat Reduction Agency; David and Patricia Giuliani Family Foundation; National Science Foundation [SCI-0221529, SCI-0438443, SCI-0506411, PHY/0555655, OCI-0721124]; NATIONAL CANCER INSTITUTE [R01CA076287, R01CA154897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB014572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, R01GM049857] Funding Source: NIH RePORTER	National Institute of General Medical Studies of the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington State Life Sciences Discovery Fund; Defence Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); David and Patricia Giuliani Family Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Studies of the National Institutes of Health (NIH) under award numbers P41GM103533 and R01GM49857; NIH grants R21EB014572, R01CA076287, and R01CA154897; the Washington State Life Sciences Discovery Fund grant 2496490 to the Center for Intracellular Delivery of Biologics; the Defence Threat Reduction Agency; and a grant by the David and Patricia Giuliani Family Foundation. Computational resources were provided by BOINC and supported by the National Science Foundation through awards SCI-0221529, SCI-0438443, SCI-0506411, PHY/0555655, and OCI-0721124. P.S.S. and O.W.P. are cofounders of PhaseRx Pharmaceuticals, which has licensed drug delivery technology from University of Washington that encompasses aspects of the polymeric carriers used in this study.	Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berguig GY, 2012, MOL PHARMACEUT, V9, P3506, DOI 10.1021/mp300338s; Caria S, 2012, ACTA CRYSTALLOGR F, V68, P1521, DOI 10.1107/S1744309112043333; Chin JW, 2001, ANGEW CHEM INT EDIT, V40, P3806, DOI 10.1002/1521-3773(20011015)40:20<3806::AID-ANIE3806>3.0.CO;2-B; Convertine AJ, 2010, BIOMACROMOLECULES, V11, P2904, DOI 10.1021/bm100652w; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Desbien AL, 2009, P NATL ACAD SCI USA, V106, P5663, DOI 10.1073/pnas.0901036106; Dutta S, 2013, ACS CHEM BIOL, V8, P778, DOI 10.1021/cb300679a; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Duvall CL, 2010, MOL PHARMACEUT, V7, P468, DOI 10.1021/mp9002267; Fire E, 2010, PROTEIN SCI, V19, P507, DOI 10.1002/pro.329; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gemperli AC, 2005, J AM CHEM SOC, V127, P1596, DOI 10.1021/ja0441211; Goulet A, 2009, P NATL ACAD SCI USA, V106, P21155, DOI 10.1073/pnas.0909893106; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3191, DOI 10.1073/pnas.0436100100; ISHII HH, 1995, IMMUNOL CELL BIOL, V73, P463, DOI 10.1038/icb.1995.72; Kelly GL, 2013, J VIROL, V87, P2882, DOI 10.1128/JVI.03003-12; Kelly GL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000341; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kvansakul M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001236; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Leao M, 2007, J VIROL, V81, P248, DOI 10.1128/JVI.01096-06; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee EF, 2009, J BIOL CHEM, V284, P30508, DOI 10.1074/jbc.M109.040725; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Manganiello MJ, 2012, BIOMATERIALS, V33, P2301, DOI 10.1016/j.biomaterials.2011.11.019; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; O'Connor OA, 2006, CLIN CANCER RES, V12, P2902, DOI 10.1158/1078-0432.CCR-05-0308; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Watanabe A, 2010, J VIROL, V84, P2893, DOI 10.1128/JVI.01616-09	38	93	107	1	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1644	1656		10.1016/j.cell.2014.04.034	http://dx.doi.org/10.1016/j.cell.2014.04.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949974	Bronze, Green Accepted			2022-12-24	WOS:000340941900018
J	King, NP; Bale, JB; Sheffler, W; McNamara, DE; Gonen, S; Gonen, T; Yeates, TO; Baker, D				King, Neil P.; Bale, Jacob B.; Sheffler, William; McNamara, Dan E.; Gonen, Shane; Gonen, Tamir; Yeates, Todd O.; Baker, David			Accurate design of co-assembling multi-component protein nanomaterials	NATURE			English	Article							COMPUTATIONAL DESIGN; DIRECTED EVOLUTION; DNA; SYMMETRY; NANOSTRUCTURES; INTERFACES; HOMODIMER; CONTAINER; ARRAYS; CAGES	The self-assembly of proteins into highly ordered nanoscale architectures is a hallmark of biological systems. The sophisticated functions of these molecular machines have inspired the development of methods to engineer self-assembling protein nanostructures; however, the design of multi-component protein nanomaterials with high accuracy remains an outstanding challenge. Here we report a computational method for designing protein nanomaterials in which multiple copies of two distinct subunits co-assemble into a specific architecture. We use the method to design five 24-subunit cage-like protein nanomaterials in two distinct symmetric architectures and experimentally demonstrate that their structures are in close agreement with the computational design models. The accuracy of the method and the number and variety of two-component materials that it makes accessible suggest a route to the construction of functional protein nanomaterials tailored to specific applications.	[King, Neil P.; Bale, Jacob B.; Sheffler, William; Gonen, Shane; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [King, Neil P.; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Bale, Jacob B.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [McNamara, Dan E.; Yeates, Todd O.] UCLA Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Gonen, Shane; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Yeates, Todd O.] UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Yeates, Todd O.] UCLA Mol Biol Inst, Los Angeles, CA 90095 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Gonen, Shane/0000-0002-4829-3151; Yeates, Todd/0000-0001-5709-9839; McNamara, Dan/0000-0003-0600-7847; Bale, Jacob/0000-0003-2444-5875	Howard Hughes Medical Institute; JFRC; National Science Foundation [CHE-1332907]; International AIDS Vaccine Initiative, DTRA [N00024-10-D-6318/0024]; AFOSR [FA950-12-10112]; DOE [DE-SC0005155]; NIH [T32GM067555]; NSF [DGE-0718124]; BER programme of the DOE Office of Science; Division Of Chemistry [1332907] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067555] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JFRC; National Science Foundation(National Science Foundation (NSF)); International AIDS Vaccine Initiative, DTRA; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); BER programme of the DOE Office of Science(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Shi and B. Nannenga (JFRC) for help with electron microscopy, F. DiMaio and R. Moretti for assistance with software development, P. Greisen for scripts used to compare side-chain conformations, J. Gallaher for technical assistance, M. Collazo for help with preliminary crystallization screening, D. Cascio and M. Sawaya for help with crystallographic experiments, and M. Capel, J. Schuermann and I. Kourinov at NE-CAT beamline 24-ID-C for help with data collection. This work was supported by the Howard Hughes Medical Institute (T. G. and D. B.) and the JFRC visitor program (S. G.), the National Science Foundation under CHE-1332907 (D. B. and T.O.Y.), grants from the International AIDS Vaccine Initiative, DTRA (N00024-10-D-6318/0024), AFOSR (FA950-12-10112) and DOE (DE-SC0005155) to D. B., an NIH Biotechnology Training Program award to D. E. M. (T32GM067555) and an NSF graduate research fellowship to J. B. B. (DGE-0718124). T.O.Y. and D.E.M. also acknowledge support from the BER programme of the DOE Office of Science. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding bodies.	Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; Boyle AL, 2012, J AM CHEM SOC, V134, P15457, DOI 10.1021/ja3053943; Bradley P, 2006, PROTEINS, V65, P922, DOI 10.1002/prot.21133; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Der BS, 2012, J AM CHEM SOC, V134, P375, DOI 10.1021/ja208015j; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; Howorka S, 2011, CURR OPIN BIOTECH, V22, P485, DOI 10.1016/j.copbio.2011.05.003; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Khare SD, 2013, FEBS LETT, V587, P1147, DOI 10.1016/j.febslet.2012.12.009; King NP, 2013, CURR OPIN STRUC BIOL, V23, P632, DOI 10.1016/j.sbi.2013.06.002; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Lai YT, 2012, TRENDS CELL BIOL, V22, P653, DOI 10.1016/j.tcb.2012.08.004; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Salgado EN, 2010, ACCOUNTS CHEM RES, V43, P661, DOI 10.1021/ar900273t; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Sinclair JC, 2013, CURR OPIN CHEM BIOL, V17, P946, DOI 10.1016/j.cbpa.2013.10.004; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Stranges PB, 2011, P NATL ACAD SCI USA, V108, P20562, DOI 10.1073/pnas.1115124108; Usui K, 2009, PROTEIN SCI, V18, P960, DOI 10.1002/pro.106; Worsdorfer B, 2012, J AM CHEM SOC, V134, P909, DOI 10.1021/ja211011k; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081	38	383	393	13	402	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					103	+		10.1038/nature13404	http://dx.doi.org/10.1038/nature13404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24870237	Green Accepted			2022-12-24	WOS:000336768900037
J	Spiegel, I; Mardinly, AR; Gabel, HW; Bazinet, JE; Couch, CH; Tzeng, CP; Harmin, DA; Greenberg, ME				Spiegel, Ivo; Mardinly, Alan R.; Gabel, Harrison W.; Bazinet, Jeremy E.; Couch, Cameron H.; Tzeng, Christopher P.; Harmin, David A.; Greenberg, Michael E.			Npas4 Regulates Excitatory-Inhibitory Balance within Neural Circuits through Cell-Type-Specific Gene Programs	CELL			English	Article							NEURONAL-ACTIVITY; CRITICAL PERIOD; VISUAL-CORTEX; INTERNEURONS; PLASTICITY; TRANSCRIPTION; EXPRESSION; MECHANISMS; MATURATION; EXPERIENCE	The nervous system adapts to experience by inducing a transcriptional program that controls important aspects of synaptic plasticity. Although the molecular mechanisms of experience-dependent plasticity are well characterized in excitatory neurons, the mechanisms that regulate this process in inhibitory neurons are only poorly understood. Here, we describe a transcriptional program that is induced by neuronal activity in inhibitory neurons. We find that, while neuronal activity induces expression of early-response transcription factors such as Npas4 in both excitatory and inhibitory neurons, Npas4 activates distinct programs of late-response genes in inhibitory and excitatory neurons. These late-response genes differentially regulate synaptic input to these two types of neurons, promoting inhibition onto excitatory neurons while inducing excitation onto inhibitory neurons. These findings suggest that the functional outcomes of activity-induced transcriptional responses are adapted in a cell-type-specific manner to achieve a circuit-wide homeostatic response.	[Spiegel, Ivo; Mardinly, Alan R.; Gabel, Harrison W.; Bazinet, Jeremy E.; Couch, Cameron H.; Tzeng, Christopher P.; Harmin, David A.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mardinly, Alan R.; Tzeng, Christopher P.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	meg@hms.harvard.edu	Spiegel, Ivo/O-4025-2014	Tzeng, Christopher/0000-0003-4734-6298; Mardinly, Alan/0000-0001-9891-6719; Spiegel, Ivo/0000-0003-0979-1358	Human Frontiers Science Program; Swiss National Science Foundation; National Institutes of Health [NS048276]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276, R37NS028829] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Polleux and J. De Marchena for help with establishing the MGE cultures, C. Mandel-Brehm and C. Chen for help with electrophysiology experiments, J. M. Gray and A. M. Costa for help with preparing RNA-seq libraries, B. L. Bloodgood for preliminary recordings from MGE cultures, N. Sharma for the lentiviral expression construct of Npas4, E. Griffith and T. Cherry for critical reading of the manuscript, and P. Zhang for managing the mouse colony. This work was funded by fellowships by the Human Frontiers Science Program and the Swiss National Science Foundation (I. S.) and the National Institutes of Health grant NS048276 (M.E.G.).	Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lee HW, 2008, J NEUROSCI, V28, P14546, DOI 10.1523/JNEUROSCI.3112-08.2008; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maya-Vetencourt JF, 2012, J PHYSIOL-LONDON, V590, P4777, DOI 10.1113/jphysiol.2012.234237; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	31	212	216	3	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1216	1229		10.1016/j.cell.2014.03.058	http://dx.doi.org/10.1016/j.cell.2014.03.058			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855953	Green Accepted, Bronze			2022-12-24	WOS:000336437200021
J	Wu, Z; Autry, AE; Bergan, JF; Watabe-Uchida, M; Dulac, CG				Wu, Zheng; Autry, Anita E.; Bergan, Joseph F.; Watabe-Uchida, Mitsuko; Dulac, Catherine G.			Galanin neurons in the medial preoptic area govern parental behaviour	NATURE			English	Article							MATERNAL-BEHAVIOR; SEXUAL-BEHAVIOR; MALE-AGGRESSION; MALE-MICE; VOMERONASAL; NUCLEUS; INFANTICIDE; EXPRESSION; ORGANIZATION; RECEPTOR	Mice display robust, stereotyped behaviours towards pups: virgin males typically attack pups, whereas virgin females and sexually experienced males and females display parental care. Here we show that virgin males genetically impaired in vomeronasal sensing do not attack pups and are parental. Furthermore, we uncover a subset of galanin-expressing neurons in the medial preoptic area (MPOA) that are specifically activated during male and female parenting, and a different subpopulation that is activated during mating. Genetic ablation of MPOA galanin neurons results in marked impairment of parental responses in males and females and affects male mating. Optogenetic activation of these neurons in virgin males suppresses inter-male and pup-directed aggression and induces pup grooming. Thus, MPOA galanin neurons emerge as an essential regulatory node of male and female parenting behaviour and other social responses. These results provide an entry point to a circuit-level dissection of parental behaviour and its modulation by social experience.	[Wu, Zheng; Autry, Anita E.; Bergan, Joseph F.; Dulac, Catherine G.] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Watabe-Uchida, Mitsuko] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Dulac, CG (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Core, Vector/CAF-4832-2022; Autry, Anita/ABF-9006-2021	Dulac, Catherine/0000-0001-5024-5418	Howard Hughes Medical Institute; National Institute of Health (NIDCD); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003903, F32DC010089, R01DC013087, R01DC009019] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Health (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Deisseroth for the Cre-dependent AAV-ChR2:EYFP construct; E. Boyden for the Cre-dependent AAV-GFP construct; N. Shah for the AAV-Flex-taCasp3-TEVp virus; S. Sullivan for behaviour annotation and scoring; R. Hellmiss for figure artwork; E. Soucy and J. Greenwood for technical assistance. We also thank members of the Dulac and Uchida laboratories and V. Murthy, A. Schier and M. Meister for advice on experiments and statistical analysis and comments on the manuscript, and the anonymous reviewers for their helpful suggestions and comments. This work was supported by the Howard Hughes Medical Institute and the National Institute of Health (NIDCD).	ARENDASH GW, 1983, BRAIN RES BULL, V10, P147, DOI 10.1016/0361-9230(83)90086-2; Bakker J, 2002, J NEUROENDOCRINOL, V14, P116, DOI 10.1046/j.0007-1331.2001.00751.x; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; BRIDGES RS, 1985, SCIENCE, V227, P782, DOI 10.1126/science.3969568; BROOKS RJ, 1983, BEHAV NEURAL BIOL, V37, P149, DOI 10.1016/S0163-1047(83)91159-7; BROWN RE, 1993, BEHAV PROCESS, V30, P1, DOI 10.1016/0376-6357(93)90009-G; CALAMANDREI G, 1994, BEHAV NEUROSCI, V108, P113, DOI 10.1037/0735-7044.108.1.113; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Champagne FA, 2003, ENDOCRINOLOGY, V144, P4720, DOI 10.1210/en.2003-0564; Dominguez JM, 2005, PHYSIOL BEHAV, V86, P356, DOI 10.1016/j.physbeh.2005.08.006; ELWOOD RW, 1985, J COMP PSYCHOL, V99, P457, DOI 10.1037/0735-7036.99.4.457; FLEMING A, 1979, SCIENCE, V203, P372, DOI 10.1126/science.760196; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; JENNES L, 1994, FRONT NEUROENDOCRIN, V15, P51, DOI 10.1006/frne.1994.1003; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; LABOV JB, 1980, BEHAV ECOL SOCIOBIOL, V6, P297, DOI 10.1007/BF00292772; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Lonstein JS, 2000, NEUROSCI BIOBEHAV R, V24, P669, DOI 10.1016/S0149-7634(00)00036-1; Lucas BK, 1998, ENDOCRINOLOGY, V139, P4102, DOI 10.1210/en.139.10.4102; McAllen RM, 2010, EUR J APPL PHYSIOL, V109, P27, DOI 10.1007/s00421-009-1295-z; Mechenthaler I, 2008, CELL MOL LIFE SCI, V65, P1826, DOI 10.1007/s00018-008-8157-4; MENNELLA JA, 1988, PHYSIOL BEHAV, V42, P303, DOI 10.1016/0031-9384(88)90087-X; MOLTZ H, 1970, PHYSIOL BEHAV, V5, P1373, DOI 10.1016/0031-9384(70)90122-8; NUMAN M, 1974, J COMP PHYSIOL PSYCH, V87, P746, DOI 10.1037/h0036974; Numan M., 2003, HORM BR BEHAV; Numan M, 2010, BEHAV BRAIN RES, V214, P368, DOI 10.1016/j.bbr.2010.06.006; Numan M, 2009, FRONT NEUROENDOCRIN, V30, P46, DOI 10.1016/j.yfrne.2008.10.002; PEDERSEN CA, 1982, SCIENCE, V216, P648, DOI 10.1126/science.7071605; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; POWERS B, 1972, SCIENCE, V175, P1003, DOI 10.1126/science.175.4025.1003; ROSENBLATT JS, 1967, SCIENCE, V156, P1512, DOI 10.1126/science.156.3781.1512; SAAL FSV, 1985, PHYSIOL BEHAV, V34, P7, DOI 10.1016/0031-9384(85)90069-1; Schneider JS, 2003, P NATL ACAD SCI USA, V100, P2951, DOI 10.1073/pnas.0130100100; SEGOVIA S, 1993, BRAIN RES REV, V18, P51, DOI 10.1016/0165-0173(93)90007-M; SIMERLY RB, 1986, J COMP NEUROL, V246, P343, DOI 10.1002/cne.902460305; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; SIMERLY RB, 1988, J COMP NEUROL, V270, P209, DOI 10.1002/cne.902700205; Soriano P, 1997, DEVELOPMENT, V124, P2691; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; SVARE B, 1981, PHYSIOL BEHAV, V27, P921, DOI 10.1016/0031-9384(81)90062-7; Tachikawa KS, 2013, J NEUROSCI, V33, P5120, DOI 10.1523/JNEUROSCI.2364-12.2013; TERKEL J, 1968, J COMP PHYSIOL PSYCH, V65, P479, DOI 10.1037/h0025817; Trainor BC, 2001, HORM BEHAV, V40, P32, DOI 10.1006/hbeh.2001.1652; VOMSAAL FS, 1982, SCIENCE, V215, P1271; Wynick D, 1998, P NATL ACAD SCI USA, V95, P12671, DOI 10.1073/pnas.95.21.12671; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	55	307	311	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					325	+		10.1038/nature13307	http://dx.doi.org/10.1038/nature13307			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828191	Green Accepted, Green Submitted			2022-12-24	WOS:000336121200031
J	Yamaguchi, N; Winter, CM; Wu, MF; Kanno, Y; Yamaguchi, A; Seo, M; Wagner, D				Yamaguchi, Nobutoshi; Winter, Cara M.; Wu, Miin-Feng; Kanno, Yuri; Yamaguchi, Ayako; Seo, Mitsunori; Wagner, Doris			Gibberellin Acts Positively Then Negatively to Control Onset of Flower Formation in Arabidopsis	SCIENCE			English	Article							TRANSCRIPTION FACTORS; FLORAL INDUCTION; THALIANA; EXPRESSION; PLANTS; GENES; INITIATION; PATHWAYS; CYP714A1; IDENTITY	The switch to reproductive development is biphasic in many plants, a feature important for optimal pollination and yield. We show that dual opposite roles of the phytohormone gibberellin underpin this phenomenon in Arabidopsis. Although gibberellin promotes termination of vegetative development, it inhibits flower formation. To overcome this effect, the transcription factor LEAFY induces expression of a gibberellin catabolism gene; consequently, increased LEAFY activity causes reduced gibberellin levels. This allows accumulation of gibberellin-sensitive DELLA proteins. The DELLA proteins are recruited by SQUAMOSA PROMOTER BINDING PROTEIN-LIKE transcription factors to regulatory regions of the floral commitment gene APETALA1 and promote APETALA1 up-regulation and floral fate synergistically with LEAFY. The two opposing functions of gibberellin may facilitate evolutionary and environmental modulation of plant inflorescence architecture.	[Yamaguchi, Nobutoshi; Winter, Cara M.; Wu, Miin-Feng; Yamaguchi, Ayako; Wagner, Doris] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kanno, Yuri; Seo, Mitsunori] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan	University of Pennsylvania; RIKEN	Wagner, D (corresponding author), Univ Penn, Dept Biol, 415 South Univ Ave, Philadelphia, PA 19104 USA.	wagnerdo@sas.upenn.edu	Yamaguchi, Nobutoshi/AAU-6928-2020; Seo, Mitsunori/N-9603-2015; kanno, yuri/C-9211-2017	Yamaguchi, Nobutoshi/0000-0003-3738-6157; Seo, Mitsunori/0000-0001-8325-7984; Wagner, Doris/0000-0003-4656-2490	NSF [IOS 0849298, 1257111];  [T32-HD007516]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to Wagner laboratory members and K. Gallagher, R. S. Poethig, and J. D. Wagner for critical comments. We thank R. Austin for the LFY binding motif functional depth analyses, T. Sun for pRGA: RGA-GFP and GA pathway mutant seeds, X. Chen for 35S: AlcR pAlcA: MIR156f and pRGA: RGA-HA seeds, M. Schmid for RGL1 and rgl1delta17 constructs, S. Poethig for pSPL9: rSPL9-FLAG and 35S: SPL9-GR seeds, H. Yu for ga1-3 rgl2-1 rga-2 35S: RGA-GR seeds, G. Angenent for pAP1: AP1-GFP seeds, and the Arabidopsis Biological Resource Center for insertion mutant seeds and the F6A4 bacterial artificial chromosome clone. This work was supported by NSF grants IOS 0849298 and 1257111 to D. W. and training grant T32-HD007516 (Developmental Biology) support to C.M.W.	Blazquez MA, 2000, NATURE, V404, P889, DOI 10.1038/35009125; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Galvao VC, 2012, DEVELOPMENT, V139, P4072, DOI 10.1242/dev.080879; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Hirano K, 2012, PLANT J, V71, P443, DOI 10.1111/j.1365-313X.2012.05000.x; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; Nomura T, 2013, PLANT CELL PHYSIOL, V54, P1837, DOI 10.1093/pcp/pct125; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; Porri A, 2012, DEVELOPMENT, V139, P2198, DOI 10.1242/dev.077164; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Steeves TA, 1989, PATTERN PLANT DEV; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Yu N, 2010, PLANT CELL, V22, P2322, DOI 10.1105/tpc.109.072579; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang YY, 2011, PLANT J, V67, P342, DOI 10.1111/j.1365-313X.2011.04596.x	30	166	191	17	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					638	641		10.1126/science.1250498	http://dx.doi.org/10.1126/science.1250498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812402				2022-12-24	WOS:000335537400045
J	Grady, JM; Enquist, BJ; Dettweiler-Robinson, E; Wright, NA; Smith, FA				Grady, John M.; Enquist, Brian J.; Dettweiler-Robinson, Eva; Wright, Natalie A.; Smith, Felisa A.			DINOSAUR PHYSIOLOGY Evidence for mesothermy in dinosaurs	SCIENCE			English	Article							BODY TEMPERATURES; GROWTH-RATES; THERMOREGULATION; EVOLUTION; PATTERNS	Were dinosaurs ectotherms or fast-metabolizing endotherms whose activities were unconstrained by temperature? To date, some of the strongest evidence for endothermy comes from the rapid growth rates derived from the analysis of fossil bones. However, these studies are constrained by a lack of comparative data and an appropriate energetic framework. Here we compile data on ontogenetic growth for extant and fossil vertebrates, including all major dinosaur clades. Using a metabolic scaling approach, we find that growth and metabolic rates follow theoretical predictions across clades, although some groups deviate. Moreover, when the effects of size and temperature are considered, dinosaur metabolic rates were intermediate to those of endotherms and ectotherms and closest to those of extant mesotherms. Our results suggest that the modern dichotomy of endothermic versus ectothermic is overly simplistic.	[Grady, John M.; Dettweiler-Robinson, Eva; Wright, Natalie A.; Smith, Felisa A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Enquist, Brian J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Enquist, Brian J.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of New Mexico; University of Arizona; The Santa Fe Institute	Grady, JM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	jgrady@unm.edu	Enquist, Brian J/B-6436-2008; Smith, Felisa/ABE-6160-2021	Enquist, Brian J/0000-0002-6124-7096; Smith, Felisa/0000-0001-6262-436X; Dettweiler-Robinson, Eva/0000-0002-9742-3434; Grady, John/0000-0001-6444-3300	Program in Interdisciplinary Biological and Biomedical Sciences at the University of New Mexico (grant from the National Institute of Biomedical Imaging and Bioengineering) [T32EB009414]; NSF CAREER; NSF ATB [EF 0742800]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009414] Funding Source: NIH RePORTER	Program in Interdisciplinary Biological and Biomedical Sciences at the University of New Mexico (grant from the National Institute of Biomedical Imaging and Bioengineering); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF ATB; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a fellowship from the Program in Interdisciplinary Biological and Biomedical Sciences at the University of New Mexico (grant no. T32EB009414 from the National Institute of Biomedical Imaging and Bioengineering to F.A.S. and J. H. Brown). B.J.E. was supported by an NSF CAREER and ATB Award (EF 0742800). We thank C. White and two anonymous reviewers for valuable feedback on our manuscript and N. Milan for assistance with the figures. Data are available in the supplementary materials.	Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; Brice PH, 2002, AUST J ZOOL, V50, P461, DOI 10.1071/ZO01080; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Chinsamy Anusuya, 2002, P421; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; ELSE PL, 1981, AM J PHYSIOL, V240, pR3, DOI 10.1152/ajpregu.1981.240.1.R3; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hou C, 2008, SCIENCE, V322, P736, DOI 10.1126/science.1162302; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reid R., 2012, COMPLETE DINOSAUR, P873; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378	23	104	105	6	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1268	1272		10.1126/science.1253143	http://dx.doi.org/10.1126/science.1253143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926017				2022-12-24	WOS:000337077500037
J	Yimlamai, D; Christodoulou, C; Galli, GG; Yanger, K; Pepe-Mooney, B; Gurung, B; Shrestha, K; Cahan, P; Stanger, BZ; Camargo, FD				Yimlamai, Dean; Christodoulou, Constantina; Galli, Giorgio G.; Yanger, Kilangsungla; Pepe-Mooney, Brian; Gurung, Basanta; Shrestha, Kriti; Cahan, Patrick; Stanger, Ben Z.; Camargo, Fernando D.			Hippo Pathway Activity Influences Liver Cell Fate	CELL			English	Article							BILE-DUCT DEVELOPMENT; EPITHELIAL-CELLS; TEAD/TEF FAMILY; YAP ONCOPROTEIN; ORGAN SIZE; STEM-CELLS; HEPATOCYTES; PROTEIN; GROWTH; INACTIVATION	The Hippo-signaling pathway is an important regulator of cellular proliferation and organ size. However, little is known about the role of this cascade in the control of cell fate. Employing a combination of lineage tracing, clonal analysis, and organoid culture approaches, we demonstrate that Hippo pathway activity is essential for the maintenance of the differentiated hepatocyte state. Remarkably, acute inactivation of Hippo pathway signaling in vivo is sufficient to dedifferentiate, at very high efficiencies, adult hepatocytes into cells bearing progenitor characteristics. These hepatocyte-derived progenitor cells demonstrate self-renewal and engraftment capacity at the single-cell level. We also identify the NOTCH-signaling pathway as a functional important effector downstream of the Hippo transducer YAP. Our findings uncover a potent role for Hippo/YAP signaling in controlling liver cell fate and reveal an unprecedented level of phenotypic plasticity in mature hepatocytes, which has implications for the understanding and manipulation of liver regeneration.	[Yimlamai, Dean; Christodoulou, Constantina; Galli, Giorgio G.; Pepe-Mooney, Brian; Gurung, Basanta; Shrestha, Kriti; Cahan, Patrick; Camargo, Fernando D.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Yimlamai, Dean] Boston Childrens Hosp, Dept Med, Div Gastroenterol & Nutr, Boston, MA 02115 USA; [Christodoulou, Constantina; Galli, Giorgio G.; Pepe-Mooney, Brian; Gurung, Basanta; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Christodoulou, Constantina; Galli, Giorgio G.; Pepe-Mooney, Brian; Gurung, Basanta; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Yanger, Kilangsungla; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Camargo, FD (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	fernando.camargo@childrens.harvard.edu	Yimlamai, Dean/AAA-6607-2020; Yanger, Kilang/N-2888-2015	Yimlamai, Dean/0000-0002-7936-7168; Yanger, Kilang/0000-0002-1710-5306; Cahan, Patrick/0000-0003-3652-2540; Christodoulou, Constantina/0000-0001-5371-2210; camargo, fernando/0000-0002-5630-5909; Gurung, Basanta/0000-0003-3196-7495; Galli, Giorgio/0000-0002-9401-060X	Stand Up to Cancer-AACR initiative; National Institutes of Health [AR064036, DK099559, DK083355]; Department of Defense [W81XWH-9]; Harvard Stem Cell Institute; National Institute of Diabetes and Digestive and Kidney Diseases [5T32 DK007477-27]; Boston Children's Hospital Career Development Award; American-Italian Cancer Foundation postdoctoral research fellowship; National Science Foundation Graduate Research Fellowship Program [DGE1144152]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007477, R01DK099559, R01DK083355, K08DK105351, P30DK034854] Funding Source: NIH RePORTER	Stand Up to Cancer-AACR initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Harvard Stem Cell Institute; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Boston Children's Hospital Career Development Award; American-Italian Cancer Foundation postdoctoral research fellowship; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for stimulating discussions with the Camargo lab members, Barbara Trejo for help with IHC, Roderick Bronson for reviewing mouse liver pathology, and Ron Mathieu of the Stem Cell Program FACS facility. We thank G. Gu, T. Honjo, and M. Giovannini for use of Ck19-CreERT, RPBJ, and Nf2 mice, respectively. V. Factor generously donated A6 antibody for our use. This study was supported by awards from the Stand Up to Cancer-AACR initiative (FDC), grants from the National Institutes of Health (AR064036 and DK099559 to F. D. C.; DK083355 to B.Z.S.), a Department of Defense award (W81XWH-9) (to F. D. C.), and Junior Investigator funds from the Harvard Stem Cell Institute (to F. D. C.). D.Y. is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (5T32 DK007477-27) and a Boston Children's Hospital Career Development Award and is a George Ferry Young Investigator (NASPGHAN). G. G. G. is supported by an American-Italian Cancer Foundation postdoctoral research fellowship. B.P.-M. is supported by the National Science Foundation Graduate Research Fellowship Program (DGE1144152). F. D. C. is a Pew Scholar in the Biomedical Sciences.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Demetris AJ, 1996, AM J PATHOL, V149, P439; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; ENGELHARDT NV, 1993, DIFFERENTIATION, V55, P19, DOI 10.1111/j.1432-0436.1993.tb00029.x; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Greenbaum LE, 2011, GASTROENTEROLOGY, V141, P1152, DOI 10.1053/j.gastro.2011.08.023; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; McCright B, 2002, DEVELOPMENT, V129, P1075; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Michalopoulos George K, 2012, Hepatology, V55, P2024, DOI 10.1002/hep.25703; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Oertel M, 2008, BBA-MOL BASIS DIS, V1782, P61, DOI 10.1016/j.bbadis.2007.12.004; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	45	525	545	8	121	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1324	1338		10.1016/j.cell.2014.03.060	http://dx.doi.org/10.1016/j.cell.2014.03.060			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906150	Green Accepted, Bronze			2022-12-24	WOS:000340881400010
J	Barrangou, R				Barrangou, Rodolphe			Cas9 Targeting and the CRISPR Revolution	SCIENCE			English	Editorial Material							RNA; ENDONUCLEASE; COMPLEX		N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Barrangou, R (corresponding author), N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	rbarran@ncsu.edu	Barrangou, Rodolphe/I-2878-2014	Barrangou, Rodolphe/0000-0002-0648-3504				Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011	13	61	75	3	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					707	708		10.1126/science.1252964	http://dx.doi.org/10.1126/science.1252964			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833384				2022-12-24	WOS:000335912900029
J	Riccobono, F; Schobesberger, S; Scott, CE; Dommen, J; Ortega, IK; Rondo, L; Almeida, J; Amorim, A; Bianchi, F; Breitenlechner, M; David, A; Downard, A; Dunne, EM; Duplissy, J; Ehrhart, S; Flagan, RC; Franchin, A; Hansel, A; Junninen, H; Kajos, M; Keskinen, H; Kupc, A; Kurten, A; Kvashin, AN; Laaksonen, A; Lehtipalo, K; Makhmutov, V; Mathot, S; Nieminen, T; Onnela, A; Petaja, T; Praplan, AP; Santos, FD; Schallhart, S; Seinfeld, JH; Sipila, M; Spracklen, DV; Stozhkov, Y; Stratmann, F; Tome, A; Tsagkogeorgas, G; Vaattovaara, P; Viisanen, Y; Vrtala, A; Wagner, PE; Weingartner, E; Wex, H; Wimmer, D; Carslaw, KS; Curtius, J; Donahue, NM; Kirkby, J; Kulmala, M; Worsnop, DR; Baltensperger, U				Riccobono, Francesco; Schobesberger, Siegfried; Scott, Catherine E.; Dommen, Josef; Ortega, Ismael K.; Rondo, Linda; Almeida, Joao; Amorim, Antonio; Bianchi, Federico; Breitenlechner, Martin; David, Andre; Downard, Andrew; Dunne, Eimear M.; Duplissy, Jonathan; Ehrhart, Sebastian; Flagan, Richard C.; Franchin, Alessandro; Hansel, Armin; Junninen, Heikki; Kajos, Maija; Keskinen, Helmi; Kupc, Agnieszka; Kuerten, Andreas; Kvashin, Alexander N.; Laaksonen, Ari; Lehtipalo, Katrianne; Makhmutov, Vladimir; Mathot, Serge; Nieminen, Tuomo; Onnela, Antti; Petaja, Tuukka; Praplan, Arnaud P.; Santos, Filipe D.; Schallhart, Simon; Seinfeld, John H.; Sipila, Mikko; Spracklen, Dominick V.; Stozhkov, Yuri; Stratmann, Frank; Tome, Antonio; Tsagkogeorgas, Georgios; Vaattovaara, Petri; Viisanen, Yrjo; Vrtala, Aron; Wagner, Paul E.; Weingartner, Ernest; Wex, Heike; Wimmer, Daniela; Carslaw, Kenneth S.; Curtius, Joachim; Donahue, Neil M.; Kirkby, Jasper; Kulmala, Markku; Worsnop, Douglas R.; Baltensperger, Urs			Oxidation Products of Biogenic Emissions Contribute to Nucleation of Atmospheric Particles	SCIENCE			English	Article							SULFURIC-ACID; AEROSOL MICROPHYSICS; ORGANIC-COMPOUNDS; GROWTH-RATES; GLOBAL-MODEL; H2SO4; SIZE; NANOPARTICLES; UNCERTAINTY; MAGNITUDE	Atmospheric new-particle formation affects climate and is one of the least understood atmospheric aerosol processes. The complexity and variability of the atmosphere has hindered elucidation of the fundamental mechanism of new-particle formation from gaseous precursors. We show, in experiments performed with the CLOUD (Cosmics Leaving Outdoor Droplets) chamber at CERN, that sulfuric acid and oxidized organic vapors at atmospheric concentrations reproduce particle nucleation rates observed in the lower atmosphere. The experiments reveal a nucleation mechanism involving the formation of clusters containing sulfuric acid and oxidized organic molecules from the very first step. Inclusion of this mechanism in a global aerosol model yields a photochemically and biologically driven seasonal cycle of particle concentrations in the continental boundary layer, in good agreement with observations.	[Riccobono, Francesco; Dommen, Josef; Bianchi, Federico; Praplan, Arnaud P.; Weingartner, Ernest; Baltensperger, Urs] Paul Scherrer Inst, Lab Atmospher Chem, Villigen, Switzerland; [Schobesberger, Siegfried; Ortega, Ismael K.; Duplissy, Jonathan; Franchin, Alessandro; Junninen, Heikki; Kajos, Maija; Lehtipalo, Katrianne; Nieminen, Tuomo; Petaja, Tuukka; Schallhart, Simon; Sipila, Mikko; Kulmala, Markku; Worsnop, Douglas R.] Univ Helsinki, Dept Phys, Helsinki, Finland; [Scott, Catherine E.; Dunne, Eimear M.; Spracklen, Dominick V.; Carslaw, Kenneth S.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Rondo, Linda; Almeida, Joao; Ehrhart, Sebastian; Kuerten, Andreas; Wimmer, Daniela; Curtius, Joachim; Kirkby, Jasper] Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60054 Frankfurt, Germany; [Amorim, Antonio; Santos, Filipe D.; Tome, Antonio] Univ Lisbon, Lab Syst Instrumentat & Modeling Sci & Technol Sp, P-1699 Lisbon, Portugal; [Amorim, Antonio; Santos, Filipe D.; Tome, Antonio] Univ Beira Interior, Lisbon, Portugal; [Breitenlechner, Martin; Hansel, Armin] Ionicon Analyt GmbH, Innsbruck, Austria; [Breitenlechner, Martin; Hansel, Armin] Univ Innsbruck, Inst Ion & Appl Phys, A-6020 Innsbruck, Austria; [David, Andre; Mathot, Serge; Onnela, Antti; Kirkby, Jasper] CERN European Org Nucl Res, Geneva, Switzerland; [Downard, Andrew; Flagan, Richard C.; Seinfeld, John H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Keskinen, Helmi; Laaksonen, Ari; Vaattovaara, Petri] Univ Eastern Finland, Kuopio, Finland; [Kupc, Agnieszka; Vrtala, Aron; Wagner, Paul E.] Univ Vienna, Fac Phys, Vienna, Austria; [Kvashin, Alexander N.; Makhmutov, Vladimir; Stozhkov, Yuri] PN Lebedev Phys Inst, Solar & Cosm Ray Res Lab, Moscow 117924, Russia; [Duplissy, Jonathan; Nieminen, Tuomo; Sipila, Mikko; Kulmala, Markku] Univ Helsinki, Helsinki Inst Phys, Helsinki, Finland; [Stratmann, Frank; Tsagkogeorgas, Georgios; Wex, Heike] Leibniz Inst Tropospher Res, Leipzig, Germany; [Viisanen, Yrjo] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; [Donahue, Neil M.] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Helsinki; University of Leeds; Goethe University Frankfurt; Universidade de Lisboa; Universidade da Beira Interior; University of Innsbruck; European Organization for Nuclear Research (CERN); California Institute of Technology; University of Eastern Finland; University of Vienna; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Helsinki Institute of Physics; University of Helsinki; Leibniz Institut fur Tropospharenforschung (TROPOS); Finnish Meteorological Institute; Carnegie Mellon University; Aerodyne Research	Baltensperger, U (corresponding author), Paul Scherrer Inst, Lab Atmospher Chem, Villigen, Switzerland.	urs.baltensperger@psi.ch	Amorim, Antonio/C-8460-2013; Wex, Heike/X-5882-2018; Kirkby, Jasper/A-4973-2012; Duplissy, Jonathan/A-1723-2010; Santos, Filipe/M-7709-2013; Franchin, Alessandro/AAH-3069-2019; Sipilä, Mikko/G-3024-2010; Breitenlechner, Martin/AAA-3402-2021; Viisanen, Yrjö/CAG-3818-2022; Laaksonen, Ari/B-5094-2011; Praplan, Arnaud P./F-8357-2011; Dunne, Eimear M/H-1567-2014; Kulmala, Markku T/I-7671-2016; Hansel, Armin/F-3915-2010; Franchin, Alessandro/GVR-8219-2022; Schobesberger, Siegfried/L-4454-2014; Makhmutov, Vladimir/N-2086-2015; Spracklen, Dominick/AAA-6257-2019; Nieminen, Tuomo J/D-1618-2011; Yuri, Stozhkov/ABG-7096-2021; Tinoco Mendes, Andre David/D-4314-2011; Stozhkov, Yuri/M-7433-2015; Scott, Catherine E/K-8758-2013; Tome, Antonio R/A-5681-2013; Weingartner, Ernest/B-6793-2009; Donahue, Neil M/A-2329-2008; Nieminen, Tuomo/AAB-8686-2020; Spracklen, Dominick V/B-4890-2014; Curtius, Joachim/A-2681-2011; Bianchi, Federico/G-8428-2012; Kürten, Andreas/O-3851-2019; Carslaw, Ken S/C-8514-2009; Petäjä, Tuukka/A-8009-2008; Worsnop, Douglas R/D-2817-2009; Ortega Colomer, Ismael Kenneth/A-7930-2008; Junninen, Heikki/C-2157-2014	Amorim, Antonio/0000-0003-0638-2321; Wex, Heike/0000-0003-2129-9323; Kirkby, Jasper/0000-0003-2341-9069; Duplissy, Jonathan/0000-0001-8819-0264; Santos, Filipe/0000-0001-7316-1479; Sipilä, Mikko/0000-0002-8594-7003; Viisanen, Yrjö/0000-0002-9660-3281; Laaksonen, Ari/0000-0002-1657-2383; Praplan, Arnaud P./0000-0002-9944-3084; Dunne, Eimear M/0000-0001-7085-8473; Kulmala, Markku T/0000-0003-3464-7825; Hansel, Armin/0000-0002-1062-2394; Schobesberger, Siegfried/0000-0002-5777-4897; Makhmutov, Vladimir/0000-0002-2242-1055; Tinoco Mendes, Andre David/0000-0001-5854-7699; Stozhkov, Yuri/0000-0003-1917-0328; Scott, Catherine E/0000-0002-0187-969X; Tome, Antonio R/0000-0001-9144-7120; Weingartner, Ernest/0000-0002-2427-4634; Donahue, Neil M/0000-0003-3054-2364; Nieminen, Tuomo/0000-0002-2713-715X; Curtius, Joachim/0000-0003-3153-4630; Bianchi, Federico/0000-0003-2996-3604; Kürten, Andreas/0000-0002-8955-4450; Carslaw, Ken S/0000-0002-6800-154X; Petäjä, Tuukka/0000-0002-1881-9044; Worsnop, Douglas R/0000-0002-8928-8017; Kupc/Straus, Agnieszka/0000-0002-7996-2506; Ehrhart, Sebastian/0000-0002-6517-5341; Ortega Colomer, Ismael Kenneth/0000-0002-9299-2013; Breitenlechner, Martin/0000-0002-2382-6660; Junninen, Heikki/0000-0001-7178-9430; Keskinen, Helmi/0000-0003-3614-0542; Dommen, Josef/0000-0002-0006-0009; Lehtipalo, Katrianne/0000-0002-1660-2706	CERN; European Commission Seventh Framework Programme (Marie Curie Initial Training Network "CLOUD-ITN") [215072]; European Research Council [227463]; Academy of Finland via the Centre of Excellence program [1118615, 1133872]; German Federal Ministry of Education and Research [01LK0902A]; Swiss National Science Foundation [206621_125025, 206620_130527]; Austrian Science Fund [P19546, L593]; Portuguese Foundation for Science and Technology [CERN/FP/116387/2010]; Russian Foundation for Basic Research [N08-02-91006-CERN]; Davidow Foundation; Royal Society Wolfson Award; NSF [AGS1136479, CHE1012293]; Direct For Mathematical & Physical Scien [1012293] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1136479] Funding Source: National Science Foundation; Austrian Science Fund (FWF) [L 593] Funding Source: researchfish; Natural Environment Research Council [NE/G015015/1] Funding Source: researchfish	CERN; European Commission Seventh Framework Programme (Marie Curie Initial Training Network "CLOUD-ITN"); European Research Council(European Research Council (ERC)European Commission); Academy of Finland via the Centre of Excellence program; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Davidow Foundation; Royal Society Wolfson Award(Royal Society of London); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank CERN for supporting CLOUD with important technical and financial resources and providing a particle beam from the CERN PS; J.-L. Agostini, P. Carrie, L.-P. De Menezes, F. Josa, I. Krasin, R. Kristic, O. S. Maksumov, S. V. Mizin, R. Sitals, A. Wasem, and M. Wilhelmsson for their important contributions to the experiment; and C. Kuang and V.-M. Kerminen for providing the observational data sets used in Fig. 1A and the authors that contributed to them. This research was funded by the European Commission Seventh Framework Programme (Marie Curie Initial Training Network "CLOUD-ITN," grant no. 215072), the European Research Council Advanced Grant "ATMNUCLE" (no. 227463), the Academy of Finland via the Centre of Excellence program (project no. 1118615) and grant no. 1133872, the German Federal Ministry of Education and Research (project no. 01LK0902A), the Swiss National Science Foundation (project no. 206621_125025 and 206620_130527), the Austrian Science Fund (project no. P19546 and L593), the Portuguese Foundation for Science and Technology (project no. CERN/FP/116387/2010), the Russian Foundation for Basic Research (grant N08-02-91006-CERN), the Davidow Foundation, the Royal Society Wolfson Award, and the NSF (grants AGS1136479 and CHE1012293). The data reported in this paper are available online as .txt files in the supplementary materials).	Almeida J, 2013, NATURE, V502, P359, DOI 10.1038/nature12663; Ball SM, 1999, J GEOPHYS RES-ATMOS, V104, P23709, DOI 10.1029/1999JD900411; Carslaw KS, 2013, FARADAY DISCUSS, V165, P495, DOI 10.1039/c3fd00043e; Chen M, 2012, P NATL ACAD SCI USA, V109, P18713, DOI 10.1073/pnas.1210285109; Ehn M, 2010, ATMOS CHEM PHYS, V10, P8513, DOI 10.5194/acp-10-8513-2010; Ehrhart S, 2013, ATMOS CHEM PHYS, V13, P11465, DOI 10.5194/acp-13-11465-2013; Eisele FL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006568; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hakola H, 2012, ATMOS CHEM PHYS, V12, P11665, DOI 10.5194/acp-12-11665-2012; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kuang C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009253; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Kurten T, 2008, ATMOS CHEM PHYS, V8, P4095, DOI 10.5194/acp-8-4095-2008; Laaksonen A, 2008, ATMOS CHEM PHYS, V8, P7255, DOI 10.5194/acp-8-7255-2008; Lee LA, 2013, ATMOS CHEM PHYS, V13, P8879, DOI 10.5194/acp-13-8879-2013; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Mann GW, 2010, GEOSCI MODEL DEV, V3, P519, DOI 10.5194/gmd-3-519-2010; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Metzger A, 2010, P NATL ACAD SCI USA, V107, P6646, DOI 10.1073/pnas.0911330107; Nadykto AB, 2007, CHEM PHYS LETT, V435, P14, DOI 10.1016/j.cplett.2006.12.050; OXTOBY DW, 1994, J CHEM PHYS, V100, P7665, DOI 10.1063/1.466859; Paasonen P, 2010, ATMOS CHEM PHYS, V10, P11223, DOI 10.5194/acp-10-11223-2010; Riccobono F, 2012, ATMOS CHEM PHYS, V12, P9427, DOI 10.5194/acp-12-9427-2012; Riipinen I, 2007, ATMOS CHEM PHYS, V7, P1899, DOI 10.5194/acp-7-1899-2007; Schobesberger S, 2013, P NATL ACAD SCI USA, V110, P17223, DOI 10.1073/pnas.1306973110; Sihto SL, 2006, ATMOS CHEM PHYS, V6, P4079, DOI 10.5194/acp-6-4079-2006; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Sorokin A, 2007, ATMOS ENVIRON, V41, P3740, DOI 10.1016/j.atmosenv.2007.01.017; Spracklen DV, 2010, ATMOS CHEM PHYS, V10, P4775, DOI 10.5194/acp-10-4775-2010; Spracklen DV, 2005, ATMOS CHEM PHYS, V5, P2227, DOI 10.5194/acp-5-2227-2005; Weber RJ, 1996, CHEM ENG COMMUN, V151, P53, DOI 10.1080/00986449608936541; Weber RJ, 1997, J GEOPHYS RES-ATMOS, V102, P4375, DOI 10.1029/96JD03656; Weber RJ, 1998, J GEOPHYS RES-ATMOS, V103, P16385, DOI 10.1029/97JD02465; Young LH, 2008, ATMOS CHEM PHYS, V8, P4997, DOI 10.5194/acp-8-4997-2008; Yu F, 2009, ATMOS CHEM PHYS, V9, P7691, DOI 10.5194/acp-9-7691-2009; Zhang RY, 2012, CHEM REV, V112, P1957, DOI 10.1021/cr2001756; Zhang RY, 2009, P NATL ACAD SCI USA, V106, P17650, DOI 10.1073/pnas.0910125106; Zhang RY, 2004, SCIENCE, V304, P1487, DOI 10.1126/science.1095139	39	357	361	21	578	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					717	721		10.1126/science.1243527	http://dx.doi.org/10.1126/science.1243527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833386	Green Accepted, Green Submitted			2022-12-24	WOS:000335912900033
J	Bessede, A; Gargaro, M; Pallotta, MT; Matino, D; Servillo, G; Brunacci, C; Bicciato, S; Mazza, EMC; Macchiarulo, A; Vacca, C; Iannitti, R; Tissi, L; Volpi, C; Belladonna, ML; Orabona, C; Bianchi, R; Lanz, TV; Platten, M; Della Fazia, MA; Piobbico, D; Zelante, T; Funakoshi, H; Nakamura, T; Gilot, D; Denison, MS; Guillemin, GJ; DuHadaway, JB; Prendergast, GC; Metz, R; Geffard, M; Boon, L; Pirro, M; Iorio, A; Veyret, B; Romani, L; Grohmann, U; Fallarino, F; Puccetti, P				Bessede, Alban; Gargaro, Marco; Pallotta, Maria T.; Matino, Davide; Servillo, Giuseppe; Brunacci, Cinzia; Bicciato, Silvio; Mazza, Emilia M. C.; Macchiarulo, Antonio; Vacca, Carmine; Iannitti, Rossana; Tissi, Luciana; Volpi, Claudia; Belladonna, Maria L.; Orabona, Ciriana; Bianchi, Roberta; Lanz, Tobias V.; Platten, Michael; Della Fazia, Maria A.; Piobbico, Danilo; Zelante, Teresa; Funakoshi, Hiroshi; Nakamura, Toshikazu; Gilot, David; Denison, Michael S.; Guillemin, Gilles J.; DuHadaway, James B.; Prendergast, George C.; Metz, Richard; Geffard, Michel; Boon, Louis; Pirro, Matteo; Iorio, Alfonso; Veyret, Bernard; Romani, Luigina; Grohmann, Ursula; Fallarino, Francesca; Puccetti, Paolo			Aryl hydrocarbon receptor control of a disease tolerance defence pathway	NATURE			English	Article							REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; ENDOTOXIN TOLERANCE; LIGAND-BINDING; AH RECEPTOR; KYNURENINE; IDO; INFECTION	Disease tolerance is the ability of the host to reduce the effect of infection on host fitness. Analysis of disease tolerance pathways could provide new approaches for treating infections and other inflammatory diseases. Typically, an initial exposure to bacterial lipopolysaccharide (LPS) induces a state of refractoriness to further LPS challenge (endotoxin tolerance). We found that a first exposure of mice to LPS activated the ligand-operated transcription factor aryl hydrocarbon receptor (AhR) and the hepatic enzyme tryptophan 2,3-dioxygenase, which provided an activating ligand to the former, to down-regulate early inflammatory gene expression. However, on LPS rechallenge, AhR engaged in long-term regulation of systemic inflammation only in the presence of indoleamine 2,3-dioxygenase 1 (IDO1). AhR-complex-associated Src kinase activity promoted IDO1 phosphorylation and signalling ability. There sulting endotoxin-tolerant state was found to protect mice against immunopathology in Gram-negative and Gram-positive infections, pointing to a role for AhRin contributing to host fitness.	[Bessede, Alban; Gargaro, Marco; Pallotta, Maria T.; Matino, Davide; Servillo, Giuseppe; Brunacci, Cinzia; Vacca, Carmine; Iannitti, Rossana; Tissi, Luciana; Volpi, Claudia; Belladonna, Maria L.; Orabona, Ciriana; Bianchi, Roberta; Della Fazia, Maria A.; Piobbico, Danilo; Zelante, Teresa; Romani, Luigina; Grohmann, Ursula; Fallarino, Francesca; Puccetti, Paolo] Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy; [Bessede, Alban; Geffard, Michel; Veyret, Bernard] Univ Bordeaux, IMS Lab, F-33607 Pessac, France; [Bicciato, Silvio; Mazza, Emilia M. C.] Univ Modena & Reggio Emilia, Ctr Genome Res, I-41125 Modena, Italy; [Macchiarulo, Antonio] Univ Perugia, Dept Chem & Technol Drugs, I-06123 Perugia, Italy; [Lanz, Tobias V.; Platten, Michael] German Canc Res Ctr, Expt Neuroimmunol Unit, D-69120 Heidelberg, Germany; [Lanz, Tobias V.; Platten, Michael] Univ Hosp, Dept Neurooncol, D-69120 Heidelberg, Germany; [Funakoshi, Hiroshi] Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido 0788510, Japan; [Nakamura, Toshikazu] Osaka Univ, Kringle Pharma Joint Res Div Regenerat Drug Disco, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan; [Gilot, David] Univ Rennes 1, CNRS UMR6290, Inst Genet & Dev Rennes, F-35043 Rennes, France; [Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Guillemin, Gilles J.] Macquarie Univ, ASAM, N Ryde, NSW 2109, Australia; [DuHadaway, James B.; Prendergast, George C.] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Metz, Richard] New Link Genetics Corp, Ames, IA 50010 USA; [Boon, Louis] Bioceros, NL-3584 Utrecht, Netherlands; [Pirro, Matteo] Univ Perugia, Dept Med, I-06132 Perugia, Italy; [Iorio, Alfonso] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada	University of Perugia; UDICE-French Research Universities; Universite de Bordeaux; Universita di Modena e Reggio Emilia; University of Perugia; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Asahikawa Medical College; Osaka University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; University of California System; University of California Davis; Macquarie University; Lankenau Medical Center; Lankenau Institute for Medical Research; University of Perugia; McMaster University	Puccetti, P (corresponding author), Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy.	fllfnc@tin.it; plopcc@tin.it	Boon, Laurence/HCI-3629-2022; BICCIATO, Silvio/J-4466-2019; Matino, Davide/J-9576-2019; Gargaro, Marco/K-7077-2016; Orabona, Ciriana/L-8725-2015; Macchiarulo, Antonio/L-2846-2017; Mazza, Emilia Maria Cristina/HHZ-8915-2022; Iorio, Alfonso/B-9478-2013; Vacca, Carmine/AAE-7046-2019; Grohmann, Ursula/T-6545-2019; Matino, Davide/M-1426-2015; Pallotta, Maria Teresa/K-7021-2016; Guillemin, Gilles J/C-3878-2015; Platten, Michael/F-2902-2013; Romani, Luigina/O-9987-2018; Pirro, Matteo/AAC-2318-2022; Bicciato, Silvio/C-9825-2009; zelante, teresa/F-7933-2017; Fallarino, Francesca/O-3358-2013	BICCIATO, Silvio/0000-0002-1944-7078; Gargaro, Marco/0000-0003-0645-9800; Orabona, Ciriana/0000-0003-3113-0572; Macchiarulo, Antonio/0000-0001-9535-4183; Mazza, Emilia Maria Cristina/0000-0003-2424-3640; Iorio, Alfonso/0000-0002-3331-8766; Vacca, Carmine/0000-0002-3799-8164; Matino, Davide/0000-0002-9902-4074; Pallotta, Maria Teresa/0000-0002-0417-1638; Guillemin, Gilles J/0000-0001-8105-4470; Platten, Michael/0000-0002-4746-887X; Bicciato, Silvio/0000-0002-1944-7078; zelante, teresa/0000-0002-7071-0302; Piobbico, Danilo/0000-0003-4240-1526; Della Fazia, Maria Agnese/0000-0002-5373-8477; Romani, Luigina/0000-0002-1356-525X; Belladonna, Maria Laura/0000-0001-6522-0870; Servillo, Giuseppe/0000-0001-7960-7689; Boon, Louis/0000-0002-0937-9171; Puccetti, Paolo/0000-0001-6674-2128; Grohmann, Ursula/0000-0001-7952-1850; VOLPI, CLAUDIA/0000-0002-3967-7954; Bianchi, Roberta/0000-0001-5914-4701; Fallarino, Francesca/0000-0002-8501-2136; Pirro, Matteo/0000-0002-5527-4821	Italian Association for Cancer Research (AIRC); Fondazione Italiana Sclerosi Multipla [2010/R/17]; Associazione Umbra Contro il Cancro; Bayer Grants4Target Focus [2012-03-0630]; Bayer Early Career Investigator Award from the US National Institutes of Environmental Health Sciences [R01ES007685]; Specific Targeted Research Project FUNMETA; Regione dell'Umbria [GR-2008-1138004]; Italian Ministry of Health; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA109542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685] Funding Source: NIH RePORTER	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Associazione Umbra Contro il Cancro; Bayer Grants4Target Focus; Bayer Early Career Investigator Award from the US National Institutes of Environmental Health Sciences; Specific Targeted Research Project FUNMETA; Regione dell'Umbria(Regione Umbria); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funding from the Italian Association for Cancer Research (AIRC, to P. P.), Fondazione Italiana Sclerosi Multipla Project No. 2010/R/17 (to F. F.), Associazione Umbra Contro il Cancro (to G. S. & M. A. D. F.), Bayer Grants4Target Focus Grant no. 2012-03-0630 (to A. I., F. F. and D. M.), Bayer Early Career Investigator Award (to D. M.), Grant no. R01ES007685 from the US National Institutes of Environmental Health Sciences (to M. S. D.), the Specific Targeted Research Project FUNMETA (to L. R.), and the Italian Ministry of Health in association with Regione dell'Umbria (GR-2008-1138004 to C.O.) We thank D. Fuchs for serum kynurenine determinations. We also thank G. Andrielli for digital art and image editing and G. Ricci for histopathology.	Abdi K, 2012, J IMMUNOL, V188, P5981, DOI 10.4049/jimmunol.1102868; Backlund M, 2005, CELL SIGNAL, V17, P39, DOI 10.1016/j.cellsig.2004.05.010; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Chambers MC, 2012, P NATL ACAD SCI USA, V109, P13886, DOI 10.1073/pnas.1211724109; Changsirivathanathamrong D, 2011, CRIT CARE MED, V39, P2678, DOI 10.1097/CCM.0b013e31822827f2; Chen WJ, 2011, NAT IMMUNOL, V12, P809, DOI 10.1038/ni.2088; De Luca A, 2007, J IMMUNOL, V179, P5999, DOI 10.4049/jimmunol.179.9.5999; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Doreswamy V, 2011, CLIN EXP ALLERGY, V41, P9, DOI 10.1111/j.1365-2222.2010.03628.x; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Howard G. J., 2009, ENV HLTH PERSPECT, V118, P666; Jung ID, 2009, J IMMUNOL, V182, P3146, DOI 10.4049/jimmunol.0803104; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Murray MF, 2007, CURR DRUG METAB, V8, P197, DOI 10.2174/138920007780362509; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Puliti M, 2009, INFECT IMMUN, V77, P1524, DOI 10.1128/IAI.00965-08; Quintana FJ, 2013, IMMUNOLOGY, V138, P183, DOI 10.1111/imm.12046; Randi AS, 2008, TOXICOL LETT, V177, P116, DOI 10.1016/j.toxlet.2008.01.003; Romani L, 2006, TRENDS MICROBIOL, V14, P183, DOI 10.1016/j.tim.2006.02.003; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Sekine H, 2009, MOL CELL BIOL, V29, P6391, DOI 10.1128/MCB.00337-09; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Volpi C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2874; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007	50	419	446	6	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					184	+		10.1038/nature13323	http://dx.doi.org/10.1038/nature13323			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24930766	Green Submitted, Green Accepted			2022-12-24	WOS:000338649800036
J	Shin, J; Wallingford, MC; Gallant, J; Marcho, C; Jiao, BW; Byron, M; Bossenz, M; Lawrence, JB; Jones, SN; Mager, J; Bach, I				Shin, JongDae; Wallingford, Mary C.; Gallant, Judith; Marcho, Chelsea; Jiao, Baowei; Byron, Meg; Bossenz, Michael; Lawrence, Jeanne B.; Jones, Stephen N.; Mager, Jesse; Bach, Ingolf			RLIM is dispensable for X-chromosome inactivation in the mouse embryonic epiblast	NATURE			English	Article							FUNCTIONAL-ACTIVITY; RNF12; RNA; PLURIPOTENCY; RLIM/RNF12; NANOG; GENE; JPX	In female mice, two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Beginning at the four-cell stage, imprinted XCI (iXCI) exclusively silences the paternal X chromosome. Later, around implantation, epiblast cells of the inner cell mass that give rise to the embryo reactivate the paternal X chromosome and undergo a random form of XCI (rXCI)(1,2). Xist, a long non-coding RNA crucial for both forms of XCI, is activated by the ubiquitin ligase RLIM (also known as Rnf12)(3-5). Although RLIM is required for triggering iXCI in mice, its importance for rXCI has been controversial. Here we show that RLIM levels are downregulated in embryonic cells undergoing rXCI. Using mouse genetics we demonstrate that female cells lacking RLIM from pre-implantation stages onwards show hallmarks of XCI, including Xist clouds and H3K27me3 foci, and have full embryogenic potential. These results provide evidence that RLIM is dispensable for rXCI, indicating that in mice an RLIM-independent mechanism activates Xist in the embryo proper.	[Shin, JongDae; Jiao, Baowei; Bach, Ingolf] UMMS, Program Gene Funct & Express, Worcester, MA 01605 USA; [Wallingford, Mary C.; Marcho, Chelsea; Mager, Jesse] Univ Massachusetts, Amherst, MA 01003 USA; [Gallant, Judith; Byron, Meg; Lawrence, Jeanne B.; Jones, Stephen N.] UMMS, Dept Cell & Dev Biol, Worcester, MA 01605 USA; [Bossenz, Michael] Ortenau Klinikum Lahr Ettenheim, Inst Pathol, D-77933 Lahr, Germany; [Bach, Ingolf] UMMS, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Amherst	Bach, I (corresponding author), UMMS, Program Gene Funct & Express, Worcester, MA 01605 USA.	Ingolf.bach@umassmed.edu	Marcho, Chelsea/N-8230-2019	Marcho, Chelsea/0000-0003-0932-7416; JIAO, BAOWEI/0000-0001-8559-9160; Lawrence, Jeanne/0000-0001-6572-3128	National Institutes of Health grants [CA131158, CA077735, GM053234]; NATIONAL CANCER INSTITUTE [R01CA131158, R56CA077735, R01CA077735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053234] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to H. Ma for help in the mouse facility, M. Keeler for culturing ES cells, T. Fazzio, N. Lawson and Y. Yoon for advice, and T. Fazzio for helpful discussions and reading of the manuscript. I.B. is a member of the University of Massachusetts Diabetes-Endocrinology Research Center (DK32520). This work was supported by National Institutes of Health grants CA131158 to I.B., CA077735 to S.N.J. and GM053234 to J.B.L.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dupont C, 2013, CURR OPIN CELL BIOL, V25, P314, DOI 10.1016/j.ceb.2013.03.001; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Griffith GJ, 2011, BIOL REPROD, V84, P654, DOI 10.1095/biolreprod.110.087213; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Jiao BW, 2013, MOL BIOL CELL, V24, P3085, DOI 10.1091/mbc.E13-05-0239; Jiao BW, 2012, CELL, V149, P630, DOI 10.1016/j.cell.2012.02.056; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagy A., 2003, MANIPULATING MOUSE E; Ostendorff HP, 2006, DEV DYNAM, V235, P786, DOI 10.1002/dvdy.20669; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Panning B, 2004, METHOD ENZYMOL, V376, P419; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Schulz EG, 2013, CURR OPIN GENET DEV, V23, P109, DOI 10.1016/j.gde.2013.01.008; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Zhang L, 2012, MOL CELL, V46, P650, DOI 10.1016/j.molcel.2012.04.003	29	39	39	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					86	U443		10.1038/nature13286	http://dx.doi.org/10.1038/nature13286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870238	Green Accepted			2022-12-24	WOS:000338199400041
J	Dunn, SJ; Martello, G; Yordanov, B; Emmott, S; Smith, AG				Dunn, S. -J.; Martello, G.; Yordanov, B.; Emmott, S.; Smith, A. G.			Defining an essential transcription factor program for naive pluripotency	SCIENCE			English	Article							SELF-RENEWAL; STEM-CELLS; DIFFERENTIATION; EXPRESSION; NETWORK; TARGET; NANOG	The gene regulatory circuitry through which pluripotent embryonic stem (ES) cells choose between self-renewal and differentiation appears vast and has yet to be distilled into an executive molecular program. We developed a data-constrained, computational approach to reduce complexity and to derive a set of functionally validated components and interaction combinations sufficient to explain observed ES cell behavior. This minimal set, the simplest version of which comprises only 16 interactions, 12 components, and three inputs, satisfies all prior specifications for self-renewal and furthermore predicts unknown and nonintuitive responses to compound genetic perturbations with an overall accuracy of 70%. We propose that propagation of ES cell identity is not determined by a vast interactome but rather can be explained by a relatively simple process of molecular computation.	[Dunn, S. -J.; Yordanov, B.; Emmott, S.] Microsoft Res, Computat Sci Lab, Cambridge CB1 2FB, England; [Martello, G.; Smith, A. G.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Smith, A. G.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Microsoft; University of Cambridge; University of Cambridge	Martello, G (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England.	graziano.martello@unipd.it; austin.smith@cscr.cam.ac.uk	Martello, Graziano/AAM-3325-2021	Smith, Austin/0000-0002-3029-4682; Martello, Graziano/0000-0001-5520-085X	Human Frontier Science Program fellowship; Wellcome Trust; Medical Research Council [G19/38, G1100526, MC_PC_12009] Funding Source: researchfish	Human Frontier Science Program fellowship(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Kalkan, H. Kugler, and S. Dupont for stimulating discussions and comments on this manuscript and B. Simons for reading the manuscript. G. M. was a recipient of a Human Frontier Science Program fellowship. A. G. S. is a Medical Research Council Professor and is also funded by the Wellcome Trust.	Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Som A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015165; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wilczynski B, 2009, BIOINFORMATICS, V25, P286, DOI 10.1093/bioinformatics/btn505; Yeo JC, 2013, CELL RES, V23, P20, DOI 10.1038/cr.2012.172; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yordanov Boyan, 2013, NASA Formal Methods. 5th International Symposium, NFM 2013. Proceedings, P78, DOI 10.1007/978-3-642-38088-4_6	20	250	256	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1156	1160		10.1126/science.1248882	http://dx.doi.org/10.1126/science.1248882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904165	Green Accepted			2022-12-24	WOS:000336791200047
J	Qiu, YF; Nguyen, KD; Odegaard, JI; Cui, XJ; Tian, XY; Locksley, RM; Palmiter, RD; Chawla, A				Qiu, Yifu; Nguyen, Khoa D.; Odegaard, Justin I.; Cui, Xiaojin; Tian, Xiaoyu; Locksley, Richard M.; Palmiter, Richard D.; Chawla, Ajay			Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat	CELL			English	Article							BROWN ADIPOSE-TISSUE; NONSHIVERING THERMOGENESIS; ADAPTIVE THERMOGENESIS; GENE-EXPRESSION; IN-VIVO; ADULT HUMANS; WHITE; ACTIVATION; ADIPOCYTES; INFLAMMATION	Beige fat, which expresses the thermogenic protein UCP1, provides a defense against cold and obesity. Although a cold environment is the physiologic stimulus for inducing beige fat in mice and humans, the events that lead from the sensing of cold to the development of beige fat remain poorly understood. Here, we identify the efferent beige fat thermogenic circuit, consisting of eosinophils, type 2 cytokines interleukin (IL)-4/13, and alternatively activated macrophages. Genetic loss of eosinophils or IL-4/13 signaling impairs cold-induced biogenesis of beige fat. Mechanistically, macrophages recruited to cold-stressed subcutaneous white adipose tissue (scWAT) undergo alternative activation to induce tyrosine hydroxylase expression and catecholamine production, factors required for browning of scWAT. Conversely, administration of IL-4 to thermoneutral mice increases beige fat mass and thermogenic capacity to ameliorate pre-established obesity. Together, our findings have uncovered the efferent circuit controlling biogenesis of beige fat and provide support for its targeting to treat obesity.	[Qiu, Yifu; Nguyen, Khoa D.; Odegaard, Justin I.; Cui, Xiaojin; Tian, Xiaoyu; Chawla, Ajay] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Locksley, Richard M.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu	Tian, Xiao Yu/P-1092-2016	Tian, Xiao Yu/0000-0003-3472-9898; Nguyen, Khoa/0000-0002-6720-2470; Qiu, Yifu/0000-0001-5645-3189	NIH [HL076746, DK094641]; American Heart Association Innovative Science Award [12PILT11840038]; NIH Director's Pioneer Award [DP1AR064158]; AHA Postdoctoral Fellowship; AHA Predoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746, P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026918, R01AI030663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094641, P30DK026743] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Innovative Science Award; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Postdoctoral Fellowship(American Heart Association); AHA Predoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Chawla laboratory, A. Loh for comments on the manuscript, P. Cohen for providing the protocol to measure oxygen consumption in isolated adipose tissues, and S. Kajimura for assistance with use of their Clark electrode. The authors' work was supported by grants from NIH (HL076746, DK094641), American Heart Association Innovative Science Award (12PILT11840038), and an NIH Director's Pioneer Award (DP1AR064158) to A. C. Y.Q was supported by an AHA Postdoctoral Fellowship, and K.D.N. was supported by an AHA Predoctoral Fellowship. All animal care and procedures were performed in accordance with UCSF's IACUC guidelines. The authors declare that they have no competing financial interests.	Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DANIEL H, 1969, CAN J PHYSIOL PHARM, V47, P941, DOI 10.1139/y69-154; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Liu WY, 2013, J CELL SCI, V126, P3527, DOI 10.1242/jcs.124321; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Maier E, 2012, EUR J IMMUNOL, V42, P2827, DOI 10.1002/eji.201242433; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Morrison Shaun F, 2012, Front Endocrinol (Lausanne), V3; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; SLAVIN BG, 1978, ANAT REC, V191, P377, DOI 10.1002/ar.1091910310; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TRAYHURN P, 1987, P NUTR SOC, V46, P135, DOI 10.1079/PNS19870017; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	52	574	599	9	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1292	1308		10.1016/j.cell.2014.03.066	http://dx.doi.org/10.1016/j.cell.2014.03.066			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906148	Green Accepted, Bronze			2022-12-24	WOS:000340881400008
J	Sinha, M; Jang, YC; Oh, J; Khong, D; Wu, EY; Manohar, R; Miller, C; Regalado, SG; Loffredo, FS; Pancoast, JR; Hirshman, MF; Lebowitz, J; Shadrach, JL; Cerletti, M; Kim, MJ; Serwold, T; Goodyear, LJ; Rosner, B; Lee, RT; Wagers, AJ				Sinha, Manisha; Jang, Young C.; Oh, Juhyun; Khong, Danika; Wu, Elizabeth Y.; Manohar, Rohan; Miller, Christine; Regalado, Samuel G.; Loffredo, Francesco S.; Pancoast, James R.; Hirshman, Michael F.; Lebowitz, Jessica; Shadrach, Jennifer L.; Cerletti, Massimiliano; Kim, Mi-Jeong; Serwold, Thomas; Goodyear, Laurie J.; Rosner, Bernard; Lee, Richard T.; Wagers, Amy J.			Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle	SCIENCE			English	Article							DIFFERENTIATION FACTOR 11; DNA-DAMAGE; STEM-CELLS; MYOSTATIN; REJUVENATION; HYPERTROPHY; REPAIR	Parabiosis experiments indicate that impaired regeneration in aged mice is reversible by exposure to a young circulation, suggesting that young blood contains humoral "rejuvenating" factors that can restore regenerative function. Here, we demonstrate that the circulating protein growth differentiation factor 11 (GDF11) is a rejuvenating factor for skeletal muscle. Supplementation of systemic GDF11 levels, which normally decline with age, by heterochronic parabiosis or systemic delivery of recombinant protein, reversed functional impairments and restored genomic integrity in aged muscle stem cells (satellite cells). Increased GDF11 levels in aged mice also improved muscle structural and functional features and increased strength and endurance exercise capacity. These data indicate that GDF11 systemically regulates muscle aging and may be therapeutically useful for reversing age-related skeletal muscle and stem cell dysfunction.	[Sinha, Manisha; Jang, Young C.; Oh, Juhyun; Khong, Danika; Wu, Elizabeth Y.; Manohar, Rohan; Miller, Christine; Regalado, Samuel G.; Loffredo, Francesco S.; Pancoast, James R.; Lebowitz, Jessica; Shadrach, Jennifer L.; Cerletti, Massimiliano; Lee, Richard T.; Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Sinha, Manisha; Jang, Young C.; Oh, Juhyun; Khong, Danika; Wu, Elizabeth Y.; Manohar, Rohan; Miller, Christine; Regalado, Samuel G.; Loffredo, Francesco S.; Pancoast, James R.; Lebowitz, Jessica; Shadrach, Jennifer L.; Cerletti, Massimiliano; Lee, Richard T.; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Sinha, Manisha; Jang, Young C.; Oh, Juhyun; Khong, Danika; Wu, Elizabeth Y.; Manohar, Rohan; Miller, Christine; Hirshman, Michael F.; Lebowitz, Jessica; Shadrach, Jennifer L.; Cerletti, Massimiliano; Kim, Mi-Jeong; Serwold, Thomas; Goodyear, Laurie J.; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Sinha, Manisha; Shadrach, Jennifer L.; Wagers, Amy J.] Howard Hughes Med Inst, Cambridge, MA USA; [Sinha, Manisha; Jang, Young C.; Oh, Juhyun; Khong, Danika; Wu, Elizabeth Y.; Manohar, Rohan; Miller, Christine; Lebowitz, Jessica; Wagers, Amy J.] Harvard Univ, Sch Med, Paul F Glenn Labs Biol Mech Aging, Boston, MA USA; [Regalado, Samuel G.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Loffredo, Francesco S.; Pancoast, James R.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Loffredo, Francesco S.; Pancoast, James R.] Brigham Regenerat Med Ctr, Boston, MA USA; [Goodyear, Laurie J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Goodyear, Laurie J.] Harvard Univ, Sch Med, Boston, MA USA; [Rosner, Bernard] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Wagers, AJ (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	amy_wagers@harvard.edu	Loffredo, Francesco S/F-6638-2014; Loffredo, Francesco/P-1389-2019	Loffredo, Francesco S/0000-0001-5911-780X; Loffredo, Francesco/0000-0001-5911-780X; Lee, Richard/0000-0003-4687-1381; Oh, Juhyun/0000-0002-4492-6978; Wu, Elizabeth/0000-0002-6537-9790; Khong, Danika/0000-0002-2128-8619	American Heart Association; NIH [R01 AR42238, 1R01 AG033053, 1DP2 OD004345, 5U01 HL100402, R01 AG032977 1R01 AG040019]; Glenn Foundation for Medical Research; Harvard Stem Cell Institute; Project Ascelegen; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040019, R01AG032977, R01AG033053] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Harvard Stem Cell Institute; Project Ascelegen; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Harvard Stem Cell Institute/Department of Stem Cell and Regenerative Biology's Flow Cytometry Core, Harvard's Center for Biological Imaging, and C. Dall'Osso and B. Hunter for technical assistance. This work was funded in part by grants from the American Heart Association to F. S. L. (postdoctoral fellowship); NIH (R01 AR42238) to L. J. G.; Glenn Foundation for Medical Research, Harvard Stem Cell Institute, and NIH (1R01 AG033053, 1DP2 OD004345, and 5U01 HL100402) to A. J. W.; NIH (R01 AG032977 1R01 AG040019) to R. T. L.; and Project Ascelegen to A. J. W. and R. T. L. A. J. W. is an Early Career Scientist of the Howard Hughes Medical Institute. M. F. H. owns shares in Abbott Laboratories, Amgen Inc., Colgate Palmolive Co., Eli Lilly and Co., Medtronic Inc., and Abbvie Inc. A. J. W. and R. T. L. are inventors on patent applications filed by Harvard University and Brigham and Women's Hospital entitled 'Methods and Compositions for Rejuvenating Skeletal Muscle Stem Cells' and 'Methods and Compositions for Rejuvenating Neuromuscular Junctions.'	Amthor H, 2009, P NATL ACAD SCI USA, V106, P7479, DOI 10.1073/pnas.0811129106; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; De Santis C, 2011, J EXP BIOL, V214, P2671, DOI 10.1242/jeb.056374; Hakim CH, 2011, METHODS MOL BIOL, V709, P75, DOI 10.1007/978-1-61737-982-6_5; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Lee YJ, 2010, DEV BIOL, V347, P195, DOI 10.1016/j.ydbio.2010.08.022; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-24; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021	23	544	587	9	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					649	652		10.1126/science.1251152	http://dx.doi.org/10.1126/science.1251152			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24797481	Green Accepted			2022-12-24	WOS:000335537400048
J	Vachieri, SG; Xiong, XL; Collins, PJ; Walker, PA; Martin, SR; Haire, LF; Zhang, Y; McCauley, JW; Gamblin, SJ; Skehel, JJ				Vachieri, Sebastien G.; Xiong, Xiaoli; Collins, Patrick J.; Walker, Philip A.; Martin, Stephen R.; Haire, Lesley F.; Zhang, Ying; McCauley, John W.; Gamblin, Steven J.; Skehel, John J.			Receptor binding by H10 influenza viruses	NATURE			English	Article							A VIRUS; HEMAGGLUTININ; H5; SPECIFICITY; COMPLEXES; EPITHELIUM; EVOLUTION; SELECTION; CELL; H7	H10N8 follows H7N9 and H5N1 as the latest in a line of avian influenza viruses that cause serious disease in humans and have become a threat to public health(1). Since December 2013, three human cases of H10N8 infection have been reported, two of whom are known to have died. To gather evidence relating to the epidemic potential of H10 we have determined the structure of the haemagglutinin of a previously isolated avian H10 virus and we present here results relating especially to its receptor-binding properties, as these are likely to be major determinants of virus transmissibility. Our results show, first, that the H10 virus possesses high avidity for human receptors and second, from the crystal structure of the complex formed by avian H10 haemagglutinin with human receptor, it is clear that the conformation of the bound receptor has characteristics of both the 1918 H1N1 pandemic virus(2) and the human H7 viruses isolated from patients in 2013 (ref. 3). We conclude that avian H10N8 virus has sufficient avidity for human receptors to account for its infection of humans but that its preference for avian receptors should make avian receptor-rich human airway mucins(4) an effective block to widespread infection. In terms of surveillance, particular attention will be paid to the detection of mutations in the receptor-binding site of the H10 haemagglutinin that decrease its avidity for avian receptor, and could enable it to be more readily transmitted between humans.	[Vachieri, Sebastien G.; Xiong, Xiaoli; Collins, Patrick J.; Walker, Philip A.; Martin, Stephen R.; Haire, Lesley F.; Zhang, Ying; McCauley, John W.; Gamblin, Steven J.; Skehel, John J.] MRC Natl Inst Med Res, London NW7 1AA, England	MRC National Institute for Medical Research	Gamblin, SJ (corresponding author), MRC Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk; skeheljj@nimr.mrc.ac.uk		Gamblin, Steve/0000-0001-5331-639X; Xiong, Xiaoli/0000-0002-4632-9122	Medical Research Council [U117584222, U117570592, U117585868]; Medical Research Council [MC_U117512723, G0600522, MC_U117585868] Funding Source: researchfish; MRC [MC_U117585868, MC_U117512723, G0600522] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Bovin for gifts of sulphated sialoside. We greatly acknowledge Diamond Light Source for access to synchrotron time under proposal 7707. This work was funded by the Medical Research Council through programmes U117584222, U117570592 and U117585868.	Chen H., 2014, LANCET; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gambaryan AS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-85; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Keawcharoen J, 2010, VACCINE, V28, P5803, DOI 10.1016/j.vaccine.2010.06.072; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Otwinowski Z., 1993, P CCP4 STUDY WEEKEND, P556; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; SKEHEL JJ, 1971, VIROLOGY, V44, P396, DOI 10.1016/0042-6822(71)90270-4; Xiong X, 2013, VIRUS RES, V178, P12, DOI 10.1016/j.virusres.2013.08.007; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787	27	62	65	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					475	+		10.1038/nature13443	http://dx.doi.org/10.1038/nature13443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24870229				2022-12-24	WOS:000339335700048
J	Maldarelli, F; Wu, X; Su, L; Simonetti, FR; Shao, W; Hill, S; Spindler, J; Ferris, AL; Mellors, JW; Kearney, MF; Coffin, JM; Hughes, SH				Maldarelli, F.; Wu, X.; Su, L.; Simonetti, F. R.; Shao, W.; Hill, S.; Spindler, J.; Ferris, A. L.; Mellors, J. W.; Kearney, M. F.; Coffin, J. M.; Hughes, S. H.			Specific HIV integration sites are linked to clonal expansion and persistence of infected cells	SCIENCE			English	Article							CD4(+) T-CELLS; ANTIRETROVIRAL THERAPY; RESERVOIR; GENES; CURE; IDENTIFICATION; LYMPHOMAS; DYNAMICS; DNA	The persistence of HIV-infected cells in individuals on suppressive combination antiretroviral therapy (cART) presents a major barrier for curing HIV infections. HIV integrates its DNA into many sites in the host genome; we identified 2410 integration sites in peripheral blood lymphocytes of five infected individuals on cART. About 40% of the integrations were in clonally expanded cells. Approximately 50% of the infected cells in one patient were from a single clone, and some clones persisted for many years. There were multiple independent integrations in several genes, including MKL2 and BACH2; many of these integrations were in clonally expanded cells. Our findings show that HIV integration sites can play a critical role in expansion and persistence of HIV-infected cells.	[Maldarelli, F.; Simonetti, F. R.; Hill, S.; Spindler, J.; Ferris, A. L.; Kearney, M. F.; Hughes, S. H.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Wu, X.; Su, L.; Shao, W.] Leidos Biomed Res, Frederick, MD 21702 USA; [Simonetti, F. R.] Univ Milan, Dept Biomed & Clin Sci L Sacco, I-20122 Milan, Italy; [Mellors, J. W.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Coffin, J. M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Milan; Luigi Sacco Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts University	Hughes, SH (corresponding author), NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA.	hughesst@mail.nih.gov	Maldarelli, Frank/O-2428-2016; Kearney, Mary/AAU-8132-2020	Kearney, Mary/0000-0003-3839-6576	Federal funds from the National Cancer Institute, an NIH; National Cancer Institute [HSSN261200800001E, 25XS119]; American Cancer Society; F. M. Kirby Foundation; NATIONAL CANCER INSTITUTE [R01CA089441, ZIABC011426, R37CA089441] Funding Source: NIH RePORTER	Federal funds from the National Cancer Institute, an NIH; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); F. M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are indebted to the study participants and to the clinical staff of the National Institute of Allergy and Infectious Diseases/Critical Care Medicine Department clinic who cared for them. We thank C. Lane, H. Malech, H. Imamichi, S. Matsushita, and L. Frenkel for stimulating discussions. We are grateful to J. Meyer and A. Kane for help with the figures and T. Burdette for help in preparing the manuscript. The data presented in this work is tabulated in the main paper and in the supplementary materials. The integration sites are compiled in table S3; the data can also be accessed using the National Center for Biotechnology Information accession no. PRJNA241020. Funding for this research was provided with Federal funds from the National Cancer Institute, an NIH Bench to Bedside award (F. M.), and by funds from the National Cancer Institute under contract HSSN261200800001E (X. W. and L. S.). J. M. C. was supported by a Research Professorship from the American Cancer Society with additional support from the F. M. Kirby Foundation and by funding from the National Cancer Institute (Leidos contract 25XS119). J. W. M. was supported by funding from the National Cancer Institute (Leidos contract 25XS119). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Coffin J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012526; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; De Ravin S. S., 2014, J VIROL; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Flucke U, 2013, HISTOPATHOLOGY, V62, P925, DOI 10.1111/his.12100; Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; HERNDIER BG, 1992, BLOOD, V79, P1768; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Ikeda T, 2007, J INFECT DIS, V195, P716, DOI 10.1086/510915; Imamichi H., 2014, AIDS; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Katano H, 2007, MICROBES INFECT, V9, P1581, DOI 10.1016/j.micinf.2007.09.008; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Kobayashi S, 2011, GENE CHROMOSOME CANC, V50, P207, DOI 10.1002/gcc.20845; Liu JH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-2; Mack KD, 2003, JAIDS-J ACQ IMM DEF, V33, P308, DOI 10.1097/00126334-200307010-00004; Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560; Palmer S, 2011, J INTERN MED, V270, P550, DOI 10.1111/j.1365-2796.2011.02457.x; Rosenberg N., 1997, P475; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; SHIRAMIZU B, 1994, CANCER RES, V54, P2069; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	29	531	539	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					179	183		10.1126/science.1254194	http://dx.doi.org/10.1126/science.1254194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	24968937	Green Accepted			2022-12-24	WOS:000339409900044
J	van Galen, P; Kreso, A; Mbong, N; Kent, DG; Fitzmaurice, T; Chambers, JE; Xie, S; Laurenti, E; Hermans, K; Eppert, K; Marciniak, SJ; Goodall, JC; Green, AR; Wouters, BG; Wienholds, E; Dick, JE				van Galen, Peter; Kreso, Antonija; Mbong, Nathan; Kent, David G.; Fitzmaurice, Timothy; Chambers, Joseph E.; Xie, Stephanie; Laurenti, Elisa; Hermans, Karin; Eppert, Kolja; Marciniak, Stefan J.; Goodall, Jane C.; Green, Anthony R.; Wouters, Bradly G.; Wienholds, Erno; Dick, John E.			The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress	NATURE			English	Article							ER-STRESS; MESSENGER-RNA; IDENTIFICATION; TRANSLATION; DEPHOSPHORYLATION; REINITIATION; INHIBITOR; HIERARCHY; DEATH; IRE1	The blood system is sustained by a pool of haematopoietic stem cells (HSCs) that are long-lived due to their capacity for self-renewal. A consequence of longevity is exposure to stress stimuli including reactive oxygen species (ROS), nutrient fluctuation and DNA damage(1,2). Damage that occurs within stressed HSCs must be tightly controlled to prevent either loss of function or the clonal persistence of oncogenic mutations that increase the risk of leukaemogenesis(3,4). Despite the importance of maintaining cell integrity throughout life, how the HSC pool achieves this and how individual HSCs respond to stress remain poorly understood. Many sources of stress cause misfolded protein accumulation in the endoplasmic reticulum (ER), and subsequent activation of the unfolded protein response (UPR) enables the cell to either resolve stress or initiate apoptosis(5,6). Here we show that human HSCs are predisposed to apoptosis through strong activation of the PERK branch of the UPR after ER stress, whereas closely related progenitors exhibit an adaptive response leading to their survival. Enhanced ER protein folding by overexpression of the cochaperone ERDJ4 (also called DNAJB9) increases HSC repopulation capacity in xenograft assays, linking the UPR to HSC function. Because the UPR is a focal point where different sources of stress converge, our study provides a framework for understanding how stress signalling is coordinated within tissue hierarchies and integrated with stemness. Broadly, these findings reveal that the HSC pool maintains clonal integrity by clearance of individual HSCs after stress to prevent propagation of damaged stem cells.	[van Galen, Peter; Kreso, Antonija; Mbong, Nathan; Xie, Stephanie; Laurenti, Elisa; Hermans, Karin; Wienholds, Erno; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [van Galen, Peter; Kreso, Antonija; Mbong, Nathan; Xie, Stephanie; Laurenti, Elisa; Hermans, Karin; Wienholds, Erno; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Kent, David G.; Chambers, Joseph E.; Marciniak, Stefan J.; Green, Anthony R.] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust, MRC Stem Cell Inst, Cambridge CB2 0XY, England; [Kent, David G.; Green, Anthony R.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Fitzmaurice, Timothy; Goodall, Jane C.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Sch Clin Med, Cambridge CB2 0QQ, England; [Eppert, Kolja] McGill Univ, Dept Pediat, Westmount, PQ H3Z 2Z3, Canada; [Eppert, Kolja] McGill Univ, Ctr Hlth, Res Inst, Westmount, PQ H3Z 2Z3, Canada; [Wouters, Bradly G.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada; [Wouters, Bradly G.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; McGill University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.	jdick@uhnresearch.ca	Chambers, Joseph/Z-5212-2019; Wouters, Bradly/T-1525-2017; Kent, David/AAZ-4916-2021	Chambers, Joseph/0000-0003-4675-0053; Wouters, Bradly/0000-0002-8187-592X; Kent, David/0000-0001-7871-8811; Marciniak, Stefan/0000-0001-8472-7183; Green, Anthony/0000-0002-9795-0218; Eppert, Kolja/0000-0001-9061-8856; Fitzmaurice, Tim/0000-0003-1403-2495; Xie, Stephanie/0000-0002-0284-494X; Dick, John/0000-0002-9527-8317; Laurenti, Elisa/0000-0002-9917-9092; van Galen, Peter/0000-0002-0735-1570; Goodall, Jane/0000-0002-3761-161X	Canadian Institutes for Health Research; Canadian Cancer Society; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Canada Research Chair; Ontario Ministry of Health and Long Term Care (OMOHLTC); Leukemia and Lymphoma Research; Cancer Research UK; Kay Kendall Leukaemia Fund; NIHR Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Leukemia & Lymphoma Society of America; Arthritis Research UK; Medical Research Council (UK); Terry Fox New Frontiers Research Program [PPG09-020005]; Canadian Institute for Health Research (CIHR) [201592]; Medical Research Council [G0601840, G1001765, G1002610] Funding Source: researchfish; Versus Arthritis [19639] Funding Source: researchfish; MRC [G0601840, G1001765, G1002610] Funding Source: UKRI	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); Leukemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); Arthritis Research UK(Versus Arthritis); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Terry Fox New Frontiers Research Program; Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Ron and D. Rubinsztein for critical assessment of this work; all members of the Dick laboratory, especially O. I. Gan and E. Lechman, for experimental support and advice; A. Khandani, P. Penttila and the SickKids-UHN flow facility for technical support; N. Jamal for providing bone marrow samples; J. Heijmans for providing the pLV-ca-GADD34 vector; and L. Naldini for providing the MA1 vector. Work in the Dick laboratory is supported by grants from the Canadian Institutes for Health Research, Canadian Cancer Society, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, a Canada Research Chair and the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. A. R. G. and D. G. K. are supported by Leukemia and Lymphoma Research, Cancer Research UK, the Kay Kendall Leukaemia Fund, the NIHR Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre, and the Leukemia & Lymphoma Society of America. J. C. G. and T. F. are supported by Arthritis Research UK. S. J. M. and J. E. C. are supported by the Medical Research Council (UK). B. G. W. is supported by the Terry Fox New Frontiers Research Program (PPG09-020005), the Ontario Institute for Cancer Research, and the Canadian Institute for Health Research (CIHR grant 201592).	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kurisu J, 2003, GENES CELLS, V8, P189, DOI 10.1046/j.1365-2443.2003.00625.x; Lai CW, 2012, J BIOL CHEM, V287, P7969, DOI 10.1074/jbc.M111.311290; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rouault-Pierre K, 2013, CELL STEM CELL, V13, P549, DOI 10.1016/j.stem.2013.08.011; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; van Galen P, 2014, CELL STEM CELL, V14, P94, DOI 10.1016/j.stem.2013.11.021; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Wey S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039047; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	39	226	229	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					268	+		10.1038/nature13228	http://dx.doi.org/10.1038/nature13228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24776803	Green Submitted			2022-12-24	WOS:000337032400050
J	He, HH; Kise, Y; Izadifar, A; Urwyler, O; Ayaz, D; Parthasarthy, A; Yan, B; Erfurth, ML; Dascenco, D; Schmucker, D				He, Haihuai; Kise, Yoshiaki; Izadifar, Azadeh; Urwyler, Olivier; Ayaz, Derya; Parthasarthy, Akhila; Yan, Bing; Erfurth, Maria-Luise; Dascenco, Dan; Schmucker, Dietmar			Cell-intrinsic requirement of Dscam1 isoform diversity for axon collateral formation	SCIENCE			English	Article							DENDRITIC SELF-AVOIDANCE; MOLECULAR DIVERSITY; DROSOPHILA-DSCAM; RECOGNITION; PROTOCADHERINS; ORGANIZATION; SPECIFICITY; ADHESION; GUIDANCE	The isoform diversity of the Drosophila Dscam1 receptor is important for neuronal self-recognition and self-avoidance. A canonical model suggests that homophilic binding of identical Dscam1 receptor isoforms on sister dendrites ensures self-avoidance even when only a single isoform is expressed. We detected a cell-intrinsic function of Dscam1 that requires the coexpression of multiple isoforms. Manipulation of the Dscam1 isoform pool in single neurons caused severe disruption of collateral formation of mechanosensory axons. Changes in isoform abundance led to dominant dosage-sensitive inhibition of branching. We propose that the ratio of matching to nonmatching isoforms within a cell influences the Dscam1-mediated signaling strength, which in turn controls axon growth and growth cone sprouting. Cell-intrinsic use of surface receptor diversity may be of general importance in regulating axonal branching during brain wiring.	[He, Haihuai; Kise, Yoshiaki; Izadifar, Azadeh; Urwyler, Olivier; Ayaz, Derya; Yan, Bing; Erfurth, Maria-Luise; Dascenco, Dan; Schmucker, Dietmar] Vlaams Inst Biotechnol VIB Vesalius Res Ctr, Neuronal Wiring Lab, B-3000 Louvain, Belgium; [He, Haihuai; Kise, Yoshiaki; Izadifar, Azadeh; Urwyler, Olivier; Ayaz, Derya; Yan, Bing; Erfurth, Maria-Luise; Dascenco, Dan; Schmucker, Dietmar] Univ Louvain, Sch Med, Dept Oncol, B-3000 Louvain, Belgium; [He, Haihuai; Parthasarthy, Akhila] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Erfurth, Maria-Luise] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany	Flanders Institute for Biotechnology (VIB); Harvard University; Dana-Farber Cancer Institute; University of Kiel	Schmucker, D (corresponding author), Vlaams Inst Biotechnol VIB Vesalius Res Ctr, Neuronal Wiring Lab, B-3000 Louvain, Belgium.	schmucker@vib-kuleuven.be		Urwyler, Olivier/0000-0001-8334-8667; Dascenco, Dan/0000-0002-4629-8266	NIH [2RO1NS046747-05A1]; Fonds Wetenschappelijk Onderzoek (FWO) [G059611N, G078913N, G077013N]; BELSPO IUAP VII-20 "WIBRAIN project"; VIB; JSPS postdoctoral fellowship; Human Frontier Science Program long-term fellowship; FWO Ph.D. fellowship; Swiss National Science Foundation postdoctoral fellowship; Boehringer Ingelheim Fonds Ph.D. fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046747] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds Wetenschappelijk Onderzoek (FWO)(FWO); BELSPO IUAP VII-20 "WIBRAIN project"; VIB; JSPS postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program long-term fellowship(Human Frontier Science Program); FWO Ph.D. fellowship; Swiss National Science Foundation postdoctoral fellowship(Swiss National Science Foundation (SNSF)); Boehringer Ingelheim Fonds Ph.D. fellowship(Boehringer Ingelheim); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grant 2RO1NS046747-05A1 (D. S.); Fonds Wetenschappelijk Onderzoek (FWO) grants G059611N, G078913N, and G077013N (D. S.); BELSPO IUAP VII-20 "WIBRAIN project" (D. S.); VIB funding; a JSPS postdoctoral fellowship and a Human Frontier Science Program long-term fellowship (Y.K.); an FWO Ph.D. fellowship (D. D.); a Swiss National Science Foundation postdoctoral fellowship (O.U.); and a Boehringer Ingelheim Fonds Ph.D. fellowship (M.-L. E.). We thank members of the lab and especially B. Hassan (VIB, Center for the Biology of Disease) for critical reading of the manuscript, discussions, and insightful comments.	Celotto AM, 2001, GENETICS, V159, P599; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Kise Y, 2013, CURR OPIN NEUROBIOL, V23, P983, DOI 10.1016/j.conb.2013.09.011; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2007, NAT REV NEUROSCI, V8, P915, DOI 10.1038/nrn2256; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Sun W, 2013, EMBO J, V32, P2029, DOI 10.1038/emboj.2013.144; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wu W, 2012, NEURON, V74, P261, DOI 10.1016/j.neuron.2012.02.029; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	20	44	44	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1182	1186		10.1126/science.1251852	http://dx.doi.org/10.1126/science.1251852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24831526				2022-12-24	WOS:000336791200053
J	Segawa, K; Kurata, S; Yanagihashi, Y; Brummelkamp, TR; Matsuda, F; Nagata, S				Segawa, Katsumori; Kurata, Sachiko; Yanagihashi, Yuichi; Brummelkamp, Thijn R.; Matsuda, Fumihiko; Nagata, Shigekazu			Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure	SCIENCE			English	Article							AMINOPHOSPHOLIPID TRANSLOCASE; CELL-DEATH; LYMPHOCYTES; PROTEIN; IDENTIFICATION; P-4-ATPASES; CLEARANCE; P4-ATPASE; TRANSPORT; MEMBRANES	Phospholipids are asymmetrically distributed in the plasma membrane. This asymmetrical distribution is disrupted during apoptosis, exposing phosphatidylserine (PtdSer) on the cell surface. Using a haploid genetic screen in human cells, we found that ATP11C (adenosine triphosphatase type 11C) and CDC50A (cell division cycle protein 50A) are required for aminophospholipid translocation from the outer to the inner plasma membrane leaflet; that is, they display flippase activity. ATP11C contained caspase recognition sites, and mutations at these sites generated caspase-resistant ATP11C without affecting its flippase activity. Cells expressing caspase-resistant ATP11C did not expose PtdSer during apoptosis and were not engulfed by macrophages, which suggests that inactivation of the flippase activity is required for apoptotic PtdSer exposure. CDC50A-deficient cells displayed PtdSer on their surface and were engulfed by macrophages, indicating that PtdSer is sufficient as an "eat me" signal.	[Segawa, Katsumori; Kurata, Sachiko; Yanagihashi, Yuichi; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; [Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068501, Japan; [Nagata, Shigekazu] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kyoto 6068501, Japan	Kyoto University; Netherlands Cancer Institute; Kyoto University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Ministry of Education, Science, Sports, and Culture, Japan; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank B. H. Cochran for KBM7 cells, K. Higasa and M. Shimizu for help in next-generation sequencing, K. Okamoto-Furuta and H. Kohda for support in electron microscope analysis, and M. Fujii for secretarial assistance. This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports, and Culture, Japan. Kyoto University has filed a patent entitled "Method of screening agents for the treatment or prevention of cancer or apoptosis-related diseases" (inventors, Shigekazu Nagata, Katsumori Segawa; reference number: 61/978415). Plasmids encoding human ATP11C or CDC50A, human KBM7 cells lacking ATP11C or CDC50A, and mouse W3 cell lines lacking ATP11C or CDC50A are all available under material transfer agreements. T. R. B. is a co-founder, shareholder, and member of the scientific advisory board of Haplogen, an early-phase biotech company based on haploid genetics.	Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Chen R, 2011, J IMMUNOL, V186, P3215, DOI 10.4049/jimmunol.1002710; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daleke DL, 2000, BBA-MOL CELL BIOL L, V1486, P108, DOI 10.1016/S1388-1981(00)00052-4; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tanaka M, 1997, J IMMUNOL, V158, P2303; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011	30	320	321	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1164	1168		10.1126/science.1252809	http://dx.doi.org/10.1126/science.1252809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904167	Green Published			2022-12-24	WOS:000336791200049
J	Bauer, BW; Shemesh, T; Chen, Y; Rapoport, TA				Bauer, Benedikt W.; Shemesh, Tom; Chen, Yu; Rapoport, Tom A.			A "Push and Slide" Mechanism Allows Sequence-Insensitive Translocation of Secretory Proteins by the SecA ATPase	CELL			English	Article							POLYPEPTIDE TRANSLOCATION; SECYEG COMPLEX; CHANNEL; MEMBRANE; MACHINE; BINDING; MEDIATE; PORE; MOTIONS; REVEAL	In bacteria, most secretory proteins are translocated across the plasma membrane by the interplay of the SecA ATPase and the SecY channel. How SecA moves a broad range of polypeptide substrates is only poorly understood. Here we show that SecA moves polypeptides through the SecY channel by a "push and slide" mechanism. In its ATP-bound state, SecA interacts through a two-helix finger with a subset of amino acids in a substrate, pushing them into the channel. A polypeptide can also passively slide back and forth when SecA is in the predominant ADP-bound state or when SecA encounters a poorly interacting amino acid in its ATP-bound state. SecA performs multiple rounds of ATP hydrolysis before dissociating from SecY. The proposed push and slide mechanism is supported by a mathematical model and explains how SecA allows translocation of a wide range of polypeptides. This mechanism may also apply to hexameric polypeptide-translocating ATPases.	[Bauer, Benedikt W.; Shemesh, Tom; Chen, Yu; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bauer, Benedikt W.; Shemesh, Tom; Chen, Yu; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu			Boehringer Ingelheim Fonds; NIH [GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Karl Erlandson and Stephanie Miller for providing preliminary data, the Institute of Chemistry and Cell Biology for providing access to the plate reader, Alexander Stein for helpful suggestions, and Thomas Guttler, Alexander Stein, and Long Li for critical reading of the manuscript. B. W. B. is the recipient of a fellowship from the Boehringer Ingelheim Fonds. T. A. R. is supported by NIH grant GM052586 and is a Howard Hughes Medical Institute Investigator.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Kraut DA, 2013, J BIOL CHEM, V288, P34729, DOI 10.1074/jbc.M113.512533; Kusters I, 2010, METHODS MOL BIOL, V619, P131, DOI 10.1007/978-1-60327-412-8_8; Liebermeister W, 2001, J MOL BIOL, V305, P643, DOI 10.1006/jmbi.2000.4302; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Too PHM, 2013, J BIOL CHEM, V288, P13243, DOI 10.1074/jbc.M113.452524; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Whitehouse S, 2012, J CELL BIOL, V199, P919, DOI 10.1083/jcb.201205191; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	26	77	77	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1416	1429		10.1016/j.cell.2014.03.063	http://dx.doi.org/10.1016/j.cell.2014.03.063			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906156	Bronze, Green Accepted			2022-12-24	WOS:000340881400017
J	Fang, EF; Scheibye-Knudsen, M; Brace, LE; Kassahun, H; SenGupta, T; Nilsen, H; Mitchell, JR; Croteau, DL; Bohr, VA				Fang, Evandro Fei; Scheibye-Knudsen, Morten; Brace, Lear E.; Kassahun, Henok; SenGupta, Tanima; Nilsen, Hilde; Mitchell, James R.; Croteau, Deborah L.; Bohr, Vilhelm A.			Defective Mitophagy in XPA via PARP-1 Hyperactivation and NAD(+)/SIRT1 Reduction	CELL			English	Article							PIGMENTOSUM GROUP-A; DNA-REPAIR; UNCOUPLING PROTEIN-2; MOUSE MODEL; DAMAGE; MITOCHONDRIA; METABOLISM; EXPRESSION; PROTECTS; DISEASE	Mitochondrial dysfunction is a common feature in neurodegeneration and aging. We identify mitochondrial dysfunction in xeroderma pigmentosum group A (XPA), a nucleotide excision DNA repair disorder with severe neurodegeneration, in silico and in vivo. XPA-deficient cells show defective mitophagy with excessive cleavage of PINK1 and increased mitochondrial membrane potential. The mitochondrial abnormalities appear to be caused by decreased activation of the NAD(+)-SIRT1-PGC-1 alpha axis triggered by hyperactivation of the DNA damage sensor PARP1. This phenotype is rescued by PARP-1 inhibition or by supplementation with NAD(+) precursors that also rescue the lifespan defect in xpa-1 nematodes. Importantly, this pathogenesis appears common to ataxia-telangiectasia and Cockayne syndrome, two other DNA repair disorders with neurodegeneration, but absent in XPC, a DNA repair disorder without neurodegeneration. Our findings reveal a nuclear-mitochondrial crosstalk that is critical for the maintenance of mitochondrial health.	[Fang, Evandro Fei; Scheibye-Knudsen, Morten; Croteau, Deborah L.; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Brace, Lear E.; Mitchell, James R.] Harvard Univ, Sch Med, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Kassahun, Henok; SenGupta, Tanima; Nilsen, Hilde] Univ Oslo, Ctr Biotechnol, N-0317 Oslo, Norway; [Bohr, Vilhelm A.] Univ Copenhagen, Danish Ctr Hlth Aging, DK-2200 Copenhagen, Denmark	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Harvard Medical School; University of Oslo; University of Copenhagen	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	vbohr@nih.gov	Croteau, Deb/AAP-5933-2020; Bohr, Vilhelm/AAP-5931-2020; Fang, Evandro Fei/AAV-4653-2020; Fang, Evandro Fei/AAC-5511-2019	Brace, Lear/0000-0001-6961-9758; Fang, Evandro Fei/0000-0003-0355-7202; Croteau, Deborah/0000-0002-6094-4084; Scheibye-Knudsen, Morten/0000-0002-6637-1280	Intramural Research Program of the NIH, National Institute on Aging; research council of Norway; Luke O'Brien Foundation; National Science Foundation Graduate Research Fellowship Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000733, ZIAAG000723, ZIAAG000722] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); research council of Norway(Research Council of Norway); Luke O'Brien Foundation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Kevin Becker, Yongqing Zhang, and Elin Lehrmann for their help in performing microarray and data analysis, and Dr. Magdalena Misiak for preparing rat neurons. We thank Drs. Mark Mattson and Peter Sykora for reading this manuscript. This research was supported by the Intramural Research Program of the NIH, National Institute on Aging. H.N. was supported by a grant from the research council of Norway. J.R.M. and L.E.B. were supported by the Luke O'Brien Foundation, and L.E.B. was supported by the National Science Foundation Graduate Research Fellowship Program.	Aamann MD, 2010, FASEB J, V24, P2334, DOI 10.1096/fj.09-147991; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arczewska KD, 2013, NUCLEIC ACIDS RES, V41, P5368, DOI 10.1093/nar/gkt225; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Berra CM, 2013, FREE RADICAL BIO MED, V61, P343, DOI 10.1016/j.freeradbiomed.2013.03.026; Brace LE, 2013, AGING CELL, V12, P1144, DOI 10.1111/acel.12142; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Ding J, 2001, INT J BIOCHEM CELL B, V33, P603, DOI 10.1016/S1357-2725(01)00037-1; Fensgard O, 2010, AGING-US, V2, P133, DOI 10.18632/aging.100127; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hayashi M, 2005, BRAIN DEV-JPN, V27, P34, DOI 10.1016/j.braindev.2004.04.001; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Islam R, 2012, NEUROBIOL DIS, V46, P137, DOI 10.1016/j.nbd.2011.12.055; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Murai M, 2001, P NATL ACAD SCI USA, V98, P13379, DOI 10.1073/pnas.231329598; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Scheibye-Knudsen M, 2013, AGING-US, V5, P192, DOI 10.18632/aging.100546; Scheibye-Knudsen M, 2012, J EXP MED, V209, P855, DOI 10.1084/jem.20111721; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	29	427	435	2	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					882	896		10.1016/j.cell.2014.03.026	http://dx.doi.org/10.1016/j.cell.2014.03.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813611	Green Accepted, Bronze			2022-12-24	WOS:000335765500016
J	Fink, AJP; Croce, KR; Huang, ZJ; Abbott, LF; Jessell, TM; Azim, E				Fink, Andrew J. P.; Croce, Katherine R.; Huang, Z. Josh; Abbott, L. F.; Jessell, Thomas M.; Azim, Eiman			Presynaptic inhibition of spinal sensory feedback ensures smooth movement	NATURE			English	Article							GAMMA-AMINOBUTYRIC-ACID; CORD; NEURONS; AFFERENT; CELLS; MUSCLE; CORTEX; DEPOLARIZATION; TRANSMISSION; CIRCUITS	The precision of skilled movement depends on sensory feedback and its refinement by local inhibitory microcircuits. One specialized set of spinal GABAergic interneurons forms axo-axonic contacts with the central terminals of sensory afferents, exerting presynaptic inhibitory control over sensory-motor transmission. The inability to achieve selective access to the GABAergic neurons responsible for this unorthodox inhibitory mechanism has left unresolved the contribution of presynaptic inhibition to motor behaviour. We used Gad2 as a genetic entry point to manipulate the interneurons that contact sensory terminals, and show that activation of these interneurons in mice elicits the defining physiological characteristics of presynaptic inhibition. Selective genetic ablation of Gad2-expressing interneurons severely perturbs goal-directed reaching movements, uncovering a pronounced and stereotypic forelimb motor oscillation, the core features of which are captured by modelling the consequences of sensory feedback at high gain. Our findings define the neural substrate of a genetically hardwired gain control system crucial for the smooth execution of movement.	[Fink, Andrew J. P.; Croce, Katherine R.; Jessell, Thomas M.; Azim, Eiman] Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Kavli Inst Brain Sci,Dept Neurosci, New York, NY 10032 USA; [Fink, Andrew J. P.; Croce, Katherine R.; Jessell, Thomas M.; Azim, Eiman] Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Kavli Inst Brain Sci,Dept Biochem, New York, NY 10032 USA; [Fink, Andrew J. P.; Croce, Katherine R.; Jessell, Thomas M.; Azim, Eiman] Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Kavli Inst Brain Sci,Dept Mol Biophys, New York, NY 10032 USA; [Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Abbott, L. F.] Columbia Univ, Ctr Theoret Neurosci, Dept Physiol, New York, NY 10032 USA; [Abbott, L. F.] Columbia Univ, Ctr Theoret Neurosci, Dept Neurosci, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Columbia University; Columbia University	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Kavli Inst Brain Sci,Dept Neurosci, New York, NY 10032 USA.	af2243@columbia.edu; tmj1@columbia.edu		Huang, Z. Josh/0000-0003-0592-028X; Azim, Eiman/0000-0002-1015-1772	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093338, U01MH078844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033245, R01NS033245, R01NS080932] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [T32 HD007430] Funding Source: Medline; NIMH NIH HHS [MH078844, U01 MH078844, R01 MH093338, MH093338] Funding Source: Medline; NINDS NIH HHS [R37 NS033245, R01 NS080932, R01 NS033245, NS033245] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Akay T., 2013, LOCOMOTOR PATTERN DE; Akay T, 2008, J NEUROSCI METH, V171, P39, DOI 10.1016/j.jneumeth.2008.02.001; [Anonymous], 1977, HDB PHYSL NERVOUS SY; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; BARKER JL, 1972, SCIENCE, V176, P1043, DOI 10.1126/science.176.4038.1043; BAWA P, 1976, J NEUROPHYSIOL, V39, P788, DOI 10.1152/jn.1976.39.4.788; BEHAR T, 1993, DEV BRAIN RES, V72, P203, DOI 10.1016/0165-3806(93)90185-D; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007; Capaday C, 2002, EXP BRAIN RES, V143, P67, DOI 10.1007/s00221-001-0970-z; CAPADAY C, 1987, J NEUROSCI METH, V21, P91, DOI 10.1016/0165-0270(87)90107-5; CAPADAY C, 1987, J PHYSIOL-LONDON, V392, P513, DOI 10.1113/jphysiol.1987.sp016794; Churchland MM, 2001, J NEUROPHYSIOL, V86, P741, DOI 10.1152/jn.2001.86.2.741; CLEMENTS JD, 1987, J PHYSIOL-LONDON, V383, P153; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; CONRADI S, 1969, ACTA PHYSIOL SCAND, P85; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; ECCLES JC, 1962, J PHYSIOL-LONDON, V161, P237, DOI 10.1113/jphysiol.1962.sp006884; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; EVANS CM, 1983, J PHYSIOL-LONDON, V344, P483, DOI 10.1113/jphysiol.1983.sp014953; Farr TD, 2006, J NEUROSCI METH, V153, P104, DOI 10.1016/j.jneumeth.2005.10.011; Frank K, 1957, FED PROC, V16, P49; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Hantman AW, 2010, NAT NEUROSCI, V13, P1233, DOI 10.1038/nn.2637; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KUNO M, 1964, J PHYSIOL-LONDON, V175, P100, DOI 10.1113/jphysiol.1964.sp007505; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; Li Y, 2001, J NEUROPHYSIOL, V85, P2047, DOI 10.1152/jn.2001.85.5.2047; Llinas RR, 2009, NEUROSCIENCE, V162, P797, DOI 10.1016/j.neuroscience.2009.04.045; Lomeli J, 1998, NATURE, V395, P600, DOI 10.1038/26975; LUNDBERG A., 1964, PROGR BRAIN RES, V12, P197, DOI 10.1016/S0079-6123(08)60624-X; NIELSEN J, 1993, J PHYSIOL-LONDON, V464, P575, DOI 10.1113/jphysiol.1993.sp019652; Prochazka A, 1999, PROG BRAIN RES, V123, P133, DOI 10.1016/S0079-6123(08)62850-2; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; RUDOMIN P, 1983, J NEUROPHYSIOL, V50, P743, DOI 10.1152/jn.1983.50.4.743; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; Shneider NA, 2009, J NEUROSCI, V29, P4719, DOI 10.1523/JNEUROSCI.5790-08.2009; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Sonner PM, 2013, J NEUROPHYSIOL, V109, P2118, DOI 10.1152/jn.00783.2012; STEIN RB, 1976, BIOL CYBERN, V22, P147, DOI 10.1007/BF00365525; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Varela JA, 1997, J NEUROSCI, V17, P7926; Whishaw IQ, 1996, BEHAV BRAIN RES, V78, P101, DOI 10.1016/0166-4328(95)00236-7; Whitmer D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00155; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	57	130	131	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					43	+		10.1038/nature13276	http://dx.doi.org/10.1038/nature13276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784215	Green Accepted			2022-12-24	WOS:000335199100036
J	Nguyen-Van-Tam, JS; Openshaw, PJM; Nicholson, KG				Nguyen-Van-Tam, Jonathan S.; Openshaw, Peter J. M.; Nicholson, Karl G.			Antivirals for influenza: where now for clinical practice and pandemic preparedness?	LANCET			English	Editorial Material							NEURAMINIDASE INHIBITORS; VIRUS-INFECTION; METAANALYSIS; MORTALITY; BURDEN		[Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England; [Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Nicholson, Karl G.] Univ Leicester, Dept Infect Immun & Infl ammat, Leicester, Leics, England	University of Nottingham; Imperial College London; University of Leicester	Nguyen-Van-Tam, JS (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England.	jvt@nottingham.ac.uk	Nguyen-Van-Tam, Jonathan/I-2162-2019; Openshaw, Peter/AAL-9442-2020	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Openshaw, Peter/0000-0002-7220-2555	Medical Research Council [MC_G1001212, G1000758] Funding Source: Medline; MRC [MC_G1001212] Funding Source: UKRI; National Institute for Health Research [NF-SI-0513-10150] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK		Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD008965; Centers for Disease Control and Prevention, 2014, INFL ANT MED SUMM CL; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; JEFFERSON T, 2000, COCHRANE DB SYST REV, V2, P1265; Louie JK, 2013, PEDIATRICS, V132, pE1539, DOI 10.1542/peds.2013-2149; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; National Institute for Health and Care Excellence, 2009, AM OS ZAN TREATM INF; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144	14	10	13	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					386	387		10.1016/S0140-6736(14)60726-1	http://dx.doi.org/10.1016/S0140-6736(14)60726-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	24837882	Green Accepted			2022-12-24	WOS:000340195800008
J	Yang, G; Lai, CSW; Cichon, J; Ma, L; Li, W; Gan, WB				Yang, Guang; Lai, Cora Sau Wan; Cichon, Joseph; Ma, Lei; Li, Wei; Gan, Wen-Biao			Sleep promotes branch-specific formation of dendritic spines after learning	SCIENCE			English	Article							SYNAPTIC HOMEOSTASIS; PLASTICITY; NEURONS; REPLAY; OSCILLATIONS; HIPPOCAMPUS; CORTEX; STATE	How sleep helps learning and memory remains unknown. We report in mouse motor cortex that sleep after motor learning promotes the formation of postsynaptic dendritic spines on a subset of branches of individual layer V pyramidal neurons. New spines are formed on different sets of dendritic branches in response to different learning tasks and are protected from being eliminated when multiple tasks are learned. Neurons activated during learning of a motor task are reactivated during subsequent non-rapid eye movement sleep, and disrupting this neuronal reactivation prevents branch-specific spine formation. These findings indicate that sleep has a key role in promoting learning-dependent synapse formation and maintenance on selected dendritic branches, which contribute to memory storage.	[Yang, Guang; Lai, Cora Sau Wan; Cichon, Joseph; Ma, Lei; Gan, Wen-Biao] NYU, Sch Med, Dept Neurosci & Physiol, Skirball Inst, New York, NY 10016 USA; [Yang, Guang] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Ma, Lei; Li, Wei] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, Drug Discovery Ctr, Shenzhen 518055, Peoples R China	New York University; New York University; Peking University; University Town of Shenzhen	Gan, WB (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, Skirball Inst, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	, 0000-0002-5721-4259/K-3037-2019; ma, Lei/GOV-5903-2022	, 0000-0002-5721-4259/0000-0002-5721-4259; Yang, Guang/0000-0002-5739-9126; ma, lei/0000-0001-9673-0224	NIH [R01 NS047325, P01 NS074972]; Whitehall Foundation research grant; American Federation for Aging Research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047325, P01NS074972] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation research grant; American Federation for Aging Research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the members in the Gan laboratory and T. Franke for comments on the manuscript. This work was supported by NIH R01 NS047325 and P01 NS074972 to W.-B.G. and by a Whitehall Foundation research grant and an American Federation for Aging Research grant to G.Y.	Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Benington JH, 2003, PROG NEUROBIOL, V69, P71, DOI 10.1016/S0301-0082(03)00018-2; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Born J, 2012, NEURON, V75, P933, DOI 10.1016/j.neuron.2012.09.007; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Campbell IG, 1996, J NEUROPHYSIOL, V76, P3714, DOI 10.1152/jn.1996.76.6.3714; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cirelli C, 1999, ANN MED, V31, P117, DOI 10.3109/07853899908998787; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Frank MG, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/264378; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Seibt J, 2012, CURR BIOL, V22, P676, DOI 10.1016/j.cub.2012.02.016; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Timofeev I, 2011, PROG BRAIN RES, V193, P121, DOI 10.1016/B978-0-444-53839-0.00009-0; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yang Guang, 2013, Methods Mol Biol, V1010, P35, DOI 10.1007/978-1-62703-411-1_3; Yang G, 2012, DEV NEUROBIOL, V72, P1391, DOI 10.1002/dneu.20996; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zelenin PV, 2011, J NEUROPHYSIOL, V105, P2698, DOI 10.1152/jn.00120.2011	40	357	368	5	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1173	1178		10.1126/science.1249098	http://dx.doi.org/10.1126/science.1249098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904169	Green Accepted			2022-12-24	WOS:000336791200051
J	Deng, D; Xu, C; Sun, PC; Wu, JP; Yan, CY; Hu, MX; Yan, N				Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng			Crystal structure of the human glucose transporter GLUT1	NATURE			English	Article							BLOOD-BRAIN-BARRIER; DEFICIENCY SYNDROME; MUTATIONS; EPILEPSY; ONSET; EXPRESSION; PROTEINS; SPECTRUM; MODEL	The glucose transporter GLUT1 catalyses facilitative diffusion of glucose into erythrocytes and is responsible for glucose supply to the brain and other organs. Dysfunctional mutations may lead to GLUT1 deficiency syndrome, whereas overexpression of GLUT1 is a prognostic indicator for cancer. Despite decades of investigation, the structure of GLUT1 remains unknown. Here we report the crystal structure of human GLUT1 at 3.2 angstrom resolution. The full-length protein, which has a canonical major facilitator superfamily fold, is captured in an inward-open conformation. This structure allows accurate mapping and potential mechanistic interpretation of disease-associated mutations in GLUT1. Structure-based analysis of these mutations provides an insight into the alternating access mechanism of GLUT1 and other members of the sugar porter subfamily. Structural comparison of the uniporter GLUT1 with its bacterial homologue XylE, a proton-coupled xylose symporter, allows examination of the transport mechanisms of both passive facilitators and active transporters.	[Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng] Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Deng, Dong; Xu, Chao; Wu, Jianping; Hu, Mingxu; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Yan, N (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Deng, Dong/0000-0002-8590-9525; Wu, Jianping/0000-0001-9869-7691; Sun, Pengcheng/0000-0002-7549-1161	Ministry of Science and Technology [2011CB910501]; National Natural Science Foundation of China [31321062-20131319400, 31125009, 91017011]; Tsinghua-Peking Center for Life Sciences; Howard Hughes Medical Institute	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. He, L. Tang, F. Yu and S. Huang at Shanghai Synchrotron Radiation Facility (SSRF). This work was supported by funds from the Ministry of Science and Technology (grant number 2011CB910501), Projects 31321062-20131319400, 31125009 and 91017011 of the National Natural Science Foundation of China, and funds from Tsinghua-Peking Center for Life Sciences. The research of N.Y. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afawi Z, 2010, EPILEPSIA, V51, P2466, DOI 10.1111/j.1528-1167.2010.02726.x; Amann T, 2011, MOL MEMBR BIOL, V28, P181, DOI 10.3109/09687688.2011.554447; Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Anheim M, 2011, J NEUROL, V258, P316, DOI 10.1007/s00415-010-5702-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DICK APK, 1984, P NATL ACAD SCI-BIOL, V81, P7233, DOI 10.1073/pnas.81.22.7233; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forsen S., 1978, NOBEL LECT CHEM 1971; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Henderson PJF, 2013, NAT STRUCT MOL BIOL, V20, P654, DOI 10.1038/nsmb.2604; Henderson PJF, 2012, NATURE, V490, P348, DOI 10.1038/490348a; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaira K, 2014, LUNG CANCER, V83, P197, DOI 10.1016/j.lungcan.2013.11.025; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; Klepper J, 2009, NEUROPEDIATRICS, V40, P207, DOI 10.1055/s-0030-1248264; Klepper J, 1999, NEUROCHEM RES, V24, P587, DOI 10.1023/A:1022544131826; Klepper J, 2001, HUM MOL GENET, V10, P63, DOI 10.1093/hmg/10.1.63; Leen WG, 2014, J NEUROL, V261, P589, DOI 10.1007/s00415-014-7240-z; Leen WG, 2010, BRAIN, V133, P655, DOI 10.1093/brain/awp336; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuire BB, 2009, CURR OPIN UROL, V19, P441, DOI 10.1097/MOU.0b013e32832f0c68; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mullen SA, 2010, NEUROLOGY, V75, P432, DOI 10.1212/WNL.0b013e3181eb58b4; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overweg-Plandsoen WCG, 2003, J INHERIT METAB DIS, V26, P559, DOI 10.1023/A:1025999914822; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Pascual JM, 2002, ANN NEUROL, V52, P458, DOI 10.1002/ana.10311; Pearson TS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0342-7; Perez-Duenas B, 2009, ARCH NEUROL-CHICAGO, V66, P1410, DOI 10.1001/archneurol.2009.236; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Ramani P, 2013, VIRCHOWS ARCH, V462, P203, DOI 10.1007/s00428-012-1370-4; Sanderson NM, 1998, BIOCHEM SOC T, V26, pS306, DOI 10.1042/bst026s306; Saudubray J.-M., 2011, INBORN METABOLIC DIS, P656; Schneider SA, 2009, MOVEMENT DISORD, V24, P1684, DOI 10.1002/mds.22507; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Shim BY, 2013, INT J COLORECTAL DIS, V28, P375, DOI 10.1007/s00384-012-1542-3; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Striano P, 2012, NEUROLOGY, V78, P557, DOI 10.1212/WNL.0b013e318247ff54; Suls A, 2009, ANN NEUROL, V66, P415, DOI 10.1002/ana.21724; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Urbizu A, 2010, J NEUROL SCI, V295, P110, DOI 10.1016/j.jns.2010.05.017; Wang D, 2000, HUM MUTAT, V16, P224, DOI 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P; Wang D, 2005, ANN NEUROL, V57, P111, DOI 10.1002/ana.20331; Weber YG, 2008, J CLIN INVEST, V118, P2157, DOI 10.1172/JCI34438; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003	60	457	497	36	556	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					121	+		10.1038/nature13306	http://dx.doi.org/10.1038/nature13306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24847886				2022-12-24	WOS:000336768900040
J	Wolff, SBE; Grundemann, J; Tovote, P; Krabbe, S; Jacobson, GA; Muller, C; Herry, C; Ehrlich, I; Friedrich, RW; Letzkus, JJ; Luthi, A				Wolff, Steffen B. E.; Gruendemann, Jan; Tovote, Philip; Krabbe, Sabine; Jacobson, Gilad A.; Mueller, Christian; Herry, Cyril; Ehrlich, Ingrid; Friedrich, Rainer W.; Letzkus, Johannes J.; Luethi, Andreas			Amygdala interneuron subtypes control fear learning through disinhibition	NATURE			English	Article							RAT BASOLATERAL AMYGDALA; GABAERGIC NEURONS; LATERAL NUCLEUS; CIRCUIT; SOMATOSTATIN; INHIBITION; NETWORKS; IDENTIFICATION; ORGANIZATION; ACQUISITION	Learning is mediated by experience-dependent plasticity in neuronal circuits. Activity in neuronal circuits is tightly regulated by different subtypes of inhibitory interneurons, yet their role in learning is poorly understood. Using a combination of in vivo single-unit recordings and optogenetic manipulations, we show that in the mouse basolateral amygdala, interneurons expressing parvalbumin (PV) and somatostatin (SOM) bidirectionally control the acquisition of fear conditioning-a simple form of associative learning-through two distinct disinhibitory mechanisms. During an auditory cue, PV+ interneurons are excited and indirectly disinhibit the dendrites of basolateral amygdala principal neurons via SOM+ interneurons, thereby enhancing auditory responses and promoting cue-shock associations. During an aversive footshock, however, both PV+ and SOM+ interneurons are inhibited, which boosts postsynaptic footshock responses and gates learning. These results demonstrate that associative learning is dynamically regulated by the stimulus-specific activation of distinct disinhibitory microcircuits through precise interactions between different subtypes of local interneurons.	[Wolff, Steffen B. E.; Gruendemann, Jan; Tovote, Philip; Krabbe, Sabine; Jacobson, Gilad A.; Mueller, Christian; Friedrich, Rainer W.; Letzkus, Johannes J.; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Wolff, Steffen B. E.] Univ Basel, CH-4000 Basel, Switzerland; [Herry, Cyril] INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France; [Ehrlich, Ingrid] Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany	Friedrich Miescher Institute for Biomedical Research; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	johannes.letzkus@brain.mpg.de; andreas.luthi@fmi.ch	Tovote, Philip/AAC-5668-2019; Herry, Cyril/AAP-9902-2020; Ehrlich, Ingrid/G-8551-2015	Herry, Cyril/0000-0003-2973-0843; Ehrlich, Ingrid/0000-0001-9078-2429; Friedrich, Rainer/0000-0001-9107-0482; Krabbe, Sabine/0000-0002-5735-469X; Letzkus, Johannes/0000-0001-5678-3030; Tovote, Philip/0000-0002-4598-722X; Grundemann, Jan/0000-0002-3149-0001; Jacobson, Gilad/0000-0001-8172-3144	Novartis Research Foundation; National Center of Competences in Research: 'SYNAPSY-The Synaptic Bases of Mental Diseases' - (Swiss National Science Foundation); SNSF core grant; Schering Foundation Fellowship; Swiss National Science Foundation Ambizione Fellowship; EMBO Long-Term Fellowships; Marie Curie Action Fellowships	Novartis Research Foundation; National Center of Competences in Research: 'SYNAPSY-The Synaptic Bases of Mental Diseases' - (Swiss National Science Foundation); SNSF core grant; Schering Foundation Fellowship; Swiss National Science Foundation Ambizione Fellowship; EMBO Long-Term Fellowships; Marie Curie Action Fellowships	We thank all members of the Luthi laboratory and E. Schuman for discussions and critical comments on the manuscript. We would like to thank J. Ludke, P. Argast and P. Buchmann for technical assistance. We further thank the Facility for Imaging and Microscopy at the FMI, in particular S. Bourke and M. Kirschmann, for their assistance in image acquisition and analysis. We also thank K. Deisseroth, E. Boyden, J. Huang, R. Sprengel and S. Arber for sharing materials and mouse lines. This work was supported by the Novartis Research Foundation, by the National Center of Competences in Research: 'SYNAPSY-The Synaptic Bases of Mental Diseases' (financed by the Swiss National Science Foundation) as well as by a SNSF core grant to A. L. S. B. E. W. is supported by a Schering Foundation Fellowship. J. J. L. is supported by a Swiss National Science Foundation Ambizione Fellowship. J. G. and G. A. J. are supported by EMBO Long-Term Fellowships and Marie Curie Action Fellowships.	Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Chhatwal JP, 2005, J NEUROSCI, V25, P502, DOI 10.1523/JNEUROSCI.3301-04.2005; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cuntz H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000877; Davis M., 2000, AMYGDALA, P213; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Farb CR, 1997, SYNAPSE, V27, P106, DOI 10.1002/(SICI)1098-2396(199710)27:2<106::AID-SYN2>3.3.CO;2-F; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Harris JA, 1998, PSYCHOPHARMACOLOGY, V140, P105, DOI 10.1007/s002130050745; Heidi SA, 2007, EUR J NEUROSCI, V26, P3631, DOI 10.1111/j.1460-9568.2007.05970.x; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hill MN, 2013, MOL PSYCHIATR, V18, P1125, DOI 10.1038/mp.2012.90; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Humeau Y, 2007, NEUROPHARMACOLOGY, V52, P234, DOI 10.1016/j.neuropharm.2006.07.010; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Likhtik E, 2006, J NEUROPHYSIOL, V96, P3257, DOI 10.1152/jn.00577.2006; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCDONALD AJ, 1984, J COMP NEUROL, V222, P589, DOI 10.1002/cne.902220410; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McDonald AJ, 2002, BRAIN RES, V943, P237, DOI 10.1016/S0006-8993(02)02650-1; McDonald AJ, 2001, NEUROSCIENCE, V102, P413, DOI 10.1016/S0306-4522(00)00481-4; Muller JF, 2007, J COMP NEUROL, V500, P513, DOI 10.1002/cne.21185; Muller JF, 2005, J NEUROSCI, V25, P7366, DOI 10.1523/JNEUROSCI.0899-05.2005; Muller JF, 2006, J COMP NEUROL, V494, P635, DOI 10.1002/cne.20832; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pivetta C, 2014, CELL, V156, P537, DOI 10.1016/j.cell.2013.12.014; Rainnie DG, 2006, J COMP NEUROL, V498, P142, DOI 10.1002/cne.21049; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Spampanato J, 2011, NEUROPHARMACOLOGY, V60, P765, DOI 10.1016/j.neuropharm.2010.11.006; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Waclaw RR, 2010, J NEUROSCI, V30, P6944, DOI 10.1523/JNEUROSCI.5772-09.2010; Woodruff AR, 2007, J NEUROPHYSIOL, V98, P2956, DOI 10.1152/jn.00739.2007; Woodruff AR, 2007, J NEUROSCI, V27, P553, DOI 10.1523/JNEUROSCI.3686-06.2007; Woodson W, 2000, SYNAPSE, V38, P124, DOI 10.1002/1098-2396(200011)38:2<124::AID-SYN3>3.0.CO;2-N; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	58	298	300	6	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					453	+		10.1038/nature13258	http://dx.doi.org/10.1038/nature13258			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24814341				2022-12-24	WOS:000336126000031
J	Shao, DD; Xue, W; Krall, EB; Bhutkar, A; Piccioni, F; Wang, XX; Schinzel, AC; Sood, S; Rosenbluh, J; Kim, JW; Zwang, Y; Roberts, TM; Root, DE; Jacks, T; Hahn, WC				Shao, Diane D.; Xue, Wen; Krall, Elsa B.; Bhutkar, Arjun; Piccioni, Federica; Wang, Xiaoxing; Schinzel, Anna C.; Sood, Sabina; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Roberts, Thomas M.; Root, David E.; Jacks, Tyler; Hahn, William C.			KRAS and YAP1 Converge to Regulate EMT and Tumor Survival	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION SIGNATURE; ONCOGENIC RAS; C-FOS; CANDIDATE ONCOGENE; CONTACT INHIBITION; HIPPO PATHWAY; BETA-CATENIN; ORGAN SIZE; ACTIVATION	Cancer cells that express oncogenic alleles of RAS typically require sustained expression of the mutant allele for survival, but the molecular basis of this oncogene dependency remains incompletely understood. To identify genes that can functionally substitute for oncogenic RAS, we systematically expressed 15,294 open reading frames in a human KRAS-dependent colon cancer cell line engineered to express an inducible KRAS-specific shRNA. We found 147 genes that promoted survival upon KRAS suppression. In particular, the transcriptional coactivator YAP1 rescued cell viability in KRAS-dependent cells upon suppression of KRAS and was required for KRAS-induced cell transformation. Acquired resistance to Kras suppression in a Kras-driven murine lung cancer model also involved increased YAP1 signaling. KRAS and YAP1 converge on the transcription factor FOS and activate a transcriptional program involved in regulating the epithelial-mesenchymal transition (EMT). Together, these findings implicate transcriptional regulation of EMT by YAP1 as a significant component of oncogenic RAS signaling.	[Shao, Diane D.; Krall, Elsa B.; Wang, Xiaoxing; Schinzel, Anna C.; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Roberts, Thomas M.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shao, Diane D.; Krall, Elsa B.; Piccioni, Federica; Wang, Xiaoxing; Schinzel, Anna C.; Rosenbluh, Joseph; Kim, Jong W.; Zwang, Yaara; Root, David E.; Jacks, Tyler; Hahn, William C.] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA; [Xue, Wen; Bhutkar, Arjun; Sood, Sabina; Jacks, Tyler] Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Jacks, T (corresponding author), Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA.	tjacks@mit.edu; william_hahn@dfci.harvard.edu	Shao, Diane/GRO-3470-2022	Rosenbluh, Joseph/0000-0001-9815-8049; Shao, Diane/0000-0003-2087-4082	U.S. National Institutes of Health [R01 CA140545, U01 CA176058, P01 CA050661, K99 CA169512, T32 GM007753]; National Cancer Institute [P30-CA14051]; Howard Hughes Medical Institute; Daniel K. Ludwig Fund for Cancer Research; American Association for Cancer Research; Leukemia Lymphoma Society; Svenson Family Foundation; Department of Defense [W81XWH-10-1-0062, W81XWH-12-1-0115]; Hope Funds for Cancer Research [HFCR-11-03-03]; NATIONAL CANCER INSTITUTE [P01CA154303, P01CA050661, P50CA127003, P30CA014051, K99CA169512, R01CA140545, R00CA169512, U01CA176058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Daniel K. Ludwig Fund for Cancer Research; American Association for Cancer Research; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Svenson Family Foundation; Department of Defense(United States Department of Defense); Hope Funds for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by R01 CA140545 (W.C.H.), U01 CA176058 (W.C.H.), P01 CA050661 (W.C.H. and T.M.R.), K99 CA169512 (W.X.), and T32 GM007753 (D.S.) from the U.S. National Institutes of Health; and Koch Institute Support Grant P30-CA14051 (T.J.) from the National Cancer Institute. Additional support was provided by Howard Hughes Medical Institute (T.J.), Daniel K. Ludwig Fund for Cancer Research (T.J.), American Association for Cancer Research (W.X.), the Leukemia Lymphoma Society (W.X.), the Svenson Family Foundation (J.R.), fellowships W81XWH-10-1-0062 (X.W.) and W81XWH-12-1-0115 (Y.Z.) from the Department of Defense, and fellowship HFCR-11-03-03 from Hope Funds for Cancer Research (E.B.K.). T.M.R. and W.C.H. are consultants for Novartis.	Baez MV, 2005, J BIOL CHEM, V280, P43131, DOI 10.1074/jbc.M508374200; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Ehrenreiter K, 2009, CANCER CELL, V16, P149, DOI 10.1016/j.ccr.2009.06.008; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fuchs IB, 2002, ANTICANCER RES, V22, P3415; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kielbasa SM, 2010, NUCLEIC ACIDS RES, V38, pW275, DOI 10.1093/nar/gkq438; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lau KS, 2009, MOL CELLS, V28, P315, DOI 10.1007/s10059-009-0143-7; LEDWITH BJ, 1990, MOL CELL BIOL, V10, P1545, DOI 10.1128/MCB.10.4.1545; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUDOL M, 1994, ONCOGENE, V9, P2145; Sudol M, 2013, ONCOGENE, V32, P3922, DOI 10.1038/onc.2012.520; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Wong CE, 2013, GENE DEV, V27, P670, DOI 10.1101/gad.210427.112; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031994; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	59	510	522	5	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					171	184		10.1016/j.cell.2014.06.004	http://dx.doi.org/10.1016/j.cell.2014.06.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24954536	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000340943100016
J	van Loosdrecht, MCM; Brdjanovic, D				van Loosdrecht, Mark C. M.; Brdjanovic, Damir			Anticipating the next century of wastewater treatment	SCIENCE			English	Editorial Material							RECOVERY		[van Loosdrecht, Mark C. M.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Brdjanovic, Damir] UNESCO IHE Inst Water Educ, NL-2611 AX Delft, Netherlands	Delft University of Technology; IHE Delft Institute for Water Education	van Loosdrecht, MCM (corresponding author), Delft Univ Technol, Dept Biotechnol, Julianalaan 67, NL-2628 BC Delft, Netherlands.	m.c.m.vanLoosdrecht@tudelft.nl	van Loosdrecht, Mark C.M./B-2738-2009; van Loosdrecht, Mark/AAA-9997-2019	van Loosdrecht, Mark C.M./0000-0003-0658-4775; 				[Anonymous], [No title captured]; Ardern E., 1914, J SOC CHEM IND LOND, V33, P523, DOI [DOI 10.1002/JCTB.5000331005, DOI 10.1002/JCTB.50003]; Daims H, 2006, TRENDS BIOTECHNOL, V24, P483, DOI 10.1016/j.tibtech.2006.09.002; de Kreuk M, 2005, BIOTECHNOL BIOENG, V90, P761, DOI 10.1002/bit.20470; du Pisani PL, 2006, DESALINATION, V188, P79, DOI 10.1016/j.desal.2005.04.104; Giesen A., 2012, WATER-SUI, V4, P28; Grant SB, 2012, SCIENCE, V337, P681, DOI 10.1126/science.1216852; Guest JS, 2009, ENVIRON SCI TECHNOL, V43, P6126, DOI 10.1021/es9010515; Judd S, 2008, TRENDS BIOTECHNOL, V26, P109, DOI 10.1016/j.tibtech.2007.11.005; Kartal B, 2010, SCIENCE, V328, P702, DOI 10.1126/science.1185941; Law I. B., 2003, WATER J AUST WATER A, V30, P31; Lin Y, 2010, WATER RES, V44, P3355, DOI 10.1016/j.watres.2010.03.019; Loosdrecht M. van, 2012, Water 21, P17; Ruiken CJ, 2013, WATER RES, V47, P43, DOI 10.1016/j.watres.2012.08.023; Siezen RJ, 2008, MICROB BIOTECHNOL, V1, P333, DOI 10.1111/j.1751-7915.2008.00059.x; Vairavamoorthy K., 2010, UNESCO REPORT ENG IS	16	405	415	52	676	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1452	1453		10.1126/science.1255183	http://dx.doi.org/10.1126/science.1255183			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970066				2022-12-24	WOS:000337889900022
J	Chin, RM; Fu, XD; Pai, MY; Vergnes, L; Hwang, H; Deng, G; Diep, S; Lomenick, B; Meli, VS; Monsalve, GC; Hu, E; Whelan, SA; Wang, JX; Jung, G; Solis, GM; Fazlollahi, F; Kaweeteerawat, C; Quach, A; Nili, M; Krall, AS; Godwin, HA; Chang, HR; Faull, KF; Guo, F; Jiang, MS; Trauger, SA; Saghatelian, A; Braas, D; Christofk, HR; Clarke, CF; Teitell, MA; Petrascheck, M; Reue, K; Jung, ME; Frand, AR; Huang, J				Chin, Randall M.; Fu, Xudong; Pai, Melody Y.; Vergnes, Laurent; Hwang, Heejun; Deng, Gang; Diep, Simon; Lomenick, Brett; Meli, Vijaykumar S.; Monsalve, Gabriela C.; Hu, Eileen; Whelan, Stephen A.; Wang, Jennifer X.; Jung, Gwanghyun; Solis, Gregory M.; Fazlollahi, Farbod; Kaweeteerawat, Chitrada; Quach, Austin; Nili, Mahta; Krall, Abby S.; Godwin, Hilary A.; Chang, Helena R.; Faull, Kym F.; Guo, Feng; Jiang, Meisheng; Trauger, Sunia A.; Saghatelian, Alan; Braas, Daniel; Christofk, Heather R.; Clarke, Catherine F.; Teitell, Michael A.; Petrascheck, Michael; Reue, Karen; Jung, Michael E.; Frand, Alison R.; Huang, Jing			The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR	NATURE			English	Article							CAENORHABDITIS-ELEGANS; CALORIC RESTRICTION; DEVELOPMENTAL ARREST; DIETARY RESTRICTION; PHOSPHORYLATION; AUTOPHAGY; LONGEVITY; GENETICS; DEFICIENCY; PHA-4/FOXA	Metabolism and ageing are intimately linked. Compared with ad libitum feeding, dietary restriction consistently extends lifespan and delays age-related diseases in evolutionarily diverse organisms(1,2). Similar conditions of nutrient limitation and genetic or pharmacological perturbations of nutrient or energy metabolism also have longevity benefits(3,4). Recently, several metabolites have been identified that modulate ageing(5,6); however, the molecular mechanisms underlying this are largely undefined. Here we show that alpha-ketoglutarate (alpha-KG), a tricarboxylic acid cycle intermediate, extends the lifespan of adult Caenorhabditis elegans. ATP synthase subunit beta is identified as a novel binding protein of alpha-KG using a small-molecule target identification strategy termed drug affinity responsive target stability (DARTS)(7). The ATP synthase, also known as complex V of the mitochondrial electron transport chain, is the main cellular energy generating machinery and is highly conserved throughout evolution(8,9). Although complete loss of mitochondrial function is detrimental, partial suppression of the electron transport chain has been shown to extend C. elegans lifespan(10-13). We show that alpha-KG inhibits ATP synthase and, similar to ATP synthase knockdown, inhibition by alpha-KG leads to reduced ATP content, decreased oxygen consumption, and increased autophagy in both C. elegans and mammalian cells. We provide evidence that the lifespan increase by alpha-KG requires ATP synthase subunit b and is dependent on target of rapamycin (TOR) downstream. Endogenous alpha-KG levels are increased on starvation and alpha-KG does not extend the lifespan of dietary-restricted animals, indicating that alpha-KG is a key metabolite that mediates longevity by dietary restriction. Our analyses uncover new molecular links between a common metabolite, a universal cellular energy generator and dietary restriction in the regulation of organismal lifespan, thus suggesting new strategies for the prevention and treatment of ageing and age-related diseases.	[Chin, Randall M.; Pai, Melody Y.; Clarke, Catherine F.; Teitell, Michael A.; Reue, Karen; Jung, Michael E.; Huang, Jing] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Fu, Xudong; Hwang, Heejun; Diep, Simon; Lomenick, Brett; Hu, Eileen; Jung, Gwanghyun; Quach, Austin; Krall, Abby S.; Jiang, Meisheng; Braas, Daniel; Christofk, Heather R.; Huang, Jing] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Deng, Gang; Clarke, Catherine F.; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Meli, Vijaykumar S.; Monsalve, Gabriela C.; Guo, Feng; Frand, Alison R.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Whelan, Stephen A.; Chang, Helena R.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA; [Wang, Jennifer X.; Trauger, Sunia A.] Harvard Univ, FAS Div Sci, Small Mol Mass Spectrometry Facil, Cambridge, MA 02138 USA; [Solis, Gregory M.; Petrascheck, Michael] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Fazlollahi, Farbod; Faull, Kym F.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Fazlollahi, Farbod; Faull, Kym F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Kaweeteerawat, Chitrada; Godwin, Hilary A.] Univ Calif Los Angeles, Dept Environm Hlth Sci, Los Angeles, CA 90095 USA; [Nili, Mahta; Teitell, Michael A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Saghatelian, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Braas, Daniel; Christofk, Heather R.] Univ Calif Los Angeles, UCLA Metabol Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Scripps Research Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; University of California System; University of California Los Angeles	Huang, J (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	jinghuang@mednet.ucla.edu	Meli, Vijaykumar S/A-1879-2018; Lomenick, Brett/AAR-3294-2020; Fu, Xudong/AAT-4400-2021; Fu, Xudong/AAM-9493-2020; Petrascheck, Michael/R-7832-2019; Whelan, Stephen A/I-9502-2012	Meli, Vijaykumar S/0000-0002-8690-4363; Fu, Xudong/0000-0001-7024-0200; Petrascheck, Michael/0000-0002-1010-145X; Whelan, Stephen A/0000-0002-4740-0795; Fazlollahi, Farbod/0000-0002-0954-5731; Lomenick, Brett/0000-0002-5023-9998; Solis, Gregory/0000-0002-3347-5980; Christofk, Heather/0000-0002-8662-4425; Whelan, Stephen A/0000-0002-5439-6501; Hu, Eileen/0000-0002-7720-3522; Trauger, Sunia/0000-0002-1678-8715; Chin, Randall/0000-0003-0721-3204; Frand, Alison/0000-0001-5972-989X; vergnes, laurent/0000-0002-8804-589X	National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; NIH [T32 GM007104, T32 GM007185, T32 GM008496, T32 CA009120]; China Scholarship Council Scholarship; Ford Foundation; National Science Foundation; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007104, T32GM008496, T32GM007185] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440, DP2OD008398] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Office of Research Infrastructure Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council Scholarship(China Scholarship Council); Ford Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Lee, M. Hansen, B. Lemire, A. van der Bliek, S. Clarke, T. K. Blackwell, R. Johnson, J. E. Walker, A. G. W. Leslie, K. N. Houk, B. Martin, J. Lusis, J. Gober, Y. Wang and H. Sun for advice and discussions. J. Avruch for the let-363 RNAi vector; J. Powell-Coffman for strains and advice; and K. Yan for technical assistance. Worm strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs(P40 OD010440). We thank the NIH for traineeship support of R. M. C. (T32 GM007104), M. Y. P. (T32 GM007185), B. L. (T32 GM008496) and M. N. (T32 CA009120). X. F. is a recipient of the China Scholarship Council Scholarship. G. C. M. was supported by Ford Foundation and National Science Foundation Graduate Research Fellowships.	Abada EAE, 2009, MOL CELLS, V28, P209, DOI 10.1007/s10059-009-0124-x; ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Alberti A, 2010, AUTOPHAGY, V6, P622, DOI 10.4161/auto.6.5.12252; Alberts B., 1994, MOL BIOL CELL; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; BRENNER S, 1974, GENETICS, V77, P71; Brugnara L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040600; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gems D, 2000, GENETICS, V154, P1597; Gingras AC, 2001, GENE DEV, V15, P2852; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hansen M, 2007, WESTERN HUM REV, V61, P6; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Jung ME, 2012, J ORG CHEM, V77, P11002, DOI 10.1021/jo302308q; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KAMINSKY YG, 1982, COMP BIOCHEM PHYS B, V73, P957, DOI 10.1016/0305-0491(82)90343-1; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lomenick Brett, 2011, Curr Protoc Chem Biol, V3, P163; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Lucanic M, 2011, NATURE, V473, P226, DOI 10.1038/nature10007; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Stubbs CJ, 2009, J MED CHEM, V52, P2799, DOI 10.1021/jm900285r; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200; Williams DS, 2009, AGING CELL, V8, P765, DOI 10.1111/j.1474-9726.2009.00527.x; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	59	329	354	7	171	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					397	401		10.1038/nature13264	http://dx.doi.org/10.1038/nature13264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24828042	Green Accepted, Green Submitted			2022-12-24	WOS:000337350200035
J	Pe'er, G; Dicks, LV; Visconti, P; Arlettaz, R; Baldi, A; Benton, TG; Collins, S; Dieterich, M; Gregory, RD; Hartig, F; Henle, K; Hobson, PR; Kleijn, D; Neumann, RK; Robijns, T; Schmidt, J; Shwartz, A; Sutherland, WJ; Turbe, A; Wulf, F; Scott, AV				Pe'er, G.; Dicks, L. V.; Visconti, P.; Arlettaz, R.; Baldi, A.; Benton, T. G.; Collins, S.; Dieterich, M.; Gregory, R. D.; Hartig, F.; Henle, K.; Hobson, P. R.; Kleijn, D.; Neumann, R. K.; Robijns, T.; Schmidt, J.; Shwartz, A.; Sutherland, W. J.; Turbe, A.; Wulf, F.; Scott, A. V.			AGRICULTURE POLICY EU agricultural reform fails on biodiversity	SCIENCE			English	Editorial Material							AGRI-ENVIRONMENT SCHEMES; FARMLAND BIODIVERSITY; HABITAT HETEROGENEITY; POPULATION TRENDS; CONSERVATION; EUROPE; MANAGEMENT; BIRDS; INTENSIFICATION; POLLINATORS		[Pe'er, G.; Henle, K.; Neumann, R. K.] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, D-04318 Leipzig, Germany; [Pe'er, G.; Visconti, P.; Arlettaz, R.; Baldi, A.; Dieterich, M.] Soc Conservat Biol Europe Sect, Washington, DC 20001 USA; [Dicks, L. V.; Sutherland, W. J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Visconti, P.] Microsoft Res, Computat Sci Lab Cambridge, Cambridge CB1 2FB, England; [Arlettaz, R.] Univ Bern, Inst Ecol & Evolut, Dept Conservat Biol, Bern, Switzerland; [Baldi, A.] MTA Ctr Ecol Res, H-2163 Vacratot, Hungary; [Benton, T. G.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Collins, S.] Butterfly Conservat Europe, Wageningen, Netherlands; [Dieterich, M.] Univ Hohenheim, Inst Landscape & Plant Ecol, D-70599 Stuttgart, Germany; [Gregory, R. D.] The Lodge, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Hartig, F.] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79085 Freiburg, Germany; [Hobson, P. R.] Eberswalde Univ Sustainable Dev, Ctr Econ & Ecosyst Management, D-16225 Eberswalde, Germany; [Kleijn, D.] Wageningen Univ, Resource Ecol Grp, NL-6708 PB Wageningen, Netherlands; [Kleijn, D.] Alterra, Anim Ecol Team, NL-6700 AA Wageningen, Netherlands; [Robijns, T.] Stichting BirdLife Europe, B-1060 Brussels, Belgium; [Schmidt, J.] UFZ Helmholtz Ctr Environm Res, Dept Environm Polit, D-04318 Leipzig, Germany; [Shwartz, A.] Technion Israel Inst Technol, Fac Architecture & Town Planning, IL-32000 Haifa, Israel; [Shwartz, A.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England; [Turbe, A.] BIO Intelligence Serv, F-9200 Neuilly Sur Seine, France; [Wulf, F.] Pro Natura Friends Earth Switzerland, CH-4018 Basel, Switzerland; [Scott, A. V.] Univ Reading, Sch Agr Policy & Dev, CAER, Reading RG6 6AR, Berks, England	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Cambridge; Microsoft; University of Bern; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Leeds; University Hohenheim; Royal Society for Protection of Birds; University of Freiburg; Eberswalde University for Sustainable Development; Wageningen University & Research; Wageningen University & Research; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technion Israel Institute of Technology; University of Kent; University of Reading	Pe'er, G (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, D-04318 Leipzig, Germany.	guy.peer@ufz.de; guy.peer@ufz.de	Arlettaz, Raphaël/O-2182-2016; Henle, Klaus/I-6837-2013; Dicks, Lynn V./AFH-5289-2022; Baldi, Andras/A-7501-2008; Hartig, Florian/G-4510-2010; Benton, Tim G/C-6493-2009; Kleijn, David/HCH-3477-2022; Visconti, Piero/A-3253-2009	Arlettaz, Raphaël/0000-0001-6360-5339; Henle, Klaus/0000-0002-6647-5362; Baldi, Andras/0000-0001-6063-3721; Hartig, Florian/0000-0002-6255-9059; Benton, Tim G/0000-0002-7448-1973; Visconti, Piero/0000-0001-6823-2826; Dicks, Lynn/0000-0002-8304-4468; Kleijn, David/0000-0003-2500-7164; Gregory, Richard/0000-0002-7419-5053; Sutherland, William/0000-0002-6498-0437	Biotechnology and Biological Sciences Research Council [BB/J005851/1] Funding Source: researchfish; Natural Environment Research Council [NE/K015419/1] Funding Source: researchfish; BBSRC [BB/J005851/1] Funding Source: UKRI; NERC [NE/K015419/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2011, OUR NAT CAP EU BIOD; AVIRON S, 2005, EVAL OKOMASS BER BIO; Babai D, 2014, AGR ECOSYST ENVIRON, V182, P123, DOI 10.1016/j.agee.2013.08.018; Baker DJ, 2012, J APPL ECOL, V49, P871, DOI 10.1111/j.1365-2664.2012.02161.x; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Batary P, 2011, FRONT ECOL ENVIRON, V9, P152, DOI 10.1890/11.WB.006; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; *BIRDLIFE INT, 2003, BIRDS EUR POP EST TR; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; *BTO, 2013, BIRD IND IND UPD OCT; Buri P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085635; Buri P, 2013, AGR ECOSYST ENVIRON, V181, P22, DOI 10.1016/j.agee.2013.09.003; Burton RJF, 2013, LAND USE POLICY, V30, P628, DOI 10.1016/j.landusepol.2012.05.002; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; COLLINS S, 2014, IMPROVING MANAGEMENT; Dicks LV, 2014, CONSERV LETT, V7, P119, DOI 10.1111/conl.12046; Dicks LV, 2013, INSECT CONSERV DIVER, V6, P435, DOI 10.1111/j.1752-4598.2012.00221.x; DIETERICH M, 2012, DEFIZIT NAT 2000 SIT; Dover JW, 2011, J INSECT CONSERV, V15, P129, DOI 10.1007/s10841-010-9332-0; Emery SB, 2012, J RURAL STUD, V28, P218, DOI 10.1016/j.jrurstud.2012.02.004; *EUR COMM, 2010, CAP TOW 2020 MEET FO; *EUR COMM, 2013, 6 FIN REP COMM EUR P; *EUR COMM, 2012, EU BUDG 2012 500 MIL; *EUR COMM, 2012, NAT BIOD LIFE PROJ 2; *EUR ENV AG, 2010, 122010 EEA TECH REP; *EUR ENV AG, 2013, 112013 EEA TECH REP; European Environment Agency, 2004, EEA SIGN 2004 EUR EN; European Parliament, 2013, DIR GEN INT POL POL; FAO (Food and Agriculture Organization of the United Nations), 2013, FAO STAT YB 2013; *FED OFF AGR BLW, 2013, BUND LANDW 2013 AGR; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; GEROWITT B., 2011, CHANCEN BIOL VIELFAL; Gilroy JJ, 2011, ANIM CONSERV, V14, P620, DOI 10.1111/j.1469-1795.2011.00480.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gregory RD, 2010, ORNITHOL SCI, V9, P3, DOI 10.2326/osj.9.3; Hartel T, 2013, BIOL CONSERV, V166, P267, DOI 10.1016/j.biocon.2013.06.020; Helberg N, 2012, CAN J PLANT SCI, V92, P981, DOI [10.4141/CJPS2012-035, 10.4141/cjps2012-035]; Henle K, 2008, AGR ECOSYST ENVIRON, V124, P60, DOI 10.1016/j.agee.2007.09.005; Henle K, 2013, ECOL INDIC, V33, P5, DOI 10.1016/j.ecolind.2013.03.028; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; IEEP, 2012, BACKGR STUD BIOD PRO; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Kleijn D, 2011, TRENDS ECOL EVOL, V26, P474, DOI 10.1016/j.tree.2011.05.009; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Konvicka M, 2008, J INSECT CONSERV, V12, P519, DOI 10.1007/s10841-007-9092-7; MCCULLAGH P, 1989, GENERAL LINEAR MODEL; Merckx T, 2009, AGR ECOSYST ENVIRON, V130, P177, DOI 10.1016/j.agee.2009.01.006; Mikulcak F, 2013, ENVIRON CONSERV, V40, P129, DOI 10.1017/S0376892912000392; Oppermann R., 2012, COMMON AGR POLICY 20; Pannekoek J., 2003, TRIM 3 MANUAL TRENDS; PARACCHINI ML, 2008, HIGH NAT VALUE FARML; Pe'er G, 2014, BIOL CONSERV, V170, P92, DOI 10.1016/j.biocon.2013.12.011; Pe'er G, 2011, DIVERS DISTRIB, V17, P1186, DOI 10.1111/j.1472-4642.2011.00795.x; POLAKOVA J, 2011, REP DF AGR RURAL DEV; Pywell RF, 2012, BIOL LETTERS, V8, P772, DOI 10.1098/rsbl.2012.0367; RIBBE L, 2011, EINE OKOL ERSTE EINE; Rutz C., 2013, SOCIOL RURAL; *SOC CONS BIOL EUR, 2013, EVID GRASSL MAPP MEM; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sutherland LA, 2012, LAND USE POLICY, V29, P502, DOI 10.1016/j.landusepol.2011.09.003; Sutherland LA, 2010, LAND USE POLICY, V27, P415, DOI 10.1016/j.landusepol.2009.06.003; *TEEB, 2010, EC EC BIOD EC EC FOU; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tscharntke T, 2011, AGR ECOSYST ENVIRON, V143, P37, DOI 10.1016/j.agee.2010.11.025; TUCK SL, 2014, J APPL ECOL; Tzanopoulos J, 2013, GLOBAL ENVIRON CHANG, V23, P167, DOI 10.1016/j.gloenvcha.2012.09.002; *UBA, 2014, OKOL VORR UNVERZ BIO; Van Herzele A, 2013, J ENVIRON MANAGE, V131, P110, DOI 10.1016/j.jenvman.2013.09.030; Van Strien AJ, 2001, BIRD STUDY, V48, P200, DOI 10.1080/00063650109461219; Vickery J., 2012, BIRDS HABITAT RELATI, P177, DOI DOI 10.1017/CBO9781139021654.009; Winqvist C, 2011, J APPL ECOL, V48, P570, DOI 10.1111/j.1365-2664.2010.01950.x; World Resources Institute, 2005, ECOS HUM WELL BEING	78	399	418	7	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1090	1092		10.1126/science.1253425	http://dx.doi.org/10.1126/science.1253425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904142				2022-12-24	WOS:000336791200023
J	Fernandez, IS; Bai, XC; Murshudov, G; Scheres, SHW; Ramakrishnan, V				Fernandez, Israel S.; Bai, Xiao-Chen; Murshudov, Garib; Scheres, Sjors H. W.; Ramakrishnan, V.			Initiation of Translation by Cricket Paralysis Virus IRES Requires Its Translocation in the Ribosome	CELL			English	Article							EM STRUCTURE DETERMINATION; TRANSFER-RNA DYNAMICS; ENTRY SITE; CRYO-EM; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; TERTIARY STRUCTURE; MESSENGER-RNA; DENSITY MAPS; HYBRID-STATE	The cricket paralysis virus internal ribosome entry site (CrPV-IRES) is a folded structure in a viral mRNA that allows initiation of translation in the absence of any host initiation factors. By using recent advances in single-particle electron cryomicroscopy, we have solved the structure of CrPV-IRES bound to the ribosome of the yeast Kluyveromyces lactis in both the canonical and rotated states at overall resolutions of 3.7 and 3.8 A, respectively. In both states, the pseudoknot PKI of the CrPV-IRES mimics a tRNA/mRNA interaction in the decoding center of the A site of the 40S ribosomal subunit. The structure and accompanying factor-binding data show that CrPV-IRES binding mimics a pretranslocation rather than initiation state of the ribosome. Translocation of the IRES by elongation factor 2 (eEF2) is required to bring the first codon of the mRNA into the A site and to allow the start of translation.	[Fernandez, Israel S.; Bai, Xiao-Chen; Murshudov, Garib; Scheres, Sjors H. W.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Bai, Xiao-chen/HGV-1244-2022; Scheres, Sjors H.W./AAY-2265-2021	Bai, Xiao-chen/0000-0002-4234-5686; Scheres, Sjors H.W./0000-0002-0462-6540; Fernandez, Israel/0000-0001-7218-1603; Ramakrishnan, V/0000-0002-4699-2194	EU FP7 Marie Curie postdoctoral fellowship; UK Medical Research Council [MC_U105184332, MC_UP_A025_1013]; Wellcome Trust Senior Investigator award [WT096570]; Agouron Institute; Jeantet Foundation; MRC [MC_U105184332, MC_UP_A025_1013, MC_UP_A025_1012] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1012, MC_UP_A025_1013, MC_U105184332] Funding Source: researchfish	EU FP7 Marie Curie postdoctoral fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Senior Investigator award(Wellcome Trust); Agouron Institute(Pfizer); Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Shaoxia Chen for technical support with cryo-EM, Greg McMullan for help in movie data acquisition, Toby Darling and Jake Grimmett for help with computing, David Tourigny and Alan Brown for discussions, Ann C. Kelley for advice and help in RNA production, and Wojciech Galej and Andrew Newman for advice in yeast protein expression. X.-C. B. is supported by an EU FP7 Marie Curie postdoctoral fellowship. This work was funded by grants from the UK Medical Research Council (MC_U105184332 to V. R. and MC_UP_A025_1013 to SHWS) and a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation (V.R.).	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Costantino DA, 2008, NAT STRUCT MOL BIOL, V15, P57, DOI 10.1038/nsmb1351; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nixon PL, 2000, J MOL BIOL, V296, P659, DOI 10.1006/jmbi.1999.3464; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rodicio R, 2013, YEAST, V30, P165, DOI 10.1002/yea.2954; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Yamamoto H, 2007, J BIOL CHEM, V282, P7770, DOI 10.1074/jbc.M610887200	46	141	143	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					823	831		10.1016/j.cell.2014.04.015	http://dx.doi.org/10.1016/j.cell.2014.04.015			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24792965	Green Published, hybrid			2022-12-24	WOS:000335765500011
J	Price, TD; Hooper, DM; Buchanan, CD; Johansson, US; Tietze, DT; Alstrom, P; Olsson, U; Ghosh-Harihar, M; Ishtiaq, F; Gupta, SK; Martens, J; Harr, B; Singh, P; Mohan, D				Price, Trevor D.; Hooper, Daniel M.; Buchanan, Caitlyn D.; Johansson, Ulf S.; Tietze, D. Thomas; Alstroem, Per; Olsson, Urban; Ghosh-Harihar, Mousumi; Ishtiaq, Farah; Gupta, Sandeep K.; Martens, Jochen; Harr, Bettina; Singh, Pratap; Mohan, Dhananjai			Niche filling slows the diversification of Himalayan songbirds	NATURE			English	Article							SPECIES RICHNESS; ECOLOGICAL OPPORTUNITY; RANGE LIMITS; DIVERSITY; EVOLUTION; SPECIATION; BIRDS; PATTERNS; RADIATION; GRADIENT	Speciation generally involves a three-step process-range expansion, range fragmentation and the development of reproductive isolation between spatially separated populations(1,2). Speciation relies on cycling through these three steps and each may limit the rate at which new species form(1,3). We estimate phylogenetic relationships among all Himalayan songbirds to ask whether the development of reproductive isolation and ecological competition, both factors that limit range expansions(4), set an ultimate limit on speciation. Based on a phylogeny for all 358 species distributed along the eastern elevational gradient, here we show that body size and shape differences evolved early in the radiation, with the elevational band occupied by a species evolving later. These results are consistent with competition for niche space limiting species accumulation(5). Even the elevation dimension seems to be approaching ecological saturation, because the closest relatives both inside the assemblage and elsewhere in the Himalayas are on average separated by more than five million years, which is longer than it generally takes for reproductive isolation to be completed(2,3,6); also, elevational distributions are well explained by resource availability, notably the abundance of arthropods, and not by differences in diversification rates in different elevational zones. Our results imply that speciation rate is ultimately set by niche filling(that is, ecological competition for resources), rather than by the rate of acquisition of reproductive isolation.	[Price, Trevor D.; Hooper, Daniel M.; Buchanan, Caitlyn D.; Johansson, Ulf S.; Tietze, D. Thomas] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Johansson, Ulf S.] Swedish Museum Nat Hist, Dept Zool, S-10405 Stockholm, Sweden; [Tietze, D. Thomas] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; [Alstroem, Per] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China; [Alstroem, Per] Swedish Univ Agr Sci, Swedish Species Informat Ctr, S-75007 Uppsala, Sweden; [Olsson, Urban] Univ Gothenburg, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden; [Ghosh-Harihar, Mousumi; Ishtiaq, Farah; Gupta, Sandeep K.; Singh, Pratap; Mohan, Dhananjai] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Martens, Jochen] Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; [Harr, Bettina] Max Planck Inst Evolutionary Biol, D-24306 Plon, Germany	University of Chicago; Swedish Museum of Natural History; Ruprecht Karls University Heidelberg; Chinese Academy of Sciences; Institute of Zoology, CAS; Swedish University of Agricultural Sciences; University of Gothenburg; Wildlife Institute of India; Johannes Gutenberg University of Mainz; Max Planck Society	Price, TD (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	pricet@uchicago.edu	Ghosh-Harihar, Mousumi/AGJ-8900-2022; Tietze, Dieter Thomas/A-1366-2011; GUPTA, SANDEEP KUMAR/AAD-9882-2021; Tietze, Dieter Thomas/AAG-4714-2021; Alström, Per/C-1619-2015	Tietze, Dieter Thomas/0000-0001-6868-227X; GUPTA, SANDEEP KUMAR/0000-0001-6295-0210; Tietze, Dieter Thomas/0000-0001-6868-227X; Alström, Per/0000-0001-7182-2763; Johansson, Ulf/0000-0002-2544-8528; Ishtiaq, Farah/0000-0002-6762-7014	US NSF; National Geographic Society; Jornvall Foundation, a Chinese Academy of Sciences Visiting Professorship; Swedish Research Council; Wenner-Gren Foundation; Feldbausch Foundation of Mainz University; German DFG [Ti679/1-1]	US NSF(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Jornvall Foundation, a Chinese Academy of Sciences Visiting Professorship; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundation; Feldbausch Foundation of Mainz University; German DFG(German Research Foundation (DFG))	We thank the government of India and the Chief Wildlife Wardens of the six Indian Himalayan states for permits. We also thank S. Dalvi, K. Jamdar, N. Jamdar, E. Scordato and D. Wheatcroft for help in the field, U. Borthakur and V. Mathur in the laboratory and E. Goldberg, R. Hudson, J. Kennedy, M. McPeek, A. Phillimore, D. Schluter, T. Tyrberg and J. Weir for advice. Tissue and toe pads for this project were provided by J. Cracraft (American Museum of Natural History), N. Rice (Academy of Natural Sciences, Philadelphia), M. Adams (The Natural History Museum, Tring), J. Dumbacher and M. Flannery (California Academy of Sciences), J. Bates and D. Willard (Field Museum of Natural History, Chicago), Herman Mays (Cincinnatti Museum); M. Wink (Institut fur Pharmazie und Molekulare Biotechnologie, Heidelberg); R. Brumfeld and D. Dittmann (Lousiana State Museum of Zoology); S. Edwards (Museum of Natural History, Harvard); G. Frisk (Swedish Museum of Natural History, Stockholm); J. Dean and J. Rappole (National Museum of Natural History Smithsonian); S. Birks (Burke Museum, University of Washington); the Zoologisches Forschungmuseum Alexander Koenig, Bonn; J. Bolding Kristensen and J. Fjeldsa (Zoological Museum, Copenhagen); the Zoologische Staatssammlung Munchen, Munich; and K. Zyskowski (Yale University). This work was supported in part by grants from the US NSF and the National Geographic Society (TDP), the Jornvall Foundation, a Chinese Academy of Sciences Visiting Professorship (to P. A.), the Swedish Research Council (grants to U.O. and P. A.), the Wenner-Gren Foundation (a grant to U. S. J.), the Feldbausch Foundation of Mainz University (a grant to J. M.) and the German DFG (grants to B. H. and D. T. T., grant number Ti679/1-1). We thank D. Tautz for making laboratory facilities available in Germany.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Badgley C, 2008, P NATL ACAD SCI USA, V105, P12145, DOI 10.1073/pnas.0805592105; Beaulieu JM, 2012, EVOLUTION, V66, P2369, DOI 10.1111/j.1558-5646.2012.01619.x; Bivand RS, 2008, USE R, P1; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Colwell RK, 2005, AM NAT, V166, pE149, DOI 10.1086/491689; Cornell HV, 2013, BIOL REV, V88, P140, DOI 10.1111/j.1469-185X.2012.00245.x; Coyne JA, 2000, EVOLUTION, V54, P2166; Dong F, 2010, MOL PHYLOGENET EVOL, V57, P1268, DOI 10.1016/j.ympev.2010.09.023; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endler J.A., 1977, Monographs in Population Biology, pi; Etienne RS, 2012, SYST BIOL, V61, P204, DOI 10.1093/sysbio/syr091; Ghosh-Harihar M, 2014, J ANIM ECOL, V83, P628, DOI 10.1111/1365-2656.12157; Ghosh-Harihar M, 2013, ECOL RES, V28, P125, DOI 10.1007/s11284-012-1000-2; GILL FB, 1971, AUK, V88, P35, DOI 10.2307/4083960; Goldberg EE, 2006, EVOLUTION, V60, P1344, DOI 10.1111/j.0014-3820.2006.tb01214.x; Grant P. R., 2008, WHY SPECIES MULTIPLY; Gross SJ, 2000, J BIOGEOGR, V27, P869, DOI 10.1046/j.1365-2699.2000.00440.x; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Grytnes JA, 2008, BASIC APPL ECOL, V9, P373, DOI 10.1016/j.baae.2007.05.001; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; Harvey PH, 2000, PHILOS T ROY SOC B, V355, P1599, DOI 10.1098/rstb.2000.0721; Hawkins BA, 2005, AM NAT, V166, pE140, DOI 10.1086/491686; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Helmus MR, 2012, ECOLOGY, V93, pS31, DOI 10.1890/11-0435.1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2011, RASTER GEOGRAPHIC AN; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Johansson US, 2007, EVOLUTION, V61, P324, DOI 10.1111/j.1558-5646.2007.00024.x; Jonsson KA, 2011, P NATL ACAD SCI USA, V108, P2328, DOI 10.1073/pnas.1018956108; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kennedy JD, 2012, EVOLUTION, V66, P2599, DOI 10.1111/j.1558-5646.2012.01618.x; Kraatz BP, 2010, GEOLOGY, V38, P111, DOI 10.1130/G30619.1; Laliberte E., 2011, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Mayr E., 2001, BIRDS NO MELANESIA S; Mayr G, 2013, SYST BIODIVERS, V11, P7, DOI 10.1080/14772000.2013.765521; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Packert M, 2012, J BIOGEOGR, V39, P556, DOI 10.1111/j.1365-2699.2011.02606.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pebesma E.J., 2005, R NEWS, V5, P9; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Phillimore Albert B., 2009, P240; Price T, 1997, PHILOS T ROY SOC B, V352, P519, DOI 10.1098/rstb.1997.0036; Price T, 2008, SPECIATION BIRDS; Price TD, 2002, EVOLUTION, V56, P2083; Price Trevor, 2003, Journal of the Bombay Natural History Society, V100, P394; Price TD, 2011, AM NAT, V178, pS97, DOI 10.1086/661926; Price TD, 2010, PHILOS T R SOC B, V365, P1749, DOI 10.1098/rstb.2009.0269; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2013, ANNU REV ECOL EVOL S, V44, P481, DOI 10.1146/annurev-ecolsys-110512-135800; Rabosky DL, 2013, P NATL ACAD SCI USA, V110, P15354, DOI 10.1073/pnas.1305529110; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rambaut A., 2007, TRACER V1 4; Rasmussen PC., 2005, BIRDS S ASIA RIPLEY; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2004, NATURE, V430, P338, DOI 10.1038/nature02700; Ricklefs RE, 2012, P NATL ACAD SCI USA, V109, P14482, DOI 10.1073/pnas.1212079109; Rosenzweig Michael L., 1993, P52; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schnute J. T., 2004, CAN TECH REP FISH AQ, V2549, P126; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; TERBORGH JW, 1980, AM NAT, V116, P178, DOI 10.1086/283621; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2006, EVOLUTION, V60, P842; Weir JT, 2011, AM NAT, V177, P462, DOI 10.1086/658910; White EP, 2010, AM NAT, V175, pE35, DOI 10.1086/649578; Wiens JJ, 2007, P ROY SOC B-BIOL SCI, V274, P919, DOI 10.1098/rspb.2006.0301; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zapata FA, 2005, AM NAT, V166, pE144, DOI 10.1086/491685	93	253	264	8	280	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					222	+		10.1038/nature13272	http://dx.doi.org/10.1038/nature13272			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24776798				2022-12-24	WOS:000335454300038
J	Jae, LT; Raaben, M; Herbert, AS; Kuehne, AI; Wirchnianski, AS; Soh, TK; Stubbs, SH; Janssen, H; Damme, M; Saftig, P; Whelan, SP; Dye, JM; Brummelkamp, TR				Jae, Lucas T.; Raaben, Matthijs; Herbert, Andrew S.; Kuehne, Ana I.; Wirchnianski, Ariel S.; Soh, Timothy K.; Stubbs, Sarah H.; Janssen, Hans; Damme, Markus; Saftig, Paul; Whelan, Sean P.; Dye, John M.; Brummelkamp, Thijn R.			Lassa virus entry requires a trigger-induced receptor switch	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ALPHA-DYSTROGLYCAN; HUMAN AIRWAY; MEMBRANE; BINDING; SPECIFICITY; INHIBITORS; COMPLEX; FEVER; CELLS	Lassa virus spreads from a rodent to humans and can lead to lethal hemorrhagic fever. Despite its broad tropism, chicken cells were reported 30 years ago to resist infection. We found that Lassa virus readily engaged its cell-surface receptor a-dystroglycan in avian cells, but virus entry in susceptible species involved a pH-dependent switch to an intracellular receptor, the lysosome-resident protein LAMP1. Iterative haploid screens revealed that the sialyltransferase ST3GAL4 was required for the interaction of the virus glycoprotein with LAMP1. A single glycosylated residue in LAMP1, present in susceptible species but absent in birds, was essential for interaction with the Lassa virus envelope protein and subsequent infection. The resistance of Lamp1-deficient mice to Lassa virus highlights the relevance of this receptor switch in vivo.	[Jae, Lucas T.; Raaben, Matthijs; Janssen, Hans; Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Raaben, Matthijs; Soh, Timothy K.; Stubbs, Sarah H.; Whelan, Sean P.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Herbert, Andrew S.; Kuehne, Ana I.; Wirchnianski, Ariel S.; Dye, John M.] US Army, Med Res Inst Infect Dis, Frederick, MD 21702 USA; [Damme, Markus; Saftig, Paul] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany; [Brummelkamp, Thijn R.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Brummelkamp, Thijn R.] Cancer Genom Ctr CGC Nl, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Harvard University; Harvard Medical School; University of Kiel; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Brummelkamp, TR (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	sean_whelan@hms.harvard.edu; john.m.dye1.civ@mail.mil; t.brummelkamp@nki.nl	Jae, Lucas/AAY-3438-2021; Saftig, Paul/A-7966-2010; Jae, Lucas/AAH-5342-2020	Jae, Lucas/0000-0002-3531-1760; Dye, John/0000-0002-0883-5016; Stubbs, Sarah Hulsey/0000-0002-3261-191X; Whelan, Sean/0000-0003-1564-8590; Raaben, Matthijs/0000-0001-5989-289X	CGC.nl; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant [91711316]; European Research Council (ERC) Starting Grant [ERC-2012-StG 309634]; Deutsche Forschungsgemeinschaft [DFG SPP1580, GRK1459]; NIH [AI081842, AI109740]; Defense Threat Reduction Agency [CB3947]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109740, T32AI007245, R56AI081842, R01AI081842] Funding Source: NIH RePORTER	CGC.nl; Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant; European Research Council (ERC) Starting Grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Sixma, A. Perrakis, E. von Castelmur, D. Lefeber, and members of the Brummelkamp group for discussion; M. Rusch for mouse breeding; S. Kunz for a plasmid encoding Lassa-GP; E. Ollmann-Saphire for an Fc-fusion vector; R. Schoepp for GP1 antibodies; and M. Verheije for DF1 cells. This work was supported by CGC.nl, Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant 91711316, and European Research Council (ERC) Starting Grant (ERC-2012-StG 309634) to T. R. B.; Deutsche Forschungsgemeinschaft (DFG SPP1580 and GRK1459) to P. S.; and NIH grants AI081842 and AI109740 to S. P. W. J.M.D was supported by the Defense Threat Reduction Agency (CB3947). The HAP1 cells that were used are distributed under a materials transfer agreement. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U.S. Army. T. R. B. is a cofounder and shareholder of Haplogen GmbH, a company involved in haploid genetics. Sequencing data are accessible at www.ncbi.nlm.nih.gov/sra (accession SRP041566).	Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; Cosset FL, 2009, J VIROL, V83, P3228, DOI 10.1128/JVI.01711-08; de Graaf M, 2014, EMBO J, V33, P823, DOI 10.1002/embj.201387442; DISIMONE C, 1995, VIROLOGY, V209, P3, DOI 10.1006/viro.1995.1225; Haas WH, 2003, CLIN INFECT DIS, V36, P1254, DOI 10.1086/374853; HEFFERNAN M, 1989, CANCER RES, V49, P6077; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Lozach PY, 2011, CURR OPIN VIROL, V1, P35, DOI 10.1016/j.coviro.2011.05.004; LUKASHEVICH IS, 1983, ACTA VIROL, V27, P282; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nunberg JH, 2012, VIRUSES-BASEL, V4, P83, DOI 10.3390/v4010083; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Saito F, 2005, FEBS LETT, V579, P2359, DOI 10.1016/j.febslet.2005.03.033; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; WANG WC, 1988, J BIOL CHEM, V263, P4576; York J, 2008, J VIROL, V82, P10932, DOI 10.1128/JVI.01140-08; Zhu WY, 2011, BIOMED ENVIRON SCI, V24, P81, DOI 10.3967/0895-3988.2011.01.011	23	170	176	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1506	1510		10.1126/science.1252480	http://dx.doi.org/10.1126/science.1252480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970085	Green Accepted			2022-12-24	WOS:000337889900048
J	Larson, MH; Mooney, RA; Peters, JM; Windgassen, T; Nayak, D; Gross, CA; Block, SM; Greenleaf, WJ; Landick, R; Weissman, JS				Larson, Matthew H.; Mooney, Rachel A.; Peters, Jason M.; Windgassen, Tricia; Nayak, Dhananjaya; Gross, Carol A.; Block, Steven M.; Greenleaf, William J.; Landick, Robert; Weissman, Jonathan S.			A pause sequence enriched at translation start sites drives transcription dynamics in vivo	SCIENCE			English	Article							BACTERIAL RNA-POLYMERASE; STRUCTURAL BASIS; ELONGATION; MECHANISM; TERMINATION	Transcription by RNA polymerase (RNAP) is interrupted by pauses that play diverse regulatory roles. Although individual pauses have been studied in vitro, the determinants of pauses in vivo and their distribution throughout the bacterial genome remain unknown. Using nascent transcript sequencing, we identified a 16-nucleotide consensus pause sequence in Escherichia coli that accounts for known regulatory pause sites as well as similar to 20,000 new in vivo pause sites. In vitro single-molecule and ensemble analyses demonstrate that these pauses result from RNAP-nucleic acid interactions that inhibit next-nucleotide addition. The consensus sequence also leads to pausing by RNAPs from diverse lineages and is enriched at translation start sites in both E. coli and Bacillus subtilis. Our results thus reveal a conserved mechanism unifying known and newly identified pause events.	[Larson, Matthew H.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Calif Inst Quantitat Biosci, Ctr RNA Syst Biol,Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Mooney, Rachel A.; Windgassen, Tricia; Nayak, Dhananjaya; Landick, Robert] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Peters, Jason M.; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Block, Steven M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94025 USA; [Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94025 USA; [Greenleaf, William J.] Stanford Univ, Dept Genet, Stanford, CA 94025 USA; [Landick, Robert] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; Stanford University; Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Greenleaf, WJ (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94025 USA.	wjg@stanford.edu; landick@biochem.wisc.edu; weissman@cmp.ucsf.edu	Nayak, Dhananjaya/B-2802-2015; Larson, Matthew/C-8289-2014	Nayak, Dhananjaya/0000-0003-0529-9411; Larson, Matthew/0000-0002-6778-2604; Weissman, Jonathan/0000-0003-2445-670X; Windgassen, Tricia/0000-0003-0165-7525	Center for RNA Systems Biology; Howard Hughes Medical Institute; Ruth L. Kirschstein National Research Service Award; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100611, P50GM102706, R01GM102790, R37GM057035, F32GM108222] Funding Source: NIH RePORTER	Center for RNA Systems Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Brandman, V. Chu, D. Larson, G. Li, C. McLean, and E. Simmons for critical reading of the manuscript and J. Lund and E. Chow for assistance with sequencing. This research was supported by the Center for RNA Systems Biology (J.S.W.), the Howard Hughes Medical Institute (J.S.W.), a Ruth L. Kirschstein National Research Service Award (M.H.L., J.M.P.), and grants from the NIH to C. A. G., S. M. B., W. J. G., and R. L. All data are deposited in Gene Expression Omnibus (accession number GSE56720). Jonathan Weissman and Stirling Churchman have submitted a patent on the NET-seq technology.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Greenleaf WJ, 2006, SCIENCE, V313, P801, DOI 10.1126/science.1130105; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; LANDICK R, 1987, P NATL ACAD SCI USA, V84, P1507, DOI 10.1073/pnas.84.6.1507; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Palangat M, 1998, MOL CELL, V1, P1033, DOI 10.1016/S1097-2765(00)80103-3; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Starmer J, 2006, PLOS COMPUT BIOL, V2, P454, DOI 10.1371/journal.pcbi.0020057; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020	19	193	193	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1042	1047		10.1126/science.1251871	http://dx.doi.org/10.1126/science.1251871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24789973	Green Accepted			2022-12-24	WOS:000336495800049
J	Pellissier, L; Leprieur, F; Parravicini, V; Cowman, PF; Kulbicki, M; Litsios, G; Olsen, SM; Wisz, MS; Bellwood, DR; Mouillot, D				Pellissier, Loic; Leprieur, Fabien; Parravicini, Valeriano; Cowman, Peter F.; Kulbicki, Michel; Litsios, Glenn; Olsen, Steffen M.; Wisz, Mary S.; Bellwood, David R.; Mouillot, David			Quaternary coral reef refugia preserved fish diversity	SCIENCE			English	Article							GLOBAL PATTERNS; ASSEMBLY RULES; BIODIVERSITY; HOTSPOTS; CRADLES; MUSEUMS; AREAS	The most prominent pattern in global marine biogeography is the biodiversity peak in the Indo-Australian Archipelago. Yet the processes that underpin this pattern are still actively debated. By reconstructing global marine paleoenvironments over the past 3 million years on the basis of sediment cores, we assessed the extent to which Quaternary climate fluctuations can explain global variation in current reef fish richness. Comparing global historical coral reef habitat availability with the present-day distribution of 6316 reef fish species, we find that distance from stable coral reef habitats during historical periods of habitat loss explains 62% of the variation in fish richness, outweighing present-day environmental factors. Our results highlight the importance of habitat persistence during periods of climate change for preserving marine biodiversity.	[Pellissier, Loic] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Pellissier, Loic; Wisz, Mary S.] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Leprieur, Fabien; Mouillot, David] UM1, UM2, Inst Francais Rech Exploitat Mer, IRD,CNRS,Lab Ecol Syst Marins Cotiers UMR 5119,Cc, Pl E Bataillon, FR-34095 Montpellier 5, France; [Parravicini, Valeriano; Kulbicki, Michel] IRD, UR CoReUs 227, LABEX Lab Excellence Corail, Lab Arago, FR-66651 Banyuls Sur Mer, France; [Parravicini, Valeriano] FRB, CESAB Ctr Synth & Anal Biodiversite, FR-13857 Aix En Provence 3, France; [Cowman, Peter F.] Australian Natl Univ, Res Sch Biol, Ctr Macroevolut & Macroecol, Canberra, ACT 0200, Australia; [Litsios, Glenn] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Litsios, Glenn] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Olsen, Steffen M.] Danish Meteorol Inst, Ctr Ocean & Ice, DK-2100 Copenhagen, Denmark; [Wisz, Mary S.] DHI Water & Environm, Dept Ecol & Environm, DK-2970 Horsholm, Denmark; [Bellwood, David R.; Mouillot, David] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bellwood, David R.; Mouillot, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	University of Fribourg; Aarhus University; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Australian National University; University of Lausanne; Swiss Institute of Bioinformatics; Danish Meteorological Institute DMI; James Cook University; James Cook University	Mouillot, D (corresponding author), UM1, UM2, Inst Francais Rech Exploitat Mer, IRD,CNRS,Lab Ecol Syst Marins Cotiers UMR 5119,Cc, Pl E Bataillon, FR-34095 Montpellier 5, France.	david.mouillot@univ-montp2.fr	Pellissier, Loïc/J-2563-2015; Cowman, Peter Francis/G-9998-2017; Parravicini, Valeriano/A-8539-2011; Pellissier, Loïc/AAG-1013-2020; Leprieur, Fabien/ABA-4433-2020	Pellissier, Loïc/0000-0002-2289-8259; Cowman, Peter Francis/0000-0001-5977-5327; Pellissier, Loïc/0000-0002-2289-8259; Parravicini, Valeriano/0000-0002-3408-1625; Kulbicki, Michel/0000-0003-1258-5061; Wisz, Mary S./0000-0002-5357-6367	Danish Council for Independent Research [12-126430]; Marie Curie [IOF-GA-2009-236316]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Marie Curie(European Commission)	This study was supported by grants from the Danish Council for Independent Research no. 12-126430 to L. P., Marie Curie IOF-GA-2009-236316 to D. M., FRB CESAB-General Approach to Species-Abundance Relationships in a context of global change, reef fish species as a model, and the Australian Research Council. We thank three anonymous reviewers for valuable comments on the manuscript. We thank J. P. Krajewski and S. Gingins for the fish images. Data are available in the supplementary materials.	Barber PH, 2005, MOL PHYLOGENET EVOL, V35, P235, DOI 10.1016/j.ympev.2004.10.004; Bellwood D. R., 2002, CORAL REEF FISHES DY, P5; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bonin MC, 2011, ECOLOGY, V92, P1503, DOI 10.1890/10-0627.1; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Kiessling W, 2012, P NATL ACAD SCI USA, V109, P21378, DOI 10.1073/pnas.1214037110; Kleypas JA, 1999, AM ZOOL, V39, P146; Kohn A. J., 1995, P 5 INT COR REEF C, V4, P139; Luiz OJ, 2013, P NATL ACAD SCI USA, V110, P16498, DOI 10.1073/pnas.1304074110; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; McManus J. W., 1985, P 5 INT COR REEF C T, P133; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Mora C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001682; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parravicini V, 2013, ECOGRAPHY, V36, P1254, DOI 10.1111/j.1600-0587.2013.00291.x; PAULAY G, 1990, PALEOBIOLOGY, V16, P415, DOI 10.1017/S0094837300010162; Potts D. C., 1985, PROC 5 INT CORAL REE, V4, P127; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Veron J.E.N., 2000, CORALS WORLD, V1-3	33	127	130	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1016	1019		10.1126/science.1249853	http://dx.doi.org/10.1126/science.1249853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876495	Green Submitted			2022-12-24	WOS:000336495800042
J	Wilhelm, BG; Mandad, S; Truckenbrodt, S; Krohnert, K; Schafer, C; Rammner, B; Koo, SJ; Classen, GA; Krauss, M; Haucke, V; Urlaub, H; Rizzoli, SO				Wilhelm, Benjamin G.; Mandad, Sunit; Truckenbrodt, Sven; Kroehnert, Katharina; Schaefer, Christina; Rammner, Burkhard; Koo, Seong Joo; Classen, Gala A.; Krauss, Michael; Haucke, Volker; Urlaub, Henning; Rizzoli, Silvio O.			Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins	SCIENCE			English	Article							NEUROTRANSMITTER RELEASE; SYNTAXIN CLUSTERS; MEMBRANE; FUSION; POOL; QUANTIFICATION; EXOCYTOSIS; SYNAPSES; ENDOCYTOSIS; SUFFICIENT	Synaptic vesicle recycling has long served as a model for the general mechanisms of cellular trafficking. We used an integrative approach, combining quantitative immunoblotting and mass spectrometry to determine protein numbers; electron microscopy to measure organelle numbers, sizes, and positions; and super-resolution fluorescence microscopy to localize the proteins. Using these data, we generated a three-dimensional model of an "average" synapse, displaying 300,000 proteins in atomic detail. The copy numbers of proteins involved in the same step of synaptic vesicle recycling correlated closely. In contrast, copy numbers varied over more than three orders of magnitude between steps, from about 150 copies for the endosomal fusion proteins to more than 20,000 for the exocytotic ones.	[Wilhelm, Benjamin G.; Truckenbrodt, Sven; Kroehnert, Katharina; Schaefer, Christina; Rammner, Burkhard; Rizzoli, Silvio O.] Univ Gottingen, European Neurosci Inst, Cluster Excellence Nanoscale Microscopy & Mol Phy, Med Ctr,Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany; [Wilhelm, Benjamin G.] Int Max Planck Res Sch Neurosci, D-37077 Gottingen, Germany; [Mandad, Sunit; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Truckenbrodt, Sven] Int Max Planck Res Sch Mol Biol, D-37077 Gottingen, Germany; [Koo, Seong Joo; Classen, Gala A.; Krauss, Michael; Haucke, Volker] Leibniz Inst Mol Pharmacol, Dept Mol Pharmacol & Cell Biol, D-13125 Berlin, Germany	University of Gottingen; Max Planck Society; Max Planck Society; University of Gottingen; Max Planck Society; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Rizzoli, SO (corresponding author), Univ Gottingen, European Neurosci Inst, Cluster Excellence Nanoscale Microscopy & Mol Phy, Med Ctr,Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany.	srizzol@gwdg.de	889, CRC/L-1607-2018; Rizzoli, Silvio/ABG-2227-2020	889, CRC/0000-0002-6678-3138; Krauss, Michael/0000-0003-1010-9723; Rizzoli, Silvio/0000-0002-1667-7839; Haucke, Volker/0000-0003-3119-6993; Truckenbrodt, Sven/0000-0002-7741-3837	Boehringer Ingelheim Fonds PhD Fellowship; Excellence Stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); European Research Council (FP7 NANOMAP and ERC-CoG NeuroMolAnatomy); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain; DFG [RI 1967 2/1, RI 1967 3/1, SFB 889/A5, Exc-257-Neurocure, SFB 958/A01, SFB 889, SFB 958/A11]	Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Excellence Stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); European Research Council (FP7 NANOMAP and ERC-CoG NeuroMolAnatomy); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank the following collaborators for providing purified proteins and antibodies: R. Jahn, C. Griesinger, B. Shwaller, and A. Roux. We thank H. Martens for technical help and support, B. Rizzoli for helpful comments on the manuscript, and T. Sargeant for providing the carve source code for creation of the voltage-dependent anion channel (VDAC)-based mitochondrial membrane cut-outs. B. G. W. was supported by a Boehringer Ingelheim Fonds PhD Fellowship. S. T. was supported by an Excellence Stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB). The work was supported by grants to S.O.R. from the European Research Council (FP7 NANOMAP and ERC-2013-CoG NeuroMolAnatomy) and from the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain, as well as from DFG grants RI 1967 2/1, RI 1967 3/1, and SFB 889/A5. We acknowledge support by the DFG to V. H. (Exc-257-Neurocure and SFB 958/A01), H. U. (SFB 889), and M. K. (SFB 958/A11). Author contributions: B. G. W. prepared the synaptosomes and performed all immunoblotting experiments. K. K. performed the electron microscopy imaging and all neuromuscular junction imaging. C. S. performed the hippocampal culture imaging. S. T. performed the synaptosome imaging. B. R. generated the synapse model. S.J.K., G. A. C., and M. K. participated in the biochemistry experiments. S. M. and H. U. designed and performed all mass spectrometry experiments. S.O.R., B. G. W., and V. H. designed the experiments. All authors analyzed the data and contributed to writing the manuscript.	Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Bonanomi D, 2006, PROG NEUROBIOL, V80, P177, DOI 10.1016/j.pneurobio.2006.09.002; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Darna M, 2009, J BIOL CHEM, V284, P4300, DOI 10.1074/jbc.M805480200; Denker A, 2011, P NATL ACAD SCI USA, V108, P17183, DOI 10.1073/pnas.1112690108; Denker A, 2011, P NATL ACAD SCI USA, V108, P17177, DOI 10.1073/pnas.1112688108; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; Opazo F, 2010, TRAFFIC, V11, P800, DOI 10.1111/j.1600-0854.2010.01058.x; Rizzoli SO, 2006, TRAFFIC, V7, P1163, DOI 10.1111/j.1600-0854.2006.00466.x; Rizzoli SO, 2014, EMBO J, V33, P788, DOI 10.1002/embj.201386357; Rose T, 2013, NEURON, V77, P1109, DOI 10.1016/j.neuron.2013.01.021; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Shupliakov O, 2009, NEUROSCIENCE, V158, P204, DOI 10.1016/j.neuroscience.2008.03.035; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592	34	432	438	5	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1023	1028		10.1126/science.1252884	http://dx.doi.org/10.1126/science.1252884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876496				2022-12-24	WOS:000336495800044
J	Kim, JS; Greene, MJ; Zlateski, A; Lee, K; Richardson, M; Turaga, SC; Purcaro, M; Balkam, M; Robinson, A; Behabadi, BF; Campos, M; Denk, W; Seung, HS				Kim, Jinseop S.; Greene, Matthew J.; Zlateski, Aleksandar; Lee, Kisuk; Richardson, Mark; Turaga, Srinivas C.; Purcaro, Michael; Balkam, Matthew; Robinson, Amy; Behabadi, Bardia F.; Campos, Michael; Denk, Winfried; Seung, H. Sebastian		EyeWirers	Space-time wiring specificity supports direction selectivity in the retina	NATURE			English	Article							BIPOLAR CELLS; DENDRITES; MECHANISM; CIRCUIT; MODELS; MAP	How does the mammalian retina detect motion? This classic problem in visual neuroscience has remained unsolved for 50 years. In search of clues, here we reconstruct Off-type starburst amacrine cells (SACs) and bipolar cells (BCs) in serial electron microscopic images with help from EyeWire, an online community of 'citizen neuroscientists'. On the basis of quantitative analyses of contact area and branch depth in the retina, we find evidence that one BC type prefers to wire with a SAC dendrite near the SAC soma, whereas another BC type prefers to wire far from the soma. The near type is known to lag the far type in time of visual response. A mathematical model shows how such 'space-time wiring specificity' could endow SAC dendrites with receptive fields that are oriented in space-time and therefore respond selectively to stimuli that move in the outward direction from the soma.	[Kim, Jinseop S.; Greene, Matthew J.; Lee, Kisuk; Richardson, Mark; Turaga, Srinivas C.; Purcaro, Michael; Balkam, Matthew; Robinson, Amy; Seung, H. Sebastian] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Zlateski, Aleksandar] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Behabadi, Bardia F.; Campos, Michael] Qualcomm Res, San Diego, CA 92121 USA; [Denk, Winfried] Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Qualcomm; Max Planck Society	Seung, HS (corresponding author), Princeton Neurosci Inst, Princeton, NJ 08544 USA.	sseung@princeton.edu		Kim, Jinseop/0000-0001-7045-6140; Purcaro, Michael/0000-0002-4735-4215	Gatsby Charitable Foundation; Howard Hughes Medical Institute; Human Frontier Science Program; National Institutes of Health; Samsung Scholarship; AWS Research Grants Program gave EyeWire global reach through Amazon Cloudfront; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076467] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samsung Scholarship(Samsung); AWS Research Grants Program gave EyeWire global reach through Amazon Cloudfront; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was made possible by funding from the Gatsby Charitable Foundation, the Howard Hughes Medical Institute, the Human Frontier Science Program, an anonymous donor, and the National Institutes of Health. K. L. was supported by a Samsung Scholarship. Support from the AWS Research Grants Program gave EyeWire global reach through Amazon Cloudfront. We thank K. Briggman for providing the e2198 data set. J. Mutch created the CNS framework on which CNPKG is based. D. Jia, R. Shearer, and B. Warne assisted in early stages of software development, and W. Silversmith with recent modifications. R. Prentki, L. Trawinski, M. Sorek, A. Ostojic, C. David, R. Avery, S. Temple, A. Bost, M. Greenstein and M. Evans worked in the laboratory to reconstruct neurons, and the first six also served as GrimReaper and hosted EyeWire competitions. Additional reconstructions were provided by R. Han, M. Gavrin, G. Lu, A. Ortiz and D. Udvary. All were trained by R. Prentki, who also created training videos for EyeWirers. We are grateful to A. Norton for 3D renderings, and to E. Almeida for EyeWire graphics. We acknowledge discussions with T. Baden, M. Berry, B. Borghuis, A. Borst, E. J. Chichilnisky, D. Chklovskii, D. Clark, J. Demb, T. Euler, M. Helmstaedter, A. Huberman, S. Lee, R. Masland, J. Sanes and Z. Zhou.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Berry MJ, 1998, J NEUROSCI, V18, P2200; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borghuis BG, 2013, J NEUROSCI, V33, P10972, DOI 10.1523/JNEUROSCI.1241-13.2013; Borst A, 2003, VISION RES, V43, P1309, DOI 10.1016/S0042-6989(03)00092-0; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Ciresan D, 2012, NIPS, V2012, P2852; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Munch TA, 2006, J NEUROPHYSIOL, V96, P471, DOI 10.1152/jn.00628.2005; Mutch J, 2010, MITCSAILTR2010013CBC; Park SJH, 2014, J NEUROSCI, V34, P3976, DOI 10.1523/JNEUROSCI.5017-13.2014; Reichardt W, 1961, SENS COMMUN, P303; Snyder J.P, 1987, MAP PROJECTIONS WORK, V1395; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Surowiecki J., 2005, WISDOM CROWDS; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tukker JJ, 2004, VISUAL NEUROSCI, V21, P611, DOI 10.1017/S0952523804214109; Turaga S., 2009, ADV NEURAL INFORM PR, P1865; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Von Ahn Luis, 2004, P SIGCHI C HUM FACT, P319, DOI DOI 10.1145/985692.985733; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711	46	267	271	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					331	+		10.1038/nature13240	http://dx.doi.org/10.1038/nature13240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805243	Green Accepted			2022-12-24	WOS:000336121200032
J	Giorgetti, L; Galupa, R; Nora, EP; Piolot, T; Lam, F; Dekker, J; Tiana, G; Heard, E				Giorgetti, Luca; Galupa, Rafael; Nora, Elphege P.; Piolot, Tristan; Lam, France; Dekker, Job; Tiana, Guido; Heard, Edith			Predictive Polymer Modeling Reveals Coupled Fluctuations in Chromosome Conformation and Transcription	CELL			English	Article							GENE-EXPRESSION; CHROMATIN INTERACTIONS; NUCLEAR-ORGANIZATION; DROSOPHILA GENOME; INACTIVATION; ARCHITECTURE; DOMAINS; LOCUS; ACTIVATOR; PROTEIN	A new level of chromosome organization, topologically associating domains (TADs), was recently uncovered by chromosome conformation capture (3C) techniques. To explore TAD structure and function, we developed a polymer model that can extract the full repertoire of chromatin conformations within TADs from population-based 3C data. This model predicts actual physical distances and to what extent chromosomal contacts vary between cells. It also identifies interactions within single TADs that stabilize boundaries between TADs and allows us to identify and genetically validate key structural elements within TADs. Combining the model's predictions with high-resolution DNA FISH and quantitative RNA FISH for TADs within the X-inactivation center (Xic), we dissect the relationship between transcription and spatial proximity to cis-regulatory elements. We demonstrate that contacts between potential regulatory elements occur in the context of fluctuating structures rather than stable loops and propose that such fluctuations may contribute to asymmetric expression in the Xic during X inactivation.	[Giorgetti, Luca; Galupa, Rafael; Nora, Elphege P.; Piolot, Tristan; Lam, France; Heard, Edith] Inst Curie, F-75248 Paris 05, France; [Giorgetti, Luca; Galupa, Rafael; Piolot, Tristan; Lam, France; Heard, Edith] CNRS, UMR3215, F-75248 Paris 05, France; [Giorgetti, Luca; Galupa, Rafael; Piolot, Tristan; Lam, France; Heard, Edith] INSERM, U934, F-75248 Paris 05, France; [Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, Worcester, MA 01605 USA; [Tiana, Guido] Univ Milan, Dipartimento Fis, I-20133 Milan, Italy; [Tiana, Guido] Ist Nazl Fis Nucl, I-20133 Milan, Italy; [Heard, Edith] Coll France, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Massachusetts System; University of Massachusetts Worcester; University of Milan; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; PSL Research University Paris; College de France	Tiana, G (corresponding author), Univ Milan, Dipartimento Fis, Via Celoria 16, I-20133 Milan, Italy.	guido.tiana@unimi.it; edith.heard@curie.fr	Heard, Edith/D-7197-2017; Nora, Elphège/AAW-9646-2021; Tiana, Guido/E-2123-2015	Heard, Edith/0000-0001-8052-7117; Nora, Elphège/0000-0002-8347-4396; Tiana, Guido/0000-0001-9868-1809; Galupa, Rafael/0000-0001-7319-043X	EMBO Fellowship [ALTF 1559-2011]; Ligue Nationale contre le cancer; Fondation pour la Recherche Medical, Labex DEEP [ANR-11-LBX-0044]; EpiGeneSys FP7 257082 Network of Excellence; ERC Advanced Investigator award [250367]; EU [259743]; National Human Genome Research Institute [R01HG003143]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	EMBO Fellowship(European Molecular Biology Organization (EMBO)); Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medical, Labex DEEP; EpiGeneSys FP7 257082 Network of Excellence; ERC Advanced Investigator award; EU(European Commission); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all members of the Heard team for helpful discussions and Edda Schulz and John Sedat for critical reading of the manuscript. L.G. was supported by an EMBO Fellowship (ALTF 1559-2011); work in the lab of E.H. is supported by the ''Ligue Nationale contre le cancer,'' the Fondation pour la Recherche Medical, Labex DEEP (ANR-11-LBX-0044) part of the IDEX Idex PSL (ANR-10-IDEX-0001-02 PSL), the EpiGeneSys FP7 257082 Network of Excellence, ERC Advanced Investigator award 250367, and EU FP7 MODHEP EU grant 259743 (EH). Work in the lab of J.D. is supported by National Human Genome Research Institute (R01HG003143). Cell sorting was performed by S. Grondin in the flow cytometry platform of the Institut Curie.	Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Bau D, 2011, CHROMOSOME RES, V19, P25, DOI 10.1007/s10577-010-9167-2; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Hu Ming, 2013, Quant Biol, V1, P156; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Krijger PHL, 2013, CURR OPIN GENET DEV, V23, P191, DOI 10.1016/j.gde.2012.12.010; Masui O, 2011, CELL, V145, P447, DOI 10.1016/j.cell.2011.03.032; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Nora EP, 2013, BIOESSAYS, V35, P818, DOI 10.1002/bies.201300040; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Norgaard AB, 2008, BIOPHYS J, V94, P182, DOI 10.1529/biophysj.107.108241; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5	35	291	294	1	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					950	963		10.1016/j.cell.2014.03.025	http://dx.doi.org/10.1016/j.cell.2014.03.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813616	Green Accepted, Bronze			2022-12-24	WOS:000335765500021
J	Kvon, EZ; Kazmar, T; Stampfel, G; Yanez-Cuna, JO; Pagani, M; Schernhuber, K; Dickson, BJ; Stark, A				Kvon, Evgeny Z.; Kazmar, Tomas; Stampfel, Gerald; Yanez-Cuna, J. Omar; Pagani, Michaela; Schernhuber, Katharina; Dickson, Barry J.; Stark, Alexander			Genome-scale functional characterization of Drosophila developmental enhancers in vivo	NATURE			English	Article							GENE-EXPRESSION PATTERNS; SITU HYBRIDIZATION; TISSUE; ELEMENTS; SPECIFICITY; RESOURCE; DATABASE; PROTEIN; TOOLS	Transcriptional enhancers are crucial regulators of gene expression and animal development(1) and the characterization of their genomic organization, spatiotemporal activities and sequence properties is a key goal in modern biology(2-8). Here we characterize the in vivo activity of 7,705 Drosophila melanogaster enhancer candidates covering 13.5% of the non-coding non-repetitive genome throughout embryogenesis. 3,557 (46%) candidates are active, suggesting a high density with 50,000 to 100,000 developmental enhancers genome-wide. The vast majority of enhancers display specific spatial patterns that are highly dynamic during development. Most appear to regulate their neighbouring genes, suggesting that the cis-regulatory genome is organized locally into domains, which are supported by chromosomal domains, insulator binding and genome evolution. However, 12 to 21 per cent of enhancers appear to skip non-expressed neighbours and regulate a more distal gene. Finally, we computationally identify cis-regulatory motifs that are predictive and required for enhancer activity, as we validate experimentally. This work provides global insights into the organization of an animal regulatory genome and the make-up of enhancer sequences and confirms and generalizes principles from previous studies(1,9). All enhancer patterns are annotated manually with a controlled vocabulary and all results are available through a web interface (http://enhancers.starklab.org), including the raw images of all microscopy slides for manual inspection at arbitrary zoom levels.	[Kvon, Evgeny Z.; Kazmar, Tomas; Stampfel, Gerald; Yanez-Cuna, J. Omar; Pagani, Michaela; Schernhuber, Katharina; Dickson, Barry J.; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	stark@starklab.org	Dickson, Barry/AAE-7632-2019; Stark, Alexander/D-1473-2012	Dickson, Barry/0000-0003-0715-892X; Stark, Alexander/0000-0003-2611-0841; Kvon, Evgeny/0000-0002-1562-0945	European Research Council (ERC) from the European Community [242922]; Austrian Science Fund (FWF) [F4303-B09]; ERC; Boehringer Ingelheim GmbH	European Research Council (ERC) from the European Community(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ERC(European Research Council (ERC)European Commission); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank members of the Dickson laboratory VT project for cloning the candidate regions and generating transgenic flies and the VDRC (http://stockcenter.vdrc.at) for their maintenance and distribution. We are grateful to the IMP/IMBA Scientific Services, in particular BioOptics, Genomics, and IT for help and to C. H. Lampert (IST Austria) for advice. We thank M. Levine (UC Berkeley) and V. Hartenstein (UCLA) for their permission to reproduce figures. The Stark group is supported by a European Research Council (ERC) Starting Grant from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 242922 awarded to A.S. and by the Austrian Science Fund (FWF, F4303-B09). Generation of transgenic lines was supported in part by an ERC Advanced Investigator Grant to B.J.D. Basic research at the IMP is supported by Boehringer Ingelheim GmbH.	Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erives A, 2004, P NATL ACAD SCI USA, V101, P3851, DOI 10.1073/pnas.0400611101; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Frise E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.102; Gajewski K, 2001, DEV BIOL, V233, P425, DOI 10.1006/dbio.2001.0220; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Hartenstein V., 1993, ATLAS DROSOPHILA DEV; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; JACK J, 1991, DEVELOPMENT, V113, P735; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jory A, 2012, CELL REP, V2, P1014, DOI 10.1016/j.celrep.2012.09.010; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Lecuyer Eric, 2008, V420, P289, DOI 10.1007/978-1-59745-583-1_18; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Maeda RK, 2011, CURR OPIN GENET DEV, V21, P187, DOI 10.1016/j.gde.2011.01.021; Manning L, 2012, CELL REP, V2, P1002, DOI 10.1016/j.celrep.2012.09.009; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; The modENCODE Consortium, 2010, SCIENCE, V489, P57; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Weiszmann R, 2009, NAT PROTOC, V4, P605, DOI 10.1038/nprot.2009.55; Yanez-Cuna JO, 2013, TRENDS GENET, V29, P11, DOI 10.1016/j.tig.2012.09.007; Yanez-Cuna JO, 2012, GENOME RES, V22, P2018, DOI 10.1101/gr.132811.111; Zeitlinger J, 2010, DEV BIOL, V339, P230, DOI 10.1016/j.ydbio.2009.12.039; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	51	262	264	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					91	+		10.1038/nature13395	http://dx.doi.org/10.1038/nature13395			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	24896182				2022-12-24	WOS:000339908000038
J	Subramanian, S; Huq, S; Yatsunenko, T; Haque, R; Mahfuz, M; Alam, MA; Benezra, A; DeStefano, J; Meier, MF; Muegge, BD; Barratt, MJ; VanArendonk, LG; Zhang, QY; Province, MA; Petri, WA; Ahmed, T; Gordon, JI				Subramanian, Sathish; Huq, Sayeeda; Yatsunenko, Tanya; Haque, Rashidul; Mahfuz, Mustafa; Alam, Mohammed A.; Benezra, Amber; DeStefano, Joseph; Meier, Martin F.; Muegge, Brian D.; Barratt, Michael J.; VanArendonk, Laura G.; Zhang, Qunyuan; Province, Michael A.; Petri, William A., Jr.; Ahmed, Tahmeed; Gordon, Jeffrey I.			Persistent gut microbiota immaturity in malnourished Bangladeshi children	NATURE			English	Article							GROWTH; MALNUTRITION; AGE	Therapeutic food interventions have reduced mortality in children with severe acute malnutrition (SAM), but incomplete restoration of healthy growth remains a major problem(1,2). The relationships between the type of nutritional intervention, the gut microbiota, and therapeutic responses are unclear. In the current study, bacterial species whose proportional representation define a healthy gut microbiota as it assembles during the first two postnatal years were identified by applying amachine-learning-based approach to 16S ribosomal RNA data sets generated from monthly faecal samples obtained from birth onwards in a cohort of children living in an urban slum of Dhaka, Bangladesh, who exhibited consistently healthy growth. These age discriminatory bacterial species were incorporated into a model that computes a 'relative microbiota maturity index' and 'microbiotafor- age Z-score' that compare postnatal assembly (defined here as maturation) of a child's faecal microbiota relative to healthy children of similar chronologic age. The model was applied to twins and triplets (to test for associations of these indices with genetic and environmental factors, including diarrhoea), children with SAM enrolled in a randomized trial of two food interventions, and children with moderate acute malnutrition. Our results indicate that SAM is associated with significant relative microbiota immaturity that is only partially ameliorated following two widely used nutritional interventions. Immaturity is also evident in less severe forms of malnutrition and correlates with anthropometric measurements. Microbiota maturity indices provide a microbial measure of human postnatal development, a way of classifying malnourished states, and a parameter for judging therapeutic efficacy. More prolonged interventions with existing or new therapeutic foods and/or addition of gut microbes may be needed to achieve enduring repair of gut microbiota immaturity in childhood malnutrition and improve clinical outcomes.	[Subramanian, Sathish; Yatsunenko, Tanya; Benezra, Amber; DeStefano, Joseph; Meier, Martin F.; Muegge, Brian D.; Barratt, Michael J.; VanArendonk, Laura G.; Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Huq, Sayeeda; Haque, Rashidul; Mahfuz, Mustafa; Alam, Mohammed A.; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Ctr Nutr & Food Secur, Dhaka 1212, Bangladesh; [Benezra, Amber] New Sch Social Res, Dept Anthropol, New York, NY 10003 USA; [Zhang, Qunyuan; Province, Michael A.] Washington Univ, Div Stat Genom, St Louis, MO 63108 USA; [Petri, William A., Jr.] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA; [Petri, William A., Jr.] Univ Virginia, Sch Med, Dept Microbiol & Pathol, Charlottesville, VA 22908 USA	Washington University (WUSTL); International Centre for Diarrhoeal Disease Research (ICDDR); The New School; Washington University (WUSTL); University of Virginia; University of Virginia	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	alam, mohammed/GXH-3645-2022; Petri, William A./D-3639-2019; Petri, William/AAL-3642-2020; Alam, Ashraful/AAA-3893-2020; Benezra, Amber/ABU-7951-2022; Mahfuz, Mustafa/H-5923-2017	Petri, William/0000-0002-7268-1218; Alam, Ashraful/0000-0003-1389-8510; Benezra, Amber/0000-0002-7092-6808; Mahfuz, Mustafa/0000-0002-4090-785X; Muegge, Brian/0000-0002-0044-3704	Bill & Melinda Gates Foundation; International Atomic Energy Agency; NIH [AI043596]; SBE Doctoral Dissertation Research Improvement Grant (NSF) [SES-1027035]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); International Atomic Energy Agency(International Atomic Energy Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBE Doctoral Dissertation Research Improvement Grant (NSF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the parents and children from Dhaka, Bangladesh for their participation in this study, J. Hoisington-Lopez and S. Deng for technical assistance, and N. Griffin, A. Kau, N. Dey and J. Faith for suggestions during the course of this work. This work was supported by the Bill & Melinda Gates Foundation. The clinical component of the SAM study was funded by the International Atomic Energy Agency. The birth cohort study of singletons was supported in part by the NIH (AI043596). S. S. is a member of the Washington University Medical Scientist Training Program. A. B. is the recipient of an SBE Doctoral Dissertation Research Improvement Grant (NSF Award no. SES-1027035).	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Ahmed T., 2004, J PEDIAT GASTROENTER, V39, pS277; Ahmed Tahmeed, 2001, Indian Journal of Pediatrics, V68, P45, DOI 10.1007/BF02728857; Ashraf H, 2012, J TROP PEDIATRICS, V58, P253, DOI 10.1093/tropej/fmr083; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dewey KG, 2005, MATERN CHILD NUTR, V1, P11, DOI 10.1111/j.1740-8709.2004.00004.x; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Kuznetsova A., 2013, CHRISTENSEN RHB LMER; Lazzerini M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009584.pub2; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mondal D, 2012, CLIN INFECT DIS, V54, P185, DOI 10.1093/cid/cir807; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nahar B, 2012, EUR J CLIN NUTR, V66, P701, DOI 10.1038/ejcn.2012.13; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Pathela P, 2006, ACTA PAEDIATR, V95, P430, DOI 10.1080/08035250500444875; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; World Health Organization Department of Nutrition for Health and Development, 2009, WHO CHILD GROWTH STA; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	27	708	727	13	194	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					417	+		10.1038/nature13421	http://dx.doi.org/10.1038/nature13421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24896187	Green Accepted			2022-12-24	WOS:000337350200039
J	Franklin, RA; Liao, W; Sarkar, A; Kim, MV; Bivona, MR; Liu, K; Pamer, EG; Li, MO				Franklin, Ruth A.; Liao, Will; Sarkar, Abira; Kim, Myoungjoo V.; Bivona, Michael R.; Liu, Kang; Pamer, Eric G.; Li, Ming O.			The cellular and molecular origin of tumor-associated macrophages	SCIENCE			English	Article							DENDRITIC CELLS; SIGNALING CONTROLS; MAMMARY-TUMORS; MONOCYTES; DIFFERENTIATION; RECRUITMENT; HOMEOSTASIS; EXPRESSION; INFECTION; IMMUNITY	Long recognized as an evolutionarily ancient cell type involved in tissue homeostasis and immune defense against pathogens, macrophages are being rediscovered as regulators of several diseases, including cancer. Here we show that in mice, mammary tumor growth induces the accumulation of tumor-associated macrophages (TAMs) that are phenotypically and functionally distinct from mammary tissue macrophages (MTMs). TAMs express the adhesion molecule Vcam1 and proliferate upon their differentiation from inflammatory monocytes, but do not exhibit an "alternatively activated" phenotype. TAM terminal differentiation depends on the transcriptional regulator of Notch signaling, RBPJ; and TAM, but not MTM, depletion restores tumor-infiltrating cytotoxic T cell responses and suppresses tumor growth. These findings reveal the ontogeny of TAMs and a discrete tumor-elicited inflammatory response, which may provide new opportunities for cancer immunotherapy.	[Franklin, Ruth A.; Sarkar, Abira; Kim, Myoungjoo V.; Bivona, Michael R.; Pamer, Eric G.; Li, Ming O.] Mem Sloan Kettering Canc Ctr MSKCC, Immunol Program, New York, NY 10065 USA; [Franklin, Ruth A.; Kim, Myoungjoo V.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA; [Liao, Will] New York Genome Ctr, New York, NY 10022 USA; [Liu, Kang] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Columbia University	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr MSKCC, Immunol Program, New York, NY 10065 USA.	lim@mskcc.org	Franklin, Ruth/AFK-5723-2022; Franklin, Ruth/AAG-4161-2022	li, ming/0000-0002-1383-0535	Cancer Research Institute Tumor Immunology Predoctoral Fellowship Training Grant; NIH grant [AI101251]; Cancer Research Institute Clinic and Laboratory Integration Program Grant; American Cancer Society Research Scholar Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101251, R37AI039031] Funding Source: NIH RePORTER	Cancer Research Institute Tumor Immunology Predoctoral Fellowship Training Grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Clinic and Laboratory Integration Program Grant; American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Honjo for the Rbpj <SUP>fl/fl</SUP> mouse strain and B. Reizis for the CD11c<SUP>cre</SUP> mouse strain. We also thank J. Joyce and the M. Li lab for their insightful discussions. The data presented in this paper are tabulated in the manuscript and in the supplementary materials (Gene Expression Omnibus accession no. GSE56755). MSKCC has filed a provisional patent application with the U.S. Patent and Trademark Office (application no. 61/935,318). The application is directed toward methods and compositions for targeted cancer therapy and to identify potential responders to targeted therapy based on the presence of specific tumor-associated macrophages. R.A.F and M.O.L are listed as inventors on this patent application. This work was supported by the Cancer Research Institute Tumor Immunology Predoctoral Fellowship Training Grant (R.A.F), NIH grant AI101251 (K.L.), Cancer Research Institute Clinic and Laboratory Integration Program Grant (M.O.L.), and the American Cancer Society Research Scholar Award (M.O.L.).	Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Engelhardt JJ, 2012, CANCER CELL, V21, P402, DOI 10.1016/j.ccr.2012.01.008; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Wang HW, 2010, CELL CYCLE, V9, P4824, DOI 10.4161/cc.9.24.14322; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	30	809	841	15	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					921	925		10.1126/science.1252510	http://dx.doi.org/10.1126/science.1252510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24812208	Green Accepted			2022-12-24	WOS:000336233800053
J	Ben-Zvi, A; Lacoste, B; Kur, E; Andreone, BJ; Mayshar, Y; Yan, H; Gu, CH				Ben-Zvi, Ayal; Lacoste, Baptiste; Kur, Esther; Andreone, Benjamin J.; Mayshar, Yoav; Yan, Han; Gu, Chenghua			Mfsd2a is critical for the formation and function of the blood-brain barrier	NATURE			English	Article							CNS; INTEGRITY; RECEPTOR; DIFFERENTIATION; TRANSPORTER; MECHANISMS; EXPRESSION; PERICYTES; MOUSE	The central nervous system(CNS) requires a tightly controlled environment free of toxins and pathogens to provide the proper chemical composition for neural function. This environment is maintained by the 'blood-brain barrier' (BBB), which is composed of blood vessels whose endothelial cells display specialized tight junctions and extremely low rates of transcellular vesicular transport (transcytosis)(1-3). In concert with pericytes and astrocytes, this unique brain endothelial physiological barrier seals the CNS and controls substance influx and efflux(4-6). Although BBB breakdown has recently been associated with initiation and perpetuation of various neurological disorders, an intact BBB is a major obstacle for drug delivery to the CNS7-10. A limited understanding of the molecular mechanisms that control BBB formation has hindered our ability to manipulate the BBB in disease and therapy. Here we identify mechanisms governing the establishment of a functional BBB. First, using a novel tracer-injection method for embryos, we demonstrate spatiotemporal developmental profiles of BBB functionality and find that the mouse BBB becomes functional at embryonic day 15.5 (E15.5). We then screen for BBB-specific genes expressed during BBB formation, and find that major facilitator super family domain containing 2a (Mfsd2a) is selectively expressed in BBB-containing blood vessels in the CNS. Genetic ablation of Mfsd2a results in a leaky BBB from embryonic stages through to adulthood, but the normal patterning of vascular networks is maintained. Electron microscopy examination reveals a dramatic increase in CNS-endothelial-cell vesicular transcytosis in Mfsd2a(-/-) mice, without obvious tight-junction defects. Finally we show that Mfsd2a endothelial expression is regulated by pericytes to facilitate BBB integrity. These findings identify Mfsd2a as a key regulator of BBB function that may act by suppressing transcytosis in CNS endothelial cells. Furthermore, our findings may aid in efforts to develop therapeutic approaches for CNS drug delivery.	[Ben-Zvi, Ayal; Lacoste, Baptiste; Kur, Esther; Andreone, Benjamin J.; Yan, Han; Gu, Chenghua] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mayshar, Yoav] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gu, CH (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	chenghua_gu@hms.harvard.edu	Lacoste, Baptiste/J-9663-2016	Lacoste, Baptiste/0000-0002-1922-8801; Mayshar, Yoav/0000-0002-5553-2472	Neural Imaging Center as part of an NINDS P30 Core Center grant [NS072030]; Harold Perlman postdoctoral fellowships; Goldenson postdoctoral fellowship; Lefler postdoctoral fellowship; DFG-German Research Foundation postdoctoral fellowship; Mahoney postdoctoral fellowship; NIH training grant [5T32MH20017-15]; Sloan research fellowship; Armenise junior faculty award; Genise Goldenson fund; Freudenberger award; NIH [R01NS064583]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072030, R01NS064583] Funding Source: NIH RePORTER	Neural Imaging Center as part of an NINDS P30 Core Center grant; Harold Perlman postdoctoral fellowships; Goldenson postdoctoral fellowship; Lefler postdoctoral fellowship; DFG-German Research Foundation postdoctoral fellowship(German Research Foundation (DFG)); Mahoney postdoctoral fellowship; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan research fellowship(Alfred P. Sloan Foundation); Armenise junior faculty award; Genise Goldenson fund; Freudenberger award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Karnovsky, E. Raviola and T. Reese for advice and discussion; S. R. Datta, C. Weitz, M. Greenberg, Q. Ma, C. Harvey and members of the Gu laboratory for comments on the manuscript; D. Sabatini and J. Reeling for sharing unpublished data; C. Betsholtz and C. Olsson for providing Pdgfb<SUP>ret/ret</SUP> mouse brain samples; T. Schwarz and A. Oztan for discussion and advice on cell trafficking; W.-J. Oh for help with graphic illustrations; the Flow Cytometry Facility in the department of Systems Biology at Harvard Medical School for cell sorting; the Microarray Core at Dana-Farber Cancer Institute for Affymetrix assay; HSPH Bioinformatics Core, Harvard School of Public Health, for assistance with microarray analysis and Gene Expression Omnibus (GEO) submission; the Enhanced Neuroimaging Core at Harvard NeuroDiscovery Center for helping with confocal imaging and image analysis; the HMS Electron Microscopy Core Facility, the Neurobiology Imaging Facility for consultation and instrument availability that supported this work (this facility is supported in part by the Neural Imaging Center as part of an NINDS P30 Core Center grant no. NS072030); R. Polakiewicz and J. Xie from CST for generating Mfsd2a antibodies. This work was supported by the Harold Perlman postdoctoral fellowships, the Goldenson postdoctoral fellowship, and the Lefler postdoctoral fellowship (A.B.-Z.); the DFG-German Research Foundation postdoctoral fellowship (E. K.); the Mahoney postdoctoral fellowship (B. L.); NIH training grant 5T32MH20017-15 (B. J. A.); and the Sloan research fellowship, Armenise junior faculty award, the Genise Goldenson fund, the Freudenberger award, and NIH grant R01NS064583 (C.G.).	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BAUER H, 1995, DEV BRAIN RES, V86, P317, DOI 10.1016/0165-3806(95)00044-E; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Chen F., 2010, MOL CELL SPECIAL REV, V40; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Ek CJ, 2006, J COMP NEUROL, V496, P13, DOI 10.1002/cne.20885; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Nag S., 2003, BLOOD BRAIN BARRIE 2, P99; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108; RISAU W, 1986, DEV BIOL, V117, P537, DOI 10.1016/0012-1606(86)90321-0; Saunders NR, 2013, MOL ASPECTS MED, V34, P742, DOI 10.1016/j.mam.2012.11.006; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Siegenthaler JA, 2013, CURR OPIN NEUROBIOL, V23, P1057, DOI 10.1016/j.conb.2013.06.006; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Stern L, 1929, CR SOC BIOL, V100, P231; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Toufaily C, 2013, PLACENTA, V34, P85, DOI 10.1016/j.placenta.2012.10.012; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	31	528	549	10	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					507	+		10.1038/nature13324	http://dx.doi.org/10.1038/nature13324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828040	Green Accepted			2022-12-24	WOS:000336126000042
J	Li, J; Li, X; Wang, Q; Hu, S; Wang, YF; Masoudi, FA; Spertus, JA; Krumholz, HM; Jiang, LX				Li, Jing; Li, Xi; Wang, Qing; Hu, Shuang; Wang, Yongfei; Masoudi, Frederick A.; Spertus, John A.; Krumholz, Harlan M.; Jiang, Lixin		China PEACE Collaborative Grp	RETRACTED: ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data (Retracted article. See vol. 385, pg. 402, 2015)	LANCET			English	Article; Retracted Publication							ACUTE CORONARY SYNDROMES; STANDARDIZED MORTALITY-RATES; QUALITY-OF-CARE; REPERFUSION THERAPY; PRACTICE PATTERNS; IMPROVEMENT; TRANSITION; TRENDS; REFORM	Background Despite the importance of ST-segment elevation myocardial infarction (STEMI) in China, no nationally representative studies have characterised the clinical profiles, management, and outcomes of this cardiac event during the past decade. We aimed to assess trends in characteristics, treatment, and outcomes for patients with STEMI in China between 2001 and 2011. Methods In a retrospective analysis of hospital records, we used a two-stage random sampling design to create a nationally representative sample of patients in China admitted to hospital for STEMI in 3 years (2001, 2006, and 2011). In the first stage, we used a simple random-sampling procedure stratified by economic-geographical region to generate a list of participating hospitals. In the second stage we obtained case data for rates of STEMI, treatments, and baseline characteristics from patients attending each sampled hospital with a systematic sampling approach. We weighted our findings to estimate nationally representative rates and assess changes from 2001 to 2011. This study is registered with ClinicalTrials.gov, number NCT01624883. Findings We sampled 175 hospitals (162 participated in the study) and 18 631 acute myocardial infarction admissions, of which 13 815 were STEMI admissions. 12 264 patients were included in analysis of treatments, procedures, and tests, and 11 986 were included in analysis of in-hospital outcomes. Between 2001 and 2011, estimated national rates of hospital admission for STEMI per 100 000 people increased (from 3.5 in 2001, to 7.9 in 2006, to 15.4 in 2011; p(trend)<0.0001) and the prevalence of risk factors-including smoking, hypertension, diabetes, and dyslipidaemia-increased. We noted significant increases in use of aspirin within 24 h (79.7% [95% CI 77.9-81.5] in 2001 vs 91.2% [90.5-91.8] in 2011, p(trend)<0.0001) and clopidogrel (1.5% [95% CI 1.0-2.1] in 2001 vs 82.1% [81.1-83.0] in 2011, p(trend)<0.0001) in patients without documented contraindications. Despite an increase in the use of primary percutaneous coronary intervention (10.6% [95% CI 8.6-12.6] in 2001 vs 28.1% [26.6-29.7] in 2011, p(trend)<0.0001), the proportion of patients who did not receive reperfusion did not significantly change (45.3% [95% CI 42.1-48.5] in 2001 vs 44.8% [43.1-46.5] in 2011, p(trend)=0.69). The median length of hospital stay decreased from 12 days (IQR 7-18) in 2001 to 10 days (6-14) in 2011 (p(trend)<0.0001). Adjusted in-hospital mortality did not significantly change between 2001 and 2011 (odds ratio 0.82, 95% CI 0.62-1.10, p(trend)=0.07). Interpretation During the past decade in China, hospital admissions for STEMI have risen; in these patients, comorbidities and the intensity of testing and treatment have increased. Quality of care has improved for some treatments, but important gaps persist and in-hospital mortality has not decreased. National efforts are needed to improve the care and outcomes for patients with STEMI in China.	[Li, Jing; Li, Xi; Wang, Qing; Hu, Shuang; Jiang, Lixin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China; [Li, Jing; Li, Xi; Wang, Qing; Hu, Shuang; Jiang, Lixin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Yongfei; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Wang, Yongfei; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Dept Hlth Policy & Management, Sch Publ Hlth, New Haven, CT USA; [Masoudi, Frederick A.] Univ Colorado, Div Cardiol, Aurora, CO USA; [Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Yale University; Yale University; Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Jiang, LX (corresponding author), Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.	jiangl@fwoxford.org	Masoudi, Frederick/Q-7467-2019; , Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021	Normand, Sharon-Lise/0000-0001-7027-4769; Li, Xi/0000-0003-2249-688X	National Health and Family Planning Commission of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Health and Family Planning Commission of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Health and Family Planning Commission of China.	[Anonymous], 2010, LANCET, V376, P657, DOI 10.1016/S0140-6736(10)61315-3; [Anonymous], 2007, CHIN STAT YB; [Anonymous], 2012, CHIN STAT YB; [Anonymous], 2000, 5 CENSUS DATA COUNTY; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Bradley EH, 2005, MED CARE, V43, P282, DOI 10.1097/00005650-200503000-00011; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; China Society of Cardiology of Chinese Medical Association, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P675; Chung SC, 2014, LANCET, V383, P1305, DOI 10.1016/S0140-6736(13)62070-X; COLLINS R, 1995, LANCET, V345, P669; Dharmarajan K, 2013, CIRC-CARDIOVASC QUAL, V6, P732, DOI 10.1161/CIRCOUTCOMES.113.000441; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Du X, 2014, CIRC-CARDIOVASC QUAL, V7, P217, DOI 10.1161/CIRCOUTCOMES.113.000526; [Editorial Board of Chinese Journal of Circulation Editorial Board of Chinese Journal of Cardiology China Society of Cardiology of Chinese Medical Association], 2001, CHIN J CIRC, V16, P407; Gale CP, 2012, EUR HEART J, V33, P630, DOI 10.1093/eurheartj/ehr381; Gao R, 2008, HEART, V94, P554, DOI 10.1136/hrt.2007.119750; Gershlick AH, 2013, LANCET, V382, P624, DOI 10.1016/S0140-6736(13)61454-3; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Li J, 2007, Cochrane Database Syst Rev, pCD002755; Liu Qun, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P213, DOI 10.3760/cma.j.issn.0253-3758.2009.03.004; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Masoudi FA, 2013, J AM COLL CARDIOL, V62, P1931, DOI 10.1016/j.jacc.2013.05.099; Mehta RH, 2004, J AM COLL CARDIOL, V43, P2166, DOI 10.1016/j.jacc.2003.08.067; Ministry of Health of the People's Republic of China, QUAL STAND TERT GEN; Ministry of Health of the People's Republic of China, 2012, CHIN PUBL HLTH STAT; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Ranasinghe I, 2014, CIRC-CARDIOVASC QUAL, V7, P209, DOI 10.1161/CIRCOUTCOMES.113.000527; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Rubin DB, 2004, MULTIPLE IMPUTATION; *SAS I, MI PROC; Simms AD, 2013, HEART, V99, P35, DOI 10.1136/heartjnl-2012-302632; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; The World Bank, HLTH HARM LIF CHIN S; Thygesen K, 2007, EUR HEART J, V28, P2525; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; Wu TX, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004465.pub2; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	41	272	366	4	98	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					441	451		10.1016/S0140-6736(14)60921-1	http://dx.doi.org/10.1016/S0140-6736(14)60921-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	24969506	Green Accepted			2022-12-24	WOS:000348509900031
J	Xiol, J; Spinelli, P; Laussmann, MA; Homolka, D; Yang, Z; Cora, E; Coute, Y; Conn, S; Kadlec, J; Sachidanandam, R; Kaksonen, M; Cusack, S; Ephrussi, A; Pillai, RS				Xiol, Jordi; Spinelli, Pietro; Laussmann, Maike A.; Homolka, David; Yang, Zhaolin; Cora, Elisa; Coute, Yohann; Conn, Simon; Kadlec, Jan; Sachidanandam, Ravi; Kaksonen, Marko; Cusack, Stephen; Ephrussi, Anne; Pillai, Ramesh S.			RNA Clamping by Vasa Assembles a piRNA Amplifier Complex on Transposon Transcripts	CELL			English	Article							PIWI-INTERACTING RNAS; MESSENGER-RNA; DROSOPHILA; PROTEIN; GERMLINE; HELICASE; ELEMENTS; AMPLIFICATION; MACHINERY; MECHANISM	Germline-specific Piwi-interacting RNAs (piRNAs) protect animal genomes against transposons and are essential for fertility. piRNAs targeting active transposons are amplified by the ping-pong cycle, which couples Piwi endonucleolytic slicing of target RNAs to biogenesis of new piRNAs. Here, we describe the identification of a transient Amplifier complex that mediates biogenesis of secondary piRNAs in insect cells. Amplifier is nucleated by the DEAD box RNA helicase Vasa and contains the two Piwi proteins participating in the ping-pong loop, the Tudor protein Qin/Kumo and antisense piRNA guides. These components assemble on the surface of Vasa's helicase domain, which functions as an RNA clamp to anchor Amplifier onto transposon transcripts. We show that ATP-dependent RNP remodeling by Vasa facilitates transfer of 50 sliced piRNA precursors between ping-pong partners, and loss of this activity causes sterility in Drosophila. Our results reveal the molecular basis for the small RNA amplification that confers adaptive immunity against transposons.	[Xiol, Jordi; Spinelli, Pietro; Laussmann, Maike A.; Homolka, David; Yang, Zhaolin; Cora, Elisa; Conn, Simon; Kadlec, Jan; Cusack, Stephen; Pillai, Ramesh S.] Univ Grenoble Alpes, CNRS, EMBL, Grenoble Outstn, F-38042 Grenoble, France; [Xiol, Jordi; Spinelli, Pietro; Laussmann, Maike A.; Homolka, David; Yang, Zhaolin; Cora, Elisa; Conn, Simon; Kadlec, Jan; Cusack, Stephen; Pillai, Ramesh S.] Univ Grenoble Alpes, CNRS, EMBL, Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Laussmann, Maike A.; Kaksonen, Marko] EMBL, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Coute, Yohann] CEA, IRTSV, Lab Biol Grande Echelle, F-38054 Grenoble, France; [Sachidanandam, Ravi] Icahn Sch Med Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Ephrussi, Anne] EMBL, Dev Biol Unit, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Icahn School of Medicine at Mount Sinai; European Molecular Biology Laboratory (EMBL)	Pillai, RS (corresponding author), Univ Grenoble Alpes, CNRS, EMBL, Grenoble Outstn, 71 Ave Martyrs, F-38042 Grenoble, France.	pillai@embl.fr	sachidanandam, ravi/Q-6916-2019; Ephrussi, Anne/ABD-4393-2021; Couté, Yohann/G-2695-2015; Ephrussi, Anne/AAG-4075-2020	sachidanandam, ravi/0000-0001-9844-4459; Ephrussi, Anne/0000-0002-5061-4620; Couté, Yohann/0000-0003-3896-6196; Kadlec, Jan/0000-0002-4853-6918; Conn, Simon/0000-0002-1376-4515; Kaksonen, Marko/0000-0003-3645-7689; Cusack, Stephen/0000-0002-9324-0796	European Union (European Research Council); EMBL Interdisciplinary Postdoc Programme (EIPOD); Region Rhone Alp; EMBL	European Union (European Research Council)(European Research Council (ERC)European Commission); EMBL Interdisciplinary Postdoc Programme (EIPOD); Region Rhone Alp; EMBL	We thank Paul Lasko, Hugo Bellen, and Beat Suter for fly stocks/reagents. We are grateful to Sanjay Ghosh, Andrea Picco, Enrico Zamattia, Sandra Muller, and Anna Cyrklaff for help with data analysis and experiments. We thank the following EMBL core facilities: Advanced Light Microscopy, Genomics, Protein Expression and Purification, and High-Throughput Crystallization. Crystallographic data collection was at European Synchrotron Radiation Facility (ESRF), Grenoble, France. This work was supported by grants from European Union (European Research Council; "pisilence") to R.S.P. We are grateful for fellowships from the EMBL Interdisciplinary Postdoc Programme (EIPOD) under Marie Curie COFUND Actions (M.A.L), EMBO (D.H), and Region Rhone Alp (E.C.). This work was supported by the EMBL.	Anand A, 2012, EMBO J, V31, P870, DOI 10.1038/emboj.2011.449; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; de Vanssay A, 2012, NATURE, V490, P112, DOI 10.1038/nature11416; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grentzinger T, 2012, GENOME RES, V22, P1877, DOI 10.1101/gr.136614.111; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Kawaoka S, 2013, NUCLEIC ACIDS RES, V41, P1581, DOI 10.1093/nar/gks1275; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kirino Y, 2010, J BIOL CHEM, V285, P8148, DOI 10.1074/jbc.M109.089821; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; LEHMANN R, 1991, DEVELOPMENT, V112, P679; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mathioudakis N, 2012, RNA, V18, P2056, DOI 10.1261/rna.034181.112; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Xiol J, 2012, MOL CELL, V47, P970, DOI 10.1016/j.molcel.2012.07.019; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	44	145	152	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1698	1711		10.1016/j.cell.2014.05.018	http://dx.doi.org/10.1016/j.cell.2014.05.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24910301	Bronze			2022-12-24	WOS:000340941900022
J	Vvedenskaya, IO; Vahedian-Movahed, H; Bird, JG; Knoblauch, JG; Goldman, SR; Zhang, Y; Ebright, RH; Nickels, BE				Vvedenskaya, Irina O.; Vahedian-Movahed, Hanif; Bird, Jeremy G.; Knoblauch, Jared G.; Goldman, Seth R.; Zhang, Yu; Ebright, Richard H.; Nickels, Bryce E.			TRANSCRIPTION Interactions between RNA polymerase and the "core recognition element" counteract pausing	SCIENCE			English	Article							STRUCTURAL BASIS; SINGLE-MOLECULE; REVEALS	Transcription elongation is interrupted by sequences that inhibit nucleotide addition and cause RNA polymerase (RNAP) to pause. Here, by use of native elongating transcript sequencing (NET-seq) and a variant of NET-seq that enables analysis of mutant RNAP derivatives in merodiploid cells (mNET-seq), we analyze transcriptional pausing genome-wide in vivo in Escherichia coli. We identify a consensus pause-inducing sequence element, G(-10)Y(-1)G(+1) (where -1 corresponds to the position of the RNA 3' end). We demonstrate that sequence-specific interactions between RNAP core enzyme and a core recognition element (CRE) that stabilize transcription initiation complexes also occur in transcription elongation complexes and facilitate pause read-through by stabilizing RNAP in a posttranslocated register. Our findings identify key sequence determinants of transcriptional pausing and establish that RNAP-CRE interactions modulate pausing.	[Vvedenskaya, Irina O.; Bird, Jeremy G.; Knoblauch, Jared G.; Goldman, Seth R.; Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Vvedenskaya, Irina O.; Vahedian-Movahed, Hanif; Bird, Jeremy G.; Knoblauch, Jared G.; Goldman, Seth R.; Zhang, Yu; Ebright, Richard H.; Nickels, Bryce E.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Vahedian-Movahed, Hanif; Bird, Jeremy G.; Zhang, Yu; Ebright, Richard H.] Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu; bnickels@waksman.rutgers.edu	Zhang, Yu/AAV-5722-2021; Ebright, Richard/O-3321-2019; Nickels, Bryce/AAF-2549-2020; Zhang, Yu/J-5225-2014	Zhang, Yu/0000-0002-1778-8389; Ebright, Richard/0000-0001-8915-7140; Nickels, Bryce/0000-0001-7449-8831; Bird, Jeremy/0000-0003-2690-8474	NIH grants [GM041376, GM088343, GM096454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096454, R37GM041376, R01GM088343, R01GM041376] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM041376 (R.H.E.), GM088343 (B.E.N.), and GM096454 (B.E.N.). Reads are deposited in the Sequence Read Archive (accession SRP039384).	AIVAZASHVILI V A, 1981, Molekulyarnaya Biologiya (Moscow), V15, P915; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Dangkulwanich M, 2014, CHEM REV, V114, P3203, DOI 10.1021/cr400730x; Dangkulwanich M, 2013, ELIFE, V2, DOI 10.7554/eLife.00971; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Landick R, 2009, P NATL ACAD SCI USA, V106, P8797, DOI 10.1073/pnas.0904373106; Larson MH, 2011, MOL CELL, V41, P249, DOI 10.1016/j.molcel.2011.01.008; LEE DN, 1990, J BIOL CHEM, V265, P15145; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zhou J, 2011, MOL CELL, V44, P635, DOI 10.1016/j.molcel.2011.09.018	20	116	117	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1285	1289		10.1126/science.1253458	http://dx.doi.org/10.1126/science.1253458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926020	Green Accepted			2022-12-24	WOS:000337077500041
J	Raj, DK; Nixon, CP; Nixon, CE; Dvorin, JD; DiPetrillo, CG; Pond-Tor, S; Wu, HW; Jolly, G; Pischel, L; Lu, AL; Michelow, IC; Cheng, L; Conteh, S; McDonald, EA; Absalon, S; Holte, SE; Friedman, JF; Fried, M; Duffy, PE; Kurtis, JD				Raj, Dipak K.; Nixon, Christian P.; Nixon, Christina E.; Dvorin, Jeffrey D.; DiPetrillo, Christen G.; Pond-Tor, Sunthorn; Wu, Hai-Wei; Jolly, Grant; Pischel, Lauren; Lu, Ailin; Michelow, Ian C.; Cheng, Ling; Conteh, Solomon; McDonald, Emily A.; Absalon, Sabrina; Holte, Sarah E.; Friedman, Jennifer F.; Fried, Michal; Duffy, Patrick E.; Kurtis, Jonathan D.			Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; HUMAN RESISTANCE; INVASION; GROWTH	Novel vaccines are urgently needed to reduce the burden of severe malaria. Using a differential whole-proteome screening method, we identified Plasmodium falciparum schizont egress antigen-1 (PfSEA-1), a 244-kilodalton parasite antigen expressed in schizont-infected red blood cells (RBCs). Antibodies to PfSEA-1 decreased parasite replication by arresting schizont rupture, and conditional disruption of PfSEA-1 resulted in a profound parasite replication defect. Vaccination of mice with recombinant Plasmodium berghei PbSEA-1 significantly reduced parasitemia and delayed mortality after lethal challenge with the Plasmodium berghei strain ANKA. Tanzanian children with antibodies to recombinant PfSEA-1A (rPfSEA-1A) did not experience severe malaria, and Kenyan adolescents and adults with antibodies to rPfSEA-1A had significantly lower parasite densities than individuals without these antibodies. By blocking schizont egress, PfSEA-1 may synergize with other vaccines targeting hepatocyte and RBC invasion.	[Raj, Dipak K.; Nixon, Christian P.; Nixon, Christina E.; Pond-Tor, Sunthorn; Wu, Hai-Wei; Pischel, Lauren; Lu, Ailin; Michelow, Ian C.; Cheng, Ling; McDonald, Emily A.; Friedman, Jennifer F.; Kurtis, Jonathan D.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Ctr Int Hlth Res, Providence, RI 02903 USA; [Dvorin, Jeffrey D.; DiPetrillo, Christen G.; Absalon, Sabrina] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Dvorin, Jeffrey D.; DiPetrillo, Christen G.; Absalon, Sabrina] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wu, Hai-Wei; Michelow, Ian C.; Friedman, Jennifer F.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02903 USA; [Jolly, Grant; Kurtis, Jonathan D.] Brown Univ, Warren Alpert Med Sch, Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI 02906 USA; [Conteh, Solomon; Fried, Michal; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20892 USA; [Holte, Sarah E.] Univ Washington, Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Dept Biostat & Global Hlth, Seattle, WA 98109 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Kurtis, JD (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Ctr Int Hlth Res, Providence, RI 02903 USA.	jonathan_kurtis@brown.edu	Michelow, Ian C./AAH-2373-2020	Michelow, Ian C./0000-0002-8399-480X; Nixon, Christina/0000-0003-1934-958X; Dvorin, Jeffrey/0000-0002-5883-7271; Absalon, Sabrina/0000-0002-4167-3071; Friedman, Jennifer/0000-0001-5804-9921	U.S. National Institutes of Health (NIH) [R01-AI52059]; Bill & Melinda Gates Foundation [1364]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases-NIH; NIH [R01-AI076353, R01-AI102907, DP2-AI112219, T32-DA013911, 1K08AI100997-01A1]; internal Lifespan Hospital System Research Pilot Award Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001153, P30AI042853, R01AI102907, R01AI052059, R01AI076353, ZIAAI001134, K08AI100997, DP2AI112219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Intramural Research Program of the National Institute of Allergy and Infectious Diseases-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); internal Lifespan Hospital System Research Pilot Award Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Mother Offspring Malaria Study project staff for their efforts in collecting clinical data, processing samples, and interpreting malaria blood smears, as well as the study participants and their families. Ethical clearance was obtained from the institutitional review boards of the Seattle Biomedical Research Institute and Rhode Island Hospital; the Medical Research Coordinating Committee of the National Institute for Medical Research, Tanzania; and the Kenyan Medical Research Institute. We thank A. Muehlenbachs for assistance in interpreting the electron microscopy images, B. Morrison for assistance with data management, and D. Lanar for the LSA proteins. This work was supported by grants from the U.S. National Institutes of Health (NIH) (grant R01-AI52059) and the Bill & Melinda Gates Foundation (grant 1364) to P. E. D., the Intramural Research Program of the National Institute of Allergy and Infectious Diseases-NIH, and grants from NIH (grant R01-AI076353) and an internal Lifespan Hospital System Research Pilot Award Grant to J.D.K., and grants from NIH to J.D.D. (R01-AI102907 and DP2-AI112219). C.E.N. (grant T32-DA013911) and I.C.M. (grant 1K08AI100997-01A1) were supported by NIH. We also acknowledge research core services provided by the Rhode Island Hospital imaging core (G. Hovanesian) and core services supported by Lifespan/Tufts/Brown Center for Aids Research (P30AI042853) and Center for Biomedical Research Excellence (P20GM103421). The DNA sequence for PfSEA-1 is available in PlasmoDB (www.Plasmodb.org) as ID no. PF3D7_1021800. The work presented in this manuscript has been submitted in partial support of patent application PCT/US12/67404 filed with the U.S. Patent Office. J.D.K., J.F.F., M.F., and P.E.D. designed the study; J.D.K., D.K.R., J.F.F., M. F., and P. E. D. drafted the manuscript; M. F. and P. E. D. conducted the field-based sample and epidemiologic data collection; C.P.N. conducted the differential screening; D. K. R, L. P., A. L., C.E.N., and L. C. performed the in vitro growth assays; D. K. R. and G.J. performed the immunolocalization; D. K. R. performed the gene knockout studies; C. G. D., E. A. M., S. A., and J.D.D. performed the conditional gene knockdown studies; I. C. M. performed the single-nucleotide polymorphism detection; S.P.-T., L.C., and H.-W.W. performed the antibody detection assays; S.P.-T. expressed and purified rPf SEA-1A and rPbSEA-1A; D.K.R., C.E.N., and S. C. performed the vaccination studies; J.F.F., J.D.K., and S.E.H. performed the statistical analyses; and J.D.K., J.F.F., M.F., and P.E.D. supervised the study. The authors declare no competing financial interests.	Ahlborg N, 1996, EXP PARASITOL, V82, P155, DOI 10.1006/expr.1996.0020; [Anonymous], N ENGL J MED; [Anonymous], MAL VACC RAINB TABL; BEIER JC, 1994, AM J TROP MED HYG, V50, P529, DOI 10.4269/ajtmh.1994.50.529; Bergmann-Leitner ES, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-183; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Bull PC, 2005, J INFECT DIS, V192, P1119, DOI 10.1086/432761; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829; Gomez ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025477; Goodyer ID, 1997, MOL BIOCHEM PARASIT, V87, P13, DOI 10.1016/S0166-6851(97)00039-X; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Kadekoppala M, 2008, EUKARYOT CELL, V7, P2123, DOI 10.1128/EC.00274-08; Kurtis JD, 2001, INFECT IMMUN, V69, P123, DOI 10.1128/IAI.69.1.123-128.2001; Kurtis JD, 1999, INFECT IMMUN, V67, P3424, DOI 10.1128/IAI.67.7.3424-3429.1999; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Nixon CP, 2005, J INFECT DIS, V192, P861, DOI 10.1086/432550; Okie S, 2005, NEW ENGL J MED, V353, P1877, DOI 10.1056/NEJMp058217; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Spaccapelo R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00039; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yoshida S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013727	26	78	79	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					871	877		10.1126/science.1254417	http://dx.doi.org/10.1126/science.1254417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855263	Green Accepted			2022-12-24	WOS:000336233800040
J	Katsimpardi, L; Litterman, NK; Schein, PA; Miller, CM; Loffredo, FS; Wojtkiewicz, GR; Chen, JW; Lee, RT; Wagers, AJ; Rubin, LL				Katsimpardi, Lida; Litterman, Nadia K.; Schein, Pamela A.; Miller, Christine M.; Loffredo, Francesco S.; Wojtkiewicz, Gregory R.; Chen, John W.; Lee, Richard T.; Wagers, Amy J.; Rubin, Lee L.			Vascular and Neurogenic Rejuvenation of the Aging Mouse Brain by Young Systemic Factors	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; DENTATE GYRUS; ADULT; PROLIFERATION; DIFFERENTIATION; EXPRESSION; HIPPOCAMPUS; MICE	In the adult central nervous system, the vasculature of the neurogenic niche regulates neural stem cell behavior by providing circulating and secreted factors. Age-related decline of neurogenesis and cognitive function is associated with reduced blood flow and decreased numbers of neural stem cells. Therefore, restoring the functionality of the niche should counteract some of the negative effects of aging. We show that factors found in young blood induce vascular remodeling, culminating in increased neurogenesis and improved olfactory discrimination in aging mice. Further, we show that GDF11 alone can improve the cerebral vasculature and enhance neurogenesis. The identification of factors that slow the age-dependent deterioration of the neurogenic niche in mice may constitute the basis for new methods of treating age-related neurodegenerative and neurovascular diseases.	[Katsimpardi, Lida; Litterman, Nadia K.; Schein, Pamela A.; Miller, Christine M.; Loffredo, Francesco S.; Lee, Richard T.; Wagers, Amy J.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Katsimpardi, Lida; Litterman, Nadia K.; Schein, Pamela A.; Miller, Christine M.; Loffredo, Francesco S.; Lee, Richard T.; Wagers, Amy J.; Rubin, Lee L.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Miller, Christine M.; Wagers, Amy J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Joslin Diabet Ctr, Boston, MA 02115 USA; [Miller, Christine M.; Wagers, Amy J.] Harvard Univ, Sch Med, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; [Loffredo, Francesco S.; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Wojtkiewicz, Gregory R.; Chen, John W.] Harvard Univ, Sch Med, Ctr Syst Biol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wojtkiewicz, Gregory R.; Chen, John W.] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Katsimpardi, L (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lida_katsimpardi@harvard.edu; lee_rubin@harvard.edu	Loffredo, Francesco S/F-6638-2014; Loffredo, Francesco/P-1389-2019; Wojtkiewicz, Gregory/L-3660-2018	Loffredo, Francesco S/0000-0001-5911-780X; Loffredo, Francesco/0000-0001-5911-780X; Lee, Richard/0000-0003-4687-1381; Wojtkiewicz, Gregory/0000-0002-3148-8411; Rubin, Lee/0000-0002-8658-841X	Ellison Medical Foundation; GlaxoSmithKline; Harvard Stem Cell Institute; NIH [R01 AG032977 1R01 AG040019, 1R01 AG033053, 1DP2 OD004345, 5U01 HL100402, R01NS070835, R01NS072167]; Paul F. Glenn Foundation for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072167, R01NS070835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032977, R01AG040019, R01AG033053] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); GlaxoSmithKline(GlaxoSmithKline); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Foundation for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. McGillivray and D. Faria at the HSCRB Histology Core for providing help with sectioning and D. Smith and B. Gotze at the HCBI for providing microscope facilities. We also thank W. Stallcup for providing the anti-NG2 antibody, C. Bonal for technical help and J. LaLonde for editorial assistance. This work was supported by a Senior Scholar in Aging Award from The Ellison Medical Foundation to L. L. R.; awards from GlaxoSmithKline and the Harvard Stem Cell Institute to L. L. R.; NIH (R01 AG032977 1R01 AG040019) to R. T. L.; and the Paul F. Glenn Foundation for Medical Research, NIH (1R01 AG033053, 1DP2 OD004345, and 5U01 HL100402), and Harvard Stem Cell Institute to A. J. W. Additional data are in the Supplement. J. C. was funded by NIH R01NS070835 and R01NS072167. L. L. R., A. J. W., R. T. L., and L. K. are inventors on a U.S. patent application filed by Harvard University and Brigham and Women's Hospital entitled "Methods and Compositions for Increasing Neurogenesis and Angiogenesis" (61/833, 813).	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Balabanov R, 1998, J NEUROSCI RES, V53, P637, DOI 10.1002/(SICI)1097-4547(19980915)53:6<637::AID-JNR1>3.0.CO;2-6; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; Grady CL, 1998, NEUROIMAGE, V8, P409, DOI 10.1006/nimg.1998.0376; Katsimpardi L, 2008, STEM CELLS, V26, P1796, DOI 10.1634/stemcells.2007-0921; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Matarredona ER, 2005, BRAIN RES REV, V49, P355, DOI 10.1016/j.brainresrev.2005.01.001; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Reed May J, 2004, Sci Aging Knowledge Environ, V2004, ppe7, DOI 10.1126/sageke.2004.7.pe7; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Riddle DR, 2003, AGEING RES REV, V2, P149, DOI 10.1016/S1568-1637(02)00064-8; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tropepe V, 1997, J NEUROSCI, V17, P7850; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Witt R. M., 2009, JOVE-J VIS EXP, V28, P949; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu P, 2008, NEUROBIOL AGING, V29, P1502, DOI 10.1016/j.neurobiolaging.2007.03.028	32	630	677	4	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					630	634		10.1126/science.1251141	http://dx.doi.org/10.1126/science.1251141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24797482	Green Accepted			2022-12-24	WOS:000335537400043
J	Alpatov, R; Lesch, BJ; Nakamoto-Kinoshita, M; Blanco, A; Chen, SZ; Stutzer, A; Armache, KJ; Simon, MD; Xu, C; Ali, M; Murn, J; Prisic, S; Kutateladze, TG; Vakoc, CR; Min, JR; Kingston, RE; Fischle, W; Warren, ST; Page, DC; Shi, Y				Alpatov, Roman; Lesch, Bluma J.; Nakamoto-Kinoshita, Mika; Blanco, Andres; Chen, Shuzhen; Stuetzer, Alexandra; Armache, Karim J.; Simon, Matthew D.; Xu, Chao; Ali, Muzaffar; Murn, Jernej; Prisic, Sladjana; Kutateladze, Tatiana G.; Vakoc, Christopher R.; Min, Jinrong; Kingston, Robert E.; Fischle, Wolfgang; Warren, Stephen T.; Page, David C.; Shi, Yang			A Chromatin-Dependent Role of the Fragile X Mental Retardation Protein FMRP in the DNA Damage Response	CELL			English	Article							H3K79 METHYLATION; MICE LACKING; DYNAMICS; TARGETS; BRCA1; SURVIVAL; MUTATION; DOMAIN; TUDOR	Fragile X syndrome, a common form of inherited intellectual disability, is caused by loss of the fragile X mental retardation protein FMRP. FMRP is present predominantly in the cytoplasm, where it regulates translation of proteins that are important for synaptic function. We identify FMRP as a chromatin-binding protein that functions in the DNA damage response (DDR). Specifically, we show that FMRP binds chromatin through its tandem Tudor (Agenet) domain in vitro and associates with chromatin in vivo. We also demonstrate that FMRP participates in the DDR in a chromatin-binding-dependent manner. The DDR machinery is known to play important roles in developmental processes such as gametogenesis. We show that FMRP occupies meiotic chromosomes and regulates the dynamics of the DDR machinery during mouse spermatogenesis. These findings suggest that nuclear FMRP regulates genomic stability at the chromatin interface and may impact gametogenesis and some developmental aspects of fragile X syndrome.	[Alpatov, Roman; Blanco, Andres; Chen, Shuzhen; Murn, Jernej; Shi, Yang] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Alpatov, Roman; Blanco, Andres; Chen, Shuzhen; Murn, Jernej; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lesch, Bluma J.; Page, David C.] MIT, Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Lesch, Bluma J.; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Nakamoto-Kinoshita, Mika; Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Nakamoto-Kinoshita, Mika; Warren, Stephen T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Nakamoto-Kinoshita, Mika; Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Stuetzer, Alexandra; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Armache, Karim J.; Simon, Matthew D.; Kingston, Robert E.] Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Armache, Karim J.; Simon, Matthew D.; Kingston, Robert E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Xu, Chao; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Xu, Chao; Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Ali, Muzaffar; Kutateladze, Tatiana G.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Prisic, Sladjana] Harvard Univ, Sch Med, Div Infect Dis, Boston, MA 02115 USA; [Prisic, Sladjana] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Emory University; Emory University; Emory University; Max Planck Society; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Cold Spring Harbor Laboratory	Shi, Y (corresponding author), Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	Murn, Jernej/ABD-3624-2020; Simon, Matthew/ABF-9127-2020; Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; Blanco, M. Andres/0000-0003-4404-2301; Vakoc, Christopher/0000-0002-1158-7180; Simon, Matthew/0000-0001-7423-5265; Prisic, Sladjana/0000-0003-3137-4358; Kutateladze, Tatiana/0000-0001-7375-6990	NIH [NCI118487, MH096066, HD020521, HD024064]; National Research Training [AG00222-7]; NRSA [HD075591]; Hope Funds for Cancer Research postdoctoral fellowship; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075591, P30HD018655, P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020521, R37HD020521] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA118487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043901, R01GM101664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102690, R01MH096066, R01MH080129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Training; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Funds for Cancer Research postdoctoral fellowship; HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Elledge and B. Yankner for advice and helpful suggestions; A. Ciccia for help with DNA damage experiments; D. Reinberg and P. Voigt for help with nucleosomal preparations; J. Griesbach, A. Lazic, and S. Duhr from NanoTemper Technologies, and K. Yamagata, Y. Zheng, and X. Shang for help with microscale thermophoresis and kinetic data analysis; and E. Greer, A. Alekseyenko, and G. Shanower for logistical support. We also thank J. Mowrey, S. Ceman, S. Keeney, and U. Fischer for reagents; M. Bear for Fmr1 KO mice; S. Armstrong for Dot1L<SUP>fl/fl</SUP> mice; K. Luger, G. Narlikar, S. Ceman, and U. Fischer for helpful comments; and M. Goodheart, D. Cooper, E. Derby, L. Elow, K. Igarashi, L. Kolinski, L. Pomponi, and M. Schuck for technical assistance. We also thank our collaborators who contributed to this project but whose work was not included in the manuscript: B. Ren, U. Wagner, and the Ren laboratory for FMRP genome-wide analysis; K. Zhao and his group for H3K79me2 genome-wide analysis; A. Vaquero for Suv39h double-null MEFs; and G. Schotta and T. Jenuwein for Suv4-20h double null MEFs. This work was supported by NIH grants NCI118487 and MH096066 to Y.S., National Research Training Grant AG00222-7 to R.A., NRSA grant HD075591 and a Hope Funds for Cancer Research postdoctoral fellowship to B.J.L., and HHMI funding to D.C.P., and in part by NIH grants HD020521 and HD024064 to S.T.W.Y.S. is an American Cancer Society Research Professor, and is a cofounder of Constellation Pharmaceuticals and a member of its scientific advisory board.	Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Cabart P, 2004, ONCOGENE, V23, P5316, DOI 10.1038/sj.onc.1207684; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Collins SC, 2010, AM J MED GENET A, V152A, P2512, DOI 10.1002/ajmg.a.33626; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; Garcia-Cruz R, 2009, REPROD BIOMED ONLINE, V18, P37, DOI 10.1016/S1472-6483(10)60422-1; Isabelle M, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-22; Jenkins EC, 2008, AM J MED GENET A, V146A, P1543, DOI 10.1002/ajmg.a.32342; Jeon SJ, 2012, J NEUROCHEM, V123, P226, DOI 10.1111/j.1471-4159.2012.07886.x; Jeon SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-17; JOHANNISSON R, 1987, HUM GENET, V76, P141, DOI 10.1007/BF00284911; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Kwan KY, 2003, P NATL ACAD SCI USA, V100, P2526, DOI 10.1073/pnas.0437998100; Liu W, 2012, HUM MOL GENET, V21, P4655, DOI 10.1093/hmg/dds307; Luca R, 2013, EMBO MOL MED, V5, P1523, DOI 10.1002/emmm.201302847; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; NELSON DL, 1995, SEMIN CELL BIOL, V6, P5, DOI 10.1016/1043-4682(95)90009-8; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ontoso D, 2014, CHROMOSOMA, V123, P147, DOI 10.1007/s00412-013-0438-5; Ontoso D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003262; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; Reeve SR, 2005, CURR BIOL, V15, P1156, DOI 10.1016/j.cub.2005.05.050; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; Sabra M, 2013, J CELL SCI, V126, P3664, DOI 10.1242/jcs.126003; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Tamanini F, 1999, HUM MOL GENET, V8, P863, DOI 10.1093/hmg/8.5.863; Tian H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.138; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	38	103	110	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					869	881		10.1016/j.cell.2014.03.040	http://dx.doi.org/10.1016/j.cell.2014.03.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813610	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000335765500015
J	Pinan-Lucarre, B; Tu, HJ; Pierron, M; Cruceyra, PI; Zhan, H; Stigloher, C; Richmond, JE; Bessereau, JL				Pinan-Lucarre, Berangere; Tu, Haijun; Pierron, Marie; Cruceyra, Pablo Ibanez; Zhan, Hong; Stigloher, Christian; Richmond, Janet E.; Bessereau, Jean-Louis			C. elegans Punctin specifies cholinergic versus GABAergic identity of postsynaptic domains	NATURE			English	Article							RECEPTOR ALPHA-SUBUNIT; CAENORHABDITIS-ELEGANS; ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTION; EXTRACELLULAR-MATRIX; GABA RECEPTOR; GENE ENCODES; PROTEIN; COMPLEX	Because most neurons receive thousands of synaptic inputs, the neuronal membrane is a mosaic of specialized microdomains where neurotransmitter receptors cluster in register with the corresponding presynaptic neurotransmitter release sites. In many cases the coordinated differentiation of presynaptic and postsynaptic domains implicates trans-synaptic interactions between membrane-associated proteins such as neurexins and neuroligins(1-3). The Caenorhabditis elegans neuromuscular junction (NMJ) provides a genetically tractable system in which to analyse the segregation of neurotransmitter receptors, because muscle cells receive excitatory innervation from cholinergic neurons and inhibitory innervation from GABAergic neurons(4). Here we show that Ce-Punctin/madd-4 (ref.5), the C. elegans orthologue of mammalian punctin-1 and punctin-2, encodes neurally secreted isoforms that specify the excitatory or inhibitory identity of postsynaptic NMJ domains. These proteins belong to the ADAMTS (a disintegrin and metalloprotease with thrombospondin repeats)like family, a class of extracellular matrix proteins related to the ADAM proteases but devoid of proteolytic activity(6). Ce-Punctin deletion causes the redistribution of synaptic acetylcholine and GABA(A) (gamma-aminobutyric acid type A) receptors into extrasynaptic clusters, whereas neuronal presynaptic boutons remain unaltered. Alternative promoters generate different Ce-Punctin isoforms with distinct functions. A short isoform is expressed by cholinergic and GABAergic motoneurons and localizes to excitatory and inhibitory NMJs, whereas long isoforms are expressed exclusively by cholinergic motoneurons and are confined to cholinergic NMJs. The differential expression of these isoforms controls the congruence between presynaptic and postsynaptic domains: specific disruption of the short isoform relocalizes GABAA receptors from GABAergic to cholinergic synapses, whereas expression of a long isoform in GABAergic neurons recruits acetylcholine receptors to GABAergic NMJs. These results identify Ce-Punctin as a previously unknown synaptic organizer and show that presynaptic and postsynaptic domain identities can be genetically uncoupled in vivo. Because human punctin-2 was identified as a candidate gene for schizophrenia(7), ADAMTS-like proteins may also control synapse organization in the mammalian central nervous system.	[Pinan-Lucarre, Berangere; Tu, Haijun; Pierron, Marie; Cruceyra, Pablo Ibanez; Zhan, Hong; Stigloher, Christian; Bessereau, Jean-Louis] Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Pinan-Lucarre, Berangere; Tu, Haijun; Pierron, Marie; Zhan, Hong; Bessereau, Jean-Louis] Univ Lyon 1, CGphiMC UMR CNRS 5534, F-69622 Villeurbanne, France; [Richmond, Janet E.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bessereau, JL (corresponding author), Ecole Normale Super, Inst Biol, F-75005 Paris, France.	jean-louis.bessereau@univ-lyon1.fr	Zhan, Hong/AAS-8840-2020; Bessereau, Jean-Louis/M-2988-2017; Stigloher, Christian/E-4762-2015; Pinan-Lucarre, Berangere/H-4542-2017	Zhan, Hong/0000-0002-7625-3528; Bessereau, Jean-Louis/0000-0002-3088-7621; Stigloher, Christian/0000-0001-6941-2669; Pinan-Lucarre, Berangere/0000-0002-6866-4714	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Association Francaise contre les Myopathies; Fondation pour la Recherche Medicale; Neuropole de Recherche Francilien; Fondation Pierre-Gilles de Gennes; Human Frontier Science Program Long-Term Fellowship; Agence Nationale de la Recherche [ANR-2010-BLAN-1618-01, ANR-11-BSV4-019]; Fondation pour la Recherche Medicale ('Equipe FRM' grant)	National Institutes of Health Office of Research Infrastructure Programs; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Neuropole de Recherche Francilien; Fondation Pierre-Gilles de Gennes; Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale ('Equipe FRM' grant)	We thank C. Lena for expert assistance with analysis of postsynaptic receptor distributions; A. Boyanov for whole genome sequencing; L. Briseno-Roa for technical advice; T. Boulin and M. Jospin for critical reading of the manuscript; M. J. Caron for suggestions on the figure display; A. Valfort, H. Gendrot, P. Muller and B. Mathieu for technical help; J. Rand for the anti-UNC-17 antibodies; M. Hammarlund and E. Jorgensen for plasmids; and P. Roy, the Caenorhabditis Genetic Center (which is funded by National Institutes of Health Office of Research Infrastructure Programs, P40 OD010440) and the International C. elegans Gene Knockout Consortium for strains. B. P.-L. was supported by the Association Francaise contre les Myopathies; H.T. by the Fondation pour la Recherche Medicale and by the Neuropole de Recherche Francilien; M.P. by the Neuropole de Recherche Francilien; H.Z. by the Fondation Pierre-Gilles de Gennes; and C.S. by a Human Frontier Science Program Long-Term Fellowship. This work was funded by the Agence Nationale de la Recherche (ANR-2010-BLAN-1618-01 and ANR-11-BSV4-019), the Fondation pour la Recherche Medicale ('Equipe FRM' grant to J.-L.B.) and the Association Francaise contre les Myopathies (J.-L.B.).	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Bamber BA, 1999, J NEUROSCI, V19, P5348; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Boulin T, 2012, NAT NEUROSCI, V15, P1374, DOI 10.1038/nn.3197; BRENNER S, 1974, GENETICS, V77, P71; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Dixon SJ, 2005, DEVELOPMENT, V132, P3079, DOI 10.1242/dev.01883; Dow DJ, 2011, SCHIZOPHR RES, V127, P28, DOI 10.1016/j.schres.2010.12.009; Fleming JT, 1997, J NEUROSCI, V17, P5843; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/NMETH.1454, 10.1038/nmeth.1454]; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gally C, 2003, J NEUROSCI, V23, P2591; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gottschalk A, 2006, J NEUROSCI METH, V154, P68, DOI 10.1016/j.jneumeth.2005.11.016; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Rapti G, 2011, EMBO J, V30, P706, DOI 10.1038/emboj.2010.355; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Richmond J. E, 2006, WORMBOOK; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Sancar F, 2011, J BIOL CHEM, V286, P33501, DOI 10.1074/jbc.M111.227678; Seetharaman A, 2011, DEV CELL, V21, P669, DOI 10.1016/j.devcel.2011.07.020; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Stigloher C, 2011, J NEUROSCI, V31, P4388, DOI 10.1523/JNEUROSCI.6164-10.2011; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Towers PR, 2005, J NEUROCHEM, V93, P1, DOI 10.1111/j.1471-4159.2004.02951.x; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	41	40	43	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					466	+		10.1038/nature13313	http://dx.doi.org/10.1038/nature13313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24896188				2022-12-24	WOS:000339335700046
J	Xu, K; Wu, ZH; Renier, N; Antipenko, A; Tzvetkova-Robev, D; Xu, Y; Minchenko, M; Nardi-Dei, V; Rajashankar, KR; Himanen, J; Tessier-Lavigne, M; Nikolov, DB				Xu, Kai; Wu, Zhuhao; Renier, Nicolas; Antipenko, Alexander; Tzvetkova-Robev, Dorothea; Xu, Yan; Minchenko, Maria; Nardi-Dei, Vincenzo; Rajashankar, Kanagalaghatta R.; Himanen, Juha; Tessier-Lavigne, Marc; Nikolov, Dimitar B.			NEURAL MIGRATION Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism	SCIENCE			English	Article							HEPARAN-SULFATE; DCC; BINDING; EXPRESSION; FAMILY; MOLECULE; MIDLINE; UNC5; SLIT	Netrins are secreted proteins that regulate axon guidance and neuronal migration. Deleted in colorectal cancer (DCC) is a well-established netrin-1 receptor mediating attractive responses. We provide evidence that its close relative neogenin is also a functional netrin-1 receptor that acts with DCC to mediate guidance in vivo. We determined the structures of a functional netrin-1 region, alone and in complexes with neogenin or DCC. Netrin-1 has a rigid elongated structure containing two receptor-binding sites at opposite ends through which it brings together receptor molecules. The ligand/receptor complexes reveal two distinct architectures: a 2:2 heterotetramer and a continuous ligand/receptor assembly. The differences result from different lengths of the linker connecting receptor domains fibronectin type III domain 4 (FN4) and FN5, which differs among DCC and neogenin splice variants, providing a basis for diverse signaling outcomes.	[Xu, Kai; Antipenko, Alexander; Tzvetkova-Robev, Dorothea; Xu, Yan; Minchenko, Maria; Nardi-Dei, Vincenzo; Himanen, Juha; Nikolov, Dimitar B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Wu, Zhuhao; Renier, Nicolas; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Argonne Natl Lab, Adv Photon Source, Northeastern Collaborat Access Team, Argonne, IL 60439 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Tessier-Lavigne, M (corresponding author), Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA.	marctl@mail.rockefeller.edu; nikolovd@mskcc.org	Wu, Zhuhao/I-5852-2018; Renier, Nicolas/E-1855-2018	Renier, Nicolas/0000-0003-2642-4402; Wu, Zhuhao/0000-0002-2471-0555	National Institute of General Medical Sciences from NIH [P41 GM103403]; U.S. DOE [DE-AC02-06CH11357]; Bristol-Myers Squibb postdoctoral fellowship at the Rockefeller University; European Molecular Biology Organization long-term postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from NIH; U.S. DOE(United States Department of Energy (DOE)); Bristol-Myers Squibb postdoctoral fellowship at the Rockefeller University; European Molecular Biology Organization long-term postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kolev for technical support, M. Himanen for illustrations, Y. Goldgur for help with data collection and processing, and O. Olsen for help and support. X-ray diffraction studies were conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by a grant from the National Institute of General Medical Sciences (P41 GM103403) from NIH. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract no. DE-AC02-06CH11357. Z.W. was supported in part by a Bristol-Myers Squibb postdoctoral fellowship at the Rockefeller University; N.R. was supported by a European Molecular Biology Organization long-term postdoctoral fellowship. The netrin-1, netrin-1/neogenin, and netrin-1/DCC structures have been deposited in the Protein Data Bank under codes 4PLM, 4PLN, and 4PLO, respectively.	Bell CH, 2013, SCIENCE, V341, P77, DOI 10.1126/science.1232322; Brasch J, 2011, J MOL BIOL, V414, P723, DOI 10.1016/j.jmb.2011.10.030; Carafoli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042473; Engle EC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001784; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Kappler J, 2000, BIOCHEM BIOPH RES CO, V271, P287, DOI 10.1006/bbrc.2000.2583; Kastenhuber E, 2009, J NEUROSCI, V29, P8914, DOI 10.1523/JNEUROSCI.0568-09.2009; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kruger RP, 2004, J NEUROSCI, V24, P10826, DOI 10.1523/JNEUROSCI.3715-04.2004; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; Palmesino E, 2012, J NEUROSCI, V32, P411, DOI 10.1523/JNEUROSCI.3563-11.2012; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Rajasekharan S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-239; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Seiradake E, 2011, EMBO J, V30, P4479, DOI 10.1038/emboj.2011.346; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shen H, 2002, MECH DEVELOP, V118, P219, DOI 10.1016/S0925-4773(02)00255-1; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vulliemoz S, 2005, LANCET NEUROL, V4, P87, DOI 10.1016/S1474-4422(05)00990-7; Wang H, 1999, J NEUROSCI, V19, P4938; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018	30	117	118	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1275	1279		10.1126/science.1255149	http://dx.doi.org/10.1126/science.1255149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24876346	Green Accepted			2022-12-24	WOS:000337077500039
J	Duss, O; Michel, E; Yulikov, M; Schubert, M; Jeschke, G; Allain, FHT				Duss, Olivier; Michel, Erich; Yulikov, Maxim; Schubert, Mario; Jeschke, Gunnar; Allain, Frederic H. -T.			Structural basis of the non-coding RNA RsmZ acting as a protein sponge	NATURE			English	Article							PSEUDOMONAS-FLUORESCENS CHA0; ESCHERICHIA-COLI; REGULATORY RNAS; RECOGNITION; SENSITIVITY; AERUGINOSA; BIOCONTROL; PRINCIPLES; EFFICIENT; SEQUENCE	MicroRNA and protein sequestration by non-coding RNAs (ncRNAs) has recently generated much interest. In the bacterial Csr/Rsm system, which is considered to be the most general global post-transcriptional regulatory system responsible for bacterial virulence, ncRNAs such as CsrB or RsmZ activate translation initiation by sequestering homodimeric CsrA-type proteins from the ribosome-binding site of a subset of messenger RNAs. However, the mechanism of ncRNA-mediated protein sequestration is not understood at the molecular level. Here we show for Pseudomonas fluorescens that RsmE protein dimers assemble sequentially, specifically and cooperatively onto the ncRNA RsmZ within a narrow affinity range. This assembly yields two different native ribonucleoprotein structures. Using a powerful combination of nuclear magnetic resonance and electron paramagnetic resonance spectroscopy we elucidate these 70-kilodalton solution structures, thereby revealing the molecular mechanism of the sequestration process and how RsmE binding protects the ncRNA from RNase E degradation. Overall, our findings suggest that RsmZ is well-tuned to sequester, store and release RsmE and therefore can be viewed as an ideal protein 'sponge'.	[Duss, Olivier; Michel, Erich; Schubert, Mario; Allain, Frederic H. -T.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Yulikov, Maxim; Jeschke, Gunnar] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Allain, FHT (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	allain@mol.biol.ethz.ch	Schubert, Mario/B-3972-2008; Yulikov, Maxim/AAU-3685-2020	Schubert, Mario/0000-0003-0278-4091; Duss, Olivier/0000-0003-0929-3471; Jeschke, Gunnar/0000-0001-6853-8585	Swiss National Science Foundation (SNF) [3100A0-118118, 31003ab-133134, 31003A-149921]; SNF-NCCR structural biology Iso-lab	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF-NCCR structural biology Iso-lab	We thank G. A. Mackie for providing the RNase E (12529) clone; N. Diarra Dit Konte and B. Alila for the help with RNA production; M. Blatter for help with structure calculations; G. Wider, T. Stahel, C. Maris and F. Damberger for help with NMR spectroscopy setup; G. Braach, Y. Nikolaev and M. Sattler for discussions. This work was supported by the Swiss National Science Foundation (SNF) grant numbers 3100A0-118118, 31003ab-133134 and 31003A-149921 to F.H.-T.A. and the SNF-NCCR structural biology Iso-lab.	[Anonymous], 2006, V AMBER 9; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Briant DJ, 2003, MOL MICROBIOL, V50, P1381, DOI 10.1046/j.1365-2958.2003.03775.x; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; Dominguez C, 2011, PROG NUCL MAG RES SP, V58, P1, DOI 10.1016/j.pnmrs.2010.10.001; Dubey AK, 2005, RNA, V11, P1579, DOI 10.1261/rna.2990205; Duss O., 2014, NUCL ACIDS RES; Duss O., 2014, NATURE COMMUN; Duss O, 2012, ADV EXP MED BIOL, V992, P121, DOI 10.1007/978-94-007-4954-2_7; Duss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq756; Garrey SM, 2009, J BIOL CHEM, V284, P31843, DOI 10.1074/jbc.M109.063263; Gromov I, 2001, J MAGN RESON, V149, P196, DOI 10.1006/jmre.2001.2298; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2004, APPL MAGN RESON, V26, P223, DOI 10.1007/BF03166574; Jeschke G., 2014, STRUCTURE B IN PRESS, V152; Kaberdin VR, 2003, NUCLEIC ACIDS RES, V31, P4710, DOI 10.1093/nar/gkg690; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Michel E, 2012, J BIOMOL NMR, V53, P43, DOI 10.1007/s10858-012-9619-4; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ramos A, 1998, J AM CHEM SOC, V120, P10992, DOI 10.1021/ja982496e; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Schubert M, 2007, NAT STRUCT MOL BIOL, V14, P807, DOI 10.1038/nsmb1285; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Tschaggelar R, 2009, J MAGN RESON, V200, P81, DOI 10.1016/j.jmr.2009.06.007; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Woodson SA, 2011, ACCOUNTS CHEM RES, V44, P1312, DOI 10.1021/ar2000474	51	141	143	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					588	+		10.1038/nature13271	http://dx.doi.org/10.1038/nature13271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24828038				2022-12-24	WOS:000336457100042
J	Bowles, MW; Mogollon, JM; Kasten, S; Zabel, M; Hinrichs, KU				Bowles, Marshall W.; Mogollon, Jose M.; Kasten, Sabine; Zabel, Matthias; Hinrichs, Kai-Uwe			Global rates of marine sulfate reduction and implications for sub-sea-floor metabolic activities	SCIENCE			English	Article							SEDIMENT AARHUS BAY; REDUCING BACTERIA; MICROBIAL LIFE; ABUNDANCE; DIVERSITY; FLUXES; ZONE	Sulfate reduction is a globally important redox process in marine sediments, yet global rates are poorly quantified. We developed an artificial neural network trained with 199 sulfate profiles, constrained with geomorphological and geochemical maps to estimate global sulfate-reduction rate distributions. Globally, 11.3 teramoles of sulfate are reduced yearly (similar to 15% of previous estimates), accounting for the oxidation of 12 to 29% of the organic carbon flux to the sea floor. Combined with global cell distributions in marine sediments, these results indicate a strong contrast in sub-sea-floor prokaryote habitats: In continental margins, global cell numbers in sulfate-depleted sediment exceed those in the overlying sulfate-bearing sediment by one order of magnitude, whereas in the abyss, most life occurs in oxic and/or sulfate-reducing sediments.	[Bowles, Marshall W.; Mogollon, Jose M.; Kasten, Sabine; Zabel, Matthias; Hinrichs, Kai-Uwe] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Mogollon, Jose M.; Kasten, Sabine] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Mogollon, Jose M.] Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, NL-3508 TC Utrecht, Netherlands	University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Utrecht University	Bowles, MW (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	bowlesmw@uni-bremen.de	Zabel, Matthias/E-5044-2011; Hinrichs, Kai-Uwe/C-7675-2009	Zabel, Matthias/0000-0003-4681-1821; Hinrichs, Kai-Uwe/0000-0002-0739-9291; Kasten, Sabine/0000-0001-7453-5137; Bowles, Marshall/0000-0002-0464-5880; Mogollon, Jose Manuel/0000-0002-7110-5470	Deutsche Forschungsgemeinschaft; European Research Council (ERC) under the European Union [247153]; Helmholtz Association (AWI Bremerhaven); Utrecht University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council (ERC) under the European Union(European Research Council (ERC)); Helmholtz Association (AWI Bremerhaven)(Helmholtz Association); Utrecht University	All data used in this study are publically available via Janus and Pangea (www.pangea.de). We thank Deep Sea Drilling Project/Ocean Drilling Program/Integrated Ocean Drilling Program, Janus, and Pangea for compiling and providing these data sets. We thank A. Boetius, J. J. Middelburg, and S. Joye for helpful comments during the development of this work. Primary support for this work was provided by the Research Center/Cluster of Excellence "The Ocean in the Earth System" (MARUM) funded by the Deutsche Forschungsgemeinschaft in the framework of a Postdoctoral Fellowship awarded to M. W. B. Additional funding was provided by the European Research Council (ERC) under the European Union's Seventh Framework Programme-"Ideas" Specific Programme, ERC grant agreement no. 247153, the Helmholtz Association (AWI Bremerhaven), and Utrecht University through its strategic theme Sustainability, sub-theme Water, Climate, and Ecosystems.	Canfield DE, 2005, ADV MAR BIOL, V48, P313; CANFIELD DE, 1991, AM J SCI, V291, P177, DOI 10.2475/ajs.291.2.177; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Dale AW, 2009, GEOLOGY, V37, P235, DOI 10.1130/G25323A.1; Dunne JP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002907; EMERY KO, 1968, AM ASSOC PETR GEOL B, V0052, P00445; Feldman G. C., 2013, OCEAN COLOR WEB; Fischer D, 2013, NAT GEOSCI, V6, P647, DOI [10.1038/NGEO1886, 10.1038/ngeo1886]; Hartnett HE, 1998, NATURE, V391, P572, DOI 10.1038/35351; Heuer VB, 2009, GEOCHIM COSMOCHIM AC, V73, P3323, DOI 10.1016/j.gca.2009.03.001; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Holm N., 2003, PROC OCEAN DRILL INI, V201, DOI [10.2973/odp.proc.ir.201.2003, DOI 10.2973/ODP.PROC.IR.201.2003]; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Jorgensen B. B, 2006, MARINE GEOCHEMISTRY, P271, DOI DOI 10.1007/3-540-32144-6_8; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Knauer G. A., 1993, NATO ASI SERIES 1, V14, P211; Leloup J, 2007, ENVIRON MICROBIOL, V9, P131, DOI 10.1111/j.1462-2920.2006.01122.x; Leloup J, 2009, ENVIRON MICROBIOL, V11, P1278, DOI 10.1111/j.1462-2920.2008.01855.x; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Lin YS, 2012, GEOCHIM COSMOCHIM AC, V77, P186, DOI 10.1016/j.gca.2011.11.008; Mogollon JM, 2012, BIOGEOSCIENCES, V9, P1915, DOI 10.5194/bg-9-1915-2012; Mogollon JM, 2013, GEO-MAR LETT, V33, P299, DOI 10.1007/s00367-013-0329-z; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Ravenschlag K, 2000, APPL ENVIRON MICROB, V66, P3592, DOI 10.1128/AEM.66.8.3592-3602.2000; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/NGEO1830, 10.1038/ngeo1830]; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; Wallmann K, 2012, ENERGIES, V5, P2449, DOI 10.3390/en5072449	28	155	158	4	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					889	891		10.1126/science.1249213	http://dx.doi.org/10.1126/science.1249213			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24812207	Green Submitted			2022-12-24	WOS:000336233800044
J	Singh, DP; Saudemont, B; Guglielmi, G; Arnaiz, O; Gout, JF; Prajer, M; Potekhin, A; Przybos, E; Aubusson-Fleury, A; Bhullar, S; Bouhouche, K; Lhuillier-Akakpo, M; Tanty, V; Blugeon, C; Alberti, A; Labadie, K; Aury, JM; Sperling, L; Duharcourt, S; Meyer, E				Singh, Deepankar Pratap; Saudemont, Baptiste; Guglielmi, Gerard; Arnaiz, Olivier; Gout, Jean-Francois; Prajer, Malgorzata; Potekhin, Alexey; Przybos, Ewa; Aubusson-Fleury, Anne; Bhullar, Simran; Bouhouche, Khaled; Lhuillier-Akakpo, Maoussi; Tanty, Veronique; Blugeon, Corinne; Alberti, Adriana; Labadie, Karine; Aury, Jean-Marc; Sperling, Linda; Duharcourt, Sandra; Meyer, Eric			Genome-defence small RNAs exapted for epigenetic mating-type inheritance	NATURE			English	Article							PROGRAMMED DNA ELIMINATION; PARAMECIUM-TETRAURELIA; DEVELOPMENTAL EXCISION; SEX DETERMINATION; GENETIC-ANALYSIS; SEQUENCE; DIFFERENTIATION; REARRANGEMENTS; PROTEINS; EXPRESSION	In the ciliate Paramecium, transposable elements and their single-copy remnants are deleted during the development of somatic macronuclei from germline micronuclei, at each sexual generation. Deletions are targeted by scnRNAs, small RNAs produced from the germ line during meiosis that first scan the maternal macronuclear genome to identify missing sequences, and then allow the zygotic macronucleus to reproduce the same deletions. Here we show that this process accounts for the maternal inheritance of mating types in Paramecium tetraurelia, a long-standing problem in epigenetics. Mating type E depends on expression of the transmembrane protein mtA, and the default type O is determined during development by scnRNA-dependent excision of the mtA promoter. In the sibling species Paramecium septaurelia, mating type O is determined by coding-sequence deletions in a different gene, mtB, which is specifically required for mtA expression. These independently evolved mechanisms suggest frequent exaptation of the scnRNA pathway to regulate cellular genes and mediate transgene-rational epigenetic inheritance of essential phenotypic polymorphisms.	[Singh, Deepankar Pratap; Saudemont, Baptiste; Guglielmi, Gerard; Bhullar, Simran; Bouhouche, Khaled; Tanty, Veronique; Blugeon, Corinne; Meyer, Eric] Ecole Normale Super, Inst Biol, ENS, IBENS, F-75005 Paris, France; [Singh, Deepankar Pratap; Saudemont, Baptiste; Guglielmi, Gerard; Bhullar, Simran; Bouhouche, Khaled; Tanty, Veronique; Blugeon, Corinne; Meyer, Eric] INSERM, U1024, F-75005 Paris, France; [Singh, Deepankar Pratap; Saudemont, Baptiste; Guglielmi, Gerard; Bhullar, Simran; Bouhouche, Khaled; Tanty, Veronique; Blugeon, Corinne; Meyer, Eric] CNRS, UMR 8197, F-75005 Paris, France; [Singh, Deepankar Pratap; Saudemont, Baptiste; Lhuillier-Akakpo, Maoussi] UPMC Univ, Sorbonne Univ, IFD, F-75252 Paris 05, France; [Arnaiz, Olivier; Aubusson-Fleury, Anne] Ctr Genet Molec, CNRS, UMR 8197, F-91198 Gif Sur Yvette, France; [Arnaiz, Olivier; Aubusson-Fleury, Anne] Univ Paris Sud, Dept Biol, F-91405 Orsay 05, France; [Gout, Jean-Francois] Univ Lyon, UMR5558, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Prajer, Malgorzata; Przybos, Ewa] Polish Acad Sci, Inst Systemat & Evolut Anim, PL-31016 Krakow, Poland; [Potekhin, Alexey] St Petersburg State Univ, Dept Microbiol, Fac Biol, St Petersburg 199034, Russia; [Lhuillier-Akakpo, Maoussi; Duharcourt, Sandra] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Inst Jacques Monod,UMR 7592, F-75205 Paris, France; [Alberti, Adriana; Labadie, Karine; Aury, Jean-Marc] CEA, IG, Genoscope, F-91057 Evry, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; Saint Petersburg State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; CEA	Meyer, E (corresponding author), Ecole Normale Super, Inst Biol, ENS, IBENS, F-75005 Paris, France.	emeyer@biologie.ens.fr	Labadie, Karine/AAG-7355-2022; Potekhin, Alexey A./K-3633-2013; Bouhouche, khaled/AGR-4456-2022; Alberti, Adriana/E-7142-2017; Sperling, Linda/C-9734-2014; Labadie, Karine/AFL-7408-2022; Aury, Jean-Marc/N-1621-2019; Alberti, Adriana/AAZ-2013-2021; Duharcourt, Sandra/ABD-4460-2020	Labadie, Karine/0000-0001-7467-8509; Potekhin, Alexey A./0000-0003-4162-5923; Alberti, Adriana/0000-0003-3372-9423; Labadie, Karine/0000-0001-7467-8509; Aury, Jean-Marc/0000-0003-1718-3010; Alberti, Adriana/0000-0003-3372-9423; Duharcourt, Sandra/0000-0002-8913-8799; Przybos, Ewa/0000-0003-0523-0465; Gout, Jean-Francois/0000-0002-4549-5647; Sperling, Linda/0000-0002-7772-4774; Bhullar, Simran/0000-0002-2212-902X; Meyer, Eric/0000-0002-3161-8597; ARNAIZ, Olivier/0000-0002-9626-1015	'Investissements d'Avenir' program, Paris Sciences et Lettres* Research University [ANR-10-LABX-54 MEMO LIFE/ANR-11-IDEX-0001-02]; 'Equipe FRM' grant; CNRS ATIP-Avenir; National Science Foundation [MCB-1050161]; Erasmus Mundus program; Ligue Nationale Contre le Cancer; Ministere de l'Enseignement Superieur et de la Recherche; Fondation de la Recherche Medicale; CNRS;  [ANR-08-BLAN-0233];  [ANR-12-BSV6-0017];  [ANR-2010-BLAN-1603];  [RFBR 13-04-01683a]	'Investissements d'Avenir' program, Paris Sciences et Lettres* Research University(French National Research Agency (ANR)); 'Equipe FRM' grant; CNRS ATIP-Avenir; National Science Foundation(National Science Foundation (NSF)); Erasmus Mundus program; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); ; ; ; 	We thank S. Malinsky, C. Ciaudo and M.-A. Felix for critical reading of the manuscript, and S. Marker and all other laboratory members for continuous support and discussions. This work was supported by the 'Investissements d'Avenir' program ANR-10-LABX-54 MEMO LIFE/ANR-11-IDEX-0001-02 Paris Sciences et Lettres* Research University and by grants ANR-08-BLAN-0233 'ParaDice' and ANR-12-BSV6-0017 'INFERNO' to E. M., L. S. and S. D., an 'Equipe FRM' grant to E. M., grants ANR-2010-BLAN-1603 'GENOMAC' and CNRS ATIP-Avenir to S. D., and National Science Foundation grant MCB-1050161 to M. Lynch (JFG). D. P. S. was supported by Ph.D. fellowships from the Erasmus Mundus program and from the Ligue Nationale Contre le Cancer. M. L.-A. was supported by Ph.D. fellowships from the Ministere de l'Enseignement Superieur et de la Recherche and from the Fondation de la Recherche Medicale. A. P. was supported by grant RFBR 13-04-01683a. Some strains used in this study are maintained at the Centre of Core Facilities 'Culture Collection of Microorganisms' in St Petersburg State University. The sequencing of the mtB<SUP>O</SUP> and mtC<SUP>O</SUP> MAC genomes benefited from the facilities and expertise of the high-throughput sequencing platform of IMAGIF (Centre de Recherche de Gif, http://www.imagif.cnrs.fr). The mtB<SUP>O</SUP> and mtC<SUP>O</SUP> transcriptomes were sequenced at the Genomic Paris Centre - IBENS platform, member of 'France Genomique' (ANR10-INBS-09-08). This study was carried out in the context of the CNRS-supported European Research Group 'Paramecium Genome Dynamics and Evolution' and the European COST Action BM1102.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Arnaiz O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-547; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Beisson J., 2010, COLD SPRING HARB PRO; Betermier M, 2004, RES MICROBIOL, V155, P399, DOI 10.1016/j.resmic.2004.01.017; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; BRYGOO Y, 1977, GENETICS, V87, P633; BRYGOO Y, 1980, GENETICS, V94, P951; BUTZEL HM, 1955, GENETICS, V40, P321; BYRNE BC, 1973, GENETICS, V74, P63; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Catania F, 2013, GENOME BIOL EVOL, V5, P1200, DOI 10.1093/gbe/evt087; Catania F, 2009, MOL BIOL EVOL, V26, P421, DOI 10.1093/molbev/msn266; Cervantes MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001518; Chalker DL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017764; Chalker DL, 2011, ANNU REV GENET, V45, P227, DOI 10.1146/annurev-genet-110410-132432; Coyne RS, 2012, BIOL CELL, V104, P309, DOI 10.1111/boc.201100057; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dubois Emeline, 2012, Int J Evol Biol, V2012, P436196, DOI 10.1155/2012/436196; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Duharcourt S, 2009, TRENDS GENET, V25, P344, DOI 10.1016/j.tig.2009.05.007; Duret L, 2008, GENOME RES, V18, P585, DOI 10.1101/gr.074534.107; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; HAGGARD BW, 1974, J PROTOZOOL, V21, P152, DOI 10.1111/j.1550-7408.1974.tb03630.x; Hall MS, 2011, GENETICA, V139, P677, DOI 10.1007/s10709-011-9571-3; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kapusta A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002049; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; KLOBUTCHER LA, 1995, NUCLEIC ACIDS RES, V23, P2006, DOI 10.1093/nar/23.11.2006; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Meyer E, 1996, GENETICS, V143, P191; Meyer E, 2002, ADV GENET, V46, P305; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NANNEY DL, 1957, J PROTOZOOL, V4, P89, DOI 10.1111/j.1550-7408.1957.tb02492.x; Nowacki M, 2005, CURR BIOL, V15, P1616, DOI 10.1016/j.cub.2005.07.033; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Phadke SS, 2009, BIOL J LINN SOC, V98, P187, DOI 10.1111/j.1095-8312.2009.01250.x; Sandoval PY, 2014, DEV CELL, V28, P174, DOI 10.1016/j.devcel.2013.12.010; Schoeberl UE, 2012, GENE DEV, V26, P1729, DOI 10.1101/gad.196493.112; Schoeberl UE, 2011, J BIOL CHEM, V286, P37045, DOI 10.1074/jbc.R111.276964; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sonneborn T. M., 1954, Caryologia, P307; Sonneborn TM, 1937, P NATL ACAD SCI USA, V23, P378, DOI 10.1073/pnas.23.7.378; SONNEBORN TM, 1947, ADV GENET, V1, P263, DOI 10.1016/S0065-2660(08)60488-5; SONNEBORN TM, 1977, ANNU REV GENET, V11, P349, DOI 10.1146/annurev.ge.11.120177.002025; Sonneborn TM, 1974, HDB GENETICS PLANTS, V2, P469, DOI DOI 10.1007/978-1-4684-2994-7_20; TAUB SR, 1963, GENETICS, V48, P815; Xu XH, 2001, J EUKARYOT MICROBIOL, V48, P683, DOI 10.1111/j.1550-7408.2001.tb00209.x	64	71	74	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					447	+		10.1038/nature13318	http://dx.doi.org/10.1038/nature13318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24805235				2022-12-24	WOS:000336126000030
J	Mengerink, KJ; Van Dover, CL; Ardron, J; Baker, M; Escobar-Briones, E; Gjerde, K; Koslow, JA; Ramirez-Llodra, E; Lara-Lopez, A; Squires, D; Sutton, T; Sweetman, AK; Levin, LA				Mengerink, Kathryn J.; Van Dover, Cindy L.; Ardron, Jeff; Baker, Maria; Escobar-Briones, Elva; Gjerde, Kristina; Koslow, J. Anthony; Ramirez-Llodra, Eva; Lara-Lopez, Ana; Squires, Dale; Sutton, Tracey; Sweetman, Andrew K.; Levin, Lisa A.			A Call for Deep-Ocean Stewardship	SCIENCE			English	Editorial Material							SEA; IMPACT; DEPTH; OIL		[Mengerink, Kathryn J.] Environm Law Inst, Washington, DC 20036 USA; [Mengerink, Kathryn J.; Koslow, J. Anthony; Levin, Lisa A.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Van Dover, Cindy L.] Duke Univ, Marine Lab, Beaufort, NC 28516 USA; [Ardron, Jeff] Inst Adv Sustainabil Studies, Potsdam, Germany; [Baker, Maria] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Escobar-Briones, Elva] Univ Nacl Autonoma Mexico, ICML, Mexico City 04510, DF, Mexico; [Gjerde, Kristina] Wycliffe Management, PL-05510 Warsaw, Poland; [Ramirez-Llodra, Eva] Norwegian Inst Water Res NIVA, Oslo, Norway; [Lara-Lopez, Ana] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Squires, Dale] Univ Calif San Diego, La Jolla, CA 92093 USA; [Sutton, Tracey] Nova SE Univ, Coll Oceanog, Oceanog Ctr, Dania, FL 33004 USA; [Sweetman, Andrew K.] Int Res Inst Stavanger, Stavanger, Norway	University of California System; University of California San Diego; Scripps Institution of Oceanography; Duke University; NERC National Oceanography Centre; University of Southampton; Universidad Nacional Autonoma de Mexico; Norwegian Institute for Water Research (NIVA); University of Tasmania; University of California System; University of California San Diego; Nova Southeastern University	Levin, LA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	llevin@ucsd.edu	Sutton, Tracey/AAW-7644-2021; Ardron, Jeff/ABI-7397-2020	Sutton, Tracey/0000-0002-5280-7071; Van Dover, Cindy/0000-0001-9845-8391; Escobar Briones, Elva/0000-0002-8485-7495; Levin, Lisa/0000-0002-2858-8622; Lara-Lopez, Ana/0000-0003-2896-1367; Ramirez-Llodra, Eva/0000-0003-0137-1906				[Anonymous], REST PLAN; [Anonymous], 2007, OIL GAS J; Barbier EB, 2014, NATURE, V505, P475, DOI 10.1038/505475a; Blanchard A, 2014, MAR POLICY, V43, P313, DOI 10.1016/j.marpol.2013.07.001; House KZ, 2006, P NATL ACAD SCI USA, V103, P12291, DOI 10.1073/pnas.0605318103; Lehmann F., 2007, NZ J ENV LAW, V11, P33; Mora C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001682; Muehlenbachs L, 2013, ENERG POLICY, V55, P699, DOI 10.1016/j.enpol.2012.12.074; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Ocean Conservancy and the Gulf of Mexico University Research Collaborative, 2012, MAR REST PRIOR SCI P; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Van Dover CL, 2014, MAR POLICY, V44, P98, DOI 10.1016/j.marpol.2013.07.006; Watson RA, 2013, FISH RES, V140, P63, DOI 10.1016/j.fishres.2012.12.004; Wedding LM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1684; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109	17	157	161	11	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					696	698		10.1126/science.1251458	http://dx.doi.org/10.1126/science.1251458			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH1WQ	24833377	Green Submitted			2022-12-24	WOS:000335912900022
J	Tran, E; Turcotte, S; Gros, A; Robbins, PF; Lu, YC; Dudley, ME; Wunderlich, JR; Somerville, RP; Hogan, K; Hinrichs, CS; Parkhurst, MR; Yang, JC; Rosenberg, SA				Tran, Eric; Turcotte, Simon; Gros, Alena; Robbins, Paul F.; Lu, Yong-Chen; Dudley, Mark E.; Wunderlich, John R.; Somerville, Robert P.; Hogan, Katherine; Hinrichs, Christian S.; Parkhurst, Maria R.; Yang, James C.; Rosenberg, Steven A.			Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer	SCIENCE			English	Article							CD4(+) T-CELLS; METASTATIC MELANOMA; ESTABLISHED MELANOMA; TUMOR-REGRESSION; LUNG-CARCINOMA; IFN-GAMMA; IN-VIVO; LYMPHOCYTES; GENE; RESPONSES	Limited evidence exists that humans mount a mutation-specific T cell response to epithelial cancers. We used a whole-exomic-sequencing-based approach to demonstrate that tumor-infiltrating lymphocytes (TIL) from a patient with metastatic cholangiocarcinoma contained CD4+ T helper 1 (T(H)1) cells recognizing a mutation in erbb2 interacting protein (ERBB2IP) expressed by the cancer. After adoptive transfer of TIL containing about 25% mutation-specific polyfunctional T(H)1 cells, the patient achieved a decrease in target lesions with prolonged stabilization of disease. Upon disease progression, the patient was retreated with a >95% pure population of mutation-reactive T(H)1 cells and again experienced tumor regression. These results provide evidence that a CD4+ T cell response against a mutated antigen can be harnessed to mediate regression of a metastatic epithelial cancer.	[Tran, Eric; Turcotte, Simon; Gros, Alena; Robbins, Paul F.; Lu, Yong-Chen; Dudley, Mark E.; Wunderlich, John R.; Somerville, Robert P.; Hogan, Katherine; Hinrichs, Christian S.; Parkhurst, Maria R.; Yang, James C.; Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Surg Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	sar@nih.gov	Lu, Yong-Chen/G-4520-2014; Hinrichs, Christian/V-9851-2019; Gros, Alena/AAH-2007-2019	Lu, Yong-Chen/0000-0002-0275-9825; Hinrichs, Christian/0000-0001-5597-2841; Gros, Alena/0000-0002-1207-1880; Balmana, Judith/0000-0002-0762-6415	Intramural Research Program of the NIH; NCI;  [PRJNA243084]; NATIONAL CANCER INSTITUTE [ZIABC010984, ZICBC011569, ZIABC011337] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Milstein Family Foundation for their generous support; C.-C. R. Lee, Y. F. Li, A. Mixon, S. Farid, and J. Gartner for helpful technical support and reagents; and the Surgery Branch clinical team for outstanding patient care. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. The raw whole-exome sequence data are available on the Sequence Read Archive database: Bioproject PRJNA243084. This research was supported by the Intramural Research Program of the NIH and NCI.	Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Ding ZC, 2012, BLOOD, V120, P2229, DOI 10.1182/blood-2011-12-398321; Echchakir H, 2001, CANCER RES, V61, P4078; GREENBERG PD, 1985, J EXP MED, V161, P1122, DOI 10.1084/jem.161.5.1122; Hogan KT, 1998, CANCER RES, V58, P5144; Huang JP, 2004, J IMMUNOL, V172, P6057, DOI 10.4049/jimmunol.172.10.6057; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Karanikas V, 2001, CANCER RES, V61, P3718; Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Mandruzzato S, 1997, J EXP MED, V186, P785, DOI 10.1084/jem.186.5.785; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Shafer-Weaver KA, 2009, CANCER RES, V69, P6256, DOI 10.1158/0008-5472.CAN-08-4516; Turcotte S, 2013, J IMMUNOL, V191, P2217, DOI 10.4049/jimmunol.1300538; van der Bruggen P., 2013, CANC IMMUNITY; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weden S, 2011, INT J CANCER, V128, P1120, DOI 10.1002/ijc.25449; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105	25	1076	1168	11	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					641	645		10.1126/science.1251102	http://dx.doi.org/10.1126/science.1251102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812403	Green Accepted			2022-12-24	WOS:000335537400046
J	Chung, JJ; Shim, SH; Everley, RA; Gygi, SP; Zhuang, XW; Clapham, DE				Chung, Jean-Ju; Shim, Sang-Hee; Everley, Robert A.; Gygi, Steven P.; Zhuang, Xiaowei; Clapham, David E.			Structurally Distinct Ca2+ Signaling Domains of Sperm Flagella Orchestrate Tyrosine Phosphorylation and Motility	CELL			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; SOLUBLE ADENYLYL-CYCLASE; CATSPER2 NULL SPERM; MOUSE SPERMATOZOA; FIBROUS SHEATH; MALE-FERTILITY; PROTEIN-PHOSPHORYLATION; MAMMALIAN SPERMATOZOA; CHANNEL; CAPACITATION	Spermatozoa must leave one organism, navigate long distances, and deliver their paternal DNA into a mature egg. For successful navigation and delivery, a sperm-specific calcium channel is activated in the mammalian flagellum. The genes encoding this channel (CatSpers) appear first in ancient uniflagellates, suggesting that sperm use adaptive strategies developed long ago for single-cell navigation. Here, using genetics, super-resolution fluorescence microscopy, and phosphoproteomics, we investigate the CatSper-dependent mechanisms underlying this flagellar switch. We find that the CatSper channel is required for four linear calcium domains that organize signaling proteins along the flagella. This unique structure focuses tyrosine phosphorylation in time and space as sperm acquire the capacity to fertilize. In heterogeneous sperm populations, we find unique molecular phenotypes, but only sperm with intact CatSper domains that organize time-dependent and spatially specific protein tyrosine phosphorylation successfully migrate. These findings illuminate flagellar adaptation, signal transduction cascade organization, and fertility.	[Chung, Jean-Ju; Clapham, David E.] Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Chung, Jean-Ju; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Everley, Robert A.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Shim, Sang-Hee; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Howard Hughes Medical Institute	Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu; dclapham@enders.tch.harvard.edu	Shim, Sang-Hee/A-9051-2012; Clapham, David/R-5974-2019; Clapham, David/S-1123-2019; Shim, Sang-Hee/AAO-5492-2020	Shim, Sang-Hee/0000-0001-9964-7231; Clapham, David/0000-0002-4459-9428; Shim, Sang-Hee/0000-0001-9964-7231; Chung, Jean-Ju/0000-0001-8018-1355	NIH [U01 HDO45857, 1R01 GM 068518, 1R01 GM 096450]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD045857] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518, R01GM096450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Miki and B. Navarro for discussions; L. Zhao, Y. Shang, and H. Warren for help with mice and western blots; and M. Ericsson and E. Benecchi at the Harvard Medical School EM facility for assistance with electron microscopy. This work was supported by NIH U01 HDO45857 (to D.E.) and by NIH 1R01 GM 068518 and 1R01 GM 096450 (to X.Z.).	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Avenarius MR, 2009, AM J HUM GENET, V84, P505, DOI 10.1016/j.ajhg.2009.03.004; BALDI E, 1991, J ANDROL, V12, P323; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Chung JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1153; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Corti C, 1999, EUR J BIOCHEM, V262, P790, DOI 10.1046/j.1432-1327.1999.00441.x; Craig AWB, 2001, MOL CELL BIOL, V21, P603, DOI 10.1128/MCB.21.2.603-613.2001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Eddy E M, 2007, Soc Reprod Fertil Suppl, V65, P45; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Fawcett D. W., 1970, Biol Reprod, V2, P90, DOI 10.1095/biolreprod2.Supplement_2.90; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Heintzmann R, 2009, NAT PHOTONICS, V3, P362, DOI 10.1038/nphoton.2009.102; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Ho K, 2009, REPROD FERT DEVELOP, V21, P345, DOI 10.1071/RD08183; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Johnson LR, 1997, DEV BIOL, V192, P340, DOI 10.1006/dbio.1997.8767; Kierszenbaum AL, 2008, DEV DYNAM, V237, P3882, DOI 10.1002/dvdy.21789; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; Li YF, 2007, J BIOL CHEM, V282, P34104, DOI 10.1074/jbc.M702238200; Lin Y, 1996, BIOL REPROD, V55, P1133, DOI 10.1095/biolreprod55.5.1133; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Marquez B, 2007, DEV BIOL, V303, P214, DOI 10.1016/j.ydbio.2006.11.007; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki K, 2013, CURR BIOL, V23, P443, DOI 10.1016/j.cub.2013.02.007; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; MURAMATSU T, 1992, P NATL ACAD SCI USA, V89, P529, DOI 10.1073/pnas.89.2.529; Naaby-Hansen S, 2002, DEV BIOL, V242, P236, DOI 10.1006/dbio.2001.0527; NEILL JM, 1987, GAMETE RES, V18, P121, DOI 10.1002/mrd.1120180204; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P38121; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sakkas D, 2003, BIOL REPROD, V68, P1463, DOI 10.1095/biolreprod.102.011023; Sala-Newby GB, 2001, BBA-GENE STRUCT EXPR, V1521, P12, DOI 10.1016/S0167-4781(01)00278-0; Schalles U, 1998, DEV BIOL, V199, P250, DOI 10.1006/dbio.1998.8931; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Smith JF, 2013, P NATL ACAD SCI USA, V110, P6823, DOI 10.1073/pnas.1216588110; TASH JS, 1988, J CELL BIOL, V106, P1625, DOI 10.1083/jcb.106.5.1625; Travis AJ, 2001, DEV BIOL, V240, P599, DOI 10.1006/dbio.2001.0475; Urner F, 2001, BIOL REPROD, V64, P1350, DOI 10.1095/biolreprod64.5.1350; Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Williams AC, 2001, J ANDROL, V22, P680; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Yanagimachi R., 1994, P189; Zeng XH, 2013, J GEN PHYSIOL, V142, P305, DOI 10.1085/jgp.201311011	70	155	163	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					808	822		10.1016/j.cell.2014.02.056	http://dx.doi.org/10.1016/j.cell.2014.02.056			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813608	Green Accepted, Bronze			2022-12-24	WOS:000335765500010
J	Chen, J; Petrov, A; Johansson, M; Tsai, A; O'Leary, SE; Puglisi, JD				Chen, Jin; Petrov, Alexey; Johansson, Magnus; Tsai, Albert; O'Leary, Sean E.; Puglisi, Joseph D.			Dynamic pathways of-1 translational frameshifting	NATURE			English	Article							SINGLE-MOLECULE FLUORESCENCE; TRANSFER-RNA SELECTION; MESSENGER-RNA; HYBRID STATE; REAL-TIME; COMPOSITIONAL DYNAMICS; P-SITE; RIBOSOME; TRANSLOCATION; CODON	Spontaneous changes in the reading frame of translation are rare (frequency of 10(-3) to 10(-4) per codon)(1), but can be induced by specific features in the messenger RNA (mRNA). In the presence of mRNA secondary structures, a heptanucleotide 'slippery sequence' usually defined by the motif X XXY YYZ, and (in some prokaryotic cases) mRNA sequences that base pair with the 39 end of the 16S ribosomal rRNA (internal Shine-Dalgarno sequences), there is an increased probability that a specific programmed change of frame occurs, wherein the ribosome shifts one nucleotide backwards into an overlapping reading frame(-1 frame) and continues by translating a new sequence of amino acids(2,3). Despite extensive biochemical and genetic studies, there is no clear mechanistic description for frameshifting. Here we apply single-molecule fluorescence to track the compositional and conformational dynamics of individual ribosomes at each codon during translation of a frameshift-inducing mRNA from the dnaX gene in Escherichia coli. Ribosomes that frameshift into the -1 frame are characterized by a tenfold longer pause in elongation compared to non-frameshifted ribosomes, which translate through unperturbed. During the pause, interactions of the ribosome with the mRNA stimulatory elements uncouple EF-Gcatalysed translocation from normal ribosomal subunit reverse-rotation, leaving the ribosome in a non-canonical intersubunit rotated state with an exposed codon in the aminoacyl-tRNA site (A site). tRNA(Lys) sampling and accommodation to the empty A site and EF-G action either leads to the slippage of the tRNAs into the-1 frame or maintains the ribosome into the 0 frame. Our results provide a general mechanistic and conformational framework for -1 frameshifting, highlighting multiple kinetic branchpoints during elongation.	[Chen, Jin; Tsai, Albert] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Chen, Jin; Petrov, Alexey; Johansson, Magnus; Tsai, Albert; O'Leary, Sean E.; Puglisi, Joseph D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Puglisi, JD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu	Johansson, Magnus/J-8841-2014	Johansson, Magnus/0000-0001-8811-2629; Tsai, Albert/0000-0002-1643-0780	US National Institutes of Health (NIH) [GM51266]; NIH [GM099687]; Wenner-Gren Foundations (Stockholm); Stanford Interdisciplinary Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051266, R01GM099687] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations (Stockholm); Stanford Interdisciplinary Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) grant GM51266 to J.C., A. T. and J.D.P.; by NIH grant GM099687 to A. P., S.E.O'L. and J.D.P.; Wenner-Gren Foundations (Stockholm) to M.J.; and by a Stanford Interdisciplinary Graduate Fellowship to J.C. The authors thank D. Hsu and R. Dalal (Pacific Biosciences Inc.) for their assistance on the ZMW instrumentation; and S. Yan, H. K. Kim and I. Tinoco Jr (University of California at Berkeley) for helpful discussions. J.C. would like to thank I Lin for support.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; Baranov PV, 2004, RNA, V10, P221, DOI 10.1261/rna.5122604; Bertrand C, 2002, RNA, V8, P16, DOI 10.1017/S1355838202012086; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Chen J, 2014, P NATL ACAD SCI USA, V111, P664, DOI 10.1073/pnas.1315735111; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; Chen J, 2012, J AM CHEM SOC, V134, P5734, DOI 10.1021/ja2119964; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; HORSFIELD JA, 1995, NUCLEIC ACIDS RES, V23, P1487, DOI 10.1093/nar/23.9.1487; HUGHES D, 1987, EMBO J, V6, P4235, DOI 10.1002/j.1460-2075.1987.tb02772.x; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Johansson M, 2012, P NATL ACAD SCI USA, V109, P131, DOI 10.1073/pnas.1116480109; Kim HK, 2014, P NATL ACAD SCI USA, V111, P5538, DOI 10.1073/pnas.1403457111; Larsen B, 1997, J MOL BIOL, V271, P47, DOI 10.1006/jmbi.1997.1162; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Leger M, 2007, NUCLEIC ACIDS RES, V35, P5581, DOI 10.1093/nar/gkm578; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Liao PY, 2011, NUCLEIC ACIDS RES, V39, P300, DOI 10.1093/nar/gkq761; Liu CY, 2011, BIOPHYS J, V100, P2201, DOI 10.1016/j.bpj.2011.03.023; Lopinski JD, 2000, MOL CELL BIOL, V20, P1095, DOI 10.1128/MCB.20.4.1095-1103.2000; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; Marshall RA, 2009, MOL CELL, V35, P37, DOI 10.1016/j.molcel.2009.06.008; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; Qin PW, 2014, EMBO REP, V15, P185, DOI 10.1002/embr.201337762; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Tinoco I, 2013, BIOPOLYMERS, V99, P1147, DOI 10.1002/bip.22293; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; TSUCHIHASHI Z, 1992, GENE DEV, V6, P511, DOI 10.1101/gad.6.3.511; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; WEISS R B, 1989, New Biologist, V1, P159; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716	43	111	112	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					328	+		10.1038/nature13428	http://dx.doi.org/10.1038/nature13428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	24919156	Green Accepted			2022-12-24	WOS:000340508200039
J	Afonso, O; Matos, I; Pereira, AJ; Aguiar, P; Lampson, MA; Maiato, H				Afonso, Olga; Matos, Irina; Pereira, Antonio J.; Aguiar, Paulo; Lampson, Michael A.; Maiato, Helder			Feedback control of chromosome separation by a midzone Aurora B gradient	SCIENCE			English	Article							MITOTIC CHROMOSOMES; CENTRAL SPINDLE; CONDENSIN-I; REPO-MAN; MITOSIS; CYTOKINESIS; KINASE; EXIT; PHOSPHORYLATION; ASSOCIATION	Accurate chromosome segregation during mitosis requires the physical separation of sister chromatids before nuclear envelope reassembly (NER). However, how these two processes are coordinated remains unknown. Here, we identified a conserved feedback control mechanism that delays chromosome decondensation and NER in response to incomplete chromosome separation during anaphase. A midzone-associated Aurora B gradient was found to monitor chromosome position along the division axis and to prevent premature chromosome decondensation by retaining Condensin I. PP1/PP2A phosphatases counteracted this gradient and promoted chromosome decondensation and NER. Thus, an Aurora B gradient appears to mediate a surveillance mechanism that prevents chromosome decondensation and NER until effective separation of sister chromatids is achieved. This allows the correction and reintegration of lagging chromosomes in the main nuclei before completion of NER.	[Afonso, Olga; Matos, Irina; Pereira, Antonio J.; Aguiar, Paulo; Maiato, Helder] Univ Porto, Inst Biol Mol & Celular, Chromosome Instabil & Dynam Lab, P-4150180 Oporto, Portugal; [Aguiar, Paulo] Univ Porto, Ctr Math, P-4169007 Oporto, Portugal; [Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Maiato, Helder] Univ Porto, Fac Med, Dept Expt Biol, Cell Div Unit, P-4200319 Oporto, Portugal	Universidade do Porto; Universidade do Porto; University of Pennsylvania; Universidade do Porto	Maiato, H (corresponding author), Univ Porto, Inst Biol Mol & Celular, Chromosome Instabil & Dynam Lab, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	maiato@ibmc.up.pt	Afonso, Olga/N-4802-2017; Aguiar, Paulo/AAD-2462-2020; Maiato, Helder/J-9466-2013	Afonso, Olga/0000-0002-5054-2460; Aguiar, Paulo/0000-0003-4164-5713; Pereira, Antonio/0000-0002-1053-8715; Maiato, Helder/0000-0002-6200-9997	COMPETE [FCOMP-01-0124-FEDER-015941 (PTDC/SAU-ONC/112917/2009)]; Fundacao para a Ciencia e a Tecnologia of Portugal; Human Frontier Science Program; European Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988] Funding Source: NIH RePORTER; Fundação para a Ciência e a Tecnologia [PTDC/SAU-ONC/112917/2009] Funding Source: FCT	COMPETE; Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fundação para a Ciência e a Tecnologia	We thank all colleagues who provided reagents and P. Sampaio for technical help with FRET. H. M. is funded by FCOMP-01-0124-FEDER-015941 (PTDC/SAU-ONC/112917/2009) through COMPETE and Fundacao para a Ciencia e a Tecnologia of Portugal, the Human Frontier Science Program, and PRECISE grant from the European Research Council. Data described can be found in the main figures and supplementary materials. The authors declare no conflict of interests.	Cesario JM, 2006, J CELL SCI, V119, P4770, DOI 10.1242/jcs.03235; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nakazawa N, 2011, J CELL SCI, V124, P1795, DOI 10.1242/jcs.078733; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Qian JB, 2013, CURR BIOL, V23, P1136, DOI 10.1016/j.cub.2013.05.017; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Smurnyy Yegor, 2010, ACS Chem Biol, V5, P1015, DOI 10.1021/cb1001685; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385	26	79	81	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					332	336		10.1126/science.1251121	http://dx.doi.org/10.1126/science.1251121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	24925910	Green Submitted, Green Accepted			2022-12-24	WOS:000339400700053
J	Hill, SM; Hao, XX; Liu, BD; Nystrom, T				Hill, Sandra Malmgren; Hao, Xinxin; Liu, Beidong; Nystrom, Thomas			Life-span extension by a metacaspase in the yeast Saccharomyces cerevisiae	SCIENCE			English	Article							DAMAGED PROTEINS; ASYMMETRIC INHERITANCE; SEGREGATION; DEATH; APOPTOSIS; MUTANTS; SYSTEM; HSP104; ACTIN; YCA1	Single-cell species harbor ancestral structural homologs of caspase proteases, although the evolutionary benefit of such apoptosis-related proteins in unicellular organisms is unclear. Here, we found that the yeast metacaspase Mca1 is recruited to the insoluble protein deposit (IPOD) and juxtanuclear quality-control compartment (JUNQ) during aging and proteostatic stress. Elevating MCA1 expression counteracted accumulation of unfolded proteins and aggregates and extended life span in a heat shock protein Hsp104 disaggregase- and proteasome-dependent manner. Consistent with a role in protein quality control, genetic interaction analysis revealed that MCA1 buffers against deficiencies in the Hsp40 chaperone YDJ1 in a caspase cysteine-dependent manner. Life-span extension and aggregate management by Mca1 was only partly dependent on its conserved catalytic cysteine, which suggests that Mca1 harbors both caspase-dependent and independent functions related to life-span control.	[Hill, Sandra Malmgren; Hao, Xinxin; Liu, Beidong; Nystrom, Thomas] Gothenburg Univ, Dept Chem & Mol Biol CMB, S-41390 Gothenburg, Sweden	University of Gothenburg	Liu, BD (corresponding author), Gothenburg Univ, Dept Chem & Mol Biol CMB, Medicinaregatan 9C, S-41390 Gothenburg, Sweden.	beidong.liu@cmb.gu.se; thomas.nystrom@cmb.gu.se	Liu, Beidong/L-2485-2015; Hill, Sandra/U-4787-2017	Liu, Beidong/0000-0001-6052-8411; Hill, Sandra/0000-0001-7969-097X	Swedish Natural Research Council (VR); Knut and Alice Wallenberg Foundation; European Research Council; Swedish Cancer Society [CAN 2012/601]; Stiftelsen Olle Engkvist Byggmastare Foundation	Swedish Natural Research Council (VR)(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); Stiftelsen Olle Engkvist Byggmastare Foundation	The authors thank C. Boone for providing strain collections for the SGA analysis, L. Megeney for the MCA1C276A strain and the pLM1010 plasmid, W.-K. Huh for the pSIK1-RFP plasmid, D. Kaganovich for the pUBC9ts-RFP plasmid, D. Cyr for the pRS423-Cup1-Rnq1-mRFP plasmid, E. Deuerling for the Mca1 antibody, C. Andreasson and U. Hartl for the luciferase plasmids, F. Eisele for the pFE15 (CPY) plasmid, and A. Sigurdsson for assistance in complementation assays. This work was supported by grants from the Swedish Natural Research Council (VR) (T.N. and B. L.) and the Knut and Alice Wallenberg Foundation (Wallenberg Scholar) and European Research Council (Advanced Grant; QualiAge) to T.N., the Swedish Cancer Society (CAN 2012/601) and Stiftelsen Olle Engkvist Byggmastare Foundation to B.L.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Bufalino MR, 2013, J CELL BIOL, V201, P523, DOI 10.1083/jcb.201207052; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P377, DOI 10.1038/cdd.2009.198; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gregersen PK, 2007, NEW ENGL J MED, V356, P1263, DOI 10.1056/NEJMe078017; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Lee REC, 2010, P NATL ACAD SCI USA, V107, P13348, DOI 10.1073/pnas.1006610107; Lee REC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002956; Liu BD, 2011, CELL, V147, P959, DOI 10.1016/j.cell.2011.11.018; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Oling D, 2014, EMBO J, V33, P747, DOI 10.1002/embj.201386822; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Shrestha A, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00078; Shrestha A, 2013, J PROTEOMICS, V81, P24, DOI 10.1016/j.jprot.2013.01.014; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Wong AHH, 2012, J BIOL CHEM, V287, P29251, DOI 10.1074/jbc.M112.381806; Yuan Junying, 2004, Cell, VS116, pS53, DOI 10.1016/S0092-8674(04)00028-5	32	84	86	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1389	1392		10.1126/science.1252634	http://dx.doi.org/10.1126/science.1252634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24855027				2022-12-24	WOS:000337531700038
J	Rotimi, C				Rotimi, Charles		H3Africa Consortium	Enabling the genomic revolution in Africa	SCIENCE			English	Editorial Material							CHRONIC KIDNEY-DISEASE; APOL1 RISK VARIANTS; HIV-ASSOCIATED NEPHROPATHY; POPULATION		[Rotimi, Charles] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Rotimi, C (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA.	rotimic@mail.nih.gov	McCurdy, Sheryl A/F-9107-2016; Mayige, Mary/GLU-6412-2022; Owen, Andrew/M-7509-2017; Martin, Darren/ABE-3614-2021; Tiffin, Nicki/ABA-9391-2020; Ameni, Gobena/AAR-4201-2020; Stein, Dan/A-1752-2008; Hide, Winston Hide/C-7217-2009; Makani, Julie/E-8525-2017; Hide, Winston/R-3815-2019; Engel, Mark/AAP-6570-2020; Hide, Winston A/V-2727-2017; De Vries, Jantina/I-2752-2014; Pare, Guillaume/T-9631-2018; Ramesar, Raj S/I-6941-2015; Nicol, Mark/W-4149-2019; Adebamowo, Clement/C-8778-2011; Bishop, Ozlem Tastan/J-3084-2016; christoffels, alan/C-3269-2014; Smeeth, Liam/X-5862-2018; Mbanya, Jean Claude N/T-5147-2018; Norris, Shane/C-4664-2014; Kamal Kassim, Samar/G-4701-2015; Mpoloka, Sununguko/GQP-6235-2022; Hazelhurst, Scott/A-5591-2009; McCarthy, Mark/M-3763-2015; Anabwani, Gabriel/I-2371-2016	McCurdy, Sheryl A/0000-0003-0526-1608; Mayige, Mary/0000-0003-4861-7870; Owen, Andrew/0000-0002-9819-7651; Tiffin, Nicki/0000-0001-5083-2735; Ameni, Gobena/0000-0003-3987-0671; Stein, Dan/0000-0001-7218-7810; Hide, Winston Hide/0000-0002-8621-3271; Makani, Julie/0000-0002-4801-6250; Hide, Winston/0000-0002-8621-3271; Engel, Mark/0000-0002-1334-8829; Hide, Winston A/0000-0002-8621-3271; De Vries, Jantina/0000-0001-7192-2633; Pare, Guillaume/0000-0002-6795-4760; Ramesar, Raj S/0000-0001-5688-1634; Nicol, Mark/0000-0002-1366-4805; Adebamowo, Clement/0000-0002-6571-2880; Bishop, Ozlem Tastan/0000-0001-6861-7849; Owolabi, Mayowa/0000-0003-1146-3070; Kapiga, Saidi/0000-0003-1753-4060; Carstens, Nadia/0000-0003-4754-7030; Cordell, Heather/0000-0002-1879-5572; Wade, Alisha/0000-0002-1158-2523; Nkomazana, Oathokwa/0000-0002-2040-4059; Levitt, Naomi/0000-0001-6480-8066; Joloba, Moses/0000-0002-0334-9983; Nyarko, Alexander/0000-0002-9923-360X; Patterton, Hugh-George/0000-0003-2550-0493; Swanepoel, Carmen/0000-0002-3344-5546; Lombard, Zane/0000-0002-7997-2616; Tollman, Stephen/0000-0003-0744-7588; Tinto, Halidou/0000-0002-0472-3586; Kasvosve, Ishmael/0000-0002-2046-545X; christoffels, alan/0000-0002-0420-2916; Jongeneel, Cornelis Victor/0000-0002-3922-1906; Tukei, Vincent Joseph/0000-0002-9525-2600; Dareng, Eileen/0000-0003-0802-419X; Mulder, Nicola J/0000-0003-4905-0941; Everett, Dean/0000-0002-8458-6779; Kyobutungi, Catherine/0000-0002-5344-5631; Msefula, Chisomo/0000-0003-2304-886X; Smeeth, Liam/0000-0002-9168-6022; Fakunle, Eyitayo/0000-0001-7123-008X; Garry, Robert/0000-0002-5683-3250; Boima, Vincent/0000-0002-0562-6307; Mbanya, Jean Claude N/0000-0001-9651-8653; Akinyemi, Rufus/0000-0001-5286-428X; Kumuthini, Judit/0000-0002-8008-1917; Benkahla, Alia/0000-0001-9988-3250; ODURO, ABRAHAM/0000-0002-4191-7419; Matovu, Enock/0000-0003-0714-7032; Keavney, Bernard/0000-0001-9573-0812; Ramsay, Michele/0000-0002-4156-4801; Mahomva, Chengetai/0000-0001-7933-5441; Norris, Shane/0000-0001-7124-3788; Merle, Corinne/0000-0003-4229-365X; Kamal Kassim, Samar/0000-0002-4359-6620; Tangwa, Godfrey B./0000-0003-0062-8108; Parekh, Rulan/0000-0001-6313-5752; Happi, Christian/0000-0002-3056-6705; Rasooly, Rebekah/0000-0002-6357-5528; Adebamowo, Sally/0000-0003-4713-2433; Ofori-Acquah, Solomon/0000-0001-5000-3048; Crowther, Nigel/0000-0002-5766-1745; ElSayed, Ahmed/0000-0001-7422-7169; Zar, Heather/0000-0002-9046-759X; Motala, Ayesha/0000-0003-0517-1784; Bethke, Lara/0000-0002-1316-4704; Nguyen, Anh/0000-0001-6280-0490; Mpoloka, Sununguko/0000-0003-0147-1819; King, Mary-Claire/0000-0001-9426-1743; Mocumbi, Ana/0000-0002-9564-2860; Akpalu, Albert/0000-0002-4802-9852; lawlor, Rita/0000-0003-3160-0634; Hazelhurst, Scott/0000-0002-0581-149X; TOBIN, EKAETE/0000-0001-5059-807X; Amodu, Olukemi/0000-0003-1477-4229; Gomez-Olive, Francesc Xavier/0000-0002-4876-0848; Masiga, Daniel/0000-0001-7513-0887; Moxey-Mims, Marva/0000-0001-8542-9313; McCarthy, Mark/0000-0002-4393-0510; Kahn, Kathleen/0000-0003-3339-3931; Arulogun, Oyedunni/0000-0002-2173-4682; Anabwani, Gabriel/0000-0002-8555-4373; McIlleron, Helen/0000-0002-0982-6226; Adeyemo, Adebowale/0000-0002-3105-3231; Lesosky, Maia/0000-0002-2026-958X; Wachinou, Ablo Prudence/0000-0002-1024-9665	British Heart Foundation [RG/08/012/25941] Funding Source: Medline; FIC NIH HHS [U2R TW010679, D43 TW009140] Funding Source: Medline; Medical Research Council [MC_U123292700, G0800247] Funding Source: Medline; NHGRI NIH HHS [UH3 HG007008, U01 HG007044, U01 HG007459, U01 HG009716, U54 HG006939, U54 HG007479, U41 HG006941, U54 HG006947, U54 HG006938, U24 HG007008, UH2 HG007051] Funding Source: Medline; NHLBI NIH HHS [U24 HL135600] Funding Source: Medline; NIAID NIH HHS [R01 AI104621, U19 AI089696, U54 AI110398] Funding Source: Medline; NIMHD NIH HHS [P20 MD006899] Funding Source: Medline; NINDS NIH HHS [R01 NS107900] Funding Source: Medline; Wellcome Trust [099313, 093727, 098610, 085349, 095009, 095201, 104111, 098504] Funding Source: Medline; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish; Wellcome Trust [099310/Z/12/Z] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW009140] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010022] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362, U54HG006947, U41HG006941, UH2HG007051, U54HG007479, U01HG007459, U01HG007044, U54HG006938, UH3HG007008, U54HG006939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089696, R01AI104621, U54AI110398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002974] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER; MRC [MC_U123292700, G0800247] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2010, NATURE, V465, P990; Ayele FT, 2012, NEW ENGL J MED, V366, P1200, DOI 10.1056/NEJMoa1108448; Behar DM, 2011, AM J NEPHROL, V34, P452, DOI 10.1159/000332378; Bentley AR, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/748984; De Vre R., 2010, MCKINSEY Q REPORT; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Rotimi CN, 2010, GENOME MED, V2, DOI 10.1186/gm141; Tayo BO, 2013, INT UROL NEPHROL, V45, P485, DOI 10.1007/s11255-012-0263-4; Ulasi II, 2013, NEPHRON CLIN PRACT, V123, P123, DOI 10.1159/000353223	11	245	245	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1346	1348		10.1126/science.1251546	http://dx.doi.org/10.1126/science.1251546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948725	Green Accepted			2022-12-24	WOS:000337531700022
J	Chong, JJH; Yang, XL; Don, CW; Minami, E; Liu, YW; Weyers, JJ; Mahoney, WM; Van Biber, B; Cook, SM; Palpant, NJ; Gantz, JA; Fugate, JA; Muskheli, V; Gough, GM; Vogel, KW; Astley, CA; Hotchkiss, CE; Baldessari, A; Pabon, L; Reinecke, H; Gill, EA; Nelson, V; Kiem, HP; Laflamme, MA; Murry, CE				Chong, James J. H.; Yang, Xiulan; Don, Creighton W.; Minami, Elina; Liu, Yen-Wen; Weyers, Jill J.; Mahoney, William M., Jr.; Van Biber, Benjamin; Cook, Savannah M.; Palpant, Nathan J.; Gantz, Jay A.; Fugate, James A.; Muskheli, Veronica; Gough, G. Michael; Vogel, Keith W.; Astley, Cliff A.; Hotchkiss, Charlotte E.; Baldessari, Audrey; Pabon, Lil; Reinecke, Hans; Gill, Edward A.; Nelson, Veronica; Kiem, Hans-Peter; Laflamme, Michael A.; Murry, Charles E.			Human embryonic-stem-cell-derived cardiomyocytesregenerate non-humanprimate hearts	NATURE			English	Article							LARGE ANIMAL-MODELS; ENGRAFT	Pluripotent stem cells provide a potential solution to current epidemic rates of heart failure(1) by providing human cardiomyocytes to support heart regeneration(2). Studies of human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) in small-animal models have shown favourable effects of this treatment(3-7). However, it remains unknown whether clinical-scale hESC-CM transplantation is feasible, safe or can provide sufficient myocardial regeneration. Here we show that hESC-CMs can be produced at a clinical scale (more than one billion cells per batch) and cryopreserved with good viability. Using a non-human primate model of myocardial ischaemia followed by reperfusion, we show that cryopreservation and intramyocardial delivery of one billion hESC-CMs generates extensive remuscularization of the infarctedheart. The hESC-CMs showed progressive but incomplete maturation over a 3-month period. Grafts were perfused by host vasculature, and electromechanical junctions between graft and host myocytes were present within 2 weeks of engraftment. Importantly, grafts showed regular calcium transients that were synchronized to the host electrocardiogram, indicating electromechanical coupling. In contrast to small-animal models(7), nonfatal ventricular arrhythmias were observed in hESC-CM-engrafted primates. Thus, hESC-CMs can remuscularize substantial amounts of the infarcted monkey heart. Comparable remuscularization of a human heart should be possible, but potential arrhythmic complications need to be overcome.	[Chong, James J. H.; Yang, Xiulan; Minami, Elina; Liu, Yen-Wen; Weyers, Jill J.; Mahoney, William M., Jr.; Van Biber, Benjamin; Palpant, Nathan J.; Gantz, Jay A.; Fugate, James A.; Muskheli, Veronica; Pabon, Lil; Reinecke, Hans; Laflamme, Michael A.; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98109 USA; [Chong, James J. H.; Yang, Xiulan; Minami, Elina; Liu, Yen-Wen; Weyers, Jill J.; Mahoney, William M., Jr.; Van Biber, Benjamin; Palpant, Nathan J.; Gantz, Jay A.; Fugate, James A.; Muskheli, Veronica; Pabon, Lil; Reinecke, Hans; Laflamme, Michael A.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Chong, James J. H.] Westmead Hosp, Dept Cardiol, Westmead, NSW 2145, Australia; [Chong, James J. H.] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Chong, James J. H.; Yang, Xiulan; Minami, Elina; Liu, Yen-Wen; Weyers, Jill J.; Mahoney, William M., Jr.; Van Biber, Benjamin; Palpant, Nathan J.; Gantz, Jay A.; Fugate, James A.; Muskheli, Veronica; Pabon, Lil; Reinecke, Hans; Kiem, Hans-Peter; Laflamme, Michael A.; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Don, Creighton W.; Minami, Elina; Gill, Edward A.; Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98195 USA; [Cook, Savannah M.] Univ Washington, Inst Stem Cell & Regenerat Med, Dept Comparat Med, Seattle, WA 98109 USA; [Gantz, Jay A.; Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98109 USA; [Gough, G. Michael; Vogel, Keith W.; Astley, Cliff A.; Hotchkiss, Charlotte E.; Baldessari, Audrey] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Nelson, Veronica; Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Sydney; University of Sydney; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Murry, CE (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98109 USA.	murry@uw.edu	Gantz, Jay A/B-3581-2009; Laflamme, Michael/AAV-6791-2021; Mahoney, William/GQB-0802-2022; Chong, James/E-2924-2018; Palpant, Nathan/B-1641-2017; Weyers, Jill/AGX-7536-2022	Laflamme, Michael/0000-0001-5908-880X; Chong, James/0000-0002-5201-4856; Palpant, Nathan/0000-0002-9334-8107; Weyers, Jill/0000-0003-2358-1162	National Institutes of Health [P01HL094374, R01HL084642, U01HL100405, P01GM081619]; Institute of Translational Health Sciences/Primate Center Ignition Award; National Health and Medical Research Council of Australia; Australian-American Fulbright Commission; American Heart Association [12POST11940060, 12POST9330030]; Jose Carreras/E.D. Thomas Chair for Cancer Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117991, R01HL084642, P01HL094374, U01HL100405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619, T32GM008619, T32GM007266] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Translational Health Sciences/Primate Center Ignition Award; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian-American Fulbright Commission; American Heart Association(American Heart Association); Jose Carreras/E.D. Thomas Chair for Cancer Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Dupras, B. Brown, D. Rocha, E. Wilson, C. English, J. Randolph-Habecker and T. Goodpaster for assistance with these experiments. This work was supported by National Institutes of Health grants P01HL094374, R01HL084642, U01HL100405 and P01GM081619 and an Institute of Translational Health Sciences/Primate Center Ignition Award. J. J. H. C. was supported by National Health and Medical Research Council of Australia Overseas Training and Australian-American Fulbright Commission Fellowships. X.Y. is supported by an American Heart Association post-doctoral scholarship 12POST11940060. J. J. W. is supported by an American Heart Association post-doctoral scholarship 12POST9330030. H.-P. K. is a Markey Molecular Medicine investigator and the recipient of the Jose Carreras/E.D. Thomas Chair for Cancer Research.	Bel A, 2010, CIRCULATION, V122, pS118, DOI 10.1161/CIRCULATIONAHA.109.927293; Biermann M, 1998, J CARDIOVASC ELECTR, V9, P1348, DOI 10.1111/j.1540-8167.1998.tb00110.x; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Bretzner F, 2011, CELL STEM CELL, V8, P468, DOI 10.1016/j.stem.2011.04.012; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chen HSV, 2009, CIRCULATION, V120, P2496, DOI 10.1161/CIRCULATIONAHA.107.751412; Chong JJH, 2013, STEM CELLS DEV, V22, P1932, DOI 10.1089/scd.2012.0542; Dixon JA, 2009, CIRC-HEART FAIL, V2, P262, DOI 10.1161/CIRCHEARTFAILURE.108.814459; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Gandolfi F, 2011, THERIOGENOLOGY, V75, P1416, DOI 10.1016/j.theriogenology.2011.01.026; Gantz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046971; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; HOSHINO T, 1983, CIRCULATION, V67, P1109, DOI 10.1161/01.CIR.67.5.1109; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Laurita KR, 2001, AM J PHYSIOL-HEART C, V280, pH2053, DOI 10.1152/ajpheart.2001.280.5.H2053; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Weyers JJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000202; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu CH, 2011, REGEN MED, V6, P53, DOI 10.2217/RME.10.91; Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558; Zhu WZ, 2011, METHODS MOL BIOL, V767, P419, DOI 10.1007/978-1-61779-201-4_31	30	859	898	4	195	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					273	+		10.1038/nature13233	http://dx.doi.org/10.1038/nature13233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24776797	Green Accepted			2022-12-24	WOS:000337032400051
J	Forsberg, KJ; Patel, S; Gibson, MK; Lauber, CL; Knight, R; Fierer, N; Dantas, G				Forsberg, Kevin J.; Patel, Sanket; Gibson, Molly K.; Lauber, Christian L.; Knight, Rob; Fierer, Noah; Dantas, Gautam			Bacterial phylogeny structures soil resistomes across habitats	NATURE			English	Article							ANTIBIOTIC-RESISTANCE GENES; MICROBIAL COMMUNITIES; PROTEIN; DIVERSITY; IDENTIFICATION; MECHANISMS; ECOLOGY; UNIFRAC; DRIVES; TOOL	Ancient and diverse antibiotic resistance genes (ARGs) have previously been identified from soil(1-3), including genes identical to those in human pathogens(4). Despite the apparent overlap between soil and clinical resistomes(4-6), factors influencing ARG composition in soil and their movement between genomes and habitats remain largely unknown(3). General metagenome functions often correlate with the underlying structure of bacterial communities(7-12). However, ARGs are proposed to be highly mobile(4,5,13), prompting speculation that resistomes may not correlate with phylogenetic signatures or ecological divisions(13,14). To investigate these relationships, we performed functional metagenomic selections for resistance to 18 antibiotics from 18 agricultural and grassland soils. The 2,895 ARGs we discovered were mostly new, and represent all major resistance mechanisms(15). We demonstrate that distinct soil types harbour distinct resistomes, and that the addition of nitrogen fertilizer strongly influenced soil ARG content. Resistome composition also correlated with microbial phylogenetic and taxonomic structure, both across and within soil types. Consistent with this strong correlation, mobility elements (genes responsible for horizontal gene transfer between bacteria such as transposases and integrases) syntenic with ARGs were rare in soil by comparison with sequenced pathogens, suggesting that ARGs may not transfer between soil bacteria as readily as is observed between human pathogens. Together, our results indicate that bacterial community composition is the primary determinant of soil ARG content, challenging previous hypotheses that horizontal gene transfer effectively decouples resistomes from phylogeny(13,14).	[Forsberg, Kevin J.; Patel, Sanket; Gibson, Molly K.; Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Patel, Sanket; Dantas, Gautam] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Lauber, Christian L.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Howard Hughes Med Inst, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Dantas, Gautam] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Washington University (WUSTL)	Dantas, G (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	dantas@wustl.edu	Knight, Rob/D-1299-2010	Dantas, Gautam/0000-0003-0455-8370; Knight, Rob/0000-0002-0975-9019; FIERER, NOAH/0000-0002-6432-4261; Forsberg, Kevin/0000-0002-1545-8925	Children's Discovery Institute [MD-II-2011-117]; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives [SB2]; NIH Director's New Innovator Award [DP2-DK-098089]; Mr and Mrs Spencer T. Olin Fellowship for Women in Graduate Study at Washington University; NIGMS [GM 007067]; NHGRI Genome Analysis Training Program [T32 HG000045];  [DGE-1143954]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK098089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Children's Discovery Institute; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mr and Mrs Spencer T. Olin Fellowship for Women in Graduate Study at Washington University; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI Genome Analysis Training Program; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Pesesky for access to and assistance with the data set used to benchmark RAIphy's performance, B. Wang for suggested improvements to Illumina library preparation, the Genome Technology Access Center at Washington University in St Louis for generating Illumina sequence data, M. Sherman for discussions on modelling pathogen HGT potential, and members of the Dantas laboratory for discussions on the results and analyses presented here. This work was supported by awards to G. D. through the Children's Discovery Institute (MD-II-2011-117), the International Center for Advanced Renewable Energy and Sustainability at Washington University, the National Academies Keck Futures Initiatives (Synthetic Biology, SB2), and the NIH Director's New Innovator Award (DP2-DK-098089). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. M. K. G. is supported by a Mr and Mrs Spencer T. Olin Fellowship for Women in Graduate Study at Washington University. K.J.F. received support from the NIGMS Cell and Molecular Biology Training Grant (GM 007067) and from the NHGRI Genome Analysis Training Program (T32 HG000045). K.J.F. and M.K.G. are NSF graduate research fellows (award number DGE-1143954).	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke K. R., 2006, PRIMER V6 USER MANUA; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; de la Bastide M., 2007, ASSEMBLING GENOMIC D, V11; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Moore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078822; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nalbantoglu OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41; Pehrsson EC, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00145; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Zaneveld JR, 2010, NUCLEIC ACIDS RES, V38, P3869, DOI 10.1093/nar/gkq066; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	42	677	717	50	859	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					612	+		10.1038/nature13377	http://dx.doi.org/10.1038/nature13377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24847883	Green Submitted, Green Accepted			2022-12-24	WOS:000336457100047
J	Schmalen, I; Reischl, S; Wallach, T; Klemz, R; Grudziecki, A; Prabu, JR; Benda, C; Kramer, A; Wolf, E				Schmalen, Ira; Reischl, Silke; Wallach, Thomas; Klemz, Roman; Grudziecki, Astrid; Prabu, J. Rajan; Benda, Christian; Kramer, Achim; Wolf, Eva			Interaction of Circadian Clock Proteins CRY1 and PER2 Is Modulated by Zinc Binding and Disulfide Bond Formation	CELL			English	Article							CRYPTOCHROME1 TRANSGENIC MICE; CRYSTAL-STRUCTURE; MAMMALIAN CRY1; C-TERMINUS; RHYTHMS; IDENTIFICATION; DEGRADATION; NUCLEUS; CELLS	Period (PER) proteins are essential components of the mammalian circadian clock. They form complexes with cryptochromes (CRY), which negatively regulate CLOCK/BMAL1-dependent transactivation of clock and clock-controlled genes. To define the roles of mammalian CRY/PER complexes in the circadian clock, we have determined the crystal structure of a complex comprising the photolyase homology region of mouse CRY1 (mCRY1) and a C-terminal mouse PER2 (mPER2) fragment. mPER2 winds around the helical mCRY1 domain covering the binding sites of FBXL3 and CLOCK/BMAL1, but not the FAD binding pocket. Our structure revealed an unexpected zinc ion in one interface, which stabilizes mCRY1-mPER2 interactions in vivo. We provide evidence that mCRY1/mPER2 complex formation is modulated by an interplay of zinc binding and mCRY1 disulfide bond formation, which may be influenced by the redox state of the cell. Our studies may allow for the development of circadian and metabolic modulators.	[Schmalen, Ira; Prabu, J. Rajan; Benda, Christian; Wolf, Eva] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Wolf, Eva] Univ Munich, Butenandt Inst, Dept Physiol Chem, D-81377 Munich, Germany; [Reischl, Silke; Wallach, Thomas; Klemz, Roman; Grudziecki, Astrid; Kramer, Achim] Charite, Lab Chronobiol, D-10115 Berlin, Germany	Max Planck Society; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kramer, A (corresponding author), Charite, Lab Chronobiol, Hessische Str 3-4, D-10115 Berlin, Germany.	achim.kramer@charite.de; evawolf1@uni-mainz.de		Benda, Christian/0000-0001-5551-1332; Kramer, Achim/0000-0001-9671-6078	DFG grants [Wo695-3 (FOR526), Wo695-4, Wo695-6, SFB740/D2]; Studienstiftung des deutschen Volkes	DFG grants(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	We thank the beamline staff at Swiss Light Source (SLS, Villingen) for excellent assistance and the Max Planck Institute (MPI) of Biochemistry Crystallization Facility and Biochemistry Core Facility, especially Elisabeth Wehyer-Stingl, for technical assistance and support. Further, we thank Helmut Hartl and Jaroslava Obel (Department of Chemistry and Pharmacy, LMU Munich) for ICP-OES analysis. We thank our colleagues of the Department of Structural Cell Biology at the MPI of Biochemistry for help with data collection, fruitful discussions, and critical comments. We are indebted to Claire Basquin for assistance with ITC, thermofluor, and other biophysical methods and to Michaela Rode for assistance with insect cell culture. Anna Czarna, Sebastian Falk, Kai Hell, Debora Makino, Michael Taschner, and Justine Witosch are thanked for valuable suggestions and discussions. This study was supported by DFG grants Wo695-3 (FOR526), Wo695-4, and Wo695-6 to E.W., DFG grant SFB740/D2 to A.K., and a fellowship of the Studienstiftung des deutschen Volkes to I.S.	Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Barclay JL, 2013, AM J PHYSIOL-ENDOC M, V304, pE1053, DOI 10.1152/ajpendo.00512.2012; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Czarna A, 2011, J BIOL CHEM, V286, P22414, DOI 10.1074/jbc.M111.244749; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Evans JC, 2002, STRUCTURE, V10, P1159, DOI 10.1016/S0969-2126(02)00796-7; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; King DP, 1997, GENETICS, V146, P1049; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kucera N, 2012, P NATL ACAD SCI USA, V109, P3311, DOI 10.1073/pnas.1113280109; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Okano S, 2013, J DIABETES INVEST, V4, P428, DOI 10.1111/jdi.12080; Okano S, 2010, EUR J CLIN INVEST, V40, P1011, DOI 10.1111/j.1365-2362.2010.02359.x; Okano S, 2009, NEUROSCI LETT, V451, P246, DOI 10.1016/j.neulet.2009.01.014; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Tomita T, 2010, BBA-MOL CELL RES, V1803, P492, DOI 10.1016/j.bbamcr.2010.01.012; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Wu HH, 2000, BIOCHEM J, V351, P87, DOI 10.1042/0264-6021:3510087; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	44	121	123	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1203	1215		10.1016/j.cell.2014.03.057	http://dx.doi.org/10.1016/j.cell.2014.03.057			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855952	Bronze			2022-12-24	WOS:000336437200020
J	Aerts, JCJH; Botzen, WJW; Emanuel, K; Lin, N; de Moel, H; Michel-Kerjan, EO				Aerts, Jeroen C. J. H.; Botzen, W. J. Wouter; Emanuel, Kerry; Lin, Ning; de Moel, Hans; Michel-Kerjan, Erwann O.			Evaluating Flood Resilience Strategies for Coastal Megacities	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; YORK-CITY; CITIES; INSURANCE		[Aerts, Jeroen C. J. H.; Botzen, W. J. Wouter; de Moel, Hans] Vrije Univ Amsterdam, Inst Environm Studies, NL-1081 HV Amsterdam, Netherlands; [Emanuel, Kerry] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Lin, Ning] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Michel-Kerjan, Erwann O.] Univ Penn, Wharton Sch, Ctr Risk Management & Operat, Philadelphia, PA 19104 USA; [Michel-Kerjan, Erwann O.] Univ Penn, Wharton Sch, Informat Managment Dept, Philadelphia, PA 19104 USA	Vrije Universiteit Amsterdam; Massachusetts Institute of Technology (MIT); Princeton University; University of Pennsylvania; University of Pennsylvania	Aerts, JCJH (corresponding author), Vrije Univ Amsterdam, Inst Environm Studies, NL-1081 HV Amsterdam, Netherlands.	jeroen.aerts@vu.nl; erwan-nmk@wharton.upenn.edu	Aerts, Jeroen Cjh/M-8431-2013; de Moel, Hans/L-1311-2013; Botzen, Wouter/L-3123-2013	Botzen, Wouter/0000-0002-8563-4963; de Moel, Hans/0000-0002-6826-1974				Aerts JCJH, 2013, ANN NY ACAD SCI, V1294, P1, DOI 10.1111/nyas.12200; Aerts JCJH, 2013, RISK ANAL, V33, P772, DOI 10.1111/risa.12008; Aerts JCJH, 2011, ANN NY ACAD SCI, V1227, P1, DOI 10.1111/j.1749-6632.2011.06074.x; [Anonymous], 2013, NYC SPEC IN REB RES; Dawson RJ, 2011, GLOBAL ENVIRON CHANG, V21, P628, DOI 10.1016/j.gloenvcha.2011.01.013; Federal Emergency Management Agency, 2009, HAZ MH MR4 TECHN MAN; Hallegatte S., 2012, INVESTMENT DECISION; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; Intergovernmental Panel on Climate Change, 2012, MAN RISK EXTR EV DIS; Jongman B, 2012, GLOBAL ENVIRON CHANG, V22, P823, DOI 10.1016/j.gloenvcha.2012.07.004; Kabat P, 2005, NATURE, V438, P283, DOI 10.1038/438283a; Kunreuther H, 2013, NAT CLIM CHANGE, V3, P447, DOI [10.1038/NCLIMATE1740, 10.1038/nclimate1740]; Lin N, 2012, NAT CLIM CHANGE, V2, P462, DOI 10.1038/NCLIMATE1389; Michel-Kerjan E, 2012, NEW YORK TIMES  1125, pSR7; Michel-Kerjan E, 2012, NATURE, V491, P497, DOI 10.1038/491497a; Michel-Kerjan E, 2011, SCIENCE, V333, P408, DOI 10.1126/science.1202616; Nicholls R. J., 2008, WORKING PAPER; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Rosenzweig C, 2010, NATURE, V467, P909, DOI 10.1038/467909a; SwissRe, 2013, NAT CAT MAN MADE DIS; Tollefson J, 2012, NATURE, V491, P167, DOI 10.1038/491167a; World Bank, 2010, CLIMATE RISKS ADAPTA	23	279	294	20	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					472	474		10.1126/science.1248222	http://dx.doi.org/10.1126/science.1248222			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG1EK	24786064	Green Submitted			2022-12-24	WOS:000335157700025
J	Popow, J; Jurkin, J; Schleiffer, A; Martinez, J				Popow, Johannes; Jurkin, Jennifer; Schleiffer, Alexander; Martinez, Javier			Analysis of orthologous groups reveals archease and DDX1 as tRNA splicing factors	NATURE			English	Article							3,5-PHOSPHODIESTER LINKAGE; M(5)C METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; JUNCTION PHOSPHATE; SEQUENCE ALIGNMENT; VIRUS-REPLICATION; CELL EXTRACT; LIGASE; PROTEINS; COMPLEX	RNA ligases have essential roles in many cellular processes in eukaryotes, archaea and bacteria, including in RNA repair(1,2) and stress-induced splicing of messenger RNA(3). In archaea and eukaryotes, RNA ligases also have a role in transfer RNA splicing to generate functional tRNAs required for protein synthesis(4-7). We recently identified the human tRNA splicing ligase, a multimeric protein complex with RTCB (also known as HSPC117, C22orf28, FAAP and D10Wsu52e) as the essential subunit(8). The functions of the additional complex components ASW (also known as C2orf49), CGI-99 (also known as C14orf166), FAM98B and the DEAD-box helicase DDX1 in the context of RNA ligation have remained unclear. Taking advantage of clusters of eukaryotic orthologous groups, here we find that archease (ARCH; also known as ZBTB8OS), a protein of unknown function, is required for full activity of the human tRNA ligase complex and, in cooperation with DDX1, facilitates the formation of an RTCB-guanylate intermediate central to mammalian RNA ligation. Our findings define a role for DDX1 in the context of the human tRNA ligase complex and suggest that the widespread co-occurrence of archease and RtcB proteins implies evolutionary conservation of their functional interplay.	[Popow, Johannes; Jurkin, Jennifer; Martinez, Javier] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Popow, Johannes] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Schleiffer, Alexander] Res Inst Mol Pathol IMP, IMP IMBA Bioinformat Core Facil, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); European Molecular Biology Laboratory (EMBL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Martinez, J (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at		Popow, Johannes/0000-0002-1093-0936; Schleiffer, Alexander/0000-0001-6251-2747; Martinez, Javier/0000-0001-9152-7323	Fonds zur Forderung der wissenschaftlichen Forschung [P24687]; GEN-AU 3 research programme [820982]; Institute of Molecular Biotechnology of the Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 24687] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); GEN-AU 3 research programme; Institute of Molecular Biotechnology of the Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank S. Ameres, B. Beckmann, R. Hartmann, M. Hentze, M. Jantsch, B. Klaus, B. Mair, A.F. Nielsen, J.-M. Peters, T. Rapoport, R. Schroeder and S. Weitzer for help and advice, S. Bandini for the preparation of Flag-TSEN2 cell lines and critical discussions and J. Dammann and T. Lendl for technical assistance. This work has been funded by the Fonds zur Forderung der wissenschaftlichen Forschung (P24687), the GEN-AU 3 research programme (820982 Non-coding RNAs) (J.P.) and the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (J.M.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auxilien S, 2007, J BIOL CHEM, V282, P18711, DOI 10.1074/jbc.M607459200; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Canaves JM, 2004, PROTEINS, V56, P19, DOI 10.1002/prot.20141; Cao D, 2009, RNA, V15, P1971, DOI 10.1261/rna.1782209; Chakravarty AK, 2012, P NATL ACAD SCI USA, V109, P6072, DOI 10.1073/pnas.1201207109; Chan CM, 2009, SCIENCE, V326, P247, DOI 10.1126/science.1179480; Ciria R, 2004, BIOINFORMATICS, V20, P2307, DOI 10.1093/bioinformatics/bth216; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Desai K. K., 2014, NUCL ACIDS RES; Edgcomb SP, 2012, J MOL BIOL, V415, P61, DOI 10.1016/j.jmb.2011.10.032; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Godbout R, 1998, J BIOL CHEM, V273, P21161, DOI 10.1074/jbc.273.33.21161; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; KONARSKA M, 1981, NATURE, V293, P112, DOI 10.1038/293112a0; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Nandakumar J, 2008, MOL CELL, V31, P278, DOI 10.1016/j.molcel.2008.05.019; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; PERKINS KK, 1985, P NATL ACAD SCI USA, V82, P684, DOI 10.1073/pnas.82.3.684; PHIZICKY EM, 1992, J BIOL CHEM, V267, P4577; Popow J, 2012, CELL MOL LIFE SCI, V69, P2657, DOI 10.1007/s00018-012-0944-2; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Tanaka N, 2011, J BIOL CHEM, V286, P43134, DOI 10.1074/jbc.M111.302133; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	36	68	74	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					104	U508		10.1038/nature13284	http://dx.doi.org/10.1038/nature13284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870230	Green Accepted			2022-12-24	WOS:000338199400045
J	Zhong, XH; Du, JM; Hale, CJ; Gallego-Bartolome, J; Feng, SH; Vashisht, AA; Chory, J; Wohlschlegel, JA; Patel, DJ; Jacobsen, SE				Zhong, Xuehua; Du, Jiamu; Hale, Christopher J.; Gallego-Bartolome, Javier; Feng, Suhua; Vashisht, Ajay A.; Chory, Joanne; Wohlschlegel, James A.; Patel, Dinshaw J.; Jacobsen, Steven E.			Molecular Mechanism of Action of Plant DRM De Novo DNA Methyltransferases	CELL			English	Article							RNA-POLYMERASE V; METHYLATION; MAINTENANCE; REVEALS; ARGONAUTE4; DOMAINS; BINDING	DNA methylation is a conserved epigenetic generegulation mechanism. DOMAINS REARRANGED METHYLTRANSFERASE (DRM) is a key de novo methyltransferase in plants, but how DRM acts mechanistically is poorly understood. Here, we report the crystal structure of the methyltransferase domain of tobacco DRM (NtDRM) and reveal a molecular basis for its rearranged structure. NtDRM forms a functional homodimer critical for catalytic activity. We also show that Arabidopsis DRM2 exists in complex with the small interfering RNA (siRNA) effector ARGONAUTE4 (AGO4) and preferentially methylates one DNA strand, likely the strand acting as the template for RNA polymerase V- mediated noncoding RNA transcripts. This strand- biased DNA methylation is also positively correlated with strand- biased siRNA accumulation. These data suggest a model in which DRM2 is guided to target loci by AGO4- siRNA and involves base-pairing of associated siRNAs with nascent RNA transcripts.	[Zhong, Xuehua; Hale, Christopher J.; Gallego-Bartolome, Javier; Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Du, Jiamu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Gallego-Bartolome, Javier; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; Salk Institute; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; Salk Institute	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; jacobsen@ucla.edu	Du, Jiamu/I-1334-2013; Gallego-Bartolomé, Javier/AAV-7369-2020	Du, Jiamu/0000-0002-1337-0786; Gallego-Bartolome, Javier/0000-0003-2225-7168	Ruth L. Kirschstein National Research Service Award [F32GM096483-01]; Frontiers Science Program [LT000425/2012-L]; Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH [GM60398, GM094428]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, F32GM096483, R01GM060398, R01GM094428, R01GM089778] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frontiers Science Program; Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff members at Shanghai Synchrotron Radiation Facility (SSRF) and Advanced Photon Source for their support in diffraction data collection and the staff members at the UCLA BSCRC BioSequencing core for high-throughput sequencing. We are grateful to Craig Pikaard for discussions on strand-biased DNA methylation, Dr. Jianping Ding for access to data collection at the SSRF, and Dr. Eerappa Rajakumara for assistance with cloning. X.Z. is a research fellow of Ruth L. Kirschstein National Research Service Award (F32GM096483-01). C.J.H. is a HHMI fellow of the Damon Runyon Cancer Research Foundation. S. F. is a special fellow of the Leukemia & Lymphoma Society. J.G-B is a Human Frontiers Science Program fellow (LT000425/2012-L). This work was supported by the Abby Rockefeller Mauze Trust and Maloris and STARR foundations (to D.J.P.), NIH grant GM089778 and the UCLA Jonsson Cancer Center (to J.A.W.), NIH grant GM60398 (to S.E.J.), and NIH grant GM094428 (to J.C.). S.E.J. and J.C. are investigators of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Greenberg MVC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003946; Henderson IR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001182; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Johnson LM, 2014, NATURE, V507, P124, DOI 10.1038/nature12931; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee TF, 2012, EPIGENETICS-US, V7, P781, DOI 10.4161/epi.20290; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luo S, 2003, P NATL ACAD SCI USA, V100, P11133, DOI 10.1073/pnas.1831011100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Wada Y, 2003, J BIOL CHEM, V278, P42386, DOI 10.1074/jbc.M303892200; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zhang H, 2013, P NATL ACAD SCI USA, V110, P8290, DOI 10.1073/pnas.1300585110; Zhong XH, 2012, NAT STRUCT MOL BIOL, V19, P870, DOI 10.1038/nsmb.2354	36	182	191	4	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1050	1060		10.1016/j.cell.2014.03.056	http://dx.doi.org/10.1016/j.cell.2014.03.056			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855943	Bronze, Green Accepted			2022-12-24	WOS:000336437200009
J	Clayton, JA; Collins, FS				Clayton, Janine A.; Collins, Francis S.			NIH to balance sex in cell and animal studies	NATURE			English	Editorial Material							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS		[Clayton, Janine A.] US Natl Inst Hlth, Off Res Womens Hlth, Bethesda, MD 20892 USA; [Collins, Francis S.] US Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Clayton, JA (corresponding author), US Natl Inst Hlth, Off Res Womens Hlth, Bethesda, MD 20892 USA.	janine.clayton@nih.gov						Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Chen XQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002709; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Du S, 2014, P NATL ACAD SCI USA, V111, P2806, DOI 10.1073/pnas.1307091111; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; Fox HC, 2014, NEUROPSYCHOPHARMACOL, V39, P1527, DOI 10.1038/npp.2014.1; Franconi F, 2007, PHARMACOL RES, V55, P81, DOI 10.1016/j.phrs.2006.11.001; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Voskuhl RR, 2001, NEUROSCIENTIST, V7, P258, DOI 10.1177/107385840100700310; Wisdom AJ, 2013, J NEUROSCI RES, V91, P901, DOI 10.1002/jnr.23219; Zucker I, 2010, NATURE, V465, P690, DOI 10.1038/465690a	15	1012	1018	4	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					282	283		10.1038/509282a	http://dx.doi.org/10.1038/509282a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24834516	Green Published, Bronze			2022-12-24	WOS:000336121200013
J	Boissan, M; Montagnac, G; Shen, QF; Griparic, L; Guitton, J; Romao, M; Sauvonnet, N; Lagache, T; Lascu, I; Raposo, G; Desbourdes, C; Schlattner, U; Lacombe, ML; Polo, S; van der Bliek, AM; Roux, A; Chavrier, P				Boissan, Mathieu; Montagnac, Guillaume; Shen, Qinfang; Griparic, Lorena; Guitton, Jerome; Romao, Maryse; Sauvonnet, Nathalie; Lagache, Thibault; Lascu, Ioan; Raposo, Graca; Desbourdes, Celine; Schlattner, Uwe; Lacombe, Marie-Lise; Polo, Simona; van der Bliek, Alexander M.; Roux, Aurelien; Chavrier, Philippe			Nucleoside diphosphate kinases fuel dynamin superfamily proteins with GTP for membrane remodeling	SCIENCE			English	Article							FISSION; CARDIOLIPIN; MECHANISM; HOMOLOG; RINGS; NM23; AWD	Dynamin superfamily molecular motors use guanosine triphosphate (GTP) as a source of energy for membrane-remodeling events. We found that knockdown of nucleoside diphosphate kinases (NDPKs) NM23-H1/H2, which produce GTP through adenosine triphosphate (ATP)-driven conversion of guanosine diphosphate (GDP), inhibited dynamin-mediated endocytosis. NM23-H1/H2 localized at clathrin-coated pits and interacted with the proline-rich domain of dynamin. In vitro, NM23-H1/H2 were recruited to dynamin-induced tubules, stimulated GTP-loading on dynamin, and triggered fission in the presence of ATP and GDP. NM23-H4, a mitochondria-specific NDPK, colocalized with mitochondrial dynamin-like OPA1 involved in mitochondria inner membrane fusion and increased GTP-loading on OPA1. Like OPA1 loss of function, silencing of NM23-H4 but not NM23-H1/H2 resulted in mitochondrial fragmentation, reflecting fusion defects. Thus, NDPKs interact with and provide GTP to dynamins, allowing these motor proteins to work with high thermodynamic efficiency.	[Boissan, Mathieu; Montagnac, Guillaume; Romao, Maryse; Raposo, Graca; Chavrier, Philippe] Inst Curie, Res Ctr, Paris, France; [Boissan, Mathieu; Montagnac, Guillaume; Chavrier, Philippe] CNRS, UMR 144, Paris, France; [Boissan, Mathieu; Lacombe, Marie-Lise] Univ Paris 06, Paris, France; [Boissan, Mathieu; Lacombe, Marie-Lise] INSERM, UMR S 938, St Antoine Res Ctr, Paris, France; [Shen, Qinfang; Griparic, Lorena; van der Bliek, Alexander M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Guitton, Jerome] Hosp Civils Lyon, Pierre Benite, France; [Guitton, Jerome] Univ Lyon, Lyon, France; [Romao, Maryse; Raposo, Graca] CNRS, UMR 144, Paris, France; [Sauvonnet, Nathalie] Inst Pasteur, Unite Biol Interact Cellulaires, Paris, France; [Lagache, Thibault] Inst Pasteur, Quantitat Image Anal Unit, Paris, France; [Lascu, Ioan] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France; [Desbourdes, Celine; Schlattner, Uwe] Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget, Grenoble, France; [Desbourdes, Celine; Schlattner, Uwe] INSERM, U1055, Grenoble, France; [Polo, Simona] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Polo, Simona] Univ Milan, Dipartimento Sci Salute, Milan, Italy; [Roux, Aurelien] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Roux, Aurelien] Swiss Natl Ctr Competence Res Program Chem Biol, Geneva, Switzerland	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of Geneva	Boissan, M (corresponding author), Inst Curie, Res Ctr, Paris, France.	mathieu.boissan@inserm.fr; philippe.chavrier@curie.fr	CHAVRIER, Philippe/B-4707-2010; Schlattner, Uwe/D-1267-2009; Roux, Aurelien/AAU-1262-2021; Polo, Simona/P-3509-2014; Roux, Aurelien R/G-9541-2013; Lagache, Thibaut/AAC-1067-2020; CHAVRIER, Philippe/AAG-2645-2020	CHAVRIER, Philippe/0000-0002-7351-733X; Schlattner, Uwe/0000-0003-1159-5911; Roux, Aurelien R/0000-0002-6088-0711; Lagache, Thibaut/0000-0002-7033-4677; CHAVRIER, Philippe/0000-0002-7351-733X; Raposo, graca/0000-0001-9590-1298; sauvonnet, nathalie/0000-0003-0306-3376; Guitton, Jerome/0000-0001-6180-5708; Polo, Simona/0000-0001-5536-9399	Institut Curie; CNRS; Fondation ARC pour la Recherche sur le Cancer; Groupement des Entreprises Francaises contre le Cancer; Fondation pour la Recherche Medicale; Human Frontier Science Program; Swiss National Fund for Research Grant; European Research Council	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Groupement des Entreprises Francaises contre le Cancer; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Human Frontier Science Program(Human Frontier Science Program); Swiss National Fund for Research Grant; European Research Council(European Research Council (ERC)European Commission)	We thank P. De Camilli, E. Smythe, and J. Bertoglio for reagents; S. L. Schmid and M. Mettlen for discussion; the Nikon Imaging Center@Institut Curie & Centre National de la Recherche Scientifique (CNRS) for image acquisition; and I. Hurbain for EM quantification. This work was supported by Institut Curie, CNRS, Fondation ARC pour la Recherche sur le Cancer, Groupement des Entreprises Francaises contre le Cancer, Fondation pour la Recherche Medicale, the Human Frontier Science Program, the Swiss National Fund for Research Grant, and the European Research Council.	Binns DD, 2000, BIOCHEMISTRY-US, V39, P7188, DOI 10.1021/bi000033r; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Lascu I, 1997, J BIOL CHEM, V272, P15599, DOI 10.1074/jbc.272.25.15599; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Nallamothu G, 2008, MOL CELL BIOL, V28, P1964, DOI 10.1128/MCB.01743-07; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Schlattner U, 2013, J BIOL CHEM, V288, P111, DOI 10.1074/jbc.M112.408633; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072	21	92	93	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1510	1515		10.1126/science.1253768	http://dx.doi.org/10.1126/science.1253768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970086	Green Accepted			2022-12-24	WOS:000337889900049
J	Fan, J; Ye, JB; Kamphorst, JJ; Shlomi, T; Thompson, CB; Rabinowitz, JD				Fan, Jing; Ye, Jiangbin; Kamphorst, Jurre J.; Shlomi, Tomer; Thompson, Craig B.; Rabinowitz, Joshua D.			Quantitative flux analysis reveals folate-dependent NADPH production	NATURE			English	Article							PYRUVATE-KINASE M2; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; METABOLOMIC ANALYSIS; SERINE SYNTHESIS; CANCER; DEHYDROGENASE; GLYCINE; CONTRIBUTES; INHIBITION; MECHANISM	ATP is the dominant energy source in animals for mechanical and electrical work (for example, muscle contraction or neuronal firing). For chemical work, there is an equally important role for NADPH, which powers redox defence and reductive biosynthesis(1). The most direct route to produce NADPH from glucose is the oxidative pentose phosphate pathway, with malic enzyme sometimes also important(2,3). Although the relative contribution of glycolysis and oxidative phosphorylation to ATP production has been extensively analysed, similar analysis of NADPH metabolism has been lacking. Here we demonstrate the ability to directly track, by liquid chromatography-mass spectrometry, the passage of deuterium from labelled substrates into NADPH, and combine this approach with carbon labelling and mathematical modelling to measure NADPH fluxes. In proliferating cells, the largest contributor to cytosolic NADPH is the oxidative pentose phosphate pathway. Surprisingly, a nearly comparable contribution comes from serine-driven one-carbon metabolism, in which oxidation of methylene tetrahydrofolate to 10-formyl-tetrahydrofolate is coupled to reduction of NADP(+) to NADPH. Moreover, tracing of mitochondrial one-carbon metabolism revealed complete oxidation of 10-formyl-tetrahydrofolate to make NADPH. As folate metabolism has not previously been considered an NADPH producer, confirmation of its functional significance was undertaken through knockdown of methylenetetrahydrofolate dehydrogenase (MTHFD) genes. Depletion of either the cytosolic or mitochondrial MTHFD isozyme resulted in decreased cellular NADPH/NADP(+) and reduced/oxidized glutathione ratios (GSH/GSSG) and increased cell sensitivity to oxidative stress. Thus, although the importance of folate metabolism for proliferating cells has been long recognized and attributed to its function of producing one-carbon units for nucleic acid synthesis, another crucial function of this pathway is generating reducing power.	[Fan, Jing; Kamphorst, Jurre J.; Shlomi, Tomer; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08540 USA; [Ye, Jiangbin; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Princeton University; Memorial Sloan Kettering Cancer Center; Technion Israel Institute of Technology	Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08540 USA.	joshr@genomics.princeton.edu	Rabinowitz, Joshua/GPP-4019-2022; Ye, Jiangbin/A-1094-2007	Rabinowitz, Joshua/0000-0002-1247-4727; Ye, Jiangbin/0000-0003-1117-4869; Fan, Jing/0000-0002-5326-5358; Kamphorst, Jurre/0000-0002-2042-5474	Stand Up To Cancer; NIH [CA163591, AI097382, CA105463, CA104838, GM071508]; Hope [HFCR-11-03-01]; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA105463, R01CA163591, P01CA104838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	Stand Up To Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The iBMK parental and Akt cell lines were generously provided by E. White. The <SUP>14</SUP>C-labelled CO<INF>2</INF> release experiments were conducted with the help of E. Suh and H. Coller. NMR measurement of formate was carried out with the help of I. Lewis. We thank H. Djaballah and the High-Throughput Drug Screening Facility at MSKCC for supplying the hairpins, and M. Vander Heiden and his laboratory members for discussions. This work was supported by Stand Up To Cancer and NIH R01 grants CA163591, AI097382, and CA105463, P01 grant CA104838 and P50 grant GM071508. J.F. is a Howard Hughes Medical Institute (HHMI) international student research fellow. J.J.K. is a Hope Funds for Cancer Research fellow (HFCR-11-03-01).	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Ayromlou H, 2011, J PAK MED ASSOC, V61, P1096; Bradley KK, 2001, J PHARMACOL EXP THER, V299, P748; Brekke EMF, 2012, J CEREBR BLOOD F MET, V32, P1788, DOI 10.1038/jcbfm.2012.85; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Christensen KE, 2008, VITAM HORM, V79, P393, DOI 10.1016/S0083-6729(08)00414-7; Circu ML, 2011, ANTIOXID REDOX SIGN, V14, P2151, DOI 10.1089/ars.2010.3489; Degenhardt K, 2002, CANCER CELL, V2, P193, DOI 10.1016/S1535-6108(02)00126-5; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fan TWM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-79; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; LORANS G, 1981, BIOCHEM BIOPH RES CO, V101, P1018, DOI 10.1016/0006-291X(81)91850-7; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Pawelek PD, 1998, BIOCHEMISTRY-US, V37, P1109, DOI 10.1021/bi971906t; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Price NE, 1996, ARCH BIOCHEM BIOPHYS, V336, P215, DOI 10.1006/abbi.1996.0551; SHREVE DS, 1980, J BIOL CHEM, V255, P2670; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Voet D., 2005, BIOCHEMISTRY-US; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; YUAN ZY, 1984, J BIOL CHEM, V259, P6748; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	40	676	689	11	302	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					298	+		10.1038/nature13236	http://dx.doi.org/10.1038/nature13236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24805240	Green Accepted			2022-12-24	WOS:000337032400056
J	Ivanova, NN; Schwientek, P; Tripp, HJ; Rinke, C; Pati, A; Huntemann, M; Visel, A; Woyke, T; Kyrpides, NC; Rubin, EM				Ivanova, Natalia N.; Schwientek, Patrick; Tripp, H. James; Rinke, Christian; Pati, Amrita; Huntemann, Marcel; Visel, Axel; Woyke, Tanja; Kyrpides, Nikos C.; Rubin, Edward M.			Stop codon reassignments in the wild	SCIENCE			English	Article							METAGENOME; BACTERIA; EVOLUTION; SEQUENCE; UGA	The canonical genetic code is assumed to be deeply conserved across all domains of life with very few exceptions. By scanning 5.6 trillion base pairs of metagenomic data for stop codon reassignment events, we detected recoding in a substantial fraction of the >1700 environmental samples examined. We observed extensive opal and amber stop codon reassignments in bacteriophages and of opal in bacteria. Our data indicate that bacteriophages can infect hosts with a different genetic code and demonstrate phage-host antagonism based on code differences. The abundance and diversity of genetic codes present in environmental organisms should be considered in the design of engineered organisms with altered genetic codes in order to preclude the exchange of genetic information with naturally occurring species.	[Ivanova, Natalia N.; Schwientek, Patrick; Tripp, H. James; Rinke, Christian; Pati, Amrita; Huntemann, Marcel; Visel, Axel; Woyke, Tanja; Kyrpides, Nikos C.; Rubin, Edward M.] Dept Energy Joint Genome Inst DOE JGI, Walnut Creek, CA 94598 USA; [Visel, Axel; Rubin, Edward M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Visel, Axel] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Merced	Rubin, EM (corresponding author), Dept Energy Joint Genome Inst DOE JGI, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov	Rinke, Christian/ABA-3139-2021; Rinke, Christian/AAE-8100-2019; Huntemann, Marcel/HCH-8928-2022; Kyrpides, Nikos C./A-6305-2014; Visel, Axel/A-9398-2009	Rinke, Christian/0000-0003-4632-1187; Huntemann, Marcel/0000-0002-1284-3748; Kyrpides, Nikos C./0000-0002-6131-0462; Visel, Axel/0000-0002-4130-7784; Ivanova, Natalia/0000-0002-5802-9485	Office of Science of DOE [DE-AC02-05CH11231]	Office of Science of DOE(United States Department of Energy (DOE))	We thank the DOE JGI production sequencing, IMG, and Genomes OnLine Database teams for their support and J. Kim, A. Tadmor, and A. Nord for reviewing the manuscript. The work conducted by the DOE JGI was supported in part by the Office of Science of DOE under contract DE-AC02-05CH11231. Supporting data can be accessed through www.jgi.doe.gov and can be downloaded from http://portal.nersc.gov/dna/microbial/prokpubs/recoding.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; BOVE JM, 1993, CLIN INFECT DIS, V17, pS10, DOI 10.1093/clinids/17.Supplement_1.S10; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; INAGAKI Y, 1993, NUCLEIC ACIDS RES, V21, P1335, DOI 10.1093/nar/21.6.1335; Ivanova N, 2010, ENVIRON MICROBIOL, V12, P1803, DOI 10.1111/j.1462-2920.2010.02270.x; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; NIRENBERG M, 1965, P NATL ACAD SCI USA, V53, P1161, DOI 10.1073/pnas.53.5.1161; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; SCHNEIDER SU, 1989, MOL GEN GENET, V218, P445, DOI 10.1007/BF00332408; Shackelton LA, 2008, J THEOR BIOL, V254, P128, DOI 10.1016/j.jtbi.2008.05.024; Tu AHT, 2001, PLASMID, V45, P122, DOI 10.1006/plas.2000.1501; Voelker LL, 1999, GENE, V233, P101, DOI 10.1016/S0378-1119(99)00150-X; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041	24	72	76	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					909	913		10.1126/science.1250691	http://dx.doi.org/10.1126/science.1250691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855270				2022-12-24	WOS:000336233800050
J	Yee, C; Yang, W; Hekimi, S				Yee, Callista; Yang, Wen; Hekimi, Siegfried			The Intrinsic Apoptosis Pathway Mediates the Pro-Longevity Response to Mitochondrial ROS in C. elegans	CELL			English	Article							LIFE-SPAN EXTENSION; ELECTRON-TRANSPORT; SUPEROXIDE DISMUTASES; OXIDATIVE DAMAGE; DNA-DAMAGE; RESPIRATION; STRESS; INCREASE; BEHAVIOR; CELLS	The increased longevity of the C. elegans electron transport chain mutants isp-1 and nuo-6 is mediated by mitochondrial ROS (mtROS) signaling. Here we show that the mtROS signal is relayed by the conserved, mitochondria-associated, intrinsic apoptosis signaling pathway (CED-9/Bcl2, CED-4/Apaf1, and CED-3/Casp9) triggered by CED-13, an alternative BH3-only protein. Activation of the pathway by an elevation of mtROS does not affect apoptosis but protects from the consequences of mitochondrial dysfunction by triggering a unique pattern of gene expression that modulates stress sensitivity and promotes survival. In vertebrates, mtROS induce apoptosis through the intrinsic pathway to protect from severely damaged cells. Our observations in nematodes demonstrate that sensing of mtROS by the apoptotic pathway can, independently of apoptosis, elicit protective mechanisms that keep the organism alive under stressful conditions. This results in extended longevity when mtROS generation is inappropriately elevated. These findings clarify the relationships between mitochondria, ROS, apoptosis, and aging.	[Yee, Callista; Yang, Wen; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	siegfried.hekimi@mcgill.ca	Yee, Callista/N-9574-2019	Yee, Callista/0000-0002-2928-492X	Canadian Institutes of Health Research [MOP-114891, MOP-123295, MOP-97869, INE-117889]; McGill University; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University; NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Robyn Branicky for thoughtfully commenting on the manuscript, Eve Bigras for technical assistance, and Steve Hodgkinson for technical advice. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The work was funded by grants from the Canadian Institutes of Health Research to S.H.: MOP-114891, MOP-123295, MOP-97869 and INE-117889 (through the CoEN initiative (www.coen.org), as well as by McGill University. S.H. is Strathcona Chair of Zoology and Campbell Chair of Developmental Biology.	Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Baruah A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004097; Dasgupta N, 2007, CURR BIOL, V17, P1954, DOI 10.1016/j.cub.2007.10.017; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Ermolaeva MA, 2013, NATURE, V501, P416, DOI 10.1038/nature12452; Fairlie WD, 2006, CELL DEATH DIFFER, V13, P426, DOI 10.1038/sj.cdd.4401762; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Gartner Anton, 2008, WormBook, P1, DOI 10.1895/wormbook.1.145.1; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lu N, 2009, METHODS MOL BIOL, V559, P357, DOI 10.1007/978-1-60327-017-5_25; Lu Y, 2011, P NATL ACAD SCI USA, V108, pE813, DOI 10.1073/pnas.1103218108; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Pinan-Lucarre B, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001331; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Suthammarak W, 2013, AGING CELL, V12, P1132, DOI 10.1111/acel.12144; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Ventura N, 2009, AGING CELL, V8, P380, DOI 10.1111/j.1474-9726.2009.00482.x; Walter L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001084; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030	40	258	270	1	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					897	909		10.1016/j.cell.2014.02.055	http://dx.doi.org/10.1016/j.cell.2014.02.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813612	Green Accepted, Bronze			2022-12-24	WOS:000335765500017
J	Anderson, ST; Kaforou, M; Brent, AJ; Wright, VJ; Banwell, CM; Chagaluka, G; Crampin, AC; Dockrell, HM; French, N; Hamilton, MS; Hibberd, ML; Kern, F; Langford, PR; Ling, L; Mlotha, R; Ottenhoff, THM; Pienaar, S; Pillay, V; Scott, JAG; Twahir, H; Wilkinson, RJ; Coin, LJ; Heyderman, RS; Levin, M; Eley, B				Anderson, Suzanne T.; Kaforou, Myrsini; Brent, Andrew J.; Wright, Victoria J.; Banwell, Claire M.; Chagaluka, George; Crampin, Amelia C.; Dockrell, Hazel M.; French, Neil; Hamilton, Melissa S.; Hibberd, Martin L.; Kern, Florian; Langford, Paul R.; Ling, Ling; Mlotha, Rachel; Ottenhoff, Tom H. M.; Pienaar, Sandy; Pillay, Vashini; Scott, J. Anthony G.; Twahir, Hemed; Wilkinson, Robert J.; Coin, Lachlan J.; Heyderman, Robert S.; Levin, Michael; Eley, Brian		ILULU Consortium; KIDS TB Study Grp	Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAMMA RELEASE ASSAYS; PULMONARY TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; LATENT TUBERCULOSIS; CHILDREN; CONSENSUS; DISEASE; BIOMARKERS; SIGNATURE; INFECTION	BackgroundImproved diagnostic tests for tuberculosis in children are needed. We hypothesized that transcriptional signatures of host blood could be used to distinguish tuberculosis from other diseases in African children who either were or were not infected with the human immunodeficiency virus (HIV). MethodsThe study population comprised prospective cohorts of children who were undergoing evaluation for suspected tuberculosis in South Africa (655 children), Malawi (701 children), and Kenya (1599 children). Patients were assigned to groups according to whether the diagnosis was culture-confirmed tuberculosis, culture-negative tuberculosis, diseases other than tuberculosis, or latent tuberculosis infection. Diagnostic signatures distinguishing tuberculosis from other diseases and from latent tuberculosis infection were identified from genomewide analysis of RNA expression in host blood. ResultsWe identified a 51-transcript signature distinguishing tuberculosis from other diseases in the South African and Malawian children (the discovery cohort). In the Kenyan children (the validation cohort), a risk score based on the signature for tuberculosis and for diseases other than tuberculosis showed a sensitivity of 82.9% (95% confidence interval [CI], 68.6 to 94.3) and a specificity of 83.6% (95% CI, 74.6 to 92.7) for the diagnosis of culture-confirmed tuberculosis. Among patients with cultures negative for Mycobacterium tuberculosis who were treated for tuberculosis (those with highly probable, probable, or possible cases of tuberculosis), the estimated sensitivity was 62.5 to 82.3%, 42.1 to 80.8%, and 35.3 to 79.6%, respectively, for different estimates of actual tuberculosis in the groups. In comparison, the sensitivity of the Xpert MTB/RIF assay for molecular detection of M. tuberculosis DNA in cases of culture-confirmed tuberculosis was 54.3% (95% CI, 37.1 to 68.6), and the sensitivity in highly probable, probable, or possible cases was an estimated 25.0 to 35.7%, 5.3 to 13.3%, and 0%, respectively; the specificity of the assay was 100%. ConclusionsRNA expression signatures provided data that helped distinguish tuberculosis from other diseases in African children with and those without HIV infection. (Funded by the European Union Action for Diseases of Poverty Program and others).	[Anderson, Suzanne T.; Banwell, Claire M.; Kern, Florian] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Kaforou, Myrsini; Brent, Andrew J.; Wright, Victoria J.; Hamilton, Melissa S.; Langford, Paul R.; Wilkinson, Robert J.; Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Infect Dis, Paediat Sect, London, England; [Kaforou, Myrsini; Brent, Andrew J.; Wright, Victoria J.; Hamilton, Melissa S.; Langford, Paul R.; Heyderman, Robert S.; Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Infect Dis, Wellcome Trust Ctr Clin Trop Med, London, England; [Kaforou, Myrsini; Coin, Lachlan J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Crampin, Amelia C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Brent, Andrew J.] Univ Oxford, Nuffield Div Clin Lab Sci, Oxford, England; [French, Neil] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Anderson, Suzanne T.; Banwell, Claire M.; Chagaluka, George; Mlotha, Rachel; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Chagaluka, George; Mlotha, Rachel] Queen Elizabeth Cent Hosp, Dept Pediat, Blantyre, Malawi; [Crampin, Amelia C.; French, Neil] Karonga Prevent Study, Chilumba, Karonga Distric, Malawi; [Brent, Andrew J.; Scott, J. Anthony G.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Twahir, Hemed] Coast Prov Gen Hosp, Dept Paediat, Mombasa, Kenya; [Hibberd, Martin L.; Ling, Ling] Genome Inst Singapore, Singapore, Singapore; [Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Pienaar, Sandy; Pillay, Vashini; Eley, Brian] Red Cross War Mem Childrens Hosp, Cape Town, South Africa; [Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Coin, Lachlan J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Brighton; University of Sussex; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Malawi; Malawi Epidemiology and Intervention Research Unit; Kenya Medical Research Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cape Town; University of Queensland	Levin, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Paediat Sect, Norfolk Pl, London W2 1PG, England.		Langford, Paul/AAU-4189-2020; Coin, Lachlan JM/A-9001-2014; Coin, Lachlan/O-4976-2019; Kaforou, Myrsini/L-2470-2019; Kern, Florian/AAE-6784-2022	Langford, Paul/0000-0002-6368-4724; Coin, Lachlan JM/0000-0002-4300-455X; Coin, Lachlan/0000-0002-4300-455X; Kaforou, Myrsini/0000-0001-9878-4007; Kern, Florian/0000-0002-0368-8408; Levin, Michael/0000-0003-2767-6919; Wright, Victoria/0000-0001-7826-1516; Hibberd, Martin/0000-0001-8587-1849; Heyderman, Robert/0000-0003-4573-449X; Maitland, Kathryn/0000-0002-0007-0645; French, Neil/0000-0003-4814-8293; Dockrell, Hazel/0000-0003-1869-9107; Berkley, James/0000-0002-1236-849X; Gideon, Hannah/0000-0002-4443-2134; Wilkinson, Robert/0000-0002-2753-1800; Crampin, Amelia/0000-0002-1513-4330; Mendelson, Marc/0000-0001-6668-3893	European Union Action for Diseases of Poverty Program [Sante-2006-105-061]; Malawi-Liverpool-Wellcome Trust Clinical Research Program Core Grant, United Kingdom [084679-Z-08-Z]; Wellcome Trust [084323, 088316, 081835, 081697, 077092]; National Institute for Health Research [NF-SI-0611-10230] Funding Source: researchfish	European Union Action for Diseases of Poverty Program; Malawi-Liverpool-Wellcome Trust Clinical Research Program Core Grant, United Kingdom; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by a grant from the European Union Action for Diseases of Poverty Program (Sante-2006-105-061), a Malawi-Liverpool-Wellcome Trust Clinical Research Program Core Grant, United Kingdom (084679-Z-08-Z, to Dr. Heyderman), and additional grants from the Wellcome Trust (084323 and 088316, to Dr. Wilkinson; 081835, to Dr. Scott; and 081697, to Dr. Brent); the study also made use of infrastructure and staff at the Wellcome Trust-supported programs in Blantyre, Malawi, and Kilifi, Kenya, the University of Cape Town (084323, 077092), the Imperial College Wellcome Trust Centre for Clinical Tropical Medicine, and the Imperial College Wellcome Trust Centre for Global Health Research.	Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brent AJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/865436; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Cuevas LE, 2012, PAEDIATR INT CHILD H, V32, DOI 10.1179/2046904712Z.00000000076; Cuevas LE, 2012, J INFECT DIS, V205, pS209, DOI 10.1093/infdis/jir879; Drobac PC, 2012, PEDIATRICS, V130, pE373, DOI 10.1542/peds.2011-3048; Eamranond P, 2001, INT J TUBERC LUNG D, V5, P594; Graham SM, 2009, TUBERCULOSIS COMPREH, P154; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Hatherill M, 2012, CLIN INFECT DIS, V54, P493, DOI 10.1093/cid/cir823; Hatherill M, 2010, B WORLD HEALTH ORGAN, V88, P312, DOI 10.2471/BLT.09.062893; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Kampmann B, 2009, EUR RESPIR J, V33, P1374, DOI 10.1183/09031936.00153408; Lesho E, 2011, TUBERCULOSIS, V91, P390, DOI 10.1016/j.tube.2011.07.002; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631; Marais BJ, 2005, ARCH DIS CHILD, V90, P1162, DOI 10.1136/adc.2004.070797; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Pearce EC, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/401896; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Swingler GH, 2005, ARCH DIS CHILD, V90, P1153, DOI 10.1136/adc.2004.062315; Verhagen LM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-74; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Whittaker E, 2012, EXPERT REV RESP MED, V6, P385, DOI [10.1586/ers.12.36, 10.1586/ERS.12.36]; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zar HJ, 2010, EXPERT REV ANTI-INFE, V8, P277, DOI [10.1586/eri.10.9, 10.1586/ERI.10.9]; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	35	237	252	4	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1712	1723		10.1056/NEJMoa1303657	http://dx.doi.org/10.1056/NEJMoa1303657			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24785206	Green Accepted, Green Published			2022-12-24	WOS:000335405200009
J	Zahreddine, HA; Culjkovic-Kraljacic, B; Assouline, S; Gendron, P; Romeo, AA; Morris, SJ; Cormack, G; Jaquith, JB; Cerchietti, L; Cocolakis, E; Amri, A; Bergeron, J; Leber, B; Becker, MW; Pei, SS; Jordan, CT; Miller, WH; Borden, KLB				Zahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Assouline, Sarit; Gendron, Patrick; Romeo, Andrea A.; Morris, Stephen J.; Cormack, Gregory; Jaquith, James B.; Cerchietti, Leandro; Cocolakis, Eftihia; Amri, Abdellatif; Bergeron, Julie; Leber, Brian; Becker, Michael W.; Pei, Shanshan; Jordan, Craig T.; Miller, Wilson H., Jr.; Borden, Katherine L. B.			The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; LIVER-MICROSOMES; ONCOGENE EIF4E; INHIBITION; EXPRESSION; TRIALS; AZT	Drug resistance is a major hurdle in oncology. Responses of acute myeloid leukaemia (AML) patients to cytarabine (Ara-C)-based therapies are often short lived with a median overall survival of months(1-4). Therapies are under development to improve outcomes and include targeting the eukaryotic translation initiation factor (eIF4E) with its inhibitor ribavirin(5-7). In a Phase II clinical trial in poor prognosis AML(5), ribavirin monotherapy yielded promising responses including remissions; however, all patients relapsed. Here we identify a novel form of drug resistance to ribavirin and Ara-C. We observe that the sonic hedgehog transcription factor glioma-associated protein 1 (GLI1) and the UDP glucuronosyltransferase (UGT1A) family of enzymes are elevated in resistant cells. UGT1As add glucuronic acid to many drugs, modifying their activity in diverse tissues(8). GLI1 alone is sufficient to drive UGT1A-dependent glucuronidation of ribavirin and Ara-C, and thus drug resistance. Resistance is overcome by genetic or pharmacological inhibition of GLI1, revealing a potential strategy to overcome drug resistance in some patients.	[Zahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Gendron, Patrick; Cormack, Gregory; Amri, Abdellatif; Borden, Katherine L. B.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Zahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Gendron, Patrick; Cormack, Gregory; Amri, Abdellatif; Borden, Katherine L. B.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Assouline, Sarit; Cocolakis, Eftihia; Miller, Wilson H., Jr.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Romeo, Andrea A.; Morris, Stephen J.; Jaquith, James B.] Pharmascience Inc, Montreal, PQ H4P 2T4, Canada; [Cerchietti, Leandro] Cornell Univ, Div Hematol & Oncol, Dept Med, Weill Cornell Med Coll, New York, NY 10021 USA; [Bergeron, Julie] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; [Leber, Brian] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; [Becker, Michael W.] Univ Rochester, Dept Med, Div Hematol Oncol, Rochester, NY 14627 USA; [Pei, Shanshan; Jordan, Craig T.] Univ Colorado Denver, Dept Med,Univ, Div Hematol, Aurora, CO 80045 USA	Universite de Montreal; Universite de Montreal; Lady Davis Institute; McGill University; Cornell University; Universite de Montreal; McMaster University; University of Rochester; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Borden, KLB (corresponding author), Univ Montreal, Inst Res Immunol & Canc, POB 6128, Montreal, PQ H3C 3J7, Canada.	katherine.borden@umontreal.ca	Romeo, Andrea Antonino/AAY-2175-2021; PEI, SHANSHAN/D-8200-2016; jordan, craig/D-7666-2014	PEI, SHANSHAN/0000-0001-9619-2614; jordan, craig/0000-0003-0869-3465; Cerchietti, Leandro/0000-0003-0608-1350; Gendron, Patrick/0000-0001-9829-2600; Leber, Brian/0000-0001-5502-1480; Becker, Michael/0000-0001-9890-8815; Romeo, Andrea Antonino/0000-0002-1579-2480	National Institutes of Health [RO1 80728, 98571]; IRICoR; Leukemia and Lymphoma Society USA; Cole Foundation Fellowship; CNRS Lebanon Fellowship; NATIONAL CANCER INSTITUTE [R01CA098571, R01CA080728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IRICoR; Leukemia and Lymphoma Society USA(Leukemia and Lymphoma Society); Cole Foundation Fellowship; CNRS Lebanon Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for reading of the manuscript by A. Kentsis, M. Osborne, F. Pettersson, S. del Rincon and C. Perreault. We are grateful for the use of Pharmascience facilities thanks to M. Goodman and D. Goodman, for specimens from the Banques de Cellules Leucemiques Du Quebec (BCLQ), and for technical discussions with M. Ouellet. We thank nursing and support staff at all the clinical sites, and A. Ramteke for technical support. K.L.B.B. is supported by funds from the National Institutes of Health (RO1 80728 and 98571), IRICoR and Translational Research Program grants from the Leukemia and Lymphoma Society USA. K.L.B.B. holds a Canada Research Chair and H.A.Z. holds a Cole Foundation Fellowship and a CNRS Lebanon Fellowship.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Barbier O, 2000, DRUG METAB DISPOS, V28, P497; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Culjkovic-Kraljacic B, 2012, CELL REP, V2, P207, DOI 10.1016/j.celrep.2012.07.007; Deschler B, 2006, HAEMATOLOGICA, V91, P1513; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Dutton G., 1980, GLUCURONIDATION DRUG; Engtrakul JJ, 2005, DRUG METAB DISPOS, V33, P1621, DOI 10.1124/dmd.105.005058; Fisher MB, 2000, DRUG METAB DISPOS, V28, P560; Hiddemann W, 1999, J CLIN ONCOL, V17, P3569, DOI 10.1200/JCO.1999.17.11.3569; HORNY HP, 1994, HUM PATHOL, V25, P810, DOI 10.1016/0046-8177(94)90251-8; Jarvis SM, 1998, BRIT J PHARMACOL, V123, P1587, DOI 10.1038/sj.bjp.0701775; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kraljacic BC, 2011, LEUKEMIA, V25, P1197, DOI 10.1038/leu.2011.57; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; LoRusso PM, 2011, CLIN CANCER RES, V17, P5774, DOI 10.1158/1078-0432.CCR-11-0972; Mas C, 2010, BIOCHEM PHARMACOL, V80, P712, DOI 10.1016/j.bcp.2010.04.016; Olah E, 1996, ANTICANCER RES, V16, P2469; Pulsoni A, 2004, HAEMATOLOGICA, V89, P296; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; WILLIS RC, 1978, P NATL ACAD SCI USA, V75, P3042, DOI 10.1073/pnas.75.7.3042	23	137	143	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					90	U459		10.1038/nature13283	http://dx.doi.org/10.1038/nature13283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870236	Green Accepted			2022-12-24	WOS:000338199400042
J	Fakhri, N; Wessel, AD; Willms, C; Pasquali, M; Klopfenstein, DR; MacKintosh, FC; Schmidt, CF				Fakhri, Nikta; Wessel, Alok D.; Willms, Charlotte; Pasquali, Matteo; Klopfenstein, Dieter R.; MacKintosh, Frederick C.; Schmidt, Christoph F.			High-resolution mapping of intracellular fluctuations using carbon nanotubes	SCIENCE			English	Article							MULTIPLE-PARTICLE-TRACKING; BLEBBISTATIN INHIBITION; CELL MECHANICS; LIVING CELLS; LIVE CELLS; MYOSIN-II; SINGLE; TRANSPORT; MOVEMENT; MOTORS	Cells are active systems with molecular force generation that drives complex dynamics at the supramolecular scale. We present a quantitative study of molecular motions in cells over times from milliseconds to hours. Noninvasive tracking was accomplished by imaging highly stable near-infrared luminescence of single-walled carbon nanotubes targeted to kinesin-1 motor proteins in COS-7 cells. We observed a regime of active random "stirring" that constitutes an intermediate mode of transport, different from both thermal diffusion and directed motor activity. High-frequency motion was found to be thermally driven. At times greater than 100 milliseconds, nonequilibrium dynamics dominated. In addition to directed transport along microtubules, we observed strong random dynamics driven by myosins that result in enhanced nonspecific transport. We present a quantitative model connecting molecular mechanisms to mesoscopic fluctuations.	[Fakhri, Nikta; Wessel, Alok D.; Willms, Charlotte; Klopfenstein, Dieter R.; Schmidt, Christoph F.] Univ Gottingen, Drittes Phys Inst Biophys, D-37077 Gottingen, Germany; [Pasquali, Matteo] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem & Biomol Engn, Dept Chem, Houston, TX 77005 USA; [MacKintosh, Frederick C.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands	University of Gottingen; Rice University; Vrije Universiteit Amsterdam	MacKintosh, FC (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	fcmack@gmail.com; christoph.schmidt@phys.uni-goettingen.de	MacKintosh, Fred C/A-9450-2008; MacKintosh, Frederick/AAB-9332-2021; Fakhri, Nikta/B-4657-2008; Schmidt, Christoph/G-3787-2011; Pasquali, Matteo/A-2489-2008	MacKintosh, Fred C/0000-0002-2607-9541; MacKintosh, Frederick/0000-0002-2607-9541; Fakhri, Nikta/0000-0003-1261-7465; Schmidt, Christoph/0000-0003-2864-6973; Pasquali, Matteo/0000-0001-5951-395X	Center for Nanoscale Microscopy and Molecular Physiology of the Brain - Deutsche Forschungsgemeinschaft; Collaborative Research Center - Deutsche Forschungsgemeinschaft [SFB 937]; Foundation for Fundamental Research on Matter of the Netherlands Organization for Scientific Research, Welch Foundation [C-1668]; NSF [NSF PHY11-25915]; Human Frontier Science Program Fellowship	Center for Nanoscale Microscopy and Molecular Physiology of the Brain - Deutsche Forschungsgemeinschaft; Collaborative Research Center - Deutsche Forschungsgemeinschaft; Foundation for Fundamental Research on Matter of the Netherlands Organization for Scientific Research, Welch Foundation; NSF(National Science Foundation (NSF)); Human Frontier Science Program Fellowship(Human Frontier Science Program)	We thank L. Cognet, J. Enderlein, M. Guo, J. Lippincott-Schwartz, and D. A. Weitz for helpful discussions; I. Schaap and M. Platen for atomic force microscopy measurements; and the Kavli Institute for Theoretical Physics (University of California, Santa Barbara) for hospitality and useful discussions. Supported by the Center for Nanoscale Microscopy and Molecular Physiology of the Brain and the Collaborative Research Center SFB 937 (Project A2), both funded by the Deutsche Forschungsgemeinschaft, as well as by the Foundation for Fundamental Research on Matter of the Netherlands Organization for Scientific Research, Welch Foundation grant C-1668, and NSF grant NSF PHY11-25915. N.F. was supported by a Human Frontier Science Program Fellowship. N. F. and C. F. S. are inventors on a provisional U. S. patent application on the method used in the paper, filed by Georg-August-Universitat. The single-walled carbon nanotubes are available from M. P. under a material transfer agreement with Rice University.	Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Basu A, 2008, EUR PHYS J E, V27, P149, DOI 10.1140/epje/i2008-10364-9; Berciaud S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077402; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Courty S, 2006, NANO LETT, V6, P1491, DOI 10.1021/nl060921t; Crocker JC, 2007, METHOD CELL BIOL, V83, P141, DOI 10.1016/S0091-679X(07)83007-X; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fakhri N, 2010, SCIENCE, V330, P1804, DOI 10.1126/science.1197321; Fakhri N, 2009, P NATL ACAD SCI USA, V106, P14219, DOI 10.1073/pnas.0904148106; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Howard J., 2001, MECH MOTOR PROTEINS; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huber F, 2013, ADV PHYS, V62, P1, DOI 10.1080/00018732.2013.771509; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kim H, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/1/016601; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kulic IM, 2008, P NATL ACAD SCI USA, V105, P10011, DOI 10.1073/pnas.0800031105; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Levine AJ, 2009, J PHYS CHEM B, V113, P3820, DOI 10.1021/jp808192w; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; MacKintosh FC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018104; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; Rubinstein M., 2003, POLYM PHYS CHEM; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Tsyboulski DA, 2005, NANO LETT, V5, P975, DOI 10.1021/nl050366f; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Weisman RB, 2010, ANAL BIOANAL CHEM, V396, P1015, DOI 10.1007/s00216-009-3062-8	39	143	145	2	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1031	1035		10.1126/science.1250170	http://dx.doi.org/10.1126/science.1250170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876498				2022-12-24	WOS:000336495800046
J	Gumbinger, C; Reuter, B; Stock, C; Sauer, T; Wietholter, H; Bruder, I; Rode, S; Kern, R; Ringleb, P; Hennerici, MG; Hacke, W				Gumbinger, Christoph; Reuter, Bjoern; Stock, Christian; Sauer, Tamara; Wiethoelter, Horst; Bruder, Ingo; Rode, Susanne; Kern, Rolf; Ringleb, Peter; Hennerici, Michael G.; Hacke, Werner		AG Schlaganfall	Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE ISCHEMIC-STROKE; INTRAVENOUS THROMBOLYSIS; SAFE IMPLEMENTATION; POOLED ANALYSIS; SITS-ISTR; ALTEPLASE; ATLANTIS; GERMANY; NINDS; ECASS	Objective To study the time dependent effectiveness of thrombolytic therapy for acute ischaemic stroke in daily clinical practice. Design A retrospective cohort study using data from a large scale, comprehensive population based state-wide stroke registry in Germany. Setting All 148 hospitals involved in acute stroke care in a large state in southwest Germany with 10.4 million inhabitants. Participants Data from 84 439 patients with acute ischaemic stroke were analysed, 10 263 (12%) were treated with thrombolytic therapy and 74 176 (88%) were not treated. Main outcome measures Primary endpoint was the dichotomised score on a modified Rankin scale at discharge ("favourable outcome" score 0 or 1 or "unfavourable outcome" score 2-6) analysed by binary logistic regression. Patients treated with recombinant tissue plasminogen activator (rtPA) were categorised according to time from onset of stroke to treatment. Analogous analyses were conducted for the association between rtPA treatment of stroke and in-hospital mortality. As a co-primary endpoint the chance of a lower modified Rankin scale score at discharge was analysed by ordinal logistic regression analysis (shift analysis). Results After adjustment for characteristics of patients, hospitals, and treatment, rtPA was associated with better outcome in a time dependent pattern. The number needed to treat ranged from 4.5 (within first 1.5 hours after onset; odds ratio 2.49) to 18.0 (up to 4.5 hours; odds ratio 1.26), while mortality did not vary up to 4.5 hours. Patients treated with rtPA beyond 4.5 hours (including mismatch based approaches) showed a significantly better outcome only in dichotomised analysis (odds ratio 1.25, 95% confidence interval 1.01 to 1.55) but the mortality risk was higher (1.45, 1.08 to 1.92). Conclusion The effectiveness of thrombolytic therapy in daily clinical practice might be comparable with the effectiveness shown in randomised clinical trials and pooled analysis. Early treatment was associated with favourable outcome in daily clinical practice, which underlines the importance of speeding up the process for thrombolytic therapy in hospital and before admission to achieve shorter time from door to needle and from onset to treatment for thrombolytic therapy.	[Gumbinger, Christoph; Ringleb, Peter; Hacke, Werner] Heidelberg Univ, Dept Neurol Heidelberg, D-69120 Heidelberg, Germany; [Reuter, Bjoern; Sauer, Tamara; Kern, Rolf; Hennerici, Michael G.] Heidelberg Univ, Dept Neurol Mannheim, D-68167 Mannheim, Germany; [Stock, Christian] Heidelberg Univ, Inst Med Biometry & Informat, D-69120 Heidelberg, Germany; [Bruder, Ingo; Rode, Susanne] Baden Wuerttemberg Hosp Federat, Off Qual Assurance Hosp GeQiK Stuttgart, D-70191 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hacke, W (corresponding author), Heidelberg Univ, Dept Neurol Heidelberg, D-69120 Heidelberg, Germany.	werner.hacke@med.uni-heidelberg.de	Hacke, Werner/ABE-8661-2020; Stock, Christian/F-6180-2015	Stock, Christian/0000-0002-3493-3234; Gumbinger, Christoph/0000-0002-6137-1169	department of neurology, University of Heidelberg, Heidelberg; department of neurology, Mannheim Campus; German network "Health Services Research Baden-Wuerttemberg" of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wuerttemberg; Institute for Applied Quality Improvement and Research in Health Care GmbH (AQUA Institute)	department of neurology, University of Heidelberg, Heidelberg; department of neurology, Mannheim Campus; German network "Health Services Research Baden-Wuerttemberg" of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wuerttemberg; Institute for Applied Quality Improvement and Research in Health Care GmbH (AQUA Institute)	This study was funded by internal research funds from the departments of neurology, University of Heidelberg, Heidelberg, and Mannheim Campus. The study was supported by the young scientists programme of the German network "Health Services Research Baden-Wuerttemberg" of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wuerttemberg, in collaboration with the Institute for Applied Quality Improvement and Research in Health Care GmbH (AQUA Institute) (scholarship holder CG). The sources of funding had no role in study design, data collection, analyses, interpretation, and decision to submit the article for publication.	Ahmed N, 2013, JAMA NEUROL, V70, P837, DOI 10.1001/jamaneurol.2013.406; Ahmed N, 2010, LANCET NEUROL, V9, P866, DOI 10.1016/S1474-4422(10)70165-4; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Bender R, 2002, J CLIN EPIDEMIOL, V55, P525, DOI 10.1016/S0895-4356(01)00510-8; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Dirks M, 2013, LANCET NEUROL, V12, P120, DOI 10.1016/S1474-4422(12)70304-6; Emberson JR, 2014, ISC 2014 SAN DIEG CA; Gumbinger C, 2013, NEUROEPIDEMIOLOGY, V41, P161, DOI 10.1159/000354356; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Ovbiagele B, 2010, CEREBROVASC DIS, V29, P50, DOI 10.1159/000255974; Palm F, 2010, STROKE, V41, P1865, DOI 10.1161/STROKEAHA.110.592642; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Saposnik G, 2005, NEUROLOGY, V65, P1169, DOI 10.1212/01.wnl.0000180687.75907.4b; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Scott PA, 2013, LANCET NEUROL, V12, P139, DOI 10.1016/S1474-4422(12)70311-3; Sobesky J, 2007, CEREBROVASC DIS, V24, P56, DOI 10.1159/000103117; Strbian D, 2010, STROKE, V41, P712, DOI 10.1161/STROKEAHA.109.571976; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4	25	58	64	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2014	348								g3429	10.1136/bmj.g3429	http://dx.doi.org/10.1136/bmj.g3429			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EO	24879819	Green Published, hybrid			2022-12-24	WOS:000336742800002
J	Saponaro, M; Kantidakis, T; Mitter, R; Kelly, GP; Heron, M; Williams, H; Soding, J; Stewart, A; Svejstrup, JQ				Saponaro, Marco; Kantidakis, Theodoros; Mitter, Richard; Kelly, Gavin P.; Heron, Mark; Williams, Hannah; Soeding, Johannes; Stewart, Aengus; Svejstrup, Jesper Q.			RECQL5 Controls Transcript Elongation and Suppresses Genome Instability Associated with Transcription Stress	CELL			English	Article							RNA-POLYMERASE-II; COMMON FRAGILE SITES; HUMAN GENES; INITIATION; REPLICATION; HELICASE; MECHANISMS; CONSEQUENCES; PROMOTERS; ALIGNMENT	RECQL5 is the solemember of theRECQfamily of helicases associated with RNA polymerase II ( RNAPII). We now show that RECQL5 is a general elongation factor that is important for preserving genome stability during transcription. Depletion or overexpression of RECQL5 results in corresponding shifts in the genome- wide RNAPII density profile. Elongation is particularly affected, with RECQL5 depletion causing a striking increase in the average rate, concurrent with increased stalling, pausing, arrest, and/ or backtracking ( transcription stress). RECQL5 therefore controls the movement of RNAPII across genes. Loss of RECQL5 also results in the loss or gain of genomic regions, with the breakpoints of lost regions located in genes and common fragile sites. The chromosomal breakpoints overlap with areas of elevated transcription stress, suggesting thatRECQL5 suppresses such stress and its detrimental effects, and thereby prevents genome instability in the transcribed region of genes.	[Saponaro, Marco; Kantidakis, Theodoros; Williams, Hannah; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Mitter, Richard; Kelly, Gavin P.; Stewart, Aengus] Canc Res UK London Res Inst, Bioinformat & Biostat Grp, London WC2A 3LY, England; [Heron, Mark; Williams, Hannah] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Heron, Mark; Williams, Hannah] Univ Munich, CIPSM, D-81377 Munich, Germany	Cancer Research UK; Cancer Research UK; University of Munich; University of Munich	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England.	Jesper.Svejstrup@cancer.org.uk	Saponaro, Marco/M-1854-2015; Kelly, Gavin/ABG-2715-2021; Söding, Johannes/A-3341-2013; Kantidakis, Theo/Q-8031-2016	Saponaro, Marco/0000-0002-9302-2553; Kelly, Gavin/0000-0001-7219-560X; Söding, Johannes/0000-0001-9642-8244; Kantidakis, Theo/0000-0002-3515-5235; Mitter, Richard/0000-0002-1279-3760; Kantidakis, Theodoros/0000-0002-6901-422X; Stewart, Aengus/0000-0001-5182-653X; Svejstrup, Jesper/0000-0003-4964-6147; Williams, Hannah/0000-0003-1828-9845	Association for International Cancer Research; European Research Council; Cancer Research UK; Cancer Research UK [11567] Funding Source: researchfish; Worldwide Cancer Research [09-0730] Funding Source: researchfish	Association for International Cancer Research; European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	This work was supported by grants from Association for International Cancer Research, the European Research Council, and Cancer Research UK (to J.Q.S.). We thank Nick Matthews and staff in the Advanced Sequencing Facility for their contribution; the Cell Services facility for assistance with cell lines; and members of the Svejstrup laboratory for comments on the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Arlt MF, 2012, CURR OPIN GENET DEV, V22, P204, DOI 10.1016/j.gde.2012.01.009; Aygun O, 2009, J BIOL CHEM, V284, P23197, DOI 10.1074/jbc.M109.015750; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Fungtammasan A, 2012, GENOME RES, V22, P993, DOI 10.1101/gr.134395.111; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hartmann H, 2013, GENOME RES, V23, P181, DOI 10.1101/gr.139881.112; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Hu YD, 2005, MOL CELL BIOL, V25, P3431, DOI 10.1128/MCB.25.9.3431-3442.2005; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Hu YD, 2009, MOL BIOL CELL, V20, P114, DOI 10.1091/mbc.E08-06-0565; Islam MN, 2010, MOL CELL BIOL, V30, P2460, DOI 10.1128/MCB.01583-09; Izumikawa K, 2008, BIOCHEM J, V413, P505, DOI 10.1042/BJ20071392; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Le Tallec B, 2013, CELL REP, V4, P420, DOI 10.1016/j.celrep.2013.07.003; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, MOL CELL BIOL, V31, P2090, DOI 10.1128/MCB.01137-10; Liu YL, 2010, DNA REPAIR, V9, P325, DOI 10.1016/j.dnarep.2010.01.006; Louie E, 2003, GENOME RES, V13, P2594, DOI 10.1101/gr.1317703; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Park P, 2008, CANCER INVEST, V26, P923, DOI 10.1080/07357900801993432; Popuri V, 2012, DNA REPAIR, V11, P624, DOI 10.1016/j.dnarep.2012.05.001; Ramamoorthy M., 2012, MOL BIOL CELL, V23, P4273; Ramamoorthy M, 2013, CARCINOGENESIS, V34, P2218, DOI 10.1093/carcin/bgt183; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	41	117	119	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1037	1049		10.1016/j.cell.2014.03.048	http://dx.doi.org/10.1016/j.cell.2014.03.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24836610	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000336437200008
J	Christensen, TR				Christensen, Torben R.			Climate science: Understand Arctic methane variability	NATURE			English	Editorial Material									[Christensen, Torben R.] Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22100 Lund, Sweden; [Christensen, Torben R.] Aarhus Univ, Arctic Res Ctr, DK-8000 Aarhus C, Denmark	Lund University; Aarhus University	Christensen, TR (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22100 Lund, Sweden.			Christensen, Torben R./0000-0002-4917-148X				Bousquet P, 2011, ATMOS CHEM PHYS, V11, P3689, DOI 10.5194/acp-11-3689-2011; EHHALT DH, 1974, TELLUS, V26, P58, DOI 10.1111/j.2153-3490.1974.tb01952.x; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/ngeo1955, 10.1038/NGEO1955]; Mastepanov M, 2013, BIOGEOSCIENCES, V10, P5139, DOI 10.5194/bg-10-5139-2013; McGuire AD, 2012, BIOGEOSCIENCES, V9, P3185, DOI 10.5194/bg-9-3185-2012; Parmentier FJW, 2013, NAT CLIM CHANGE, V3, P195, DOI [10.1038/nclimate1784, 10.1038/NCLIMATE1784]; Shakhova N, 2014, NAT GEOSCI, V7, P64, DOI [10.1038/NGEO2007, 10.1038/ngeo2007]; Vonk JE, 2013, NAT GEOSCI, V6, P675, DOI 10.1038/ngeo1937; Walter KM, 2007, PHILOS T R SOC A, V365, P1657, DOI 10.1098/rsta.2007.2036	9	18	19	0	64	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					279	281		10.1038/509279a	http://dx.doi.org/10.1038/509279a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24834515	Bronze, Green Published			2022-12-24	WOS:000336121200012
J	Haynes, BF; Verkoczy, L				Haynes, Barton F.; Verkoczy, Laurent			Host Controls of HIV Neutralizing Antibodies	SCIENCE			English	Editorial Material							AUTOREACTIVITY; TOLERANCE; AFFINITY; BROAD; 4E10; 2F5		[Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Sch Med, Duke Human Vaccine Inst, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Sch Med, Duke Human Vaccine Inst, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Dept Med, Durham, NC 27710 USA.	barton.haynes@duke.edu			Intramural NIH HHS [Z01 AI000645] Funding Source: Medline; NIAID NIH HHS [UM1 AI100645, UM1-AI00645, R01-AI87202, R01 AI087202] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087202, UM1AI100645, Z01AI000645] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P17107, DOI 10.1073/pnas.1002717107; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doyle-Cooper C, 2013, J IMMUNOL, V191, P3186, DOI 10.4049/jimmunol.1301285; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI13051; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Verkoczy L, 2013, J IMMUNOL, V191, P2538, DOI 10.4049/jimmunol.1300971; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977	15	56	58	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					588	589		10.1126/science.1254990	http://dx.doi.org/10.1126/science.1254990			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812389	Green Accepted			2022-12-24	WOS:000335537400028
J	Bhatia, V; Barroso, SI; Garcia-Rubio, ML; Tumini, E; Herrera-Moyano, E; Aguilera, A				Bhatia, Vaibhav; Barroso, Sonia I.; Garcia-Rubio, Maria L.; Tumini, Emanuela; Herrera-Moyano, Emilia; Aguilera, Andres			BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2	NATURE			English	Article							REPLICATION FORK PROGRESSION; FANCONI-ANEMIA; TRANSCRIPTION ELONGATION; GENOMIC INSTABILITY; IN-VITRO; COMPLEX; IMPAIRMENT; STABILITY; GENES; RECOMBINATION	Genome instability is central to ageing, cancer and other diseases. It is not only proteins involved in DNA replication or the DNA damage response (DDR) that are important for maintaining genome integrity: from yeast to higher eukaryotes, mutations in genes involved in pre-mRNA splicing and in the biogenesis and export of messenger ribonudeoprotein (mRNP) also induce DNA damage and genome instability. This instability is frequently mediated by R-loops formed by DNA-RNA hybrids and a displaced single-stranded DNA(1). Here we show that the human TREX-2 complex, which is involved in mRNP biogenesis and export, prevents genome instability as determined by the accumulation of gamma-H2AX (Ser-139 phosphorylated histone H2AX) and 53BP1 foci and single-cell electrophoresis in cells depleted of the TREX-2 subunits PCID2, GANP and DSSI. We show that the BRCA2 repair factor, which binds to DSS1, also associates with PCID2 in the cell. The use of an enhanced green fluorescent protein-tagged hybrid-binding domain of RNase HI and the S9.6 antibody did not detect R-loops in TREX-2-depleted cells, but did detect the accumulation of R-loops in BRCA2-depleted cells. The results indicate that R-loops are frequently formed in cells and that BRCA2 is required for their processing. This link between BRCA2 and RNA-mediated genome instability indicates that R-loops may be a chief source of replication stress and cancer-associated instability.	[Bhatia, Vaibhav; Barroso, Sonia I.; Garcia-Rubio, Maria L.; Tumini, Emanuela; Herrera-Moyano, Emilia; Aguilera, Andres] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Aguilera, A (corresponding author), Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Ave Amer Vespucio S-N, Seville 41092, Spain.	aguilo@us.es	Aguilera, Andres/L-1825-2014; Herrera-Moyano, Emilia/AAV-4989-2020; Tumini, Emanuela/C-2163-2017; Barroso, Sonia/F-2288-2016; Herrera-Moyano, Emilia/F-3314-2016; Garcia-Rubio, Maria/C-2061-2017	Aguilera, Andres/0000-0003-4782-1714; Herrera-Moyano, Emilia/0000-0003-3948-3874; Tumini, Emanuela/0000-0001-9412-9355; Barroso, Sonia/0000-0002-0062-2016; Garcia-Rubio, Maria/0000-0003-0981-0555; bhatia, vaibhav/0000-0003-4553-7824	Spanish Ministry of Economy and Competitiveness [C5D2007-00015, BFU2010-16372]; Junta de Andalucia [CVI4567]; European Union (FEDER)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Andalucia(Junta de Andalucia); European Union (FEDER)(European Commission)	We thank J.C. Reyes and A. G. Rondon for comments on the manuscript,and D. Haun for style supervision. Research was funded by grants from the Spanish Ministry of Economy and Competitiveness (Consolider C5D2007-00015 and BFU2010-16372), the Junta de Andalucia (CVI4567) and the European Union (FEDER).	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Bayani J., 2005, CURR PROTOC CELL BIO, V25; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Castellano-Pozo M, 2012, EMBO REP, V13, P923, DOI 10.1038/embor.2012.119; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Ellisdon AM, 2012, NAT STRUCT MOL BIOL, V19, P328, DOI 10.1038/nsmb.2235; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gravells P, 2013, ONCOGENE, V32, P5338, DOI 10.1038/onc.2012.627; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jani D, 2012, NUCLEIC ACIDS RES, V40, P4562, DOI 10.1093/nar/gks059; Kaneko S, 2007, P NATL ACAD SCI USA, V104, P17620, DOI 10.1073/pnas.0708866104; Li J, 2006, ONCOGENE, V25, P1186, DOI 10.1038/sj.onc.1209153; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; ten Asbroek ALMA, 2002, EUR J BIOCHEM, V269, P583, DOI 10.1046/j.0014-2956.2001.02686.x; Tous C, 2007, BIOCHEM BIOPH RES CO, V360, P428, DOI 10.1016/j.bbrc.2007.06.098; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Umlauf D, 2013, J CELL SCI, V126, P2656, DOI 10.1242/jcs.118000; Urtishak KA, 2009, J BIOL CHEM, V284, P8768, DOI 10.1074/jbc.M806103200; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	33	313	321	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					362	+		10.1038/nature13374	http://dx.doi.org/10.1038/nature13374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24896180				2022-12-24	WOS:000338992200039
J	Moreno-Estrada, A; Gignoux, CR; Fernandez-Lopez, JC; Zakharia, F; Sikora, M; Contreras, AV; Acuna-Alonzo, V; Sandoval, K; Eng, C; Romero-Hidalgo, S; Ortiz-Tello, P; Robles, V; Kenny, EE; Nuno-Arana, I; Barquera-Lozano, R; Macin-Perez, G; Granados-Arriola, J; Huntsman, S; Galanter, JM; Via, M; Ford, JG; Chapela, R; Rodriguez-Cintron, W; Rodriguez-Santana, JR; Romieu, I; Sienra-Monge, JJ; Navarro, BD; London, SJ; Ruiz-Linares, A; Garcia-Herrera, R; Estrada, K; Hidalgo-Miranda, A; Jimenez-Sanchez, G; Carnevale, A; Soberon, X; Canizales-Quinteros, S; Rangel-Villalobos, H; Silva-Zolezzi, I; Burchard, EG; Bustamante, CD				Moreno-Estrada, Andres; Gignoux, Christopher R.; Carlos Fernandez-Lopez, Juan; Zakharia, Fouad; Sikora, Martin; Contreras, Alejandra V.; Acuna-Alonzo, Victor; Sandoval, Karla; Eng, Celeste; Romero-Hidalgo, Sandra; Ortiz-Tello, Patricia; Robles, Victoria; Kenny, Eimear E.; Nuno-Arana, Ismael; Barquera-Lozano, Rodrigo; Macin-Perez, Gaston; Granados-Arriola, Julio; Huntsman, Scott; Galanter, Joshua M.; Via, Marc; Ford, Jean G.; Chapela, Rocio; Rodriguez-Cintron, William; Rodriguez-Santana, Jose R.; Romieu, Isabelle; Jose Sienra-Monge, Juan; del Rio Navarro, Blanca; London, Stephanie J.; Ruiz-Linares, Andres; Garcia-Herrera, Rodrigo; Estrada, Karol; Hidalgo-Miranda, Alfredo; Jimenez-Sanchez, Gerardo; Carnevale, Alessandra; Soberon, Xavier; Canizales-Quinteros, Samuel; Rangel-Villalobos, Hector; Silva-Zolezzi, Irma; Burchard, Esteban Gonzalez; Bustamante, Carlos D.			HUMAN GENETICS The genetics of Mexico recapitulates Native American substructure and affects biomedical traits	SCIENCE			English	Article							ANCESTRY; ADMIXTURE; POPULATIONS; CHROMOSOME; DIVERSITY; SAMPLE; RISK	Mexico harbors great cultural and ethnic diversity, yet fine-scale patterns of human genome-wide variation from this region remain largely uncharacterized. We studied genomic variation within Mexico from over 1000 individuals representing 20 indigenous and 11 mestizo populations. We found striking genetic stratification among indigenous populations within Mexico at varying degrees of geographic isolation. Some groups were as differentiated as Europeans are from East Asians. Pre-Columbian genetic substructure is recapitulated in the indigenous ancestry of admixed mestizo individuals across the country. Furthermore, two independently phenotyped cohorts of Mexicans and Mexican Americans showed a significant association between subcontinental ancestry and lung function. Thus, accounting for fine-scale ancestry patterns is critical for medical and population genetic studies within Mexico, in Mexican-descent populations, and likely in many other populations worldwide.	[Moreno-Estrada, Andres; Zakharia, Fouad; Sikora, Martin; Sandoval, Karla; Ortiz-Tello, Patricia; Robles, Victoria; Kenny, Eimear E.; Rodriguez-Santana, Jose R.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Gignoux, Christopher R.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Carlos Fernandez-Lopez, Juan; Contreras, Alejandra V.; Romero-Hidalgo, Sandra; Rodriguez-Santana, Jose R.; Garcia-Herrera, Rodrigo; Estrada, Karol; Hidalgo-Miranda, Alfredo; Jimenez-Sanchez, Gerardo; Carnevale, Alessandra; Soberon, Xavier; Canizales-Quinteros, Samuel; Silva-Zolezzi, Irma] Inst Nacl Med Genom INMEGEN, Mexico City, DF, Mexico; [Acuna-Alonzo, Victor; Barquera-Lozano, Rodrigo; Macin-Perez, Gaston] ENAH, Mexico City, DF, Mexico; [Acuna-Alonzo, Victor; Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London, England; [Eng, Celeste; Huntsman, Scott; Galanter, Joshua M.; Via, Marc; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Nuno-Arana, Ismael; Rangel-Villalobos, Hector] Univ Guadalajara, Inst Invest Genet Mol, Ocotlan, Mexico; [Granados-Arriola, Julio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Galanter, Joshua M.; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Ford, Jean G.] Brooklyn Hosp Ctr, Brooklyn, NY USA; [Chapela, Rocio; Romieu, Isabelle] INER, Mexico City, DF, Mexico; [Rodriguez-Cintron, William] Vet Caribbean Hlth Care Syst, San Juan, PR USA; Ctr Neumol Pediat, San Juan, PR USA; Int Agcy Res Canc, F-69372 Lyon, France; [Jose Sienra-Monge, Juan; del Rio Navarro, Blanca] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico; [London, Stephanie J.] NIEHS, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, DF, Mexico	Stanford University; University of California System; University of California San Francisco; Instituto Nacional de Medicina Genomica; University of London; University College London; University of California System; University of California San Francisco; Universidad de Guadalajara; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of California System; University of California San Francisco; Brooklyn Hospital Center; World Health Organization; International Agency for Research on Cancer (IARC); Hospital Infantil de Mexico Federico Gomez; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Universidad Nacional Autonoma de Mexico	Moreno-Estrada, A (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	morenoe@stanford.edu; esteban.burchard@ucsf.edu; cdbustam@stanford.edu	Hidalgo-Miranda, Alfredo/B-2123-2010; Moreno-Estrada, Andres/R-3950-2017; Ruiz-Linares, Andres/AAR-1104-2021; Moreno-Estrada, Andres/AAP-4657-2021; Via, Marc/L-6511-2014; Sikora, Martin/C-8609-2015; Contreras, Alejandra/E-7815-2013; Fernandez, Juan Carlos/C-4976-2013; London, Stephanie/C-3734-2019; RANGEL-VILLALOBOS, HECTOR/C-5081-2018	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Moreno-Estrada, Andres/0000-0001-8329-8292; Ruiz-Linares, Andres/0000-0001-8372-1011; Moreno-Estrada, Andres/0000-0001-8329-8292; Via, Marc/0000-0002-9966-9921; Sikora, Martin/0000-0003-2818-8319; Contreras, Alejandra/0000-0003-3653-5958; Fernandez, Juan Carlos/0000-0003-3680-4193; London, Stephanie/0000-0003-4911-5290; Bustamante, Carlos D./0000-0002-4187-7920; Romero-Hidalgo, Sandra/0000-0003-3077-7825; Garcia Herrera, Ricardo/0000-0003-2456-4727; Sandoval, Karla/0000-0002-6175-2463; Garcia-Herrera, Rodrigo/0000-0002-7972-5746; Galanter, Joshua/0000-0002-2561-6384; Barquera, Rodrigo/0000-0003-0518-4518; RANGEL-VILLALOBOS, HECTOR/0000-0003-2641-8782	Stanford University; Department of Genetics; Federal Government of Mexico; Ministry of Health; Mexican Health Foundation (FUNSALUD); Gonzalo Rio Arronte Foundation; George Rosenkranz Prize for Health Care Research in Developing Countries; University of California San Francisco (UCSF) Chancellor's Research Fellowship; Dissertation Year Fellowship; NIH Training Grants [T32GM007175, T32HG000044]; Robert Wood Johnson Foundation Amos Medical Faculty Development Award; Sandler Foundation; American Asthma Foundation; CONACYT [129693]; BBSRC grant [BB/I021213/1]; National Institutes of Health (NIH) [R01GM090087, R01HG003229, ES015794, GM007546, GM061390, HL004464, HL078885, HL088133, HL111636, RR000083, P60MD006902, ZIA ES49019]; National Science Foundation [DMS-1201234]; Intramural Research Program of NIH, National Institute of Environmental Health Sciences; BBSRC [BB/I021213/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I021213/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000083] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL111636, R01HL078885, R01HL088133, K23HL004464] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049019, ZIAES043012, R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061390, T32GM007546, U19GM061390, R01GM083606, R01GM090087, T32GM007175] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R13MD008154, P60MD006902] Funding Source: NIH RePORTER	Stanford University(Stanford University); Department of Genetics; Federal Government of Mexico; Ministry of Health; Mexican Health Foundation (FUNSALUD); Gonzalo Rio Arronte Foundation; George Rosenkranz Prize for Health Care Research in Developing Countries; University of California San Francisco (UCSF) Chancellor's Research Fellowship; Dissertation Year Fellowship; NIH Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation Amos Medical Faculty Development Award(Robert Wood Johnson Foundation (RWJF)); Sandler Foundation; American Asthma Foundation; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of NIH, National Institute of Environmental Health Sciences; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank all volunteers for generously donating DNA samples and participating in the study. This project was possible with the joint support from multiple Institutions in Mexico and the United States. Stanford University supported C.D.B. with funding from the Department of Genetics. INMEGEN received support from the Federal Government of Mexico, particularly the Ministry of Health, the Mexican Health Foundation (FUNSALUD), and the Gonzalo Rio Arronte Foundation. State governments and universities of Durango, Campeche, Guanajuato, Guerrero, Oaxaca, Sonora, Tamaulipas, Veracruz, Yucatan, and Zacatecas contributed significantly to this work. This research was also supported by the George Rosenkranz Prize for Health Care Research in Developing Countries awarded to A.M.-E.; University of California San Francisco (UCSF) Chancellor's Research Fellowship, Dissertation Year Fellowship, and NIH Training Grants T32GM007175 and T32HG000044 (to C. R. G.); the Robert Wood Johnson Foundation Amos Medical Faculty Development Award; the Sandler Foundation; the American Asthma Foundation (to E. G. B.); CONACYT grant 129693 (to H. R.-V.); BBSRC grant BB/I021213/1 (to A. R.-L.); the National Institutes of Health (NIH) (grants R01GM090087, R01HG003229, ES015794, GM007546, GM061390, HL004464, HL078885, HL088133, HL111636, RR000083, P60MD006902, and ZIA ES49019); and National Science Foundation award DMS-1201234. This work was supported in part by the Intramural Research Program of NIH, National Institute of Environmental Health Sciences (to S.J.L.). Some computations were performed using the UCSF Biostatistics High Performance Computing System. We also thank B. Henn, S. Gravel, and J. Byrnes for helpful discussions; C. Gunter and M. Carpenter for editing the manuscript; and M. Morales for informatics and programming support. C. D. B. is on the advisory board of a project at 23andMe; and on the scientific advisory boards of Personalis, Inc.; InVitae; Etalon, Inc.; and Ancestry.com. The collections and methods for the Population Reference Sample (POPRES) are described by Nelson et al. (2008). The POPRES data sets used for the analyses described here were obtained from dbGaP through accession number phs000145.v1.p1. Access to the MCCAS data set may be obtained under the terms of a data transfer agreement with the National Institute of Environmental Health Sciences; the contact is S.J.L.. Individual-level genotypes for new data presented in this study are available, through a data access agreement to respect the privacy of the participants for the transfer of genetic data, by contacting C.D.B., A.M.-E., and INMEGEN (http://www.inmegen.gob.mx/).	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Brisbin A, 2012, HUM BIOL, V84, P343, DOI 10.3378/027.084.0401; CAMPBELL L, 1985, ANNU REV ANTHROPOL, V14, P187; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Gorostiza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044666; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lisker R, 1996, HUM BIOL, V68, P395; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pascual Soto Arturo, 2006, TAJIN BUSCA ORIGENES; Peralta CA, 2010, AM J NEPHROL, V31, P202, DOI 10.1159/000268955; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Salari K, 2005, GENET EPIDEMIOL, V29, P76, DOI 10.1002/gepi.20079; Sandoval K, 2012, AM J PHYS ANTHROPOL, V148, P395, DOI 10.1002/ajpa.22062; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Torgerson DG, 2012, J ALLERGY CLIN IMMUN, V130, P76, DOI 10.1016/j.jaci.2012.02.040; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	31	305	311	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1280	1285		10.1126/science.1251688	http://dx.doi.org/10.1126/science.1251688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926019	Green Accepted			2022-12-24	WOS:000337077500040
J	Cai, WJ; Santoso, A; Wang, GJ; Weller, E; Wu, LX; Ashok, K; Masumoto, Y; Yamagata, T				Cai, Wenju; Santoso, Agus; Wang, Guojian; Weller, Evan; Wu, Lixin; Ashok, Karumuri; Masumoto, Yukio; Yamagata, Toshio			Increased frequency of extreme Indian Ocean Dipole events due to greenhouse warming	NATURE			English	Article							EL-NINO; FOREST-FIRES; SHORT RAINS; VARIABILITY; CIRCULATION; INDONESIA; RAINFALL; PROJECT; MODELS; IMPACT	The Indian Ocean dipole is a prominent mode of coupled ocean-atmosphere variability(1-4), affecting the lives of millions of people in Indian Ocean rim countries(5-15). In its positive phase, sea surface temperatures are lower than normal off the Sumatra-Java coast, but higher in the western tropical Indian Ocean. During the extreme positive-IOD (pIOD) events of 1961, 1994 and 1997, the eastern cooling strengthened and extended westward along the equatorial Indian Ocean through strong reversal of both the mean westerly winds and the associated eastward-flowing upper ocean currents(1,2). This created anomalously dry conditions from the eastern to the central Indian Ocean along the Equator and atmospheric convergence farther west, leading to catastrophic floods in eastern tropical African countries(13,14) but devastating droughts in eastern Indian Ocean rim countries(8-10,16,17). Despite these serious consequences, the response of pIOD events to greenhouse warming is unknown. Here, using an ensemble of climate models forced by a scenario of high greenhouse gas emissions (Representative Concentration Pathway 8.5), we project that the frequency of extreme pIOD events will increase by almost a factor of three, from one event every 17.3 years over the twentieth century to one event every 6.3 years over the twenty-first century. We find that a mean state change-with weakening of both equatorial westerly winds and eastward oceanic currents in association with a faster warming in the western than the eastern equatorial Indian Ocean-facilitates more frequent occurrences of wind and oceanic current reversal. This leads to more frequent extreme pIOD events, suggesting an increasing frequency of extreme climate and weather events in regions affected by the pIOD.	[Cai, Wenju; Wang, Guojian; Weller, Evan] CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia; [Cai, Wenju; Wang, Guojian; Wu, Lixin] Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao 266003, Peoples R China; [Santoso, Agus] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Santoso, Agus] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Ashok, Karumuri] Indian Inst Trop Meteorol, Ctr Climate Change Res, Pune 411008, Maharashtra, India; [Masumoto, Yukio] Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Masumoto, Yukio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Climate Variat Predictabil & Applicatabil Res Pro, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Yamagata, Toshio] JAMSTEC, Applicat Lab, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Ocean University of China; University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM); Centre for Climate Change Research - India; University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Cai, WJ (corresponding author), CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia.	wenju.cai@csiro.au	Wang, Guojian/AAF-9297-2020; Yamagata, Toshio/A-1807-2009; Cai, Wenju/C-2864-2012; Santoso, Agus/P-1918-2019; Santoso, Agus/J-7350-2012; MASUMOTO, YUKIO/G-5021-2014	Wang, Guojian/0000-0002-8881-7394; Cai, Wenju/0000-0001-6520-0829; Santoso, Agus/0000-0001-7749-8124; Santoso, Agus/0000-0001-7749-8124; Ashok, Karumuri/0000-0002-5937-8089; Weller, Evan/0000-0002-7454-9827	Australian Climate Change Science Program; Goyder Institute; CSIRO Office of Chief Executive Science Leader award; Australian Research Council	Australian Climate Change Science Program; Goyder Institute; CSIRO Office of Chief Executive Science Leader award; Australian Research Council(Australian Research Council)	W.C. and E. W. are supported by the Australian Climate Change Science Program, and the Goyder Institute. W. C. is also supported by a CSIRO Office of Chief Executive Science Leader award. A. S. is supported by the Australian Research Council.	Abram NJ, 2003, SCIENCE, V301, P952, DOI 10.1126/science.1083841; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Ashok K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017926; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Balmaseda MA, 2008, MON WEATHER REV, V136, P3018, DOI 10.1175/2008MWR2433.1; Behera SK, 2005, J CLIMATE, V18, P4514, DOI 10.1175/JCLI3541.1; Black E, 2003, MON WEATHER REV, V131, P74, DOI 10.1175/1520-0493(2003)131<0074:AOSOTR>2.0.CO;2; Cai W, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL037604, 10.1029/2009GL039902]; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Cai WJ, 2013, NAT GEOSCI, V6, P999, DOI [10.1038/NGEO2009, 10.1038/ngeo2009]; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Emmanuel S C, 2000, Respirology, V5, P175, DOI 10.1046/j.1440-1843.2000.00247.x; Feng M, 2003, DEEP-SEA RES PT II, V50, P2263, DOI 10.1016/S0967-0645(03)00056-0; Fischer AS, 2005, J CLIMATE, V18, P3428, DOI 10.1175/JCLI3478.1; Frankenberg E, 2005, DEMOGRAPHY, V42, P109, DOI 10.1353/dem.2005.0004; Guilyardi E, 2009, B AM METEOROL SOC, V90, P325, DOI 10.1175/2008BAMS2387.1; Hashizume M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00269; Hong CC, 2008, J CLIMATE, V21, P4834, DOI 10.1175/2008JCLI2222.1; Izumo T, 2010, NAT GEOSCI, V3, P168, DOI 10.1038/NGEO760; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lorenz EN, 1956, 1 MIT DEP MET; Luo JJ, 2010, J CLIMATE, V23, P726, DOI 10.1175/2009JCLI3104.1; Meyers G, 2007, J CLIMATE, V20, P2872, DOI 10.1175/JCLI4152.1; Murtugudde R, 2000, J GEOPHYS RES-OCEANS, V105, P3295, DOI 10.1029/1999JC900294; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Udea H., 2000, J METEOR SOC JAPAN, V78, P803; Ummenhofer CC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036801; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Wijffels S, 2004, J PHYS OCEANOGR, V34, P1232, DOI 10.1175/1520-0485(2004)034<1232:AIOOWV>2.0.CO;2; WYRTKI K, 1973, SCIENCE, V181, P264; Yu LS, 1999, GEOPHYS RES LETT, V26, P735, DOI 10.1029/1999GL900072; Zheng XT, 2013, J CLIMATE, V26, P6067, DOI 10.1175/JCLI-D-12-00638.1; Zubair L, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015639	39	211	220	10	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					254	+		10.1038/nature13327	http://dx.doi.org/10.1038/nature13327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24919920				2022-12-24	WOS:000337032400047
J	Simon, AC; Zhou, JC; Perera, RL; van Deursen, F; Evrin, C; Ivanova, ME; Kilkenny, ML; Renault, L; Kjaer, S; Matak-Vinkovic, D; Labib, K; Costa, A; Pellegrini, L				Simon, Aline C.; Zhou, Jin C.; Perera, Rajika L.; van Deursen, Frederick; Evrin, Cecile; Ivanova, Marina E.; Kilkenny, Mairi L.; Renault, Ludovic; Kjaer, Svend; Matak-Vinkovic, Dijana; Labib, Karim; Costa, Alessandro; Pellegrini, Luca			A Ctf4 trimer couples the CMG helicase to DNA polymerase alpha in the eukaryotic replisome	NATURE			English	Article							SISTER-CHROMATID COHESION; MCM2-7 HELICASE; REPLICATION; COMPLEX; PROGRESSION; PROTEIN; GINS; STOICHIOMETRY; METABOLISM; ACTIVATION	Efficient duplication of the genome requires the concerted action of helicase and DNA polymerases at replication forks(1) to avoid stalling of the replication machinery and consequent genomic instability(2-4). In eukaryotes, the physical coupling between helicase and DNA polymerases remains poorly understood. Here we define the molecular mechanism by which the yeast Ctf4 protein links the Cdc45-MCM-GINS(CMG) DNA helicase to DNA polymerase alpha (Pol alpha) within the replisome. We use X-ray crystallography and electron microscopy to show that Ctf4 self-associates in a constitutive disk-shaped trimer. Trimerization depends on a beta-propeller domain in the carboxy-terminal half of the protein, which is fused to a helical extension that protrudes from one face of the trimeric disk. Critically, Pol alpha and the CMG helicase share a common mechanism of interaction with Ctf4. We show that the amino-terminal tails of the catalytic subunit of Pol alpha and the Sld5 subunit of GINS contain a conserved Ctf4-binding motif that docks onto the exposed helical extension of a Ctf4 protomer within the trimer. Accordingly, we demonstrate that one Ctf4 trimer can support binding of up to three partner proteins, including the simultaneous association with both Pol a and GINS. Our findings indicate that Ctf4 can couple two molecules of Pol alpha to one CMG helicase within the replisome, providing a new model for lagging-strand synthesis in eukaryotes that resembles the emerging model for the simpler replisome of Escherichia coli(5-8). The ability of Ctf4 to act as a platform for multivalent interactions illustrates a mechanism for the concurrent recruitment of factors that act together at the fork.	[Simon, Aline C.; Perera, Rajika L.; Ivanova, Marina E.; Kilkenny, Mairi L.; Pellegrini, Luca] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Zhou, Jin C.; Renault, Ludovic; Costa, Alessandro] Canc Res UK London Res Inst, Clare Hall Labs, London EN6 3LD, England; [van Deursen, Frederick] Univ Manchester, Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England; [Evrin, Cecile; Labib, Karim] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Kjaer, Svend] Canc Res UK London Res Inst, London WC2A 3LY, England; [Matak-Vinkovic, Dijana] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge; Cancer Research UK; Cancer Research UK; University of Manchester; University of Dundee; Cancer Research UK; University of Cambridge	Pellegrini, L (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	alessandro.costa@cancer.org.uk; lp212@cam.ac.uk	Pellegrini, Luca/AAE-2312-2022	Pellegrini, Luca/0000-0002-9300-497X; Kjaer, Susanne/0000-0002-8347-1398; Perera, Rajika/0000-0002-4932-8168; Zhou, Jin Chuan/0000-0001-5716-5170; Renault, Ludovic/0000-0001-6464-8808	Gates Cambridge PhD program; CRUK; MRC; Wellcome Trust SRF award in basic biomedical science; MRC [MC_UU_12016/13] Funding Source: UKRI; Cancer Research UK [15852] Funding Source: researchfish; Medical Research Council [MC_UU_12016/13] Funding Source: researchfish; Wellcome Trust [102943/Z/13/Z] Funding Source: researchfish	Gates Cambridge PhD program; CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust SRF award in basic biomedical science; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank L. Collinson and R. Carzaniga (LRI) for EM access; D. Frith and B. Snijder (LRI) for mass spectrometry work; J. Maman for help with SEC-MALS; and P. Zegerman and J. Gannon for comments on the manuscript. This work was supported by the Gates Cambridge PhD program (A. C. S.), CRUK (A. C. and K. L.), MRC (K. L.) and a Wellcome Trust SRF award in basic biomedical science (L.P.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Beattie TR, 2012, EMBO J, V31, P1556, DOI 10.1038/emboj.2012.12; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Chang YP, 2007, P NATL ACAD SCI USA, V104, P12685, DOI 10.1073/pnas.0705558104; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DePamphilis M. L., 2011, GENOME DUPLICATION; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Georgescu RE, 2012, NAT STRUCT MOL BIOL, V19, P113, DOI 10.1038/nsmb.2179; Gosnell JA, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-13; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; Lia G, 2012, SCIENCE, V335, P328, DOI 10.1126/science.1210400; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Zegerman P, 2009, DNA REPAIR, V8, P1077, DOI 10.1016/j.dnarep.2009.04.023; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	44	134	134	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					293	+		10.1038/nature13234	http://dx.doi.org/10.1038/nature13234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24805245	Green Accepted			2022-12-24	WOS:000337032400055
J	Jiang, Y; Xie, M; Chen, WB; Talbot, R; Maddox, JF; Faraut, T; Wu, CH; Muzny, DM; Li, YX; Zhang, WG; Stanton, JA; Brauning, R; Barris, WC; Hourlier, T; Aken, BL; Searle, SMJ; Adelson, DL; Bian, C; Cam, GR; Chen, YL; Cheng, SF; DeSilva, U; Dixen, K; Dong, Y; Fan, GY; Franklin, IR; Fu, SY; Fuentes-Utrilla, P; Guan, R; Highland, MA; Holder, ME; Huang, GD; Ingham, AB; Jhangiani, SN; Kalra, D; Kovar, CL; Lee, SL; Liu, WQ; Liu, X; Lu, CX; Lv, T; Mathew, T; McWilliam, S; Menzies, M; Pan, SK; Robelin, D; Servin, B; Townley, D; Wang, WL; Wei, B; White, SN; Yang, XH; Ye, C; Yue, YJ; Zeng, P; Zhou, Q; Hansen, JB; Kristiansen, K; Gibbs, RA; Flicek, P; Warkup, CC; Jones, HE; Oddy, VH; Nicholas, FW; McEwan, JC; Kijas, JW; Wang, J; Worley, KC; Archibald, AL; Cockett, N; Xu, X; Wang, W; Dalrymple, BP				Jiang, Yu; Xie, Min; Chen, Wenbin; Talbot, Richard; Maddox, Jillian F.; Faraut, Thomas; Wu, Chunhua; Muzny, Donna M.; Li, Yuxiang; Zhang, Wenguang; Stanton, Jo-Ann; Brauning, Rudiger; Barris, Wesley C.; Hourlier, Thibaut; Aken, Bronwen L.; Searle, Stephen M. J.; Adelson, David L.; Bian, Chao; Cam, Graham R.; Chen, Yulin; Cheng, Shifeng; DeSilva, Udaya; Dixen, Karen; Dong, Yang; Fan, Guangyi; Franklin, Ian R.; Fu, Shaoyin; Fuentes-Utrilla, Pablo; Guan, Rui; Highland, Margaret A.; Holder, Michael E.; Huang, Guodong; Ingham, Aaron B.; Jhangiani, Shalini N.; Kalra, Divya; Kovar, Christie L.; Lee, Sandra L.; Liu, Weiqing; Liu, Xin; Lu, Changxin; Lv, Tian; Mathew, Tittu; McWilliam, Sean; Menzies, Moira; Pan, Shengkai; Robelin, David; Servin, Bertrand; Townley, David; Wang, Wenliang; Wei, Bin; White, Stephen N.; Yang, Xinhua; Ye, Chen; Yue, Yaojing; Zeng, Peng; Zhou, Qing; Hansen, Jacob B.; Kristiansen, Karsten; Gibbs, Richard A.; Flicek, Paul; Warkup, Christopher C.; Jones, Huw E.; Oddy, V. Hutton; Nicholas, Frank W.; McEwan, John C.; Kijas, James W.; Wang, Jun; Worley, Kim C.; Archibald, Alan L.; Cockett, Noelle; Xu, Xun; Wang, Wen; Dalrymple, Brian P.			The sheep genome illuminates biology of the rumen and lipid metabolism	SCIENCE			English	Article							PROLINE-RICH PROTEINS; IDENTIFICATION; EVOLUTIONARY; EXPRESSION; ENVELOPES; RUMINANT; GENES; SITE; FAT	Sheep (Ovis aries) are a major source of meat, milk, and fiber in the form of wool and represent a distinct class of animals that have a specialized digestive organ, the rumen, that carries out the initial digestion of plant material. We have developed and analyzed a high-quality reference sheep genome and transcriptomes from 40 different tissues. We identified highly expressed genes encoding keratin cross-linking proteins associated with rumen evolution. We also identified genes involved in lipid metabolism that had been amplified and/or had altered tissue expression patterns. This may be in response to changes in the barrier lipids of the skin, an interaction between lipid metabolism and wool synthesis, and an increased role of volatile fatty acids in ruminants compared with nonruminant animals.	[Jiang, Yu; Zhang, Wenguang; Dong, Yang; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Jiang, Yu; Barris, Wesley C.; Adelson, David L.; Cam, Graham R.; DeSilva, Udaya; Franklin, Ian R.; Ingham, Aaron B.; McWilliam, Sean; Menzies, Moira; Townley, David; Kijas, James W.; Dalrymple, Brian P.] Commonwealth Sci & Ind Res Org Anim Food & Hlth S, St Lucia, Qld 4067, Australia; [Jiang, Yu; Chen, Yulin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Xie, Min; Chen, Wenbin; Li, Yuxiang; Bian, Chao; Cheng, Shifeng; Fan, Guangyi; Guan, Rui; Huang, Guodong; Liu, Weiqing; Liu, Xin; Lu, Changxin; Lv, Tian; Pan, Shengkai; Wang, Wenliang; Wei, Bin; Yang, Xinhua; Ye, Chen; Zeng, Peng; Zhou, Qing; Wang, Jun; Xu, Xun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Talbot, Richard; Fuentes-Utrilla, Pablo] Univ Edinburgh, Ediburgh Genom, Easter Bush EH25 9RG, Midlothian, Scotland; [Maddox, Jillian F.; Wu, Chunhua; Cockett, Noelle] Utah State Univ, Logan, UT 84322 USA; [Faraut, Thomas; Robelin, David; Servin, Bertrand] INRA, Lab Genet Cellulaire, UMR 444, F-31326 Castanet Tolosan, France; [Muzny, Donna M.; Holder, Michael E.; Jhangiani, Shalini N.; Kalra, Divya; Kovar, Christie L.; Lee, Sandra L.; Mathew, Tittu; Gibbs, Richard A.; Worley, Kim C.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Zhang, Wenguang; Fu, Shaoyin] Inner Mongolia Agr Univ, Hohhot 010018, Peoples R China; [Zhang, Wenguang] Nei Mongol Bioinformat, Inst ATCG, Hohhot, Peoples R China; [Stanton, Jo-Ann] Univ Otago, Dept Anat, Dunedin 9054, New Zealand; [Brauning, Rudiger; McEwan, John C.] AgResearch, Invermay Agr Ctr, Mosgiel 9053, New Zealand; [Hourlier, Thibaut; Aken, Bronwen L.; Searle, Stephen M. J.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Dixen, Karen; Hansen, Jacob B.] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen O, Denmark; [Highland, Margaret A.; White, Stephen N.] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Highland, Margaret A.; White, Stephen N.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Wei, Bin] Sichuan Agr Univ, Maize Res Inst, Chengdu 611130, Peoples R China; [Yue, Yaojing] Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou 730050, Peoples R China; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Hourlier, Thibaut; Aken, Bronwen L.; Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SA, England; [Warkup, Christopher C.; Jones, Huw E.] Roslin Inst, Biosci Knowledge Transfer Network, Easter Bush EH25 9RG, Midlothian, Scotland; [Oddy, V. Hutton] Univ New England, Sch Environm & Rural Sci, Armidale, NSW 2351, Australia; [Nicholas, Frank W.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Macau 999078, Peoples R China; [Archibald, Alan L.] Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Archibald, Alan L.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland	Chinese Academy of Sciences; Kunming Institute of Zoology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Northwest A&F University - China; Beijing Genomics Institute (BGI); University of Edinburgh; Utah System of Higher Education; Utah State University; INRAE; Baylor College of Medicine; Inner Mongolia Agricultural University; University of Otago; AgResearch - New Zealand; Wellcome Trust Sanger Institute; University of Copenhagen; United States Department of Agriculture (USDA); Washington State University; Washington State University; Sichuan Agricultural University; Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; University of Copenhagen; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of New England; University of Sydney; King Abdulaziz University; Macau University of Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Dalrymple, BP (corresponding author), Commonwealth Sci & Ind Res Org Anim Food & Hlth S, St Lucia, Qld 4067, Australia.	kworley@bcm.edu; alan.archibald@roslin.ed.ac.uk; noelle.cockett@usu.edu; xuxun@genomics.cn; wwang@mail.kiz.ac.cn; brian.dalrymple@csiro.au	Servin, Bertrand/B-2206-2008; Wang, Wen/AAP-9873-2020; McEwan, John/A-1143-2008; Kalra, D/H-6661-2019; Adelson, David L/E-5506-2011; Menzies, Moira/AAY-2850-2020; Li, yu/HHZ-5236-2022; Jiang, Yu/O-5114-2015; Kristiansen, Karsten/J-5148-2014; Nicholas, Frank William/AAE-5566-2022; Stanton, Jo-Ann L/C-6621-2009; Highland, Margaret/ABF-3396-2021; Xu, Xun/AAI-6763-2020; Dalrymple, Brian P/F-8721-2010; Nicholas, Frank/AGY-8318-2022; Hansen, Jacob B/F-3775-2010; Kalra, Divya/N-5453-2014; Ingham, Aaron/C-1166-2008; XIE, MIN/P-8062-2019; McWilliam, Sean M/H-8978-2013; Kijas, James W/A-4656-2011; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Servin, Bertrand/0000-0001-5141-0913; McEwan, John/0000-0003-4801-6207; Kalra, D/0000-0001-5254-4067; Adelson, David L/0000-0003-2404-5636; Menzies, Moira/0000-0002-5752-0846; Jiang, Yu/0000-0003-4821-3585; Kristiansen, Karsten/0000-0002-6024-0917; Nicholas, Frank William/0000-0002-9178-3965; Stanton, Jo-Ann L/0000-0001-8139-4694; Xu, Xun/0000-0002-5338-5173; Dalrymple, Brian P/0000-0003-3891-5233; Nicholas, Frank/0000-0002-9178-3965; Hansen, Jacob B/0000-0001-5249-2586; Ingham, Aaron/0000-0001-8006-9443; XIE, MIN/0000-0002-5652-5039; McWilliam, Sean M/0000-0002-3148-0428; Kijas, James W/0000-0002-1417-8278; Worley, Kim/0000-0002-0282-1000; Bian, Chao/0000-0001-9904-721X; White, Stephen N./0000-0001-9255-6054; Aken, Bronwen/0000-0002-3032-4095; Oddy, Hutton/0000-0003-1783-1049; Wang, Wen/0000-0002-7801-2066; Guan, Rui/0000-0003-0862-2368; Archibald, Alan/0000-0001-9213-1830; Liu, Xin/0000-0003-3256-2940; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Brauning, Rudiger/0000-0001-5068-9166; Flicek, Paul/0000-0002-3897-7955; DeSilva, Udaya/0000-0003-2517-6566; Hourlier, Thibaut/0000-0003-4894-7773	one 973 Program [2013CB835200]; one CAS Program [XDB13000000]; BGI-Shenzhen [ZYC200903240077A, ZYC200903240078A]; Inner Mongolia Agricultural University [30960246, 31260538]; Roslin Institute; University of Edinburgh and Biotechnology; Biological Sciences Research Council, UK (BBSRC) [BB/1025360/1, BB/I025328/1]; Institute Strategic Programme; National Capability Grants; Roslin Foundation; Scottish Government, UK; Department for Environment, Food and Rural Affairs/Higher Education Funding Council/Scottish Higher Education Funding Council Veterinary Training and Research Initiative, UK; USDA-ARS, USA; USDA-National Research Initiative Competitive Grants Program, USA [2008-03923, 2009-03305]; Wellcome Trust [WT095908, WT098051]; BBSRC [BB/I025506/1, BB/I025360/1]; European Molecular Biology Laboratory; USDA-NRSP-8, USA; USDA-ARS [5348-32000-031-00D]; Meat and Livestock Australia; Australian Wool Innovation Limited through SheepGENOMICS, Australia; Australian Government International Science Linkages Grant, Australia [CG090143]; University of Sydney, Australia; CSIRO, Australia; AgResearch, NZ, Beef + Lamb NZ through Ovita, New Zealand; INRA, France; Agence Nationale de la Recherche project SheepSNPQTL, France; European Union through the Seventh Framework Programme Quantomics project [KBBE222664]; 3SR project [KBBE245140]; Ole Romer grant from Danish Natural Science Research Council, BGI-Shenzhen, China; Earmarked Fund for Modern China Wool & Cashmere Technology Research System [nycytx-40-3]; Australian Department of Agriculture Food and Fisheries, Filling the Research Gap project, "Host control of methane emissions"; BBSRC [BBS/E/D/20211550, BBS/E/D/20310000, BBS/E/D/05191130, BB/I025360/2, BB/I025328/1, BBS/E/D/20211552] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191130, BBS/E/D/20211550, BB/I025360/2, BBS/E/D/20211552, BBS/E/D/20310000, BB/I025360/1, BB/I025506/1, BB/I025328/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	one 973 Program; one CAS Program; BGI-Shenzhen; Inner Mongolia Agricultural University; Roslin Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Edinburgh and Biotechnology; Biological Sciences Research Council, UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Strategic Programme; National Capability Grants; Roslin Foundation; Scottish Government, UK; Department for Environment, Food and Rural Affairs/Higher Education Funding Council/Scottish Higher Education Funding Council Veterinary Training and Research Initiative, UK; USDA-ARS, USA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-National Research Initiative Competitive Grants Program, USA(United States Department of Agriculture (USDA)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Laboratory; USDA-NRSP-8, USA; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Meat and Livestock Australia(Meat and Livestock Australia); Australian Wool Innovation Limited through SheepGENOMICS, Australia(Australian Wool Innovation); Australian Government International Science Linkages Grant, Australia(Australian GovernmentDepartment of Industry, Innovation and Science); University of Sydney, Australia(University of Sydney); CSIRO, Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); AgResearch, NZ, Beef + Lamb NZ through Ovita, New Zealand; INRA, France; Agence Nationale de la Recherche project SheepSNPQTL, France(French National Research Agency (ANR)); European Union through the Seventh Framework Programme Quantomics project; 3SR project; Ole Romer grant from Danish Natural Science Research Council, BGI-Shenzhen, China; Earmarked Fund for Modern China Wool & Cashmere Technology Research System; Australian Department of Agriculture Food and Fisheries, Filling the Research Gap project, "Host control of methane emissions"(Australian GovernmentDepartment of Agriculture and Water Resources); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The International Sheep Genomics Sequencing Consortium is grateful to the following for funding support for the sheep genome sequencing project: one 973 Program (no. 2013CB835200) and one CAS Program (XDB13000000) to Kunming Institute of Zoology, China; BGI-Shenzhen (ZYC200903240077A and ZYC200903240078A); China National GeneBank-Shenzhen for support for the storage of samples and data; Inner Mongolia Agricultural University (30960246 and 31260538); The Roslin Institute, University of Edinburgh and Biotechnology and Biological Sciences Research Council, UK (BBSRC): BB/1025360/1, BB/I025328/1, Institute Strategic Programme, and National Capability Grants; The Roslin Foundation; The Scottish Government, UK; Department for Environment, Food and Rural Affairs/Higher Education Funding Council/Scottish Higher Education Funding Council Veterinary Training and Research Initiative, UK; USDA-ARS, USA, USDA-National Research Initiative Competitive Grants Program, USA (grant nos. 2008-03923 and 2009-03305); Wellcome Trust (grant nos. WT095908 and WT098051), BBSRC (grant nos. BB/I025506/1 and BB/I025360/1) and European Molecular Biology Laboratory; USDA-NRSP-8, USA; USDA-ARS grant 5348-32000-031-00D; Meat and Livestock Australia and Australian Wool Innovation Limited through SheepGENOMICS, Australia; Australian Government International Science Linkages Grant (CG090143), Australia; University of Sydney, Australia; CSIRO, Australia; AgResearch, NZ, Beef + Lamb NZ through Ovita, New Zealand; INRA and Agence Nationale de la Recherche project SheepSNPQTL, France; European Union through the Seventh Framework Programme Quantomics (KBBE222664) and 3SR (KBBE245140) projects; the Ole Romer grant from Danish Natural Science Research Council, BGI-Shenzhen, China; the Earmarked Fund for Modern China Wool & Cashmere Technology Research System (no. nycytx-40-3); and the Australian Department of Agriculture Food and Fisheries, Filling the Research Gap project, "Host control of methane emissions." We thank B. Freking (USDA-ARS-U.S. Meat Animal Research Center) for provision of Texel ram tissue samples for DNA extraction and sequencing. We thank the sequencing teams and other contributors; full details are in the acknowledgements section of the supplementary materials. We thank SheepGENOMICS and Utah State University for access to the genotyping data for the SheepGENOMICS and Louisiana State University flocks, respectively. We thank L. Goodman for help with condensing the text. The genome assemblies have been deposited in GenBank, Oar v1.0 (GCA_000005525.1), and Oar v3.1 (GCA_000298735.1) and in GigaDB, Oar v2.0 (http://dx.doi.org/10.5524/100023). The Ensembl annotation of the Oar v3.1 assembly is available at http://e74.ensembl.org, and the gene builds are available from ftp://ftp.ensembl.org/pub/release-74/bam/ovis_aries/genebuild/. The RNA-Seq data sets have been deposited in public databases: 83 samples from The Roslin Institute (European Nucleotide Archive (ENA) study accession PRJEB6169), seven tissues from the genome-sequenced Texel ewe and Gansu alpine fine wool sheep skin (GenBank accession GSE56643), and three blood samples (GenBank BioProject accession PRJNA245615). The methylated DNA immunoprecipitation sequencing (MeDIP-seq) raw reads from the Texel ewe liver have been deposited in GenBank (GSE56644). The bacterial artificial chromosome sequence assembly has been deposited in GenBank (KJ735098).; The raw reads of the genome sequencing projects have been deposited in public nucleotide databases: Texel ewe (GenBank accession SRA059406), Texel ram (ENA study accession PRJEB6251, GenBank accession SRP015759), and 0.5-fold coverage 454 sequencing of six animals (GenBank accessions SRP000982, SRP003883, and SRP006794). The authors declare no competing financial interests.	BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Deng J, 2000, J BIOL CHEM, V275, P5739, DOI 10.1074/jbc.275.8.5739; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Hackmann TJ, 2010, J DAIRY SCI, V93, P1320, DOI 10.3168/jds.2009-2071; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; INGLE DL, 1972, J NUTR, V102, P617, DOI 10.1093/jn/102.5.617; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Radner FPW, 2011, DERM-ENDOCRINOL, V3, P77, DOI 10.4161/derm.3.2.15472; SCHLOSSMAN ML, 1978, J AM OIL CHEM SOC, V55, P447, DOI 10.1007/BF02911911; Song HJ, 1999, GENOMICS, V55, P28, DOI 10.1006/geno.1998.5607; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; Stewart M. E., 1986, BIOL INTEGUMENT, V2, P824; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Wang LQ, 1996, BIOCHEM J, V317, P225, DOI 10.1042/bj3170225; WOLIN MJ, 1981, SCIENCE, V213, P1463, DOI 10.1126/science.7280665	24	282	309	10	323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1168	1173		10.1126/science.1252806	http://dx.doi.org/10.1126/science.1252806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904168	Green Accepted			2022-12-24	WOS:000336791200050
J	Song, R; Walentek, P; Sponer, N; Klimke, A; Lee, JS; Dixon, G; Harland, R; Wan, Y; Lishko, P; Lize, M; Kessel, M; He, L				Song, Rui; Walentek, Peter; Sponer, Nicole; Klimke, Alexander; Lee, Joon Sub; Dixon, Gary; Harland, Richard; Wan, Ying; Lishko, Polina; Lize, Muriel; Kessel, Michael; He, Lin			miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110	NATURE			English	Article							PRIMARY CILIARY DYSKINESIA; EPITHELIAL-CELLS; BASAL BODIES; SMALL RNAS; C-ELEGANS; MICRORNA; XENOPUS; BIOGENESIS; EXPRESSION; MUTATIONS	The mir-34/449 family consists of six homologous miRNAs at three genomic loci. Redundancy of miR-34/449 miRNAs and their dominant expression in multiciliated epithelia suggest a functional significance in ciliogenesis. Here we report that mice deficient for all miR-34/449 miRNAs exhibited postnatal mortality, infertility and strong respiratory dysfunction caused by defective mucociliary clearance. In both mouse and Xenopus, miR-34/449-deficient multiciliated cells (MCCs) exhibited a significant decrease in cilia length and number, due to defective basal body maturation and apical docking. The effect of miR-34/449 on ciliogenesis was mediated, at least in part, by post-transcriptional repression of Cp110, a centriolar protein suppressing cilia assembly. Consistent with this, cp110 knockdown in miR-34/449-deficient MCCs restored ciliogenesis by rescuing basal body maturation and docking. Altogether, our findings elucidate conserved cellular and molecular mechanisms through which miR-34/449 regulate motile ciliogenesis.	[Song, Rui; Sponer, Nicole; Lee, Joon Sub; Dixon, Gary; Lishko, Polina; He, Lin] Univ Calif Berkeley, Div Cellular & Dev Biol, MCB Dept, Berkeley, CA 94705 USA; [Walentek, Peter; Harland, Richard] Univ Calif Berkeley, Div Genet Genom & Dev, MCB Dept, Ctr Integrat Genom, Berkeley, CA 94705 USA; [Klimke, Alexander; Kessel, Michael] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; [Wan, Ying] Third Mil Med Univ, Chongqing 400038, Peoples R China; [Lize, Muriel] Univ Gottingen, Dept Mol Oncol, D-37073 Gottingen, Germany	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Max Planck Society; Army Medical University; University of Gottingen	He, L (corresponding author), Univ Calif Berkeley, Div Cellular & Dev Biol, MCB Dept, Berkeley, CA 94705 USA.	rui.song@berkeley.edu; lhe@berkeley.edu	Lishko, Polina/L-1191-2017; Lishko, Polina/GQH-9569-2022	Lize, Muriel/0000-0002-4954-3503; Lee, Joon Sub/0000-0003-1151-1343; Walentek, Peter/0000-0002-2332-6068	NCI [R01 CA139067, 1R21CA175560-01]; CIRM new faculty award [RN2-00923-1]; TRDRP research grant [21RT-0133]; American Cancer Society (ACS) [123339-RSG-12-265-01-RMC]; Siebel postdoctoral fellowship; CIRM postdoctoral fellowship; Deutsche Forschungsgemeinschaft (DFG) [Wa 3365/1-1]; NIH [GM42341]; Dorothea Schloezer Fellowship; NATIONAL CANCER INSTITUTE [R01CA139067, R21CA175560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042341] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CIRM new faculty award; TRDRP research grant; American Cancer Society (ACS)(American Cancer Society); Siebel postdoctoral fellowship; CIRM postdoctoral fellowship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorothea Schloezer Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. J. Bennett, M. Butler, B. Dynlacht, W. Finkbeiner, P. Kysar, B. Lee, T. Machen, B. Mitchell and J. Wallingford for constructs, technical assistance, stimulating discussions and helpful input. We also thank P. Margolis for careful reading of our manuscript. L. H. acknowledges an R01 and an R21 grant from NCI (R01 CA139067, 1R21CA175560-01), a CIRM new faculty award (RN2-00923-1), a TRDRP research grant (21RT-0133), and a research scholar award from American Cancer Society (ACS, 123339-RSG-12-265-01-RMC). R. S. acknowledges the support of Siebel postdoctoral fellowship and CIRM postdoctoral fellowship. P. W. was funded by the Deutsche Forschungsgemeinschaft (DFG, Wa 3365/1-1), and frog work in the Harland laboratory was funded by NIH grant GM42341. M. L. would like to thank M. Dobbelstein for support and discussions, and was financed by a Dorothea Schloezer Fellowship.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Deblandre GA, 1999, DEVELOPMENT, V126, P4715; Dehring DAK, 2013, DEV CELL, V27, P103, DOI 10.1016/j.devcel.2013.08.021; Delaval B, 2011, CELL CYCLE, V10, P3964, DOI 10.4161/cc.10.22.18150; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Hagenlocher Cathrin, 2013, Cilia, V2, P12, DOI 10.1186/2046-2530-2-12; HE L, 2004, NAT REV GENET, V5, P522; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Kim VN, 2005, MOL CELLS, V19, P1; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Kunimoto K, 2012, CELL, V148, P189, DOI 10.1016/j.cell.2011.10.052; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martinez-Anton A, 2013, AM J RESP CELL MOL, V49, P384, DOI 10.1165/rcmb.2012-0368OC; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Okada N., 2014, GENES DEV; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Tsang William Y, 2013, Cilia, V2, P9, DOI 10.1186/2046-2530-2-9; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Vladar EK, 2013, METHOD ENZYMOL, V525, P285, DOI 10.1016/B978-0-12-397944-5.00014-6; Walentek P, 2014, DEVELOPMENT, V141, P1526, DOI 10.1242/dev.102343; Walentek P, 2012, CELL REP, V1, P516, DOI 10.1016/j.celrep.2012.03.005; Werner ME, 2012, GENESIS, V50, P176, DOI 10.1002/dvg.20824; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	50	144	149	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					115	+		10.1038/nature13413	http://dx.doi.org/10.1038/nature13413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899310	Green Accepted, Green Submitted			2022-12-24	WOS:000336768900039
J	Wilhelm, M; Schlegl, J; Hahne, H; Gholami, AM; Lieberenz, M; Savitski, MM; Ziegler, E; Butzmann, L; Gessulat, S; Marx, H; Mathieson, T; Lemeer, S; Schnatbaum, K; Reimer, U; Wenschuh, H; Mollenhauer, M; Slotta-Huspenina, J; Boese, JH; Bantscheff, M; Gerstmair, A; Faerber, F; Kuster, B				Wilhelm, Mathias; Schlegl, Judith; Hahne, Hannes; Gholami, Amin Moghaddas; Lieberenz, Marcus; Savitski, Mikhail M.; Ziegler, Emanuel; Butzmann, Lars; Gessulat, Siegfried; Marx, Harald; Mathieson, Toby; Lemeer, Simone; Schnatbaum, Karsten; Reimer, Ulf; Wenschuh, Holger; Mollenhauer, Martin; Slotta-Huspenina, Julia; Boese, Joos-Hendrik; Bantscheff, Marcus; Gerstmair, Anja; Faerber, Franz; Kuster, Bernhard			Mass-spectrometry-based draft of the human proteome	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; NONCODING RNAS; IDENTIFICATION; EXPRESSION; QUANTIFICATION; PROTEINS; DATABASE; REVEALS; PEPTIDE; PROJECT	Proteomes are characterized by large protein-abundance differences, cell-type- and time-dependent expression patterns and post-translational modifications, all of which carry biological information that is not accessible by genomics or transcriptomics. Here we present a mass-spectrometry-based draft of the human proteome and a public, high-performance, in-memory database for real-time analysis of terabytes of big data, called ProteomicsDB. The information assembled from human tissues, cell lines and body fluids enabled estimation of the size of the protein-coding genome, and identified organ-specific proteins and a large number of translated lincRNAs (long intergenic non-coding RNAs). Analysis of messenger RNA and protein-expression profiles of human tissues revealed conserved control of protein abundance, and integration of drug-sensitivity data enabled the identification of proteins predicting resistance or sensitivity. The proteome profiles also hold considerable promise for analysing the composition and stoichiometry of protein complexes. ProteomicsDB thus enables navigation of proteomes, provides biological insight and fosters the development of proteomic technology.	[Wilhelm, Mathias; Hahne, Hannes; Gholami, Amin Moghaddas; Marx, Harald; Lemeer, Simone; Kuster, Bernhard] Tech Univ Munich, Chair Prote & Bioanalyt, D-85354 Freising Weihenstephan, Germany; [Wilhelm, Mathias; Schlegl, Judith; Lieberenz, Marcus; Ziegler, Emanuel; Butzmann, Lars; Gessulat, Siegfried; Boese, Joos-Hendrik; Gerstmair, Anja; Faerber, Franz] SAP AG, D-69190 Walldorf, Germany; [Savitski, Mikhail M.; Mathieson, Toby; Bantscheff, Marcus] Cellzome GmbH, D-69117 Heidelberg, Germany; [Schnatbaum, Karsten; Reimer, Ulf; Wenschuh, Holger] JPT Peptide Technol GmbH, D-12489 Berlin, Germany; [Mollenhauer, Martin; Slotta-Huspenina, Julia] Tech Univ Munich, Inst Pathol, D-81675 Munich, Germany; [Kuster, Bernhard] Ctr Integrated Prot Sci Munich, Munich, Germany	Technical University of Munich; SAP; GlaxoSmithKline; Cellzome GmbH; Technical University of Munich; University of Munich	Kuster, B (corresponding author), Tech Univ Munich, Chair Prote & Bioanalyt, Emil Erlenmeyer Forum 5, D-85354 Freising Weihenstephan, Germany.	kuster@tum.de	Kuster, Bernhard/Q-6031-2016; Ziegler, Emanuel CM/V-4496-2018; Lemeer, Simone/I-4363-2016; Bantscheff, Marcus/AAQ-2903-2021	Kuster, Bernhard/0000-0002-9094-1677; Ziegler, Emanuel CM/0000-0001-8330-7144; Bantscheff, Marcus/0000-0002-8343-8977; Gessulat, Siegfried/0000-0001-5530-0674; Mathieson, Toby/0000-0002-6153-3113; Reimer, Ulf/0000-0002-3375-6889; Wilhelm, Mathias/0000-0002-9224-3258				Ahrne E, 2013, PROTEOMICS, V13, P2567, DOI 10.1002/pmic.201300135; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Argenzio E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.118; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Domon B, 2012, PROTEOM CLIN APPL, V6, P609, DOI 10.1002/prca.201200111; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Farrah T, 2014, J PROTEOME RES, V13, P60, DOI 10.1021/pr4010037; Flintoft L, 2013, NAT REV GENET, V14, P3534, DOI 10.1038/nrg3534; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Geiger T, 2013, MOL CELL PROTEOMICS, V12, P1709, DOI 10.1074/mcp.M112.024919; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gupta N, 2011, J AM SOC MASS SPECTR, V22, P1111, DOI 10.1007/s13361-011-0139-3; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Higdon R, 2011, J PROTEOMICS, V75, P116, DOI 10.1016/j.jprot.2011.06.003; Hisamatsu H, 1996, J EXP MED, V183, P1807, DOI 10.1084/jem.183.4.1807; Hughes GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084714; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Johansson HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3175; Klingelhofer J, 2009, FEBS J, V276, P5936, DOI 10.1111/j.1742-4658.2009.07274.x; Koumangoye RB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-167; Lane L, 2014, J PROTEOME RES, V13, P15, DOI 10.1021/pr401144x; Low TY, 2013, CELL REP, V5, P1469, DOI 10.1016/j.celrep.2013.10.041; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Marx H, 2013, NAT BIOTECHNOL, V31, P557, DOI 10.1038/nbt.2585; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nandi D, 1996, J IMMUNOL, V156, P2361; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704	46	1259	1289	8	595	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					582	+		10.1038/nature13319	http://dx.doi.org/10.1038/nature13319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870543				2022-12-24	WOS:000336457100041
J	Barnett, ML; Linder, JA				Barnett, Michael L.; Linder, Jeffrey A.			Antibiotic Prescribing for Adults With Acute Bronchitis in the United States, 1996-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Barnett, Michael L.; Linder, Jeffrey A.] Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital	Linder, JA (corresponding author), Brigham & Womens Hosp, 1620 Tremont St, Boston, MA 02120 USA.	jlinder@partners.org	Linder, Jeffrey/AAF-3424-2021; Barnett, Michael/AAF-4017-2019; Barnett, Michael/ABA-4159-2021	Linder, Jeffrey/0000-0003-2217-184X; Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609	AHRQ HHS [R18 HS018419] Funding Source: Medline; NIAID NIH HHS [R21 AI097759] Funding Source: Medline; NIA NIH HHS [RC4 AG039115] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS018419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC4AG039115] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Centers for Disease Control and Prevention, GET SMART KNOW ANT W; Centers for Disease Control and Prevention Division of Health Care Statistics National Center for Health Statistics, NAT HLTH CAR SURV; Gonzales R, 2001, ANN INTERN MED, V134, P521, DOI 10.7326/0003-4819-134-6-200103200-00021; National Committee for Quality Assurance, HEDIS 2012 MEAS; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub3; Steinman MA, 2003, ANN INTERN MED, V138, P525, DOI 10.7326/0003-4819-138-7-200304010-00008	6	100	103	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					2020	2022		10.1001/jama.2013.286141	http://dx.doi.org/10.1001/jama.2013.286141			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846041	Green Accepted, Bronze			2022-12-24	WOS:000336122800026
J	Palmer, JC; Martelli, F; Liu, Y; Car, R; Panagiotopoulos, AZ; Debenedetti, PG				Palmer, Jeremy C.; Martelli, Fausto; Liu, Yang; Car, Roberto; Panagiotopoulos, Athanassios Z.; Debenedetti, Pablo G.			Metastable liquid-liquid transition in a molecular model of water	NATURE			English	Article							SUPERCOOLED WATER; HEAT-CAPACITY; CUBIC ICE; ST2 WATER; ENERGY; SIMULATION; DYNAMICS; BEHAVIOR; SINGULARITY; STABILITY	Liquid water's isothermal compressibility(1) and isobaric heat capacity(2), and the magnitude of its thermal expansion coefficient(3), increase sharply on cooling below the equilibrium freezing point. Many experimental(4-8), theoretical(9-11) and computational(12,13) studies have sought to understand the molecular origin and implications of this anomalous behaviour. Of the different theoretical scenarios(9,14,15) put forward, one posits the existence of a first-order phase transition that involves two forms of liquid water and terminates at a critical point located at deeply supercooled conditions(9,12). Some experimental evidence is consistent with this hypothesis(4,16), but no definitive proof of a liquid-liquid transition in water has been obtained to date: rapid ice crystallization has so far prevented decisive measurements on deeply supercooled water, although this challenge has been overcome recently(16). Computer simulations are therefore crucial for exploring water's structure and behaviour in this regime, and have shown(13,17-21) that some water models exhibit liquid-liquid transitions and others do not. However, recent work(22,23) has argued that the liquid-liquid transition has been mistakenly interpreted, and is in fact a liquid-crystal transition in all atomistic models of water. Here we show, by studying the liquid-liquid transition in the ST2 model of water(24) with the use of six advanced sampling methods to compute the free-energy surface, that two metastable liquid phases and a stable crystal phase exist at the same deeply supercooled thermodynamic condition, and that the transition between the two liquids satisfies the thermodynamic criteria of a first-order transition(25). We follow the rearrangement of water's coordination shell and topological ring structure along a thermodynamically reversible path from the low-density liquid to cubic ice(26). We also show that the system fluctuates freely between the two liquid phases rather than crystallizing. These findings provide unambiguous evidence for a liquid-liquid transition in the ST2 model of water, and point to the separation of time scales between crystallization and relaxation as being crucial for enabling it.	[Palmer, Jeremy C.; Liu, Yang; Panagiotopoulos, Athanassios Z.; Debenedetti, Pablo G.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Martelli, Fausto; Car, Roberto] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University	Debenedetti, PG (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	pdebene@princeton.edu	Panagiotopoulos, Athanassios Z/K-2955-2014; Debenedetti, Pablo/ABD-1497-2021; Martelli, Fausto/A-6148-2017	Panagiotopoulos, Athanassios Z/0000-0002-8152-6615; Debenedetti, Pablo/0000-0003-1881-1728; Martelli, Fausto/0000-0002-5350-8225	National Science Foundation [CHE 1213343]; US Department of Energy [DE-SC0002128, DE-SC0008626]; Direct For Mathematical & Physical Scien [1213343] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Computations were performed at the Terascale Infrastructure for Groundbreaking Research in Engineering and Science (TIGRESS) facility at Princeton University. P.G.D. acknowledges support from the National Science Foundation (CHE 1213343), A.Z.P. acknowledges support from the US Department of Energy (DE-SC0002128), and R.C. acknowledges support from the US Department of Energy (DE-SC0008626).	Amann-Winkel K, 2013, P NATL ACAD SCI USA, V110, P17720, DOI 10.1073/pnas.1311718110; ANGELL CA, 1982, J PHYS CHEM-US, V86, P998, DOI 10.1021/j100395a032; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305; Choukroun M, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3487520; Choukroun M, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768957; Clark GNI, 2010, P NATL ACAD SCI USA, V107, P14003, DOI 10.1073/pnas.1006599107; DUANE S, 1987, PHYS LETT B, V195, P216, DOI 10.1016/0370-2693(87)91197-X; Frenkel D., 2000, UNDERSTANDING MOL SI; Gee J, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3551576; HANDA YP, 1986, J CHEM PHYS, V84, P7009, DOI 10.1063/1.450622; Handel R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036104; HARE DE, 1986, J CHEM PHYS, V84, P5085, DOI 10.1063/1.450660; Holten V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00713; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; HUNTER JE, 1995, J CHEM PHYS, V103, P8627, DOI 10.1063/1.470121; Kesselring TA, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4808355; KING SV, 1967, NATURE, V213, P1112, DOI 10.1038/2131112a0; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LEE JY, 1990, PHYS REV LETT, V65, P137, DOI 10.1103/PhysRevLett.65.137; Li YP, 2013, P NATL ACAD SCI USA, V110, P12209, DOI 10.1073/pnas.1309042110; Limmer DT, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4807479; Limmer DT, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3643333; Liu Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769126; Liu Y, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3229892; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; MAYER E, 1987, NATURE, V325, P601, DOI 10.1038/325601a0; MCMILLAN JA, 1965, NATURE, V206, P806, DOI 10.1038/206806a0; Miller TF, 2002, J CHEM PHYS, V116, P8649, DOI 10.1063/1.1473654; Mishima O, 1998, NATURE, V392, P164, DOI 10.1038/32386; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moore EB, 2011, NATURE, V479, P506, DOI 10.1038/nature10586; Moore EB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3451112; Overduin SD, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4803868; Palmer J. C., 2013, FARADAY DISCUSS, V167, P118; Palmer JC, 2013, FARADAY DISCUSS, V167, P77, DOI 10.1039/c3fd00074e; Poole PH, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4775738; POOLE PH, 1994, PHYS REV LETT, V73, P1632, DOI 10.1103/PhysRevLett.73.1632; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; Reinhardt A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4766362; ROSSKY PJ, 1978, J CHEM PHYS, V69, P4628, DOI 10.1063/1.436415; Sastry S, 1996, PHYS REV E, V53, P6144, DOI 10.1103/PhysRevE.53.6144; Shilling JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026671; Shiratani E, 1998, J CHEM PHYS, V108, P3264, DOI 10.1063/1.475723; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; SPEEDY RJ, 1976, J CHEM PHYS, V65, P851, DOI 10.1063/1.433153; SPEEDY RJ, 1982, J PHYS CHEM-US, V86, P982, DOI 10.1021/j100395a030; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; STILLINGER FH, 1974, J CHEM PHYS, V60, P1545, DOI 10.1063/1.1681229; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tanaka H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064202; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Vega C, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715577; WEBER TA, 1984, J CHEM PHYS, V80, P438, DOI 10.1063/1.446468; Winkel K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2830029; YAMAMURO O, 1987, J PHYS CHEM SOLIDS, V48, P935, DOI 10.1016/0022-3697(87)90130-2	57	359	362	16	426	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					385	+		10.1038/nature13405	http://dx.doi.org/10.1038/nature13405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24943954				2022-12-24	WOS:000337350200032
J	Regot, S; Hughey, JJ; Bajar, BT; Carrasco, S; Covert, MW				Regot, Sergi; Hughey, Jacob J.; Bajar, Bryce T.; Carrasco, Silvia; Covert, Markus W.			High-Sensitivity Measurements of Multiple Kinase Activities in Live Single Cells	CELL			English	Article							PROTEIN-PHOSPHORYLATION; FRET BIOSENSORS; GROWTH-FACTOR; DYNAMICS; ACTIVATION; REPORTERS; DECISION; PATHWAY; SIGNALS; BRIGHT	Increasing evidence has shown that population dynamics are qualitatively different from single-cell behaviors. Reporters to probe dynamic, single-cell behaviors are desirable yet relatively scarce. Here, we describe an easy-to-implement and generalizable technology to generate reporters of kinase activity for individual cells. Our technology converts phosphorylation into a nucleocytoplasmic shuttling event that can be measured by epifluorescence microscopy. Our reporters reproduce kinase activity for multiple types of kinases and allow for calculation of active kinase concentrations via a mathematical model. Using this technology, we made several experimental observations that had previously been technically-unfeasible, including stimulus-dependent patterns of c-Jun N-terminal kinase (JNK) and nuclear factor kappa B (NF-kappa B) activation. We also measured JNK, p38, and ERK activities simultaneously, finding that p38 regulates the peak number, but not the intensity, of ERK fluctuations. Our approach opens the possibility of analyzing a wide range of kinase-mediated processes in individual cells.	[Regot, Sergi; Hughey, Jacob J.; Bajar, Bryce T.; Carrasco, Silvia; Covert, Markus W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Regot, S (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	sregot@stanford.edu; mcovert@stanford.edu		Covert, Markus/0000-0002-5993-8912; Hughey, Jacob/0000-0002-1558-6089; Bajar, Bryce/0000-0002-0169-0870; Regot, Sergi/0000-0001-9786-3897	Human Frontier Science Program (HFSP) postdoctoral fellowship [LT000529/2012-L]; NIH [5R21AI104305-02, 5DP1LM01150-05]; Stanford Center for Systems Biology [NIH P50GM107615]; Allen Distinguished Investigator Award; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R18DP001150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI104305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [DP1LM011510] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006413] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP) postdoctoral fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Center for Systems Biology; Allen Distinguished Investigator Award; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Collins and members of the Covert lab, in particular D. Macklin, for helpful discussions and comments on the manuscript. We thank Dr. K. Aoki for providing the FRET-based JNKAR plasmid. We also gratefully acknowledge a Human Frontier Science Program (HFSP) postdoctoral fellowship (LT000529/2012-L) to S.R., as well as an NIH R21 (5R21AI104305-02), an NIH Pioneer Award (5DP1LM01150-05), the Stanford Center for Systems Biology (NIH P50GM107615), and an Allen Distinguished Investigator Award to M.W.C. S.R., J.J.H., and M.W.C. are listed as inventors in a patent application for KTR technology.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fosbrink M, 2010, P NATL ACAD SCI USA, V107, P5459, DOI 10.1073/pnas.0909671107; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Jensen KJ, 2013, CELL HOST MICROBE, V13, P67, DOI 10.1016/j.chom.2012.11.009; Joaquin M, 2012, EMBO J, V31, P2952, DOI 10.1038/emboj.2012.122; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	36	284	286	2	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1724	1734		10.1016/j.cell.2014.04.039	http://dx.doi.org/10.1016/j.cell.2014.04.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949979	Green Accepted, Bronze			2022-12-24	WOS:000340941900024
J	Weekes, MP; Tomasec, P; Huttlin, EL; Fielding, CA; Nusinow, D; Stanton, RJ; Wang, ECY; Aicheler, R; Murrell, I; Wilkinson, GWG; Lehner, PJ; Gygi, SP				Weekes, Michael P.; Tomasec, Peter; Huttlin, Edward L.; Fielding, Ceri A.; Nusinow, David; Stanton, Richard J.; Wang, Eddie C. Y.; Aicheler, Rebecca; Murrell, Isa; Wilkinson, Gavin W. G.; Lehner, Paul J.; Gygi, Steven P.			Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction	CELL			English	Article							DOWN-REGULATION; FAMILY-MEMBERS; GENE-PRODUCTS; CYTOMEGALOVIRUS; PROTEIN; DEGRADATION; EXPRESSION; PHOSPHORYLATION; TRANSCRIPTION; RECOGNITION	A systematic quantitative analysis of temporal changes in host and viral proteins throughout the course of a productive infection could provide dynamic insights into virus-host interaction. We developed a proteomic technique called "quantitative temporal viromics" (QTV), which employs multiplexed tandem-mass-tag-based mass spectrometry. Human cytomegalovirus (HCMV) is not only an important pathogen but a paradigm of viral immune evasion. QTV detailed how HCMV orchestrates the expression of >8,000 cellular proteins, including 1,200 cell-surface proteins to manipulate signaling pathways and counterintrinsic, innate, and adaptive immune defenses. QTV predicted natural killer and T cell ligands, as well as 29 viral proteins present at the cell surface, potential therapeutic targets. Temporal profiles of >80% of HCMV canonical genes and 14 noncanonical HCMV open reading frames were defined. QTV is a powerful method that can yield important insights into viral infection and is applicable to any virus with a robust in vitro model.	[Weekes, Michael P.; Huttlin, Edward L.; Nusinow, David; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Tomasec, Peter; Fielding, Ceri A.; Stanton, Richard J.; Wang, Eddie C. Y.; Aicheler, Rebecca; Murrell, Isa; Wilkinson, Gavin W. G.] Cardiff Univ, Sch Med, Cardiff CF14 4XX, S Glam, Wales; [Weekes, Michael P.; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Harvard University; Harvard Medical School; Cardiff University; University of Cambridge	Weekes, MP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	mpw1001@cam.ac.uk; steven_gygi@hms.harvard.edu	Wilkinson, Gavin WG/J-6388-2015; Fielding, Ceri A/F-5638-2014; Stanton, Richard James/B-4695-2008; Nusinow, David/AAJ-4284-2020	Wilkinson, Gavin WG/0000-0002-5623-0126; Fielding, Ceri A/0000-0002-5817-3153; Stanton, Richard James/0000-0002-6799-1182; Nusinow, David/0000-0002-7819-5261; Weekes, Michael/0000-0003-3196-5545; Wang, Eddie/0000-0002-2243-4964; Lehner, Paul Joseph/0000-0001-9383-1054; Huttlin, Edward/0000-0002-1822-1173	Wellcome Trust [093966/Z/10/Z, G1000236, WT090323MA, 084957/Z/08/Z]; MRC; National Institute of Health [GM067945]; Cambridge Biomedical Research Centre, UK; MRC [MR/L008734/1, G0901119, G1000236] Funding Source: UKRI; Medical Research Council [MR/L018373/1, G1000236, G0901119, MR/L008734/1] Funding Source: researchfish; Wellcome Trust [090323/Z/09/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cambridge Biomedical Research Centre, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Andrew Davison for assistance with the assembly of HCMV FASTA files; to Joao Paulo, Ryan Kunz, and Martin Wuehr for mass spectrometry and to Alexander Devaux for technical assistance. This work was supported by a Wellcome Trust Fellowship (093966/Z/10/Z) to M. P. W.; an MRC Project Grant and a Wellcome Trust Programme Grant (G1000236, WT090323MA) to G. W. G. W., P. T., and E.C.Y.W.; a Wellcome Trust Senior Fellowship (084957/Z/08/Z) to P.J.L. and National Institute of Health grant (GM067945) to S. P. G. This study was additionally supported by the Cambridge Biomedical Research Centre, UK. We have filed a provisional patent based on our findings.	Alexander BT, 2010, PHARMACOTHERAPY, V30, P554, DOI 10.1592/phco.30.6.554; Alwine JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002878; Amsler L, 2013, J MOL BIOL, V425, P4857, DOI 10.1016/j.jmb.2013.08.023; Angelova M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002959; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Ceeraz S, 2013, TRENDS IMMUNOL, V34, P556, DOI 10.1016/j.it.2013.07.003; Chambers J, 1999, J VIROL, V73, P5757, DOI 10.1128/JVI.73.7.5757-5766.1999; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Feng XY, 2006, J VIROL, V80, P8371, DOI 10.1128/JVI.00399-06; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Khan Z, 2014, CARCINOGENESIS, V35, P145, DOI 10.1093/carcin/bgt292; Kim YE, 2011, J VIROL, V85, P11928, DOI 10.1128/JVI.00758-11; Koyuncu E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003333; Le VTK, 2008, J GEN VIROL, V89, P2416, DOI 10.1099/vir.0.2008/001669-0; Ma YP, 2012, FUTURE MICROBIOL, V7, P577, DOI [10.2217/FMB.12.32, 10.2217/fmb.12.32]; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Mocarski E. S., 2013, CYTOMEGALOVIRUSES; Nichols WG, 2002, J INFECT DIS, V185, P273, DOI 10.1086/338624; Nikolov DB, 2013, BBA-PROTEINS PROTEOM, V1834, P2160, DOI 10.1016/j.bbapap.2013.04.020; Omoto S, 2014, J VIROL, V88, P120, DOI 10.1128/JVI.02983-13; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Prod'homme V, 2010, J GEN VIROL, V91, P2034, DOI 10.1099/vir.0.021931-0; Rahm N, 2012, CURR OPIN HIV AIDS, V7, P180, DOI 10.1097/COH.0b013e32835048e1; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Scott I, 2009, MICROBES INFECT, V11, P973, DOI 10.1016/j.micinf.2009.07.001; Stanton RJ, 2007, J VIROL, V81, P7860, DOI 10.1128/JVI.02247-06; STENBERG RM, 1989, J VIROL, V63, P2699, DOI 10.1128/JVI.63.6.2699-2708.1989; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SULLIVAN R, 1971, APPL MICROBIOL, V22, P61, DOI 10.1128/AEM.22.1.61-65.1971; Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008; Terhune SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000965; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Tomasec P, 2005, NAT IMMUNOL, V6, P181, DOI 10.1038/ni1156; van der Wal FJ, 2002, CURR TOP MICROBIOL, V269, P37; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Weekes MP, 2013, SCIENCE, V340, P199, DOI 10.1126/science.1235047; Weekes MP, 2012, J PROTEOME RES, V11, P1475, DOI 10.1021/pr201135e; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Witherden DA, 2012, IMMUNITY, V37, P314, DOI 10.1016/j.immuni.2012.05.026	50	285	294	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1460	1472		10.1016/j.cell.2014.04.028	http://dx.doi.org/10.1016/j.cell.2014.04.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906157	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000340881400020
J	Karakas, E; Furukawa, H				Karakas, Erkan; Furukawa, Hiro			Crystal structure of a heterotetrameric NMDA receptor ion channel	SCIENCE			English	Article							AMINO-TERMINAL DOMAIN; K+ CHANNEL; SUBUNIT ARRANGEMENT; BINDING DOMAIN; MECHANISM; SENSITIVITY; INSIGHTS; COMPLEX; RESIDUE	N-Methyl-D-aspartate (NMDA) receptors belong to the family of ionotropic glutamate receptors, which mediate most excitatory synaptic transmission in mammalian brains. Calcium permeation triggered by activation of NMDA receptors is the pivotal event for initiation of neuronal plasticity. Here, we show the crystal structure of the intact heterotetrameric GluN1-GluN2B NMDA receptor ion channel at 4 angstroms. The NMDA receptors are arranged as a dimer of GluN1-GluN2B heterodimers with the twofold symmetry axis running through the entire molecule composed of an amino terminal domain (ATD), a ligand-binding domain (LBD), and a transmembrane domain (TMD). The ATD and LBD are much more highly packed in the NMDA receptors than non-NMDA receptors, which may explain why ATD regulates ion channel activity in NMDA receptors but not in non-NMDA receptors.	[Karakas, Erkan; Furukawa, Hiro] Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Furukawa, H (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, One Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	furukawa@cshl.edu			NIH [MH085926]; Mirus Research Award; Robertson Research Fund of Cold Spring Harbor Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mirus Research Award; Robertson Research Fund of Cold Spring Harbor Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank staffs at the 23-ID-B and D beamlines at the Advanced Photon System in the Argonne National Laboratory and the BL41XU beamline at the Spring 8 for their excellent beamline supports. We thank N. Simorowski for her technical support, H. Yuan and S. Traynelis for sharing unpublished data with us and for critical comments on this manuscript, and S. Harrison for making important comments on this work. This work was supported by NIH (MH085926 to H. F.), Mirus Research Award (to H. F.), and a Robertson Research Fund of Cold Spring Harbor Laboratory (to H. F.). Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 4PE5. DNA constructs, recombinant virus, and proteins used in this study are available from H. F. under a material transfer agreement with Cold Spring Harbor Laboratory.	Das U, 2010, P NATL ACAD SCI USA, V107, P8463, DOI 10.1073/pnas.1000838107; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hayashi T, 1954, KEIO J MED, V3; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jespersen A, 2014, NEURON, V81, P366, DOI 10.1016/j.neuron.2013.11.033; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kashiwagi K, 1996, MOL PHARMACOL, V49, P1131; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Li WY, 2009, P NATL ACAD SCI USA, V106, P1075, DOI 10.1073/pnas.0812008106; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; Retchless BS, 2012, NAT NEUROSCI, V15, P406, DOI 10.1038/nn.3025; Riou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035134; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vance KM, 2012, J PHYSIOL-LONDON, V590, P3857, DOI 10.1113/jphysiol.2012.234062; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; Watanabe J, 2002, J NEUROSCI, V22, P10209; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	38	400	409	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					992	997		10.1126/science.1251915	http://dx.doi.org/10.1126/science.1251915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876489	Green Accepted			2022-12-24	WOS:000336495800036
J	Kiuchi, T; Koga, H; Kawamoto, M; Shoji, K; Sakai, H; Arai, Y; Ishihara, G; Kawaoka, S; Sugano, S; Shimada, T; Suzuki, Y; Suzuki, MG; Katsuma, S				Kiuchi, Takashi; Koga, Hikaru; Kawamoto, Munetaka; Shoji, Keisuke; Sakai, Hiroki; Arai, Yuji; Ishihara, Genki; Kawaoka, Shinpei; Sugano, Sumio; Shimada, Toru; Suzuki, Yutaka; Suzuki, Masataka G.; Katsuma, Susumu			A single female-specific piRNA is the primary determiner of sex in the silkworm	NATURE			English	Article							W-CHROMOSOME; BOMBYX-MORI; RNA; EXPRESSION; SYSTEM; GENE; IDENTIFICATION; TRANSLOCATION; AMPLIFICATION; TRANSPOSONS	The silkworm Bombyx mori uses a WZ sex determination system that is analogous to the one found in birds and some reptiles. In this system, males have two Z sex chromosomes, whereas females have Z and W sex chromosomes. The silkworm W chromosome has a dominant role in female determination(1,2), suggesting the existence of a dominant feminizing gene in this chromosome. However, the W chromosomeis almost fully occupied by transposable element sequences(3-5), and no functional protein-coding gene has been identified so far. Female-enriched PIWI-interacting RNAs (piRNAs) are the only known transcripts that are produced from the sex-determining region of the W chromosome(6), but the function(s) of these piRNAs are unknown. Here we show that a W-chromosome-derived, female-specific piRNA is the feminizing factor of B. mori. This piRNA is produced from a piRNA precursor which we named Fem. Fem sequences were arranged in tandem in the sex-determining region of the W chromosome. Inhibition of Fem-derived piRNA-mediated signalling in female embryos led to the production of the male-specific splice variants of B. mori doublesex (Bmdsx), a gene which acts at the downstream end of the sex differentiation cascade(7,8). A target gene of Fem-derived piRNA was identified on the Z chromosome of B. mori. This gene, which we named Masc, encoded a CCCH-type zinc finger protein. We show that the silencing of Masc messenger RNA by Fem piRNA is required for the production of female-specific isoforms of Bmdsx in female embryos, and that Masc protein controls both dosage compensation and masculinization in male embryos. Our study characterizes a single small RNA that is responsible for primary sex determination in the WZ sex determination system.	[Kiuchi, Takashi; Koga, Hikaru; Kawamoto, Munetaka; Shoji, Keisuke; Arai, Yuji; Ishihara, Genki; Kawaoka, Shinpei; Shimada, Toru; Katsuma, Susumu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Sakai, Hiroki; Suzuki, Masataka G.] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Sugano, Sumio; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Katsuma, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	katsuma@ss.ab.a.u-tokyo.ac.jp	Shimada, Toru/AAZ-2703-2021; Shimada, Toru/A-2033-2011; Kiuchi, Takashi/AAG-4913-2020; Sakai, Hiroki/O-1028-2019	Shimada, Toru/0000-0002-5791-0000; Shimada, Toru/0000-0002-5791-0000; Kiuchi, Takashi/0000-0003-3616-1650; Sakai, Hiroki/0000-0001-6128-7680; Shoji, Keisuke/0000-0003-0183-654X; Kawamoto, Munetaka/0000-0003-3554-8407	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry;  [22115502];  [22128004]	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; ; 	We thank S. G. Kamita for critical reading of the manuscript; Y. Tomari for critical reading of the manuscript and technical suggestions. This work was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry to Su.K. and Grants-in-Aid for Scientific Research on Innovative Areas (Nos. 22115502 and 22128004) to Su.K. and T.S.	Abe H, 2008, GENETICA, V133, P269, DOI 10.1007/s10709-007-9210-1; Abe H, 1998, GENES GENET SYST, V73, P243, DOI 10.1266/ggs.73.243; Abe H, 2005, CYTOGENET GENOME RES, V110, P144, DOI 10.1159/000084946; Abe H, 2005, INSECT MOL BIOL, V14, P339, DOI 10.1111/j.1365-2583.2005.00565.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Fujii T, 2006, GENETICA, V127, P253, DOI 10.1007/s10709-005-4147-8; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hara K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-119; Hasimoto H., 1933, JPN J GENET, V8, P245; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; Kawaoka S, 2008, BIOCHEM BIOPH RES CO, V367, P755, DOI 10.1016/j.bbrc.2008.01.013; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Kawaoka S, 2011, RNA, V17, P1401, DOI 10.1261/rna.2709411; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Kawaoka S, 2008, INSECT BIOCHEM MOLEC, V38, P1058, DOI 10.1016/j.ibmb.2008.03.007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Ohbayashi F, 2001, COMP BIOCHEM PHYS B, V128, P145, DOI 10.1016/S1096-4959(00)00304-3; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Sakai H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00235; Sakudoh T, 2011, GENETICS, V187, P965, DOI 10.1534/genetics.110.124982; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shoji K, 2013, GENE, V527, P649, DOI 10.1016/j.gene.2013.06.071; Sugimoto TN, 2012, BIOL LETTERS, V8, P412, DOI 10.1098/rsbl.2011.1114; Suzuki MG, 2008, MOL CELL BIOL, V28, P333, DOI 10.1128/MCB.01528-07; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; Suzuki MG, 2003, DEV GENES EVOL, V213, P345, DOI 10.1007/s00427-003-0334-8; TAZIMA Y, 1944, B SERIC EXP STA JPN, V12, P109; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Wang LY, 2013, INSECT BIOCHEM MOLEC, V43, P562, DOI 10.1016/j.ibmb.2013.03.011; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Yamaguchi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025469	37	289	312	5	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					633	+		10.1038/nature13315	http://dx.doi.org/10.1038/nature13315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24828047				2022-12-24	WOS:000336457100051
J	Anantharaman, K; Duhaime, MB; Breier, JA; Wendt, KA; Toner, BM; Dick, GJ				Anantharaman, Karthik; Duhaime, Melissa B.; Breier, John A.; Wendt, Kathleen A.; Toner, Brandy M.; Dick, Gregory J.			Sulfur Oxidation Genes in Diverse Deep-Sea Viruses	SCIENCE			English	Article							MARINE VIRUSES; PHOTOSYNTHESIS GENES; HYDROTHERMAL PLUME; GENOME SEQUENCE; BACTERIA; LINEAGES; HYDROGEN; WATERS	Viruses are the most abundant biological entities in the oceans and a pervasive cause of mortality of microorganisms that drive biogeochemical cycles. Although the ecological and evolutionary effects of viruses on marine phototrophs are well recognized, little is known about their impact on ubiquitous marine lithotrophs. Here, we report 18 genome sequences of double-stranded DNA viruses that putatively infect widespread sulfur-oxidizing bacteria. Fifteen of these viral genomes contain auxiliary metabolic genes for the alpha and gamma subunits of reverse dissimilatory sulfite reductase (rdsr). This enzyme oxidizes elemental sulfur, which is abundant in the hydrothermal plumes studied here. Our findings implicate viruses as a key agent in the sulfur cycle and as a reservoir of genetic diversity for bacterial enzymes that underpin chemosynthesis in the deep oceans.	[Anantharaman, Karthik; Dick, Gregory J.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Duhaime, Melissa B.; Dick, Gregory J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Breier, John A.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Wendt, Kathleen A.; Toner, Brandy M.] Univ Minnesota Twin Cities, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Dick, Gregory J.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Woods Hole Oceanographic Institution; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan	Dick, GJ (corresponding author), Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA.	gdick@umich.edu	Toner, Brandy/N-7911-2016	Toner, Brandy/0000-0002-3681-3455; Duhaime, Melissa/0000-0001-7884-5087; Breier, John/0000-0002-3591-5548	Gordon and Betty Moore Foundation [GBMF2609]; NSF [OCE1038006, OCE1038055, OCE1037991, OCE1029242]; University of Michigan Rackham Graduate School Faculty Research Fellowship Program; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; National Center for Biotechnology Information (BioProject) [PRJNA234377]; Directorate For Geosciences [1029242, 1038006] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); University of Michigan Rackham Graduate School Faculty Research Fellowship Program; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Center for Biotechnology Information (BioProject); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project is funded in part by the Gordon and Betty Moore Foundation (grant GBMF2609) and the NSF (grants OCE1038006, OCE1038055, OCE1037991, and OCE1029242). We thank the University of Michigan Rackham Graduate School Faculty Research Fellowship Program for their support and M. Li and S. Jain for their assistance. DNA sequencing was conducted at the University of Michigan DNA Sequencing Core. We acknowledge the captain and crew of R/V Thomas G. Thompson, Chief Scientist A.-L. Reysenbach, and J. Sylvan for sampling and logistical support. For assistance with synchrotron measurements at BL10.3.2, we thank K. J. Edwards, J. V. Sorensen, M. A. Marcus, and S. C. Fakra. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231. The nucleotide sequences are available from DOE JGI-IMG/MER (Taxon Object IDs: Kilo Moana, 3300001680; ABE, 3300001681; Mariner, 3300001678; Tahi Moana, 3300001679; Tui Malila, 3300001676; Guaymas, 3300001683) and the National Center for Biotechnology Information (BioProject: PRJNA234377). We declare no competing financial interests.	Anantharaman K, 2013, P NATL ACAD SCI USA, V110, P330, DOI 10.1073/pnas.1215340110; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Breier JA, 2012, GEOCHIM COSMOCHIM AC, V88, P216, DOI 10.1016/j.gca.2012.04.003; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Dick GJ, 2010, ENVIRON MICROBIOL, V12, P1334, DOI 10.1111/j.1462-2920.2010.02177.x; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Hara S, 1996, MAR ECOL PROG SER, V145, P269, DOI 10.3354/meps145269; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Klein M, 2001, J BACTERIOL, V183, P6028, DOI 10.1128/JB.183.20.6028-6035.2001; Lesniewski RA, 2012, ISME J, V6, P2257, DOI 10.1038/ismej.2012.63; Li M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4192; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Marshall KT, 2013, ISME J, V7, P452, DOI 10.1038/ismej.2012.78; McCollom TM, 2000, DEEP-SEA RES PT I, V47, P85, DOI 10.1016/S0967-0637(99)00048-5; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Petersen JM, 2011, NATURE, V476, P176, DOI 10.1038/nature10325; Reinthaler T, 2010, DEEP-SEA RES PT II, V57, P1572, DOI 10.1016/j.dsr2.2010.02.023; Sheik CS, 2014, ENVIRON MICROBIOL, V16, P304, DOI 10.1111/1462-2920.12165; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309	28	141	146	6	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					757	760		10.1126/science.1252229	http://dx.doi.org/10.1126/science.1252229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24789974	Green Submitted			2022-12-24	WOS:000335912900044
J	Handa, IT; Aerts, R; Berendse, F; Berg, MP; Bruder, A; Butenschoen, O; Chauvet, E; Gessner, MO; Jabiol, J; Makkonen, M; McKie, BG; Malmqvist, B; Peeters, ETHM; Scheu, S; Schmid, B; van Ruijven, J; Vos, VCA; Hattenschwiler, S				Handa, I. Tanya; Aerts, Rien; Berendse, Frank; Berg, Matty P.; Bruder, Andreas; Butenschoen, Olaf; Chauvet, Eric; Gessner, Mark O.; Jabiol, Jeremy; Makkonen, Marika; McKie, Brendan G.; Malmqvist, Bjoern; Peeters, Edwin T. H. M.; Scheu, Stefan; Schmid, Bernhard; van Ruijven, Jasper; Vos, Veronique C. A.; Haettenschwiler, Stephan			Consequences of biodiversity loss for litter decomposition across biomes	NATURE			English	Article							SPECIES FUNCTIONAL DIVERSITY; LEAF-LITTER; ECOSYSTEMS; PATTERNS; SERVICES; CLIMATE; TRAITS	The decomposition of dead organic matter is a major determinant of carbon and nutrient cycling in ecosystems, and of carbon fluxes between the biosphere and the atmosphere(1-3). Decomposition is driven by a vast diversity of organisms that are structured in complex food webs(2,4). Identifying the mechanisms underlying the effects of biodiversity on decomposition is critical(4-6) given the rapid loss of species worldwide and the effects of this loss on human well-being(7-9). Yet despite comprehensive syntheses of studies on how biodiversity affects litter decomposition(4-6,10), key questions remain, including when, where and how biodiversity has a role and whether general patterns and mechanisms occur across ecosystems and different functional types of organism(4,9-12). Here, in field experiments across five terrestrial and aquatic locations, ranging from the subarctic to the tropics, we show that reducing the functional diversity of decomposer organisms and plant litter types slowed the cycling of litter carbon and nitrogen. Moreover, we found evidence of nitrogen transfer from the litter of nitrogen-fixing plants to that of rapidly decomposing plants, but not between other plant functional types, highlighting that specific interactions in litter mixtures control carbon and nitrogen cycling during decomposition. The emergence of this general mechanism and the coherence of patterns across contrasting terrestrial and aquatic ecosystems suggest that biodiversity loss has consistent consequences for litter decomposition and the cycling of major elements on broad spatial scales.	[Handa, I. Tanya; Haettenschwiler, Stephan] CNRS, CEFE, F-34293 Montpellier, France; [Handa, I. Tanya] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Aerts, Rien; Berg, Matty P.; Makkonen, Marika] Vrije Univ Amsterdam, Dept Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [Berendse, Frank; van Ruijven, Jasper; Vos, Veronique C. A.] Wageningen Univ, Nat Conservat & Plant Ecol Grp, NL-6708 PB Wageningen, Netherlands; [Bruder, Andreas; Gessner, Mark O.] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, CH-8600 Dubendorf, Switzerland; [Bruder, Andreas; Gessner, Mark O.] ETH, Inst Integrat Biol IBZ, CH-8092 Zurich, Switzerland; [Butenschoen, Olaf; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Chauvet, Eric; Jabiol, Jeremy] Univ Toulouse, INP, UPS, EcoLab Lab Ecol Fonctionnelle & Environm, F-31062 Toulouse, France; [Chauvet, Eric; Jabiol, Jeremy] CNRS, EcoLab, F-31062 Toulouse, France; [Gessner, Mark O.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, D-16775 Stechlin, Germany; [Gessner, Mark O.] TU Berlin, Berlin Inst Technol, Dept Ecol, D-10587 Berlin, Germany; [Makkonen, Marika] Finnish Environm Inst, Climate Change Programme, Helsinki 00251, Finland; [McKie, Brendan G.] Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; [McKie, Brendan G.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, S-75007 Uppsala, Sweden; [Peeters, Edwin T. H. M.] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, NL-6700 AA Wageningen, Netherlands; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Schmid, Bernhard] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8057 Zurich, Switzerland	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Quebec; University of Quebec Montreal; Vrije Universiteit Amsterdam; Wageningen University & Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Gottingen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Technical University of Berlin; Finnish Environment Institute; Umea University; Swedish University of Agricultural Sciences; Wageningen University & Research; University of Zurich; University of Zurich	Hattenschwiler, S (corresponding author), CNRS, CEFE, 1919 Route Mende, F-34293 Montpellier, France.	stephan.hattenschwiler@cefe.cnrs.fr	van Ruijven, Jasper/D-9848-2011; Chauvet, Eric/F-7644-2011; Bruder, Andreas/AFC-9051-2022; van Ruijven, Jasper/ABE-7791-2020; Schmid, Bernhard/C-8625-2009; Scheu, Stefan/H-7049-2015	Chauvet, Eric/0000-0001-8676-392X; Bruder, Andreas/0000-0002-4591-491X; van Ruijven, Jasper/0000-0003-0003-2363; Schmid, Bernhard/0000-0002-8430-3214; McKie, Brendan/0000-0002-1796-9497; Butenschoen, Olaf/0000-0003-1866-9805; Peeters, Edwin T.H.M./0000-0003-2541-1829; Aerts, Rien/0000-0001-6694-0669; Berg, Matty P./0000-0001-8442-8503; Jabiol, Jeremy/0000-0003-4279-2379	European Science Foundation (ESF) as part of its EUROCORES programme EuroDIVERSITY	European Science Foundation (ESF) as part of its EUROCORES programme EuroDIVERSITY	We thank A. Lecerf and P. Garcia-Palacios for comments on the manuscript. We are grateful to numerous technicians in Montpellier (France) for building field microcosms, in Dubendorf (Switzerland) for water chemical analyses, and in Dubendorf and Gottingen (Germany) for grinding litter samples. We also thank M. Schindler for assistance, B. Buatois, R. Leclerc, P. Schevin and L. Sonie for analyses performed at the Plate-Forme d'Analyses Chimiques en Ecologie, LabEx CeMEB (France), G. Larocque for help with R code and our many colleagues at the field sites and research institutes for their support in various ways. This study is part of the BioCycle research project funded by the European Science Foundation (ESF) as part of its EUROCORES programme EuroDIVERSITY. BioCycle has been endorsed by DIVERSITAS as contributing towards their scientific research priorities in biodiversity science.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bardgett RD., 2005, THE BIOL OF SOIL, DOI [10.1093/acprof:oso/9780198525035.001.0001, DOI 10.1093/ACPROF:OSO/9780198525035.001.0001]; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Finzi AC, 1998, FOREST ECOL MANAG, V105, P129, DOI 10.1016/S0378-1127(97)00277-6; Frainer A, 2014, J ANIM ECOL, V83, P460, DOI 10.1111/1365-2656.12142; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Lepori F, 2009, OIKOS, V118, P471, DOI 10.1111/j.1600-0706.2008.16989.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; Lummer D, 2012, OIKOS, V121, P1649, DOI 10.1111/j.1600-0706.2011.20073.x; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; May RM, 2011, CR BIOL, V334, P346, DOI 10.1016/j.crvi.2010.12.002; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nijboer R., 1999, 455 IBN; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Schimel JP, 2007, SOIL BIOL BIOCHEM, V39, P1428, DOI 10.1016/j.soilbio.2006.12.037; Swan CM, 2006, OECOLOGIA, V149, P107, DOI 10.1007/s00442-006-0436-x; Vitousek PM, 2000, ECOLOGY, V81, P2366, DOI 10.1890/0012-9658(2000)081[2366:HNFIDL]2.0.CO;2; Vos VCA, 2011, OIKOS, V120, P1092, DOI 10.1111/j.1600-0706.2010.18650.x; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 2002, COMMUNITIES ECOSYSTE; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Woodward G, 2012, SCIENCE, V336, P1438, DOI 10.1126/science.1219534	35	440	477	68	987	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					218	+		10.1038/nature13247	http://dx.doi.org/10.1038/nature13247			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805346	Green Accepted			2022-12-24	WOS:000335454300037
J	Kapoor, A; Yao, WT; Ying, HQ; Hua, SJ; Liewen, A; Wang, QY; Zhong, Y; Wu, CJ; Sadanandam, A; Hu, BL; Chang, Q; Chu, GC; Al-Khalil, R; Jiang, S; Xia, HA; Fletcher-Sananikone, E; Lim, C; Horwitz, GI; Viale, A; Pettazzoni, P; Sanchez, N; Wang, HM; Protopopov, A; Zhang, JH; Heffernan, T; Johnson, RL; Chin, LD; Wang, YA; Draetta, G; DePinho, RA				Kapoor, Avnish; Yao, Wantong; Ying, Haoqiang; Hua, Sujun; Liewen, Alison; Wang, Qiuyun; Zhong, Yi; Wu, Chang-Jiun; Sadanandam, Anguraj; Hu, Baoli; Chang, Qing; Chu, Gerald C.; Al-Khalil, Ramsey; Jiang, Shan; Xia, Hongai; Fletcher-Sananikone, Eliot; Lim, Carol; Horwitz, Gillian I.; Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Wang, Huamin; Protopopov, Alexei; Zhang, Jianhua; Heffernan, Timothy; Johnson, Randy L.; Chin, Lynda; Wang, Y. Alan; Draetta, Giulio; DePinho, Ronald A.			Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer	CELL			English	Article							HIPPO PATHWAY; GROWTH; ADENOCARCINOMA; PROLIFERATION; INACTIVATION; INHIBITION; RESISTANCE; INDUCTION; TARGET	Activating mutations in KRAS are among the most frequent events in diverse human carcinomas and are particularly prominent in human pancreatic ductal adenocarcinoma (PDAC). An inducible Kras(G12D) driven mouse model of PDAC has established a critical role for sustained Kras(G12D) expression in tumor maintenance, providing a model to determine the potential for and the underlying mechanisms of Kras(G12D)-independent PDAC recurrence. Here, we show that some tumors undergo spontaneous relapse and are devoid of Kras(G12D) expression and downstream canonical MAPK signaling and instead acquire amplification and overexpression of the transcriptional coactivator Yap1. Functional studies established the role of Yap1 and the transcriptional factor Tead2 in driving Kras(G12D)-independent tumor maintenance. The Yap1/Tead2 complex acts cooperatively with E2F transcription factors to activate a cell cycle and DNA replication program. Our studies, along with corroborating evidence from human PDAC models, portend a novel mechanism of escape from oncogenic Kras addiction in PDAC.	[DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Kapoor, Avnish; Yao, Wantong; Ying, Haoqiang; Hua, Sujun; Liewen, Alison; Wang, Qiuyun; Wu, Chang-Jiun; Hu, Baoli; Al-Khalil, Ramsey; Jiang, Shan; Xia, Hongai; Fletcher-Sananikone, Eliot; Lim, Carol; Horwitz, Gillian I.; Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Chin, Lynda; Wang, Y. Alan; Draetta, Giulio] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Yao, Wantong; Ying, Haoqiang; Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Draetta, Giulio] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Zhong, Yi; Chang, Qing; Protopopov, Alexei; Zhang, Jianhua; Heffernan, Timothy; Chin, Lynda; Draetta, Giulio] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sadanandam, Anguraj] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Sadanandam, Anguraj] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Stn 19, CH-1015 Lausanne, Switzerland; [Chu, Gerald C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of London; Institute of Cancer Research - UK; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Brigham & Women's Hospital	Ying, HQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hying@mdanderson.org; rdepinho@mdanderson.org	Ying, Haoqiang/AAK-4325-2020; Pettazzoni, Piergiorgio/GRJ-3011-2022	DePinho, Ronald/0000-0002-5625-577X; Sadanandam, Anguraj/0000-0001-8485-5150	Small Animal Imaging Facility, Flow Cytometry and Cellular Imaging Core, Histopathology Core, Sequencing and Non-Coding RNA Core Services at The University of Texas, MD Anderson Cancer Center [CA16672]; National Institutes of Health [5U01CA084313, P01CA117969, R56DK094865]; UT Star Award; American-Italian Cancer Foundation Award; NHS; Department of Defense [W81XWH-12-1-0459]; Sheikh Ahmed Center for Pancreatic Cancer Research at the University of Texas MD Anderson Cancer Center; Jane Coffin Childs Postdoctoral Fellowship [61-1512]; Damon Runyon Foundation Postdoctoral Fellowship; TRIUMPH Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [P01CA117969, U01CA084313, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102611, R56DK094865] Funding Source: NIH RePORTER	Small Animal Imaging Facility, Flow Cytometry and Cellular Imaging Core, Histopathology Core, Sequencing and Non-Coding RNA Core Services at The University of Texas, MD Anderson Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Star Award; American-Italian Cancer Foundation Award; NHS; Department of Defense(United States Department of Defense); Sheikh Ahmed Center for Pancreatic Cancer Research at the University of Texas MD Anderson Cancer Center; Jane Coffin Childs Postdoctoral Fellowship; Damon Runyon Foundation Postdoctoral Fellowship; TRIUMPH Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the laboratory of Kun-Liang Guan, William Kaelin, Jiandie D. Lin, Hiroshi Sasaki, and Marius Sudol for sharing various reagents; Mien-Chie Hung and William Hahn for sharing unpublished data; Douglas Hanahan for helpful suggestions and support for PDAC subtype analysis; Shreya Malu for help with the graphical abstract; and Giannicola Genovese, Sharmistha Sarkar, Shruti Malu, Simona Colla, and other members of the DePinho laboratory for helpful suggestions and technical support. We would also like to thank the Small Animal Imaging Facility, Flow Cytometry and Cellular Imaging Core, Histopathology Core, Sequencing and Non-Coding RNA Core Services at The University of Texas, MD Anderson Cancer Center (Cancer Center Support grant, CA16672).; The project was supported by 5U01CA084313 (R.A.D.), P01CA117969 (R.A.D.), R56DK094865 (R.L.J.) from National Institutes of Health; UT Star Award (R.A.D.); American-Italian Cancer Foundation Award (G.D.); NHS funding to the National Institute for Health Research (NIHR) Biomedical Research Centre for Cancer (A.S.); and Discovery Award W81XWH-12-1-0459 from Department of Defense (H.Y.). G.D., H.Y., and T.H. were also supported by funds from the Sheikh Ahmed Center for Pancreatic Cancer Research at the University of Texas MD Anderson Cancer Center. Additional support was provided by the Jane Coffin Childs Postdoctoral Fellowship to A.K. (61-1512), Damon Runyon Foundation Postdoctoral Fellowship to S.H., and TRIUMPH Postdoctoral Fellowship to N.S.	Adams PD, 1996, CURR TOP MICROBIOL, V208, P79; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Berns K, 2012, DRUG RESIST UPDATE, V15, P268, DOI 10.1016/j.drup.2012.10.002; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gao T, 2013, GASTROENTEROLOGY, V144, P1543, DOI 10.1053/j.gastro.2013.02.037; George NM, 2012, MOL CELL BIOL, V32, P5116, DOI 10.1128/MCB.01034-12; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hill R, 2010, CANCER RES, V70, P7114, DOI 10.1158/0008-5472.CAN-10-1649; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Stanger BZ, 2012, GENE DEV, V26, P1263, DOI 10.1101/gad.196501.112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	45	446	456	0	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					185	197		10.1016/j.cell.2014.06.003	http://dx.doi.org/10.1016/j.cell.2014.06.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24954535	Green Accepted, Bronze			2022-12-24	WOS:000340943100017
J	Gunaydin, LA; Grosenick, L; Finkelstein, JC; Kauvar, IV; Fenno, LE; Adhikari, A; Lammel, S; Mirzabekov, JJ; Airan, RD; Zalocusky, KA; Tye, KM; Anikeeva, P; Malenka, RC; Deisseroth, K				Gunaydin, Lisa A.; Grosenick, Logan; Finkelstein, Joel C.; Kauvar, Isaac V.; Fenno, Lief E.; Adhikari, Avishek; Lammel, Stephan; Mirzabekov, Julie J.; Airan, Raag D.; Zalocusky, Kelly A.; Tye, Kay M.; Anikeeva, Polina; Malenka, Robert C.; Deisseroth, Karl			Natural Neural Projection Dynamics Underlying Social Behavior	CELL			English	Article							VENTRAL TEGMENTAL AREA; IN-VIVO CONTROL; NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; CALCIUM INDICATOR; NEURONAL-ACTIVITY; INBRED STRAINS; PRAIRIE VOLES; REWARD; MICE	Social interaction is a complex behavior essential for many species and is impaired in major neuropsychiatric disorders. Pharmacological studies have implicated certain neurotransmitter systems in social behavior, but circuit-level understanding of endogenous neural activity during social interaction is lacking. We therefore developed and applied a new methodology, termed fiber photometry, to optically record natural neural activity in genetically and connectivity-defined projections to elucidate the realtime role of specified pathways in mammalian behavior. Fiber photometry revealed that activity dynamics of a ventral tegmental area (VTA)-to-nucleus accumbens (NAc) projection could encode and predict key features of social, but not novel object, interaction. Consistent with this observation, optogenetic control of cells specifically contributing to this projection was sufficient to modulate social behavior, which was mediated by type 1 dopamine receptor signaling downstream in the NAc. Direct observation of deep projection-specific activity in this way captures a fundamental and previously inaccessible dimension of mammalian circuit dynamics.	[Gunaydin, Lisa A.; Grosenick, Logan; Finkelstein, Joel C.; Kauvar, Isaac V.; Fenno, Lief E.; Adhikari, Avishek; Mirzabekov, Julie J.; Airan, Raag D.; Zalocusky, Kelly A.; Tye, Kay M.; Anikeeva, Polina; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Grosenick, Logan; Fenno, Lief E.; Zalocusky, Kelly A.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Lammel, Stephan; Malenka, Robert C.; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Adhikari, Avishek/A-3339-2012; Fenno, Lief/AAK-2924-2020; Fenno, Lief/AAF-9638-2019; Adhikari, Avishek/AAF-4444-2021; Adhikari, Avishek/N-1284-2015; Lammel, Stephan/O-8295-2018	Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211; Lammel, Stephan/0000-0002-3350-3208; Airan, Raag/0000-0001-5259-5606	Stanford Bio-X Fellowship; NSF [0801700]; Stanford Medical Scientist Training Program; Simons Foundation Autism Research Initiative; NIMH; NIDA; DARPA; Gatsby Charitable Foundation; James Doty; CCARE center at Stanford; Stanford Institute for Neuroinnovation and Translational Neurosciences; Wiegers Family Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH106649, R01MH099647, R01MH075957, R01MH086373, T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794, R37DA035377] Funding Source: NIH RePORTER	Stanford Bio-X Fellowship; NSF(National Science Foundation (NSF)); Stanford Medical Scientist Training Program; Simons Foundation Autism Research Initiative; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gatsby Charitable Foundation; James Doty; CCARE center at Stanford; Stanford Institute for Neuroinnovation and Translational Neurosciences; Wiegers Family Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the entire Deisseroth lab for helpful discussions and T. Jardetzky for use of a Biotek Synergy4 plate reader. L.A.G. is supported by a Stanford Bio-X Fellowship. L.G. is supported by NSF 0801700. L.E.F. is supported by the Stanford Medical Scientist Training Program. K.D. is supported by the Simons Foundation Autism Research Initiative, a Conte Center grant from NIMH, and NIDA, DARPA, the Gatsby Charitable Foundation, James Doty and the CCARE center at Stanford, the Stanford Institute for Neuroinnovation and Translational Neurosciences, and the Wiegers Family Fund. R.C.M. and S.L. were supported by a grant from the Simons Foundation Autism Research Initiative and a Conte Center grant from NIMH. All optogenetic tools and methods described are distributed and supported freely (http://www.optogenetics.org).	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Budygin EA, 2012, NEUROSCIENCE, V201, P331, DOI 10.1016/j.neuroscience.2011.10.056; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Curtis JT, 2005, PHYSIOL BEHAV, V86, P338, DOI 10.1016/j.physbeh.2005.08.022; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Dong YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025615; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Moratalla R, 1996, P NATL ACAD SCI USA, V93, P14928, DOI 10.1073/pnas.93.25.14928; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; PALIJ P, 1990, BRAIN RES, V509, P172, DOI 10.1016/0006-8993(90)90329-A; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Perez MF, 2006, J NEUROPHYSIOL, V96, P2217, DOI 10.1152/jn.00254.2006; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Podda MV, 2010, NEUROSCIENCE, V167, P678, DOI 10.1016/j.neuroscience.2010.02.075; PuglisiAllegra S, 1997, PROG NEUROBIOL, V51, P637, DOI 10.1016/S0301-0082(97)00008-7; Robinson DL, 2011, NEUROSCIENCE, V176, P296, DOI 10.1016/j.neuroscience.2010.12.016; Robinson DL, 2002, J NEUROSCI, V22, P10477; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/NMETH.2013, 10.1038/nmeth.2013]; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Winslow James T, 2003, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0816s22; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Yuan KX, 2011, J NEUROSCI, V31, P13333, DOI 10.1523/JNEUROSCI.1000-11.2011	50	714	724	8	130	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1535	1551		10.1016/j.cell.2014.05.017	http://dx.doi.org/10.1016/j.cell.2014.05.017			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949967	Bronze, Green Accepted			2022-12-24	WOS:000340941900010
J	Peters, AJ; Chen, SX; Komiyama, T				Peters, Andrew J.; Chen, Simon X.; Komiyama, Takaki			Emergence of reproducible spatiotemporal activity during motor learning	NATURE			English	Article							INTRACORTICAL MICROSTIMULATION; LAMINAR ORGANIZATION; NEURAL ACTIVITY; BEHAVING MICE; IN-VIVO; CORTEX; REPRESENTATIONS; MOVEMENT; NEURONS; INFORMATION	The motor cortex is capable of reliably driving complex movements(1,2) yet exhibits considerable plasticity during motor learning(3-10). These observations suggest that the fundamental relationship between motor cortex activity and movement may not be fixed but is instead shaped by learning; however, to what extent and how motor learning shapes this relationship are not fully understood. Here we addressed this issue by using in vivo two-photon calcium imaging(11) to monitor the activity of the same population of hundreds of layer 2/3 neurons while mice learned a forelimb lever-press task over two weeks. Excitatory and inhibitory neurons were identified by transgenic labelling(12,13). Inhibitory neuron activity was relatively stable and balanced local excitatory neuron activity on a movement-by-movement basis, whereas excitatory neuron activity showed higher dynamism during the initial phase of learning. The dynamics of excitatory neurons during the initial phase involved the expansion of the movement-related population which explored various activity patterns even during similar movements. This was followed by a refinement into a smaller population exhibiting reproducible spatiotemporal sequences of activity. This pattern of activity associated with the learned movement was unique to expert animals and not observed during similar movements made during the naive phase, and the relationship between neuronal activity and individual movements became more consistent with learning. These changes in population activity coincided with a transient increase in dendritic spine turnover in these neurons. Our results indicate that a novel and reproducible activity-movement relationship develops as a result of motor learning, and we speculate that synaptic plasticity within the motor cortex underlies the emergence of reproducible spatiotemporal activity patterns for learned movements. These results underscore the profound influence of learning on the way that the cortex produces movements.	[Peters, Andrew J.; Chen, Simon X.; Komiyama, Takaki] Univ Calif San Diego, Neurobiol Sect, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Peters, Andrew J.; Chen, Simon X.; Komiyama, Takaki] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Komiyama, Takaki] Univ Calif San Diego, PRESTO, JST, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Komiyama, T (corresponding author), Univ Calif San Diego, Neurobiol Sect, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA.	tkomiyama@ucsd.edu		Chen, Simon/0000-0002-7595-7443; Peters, Andrew/0000-0001-9351-1456; Komiyama, Takaki/0000-0001-9609-4600	Japan Science and Technology Agency (PRESTO); Pew Charitable Trusts; Alfred P. Sloan Foundation; David & Lucile Packard Foundation; Human Frontier Science Program; New York Stem Cell Foundation; Neuroplasticity of Aging Training Grant [AG000216]	Japan Science and Technology Agency (PRESTO)(Japan Science & Technology Agency (JST)); Pew Charitable Trusts; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); Human Frontier Science Program(Human Frontier Science Program); New York Stem Cell Foundation; Neuroplasticity of Aging Training Grant	We thank A. Kim and S. Kalina for technical assistance; L. L. Looger, J. Akerboom, D. S. Kim and the GENIE Project at Janelia Farm for making GCaMP available; E. Kyubwa and J. Keller for help with task development; A. D. Lien and M. Caudill for help with two-photon guided recordings; and M. Long, R. Malinow, G. Murphy, M. Scanziani and members of the Komiyama laboratory for comments and discussions. This work was supported by grants from Japan Science and Technology Agency (PRESTO), Pew Charitable Trusts, Alfred P. Sloan Foundation, David & Lucile Packard Foundation, Human Frontier Science Program and New York Stem Cell Foundation to T. K. A. J. P. is supported by the Neuroplasticity of Aging Training Grant (AG000216). S. X. C. is a Human Frontier Science Program postdoctoral fellow. T. K. is a NYSCF-Robertson Investigator.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Arduin PJ, 2013, J NEUROSCI, V33, P8308, DOI 10.1523/JNEUROSCI.2744-12.2013; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Chestek CA, 2007, J NEUROSCI, V27, P10742, DOI 10.1523/JNEUROSCI.0959-07.2007; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Graziano M.S.A., 2009, INTELLIGENT MOVEMENT; Harrison TC, 2012, NEURON, V74, P397, DOI 10.1016/j.neuron.2012.02.028; Hira R, 2013, J NEUROSCI, V33, P1377, DOI 10.1523/JNEUROSCI.2550-12.2013; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Kwan AC, 2012, CURR BIOL, V22, P1459, DOI 10.1016/j.cub.2012.06.007; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mandelblat-Cerf Y, 2009, J NEUROSCI, V29, P15053, DOI 10.1523/JNEUROSCI.3011-09.2009; Nudo RJ, 1996, J NEUROSCI, V16, P785; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Picard N, 2013, NAT NEUROSCI, V16, P1340, DOI 10.1038/nn.3477; Pronichev I V, 1998, Neurosci Behav Physiol, V28, P80, DOI 10.1007/BF02461916; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	39	251	252	3	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					263	+		10.1038/nature13235	http://dx.doi.org/10.1038/nature13235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24805237				2022-12-24	WOS:000337032400049
J	Chivukula, RR; Shi, GL; Acharya, A; Mills, EW; Zeitels, LR; Anandam, JL; Abdelnaby, AA; Balch, GC; Mansour, JC; Yopp, AC; Maitra, A; Mendell, JT				Chivukula, Raghu R.; Shi, Guanglu; Acharya, Asha; Mills, Eric W.; Zeitels, Lauren R.; Anandam, Joselin L.; Abdelnaby, Abier A.; Balch, Glen C.; Mansour, John C.; Yopp, Adam C.; Maitra, Anirban; Mendell, Joshua T.			An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration	CELL			English	Article							SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; STEM-CELLS; IN-VIVO; MICRORNAS; CANCER; MYOFIBROBLASTS; GROWTH; COLON; CRYPT	Downregulation of the miR-143/145 microRNA (miRNA) cluster has been repeatedly reported in colon cancer and other epithelial tumors. In addition, overexpression of these miRNAs inhibits tumorigenesis, leading to broad consensus that they function as cell-autonomous epithelial tumor suppressors. We generated mice with deletion of miR-143/145 to investigate the functions of these miRNAs in intestinal physiology and disease in vivo. Although intestinal development proceeded normally in the absence of these miRNAs, epithelial regeneration after injury was dramatically impaired. Surprisingly, we found that miR-143/145 are expressed and function exclusively within the mesenchymal compartment of intestine. Defective epithelial regeneration in miR-143/145-deficient mice resulted from the dysfunction of smooth muscle and myofibroblasts and was associated with derepression of the miR-143 target Igfbp5, which impaired IGF signaling after epithelial injury. These results provide important insights into the regulation of epithelial wound healing and argue against a cell-autonomous tumor suppressor role for miR-143/145 in colon cancer.	[Chivukula, Raghu R.; Mills, Eric W.; Zeitels, Lauren R.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Shi, Guanglu; Acharya, Asha; Mendell, Joshua T.] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; [Anandam, Joselin L.; Abdelnaby, Abier A.; Balch, Glen C.; Mansour, John C.; Yopp, Adam C.] UT Southwestern Med Ctr, Dept Surg, Dallas, TX 75390 USA; [Maitra, Anirban] UT MD Anderson Canc Ctr, Sheikh Ahmed Bin Zayed Al Nahyan Ctr Pancreat Can, Houston, TX 77030 USA; [Mendell, Joshua T.] UT Southwestern Med Ctr, Harold C Simmons Canc Ctr, Dallas, TX 75390 USA	Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendell, JT (corresponding author), UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.	joshua.mendell@utsouthwestern.edu	Shi, Guanglu/G-1641-2013	Shi, Guanglu/0000-0001-5562-111X; Balch, Glen/0000-0002-1575-9170	CPRIT [R1008]; NIH [R01CA120185, P01CA134292, 5P30CA142543, 5T32GM007309]; NATIONAL CANCER INSTITUTE [P30CA142543, P30CA016672, R01CA120185, P01CA134292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309, T32GM007814] Funding Source: NIH RePORTER	CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chip Hawkins in the Johns Hopkins Transgenic Core for assistance with generation of miR-143/145<SUP>Neo/+</SUP> mice, John Shelton in the UT Southwestern Molecular Pathology Core for assistance with histopathology, Cheryl Lewis in the UT Southwestern Tissue Resource Core for assistance with human tissue specimens, Jose Cabrera for assistance with figures, and Eric Olson and Kathryn O'Donnell for helpful suggestions on the manuscript. This work was supported by grants from CPRIT (R1008 to J.T.M.) and the NIH (R01CA120185 to J.T.M., P01CA134292 to J.T.M. and A. M., 5P30CA142543 to the UTSW Simmons Cancer Center, and 5T32GM007309 to R.R.C., L.R.Z., and E.M.).	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Andoh A, 2007, PHARMACOL THERAPEUT, V114, P94, DOI 10.1016/j.pharmthera.2006.12.004; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Haigis KM, 2002, P NATL ACAD SCI USA, V99, P8927, DOI 10.1073/pnas.132275099; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Howarth GS, 1998, SCAND J GASTROENTERO, V33, P180; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lamlum H, 2000, P NATL ACAD SCI USA, V97, P2225, DOI 10.1073/pnas.040564697; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Otte JM, 2003, GASTROENTEROLOGY, V124, P1866, DOI 10.1016/S0016-5085(03)00403-7; Papaconstantinou IG, 2013, PANCREAS, V42, P67, DOI 10.1097/MPA.0b013e3182592ba7; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shaker A, 2010, J CLIN INVEST, V120, P2081, DOI 10.1172/JCI40676; Shao JY, 2006, CANCER RES, V66, P846, DOI 10.1158/0008-5472.CAN-05-2606; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zeng L, 2012, DEV BIOL, V367, P178, DOI 10.1016/j.ydbio.2012.05.009; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	59	161	165	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1104	1116		10.1016/j.cell.2014.03.055	http://dx.doi.org/10.1016/j.cell.2014.03.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855947	Green Accepted, Bronze			2022-12-24	WOS:000336437200013
J	Wang, L; Zhang, J; Duan, J; Gao, X; Zhu, W; Lu, X; Yang, L; Zhang, J; Li, G; Ci, W; Li, W; Zhou, Q; Aluru, N; Tang, F; He, C; Huang, X; Liu, J				Wang, Lu; Zhang, Jun; Duan, Jialei; Gao, Xinxing; Zhu, Wei; Lu, Xingyu; Yang, Lu; Zhang, Jing; Li, Guoqiang; Ci, Weimin; Li, Wei; Zhou, Qi; Aluru, Neel; Tang, Fuchou; He, Chuan; Huang, Xingxu; Liu, Jiang			Programming and Inheritance of Parental DNA Methylomes in Mammals	CELL			English	Article							METHYLATION; GENOME; 5-HYDROXYMETHYLCYTOSINE; IDENTIFICATION; CELLS; 5-FORMYLCYTOSINE; FERTILIZATION; DEMETHYLATION; CONFLICT; DYNAMICS	The reprogramming of parental methylomes is essential for embryonic development. In mammals, paternal 5-methylcytosines (5mCs) have been proposed to be actively converted to oxidized bases. These paternal oxidized bases and maternal 5mCs are believed to be passively diluted by cell divisions. By generating single-base resolution, allele-specific DNA methylomes from mouse gametes, early embryos, and primordial germ cell (PGC), as well as single-base-resolution maps of oxidized cytosine bases for early embryos, we report the existence of 5hmC and 5fC in both maternal and paternal genomes and find that 5mC or its oxidized derivatives, at the majority of demethylated CpGs, are converted to unmodified cytosines independent of passive dilution from gametes to four-cell embryos. Therefore, we conclude that paternal methylome and at least a significant proportion of maternal methylome go through active demethylation during embryonic development. Additionally, all the known imprinting control regions (ICRs) were classified into germ-line or somatic ICRs.	[Wang, Lu; Duan, Jialei; Zhu, Wei; Zhang, Jing; Li, Guoqiang; Liu, Jiang] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Ci, Weimin] Chinese Acad Sci, Beijing Inst Gen, Lab Dis Genom & Individualized Med, Beijing 100101, Peoples R China; [Wang, Lu; Zhu, Wei; Li, Guoqiang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Jun; Gao, Xinxing; Huang, Xingxu] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Lu, Xingyu; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Lu, Xingyu; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Yang, Lu; Tang, Fuchou] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Li, Wei; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Aluru, Neel] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing University; University of Chicago; University of Chicago; Peking University; Chinese Academy of Sciences; Institute of Zoology, CAS; Woods Hole Oceanographic Institution	Huang, X (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China.	xingxuhuang@mail.nju.edu.cn; liuj@big.ac.cn	Ci, Weimin/AAS-5984-2021; Duan, Jialei/F-4539-2011; Zhang, Jing/F-4707-2015; Zhu, Wei/HGA-4471-2022; Li, Guoqiang/K-2850-2016; Wang, Lu/I-8245-2018	Ci, Weimin/0000-0002-4111-5360; Duan, Jialei/0000-0003-4086-7461; Zhang, Jing/0000-0001-5903-6487; Zhu, Wei/0000-0003-1459-6733; Li, Guoqiang/0000-0001-5303-5707; Wang, Lu/0000-0002-8896-0115; Liu, Jiang/0000-0002-5687-5047; huang, xingxu/0000-0001-8934-1247	973 Program of China [2010CB945101, 2011CB510101]; National Natural Science Foundation of China [91219104, 81171902, 91231112, 31171244, 31200958]; National Institutes of Health [HG006827]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES021923] Funding Source: NIH RePORTER; Directorate For Geosciences [1314642] Funding Source: National Science Foundation	973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grants from the 973 Program of China to X.H. (2010CB945101), to J.L. (2011CB510101); from National Natural Science Foundation of China to J.L. (91219104 and 81171902), to W.C. (91231112 and 31171244), to J.Z. (31200958). C.H. is supported by National Institutes of Health (HG006827). We thank the sequencing facility in BIG, CAS.	Collado-Fernandez E, 2012, INT J DEV BIOL, V56, P799, DOI 10.1387/ijdb.120140ec; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hackett JA, 2013, CELL, V153, P737, DOI 10.1016/j.cell.2013.04.044; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hiura H, 2010, NUCLEIC ACIDS RES, V38, P4929, DOI 10.1093/nar/gkq200; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iwasa Y, 1998, CURR TOP DEV BIOL, V40, P255, DOI 10.1016/S0070-2153(08)60369-5; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; MOORE T, 1995, DEV GENET, V17, P206, DOI 10.1002/dvg.1020170305; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; SURANI MA, 1990, DEVELOPMENT, P89; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Veenstra GJC, 2001, BBA-GENE STRUCT EXPR, V1521, P39, DOI 10.1016/S0167-4781(01)00280-9; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	47	341	367	5	196	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					979	991		10.1016/j.cell.2014.04.017	http://dx.doi.org/10.1016/j.cell.2014.04.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813617	Green Accepted, Bronze			2022-12-24	WOS:000335765500023
J	Hovestadt, V; Jones, DTW; Picelli, S; Wang, W; Kool, M; Northcott, PA; Sultan, M; Stachurski, K; Ryzhova, M; Warnatz, HJ; Ralser, M; Brun, S; Bunt, J; Jager, N; Kleinheinz, K; Erkek, S; Weber, UD; Bartholomae, CC; von Kalle, C; Lawerenz, C; Eils, J; Koster, J; Versteeg, R; Milde, T; Witt, O; Schmidt, S; Wolf, S; Pietsch, T; Rutkowski, S; Scheurlen, W; Taylor, MD; Brors, B; Felsberg, J; Reifenberger, G; Borkhardt, A; Lehrach, H; Wechsler-Reya, RJ; Eils, R; Yaspo, ML; Landgraf, P; Korshunov, A; Zapatka, M; Radlwimmer, B; Pfister, SM; Lichter, P				Hovestadt, Volker; Jones, David T. W.; Picelli, Simone; Wang, Wei; Kool, Marcel; Northcott, Paul A.; Sultan, Marc; Stachurski, Katharina; Ryzhova, Marina; Warnatz, Hans-Joerg; Ralser, Meryem; Brun, Sonja; Bunt, Jens; Jaeger, Natalie; Kleinheinz, Kortine; Erkek, Scrap; Weber, Ursula D.; Bartholomae, Cynthia C.; von Kalle, Christof; Lawerenz, Chris; Eils, Jurgen; Koster, Jan; Versteeg, Rogier; Milde, Till; Witt, Olaf; Schmidt, Sabine; Wolf, Stephan; Pietsch, Torsten; Rutkowski, Stefan; Scheurlen, Wolfram; Taylor, Michael D.; Brors, Benedikt; Felsberg, Joerg; Reifenberger, Guido; Borkhardt, Arndt; Lehrach, Hans; Wechsler-Reya, Robert J.; Eils, Roland; Yaspo, Marie-Laure; Landgraf, Pablo; Korshunov, Andrey; Zapatka, Marc; Radlwimmer, Bernhard; Pfister, Stefan M.; Lichter, Peter			Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing	NATURE			English	Article							CANCER GENOME; GENE; DIFFERENTIATION; HYPERMETHYLATION; IDENTIFICATION; SUPPRESSOR; METHYLOME; ULTRAFAST; ALIGNMENT; MUTATION	Epigenetic alterations, that is, disruption of DNA methylation and chromatin architecture, are now acknowledged as a universal feature of tumorigenesis(1). Medulloblastoma, a clinically challenging, malignant childhood brain tumour, is no exception. Despite much progress from recent genomics studies, with recurrent changes identified in each of the four distinct tumour subgroups(WNT-pathway-activated, SHH-pathway-activated, and the less-well-characterized Group 3 and Group 4)(2-4), many cases still lack an obvious genetic driver. Here we present whole-genome bisulphite-sequencing data from thirty-four human and five murine tumours plus eight human and three murine normal controls, augmented with matched whole-genome, RNA and chromatin immunoprecipitation sequencing data. This comprehensive data set allowed us to decipher several features underlying the interplay between the genome, epigenome and transcriptome, and its effects on medulloblastoma pathophysiology. Most notable were highly prevalent regions of hypomethylation correlating with increased gene expression, extending tens of kilobases downstream of transcription start sites. Focal regions of low methylation linked to transcription-factor-binding sites shed light on differential transcriptional networks between subgroups, whereas increased methylation due to re-normalization of repressed chromatin in DNA methylation valleys was positively correlated with gene expression. Large, partially methylated domains affecting up to one-third of the genome showed increased mutation rates and gene silencing in a subgroup-specific fashion. Epigenetic alterations also affected novel medulloblastoma candidate genes (for example, LIN28B), resulting in alternative promoter usage and/or differential messenger RNA/microRNA expression. Analysis of mouse medulloblastoma and precursor-cell methylation demonstrated a somatic origin for many alterations. Our data provide insights into the epigenetic regulation of transcription and genome organization in medulloblastoma pathogenesis, which are probably also of importance in a wider developmental and disease context.	[Hovestadt, Volker; Picelli, Simone; Wang, Wei; Kleinheinz, Kortine; Weber, Ursula D.; Zapatka, Marc; Radlwimmer, Bernhard; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Jones, David T. W.; Kool, Marcel; Northcott, Paul A.; Erkek, Scrap; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Sultan, Marc; Warnatz, Hans-Joerg; Ralser, Meryem; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Stachurski, Katharina; Borkhardt, Arndt; Landgraf, Pablo] Univ Dusseldorf, Dept Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow 125047, Russia; [Brun, Sonja; Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, Designated Canc Ctr, NCI, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Bunt, Jens] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia; [Bunt, Jens; Koster, Jan; Versteeg, Rogier] Univ Amsterdam, AMC, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Jaeger, Natalie; Kleinheinz, Kortine; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Erkek, Scrap] EMBL, D-69117 Heidelberg, Germany; [Bartholomae, Cynthia C.; von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; von Kalle, Christof] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [Lawerenz, Chris; Eils, Jurgen] German Canc Res Ctr, Data Management Facil, D-69120 Heidelberg, Germany; [Milde, Till; Witt, Olaf; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Milde, Till; Witt, Olaf] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, D-69120 Heidelberg, Germany; [Schmidt, Sabine; Wolf, Stephan] German Canc Res Ctr, Genom & Prote Core Facil, D-69120 Heidelberg, Germany; [Pietsch, Torsten] Univ Bonn, Med Ctr, Dept Neuropathol, D-53105 Bonn, Germany; [Rutkowski, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Paediat Haematol & Oncol, D-20246 Hamburg, Germany; [Scheurlen, Wolfram] Nurnberg Childrens Hosp, Cnopfsche Kinderklin, D-90419 Nurnberg, Germany; [Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Felsberg, Joerg; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Felsberg, Joerg; Reifenberger, Guido] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, D-69120 Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, IPMB, D-69120 Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Bioquant Ctr, D-69120 Heidelberg, Germany; [Eils, Roland; Lichter, Peter] Heidelberg Ctr Personalised Oncol DKFZ HIPO, D-69120 Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Heinrich Heine University Dusseldorf; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanford Burnham Prebys Medical Discovery Institute; University of Queensland; University of Amsterdam; Academic Medical Center Amsterdam; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Heinrich Heine University Dusseldorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Hovestadt, V (corresponding author), German Canc Res Ctr, Div Mol Genet, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Northcott, Paul A/N-4022-2018; Versteeg, Rogier/AAQ-1765-2020; Zapatka, Marc/G-9896-2013; Jones, David TW/G-9588-2013; Milde, Till/AAR-4528-2021; Ryzhova, Marina/G-4178-2014; Bunt, Jens/C-4775-2014; Pfister, Stefan M/F-6860-2013; Hovestadt, Volker/ABG-2076-2021; Erkek, Serap/AAV-5549-2020; Brors, Benedikt/E-5620-2013; Milde, Till/L-7755-2015; Kool, Marcel/H-2541-2013; Eils, Roland/B-6121-2009; Koster, Jan/C-5934-2008; Radlwimmer, Bernhard F/I-3229-2013; Reifenberger, Guido/AAE-3599-2019; Jones, David T. W./Z-1963-2019	Northcott, Paul A/0000-0002-1220-5252; Zapatka, Marc/0000-0001-8287-5967; Jones, David TW/0000-0002-2036-5141; Milde, Till/0000-0002-7267-1052; Ryzhova, Marina/0000-0001-7206-6365; Bunt, Jens/0000-0003-0397-2019; Pfister, Stefan M/0000-0002-5447-5322; Hovestadt, Volker/0000-0002-3480-6649; Brors, Benedikt/0000-0001-5940-3101; Eils, Roland/0000-0002-0034-4036; Koster, Jan/0000-0002-0890-7585; Radlwimmer, Bernhard F/0000-0002-4553-7800; Warnatz, Hans-Jorg/0000-0002-0327-9209; Korshunov, Andrey/0000-0002-5257-3623; Jaeger, Natalie/0000-0002-9589-7580; Kleinheinz, Kortine/0000-0002-1859-2281; Erkek, Serap/0000-0003-4439-5203; Versteeg, Rogier/0000-0001-7172-0388; Taylor, Michael/0000-0001-7009-3466; Picelli, Simone/0000-0002-1747-614X	German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A]; German Federal Ministry of Education and Research (MedSys) [0315416C]; German Federal Ministry of Education and Research (NGFNplus) [01GS0883]; DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Dutch Cancer Foundations KWF [2010-4713]; KIKA; German Research Foundation (DFG) [LA2983/2-1]	German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (MedSys)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (NGFNplus)(Federal Ministry of Education & Research (BMBF)); DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Dutch Cancer Foundations KWF; KIKA; German Research Foundation (DFG)(German Research Foundation (DFG))	We thank the members of the ICGC PedBrain Tumor Project, the German Cancer Research Center (DKFZ) Genomics and Proteomics Core Facility, the European Molecular Biology Laboratory (EMBL) Genomics Core Facility, M. Schick, R. Fischer, M. Bewerunge-Hudler, M. Knopf, R. Kabbe, A. Benner, R. Volckman and P. van Sluis for technical support and helpful discussion. Active Motif, Inc. is acknowledged for ChIP and library preparation. We also thank C. Plass for critical reading of the manuscript. This work was principally supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and the German Federal Ministry of Education and Research (BMBF, grants #01KU1201A, MedSys #0315416C and NGFN<SUP>plus</SUP> #01GS0883). Additional support came from the DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the Dutch Cancer Foundations KWF (2010-4713) and KIKA (M.Ko.), and the German Research Foundation (DFG; grant LA2983/2-1 to P.La.).	[Anonymous], 2010, R LANG ENV STAT COMP; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bunt J, 2012, INT J CANCER, V131, pE21, DOI 10.1002/ijc.26474; Bunt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026058; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Manoranjan B, 2013, STEM CELLS, V31, P1266, DOI 10.1002/stem.1401; Milde T, 2012, J NEURO-ONCOL, V110, P335, DOI 10.1007/s11060-012-0978-1; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	48	288	291	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					537	+		10.1038/nature13268	http://dx.doi.org/10.1038/nature13268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24847876	Green Published			2022-12-24	WOS:000337806300047
J	Schauder, CM; Wu, XD; Saheki, Y; Narayanaswamy, P; Torta, F; Wenk, MR; De Camilli, P; Reinisch, KM				Schauder, Curtis M.; Wu, Xudong; Saheki, Yasunori; Narayanaswamy, Pradeep; Torta, Federico; Wenk, Markus R.; De Camilli, Pietro; Reinisch, Karin M.			Structure of a lipid-bound extended synaptotagmin indicates a role in lipid transfer	NATURE			English	Article							CONTACT SITES; CRYSTAL-STRUCTURE; PROTEINS; ER; REVEALS; DOMAINS	Growing evidence suggests that close appositions between the endoplasmic reticulum(ER) and other membranes, including appositions with the plasma membrane (PM), mediate exchange of lipids between these bilayers. The mechanisms of such exchange, which allows lipid transfer independently of vesicular transport, remain poorly understood. The presence of a synaptotagmin-like mitochondrial-lipid-binding protein (SMP) domain, a proposed lipid-binding module, in several proteins localized at membrane contact sites has raised the possibility that such domains may be implicated in lipid transport(1,2). SMP-containing proteins include components of the ERMES complex, an ER-mitochondrial tether(3), and the extended synaptotagmins (known as tricalbins in yeast), which are ER-PM tethers(4-6). Here we present at 2.44 angstrom resolution the crystal structure of a fragment of human extended synaptotagmin 2 (E-SYT2), including an SMP domain and two adjacent C2 domains. The SMP domain has a beta-barrel structure like protein modules in the tubular-lipid-binding (TULIP) superfamily. It dimerizes to form an approximately 90-angstrom-long cylinder traversed by a channel lined entirely with hydrophobic residues, with the two C2A-C2B fragments forming arched structures flexibly linked to the SMP domain. Importantly, structural analysis complemented by mass spectrometry revealed the presence of glycerophospholipids in the E-SYT2 SMP channel, indicating a direct role for E-SYTs in lipid transport. These findings provide strong evidence for a role of SMP-domain-containing proteins in the control of lipid transfer at membrane contact sites and have broad implications beyond the field of ER-to-PM appositions.	[Schauder, Curtis M.; Wu, Xudong; Saheki, Yasunori; De Camilli, Pietro; Reinisch, Karin M.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Saheki, Yasunori; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Saheki, Yasunori; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Narayanaswamy, Pradeep] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Torta, Federico; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117599, Singapore	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; National University of Singapore; National University of Singapore	Reinisch, KM (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	pietro.decamilli@yale.edu; karin.reinisch@yale.edu	Wenk, Markus Rene/D-1441-2014; Saheki, Yasunori/D-5430-2016	Saheki, Yasunori/0000-0002-1229-6668; Torta, Federico/0000-0001-7545-7484	National Institutes of Health [GM080616, R37NS36251, DK082700]; National University of Singapore via the Life Sciences Institute (LSI); Biochemical Research Council [BMRC-SERC Diag-034]; National Science Foundation Graduate Research Fellowship [DGE-1122492]; Uehara Memorial Foundation; Japanese Society for Promotion of Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National University of Singapore via the Life Sciences Institute (LSI); Biochemical Research Council; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to the staff at NE-CAT beamline 24ID-C at the Advanced Photon Source for assistance with data collection. We thank H. Shen and N. Kumar for discussion. This work was supported by the National Institutes of Health (GM080616 to K.M.R., R37NS36251 and DK082700 to P.D.C.). M.R.W. and F.T. are funded by grants from the National University of Singapore via the Life Sciences Institute (LSI) and the Biochemical Research Council (BMRC-SERC Diag-034). C.M.S. is recipient of an National Science Foundation Graduate Research Fellowship (DGE-1122492). Y.S. was supported by the Uehara Memorial Foundation and the Japanese Society for Promotion of Science.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kopec KO, 2011, BIOCHEM SOC T, V39, P1033, DOI 10.1042/BST0391033; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Xu JJ, 2014, STRUCTURE, V22, P269, DOI 10.1016/j.str.2013.11.011; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]	30	201	206	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					552	+		10.1038/nature13269	http://dx.doi.org/10.1038/nature13269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24847877	Green Accepted			2022-12-24	WOS:000337806300050
J	Poelstra, JW; Vijay, N; Bossu, CM; Lantz, H; Ryll, B; Muller, I; Baglione, V; Unneberg, P; Wikelski, M; Grabherr, MG; Wolf, JBW				Poelstra, J. W.; Vijay, N.; Bossu, C. M.; Lantz, H.; Ryll, B.; Mueller, I.; Baglione, V.; Unneberg, P.; Wikelski, M.; Grabherr, M. G.; Wolf, J. B. W.			The genomic landscape underlying phenotypic integrity in the face of gene flow in crows	SCIENCE			English	Article							HOODED CROWS; HYBRID ZONE; SPECIATION; DIVERGENCE; INVERSIONS; EXPRESSION; EVOLUTION; EXCHANGE	The importance, extent, and mode of interspecific gene flow for the evolution of species has long been debated. Characterization of genomic differentiation in a classic example of hybridization between all-black carrion crows and gray-coated hooded crows identified genome-wide introgression extending far beyond the morphological hybrid zone. Gene expression divergence was concentrated in pigmentation genes expressed in gray versus black feather follicles. Only a small number of narrow genomic islands exhibited resistance to gene flow. One prominent genomic region (<2 megabases) harbored 81 of all 82 fixed differences (of 8.4 million single-nucleotide polymorphisms in total) linking genes involved in pigmentation and in visual perception-a genomic signal reflecting color-mediated prezygotic isolation. Thus, localized genomic selection can cause marked heterogeneity in introgression landscapes while maintaining phenotypic divergence.	[Poelstra, J. W.; Vijay, N.; Bossu, C. M.; Wolf, J. B. W.] Uppsala Univ, Sci Life Lab, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Poelstra, J. W.; Vijay, N.; Bossu, C. M.; Wolf, J. B. W.] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Lantz, H.] Uppsala Univ, S-75124 Uppsala, Sweden; [Lantz, H.; Grabherr, M. G.] Uppsala Univ, Sci Life Lab, S-75123 Uppsala, Sweden; [Lantz, H.; Grabherr, M. G.] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Ryll, B.] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Mueller, I.; Wikelski, M.] Max Planck Inst Ornithol, D-78315 Radolfzell am Bodensee, Germany; [Mueller, I.; Wikelski, M.] Univ Konstanz, Dept Biol, D-78464 Constance, Germany; [Baglione, V.] Univ Valladolid, Dept Ciencias Agroforestales, Palencia 34004, Spain; [Unneberg, P.] Stockholm Univ, Sci Life Lab, S-17121 Solna, Sweden; [Unneberg, P.] Stockholm Univ, Dept Biochem & Biophys, S-17121 Solna, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University; Max Planck Society; University of Konstanz; Universidad de Valladolid; Stockholm University; Stockholm University	Wolf, JBW (corresponding author), Uppsala Univ, Sci Life Lab, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden.	jochen.wolf@ebc.uu.se	Vijay, Nagarjun/AAM-7687-2021; Baglione, Vittorio/D-6456-2014; Wolf, Jochen/U-2243-2017; Vijay, Nagarjun/AAI-9433-2020	Vijay, Nagarjun/0000-0002-8703-6991; Wolf, Jochen/0000-0002-2958-5183; Baglione, Vittorio/0000-0001-8464-7861; Poelstra, Jelmer/0000-0002-3514-7462; Bossu, Christen/0000-0002-0458-9305; Unneberg, Per/0000-0001-5735-3315; Lantz, Henrik/0000-0003-2419-0075; Grabherr, Manfred/0000-0001-8792-6508	VolkswagenStiftung grant [I/83 496]; Swedish Research Council [621-2010-5553]; Wallenberg Advanced Bioinformatics Infrastructure - (Knut and Alice Wallenberg Foundation); Carl Tryggers foundation [CTS11:517, CTS12:543]; European Research Council [ERCStG-336536]; Max Planck Society; SciLifeLab Uppsala; Knut and Alice Wallenberg Foundation; Swedish National Infrastructure for Computing; NCBI [PRJNA192205]	VolkswagenStiftung grant(Volkswagen); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg Advanced Bioinformatics Infrastructure - (Knut and Alice Wallenberg Foundation); Carl Tryggers foundation; European Research Council(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); SciLifeLab Uppsala; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish National Infrastructure for Computing; NCBI	We thank W. Fiedler, K. Temnow, L. Vossen, M. Dopfner, T. Part, K.-H. Siebenrock, and the other staff of the Max Planck Institute for Ornithology for help with field work and animal husbandry. R. Burri assisted in population genetic analyses. Supported by VolkswagenStiftung grant I/83 496, Swedish Research Council grant 621-2010-5553, the Wallenberg Advanced Bioinformatics Infrastructure (funded by the Knut and Alice Wallenberg Foundation), Carl Tryggers foundation grant CTS11:517, CTS12:543, and European Research Council grant ERCStG-336536 (J.B.W.W.); the Max Planck Society (M. W., I. M.); and SciLifeLab Uppsala (M. G. G., H. L.). C. brachyrhynchos samples were provided by courtesy of the American Museum of Natural History, New York; Polish hooded crows by A. Kruszewicz and M. Gajownik, Warsaw Zoo. We thank the UPPMAX Next-Generation Sequencing Cluster and Storage (UPPNEX) project, funded by the Knut and Alice Wallenberg Foundation and the Swedish National Infrastructure for Computing, for access to computational resources. All sequencing data and the genome assembly are available in the NCBI short read archive under project PRJNA192205.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Guerrero RF, 2012, PHILOS T R SOC B, V367, P430, DOI 10.1098/rstb.2011.0246; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Hoogduijn MJ, 2006, PIGM CELL RES, V19, P58, DOI 10.1111/j.1600-0749.2005.00284.x; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kunte K, 2014, NATURE, V507, P229, DOI 10.1038/nature13112; Martemyanov KA, 2009, PROG MOL BIOL TRANSL, V86, P205, DOI 10.1016/S1877-1173(09)86007-9; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; McLean CA, 2014, BIOL REV, V89, P860, DOI 10.1111/brv.12083; MEISE WILHELM, 1928, JOUR ORNITHOL [BERLIN], V76, P1; Moniot B, 2011, DEV DYNAM, V240, P2335, DOI 10.1002/dvdy.22726; Parkin David T, 2003, British Birds, V96, P274; Randler C, 2007, ARDEA, V95, P143, DOI 10.5253/078.095.0116; Renaut S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2833; SAINO N, 1991, B ZOOL, V58, P255, DOI 10.1080/11250009109355762; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schnetkamp PPM, 2013, MOL ASPECTS MED, V34, P455, DOI 10.1016/j.mam.2012.07.008; THORNEYCROFT HB, 1975, EVOLUTION, V29, P611, DOI 10.1111/j.1558-5646.1975.tb00855.x; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x	24	347	357	2	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1410	1414		10.1126/science.1253226	http://dx.doi.org/10.1126/science.1253226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24948738	Green Submitted			2022-12-24	WOS:000337531700043
J	Rodgers, JT; King, KY; Brett, JO; Cromie, MJ; Charville, GW; Maguire, KK; Brunson, C; Mastey, N; Liu, L; Tsai, CR; Goodell, MA; Rando, TA				Rodgers, Joseph T.; King, Katherine Y.; Brett, Jamie O.; Cromie, Melinda J.; Charville, Gregory W.; Maguire, Katie K.; Brunson, Christopher; Mastey, Namrata; Liu, Ling; Tsai, Chang-Ru; Goodell, Margaret A.; Rando, Thomas A.			mTORC1 controls the adaptive transition of quiescent stem cells from G(0) to G(Alert)	NATURE			English	Article							HEPATOCYTE GROWTH-FACTOR; SKELETAL-MUSCLE; MOLECULAR REGULATION; EXPRESSION DATA; REGENERATION; PROGENITORS; RENEWAL; EVENTS; SYSTEM; INJURY	A unique property of many adult stem cells is their ability to exist in a non-cycling, quiescent state(1). Although quiescence serves an essential role in preserving stem cell function until the stem cell is needed in tissue homeostasis or repair, defects in quiescence can lead to an impairment in tissue function(2). The extent to which stem cells can regulate quiescence is unknown. Here we show that the stem cell quiescent state is composed of two distinct functional phases, G(0) and an 'alert' phase we term G(Alert). Stem cells actively and reversibly transition between these phases in response to injury-induced systemic signals. Using genetic mouse models specific to muscle stem cells (or satellite cells), we show that mTORC1 activity is necessary and sufficient for the transition of satellite cells from G(0) into G(Alert) and that signalling through the HGF receptor cMet is also necessary. We also identify G(0)-to-G(Alert) transitions in several populations of quiescent stem cells. Quiescent stem cells that transition into GAlert possess enhanced tissue regenerative function. We propose that the transition of quiescent stem cells into G(Alert) functions as an 'alerting' mechanism, an adaptive response that positions stem cells to respond rapidly under conditions of injury and stress, priming them for cell cycle entry.	[Rodgers, Joseph T.; Brett, Jamie O.; Cromie, Melinda J.; Charville, Gregory W.; Maguire, Katie K.; Brunson, Christopher; Mastey, Namrata; Liu, Ling; Rando, Thomas A.] Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Rodgers, Joseph T.; Brett, Jamie O.; Cromie, Melinda J.; Charville, Gregory W.; Maguire, Katie K.; Brunson, Christopher; Mastey, Namrata; Liu, Ling; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [King, Katherine Y.; Tsai, Chang-Ru; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [King, Katherine Y.; Tsai, Chang-Ru; Goodell, Margaret A.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr Excellence, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA.	rando@stanford.edu	King, Katherine/AAI-2436-2021	Rodgers, Joseph/0000-0002-6598-5520; Rando, Thomas/0000-0001-5843-8564; King, Katherine/0000-0002-5093-6005; Goodell, Margaret A./0000-0003-1111-2932	Glenn Foundation for Medical Research; Department of Veterans Affairs; National Institutes of Health [K99 AG041764, K08 HL098898, R01 DK092883, P01 AG036695, R01 AG23806, R01 AR062185]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG035521, R01AG023806, R37AG023806, R01AG047820, P01AG036695, K99AG041764] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002324] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We would like to thank members of the Rando laboratory for discussions critical to the preparation of this manuscript, especially T. Cheung and S. Biressi. We thank L. Rott for providing assistance with FACS. This work was supported by The Glenn Foundation for Medical Research, by a grant from the Department of Veterans Affairs to T. A. R., and grants from the National Institutes of Health to J.T.R. (K99 AG041764), K.Y.K (K08 HL098898), M.A.G. (R01 DK092883) and to T.A.R. (P01 AG036695, R01 AG23806 and R01 AR062185).	Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Fontanillo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024289; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Mieczkowski J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-104; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Miyazawa K, 2010, FEBS J, V277, P2208, DOI 10.1111/j.1742-4658.2010.07637.x; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; SOPRANO KJ, 1994, J CELL BIOCHEM, V54, P405, DOI 10.1002/jcb.240540407; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Valentini G, 2006, BIOINFORMATICS, V22, P369, DOI 10.1093/bioinformatics/bti817; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamada M, 2010, AM J PHYSIOL-CELL PH, V298, pC465, DOI 10.1152/ajpcell.00449.2009	35	404	420	1	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					393	+		10.1038/nature13255	http://dx.doi.org/10.1038/nature13255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24870234	Green Accepted			2022-12-24	WOS:000337350200034
J	Koren, I; Dagan, G; Altaratz, O				Koren, Ilan; Dagan, Guy; Altaratz, Orit			From aerosol-limited to invigoration of warm convective clouds	SCIENCE			English	Article							CONDENSATION NUCLEI; CCN CONCENTRATIONS; PRECIPITATION; MODEL; UNCERTAINTY; ALGORITHM; PRODUCTS; RAIN	Among all cloud-aerosol interactions, the invigoration effect is the most elusive. Most of the studies that do suggest this effect link it to deep convective clouds with a warm base and cold top. Here, we provide evidence from observations and numerical modeling of a dramatic aerosol effect on warm clouds. We propose that convective-cloud invigoration by aerosols can be viewed as an extension of the concept of aerosol-limited clouds, where cloud development is limited by the availability of cloud-condensation nuclei. A transition from pristine to slightly polluted atmosphere yields estimated negative forcing of similar to 15 watts per square meter (cooling), suggesting that a substantial part of this anthropogenic forcing over the oceans occurred at the beginning of the industrial era, when the marine atmosphere experienced such transformation.	[Koren, Ilan; Dagan, Guy; Altaratz, Orit] Weizmann Inst Sci, Dept Earth & Planetary Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Koren, I (corresponding author), Weizmann Inst Sci, Dept Earth & Planetary Sci, IL-76100 Rehovot, Israel.	ilan.koren@weizmann.ac.il	Keyes, Dennis/AAZ-9285-2021; Koren, Ilan/K-1417-2012; Dagan, Guy/ABH-4574-2020	Koren, Ilan/0000-0001-6759-6265; Dagan, Guy/0000-0002-8391-6334	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC [306965]	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC))	The research leading to these results received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 306965 (CAPRI).	Altaratz O, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034025; Andreae MO, 2008, EARTH-SCI REV, V89, P13, DOI 10.1016/j.earscirev.2008.03.001; Andreae MO, 2009, ATMOS CHEM PHYS, V9, P543, DOI 10.5194/acp-9-543-2009; Andreae MO, 2007, SCIENCE, V315, P50, DOI 10.1126/science.1136529; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; BAKER MB, 1990, NATURE, V345, P142, DOI 10.1038/345142a0; Carslaw KS, 2013, NATURE, V503, P67, DOI 10.1038/nature12674; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; HEGG DA, 1991, J GEOPHYS RES-ATMOS, V96, P18727, DOI 10.1029/91JD01870; HINDMAN EE, 1994, ATMOS ENVIRON, V28, P3393, DOI 10.1016/1352-2310(94)00171-G; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Jiang HL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006138; Kaufman YJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023125; Kaufman YJ, 2005, P NATL ACAD SCI USA, V102, P11207, DOI 10.1073/pnas.0505191102; Koren I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023187; Koren I, 2010, ATMOS CHEM PHYS, V10, P8855, DOI 10.5194/acp-10-8855-2010; Koren I, 2010, ATMOS CHEM PHYS, V10, P5001, DOI 10.5194/acp-10-5001-2010; Koren I, 2009, ATMOS CHEM PHYS, V9, P155, DOI 10.5194/acp-9-155-2009; Koren I, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029253; Koren I, 2012, NAT GEOSCI, V5, P118, DOI [10.1038/ngeo1364, 10.1038/NGEO1364]; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; PARRISH DF, 1992, MON WEATHER REV, V120, P1747, DOI 10.1175/1520-0493(1992)120<1747:TNMCSS>2.0.CO;2; Pierce JR, 2009, ATMOS CHEM PHYS, V9, P1339, DOI 10.5194/acp-9-1339-2009; Platnick S, 2003, IEEE T GEOSCI REMOTE, V41, P459, DOI 10.1109/TGRS.2002.808301; Reisin T, 1996, J APPL METEOROL, V35, P1416, DOI 10.1175/1520-0450(1996)035<1416:SCCWIN>2.0.CO;2; Remer LA, 2005, J ATMOS SCI, V62, P947, DOI 10.1175/JAS3385.1; Reutter P, 2009, ATMOS CHEM PHYS, V9, P7067, DOI 10.5194/acp-9-7067-2009; Rosenfeld D., 2013, CLIMATE SCI SERVING, P105, DOI [DOI 10.1007/978-94-007-6692-1_5, 10.1007/978-94-007-6692-1_5]; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Tao WK, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000369; TRIPOLI GJ, 1980, J APPL METEOROL, V19, P1037, DOI 10.1175/1520-0450(1980)019<1037:ANIOSF>2.0.CO;2; TWOMEY S, 1959, TELLUS, V11, P408; TZIVION S, 1994, J APPL METEOROL, V33, P252, DOI 10.1175/1520-0450(1994)033<0252:NSOHSI>2.0.CO;2; Wang M, 2009, ATMOS CHEM PHYS, V9, P239, DOI 10.5194/acp-9-239-2009; Wen GY, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008267; Wielicki BA, 1998, IEEE T GEOSCI REMOTE, V36, P1127, DOI 10.1109/36.701020; Xue HW, 2008, J ATMOS SCI, V65, P392, DOI 10.1175/2007JAS2428.1; Yu HB, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010648; Yuan T, 2011, ATMOS CHEM PHYS, V11, P7119, DOI 10.5194/acp-11-7119-2011; Yum SS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003864	41	153	155	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1143	1146		10.1126/science.1252595	http://dx.doi.org/10.1126/science.1252595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904161				2022-12-24	WOS:000336791200043
J	Akers, KG; Martinez-Canabal, A; Restivo, L; Yiu, AP; De Cristofaro, A; Hsiang, HL; Wheeler, AL; Guskjolen, A; Niibori, Y; Shoji, H; Ohira, K; Richards, BA; Miyakawa, T; Josselyn, SA; Frankland, PW				Akers, Katherine G.; Martinez-Canabal, Alonso; Restivo, Leonardo; Yiu, Adelaide P.; De Cristofaro, Antonietta; Hsiang, Hwa-Lin (Liz); Wheeler, Anne L.; Guskjolen, Axel; Niibori, Yosuke; Shoji, Hirotaka; Ohira, Koji; Richards, Blake A.; Miyakawa, Tsuyoshi; Josselyn, Sheena A.; Frankland, Paul W.			Hippocampal Neurogenesis Regulates Forgetting During Adulthood and Infancy	SCIENCE			English	Article							DENTATE GYRUS; RAT HIPPOCAMPUS; GRANULE CELLS; NEURONS BORN; MEMORY; FEAR; PROLIFERATION; STIMULATION; HYPOTHESIS; ONTOGENY	Throughout life, new neurons are continuously added to the dentate gyrus. As this continuous addition remodels hippocampal circuits, computational models predict that neurogenesis leads to degradation or forgetting of established memories. Consistent with this, increasing neurogenesis after the formation of a memory was sufficient to induce forgetting in adult mice. By contrast, during infancy, when hippocampal neurogenesis levels are high and freshly generated memories tend to be rapidly forgotten (infantile amnesia), decreasing neurogenesis after memory formation mitigated forgetting. In precocial species, including guinea pigs and degus, most granule cells are generated prenatally. Consistent with reduced levels of postnatal hippocampal neurogenesis, infant guinea pigs and degus did not exhibit forgetting. However, increasing neurogenesis after memory formation induced infantile amnesia in these species.	[Akers, Katherine G.; Martinez-Canabal, Alonso; Restivo, Leonardo; Yiu, Adelaide P.; De Cristofaro, Antonietta; Hsiang, Hwa-Lin (Liz); Wheeler, Anne L.; Guskjolen, Axel; Niibori, Yosuke; Richards, Blake A.; Josselyn, Sheena A.; Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Martinez-Canabal, Alonso; Hsiang, Hwa-Lin (Liz); Wheeler, Anne L.; Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Guskjolen, Axel; Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Shoji, Hirotaka; Ohira, Koji; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med Sci, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan; [Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Psychol, Toronto, ON M5S 3GM, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Fujita Health University; University of Toronto	Josselyn, SA (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sheena.josselyn@sickkids.ca; paul.frankland@sickkids.ca	Martinez-Canabal, Alonso/K-8734-2018; Wheeler, Anne/V-1215-2019; Martinez-Canabal, Alonso/N-5288-2019; Martinez-canabal, Alonso/AAJ-9239-2021; Akers, Katherine G./A-4537-2013; Miyakawa, Tsuyoshi/A-7741-2008	Martinez-Canabal, Alonso/0000-0001-6638-5618; Akers, Katherine G./0000-0002-4578-6575; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Restivo, Leonardo/0000-0002-3709-5504; Ohira, Koji/0000-0003-0170-8652; Wheeler, Anne/0000-0002-1103-0526; Richards, Blake/0000-0001-9662-2151	Brain Canada; Canadian Institutes of Health Research (CIHR) [MOP86762, MOP74650]; Centre for Brain and Behavior at the Hospital for Sick Children; Core Research for Evolutional Science and Technology of Japan Science and Technology Agency (JST-CREST); Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (KAKENHI); CIHR; El Consejo Nacional de Ciencia y Tecnologia; Donald and Doris Milne Alzheimer's Disease Fellowship; Ontario Mental Health Foundation; Natural Sciences and Engineering Research Council of Canada	Brain Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Centre for Brain and Behavior at the Hospital for Sick Children; Core Research for Evolutional Science and Technology of Japan Science and Technology Agency (JST-CREST); Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (KAKENHI); CIHR(Canadian Institutes of Health Research (CIHR)); El Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Donald and Doris Milne Alzheimer's Disease Fellowship; Ontario Mental Health Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from Brain Canada to P. W. F., the Canadian Institutes of Health Research (CIHR) to P. W. F. (MOP86762) and S.A.J. (MOP74650), the Centre for Brain and Behavior at the Hospital for Sick Children to P. W. F. and S.A.J., and the Core Research for Evolutional Science and Technology of Japan Science and Technology Agency (JST-CREST) and Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (KAKENHI) to T. M. K. G. A. and H.-L. H. (CIHR), A. M.-C. (El Consejo Nacional de Ciencia y Tecnologia), A.P.Y. (Donald and Doris Milne Alzheimer's Disease Fellowship), A. L. W. (Ontario Mental Health Foundation), and A. G. and B. A. R. (Natural Sciences and Engineering Research Council of Canada) were supported by fellowships. Data are archived in the Dryad repository (doi: 10.5061/dryad.s7q3c).	Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Acsady L, 1998, J NEUROSCI, V18, P3386; Akers KG, 2012, LEARN MEMORY, V19, P598, DOI 10.1101/lm.027581.112; Campbell B. A., 1984, COMP PERSPECTIVES DE, P23; CAMPBELL BA, 1972, PSYCHOL REV, V79, P215, DOI 10.1037/h0032690; Danker JF, 2010, PSYCHOL BULL, V136, P87, DOI 10.1037/a0017937; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Frankland PW, 2013, TRENDS NEUROSCI, V36, P497, DOI 10.1016/j.tins.2013.05.002; Freud S., 1905, BASIC WRITINGS S FRE, P30; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Guidi S, 2005, HIPPOCAMPUS, V15, P285, DOI 10.1002/hipo.20050; Josselyn SA, 2004, NEUROBIOL LEARN MEM, V82, P159, DOI 10.1016/j.nlm.2004.05.008; Josselyn SA, 2012, LEARN MEMORY, V19, P423, DOI 10.1101/lm.021311.110; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Maekawa M, 2009, NEUROSCI RES, V63, P259, DOI 10.1016/j.neures.2008.12.006; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McGonigal R, 2012, HIPPOCAMPUS, V22, P1242, DOI 10.1002/hipo.20998; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Meltzer LA, 2005, TRENDS NEUROSCI, V28, P653, DOI 10.1016/j.tins.2005.09.007; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Niibori Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2261; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Richards BA, 2013, HIPPOCAMPUS, V23, P207, DOI 10.1002/hipo.22089; Rubin DC, 2000, MEMORY, V8, P265, DOI 10.1080/096582100406810; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2009, TRENDS NEUROSCI, V32, P283, DOI 10.1016/j.tins.2008.12.007; Weisz VI, 2012, COGNITION, V125, P13, DOI 10.1016/j.cognition.2012.07.002; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	46	428	439	9	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					598	602		10.1126/science.1248903	http://dx.doi.org/10.1126/science.1248903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812394				2022-12-24	WOS:000335537400035
J	Kirschke, E; Goswami, D; Southworth, D; Griffin, PR; Agard, DA				Kirschke, Elaine; Goswami, Devrishi; Southworth, Daniel; Griffin, Patrick R.; Agard, David A.			Glucocorticoid Receptor Function Regulated by Coordinated Action of the Hsp90 and Hsp70 Chaperone Cycles	CELL			English	Article							LIGAND-BINDING DOMAIN; SHOCK-PROTEIN 90; CONFORMATIONAL DYNAMICS; PROGESTERONE-RECEPTOR; SIGNAL-TRANSDUCTION; ELECTRON-MICROSCOPY; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATP HYDROLYSIS	The glucocorticoid receptor (GR), like many signaling proteins, depends on the Hsp90 molecular chaperone for in vivo function. Although Hsp90 is required for ligand binding in vivo, purified apo GR is capable of binding ligand with no enhancement from Hsp90. We reveal that Hsp70, known to facilitate client delivery to Hsp90, inactivates GR through partial unfolding, whereas Hsp90 reverses this inactivation. Full recovery of ligand binding requires ATP hydrolysis on Hsp90 and the Hop and p23 cochaperones. Surprisingly, Hsp90 ATP hydrolysis appears to regulate client transfer from Hsp70, likely through a coupling of the two chaperone's ATP cycles. Such coupling is embodied in contacts between Hsp90 and Hsp70 in the GR: Hsp70: Hsp90: Hop complex imaged by cryoelectron microscopy. Whereas GR released from Hsp70 is aggregation prone, release from Hsp90 protects GR from aggregation and enhances its ligand affinity. Together, this illustrates how coordinated chaperone interactions can enhance stability, function, and regulation.	[Kirschke, Elaine; Southworth, Daniel; Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Kirschke, Elaine; Southworth, Daniel; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Scripps Research Institute	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu			PSI-Biology grant [U01 GM098254]; UCSF Quantitative Biosciences Consortium; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098254, T32GM008284] Funding Source: NIH RePORTER	PSI-Biology grant; UCSF Quantitative Biosciences Consortium; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Liao and Y. Cheng for help with the initial model for EM refinement and members of the D.A.A. lab for helpful discussions. Support for this work was provided by the PSI-Biology grant U01 GM098254 (to D.A.A.), the UCSF Quantitative Biosciences Consortium (to E.K.), and the Howard Hughes Medical Institute.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chrousos GP, 2009, ANN NY ACAD SCI, V1179, P153, DOI 10.1111/j.1749-6632.2009.04988.x; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Fang L, 2006, P NATL ACAD SCI USA, V103, P18487, DOI 10.1073/pnas.0609163103; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freeman BC, 2001, TRENDS BIOCHEM SCI, V26, P285, DOI 10.1016/S0968-0004(01)01834-5; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; HOWARD KJ, 1990, J BIOL CHEM, V265, P11928; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Johnson JL, 2007, MOL CELL BIOL, V27, P768, DOI 10.1128/MCB.01034-06; KIMURA Y, 1995, SCIENCE, V268, P1362, DOI 10.1126/science.7761857; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLaughlin SH, 2002, PROTEIN SCI, V11, P1926, DOI 10.1110/ps.5000102; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Pfaff SJ, 2010, J BIOL CHEM, V285, P15256, DOI 10.1074/jbc.M110.108118; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	51	256	264	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1685	1697		10.1016/j.cell.2014.04.038	http://dx.doi.org/10.1016/j.cell.2014.04.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949977	Bronze, Green Accepted			2022-12-24	WOS:000340941900021
J	Koyano, F; Okatsu, K; Kosako, H; Tamura, Y; Go, E; Kimura, M; Kimura, Y; Tsuchiya, H; Yoshihara, H; Hirokawa, T; Endo, T; Fon, EA; Trempe, JF; Saeki, Y; Tanaka, K; Matsuda, N				Koyano, Fumika; Okatsu, Kei; Kosako, Hidetaka; Tamura, Yasushi; Go, Etsu; Kimura, Mayumi; Kimura, Yoko; Tsuchiya, Hikaru; Yoshihara, Hidehito; Hirokawa, Takatsugu; Endo, Toshiya; Fon, Edward A.; Trempe, Jean-Francois; Saeki, Yasushi; Tanaka, Keiji; Matsuda, Noriyuki			Ubiquitin is phosphorylated by PINK1 to activate parkin	NATURE			English	Article							MITOCHONDRIAL TRANSLOCATION; MECHANISMS; DROSOPHILA-PINK1; RECRUITMENT; DYSFUNCTION; MUTATIONS; DEFECTS; COMPLEX; DOMAIN	PINK1 (PTEN induced putative kinase 1) and PARKIN (also known as PARK2) have been identified as the causal genes responsible for hereditary recessive early-onset Parkinsonism(1,2). PINK1 is a Ser/Thr kinase that specifically accumulates on depolarized mitochondria, whereas parkin is an E3 ubiquitin ligase that catalyses ubiquitin transfer to mitochondrial substrates(3-5). PINK1 acts as an upstream factor for parkin(6,7) and is essential both for the activation of latent E3 parkin activity(8) and for recruiting parkin onto depolarized mitochondria(8-12). Recently, mechanistic insights into mitochondrial quality control mediated by PINK1 and parkin have been revealed(3-5), and PINK1-dependent phosphorylation of parkin has been reported(13-15). However, the requirement of PINK1 for parkin activation was not bypassed by phosphomimetic parkin mutation(15), and how PINK1 accelerates the E3 activity of parkin on damaged mitochondria is still obscure. Here we report that ubiquitin is the genuine substrate of PINK1. PINK1 phosphorylated ubiquitin at Ser 65 both in vitro and in cells, and a Ser 65 phosphopeptide derived from endogenous ubiquitin was only detected in cells in the presence of PINK1 and following a decrease in mitochondrial membrane potential. Unexpectedly, phosphomimetic ubiquitin bypassed PINK1-dependent activation of a phosphomimetic parkin mutant in cells. Furthermore, phosphomimetic ubiquitin accelerates discharge of the thioester conjugate formed by UBCH7 (also known as UBE2L3) and ubiquitin (UBCH7 ubiquitin) in the presence of parkin in vitro, indicating that it acts allosterically. The phosphorylation-dependent interaction between ubiquitin and parkin suggests that phosphorylated ubiquitin unlocks autoinhibition of the catalytic cysteine. Our results show that PINK1-dependent phosphorylation of both parkin and ubiquitin is sufficient for full activation of parkin E3 activity. These findings demonstrate that phosphorylated ubiquitin is a parkin activator.	[Koyano, Fumika; Okatsu, Kei; Go, Etsu; Kimura, Mayumi; Kimura, Yoko; Tsuchiya, Hikaru; Yoshihara, Hidehito; Saeki, Yasushi; Tanaka, Keiji; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Koyano, Fumika; Okatsu, Kei] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Kosako, Hidetaka] Univ Tokushima, Div Cell Signaling, Fujii Mem Inst Med Sci, Tokushima 7708503, Japan; [Tamura, Yasushi] Nagoya Univ, Res Ctr Mat Sci, Nagoya, Aichi 4648602, Japan; [Kimura, Yoko] Shizuoka Univ, Grad Sch Agr, Shizuoka 4228529, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo 1350064, Japan; [Endo, Toshiya] Nagoya Univ, Grad Sch Sci, JST CREST Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Endo, Toshiya] Kyoto Sangyo Univ, JST CREST Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Fon, Edward A.] McGill Univ, McGill Parkinson Program, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada; [Trempe, Jean-Francois] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Tokushima University; Nagoya University; Shizuoka University; National Institute of Advanced Industrial Science & Technology (AIST); Nagoya University; Kyoto Sangyo University; McGill University; McGill University; Tokyo Metropolitan Institute of Medical Science	Matsuda, N (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan.	tanaka-kj@igakuken.or.jp; matsuda-nr@igakuken.or.jp	Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/H-8270-2017; Kimura, Yoko/E-6845-2013; Saeki, Yasushi/AAR-8198-2021; Matsuda, Noriyuki/AAI-3156-2020	Tamura, Yasushi/0000-0002-8462-0607; Kimura, Yoko/0000-0002-3054-9753; Saeki, Yasushi/0000-0002-9202-5453; Matsuda, Noriyuki/0000-0001-8199-952X; Okatsu, Kei/0000-0001-8949-3750	JSPS KAKENHI [23687018, 23-6061, 21000012, 24657072, 22227003]; MEXT KAKENHI [24111557, 25112522, 24112008]; Tomizawa Jun-ichi and Keiko Fund; JST CREST; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; McGill University; GRASP from the FRSQ; CIHR; FRSQ; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24657072, 26650042, 26440101, 26000014] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tomizawa Jun-ichi and Keiko Fund; JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; McGill University; GRASP from the FRSQ; CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers 23687018 (to N.M.), 23-6061 (to K.O.), 21000012 (to K. T.), 24657072 and 22227003 (to Y.T. and T.E.); MEXT KAKENHI grant numbers 24111557 and 25112522 (to N.M.), 24112008 (to Y.S.); the Tomizawa Jun-ichi and Keiko Fund (to N.M.); JST CREST (to T. E.); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT (to T. H.); startup funds from McGill University and the GRASP from the FRSQ (to J.-F.T.); an Operating Grant from the CIHR and a Chercheur National Award from the FRSQ (to E. A. F.); and the Takeda Science Foundation (to H. K., K. T. and N.M.). We thank N. Croteau and S. Rasool for technical assistance, T. Ueno for anti-FoF1 antibody, and D. Finley for yeast strain SUB328.	Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Narendra D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011338; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Schapira AHV, 2010, EXP NEUROL, V224, P331, DOI 10.1016/j.expneurol.2010.03.028; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Tsuchiya H, 2013, BIOCHEM BIOPH RES CO, V436, P223, DOI 10.1016/j.bbrc.2013.05.080; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	30	933	962	11	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					162	+		10.1038/nature13392	http://dx.doi.org/10.1038/nature13392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24784582				2022-12-24	WOS:000336768900049
J	Laganowsky, A; Reading, E; Allison, TM; Ulmschneider, MB; Degiacomi, MT; Baldwin, AJ; Robinson, CV				Laganowsky, Arthur; Reading, Eamonn; Allison, Timothy M.; Ulmschneider, Martin B.; Degiacomi, Matteo T.; Baldwin, Andrew J.; Robinson, Carol V.			Membrane proteins bind lipids selectively to modulate their structure and function	NATURE			English	Article							MOBILITY-MASS SPECTROMETRY; ATOM FORCE-FIELD; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR-DYNAMICS; ION-CHANNEL; COMPLEXES; MODEL; MSCL; PURIFICATION; WATER	Previous studies have established that the folding, structure and function of membrane proteins are influenced by their lipid environments(1-7) and that lipids can bind to specific sites, for example, in potassium channels(8). Fundamental questions remain however regarding the extent of membrane protein selectivity towards lipids. Here we report a mass spectrometry approach designed to determine the selectivity of lipid binding to membrane protein complexes. We investigate the mechanosensitive channel of large conductance (MscL) from Myco-bacterium tuberculosis and aquaporin Z (AqpZ) and the ammonia channel (AmtB) from Escherichia coli, using ion mobility mass spectrometry (IM-MS), which reports gas-phase collision cross-sections. We demonstrate that folded conformations of membrane protein complexes can exist in the gas phase. By resolving lipid-bound states, we then rank bound lipids on the basis of their ability to resist gas phase unfolding and thereby stabilize membrane protein structure. Lipids bind non-selectively and with high avidity to MscL, all imparting comparable stability; however, the highest-ranking lipid is phosphatidylinositol phosphate, in line with its proposed functional role in mechanosensation(9). AqpZ is also stabilized by many lipids, with cardiolipin imparting the most significant resistance to unfolding. Subsequently, through functional assays we show that cardiolipin modulates AqpZ function. Similar experiments identify AmtB as being highly selective for phosphatidylglycerol, prompting us to obtain an X-ray structure in this lipid membrane-like environment. The 2.3 angstrom resolution structure, when compared with others obtained without lipid bound, reveals distinct conformational changes that re-position AmtB residues to interact with the lipid bilayer. Our results demonstrate that resistance to unfolding correlates with specific lipid-binding events, enabling a distinction to be made between lipids that merely bind from those that modulate membrane protein structure and/or function. We anticipate that these findings will be important not only for defining the selectivity of membrane proteins towards lipids, but also for understanding the role of lipids in modulating protein function or drug binding.	[Laganowsky, Arthur; Reading, Eamonn; Allison, Timothy M.; Degiacomi, Matteo T.; Baldwin, Andrew J.; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 5QY, England; [Ulmschneider, Martin B.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	University of Oxford; Johns Hopkins University	Laganowsky, A (corresponding author), Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 5QY, England.	art.laganowsky@chem.ox.ac.uk; carol.robinson@chem.ox.ac.uk	Baldwin, Andrew/A-5830-2015; Degiacomi, Matteo/M-4342-2017; Ulmschneider, Martin/J-4374-2012	Baldwin, Andrew/0000-0001-7579-8844; Degiacomi, Matteo/0000-0003-4672-471X; Reading, Eamonn/0000-0001-8219-0052; robinson, carol/0000-0001-7829-5505; Ulmschneider, Martin/0000-0001-8103-0516; Laganowsky, Arthur/0000-0001-5012-5547	Medical Research Council (MRC); BBSRC; ERC; Biotechnology and Biological Sciences Research Council [BB/J014346/1] Funding Source: researchfish; Medical Research Council [MC_PC_12020, G1000819] Funding Source: researchfish; BBSRC [BB/J014346/1] Funding Source: UKRI; MRC [MC_PC_12020, G1000819] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Hobman and D. Lee for providing gene-doctoring plasmids, Z. Guan and C. Li for providing E. coli strains and plasmids containing cardiolipin genes. We also thank D. Staunton and N. Housden for training on the stopped-flow apparatus; and T. Mize, J. Benesch, M. McDonough, T. Walton and D. Rees for discussions. We also gratefully acknowledge E. Lowe and S. Lea for organizing synchrotron proposals and Diamond Light Source beam line I04 and staff, the Medical Research Council (MRC), BBSRC and ERC advanced grant (IMPRESS) for funding. A.L. is a Nicholas Kurti Junior Research Fellow of Brasenose College, A. J. B. is a BBSRC David Phillip's Fellow and C.V.R. is a Royal Society Professor.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Benesch JLP, 2011, CURR OPIN STRUC BIOL, V21, P641, DOI 10.1016/j.sbi.2011.08.002; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cantor RS, 1999, CHEM PHYS LIPIDS, V101, P45, DOI 10.1016/S0009-3084(99)00054-7; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; FINE JB, 1982, J LIPID RES, V23, P660; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gandhi CS, 2011, PROTEIN SCI, V20, P313, DOI 10.1002/pro.562; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Hall Z, 2012, STRUCTURE, V20, P1596, DOI 10.1016/j.str.2012.07.001; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hite RK, 2010, EMBO J, V29, P1652, DOI 10.1038/emboj.2010.68; Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hyung SJ, 2009, CHEM BIOL, V16, P382, DOI 10.1016/j.chembiol.2009.02.008; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Izzo D., 2012, P ICATT; Izzo D, 2012, STUD COMPUT INTELL, V415, P151; Jones E., 2001, SCIPY OPEN SOURCE SC; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Laganowsky A, 2013, NAT PROTOC, V8, P639, DOI 10.1038/nprot.2013.024; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MASON EA, 1958, ANN PHYS-NEW YORK, V4, P233, DOI 10.1016/0003-4916(58)90049-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newby ZER, 2009, NAT PROTOC, V4, P619, DOI 10.1038/nprot.2009.27; Pace C N, 1986, Methods Enzymol, V131, P266; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Powl AM, 2003, BIOCHEMISTRY-US, V42, P14306, DOI 10.1021/bi034995k; Romantsov T, 2010, J BACTERIOL, V192, P912, DOI 10.1128/JB.00967-09; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sanders CR, 2011, BIOCHEMISTRY-US, V50, P7858, DOI 10.1021/bi2011527; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shvartsburg AA, 1996, CHEM PHYS LETT, V261, P86, DOI 10.1016/0009-2614(96)00941-4; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Stengel F, 2012, CHEM BIOL, V19, P599, DOI 10.1016/j.chembiol.2012.04.007; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Ulmschneider JP, 2009, J CHEM THEORY COMPUT, V5, P1803, DOI 10.1021/ct900086b; Whitelegge JP, 2013, ANAL CHEM, V85, P2558, DOI 10.1021/ac303064a; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhong DL, 2013, BIOCHEMISTRY-US, V52, P5415, DOI 10.1021/bi400790j	70	496	506	16	515	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					172	+		10.1038/nature13419	http://dx.doi.org/10.1038/nature13419			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899312	Green Accepted, Green Submitted			2022-12-24	WOS:000336768900051
J	Soria-Carrasco, V; Gompert, Z; Comeault, AA; Farkas, TE; Parchman, TL; Johnston, JS; Buerkle, CA; Feder, JL; Bast, J; Schwander, T; Egan, SP; Crespi, BJ; Nosil, P				Soria-Carrasco, Victor; Gompert, Zachariah; Comeault, Aaron A.; Farkas, Timothy E.; Parchman, Thomas L.; Johnston, J. Spencer; Buerkle, C. Alex; Feder, Jeffrey L.; Bast, Jens; Schwander, Tanja; Egan, Scott P.; Crespi, Bernard J.; Nosil, Patrik			Stick Insect Genomes Reveal Natural Selection's Role in Parallel Speciation	SCIENCE			English	Article							HOST-PLANT ADAPTATION; REPRODUCTIVE ISOLATION; GENE-FLOW; EVOLUTION; DIVERGENCE; ISLANDS	Natural selection can drive the repeated evolution of reproductive isolation, but the genomic basis of parallel speciation remains poorly understood. We analyzed whole-genome divergence between replicate pairs of stick insect populations that are adapted to different host plants and undergoing parallel speciation. We found thousands of modest-sized genomic regions of accentuated divergence between populations, most of which are unique to individual population pairs. We also detected parallel genomic divergence across population pairs involving an excess of coding genes with specific molecular functions. Regions of parallel genomic divergence in nature exhibited exceptional allele frequency changes between hosts in a field transplant experiment. The results advance understanding of biological diversification by providing convergent observational and experimental evidence for selection's role in driving repeatable genomic divergence.	[Soria-Carrasco, Victor; Comeault, Aaron A.; Farkas, Timothy E.; Nosil, Patrik] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Gompert, Zachariah] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Parchman, Thomas L.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Buerkle, C. Alex] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Feder, Jeffrey L.] Univ Notre Dame, Dept Biol, South Bend, IN 46556 USA; [Bast, Jens] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Schwander, Tanja] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Egan, Scott P.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Crespi, Bernard J.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	University of Sheffield; Utah System of Higher Education; Utah State University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Texas A&M University System; Texas A&M University College Station; University of Wyoming; University of Notre Dame; University of Gottingen; University of Lausanne; Rice University; Simon Fraser University	Nosil, P (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	p.nosil@sheffield.ac.uk		Soria-Carrasco, Victor/0000-0002-6568-5544; Gompert, Zachariah/0000-0003-2248-2488; Schwander, Tanja/0000-0003-1945-5374; Bast, Jens/0000-0003-0017-3860; Comeault, Aaron/0000-0003-3954-2416	European Research Council [R/129639]; Utah State University; Wellcome Trust [090532/Z/09/Z]; Medical Research Council Hub grant [G0900747 91070]; NCBI short read archive (BioProject) [PRJNA243533]	European Research Council(European Research Council (ERC)European Commission); Utah State University; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCBI short read archive (BioProject)	The work was funded by the European Research Council (grant R/129639) and Utah State University start-up funds. We thank J. Slate, A. Beckerman, D. Schluter, and two anonymous reviewers for constructive feedback and the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z and Medical Research Council Hub grant G0900747 91070) for generation of the sequencing data. O. Simakov and A. Kapusta provided scripts for transposable elements annotation. The data reported in this paper are tabulated in the supplementary materials and archived at the following databases. The raw sequencing reads are in the NCBI short read archive (BioProject ID: PRJNA243533), and the whole genome assembly and annotation at http://nosil-lab.group.shef.ac.uk/resources. Additional data and computer source code have been deposited in the Dryad repository, datadryad.org, and are also available from the authors upon request. The authors declare no conflicts of interest.	Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Burke MK, 2012, P ROY SOC B-BIOL SCI, V279, P5029, DOI 10.1098/rspb.2012.0799; Conte GL, 2012, P ROY SOC B-BIOL SCI, V279, P5039, DOI 10.1098/rspb.2012.2146; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Dittmer NT, 2010, INSECT BIOCHEM MOLEC, V40, P179, DOI 10.1016/j.ibmb.2010.02.006; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Gompert Z, 2014, ECOL LETT, V17, P369, DOI 10.1111/ele.12238; Hofer T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-107; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Losos JB, 2009, LIZARDS IN AN EVOLUT; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; Nosil P, 2012, P ROY SOC B-BIOL SCI, V279, P5058, DOI 10.1098/rspb.2012.0813; Renaut S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2833; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; van Ooik T, 2010, ANN ZOOL FENN, V47, P215, DOI 10.5735/086.047.0306; Vincent J, 1990, STRUCTURAL BIOMATERI; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	24	296	302	9	360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					738	742		10.1126/science.1252136	http://dx.doi.org/10.1126/science.1252136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833390				2022-12-24	WOS:000335912900039
J	Raj, T; Rothamel, K; Mostafavi, S; Ye, C; Lee, MN; Replogle, JM; Feng, T; Lee, M; Asinovski, N; Frohlich, I; Imboywa, S; Von Korff, A; Okada, Y; Patsopoulos, NA; Davis, S; McCabe, C; Paik, HI; Srivastava, GP; Raychaudhuri, S; Hafler, DA; Koller, D; Regev, A; Hacohen, N; Mathis, D; Benoist, C; Stranger, BE; De Jager, PL				Raj, Towfique; Rothamel, Katie; Mostafavi, Sara; Ye, Chun; Lee, Mark N.; Replogle, Joseph M.; Feng, Ting; Lee, Michelle; Asinovski, Natasha; Frohlich, Irene; Imboywa, Selina; Von Korff, Alina; Okada, Yukinori; Patsopoulos, Nikolaos A.; Davis, Scott; McCabe, Cristin; Paik, Hyun-il; Srivastava, Gyan P.; Raychaudhuri, Soumya; Hafler, David A.; Koller, Daphne; Regev, Aviv; Hacohen, Nir; Mathis, Diane; Benoist, Christophe; Stranger, Barbara E.; De Jager, Philip L.			Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTOME	To extend our understanding of the genetic basis of human immune function and dysfunction, we performed an expression quantitative trait locus (eQTL) study of purified CD4(+) T cells and monocytes, representing adaptive and innate immunity, in a multi-ethnic cohort of 461 healthy individuals. Context-specific cis- and trans-eQTLs were identified, and cross-population mapping allowed, in some cases, putative functional assignment of candidate causal regulatory variants for disease-associated loci. We note an over-representation of T cell-specific eQTLs among susceptibility alleles for autoimmune diseases and of monocyte-specific eQTLs among Alzheimer's and Parkinson's disease variants. This polarization implicates specific immune cell types in these diseases and points to the need to identify the cell-autonomous effects of disease susceptibility variants.	[Raj, Towfique; Replogle, Joseph M.; Lee, Michelle; Frohlich, Irene; Imboywa, Selina; Von Korff, Alina; Patsopoulos, Nikolaos A.; McCabe, Cristin; Srivastava, Gyan P.; De Jager, Philip L.] Brigham & Womens Hosp, Programin Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, Boston, MA 02115 USA; [Raj, Towfique; Replogle, Joseph M.; Lee, Michelle; Frohlich, Irene; Imboywa, Selina; Von Korff, Alina; Patsopoulos, Nikolaos A.; McCabe, Cristin; Srivastava, Gyan P.; De Jager, Philip L.] Brigham & Womens Hosp, Programin Translat NeuroPsychiat Genom, Inst Neurosci, Dept Psychiat, Boston, MA 02115 USA; [Raj, Towfique; Okada, Yukinori; Patsopoulos, Nikolaos A.; Srivastava, Gyan P.; Raychaudhuri, Soumya; De Jager, Philip L.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Raj, Towfique; Lee, Mark N.; Okada, Yukinori; Patsopoulos, Nikolaos A.; Srivastava, Gyan P.; Raychaudhuri, Soumya; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Raj, Towfique; Ye, Chun; Lee, Mark N.; Replogle, Joseph M.; Okada, Yukinori; Patsopoulos, Nikolaos A.; McCabe, Cristin; Srivastava, Gyan P.; Raychaudhuri, Soumya; Hafler, David A.; Regev, Aviv; Hacohen, Nir; De Jager, Philip L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rothamel, Katie; Feng, Ting; Asinovski, Natasha; Davis, Scott; Paik, Hyun-il; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Div Immunol, Microbiol & Immunobiol Immunol, Boston, MA 02115 USA; [Mostafavi, Sara; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA; [Stranger, Barbara E.] Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA; [Stranger, Barbara E.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Stanford University; Tokyo Medical & Dental University (TMDU); RIKEN; Harvard University; Brigham & Women's Hospital; Yale University; Yale University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; University of Chicago; University of Chicago	Benoist, C (corresponding author), Harvard Univ, Sch Med, Div Immunol, Microbiol & Immunobiol Immunol, Boston, MA 02115 USA.	christophe_benoist@hms.harvard.edu; bstranger@medicine.bsd.uchicago.edu; pdejager@partners.org	Ye, Chun/AAK-4868-2021; Raj, Towfique/ABD-7620-2021	Ye, Chun/0000-0001-6560-3783; Patsopoulos, Nikolaos/0000-0003-3757-8941; Replogle, Joseph/0000-0003-1832-919X; Stranger, Barbara/0000-0001-9021-7331; Raychaudhuri, Soumya/0000-0002-1901-8265; Lee, Mark/0000-0002-9576-9589	U.S. National Institute of General Medical Sciences [RC2 GM093080]; NIH [F32 AG043267]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063759, K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG043267] Funding Source: NIH RePORTER	U.S. National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the study participants in the Phenogenetic Project for their contributions. We are grateful to T. Flutre and X. Wen for assistance with running the Bayesian model averaging software. This work was supported by U.S. National Institute of General Medical Sciences grant RC2 GM093080 (C. B.). T. R. is supported by the NIH F32 Fellowship (F32 AG043267). Gene expression data are deposited in the National Center for Biotechnology Information Gene Expression Omnibus under accession no. GSE56035.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756	16	320	325	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					519	523		10.1126/science.1249547	http://dx.doi.org/10.1126/science.1249547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786080	Green Submitted, Green Accepted			2022-12-24	WOS:000335157700044
J	Jorgensen, AB; Frikke-Schmidt, R; Nordestgaard, BG; Tybjaerg-Hansen, A				Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne			Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-C-III; TRIGLYCERIDE-RICH LIPOPROTEINS; HIGH-DENSITY-LIPOPROTEIN; NONFASTING TRIGLYCERIDES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; REMNANT CHOLESTEROL; ARTERIAL INTIMA; IN-VIVO; PLASMA	Background High plasma levels of nonfasting triglycerides are associated with an increased risk of ischemic cardiovascular disease. Whether lifelong low levels of nonfasting triglycerides owing to mutations in the gene encoding apolipoprotein C3 (APOC3) are associated with a reduced risk of ischemic cardiovascular disease in the general population is unknown. Methods Using data from 75,725 participants in two general-population studies, we first tested whether low levels of nonfasting triglycerides were associated with reduced risks of ischemic vascular disease and ischemic heart disease. Second, we tested whether loss-of-function mutations in APOC3, which were associated with reduced levels of nonfasting triglycerides, were also associated with reduced risks of ischemic vascular disease and ischemic heart disease. During follow-up, ischemic vascular disease developed in 10,797 participants, and ischemic heart disease developed in 7557 of these 10,797 participants. Results Participants with nonfasting triglyceride levels of less than 1.00 mmol per liter (90 mg per deciliter) had a significantly lower incidence of cardiovascular disease than those with levels of 4.00 mmol per liter (350 mg per deciliter) or more (hazard ratio for ischemic vascular disease, 0.43; 95% confidence interval [CI], 0.35 to 0.54; hazard ratio for ischemic heart disease, 0.40; 95% CI, 0.31 to 0.52). Heterozygosity for loss-of-function mutations in APOC3, as compared with no APOC3 mutations, was associated with a mean reduction in nonfasting triglyceride levels of 44% (P<0.001). The cumulative incidences of ischemic vascular disease and ischemic heart disease were reduced in heterozygotes as compared with noncarriers of APOC3 mutations (P = 0.009 and P = 0.05, respectively), with corresponding risk reductions of 41% (hazard ratio, 0.59; 95% CI, 0.41 to 0.86; P = 0.007) and 36% (hazard ratio, 0.64; 95% CI, 0.41 to 0.99; P = 0.04). Conclusions Loss-of-function mutations in APOC3 were associated with low levels of triglycerides and a reduced risk of ischemic cardiovascular disease. (Funded by the European Union and others.)	[Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen Hosp, DK-2100 Copenhagen O, Denmark; [Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jorgensen, Anders Berg; Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nordestgaard, Borge G.] Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Frikke-Schmidt, Ruth; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Tybjaerg-Hansen, A (corresponding author), Univ Copenhagen Hosp, Dept Clin Chem KB 3011, Mol Genet Sect, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	anne.tybjaerg.hansen@regionh.dk	Girelli, Domenico/B-1183-2008; Nordestgaard, Borge Gronne/ABF-1310-2020	Girelli, Domenico/0000-0001-9684-1899; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Nordestgaard, Borge/0000-0002-1954-7220	European Union	European Union(European Commission)	Funded by the European Union and others.	AIM- HIGH Investigators, 2012, NEW ENGL J MED, V367, P189; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bochem AE, 2014, CLIN GENET, V85, P433, DOI 10.1111/cge.12201; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Johannsen TH, 2009, J CLIN ENDOCR METAB, V94, P1264, DOI 10.1210/jc.2008-1342; Jorgensen AB, 2013, EUR HEART J, V34, P1826, DOI 10.1093/eurheartj/ehs431; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Liu HQ, 2000, J LIPID RES, V41, P1760; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Novelli V, 2008, BIOGERONTOLOGY, V9, P85, DOI 10.1007/s10522-007-9116-4; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; SHAIKH M, 1991, ARTERIOSCLER THROMB, V11, P569, DOI 10.1161/01.ATV.11.3.569; Sundaram M, 2010, J LIPID RES, V51, P150, DOI [10.1194/jlr.M900346-JLR200, 10.1194/M900346-JLR200]; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Varbo A, 2011, ANN NEUROL, V69, P628, DOI 10.1002/ana.22384; Voight BF, 2012, LANCET, V380, P564; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; WINDLER E, 1985, J LIPID RES, V26, P556; Yao ZM, 2012, CURR OPIN LIPIDOL, V23, P206, DOI 10.1097/MOL.0b013e328352dc70	41	603	645	4	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2014	371	1					32	41		10.1056/NEJMoa1308027	http://dx.doi.org/10.1056/NEJMoa1308027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK2RA	24941082				2022-12-24	WOS:000338265700007
J	Rodriguez, A; Laio, A				Rodriguez, Alex; Laio, Alessandro			Clustering by fast search and find of density peaks	SCIENCE			English	Article								a Cluster analysis is aimed at classifying elements into categories on the basis of their similarity. Its applications range from astronomy to bioinformatics, bibliometrics, and pattern recognition. We propose an approach based on the idea that cluster centers are characterized by a higher density than their neighbors and by a relatively large distance from points with higher densities. This idea forms the basis of a clustering procedure in which the number of clusters arises intuitively, outliers are automatically spotted and excluded fromthe analysis, and clusters are recognized regardless of their shape and of the dimensionality of the space inwhich they are embedded. We demonstrate the power of the algorithm on several test cases.	[Rodriguez, Alex; Laio, Alessandro] SISSA, I-34136 Trieste, Italy	International School for Advanced Studies (SISSA)	Rodriguez, A (corresponding author), SISSA, Via Bonomea 265, I-34136 Trieste, Italy.	alexrod@sissa.it; laio@sissa.it	Laio, Alessandro/K-2117-2012	Laio, Alessandro/0000-0001-9164-7907; Rodriguez, Alex/0000-0002-0213-6695	grant Associazione Italiana per la Ricerca sul Cancro 5 per mille [12214]; Fondo per gli Investimenti della Ricerca di Base-Accordo di programma [RBAP11ETKA]	grant Associazione Italiana per la Ricerca sul Cancro 5 per mille(Fondazione AIRC per la ricerca sul cancro); Fondo per gli Investimenti della Ricerca di Base-Accordo di programma(Ministry of Education, Universities and Research (MIUR))	We thank E. Tosatti, D. Amati, F. Laio, F. Marinelli, A. Maritan, R. Allen, J. Nasica, and M. d'Errico for stimulating discussion. We acknowledge financial support from the grant Associazione Italiana per la Ricerca sul Cancro 5 per mille, Rif. 12214, and Fondo per gli Investimenti della Ricerca di Base-Accordo di programma, Rif. RBAP11ETKA.	Chang H, 2008, PATTERN RECOGN, V41, P191, DOI 10.1016/j.patcog.2007.04.010; Charytanowicz M, 2010, ADV INTEL SOFT COMPU, V69, P15; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790, DOI 10.1109/34.400568; Dueck D, 2007, IEEE I CONF COMP VIS, P198; Ester M., 1996, KDD, V96, P226; Franti P, 2006, PATTERN RECOGN, V39, P761, DOI 10.1016/j.patcog.2005.09.012; Franti P, 2006, IEEE T PATTERN ANAL, V28, P1875, DOI 10.1109/TPAMI.2006.227; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Hoppner F, 1999, FUZZY CLUSTER ANAL M; Horenko I, 2006, MULTISCALE MODEL SIM, V5, P802, DOI 10.1137/050623310; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kaufman L., 2009, FINDING GROUPS DATA, V344; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Marinelli F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000452; McLachlan G.J., 2007, WILEY SERIES PROBABI, V382; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Sampat MP, 2009, IEEE T IMAGE PROCESS, V18, P2385, DOI 10.1109/TIP.2009.2025923; Tsaparas, 2007, ACM T KNOWL DISCOV D, V1, P4, DOI [10.1145/1217299.1217303, DOI 10.1145/1217299.1217303]; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141	22	2714	3275	150	1735	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1492	1496		10.1126/science.1242072	http://dx.doi.org/10.1126/science.1242072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970081				2022-12-24	WOS:000337889900044
J	Kim, MS; Pinto, SM; Getnet, D; Nirujogi, RS; Manda, SS; Chaerkady, R; Madugundu, AK; Kelkar, DS; Isserlin, R; Jain, S; Thomas, JK; Muthusamy, B; Leal-Rojas, P; Kumar, P; Sahasrabuddhe, NA; Balakrishnan, L; Advani, J; George, B; Renuse, S; Selvan, LDN; Patil, AH; Nanjappa, V; Radhakrishnan, A; Prasad, S; Subbannayya, T; Raju, R; Kumar, M; Sreenivasamurthy, SK; Marimuthu, A; Sathe, GJ; Chavan, S; Datta, KK; Subbannayya, Y; Sahu, A; Yelamanchi, SD; Jayaram, S; Rajagopalan, P; Sharma, J; Murthy, KR; Syed, N; Goel, R; Khan, AA; Ahmad, S; Dey, G; Mudgal, K; Chatterjee, A; Huang, TC; Zhong, J; Wu, XY; Shaw, PG; Freed, D; Zahari, MS; Mukherjee, KK; Shankar, S; Mahadevan, A; Lam, H; Mitchell, CJ; Shankar, SK; Satishchandra, P; Schroeder, JT; Sirdeshmukh, R; Maitra, A; Leach, SD; Drake, CG; Halushka, MK; Prasad, TSK; Hruban, RH; Kerr, CL; Bader, GD; Iacobuzio-Donahue, CA; Gowda, H; Pandey, A				Kim, Min-Sik; Pinto, Sneha M.; Getnet, Derese; Nirujogi, Raja Sekhar; Manda, Srikanth S.; Chaerkady, Raghothama; Madugundu, Anil K.; Kelkar, Dhanashree S.; Isserlin, Ruth; Jain, Shobhit; Thomas, Joji K.; Muthusamy, Babylakshmi; Leal-Rojas, Pamela; Kumar, Praveen; Sahasrabuddhe, Nandini A.; Balakrishnan, Lavanya; Advani, Jayshree; George, Bijesh; Renuse, Santosh; Selvan, Lakshmi Dhevi N.; Patil, Arun H.; Nanjappa, Vishalakshi; Radhakrishnan, Aneesha; Prasad, Samarjeet; Subbannayya, Tejaswini; Raju, Rajesh; Kumar, Manish; Sreenivasamurthy, Sreelakshmi K.; Marimuthu, Arivusudar; Sathe, Gajanan J.; Chavan, Sandip; Datta, Keshava K.; Subbannayya, Yashwanth; Sahu, Apeksha; Yelamanchi, Soujanya D.; Jayaram, Savita; Rajagopalan, Pavithra; Sharma, Jyoti; Murthy, Krishna R.; Syed, Nazia; Goel, Renu; Khan, Aafaque A.; Ahmad, Sartaj; Dey, Gourav; Mudgal, Keshav; Chatterjee, Aditi; Huang, Tai-Chung; Zhong, Jun; Wu, Xinyan; Shaw, Patrick G.; Freed, Donald; Zahari, Muhammad S.; Mukherjee, Kanchan K.; Shankar, Subramanian; Mahadevan, Anita; Lam, Henry; Mitchell, Christopher J.; Shankar, Susarla Krishna; Satishchandra, Parthasarathy; Schroeder, John T.; Sirdeshmukh, Ravi; Maitra, Anirban; Leach, Steven D.; Drake, Charles G.; Halushka, Marc K.; Prasad, T. S. Keshava; Hruban, Ralph H.; Kerr, Candace L.; Bader, Gary D.; Iacobuzio-Donahue, Christine A.; Gowda, Harsha; Pandey, Akhilesh			A draft map of the human proteome	NATURE			English	Article							IDENTIFICATION; DATABASE; KNOWLEDGE; PROTEINS; PROJECT; TANDEM	The availability of human genome sequence has transformed biomedical research over the past decade. However, an equivalent map for the human proteome with direct measurements of proteins and peptides does not exist yet. Here we present a draft map of the human proteome using high-resolution Fourier-transform mass spectrometry. In-depth proteomic profiling of 30 histologically normal human samples, including 17 adult tissues, 7 fetal tissues and 6 purified primary haematopoietic cells, resulted in identification of proteins encoded by 17,294 genes accounting for approximately 84% of the total annotated protein-coding genes in humans. A unique and comprehensive strategy for proteogenomic analysis enabled us to discover a number of novel protein-coding regions, which includes translated pseudogenes, non-coding RNAs and upstream open reading frames. This large human proteome catalogue ( available as an interactive web-based resource at http://www.humanproteomemap.org) will complement available human genome and transcriptome data to accelerate biomedical research in health and disease.	[Kim, Min-Sik; Getnet, Derese; Chaerkady, Raghothama; Leal-Rojas, Pamela; Prasad, Samarjeet; Huang, Tai-Chung; Zhong, Jun; Wu, Xinyan; Shaw, Patrick G.; Freed, Donald; Mitchell, Christopher J.; Leach, Steven D.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Kim, Min-Sik; Chaerkady, Raghothama; Wu, Xinyan; Zahari, Muhammad S.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Pinto, Sneha M.; Nirujogi, Raja Sekhar; Manda, Srikanth S.; Madugundu, Anil K.; Kelkar, Dhanashree S.; Thomas, Joji K.; Muthusamy, Babylakshmi; Kumar, Praveen; Sahasrabuddhe, Nandini A.; Balakrishnan, Lavanya; Advani, Jayshree; George, Bijesh; Renuse, Santosh; Selvan, Lakshmi Dhevi N.; Patil, Arun H.; Nanjappa, Vishalakshi; Radhakrishnan, Aneesha; Subbannayya, Tejaswini; Raju, Rajesh; Kumar, Manish; Sreenivasamurthy, Sreelakshmi K.; Marimuthu, Arivusudar; Sathe, Gajanan J.; Chavan, Sandip; Datta, Keshava K.; Subbannayya, Yashwanth; Sahu, Apeksha; Yelamanchi, Soujanya D.; Jayaram, Savita; Rajagopalan, Pavithra; Sharma, Jyoti; Murthy, Krishna R.; Syed, Nazia; Goel, Renu; Khan, Aafaque A.; Ahmad, Sartaj; Dey, Gourav; Chatterjee, Aditi; Sirdeshmukh, Ravi; Prasad, T. S. Keshava; Gowda, Harsha; Pandey, Akhilesh] Inst Bioinformat, Bangalore 560066, Karnataka, India; [Getnet, Derese; Pandey, Akhilesh] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Isserlin, Ruth; Jain, Shobhit; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Leal-Rojas, Pamela] Univ La Frontera, Dept Pathol, Ctr Genet & Immunol Studies Sci & Technol Bioreso, Temuco 4811230, Chile; [Mudgal, Keshav] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England; [Mukherjee, Kanchan K.] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India; [Shankar, Subramanian] Armed Forces Med Coll, Dept Internal Med, Pune 411040, Maharashtra, India; [Mahadevan, Anita; Shankar, Susarla Krishna] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Mahadevan, Anita; Shankar, Susarla Krishna] Natl Inst Mental Hlth & Neurosci, Neurobiol Res Ctr, Bangalore 560029, Karnataka, India; [Lam, Henry] Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Hong Kong, Hong Kong, Peoples R China; [Lam, Henry] Hong Kong Univ Sci & Technol, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Satishchandra, Parthasarathy] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India; [Schroeder, John T.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21224 USA; [Maitra, Anirban; Halushka, Marc K.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.; Pandey, Akhilesh] Johns Hopkins Univ, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Sch Med, Baltimore, MD 21231 USA; [Maitra, Anirban; Drake, Charles G.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Leach, Steven D.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21231 USA; [Drake, Charles G.] Johns Hopkins Univ, Sch Med, Dept Immunol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Drake, Charles G.] Johns Hopkins Univ, Sch Med, Dept Urol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Kerr, Candace L.] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Diana Helis Henry Med Res Fdn, New Orleans, LA 70130 USA	Johns Hopkins University; Johns Hopkins University; University of Toronto; Universidad de La Frontera; Imperial College London; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Armed Forces Medical College; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; National Institute of Mental Health & Neurosciences - India; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Gowda, H (corresponding author), Inst Bioinformat, Bangalore 560066, Karnataka, India.	harsha@ibioinformatics.org; pandey@jhmi.edu	Pinto, Sneha/Q-7308-2018; M., Srikanth/H-7457-2012; Chavan, Sandip/K-6889-2015; Bader, Gary/C-1176-2009; Lam, Henry/D-8629-2011; Kim, Min-Sik/M-3488-2016; Zhong, Jun/D-1662-2010; Khan, Aafaque/AFA-0670-2022; RENUSE, SANTOSH/A-2072-2010; Hanumana Gouda Patil, Arun Kumar/GLU-6821-2022; Subbannayya, Tejaswini/A-5524-2012; Kim, Min-Sik/N-5010-2018; Iacobuzio-Donahue, Christine/ABF-1295-2020; Manda, Srinivas Srikanth/AAC-1376-2022; Subbannayya, Yashwanth/A-7796-2012; Sreenivasamurthy, Sreelakshmi K/ABD-4253-2021; Madugundu, Anil Kumar/ABE-2128-2021; Renuse, Santosh/ABA-6792-2020; Sreenivasamurthy, Sreelakshmi Kenkere/W-1942-2019; Gowda, Harsha/A-8526-2011; Muthusamy, Babylakshmi/AAS-8226-2020; John, Arivusudar Everad/ABB-1691-2020; Prasad, Keshava/F-7631-2010; Mir, Sartaj Ahmad/J-8933-2014; Raju, Rajesh/E-1104-2014; Huang, Tai-Chung/I-3730-2013	Pinto, Sneha/0000-0001-8541-8761; M., Srikanth/0000-0003-1690-8403; Chavan, Sandip/0000-0002-8469-7882; Bader, Gary/0000-0003-0185-8861; Lam, Henry/0000-0001-7928-0364; Kim, Min-Sik/0000-0001-7317-5360; Zhong, Jun/0000-0003-3148-4143; RENUSE, SANTOSH/0000-0002-4051-5637; Hanumana Gouda Patil, Arun Kumar/0000-0002-3125-8958; Subbannayya, Tejaswini/0000-0002-5384-0631; Kim, Min-Sik/0000-0001-7317-5360; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Manda, Srinivas Srikanth/0000-0003-1690-8403; Subbannayya, Yashwanth/0000-0002-3885-3514; Sreenivasamurthy, Sreelakshmi K/0000-0002-8891-3714; Madugundu, Anil Kumar/0000-0003-4274-7316; Gowda, Harsha/0000-0002-4118-6855; Prasad, Keshava/0000-0002-6206-2384; Freed, Donald/0000-0003-4534-7254; Mukherjee, Kanchan Kumar/0000-0001-7525-6172; Dey, Gourav/0000-0002-2703-699X; Sharma, Jyoti/0000-0003-3299-9907; Nirujogi, Raja Sekhar/0000-0002-3177-8566; Mir, Sartaj Ahmad/0000-0001-6032-0936; Yelamanchi, Soujanya D./0000-0002-8477-9618; Sathe, Gajanan/0000-0002-6239-5365; Khan, Aafaque Ahmad/0000-0002-8127-9677; Mudgal, Keshav/0000-0002-6065-0617; Raju, Rajesh/0000-0003-2319-121X; Halushka, Marc/0000-0002-7112-7389; Syed, Nazia/0000-0002-0396-9357; Huang, Tai-Chung/0000-0002-1625-7295	NIH [U54GM103520]; NCI's Clinical Proteomic Tumor Analysis Consortium initiative [U24CA160036]; National Heart, Lung and Blood Institute [HHSN268201000032C]; Sol Goldman Pancreatic Cancer Research Center; National Resource for Network Biology [P41GM103504]; DBT Program Support on Neuroproteomics [BT/01/COE/08/05]; NIMHANS; Council of Scientific and Industrial Research; University Grants Commission; Department of Science and Technology, Government of India; NATIONAL CANCER INSTITUTE [U24CA160036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103520, P41GM103504, T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI's Clinical Proteomic Tumor Analysis Consortium initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Sol Goldman Pancreatic Cancer Research Center; National Resource for Network Biology; DBT Program Support on Neuroproteomics; NIMHANS; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge the National Development and Research Institutes for some of the tissues. We acknowledge the assistance of V. Sandhya, V. Puttamallesh, U. Guha and B. Cole for help with analysis of some of the samples. We thank L. Lane and B. Amos for their assistance with the list of missing genes. This work was supported by an NIH roadmap grant for Technology Centers of Networks and Pathways (U54GM103520), NCI's Clinical Proteomic Tumor Analysis Consortium initiative (U24CA160036), a contract (HHSN268201000032C) from the National Heart, Lung and Blood Institute and the Sol Goldman Pancreatic Cancer Research Center. The authors acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with The Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Programs. The analysis work was partially supported by the National Resource for Network Biology (P41GM103504). A.Mah., S.K.Sh., P. S. and T. S. K. P. are supported by DBT Program Support on Neuroproteomics (BT/01/COE/08/05) to IOB and NIMHANS. H. G. is a Wellcome Trust-DBT India Alliance Early Career Fellow. We thank Council of Scientific and Industrial Research, University Grants Commission and Department of Science and Technology, Government of India for research fellowships for S. M. P., R.S.N., A. R., M. K., G.J.S., S. C., P. R., J.S., S. S. M., D. S. K., S. R., S.K.Sr., K. K. D., Y.S., A. S., S.D.Y., N.S., S. A. and G.D.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Farrah T, 2013, J PROTEOME RES, V12, P162, DOI [10.1021/Pr301012j, 10.1021/pr301012j]; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Fountoulakis M, 2002, PROTEOMICS, V2, P1547, DOI 10.1002/1615-9861(200211)2:11<1547::AID-PROT1547>3.0.CO;2-M; Gaudet P, 2013, J PROTEOME RES, V12, P293, DOI 10.1021/pr300830v; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; Lane L, 2014, J PROTEOME RES, V13, P15, DOI 10.1021/pr401144x; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; Marko-Varga G, 2013, J PROTEOME RES, V12, P1, DOI [10.1021/pr301183aIJ, 10.1021/pr301183a]; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Peri S, 2001, TRENDS GENET, V17, P685, DOI 10.1016/S0168-9525(01)02493-3; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Picotti P, 2013, NATURE, V494, P266, DOI 10.1038/nature11835; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Sugimoto J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01462; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Ying WT, 2006, MOL CELL PROTEOMICS, V5, P1703, DOI 10.1074/mcp.M500344-MCP200; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	44	1431	1460	16	518	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					575	+		10.1038/nature13302	http://dx.doi.org/10.1038/nature13302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870542	Green Accepted			2022-12-24	WOS:000336457100040
J	Cai, DF; Chen, SC; Prasad, M; He, L; Wang, XB; Choesmel-Cadamuro, V; Sawyer, JK; Danuser, G; Montell, DJ				Cai, Danfeng; Chen, Shann-Ching; Prasad, Mohit; He, Li; Wang, Xiaobo; Choesmel-Cadamuro, Valerie; Sawyer, Jessica K.; Danuser, Gaudenz; Montell, Denise J.			Mechanical Feedback through E-Cadherin Promotes Direction Sensing during Collective Cell Migration	CELL			English	Article							VE-CADHERIN; RAC; GUIDANCE; TENSION; ACTIVATION; EXPRESSION; MOVEMENT; REVEALS; GROWTH	E-cadherin is a major homophilic cell-cell adhesion molecule that inhibits motility of individual cells on matrix. However, its contribution to migration of cells through cell-rich tissues is less clear. We developed an in vivo sensor of mechanical tension across E-cadherin molecules, which we combined with cell-type-specific RNAi, photoactivatable Rac, and morphodynamic profiling, to interrogate how E-cadherin contributes to collective migration of cells between other cells. Using the Drosophila ovary as a model, we found that adhesion between border cells and their substrate, the nurse cells, functions in a positive feedback loop with Rac and actin assembly to stabilize forward-directed protrusion and directionally persistent movement. Adhesion between individual border cells communicates direction from the lead cell to the followers. Adhesion between motile cells and polar cells holds the cluster together and polarizes each individual cell. Thus, E-cadherin is an integral component of the guidance mechanisms that orchestrate collective chemotaxis in vivo.	[Cai, Danfeng; Chen, Shann-Ching; Prasad, Mohit; He, Li; Wang, Xiaobo; Sawyer, Jessica K.; Montell, Denise J.] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Cai, Danfeng; Montell, Denise J.] Univ Calif Santa Barbara, Mol Cellular & Dev Biol Dept, Santa Barbara, CA 93106 USA; [Chen, Shann-Ching; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Wang, Xiaobo] Univ P Sabatier Toulouse III, F-31062 Toulouse 9, France; [Wang, Xiaobo] CNRS, LBCMCP, F-31062 Toulouse 9, France	Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Santa Barbara; Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS)	Montell, DJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	denise.montell@lifesci.ucsb.edu	Cai, Danfeng/E-7509-2016	Cai, Danfeng/0000-0003-1623-5077; HE, LI/0000-0003-2155-606X; Sawyer, Jessica/0000-0001-9026-0559; Danuser, Gaudenz/0000-0001-8583-2014; Wang, Xiaobo/0000-0002-3311-1378	Cell Migration Consortium [GM73164, GM46425, GM64346, GM71868]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R29GM046425, R01GM046425, R01GM073164, R01GM071868] Funding Source: NIH RePORTER	Cell Migration Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the D.J.M. lab for helpful discussions and Craig Montell for insightful comments on the manuscript. We thank the Erika Matunis laboratory and Bloomington Stock Center for generous sharing of fly stocks. Peter Allen produced the artwork in Figure 7 as well as the cover art. This work was supported by grants GM73164 and GM46425 (to D.J.M.), GM64346 (Cell Migration Consortium; to D.J.M. and G.D.), and GM71868 (to G.D.).	Arboleda-Estudillo Y, 2010, CURR BIOL, V20, P161, DOI 10.1016/j.cub.2009.11.036; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Borghi N, 2012, P NATL ACAD SCI USA, V109, P19034, DOI 10.1073/pnas.1217417109; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Fernandez-Espartero CH, 2013, J CELL SCI, V126, P2285, DOI 10.1242/jcs.124438; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; McDonald JA, 2006, DEV BIOL, V296, P94, DOI 10.1016/j.ydbio.2006.04.438; McDonald Jocelyn A., 2004, V294, P175; Meinhardt H, 1999, J CELL SCI, V112, P2867; Montell DJ, 2012, NAT REV MOL CELL BIO, V13, P631, DOI 10.1038/nrm3433; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Rakshit S, 2012, P NATL ACAD SCI USA, V109, P18815, DOI 10.1073/pnas.1208349109; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Shih WT, 2012, J CELL SCI, V125, P3661, DOI 10.1242/jcs.103861; Theveneau E, 2012, CURR OPIN CELL BIOL, V24, P677, DOI 10.1016/j.ceb.2012.08.002; Van Doren M, 1998, CURR BIOL, V8, P243; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013	42	303	307	1	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1146	1159		10.1016/j.cell.2014.03.045	http://dx.doi.org/10.1016/j.cell.2014.03.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855950	Green Accepted, Bronze			2022-12-24	WOS:000336437200016
J	Nguyen, LN; Ma, DL; Shui, GH; Wong, PY; Cazenave-Gassiot, A; Zhang, XD; Wenk, MR; Goh, ELK; Silver, DL				Nguyen, Long N.; Ma, Dongliang; Shui, Guanghou; Wong, Peiyan; Cazenave-Gassiot, Amaury; Zhang, Xiaodong; Wenk, Markus R.; Goh, Eyleen L. K.; Silver, David L.			Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid	NATURE			English	Article							CARDIOVASCULAR-DISEASE; BRAIN; DEFICIENCY; MECHANISM	Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is essential for normal brain growth and cognitive function(1-4). Consistent with its importance in the brain, DHA is highly enriched in brain phospholipids(5-7). Despite being an abundant fatty acid in brain phospholipids, DHA cannot be de novo synthesized in brain and must be imported across the blood-brain barrier, but mechanisms for DHA uptake in brain have remained enigmatic. Here we identify a member of the major facilitator superfamily-Mfsd2a (previously an orphan transporter)-as the major transporter for DHA uptake into brain. Mfsd2a is found to be expressed exclusively in endothelium of the blood-brain barrier of micro-vessels. Lipidomic analysis indicates that Mfsd2a-deficient (Mfsd2a-knockout) mice show markedly reduced levels of DHA in brain accompanied by neuronal cell loss in hippocampus and cerebellum, as well as cognitive deficits and severe anxiety, and microcephaly. Unexpectedly, cell-based studies indicate that Mfsd2a transports DHA in the form of lysophosphatidylcholine (LPC), but not unesterified fatty acid, in a sodium-dependent manner. Notably, Mfsd2a transports common plasma LPCs carrying long-chain fatty acids such LPC oleate and LPC palmitate, but not LPCs with less than a 14-carbon acyl chain. Moreover, we determine that the phosphor-zwitterionic headgroup of LPC is critical for transport. Importantly, Mfsd2a-knockout mice have markedly reduced uptake of labelled LPC DHA, and other LPCs, from plasma into brain, demonstrating that Mfsd2a is required for brain uptake of DHA. Our findings reveal an unexpected essential physiological role of plasma-derived LPCs in brain growth and function.	[Nguyen, Long N.; Silver, David L.] Duke NUS Grad Med Sch Singapore, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Ma, Dongliang; Wong, Peiyan; Zhang, Xiaodong; Goh, Eyleen L. K.] Duke NUS Grad Med Sch Singapore, Signature Res Program Neurosci & Behav Disorders, Singapore 169857, Singapore; [Shui, Guanghou; Cazenave-Gassiot, Amaury; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Silver, DL (corresponding author), Duke NUS Grad Med Sch Singapore, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	david.silver@duke-nus.edu.sg	Cazenave-Gassiot, Amaury/E-4536-2014; Nguyen, Long/AAY-6172-2021; Wenk, Markus Rene/D-1441-2014	Cazenave-Gassiot, Amaury/0000-0002-3050-634X; TAN, BRYAN CASSIDY/0000-0001-6399-8814; Shui, Guanghou/0000-0002-1621-9643; Goh, Eyleen/0000-0002-8244-6959; Silver, David/0000-0002-7289-9890; Wong, Peiyan/0000-0003-3734-2461; ma, Dongliang/0000-0003-3077-1968; Nguyen, Long N/0000-0002-9857-2239	Singapore Ministry of Health's National Medical Research Council [CBRG/0012/2012]; Singapore National Research Foundation Competitive Research Program [2008-01, 2007-04]; National University of Singapore's Life Sciences Institute; Singapore National Medical Research Council Translational and Clinical Research Program [NMRC/TCR/003-GMS/2008]	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Singapore National Research Foundation Competitive Research Program(National Research Foundation, Singapore); National University of Singapore's Life Sciences Institute(National University of Singapore); Singapore National Medical Research Council Translational and Clinical Research Program(National Medical Research Council, Singapore)	This work was supported in part by grants from the Singapore Ministry of Health's National Medical Research Council CBRG/0012/2012 (to D. L. S.), the Singapore National Research Foundation Competitive Research Program grants 2008-01 (to E. L. G.) and 2007-04 (to M. R. W.), National University of Singapore's Life Sciences Institute (to M. R. W.), and Singapore National Medical Research Council Translational and Clinical Research Program NMRC/TCR/003-GMS/2008 (to X.Z.). We would like to thank B. Tan (Duke-NUS) for technical assistance with lipid extractions, and S. Ying (Duke-NUS) for assistance with behavioural phenotyping.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; Carrie I, 2000, J LIPID RES, V41, P473; Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Granell M, 2010, P NATL ACAD SCI USA, V107, P22078, DOI 10.1073/pnas.1008649107; Horrocks LA, 1999, PHARMACOL RES, V40, P211, DOI 10.1006/phrs.1999.0495; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Kidd PM, 2007, ALTERN MED REV, V12, P207; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Paroder-Belenitsky M, 2011, P NATL ACAD SCI USA, V108, P17933, DOI 10.1073/pnas.1108278108; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Shui GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019731; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Wong PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051455	19	551	571	6	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					503	+		10.1038/nature13241	http://dx.doi.org/10.1038/nature13241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828044				2022-12-24	WOS:000336126000041
J	Malyshev, DA; Dhami, K; Lavergne, T; Chen, TJ; Dai, N; Foster, JM; Correa, IR; Romesberg, FE				Malyshev, Denis A.; Dhami, Kirandeep; Lavergne, Thomas; Chen, Tingjian; Dai, Nan; Foster, Jeremy M.; Correa, Ivan R., Jr.; Romesberg, Floyd E.			A semi-synthetic organism with an expanded genetic alphabet	NATURE			English	Article							UNNATURAL BASE-PAIR; DNA; NUCLEOTIDE; REPLICATION; TRANSPORT; PROTEINS; EFFICIENT; MUTATION; ATP/ADP	Organisms are defined by the information encoded in their genomes, and since the origin of life this information has been encoded using a two-base-pair genetic alphabet (A-T and G-C). In vitro, the alphabet has been expanded to include several unnatural base pairs (UBPs)(1-3). We have developed a class of UBPs formed between nucleotides bearing hydrophobic nucleobases, exemplified by the pair formed between d5SICS and dNaM (d5SICS-dNaM), which is efficiently PCR-amplified(1) and transcribed(4,5) in vitro, and whose unique mechanism of replication has been characterized(6,7). However, expansion of an organism's genetic alphabet presents new and unprecedented challenges: the unnatural nucleoside triphosphates must be available inside the cell; endogenous polymerases must be able to use the unnatural triphosphates to faithfully replicate DNA containing the UBP within the complex cellular milieu; and finally, the UBP must be stable in the presence of pathways that maintain the integrity of DNA. Here we show that an exogenously expressed algal nucleotide triphosphate transporter efficiently imports the triphosphates of both d5SICS and dNaM (d5SICSTP and dNaMTP) into Escherichia coli, and that the endogenous replication machinery uses them to accurately replicate a plasmid containing d5SICS-dNaM. Neither the presence of the unnatural triphosphates nor the replication of the UBP introduces a notable growth burden. Lastly, we find that the UBP is not efficiently excised by DNA repair pathways. Thus, the resulting bacterium is the first organism to propagate stably an expanded genetic alphabet.	[Malyshev, Denis A.; Dhami, Kirandeep; Lavergne, Thomas; Chen, Tingjian; Romesberg, Floyd E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Dai, Nan; Foster, Jeremy M.; Correa, Ivan R., Jr.] New England Biolabs Inc, Ipswich, MA 01938 USA	Scripps Research Institute; New England Biolabs	Romesberg, FE (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	floyd@scripps.edu	LAVERGNE, Thomas G/N-8896-2013; Chen, Tingjian/L-2659-2013; Romesberg, Floyd/M-2821-2017; Dai, Nan/I-5950-2013	LAVERGNE, Thomas G/0000-0002-0029-0015; Chen, Tingjian/0000-0002-4458-4269; Romesberg, Floyd/0000-0001-6317-1315; Correa, Ivan/0000-0002-3169-6878	US National Institutes of Health (NIH) [GM 060005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060005] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Haferkamp and J. Audia for kindly providing the NTT plasmids and helpful discussions, and P. Ordoukhanian for providing access to the Center for Protein and Nucleic Acid Research at TSRI. This work was supported by the US National Institutes of Health (NIH) (GM 060005).	Allen JM, 2011, NUCLEIC ACIDS RES, V39, P7020, DOI 10.1093/nar/gkr157; Alpert A., 2003, ABRF 2003; Amiri H, 2003, J MOL EVOL, V56, P137, DOI 10.1007/s00239-002-2387-0; Ast M, 2009, P NATL ACAD SCI USA, V106, P3621, DOI 10.1073/pnas.0808862106; Audia JP, 2006, J BACTERIOL, V188, P6261, DOI 10.1128/JB.00371-06; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Betz K, 2013, J AM CHEM SOC, V135, P18637, DOI 10.1021/ja409609j; Betz K, 2012, NAT CHEM BIOL, V8, P612, DOI [10.1038/NCHEMBIO.966, 10.1038/nchembio.966]; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Haferkamp I, 2012, PLANT BIOLOGY, V14, P675, DOI 10.1111/j.1438-8677.2012.00591.x; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; HATCH TP, 1982, J BACTERIOL, V150, P662, DOI 10.1128/JB.150.2.662-670.1982; Hirao I, 2006, NAT METHODS, V3, P729, DOI 10.1038/nmeth915; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Horn M, 2004, J EUKARYOT MICROBIOL, V51, P509, DOI 10.1111/j.1550-7408.2004.tb00278.x; Knab S, 2011, J BACTERIOL, V193, P225, DOI 10.1128/JB.00919-10; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P1466, DOI 10.1128/jb.168.3.1466-1467.1986; Lavergne T, 2012, CHEM-EUR J, V18, P1231, DOI 10.1002/chem.201102066; Li LJ, 2014, J AM CHEM SOC, V136, P826, DOI 10.1021/ja408814g; LUDWIG J, 1989, J ORG CHEM, V54, P631, DOI 10.1021/jo00264a024; Malyshev DA, 2012, P NATL ACAD SCI USA, V109, P12005, DOI 10.1073/pnas.1205176109; Malyshev DA, 2009, J AM CHEM SOC, V131, P14620, DOI 10.1021/ja906186f; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; REIJENGA JC, 1986, J CHROMATOGR, V374, P162, DOI 10.1016/S0378-4347(00)83266-1; Seidman C E, 2001, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0108s37; Seo YJ, 2011, J AM CHEM SOC, V133, P19878, DOI 10.1021/ja207907d; Seo YJ, 2009, J AM CHEM SOC, V131, P3246, DOI 10.1021/ja807853m; Seo YJ, 2009, J AM CHEM SOC, V131, P5046, DOI 10.1021/ja9006996; TOMIZAWA J, 1979, ANNU REV BIOCHEM, V48, P999, DOI 10.1146/annurev.bi.48.070179.005031; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; WINKLER HH, 1976, J BIOL CHEM, V251, P389; Wu YQ, 2002, J AM CHEM SOC, V124, P14626, DOI 10.1021/ja028050m; Yamashige R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1068; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; Yanes O, 2011, ANAL CHEM, V83, P2152, DOI 10.1021/ac102981k; Yang ZY, 2011, J AM CHEM SOC, V133, P15105, DOI 10.1021/ja204910n	38	357	381	27	433	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					385	+		10.1038/nature13314	http://dx.doi.org/10.1038/nature13314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805238	Green Accepted			2022-12-24	WOS:000336121200044
J	Voss, FK; Ullrich, F; Munch, J; Lazarow, K; Lutter, D; Mah, N; Andrade-Navarro, MA; von Kries, JP; Stauber, T; Jentsch, TJ				Voss, Felizia K.; Ullrich, Florian; Muench, Jonas; Lazarow, Katina; Lutter, Darius; Mah, Nancy; Andrade-Navarro, Miguel A.; von Kries, Jens P.; Stauber, Tobias; Jentsch, Thomas J.			Identification of LRRC8 Heteromers as an Essential Component of the Volume-Regulated Anion Channel VRAC	SCIENCE			English	Article							CHLORIDE CHANNELS; SEPARATE TAURINE; ACTIVATION; CURRENTS; EFFLUX; FAMILY	Regulation of cell volume is critical for many cellular and organismal functions, yet the molecular identity of a key player, the volume-regulated anion channel VRAC, has remained unknown. A genome-wide small interfering RNA screen in mammalian cells identified LRRC8A as a VRAC component. LRRC8A formed heteromers with other LRRC8 multispan membrane proteins. Genomic disruption of LRRC8A ablated VRAC currents. Cells with disruption of all five LRRC8 genes required LRRC8A cotransfection with other LRRC8 isoforms to reconstitute VRAC currents. The isoform combination determined VRAC inactivation kinetics. Taurine flux and regulatory volume decrease also depended on LRRC8 proteins. Our work shows that VRAC defines a class of anion channels, suggests that VRAC is identical to the volume-sensitive organic osmolyte/anion channel VSOAC, and explains the heterogeneity of native VRAC currents.	[Voss, Felizia K.; Ullrich, Florian; Muench, Jonas; Lazarow, Katina; Lutter, Darius; von Kries, Jens P.; Stauber, Tobias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Voss, Felizia K.; Ullrich, Florian; Muench, Jonas; Lutter, Darius; Mah, Nancy; Andrade-Navarro, Miguel A.; Stauber, Tobias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Voss, Felizia K.; Ullrich, Florian; Muench, Jonas; Lutter, Darius] Free Univ Berlin, Grad Program, Berlin, Germany; [Jentsch, Thomas J.] Charite, D-13353 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stauber, T (corresponding author), Leibniz Inst Mol Pharmakol FMP, Berlin, Germany.	tstauber@fmp-berlin.de; jentsch@fmp-berlin.de	Stauber, Tobias/E-4005-2010; Ullrich, Florian/AAA-6043-2019	Stauber, Tobias/0000-0003-0727-6109; Ullrich, Florian/0000-0002-1153-2040; Mah, Nancy/0000-0002-1240-8076; Jentsch, Thomas/0000-0002-3509-2553	European Research Council Advanced Grant [294435]; Deutsche Forschungsgemeinschaft [Exc 257]	European Research Council Advanced Grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Neuenschwander for technical advice concerning the assay; H.-P. Rahn for help with fluorescence-activated cell sorting; A. Brockhoff and W. Meyerhof for use of their Fluorometric Image Plate Reader in a pilot experiment; and J. Liebold, N. Kronke, J. Jedamzick, and S. Kleissle for technical assistance. Supported by the European Research Council Advanced Grant (FP/2007-2013) 294435 "Cytovolion" and the Deutsche Forschungsgemeinschaft (Exc 257 "Neurocure") to T.J.J	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Chien LT, 2008, J GEN PHYSIOL, V132, P537, DOI 10.1085/jgp.200810065; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fischmeister R, 2005, J PHYSIOL-LONDON, V562, P477, DOI 10.1113/jphysiol.2004.075622; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Hayashi T, 2011, BIOL PHARM BULL, V34, P1257, DOI 10.1248/bpb.34.1257; Hernandez-Carballo CY, 2010, PFLUG ARCH EUR J PHY, V460, P633, DOI 10.1007/s00424-010-0842-0; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; Kubota K, 2004, FEBS LETT, V564, P147, DOI 10.1016/S0014-5793(04)00332-1; LAMBERT IH, 1994, J MEMBRANE BIOL, V142, P289; Leaney JL, 1997, J PHYSIOL-LONDON, V501, P555, DOI 10.1111/j.1469-7793.1997.555bm.x; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Moser T, 1995, PFLUG ARCH EUR J PHY, V431, P196, DOI 10.1007/BF00410191; NILIUS B, 1994, PFLUG ARCH EUR J PHY, V428, P364, DOI 10.1007/BF00724520; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Shennan DB, 2008, CELL PHYSIOL BIOCHEM, V21, P15, DOI 10.1159/000113743; Smits G, 2004, MOL IMMUNOL, V41, P561, DOI 10.1016/j.molimm.2004.04.001; Stotz SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046865; STRANGE K, 1995, KIDNEY INT, V48, P994, DOI 10.1038/ki.1995.381; Stutzin A, 1999, AM J PHYSIOL-CELL PH, V277, pC392, DOI 10.1152/ajpcell.1999.277.3.C392; Wang GX, 2004, AM J PHYSIOL-HEART C, V287, pH533, DOI 10.1152/ajpheart.00228.2003	31	380	394	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					634	638		10.1126/science.1252826	http://dx.doi.org/10.1126/science.1252826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24790029	Green Accepted			2022-12-24	WOS:000335537400044
J	Shalek, AK; Satija, R; Shuga, J; Trombetta, JJ; Gennert, D; Lu, DN; Chen, PL; Gertner, RS; Gaublomme, JT; Yosef, N; Schwartz, S; Fowler, B; Weaver, S; Wang, J; Wang, XH; Ding, RH; Raychowdhury, R; Friedman, N; Hacohen, N; Park, H; May, AP; Regev, A				Shalek, Alex K.; Satija, Rahul; Shuga, Joe; Trombetta, John J.; Gennert, Dave; Lu, Diana; Chen, Peilin; Gertner, Rona S.; Gaublomme, Jellert T.; Yosef, Nir; Schwartz, Schraga; Fowler, Brian; Weaver, Suzanne; Wang, Jing; Wang, Xiaohui; Ding, Ruihua; Raychowdhury, Raktima; Friedman, Nir; Hacohen, Nir; Park, Hongkun; May, Andrew P.; Regev, Aviv			Single-cell RNA-seq reveals dynamic paracrine control of cellular variation	NATURE			English	Article							GENE-EXPRESSION; I INTERFERON; IMMUNE; QUANTIFICATION; STOCHASTICITY; TRANSCRIPTOME; VARIABILITY; DETERMINES; ACTIVATION; PRINCIPLES	High-throughput single-cell transcriptomics offers an unbiased approach for understanding the extent, basis and function of gene expression variation between seemingly identical cells. Here we sequence single-cell RNA-seq libraries prepared from over 1,700 primary mouse bone-marrow-derived dendritic cells spanning several experimental conditions. We find substantial variation between identically stimulated dendritic cells, in both the fraction of cells detectably expressing a given messenger RNA and the transcript's level within expressing cells. Distinct gene modules are characterized by different temporal heterogeneity profiles. In particular, a 'core' module of antiviral genes is expressed very early by a few 'precocious' cells in response to uniform stimulation with a pathogenic component, but is later activated in all cells. By stimulating cells individually in sealed microfluidic chambers, analysing dendritic cells from knockout mice, and modulating secretion and extracellular signalling, we show that this response is coordinated by interferon-mediated paracrine signalling from these precocious cells. Notably, preventing cell-to-cell communication also substantially reduces variability between cells in the expression of an early-induced 'peaked' inflammatory module, suggesting that paracrine signalling additionally represses part of the inflammatory program. Our study highlights the importance of cell-to-cell communication in controlling cellular heterogeneity and reveals general strategies that multicellular populations can use to establish complex dynamic responses.	[Shalek, Alex K.; Gertner, Rona S.; Gaublomme, Jellert T.; Ding, Ruihua; Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.; Gertner, Rona S.; Gaublomme, Jellert T.; Ding, Ruihua; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Shalek, Alex K.; Satija, Rahul; Trombetta, John J.; Gennert, Dave; Lu, Diana; Yosef, Nir; Schwartz, Schraga; Raychowdhury, Raktima; Hacohen, Nir; Park, Hongkun; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Shuga, Joe; Chen, Peilin; Fowler, Brian; Weaver, Suzanne; Wang, Jing; Wang, Xiaohui; May, Andrew P.] Fluidigm Corp, San Francisco, CA 94080 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Hebrew University of Jerusalem; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Satija, R (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	rahuls@broadinstitute.org; Hongkun_Park@harvard.edu; apmay1@gmail.com	Park, Hongkun/R-9842-2019; Shalek, Alex/Y-2434-2019; Friedman, Nir/H-9692-2012; Satija, Rahul/AAF-9564-2019	Park, Hongkun/0000-0001-9576-8829; Shalek, Alex/0000-0001-5670-8778; Friedman, Nir/0000-0002-9678-3550; Schwartz, Schraga/0000-0002-3671-9709	NIH [1F32HD075541-01, U54 AI057159, DP2 OD002230, 5DP1OD003893-03, DP1OD003958-01]; NIH CEGS [1P50HG006193-01]; Broad Institute; Klarman Cell Observatory at the Broad Institute; ISF-Broad Grant; ERC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230, DP1OD003958, DP1OD003893] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CEGS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Klarman Cell Observatory at the Broad Institute; ISF-Broad Grant; ERC(European Research Council (ERC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Tilton, T. Rogers and M. Tam for assistance with cell sorting; E. Shefler, C. Guiducci, D. Thompson, and O. Rozenblatt-Rosen for project management and discussions and the Broad Genomics Platform for sequencing. We thank J. West, R. Lebofsky, A. Leyrat, M. Thu, M. Wong, W. Yorza, D. Toppani, M. Norris and B. Clerkson for contributions to C<INF>1</INF> system development; B. Alvarado, M. Ray and L. Knuttson for assistance with C<INF>1</INF> experiments; and M. Unger for discussions. Work was supported by an NIH Postdoctoral Fellowship (1F32HD075541-01, R.S.), an NIH grant (U54 AI057159, N.H.), an NIH New Innovator Award (DP2 OD002230, N.H.), an NIH CEGS(1P50HG006193-01, H.P., N.H., A.R.), NIH Pioneer Awards (5DP1OD003893-03 to H.P., DP1OD003958-01 to A.R.), the Broad Institute (H.P. and A.R.), HHMI (A.R.), the Klarman Cell Observatory at the Broad Institute (A.R.), an ISF-Broad Grant (N.F.), and the ERC (N.F.).	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Benveniste E. N., 2007, SCI STKE, V416, ppe70, DOI DOI 10.1126/STKE.4162007PE70; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Fang MQ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001618; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Islam S., 2012, NATURE PROTOCOLS, V7, P823; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weibrecht I, 2012, NEW BIOTECHNOL, V29, P589, DOI 10.1016/j.nbt.2011.08.002; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249	36	573	597	7	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					363	+		10.1038/nature13437	http://dx.doi.org/10.1038/nature13437			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24919153	Green Submitted, Green Accepted			2022-12-24	WOS:000337350200028
J	Manzoli, L; Flacco, ME; D'Addario, M; Capasso, L; De Vito, C; Marzuillo, C; Villari, P; Ioannidis, JPA				Manzoli, Lamberto; Flacco, Maria Elena; D'Addario, Maddalena; Capasso, Lorenzo; De Vito, Corrado; Marzuillo, Carolina; Villari, Paolo; Ioannidis, John P. A.			Non-publication and delayed publication of randomized trials on vaccines: survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CROSS-SECTIONAL ANALYSIS; OUTCOME REPORTING BIAS; BIOMEDICAL-RESEARCH; CLINICAL-RESEARCH; RETROSPECTIVE COHORT; INCREASING VALUE; HEALTH-RESEARCH; ADVERSE EVENTS; REDUCING WASTE; COMPLETENESS	Objective To evaluate the extent of non-publication or delayed publication of registered randomized trials on vaccines, and to investigate potential determinants of delay to publication. Design Survey. Data sources Trials registry websites, Scopus, PubMed, Google. Study selection Randomized controlled trials evaluating the safety or the efficacy or immunogenicity of human papillomavirus (HPV), pandemic A/H1N1 2009 influenza, and meningococcal, pneumococcal, and rotavirus vaccines that were registered in ClinicalTrials.gov, Current Controlled Trials, WHO International Clinical Trials Registry Platform, Clinical Study Register, or Indian, Australian-New Zealand, and Chinese trial registries in 2006-12. Electronic databases were searched up to February 2014 to identify published manuscripts containing trial results. These were reviewed and classified as positive, mixed, or negative. We also reviewed the results available in ClinicalTrials.gov. Main outcome measures Publication status of trial results and time from completion to publication in peer reviewed journals. Data synthesis Cox proportional hazards regression was used to evaluate potential predictors of publication delay. Results We analysed 384 trials (85% sponsored by industry). Of 355 trials (404 758 participants) that were completed, 176 (n = 151 379) had been published in peer reviewed journals. Another 42 trials (total sample 62 765) remained unpublished but reported results in ClinicalTrials.gov. The proportion of trials published 12, 24, 36, and 48 months after completion was 12%, 29%, 53%, and 73%, respectively. Including results posted in ClinicalTrials.gov, 48 months after study completion results were available for 82% of the trials and 90% of the participants. Delay to publication between non-industry and industry sponsored trials did not differ, but non-industry sponsored trials were 4.42-fold (P = 0.008) more likely to report negative or mixed findings. Negative results were reported by only 2% of the published trials. Conclusions Most vaccine trials are published eventually or the results posted in ClinicalTrials.gov, but delays to publication of several years are common. Actions should focus on the timely dissemination of data from vaccine trials to the public.	[Manzoli, Lamberto; Flacco, Maria Elena; Capasso, Lorenzo] Univ G dAnnunzio, Dept Med & Aging Sci, I-66013 Chieti, Italy; [Manzoli, Lamberto; Capasso, Lorenzo] CeSI Biotech, Chieti, Italy; [Flacco, Maria Elena] Local Hlth Unit Pescara, Pescara, Italy; [D'Addario, Maddalena] Univ Bern, Div Clin Epidemiol & Biostat, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [D'Addario, Maddalena] Univ Bern, Div Int & Environm Hlth, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [De Vito, Corrado; Marzuillo, Carolina; Villari, Paolo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA	G d'Annunzio University of Chieti-Pescara; University of Bern; University of Bern; Sapienza University Rome; Stanford University; Stanford University	Manzoli, L (corresponding author), Univ G dAnnunzio, Dept Med & Aging Sci, Via Vestini 5, I-66013 Chieti, Italy.	lmanzoli@post.harvard.edu	Capasso, Lorenzo/F-2389-2017; Manzoli, Lamberto/K-1895-2018; Flacco, Maria Elena/E-3306-2017; Ioannidis, John P. A./G-9836-2011	Capasso, Lorenzo/0000-0002-9902-8577; Manzoli, Lamberto/0000-0002-8129-9344; Flacco, Maria Elena/0000-0003-1404-4314; DE VITO, CORRADO/0000-0002-7846-672X; villari, paolo/0000-0002-3139-0668; MARZUILLO, CAROLINA/0000-0002-7299-5727				Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Cobo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000332; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Decullier E, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-165; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Galsworthy MJ, 2012, LANCET, V380, P971, DOI 10.1016/S0140-6736(12)61528-1; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Ioannidis JPA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028346; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Leung GM, 2010, PLOS MED, V7; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Manzoli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024384; Manzoli L, 2009, LANCET INFECT DIS, V9, P482, DOI 10.1016/S1473-3099(09)70153-7; Patsopoulos Nikolaos A, 2009, Open Med, V3, pe62; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Schulz K.F., 2010, BMJ-BRIT MED J, V340, pe332; Scott P, 2012, PEDIATR INFECT DIS J, V31, P1286, DOI 10.1097/INF.0b013e31827032bb; Shamliyan T, 2012, PEDIATRICS, V129, pE1291, DOI 10.1542/peds.2010-2847; Sibbald B, 1998, BRIT MED J, V316, P201; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Strech D, 2012, J CLIN EPIDEMIOL, V65, P276, DOI 10.1016/j.jclinepi.2011.07.002; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Turner EH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001189; Turner S, 2013, BMJ OPEN, V3; van de Wetering FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049599; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Verstraeten T, 2008, VACCINE, V26, P6630, DOI 10.1016/j.vaccine.2008.09.049; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; World Medical Association, 2013, DECL HELS ETH PRINC; Wu JA, 2010, J INFECT DIS, V202, P675, DOI 10.1086/655226; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	46	62	62	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2014	348								g3058	10.1136/bmj.g3058	http://dx.doi.org/10.1136/bmj.g3058			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5HF	24838102	Green Published, hybrid			2022-12-24	WOS:000336158400001
J	Georgescauld, F; Popova, K; Gupta, AJ; Bracher, A; Engen, JR; Hayer-Hartl, M; Hartl, FU				Georgescauld, Florian; Popova, Kristina; Gupta, Amit J.; Bracher, Andreas; Engen, John R.; Hayer-Hartl, Manajit; Hartl, F. Ulrich			GroEL/ES Chaperonin Modulates the Mechanism and Accelerates the Rate of TIM-Barrel Domain Folding	CELL			English	Article							MASS-SPECTROMETRY; HYDROGEN-EXCHANGE; ESCHERICHIA-COLI; IN-VIVO; E. COLI; PROTEIN; CONFINEMENT; RESOLUTION; KINETICS; MODEL	The GroEL/ES chaperonin system functions as a protein folding cage. Many obligate substrates of GroEL share the (beta alpha)(8) TIM-barrel fold, but how the chaperonin promotes folding of these proteins is not known. Here, we analyzed the folding of DapA at peptide resolution using hydrogen/deuterium exchange and mass spectrometry. During spontaneous folding, all elements of the DapA TIM barrel acquire structure simultaneously in a process associated with a long search time. In contrast, GroEL/ES accelerates folding more than 30-fold by catalyzing segmental structure formation in the TIM barrel. Segmental structure formation is also observed during the fast spontaneous folding of a structural homolog of DapA from a bacterium that lacks GroEL/ES. Thus, chaperonin independence correlates with folding properties otherwise enforced by protein confinement in the GroEL/ES cage. We suggest that folding catalysis by GroEL/ES is required by a set of proteins to reach native state at a biologically relevant time scale, avoiding aggregation or degradation.	[Georgescauld, Florian; Popova, Kristina; Gupta, Amit J.; Bracher, Andreas; Hayer-Hartl, Manajit; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Engen, John R.] Northeastern Univ, Dept Chem & Biol Chem, Boston, MA 02115 USA; [Hartl, F. Ulrich] Univ Munich, Munich Ctr Integrated Prot Sci CiPSM, D-81377 Munich, Germany	Max Planck Society; Northeastern University; University of Munich	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	mhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Georgescauld, Florian/AAH-7125-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742; Gupta, Amit Jean/0000-0002-6045-2848; Popova, Kristina/0000-0002-3957-2060; Engen, John R./0000-0002-6918-9476; Georgescauld, Florian/0000-0003-0530-1884	Munich Center for Integrated Protein Science (CiPSM); NIH [R01 GM101135]; Waters Corporation; La Fondation pour la Recherche Medicale [FRM SPE20071211473];  [06/2012-06/2013]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101135] Funding Source: NIH RePORTER	Munich Center for Integrated Protein Science (CiPSM); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waters Corporation; La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Moroder and H.J. Musiol for the synthesis of beta-semialdehyde. Expert technical assistance by N. Wischnewski and A. R. Lange is acknowledged, as is assistance with the H/DX experiments from T.E. Wales, R.E. Iacob, and R. Korner. We thank the MPIB crystallization facility and the personnel at beamline X10SA of SLS Villigen, Switzerland for their assistance. We gratefully acknowledge the financial support from the Munich Center for Integrated Protein Science (CiPSM). J.R.E. was on sabbatical at the Department of Cellular Biochemistry, Max Planck Institute of Biochemistry from 06/2012-06/2013 and was partially supported during this time by NIH R01 GM101135 and a research collaboration with the Waters Corporation. F.G. was supported by a postdoctoral fellowship from La Fondation pour la Recherche Medicale (code FRM SPE20071211473).	Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; Azia A, 2012, FEBS J, V279, P543, DOI 10.1111/j.1742-4658.2011.08458.x; Baumketner A, 2003, J MOL BIOL, V332, P701, DOI 10.1016/S0022-2836(03)00929-X; Bicout DJ, 2000, PROTEIN SCI, V9, P452; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; England JL, 2008, BIOPHYS J, V95, P3391, DOI [10.1529/biophysj.108.131037, 10.1529/biophysj.l08.131037]; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Groebke K, 1996, P NATL ACAD SCI USA, V93, P4025, DOI 10.1073/pnas.93.9.4025; Hayer-Hartl M, 2006, BIOCHEMISTRY-US, V45, P13356, DOI 10.1021/bi061597j; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Hu WB, 2013, P NATL ACAD SCI USA, V110, P7684, DOI 10.1073/pnas.1305887110; Jewett AI, 2010, CELL MOL LIFE SCI, V67, P255, DOI 10.1007/s00018-009-0164-6; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Lin MM, 2012, P NATL ACAD SCI USA, V109, P9851, DOI 10.1073/pnas.1207382109; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Matagne A, 2000, J MOL BIOL, V297, P193, DOI 10.1006/jmbi.2000.3540; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Powers ET, 2012, CELL REP, V1, P265, DOI 10.1016/j.celrep.2012.02.011; Reboul CF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002537; ROBINSON CV, 1994, NATURE, V372, P646, DOI 10.1038/372646a0; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Schmid F X, 1986, Methods Enzymol, V131, P70; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; SINGH J, 1985, FEBS LETT, V191, P1, DOI 10.1016/0014-5793(85)80982-0; Sirur A, 2013, BIOPHYS J, V104, P1098, DOI 10.1016/j.bpj.2013.01.034; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WOODWARD CK, 1979, ANNU REV BIOPHYS BIO, V8, P99, DOI 10.1146/annurev.bb.08.060179.000531; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	51	86	90	2	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					922	934		10.1016/j.cell.2014.03.038	http://dx.doi.org/10.1016/j.cell.2014.03.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813614	Green Accepted, Bronze			2022-12-24	WOS:000335765500019
J	Meyer, HJ; Rape, M				Meyer, Hermann-Josef; Rape, Michael			Enhanced Protein Degradation by Branched Ubiquitin Chains	CELL			English	Article							MULTIUBIQUITIN CHAIN; ENZYMES; E2S	Posttranslational modification of cell-cycle regulators with ubiquitin chains is essential for eukaryotic cell division. Such chains can be connected through seven lysine residues or the amino terminus of ubiquitin, thereby allowing the assembly of eight homogenous and multiple mixed or branched conjugates. Although functions of homogenous chain types have been described, physiological roles of branched structures are unknown. Here, we report that the anaphase-promoting complex (APC/C) efficiently synthesizes branched conjugates that contain multiple blocks of K11-linked chains. Compared to homogenous chains, the branched conjugates assembled by the APC/C strongly enhance substrate recognition by the proteasome, thereby driving degradation of cell-cycle regulators during early mitosis. Our work, therefore, identifies an enzyme and substrates for modification with branched ubiquitin chains and points to an important role of these conjugates in providing an improved signal for proteasomal degradation.	[Rape, Michael] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Meyer, Hermann-Josef; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rape, M (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	mrape@berkeley.edu		Rape, Michael/0000-0003-4849-6343	NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083064] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this work to the memory of Gabriel Hayes. We thank Xianfang Donna Xia for early contributions and Rebecca Heald for fluorescently tagged HeLa cells. We are grateful to Julia Schaletzky and members of the M.R. lab for comments on the manuscript and encouraging discussions. This work was funded by grants from the NIH (to M.R.). M.R. is an investigator of the Howard Hughes Medical Institute.	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Sedgwick GG, 2013, EMBO J, V32, P303, DOI 10.1038/emboj.2012.335; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8	27	293	307	2	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					910	921		10.1016/j.cell.2014.03.037	http://dx.doi.org/10.1016/j.cell.2014.03.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813613	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000335765500018
J	Boumahdi, S; Driessens, G; Lapouge, G; Rorive, S; Nassar, D; Le Mercier, M; Delatte, B; Caauwe, A; Lenglez, S; Nkusi, E; Brohee, S; Salmon, I; Dubois, C; del Marmol, V; Fuks, F; Beck, B; Blanpain, C				Boumahdi, Soufiane; Driessens, Gregory; Lapouge, Gaelle; Rorive, Sandrine; Nassar, Dany; Le Mercier, Marie; Delatte, Benjamin; Caauwe, Amelie; Lenglez, Sandrine; Nkusi, Erwin; Brohee, Sylvain; Salmon, Isabelle; Dubois, Christine; del Marmol, Veronique; Fuks, Francois; Beck, Benjamin; Blanpain, Cedric			SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma	NATURE			English	Article							SELF-RENEWAL; EXPRESSION; DIFFERENTIATION; MAINTENANCE; POPULATIONS; SURVIVAL; ABLATION; CATENIN; MARKER; GENES	Cancer stem cells (CSCs) have been reported in various cancers, including in skin squamous-cell carcinoma (SCC)(1-4). The molecular mechanisms regulating tumour initiation and stemness are still poorly characterized. Here we find that Sox2, a transcription factor expressed in various types of embryonic and adult stem cells(5,6), was the most upregulated transcription factor in the CSCs of squamous skin tumours in mice. SOX2 is absent in normal epidermis but begins to be expressed in the vast majority of mouse and human pre-neoplastic skin tumours, and continues to be expressed in a heterogeneous manner in invasive mouse and human SCCs. In contrast to other SCCs, in which SOX2 is frequently genetically amplified(7), the expression of SOX2 in mouse and human skin SCCs is transcriptionally regulated. Conditional deletion of Sox2 in the mouse epidermis markedly decreases skin tumour formation after chemical-induced carcinogenesis. Using green fluorescent protein (GFP) as a reporter of Sox2 transcriptional expression (SOX2-GFP knock-in mice), we showed that SOX2-expressing cells in invasive SCC are greatly enriched in tumour-propagating cells, which further increase upon serial transplantations. Lineage ablation of SOX2-expressing cells within primary benign and malignant SCCs leads to tumour regression, consistent with the critical role of SOX2-expressing cells in tumour maintenance. Conditional Sox2 deletion in pre-existing skin papilloma and SCC leads to tumour regression and decreases the ability of cancer cells to be propagated upon transplantation into immunodeficient mice, supporting the essential role of SOX2 in regulating CSC functions. Transcriptional profiling of SOX2-GFP expressing CSCs and of tumour epithelial cells upon Sox2 deletion uncovered a gene network regulated by SOX2 in primary tumour cells in vivo. Chromatin immunoprecipitation identified several direct SOX2 target genes controlling tumour stemness, survival, proliferation, adhesion, invasion and paraneoplastic syndrome. We demonstrate that SOX2, by marking and regulating the functions of skin tumour-initiating cells and CSCs, establishes a continuum between tumour initiation and progression in primary skin tumours.	[Boumahdi, Soufiane; Driessens, Gregory; Lapouge, Gaelle; Nassar, Dany; Caauwe, Amelie; Lenglez, Sandrine; Nkusi, Erwin; Dubois, Christine; Beck, Benjamin; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Rorive, Sandrine; Le Mercier, Marie; Salmon, Isabelle] Univ Libre Bruxelles, Erasme Hosp, Dept Pathol, B-1070 Brussels, Belgium; [Rorive, Sandrine; Salmon, Isabelle] CMMI, DIAPATH, B-6041 Gosselies, Belgium; [Delatte, Benjamin; Fuks, Francois] Univ Libre Bruxelles, Lab Canc Epigenet, B-1070 Brussels, Belgium; [Brohee, Sylvain] Univ Libre Bruxelles, Fac Sci, Dept Comp Sci, Machine Learning Grp, B-1050 Brussels, Belgium; [del Marmol, Veronique] Univ Libre Bruxelles, Erasme Hosp, Dept Dermatol, B-1070 Brussels, Belgium; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; del marmol, veronique/AAZ-8117-2020; Delatte, Benjamin/AAE-9276-2020	Delatte, Benjamin/0000-0002-6798-0600; Nassar, Dany/0000-0001-6780-0721; Beck, Benjamin/0000-0001-8162-7566	FNRS/FRIA; FNRS; TELEVIE; Brussels Region through the BB2B program; BB2B; IUAP; Fondation Contre le Cancer; ULB foundation; Fonds Yvonne Boel; Fonds Gaston Ithier; foundation Bettencourt Schueller; European Research Council	FNRS/FRIA(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; Brussels Region through the BB2B program; BB2B; IUAP; Fondation Contre le Cancer; ULB foundation; Fonds Yvonne Boel; Fonds Gaston Ithier; foundation Bettencourt Schueller; European Research Council(European Research Council (ERC)European Commission)	We thank our colleagues who provided us with reagents. We also thank the animal house facility of the Universite Libre de Bruxelles (ULB) (Erasme campus). C. B. is an investigator of WELBIO. S.Bo., B. B., B. D., S.Br., G. L. and D.N. are supported by a FNRS/FRIA, FNRS and TELEVIE fellowships. G. D. is supported by the Brussels Region through the BB2B program. This work was supported by the FNRS, TELEVIE, BB2B program, the IUAP program, a research grant from the Fondation Contre le Cancer, the ULB foundation, the Fonds Yvonne Boel, the Fonds Gaston Ithier, the foundation Bettencourt Schueller, and a starting grant from the European Research Council.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bardot ES, 2013, EMBO J, V32, P1990, DOI 10.1038/emboj.2013.110; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chuang WY, 2013, HISTOL HISTOPATHOL, V28, P293, DOI 10.14670/HH-28.293; Coletta A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r104; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Esbrit P, 2001, Clin Lab, V47, P67; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Granter S. R., 2008, PATHOLOGY SKIN CLIN; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Laga AC, 2010, AM J PATHOL, V176, P903, DOI 10.2353/ajpath.2010.090495; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Liborio TN, 2011, HISTOPATHOLOGY, V58, P225, DOI 10.1111/j.1365-2559.2011.03751.x; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Philip E., 2006, WHO CLASSIFICATION T, P20; Rorive S, 2010, MODERN PATHOL, V23, P1418, DOI 10.1038/modpathol.2010.136; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Soh BS, 2007, STEM CELLS, V25, P3029, DOI 10.1634/stemcells.2007-0372; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646	53	442	458	6	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					246	+		10.1038/nature13305	http://dx.doi.org/10.1038/nature13305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24909994				2022-12-24	WOS:000338649800049
J	Xu, HT; Han, Z; Gao, P; He, SJ; Li, ZZ; Shi, W; Kodish, O; Shao, W; Brown, KN; Huang, K; Shi, SH				Xu, Hua-Tai; Han, Zhi; Gao, Peng; He, Shuijin; Li, Zhizhong; Shi, Wei; Kodish, Oren; Shao, Wei; Brown, Keith N.; Huang, Kun; Shi, Song-Hai			Distinct Lineage-Dependent Structural and Functional Organization of the Hippocampus	CELL			English	Article							RADIAL GLIAL-CELLS; IN-VIVO; EXCITATORY NEURONS; GABAERGIC NEURONS; PYRAMIDAL CELLS; PLACE CELLS; INTERNEURONS; MIGRATION; RAT; SPECIFICATION	The hippocampus, as part of the cerebral cortex, is essential for memory formation and spatial navigation. Although it has been extensively studied, especially as a model system for neurophysiology, the cellular processes involved in constructing and organizing the hippocampus remain largely unclear. Here, we show that clonally related excitatory neurons in the developing hippocampus are progressively organized into discrete horizontal, but not vertical, clusters in the stratum pyramidale, as revealed by both cell-type-specific retroviral labeling and mosaic analysis with double markers (MADM). Moreover, distinct from those in the neocortex, sister excitatory neurons in the cornu ammonis 1 region of the hippocampus rarely develop electrical or chemical synapses with each other. Instead, they preferentially receive common synaptic input from nearby fast-spiking (FS), but not non-FS, interneurons and exhibit synchronous synaptic activity. These results suggest that shared inhibitory input may specify horizontally clustered sister excitatory neurons as functional units in the hippocampus.	[Xu, Hua-Tai; Gao, Peng; He, Shuijin; Li, Zhizhong; Shi, Wei; Kodish, Oren; Shao, Wei; Brown, Keith N.; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Han, Zhi] Nankai Univ, Coll Software, Tianjin 300071, Peoples R China; [Gao, Peng; Shi, Wei; Brown, Keith N.; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Neurosci, New York, NY 10065 USA; [Shi, Wei; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Biochem & Struct Biol Cell & Dev Bio, New York, NY 10065 USA; [Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	Memorial Sloan Kettering Cancer Center; Nankai University; Cornell University; Cornell University; University System of Ohio; Ohio State University	Shi, SH (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	shis@mskcc.org	Huang, Kun/E-3272-2011	Han, Zhi/0000-0002-5603-8433	NIH [R01DA024681, R01MH101382, P01NS048120]; Simons Foundation [GC221194]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083624, R01MH101382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Nicoletta Tekki-Kessaris and Dieter Saur for providing the Emx1-CreER<SUP>T2</SUP> and R26<SUP>LSLTVA-iLacZ</SUP> mouse lines, Dr. Shaoyu Ge for sharing retroviral vectors, and Dr. Eric Holland for initially supporting our avian retroviral engineering. We are grateful to Drs. Yasunori Hayashi, Alexandra L. Joyner, Mary E. Hatten, and Mu-ming Poo and Ildiko Lily Erdy for critical reading of the manuscript. This work was supported by grants from the NIH (R01DA024681, R01MH101382, and P01NS048120) and the Simons Foundation (GC221194).	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; EICHENBAUM H, 1989, J NEUROSCI, V9, P2764; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fiala JC, 1998, J NEUROSCI, V18, P8900; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gorski JA, 2002, J NEUROSCI, V22, P6309; GROVE EA, 1992, NEURON, V8, P217, DOI 10.1016/0896-6273(92)90289-P; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hilscher MM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00120; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kitazawa A, 2014, J NEUROSCI, V34, P1115, DOI 10.1523/JNEUROSCI.2254-13.2014; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; KNOWLES WD, 1981, J NEUROSCI, V1, P318; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; Lee SMK, 2000, DEVELOPMENT, V127, P457; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Martin LA, 2002, J NEUROSCI, V22, P3520; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nauta W., 1986, FUNDAMENTAL NEUROANA; Nielsen JV, 2007, DEVELOPMENT, V134, P1133, DOI 10.1242/dev.000265; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; NOWAKOWSKI RS, 1979, J NEUROCYTOL, V8, P697, DOI 10.1007/BF01206671; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; SIK A, 1995, J NEUROSCI, V15, P6651; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Tole S, 1997, DEVELOPMENT, V124, P4959; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Xie ZF, 2010, P NATL ACAD SCI USA, V107, P6510, DOI 10.1073/pnas.0912315107; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	66	46	46	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1552	1564		10.1016/j.cell.2014.03.067	http://dx.doi.org/10.1016/j.cell.2014.03.067			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949968	Green Accepted, Bronze			2022-12-24	WOS:000340941900011
J	van Berlo, JH; Kanisicak, O; Maillet, M; Vagnozzi, RJ; Karch, J; Lin, SCJ; Middleton, RC; Marban, E; Molkentin, JD				van Berlo, Jop H.; Kanisicak, Onur; Maillet, Marjorie; Vagnozzi, Ronald J.; Karch, Jason; Lin, Suh-Chin J.; Middleton, Ryan C.; Marban, Eduardo; Molkentin, Jeffery D.			c-kit(+) cells minimally contribute cardiomyocytes to the heart	NATURE			English	Article							CARDIAC STEM-CELLS; C-KIT; ADULT; FUSION; REGENERATION; MYOCARDIUM; EXPRESSION; MOUSE; ADOPT	If and how the heart regenerates after an injury event is highly debated. c-kit-expressing cardiac progenitor cells have been reported as the primary source for generation of new myocardium after injury. Here we generated two genetic approaches in mice to examine whether endogenous c-kit(+) cells contribute differentiated cardiomyocytes to the heart during development, with ageing or after injury in adulthood. A complementary DNA encoding either Cre recombinase or a tamoxifen-inducible MerCreMer chimaeric protein was targeted to the Kit locus in mice and then bred with reporter lines to permanently mark cell lineage. Endogenous c-kit(+) cells did produce new cardiomyocytes within the heart, although at a percentage of approximately 0.03 or less, and if a preponderance towards cellular fusion is considered, the percentage falls to below approximately 0.008. By contrast, c-kit(+) cells amply generated cardiac endothelial cells. Thus, endogenous c-kit(+) cells cangenerate cardiomyocytes within the heart, although probably at a functionally insignificant level.	[van Berlo, Jop H.; Kanisicak, Onur; Maillet, Marjorie; Vagnozzi, Ronald J.; Karch, Jason; Lin, Suh-Chin J.; Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [van Berlo, Jop H.] Univ Minnesota, Lillehei Heart Inst, Div Cardiol, Dept Med, Minneapolis, MN 55455 USA; [Middleton, Ryan C.; Marban, Eduardo] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Cedars Sinai Medical Center; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute	Molkentin, JD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	Jeff.Molkentin@cchmc.org	Vagnozzi, Ronald/AAR-6891-2020; Marban, Eduardo/GWC-8514-2022; Kanisicak, Onur/AAU-4586-2020	Vagnozzi, Ronald/0000-0002-8027-1809; Kanisicak, Onur/0000-0002-8393-4874; van Berlo, Jop/0000-0001-9229-4429; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL112852, P50HL077101, P50HL052318, P01HL108806, R01HL105924, R37HL060562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (to J.H.v.B., E. M. and J.D.M.). J.D.M. is an investigator of the Howard Hughes Medical Institute.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Hosoda T, 2009, P NATL ACAD SCI USA, V106, P17169, DOI 10.1073/pnas.0903089106; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Karch J, 2013, ELIFE, V2, DOI 10.7554/eLife.00772; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Liu QH, 2009, CIRC RES, V105, P1110, DOI 10.1161/CIRCRESAHA.109.200741; Matsuura K, 2004, J CELL BIOL, V167, P351, DOI 10.1083/jcb.200312111; Mauduit C, 1999, HUM REPROD UPDATE, V5, P535, DOI 10.1093/humupd/5.5.535; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; NAGY ARJ, 2000, GENE TARGETING PRACT; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; OKURA M, 1995, J INVEST DERMATOL, V105, P322, DOI 10.1111/1523-1747.ep12319939; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Peters EMJ, 2002, J HISTOCHEM CYTOCHEM, V50, P751, DOI 10.1177/002215540205000602; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; Sandlow JI, 1996, J ANDROL, V17, P403; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Waskow C, 2002, IMMUNITY, V17, P277, DOI 10.1016/S1074-7613(02)00386-2; Ye L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033407; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093	27	564	581	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					337	+		10.1038/nature13309	http://dx.doi.org/10.1038/nature13309			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805242	Green Accepted, Green Published			2022-12-24	WOS:000336121200033
J	Hsu, YC; Li, LS; Fuchs, E				Hsu, Ya-Chieh; Li, Lishi; Fuchs, Elaine			Transit-Amplifying Cells Orchestrate Stem Cell Activity and Tissue Regeneration	CELL			English	Article							HAIR-FOLLICLE; SONIC-HEDGEHOG; SELF-RENEWAL; NICHE; ORGANIZATION; ACTIVATION; PROGENY; TRANSDUCTION; PRECURSORS; QUIESCENT	Transit-amplifying cells (TACs) are an early intermediate in tissue regeneration. Here, using hair follicles (HFs) as a paradigm, we show that emerging TACs constitute a signaling center that orchestrates tissue growth. Whereas primed stem cells (SCs) generate TACs, quiescent SCs only proliferate after TACs form and begin expressing Sonic Hedgehog (SHH). TAC generation is independent of autocrine SHH, but the TAC pool wanes if they can't produce SHH. We trace this paradox to two direct actions of SHH: promoting quiescent-SC proliferation and regulating dermal factors that stoke TAC expansion. Ingrained within quiescent SCs' special sensitivity to SHH signaling is their high expression of GAS1. Without sufficient input from quiescent SCs, replenishment of primed SCs for the next hair cycle is compromised, delaying regeneration and eventually leading to regeneration failure. Our findings unveil TACs as transient but indispensable integrators of SC niche components and reveal an intriguing interdependency of primed and quiescent SC populations on tissue regeneration.	[Hsu, Ya-Chieh; Li, Lishi; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NIH [K99-AR063127]; NIH/NIAMS [R01AR050452]; Empire State Stem Cell (NYSTEM) [N09G074]; NYSDOH [C023046]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR063127, R01AR050452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Empire State Stem Cell (NYSTEM); NYSDOH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to C-M. Fan for Gas1<SUP>-/-</SUP>, H. Westphal for the Shh<SUP>null</SUP> mice, and many colleagues who donated mice to JAX; S. Mazel, L. Li,S. Semova, and S. Tadesse for sorting (RU FCRC facility, supported by NYSDOH Contract #C023046); RU Comparative Biology Center (AAALAC-accredited) for veterinary care; members of the Fuchs' lab, in particular, M. Kadaja for lentiviral constructs, C-Y. Chang, S-J. Luo, N. Oshimori, B. Keyes, and K. Tumaneng for comments on the manuscript, L. Polak, N. Stokes, D. Oristian A. Aldeguer, and S. Hacker for assistance in mouse research, and J. Racelis for assistance with in situ hybridization. Y-C.H. was a NYSCF-Druckenmiller Postdoctoral Fellow and is now supported by NIH K99-R00 pathway to independence award K99-AR063127. L. L. is a Helen Hay Whitney Postdoctoral Fellow. E. F. is an HHMI Investigator. This work was supported by a grant (to E. F.) from the NIH/NIAMS (R01AR050452) and partially by a grant from Empire State Stem Cell (NYSTEM; N09G074), NYSTEM funds through NYSDOH (Contract C023046; RU FCRC).	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Fantauzzo KA, 2011, CELL STEM CELL, V8, P8, DOI 10.1016/j.stem.2010.12.018; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Paladini RD, 2005, J INVEST DERMATOL, V125, P638, DOI 10.1111/j.0022-202X.2005.23867.x; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Plikus MV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015198; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vied C, 2012, DEV CELL, V23, P836, DOI 10.1016/j.devcel.2012.09.010; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Xiong YQ, 2013, DEV CELL, V25, P169, DOI 10.1016/j.devcel.2013.03.015; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	59	225	229	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					935	949		10.1016/j.cell.2014.02.057	http://dx.doi.org/10.1016/j.cell.2014.02.057			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813615	Bronze, Green Accepted			2022-12-24	WOS:000335765500020
J	Liu, SP; Lorenzen, ED; Fumagalli, M; Li, B; Harris, K; Xiong, ZJ; Zhou, L; Korneliussen, TS; Somel, M; Babbitt, C; Wray, G; Li, JW; He, WM; Wang, Z; Fu, WJ; Xiang, XY; Morgan, CC; Doherty, A; O'Connell, MJ; McInerney, JO; Born, EW; Dalen, L; Dietz, R; Orlando, L; Sonne, C; Zhang, GJ; Nielsen, R; Willerslev, E; Wang, J				Liu, Shiping; Lorenzen, Eline D.; Fumagalli, Matteo; Li, Bo; Harris, Kelley; Xiong, Zijun; Zhou, Long; Korneliussen, Thorfinn Sand; Somel, Mehmet; Babbitt, Courtney; Wray, Greg; Li, Jianwen; He, Weiming; Wang, Zhuo; Fu, Wenjing; Xiang, Xueyan; Morgan, Claire C.; Doherty, Aoife; O'Connell, Mary J.; McInerney, James O.; Born, Erik W.; Dalen, Love; Dietz, Rune; Orlando, Ludovic; Sonne, Christian; Zhang, Guojie; Nielsen, Rasmus; Willerslev, Eske; Wang, Jun			Population Genomics Reveal Recent Speciation and Rapid Evolutionary Adaptation in Polar Bears	CELL			English	Article							SOUTHERN BEAUFORT SEA; URSUS-MARITIMUS; DILATED CARDIOMYOPATHY; BODY-COMPOSITION; LYST GENE; MUTATION; GREENLAND; PREDATION; ADMIXTURE; SEQUENCE	Polar bears are uniquely adapted to life in the High Arctic and have undergone drastic physiological changes in response to Arctic climates and a hyper-lipid diet of primarily marine mammal prey. We analyzed 89 complete genomes of polar bear and brown bear using population genomic modeling and show that the species diverged only 479-343 thousand years BP. We find that genes on the polar bear lineage have been under stronger positive selection than in brown bears; nine of the top 16 genes under strong positive selection are associated with cardiomyopathy and vascular disease, implying important reorganization of the cardiovascular system. One of the genes showing the strongest evidence of selection, APOB, encodes the primary lipoprotein component of low-density lipoprotein (LDL); functional mutations in APOB may explain how polar bears are able to cope with life-long elevated LDL levels that are associated with high risk of heart disease in humans.	[Liu, Shiping; Li, Bo; Xiong, Zijun; Zhou, Long; Li, Jianwen; He, Weiming; Wang, Zhuo; Fu, Wenjing; Xiang, Xueyan; Zhang, Guojie; Nielsen, Rasmus; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Liu, Shiping; He, Weiming] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou 510641, Guangdong, Peoples R China; [Lorenzen, Eline D.; Fumagalli, Matteo; Somel, Mehmet; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Lorenzen, Eline D.; Korneliussen, Thorfinn Sand; Orlando, Ludovic; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark; [Harris, Kelley] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Babbitt, Courtney; Wray, Greg] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Babbitt, Courtney; Wray, Greg] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Xiang, Xueyan] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China; [Morgan, Claire C.; O'Connell, Mary J.] Dublin City Univ, Sch Biotechnol, Bioinformat & Mol Evolut Grp, Dublin 9, Ireland; [Doherty, Aoife; McInerney, James O.] Natl Univ Ireland, Dept Biol, Bioinformat & Mol Evolut Unit, Maynooth, Co Kildare, Ireland; [Born, Erik W.] Govt Greenland Representat Denmark, Greenland Inst Nat Resources, DK-1016 Copenhagen K, Denmark; [Dalen, Love] Swedish Museum Nat Hist, Dept Bioinformat & Genet, S-10405 Stockholm, Sweden; [Dietz, Rune; Sonne, Christian] Aarhus Univ, Arctic Res Ctr, Dept Biosci, DK-4000 Roskilde, Denmark; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Willerslev, Eske; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen O, Denmark; [Wang, Jun] King Abdulaziz Univ, Princess Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China	Beijing Genomics Institute (BGI); South China University of Technology; University of California System; University of California Berkeley; University of Copenhagen; University of California System; University of California Berkeley; Duke University; Duke University; Sichuan University; Dublin City University; Maynooth University; Greenland Institute of Natural Resources; Swedish Museum of Natural History; Aarhus University; University of Copenhagen; University of California System; University of California Berkeley; University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong	Nielsen, R (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	rasmus_nielsen@berkeley.edu; ewillerslev@snm.ku.dk; wangj@genomics.org.cn	Willerslev, Eske/AAA-5686-2019; Zhang, Guojie/B-6188-2014; Dietz, Rune/F-9154-2015; Korneliussen, Thorfinn Sand/ABB-7656-2021; Fumagalli, Matteo/H-6448-2019; McInerney, James/B-5108-2012; Somel, Mehmet/B-1471-2016; Sonne, Christian/I-7532-2013; Korneliussen, Thorfinn Sand/F-6421-2014; Zhang, Guojie/J-7273-2019; Orlando, Ludovic/A-8932-2013; Willerslev, Eske/A-9619-2011; Dalén, Love/A-6686-2008; Mcinerney, James/AAF-7234-2020; Lorenzen, Eline/D-1442-2012; Nielsen, Rasmus/D-4405-2009; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Zhang, Guojie/0000-0001-6860-1521; Dietz, Rune/0000-0001-9652-317X; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Fumagalli, Matteo/0000-0002-4084-2953; McInerney, James/0000-0003-1885-2503; Sonne, Christian/0000-0001-5723-5263; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Zhang, Guojie/0000-0001-6860-1521; Orlando, Ludovic/0000-0003-3936-1850; Willerslev, Eske/0000-0002-7081-6748; Dalén, Love/0000-0001-8270-7613; Xiang, Xueyan/0000-0003-1843-0474; Lorenzen, Eline/0000-0002-6353-2819; Nielsen, Rasmus/0000-0003-0513-6591; Somel, Mehmet/0000-0002-3138-1307; Wang, Jun/0000-0002-2113-5874; O'Connell, Mary/0000-0002-1877-1001; Wang, Jun/0000-0002-8540-8931; Wang, Zhuo/0000-0002-4069-9501; LIU, Shiping/0000-0003-0019-619X; Xiong, Zijun/0000-0003-3923-0703	NIH [2R14003229-07, 5P-50-GM- 081883]; Swedish Research Council; BiodivERsA ERA-NET project Climigrate; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); BiodivERsA ERA-NET project Climigrate; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the subsistence Greenland hunters for their valuable participation in obtaining the polar bear samples used in this study, which were collected through a number of projects funded under the DANCEA (Danish Cooperation for Environment in the Arctic) programme. We thank the University of Alaska Museum of the North for providing the ABC brown bear samples and IIpo Kojola, Katherine Kendall, and John Waller for providing additional samples. We thank Zhaolei Zhang, Yaping Zhang, Fang Li, and Weilin Qiu for help and Xiaoning Wang (South China University of Technology) and the National Gene Bank Project of China and Shenzhen Municipal Government of China (NO. JC201005260191A, CXB201108250096A). E.D.L. was supported by grants from the Danish Council for Independent Research broken vertical bar Natural Sciences (09-069307) and a Marie Curie International Outgoing Fellowship within the European Community 7th Framework Programme (PIOF-GA-2009-253376). M F. and M.S. were supported by EMBO Long-term Postdoctoral Fellowships (ALTF-229-2011 and ALTF-1475-2010) and grant PJ008116 from Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea. K. H. was supported by a National Science Foundation Graduate Research Fellowship and a UC Berkeley Chancellors Fellowship. R. N. was supported by NIH (2R14003229-07). G.A.W. was supported by NIH (5P-50-GM- 081883 to the Duke Center for Systems Biology). C.C.M. and M J.O'C. thank the Irish Research Council for Science, Engineering and Technology (Embark Initiative to CCM (RS2000172) and Science Foundation Ireland Research Frontiers Program (EOB2673). L.D. was supported by grants from the Swedish Research Council and the BiodivERsA ERA-NET project Climigrate.	Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Atkinson SN, 1996, PHYSIOL ZOOL, V69, P304, DOI 10.1086/physzool.69.2.30164186; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Benn M, 2009, ATHEROSCLEROSIS, V206, P17, DOI 10.1016/j.atherosclerosis.2009.01.004; Cahill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003345; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Cronin MA, 2009, J HERED, V100, P681, DOI 10.1093/jhered/esp061; De Barba M, 2010, MOL ECOL, V19, P3938, DOI 10.1111/j.1365-294X.2010.04791.x; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Dickson AJ, 2009, NAT GEOSCI, V2, P428, DOI 10.1038/NGEO527; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Fumagalli M., 2014, BIOINFORMATICS; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Gutierrez-Gil B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-56; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hedberg GE, 2011, ZOO BIOL, V30, P550, DOI 10.1002/zoo.20375; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Kunieda T, 1999, MAMM GENOME, V10, P1146, DOI 10.1007/s003359901181; Kurten B., 1964, Acta Zoologica Fennica, V108, P1; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Ormbostad I., 2012, THESIS NORWEGIAN U S; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; Pagano AM, 2012, CAN J ZOOL, V90, P663, DOI 10.1139/Z2012-033; Pages M, 2008, MOL PHYLOGENET EVOL, V47, P73, DOI 10.1016/j.ympev.2007.10.019; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Prassl R, 2009, EUR BIOPHYS J BIOPHY, V38, P145, DOI 10.1007/s00249-008-0368-y; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Runkel F, 2006, MAMM GENOME, V17, P203, DOI 10.1007/s00335-005-0015-1; SMITH TG, 1980, CAN J ZOOL, V58, P2201, DOI 10.1139/z80-302; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; STIRLING I, 1977, J FISH RES BOARD CAN, V34, P1126, DOI 10.1139/f77-169; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Trantow CM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001008; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; Trip MD, 2002, CIRCULATION, V106, P773, DOI 10.1161/01.CIR.0000028420.27813.C0; Van Sligtenhorst I, 2012, VET PATHOL, V49, P131, DOI 10.1177/0300985811402841; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang GQ, 2012, J HUM GENET, V57, P727, DOI 10.1038/jhg.2012.101; Whitfield AJ, 2004, CLIN CHEM, V50, P1725, DOI 10.1373/clinchem.2004.038026; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758	49	214	216	10	547	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					785	794		10.1016/j.cell.2014.03.054	http://dx.doi.org/10.1016/j.cell.2014.03.054			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813606	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000335765500008
J	Donoso, M; Collins, AGE; Koechlin, E				Donoso, Mael; Collins, Anne G. E.; Koechlin, Etienne			Foundations of human reasoning in the prefrontal cortex	SCIENCE			English	Article							COGNITIVE CONTROL; FRONTAL-CORTEX; INFORMATION	The prefrontal cortex (PFC) subserves reasoning in the service of adaptive behavior. Little is known, however, about the architecture of reasoning processes in the PFC. Using computational modeling and neuroimaging, we show here that the human PFC has two concurrent inferential tracks: (i) one from ventromedial to dorsomedial PFC regions that makes probabilistic inferences about the reliability of the ongoing behavioral strategy and arbitrates between adjusting this strategy versus exploring new ones from long-term memory, and (ii) another from polar to lateral PFC regions that makes probabilistic inferences about the reliability of two or three alternative strategies and arbitrates between exploring new strategies versus exploiting these alternative ones. The two tracks interact and, along with the striatum, realize hypothesis testing for accepting versus rejecting newly created strategies.	[Donoso, Mael; Koechlin, Etienne] INSERM, U960, Cognit Neurosci Lab, F-75005 Paris, France; [Donoso, Mael; Collins, Anne G. E.; Koechlin, Etienne] Ecole Normale Super, DEC, F-75005 Paris, France; [Donoso, Mael; Koechlin, Etienne] Univ Paris 06, Ctr Neuroimagerie Rech CENIR, F-75005 Paris, France; [Collins, Anne G. E.] Brown Univ, Providence, RI 02912 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Sorbonne Universite; Brown University	Koechlin, E (corresponding author), INSERM, U960, Cognit Neurosci Lab, 29 Rue Ulm, F-75005 Paris, France.	etienne.koechlin@upmc.fr	Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311	European Research Council Grant (ERC-AdG) [250106]	European Research Council Grant (ERC-AdG)	We thank C. Summerfield and S. Palminteri for their helpful comments. Funded by a European Research Council Grant (ERC-2009-AdG#250106) to E. K. MRI data are available at http://central.xnat.org, project ID: PROBE.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Boorman ED, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001093; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Charron S, 2010, SCIENCE, V328, P360, DOI 10.1126/science.1183614; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Cowan N, 2005, HUMAN LEARING AND MEMORY: ADVANCES IN THEORY AND APPLICATION, P155; Daw N, 2007, ADV NEURAL INFORM PR, V20, P369; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Doshi-Velez F., 2009, ADV NEURAL INFORM PR, V22, P477; Doya K, 2007, HFSP J, V1, P30, DOI [10.2976/1.2732246/10.2976/1, 10.2976/1.2732246]; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Neubert FX, 2014, NEURON, V81, P700, DOI 10.1016/j.neuron.2013.11.012; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Oaksford M, 2009, BEHAV BRAIN SCI, V32, P69, DOI 10.1017/S0140525X09000284; Ribas-Fernandes JJF, 2011, NEURON, V71, P370, DOI 10.1016/j.neuron.2011.05.042; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Teffer K, 2012, PROG BRAIN RES, V195, P191, DOI 10.1016/B978-0-444-53860-4.00009-X; Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302	31	224	225	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1481	1486		10.1126/science.1252254	http://dx.doi.org/10.1126/science.1252254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24876345				2022-12-24	WOS:000337889900041
J	Kelly, RP; Port, JA; Yamahara, KM; Martone, RG; Lowell, N; Thomsen, PF; Mach, ME; Bennett, M; Prahler, E; Caldwell, MR; Crowder, LB				Kelly, Ryan P.; Port, Jesse A.; Yamahara, Kevan M.; Martone, Rebecca G.; Lowell, Natalie; Thomsen, Philip Francis; Mach, Megan E.; Bennett, Meredith; Prahler, Erin; Caldwell, Margaret R.; Crowder, Larry B.			Harnessing DNA to improve environmental management	SCIENCE			English	Editorial Material							FUTURE		[Kelly, Ryan P.; Lowell, Natalie] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98103 USA; [Kelly, Ryan P.; Port, Jesse A.; Yamahara, Kevan M.; Martone, Rebecca G.; Mach, Megan E.; Bennett, Meredith; Prahler, Erin; Caldwell, Margaret R.; Crowder, Larry B.] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Thomsen, Philip Francis] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	University of Washington; University of Washington Seattle; Stanford University; University of Copenhagen	Kelly, RP (corresponding author), Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98103 USA.	rpkelly@uw.edu	Thomsen, Philip Francis/AAE-9354-2019	Thomsen, Philip Francis/0000-0002-9867-4366; Mach, Megan/0000-0003-2697-1254; Kelly, Ryan/0000-0001-5037-2441				BAKER CS, 1994, SCIENCE, V265, P1538, DOI 10.1126/science.265.5178.1538; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Gooding JJ, 2006, ANAL CHIM ACTA, V559, P137, DOI 10.1016/j.aca.2005.12.020; Griffith J.F., 2013, CALIFORNIA MICROBIAL; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wood SA, 2013, NEW ZEAL J MAR FRESH, V47, P90, DOI 10.1080/00288330.2012.745885	14	132	141	8	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1455	1456		10.1126/science.1251156	http://dx.doi.org/10.1126/science.1251156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24970068				2022-12-24	WOS:000337889900024
J	Caliskan, N; Katunin, VI; Belardinelli, R; Peske, F; Rodnina, MV				Caliskan, Neva; Katunin, Vladimir I.; Belardinelli, Riccardo; Peske, Frank; Rodnina, Marina V.			Programmed-1 Frameshifting by Kinetic Partitioning during Impeded Translocation	CELL			English	Article							MESSENGER-RNA TRANSLOCATION; E-SITE; HYBRID STATE; P-SITE; RIBOSOMAL FRAMESHIFT; ESCHERICHIA-COLI; SINGLE RIBOSOMES; A-SITE; TRANSLATION; SIGNAL	Programmed -1 ribosomal frameshifting (-1PRF) is an mRNA recoding event utilized by cells to enhance the information content of the genome and to regulate gene expression. The mechanism of -1PRF and its timing during translation elongation are unclear. Here, we identified the steps that govern -1PRF by following the stepwise movement of the ribosome through the frameshifting site of a model mRNA derived from the IBV 1a/1b gene in a reconstituted in vitro translation system from Escherichia coli. Frameshifting occurs at a late stage of translocation when the two tRNAs are bound to adjacent slippery sequence codons of the mRNA. The downstream pseudoknot in the mRNA impairs the closing movement of the 30S subunit head, the dissociation of EF-G, and the release of tRNA from the ribosome. The slippage of the ribosome into the -1 frame accelerates the completion of translocation, thereby further favoring translation in the new reading frame.	[Caliskan, Neva; Belardinelli, Riccardo; Peske, Frank; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Katunin, Vladimir I.] BP Konstantinov Petersburg Nucl Phys Inst, Dept Mol & Radiat Biophys, Gatchina 188300, Russia	Max Planck Society; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Caliskan, Neva/N-5537-2017; Belardinelli, Riccardo/I-4363-2013; Rodnina, Marina V./AAD-4667-2019	Caliskan, Neva/0000-0003-0435-4757; Belardinelli, Riccardo/0000-0002-3333-0466; Rodnina, Marina V./0000-0003-0105-3879	Deutsche Forschungsgemeinschaft [RO 2004/9-1, SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This paper is dedicated to the memory of Vladimir Katunin, who sadly passed away before submission of the manuscript. We thank Anja Lehwess-Litzmann and Carlos da Cunha for sharing their L12-EF-G FRET reporter system prior to publication. We thank Anna Bursy, Olaf Geintzer, Sandra Kappler, Christina Kothe, Theresia Uhlendorf, Tanja Wiles, and Michael Zimmermann for expert technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (RO 2004/9-1 and SFB860 to M.V.R.).	Bekaert M, 2005, MOL CELL, V17, P61, DOI 10.1016/j.molcel.2004.12.009; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Brierley I, 1997, J MOL BIOL, V270, P360, DOI 10.1006/jmbi.1997.1134; Brierley I, 2010, NUCLEIC ACIDS MOL BI, V24, P149, DOI 10.1007/978-0-387-89382-2_7; Chen CL, 2013, NAT STRUCT MOL BIOL, V20, P582, DOI 10.1038/nsmb.2544; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Fayet O, 2010, NUCLEIC ACIDS MOL BI, V24, P259, DOI 10.1007/978-0-387-89382-2_12; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Holtkamp W, 2014, EMBO J, V33, P1073, DOI 10.1002/embj.201387465; HORSFIELD JA, 1995, NUCLEIC ACIDS RES, V23, P1487, DOI 10.1093/nar/23.9.1487; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Leger M, 2004, RNA, V10, P1225, DOI 10.1261/rna.7670704; Leger M, 2007, NUCLEIC ACIDS RES, V35, P5581, DOI 10.1093/nar/gkm578; Liao PY, 2011, NUCLEIC ACIDS RES, V39, P300, DOI 10.1093/nar/gkq761; LILL R, 1987, J MOL BIOL, V196, P137, DOI 10.1016/0022-2836(87)90516-X; Lin ZR, 2012, NUCLEIC ACIDS RES, V40, P8674, DOI 10.1093/nar/gks629; McGarry KG, 2005, MOL CELL, V20, P613, DOI 10.1016/j.molcel.2005.10.007; Mittelstaet J, 2013, J AM CHEM SOC, V135, P17031, DOI 10.1021/ja407511q; Mouzakis KD, 2013, NUCLEIC ACIDS RES, V41, P1901, DOI 10.1093/nar/gks1254; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Napthine S, 2003, EMBO J, V22, P3941, DOI 10.1093/emboj/cdg365; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; Qin PW, 2014, EMBO REP, V15, P185, DOI 10.1002/embr.201337762; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; SEMENKOV Y, 1992, FEBS LETT, V296, P207, DOI 10.1016/0014-5793(92)80380-Y; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Sharma D, 2004, RNA, V10, P102, DOI 10.1261/rna.5148704; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Uemura S, 2007, NATURE, V446, P454, DOI 10.1038/nature05625; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; WEISS R B, 1989, New Biologist, V1, P159; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; YELVERTON E, 1994, MOL MICROBIOL, V11, P303, DOI 10.1111/j.1365-2958.1994.tb00310.x	42	107	109	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1619	1631		10.1016/j.cell.2014.04.041	http://dx.doi.org/10.1016/j.cell.2014.04.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949973	Bronze, Green Published			2022-12-24	WOS:000340941900016
J	Soleimanpour, SA; Gupta, A; Bakay, M; Ferrari, AM; Groff, DN; Fadista, J; Spruce, LA; Kushner, JA; Groop, L; Seeholzer, SH; Kaufman, BA; Hakonarson, H; Stoffers, DA				Soleimanpour, Scott A.; Gupta, Aditi; Bakay, Marina; Ferrari, Alana M.; Groff, David N.; Fadista, Joao; Spruce, Lynn A.; Kushner, Jake A.; Groop, Leif; Seeholzer, Steven H.; Kaufman, Brett A.; Hakonarson, Hakon; Stoffers, Doris A.			The Diabetes Susceptibility Gene Clec16a Regulates Mitophagy	CELL			English	Article							PANCREATIC BETA-CELL; MITOFUSIN 2; ENDOPLASMIC-RETICULUM; MITOCHONDRIAL DYNAMICS; PARKIN OVEREXPRESSION; STRESS; MORPHOLOGY; INSULITIS; PROTEINS; PRECEDES	Clec16a has been identified as a disease susceptibility gene for type 1 diabetes, multiple sclerosis, and adrenal dysfunction, but its function is unknown. Here we report that Clec16a is a membrane-associated endosomal protein that interacts with E3 ubiquitin ligase Nrdp1. Loss of Clec16a leads to an increase in the Nrdp1 target Parkin, a master regulator of mitophagy. Islets from mice with pancreas-specific deletion of Clec16a have abnormal mitochondria with reduced oxygen consumption and ATP concentration, both of which are required for normal beta cell function. Indeed, pancreatic Clec16a is required for normal glucose-stimulated insulin release. Moreover, patients harboring a diabetogenic SNP in the Clec16a gene have reduced islet Clec16a expression and reduced insulin secretion. Thus, Clec16a controls beta cell function and prevents diabetes by controlling mitophagy. This pathway could be targeted for prevention and control of diabetes and may extend to the pathogenesis of other Clec16a- and Parkin-associated diseases.	[Soleimanpour, Scott A.; Gupta, Aditi; Ferrari, Alana M.; Groff, David N.; Stoffers, Doris A.] Univ Penn Perelman, Sch Med, Inst Diabet Obes & Metab, Dept Med,Div Endrocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Soleimanpour, Scott A.] Univ Michigan, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48105 USA; [Bakay, Marina; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Fadista, Joao; Groop, Leif] Lund Univ, Skane Univ Hosp, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, S-20502 Malmo, Sweden; [Spruce, Lynn A.; Seeholzer, Steven H.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Kushner, Jake A.] Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA; [Kaufman, Brett A.] Univ Penn, Sch Vet Med, Dept Biol Anim, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn Perelman, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Lund University; Skane University Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine; University of Pennsylvania; University of Pennsylvania	Stoffers, DA (corresponding author), Univ Penn Perelman, Sch Med, Inst Diabet Obes & Metab, Dept Med,Div Endrocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	stoffers@mail.med.upenn.edu	Fadista, Joao/AAM-4870-2020; Ferrari, Alana/S-4566-2019; Kushner, Jake A/AFJ-8198-2022; Kushner, Jake A/AAF-5049-2022; Gupta, Aditi/HGD-9632-2022	Fadista, Joao/0000-0003-2539-634X; Ferrari, Alana/0000-0002-9058-8041; Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744; fadista, joao/0000-0001-7558-7043; Soleimanpour, Scott/0000-0001-6777-4498	Margaret Q. Landenberger Foundation; Charles H. Humpton, Jr. Endowment; JDRF; NIH [K08-DK089117, 5-P01-DK049210-15, 1DP3DK085708-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK089117, P30DK020572, P30DK019525, DP3DK085708, P01DK049210] Funding Source: NIH RePORTER	Margaret Q. Landenberger Foundation; Charles H. Humpton, Jr. Endowment; JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge Dr. N. Doliba and Q. Wei of the Penn Islet Cell Biology Core of the University of Pennsylvania DRC (P30DK19525) for assistance with islet oxygen consumption studies, Dr. D. Williams of the Penn EM Resource Laboratory for imaging assistance, Dr. J. Florez for access to and assistance with MAGIC data, Drs. B. Keith and S. Reiner for immune cell samples, and Dr. P. Herrera for Pdx1-Cre mice. We thank Drs. M. Lazar, M. Birnbaum, M. Marks, J. Raum, and J. Baur for helpful advice. We acknowledge funding support from the Margaret Q. Landenberger Foundation, the Charles H. Humpton, Jr. Endowment, the JDRF, and the NIH (K08-DK089117, 5-P01-DK049210-15, and 1DP3DK085708-01).	Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Herrera PL, 2000, DEVELOPMENT, V127, P2317; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kim S, 2012, P NATL ACAD SCI USA, V109, pE1072, DOI 10.1073/pnas.1120320109; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Pociot F, 2010, DIABETES, V59, P1561, DOI 10.2337/db10-0076; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Soleimanpour SA, 2013, TRENDS ENDOCRIN MET, V24, P324, DOI 10.1016/j.tem.2013.03.005; Stiles L, 2012, BEST PRACT RES CL EN, V26, P725, DOI 10.1016/j.beem.2012.05.004; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; 't Hart LM, 2013, DIABETES, V62, P3275, DOI 10.2337/db13-0227; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Teplova VV, 2007, J BIOENERG BIOMEMBR, V39, P321, DOI 10.1007/s10863-007-9095-9; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao T, 2012, J BIOL CHEM, V287, P23615, DOI 10.1074/jbc.M112.379164; Zhong L, 2005, J BIOL CHEM, V280, P9425, DOI 10.1074/jbc.M408955200; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002; Zouk H, 2014, CLIN EXP IMMUNOL, V175, P485, DOI 10.1111/cei.12240	49	123	133	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1577	1590		10.1016/j.cell.2014.05.016	http://dx.doi.org/10.1016/j.cell.2014.05.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24949970	Bronze, Green Accepted			2022-12-24	WOS:000340941900013
J	Wahl, AS; Omlor, W; Rubio, JC; Chen, JL; Zheng, H; Schroter, A; Gullo, M; Weinmann, O; Kobayashi, K; Helmchen, F; Ommer, B; Schwab, ME				Wahl, A. S.; Omlor, W.; Rubio, J. C.; Chen, J. L.; Zheng, H.; Schroeter, A.; Gullo, M.; Weinmann, O.; Kobayashi, K.; Helmchen, F.; Ommer, B.; Schwab, M. E.			NEURONAL REPAIR Asynchronous therapy restores motor control by rewiring of the rat corticospinal tract after stroke	SCIENCE			English	Article							ADULT RATS; REHABILITATION; PLASTICITY; RECOVERY; PATHWAYS; CIRCUIT	The brain exhibits limited capacity for spontaneous restoration of lost motor functions after stroke. Rehabilitation is the prevailing clinical approach to augment functional recovery, but the scientific basis is poorly understood. Here, we show nearly full recovery of skilled forelimb functions in rats with large strokes when a growth-promoting immunotherapy against a neurite growth-inhibitory protein was applied to boost the sprouting of new fibers, before stabilizing the newly formed circuits by intensive training. In contrast, early high-intensity training during the growth phase destroyed the effect and led to aberrant fiber patterns. Pharmacogenetic experiments identified a subset of corticospinal fibers originating in the intact half of the forebrain, side-switching in the spinal cord to newly innervate the impaired limb and restore skilled motor function.	[Wahl, A. S.; Gullo, M.; Weinmann, O.; Schwab, M. E.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Wahl, A. S.; Omlor, W.; Chen, J. L.; Gullo, M.; Weinmann, O.; Helmchen, F.; Schwab, M. E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Rubio, J. C.; Zheng, H.; Ommer, B.] Heidelberg Univ, Comp Vis Grp, Heidelberg Collaboratory Image Proc, Heidelberg, Germany; [Rubio, J. C.; Zheng, H.; Ommer, B.] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany; [Schroeter, A.] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland; [Kobayashi, K.] Natl Inst Nat Sci Myodaiji, Natl Inst Physiol Sci, Okazaki, Aichi, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Wahl, AS (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.	wahl@hifo.uzh.ch; schwab@hifo.uzh.ch	Schwab, Martin E/B-6818-2016; Omlor, Wolfgang/AAJ-8288-2021; Omlor, Wolfgang/AAS-3163-2020; Helmchen, Fritjof/A-6255-2008	Helmchen, Fritjof/0000-0002-8867-9569; Omlor, Wolfgang/0000-0003-1979-7147; Wahl, Anna-Sophia/0000-0001-9498-4263; Chen, Jerry/0000-0002-7409-7859	European Union [201024, 223524]; advanced European Research Council grant NOGORISE; Swiss National Science Foundation [31-138676, 3100A0_12252711, 31003A_149858]; Christopher and Dana Reeve Foundation; Dr. Wilhelm Hurka Foundation; German Excellence Initiative, Deutsche Forschungsgemeinschaft project [49/2]	European Union(European Commission); advanced European Research Council grant NOGORISE; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Christopher and Dana Reeve Foundation; Dr. Wilhelm Hurka Foundation; German Excellence Initiative, Deutsche Forschungsgemeinschaft project	We thank T. Isa from the National Institute for Physiological Sciences, Okazaki, Japan, as well as K. Kobayashi, Fukushima Medical University, and D. Watanabe, Kyoto University, for kindly providing plasmids for viral vector production. We thank H. Kasper, C. Bleul, and N. Lindau for technical advice and fruitful discussions, as well as B. Seifert for statistical assistance. This work is supported by the European Union grants FP7 Collaborative Projects ARISE (201024) and PLASTICISE (223524), the advanced European Research Council grant NOGORISE (to M. E. S.), the Swiss National Science Foundation grants Nr. 31-138676 and 3100A0_12252711 (to M. E. S.) and Nr. 31003A_149858 (to F. H.), the Christopher and Dana Reeve Foundation (to M. E. S.), and the Dr. Wilhelm Hurka Foundation (F.H. and W.O.). The work by J.C.R and B.O. was supported by the German Excellence Initiative, Deutsche Forschungsgemeinschaft project number 49/2. A. S. W. and M. E. S. designed the study; A. S. W. and M. G. carried out experiments; A.S.W., W.O., B.O., and F.H. performed data analysis; J.C.R., H.Z., and B.O. developed computer and machine learning algorithm tools for data analysis; J. L. C. and K. K. provided virus vectors; A. S. performed magnetic resonance imaging; O.W. carried out histological analysis; and A.S.W, B.O., F.H., and M.E.S. prepared figures and wrote the manuscript. The University of Zurich holds joint patents with Novartis Pharma for antibodies against Nogo-A and their use in neurological diseases. Otherwise, we have no patents pending or financial conflicts to disclose. Materials and methods are available as supplementary materials on Science Online. Plasmids for lentiviral and AAV vectors for the TeNT experiment were obtained under material transfer agreements (MTAs) with Kyoto University, Japan (pLenti-TRE-EGFP-eTeNT-PEST-WPRE, pLenti-TRE-EGFP-WPRE, pRSV-Rev, pMDLg/pRRE, pAAV2-RC, pAAV2-CMV-rtTAV16), and Fukushima Medical University, Japan (pCAGGS-FuG-B2), respectively. Viral vectors for the DREADD experiment were obtained under a MTA with the University of Pennsylvania, Philadelphia, PA (AAV2.9-CamKII alpha.-Cre vector). The anti-Nogo-A antibody (11C7) was a gift from Novartis Pharma. The supplementary materials contain additional data.	Adkins DL, 2005, NEUROSCI LETT, V380, P214, DOI 10.1016/j.neulet.2005.01.036; Alaverdashvili M, 2008, BEHAV BRAIN RES, V188, P281, DOI 10.1016/j.bbr.2007.11.007; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Asante CO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074454; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Oertle T, 2003, J NEUROSCI, V23, P5393; Ommer B, 2009, INT J COMPUT VISION, V83, P57, DOI 10.1007/s11263-009-0211-7; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Starkey ML, 2011, EXP NEUROL, V232, P81, DOI 10.1016/j.expneurol.2011.08.006; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Zeiler SR, 2013, CURR OPIN NEUROL, V26, P609, DOI 10.1097/WCO.0000000000000025	23	224	235	5	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1250	1255		10.1126/science.1253050	http://dx.doi.org/10.1126/science.1253050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926013				2022-12-24	WOS:000337077500032
J	Martins, VC; Busch, K; Juraeva, D; Blum, C; Ludwig, C; Rasche, V; Lasitschka, F; Mastitsky, SE; Brors, B; Hielscher, T; Fehling, HJ; Rodewald, HR				Martins, Vera C.; Busch, Katrin; Juraeva, Dilafruz; Blum, Carmen; Ludwig, Carolin; Rasche, Volker; Lasitschka, Felix; Mastitsky, Sergey E.; Brors, Benedikt; Hielscher, Thomas; Fehling, Hans Joerg; Rodewald, Hans-Reimer			Cell competition is a tumour suppressor mechanism in the thymus	NATURE			English	Article							MOLECULAR PATHOGENESIS; HEMATOPOIETIC STEM; NOTCH1 MUTATIONS; C-KIT; MICE; EXPRESSION; EXPANSION; LEUKEMIA; ACTIVATION; THYMOCYTES	Cell competitionis an emerging principle underlying selection for cellular fitness during development and disease. Competition may be relevant for cancer, but an experimental link between defects in competition and tumorigenesis is elusive. In the thymus, T lymphocytes develop from precursors that are constantly replaced by bone-marrow-derived progenitors. Here we show that in mice this turnover is regulated by natural cell competition between 'young' bone-marrow-derived and 'old' thymus-resident progenitors that, although genetically identical, execute differential gene expression programs. Disruption of cell competition leads to progenitor self-renewal, upregulation of Hmga1, transformation, and T-cell acute lymphoblastic leukaemia (T-ALL) resembling the human disease in pathology, genomic lesions, leukaemia-associated transcripts, and activating mutations in Notch1. Hence, cell competition is a tumour suppressor mechanism in the thymus. Failure to select fit progenitors through cell competition may explain leukaemia in X-linked severe combined immune deficiency patients who showed thymus-autonomous T-cell development after therapy with gene-corrected autologous progenitors.	[Martins, Vera C.; Busch, Katrin; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Martins, Vera C.; Blum, Carmen; Ludwig, Carolin; Fehling, Hans Joerg] Univ Ulm, Inst Immunol, D-89081 Ulm, Germany; [Juraeva, Dilafruz; Mastitsky, Sergey E.; Brors, Benedikt] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Rasche, Volker] Univ Ulm, Core Facil Small Anim MRI, D-89081 Ulm, Germany; [Lasitschka, Felix] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Hielscher, Thomas] German Canc Res Ctr, Div Biostat, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Rodewald, HR (corresponding author), German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany.	hr.rodewald@dkfz.de	Martins, Vera/M-1356-2015; Martins, Vera C./AAF-5238-2020; Rasche, Volker/P-6523-2016; Brors, Benedikt/E-5620-2013	Martins, Vera/0000-0001-8717-9709; Martins, Vera C./0000-0001-8717-9709; Rasche, Volker/0000-0001-8844-3583; Brors, Benedikt/0000-0001-5940-3101; Mastitsky, Sergey/0000-0002-1068-4579	ERC Advanced Grant [233074]; DFG-SFB938-project L; Helmholtz PCCC Alliance	ERC Advanced Grant(Estonian Research Council); DFG-SFB938-project L; Helmholtz PCCC Alliance	We thank A. Tietz and T. Arnsperger for technical assistance, T. Ashworth and J. Aster, M. Nussenzweig and P. Fink for materials and mice, the animal facilities for mouse husbandry, S. Henze, O. Heil and E. Korpelainen for expression array experiments and support on Chipster. We thank B. Edgar, L. Johnston, T. Boehm, A. Rudensky, R. Medzhitov, M. Muckenthaler, A. Kulodzik, T. Sanda, T. Look, P. Lichter, T. Feyerabend and I. Rode for help and discussions. H.-R.R. was supported by ERC Advanced Grant No. 233074, DFG-SFB938-project L, and the Helmholtz PCCC Alliance.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Baker NE, 2011, CURR BIOL, V21, pR11, DOI 10.1016/j.cub.2010.11.030; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cavazzana-Calvo M, 2011, BLOOD, V117, P4420, DOI 10.1182/blood-2010-09-255679; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Di Cello F, 2013, LEUKEMIA LYMPHOMA, V54, P1762, DOI 10.3109/10428194.2013.764422; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FREY JR, 1992, J EXP MED, V175, P1067, DOI 10.1084/jem.175.4.1067; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Lin YW, 2006, BLOOD, V107, P2540, DOI 10.1182/blood-2005-07-3013; Martins VC, 2012, J EXP MED, V209, P1409, DOI 10.1084/jem.20120846; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Peaudecerf L, 2012, J EXP MED, V209, P1401, DOI 10.1084/jem.20120845; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Porter CC, 2011, LEUKEMIA, V25, P891, DOI 10.1038/leu.2011.22; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; Stam RW, 2010, BLOOD, V115, P2835, DOI 10.1182/blood-2009-07-233049; Tiemessen MM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001430; Tsuji H, 2009, MUTAT RES-FUND MOL M, V660, P22, DOI 10.1016/j.mrfmmm.2008.10.002; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/nmeth.1309, 10.1038/NMETH.1309]; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	45	154	158	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					465	+		10.1038/nature13317	http://dx.doi.org/10.1038/nature13317			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828041				2022-12-24	WOS:000336126000033
J	Jones, AM; Xuan, YH; Xu, M; Wang, RS; Ho, CH; Lalonde, S; You, CH; Sardi, MI; Parsa, SA; Smith-Valle, E; Su, TY; Frazer, KA; Pilot, G; Pratelli, R; Grossmann, G; Acharya, BR; Hu, HC; Engineer, C; Villiers, F; Ju, CL; Takeda, K; Su, Z; Dong, QF; Assmann, SM; Chen, J; Kwak, JM; Schroeder, JI; Albert, R; Rhee, SY; Frommer, WB				Jones, Alexander M.; Xuan, Yuanhu; Xu, Meng; Wang, Rui-Sheng; Ho, Cheng-Hsun; Lalonde, Sylvie; You, Chang Hun; Sardi, Maria I.; Parsa, Saman A.; Smith-Valle, Erika; Su, Tianying; Frazer, Keith A.; Pilot, Guillaume; Pratelli, Rejane; Grossmann, Guido; Acharya, Biswa R.; Hu, Heng-Cheng; Engineer, Cawas; Villiers, Florent; Ju, Chuanli; Takeda, Kouji; Su, Zhao; Dong, Qunfeng; Assmann, Sarah M.; Chen, Jin; Kwak, June M.; Schroeder, Julian I.; Albert, Reka; Rhee, Seung Y.; Frommer, Wolf B.			Border Control-A Membrane-Linked Interactome of Arabidopsis	SCIENCE			English	Article							ABSCISIC-ACID; PROTEIN-KINASE; ENDOCYTOSIS; NETWORK; VERSION; MAP	Cellular membranes act as signaling platforms and control solute transport. Membrane receptors, transporters, and enzymes communicate with intracellular processes through protein-protein interactions. Using a split-ubiquitin yeast two-hybrid screen that covers a test-space of 6.4 x 10(6) pairs, we identified 12,102 membrane/signaling protein interactions from Arabidopsis. Besides confirmation of expected interactions such as heterotrimeric G protein subunit interactions and aquaporin oligomerization, >99% of the interactions were previously unknown. Interactions were confirmed at a rate of 32% in orthogonal in planta split-green flourescent protein interaction assays, which was statistically indistinguishable from the confirmation rate for known interactions collected from literature (38%). Regulatory associations in membrane protein trafficking, turnover, and phosphorylation include regulation of potassium channel activity through abscisic acid signaling, transporter activity by a WNK kinase, and a brassinolide receptor kinase by trafficking-related proteins. These examples underscore the utility of the membrane/signaling protein interaction network for gene discovery and hypothesis generation in plants and other organisms.	[Jones, Alexander M.; Xuan, Yuanhu; Xu, Meng; Ho, Cheng-Hsun; Lalonde, Sylvie; You, Chang Hun; Sardi, Maria I.; Parsa, Saman A.; Smith-Valle, Erika; Su, Tianying; Frazer, Keith A.; Pilot, Guillaume; Pratelli, Rejane; Grossmann, Guido; Chen, Jin; Rhee, Seung Y.; Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Wang, Rui-Sheng; Albert, Reka] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Pilot, Guillaume; Pratelli, Rejane] Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Acharya, Biswa R.; Su, Zhao; Assmann, Sarah M.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Hu, Heng-Cheng; Villiers, Florent; Ju, Chuanli; Takeda, Kouji; Kwak, June M.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Engineer, Cawas; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Dong, Qunfeng] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Chen, Jin] Michigan State Univ, US DOE, Plant Res Lab, E Lansing, MI 48824 USA; [Chen, Jin] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Kwak, June M.] Daegu Gyeongbuk Inst Sci & Technol, Dept New Biol, Ctr Plant Aging Res, Inst Basic Sci, Taegu 711873, South Korea	Carnegie Institution for Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University of California System; University of California San Diego; University of North Texas System; University of North Texas Denton; Michigan State University; United States Department of Energy (DOE); Michigan State University; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Institute for Basic Science - Korea (IBS)	Rhee, SY (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	srhee@carnegiescience.edu; wfrommer@stanford.edu	Frommer, Wolf B/A-8256-2008; Grossmann, Guido/GQA-5985-2022; Grossmann, Guido/D-3537-2014; Albert, Reka/E-2195-2011; Kwak, June M/G-8332-2011; Frommer, Wolf B/K-5042-2017	Frommer, Wolf B/0000-0001-6465-0115; Grossmann, Guido/0000-0001-7529-9244; Grossmann, Guido/0000-0001-7529-9244; Albert, Reka/0000-0002-9485-0828; Kwak, June M/0000-0001-6948-5155; Frommer, Wolf B/0000-0001-6465-0115; Chen, Jin/0000-0001-6721-3199; Wang, Ruisheng/0000-0003-4920-4357; , Yuanhu/0000-0002-4704-8090; Ho, Cheng-Hsun/0000-0002-0895-1914; Schroeder, Julian/0000-0002-3283-5972; Jones, Alexander/0000-0002-3662-2915; Pilot, Guillaume/0000-0001-7520-1059	National Science Foundation (NSF) Arabidopsis grant [MCB-0618402, MCB-1052348];  [NSF-MCB-1021677];  [NSF-MCB-0918220];  [NSF-MCB-1121612]; Div Of Molecular and Cellular Bioscience [1052348, 1414339, 1121612] Funding Source: National Science Foundation	National Science Foundation (NSF) Arabidopsis grant(National Science Foundation (NSF)); ; ; ; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank W. Monsell (Pennsylvania State University) and Y. S. Han (University of Maryland) for technical assistance and K. Revanna and V. Desu (University of North Texas) for assistance with the MIND web portal development. This work was made possible by a National Science Foundation (NSF) Arabidopsis 2010 grant (MCB-0618402) to W.B.F., S.M.A., R.A., J.M.K., S.Y.R., and J.I.S. and NSF Arabidopsis 2010 grant (MCB-1052348) to W.B.F. and S.Y.R., with partial support from NSF-MCB-1021677 (W.B.F.), NSF-MCB-0918220 (J.I.S.) and NSF-MCB-1121612 (S.M.A. and R.A.). Because of the large number of constructs, we are not able to distribute individual clones. We make split-ubiquitin system vectors and an Arabidopsis ORF collection available through the Arabidopsis Biological Resource Center (https://abrc.osu.edu) and split-GFP assay vectors available through AddGene (www.addgene.org). Instructions for acquiring other materials as well as a materials transfer agreement governing plasmids are provided online at www.associomics.org. Additional materials are included in the suplementary materials. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Andersson ER, 2012, CELL MOL LIFE SCI, V69, P1755, DOI 10.1007/s00018-011-0877-1; Anschutz U, 2014, J PLANT PHYSIOL, V171, P670, DOI 10.1016/j.jplph.2014.01.009; Beck M, 2012, PLANT CELL, V24, P4205, DOI 10.1105/tpc.112.100263; Bienert GP, 2012, BIOCHEM J, V445, P101, DOI 10.1042/BJ20111704; Bommert P, 2013, NATURE, V502, P555, DOI 10.1038/nature12583; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brock AK, 2010, PLANT PHYSIOL, V153, P1098, DOI 10.1104/pp.110.156109; Contento AL, 2012, J CELL SCI, V125, P3511, DOI 10.1242/jcs.093559; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Ebine K, 2011, NAT CELL BIOL, V13, P853, DOI 10.1038/ncb2270; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; Fu Y, 2014, CELL, V156, P1084, DOI 10.1016/j.cell.2014.01.013; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gish LA, 2011, PLANT J, V66, P117, DOI 10.1111/j.1365-313X.2011.04518.x; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Ho CH, 2014, ELIFE, V3, DOI 10.7554/eLife.01917; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang ZQ, 2011, NUCLEIC ACIDS RES, V39, pD1123, DOI 10.1093/nar/gkq1066; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Lalonde S, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00024; Lewis JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-8; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Schulze Waltraud X, 2003, BMC Biochem, V4, P3, DOI 10.1186/1471-2091-4-3; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Song L, 2009, CELL RES, V19, P864, DOI 10.1038/cr.2009.66; Sterken R, 2009, PLANT CELL, V21, P2987, DOI 10.1105/tpc.109.067017; Takahashi D., 2014, BIOSCI REP; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Van Zeebroeck G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024275; Viotti C, 2010, PLANT CELL, V22, P1344, DOI 10.1105/tpc.109.072637; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	42	149	150	3	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					711	716		10.1126/science.1251358	http://dx.doi.org/10.1126/science.1251358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833385				2022-12-24	WOS:000335912900032
J	Hede, K				Hede, Karyn			AN INFECTIOUS ARMS RACE	NATURE			English	Editorial Material													Hede, Karyn/AGR-8461-2022	Hede, Karyn/0000-0003-2815-0636					0	80	85	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S2	S3		10.1038/509S2a	http://dx.doi.org/10.1038/509S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784426	Bronze			2022-12-24	WOS:000335199100002
J	Savage, N				Savage, Neil			BIOINFORMATICS Big data versus the big C	NATURE			English	Editorial Material																		Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; McNerney ME, 2013, BLOOD, V121, P975, DOI 10.1182/blood-2012-04-426965	2	25	28	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S66	S67		10.1038/509S66a	http://dx.doi.org/10.1038/509S66a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24860876	Bronze			2022-12-24	WOS:000336457100009
J	Gammon, K				Gammon, Katharine			DRUG DISCOVERY Leaving no stone unturned	NATURE			English	Editorial Material																		Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/NNANO.2013.254, 10.1038/nnano.2013.254]; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]; Lee RE, 2014, NAT MED, V20, P152, DOI 10.1038/nm.3458; Scholl D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033637; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Zlitni S, 2013, NAT CHEM BIOL, V9, P796, DOI [10.1038/nchembio.1361, 10.1038/NCHEMBIO.1361]	9	15	15	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S10	S12		10.1038/509S10a	http://dx.doi.org/10.1038/509S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784422	Bronze			2022-12-24	WOS:000335199100006
J	Gilissen, C; Hehir-Kwa, JY; Thung, DT; van de Vorst, M; van Bon, BWM; Willemsen, MH; Kwint, M; Janssen, IM; Hoischen, A; Schenck, A; Leach, R; Klein, R; Tearle, R; Bo, T; Pfundt, R; Yntema, HG; de Vries, BBA; Kleefstra, T; Brunner, HG; Vissers, LELM; Veltman, JA				Gilissen, Christian; Hehir-Kwa, Jayne Y.; Thung, Djie Tjwan; van de Vorst, Maartje; van Bon, Bregje W. M.; Willemsen, Marjolein H.; Kwint, Michael; Janssen, Irene M.; Hoischen, Alexander; Schenck, Annette; Leach, Richard; Klein, Robert; Tearle, Rick; Bo, Tan; Pfundt, Rolph; Yntema, Helger G.; de Vries, Bert B. A.; Kleefstra, Tjitske; Brunner, Han G.; Vissers, Lisenka E. L. M.; Veltman, Joris A.			Genome sequencing identifies major causes of severe intellectual disability	NATURE			English	Article							DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; MENTAL-RETARDATION; AUTISM; SCHIZOPHRENIA; VARIANTS; SPECTRUM; PROTEIN; PARADIGM; NETWORK	Severe intellectual disability (ID) occurs in 0.5% of newborns and is thought to be largely genetic in origin(1,2). The extensive genetic heterogeneity of this disorder requires a genome-wide detection of all types of genetic variation. Microarray studies and, more recently, exome sequencing have demonstrated the importance of de novo copy number variations (CNVs) and single-nucleotide variations (SNVs) in ID, but the majority of cases remain undiagnosed(3-6). Here we applied whole-genome sequencing to 50 patients with severe ID and their unaffected parents. All patients included had not received a molecular diagnosis after extensive genetic prescreening, including microarray-based CNV studies and exome sequencing. Notwithstanding this prescreening, 84 de novo SNVs affecting the coding region were identified, which showed a statistically significant enrichment of loss-of-function mutations as well as an enrichment for genes previously implicated in ID-related disorders. In addition, we identified eight de novo CNVs, including single-exon and intra-exonic deletions, as well as interchromosomal duplications. These CNVs affected known ID genes more frequently than expected. On the basis of diagnostic interpretation of all de novo variants, a conclusive genetic diagnosis was reached in 20 patients. Together with one compound heterozygous CNV causing disease in a recessive mode, this results in a diagnostic yield of 42% in this extensively studied cohort, and 62% as a cumulative estimate in an unselected cohort. These results suggest that de novo SNVs and CNVs affecting the coding region are a major cause of severe ID. Genome sequencing can be applied as a single genetic test to reliably identify and characterize the comprehensive spectrum of genetic variation, providing a genetic diagnosis in the majority of patients with severe ID.	[Gilissen, Christian; Hehir-Kwa, Jayne Y.; Thung, Djie Tjwan; van de Vorst, Maartje; van Bon, Bregje W. M.; Willemsen, Marjolein H.; Kwint, Michael; Janssen, Irene M.; Hoischen, Alexander; Schenck, Annette; Bo, Tan; Pfundt, Rolph; Yntema, Helger G.; de Vries, Bert B. A.; Kleefstra, Tjitske; Brunner, Han G.; Vissers, Lisenka E. L. M.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Gilissen, Christian; Hehir-Kwa, Jayne Y.; Thung, Djie Tjwan; van de Vorst, Maartje; van Bon, Bregje W. M.; Willemsen, Marjolein H.; Kwint, Michael; Janssen, Irene M.; Hoischen, Alexander; Schenck, Annette; Bo, Tan; Pfundt, Rolph; Yntema, Helger G.; de Vries, Bert B. A.; Kleefstra, Tjitske; Brunner, Han G.; Vissers, Lisenka E. L. M.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, NL-6525 GA Nijmegen, Netherlands; [Leach, Richard; Klein, Robert; Tearle, Rick] Complete Genom Inc, Mountain View, CA 94043 USA; [Bo, Tan] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Gilissen, Christian; Brunner, Han G.; Veltman, Joris A.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 ER Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Central South University; Maastricht University	Veltman, JA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands.	joris.veltman@radboudumc.nl	Kleefstra, Tjitske/G-2619-2012; Schenck, Annette/E-4514-2012; Veltman, Joris A/F-5128-2010; Hehir, g. J.Y./L-4358-2015; van Bon, Bregje/Q-2445-2015; Kwint, Michael/AAC-9062-2019; Willemsen, Marjolein/R-5958-2019; Gilissen, Christian/E-5246-2012; Vissers, Lisenka ELM/A-2598-2015; Hoischen, Alexander/D-1282-2013; Brunner, Han/C-9928-2013; Janssen, Irene M/V-3667-2018; Hoischen, Alexander/AGF-7293-2022; Yntema, H.G./L-4771-2015; Pfundt, Rolph/L-4576-2015; Thung, Djie Tjwan/Q-2104-2015	Schenck, Annette/0000-0002-6918-3314; Veltman, Joris A/0000-0002-3218-8250; van Bon, Bregje/0000-0003-2234-0105; Gilissen, Christian/0000-0003-1693-9699; Vissers, Lisenka ELM/0000-0001-6470-5497; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; Hehir-Kwa, Jayne/0000-0003-0837-304X; Wagner, Jennifer/0000-0001-8174-0534; Keehn, Brandon/0000-0001-8796-2250; Tager-Flusberg, Helen/0000-0002-8768-5414	Netherlands Organization for Scientific Research [912-12-109, 916-14-043, 916-12-095, 907-00-365, SH-271-13]; European Research Council (ERC) [DENOVO 281964]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC))	We thank R. Drmanac, K. Albers, J. Goeman, D. Lugtenberg and P. N. Robinson for useful discussions, and M. Steehouwer, P. de Vries and W. Nillesen for technical support. This work was in part financially supported by grants from the Netherlands Organization for Scientific Research (912-12-109 to J. A. V., A. S. and B.B.A.d.V., 916-14-043 to C. G., 916-12-095 to A. H., 907-00-365 to T. K. and SH-271-13 to C. G. and J. A. V.) and the European Research Council (ERC Starting grant DENOVO 281964 to J.A.V.).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Bell J, 2007, PRACTICE GUIDELINES; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hehir-Kwa JY, 2013, CLIN GENET, V84, P415, DOI 10.1111/cge.12242; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rippey C, 2013, AM J HUM GENET, V93, P697, DOI 10.1016/j.ajhg.2013.09.004; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Vulto-van Silfhout AT, 2013, HUM MUTAT, V34, P1679, DOI 10.1002/humu.22442; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	30	767	794	3	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					344	+		10.1038/nature13394	http://dx.doi.org/10.1038/nature13394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	23964223				2022-12-24	WOS:000338992200035
J	Goncalves, BP; Huang, CY; Morrison, R; Holte, S; Kabyemela, E; Prevots, DR; Fried, M; Duffy, PE				Goncalves, Bronner P.; Huang, Chiung-Yu; Morrison, Robert; Holte, Sarah; Kabyemela, Edward; Prevots, D. Rebecca; Fried, Michal; Duffy, Patrick E.			Parasite Burden and Severity of Malaria in Tanzanian Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SICKLE-CELL GENE; RURAL AREA; AFRICAN CHILDREN; MORBIDITY; MORTALITY; TRANSMISSION; TRIAL; EXPOSURE; VACCINES	BackgroundSevere Plasmodium falciparum malaria is a major cause of death in children. The contribution of the parasite burden to the pathogenesis of severe malaria has been controversial. MethodsWe documented P. falciparum infection and disease in Tanzanian children followed from birth for an average of 2 years and for as long as 4 years. ResultsOf the 882 children in our study, 102 had severe malaria, but only 3 had more than two episodes. More than half of first episodes of severe malaria occurred after a second infection. Although parasite levels were higher on average when children had severe rather than mild disease, most children (67 of 102) had high-density infection (>2500 parasites per 200 white cells) with only mild symptoms before severe malaria, after severe malaria, or both. The incidence of severe malaria decreased considerably after infancy, whereas the incidence of high-density infection was similar among all age groups. Infections before and after episodes of severe malaria were associated with similar parasite densities. Nonuse of bed nets, placental malaria at the time of a woman's second or subsequent delivery, high-transmission season, and absence of the sickle cell trait increased severe-malaria risk and parasite density during infections. ConclusionsResistance to severe malaria was not acquired after one or two mild infections. Although the parasite burden was higher on average during episodes of severe malaria, a high parasite burden was often insufficient to cause severe malaria even in children who later were susceptible. The diverging rates of severe disease and high-density infection after infancy, as well as the similar parasite burdens before and after severe malaria, indicate that naturally acquired resistance to severe malaria is not explained by improved control of parasite density. (Funded by the National Institute of Allergy and Infectious Diseases and others.) The pathogenesis of severe malaria due to Plasmodium falciparum remains controversial. In this study conducted over several years and involving 882 Tanzanian children, parasite burden was insufficient to explain the development of severe illness. Although almost 600,000 African children die each year from malaria,(1) most infections in children are mild.(2),(3) Fundamental questions about the pathogenesis of malaria remain unresolved, such as the relative contributions of parasite burden and host inflammation to severe disease.(4) In areas where transmission is stable, severe malaria is unlikely to occur after 5 years of age, presumably as a result of immunity,(5) and mathematical models suggest that protection against noncerebral severe malaria develops after one or two infections.(6) The mechanism of protective immunity is unclear; it might, for example, involve the reduction of parasite density or the blocking of ...	[Goncalves, Bronner P.; Fried, Michal; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA; [Goncalves, Bronner P.; Prevots, D. Rebecca] NIAID, Lab Clin Infect Dis, Epidemiol Unit, NIH, Rockville, MD 20852 USA; [Huang, Chiung-Yu] NIAID, Biostat Res Branch, NIH, Rockville, MD 20852 USA; [Morrison, Robert; Fried, Michal; Duffy, Patrick E.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Holte, Sarah] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Kabyemela, Edward; Fried, Michal; Duffy, Patrick E.] Muheza Designated Dist Hosp, Offspring Malaria Studies Project, Muheza, Tanzania	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Center for Infectious Disease Research; Fred Hutchinson Cancer Center	Duffy, PE (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Twinbrook 1,Rm 111,5640 Fishers Lane, Rockville, MD 20852 USA.	patrick.duffy@nih.gov		Prevots, D Rebecca/0000-0003-0339-9873	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIAID extramural program [R01AI52059]; Fogarty International Center of the NIH [D43 TW005509]; Foundation for the NIH through the Grand Challenges in Global Health Initiative - Bill and Melinda Gates Foundation [1364]; FOGARTY INTERNATIONAL CENTER [D43TW005509] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052059, ZIAAI001178, ZIAAI001134] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIAID extramural program; Fogarty International Center of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Foundation for the NIH through the Grand Challenges in Global Health Initiative - Bill and Melinda Gates Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), and by grants from the NIAID extramural program (R01AI52059), the Fogarty International Center (D43 TW005509) of the NIH, and the Foundation for the NIH through the Grand Challenges in Global Health Initiative, which is funded by the Bill and Melinda Gates Foundation (1364).	Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; [Anonymous], 2012, WORLD MALARIA REPORT; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Casals-Pascual C, 2006, CURR MOL MED, V6, P155, DOI 10.2174/156652406776055159; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Ellman R, 1998, ANN TROP MED PARASIT, V92, P741, DOI 10.1080/00034989858989; ERUNKULU OA, 1992, CLIN EXP IMMUNOL, V89, P296, DOI 10.1111/j.1365-2249.1992.tb06948.x; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; NELSON W, 1988, J QUAL TECHNOL, V20, P24, DOI 10.1080/00224065.1988.11979080; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC.49.8.3575-3577.2005; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; PROCACCI PG, 1991, T ROY SOC TROP MED H, V85, P181, DOI 10.1016/0035-9203(91)90013-O; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; SALUM FM, 1994, ACTA TROP, V58, P29, DOI 10.1016/0001-706X(94)90119-8; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P212, DOI 10.1016/0035-9203(88)90414-2; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Snow RW, 2004, AM J TROP MED HYG, V71, P16, DOI 10.4269/ajtmh.2004.71.16; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Warimwe GM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003247; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; WEATHERALL DJ, 1982, BRIT MED BULL, V38, P147, DOI 10.1093/oxfordjournals.bmb.a071751; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	40	95	95	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1799	1808		10.1056/NEJMoa1303944	http://dx.doi.org/10.1056/NEJMoa1303944			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH3CD	24806160	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-24	WOS:000335997900008
